Citrus Sinensis ID: 042746

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------41
Protein Sequence
MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRREYLNSVSSSASTEGGRSVNPESVGVKEEIETRVNWGLDNVGGCLSCRDGSPEVELAVEMKETGICRMRMRKSLFLSLPFCRTRIFRYILLVACGIC
Secondary Structure (PSIPRED)
ccccccccccccccccEEEEEEEcccccEEEEEEEEEEEEcccccccEEEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEEccccccccccccccccccccccccccccHHHHcccccccccHHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccEEEEEEEccccccccccHHHHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEccccHHHEEEEEEEccccEEEEEEEEEEEEEEEEccccEEEEEEEcccHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEEccccHHHEEEcccccEEEEEcccccccccccccccEEEcccccHHHccHHHHccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccccHHHHHHHHHHccccHcccccHHHHHccHHHHcccHHHccccccccccccccccHHHccHHHcccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHcccccccccccccHHHHHHHHHHccccEEEEEEcccccccccccHHHHHEEEHHHcccc
Coil and Loop (DISEMBL)
mvswvrgkcigrgsfgtVNVAVDRFngdvfaylgddvsyeapttssscrnlhleylpggtvsdLATTLNAYADEITLRSHTYCIVSALKYLHsrnivhcdvkgknvlvgpnssfvkladfgaageatvsdtrgvkiqprgsplwmapevvrgecqgpesdvwsLGCTIIEmvtgkpawedfgantlsrigfsdelprfptqsselgRDFLDKclrrepgerwscdqllkhpflqsvspsdantvaessprcvldwvnsefeeegtsddeKLEASARERMGklagssgaiwepngwvavrggddevveggtrreylnsvsssasteggrsvnpesvgvkeEIETRVNwgldnvggclscrdgspeVELAVEMKETGICRMRMRKSlflslpfcrtRIFRYILLVACGIC
Flexible Loop (DISEMBL)
mvswvrgkcigrgsfgtvnvAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAageatvsdtrgvkiqprgsplwmapeVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFsdelprfptqsselgrDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSefeeegtsddeklEASARERMGKlagssgaiwepngwvavrGGDDEVVEGGTRREylnsvsssasteggrsvnpesvgvkeeIETRVNWGLDNVGGCLSCRDGSPEVELAVEMKETGICRMRMRKSlflslpfcrtrIFRYILLVACGIC
Low Complexity Region (SEG)
MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGAIWEPNGWVAVRggddevveggTRREYLNSVSSSASTEGGRSVNPESVGVKEEIETRVNWGLDNVGGCLSCRDGSPEVELAVEMKETGICRMRMRKSLFLSLPFCRTRIFRYILLVACGIC
Disordered region (IsUnstruct)
***WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL***********RDFLDKCLRREPGERWSCDQLLKHPFL*****************CVLDWV*******************************AIWEPNGWVAVRGGDD*V**********************************EIETRVNWGLDNVGGCLSCRDGSPEVELAVEMKETGICRMRMRKSLFLSLPFCRTRIFRYILLVACGI*
Disordered Region (DISOPRED)
MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA***********PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ************************************************************WV**********************************************************************************MRMRKSLFLSLPFCRTRIFRYILLVACGIC
Disordered Region (DISEMBL)
MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS***********PRCVLDWVNSE*************ASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRREYLN******************VGVKEEIETRVNWGLDNVGGCLSCRDGSPEVELAVEMKETGICRMRMRKSLFLSLPFCRTRIFRYILLVACGIC
Disordered Region (DISPRO)
MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGAIWEPNGW*****************************************************************GSPEVELAVEMKETGICRMRMRKSLFLSLPFCRTRIFRYILLVACGIC
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRREYLNSVSSSASTEGGRSVNPESVGVKEEIETRVNWGLDNVGGCLSCRDGSPEVELAVEMKETGICRMRMRKSLFLSLPFCRTRIFRYILLVACGIC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	408	2.2.26 [Sep-21-2011]
Q54R82	942	Mitogen-activated protein	no	no	0.561	0.243	0.321	3e-39
Q9FZ36	651	Mitogen-activated protein	no	no	0.549	0.344	0.340	8e-37
O22040	666	Mitogen-activated protein	no	no	0.585	0.358	0.330	3e-35
Q61084	626	Mitogen-activated protein	yes	no	0.568	0.370	0.349	7e-35
O22042	651	Mitogen-activated protein	no	no	0.580	0.364	0.320	1e-34
Q99759	626	Mitogen-activated protein	yes	no	0.563	0.367	0.344	2e-34
P28829	659	Protein kinase byr2 OS=Sc	yes	no	0.561	0.347	0.329	1e-32
Q9Y2U5	619	Mitogen-activated protein	no	no	0.563	0.371	0.318	9e-31
Q0CL79	1342	Cytokinesis protein sepH	N/A	no	0.590	0.179	0.314	2e-30
Q5B4Z3	1346	Cytokinesis protein sepH	no	no	0.590	0.179	0.318	4e-30

>sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2

 Score =  162 bits (411), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 145/271 (53%), Gaps = 42/271 (15%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY----------------------------- 32
           + W +G+ +GRG +G+V + +++  G++FA                              
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMR 227

Query: 33  -LGDD--VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
            L  D  V Y   +   S  ++ LEY+PGG++S L     A+++ + ++ +T  I+  L 
Sbjct: 228 SLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENV-IKVYTKQILQGLS 286

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT--VSDTRGVKIQPRGSPLWMAP 147
           +LH+ +I+H D+KG N+L+      VKL+DFG +   +  VS  + +    +G+P WMAP
Sbjct: 287 FLHANSIIHRDIKGANILID-TKGIVKLSDFGCSKSFSGIVSQFKSM----QGTPYWMAP 341

Query: 148 EVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSEL 205
           EV++    G  SD+WSLGC I+EM T +P W +    A  +  I  S+ +P  P+  S+ 
Sbjct: 342 EVIKQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQE 401

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
             DFL+ C +R+P ER   +QLLKHPF+ ++
Sbjct: 402 AFDFLNLCFKRDPKERPDANQLLKHPFIMNL 432

Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation.
Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5

>sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1

 Score =  154 bits (390), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 144/273 (52%), Gaps = 49/273 (17%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY---------------------LGDDVS-- 38
           + W +G+ IGRG+FGTV + ++  +G++ A                      L ++V   
Sbjct: 66  IRWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLL 125

Query: 39  ----------YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
                     Y          N+ LE++PGG++S L     A+ + + +R++T  ++  L
Sbjct: 126 KNLSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESV-VRTYTNQLLLGL 184

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE----ATVSDTRGVKIQPRGSPLW 144
           +YLH+  I+H D+KG N+LV  N   +KLADFGA+ +    AT+S  + +K    G+P W
Sbjct: 185 EYLHNHAIMHRDIKGANILVD-NQGCIKLADFGASKQVAELATISGAKSMK----GTPYW 239

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIGFSDELPRFPT 200
           MAPEV+        +D+WS+GCT+IEMVTGK  W    ++  A  +  IG +   P  P 
Sbjct: 240 MAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAA--IFHIGTTKSHPPIPD 297

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
             S    DFL KCL++EP  R +  +LLKHPF+
Sbjct: 298 NISSDANDFLLKCLQQEPNLRPTASELLKHPFV 330

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2

 Score =  149 bits (377), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 142/278 (51%), Gaps = 39/278 (14%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY---------------------LGDDVS-- 38
           +SW +G+ IGRG+FGTV + ++  +G++ A                      L ++V   
Sbjct: 67  ISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLL 126

Query: 39  ----------YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
                     Y          N+ LE++PGG++S L      + + + +R++T  ++  L
Sbjct: 127 KNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESV-VRTYTRQLLLGL 185

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE-ATVSDTRGVKIQPRGSPLWMAP 147
           +YLH+  I+H D+KG N+LV  N   +KLADFGA+ + A ++   G K   +G+P WMAP
Sbjct: 186 EYLHNHAIMHRDIKGANILVD-NKGCIKLADFGASKQVAELATMTGAKSM-KGTPYWMAP 243

Query: 148 EVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRFPTQSSEL 205
           EV+        +D+WS+GCT+IEMVTGK  W         +  IG +   P  P   S  
Sbjct: 244 EVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSD 303

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANT 243
            +DFL KCL+  P  R +  +LLKHPF+       A+T
Sbjct: 304 AKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESAST 341

May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1

 Score =  148 bits (374), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 135/269 (50%), Gaps = 37/269 (13%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC----------RNL 51
           ++W RGK +G+G+FG V +  D   G   A        ++P TS             +NL
Sbjct: 360 INWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNL 419

Query: 52  H----------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                                  +EY+PGG+V D      A  + +T R +T  I+  + 
Sbjct: 420 QHERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYGALTESVT-RKYTRQILEGMS 478

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPE 148
           YLHS  IVH D+KG N+L   ++  VKL DFGA+         G  I+   G+P WM+PE
Sbjct: 479 YLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 537

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGR 207
           V+ GE  G ++DVWSLGCT++EM+T KP W ++ A   + +I      P+ P+  SE GR
Sbjct: 538 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGR 597

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           DFL +    E  +R S ++LL H F Q V
Sbjct: 598 DFLRRIF-VEARQRPSAEELLTHHFAQLV 625

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1

 Score =  147 bits (372), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 93/290 (32%), Positives = 148/290 (51%), Gaps = 53/290 (18%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY---------------------LGDDVS-- 38
           + W +G+ IG G+FG V + ++  +G++ A                      L ++V   
Sbjct: 66  IRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLL 125

Query: 39  ----------YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
                     Y      S   N+ +E++PGG++S L     ++ + + +  +T  ++  L
Sbjct: 126 KNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIM-YTKQLLLGL 184

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE----ATVSDTRGVKIQPRGSPLW 144
           +YLH+  I+H D+KG N+LV  N   ++LADFGA+ +    ATV+  + +K    G+P W
Sbjct: 185 EYLHNNGIMHRDIKGANILVD-NKGCIRLADFGASKKVVELATVNGAKSMK----GTPYW 239

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIGFSDELPRFPT 200
           MAPEV+        +D+WS+GCT+IEM TGKP W    + F A  +  IG +   P  P 
Sbjct: 240 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAA--VLHIGRTKAHPPIPE 297

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL----QSVSPSDANTVAE 246
             S   +DFL KCL +EP  R S  +LL+HPF+    Q   P+  N++ E
Sbjct: 298 DLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPAYRNSLTE 347

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2

 Score =  146 bits (369), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 134/267 (50%), Gaps = 37/267 (13%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC----------RNL 51
           ++W RGK +G+G+FG V +  D   G   A        ++P TS             +NL
Sbjct: 360 INWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNL 419

Query: 52  H----------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                                  +EY+PGG+V D      A  + +T R +T  I+  + 
Sbjct: 420 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT-RKYTRQILEGMS 478

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPE 148
           YLHS  IVH D+KG N+L   ++  VKL DFGA+         G  ++   G+P WM+PE
Sbjct: 479 YLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPE 537

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGR 207
           V+ GE  G ++DVWSLGCT++EM+T KP W ++ A   + +I      P+ P+  SE GR
Sbjct: 538 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHGR 597

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
           DFL +    E  +R S ++LL H F Q
Sbjct: 598 DFLRRIF-VEARQRPSAEELLTHHFAQ 623

Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1

 Score =  140 bits (354), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/270 (32%), Positives = 138/270 (51%), Gaps = 41/270 (15%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY---LGDDVS-------------------- 38
           + W+RG  IG GSFG V + ++  +G++ A    + D VS                    
Sbjct: 392 IKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALL 451

Query: 39  ----------YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
                     Y     +S   N+ LEY+PGG+V+ L T   ++ +E  +++     +  L
Sbjct: 452 QELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSF-EETLVKNFIKQTLKGL 510

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE----ATVSDTRGVKIQPRGSPLW 144
           +YLHSR IVH D+KG N+LV  N   +K++DFG + +    +T + T G +   +GS  W
Sbjct: 511 EYLHSRGIVHRDIKGANILVD-NKGKIKISDFGISKKLELNSTSTKTGGARPSFQGSSFW 569

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSS 203
           MAPEVV+      ++D+WSLGC +IEM+T K  + +      + RIG  + LP FP+  S
Sbjct: 570 MAPEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPYPNCDQMQAIFRIG-ENILPEFPSNIS 628

Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               DFL+K    +   R +  +LL HPF+
Sbjct: 629 SSAIDFLEKTFAIDCNLRPTASELLSHPFV 658

Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase.

Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2

 Score =  134 bits (338), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 127/267 (47%), Gaps = 37/267 (13%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLH--------- 52
            +W  GK +G+G+FG V +  D   G   A        ++P TS     L          
Sbjct: 354 TNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALECEIQLLKNL 413

Query: 53  -----------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                                  +EY+PGG++ D      A  + +T R +T  I+  + 
Sbjct: 414 LHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVT-RKYTRQILEGVH 472

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPE 148
           YLHS  IVH D+KG N+L   ++  VKL DFGA+         G  ++   G+P WM+PE
Sbjct: 473 YLHSNMIVHRDIKGANILRD-STGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 531

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGR 207
           V+ GE  G ++D+WS+ CT++EM+T KP W +F A   + +I      P+ P   S+  R
Sbjct: 532 VISGEGYGRKADIWSVACTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPKLPPHVSDYTR 591

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
           DFL +    E   R S D+LL+H F+ 
Sbjct: 592 DFLKRIF-VEAKLRPSADELLRHMFVH 617

Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

>sp|Q0CL79|SEPH_ASPTN Cytokinesis protein sepH OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=sepH PE=3 SV=2

 Score =  133 bits (335), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 141/280 (50%), Gaps = 39/280 (13%)

Query: 7   GKCIGRGSFGTVNVAVD----------------------RFNGDVFAYLG--DDVSYEAP 42
           G C+G+G+FG+V  A++                      R   D+   L   + V Y+  
Sbjct: 64  GDCLGKGAFGSVYRALNWNTGETVAVKQIKLADLPKSELRLEIDLLKNLDHPNIVKYQGF 123

Query: 43  TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
             S+   N+ LEY   G++  +A     + + + +  +   ++  L YLH + ++H D+K
Sbjct: 124 VKSAETLNIILEYCENGSLHSIAKNFGRFPENL-VGLYMSQVLHGLLYLHEQGVIHRDIK 182

Query: 103 GKNVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           G N+L       VKLADFG A   T +S++  V     G+P WMAPEV+        SD+
Sbjct: 183 GANILTT-KEGLVKLADFGVASRTTGLSESSVV-----GTPYWMAPEVIELSGATTASDI 236

Query: 162 WSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
           WSLGCT+IE++ GKP + +      L RI  +D+ P  P  +S   +DFL +C +++P  
Sbjct: 237 WSLGCTVIELLEGKPPYYNMQPMPALFRI-VNDDHPPLPQGASPAVKDFLMQCFQKDPNL 295

Query: 221 RWSCDQLLKHPFLQSVSPSD-----ANTVAESSPRCVLDW 255
           R S  +LLKHP++ +   SD     ++T  E + R V +W
Sbjct: 296 RVSARKLLKHPWIVNARRSDSVVPKSSTEYEEAVRSVQEW 335

Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring.

Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5B4Z3|SEPH_EMENI Cytokinesis protein sepH OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) GN=sepH PE=3 SV=2

 Score =  132 bits (332), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 140/283 (49%), Gaps = 42/283 (14%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----LGD-----------------------DVSY 39
           G C+GRG+FG+V  A++   G+  A     L D                        V Y
Sbjct: 63  GDCLGRGAFGSVYRALNWNTGETVAVKQIKLADLPKSELRVIMLEIDLLKNLDHPNIVKY 122

Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
           +    S+   N+ LEY   G++  +A     +  E  +  +   ++  L YLH + ++H 
Sbjct: 123 QGFVKSAETLNIILEYCENGSLHSIAKNFGRFP-ETLVGVYMSQVLHGLLYLHDQGVIHR 181

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           D+KG N+L       VKLADFG A   T +S++  V     G+P WMAPEV+        
Sbjct: 182 DIKGANILTT-KEGLVKLADFGVASRTTGLSESSVV-----GTPYWMAPEVIELSGATTA 235

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE 217
           SD+WSLGCT+IE++ GKP + +      L RI  +D+ P  P  +S   +DFL +C +++
Sbjct: 236 SDIWSLGCTVIELLEGKPPYYNLQPMPALFRI-VNDDHPPLPQGASPAVKDFLMQCFQKD 294

Query: 218 PGERWSCDQLLKHPFLQSVSPSDA-----NTVAESSPRCVLDW 255
           P  R S  +LLKHP++ +   SD+     +T  E + + V +W
Sbjct: 295 PNLRVSARKLLKHPWIVNARRSDSVVPKKSTEYEEAVKSVQEW 337

Required for early events during cytokinesis including localization of cytoskeletal components to the cytokinetic ring.

Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (taxid: 227321)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
224105939	328	predicted protein [Populus trichocarpa]	0.705	0.878	0.584	1e-100
224055333	329	predicted protein [Populus trichocarpa]	0.705	0.875	0.565	5e-95
359478535	521	PREDICTED: serine/threonine-protein kina	0.941	0.737	0.471	1e-90
147778640	441	hypothetical protein VITISV_012221 [Viti	0.845	0.782	0.497	2e-89
449528371	357	PREDICTED: mitogen-activated protein kin	0.735	0.840	0.525	5e-88
449471765	491	PREDICTED: mitogen-activated protein kin	0.735	0.610	0.522	2e-86
449455144	491	PREDICTED: mitogen-activated protein kin	0.735	0.610	0.519	4e-86
297849004	705	hypothetical protein ARALYDRAFT_334013 [	0.735	0.425	0.518	8e-86
15222311	499	mitogen-activated protein kinase kinase	0.769	0.629	0.501	5e-85
356498956	464	PREDICTED: mitogen-activated protein kin	0.703	0.618	0.504	5e-85

>gi|224105939|ref|XP_002313986.1| predicted protein [Populus trichocarpa] gi|222850394|gb|EEE87941.1| predicted protein [Populus trichocarpa]

 Score =  372 bits (956), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 197/337 (58%), Positives = 235/337 (69%), Gaps = 49/337 (14%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFA------------------------------Y 32
           SWVRGKC+G+GSFG+VN+A ++  G VFA                              +
Sbjct: 1   SWVRGKCVGKGSFGSVNLAFNKQTGAVFAVKTASEANQVQALDNEIKILSSLSSPFIVKF 60

Query: 33  LGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYAD--EITLRSHTYCIVSALKY 90
           LGDDVS+E    S +CRNLH+EYLPGGTV+DLA++   +AD  E T+RS TYCIVSALKY
Sbjct: 61  LGDDVSFE---NSRACRNLHMEYLPGGTVADLASSTQRFADVNEETVRSFTYCIVSALKY 117

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
           +HSR IVHCDVKG+N+L+G +   VKLADFG+A +AT     G  + PRGSPLWMAPEV+
Sbjct: 118 IHSRGIVHCDVKGRNILLGHSFDSVKLADFGSAIDAT----SGEPLLPRGSPLWMAPEVI 173

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL 210
           + E QGPESDVWSLGCTIIEMVTGKPAWED G ++LSRIGFS+ELP  P Q S LGRDFL
Sbjct: 174 KREYQGPESDVWSLGCTIIEMVTGKPAWEDHGVDSLSRIGFSNELPELPGQLSVLGRDFL 233

Query: 211 DKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEE------- 263
            KCL REP +RWSCDQLL+HPFL SVSP+      E SPRCVLDW NS+FEE+       
Sbjct: 234 KKCLEREPSKRWSCDQLLEHPFLASVSPNLLGN--ELSPRCVLDWFNSDFEEDIDVMERG 291

Query: 264 GTSDDEKLEASARERMGKLAGSSGAIWE-PNGWVAVR 299
            +S  E +E +AR R+GKL  S G  WE  +GWV VR
Sbjct: 292 MSSSFENIEVAARNRIGKLVASGGVNWETKDGWVEVR 328

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224055333|ref|XP_002298485.1| predicted protein [Populus trichocarpa] gi|222845743|gb|EEE83290.1| predicted protein [Populus trichocarpa]

 Score =  354 bits (908), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 191/338 (56%), Positives = 230/338 (68%), Gaps = 50/338 (14%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFA------------------------------Y 32
           SWVRGKCIGRGS+GTVN+A ++    VFA                              +
Sbjct: 1   SWVRGKCIGRGSYGTVNLAFNKQTDAVFAVKSASEANHVQALDNEIKILSSLSSPFIVKF 60

Query: 33  LGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYAD--EITLRSHTYCIVSALKY 90
           LGDDVS+E  TT   CRNLH+EYLPGGT++DLA++ +  AD  E  +RS TYCIVSALKY
Sbjct: 61  LGDDVSFENSTT---CRNLHMEYLPGGTLADLASSTHRLADVDEQAVRSFTYCIVSALKY 117

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
           +HSR IVHCDVKG+N+L+G NS  VKLADFG+A +A      G  + PRGSPLWMAPEV+
Sbjct: 118 IHSRGIVHCDVKGRNILLGNNSDSVKLADFGSAIDAAC----GEPLLPRGSPLWMAPEVI 173

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL 210
           R E QGP+SDVWSLGCTIIEMVTGKPAWED GA++LS IGFS+E+P  P++   LG+DFL
Sbjct: 174 RREYQGPKSDVWSLGCTIIEMVTGKPAWEDRGADSLSLIGFSNEVPELPSKLCVLGQDFL 233

Query: 211 DKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDW-VNSEFEEEG----- 264
            KCL+REP +RWSCDQLL+HPFL SV+        E SPRCVLDW  NS+FEE+      
Sbjct: 234 MKCLKREPNQRWSCDQLLQHPFLASVNSDLLGD--ELSPRCVLDWYFNSDFEEDNDVMEQ 291

Query: 265 --TSDDEKLEASARERMGKLAGSSGAIWEPN-GWVAVR 299
              S  + +E SA+ R+GKL  S G  WE N GW  VR
Sbjct: 292 GSASSFDNIEVSAKNRIGKLVTSGGVNWETNDGWAEVR 329

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359478535|ref|XP_002278763.2| PREDICTED: serine/threonine-protein kinase DDB_G0283821-like [Vitis vinifera]

 Score =  339 bits (869), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 220/467 (47%), Positives = 270/467 (57%), Gaps = 83/467 (17%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA----------------------------- 31
           + SW+R K IG GSFGTV++AV R +G VFA                             
Sbjct: 7   VCSWIRAKRIGEGSFGTVDLAVTRSDGGVFAVKSVDRRVGQECRVEALENEIGVLRRLSS 66

Query: 32  -----YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLN---AYADEITLRSHTYC 83
                YLGDDVS E  T  +  RNLH+EY+PGGTV+DLA       A  DE  +RS+TYC
Sbjct: 67  PYVVRYLGDDVSVEGGT--APFRNLHVEYMPGGTVADLAVLSGGKCADVDERIVRSYTYC 124

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-GVKIQPRGSP 142
           IVS+L+Y+HS  +VHCDVKG+NVLVG  +   KLADFGAA   T    R    I PRGSP
Sbjct: 125 IVSSLRYVHSMGLVHCDVKGRNVLVGGGAGVAKLADFGAARRITGEVGRQSSAILPRGSP 184

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           LWMAPEV+R E QGPESDVWSLGCT+IEMV+GKPAWED GA+TL RIGFSDELP+FP Q 
Sbjct: 185 LWMAPEVIRREYQGPESDVWSLGCTVIEMVSGKPAWEDCGADTLFRIGFSDELPKFPAQL 244

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           S+LGRDFL+KCLRREP ERWSCDQLL+HPF+ S SP   N + ++SPR VLD  N  F +
Sbjct: 245 SDLGRDFLEKCLRREPTERWSCDQLLQHPFVSSSSP---NYITDASPRSVLDCFN--FSD 299

Query: 263 EGTSDDEKLE----------ASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRR 312
           +   DDE+ E           SA +R+ KLA + G +WE   W+ VR    +      R 
Sbjct: 300 D---DDEETELNPNPAPKNSVSAHDRIRKLASNRGPVWESEDWMDVRTWISD------RA 350

Query: 313 EYLNSVSSSASTEGGRSVNPESVGVKEEIE--------TRVNWGLDNVGGCLSCRDGS-- 362
           E   +       EG  S    S G  EE E        TR    LD VG  L C  GS  
Sbjct: 351 EATAASCCGDEGEGTNSAYSNSTGKTEESEKTFAECPSTRGTPLLDTVGK-LGCDPGSSC 409

Query: 363 ---PEVELAVEMKETGI---CRMRMRKSLFLSLPFCRTRIFRYILLV 403
                   + E KETG+   C++ +  S +L +    ++IF YI ++
Sbjct: 410 GYESGTNGSGESKETGVYSHCKLILLLS-YLRIMRRNSQIF-YIYII 454

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147778640|emb|CAN71722.1| hypothetical protein VITISV_012221 [Vitis vinifera]

 Score =  335 bits (859), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 208/418 (49%), Positives = 247/418 (59%), Gaps = 73/418 (17%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA----------------------------- 31
           + SW+R K IG GSFGTV++AV R +G VFA                             
Sbjct: 7   VCSWIRAKRIGEGSFGTVDLAVTRSDGGVFAVKSVDRRVGQECRVEALENEIGVLRRLSS 66

Query: 32  -----YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLN---AYADEITLRSHTYC 83
                YLGDDVS E  T  +  RNLH+EY+PGGTV+DLA       A  DE  +RS+TYC
Sbjct: 67  PYVVRYLGDDVSVEGGT--APFRNLHVEYMPGGTVADLAVLSGGKCADVDERIVRSYTYC 124

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-GVKIQPRGSP 142
           IVS+L+Y+HS  +VHCDVKG+NVLVG  +   KLADFGAA   T    R    I PRGSP
Sbjct: 125 IVSSLRYVHSMGLVHCDVKGRNVLVGGGAGVAKLADFGAARRITGEVGRQSSAILPRGSP 184

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           LWMAPEV+R E QGPESDVWSLGCT+IEMV+GKPAWED GA+TL RIGFSDELP+FP Q 
Sbjct: 185 LWMAPEVIRREYQGPESDVWSLGCTVIEMVSGKPAWEDCGADTLFRIGFSDELPKFPAQL 244

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           S+LGRDFL+KCLRREP ERWSCDQLL+HPF+ S SP   N + ++SPR VLD  N  F +
Sbjct: 245 SDLGRDFLEKCLRREPTERWSCDQLLQHPFVSSSSP---NYITDASPRSVLDCFN--FSD 299

Query: 263 EGTSDDEKLE----------ASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRR 312
           +   DDE+ E           SA +R+ KLA + G +WE   W+ VR    +      R 
Sbjct: 300 D---DDEETELNPNPAPKNSVSAHDRIRKLASNRGPVWESEDWMDVRTWISD------RA 350

Query: 313 EYLNSVSSSASTEGGRSVNPESVGVKEEIE--------TRVNWGLDNVGGCLSCRDGS 362
           E   +       EG  S    S G  EE E        TR    LD VG  L C  GS
Sbjct: 351 EATAASCCGDEGEGTNSAYSNSTGKTEESEKTFAECPSTRGTPLLDTVGK-LGCDPGS 407

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449528371|ref|XP_004171178.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like, partial [Cucumis sativus]

 Score =  330 bits (847), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 185/352 (52%), Positives = 224/352 (63%), Gaps = 52/352 (14%)

Query: 2   VSWVRGKC-IGRGSFGTVNVAVDRFNGDVFA----------------------------- 31
           +SW R    IG+GSF TV++ + + +  +FA                             
Sbjct: 7   LSWTRSNSPIGKGSFATVSLGIRKPDARIFAVKSVHQTQTLRPQIDCLENEIRILRSLNS 66

Query: 32  -----YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVS 86
                +LGDDVS+E+PTTS   RNLH+EYLPGGT +D  T      D+  LR  T+C+VS
Sbjct: 67  PYVVAFLGDDVSHESPTTS--FRNLHMEYLPGGTAADDPT---GTRDDKLLRERTWCLVS 121

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV-KIQPRGSPLWM 145
           AL Y+HS+ IVHCDVKG+NVL+G N  F+KLADFG+A E      R    + PRGSPLWM
Sbjct: 122 ALSYIHSKGIVHCDVKGRNVLIGLNPGFLKLADFGSAIELHGPGHRSRDSLAPRGSPLWM 181

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           APEVVRGE QGPESDVWSLGCT+IEMVTGKPAWEDFGA+TLSRIGFSD+LP FPT  SE+
Sbjct: 182 APEVVRGEFQGPESDVWSLGCTVIEMVTGKPAWEDFGADTLSRIGFSDDLPDFPTCLSEV 241

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEF---EE 262
            RDFL KCLRR P ERWSCD+LL+HPFL + + +      E+SPRCVLDWVN  F   EE
Sbjct: 242 CRDFLRKCLRRNPSERWSCDRLLQHPFLAAAAAASPKIAVENSPRCVLDWVNVSFSDDEE 301

Query: 263 EGTSDDE-------KLEASARERMGKLAGSSG-AIWEPNGWVAVRGGDDEVV 306
           E    DE       + E   +ER+GKL+ +S    WE +GW AVR    E  
Sbjct: 302 EIPHADEASGSGGQENEIYGKERIGKLSTTSEWPNWESDGWSAVRSSYSEAA 353

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449471765|ref|XP_004153402.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Cucumis sativus]

 Score =  325 bits (834), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 185/354 (52%), Positives = 224/354 (63%), Gaps = 54/354 (15%)

Query: 2   VSWVRGKC-IGRGSFGTVNVAVDRFNGDVFA----------------------------- 31
           +SW R    IG+GSF TV++ + + +  +FA                             
Sbjct: 7   LSWTRSNSPIGKGSFATVSLGIRKPDARIFAVKSVQQTQTLRPQIDCLENEIRILRSLNS 66

Query: 32  -----YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVS 86
                +LGDDVS+E+PTTS   RNLH+EYLPGGT +D  T      D+  LR  T+C+VS
Sbjct: 67  PYVVAFLGDDVSHESPTTS--FRNLHMEYLPGGTAADDPT---GTRDDKLLRERTWCLVS 121

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV-KIQPRGSPLWM 145
           AL Y+HS+ IVHCDVKG+NVL+G N  F+KLADFG+A E      R    + PRGSPLWM
Sbjct: 122 ALSYIHSKGIVHCDVKGRNVLIGLNPGFLKLADFGSAIELHGPGHRSRDSLAPRGSPLWM 181

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           APEVVRGE QGPESDVWSLGCT+IEMVTGKPAWEDFGA+TLSRIGFSD+LP FPT  SE+
Sbjct: 182 APEVVRGEFQGPESDVWSLGCTVIEMVTGKPAWEDFGADTLSRIGFSDDLPDFPTCLSEV 241

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFL--QSVSPSDANTVAESSPRCVLDWVNSEF--- 260
            RDFL KCLRR P ERWSCD+LL+HPFL   + + +      E+SPRCVLDWVN  F   
Sbjct: 242 CRDFLRKCLRRNPSERWSCDRLLQHPFLAAAAAAAASPKIAVENSPRCVLDWVNVSFSDD 301

Query: 261 EEEGTSDDE-------KLEASARERMGKLAGSSG-AIWEPNGWVAVRGGDDEVV 306
           EEE    DE       + E   +ER+GKL+ +S    WE +GW AVR    E  
Sbjct: 302 EEEIPHADEASGSGGQENEIYGKERIGKLSTTSEWPNWESDGWSAVRSSYSEAA 355

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449455144|ref|XP_004145313.1| PREDICTED: mitogen-activated protein kinase kinase kinase A-like [Cucumis sativus]

 Score =  324 bits (831), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 184/354 (51%), Positives = 224/354 (63%), Gaps = 54/354 (15%)

Query: 2   VSWVRGKC-IGRGSFGTVNVAVDRFNGDVFA----------------------------- 31
           +SW R    IG+GSF TV++ + + +  +FA                             
Sbjct: 7   LSWTRSNSPIGKGSFATVSLGIRKPDARIFAVKSVQQTQTLRPQIDCLENEIRILRSLNS 66

Query: 32  -----YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVS 86
                +LGDDVS+E+PTTS   RNLH+EYLPGGT +D  T      D+  LR  T+C+VS
Sbjct: 67  PYVVAFLGDDVSHESPTTS--FRNLHMEYLPGGTAADDPT---GTRDDKLLRERTWCLVS 121

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV-KIQPRGSPLWM 145
           AL Y+HS+ IVHCDVKG+NVL+G N  F+KLADFG+A E      R    + PRGSPLWM
Sbjct: 122 ALSYIHSKGIVHCDVKGRNVLIGLNPGFLKLADFGSAIELHGPGHRSRDSLAPRGSPLWM 181

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           APEVVRGE QGPESDVWSLGCT+IEMVTGKPAWEDFGA+TLSRIGFSD+LP FPT  SE+
Sbjct: 182 APEVVRGEFQGPESDVWSLGCTVIEMVTGKPAWEDFGADTLSRIGFSDDLPDFPTCLSEV 241

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFL--QSVSPSDANTVAESSPRCVLDWVNSEF--- 260
            RDFL KCLRR P ERWSCD+L++HPFL   + + +      E+SPRCVLDWVN  F   
Sbjct: 242 CRDFLRKCLRRNPSERWSCDRLVQHPFLAAAAAAAASPKIAVENSPRCVLDWVNVSFSDD 301

Query: 261 EEEGTSDDE-------KLEASARERMGKLAGSSG-AIWEPNGWVAVRGGDDEVV 306
           EEE    DE       + E   +ER+GKL+ +S    WE +GW AVR    E  
Sbjct: 302 EEEIPHADEASGSGGQENEIYGKERIGKLSTTSEWPNWESDGWSAVRSSYSEAA 355

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849004|ref|XP_002892383.1| hypothetical protein ARALYDRAFT_334013 [Arabidopsis lyrata subsp. lyrata] gi|297338225|gb|EFH68642.1| hypothetical protein ARALYDRAFT_334013 [Arabidopsis lyrata subsp. lyrata]

 Score =  323 bits (829), Expect = 8e-86,   Method: Compositional matrix adjust.
 Identities = 183/353 (51%), Positives = 221/353 (62%), Gaps = 53/353 (15%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------- 31
           WVRG CIGRG FG V+ A+ + NG+VFA                                
Sbjct: 22  WVRGACIGRGCFGAVSTAISKTNGEVFAVKSVDLTTCLPTQSESLENEISVLCSLKPHPY 81

Query: 32  ---YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
              +LGD VS E  TT    RN++LEYLP G V++   T     DE  L+ +T C+VSAL
Sbjct: 82  IVKFLGDGVSKEGTTTF---RNIYLEYLPEGDVANY--TAGGINDETLLQRYTACLVSAL 136

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
            ++HS   VHCDVK +NVLV   SS +KLADFG+A       T   +I PRGSPLWMAPE
Sbjct: 137 HHVHSHGFVHCDVKARNVLVS-QSSMIKLADFGSAFRI---HTPTAQITPRGSPLWMAPE 192

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGR 207
           V+R E QGPESDVWSLGCTIIE+ TGKPAWED G  ++LSRIGFSDELP FP++ SE+GR
Sbjct: 193 VIRREYQGPESDVWSLGCTIIEIFTGKPAWEDHGIIDSLSRIGFSDELPVFPSKLSEIGR 252

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSD 267
           DFL+KCL+R+P +RWSCDQLL+HPFL     S     AESSPRCVLDWVNS F+ E   +
Sbjct: 253 DFLEKCLKRDPNQRWSCDQLLQHPFLSQCHNSSP---AESSPRCVLDWVNSGFDLEEEEE 309

Query: 268 D---EKLEASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRREYLNS 317
           +    + E +A  R+  LA + GAIWE + WV VR    E  E GTR EY  S
Sbjct: 310 EVGRSEFEDAAMARICNLATTGGAIWESDCWVEVRCHSSE--EEGTRMEYSES 360

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15222311|ref|NP_172195.1| mitogen-activated protein kinase kinase kinase 13 [Arabidopsis thaliana] gi|8954031|gb|AAF82205.1|AC067971_13 Strong similarity to a protein kinase homolog F23F1.4 gi|7488253 from Arabidopsis thaliana BAC F23F1 gb|AC004680. It contains a eukaryotic protein kinase domain PF|00069. ESTs gb|F13903 and gb|F13904 come from this gene [Arabidopsis thaliana] gi|332189961|gb|AEE28082.1| mitogen-activated protein kinase kinase kinase 13 [Arabidopsis thaliana]

 Score =  321 bits (822), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 184/367 (50%), Positives = 224/367 (61%), Gaps = 53/367 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------- 31
           WVRG CIGRG FG V+ A+ + NG+VFA                                
Sbjct: 23  WVRGACIGRGCFGAVSTAISKTNGEVFAVKSVDLATSLPTQSESLENEISVFRSLKPHPY 82

Query: 32  ---YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
              +LGD VS E  TT    RNL+LEYLP G V+          DE  L+ +T C+VSAL
Sbjct: 83  IVKFLGDGVSKEGTTT---FRNLYLEYLPNGDVASHRAG-GKIEDETLLQRYTACLVSAL 138

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
           +++HS+  VHCDVK +N+LV   SS VKLADFG+A       T    I PRGSPLWMAPE
Sbjct: 139 RHVHSQGFVHCDVKARNILVS-QSSMVKLADFGSAFRI---HTPRALITPRGSPLWMAPE 194

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD 208
           V+R E QGPESDVWSLGCTIIEM TGKPAWED G ++LSRI FSDELP FP++ SE+GRD
Sbjct: 195 VIRREYQGPESDVWSLGCTIIEMFTGKPAWEDHGIDSLSRISFSDELPVFPSKLSEIGRD 254

Query: 209 FLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDD 268
           FL+KCL+R+P +RWSCDQLL+HPFL     S      ESSPRCVLDWVNS F+ E   ++
Sbjct: 255 FLEKCLKRDPNQRWSCDQLLQHPFLSQCHNSSPT---ESSPRCVLDWVNSGFDLEEEEEE 311

Query: 269 ---EKLEASARERMGKLAGSSGAIWEPNGWVAVRGGDDEVVEGGTRREYLNSVSSSASTE 325
               + E +A+  +  LA + G IWE +GWV VR    E  E GT  EY  S S+   +E
Sbjct: 312 VGRSEFEDAAKAIICNLATTGGVIWESDGWVEVRCHASE--EEGTTMEY--SGSTRVESE 367

Query: 326 GGRSVNP 332
              S +P
Sbjct: 368 YNTSSDP 374

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498956|ref|XP_003518311.1| PREDICTED: mitogen-activated protein kinase kinase kinase 2-like [Glycine max]

 Score =  321 bits (822), Expect = 5e-85,   Method: Compositional matrix adjust.
 Identities = 175/347 (50%), Positives = 213/347 (61%), Gaps = 60/347 (17%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA----------------------------- 31
           MVSWVRGKC+G G+FG VNVA+ + +  VFA                             
Sbjct: 1   MVSWVRGKCVGNGAFGVVNVAISKRDNRVFAVKSVDCGRGLSGHQVEALENEIGILKRVA 60

Query: 32  ------YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV 85
                 YLGDDV+ E    ++S RNLHLEY+PGGTV+DL     A  DE  +R   +C+V
Sbjct: 61  SPHVVAYLGDDVTCEG---TASFRNLHLEYMPGGTVADLD---RADVDERLVRRFAWCLV 114

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM 145
           SAL+ +H++  VHCDVKG+NVL+  +   VKLADFG A E   S    + +  RGSP+WM
Sbjct: 115 SALRDVHAQGFVHCDVKGRNVLLSGDGEIVKLADFGTAVEIESSPAE-MLLLSRGSPMWM 173

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           APEVVR + QGPESDVWSLGCT+IE+VTGKPAWED G +TL+RIG+SDELP FP Q SEL
Sbjct: 174 APEVVRRQRQGPESDVWSLGCTVIEIVTGKPAWEDRGVDTLTRIGYSDELPEFPKQLSEL 233

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGT 265
           G+DFL+KCLRRE  ERWSCDQLL+HPFL          VAESSPRCVLDWV+SE   E  
Sbjct: 234 GKDFLEKCLRREHSERWSCDQLLQHPFLLPYY-----AVAESSPRCVLDWVDSELNSESD 288

Query: 266 SDDEKLEASA-------------RERMGKLAGSSGAIWEPNGWVAVR 299
            +D   +                + R+ K A  S   WE  GW+ VR
Sbjct: 289 CNDRDHQEDVFIKFTNSEEKSVIKNRISKFATESRVNWETQGWIVVR 335

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
TAIR|locus:2045658	463	MAPKKK14 "mitogen-activated pr	0.634	0.559	0.583	9.1e-88
TAIR|locus:2007337	499	MAPKKK13 "mitogen-activated pr	0.708	0.579	0.537	1.5e-87
TAIR|locus:2161690	448	MAPKKK15 "mitogen-activated pr	0.531	0.484	0.406	7.6e-53
TAIR|locus:2205523	339	MAPKKK18 "mitogen-activated pr	0.651	0.784	0.395	7.7e-52
TAIR|locus:2060246	372	MAPKKK17 "mitogen-activated pr	0.585	0.642	0.402	6e-48
TAIR|locus:2116417	444	MAPKKK16 "mitogen-activated pr	0.627	0.576	0.373	7.6e-46
TAIR|locus:2155568	344	MAPKKK19 "mitogen-activated pr	0.681	0.808	0.348	2.8e-42
TAIR|locus:2074835	342	MAPKKK20 "mitogen-activated pr	0.647	0.771	0.337	9.5e-42
TAIR|locus:2114990	336	MAPKKK21 "mitogen-activated pr	0.598	0.726	0.377	1.1e-40
TAIR|locus:2024832	609	MAP3KA "mitogen-activated prot	0.509	0.341	0.381	5.6e-40

TAIR|locus:2045658 MAPKKK14 "mitogen-activated protein kinase kinase kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 783 (280.7 bits), Expect = 9.1e-88, Sum P(2) = 9.1e-88
 Identities = 160/274 (58%), Positives = 194/274 (70%)

Query:    28 DVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSA 87
             ++  +LGDDVS E    ++S RNLHLEY P G V++         +E  LR + +C+VSA
Sbjct:    76 NIVRFLGDDVSKEG---TASFRNLHLEYSPEGDVAN-----GGIVNETLLRRYVWCLVSA 127

Query:    88 LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAP 147
             L ++HS  IVHCDVK KNVLV    S VKLADFG+A E   S    + + PRGSPLWMAP
Sbjct:   128 LSHVHSNGIVHCDVKSKNVLVFNGGSSVKLADFGSAVEFEKST---IHVSPRGSPLWMAP 184

Query:   148 EVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
             EVVR E QGPESDVWSLGCT+IEM+TGKPAWED G ++LSRIGFS++LP  P   SELGR
Sbjct:   185 EVVRREYQGPESDVWSLGCTVIEMLTGKPAWEDHGFDSLSRIGFSNDLPFIPVGLSELGR 244

Query:   208 DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSD 267
             DFL+KCL+R+  +RWSCDQLL+HPFL        +   ESSPRCVLDWVNSEF+EE  SD
Sbjct:   245 DFLEKCLKRDRSQRWSCDQLLQHPFL--CQDHHDSFFTESSPRCVLDWVNSEFDEEEESD 302

Query:   268 DEKLEA--SARERMGKLAGSSGAIWEPNGWVAVR 299
             + + E+  SA  R+ KLA + GA WE NGW  VR
Sbjct:   303 EWRPESMVSAMARISKLAITGGANWESNGWTEVR 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IMP

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

TAIR|locus:2007337 MAPKKK13 "mitogen-activated protein kinase kinase kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 765 (274.4 bits), Expect = 1.5e-87, Sum P(2) = 1.5e-87
 Identities = 165/307 (53%), Positives = 201/307 (65%)

Query:    29 VFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
             +  +LGD VS E  TT    RNL+LEYLP G V+          DE  L+ +T C+VSAL
Sbjct:    83 IVKFLGDGVSKEGTTTF---RNLYLEYLPNGDVASHRAG-GKIEDETLLQRYTACLVSAL 138

Query:    89 KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
             +++HS+  VHCDVK +N+LV   SS VKLADFG+A    +   R + I PRGSPLWMAPE
Sbjct:   139 RHVHSQGFVHCDVKARNILVS-QSSMVKLADFGSAFR--IHTPRAL-ITPRGSPLWMAPE 194

Query:   149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD 208
             V+R E QGPESDVWSLGCTIIEM TGKPAWED G ++LSRI FSDELP FP++ SE+GRD
Sbjct:   195 VIRREYQGPESDVWSLGCTIIEMFTGKPAWEDHGIDSLSRISFSDELPVFPSKLSEIGRD 254

Query:   209 FLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEF---EEEGT 265
             FL+KCL+R+P +RWSCDQLL+HPFL     S      ESSPRCVLDWVNS F   EEE  
Sbjct:   255 FLEKCLKRDPNQRWSCDQLLQHPFLSQCHNSSPT---ESSPRCVLDWVNSGFDLEEEEEE 311

Query:   266 SDDEKLEASARERMGKLAGSSGAIWEPNGWVAVRXXXXXXXXXXTRREYLNSVSSSASTE 325
                 + E +A+  +  LA + G IWE +GWV VR          T  EY  S S+   +E
Sbjct:   312 VGRSEFEDAAKAIICNLATTGGVIWESDGWVEVRCHASEEEG--TTMEY--SGSTRVESE 367

Query:   326 GGRSVNP 332
                S +P
Sbjct:   368 YNTSSDP 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161690 MAPKKK15 "mitogen-activated protein kinase kinase kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 433 (157.5 bits), Expect = 7.6e-53, Sum P(3) = 7.6e-53
 Identities = 94/231 (40%), Positives = 134/231 (58%)

Query:    29 VFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
             +  Y+G +V+ E         NL +EY+ GG++ DL         E  +RS+T  I+  L
Sbjct:    59 IVKYIGSNVTKE---NDKLMYNLLMEYVSGGSLHDLIKNSGGKLPEPLIRSYTRQILKGL 115

Query:    89 KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
              YLH + IVHCDVK +NV++G      K+ D G A   TV +   ++    G+P +M+PE
Sbjct:   116 MYLHDQGIVHCDVKSQNVMIG--GEIAKIVDLGCA--KTVEENENLEFS--GTPAFMSPE 169

Query:   149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSELG 206
             V RGE Q   +DVW+LGCT+IEM TG   W +       + +IGF+ E P  P   SE G
Sbjct:   170 VARGEEQSFPADVWALGCTVIEMATGSSPWPELNDVVAAIYKIGFTGESPVIPVWLSEKG 229

Query:   207 RDFLDKCLRREPGERWSCDQLLKHPFL-QSVSPSD--ANTVAESSPRCVLD 254
             +DFL KCLR++P +RW+ ++LL+HPFL +  + SD   N +  SSP  VLD
Sbjct:   230 QDFLRKCLRKDPKQRWTVEELLQHPFLDEEDNDSDQTGNCLNSSSPSTVLD 280

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2205523 MAPKKK18 "mitogen-activated protein kinase kinase kinase 18" [Arabidopsis thaliana (taxid:3702)]

 Score = 485 (175.8 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 113/286 (39%), Positives = 157/286 (54%)

Query:    29 VFAYLGDDVSYEA--PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVS 86
             V  Y G +++ E       ++  +L +EY P GT++D+AT    + DE  +  +T  I+ 
Sbjct:    57 VIGYRGCEITREPFHNNGEATTYSLLMEYAPYGTLTDVATKNGGFIDEARVVKYTRQILL 116

Query:    87 ALKYLH-SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM 145
              L+Y+H S+ I HCD+KG NVLVG N    K+ADFG A       T  V    RG+P +M
Sbjct:   117 GLEYIHNSKGIAHCDIKGSNVLVGENGE-AKIADFGCAKWVEPEITEPV----RGTPAFM 171

Query:   146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAW--EDFG--ANTLSRIGFSDELPRFPTQ 201
             APE  RGE QG ESD+W++GCT+IEMVTG   W   DF    + L R+G+  ELP  P  
Sbjct:   172 APEAARGERQGKESDIWAVGCTVIEMVTGSQPWIGADFTDPVSVLYRVGYLGELPELPCS 231

Query:   202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFE 261
              +E  +DFL KCL++E  ERW+  QLL HPFL +  P     +  +SP  V D +     
Sbjct:   232 LTEQAKDFLGKCLKKEATERWTASQLLNHPFLVNKEPELVTGLVTNSPTSVTDQMFWRSV 291

Query:   262 EEGTSDDEKL--EASARERMGKLAGSSGAI----WEPNG--WVAVR 299
             EE  S+D     E    ER+G L+     +    W+ +G  W+ VR
Sbjct:   292 EEEVSEDRSSWWECHEDERIGVLSWIGHVVVESTWDLDGEDWITVR 337

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2060246 MAPKKK17 "mitogen-activated protein kinase kinase kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 454 (164.9 bits), Expect = 6.0e-48, Sum P(2) = 6.0e-48
 Identities = 105/261 (40%), Positives = 144/261 (55%)

Query:    29 VFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
             V  Y G +   E+        NL +EY P GT++D A       DE  +  +T  I+  L
Sbjct:    57 VIGYRGSETKRES--NGVVMYNLLMEYAPYGTLTDAAAKDGGRVDETRVVKYTRDILKGL 114

Query:    89 KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
             +Y+HS+ IVHCDVKG NV++       K+ADFG A          V     G+P +MAPE
Sbjct:   115 EYIHSKGIVHCDVKGSNVVISEKGE-AKIADFGCAKRVDPVFESPVM----GTPAFMAPE 169

Query:   149 VVRGECQGPESDVWSLGCTIIEMVTGKPAW------EDFGANTLSRIGFSDELPRFPTQS 202
             V RGE QG ESD+W++GCT+IEMVTG P W      ED   + L R+G+S E P  P   
Sbjct:   170 VARGEKQGKESDIWAVGCTMIEMVTGSPPWTKADSRED-PVSVLYRVGYSSETPELPCLL 228

Query:   203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS---VSPSDANTVAESSPRCVLD---WV 256
             +E  +DFL+KCL+RE  ERW+  QLL HPFL +   + P     +  +SP  V D   W 
Sbjct:   229 AEEAKDFLEKCLKREANERWTATQLLNHPFLTTKPDIEPVLVPGLISNSPTSVTDQTFWR 288

Query:   257 NSEFEEEGTSDDEKLEASARE 277
             + E EEE   + E+++  +R+
Sbjct:   289 SVEEEEE--EETEEIQKDSRD 307

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2116417 MAPKKK16 "mitogen-activated protein kinase kinase kinase 16" [Arabidopsis thaliana (taxid:3702)]

 Score = 415 (151.1 bits), Expect = 7.6e-46, Sum P(2) = 7.6e-46
 Identities = 109/292 (37%), Positives = 153/292 (52%)

Query:    32 YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
             Y+G  ++ E+   +    N+ +EY+ GG + DL         E  +RS+T  I++ L YL
Sbjct:    61 YIGTGLTRES---NGLVYNILMEYVSGGNLHDLIKNSGGKLPEPEIRSYTRQILNGLVYL 117

Query:    92 HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
             H R IVHCD+K  NVLV  N   +K+AD G A     S+  G       +P +MAPEV R
Sbjct:   118 HERGIVHCDLKSHNVLVEENG-VLKIADMGCAKSVDKSEFSG-------TPAFMAPEVAR 169

Query:   152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSELGRDF 209
             GE Q   +DVW+LGCT+IEM+TG   W +       + +IGFS E P  P   S+  +DF
Sbjct:   170 GEEQRFPADVWALGCTMIEMMTGSSPWPELNDVVAAMYKIGFSGESPAIPAWISDKAKDF 229

Query:   210 LDKCLRREPGERWSCDQLLKHPFL---QSVSPSDANTVAESSPRCVLD---W-------- 255
             L  CL+ +  +RW+ ++LLKHPFL   +    SD      SSP  VLD   W        
Sbjct:   230 LKNCLKEDQKQRWTVEELLKHPFLDDDEESQTSDCLKNKTSSPSTVLDQRFWDSCESSKS 289

Query:   256 --VNSEFEEEGTSDDEKLEASARERMGKLAG---SSGAIWEPN---GWVAVR 299
               V+ + E+      E L++ A +R+ KLAG   SS   W+     GW+ VR
Sbjct:   290 HLVSIDHEDPFAEYSESLDSPA-DRIEKLAGDEFSSLLDWDTEDDGGWIQVR 340

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2155568 MAPKKK19 "mitogen-activated protein kinase kinase kinase 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 396 (144.5 bits), Expect = 2.8e-42, Sum P(2) = 2.8e-42
 Identities = 109/313 (34%), Positives = 154/313 (49%)

Query:    11 GRGSFGTVNVAVDRFNGD---VFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTV-SDLAT 66
             G  S       +D    D   +    G+D + E         NL LEY   G++ S L  
Sbjct:    43 GAASLANEKSVLDNLGDDCNEIVRCFGEDRTVE---NGEEMHNLFLEYASRGSLESYLKK 99

Query:    67 TLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--- 123
                    E T+R HT  ++  L+++H+    HCD+K  N+L+  + + VK+ADFG A   
Sbjct:   100 LAGEGVPESTVRRHTGSVLRGLRHIHANGFAHCDLKLGNILLFGDGA-VKIADFGLAKRI 158

Query:   124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFG 182
             G+ T  +  GV+I  RG+PL+MAPE V     G E DVW+LGC ++EM +GK AW    G
Sbjct:   159 GDLTALNY-GVQI--RGTPLYMAPESVNDNEYGSEGDVWALGCVVVEMFSGKTAWSLKEG 215

Query:   183 ANTLS---RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS---- 235
             +N +S   RIG  DE+P  P + SE GRDFL KC  ++P +RW+ + LL HPF+      
Sbjct:   216 SNFMSLLLRIGVGDEVPMIPEELSEQGRDFLSKCFVKDPKKRWTAEMLLNHPFVTVDVDH 275

Query:   236 ---VSPSD--ANTVAE---SSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
                V   D   N   E   +SPRC  ++ +      G+   +    S  ER+  L     
Sbjct:   276 DVLVKEEDFVVNMKTEDVSTSPRCPFEFPDWVSVSSGSQTID----SPDERVASLVTDMI 331

Query:   288 AIWE-PNGWVAVR 299
               W   N WV VR
Sbjct:   332 PDWSVTNSWVTVR 344

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2074835 MAPKKK20 "mitogen-activated protein kinase kinase kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 392 (143.0 bits), Expect = 9.5e-42, Sum P(2) = 9.5e-42
 Identities = 98/290 (33%), Positives = 147/290 (50%)

Query:    28 DVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVS 86
             ++    G+D + E         NL LEY   G+++     L      E T+R HT  ++ 
Sbjct:    61 EIIRCYGEDSTVE---NGEEMHNLLLEYASRGSLASYMKKLGGEGLPESTVRRHTGSVLR 117

Query:    87 ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK--IQPRGSPLW 144
              L+++H++   HCD+K  N+L+  N   VK+ADFG A      D   ++  ++ RG+PL+
Sbjct:   118 GLRHIHAKGFAHCDIKLANILLF-NDGSVKIADFGLAMRVD-GDLTALRKSVEIRGTPLY 175

Query:   145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLS---RIGFSDELPRFPT 200
             MAPE V     G  +DVW+LGC ++EM +GK AW    G++ +S   RIG  DELP+ P 
Sbjct:   176 MAPECVNDNEYGSAADVWALGCAVVEMFSGKTAWSVKEGSHFMSLLIRIGVGDELPKIPE 235

Query:   201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD--ANTVAE--------SSPR 250
               SE G+DFL KC  ++P +RW+ + LL H F+      D   N V +         SP+
Sbjct:   236 MLSEEGKDFLSKCFVKDPAKRWTAEMLLNHSFVTIDLEDDHRENFVVKVKDEDKVLMSPK 295

Query:   251 CVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGAIWEPNG-WVAVR 299
             C  ++   +  +  T D      S  ER+G L   S   W   G W+ VR
Sbjct:   296 CPFEF---DDWDSFTLDSNPSFDSPVERLGSLVSGSIPDWSVGGSWLTVR 342

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IMP

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0048235 "pollen sperm cell differentiation" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0009409 "response to cold" evidence=IEP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2114990 MAPKKK21 "mitogen-activated protein kinase kinase kinase 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 390 (142.3 bits), Expect = 1.1e-40, Sum P(2) = 1.1e-40
 Identities = 99/262 (37%), Positives = 136/262 (51%)

Query:    50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
             NL LEY  GG+++D   +      E  +R  T  IV  L ++H     HCD+K +NVLV 
Sbjct:    81 NLFLEYASGGSLADRIKSSGEALPEFEVRRFTRSIVKGLCHIHGNGFTHCDIKLENVLVF 140

Query:   110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTI 168
              +   VK++DFG A   +      V ++ RG+PL+MAPE V  GE + P +D+W+LGC++
Sbjct:   141 GDGD-VKISDFGLAKRRSGE----VCVEIRGTPLYMAPESVNHGEFESP-ADIWALGCSV 194

Query:   169 IEMVTGKPAW--EDFGANT----LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
             +EM +GK AW  ED   N     L RIG  DE+PR P + SE G+DF+ KC  +   ERW
Sbjct:   195 VEMSSGKTAWCLEDGVMNNVMSLLVRIGSGDEVPRIPVELSEEGKDFVSKCFVKNAAERW 254

Query:   223 SCDQLLKHPFLQSVSPSDANTVAES-SPRCVLDWVNSEFEEEGTSDDE---KLEASARER 278
             + + LL HPFL     S     A S SPR   D+      +   +D      L  S  ER
Sbjct:   255 TAEMLLDHPFLAVDDESGEEDEACSVSPRNPFDFPGWNSVQSPVNDSVMFGSLVGSPEER 314

Query:   279 MGKLAGSSGAIWEPN-GWVAVR 299
             +  L       W  +  WV VR
Sbjct:   315 ISGLVSEKVPDWSVSCDWVNVR 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 392 (143.0 bits), Expect = 5.6e-40, Sum P(2) = 5.6e-40
 Identities = 82/215 (38%), Positives = 123/215 (57%)

Query:    37 VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
             V Y     S    +++LEY+ GG++  L     ++ + + ++++T  I++ L YLH RN 
Sbjct:   277 VQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPV-IQNYTRQILAGLAYLHGRNT 335

Query:    97 VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
             VH D+KG N+LV PN   +KLADFG A   T   T    +  +GSP WMAPEVV  +   
Sbjct:   336 VHRDIKGANILVDPNGE-IKLADFGMAKHVTAFSTM---LSFKGSPYWMAPEVVMSQNGY 391

Query:   157 PES-DVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCL 214
               + D+WSLGCTI+EM T KP W  F G   + +IG S + P  P   S   ++F+  CL
Sbjct:   392 THAVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAKNFIRLCL 451

Query:   215 RREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
             +R P  R +  QLL+HPFL++ +   + ++ +  P
Sbjct:   452 QRNPTVRPTASQLLEHPFLRNTTRVASTSLPKDFP 486

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.IX.3016.1 hypothetical protein (328 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	408
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-94
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-63
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-55
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-53
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-51
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-48
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-46
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-45
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-44
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-43
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-43
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-40
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-40
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-38
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-37
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-36
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-35
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-35
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-35
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-34
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-33
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-32
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-32
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-31
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-30
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-30
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-29
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-29
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-28
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-27
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-27
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-26
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-26
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-26
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-25
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-25
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-25
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-25
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-24
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-23
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-23
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-22
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-21
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-18
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-18
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-17
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-16
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-15
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-15
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-15
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-09
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-08
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-08
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-07
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  282 bits (724), Expect = 5e-94
 Identities = 108/269 (40%), Positives = 143/269 (53%), Gaps = 47/269 (17%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFA------------------------------- 31
            W RG+ +GRGSFG+V +A+D+  G++ A                               
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 32  ---YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVS 86
              Y G +   E      +  N+ LEY+ GG++S L   L  +    E  +R +T  I+ 
Sbjct: 61  IVRYYGSERDEEK-----NTLNIFLEYVSGGSLSSL---LKKFGKLPEPVIRKYTRQILE 112

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
            L YLHS  IVH D+KG N+LV  +   VKLADFG A      +T       RG+P WMA
Sbjct: 113 GLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSE 204
           PEV+RGE  G  +D+WSLGCT+IEM TGKP W + G     L +IG S E P  P   SE
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231

Query: 205 LGRDFLDKCLRREPGERWSCDQLLKHPFL 233
             +DFL KCLRR+P +R + D+LL+HPFL
Sbjct: 232 EAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  202 bits (515), Expect = 9e-63
 Identities = 98/264 (37%), Positives = 137/264 (51%), Gaps = 39/264 (14%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAY----LGDD---------------------- 36
            W +G+ +G GSFG+V   ++  +GD FA     L DD                      
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 37  ----VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH 92
               V Y           + LE +PGG+++ L     ++  E  +R +T  I+  L+YLH
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSF-PEPVIRLYTRQILLGLEYLH 119

Query: 93  SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA-TVSDTRGVKIQPRGSPLWMAPEVVR 151
            RN VH D+KG N+LV  N   VKLADFG A +    S  +  K    GSP WMAPEV+ 
Sbjct: 120 DRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFSFAKSFK----GSPYWMAPEVIA 174

Query: 152 GECQ-GPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDF 209
            +   G  +D+WSLGCT++EM TGKP W    G   + +IG S ELP  P   S+  +DF
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234

Query: 210 LDKCLRREPGERWSCDQLLKHPFL 233
           + KCL+R+P  R +  +LL+HPF+
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  183 bits (466), Expect = 2e-55
 Identities = 74/261 (28%), Positives = 115/261 (44%), Gaps = 38/261 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDDVSYEAPTTS--SSCRNLH----- 52
           +   + +G GSFG V +A D+  G + A                       + L      
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 53  ---------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
                          +EY  GG + DL         E   R +   I+SAL+YLHS+ IV
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL-SEDEARFYLRQILSALEYLHSKGIV 119

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           H D+K +N+L+  +   VKLADFG A +    +     +   G+P +MAPEV+ G+  G 
Sbjct: 120 HRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGKGYGK 175

Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDK 212
             D+WSLG  + E++TGKP +   G + L  +           P      S   +D + K
Sbjct: 176 AVDIWSLGVILYELLTGKPPFP--GDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 213 CLRREPGERWSCDQLLKHPFL 233
            L ++P +R + ++ L+HPF 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  176 bits (449), Expect = 5e-53
 Identities = 80/257 (31%), Positives = 116/257 (45%), Gaps = 37/257 (14%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-----YLGDD----------------------VSY 39
           G  IGRG+FG V   ++   GD  A                                V Y
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYAD--EITLRSHTYCIVSALKYLHSRNIV 97
                +S    + LEY   G+   L   +  +    E  +  + Y ++  L YLH + ++
Sbjct: 65  IGSIETSDSLYIILEYAENGS---LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           H D+K  N+L       VKLADFG A +  ++D         G+P WMAPEV+       
Sbjct: 122 HRDIKAANILTT-KDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
            SD+WSLGCT+IE++TG P + D      L RI   D+ P  P   S   +DFL +C ++
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQK 237

Query: 217 EPGERWSCDQLLKHPFL 233
           +P  R +  QLLKHP++
Sbjct: 238 DPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  173 bits (442), Expect = 7e-52
 Identities = 82/265 (30%), Positives = 122/265 (46%), Gaps = 49/265 (18%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------- 31
           +   + IG+G FG V  A  +  G   A                                
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 32  YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
           Y G   SY             +E+  GG++ DL  + N    E  +      ++  L+YL
Sbjct: 62  YYG---SYLKKDELWIV----MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114

Query: 92  HSRNIVHCDVKGKNVLVGPNSSF-VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
           HS  I+H D+K  N+L+   S   VKL DFG +  A +SDT+  +    G+P WMAPEV+
Sbjct: 115 HSNGIIHRDIKAANILL--TSDGEVKLIDFGLS--AQLSDTKA-RNTMVGTPYWMAPEVI 169

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSD--ELPRFPTQSSELGR 207
            G+    ++D+WSLG T IE+  GKP + +      L +I  +    L   P + S+  +
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-PEKWSDEFK 228

Query: 208 DFLDKCLRREPGERWSCDQLLKHPF 232
           DFL KCL++ P +R + +QLLKHPF
Sbjct: 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  173 bits (441), Expect = 1e-51
 Identities = 77/264 (29%), Positives = 116/264 (43%), Gaps = 38/264 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVSYEAPTTSSSCRNLH---- 52
           +   + +G GSFGTV  A  +  G + A                A       R L     
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 53  ----------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                           +EY  GG + D  +       E   +     I+  L+YLHS  I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPL-SEDEAKKIALQILRGLEYLHSNGI 119

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC-Q 155
           +H D+K +N+L+  N   VK+ADFG A +   S          G+P +MAPEV+ G    
Sbjct: 120 IHRDLKPENILLDENGV-VKIADFGLAKKLLKSS--SSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 156 GPESDVWSLGCTIIEMVTGKPAW-EDFGANTLSRI----GFSDELPRFPTQS-SELGRDF 209
           GP+ DVWSLG  + E++TGKP +  +   + L  I    G   E       S SE  +D 
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236

Query: 210 LDKCLRREPGERWSCDQLLKHPFL 233
           + KCL ++P +R + +++L+HP+ 
Sbjct: 237 IKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  165 bits (419), Expect = 2e-48
 Identities = 85/263 (32%), Positives = 128/263 (48%), Gaps = 34/263 (12%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLH--------- 52
            +W RGK +G+G+FG V +  D   G   A        ++P T      L          
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 53  ---------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
                                +EY+PGG+V D      A  + +T R +T  I+  ++YL
Sbjct: 62  QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT-RKYTRQILEGVEYL 120

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVV 150
           HS  IVH D+KG N+L     + VKL DFGA+       + G  ++   G+P WM+PEV+
Sbjct: 121 HSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGRDF 209
            GE  G ++DVWS+GCT++EM+T KP W +F A   + +I      P+ P+  S   R+F
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF 239

Query: 210 LDKCLRREPGERWSCDQLLKHPF 232
           L +       +R S ++LL+H F
Sbjct: 240 LRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  158 bits (402), Expect = 6e-46
 Identities = 87/269 (32%), Positives = 135/269 (50%), Gaps = 42/269 (15%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFAYL----------GDD----------------- 36
           W++G  IG GSFG+V + ++  +G++ A              D                 
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 37  -------VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                  V Y   +  +   N+ LEY+PGG+V+ L     A+ +E  +R+    I+  L 
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAF-EETLVRNFVRQILKGLN 120

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG--EATVSDTRGVKIQP--RGSPLWM 145
           YLH+R I+H D+KG N+LV  N   +K++DFG +   EA    T+    +P  +GS  WM
Sbjct: 121 YLHNRGIIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSE 204
           APEVV+      ++D+WSLGC ++EM+TGK  + D      + +IG  +  P  P+  S 
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISS 238

Query: 205 LGRDFLDKCLRREPGERWSCDQLLKHPFL 233
              DFL+K    +  +R +  +LLKHPFL
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  156 bits (396), Expect = 5e-45
 Identities = 87/274 (31%), Positives = 124/274 (45%), Gaps = 55/274 (20%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------- 31
           W RG  IG G+FG V  AV+   G++ A                                
Sbjct: 2   WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61

Query: 32  --YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
             Y G +V  E          + +EY  GGT+ +L        DE  +R +T  ++  L 
Sbjct: 62  VKYYGVEVHREK-------VYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLA 113

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMA 146
           YLHS  IVH D+K  N+ +  N   +KL DFG A      T +    V+    G+P +MA
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGEEVQ-SLAGTPAYMA 171

Query: 147 PEVVRGEC---QGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRFPT- 200
           PEV+ G      G  +D+WSLGC ++EM TGK  W +       +  +G     P  P  
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDS 230

Query: 201 -QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            Q S  G+DFLD+CL  +P +R +  +LL+HPF+
Sbjct: 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 2e-44
 Identities = 81/263 (30%), Positives = 122/263 (46%), Gaps = 38/263 (14%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY----LG------DDVSYEAPTTSSSCRNLH----- 52
           +CIG+GSFG V  A+D+    V A     L       +D+  E     S CR+ +     
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEI-QFLSQCRSPYITKYY 65

Query: 53  ------------LEYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSRNIVHC 99
                       +EY  GG+  DL   L     DE  +      ++  L+YLH    +H 
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLDL---LKPGKLDETYIAFILREVLLGLEYLHEEGKIHR 122

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K  N+L+      VKLADFG +G+  ++ T   +    G+P WMAPEV++      ++
Sbjct: 123 DIKAANILLSEEGD-VKLADFGVSGQ--LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQS-SELGRDFLDKCLRRE 217
           D+WSLG T IE+  G+P   D      L  I   +  P       S+  +DF+  CL ++
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNKD 238

Query: 218 PGERWSCDQLLKHPFLQSVSPSD 240
           P ER S  +LLKH F++    + 
Sbjct: 239 PKERPSAKELLKHKFIKKAKKTS 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  152 bits (386), Expect = 1e-43
 Identities = 95/267 (35%), Positives = 135/267 (50%), Gaps = 37/267 (13%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC----------RNL 51
           ++W RGK +G+G+FG V +  D   G   A        E+P TS             +NL
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 52  H----------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                                  +EY+PGG+V D      A  + +T R +T  I+  + 
Sbjct: 62  QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT-RKYTRQILEGMS 120

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPE 148
           YLHS  IVH D+KG N+L   ++  VKL DFGA+         G  I+   G+P WM+PE
Sbjct: 121 YLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGR 207
           V+ GE  G ++DVWSLGCT++EM+T KP W ++ A   + +I      P+ P+  SE  R
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR 239

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
           DFL  C+  E   R S ++LL+HPF Q
Sbjct: 240 DFL-GCIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  151 bits (383), Expect = 3e-43
 Identities = 83/266 (31%), Positives = 121/266 (45%), Gaps = 38/266 (14%)

Query: 4   WVRGKCIGRGSFGTV--------------NVAVDRFNGDV----FAYLGDDV-------- 37
           W +G+ +G+G++GTV               V +D  N       +  L ++V        
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 38  ----SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                Y       +  ++ +E++PGG++S +         E     +T  I+  + YLH+
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP-EPVFCKYTKQILDGVAYLHN 120

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ----PRGSPLWMAPEV 149
             +VH D+KG NV++ PN   +KL DFG A         G          G+P WMAPEV
Sbjct: 121 NCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDEL-PRFPTQSSELGR 207
           +     G +SD+WS+GCT+ EM TGKP          +  IG    L PR P   S    
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI 239

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFL 233
           DF+  CL R+  ER S  QLL+H FL
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  150 bits (379), Expect = 1e-42
 Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 48/270 (17%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNG-------------------DVFAYLGDDVSYEA--- 41
           W++G+ +G G+F +   A D   G                   +V   L  ++   A   
Sbjct: 2   WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61

Query: 42  ---------PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKY 90
                     T   S  NL +E++ GG+VS L +   A+ + + +    Y   ++  L Y
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN---YTEQLLRGLSY 118

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR--GSPLWMAPE 148
           LH   I+H DVKG N+L+      +++ADFGAA       T   + Q +  G+  +MAPE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS-------RIGFSDELPRFPTQ 201
           V+RGE  G   DVWS+GC IIEM T KP W    A   S       +I  +   P  P  
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPW---NAEKHSNHLALIFKIASATTAPSIPEH 235

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHP 231
            S   RD   +CL  +P +R    +LLKHP
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  143 bits (362), Expect = 1e-40
 Identities = 61/250 (24%), Positives = 105/250 (42%), Gaps = 63/250 (25%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA----------YLGDDVSYEAPTTSSSCRNLH------- 52
           +G G FGTV +A D+  G   A           L +++  E         + +       
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREI-EILKKLNHPNIVKLYGV 59

Query: 53  ----------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
                     +EY  GG++ DL         E  +      I+  L+YLHS  I+H D+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC-QGPESDV 161
            +N+L+  ++  VKLADFG +    ++  + +     G+P +MAPEV+ G+     +SD+
Sbjct: 120 PENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           WSLG  + E+        +                          +D + K L+++P +R
Sbjct: 178 WSLGVILYEL-------PEL-------------------------KDLIRKMLQKDPEKR 205

Query: 222 WSCDQLLKHP 231
            S  ++L+H 
Sbjct: 206 PSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  144 bits (365), Expect = 2e-40
 Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 41/266 (15%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDDVSY------EAPT-TSSSCRNL--- 51
           R K +G+GS G V     +  G ++A    ++  D  +      E  T  S     +   
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64

Query: 52  H------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVH 98
           +            LEY+ GG+++DL   +     E  L      I+  L YLH+ R+I+H
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP-EPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 99  CDVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
            D+K  N+L+  NS   VK+ADFG +    + +T        G+  +M+PE ++GE    
Sbjct: 124 RDIKPSNLLI--NSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 158 ESDVWSLGCTIIEMVTGK-----PAWEDFGANTLSRIGFSDELPRFP-TQSSELGRDFLD 211
            +D+WSLG T++E   GK     P    F    L +       P  P  + S   RDF+ 
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFE--LMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 212 KCLRREPGERWSCDQLLKHPFLQSVS 237
            CL+++P +R S  +LL+HPF++   
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  143 bits (362), Expect = 9e-40
 Identities = 72/199 (36%), Positives = 110/199 (55%), Gaps = 37/199 (18%)

Query: 54  EYLPGGTVSDLAT----TLN----AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           EY+ GG+++D+ T     +N    AY     L+         L+YLHS+N++H D+K  N
Sbjct: 95  EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQ--------GLEYLHSQNVIHRDIKSDN 146

Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRGECQGPESD 160
           +L+  + S VKLADFG A + T       K + +     G+P WMAPEV++ +  GP+ D
Sbjct: 147 ILLSKDGS-VKLADFGFAAQLT-------KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVD 198

Query: 161 VWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDE-LPRFPTQ---SSELGRDFLDKCLR 215
           +WSLG   IEM  G+P +        L  I  + + +P        S E  +DFL+KCL 
Sbjct: 199 IWSLGIMCIEMAEGEPPYLREPPLRALFLI--TTKGIPPLKNPEKWSPEF-KDFLNKCLV 255

Query: 216 REPGERWSCDQLLKHPFLQ 234
           ++P +R S ++LL+HPFL+
Sbjct: 256 KDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  138 bits (349), Expect = 3e-38
 Identities = 82/257 (31%), Positives = 117/257 (45%), Gaps = 42/257 (16%)

Query: 9   CIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSS--------CRNLH-------- 52
            +G GS+G+V  A+ +  G V A     V  E               C + +        
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAI--KVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EY   G+VSD+    N    E  + +  Y  +  L+YLHS   +H D+K 
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            N+L+       KLADFG +G+ T  DT   +    G+P WMAPEV++      ++D+WS
Sbjct: 128 GNILLN-EEGQAKLADFGVSGQLT--DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWS 184

Query: 164 LGCTIIEMVTGKPAWEDFGA-NTLSRI------GFSDELPRFPTQSSELGRDFLDKCLRR 216
           LG T IEM  GKP + D      +  I        SD     P + S    DF+ KCL +
Sbjct: 185 LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD-----PEKWSPEFNDFVKKCLVK 239

Query: 217 EPGERWSCDQLLKHPFL 233
           +P ER S  QLL+HPF+
Sbjct: 240 DPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  135 bits (342), Expect = 3e-37
 Identities = 86/266 (32%), Positives = 127/266 (47%), Gaps = 37/266 (13%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLH---------- 52
           +W  GK +G+G+FG V +  D   G   A        E+P TS     L           
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 53  ----------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKY 90
                                 +E++PGG++ D   +  A  + +T R +T  I+  + Y
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT-RKYTRQILEGVSY 121

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEV 149
           LHS  IVH D+KG N+L     + VKL DFGA+         G  ++   G+P WM+PEV
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGN-VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGRD 208
           + GE  G ++D+WS+GCT++EM+T KP W +F A   + +I      P  P   S+  RD
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240

Query: 209 FLDKCLRREPGERWSCDQLLKHPFLQ 234
           FL +    E   R S D+LL+H F+ 
Sbjct: 241 FLKRIF-VEAKLRPSADELLRHTFVH 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  132 bits (334), Expect = 8e-36
 Identities = 71/191 (37%), Positives = 108/191 (56%), Gaps = 13/191 (6%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H D+K  N+L+G + 
Sbjct: 95  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 152

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG    A ++  +  +    G+P WMAPEVV  +  GP+ D+WSLG   IEMV
Sbjct: 153 S-VKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Query: 173 TGKPAWEDFGANTLSRIGF-----SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            G+P +     N L  +       + EL   P + S + RDFL++CL  +  +R S  +L
Sbjct: 210 EGEPPY--LNENPLRALYLIATNGTPELQN-PEKLSAIFRDFLNRCLEMDVEKRGSAKEL 266

Query: 228 LKHPFLQSVSP 238
           L+HPFL+   P
Sbjct: 267 LQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  131 bits (332), Expect = 2e-35
 Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 25/200 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           +E+L GG ++D+ T      ++I     T C  ++ AL +LH++ ++H D+K  ++L+  
Sbjct: 95  MEFLEGGALTDIVTHTRMNEEQIA----TVCLAVLKALSFLHAQGVIHRDIKSDSILLTS 150

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRGECQGPESDVWSLG 165
           +   VKL+DFG   + +          PR     G+P WMAPEV+     G E D+WSLG
Sbjct: 151 DGR-VKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG 202

Query: 166 CTIIEMVTGKPAW-EDFGANTLSRIGFSDELPRF---PTQSSELGRDFLDKCLRREPGER 221
             +IEMV G+P +  +     + RI   D LP       + S   R FLD+ L R+P +R
Sbjct: 203 IMVIEMVDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260

Query: 222 WSCDQLLKHPFLQSVSPSDA 241
            +  +LL HPFL    P  +
Sbjct: 261 ATAAELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  131 bits (330), Expect = 2e-35
 Identities = 85/265 (32%), Positives = 123/265 (46%), Gaps = 37/265 (13%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLH--------- 52
           V+W  GK +GRG+FG V +  D   G   A        ++  TS     L          
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 53  -----------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                                  +EY+PGG++ D      A  + +T R +T  I+  + 
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT-RRYTRQILQGVS 120

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPE 148
           YLHS  IVH D+KG N+L   ++  VKL DFGA+         G  I+   G+P WM+PE
Sbjct: 121 YLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGR 207
           V+ GE  G ++DVWS+ CT++EM+T KP W ++ A   + +I      P  P   S+  R
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR 239

Query: 208 DFLDKCLRREPGERWSCDQLLKHPF 232
           DFL +    E     +   LL+HPF
Sbjct: 240 DFLKQIFVEEKRRPTAEF-LLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  134 bits (336), Expect = 2e-35
 Identities = 81/306 (26%), Positives = 117/306 (38%), Gaps = 47/306 (15%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNG-----------------------DVFAYLGDD--- 36
           S+   + +G GSFG V +A DR                           + A L      
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSR 94
           V             L +EY+ GG++ DL   +       E         I+SAL+YLHS+
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVV 150
            I+H D+K +N+L+  +   VKL DFG A       +            G+P +MAPEV+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 151 RGECQ---GPESDVWSLGCTIIEMVTGKPAWEDFGAN-----TLSRIGF-------SDEL 195
            G         SD+WSLG T+ E++TG P +E    +     TL  I         S   
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDW 255
           P  P   S+   D L K L ++P  R S    L H  L  +   +++      P      
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPL 300

Query: 256 VNSEFE 261
             S   
Sbjct: 301 RLSLPP 306

Length = 384

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  130 bits (328), Expect = 4e-35
 Identities = 72/195 (36%), Positives = 105/195 (53%), Gaps = 20/195 (10%)

Query: 51  LHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           + +E +PGG++S L  +       +E T+  +T  I+  LKYLH   IVH D+KG NVLV
Sbjct: 82  IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141

Query: 109 GPNSSFVKLADFGA----AGEATVSDTRGVKIQPRGSPLWMAPEVV----RGECQGPESD 160
              S  VK++DFG     AG    ++T    +Q      +MAPEV+    RG   G  +D
Sbjct: 142 NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ------YMAPEVIDKGPRG--YGAPAD 193

Query: 161 VWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
           +WSLGCTI+EM TGKP + + G     + ++G     P  P   S   ++F+ +C   +P
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDP 253

Query: 219 GERWSCDQLLKHPFL 233
            +R S   LL+ PFL
Sbjct: 254 DKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  128 bits (325), Expect = 1e-34
 Identities = 81/280 (28%), Positives = 123/280 (43%), Gaps = 60/280 (21%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YL-----GDDVSYEAPT----------- 43
           GK IG GSF TV +A ++     +A        L        V  E              
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 44  ----TSSSCRNLH--LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRN 95
               T     NL+  LEY P G   +L   +  Y   DE   R +   I+ AL+YLHS+ 
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNG---ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAA-------------GEATVSDTRGVKIQPR--- 139
           I+H D+K +N+L+  +   +K+ DFG A             G+AT  D++  K + R   
Sbjct: 123 IIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181

Query: 140 --GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELP 196
             G+  +++PE++  +  G  SD+W+LGC I +M+TGKP +       T  +I       
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI--LKLEY 239

Query: 197 RFPTQSSELGRDFLDKCLRREPGER----WSCDQLLKHPF 232
            FP       +D ++K L  +P +R       D+L  HPF
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  126 bits (319), Expect = 7e-34
 Identities = 80/284 (28%), Positives = 126/284 (44%), Gaps = 66/284 (23%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFA------------------------------ 31
             WV+G+ IG+G++G V +A++   G++ A                              
Sbjct: 1   FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60

Query: 32  ------------YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA--DEITL 77
                       YLG    +E      S   + LEY+PGG++    + L  Y   +E  +
Sbjct: 61  TLKDLDHLNIVQYLG----FETTEEYLS---IFLEYVPGGSI---GSCLRTYGRFEEQLV 110

Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R  T  ++  L YLHS+ I+H D+K  N+LV  +    K++DFG + ++         + 
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-CKISDFGISKKSDDIYDNDQNMS 169

Query: 138 PRGSPLWMAPEVVRGECQG--PESDVWSLGCTIIEMVTGKPAW---EDFGANTLSRIGFS 192
            +GS  WMAPEV+    QG   + D+WSLGC ++EM  G+  W   E   A  + ++G  
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLGNK 227

Query: 193 DELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPF 232
              P  P       S +  DFL+ C    P  R +  +LL+HPF
Sbjct: 228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 3e-33
 Identities = 64/194 (32%), Positives = 98/194 (50%), Gaps = 20/194 (10%)

Query: 49  RNLH--LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
             L+  LEY PGG   +L + L+      E   R +   IV AL+YLHS  I++ D+K +
Sbjct: 66  EKLYLVLEYAPGG---ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPE 122

Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSL 164
           N+L+      +KL DFG A E +   +R       G+P ++APEV+ G+  G   D WSL
Sbjct: 123 NILLD-ADGHIKLTDFGLAKELSSEGSRTN--TFCGTPEYLAPEVLLGKGYGKAVDWWSL 179

Query: 165 GCTIIEMVTGKPAWEDFGAN---TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           G  + EM+TGKP +  +  +      +I       RFP   S   RD +   L+++P +R
Sbjct: 180 GVLLYEMLTGKPPF--YAEDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKDPTKR 235

Query: 222 WSC---DQLLKHPF 232
                 +++  HPF
Sbjct: 236 LGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (312), Expect = 8e-33
 Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 53/266 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD--------------------VSYE 40
           K IG+GSFG V +   + +G ++         + +                     + Y 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADE-ITLRSHTYC-----IVSALKYLHSR 94
                     + +EY  GG   DL+  +     E               +  ALKYLHSR
Sbjct: 66  ESFEEKGKLCIVMEYADGG---DLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV---KIQPRGSPLWMAPEVVR 151
            I+H D+K +N+ +  N   VKL DFG +    +S T  +    +   G+P +++PE+ +
Sbjct: 123 KILHRDIKPQNIFLTSN-GLVKLGDFGIS--KVLSSTVDLAKTVV---GTPYYLSPELCQ 176

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SDELPRFPTQ-SSELGR 207
            +    +SD+WSLGC + E+ T K     F    L  +       + P  P+Q SSEL R
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP---FEGENLLELALKILKGQYPPIPSQYSSEL-R 232

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFL 233
           + +   L+++P ER S  Q+L+ PF+
Sbjct: 233 NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  122 bits (308), Expect = 3e-32
 Identities = 79/275 (28%), Positives = 117/275 (42%), Gaps = 60/275 (21%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA---------------------------YLGDDVS--YE 40
           I +G++G V +A  +  GD++A                                V   Y 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 41  APTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           +        NL+L  EYLPGG   DLA+ L      DE   R +   IV AL+YLHS  I
Sbjct: 61  SFQGKK---NLYLVMEYLPGG---DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI 114

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMAPEVV 150
           +H D+K  N+L+  ++  +KL DFG +    V     +    +      G+P ++APEV+
Sbjct: 115 IHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD------ELPRFPTQSSE 204
            G+      D WSLGC + E + G P    F   T   I F +      E P     S E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP---FHGETPEEI-FQNILNGKIEWPEDVEVSDE 229

Query: 205 LGRDFLDKCLRREPGER---WSCDQLLKHPFLQSV 236
              D + K L  +P +R    S +++  HPF + +
Sbjct: 230 A-IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 3e-32
 Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 20/197 (10%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+  GG +  +   L     E  +R     ++ AL +LHS  ++H D+K  N+L+  + 
Sbjct: 81  IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG 140

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGEC--QGP---ESDVWS 163
             VKLADFG      VS      +Q R    G+P WMAPEVV  E     P   ++D+WS
Sbjct: 141 D-VKLADFG------VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWS 193

Query: 164 LGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGE 220
           LG T+IE+   +P   +      L +I  S+  P    P++ S    DFL  CL ++P +
Sbjct: 194 LGITLIELAQMEPPHHELNPMRVLLKILKSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDD 252

Query: 221 RWSCDQLLKHPFLQSVS 237
           R +  +LLKHPF+   S
Sbjct: 253 RPTAAELLKHPFVSDQS 269

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  122 bits (307), Expect = 5e-32
 Identities = 70/190 (36%), Positives = 108/190 (56%), Gaps = 11/190 (5%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LH+  ++H D+K  NVL+G + 
Sbjct: 95  MEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG 152

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++   +   G+P WMAPEVV  +  GP+ D+WSLG   IEMV
Sbjct: 153 S-VKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +LL
Sbjct: 210 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Query: 229 KHPFLQSVSP 238
           +HPFL+   P
Sbjct: 268 QHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  120 bits (302), Expect = 3e-31
 Identities = 70/190 (36%), Positives = 106/190 (55%), Gaps = 11/190 (5%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL +LHS  ++H D+K  N+L+G + 
Sbjct: 95  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG 152

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++   +   G+P WMAPEVV  +  GP+ D+WSLG   IEMV
Sbjct: 153 S-VKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +   R S  +LL
Sbjct: 210 EGEPPY--LNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267

Query: 229 KHPFLQSVSP 238
           +HPFL+   P
Sbjct: 268 QHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  118 bits (296), Expect = 2e-30
 Identities = 68/190 (35%), Positives = 107/190 (56%), Gaps = 11/190 (5%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H D+K  N+L+G + 
Sbjct: 96  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++  +    G+P WMAPEVV  +  GP+ D+WSLG   IEM+
Sbjct: 154 S-VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +LL
Sbjct: 211 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268

Query: 229 KHPFLQSVSP 238
           +H FL+   P
Sbjct: 269 QHQFLKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  117 bits (296), Expect = 3e-30
 Identities = 79/266 (29%), Positives = 120/266 (45%), Gaps = 46/266 (17%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA-----YLG-----------------------DDVSYEA 41
           IG GSFG V  A D    +V A     Y G                       + + Y+ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                    L +EY  G + SD+         E+ + +  +  +  L YLHS   +H D+
Sbjct: 83  CYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDI 141

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV----RGECQGP 157
           K  N+L+    + VKLADFG+A   + +++        G+P WMAPEV+     G+  G 
Sbjct: 142 KAGNILLTEPGT-VKLADFGSASLVSPANSF------VGTPYWMAPEVILAMDEGQYDG- 193

Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SDELPRFPTQS-SELGRDFLDKCL 214
           + DVWSLG T IE+   KP    F  N +S +     ++ P   +   S+  R+F+D CL
Sbjct: 194 KVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCL 251

Query: 215 RREPGERWSCDQLLKHPFLQSVSPSD 240
           ++ P +R S ++LLKH F+    P  
Sbjct: 252 QKIPQDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  117 bits (295), Expect = 3e-30
 Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 25/207 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           +E+L GG ++D+ +      ++I     T C  ++ AL YLHS+ ++H D+K  ++L+  
Sbjct: 97  MEFLQGGALTDIVSQTRLNEEQIA----TVCESVLQALCYLHSQGVIHRDIKSDSILLTL 152

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           +   VKL+DFG    A +S     +    G+P WMAPEV+     G E D+WSLG  +IE
Sbjct: 153 DGR-VKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209

Query: 171 MVTGKPAW-EDFGANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           MV G+P +  D     + R+   D  P   +   + S + RDFL++ L REP ER +  +
Sbjct: 210 MVDGEPPYFSDSPVQAMKRL--RDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQE 267

Query: 227 LLKHPFLQSVSPSDANTVAESSPRCVL 253
           LL HPFL          +    P C++
Sbjct: 268 LLDHPFL----------LQTGLPECLV 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 9e-30
 Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 35/202 (17%)

Query: 53  LEYLPGGTVSDLATTLNAYADEIT-------LRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +E   GG+V+DL   L      +        LR      +  L YLH   ++H D+KG+N
Sbjct: 88  MELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE----TLRGLAYLHENKVIHRDIKGQN 143

Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE------S 159
           +L+  N+  VKL DFG +  A +  T G +    G+P WMAPEV+  + + P+      S
Sbjct: 144 ILLTKNAE-VKLVDFGVS--AQLDSTLGRRNTFIGTPYWMAPEVIACD-EQPDASYDARS 199

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPR-------FPTQSSELGRDFLD 211
           DVWSLG T IE+  GKP   D      L +I      PR        P   S+   DF+ 
Sbjct: 200 DVWSLGITAIELADGKPPLCDMHPMRALFKI------PRNPPPTLKSPENWSKKFNDFIS 253

Query: 212 KCLRREPGERWSCDQLLKHPFL 233
           +CL +   +R   ++LL+HPF+
Sbjct: 254 ECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  115 bits (289), Expect = 1e-29
 Identities = 84/256 (32%), Positives = 121/256 (47%), Gaps = 43/256 (16%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLG----------DDVSYEAPTTSSSCRNLH------- 52
           IG+GSFG V   +D     V A             +D+  E  T  S C + +       
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGS 70

Query: 53  ----------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
                     +EYL GG+  DL        DE  + +    I+  L YLHS   +H D+K
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVW 162
             NVL+      VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+W
Sbjct: 129 AANVLLSEQGD-VKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185

Query: 163 SLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGR---DFLDKCLRRE 217
           SLG T IE+  G+P   D       R+ F   +P+   PT + E  +   +F+D CL ++
Sbjct: 186 SLGITAIELAKGEPPNSDMHP---MRVLF--LIPKNNPPTLTGEFSKPFKEFIDACLNKD 240

Query: 218 PGERWSCDQLLKHPFL 233
           P  R +  +LLKH F+
Sbjct: 241 PSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 3e-29
 Identities = 64/156 (41%), Positives = 90/156 (57%), Gaps = 11/156 (7%)

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
           ALKY+H   ++H D+K  N+LV  N+  VKL DFG A  A ++     +    G+P WMA
Sbjct: 113 ALKYIHKVGVIHRDIKAANILV-TNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTPYWMA 169

Query: 147 PEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWED---FGANTLSRIGFSDELPRFPTQS 202
           PEV+  G+    ++D+WSLG TI EM TG P + D   F A  L  I  S + PR     
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML--IPKS-KPPRLEDNG 226

Query: 203 -SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
            S+L R+F+  CL  EP ER S ++LLK  ++++ S
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  113 bits (285), Expect = 6e-29
 Identities = 65/192 (33%), Positives = 103/192 (53%), Gaps = 15/192 (7%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           +E+L GG ++D+ T      ++I       C  ++ AL  LH++ ++H D+K  ++L+  
Sbjct: 96  MEFLEGGALTDIVTHTRMNEEQIA----AVCLAVLKALSVLHAQGVIHRDIKSDSILLTH 151

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           +   VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IE
Sbjct: 152 DGR-VKLSDFGFCAQVSKEVPRRKSLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208

Query: 171 MVTGKPAWEDFGANTLSRIGF-SDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           MV G+P +  F    L  +    D LP   +   + S   + FLD+ L R+P +R +  +
Sbjct: 209 MVDGEPPY--FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 266

Query: 227 LLKHPFLQSVSP 238
           LLKHPFL    P
Sbjct: 267 LLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 1e-28
 Identities = 81/271 (29%), Positives = 118/271 (43%), Gaps = 67/271 (24%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY------LGDDVSY--EAPTTSSSCRNLH--------- 52
           IG G++G V  A D   G++ A        GDD     +  +    CR  H         
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR--HPNIVAYFGS 68

Query: 53  ----------LEYLPGGTVSD--------LATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                     +EY  GG++ D        L+    AY    TL+         L YLH  
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK--------GLAYLHET 120

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVV 150
             +H D+KG N+L+  +   VKLADFG + + T +      I  R    G+P WMAPEV 
Sbjct: 121 GKIHRDIKGANILLTEDGD-VKLADFGVSAQLTAT------IAKRKSFIGTPYWMAPEVA 173

Query: 151 RGECQGP---ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQS---- 202
             E +G    + D+W+LG T IE+   +P  ++      L  I  S+  P  P       
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--PKLKDKEK 231

Query: 203 -SELGRDFLDKCLRREPGERWSCDQLLKHPF 232
            S +  DF+ KCL ++P +R +  +LL+HPF
Sbjct: 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  112 bits (282), Expect = 1e-28
 Identities = 82/254 (32%), Positives = 119/254 (46%), Gaps = 39/254 (15%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLG----------DDVSYEAPTTSSSCRNLH------- 52
           IG+GSFG V   +D    +V A             +D+  E  T  S C + +       
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYITRYYGS 70

Query: 53  ----------LEYLPGGTVSDL---ATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                     +EYL GG+  DL         Y   I LR     I+  L YLHS   +H 
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI-LRE----ILKGLDYLHSERKIHR 125

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K  NVL+      VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++
Sbjct: 126 DIKAANVLLSEQGD-VKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D+WSLG T IE+  G+P   D     +  +   +  P    Q S+  ++F++ CL ++P 
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPR 242

Query: 220 ERWSCDQLLKHPFL 233
            R +  +LLKH F+
Sbjct: 243 FRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  110 bits (278), Expect = 5e-28
 Identities = 64/194 (32%), Positives = 105/194 (54%), Gaps = 22/194 (11%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPN 111
           +EY+ GG++  +   +     E  L      ++  L YLH    I+H DVK  N+LV  N
Sbjct: 78  MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV--N 135

Query: 112 SS-FVKLADFGAAGE--ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
           S   +KL DFG +G+   +++ T        G+  +MAPE ++G     +SD+WSLG ++
Sbjct: 136 SRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPERIQGNDYSVKSDIWSLGLSL 189

Query: 169 IEMVTGK-PAW-EDFGANT----LSRIGFSDELPRFPTQ--SSELGRDFLDKCLRREPGE 220
           IE+ TG+ P   E+   +     L  I  ++  PR P+   S +  +DF++ CL ++P E
Sbjct: 190 IELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSPDF-QDFVNLCLIKDPRE 247

Query: 221 RWSCDQLLKHPFLQ 234
           R S  +LL+HPF++
Sbjct: 248 RPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  111 bits (278), Expect = 6e-28
 Identities = 69/192 (35%), Positives = 105/192 (54%), Gaps = 15/192 (7%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           +E+L GG ++D+ T      ++I     T C  ++ AL YLH++ ++H D+K  ++L+  
Sbjct: 98  MEFLEGGALTDIVTHTRMNEEQIA----TVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 153

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           +   +KL+DFG    A VS     +    G+P WMAPEV+     G E D+WSLG  +IE
Sbjct: 154 DGR-IKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 210

Query: 171 MVTGKPAW-EDFGANTLSRIGFSDELPRFPTQS---SELGRDFLDKCLRREPGERWSCDQ 226
           M+ G+P +  +     + RI   D LP     S   S + R FLD  L REP +R +  +
Sbjct: 211 MIDGEPPYFNEPPLQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQE 268

Query: 227 LLKHPFLQSVSP 238
           LL+HPFL+   P
Sbjct: 269 LLQHPFLKLAGP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  110 bits (277), Expect = 6e-28
 Identities = 78/250 (31%), Positives = 117/250 (46%), Gaps = 31/250 (12%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------YEAPTTSSSCRNLH-------- 52
           IG+GSFG V   +D     V A    D+           +  T  S C + +        
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EYL GG+  DL        DE  + +    I+  L YLHS   +H D+K 
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 129

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NVL+  +   VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+WS
Sbjct: 130 ANVLLSEHGE-VKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186

Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LG T IE+  G+P   +     +  +   +  P      S+  ++F++ CL +EP  R +
Sbjct: 187 LGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 246

Query: 224 CDQLLKHPFL 233
             +LLKH F+
Sbjct: 247 AKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 2e-27
 Identities = 73/297 (24%), Positives = 111/297 (37%), Gaps = 86/297 (28%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA---YLGDDVSYEAPTTSSSCR------------- 49
           + + +G G++G V  A D+  G++ A      D+     P  S++ R             
Sbjct: 3   KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNI 60

Query: 50  -----------NLHL--EYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKYLHS 93
                       L+L  EY       DL   L+          ++S  Y ++  L Y HS
Sbjct: 61  VKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV---SDTRGVKIQPRGSPLWM-APEV 149
             I+H D+K +N+L+      +KLADFG A    +   + T  V        LW  APE+
Sbjct: 117 HRILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVVT------LWYRAPEI 169

Query: 150 VRGE-CQGPESDVWSLGCTIIEMVTGKP------------------------AWEDFGAN 184
           + G        D+WS+GC   EM+TGKP                        +W      
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 185 TLSRIGFSDELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
                 +    P+FP +            G D L K L+  P +R S  + LKHP+ 
Sbjct: 230 ----PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (271), Expect = 5e-27
 Identities = 71/262 (27%), Positives = 118/262 (45%), Gaps = 43/262 (16%)

Query: 10  IGRGSFGTV----------NVAVDRFNGDVFAYLGDDVSYEAPTTSSS------------ 47
           IG G+   V           VA+ R + +      D++  E    S              
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 48  ----CRNLHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                  L + YL GG++ D+  +       DE  + +    ++  L+YLHS   +H D+
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDI 128

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVV-RGECQG 156
           K  N+L+G + S VK+ADFG +  A+++D      + R    G+P WMAPEV+ +     
Sbjct: 129 KAGNILLGEDGS-VKIADFGVS--ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQS-----SELGRDFL 210
            ++D+WS G T IE+ TG   +  +     L     +D  P   T +     S+  R  +
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP-PSLETGADYKKYSKSFRKMI 244

Query: 211 DKCLRREPGERWSCDQLLKHPF 232
             CL+++P +R + ++LLKH F
Sbjct: 245 SLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 6e-27
 Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 64/227 (28%)

Query: 49  RNLH--LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           R L   LE  PGG                 +RS+ + ++ A+ Y HS NI+H D+K +N+
Sbjct: 84  RTLLELLEASPGGL------------PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131

Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-------WM-APEVVRGECQ-GP 157
           LV  +   +KL DFG A        R ++     SPL       W  APE++ G+   G 
Sbjct: 132 LVSESGV-LKLCDFGFA--------RALR-ARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 158 ESDVWSLGCTIIEMVTGKPAW------------------------EDFGAN----TLSRI 189
             DVW++GC + E++ G+P +                        E F +N     ++  
Sbjct: 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFP 241

Query: 190 GFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
             S       R+P + S    DFL  CLR +P ER +CD+LL+HP+ 
Sbjct: 242 EPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 76/272 (27%), Positives = 118/272 (43%), Gaps = 59/272 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYL----GDDVSY-----------------EAPTTS- 45
           K I +G+FG+V +A  R  GD FA       D ++                  E+P  + 
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 46  -----SSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                 S   L+L  EYL GG  + L  TL     E   + +   +V  ++ LH R I+H
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR--GSPLWMAPEVVRGECQG 156
            D+K +N+L+   +  +KL DFG         +R      +  G+P ++APE + G    
Sbjct: 121 RDIKPENLLID-QTGHLKLTDFGL--------SRNGLENKKFVGTPDYLAPETILGVGDD 171

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLS---------RIGFSDELPRFPTQSSELGR 207
             SD WSLGC I E + G P    F A T           RI + +E+  F    S    
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP---FHAETPDAVFDNILSRRINWPEEVKEF---CSPEAV 225

Query: 208 DFLDKCLRREPGERWSCD---QLLKHPFLQSV 236
           D +++ L  +P +R   +   ++  HPF +S+
Sbjct: 226 DLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 74/209 (35%), Positives = 109/209 (52%), Gaps = 22/209 (10%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+ PGG V  +   L+    E  ++     ++ AL+YLHS  I+H D+K  NVL+  + 
Sbjct: 88  IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG 147

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGEC--QGP---ESDVWS 163
             +KLADFG + +   +      +Q R    G+P WMAPEVV  E     P   ++D+WS
Sbjct: 148 D-IKLADFGVSAKNVKT------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 200

Query: 164 LGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGE 220
           LG T+IEM   +P   +      L +I  S+  P    P++ S   RDFL   L + P  
Sbjct: 201 LGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPET 259

Query: 221 RWSCDQLLKHPFLQSVSPSDA--NTVAES 247
           R S  QLL+HPF+ SV+ +      VAE+
Sbjct: 260 RPSAAQLLEHPFVSSVTSNRPLRELVAEA 288

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  106 bits (265), Expect = 6e-26
 Identities = 82/265 (30%), Positives = 119/265 (44%), Gaps = 48/265 (18%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRN------------------- 50
           IG GSFG V  A D  N +V A     +SY    ++   ++                   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAI--KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 51  -----------LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                      L +EY  G + SDL         E+ + + T+  +  L YLHS N++H 
Sbjct: 81  RGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP-- 157
           DVK  N+L+      VKL DFG+A     ++         G+P WMAPEV+    +G   
Sbjct: 140 DVKAGNILL-SEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEVILAMDEGQYD 192

Query: 158 -ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SDELPRFPT-QSSELGRDFLDKC 213
            + DVWSLG T IE+   KP    F  N +S +     +E P   +   SE  R+F+D C
Sbjct: 193 GKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250

Query: 214 LRREPGERWSCDQLLKHPFLQSVSP 238
           L++ P +R + + LLKH F+    P
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 74/209 (35%), Positives = 102/209 (48%), Gaps = 27/209 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVG 109
           +EY+  G++  L     A     E  LR  TY +V  LK+L    NI+H DVK  NVLV 
Sbjct: 78  MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN 137

Query: 110 PNSSFVKLADFGAAG--EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP--------ES 159
            N   VKL DFG +G   A+++ T        G   +MAPE ++    GP        +S
Sbjct: 138 GNGQ-VKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSG--GPNQNPTYTVQS 188

Query: 160 DVWSLGCTIIEMVTGK----PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
           DVWSLG +I+EM  G+    P         LS I   D  P  P+  S+  +DF+ KCL 
Sbjct: 189 DVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-PTLPSGYSDDAQDFVAKCLN 247

Query: 216 REPGERWSCDQLLKHPFLQSVSPSDANTV 244
           + P  R +  QLL+HP+L     +D +  
Sbjct: 248 KIPNRRPTYAQLLEHPWLVKYKNADVDMA 276

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/179 (31%), Positives = 90/179 (50%), Gaps = 23/179 (12%)

Query: 81  TYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS--DTRGVKIQ 137
           T  IV AL YL  +  ++H DVK  N+L+  + + VKL DFG +G    S   TR     
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN-VKLCDFGISGRLVDSKAKTRSA--- 175

Query: 138 PRGSPLWMAPEVVRGECQGPE----SDVWSLGCTIIEMVTGKPAWE----DFGANTLSRI 189
             G   +MAPE +      P+    +DVWSLG +++E+ TG+  ++    +F    L++I
Sbjct: 176 --GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKI 231

Query: 190 GFSDELPRFPT--QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
              +E P  P     S     F+D CL ++  +R    +LL+HPF++    ++   VA 
Sbjct: 232 -LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE-VDVAG 288

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (259), Expect = 2e-25
 Identities = 67/259 (25%), Positives = 97/259 (37%), Gaps = 43/259 (16%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA--YLGDDVSYEAPTTSSSCR--------------NLH- 52
           IG+G+FG V +   R    +FA  Y+      E  +  +                 NL  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 53  -----------LEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                      ++ L GG   DL   L       E  ++     IV AL+YLHS+ I+H 
Sbjct: 68  SFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPE 158
           D+K  N+L+      V + DF  A       T         G+P +MAPEV+  +     
Sbjct: 125 DIKPDNILLD-EQGHVHITDFNIA----TKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA 179

Query: 159 SDVWSLGCTIIEMVTGKPAWE--DFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
            D WSLG T  E + GK  +           R         +P   S    D ++K L R
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239

Query: 217 EPGERWSC--DQLLKHPFL 233
           +P +R       L  HP+ 
Sbjct: 240 DPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  104 bits (261), Expect = 3e-25
 Identities = 82/263 (31%), Positives = 122/263 (46%), Gaps = 44/263 (16%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA-----YLG-----------------------DDVSYEA 41
           IG GSFG V  A D    +V A     Y G                       + + Y+ 
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                    L +EY  G + SDL         E+ + + T+  +  L YLHS N++H D+
Sbjct: 93  CYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 151

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---E 158
           K  N+L+      VKLADFG+A  A+ +++        G+P WMAPEV+    +G    +
Sbjct: 152 KAGNILLTEPGQ-VKLADFGSASIASPANSF------VGTPYWMAPEVILAMDEGQYDGK 204

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SDELPRF-PTQSSELGRDFLDKCLR 215
            DVWSLG T IE+   KP    F  N +S +     +E P     + S+  R+F+D CL+
Sbjct: 205 VDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262

Query: 216 REPGERWSCDQLLKHPFLQSVSP 238
           + P +R + ++LLKH F+    P
Sbjct: 263 KIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  103 bits (258), Expect = 3e-25
 Identities = 69/275 (25%), Positives = 109/275 (39%), Gaps = 65/275 (23%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA--YLGDD--VSYEAP------------TTSSSCRNLH- 52
           +G G FG V +   +     FA   +     V                         L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 53  -----------LEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                      +EY  GG   +L T L      DE T R +  C+V A +YLH+R I++ 
Sbjct: 61  TFKDKKYIYMLMEYCLGG---ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-------GSPLWMAPEVVRG 152
           D+K +N+L+  N  +VKL DFG A           K++         G+P ++APE++  
Sbjct: 118 DLKPENLLLDSN-GYVKLVDFGFAK----------KLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN------TLSRIGFSDELPRFPTQSSELG 206
           +      D WSLG  + E++TG+P    FG +        + I   +    FP    +  
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPP---FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAA 223

Query: 207 RDFLDKCLRREPGERWSCDQ-----LLKHPFLQSV 236
           +D + + LRR P ER    +     + KH +    
Sbjct: 224 KDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  103 bits (259), Expect = 3e-25
 Identities = 58/159 (36%), Positives = 90/159 (56%), Gaps = 13/159 (8%)

Query: 84  IVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           IV AL+YLHS+ +++H DVK  NVL+  N   VKL DFG +G    S  + +     G  
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGYLVDSVAKTIDA---GCK 167

Query: 143 LWMAPEVVRGECQGP----ESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELP 196
            +MAPE +  E        +SDVWSLG T+IE+ TG+  ++ +      L ++   +  P
Sbjct: 168 PYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSP 226

Query: 197 RFPTQS-SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           + P +  S   +DF++KCL++   ER +  +LL+HPF +
Sbjct: 227 QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  103 bits (258), Expect = 3e-25
 Identities = 70/197 (35%), Positives = 98/197 (49%), Gaps = 20/197 (10%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+  GG V  +   L     E  +R      + AL YLH   I+H D+K  N+L   + 
Sbjct: 81  IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG 140

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGECQGP-----ESDVWS 163
             +KLADFG + + T +      IQ R    G+P WMAPEVV  E         ++DVWS
Sbjct: 141 D-IKLADFGVSAKNTRT------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 193

Query: 164 LGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGE 220
           LG T+IEM   +P   +      L +I  S+  P    P++ S   +DFL KCL +    
Sbjct: 194 LGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDA 252

Query: 221 RWSCDQLLKHPFLQSVS 237
           RW+  QLL+HPF+   S
Sbjct: 253 RWTTTQLLQHPFVTVNS 269

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 85/280 (30%), Positives = 123/280 (43%), Gaps = 49/280 (17%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY-----EAPTTSSS-------- 47
           +GRG FG V V  ++  GD++A            + VS+     +  + S+S        
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 48  ----CRNLHL--EYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKYLHSRNIVH 98
                 NL+L  EY PGG   DL + LN Y    DE   + +   +V A+  +H    VH
Sbjct: 69  AFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR------G 152
            D+K +NVL+   +  +KLADFG+A   T +     K+ P G+P ++APEV+        
Sbjct: 126 RDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKL-PVGTPDYIAPEVLTTMNGDGK 183

Query: 153 ECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPT--QSSELGRDF 209
              G E D WSLG    EM+ G+ P  E   A T + I       +FP   + S    D 
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243

Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
           +   L     ER   + L  HPF   +   D N +  S P
Sbjct: 244 IQSLL-CGQKERLGYEGLCCHPFFSKI---DWNNIRNSLP 279

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  101 bits (253), Expect = 3e-24
 Identities = 83/265 (31%), Positives = 124/265 (46%), Gaps = 48/265 (18%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA-----YLG-----------------------DDVSYEA 41
           IG GSFG V  A +    +V A     Y G                       + + Y+ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                    L +EY  G + SDL         E+ + + T+  +  L YLHS N++H D+
Sbjct: 89  CYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---E 158
           K  N+L+      VKLADFG+A +++ +++        G+P WMAPEV+    +G    +
Sbjct: 148 KAGNILLTEPGQ-VKLADFGSASKSSPANSF------VGTPYWMAPEVILAMDEGQYDGK 200

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPT-QSSELG---RDFLDKC 213
            DVWSLG T IE+   KP   +  A + L  I  +D     PT QS+E     R F+D C
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS----PTLQSNEWTDSFRGFVDYC 256

Query: 214 LRREPGERWSCDQLLKHPFLQSVSP 238
           L++ P ER +  +LL+H F++   P
Sbjct: 257 LQKIPQERPASAELLRHDFVRRDRP 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  100 bits (251), Expect = 8e-24
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 45/266 (16%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY---------LGDDVSY---EAPTTSSSCR-----N 50
           K +G+GSFG V +A  +   +++A            DDV     E    + + +      
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           LH            +EY+ GG   DL   +      DE   R +   IV  L++LH R I
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI 117

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQ 155
           ++ D+K  NVL+  +   +K+ADFG   E       GV      G+P ++APE++  +  
Sbjct: 118 IYRDLKLDNVLLD-SEGHIKIADFGMCKEGI---LGGVTTSTFCGTPDYIAPEILSYQPY 173

Query: 156 GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
           GP  D W+LG  + EM+ G+  +E    + L +    DE  R+P   S+  +  L   L 
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLT 232

Query: 216 REPGERWSC-----DQLLKHPFLQSV 236
           + P +R  C       +  HPF + +
Sbjct: 233 KNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 70/272 (25%), Positives = 113/272 (41%), Gaps = 58/272 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTS------SSC---RNLH------ 52
           + IG+GSFGTV     + +G +  +   ++ Y   T        S     R L       
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVW--KEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63

Query: 53  ----------------LEYLPGGTVSDLATTL------NAYADEITLRSHTYCIVSALKY 90
                           +EY  GG   DLA  +        Y +E  +      ++ AL  
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGG---DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 91  LHSRN-----IVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSP 142
            H+R+     ++H D+K  N+ +  N++ VKL DFG A   G  +      V     G+P
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN-VKLGDFGLAKILGHDSSFAKTYV-----GTP 174

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ- 201
            +M+PE +       +SD+WSLGC I E+    P +       L+      +  R P + 
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY 234

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           SSEL  + +   L  +P +R S ++LL+ P +
Sbjct: 235 SSEL-NEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 16/164 (9%)

Query: 83  CIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
            ++  L YLHSR I+H D+K  N+L+      VKL DFG +GE  V+   G      G+ 
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ-VKLCDFGVSGEL-VNSLAGTFT---GTS 167

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--------GFSDE 194
            +MAPE ++G+     SDVWSLG T++E+   +  +   G   L  I          + E
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227

Query: 195 LPRFPTQS---SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
           L   P      SE  +DF+ +CL ++P  R +   +L+HP++++
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 87/349 (24%), Positives = 141/349 (40%), Gaps = 76/349 (21%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY-----EAPTTSSSC-- 48
              K IGRG+FG V +  D+  G V+A            + +++     +    + S   
Sbjct: 4   EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63

Query: 49  ----------RNLHL--EYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSR 94
                      +L+L  EY+PGG   DL   L       E T R +   +V AL  +H  
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAA--------------GEATVSDTRGVKIQPR- 139
             +H D+K  N+L+      +KLADFG                    +     V ++ R 
Sbjct: 121 GFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 140 ------------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-EDFGANTL 186
                       G+P ++APEV+RG   G E D WSLG  + EM+ G P +  D    T 
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 187 SRIGFSDELPRFPTQS--SELGRDFLDKCLRREPGERW-SCDQLLKHPFLQSVSPSDANT 243
           ++I    E  RFP     S    D + + L  +P +R  S +++  HPF + +   D   
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKGI---DWEN 295

Query: 244 VAESSPRCVLDWVNSE-----FEE-EGTSDDEKLEASARERMGKLAGSS 286
           + E+ P  V + ++S      F++ E   D     +   +++ K    +
Sbjct: 296 LRETKPPFVPE-LSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLA 343

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 64/241 (26%), Positives = 94/241 (39%), Gaps = 64/241 (26%)

Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
            Y I+  LKYLHS N++H D+K  N+LV  N   +K+ DFG A        RGV      
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNSNCD-LKICDFGLA--------RGVDPDEDE 159

Query: 141 SPLWM---------APEVVRGECQ--GPESDVWSLGCTIIEMVT---------------- 173
                         APE++           D+WS+GC   E++T                
Sbjct: 160 KGFLTEYVVTRWYRAPELL-LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Query: 174 -----GKPAWEDFGANTLSR-IGFSDELPRFPTQS--------SELGRDFLDKCLRREPG 219
                G P+ ED    T  +   +   LP+ P +         S    D L+K L  +P 
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK 278

Query: 220 ERWSCDQLLKHPFLQSV-SPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARER 278
           +R + D+ L HP+L  +  P D   VA+            +F +    DDE  E   +E 
Sbjct: 279 KRITADEALAHPYLAQLHDPEDE-PVAKPPFDF-------DFFD----DDELTEEELKEL 326

Query: 279 M 279
           +
Sbjct: 327 I 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 67/227 (29%), Positives = 97/227 (42%), Gaps = 57/227 (25%)

Query: 49  RNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           R LHL  EY     +++L         E  ++   +  + A+ + H  N +H DVK +N+
Sbjct: 73  RKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131

Query: 107 LVGPNSSFVKLADFGAA-----GEATVSD---TRGVKIQPRGSPLWM-APEVVRGECQ-G 156
           L+      +KL DFG A          +D   TR           W  APE++ G+ Q G
Sbjct: 132 LITKQGQ-IKLCDFGFARILTGPGDDYTDYVATR-----------WYRAPELLVGDTQYG 179

Query: 157 PESDVWSLGCTIIEMVTGKPAW---EDFGANTLSRIGFSDELPR---------------- 197
           P  DVW++GC   E++TG+P W    D     L R    D +PR                
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239

Query: 198 ------------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF 232
                       FP  SS     FL  CL+ +P ER SC++LL+HP+
Sbjct: 240 PEPETREPLESKFPNISS-PALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 98.0 bits (244), Expect = 9e-23
 Identities = 83/272 (30%), Positives = 118/272 (43%), Gaps = 62/272 (22%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA------YLGDDV------------SYEAPTTSSS 47
           R   IG G+ GTV   + R  G ++A         D V                P     
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK- 136

Query: 48  CRNLH---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
           C ++          LE++ GG++          ADE  L      I+S + YLH R+IVH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVH 191

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL----WMAPEVV---- 150
            D+K  N+L+    + VK+ADFG      VS      + P  S +    +M+PE +    
Sbjct: 192 RDIKPSNLLINSAKN-VKIADFG------VSRILAQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 151 -RGECQGPESDVWSLGCTIIEMVTGK-PAWEDFG-------ANTLSRIGFSDELPRFPTQ 201
             G   G   D+WSLG +I+E   G+ P    FG       A+ +  I  S   P  P  
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFP----FGVGRQGDWASLMCAICMSQP-PEAPAT 299

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           +S   R F+  CL+REP +RWS  QLL+HPF+
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.0 bits (239), Expect = 9e-23
 Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 5/150 (3%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++  L+ LH + I+H D+K  N+L+  N   VK+ D G +    V      K Q  G+P 
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGIS---KVLKKNMAKTQI-GTPH 166

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           +MAPEV +G     +SD+WSLGC + EM T  P +E      L       + P  P   S
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYS 226

Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           +  ++F+   L+ +P  R +CD++L  P +
Sbjct: 227 QDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 69/193 (35%), Positives = 102/193 (52%), Gaps = 16/193 (8%)

Query: 51  LHLEYLPGGTVSDLA--TTLNAYA-DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L +E+   G+V+DL   T  NA   D I        I+  L +LH+  ++H D+KG+NVL
Sbjct: 96  LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE--ILRGLAHLHAHKVIHRDIKGQNVL 153

Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE------SDV 161
           +  N+  VKL DFG +  A +  T G +    G+P WMAPEV+  + + P+      SD+
Sbjct: 154 LTENAE-VKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACD-ENPDATYDYRSDI 209

Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS-SELGRDFLDKCLRREPGE 220
           WSLG T IEM  G P   D        +   +  P+  ++  S+   DF++ CL +    
Sbjct: 210 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLS 269

Query: 221 RWSCDQLLKHPFL 233
           R S +QLLKHPF+
Sbjct: 270 RPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 16/193 (8%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVL 107
           L +E+   G+V+DL    N   + +      Y    I+  L +LH   ++H D+KG+NVL
Sbjct: 86  LVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 143

Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE------SDV 161
           +  N+  VKL DFG +  A +  T G +    G+P WMAPEV+  + + P+      SD+
Sbjct: 144 LTENAE-VKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACD-ENPDATYDFKSDL 199

Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS-SELGRDFLDKCLRREPGE 220
           WSLG T IEM  G P   D        +   +  PR  ++  S+  + F++ CL +   +
Sbjct: 200 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQ 259

Query: 221 RWSCDQLLKHPFL 233
           R + +QL+KHPF+
Sbjct: 260 RPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 63/201 (31%), Positives = 92/201 (45%), Gaps = 54/201 (26%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG-----AAGEAT 127
           DE  +R + + I+  +++ HS NI+H D+K +N+LV   S  VKL DFG     AA    
Sbjct: 98  DESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEV 156

Query: 128 VSD---TRGVKIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW---- 178
            +D   TR           W  APE++ G+ + G   D+W++GC + EM+TG+P +    
Sbjct: 157 YTDYVATR-----------WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205

Query: 179 --------------------EDFGANTL---SRIGFSDELP----RFPTQSSELGRDFLD 211
                               E F  N L    R+    E+     RFP  S  +  D   
Sbjct: 206 DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV-LDLAK 264

Query: 212 KCLRREPGERWSCDQLLKHPF 232
           +CLR +P +R S  QLL H F
Sbjct: 265 QCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 48/223 (21%)

Query: 49  RNLHL--EYLPGGTVSDLATTLNAYADEIT---LRSHTYCIVSALKYLHSRNIVHCDVKG 103
            +L+L  E++     +DL   +      +    ++S+ Y ++  L + HS  I+H D+K 
Sbjct: 71  GDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKP 126

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEVVRGECQ-GPESDV 161
           +N+L+      +KLADFG A       +            W  APE++ G+       D+
Sbjct: 127 ENLLINTEGV-LKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182

Query: 162 WSLGCTIIEMVTGKPAWEDFGAN---TLSRI-----------------GFSDELPRFPTQ 201
           WS+GC   E+++ +P +   G +    L +I                    +    FP +
Sbjct: 183 WSVGCIFAELLSRRPLFP--GKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240

Query: 202 -----------SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
                      +S    D L + L  +P +R + +Q L HP+ 
Sbjct: 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 69/195 (35%), Positives = 97/195 (49%), Gaps = 15/195 (7%)

Query: 51  LHLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L LE   GG+V++L   L       DE  +    Y  +  L++LH+  I+H DVKG N+L
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160

Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-----DVW 162
           +      VKL DFG +  A ++ TR  +    G+P WMAPEV+  E Q   S     DVW
Sbjct: 161 LTTEGG-VKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217

Query: 163 SLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELP--RFPTQSSELGRDFLDKCLRREPG 219
           SLG T IE+  G P   D     TL +I   +  P    P +       F+ +CL ++  
Sbjct: 218 SLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPTLLHPEKWCRSFNHFISQCLIKDFE 276

Query: 220 ERWSCDQLLKHPFLQ 234
            R S   LL+HPF++
Sbjct: 277 ARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 52/188 (27%), Positives = 97/188 (51%), Gaps = 16/188 (8%)

Query: 53  LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +EY  GGT+ D +        +E  +  + + IVSA+ Y+H   I+H D+K  N+ +   
Sbjct: 78  MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL-TK 136

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
           +  +KL DFG +     S+    +    G+P +M+PE+ +G     +SD+W+LGC + E+
Sbjct: 137 AGLIKLGDFGISKILG-SEYSMAE-TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYEL 194

Query: 172 VTGKPAWEDFGANTLSRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCD 225
           +T K  ++    N L+ +       ++  +  +   SSEL    +   L+++P +R + D
Sbjct: 195 LTLKRTFD--ATNPLNLVVKIVQGNYTPVVSVY---SSEL-ISLVHSLLQQDPEKRPTAD 248

Query: 226 QLLKHPFL 233
           ++L  P L
Sbjct: 249 EVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 61/174 (35%), Positives = 92/174 (52%), Gaps = 25/174 (14%)

Query: 84  IVSALKYLHSRN-IVHCDVKGKNVLVGPNSS-FVKLADFGAAGEA--TVSDTRGVKIQPR 139
           +V  L YL++ + I+H D+K  N+LV  NS   +KL DFG +GE   +++DT        
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILV--NSRGQIKLCDFGVSGELINSIADTF------V 163

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW---EDFGANTLSRIGFSDEL- 195
           G+  +M+PE ++G     +SDVWSLG +IIE+  GK  +             +G  D L 
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ 223

Query: 196 -------PRFPTQS-SELGRDFLDKCLRREPGERWSCDQLLK-HPFLQSVSPSD 240
                  PR P+    E  RDF+D CL ++P ER +  QL    PF+Q++  S+
Sbjct: 224 QIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 91.1 bits (226), Expect = 6e-21
 Identities = 52/183 (28%), Positives = 95/183 (51%), Gaps = 10/183 (5%)

Query: 53  LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +EY PGGT+++ +    N+  DE T+      I+ AL ++H++ I+H D+K +N+L+  +
Sbjct: 78  MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VK+ DFG +   +        +   G+P +++PE+  G+    +SD+W+LGC + E+
Sbjct: 138 KMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194

Query: 172 VTGKPAWEDFGAN---TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            + K A+E   AN    + +I      P     S +L R  +   L  +P +R    Q++
Sbjct: 195 ASLKRAFE--AANLPALVLKIMSGTFAPISDRYSPDL-RQLILSMLNLDPSKRPQLSQIM 251

Query: 229 KHP 231
             P
Sbjct: 252 AQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 72/295 (24%), Positives = 112/295 (37%), Gaps = 87/295 (29%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA---YLGDDVSYEAPTTS----SSCRNLHLEYL------ 56
           IG G++G V  A ++  G++ A      ++     P T+       + L    +      
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 57  ----PGGTVS--------DLATTLNAYADEIT---LRSHTYCIVSALKYLHSRNIVHCDV 101
                 G++         DL   L++   + T   ++ +   ++  L+YLHS  I+H D+
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDI 126

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP--------LWM-APEVVRG 152
           KG N+L+  N   +KLADFG A        R      R S         LW   PE++ G
Sbjct: 127 KGSNILIN-NDGVLKLADFGLA--------R--PYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 153 ECQ-GPESDVWSLGCTIIEMVTGKP------------------------AWEDF----GA 183
             + GPE D+WS+GC + E+  GKP                         W         
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235

Query: 184 NTLS------RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF 232
             L       R    +        S+    D LDK L  +P +R S DQ L+H +
Sbjct: 236 ENLKPKKPYKRR-LREFFKHLIDPSA---LDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 69/219 (31%), Positives = 100/219 (45%), Gaps = 30/219 (13%)

Query: 54  EYLPGGTVSDLATTLNAYAD--EITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           E++ GG+       L+ Y    E  L      +V  L YL S  I+H DVK  N+LV   
Sbjct: 79  EFMDGGS-------LDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR 131

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VKL DFG + +   S    +     G+  +MAPE + GE  G  SDVWSLG + +E+
Sbjct: 132 GQ-VKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186

Query: 172 VTGKPAWEDFGANTLSRIGFS-------DELPRFPT-QSSELGRDFLDKCLRREPGERWS 223
             G+  +     N  S +          ++ P  P  Q SE    F+ +C+R++P ER +
Sbjct: 187 ALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246

Query: 224 CDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
            + L+ HPF+  V  +D N    S       WV    EE
Sbjct: 247 PENLMDHPFI--VQYNDGNAEVVSM------WVCRALEE 277

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 68/198 (34%), Positives = 95/198 (47%), Gaps = 23/198 (11%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL---KYLHSRNIVHCDVKGKNVL 107
           L LE   GG+V+DL        + +      Y +  AL   ++LH    +H DVKG N+L
Sbjct: 97  LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNIL 156

Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-----DVW 162
           +      VKL DFG +  A ++ TR  +    G+P WMAPEV+  E Q   +     DVW
Sbjct: 157 LTTEGG-VKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213

Query: 163 SLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPT---QSSELG----RDFLDKCLR 215
           SLG T IE+  G P   D       R  F  ++PR P       EL      DF+ KCL 
Sbjct: 214 SLGITAIELGDGDPPLADLHP---MRALF--KIPRNPPPTLHQPELWSNEFNDFIRKCLT 268

Query: 216 REPGERWSCDQLLKHPFL 233
           ++  +R +   LL+H F+
Sbjct: 269 KDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.7 bits (220), Expect = 6e-20
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 16/175 (9%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
            E     +   I+  L++LH R IV+ D+K +NVL+  +   V+++D G A    V    
Sbjct: 93  PEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLA----VELKG 147

Query: 133 GVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LS 187
           G KI+ R G+P +MAPEV++GE      D ++LGCT+ EM+ G+  +           L 
Sbjct: 148 GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207

Query: 188 RIGFSDELPRFPTQSSELGRDFLDKCLRREPGER-----WSCDQLLKHPFLQSVS 237
           R      +  +P + S   +D  +  L+++P +R      S D++ +HP  + ++
Sbjct: 208 RRTLEMAV-EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 52/210 (24%)

Query: 74  EITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFVKLADFGAAGEATVSDTR 132
           ++  R   Y ++ ALKY+HS N++H D+K  N+L+  NS   VKLADFG A   ++S+  
Sbjct: 106 DVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL--NSDCRVKLADFGLA--RSLSELE 161

Query: 133 GVKIQP--------RGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW---- 178
                P        R    W  APE++ G  +  +  D+WS+GC + EM+ GKP +    
Sbjct: 162 ENPENPVLTDYVATR----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217

Query: 179 -----------------ED-------FGANTLSRIGFSDELP---RFPTQSSELGRDFLD 211
                            ED       F A  L  +      P     P  S +   D L 
Sbjct: 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDD-ALDLLK 276

Query: 212 KCLRREPGERWSCDQLLKHPFL-QSVSPSD 240
           K L   P +R + ++ L+HP++ Q  +PSD
Sbjct: 277 KLLVFNPNKRLTAEEALEHPYVAQFHNPSD 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 28/238 (11%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY+PGG    L   L   +++   R +   +  A+  LH    +H D+K +N L+  
Sbjct: 78  LAMEYVPGGDFRTLLNNLGVLSEDHA-RFYMAEMFEAVDALHELGYIHRDLKPENFLID- 135

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
            S  +KL DFG +    V+    V     GSP +MAPEV+RG+      D WSLGC + E
Sbjct: 136 ASGHIKLTDFGLSKG-IVTYANSVV----GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE 190

Query: 171 MVTGKPAWEDFGAN-----------TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
            + G P +     N           TL R  + D  PRF    S+   D + K +  +P 
Sbjct: 191 FLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD--PRF--NLSDEAWDLITKLI-NDPS 245

Query: 220 ERW-SCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASAR 276
            R+ S + +  HPF + V   D N + E  P  V + + SE +     D E  +  A+
Sbjct: 246 RRFGSLEDIKNHPFFKEV---DWNELRELKPPFVPE-LESEIDTGYFDDFENEDDMAK 299

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 44/206 (21%)

Query: 63  DLATTLNAYA----DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA 118
           DLAT L+          T++     ++  + +LHS  IVH D+K +N+LV  +   VK+A
Sbjct: 91  DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT-SDGQVKIA 149

Query: 119 DFGAAGEATVSDTRGVKIQPRGSP----LWM-APEVVRGECQGPESDVWSLGCTIIEM-- 171
           DFG A        R    +   +     LW  APEV+         D+WS+GC   E+  
Sbjct: 150 DFGLA--------RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR 201

Query: 172 -------------------VTGKPAWEDFGANT-LSRIGFSDELPR----FPTQSSELGR 207
                              V G P+ E++  N  L R  F    PR    F  +  E G 
Sbjct: 202 RRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGL 261

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFL 233
           D L K L   P +R S  + L+HP+ 
Sbjct: 262 DLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 45/265 (16%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGD-------------------------VFAYLG--DD 36
           +V+ K IG GSFG   +   + +G                          V + +   + 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAY------ADEITLRSHTYCIVSALKY 90
           V Y+     +    + ++Y  GG   DL   +NA        D+I       C+  ALK+
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICL--ALKH 116

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG--EATVSDTRGVKIQPRGSPLWMAPE 148
           +H R I+H D+K +N+ +  + + +KL DFG A    +TV   R       G+P +++PE
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGT-IKLGDFGIARVLNSTVELARTCI----GTPYYLSPE 171

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD 208
           +        +SD+W+LGC + EM T K A+E      L         P   +  S   R+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRN 231

Query: 209 FLDKCLRREPGERWSCDQLLKHPFL 233
            + +  +R P +R S + +L+  F+
Sbjct: 232 LVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 17/216 (7%)

Query: 45  SSSCRNLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
           + +  +L L+Y+ GG   +L T L    +  E  +R +   IV AL +LH   I++ D+K
Sbjct: 76  TDTKLHLILDYVNGG---ELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIK 132

Query: 103 GKNVLVGPNSSFVKLADFGAAGE-ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-- 159
            +N+L+      V L DFG + E     + R       G+  +MAPEV+RG   G +   
Sbjct: 133 LENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFC--GTIEYMAPEVIRGGSGGHDKAV 189

Query: 160 DVWSLGCTIIEMVTG-KPAWEDFGANTLSRIG--FSDELPRFPTQSSELGRDFLDKCLRR 216
           D WSLG    E++TG  P   D   N+ S I        P FP   S   RDF+ K L +
Sbjct: 190 DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEK 249

Query: 217 EPGERWSC---DQLLKHPFLQSVSPSDANTVAESSP 249
           +P +R      D++  HPF Q +   D       +P
Sbjct: 250 DPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 81/284 (28%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAY-----------------------LGDDVSYEAP 42
             K +G GSFG V +   + +G  +A                        L    S   P
Sbjct: 5   FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ---SIRHP 61

Query: 43  ------TTSSSCRNLHL--EYLPGGTVSDLATTLNA-----------YADEITLRSHTYC 83
                  +     NL+L  EY+PGG   +L + L             YA ++ L      
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGG---ELFSHLRKSGRFPEPVARFYAAQVVL------ 112

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---- 139
              AL+YLHS +IV+ D+K +N+L+  +  ++K+ DFG A           +++ R    
Sbjct: 113 ---ALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFA----------KRVKGRTYTL 158

Query: 140 -GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF 198
            G+P ++APE++  +  G   D W+LG  I EM+ G P + D     +       ++ RF
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV-RF 217

Query: 199 PTQSSELGRDFLDKCLRREPGERW------SCDQLLKHPFLQSV 236
           P+  S   +D +   L+ +  +R         D +  HP+   +
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVND-IKNHPWFAGI 260

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 56/234 (23%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPN 111
           +E++ GG++ D          E  L   +  ++  L YL     I+H DVK  N+LV   
Sbjct: 78  MEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR 136

Query: 112 SSFVKLADFGAAGEATVS------DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
              +KL DFG +G+   S       TR           +M+PE ++G     +SD+WSLG
Sbjct: 137 GE-IKLCDFGVSGQLIDSMANSFVGTRS----------YMSPERLQGTHYTVQSDIWSLG 185

Query: 166 CTIIEMVTGK-----------------PAWEDFGANTLSRIG--FSD--------EL--- 195
            +++EM  G+                 P  E     +   +     D        EL   
Sbjct: 186 LSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDY 245

Query: 196 ------PRFPTQS-SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
                 P+ P+ + S+  +DF+DKCL++ P ER    +L KHPF++     + +
Sbjct: 246 IVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVD 299

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 25/194 (12%)

Query: 53  LEYLPGGTVSD-------LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +E+  GG++ D       L+ +  AY    TL+         L YLHS+  +H D+KG N
Sbjct: 85  MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ--------GLYYLHSKGKMHRDIKGAN 136

Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES---DVW 162
           +L+  N   VKLADFG +  A ++ T   +    G+P WMAPEV   E +G  +   D+W
Sbjct: 137 ILLTDN-GHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 193

Query: 163 SLGCTIIEMVTGKPAWEDF----GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
           ++G T IE+   +P   D         +++  F     +   + S     F+   L + P
Sbjct: 194 AVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNP 253

Query: 219 GERWSCDQLLKHPF 232
            +R + ++LL+HPF
Sbjct: 254 KKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 21/205 (10%)

Query: 50  NLHLEYLPGGTV-SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           +L L+Y+ GG + + L+        E+ + S    IV AL++LH   I++ D+K +N+L+
Sbjct: 81  HLILDYINGGELFTHLSQRERFKEQEVQIYSGE--IVLALEHLHKLGIIYRDIKLENILL 138

Query: 109 GPNSSFVKLADFGAAGEATVSDT-RGVKIQPRGSPLWMAPEVVRGECQGPES--DVWSLG 165
             N   V L DFG + E    +  R       G+  +MAP++VRG   G +   D WS+G
Sbjct: 139 DSNGHVV-LTDFGLSKEFHEDEVERAYSFC--GTIEYMAPDIVRGGDGGHDKAVDWWSMG 195

Query: 166 CTIIEMVTGKPAW-----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
             + E++TG   +     ++  A    RI  S+  P +P + S L +D + + L ++P +
Sbjct: 196 VLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKK 253

Query: 221 RWSC-----DQLLKHPFLQSVSPSD 240
           R  C     D++ KHPF Q ++  D
Sbjct: 254 RLGCGPSDADEIKKHPFFQKINWDD 278

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 10/155 (6%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
            E T+  +   + SAL+++HS+ I+H D+K  NV +      VKL D G  G    S T 
Sbjct: 104 PERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV-VKLGDLGL-GRFFSSKTT 161

Query: 133 GV--KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS--- 187
                +   G+P +M+PE +       +SD+WSLGC + EM   +  +     N  S   
Sbjct: 162 AAHSLV---GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218

Query: 188 RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
           +I   D  P      SE  RD + +C+  +P +R 
Sbjct: 219 KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 80/306 (26%), Positives = 130/306 (42%), Gaps = 46/306 (15%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDV------------SYEAP---- 42
           K +G+GSFG V +A  +     FA          + DDV            ++E P    
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 43  --TTSSSCRNLH--LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
              T  +  NL   +EYL GG   DL   + +       R+  Y   I+  L++LHS+ I
Sbjct: 61  LYCTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           V+ D+K  N+L+  +   +K+ADFG   E  + D +       G+P ++APE++ G+   
Sbjct: 118 VYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEILLGQKYN 174

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
              D WS G  + EM+ G+  +       L +    D  P +P   +   +D L K   R
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVR 233

Query: 217 EPGERWSCD-QLLKHPFLQSVSPSDANTVAESSP-----RCVLDWVNSEFEEEGTSDDEK 270
           EP  R      + +HPF + +  S         P     +   D  N  F++E  ++  +
Sbjct: 234 EPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSN--FDKEFLNEKPR 291

Query: 271 LEASAR 276
           L  + R
Sbjct: 292 LSVTDR 297

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 23/180 (12%)

Query: 81  TYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAG--EATVSDTRGVKIQ 137
               V AL YL     I+H DVK  N+L+  N + +KL DFG +G    +++ TR    +
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCR 171

Query: 138 PRGSPLWMAPEVVRGECQGP---ESDVWSLGCTIIEMVTGK---PAWED-FGANTLSRIG 190
           P     +MAPE +    +      SDVWSLG T+ E+ TGK   P W   F  + L+++ 
Sbjct: 172 P-----YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF--DQLTQVV 224

Query: 191 FSDELPRFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
             D  P          S    +F++ CL ++  +R    +LL+HPF++     + +  A 
Sbjct: 225 KGDP-PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAY 283

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 8/153 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   LK++H R I+H D+K +N+ +  N    KL DFG A    ++D+  +     G+P 
Sbjct: 110 ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA--RQLNDSMELAYTCVGTPY 167

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           +++PE+ +      ++D+WSLGC + E+ T K  +E    N L ++        F   S 
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLVLKICQGYFAPISP 224

Query: 204 ELGRD---FLDKCLRREPGERWSCDQLLKHPFL 233
              RD    + +  +  P +R S   +LK PFL
Sbjct: 225 NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 44/192 (22%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           ++S+ Y ++  + Y HS  ++H D+K +N+L+    + +KLADFG A        R   +
Sbjct: 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA-LKLADFGLA--------RAFGV 151

Query: 137 QPRG-----SPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWE-DFGANTLSR 188
             R        LW  APE++ G  Q     D+WS+GC   EMV  +P +  D   + L R
Sbjct: 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211

Query: 189 I----GFSDE---------------LPRFPTQS--------SELGRDFLDKCLRREPGER 221
           I    G  DE                P++  Q          E G D L K L  +P +R
Sbjct: 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKR 271

Query: 222 WSCDQLLKHPFL 233
            S    L+HP+ 
Sbjct: 272 ISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 48/151 (31%), Positives = 81/151 (53%), Gaps = 5/151 (3%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I  AL+YLH ++I+H D+K +NV +   ++ +K+ D G A    + +   +     G+P 
Sbjct: 111 IAMALQYLHEKHILHRDLKTQNVFL-TRTNIIKVGDLGIA--RVLENQCDMASTLIGTPY 167

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ-S 202
           +M+PE+   +    +SDVW+LGC + EM T K A+     N+L       +LP  P   S
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYS 227

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            ELG + +   L + P +R S   +L+ P++
Sbjct: 228 PELG-ELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 41/227 (18%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  LKY+HS N++H D+K  N+L+  N   +K+ DFG A   T S+      +   +
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLA--RTTSEKGDFMTEYVVT 171

Query: 142 PLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW-------------EDFGANTLS 187
             + APE++    +     DVWS+GC   E++  KP +             E  G+ +  
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231

Query: 188 RIGFSD---------ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKH 230
            +GF            LP  P QS        + L  D L+K L  +P +R + ++ L H
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291

Query: 231 PFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARE 277
           P+L S+       V ++         + +FEE+  ++++  E    E
Sbjct: 292 PYLASLHDPSDEPVCQTP-------FSFDFEEDALTEEDIKELIYNE 331

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 58/187 (31%), Positives = 92/187 (49%), Gaps = 11/187 (5%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY  GG++ D+       + E+ +       +  L YLHS+  +H D+KG N+L+  N 
Sbjct: 85  MEYCGGGSLQDIYHVTGPLS-ELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG 143

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES---DVWSLGCTII 169
             VKLADFG A  A ++ T   +    G+P WMAPEV   E  G  +   D+W++G T I
Sbjct: 144 D-VKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAI 200

Query: 170 EMVTGKPAWEDF----GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCD 225
           E+   +P   D         +S+  F     +  T+ S    +F+   L + P +R + +
Sbjct: 201 ELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAE 260

Query: 226 QLLKHPF 232
           +LL H F
Sbjct: 261 RLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 66/236 (27%), Positives = 101/236 (42%), Gaps = 61/236 (25%)

Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S  Y I+  LKY+HS N++H D+K  N+LV  +   +K+ DFG A        RG    
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLA--------RGFSEN 158

Query: 138 PRGSPLWM----------APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWE--DF--- 181
           P  +  +M          APE++       ++ DVWS+GC + E++  KP ++  D+   
Sbjct: 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218

Query: 182 -----------GANTLSRIG------FSDELPRFPTQS--------SELGRDFLDKCLRR 216
                         TLSRIG      +   LP  P +         + L  D L+K L  
Sbjct: 219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF 278

Query: 217 EPGERWSCDQLLKHPFLQSV-SPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKL 271
           +P +R S ++ L+HP+L     P D        P C       +F  E     E+L
Sbjct: 279 DPTKRISVEEALEHPYLAIWHDPDD-------EPVCQ---KPFDFSFESEDSMEEL 324

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 39/261 (14%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA--------YLGDD-------------VSYEAP-TTS 45
           K +G+GSFG V +A  +   + FA         L DD             +++E P  T 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 46  SSCR---NLHL----EYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
             C      HL    EYL GG   DL   + +    DE   R +   I+  L++LH + I
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K  NVL+  +   +K+ADFG   E    + +       G+P ++APE+++G+   
Sbjct: 118 IYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFC--GTPDYIAPEILKGQKYN 174

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
              D WS G  + EM+ G+  +     + L      ++ P FP   S+  +D L K   R
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD-SILNDRPHFPRWISKEAKDCLSKLFER 233

Query: 217 EPGERWSCD-QLLKHPFLQSV 236
           +P +R   D  + +HPF + +
Sbjct: 234 DPTKRLGVDGDIRQHPFFRGI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 56/184 (30%), Positives = 83/184 (45%), Gaps = 45/184 (24%)

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSP 142
           S + +LH   I+H D+K  N+L+  N   +K+ DFG A   G      T+ V        
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLV------VT 169

Query: 143 LWM-APEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI---------- 189
           LW  APE++ G        D+WS+GC   E++T KP +      + L++I          
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229

Query: 190 ---GFSDELP-----------------RFPTQS-SELGRDFLDKCLRREPGERWSCDQLL 228
              GFS ELP                 +FP  S S+ G D L++ L  +P +R S +  L
Sbjct: 230 IWPGFS-ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288

Query: 229 KHPF 232
           KHP+
Sbjct: 289 KHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 54/217 (24%)

Query: 52  HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +L+ LP G           Y D   ++S+ Y I+  + + HSR ++H D+K +N+L+  N
Sbjct: 88  YLDSLPKG----------QYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID-N 136

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRG-----SPLWM-APEVVRGECQ-GPESDVWSL 164
              +KLADFG A        R   I  R        LW  APEV+ G  +     D+WS+
Sbjct: 137 KGVIKLADFGLA--------RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSI 188

Query: 165 GCTIIEMVTGKPAWE-DFGANTLSRI----------------GFSDELPRFPTQS----- 202
           G    EM T KP +  D   + L RI                   D    FP        
Sbjct: 189 GTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR 248

Query: 203 ------SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
                  E G D L+K L  +P +R S  + L HP+ 
Sbjct: 249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.9 bits (198), Expect = 9e-17
 Identities = 70/298 (23%), Positives = 113/298 (37%), Gaps = 84/298 (28%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDD---------------VSY 39
           + +GK +G G++  V  A D+  G + A             D               + +
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 40  E------APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLR-SHTYCIVS----AL 88
                        S  NL  E++     +DL   +      I L  +     +      L
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME----TDLEKVIKD--KSIVLTPADIKSYMLMTLRGL 115

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-AP 147
           +YLHS  I+H D+K  N+L+  +   +KLADFG A  +  S  R  K+  +    W  AP
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGV-LKLADFGLA-RSFGSPNR--KMTHQVVTRWYRAP 171

Query: 148 EVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDF--GANTLSRIG--------FSDE-- 194
           E++ G    G   D+WS+GC   E++   P    F  G + + ++G         ++E  
Sbjct: 172 ELLFGARHYGVGVDMWSVGCIFAELLLRVP----FLPGDSDIDQLGKIFEALGTPTEENW 227

Query: 195 -----LP---------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF 232
                LP                FP  S +   D L + L   P +R +  Q L+HP+
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDD-ALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 42/126 (33%), Positives = 62/126 (49%), Gaps = 9/126 (7%)

Query: 53  LEYLPGGTVSDLATTLNAYADEIT---LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            EY+PGG   DL   L  + +++T   L      I   ++YL S+N VH D+  +N LV 
Sbjct: 80  TEYMPGG---DLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVT 136

Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTI 168
             +  VK++DFG +      D    K      P+ WMAPE ++      +SDVWS G  +
Sbjct: 137 -ENLVVKISDFGLS-RDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194

Query: 169 IEMVTG 174
            E+ T 
Sbjct: 195 WEIFTL 200

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 13/175 (7%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRS-HTYC--IVSALKYLHSRNIVHCDVKGKNVLVG 109
           +EY+ GG   DL + L     +++L    ++   I   ++YL S+N +H D+  +N LVG
Sbjct: 80  MEYMEGG---DLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 136

Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTI 168
            N   VK++DFG + +    D    + +    P+ WMAPE ++      +SDVWS G  +
Sbjct: 137 ENLV-VKISDFGLSRDLYDDDY--YRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 193

Query: 169 IEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
            E+ T   +P         L  +     LP+ P    EL  D + +C   +P +R
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL-YDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 50/169 (29%), Positives = 88/169 (52%), Gaps = 17/169 (10%)

Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQ 137
           +T  I+S L++LH R I++ D+K +NVL+  N   V+++D G A E     S T+G    
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA-- 158

Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRIGFSD 193
             G+P +MAPE+++GE      D ++LG T+ EM+  +  +   G       L +   +D
Sbjct: 159 --GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND 216

Query: 194 ELPRFPTQSSELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVS 237
            +  +P + S   + F +  L ++P +R      +CD L  HP  + ++
Sbjct: 217 SV-TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 70/289 (24%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---APTT---------------------- 44
           IG G++G V  A DR   +  A     +  E    P+T                      
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 45  --SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
             S     L  EYL       + ++ +   +   ++++ Y I+  + Y HS  ++H D+K
Sbjct: 70  VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLK 129

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-----SPLWM-APEVVRGECQ- 155
            +N+L+   ++ +KLADFG A        R   I  R        LW  APE++ G    
Sbjct: 130 PQNLLIDRRTNALKLADFGLA--------RAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181

Query: 156 GPESDVWSLGCTIIEMVTGKPAW--------------------EDFGANTLSRIGFSDEL 195
               D+WS+GC   EMV  KP +                    E+      S   +    
Sbjct: 182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAF 241

Query: 196 PRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           P++P +            G D L K LR +P +R +    L+H + + +
Sbjct: 242 PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Length = 294

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 64/285 (22%), Positives = 112/285 (39%), Gaps = 68/285 (23%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY-----------LGDDVSYEAPTTSSSCRNLH----LE 54
           IG G+ G V  A DR  G+  A            + +    E      +C++ +    L+
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREI-KALQACQHPYVVKLLD 66

Query: 55  YLPGGT---------VSDLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVK 102
             P G+          SDL+  L      +     +S+   ++  + Y+H+  I+H D+K
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ--GPESD 160
             N+L+  +   +K+ADFG A      +   +      +  + APE++ G  +   P  D
Sbjct: 127 PANLLISADGV-LKIADFGLA-RLFSEEEPRLYSHQVATRWYRAPELLYG-ARKYDPGVD 183

Query: 161 VWSLGCTIIEMVTGKPAWEDFGAN---TLSRI-------------GFSDELP-----RFP 199
           +W++GC   E++ G P +   G N    L+ +             G +  LP      FP
Sbjct: 184 LWAVGCIFAELLNGSPLFP--GENDIEQLAIVFRTLGTPNEETWPGLTS-LPDYNKITFP 240

Query: 200 TQ-----------SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
                        +S    D L   L  +P +R S  + L+HP+ 
Sbjct: 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 72/267 (26%), Positives = 117/267 (43%), Gaps = 46/267 (17%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA--YLGDDV-----SYEAPTTSSSCRNL---H----- 52
           + +G+GSFG V +A  + +G ++A   L  DV       E   T     +L   H     
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 53  --------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
                         +E++ GG   DL   +      DE   R +   I SAL +LH + I
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGI 117

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQ 155
           ++ D+K  NVL+  +    KLADFG   E   +   G       G+P ++APE+++    
Sbjct: 118 IYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFN---GKTTSTFCGTPDYIAPEILQEMLY 173

Query: 156 GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
           GP  D W++G  + EM+ G   +E    + L     +DE+  +PT  S+   D L   + 
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-YPTWLSQDAVDILKAFMT 232

Query: 216 REPGERWSC------DQLLKHPFLQSV 236
           + P  R         + +L+HPF + +
Sbjct: 233 KNPTMRLGSLTLGGEEAILRHPFFKEL 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 51/211 (24%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYEAPT------------------ 43
           R K +G G+FG V++  DR +   +A     + + +  +                     
Sbjct: 5   RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII 64

Query: 44  ----TSSSCRNLH--LEYLPGGTV-SDL-------ATTLNAYADEITLRSHTYCIVSALK 89
               T    R L+  +EY+PGG + S L        +T   YA EI         V AL+
Sbjct: 65  RLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI---------VCALE 115

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
           YLHS+ IV+ D+K +N+L+      +KL DFG A +  + D R   +   G+P ++APEV
Sbjct: 116 YLHSKEIVYRDLKPENILLD-KEGHIKLTDFGFAKK--LRD-RTWTLC--GTPEYLAPEV 169

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWED 180
           ++ +      D W+LG  I EM+ G P + D
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 76.8 bits (190), Expect = 5e-16
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 30/197 (15%)

Query: 53  LEYLPGGTVSDLATTL--------NAYADEITLR---SHTYCIVSALKYLHSRNIVHCDV 101
           LEY+ GG   DL   L        +     ++L+   S    I   ++YL S+  VH D+
Sbjct: 75  LEYMEGG---DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDL 131

Query: 102 KGKNVLVGPNSSFVKLADFG-----AAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQ 155
             +N LVG +   VK++DFG        +     T G        P+ WMAPE ++    
Sbjct: 132 AARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGK------LPIRWMAPESLKDGIF 184

Query: 156 GPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ-SSELGRDFLDKC 213
             +SDVWS G  + E+ T G   +       +            P     EL  + +  C
Sbjct: 185 TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL-YELMLSC 243

Query: 214 LRREPGERWSCDQLLKH 230
            + +P +R +  +L++ 
Sbjct: 244 WQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 77.2 bits (191), Expect = 6e-16
 Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 58/203 (28%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF-VKLADFGAAGE------ 125
            E  +RS  Y I+  L ++H     H D+K +N+LV  +    VK+ADFG A E      
Sbjct: 97  SESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLAREIRSRPP 154

Query: 126 --ATVSDTRGVKIQPRGSPLWM-APEVV-RGECQGPESDVWSLGCTIIEMVT-------- 173
               VS TR           W  APE++ R        D+W+LGC + E+ T        
Sbjct: 155 YTDYVS-TR-----------WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202

Query: 174 -------------GKPAWEDF--GANTLSRIGFSDELPRFP--------TQSSELGRDFL 210
                        G P  +D+  G    S++GF    P+F           +S    D +
Sbjct: 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR--FPQFAPTSLHQLIPNASPEAIDLI 260

Query: 211 DKCLRREPGERWSCDQLLKHPFL 233
              LR +P +R +  Q L+HP+ 
Sbjct: 261 KDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.8 bits (189), Expect = 7e-16
 Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 39/256 (15%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC--------------------- 48
           IG+GSFG V   V + +  V+A    D+S                               
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 49  ------RNLHLEYLPGGTVSDLATTLNAY-----ADEITLRSHTYCIVSALKYLHSRNIV 97
                  N+ +EY   G +  L   L         ++   R     I+  L +LHS+ I+
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKL---LKMQRGRPLPEDQVWRFFIQ-ILLGLAHLHSKKIL 123

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           H D+K  N+ +    + VK+ D G A    +SD         G+P +++PE+   +    
Sbjct: 124 HRDIKSLNLFLDAYDN-VKIGDLGVA--KLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180

Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE 217
           +SDVW+LG  + E  TGK  ++      L         P      S+     +D+CL ++
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240

Query: 218 PGERWSCDQLLKHPFL 233
             +R    QLL++P L
Sbjct: 241 YRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 4/140 (2%)

Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+        R+L L  EYLP G++ D         +   L   +  I   + YL S+
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGE 153
             +H D+  +N+LV  +   VK++DFG A             +P  SP+ W APE +R  
Sbjct: 129 RYIHRDLAARNILV-ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 154 CQGPESDVWSLGCTIIEMVT 173
                SDVWS G T+ E+ T
Sbjct: 188 KFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 9/162 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           IVSAL+YLHSR++V+ D+K +N+++      +K+ DFG   E  +SD   +K    G+P 
Sbjct: 104 IVSALEYLHSRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEG-ISDGATMKTFC-GTPE 160

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           ++APEV+     G   D W LG  + EM+ G+  + +     L  +   +E+ RFP   S
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLS 219

Query: 204 ELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPSD 240
              +  L   L+++P +R         ++++H F  S++  D
Sbjct: 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 70/262 (26%), Positives = 119/262 (45%), Gaps = 39/262 (14%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDV------------SYEAP---- 42
           K +G+GSFG V +A  +  G+ FA          + DDV            ++E P    
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 43  --TTSSSCRNLH--LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
              T  +  +L   +E+L GG   DL   +         R+  Y   IV  L++LHS+ I
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K  NV++  +   +K+ADFG   E    D R       G+P ++APE+++G    
Sbjct: 118 IYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFC--GTPDYIAPEILQGLKYT 174

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
              D WS G  + EM+ G+  +     + L       + P +P   ++  +D L+K   R
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE-SIRVDTPHYPRWITKESKDILEKLFER 233

Query: 217 EPGERWSCDQLLK-HPFLQSVS 237
           +P  R      ++ HPF ++++
Sbjct: 234 DPTRRLGVVGNIRGHPFFKTIN 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 73/234 (31%), Positives = 112/234 (47%), Gaps = 27/234 (11%)

Query: 50  NLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           +L L+Y+ GG   ++ T L       E  +R ++  I+ AL++LH   IV+ D+K +N+L
Sbjct: 81  HLILDYVSGG---EMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137

Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC-QGPESDVWSLGC 166
           +      V L DFG + E  +S+ +       G+  +MAPE++RG+   G   D WSLG 
Sbjct: 138 LDSEGHVV-LTDFGLSKE-FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI 195

Query: 167 TIIEMVTGKPAWEDFGA-NTLS----RIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
            I E++TG   +   G  NT S    RI   D  P FP+      +D L K LR++P +R
Sbjct: 196 LIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKR 253

Query: 222 -----WSCDQLLKHPFLQSVSPSDANTVAESSP-----RCVLDWVNSEFEEEGT 265
                    ++ +HPF + +          + P     R  LD  N  F EE T
Sbjct: 254 LGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGN--FAEEFT 305

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 42/206 (20%)

Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPR 139
            Y I+  LKY+HS N++H D+K  N+L+  N   +K+ DFG A  A    D  G   +  
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPEHDHTGFLTEYV 170

Query: 140 GSPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW-------------------- 178
            +  + APE++       ++ D+WS+GC + EM++ +P +                    
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230

Query: 179 -EDFGA----------NTL---SRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC 224
            ED              +L    ++ ++   P     +     D LDK L   P +R + 
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPN----ADPKALDLLDKMLTFNPHKRITV 286

Query: 225 DQLLKHPFLQSV-SPSDANTVAESSP 249
           ++ L HP+L+    PSD     E  P
Sbjct: 287 EEALAHPYLEQYHDPSDEPVAEEPFP 312

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 64/275 (23%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAYL----GDDVSY-EAPTTSSSCR--------------N 50
           +GRG FG V +A  +  G+++A      GD ++  E  +     R              N
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTY---CIVSALKYLHSRN 95
           L             +EY  GG   DL   ++ + D  +     +   C+V  L+YLH   
Sbjct: 67  LFACFQTEDHVCFVMEYAAGG---DL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGEC 154
           IV+ D+K  N+L+     FVK+ADFG   E     D         G+P ++APEV+    
Sbjct: 122 IVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDRTSTFC---GTPEFLAPEVLTETS 177

Query: 155 QGPESDVWSLGCTIIEMVTGKPAW------EDFGANTLSRIGFSDELPRFPTQSSELGRD 208
                D W LG  I EM+ G+  +      E F +     I  +DE  R+P   S     
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS-----I-VNDE-VRYPRFLSREAIS 230

Query: 209 FLDKCLRREP------GERWSCDQLLKHPFLQSVS 237
            + + LRR P      GE+   + + K PF + ++
Sbjct: 231 IMRRLLRRNPERRLGSGEK-DAEDVKKQPFFRDIN 264

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 14/211 (6%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           IVSAL YLHS ++V+ D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P 
Sbjct: 104 IVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKTFC-GTPE 160

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           ++APEV+     G   D W LG  + EM+ G+  + +     L  +   +E+ RFP   S
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLS 219

Query: 204 ELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPSDA---NTVAESSPRCVLDW 255
              +  L   L+++P +R         ++++H F  S++  D           P+   + 
Sbjct: 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSET 279

Query: 256 VNSEFEEEGTSDDEKLEASARERMGKLAGSS 286
               F+EE T+  + +  +  +R   L    
Sbjct: 280 DTRYFDEEFTA--QSITITPPDRYDSLGLLQ 308

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 18/151 (11%)

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWM 145
           Y+H R I+H D+K KN+ +  N   +K+ DFG +    G   ++ T        G+P +M
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTF------TGTPYYM 172

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RIGFSDELPRFPTQS 202
           +PE ++ +    +SD+WSLGC + EM     A+E  G N LS   RI      P  P   
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE--GQNFLSVVLRI-VEGPTPSLPETY 229

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           S      +   L ++P  R S  ++L++PF+
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.1 bits (185), Expect = 5e-15
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 47/202 (23%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-GEATVSDTRGVKIQPRG 140
           Y ++  LKY+HS N++H D+K  N+LV  +   +++ DFG A G ++        +    
Sbjct: 114 YQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 141 SPLWM-APEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPA 177
           +  W  APE++    +   + D+WS+GC   EM                     V G P+
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232

Query: 178 WEDFGANTLSRIG------FSDELPR---------FPTQSSELGRDFLDKCLRREPGERW 222
            E+     L+RIG      +   LPR         FP  S E   D L + L+ +P ER 
Sbjct: 233 -EEV----LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE-ALDLLSQMLQFDPEERI 286

Query: 223 SCDQLLKHPFLQS-VSPSDANT 243
           + +Q L+HPFL     P D  T
Sbjct: 287 TVEQALQHPFLAQYHDPDDEPT 308

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 74.1 bits (183), Expect = 5e-15
 Identities = 53/173 (30%), Positives = 82/173 (47%), Gaps = 8/173 (4%)

Query: 53  LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +EY+PGG + D L            L S    I   ++YL S+N +H D+  +N LVG N
Sbjct: 80  MEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN 139

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIE 170
              VK++DFG + +    D    K++    P+ WMAPE ++      +SDVWS G  + E
Sbjct: 140 LV-VKISDFGLSRDLYDDDY--YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWE 196

Query: 171 MVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           + T G+  +     A  L  +     LP+ P    EL    + +C   +P +R
Sbjct: 197 IFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL-YKLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 58/288 (20%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--LGD-DVSYEAPTT----------SSSCR---NL 51
           K IGRG+FG V V   +  G V+A   L   ++   A T           +   R   NL
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 52  H------------LEYLPGGTVSDLATTLNAYADEI---TLRSHTYCIVSALKYLHSRNI 96
           H            ++Y  GG   DL T L+ + D +     R +   +V A+  +H    
Sbjct: 67  HYAFQDENNLYLVMDYYVGG---DLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY 123

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVR- 151
           VH D+K  NVL+  N   ++LADFG+      + TV     V     G+P +++PE+++ 
Sbjct: 124 VHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAV-----GTPDYISPEILQA 177

Query: 152 ---GECQ-GPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPTQS---S 203
              G+ + GPE D WSLG  + EM+ G+ P + +    T  +I    E  +FP      S
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVS 237

Query: 204 ELGRDFLDK--CLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
           E  +D + +  C       R        HPF + +   D + +  S+ 
Sbjct: 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI---DWDNIRNSTA 282

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 75.5 bits (185), Expect = 8e-15
 Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 42/188 (22%)

Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRGV 134
           ++Y +  AL Y+HS+ I H D+K +N+L+ PN+  +KL DFG+A     G+ +VS     
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI--- 231

Query: 135 KIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI--- 189
                 S  + APE++ G        D+WSLGC I EM+ G P +      + L RI   
Sbjct: 232 -----CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286

Query: 190 -------------------GFSDELPR-----FPTQSSELGRDFLDKCLRREPGERWSCD 225
                               F D  P+     FP  + +   +F+ + L+ EP +R +  
Sbjct: 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346

Query: 226 QLLKHPFL 233
           + L  PF 
Sbjct: 347 EALADPFF 354

Length = 440

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 54/236 (22%), Positives = 92/236 (38%), Gaps = 53/236 (22%)

Query: 47  SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           SC +L   + P G    L     A+     L+     +++AL Y+HS+  +H  VK  ++
Sbjct: 85  SCEDLLKTHFPEG----LPELAIAF----ILKD----VLNALDYIHSKGFIHRSVKASHI 132

Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQ--PRGSPL---WMAPEVVRGECQG--PES 159
           L+  +   V L+    +        R   +   P+ S     W++PEV++   QG   +S
Sbjct: 133 LLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS 191

Query: 160 DVWSLGCTIIE---------------MVTGK--------------PAWEDFGANTLSRIG 190
           D++S+G T  E               M+  K              P +ED  + + S   
Sbjct: 192 DIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251

Query: 191 FSDELPRFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
             +             SE    F++ CL+R+P  R S  QLL H F +     + +
Sbjct: 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 64/206 (31%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD 130
              E  ++S+ Y ++ +L ++H   I H D+K +N+L+      +KLADFG+        
Sbjct: 96  PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI--KDDILKLADFGSC------- 146

Query: 131 TRGVKIQPRGSPL-------WM-APEVVRGEC------QGPESDVWSLGCTIIEMVTGKP 176
            RG+  +P   P        W  AP     EC       GP+ D+W++GC   E+++  P
Sbjct: 147 -RGIYSKP---PYTEYISTRWYRAP-----ECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197

Query: 177 AWEDFGANTL---SRI----GFSDEL------------PRFPTQS-----------SELG 206
            +   G N L   ++I    G  D                FP++            S  G
Sbjct: 198 LFP--GTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEG 255

Query: 207 RDFLDKCLRREPGERWSCDQLLKHPF 232
            D L K L  +P ER +  Q L+HP+
Sbjct: 256 LDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.2 bits (179), Expect = 2e-14
 Identities = 74/318 (23%), Positives = 136/318 (42%), Gaps = 52/318 (16%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++ +G  +A         +  D      T S   +N         
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY+ GG +    +    ++++ T R +   IVSAL YLHS  IV+ 
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-RFYGAEIVSALDYLHSGKIVYR 119

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  ++D   +K    G+P ++APEV+     G   
Sbjct: 120 DLKLENLMLDKDGH-IKITDFGLCKEG-ITDAATMKTFC-GTPEYLAPEVLEDNDYGRAV 176

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +++ +FP   S   +  L   L ++P 
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI-KFPRTLSADAKSLLSGLLIKDPN 235

Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA---NTVAESSPRCVLDWVNSEFEEEGTS----- 266
           +R         ++++H F   V+  D      V    P+   +     F+EE T+     
Sbjct: 236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITI 295

Query: 267 ------DDEKLEASARER 278
                 D++ ++    ER
Sbjct: 296 TPPEKYDEDGMDCMDNER 313

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 32/229 (13%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D    R +T  ++ AL+ LH  N+++ D+K +N+L+      + L DFG        D +
Sbjct: 91  DLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDK 149

Query: 133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS 192
                  G+P ++APE++ G       D W+LG  + EM+TG P + D   N + R    
Sbjct: 150 TNTFC--GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Query: 193 DELPRFPTQSSELGRDFLDKCLRREPGERW---SCDQLLKHPFLQSVS----------PS 239
           + L RFP       +D L   L R+P  R       ++  HPF   +S          P 
Sbjct: 208 EPL-RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPP 266

Query: 240 DANTVAESSPRCVLDWVNSEFEEEGTS--------DDEKLEASARERMG 280
               V+ +     +D   S F+EE T         DD  L  + +++ G
Sbjct: 267 FKPAVSSA-----ID--TSNFDEEFTREKPIDSVVDDSHLSETVQQQFG 308

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 64/238 (26%), Positives = 99/238 (41%), Gaps = 65/238 (27%)

Query: 29  VFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
           VF +L  D+                +++    +S +   L        ++S+ + ++  L
Sbjct: 77  VFEFLHQDLK---------------KFMDASPLSGIPLPL--------IKSYLFQLLQGL 113

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM 145
            + HS  ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW 
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWY 166

Query: 146 -APEVVRGECQ--GPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDE--- 194
            APE++ G C+      D+WSLGC   EMVT +  +  D   + L RI    G  DE   
Sbjct: 167 RAPEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225

Query: 195 ------------LPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPF 232
                        P++  Q          E GRD L + L  +P +R S    L HPF
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 85/311 (27%), Positives = 127/311 (40%), Gaps = 62/311 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----------------YLGDDVSYEAPTTSSSCRNL 51
           K IGRG+FG V +   + +  V+A                +  ++    A   S     L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 52  H------------LEYLPGGTVSDLATTLNAY-ADEITLRSHTYCIVSALKYLHSRNIVH 98
           H            +EY+PGG   DL   ++ Y   E   R +T  +V AL  +HS   +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH 165

Query: 99  CDVKGKNVLVGPNSSFVKLADFGA-----AGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
            DVK  N+L+  +   +KLADFG      A      DT        G+P +++PEV++ +
Sbjct: 166 RDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRCDT------AVGTPDYISPEVLKSQ 218

Query: 154 CQ----GPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI-------GFSDELPRFPTQ 201
                 G E D WS+G  + EM+ G  P + D    T S+I        F D+      Q
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD-IEISKQ 277

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN---TVAESSPRCVLDWVNS 258
           + +L   FL    R     R   D++  HPF ++   +  N   TVA   P    D   S
Sbjct: 278 AKDLICAFLTD--REVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTS 335

Query: 259 EFEEEGTSDDE 269
            F++    D  
Sbjct: 336 NFDDIEDDDKN 346

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 40/184 (21%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++  L Y H +N +H D+K  N+L+  N   +KLADFG A      ++R      +   L
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESR--PYTNKVITL 181

Query: 144 WM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGAN-------TLSRIGFS-- 192
           W   PE++ GE + GP  DVWS GC + E+ T KP    F AN        +SR+  S  
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI---FQANQELAQLELISRLCGSPC 238

Query: 193 -------DELPRFPTQSSE----------------LGRDFLDKCLRREPGERWSCDQLLK 229
                   +LP F T   +                   D LD  L  +P +R + ++ L 
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 230 HPFL 233
            P+L
Sbjct: 299 SPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 3/157 (1%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y IV AL  +HSR ++H D+K  N+ + P +  +KL DFG + + + S +  V     G+
Sbjct: 176 YQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT 200
           P ++APE+   +    ++D+WSLG  + E++T  +P         + ++ +    P FP 
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPC 293

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
             S   +  LD  L + P  R +  QLL   FL+ V+
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA 330

Length = 478

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 12/162 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + +LHS +IV+ D+K +NVL+    +  +L+D G A E  + D + +  Q  G+  
Sbjct: 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGN-CRLSDLGLAVE--LKDGKTIT-QRAGTNG 159

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF----GANTLSRIGFSDELP--- 196
           +MAPE+++ E      D +++GC+I EMV G+  ++D         L R    DE+    
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEH 219

Query: 197 -RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
             F  +S ++ R FL K      G R   D   KH F ++++
Sbjct: 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 61/215 (28%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ-PR- 139
           Y I+  LKY+HS  +VH D+K  N+L+  N   +K+ DFG A           +IQ P+ 
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCD-LKICDFGLA-----------RIQDPQM 162

Query: 140 ----GSPLWMAPEV-VRGECQGPESDVWSLGCTIIEMVTGKPAW---------------- 178
                +  + APE+ +  +    E D+WS GC   EM+ GKP +                
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL 222

Query: 179 ----EDF-----GANTLSRIGFSDELP-RFPTQSSEL-------GRDFLDKCLRREPGER 221
               +D        NTL    F   LP R P   SE          D L+K L  +P +R
Sbjct: 223 GTPPDDVINTICSENTLR---FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279

Query: 222 WSCDQLLKHPFLQSV-SPSDANTVAESSPRCVLDW 255
            S  + L HP+L     P+D     E       DW
Sbjct: 280 ISAAEALAHPYLAPYHDPTDEPVAEE-----KFDW 309

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 70/307 (22%)

Query: 4   WVRGKCIGRGSFGTVNVAVDR--------------FNGDVFA-------YLGDDVSYE-- 40
           +   K +G G++G+V  A+D+              F  ++FA        L   + +E  
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 41  -----APTTSSSCRNLHLEYLPGGTV-SDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                  T++ S       YL    + +DL   +     E  ++   Y ++  LKY+HS 
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
            I+H D+K  N+ V  +   +K+ DFG A  A    T  V  +      + APEV+    
Sbjct: 137 GIIHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWM 190

Query: 155 QGPES-DVWSLGCTIIEMVTGKPAWE--DFGANTLSRI---------------------G 190
              ++ D+WS+GC + EM+TGK  ++  D+  + L++I                      
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGPEFVQKLEDKAAKS 249

Query: 191 FSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           +   LP++P +        +S    D L+K L  +  +R +  + L+HP+  S    DA+
Sbjct: 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF--RDAD 307

Query: 243 TVAESSP 249
              E  P
Sbjct: 308 EETEQQP 314

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 83/350 (23%), Positives = 139/350 (39%), Gaps = 107/350 (30%)

Query: 10  IGRGSFGTVNVAVDRFNG---------DVFAYLGD-----------------DV----SY 39
           IG+GS+G V  A+D   G         DVF ++ D                 D+      
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 40  EAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHT---YCIVSALKYLHSR 94
             P +    +++++  E +     SDL   + A  D++T   H    Y ++ ALKY+H+ 
Sbjct: 68  MLPPSRREFKDIYVVFELME----SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTA 122

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM--------- 145
           N+ H D+K KN+L   +   +K+ DFG A     +DT         +  W          
Sbjct: 123 NVFHRDLKPKNILANADCK-LKICDFGLA-RVAFNDT-------PTAIFWTDYVATRWYR 173

Query: 146 APEVVRGECQG------PESDVWSLGCTIIEMVTGKPAWEDFGAN--------------- 184
           APE+    C        P  D+WS+GC   E++TGKP +   G N               
Sbjct: 174 APEL----CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP--GKNVVHQLDLITDLLGTP 227

Query: 185 ---TLSRIG-------FSDELPRFPTQSSE-------LGRDFLDKCLRREPGERWSCDQL 227
              T+SR+         S    + P   S+       L    L++ L  +P +R + ++ 
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287

Query: 228 LKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARE 277
           L  P+ + ++  +    A+  P   L++   EFE    + ++  E   RE
Sbjct: 288 LADPYFKGLAKVEREPSAQ--PITKLEF---EFERRRLTKEDVRELIYRE 332

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 71.4 bits (175), Expect = 9e-14
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 28/204 (13%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYC-----IVSALKYLHSRNIVHCDVKGKN 105
           L LEYL GG   +L   L     E      T C     I  AL++LH + I++ D+K +N
Sbjct: 77  LILEYLSGG---ELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPEN 130

Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
           +L+      VKL DFG   E+    T  V     G+  +MAPE++     G   D WSLG
Sbjct: 131 ILLDAQGH-VKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLG 187

Query: 166 CTIIEMVTGKPAWEDFGAN---TLSRIGFSD-ELPRFPTQSSELGRDFLDKCLRREPGER 221
             + +M+TG P +     N   T+ +I      LP + T  +   RD L K L+R P  R
Sbjct: 188 ALMYDMLTGAPPFT--AENRKKTIDKILKGKLNLPPYLTPEA---RDLLKKLLKRNPSSR 242

Query: 222 W-----SCDQLLKHPFLQSVSPSD 240
                    ++  HPF + V+  D
Sbjct: 243 LGAGPGDAAEVQSHPFFRHVNWDD 266

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 14/144 (9%)

Query: 84  IVSALKYLH-SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           +V AL+YLH  + IVH D+   N+++G +   V + DFG A +          +   G+ 
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVV---GTI 177

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RI--GFSDELPR 197
           L+  PE+V+ E  G ++DVW+ GC + +M T +P +  +  N LS   +I     + LP 
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--YSTNMLSLATKIVEAVYEPLPE 235

Query: 198 FPTQSSELGRDFLDKCLRREPGER 221
                SE   D +  CL  +   R
Sbjct: 236 --GMYSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 55/181 (30%), Positives = 82/181 (45%), Gaps = 28/181 (15%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA-TVS 129
           Y+ EI+L         AL YLH R I++ D+K  NVL+  +   +KL D+G   E     
Sbjct: 101 YSAEISL---------ALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPG 150

Query: 130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI 189
           DT        G+P ++APE++RGE  G   D W+LG  + EM+ G+  ++  G++     
Sbjct: 151 DTTSTFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Query: 190 GFSDEL--------PRFPTQSSELGRDFLDKCLRREPGERWSC------DQLLKHPFLQS 235
              D L         R P   S      L   L ++P ER  C        +  HPF ++
Sbjct: 208 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267

Query: 236 V 236
           V
Sbjct: 268 V 268

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 57/178 (32%), Positives = 77/178 (43%), Gaps = 34/178 (19%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
            +  L +LH+  IVH D+K +N+LV      VKLADFG A   +      + + P    L
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQ-VKLADFGLARIYSCQ----MALTPVVVTL 171

Query: 144 WM-APEVVRGECQGPESDVWSLGCTIIEM---------------------VTGKPAWEDF 181
           W  APEV+         D+WS+GC   EM                     + G P  +D+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231

Query: 182 GAN-TLSRIGFSDELPRFPTQS-----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
             + TL R  FS   PR P QS      E G   L + L   P +R S  + L+HPF 
Sbjct: 232 PRDVTLPRGAFSPRGPR-PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 27/204 (13%)

Query: 51  LHLEYLPGGTVSDLATTLNAYAD---EITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L ++Y  GG   DL T L+ + D   E   R +   +V A+  +H  + VH D+K  NVL
Sbjct: 78  LVMDYYVGG---DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134

Query: 108 VGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG-----PE 158
           +  N   ++LADFG+      + TV  +  V     G+P +++PE+++    G     PE
Sbjct: 135 LDMNGH-IRLADFGSCLKMNQDGTVQSSVAV-----GTPDYISPEILQAMEDGMGKYGPE 188

Query: 159 SDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFP---TQSSELGRDFLDK-- 212
            D WSLG  + EM+ G+ P + +    T  +I   +E  +FP   T  SE  +D + +  
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248

Query: 213 CLRREPGERWSCDQLLKHPFLQSV 236
           C R     +   +   KH F + +
Sbjct: 249 CSRERRLGQNGIEDFKKHAFFEGI 272

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 40/193 (20%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  T++S TY ++  + + H   ++H D+K +N+L+      +KLADFG A         
Sbjct: 98  DPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLA------RAF 150

Query: 133 GVKIQPRGS---PLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW-----ED-- 180
           G+ +    +    LW  AP+V+ G      S D+WS+GC + EM+TG+P +     ED  
Sbjct: 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210

Query: 181 ------FGA---NTLSRIGFSDE----LPRFPTQSSE--------LGRDFLDKCLRREPG 219
                  G    +T   I    E     PR+P Q  +        LG D L + L+  P 
Sbjct: 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPE 270

Query: 220 ERWSCDQLLKHPF 232
            R S    L+HP+
Sbjct: 271 LRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 74/297 (24%), Positives = 114/297 (38%), Gaps = 95/297 (31%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYEAPTTSSSCRN--------------- 50
           IG G++GTV  A +R   ++ A     L DD   +    SS+ R                
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRL 64

Query: 51  ---LH--------LEYLPGGTVSDLAT---TLNAYADEITLRSHTYCIVSALKYLHSRNI 96
              LH         EY       DL     + N   D   ++S  + ++  L + HS N+
Sbjct: 65  YDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP----------LWM- 145
           +H D+K +N+L+  N   +KLADFG A             +  G P          LW  
Sbjct: 121 LHRDLKPQNLLINKNGE-LKLADFGLA-------------RAFGIPVRCYSAEVVTLWYR 166

Query: 146 APEVVRGECQGPES-DVWSLGCTIIEMVT-GKPAW-----ED--------FGANT----- 185
            P+V+ G      S D+WS GC   E+   G+P +     +D         G  T     
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226

Query: 186 -LSRIGFSDELPRFPTQS---------SELGRDFLDKCLRREPGERWSCDQLLKHPF 232
            +S++      P +P  +         +  GRD L   L   P +R S ++ L+HP+
Sbjct: 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 36/185 (19%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT-VS 129
           Y+ EI+L         AL +LH R I++ D+K  NVL+      +KL D+G   E     
Sbjct: 101 YSAEISL---------ALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPG 150

Query: 130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI 189
           DT        G+P ++APE++RGE  G   D W+LG  + EM+ G+  ++  G +     
Sbjct: 151 DTTSTFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207

Query: 190 GFSDEL-----------PRF-PTQSSELGRDFLDKCLRREPGERWSCD------QLLKHP 231
              D L           PR    ++S + + FL+K    +P ER  C        +  HP
Sbjct: 208 NTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNK----DPKERLGCHPQTGFRDIKSHP 263

Query: 232 FLQSV 236
           F +++
Sbjct: 264 FFRNI 268

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 66/242 (27%), Positives = 98/242 (40%), Gaps = 61/242 (25%)

Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLR-SHTYCIVS----ALKYLHSRNIVHCDVKGK 104
           NL ++ +     SDL   ++    +I L  S   CI+      L  LH    +H D+   
Sbjct: 96  NLVMDIMA----SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPA 148

Query: 105 NVLVGPNSSFVKLADFGAA---GEATVSDT--------RGVKIQPRGSPLWM-APEVVRG 152
           N+ +  +    K+ADFG A   G    SDT        R  ++  +   LW  APE++ G
Sbjct: 149 NIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207

Query: 153 -ECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRIGF------------SDELP 196
            E      D+WS+GC   E++TGKP +   G N    L RI              + +LP
Sbjct: 208 AEKYHFAVDMWSVGCIFAELLTGKPLFP--GENEIDQLGRIFELLGTPNEDNWPQAKKLP 265

Query: 197 RF-------PTQ-------SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS----VSP 238
            +       P         +S+   D L   L+  P ER S  + LKH + +S      P
Sbjct: 266 LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDP 325

Query: 239 SD 240
           S 
Sbjct: 326 SQ 327

Length = 335

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 68/268 (25%), Positives = 114/268 (42%), Gaps = 47/268 (17%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDD-------------VSYEAPTTSS 46
           K +G+GSFG V +A  +   +V+A         L DD             ++ + P  ++
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 47  SCRNLH--------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
                         +EY+ GG   DL   +      DE   R +   +  AL +LH   +
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV 117

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K  N+L+       KLADFG   E  ++          G+P ++APE+++    G
Sbjct: 118 IYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFC--GTPDYIAPEILQELEYG 174

Query: 157 PESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
           P  D W+LG  + EM+ G+P +E D   +    I   D L  +P   S+     L   + 
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--YPVWLSKEAVSILKAFMT 232

Query: 216 REPGERWSC-------DQLLKHPFLQSV 236
           + P +R  C       D + +HPF + +
Sbjct: 233 KNPNKRLGCVASQGGEDAIKQHPFFKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 13/192 (6%)

Query: 84  IVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           IVSAL YLHS +N+V+ D+K +N+++  +   +K+ DFG   E  + D   +K    G+P
Sbjct: 104 IVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEG-IKDGATMKTFC-GTP 160

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
            ++APEV+     G   D W LG  + EM+ G+  + +     L  +   +E+ RFP   
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTL 219

Query: 203 SELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPSDA---NTVAESSPRCVLD 254
           S   +  L   L+++P +R         ++++H F   +   D      V    P+   +
Sbjct: 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSE 279

Query: 255 WVNSEFEEEGTS 266
                F+EE T+
Sbjct: 280 TDTRYFDEEFTA 291

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 8/161 (4%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA-TVSDTRGVKIQPRGSP 142
           I SAL YLHS NIV+ D+K +N+L+      V L DFG   E    SDT        G+P
Sbjct: 105 IASALGYLHSINIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFC---GTP 160

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFP 199
            ++APEV+R +      D W LG  + EM+ G P +       +        L   P   
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGAS 220

Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             +  +  + L+K  +R  G +    ++ +HPF +S+S +D
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 8/142 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + SA++++HSR ++H D+K  NV +   +  VKL D G  G    S T        G+P 
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGL-GRFFSSKTTAAH-SLVGTPY 171

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEM-VTGKPAWEDFGANTLSRIGFSD--ELPRFPT 200
           +M+PE +       +SD+WSLGC + EM     P + D   N  S     +  + P  PT
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLFSLCQKIEQCDYPPLPT 230

Query: 201 QS-SELGRDFLDKCLRREPGER 221
           +  SE  R+ +  C+  +P +R
Sbjct: 231 EHYSEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 50  NLHL--EYLPGGTVSDLATTLNAYAD---EITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
           NL+L  +Y  GG   DL T L+ + D   E   R +   +V A+  +H  + VH D+K  
Sbjct: 75  NLYLVMDYYVGG---DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPD 131

Query: 105 NVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVR----GECQ- 155
           N+L+  N   ++LADFG+      + TV  +  V     G+P +++PE+++    G+ + 
Sbjct: 132 NILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAV-----GTPDYISPEILQAMEDGKGKY 185

Query: 156 GPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPTQ---SSELGRDFLD 211
           GPE D WSLG  + EM+ G+ P + +    T  +I    E  +FP Q    SE  +D + 
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIR 245

Query: 212 K--CLRREPGERWSCDQLLKHPFLQSV 236
           +  C R     +   +   +HPF   +
Sbjct: 246 RLICSREHRLGQNGIEDFKQHPFFTGI 272

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 50/199 (25%), Positives = 75/199 (37%), Gaps = 48/199 (24%)

Query: 79  SHTYCIVSAL----KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSD 130
           S   C +  L     YLH  +I+H D+K  N+L+  N   +K+ADFG A    G      
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPK 173

Query: 131 TRGVKIQPRGSPL----WM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP-------- 176
             G     + + L    W   PE++ GE +     D+W +GC   EM T +P        
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233

Query: 177 -----AWEDFGANTLSRIGFS--DELPRFPTQSS----------------ELGRDFLDKC 213
                 ++  G  T +   +     LP      S                  G D L K 
Sbjct: 234 DQLHLIFKLCG--TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291

Query: 214 LRREPGERWSCDQLLKHPF 232
           L  +P +R +    L+HP+
Sbjct: 292 LSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 51/195 (26%), Positives = 76/195 (38%), Gaps = 44/195 (22%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
              T++S  Y ++  + + H   ++H D+K +N+LV      +K+AD G     ++    
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI---- 163

Query: 133 GVKIQPRGS------PLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWE-DFGA 183
                P  S       LW  APEV+ G        D+WS+GC   EM   +P +  D   
Sbjct: 164 -----PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218

Query: 184 NTLSRI----------------GFSD--ELPRFPTQS--------SELGRDFLDKCLRRE 217
             L  I                   D  E P++  Q         S  G D L K LR +
Sbjct: 219 QQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYD 278

Query: 218 PGERWSCDQLLKHPF 232
           P +R S    L HP+
Sbjct: 279 PAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 82/308 (26%), Positives = 127/308 (41%), Gaps = 54/308 (17%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----------------YLGDDVSYEAPTTSSSCRNL 51
           K IGRG+FG V +   +    V+A                +  ++    A   S     L
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 52  H------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY+PGG + +L +  N    E   R +T  +V AL  +HS   +H 
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHR 166

Query: 100 DVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGE-- 153
           DVK  N+L+   S  +KLADFG       E  V     V     G+P +++PEV++ +  
Sbjct: 167 DVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGG 220

Query: 154 --CQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQS--SELGRD 208
               G E D WS+G  + EM+ G  P + D    T S+I        FP  +  S+  ++
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280

Query: 209 FLDKCL--RREPGERWSCDQLLKHPFL---QSVSPSDANTVAESSPRCVLDWVNSEFE-- 261
            +   L  R     R   +++ +H F    Q    +  +TVA   P    D   S F+  
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDI 340

Query: 262 EEGTSDDE 269
           EE   ++E
Sbjct: 341 EEDKGEEE 348

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 41/198 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS  I+H D+K  N+ V  +   +K+ DFG A       T  V    R  
Sbjct: 125 YQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARHTDDEMTGYV--ATR-- 179

Query: 142 PLW-MAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGANTLSRI----GFSD 193
             W  APE++       ++ D+WS+GC + E++TGK  +   D   + L RI    G  D
Sbjct: 180 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPD 236

Query: 194 E-----------------LPRFP--------TQSSELGRDFLDKCLRREPGERWSCDQLL 228
           E                 LP+ P        + ++ L  D L+K L  +P +R +  + L
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296

Query: 229 KHPFLQSVSPSDANTVAE 246
            HP+L      +   VA 
Sbjct: 297 AHPYLAEYHDPEDEPVAP 314

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 26/190 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSA---LKYLHSRNIVHCDVKGKNVLVG 109
           +E +PGG    L T L    + +T++      + A   ++YL S+N +H D+  +N LVG
Sbjct: 71  MELVPGG---SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG 127

Query: 110 PNSSFVKLADFG-----AAGEATVSD-TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            N+  +K++DFG       G  TVSD  + + I+      W APE +       ESDVWS
Sbjct: 128 ENNV-LKISDFGMSREEEGGIYTVSDGLKQIPIK------WTAPEALNYGRYTSESDVWS 180

Query: 164 LGCTIIEMVTGK----PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
            G  + E  +      P   +    T  RI     +P  P    E     + +C   +P 
Sbjct: 181 YGILLWETFSLGDTPYPGMSN--QQTRERIESGYRMPA-PQLCPEEIYRLMLQCWAYDPE 237

Query: 220 ERWSCDQLLK 229
            R S  ++  
Sbjct: 238 NRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 25/176 (14%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD 130
           YA EIT           L+ LH   IV+ D+K +N+L+  +   ++++D G A E    +
Sbjct: 107 YAAEITC---------GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGE 156

Query: 131 TRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANT 185
           T    I+ R G+  +MAPEVV+ E      D W LGC I EM+ GK  +    E      
Sbjct: 157 T----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212

Query: 186 LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSV 236
           + R    D+   +  + SE  R    + L ++PG R  C     +++  HPF ++ 
Sbjct: 213 VERRVKEDQ-EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 67/248 (27%), Positives = 98/248 (39%), Gaps = 37/248 (14%)

Query: 8   KCIGRGSFGTV-------------NVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLE 54
           K +G GSFG V              VAV     D  + + DD   EA     S  + +L 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEA-AIMHSLDHENLI 59

Query: 55  YL-------PGGTVSDLAT------TLNAYADEITL--RSHTYC--IVSALKYLHSRNIV 97
            L       P   V++LA        L   A    L      Y   I + ++YL S+  +
Sbjct: 60  RLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQG 156
           H D+  +N+L+  +   VK+ DFG       ++   V  +    P  W APE +R     
Sbjct: 120 HRDLAARNILLASDDK-VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 157 PESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKC 213
             SDVW  G T+ EM T G+  W    G+  L +I    E L R P    +   + + +C
Sbjct: 179 HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER-PEACPQDIYNVMLQC 237

Query: 214 LRREPGER 221
               P +R
Sbjct: 238 WAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 56/196 (28%), Positives = 83/196 (42%), Gaps = 50/196 (25%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG A  A  S      +  R  
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTR-- 181

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK---PA------W----EDFGANT--- 185
             + APEV+ G       D+WS+GC + EM+ G    P       W    E  G  +   
Sbjct: 182 -YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240

Query: 186 LSRIG---------------------FSDELPRFPTQSSELG-------RDFLDKCLRRE 217
           +SR+                      F D L  FP  S           RD L K L  +
Sbjct: 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVL--FPPDSESHNKLKASQARDLLSKMLVID 298

Query: 218 PGERWSCDQLLKHPFL 233
           P +R S D  L+HP++
Sbjct: 299 PEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 53/197 (26%), Positives = 75/197 (38%), Gaps = 56/197 (28%)

Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPR 139
            Y I+  LKYLHS  I+H D+K  N+LV  NS+ V K+ DFG A           +++  
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLV--NSNCVLKICDFGLA-----------RVEEP 155

Query: 140 GSPLWMAPEVVRGECQGPE-----------SDVWSLGCTIIEMVTGK------------- 175
                M  EVV    + PE            D+WS+GC   E++  +             
Sbjct: 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215

Query: 176 --------PAWEDFG-------ANTLSRIGFSDELPRFPTQSSELGR---DFLDKCLRRE 217
                   P+ E          A+ L        LP   T SS+        L + L  +
Sbjct: 216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD 275

Query: 218 PGERWSCDQLLKHPFLQ 234
           P +R S    L HP+L 
Sbjct: 276 PDKRISAADALAHPYLD 292

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 52/186 (27%), Positives = 75/186 (40%), Gaps = 41/186 (22%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV--KIQPRGS 141
           +++ L Y+H   I+H D+K  N+L+  +   +KLADFG A  A          +   R  
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLA-RAFSLSKNSKPNRYTNRVV 185

Query: 142 PLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIGFS--- 192
            LW   PE++ GE   GP  D+W  GC + EM T  P      E      +S++  S   
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245

Query: 193 ------DELPRFPTQSSEL--------------------GRDFLDKCLRREPGERWSCDQ 226
                 D+L  F  +  EL                      D +DK L  +P +R   D 
Sbjct: 246 EVWPGVDKLELF--KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303

Query: 227 LLKHPF 232
            L H F
Sbjct: 304 ALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 79/286 (27%), Positives = 112/286 (39%), Gaps = 68/286 (23%)

Query: 10  IGRGSFGTVNVAVDRFNGDVF-----------------------AYLGDDVSYEAP---- 42
           IG G++G V  A D  NG  F                       A L    ++E P    
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 43  -----TTSSSCRNLHLEYLPGGTVSDLATTLNAYAD----EITLRSHTYCIVSALKYLHS 93
                T S + R   L  +      DL T L+   +      T++   + ++  L +LHS
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEVVRG 152
             +VH D+K +N+LV  +S  +KLADFG A   +        +      LW  APEV+  
Sbjct: 129 HRVVHRDLKPQNILV-TSSGQIKLADFGLARIYSFQMALTSVV----VTLWYRAPEVLLQ 183

Query: 153 ECQGPESDVWSLGCTIIEM---------------------VTGKPAWEDFGANT-LSRIG 190
                  D+WS+GC   EM                     V G P  ED+  +  L R  
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243

Query: 191 FSDE----LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF 232
           F  +    + +F T   ELG+D L KCL   P +R S    L HP+
Sbjct: 244 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 51/155 (32%), Positives = 86/155 (55%), Gaps = 15/155 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG--EATVSDTRGVKIQPRGS 141
           ++ A+ ++HS++++H D+K  N+L+  N   VKL DFG +    ATVSD  G      G+
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFC--GT 208

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-----EDFGANTLSRIGFSDELP 196
           P ++APE+ R +    ++D++SLG  + E++T K  +     E+    TL+  G  D LP
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA--GRYDPLP 266

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP 231
             P+ S E+ ++ +   L  +P  R S  +LL  P
Sbjct: 267 --PSISPEM-QEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 53/191 (27%), Positives = 84/191 (43%), Gaps = 9/191 (4%)

Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNA---YADEITLRSHTYCIVSALKYLHS 93
           + Y A     +  N+ LE    G +S +            E T+  +   + SAL+++HS
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
           R ++H D+K  NV +   +  VKL D G  G    S T        G+P +M+PE +   
Sbjct: 125 RRVMHRDIKPANVFITA-TGVVKLGDLGL-GRFFSSKTTAAH-SLVGTPYYMSPERIHEN 181

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RIGFSDELPRFPTQSSELGRDFL 210
               +SD+WSLGC + EM   +  +     N  S   +I   D  P      SE  R  +
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241

Query: 211 DKCLRREPGER 221
           + C+  +P +R
Sbjct: 242 NMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 64/232 (27%)

Query: 53  LEYLPGGTVSDLATTLNA-------------YADEITLRSHTYCIVSALKYLHSRNIVHC 99
           ++Y PGG   +L   L               YA E+ L         AL+YLH   IV+ 
Sbjct: 80  MDYCPGG---ELFRLLQRQPGKCLSEEVARFYAAEVLL---------ALEYLHLLGIVYR 127

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL---------------- 143
           D+K +N+L+   S  + L+DF  + ++ V      K   +GS                  
Sbjct: 128 DLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186

Query: 144 -----------WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI 189
                      ++APEV+ G+  G   D W+LG  + EM+ G   +   G+N   T S I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF--KGSNRDETFSNI 244

Query: 190 GFSD-ELPRFPTQSSELGRDFLDKCLRREPGERWSC----DQLLKHPFLQSV 236
              +   P  P  SS   RD + K L ++P +R        ++ +HPF + V
Sbjct: 245 LKKEVTFPGSPPVSSSA-RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 45/140 (32%), Positives = 64/140 (45%), Gaps = 4/140 (2%)

Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D   L  +   I   ++YL S+
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGE 153
             VH D+  +N+LV  + + VK+ DFG               +P  SP+ W APE +   
Sbjct: 128 RYVHRDLATRNILV-ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186

Query: 154 CQGPESDVWSLGCTIIEMVT 173
                SDVWS G  + E+ T
Sbjct: 187 KFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 46/188 (24%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           LE++ GG +         + +++   +  Y   +V A +YLHS++I++ D+K +N+L+  
Sbjct: 97  LEFVVGGELFTHLRKAGRFPNDV---AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD- 152

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRGECQGPESDVWSLG 165
           N   VK+ DFG A           K+  R     G+P ++APEV++ +  G   D W++G
Sbjct: 153 NKGHVKVTDFGFAK----------KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMG 202

Query: 166 CTIIEMVTGKPAWEDFGANTLSRIGFSDELP------------RFPTQSSELGRDFLDKC 213
             + E + G P              F D+ P            +FP       RD +   
Sbjct: 203 VLLYEFIAGYPP-------------FFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249

Query: 214 LRREPGER 221
           L+ +  +R
Sbjct: 250 LQTDHTKR 257

Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 46/203 (22%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG A  A  +      +  R  
Sbjct: 130 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTACTNFMMTPYVVTR-- 186

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK---------PAW----EDFGANTLS- 187
             + APEV+ G       D+WS+GC + E+V G            W    E  G  +   
Sbjct: 187 -YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245

Query: 188 -------------------RIGFSDELPR--FPTQS------SELGRDFLDKCLRREPGE 220
                               I F +  P   FP++S      +   RD L K L  +P +
Sbjct: 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305

Query: 221 RWSCDQLLKHPFLQS-VSPSDAN 242
           R S D+ L+HP++     P++A 
Sbjct: 306 RISVDEALRHPYITVWYDPAEAE 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 60/223 (26%), Positives = 89/223 (39%), Gaps = 46/223 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG A  A  S      +  R  
Sbjct: 133 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTR-- 189

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-------------------------- 175
             + APEV+ G       D+WS+GC + EM+ G                           
Sbjct: 190 -YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248

Query: 176 -----PAWEDFGANTLSRIGFSDE--LPR--FPTQS------SELGRDFLDKCLRREPGE 220
                P    +  N     G+S E   P   FP  S      +   RD L K L  +  +
Sbjct: 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308

Query: 221 RWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSEFEE 262
           R S D+ L+HP++     PS+A       P   LD      EE
Sbjct: 309 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE 351

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 9e-12
 Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 13/144 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRG 140
           + S + YL ++N +H D+  +NVLVG  ++  K+ADFG A    E       G K     
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKF---- 166

Query: 141 SPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPR 197
            P+ W APE         +SDVWS G  + E+VT G+  +     A  L ++     +P 
Sbjct: 167 -PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC 225

Query: 198 FPTQSSELGRDFLDKCLRREPGER 221
            P    EL  D +  C + +P +R
Sbjct: 226 PPGCPKEL-YDIMLDCWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 42/214 (19%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  LKY+H+  I+H D+K  N+ V  +   +K+ DFG A +   S+  G  +    +
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTD-SEMTGYVV----T 178

Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRI----------- 189
             + APEV+       ++ D+WS+GC + EM+TGKP ++  G + L ++           
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK--GHDHLDQLMEIMKVTGTPS 236

Query: 190 -------------GFSDELPRFP--------TQSSELGRDFLDKCLRREPGERWSCDQLL 228
                         +  +LPRF           ++ L  + L+K L  +   R +  + L
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296

Query: 229 KHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
            HP+ +     +  T A        D V+   EE
Sbjct: 297 AHPYFEEFHDPEDETEAPPYDDS-FDEVDQSLEE 329

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT-VS 129
           YA EI       CI  AL +LH R I++ D+K  NVL+  +   +KL D+G   E     
Sbjct: 101 YAAEI-------CI--ALNFLHERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPG 150

Query: 130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT---- 185
           DT        G+P ++APE++RGE  G   D W+LG  + EM+ G+  ++    N     
Sbjct: 151 DTTSTFC---GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207

Query: 186 ---LSRIGFSD--ELPRF-PTQSSELGRDFLDKCLRREPGERWSC------DQLLKHPFL 233
              L ++       +PRF   ++S + + FL+K    +P ER  C        +  H F 
Sbjct: 208 EDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK----DPKERLGCQPQTGFSDIKSHTFF 263

Query: 234 QSVS---PSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKL 271
           +S+               P+   D+    F+ + TS+  +L
Sbjct: 264 RSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQL 304

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 54/195 (27%), Positives = 81/195 (41%), Gaps = 49/195 (25%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG A  A  S      +  R  
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTR-- 182

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-------------------------- 175
             + APEV+ G       D+WS+GC + EMV  K                          
Sbjct: 183 -YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 176 -----PAWEDFGANTLSRIG------FSDELPRFPTQS------SELGRDFLDKCLRREP 218
                P   ++  N     G      F D L  FP  S      +   RD L K L  +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 219 GERWSCDQLLKHPFL 233
            +R S D+ L+HP++
Sbjct: 300 AKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 43/147 (29%), Positives = 65/147 (44%), Gaps = 2/147 (1%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S + YL S++ VH D+  +N LVG  +  VK+ DFG + +   +D   V         
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           WM PE +       ESDVWS G  + E+ T GK  W       +        +   P   
Sbjct: 191 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVC 250

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK 229
            +   D +  C +REP +R +  ++ K
Sbjct: 251 PKEVYDIMLGCWQREPQQRLNIKEIYK 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 47/219 (21%)

Query: 62  SDLATTLNA---YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA 118
           +DLA  L       +   L    Y ++  LKY+HS N++H D+K  NV +      +K+ 
Sbjct: 100 TDLANVLEQGPLSEEHARL--FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157

Query: 119 DFGAAGEATVSDT----RGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVT 173
           DFG A    + D     +G   +   +  + +P ++       ++ D+W+ GC   EM+T
Sbjct: 158 DFGLA---RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214

Query: 174 GKPAWEDFGANTL--------------------------SRIGFSDELPRFPTQ-----S 202
           GKP +   GA+ L                          S +      PR P +      
Sbjct: 215 GKPLFA--GAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGV 272

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS-PSD 240
           +    DFL++ L   P +R + ++ L HP++   S P D
Sbjct: 273 NPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFD 311

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 57/239 (23%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 82  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 140

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 141 GE-IKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Query: 172 VTGK----------------------PAWED--------------FGANTLSRIGFSDEL 195
             G+                      PA  +              +G ++   +   + L
Sbjct: 196 AIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELL 255

Query: 196 --------PRFPTQ--SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
                   P+ P+    +E  +DF++KCL + P ER    QL+ H F++    S+A  V
Sbjct: 256 DYIVNEPPPKLPSGVFGAEF-QDFVNKCLIKNPAERADLKQLMVHAFIKR---SEAEEV 310

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 4/157 (2%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I + + YL S++ VH D+  +N LVG N   VK+ DFG + +   +D   V         
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           WM PE +       ESDVWSLG  + E+ T GK  W     N +        + + P   
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 247

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
            +   D +  C +REP  R +  ++  H  LQ+++ +
Sbjct: 248 PKEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKA 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 37/183 (20%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++  L+YLH   I+H D+K  N+L+  +   +K+ADFG A    +       + P+   L
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAK---PMTPKVVTL 172

Query: 144 WM-APEVVRG-ECQGPESDVWSLGCTIIEMVTGKP------------------------A 177
           W  APE++ G        D+W++GC + E++  KP                         
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232

Query: 178 WEDF------GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP 231
           W  F      G  TL +  +++   +FP   SE G   L+  L  +P +R + ++ L+  
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEALESS 291

Query: 232 FLQ 234
           + +
Sbjct: 292 YFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 46/180 (25%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA-TVSDTRGVKIQPRGSP 142
           I SAL YLHS NI++ D+K +N+L+  +   V L DFG   E    S T        G+P
Sbjct: 105 IASALGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC---GTP 160

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
            ++APEV+R +      D W LG  + EM+ G P                   P +   +
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP-------------------PFYSRDT 201

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK----------------------HPFLQSVSPSD 240
           +E+  + L+K LR +P    S   LL+                      H F  S++  D
Sbjct: 202 AEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 16/163 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           I+  L+ LH  N V+ D+K +N+L+  +   ++++D G A    V    G  I+ R G+ 
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLD-DYGHIRISDLGLA----VKIPEGESIRGRVGTV 165

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIGFSDELPRF 198
            +MAPEV+  +      D W LGC I EM+ G+  +    E      + R     E   +
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-EVY 224

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCD-----QLLKHPFLQSV 236
             + SE  +      L ++P +R  C      ++ +HPF +++
Sbjct: 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 29/186 (15%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV----- 108
           EY+PG T+ ++     A     T R     ++ AL   H++ IVH D+K +N++V     
Sbjct: 59  EYVPGRTLREVLAADGALPAGETGRLMLQ-VLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 109 GPNSSFVK------LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVW 162
            P++  +       L     A  AT++ T  V     G+P + APE +RGE   P SD++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEV----LGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 163 SLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
           + G   +E +TG+   +  GA+        LS +  S  LP +      LG   L K L 
Sbjct: 174 AWGLIFLECLTGQRVVQ--GASVAEILYQQLSPVDVS--LPPW-IAGHPLG-QVLRKALN 227

Query: 216 REPGER 221
           ++P +R
Sbjct: 228 KDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 66/235 (28%), Positives = 99/235 (42%), Gaps = 66/235 (28%)

Query: 26  NGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV 85
           NGD+  +L     + A T+  +C   + + L   T+  +AT                 I 
Sbjct: 103 NGDLNQFLQ---KHVAETSGLAC---NSKSLSFSTLLYMATQ----------------IA 140

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-- 143
           S ++YL S N VH D+  +N LVG N + +K+ADFG +     SD    ++Q R +PL  
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLVGKNYT-IKIADFGMSRNLYSSDY--YRVQGR-APLPI 196

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR-------------- 188
            WMA E V       +SDVW+ G T+         WE     TL R              
Sbjct: 197 RWMAWESVLLGKFTTKSDVWAFGVTL---------WEIL---TLCREQPYEHLTDQQVIE 244

Query: 189 ---IGFSDE-----LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
                F D+     LPR P    +   + + +C RR+  +R +  ++  H FLQ 
Sbjct: 245 NAGHFFRDDGRQIYLPR-PPNCPKDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 28/206 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG  + L   + A   ++  R +    V AL+YLH+  IVH D+K  N+L+  + 
Sbjct: 80  MEYVEGGDCATLLKNIGALPVDMA-RMYFAETVLALEYLHNYGIVHRDLKPDNLLI-TSM 137

Query: 113 SFVKLADFGAAGEATVS------------DTRG-VKIQPRGSPLWMAPEVVRGECQGPES 159
             +KL DFG +    +S            DTR  +  Q  G+P ++APEV+  +  G   
Sbjct: 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV 197

Query: 160 DVWSLGCTIIEMVTGKPAW------EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC 213
           D W++G  + E + G   +      E FG      I + +     P  + +L        
Sbjct: 198 DWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRL---- 253

Query: 214 LRREPGERW---SCDQLLKHPFLQSV 236
           LR+ P ER       ++ +H F   +
Sbjct: 254 LRQNPLERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 18/223 (8%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+PGG + +L +  N    E   + +T  +V AL  +HS  ++H DVK  N+L+  + 
Sbjct: 122 MEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 179

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGE----CQGPESDVWSLGCT 167
             +KLADFG      + +T  V+     G+P +++PEV++ +      G E D WS+G  
Sbjct: 180 H-LKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 168 IIEMVTG-KPAWEDFGANTLSRIGFSDELPRFP--TQSSELGRDFLDKCL--RREPGERW 222
           + EM+ G  P + D    T S+I        FP   + S+  ++ +   L  R     R 
Sbjct: 237 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRN 296

Query: 223 SCDQLLKHPFLQSVSPSDAN---TVAESSPRCVLDWVNSEFEE 262
             +++ +HPF ++   +  N   T A   P    D  +S F++
Sbjct: 297 GVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDD 339

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 49/146 (33%), Positives = 71/146 (48%), Gaps = 16/146 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFG-----AAGEATVSDTRGVKIQ 137
           I S +KYL   N VH D+  +N+LV  NS+ V K++DFG        EAT   T+G KI 
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRRLEDSEATY-TTKGGKIP 171

Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDEL 195
            R    W APE +        SDVWS G  + E+++   +P W+    + +  +     L
Sbjct: 172 IR----WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL 227

Query: 196 PRFPTQSSELGRDFLDKCLRREPGER 221
           P      S L +  LD C +++  ER
Sbjct: 228 PPPMDCPSALYQLMLD-CWQKDRNER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 95/314 (30%)

Query: 9   CIGRGSFGTVNVAV--DRFNGDVFA---YLGDDVSYEAPTTSSS-----CRNLHLEYL-- 56
           CIGRG++G V  A   +  +G  +A   + GD   Y   + S+       R L  E +  
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 57  --------PGGTVS--------DL-------ATTLNAYADEITLRSHTYCIVSALKYLHS 93
                      +V         DL                   ++S  + I++ + YLHS
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126

Query: 94  RNIVHCDVKGKNVLV---GPNSSFVKLADFGAA-----GEATVSDTRGVKIQPRGSPLWM 145
             ++H D+K  N+LV   GP    VK+ D G A         ++D   V +      +W 
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT-----IWY 181

Query: 146 -APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW----ED------FGANTLSRI---- 189
            APE++ G        D+W++GC   E++T +P +            F  + L RI    
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241

Query: 190 GFSDE--------LPRFPTQ----------SSEL-------------GRDFLDKCLRREP 218
           G   E        +P + T           S+ L             G D L K L  +P
Sbjct: 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301

Query: 219 GERWSCDQLLKHPF 232
            +R + ++ L+HP+
Sbjct: 302 TKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 6/93 (6%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           IV   +YL S NIV+ D+K +N+L+  +  F+K+ DFG A    V DTR   +   G+P 
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFA---KVVDTRTYTLC--GTPE 193

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP 176
           ++APE++     G  +D W+LG  I E++ G P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226

Length = 340

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 47/156 (30%), Positives = 72/156 (46%), Gaps = 13/156 (8%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + Y+  +N +H D++  NVLV   S   K+ADFG A    + D      +    P+
Sbjct: 112 IAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLA--RVIEDNEYTAREGAKFPI 168

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPT 200
            W APE +       +SDVWS G  + E+VT GK  +     ++ +S +     +PR   
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
              EL  D +  C + +  ER + D      +LQSV
Sbjct: 229 CPDEL-YDIMKTCWKEKAEERPTFD------YLQSV 257

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 53/214 (24%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE +P G   +             +RS+ Y ++ A+ + H  +IVH D+K +N+L+  N 
Sbjct: 90  LEEMPNGVPPE------------KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN- 136

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEVVRGECQGPESDVWSLGCTIIEM 171
             +KL DFG A    +S+          +  W  +PE++ G   G   D+WS+GC + E+
Sbjct: 137 DVLKLCDFGFA--RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Query: 172 VTGKPAWEDFGANTLSRIGFSDE-----LP----------------RFPTQS-------- 202
             G+P +   G + + ++ F+ +     LP                RFP  +        
Sbjct: 195 SDGQPLFP--GESEIDQL-FTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERR 251

Query: 203 -----SELGRDFLDKCLRREPGERWSCDQLLKHP 231
                S +  D +   L+  P +R+  +Q L HP
Sbjct: 252 YLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 5/143 (3%)

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
            ++++H + ++H D+K KN+ +  N   VKL DFG+A    ++          G+P ++ 
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSA--RLLTSPGAYACTYVGTPYYVP 168

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           PE+        +SD+WSLGC + E+ T K P   +   N + ++      P  P+  S  
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-LPSHYSYE 227

Query: 206 GRDFLDKCLRREPGERWSCDQLL 228
            R  + +  +R P  R S   +L
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 42/144 (29%), Positives = 64/144 (44%), Gaps = 14/144 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG--EATVSDTRGVKIQPRGS 141
           +   + YL  +N +H D+  +N+LVG +    K+ADFG A   +  V  +   KI  +  
Sbjct: 113 VAEGMAYLEEQNSIHRDLAARNILVGEDLV-CKVADFGLARLIKEDVYLSSDKKIPYK-- 169

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN---TLSRIGFSDELPR 197
             W APE         +SDVWS G  + EM T G+  +   G N      +I     +P 
Sbjct: 170 --WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP--GMNNHEVYDQITAGYRMPC 225

Query: 198 FPTQSSELGRDFLDKCLRREPGER 221
                 E+ +  L +C   EP +R
Sbjct: 226 PAKCPQEIYKIML-ECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 22/165 (13%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG-AAGEATVSDTRGVKIQPRGSP 142
           +V AL++LH  +IV+ D+K +N+L+      + L DFG +    T + T        G+ 
Sbjct: 105 LVLALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFC---GTT 160

Query: 143 LWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR----IGFSDELPR 197
            ++APEV+  E       D WSLG  + EM  G   W  F A    +    I F     R
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGK--VR 215

Query: 198 FP--TQSSELGRDFLDKCLRREPGERW----SCDQLLKHPFLQSV 236
           FP    S E GR F+   L R P  R        +L +HPF   +
Sbjct: 216 FPKNVLSDE-GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 7/93 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSF-VKLADFGAAGEATVSDT-RGVKIQPRGS 141
           I   + YL ++  VH D+  +N +V       VK+ DFG   +   +D  R  K      
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDIYETDYYR--KGGKGLL 183

Query: 142 PL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           P+ WMAPE ++      +SDVWS G  + EM T
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 28/152 (18%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S + YL S++ VH D+  +N LVG +   VK+ DFG + +   +D   V     G  +
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYD-LVVKIGDFGMSRDVYTTDYYRVG----GHTM 185

Query: 144 ----WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRF 198
               WM PE +       ESDVWS G  + E+ T GK  W  +G +       ++E+   
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW--YGLS-------NEEVIEC 236

Query: 199 PTQSSELGR---------DFLDKCLRREPGER 221
            TQ   L R         D +  C +R+P +R
Sbjct: 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 16/114 (14%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I + ++YL S + VH D+  +N LVG   + VK++DFG + +   +D    ++Q + S L
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLT-VKISDFGLSRDIYSADY--YRVQSK-SLL 188

Query: 144 ---WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
              WM PE +       ESD+WS G  +         WE F        GFS++
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVL---------WEIFSYGLQPYYGFSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 30/168 (17%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-----T 131
           L S  Y +   +++L S+  +H D+  +NVLV  +   +K+ADFG A +    D     T
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTT 192

Query: 132 RG---VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-------GKPAWEDF 181
            G   VK        WMAPE +       +SDVWS G  + E+ T       G P  E F
Sbjct: 193 NGRLPVK--------WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244

Query: 182 GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
               L + G+  E P+  TQ  EL     D C    P +R +  QL++
Sbjct: 245 ---KLLKEGYRMEKPQNCTQ--ELYHLMRD-CWHEVPSQRPTFKQLVE 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 23/153 (15%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSP 142
           +  A++YL + N VH D+  +NVLV  ++   K++DFG   EA+   DT  + ++     
Sbjct: 111 VCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPVK----- 164

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF---- 198
            W APE +R +    +SDVWS G  + E+ +       FG     RI   D +PR     
Sbjct: 165 -WTAPEALREKKFSTKSDVWSFGILLWEIYS-------FGRVPYPRIPLKDVVPRVEKGY 216

Query: 199 ----PTQSSELGRDFLDKCLRREPGERWSCDQL 227
               P     +  D + +C   +   R S  QL
Sbjct: 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 52/161 (32%), Positives = 75/161 (46%), Gaps = 23/161 (14%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRGVKIQP 138
           I   + YL SRN +H D+  +N+LVG N    K+ADFG A      E T  +  G K   
Sbjct: 112 IAEGMAYLESRNYIHRDLAARNILVGENLV-CKIADFGLARLIEDDEYTARE--GAKF-- 166

Query: 139 RGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDEL 195
              P+ W APE         +SDVWS G  + E+VT G+  +        L ++     +
Sbjct: 167 ---PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM 223

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           PR P    EL  D + +C  ++P ER + +      +LQS 
Sbjct: 224 PRPPNCPEEL-YDLMLQCWDKDPEERPTFE------YLQSF 257

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 8/126 (6%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY+P G++ D          ++ L +   C    + YLHS++ +H D+  +NVL+  
Sbjct: 85  LIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC--EGMAYLHSQHYIHRDLAARNVLL-D 141

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRG-SPL-WMAPEVVRGECQ-GPESDVWSLGCT 167
           N   VK+ DFG A +A        +++  G SP+ W A E ++ E +    SDVWS G T
Sbjct: 142 NDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAVECLK-ENKFSYASDVWSFGVT 199

Query: 168 IIEMVT 173
           + E++T
Sbjct: 200 LYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 56/222 (25%), Positives = 89/222 (40%), Gaps = 47/222 (21%)

Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
            L  EYL     +DL   ++     +++   R   + ++  L Y H R ++H D+K +N+
Sbjct: 79  TLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL 134

Query: 107 LVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWM-APEVVRGE-CQGPESDVWS 163
           L+      +KLADFG A   +V S T   ++      LW   P+V+ G        D+W 
Sbjct: 135 LISERGE-LKLADFGLARAKSVPSKTYSNEV----VTLWYRPPDVLLGSTEYSTSLDMWG 189

Query: 164 LGCTIIEMVTGKPA--------------WEDFGANT-------LSRIGFSDE-LPRFPTQ 201
           +GC   EM TG+P               +   G  T        S   F     P +P +
Sbjct: 190 VGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPR 249

Query: 202 S----------SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
                         G +   K L+ EP +R S  + +KHP+ 
Sbjct: 250 PLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 45/146 (30%), Positives = 67/146 (45%), Gaps = 22/146 (15%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SAL YLHS NIV+ D+K +N+L+      V L DFG   E    +  G      G+P 
Sbjct: 105 IASALGYLHSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENI--EHNGTTSTFCGTPE 161

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           ++APEV+  +      D W LG  + EM+ G P                   P +   ++
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP-------------------PFYSRNTA 202

Query: 204 ELGRDFLDKCLRREPGERWSCDQLLK 229
           E+  + L+K L+ +P    S   LL+
Sbjct: 203 EMYDNILNKPLQLKPNITNSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 57/236 (24%), Positives = 82/236 (34%), Gaps = 72/236 (30%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----------YLGD--------DVSYEAPT------ 43
           K IGRG+FG V +   +  G ++A                      D+  EA        
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 44  --TSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCI---VSALKYLHSRNI 96
             +      L+L  EYLPGG   D+ T L    D  T     + I   + A+  +H    
Sbjct: 67  YYSFQDENYLYLIMEYLPGG---DMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFG-------------------AAGEATVSDTRGVKIQ 137
           +H D+K  N+L+      +KL+DFG                   A     +         
Sbjct: 123 IHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181

Query: 138 PR-----------------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP 176
            R                 G+P ++APEV        E D WSLG  + EM+ G P
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 39/190 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  L Y H R ++H D+K +N+L+      +KLADFG A   +V + T   ++    
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSVPTKTYSNEV---- 165

Query: 141 SPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW-----ED--------FGA-- 183
             LW   P+V+ G  +   + D+W +GC   EM +G+P +     ED         G   
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225

Query: 184 -NTLSRIGFSDE-----LPRF---------PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             T   I  +DE      P++         P   +E G + L K L+ E  +R S ++ +
Sbjct: 226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTE-GIELLTKFLQYESKKRISAEEAM 284

Query: 229 KHPFLQSVSP 238
           KH + +S+  
Sbjct: 285 KHAYFRSLGT 294

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 69/295 (23%), Positives = 112/295 (37%), Gaps = 73/295 (24%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAY------LGDDVSYEAPTTSSSCRNLH---- 52
           S++  + +G GS+ TV   + R NG + A         + V + A   +S  + L     
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 53  ----------------LEYLPGGTVSDLATTLNAYADEI---TLRSHTYCIVSALKYLHS 93
                            EY+     +DLA  +  +   +    +R   + ++  L Y+H 
Sbjct: 66  VLLHDIIHTKETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWM-APEVVR 151
           ++I+H D+K +N+L+      +KLADFG A   ++ S T   ++      LW   P+V+ 
Sbjct: 122 QHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQTYSSEV----VTLWYRPPDVLL 176

Query: 152 GECQ-GPESDVWSLGCTIIEMVTGKPA--------------WEDFGANTLSRIGFSDELP 196
           G        D+W  GC  IEM+ G+PA              W   G  T        +LP
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236

Query: 197 RF--------PTQS-----SELGR-----DFLDKCLRREPGERWSCDQLLKHPFL 233
            +          Q        L R     D   + L   P +R S    L HP+ 
Sbjct: 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 48/210 (22%)

Query: 51  LHLEYLPGGTVSDLATTLNA-----------YADEITLRSHTYCIVSALKYLHSRNIVHC 99
           L L++L GG   DL T L+            Y  E+ L         AL +LHS  I++ 
Sbjct: 75  LILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELAL---------ALDHLHSLGIIYR 122

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV--RGECQGP 157
           D+K +N+L+      +KL DFG + E+   + +       G+  +MAPEVV  RG  Q  
Sbjct: 123 DLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRGHTQS- 178

Query: 158 ESDVWSLGCTIIEMVT------GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
            +D WS G  + EM+T      GK   E       +++G    +P+F +  ++     L 
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ---SLLR 230

Query: 212 KCLRREPGERWSC-----DQLLKHPFLQSV 236
              +R P  R        +++ +HPF  ++
Sbjct: 231 ALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 3/93 (3%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + SA+ YLHS NI++ D+K +N+L+      V L DFG   E    +         G+P 
Sbjct: 105 VASAIGYLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGV--EPEETTSTFCGTPE 161

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP 176
           ++APEV+R E      D W LG  + EM+ G P
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 6/141 (4%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S + YL S + VH D+  +N LVG     VK+ DFG + +   +D   V  +      
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT--LSRIGFSDELPRFPT 200
           WM PE +       ESD+WS G  + E+ T GK  W    +NT  +  I    EL R  T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-SNTEAIECITQGRELERPRT 248

Query: 201 QSSELGRDFLDKCLRREPGER 221
              E+    +  C +REP +R
Sbjct: 249 CPPEV-YAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 19/163 (11%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD--TRGVKIQPRGS 141
           I   L +LHS+ I++ D+K  NV++      +K+ADFG   E       TR       G+
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFC----GT 164

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ 201
           P ++APE++  +  G   D W+ G  + EM+ G+P ++    + L    F   +    + 
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIMEHNVSY 220

Query: 202 SSELGRDFLDKC---LRREPGERWSC-----DQLLKHPFLQSV 236
              L ++ +  C   L + P +R  C       + +H F + +
Sbjct: 221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 40/131 (30%), Positives = 57/131 (43%), Gaps = 16/131 (12%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +E+LP G++ +         +      +   I   + YL SR  VH D+  +NVLV  
Sbjct: 85  LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-E 143

Query: 111 NSSFVKLADFGAA-------GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVW 162
           +   VK+ DFG            TV D          SP+ W APE +        SDVW
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDD-------LDSPVFWYAPECLIQSKFYIASDVW 196

Query: 163 SLGCTIIEMVT 173
           S G T+ E++T
Sbjct: 197 SFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 19/156 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV---GPNSS---FVKLADFGAAGEATVSDTRGVKIQ 137
           + SAL YL  + +VH +V GKN+LV   G N     F+KL+D G      +  T   + +
Sbjct: 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG------IPITVLSREE 163

Query: 138 PRGSPLWMAPEVVRGECQGPES--DVWSLGCTIIEMVTGKPAWEDFGANTLSR-IGFSDE 194
                 W+APE +R          D WS G T++E+ +     E     + S    F  +
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE--EPLSTLSSSEKERFYQD 221

Query: 195 LPRFPTQSS-ELGRDFLDKCLRREPGERWSCDQLLK 229
             R P     EL  + +++C   +P +R S   +L+
Sbjct: 222 QHRLPMPDCAELA-NLINQCWTYDPTKRPSFRAILR 256

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 51/208 (24%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRG 133
           ++S  Y I+  + YLH+  ++H D+K  N+LV   GP    VK+AD G A          
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 134 VKIQPRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW----ED------F 181
             + P     W  APE++ G     ++ D+W++GC   E++T +P +    ED      F
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229

Query: 182 GANTLSRI----GFSDE--------LPRFPTQSSELGRD--------------------- 208
             + L RI    GF  +        +P +PT   +  R                      
Sbjct: 230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSK 289

Query: 209 ---FLDKCLRREPGERWSCDQLLKHPFL 233
               L K L  +P +R + +Q L+ P+ 
Sbjct: 290 VFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 46/220 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  LKY+HS  I+H D+K  NV V  +   +++ DFG A +A    T  V  +    
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADDEMTGYVATR---- 179

Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGANTLSRI--------- 189
             + APE++       ++ D+WS+GC + E++ GK  +   D+  + L RI         
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTPSP 237

Query: 190 ------------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLK 229
                        +   LP  P Q        ++ L  D L+K L  +  +R S  + L 
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297

Query: 230 HP-FLQSVSPSDA------NTVAESSPRCVLDWVNSEFEE 262
           HP F Q   P D       +   E+  R + +W    +EE
Sbjct: 298 HPYFSQYHDPEDEPEAEPYDESPENKERTIEEWKELTYEE 337

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 39/119 (32%), Positives = 53/119 (44%), Gaps = 23/119 (19%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG---VKIQPRG 140
           +   ++YL  +N VH D+  +NVLV       K++DFG A EA+     G   VK     
Sbjct: 111 VCEGMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQDSGKLPVK----- 164

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE--DFGANTLSRIGFSDELPR 197
              W APE +R +    +SDVWS G  +         WE   FG     RI   D +P 
Sbjct: 165 ---WTAPEALREKKFSTKSDVWSFGILL---------WEIYSFGRVPYPRIPLKDVVPH 211

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 10/171 (5%)

Query: 63  DLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD 119
           +L + L      + L S   ++Y + +AL YL S+  VH D+  +NVLV      VKL D
Sbjct: 92  ELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGD 150

Query: 120 FGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIE-MVTGKPA 177
           FG +    + D    K      P+ WMAPE +        SDVW  G  + E ++ G   
Sbjct: 151 FGLS--RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Query: 178 WEDFGAN-TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           ++    N  + RI   + LP  P          + KC   +P +R    +L
Sbjct: 209 FQGVKNNDVIGRIENGERLPM-PPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 39/188 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           + ++  L Y H R ++H D+K +N+L+      +KLADFG A   ++ + T   ++    
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYSNEV---- 165

Query: 141 SPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP---------------------- 176
             LW   P+++ G      + D+W +GC   EM TG+P                      
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225

Query: 177 --AW------EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
              W      E+F +    +   +D L     +    G + L K L+ E  +R S ++ +
Sbjct: 226 EETWPGILSNEEFKSYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 229 KHPFLQSV 236
           KHP+   +
Sbjct: 285 KHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 37/102 (36%), Positives = 52/102 (50%), Gaps = 3/102 (2%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N+  +K+ADFG A +    D      
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTT 197

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKP 176
             R    WMAPE +       +SDVWS G  + E+ T  G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 36/124 (29%), Positives = 66/124 (53%), Gaps = 7/124 (5%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        +EI L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 82  MEHMDGGSLDQVLKEAKRIPEEI-LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR 140

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++E+
Sbjct: 141 GE-IKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195

Query: 172 VTGK 175
             G+
Sbjct: 196 AIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 43/211 (20%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAY------LGDDVSYEAPT-------TSSSCRNLH 52
           + K +G G+FGTV   V    G+          L ++ S +A           +S  + H
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70

Query: 53  L----------------EYLPGGT----VSDLATTLNAYADEITLRSHTYCIVSALKYLH 92
           +                + +P G     V +    + +      L +    I   + YL 
Sbjct: 71  VVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQ----YLLNWCVQIAKGMSYLE 126

Query: 93  SRNIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVV 150
            + +VH D+  +NVLV  P    VK+ DFG A +    D +    +    P+ WMA E +
Sbjct: 127 EKRLVHRDLAARNVLVKTPQ--HVKITDFGLA-KLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 151 RGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
                  +SDVWS G T+ E++T G   +E 
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           I   L+ LH   IV+ D+K +N+L+  +   ++++D G A    V    G  I+ R G+ 
Sbjct: 111 ICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLA----VHVPEGQTIKGRVGTV 165

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWED----FGANTLSRIGFSDELPRF 198
            +MAPEVV+ E      D W+LGC + EM+ G+  ++          + R+   +    +
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQEEY 224

Query: 199 PTQSSELGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSVS 237
             + S   R      L ++P ER  C      ++ +HP  + ++
Sbjct: 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 12/133 (9%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHT---YCIVSALKYLHSRNIVHCDVKGKNVL 107
           L +E   GG ++     L+   DEIT+ +     + +   +KYL  +N VH D+  +NVL
Sbjct: 71  LVMEMASGGPLNKF---LSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL 127

Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WMAPEVVRGECQGPESDVWSLG 165
           +  N  + K++DFG + +A  +D    K +  G  PL W APE +        SDVWS G
Sbjct: 128 L-VNQHYAKISDFGLS-KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 185

Query: 166 CTIIEMVT--GKP 176
            T+ E  +   KP
Sbjct: 186 ITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 60/278 (21%), Positives = 106/278 (38%), Gaps = 63/278 (22%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           ++Y+PGG +  L   L  + +++  R +   +  A++ +H    +H D+K  N+L+  + 
Sbjct: 80  MDYIPGGDMMSLLIRLGIFEEDLA-RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 138

Query: 113 SFVKLADFG----------------------------------AAGEATVSDTRGVKIQP 138
             +KL DFG                                          + R  +   
Sbjct: 139 H-IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQ 197

Query: 139 R-------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-----L 186
           R       G+P ++APEV+         D WS+G  + EM+ G+P    F A+T     L
Sbjct: 198 RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP---FLADTPAETQL 254

Query: 187 SRIGFSDELPRFPTQSSELGRDFLDKCLR--REPGERW---SCDQLLKHPFLQSVSPSDA 241
             I +   L   P+Q ++L R+  D  LR      +R      D++  HPF + +  +  
Sbjct: 255 KVINWETTL-HIPSQ-AKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASL 312

Query: 242 NTVAESS--PRCVLDWVNSEFEEEGTSDDEKLEASARE 277
               ++   P+       S F+     D EKL +    
Sbjct: 313 IRRQKAPYIPKITHPTDTSNFD---PVDPEKLRSDDSG 347

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V  +    
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYVATR---- 181

Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 182 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240

Query: 185 TLSRI------GFSDELPRFPTQSSE--------LGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P  +          L  D L+K L  +  +R +  Q L H
Sbjct: 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300

Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 301 AYFAQYHDPDDEPVAD 316

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 15/145 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRGVKIQP 138
           +  A++YL S   +H D+  +N LVG ++  VK++DFG A      + T S   G K   
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNV-VKVSDFGLARYVLDDQYTSSQ--GTKFPV 165

Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELP 196
           +    W  PEV        +SDVWS G  + E+ + GK  +E F  +  +  +     L 
Sbjct: 166 K----WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY 221

Query: 197 RFPTQSSELGRDFLDKCLRREPGER 221
           R P  +       +  C   +P +R
Sbjct: 222 R-PKLAPTEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 45/141 (31%), Positives = 65/141 (46%), Gaps = 7/141 (4%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S + Y+   N VH D++  N+LVG N    K+ADFG A    + D      Q    P+
Sbjct: 111 IASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLA--RLIEDNEYTARQGAKFPI 167

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPT 200
            W APE         +SDVWS G  + E+ T G+  +        L ++     +P  P 
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPP 226

Query: 201 QSSELGRDFLDKCLRREPGER 221
           +  E   D + +C R+EP ER
Sbjct: 227 ECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 52/225 (23%)

Query: 48  CRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGK 104
           C  L  EYL     SDL   L+   + +++ +     + ++  L Y H R I+H D+K +
Sbjct: 77  CLTLVFEYLD----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQ 132

Query: 105 NVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWM-APEVVRGECQ-GPESDV 161
           N+L+      +KLADFG A   +V + T   ++      LW   P+V+ G  +     D+
Sbjct: 133 NLLINEKGE-LKLADFGLARAKSVPTKTYSNEV----VTLWYRPPDVLLGSTEYSTPIDM 187

Query: 162 WSLGCTIIEMVTGKP------------------------AWEDFGANTLSR-IGFS---- 192
           W +GC + EM TG+P                         W    +N   R   F     
Sbjct: 188 WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRA 247

Query: 193 ----DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +  PR  T     G D L   L  E   R S +  L+H + 
Sbjct: 248 QPLINHAPRLDTD----GIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 13/150 (8%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAA--GEATVSDTRGVKIQPRG 140
           +   + YL  +  +H D+  +N+LVG N  +V K+ADFG +   E  V  T G     R 
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMG-----RL 185

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRF 198
              WMA E +        SDVWS G  + E+V+  G P      A    ++     L + 
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK- 244

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           P    +   D + +C R +P ER S  Q+L
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 21/150 (14%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSA---LKYLHSRNIVHCDVKGKNVLVG 109
           +E +PGG   D  + L    DE+  +      + A   + YL S+N +H D+  +N LVG
Sbjct: 71  MELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG 127

Query: 110 PNSSFVKLADFGAAGEAT--VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCT 167
            N+  +K++DFG + +    +  + G+K  P     W APE +       ESDVWS G  
Sbjct: 128 ENNV-LKISDFGMSRQEDDGIYSSSGLKQIPIK---WTAPEALNYGRYSSESDVWSYGIL 183

Query: 168 IIEMVTGKPAWEDFGANTLSRIGFSDELPR 197
           +         WE F        G +++  R
Sbjct: 184 L---------WETFSLGVCPYPGMTNQQAR 204

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 30/192 (15%)

Query: 62  SDLATTLNAYADEITLRSHTYCIVSA----LKYLHSRNIVHCDVKGKNVLVGPNSSFVKL 117
           SDL T L   +  + +      I       L+YLH++ I+H DVK +N+ +      V +
Sbjct: 141 SDLYTYLTKRSRPLPIDQ-ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ-VCI 198

Query: 118 ADFGAAGEATVS-DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV---- 172
            D GAA    V+    G+     G+    APEV+  +    ++D+WS G  + EM+    
Sbjct: 199 GDLGAAQFPVVAPAFLGLA----GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS 254

Query: 173 -------TGKPAWEDFGANTLSRIGFS-----DELPRFPTQSSELGRDFLDKC-LRREPG 219
                  +    +     + L +I  +     +E PR P   S L R F++   L R+P 
Sbjct: 255 TIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG--SRLVRGFIEYASLERQPY 312

Query: 220 ERWSCDQLLKHP 231
            R+ C Q +  P
Sbjct: 313 TRYPCFQRVNLP 324

Length = 357

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 56.0 bits (135), Expect = 7e-09
 Identities = 39/125 (31%), Positives = 59/125 (47%), Gaps = 11/125 (8%)

Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D L        + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 82  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 140

Query: 113 SFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTI 168
             VK+ADFG +      T +   G K      P+ W APE +       +SDVW+ G  +
Sbjct: 141 HLVKVADFGLSRLMTGDTYTAHAGAKF-----PIKWTAPESLAYNKFSIKSDVWAFGVLL 195

Query: 169 IEMVT 173
            E+ T
Sbjct: 196 WEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 15/146 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG-----AAGEATVSDTRGVKIQP 138
           +   + YL S++ VH D+  +NVL+  N    K++DFG      AG      T   +   
Sbjct: 104 VAMGMAYLESKHFVHRDLAARNVLL-VNRHQAKISDFGMSRALGAGSDYYRATTAGRW-- 160

Query: 139 RGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDEL 195
              PL W APE +       +SDVWS G T+ E  +   KP  E  GA  ++ +   + L
Sbjct: 161 ---PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL 217

Query: 196 PRFPTQSSELGRDFLDKCLRREPGER 221
           PR P +  +     +  C +  P +R
Sbjct: 218 PR-PEECPQEIYSIMLSCWKYRPEDR 242

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 25/167 (14%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFG-------AAGEATVSDTRGVK 135
           I + +KYL   N VH D+  +N+LV  NS+ V K++DFG          + T + + G K
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSD 193
           I  R    W APE +        SDVWS G  + E+++   +P W+    + ++ I    
Sbjct: 173 IPIR----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY 228

Query: 194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
            LP      + L +  LD C        W  D+  +  F Q VS  D
Sbjct: 229 RLPPPMDCPTALHQLMLD-C--------WQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG------PNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           + SAL YL  +N+VH +V  KN+L+         S F+KL+D G +  A   + R  +I 
Sbjct: 126 LASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIP 185

Query: 138 PRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMV-TGKPAWEDFGANTLSRIGFSDEL 195
                 W+APE V  G      +D WS G T++E+   G+   ++   +   R  F ++ 
Sbjct: 186 ------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER--FYEKK 237

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            R P  S +     + +CL  EP +R S   +L+
Sbjct: 238 HRLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.6 bits (135), Expect = 1e-08
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 35/197 (17%)

Query: 53  LEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           ++Y+  G   DL   L       E  ++     +V AL  LH  NI+H D+K +NVL   
Sbjct: 88  MDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-------WMAPEVVRGECQGPESDVWS 163
               + L D+G             KI   G+P        + +PE ++G       D W+
Sbjct: 145 AKDRIYLCDYGL-----------CKI--IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWA 191

Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR------FPTQSSELGRDFLDKCLRRE 217
           +G    E++TGK  +++     L        L R      F    S+   DF+   L+  
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEELD---LESLLKRQQKKLPFIKNVSKNANDFVQSMLKYN 248

Query: 218 PGERWSC-DQLLKHPFL 233
              R +  ++++KHPFL
Sbjct: 249 INYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 17/189 (8%)

Query: 35  DDVSYEAPTTSSSCRNLHLEYL---PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
             V Y A   SS+  + + +YL   P  T  D     +     + L   +Y + + +++L
Sbjct: 197 GTVKY-ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL 255

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVV 150
            S+N VH D+  +NVL+      VK+ DFG A +  + D+  +       PL WMAPE +
Sbjct: 256 ASKNCVHRDLAARNVLIC-EGKLVKICDFGLARD-IMRDSNYISKGSTFLPLKWMAPESI 313

Query: 151 RGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPR-----FPTQSSE 204
                   SDVWS G  + E+ T G   + +   N      F + + R      P  +S+
Sbjct: 314 FNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ----FYNAIKRGYRMAKPAHASD 369

Query: 205 LGRDFLDKC 213
              + + KC
Sbjct: 370 EIYEIMQKC 378

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           +   L+ L    IV+ D+K +N+L+  +   ++++D G A    V    G  ++ R G+ 
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLA----VQIPEGETVRGRVGTV 165

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIGFSDELPRF 198
            +MAPEV+  E      D W LGC I EM+ G+  +    E      + R    D+   +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-EEY 224

Query: 199 PTQSSELGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSVS 237
             + SE  +      L + P ER  C       + +HP  ++++
Sbjct: 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 38/167 (22%), Positives = 59/167 (35%), Gaps = 28/167 (16%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
            +  L  L     +H   K  N+L+  +   +KL   G+    T         Q R  P 
Sbjct: 23  CLQCLGALRE---LHRQAKSGNILLTWDG-LLKL--DGSVAFKTPE-------QSRPDPY 69

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           +MAPEV++G+    ++D++SLG T+ E +  +          LS I     L   P    
Sbjct: 70  FMAPEVIQGQSYTEKADIYSLGITLYEALDYEL--PYNEERELSAI-LEILLNGMPADDP 126

Query: 204 ELG------------RDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
                           DF+  C  R P  R + +  L H        
Sbjct: 127 RDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAET 173

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 15/155 (9%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD 130
           YA EI +          L +LHS+ I++ D+K  NV++  +   +K+ADFG   E     
Sbjct: 106 YAAEIAI---------GLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWD- 154

Query: 131 TRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI 189
             GV  +   G+P ++APE++  +  G   D W+ G  + EM+ G+  +E    + L + 
Sbjct: 155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ- 211

Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC 224
              +    +P   S+         + + PG+R  C
Sbjct: 212 SIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 16/105 (15%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKI 136
           I + +KYL   N VH D+  +N+LV  NS+   K++DFG +       E T + T G KI
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSRVLEDDPEGTYT-TSGGKI 172

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWE 179
             R    W APE +        SDVWS G  + E+++   +P W+
Sbjct: 173 PIR----WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 53/209 (25%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRG 133
           ++S  Y I+  + YLH+  ++H D+K  N+LV   GP    VK+AD G A          
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Query: 134 VKIQPRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW----ED------F 181
             + P     W  APE++ G     ++ D+W++GC   E++T +P +    ED      +
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 229

Query: 182 GANTLSRI----GFS-----DELPRFPTQSSELGRDF----------------------- 209
             + L RI    GF      +++ + P  S+ L +DF                       
Sbjct: 230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHST-LMKDFRRNTYTNCSLIKYMEKHKVKPDS 288

Query: 210 -----LDKCLRREPGERWSCDQLLKHPFL 233
                L K L  +P +R + +Q ++ P+ 
Sbjct: 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 38/100 (38%), Positives = 53/100 (53%), Gaps = 5/100 (5%)

Query: 76  TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
           TL      I S +KYL S N VH D+  +N LVG N + +K+ADFG +      D    +
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT-IKIADFGMSRNLYSGDY--YR 187

Query: 136 IQPRGS-PL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           IQ R   P+ WM+ E +        SDVW+ G T+ E++T
Sbjct: 188 IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 41/120 (34%), Positives = 60/120 (50%), Gaps = 7/120 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           I   + YL  R +VH D+  +NVLV  P    VK+ DFG A     +D +    +    P
Sbjct: 118 IAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG-ADEKEYHAEGGKVP 174

Query: 143 L-WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           + WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 52/193 (26%), Positives = 81/193 (41%), Gaps = 42/193 (21%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           + ++  L Y+H R I+H D+K +N+L+  ++  +KLADFG A   +V S T   ++    
Sbjct: 110 FQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEV---- 164

Query: 141 SPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDFGANTLSRI----GF 191
             LW   P+V+ G  +     D+W +GC  +EM+ G    P  +D   + L RI    G 
Sbjct: 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLERIFLVLGT 223

Query: 192 SDE--------LPRFPTQSSEL------------------GRDFLDKCLRREPGERWSCD 225
            +E        LP F  +   L                    D   K L+  P  R S  
Sbjct: 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283

Query: 226 QLLKHPFLQSVSP 238
             L H +   + P
Sbjct: 284 AALSHEYFSDLPP 296

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 3/102 (2%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV  ++  +K+ADFG A +    D      
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 200

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKP 176
             R    WMAPE +       +SDVWS G  + E+ T  G P
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 28/176 (15%)

Query: 71  YADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT 127
           Y   +TL     +++ +   +++L SR  +H D+  +N+L+  N+  VK+ DFG A +  
Sbjct: 172 YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARD-I 229

Query: 128 VSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF--GAN 184
             D   V+      PL WMAPE +       +SDVWS G  +         WE F  GA+
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL---------WEIFSLGAS 280

Query: 185 TLSRIGFSDELPRFPTQ----------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
               +   +E  R   +          + E+ +  LD C   EP +R +  +L++H
Sbjct: 281 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 43/113 (38%), Positives = 57/113 (50%), Gaps = 6/113 (5%)

Query: 62  SDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKL 117
           SDL T L A    + L   T     ++SA+ Y+H   I+H D+K +NVLV GP    + L
Sbjct: 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICL 301

Query: 118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
            DFGAA  A  S +        G+    APEV+ G+   P  D+WS G  I E
Sbjct: 302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 1/101 (0%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLV-TEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA 177
             R    WMAPE +       +SDVWS G  + E+ T   +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 38/92 (41%), Positives = 49/92 (53%), Gaps = 5/92 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-P 142
           I S +KYL S N VH D+  +N LVG N   +K+ADFG +      D    +IQ R   P
Sbjct: 138 IASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNLYSGDY--YRIQGRAVLP 194

Query: 143 L-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           + WMA E +        SDVW+ G T+ EM T
Sbjct: 195 IRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 39/100 (39%), Positives = 52/100 (52%), Gaps = 13/100 (13%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKLADFGAA----GEATVSDTRGVKIQP 138
           I   + YL  R +VH D+  +NVLV  PN   VK+ DFG A    G+    +  G K+  
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPI 175

Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKP 176
           +    WMA E +       +SDVWS G TI E++T  GKP
Sbjct: 176 K----WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 3/102 (2%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL SR  +H D+  +NVLV  ++  +K+ADFG A      D      
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTS 194

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKP 176
             R    WMAPE +       +SDVWS G  + E+ T  G P
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 1/97 (1%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S +Y +   + +L S+N +H D+  +NVL+  +   VK+ DFG A +        VK 
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKG 201

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       ESDVWS G  + E+ +
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 5/91 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-P 142
           I S +KYL S N VH D+  +N LVG N + +K+ADFG +      D    +IQ R   P
Sbjct: 147 IASGMKYLSSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGDY--YRIQGRAVLP 203

Query: 143 L-WMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           + WMA E +        SDVW+ G T+ E++
Sbjct: 204 IRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 14/110 (12%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD 130
           YA EI++          L +LH R I++ D+K  NV++  +   +K+ADFG   E  V  
Sbjct: 106 YAAEISV---------GLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVD- 154

Query: 131 TRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE 179
             GV  +   G+P ++APE++  +  G   D W+ G  + EM+ G+P ++
Sbjct: 155 --GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 17/196 (8%)

Query: 45  SSSCRNLHLEYLPG--------GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           SS   + ++E  P          +  +  T  +   D   L   +  +   + +L S+N 
Sbjct: 174 SSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC 233

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H DV  +NVL+  +    K+ DFG A +        VK   R    WMAPE +      
Sbjct: 234 IHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT 292

Query: 157 PESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRFPTQSSELGRDFLD 211
            +SDVWS G  + E+ + GK  +     N+    + + G+    P F     E+    + 
Sbjct: 293 VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDF--APPEIYS-IMK 349

Query: 212 KCLRREPGERWSCDQL 227
            C   EP ER +  Q+
Sbjct: 350 MCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 70/296 (23%), Positives = 111/296 (37%), Gaps = 70/296 (23%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY------------------LGDDVSYEAPT------ 43
           K IGRG+FG V +   +  G ++A                      D+  EA        
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 44  --TSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
             +    RNL+L  E+LPGG +  L    +  ++E T + +    V A+  +H    +H 
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT-QFYIAETVLAIDAIHQLGFIHR 125

Query: 100 DVKGKNVLVGPNSSFVKLADFGAA---------------------------------GEA 126
           D+K  N+L+      VKL+DFG                                    E 
Sbjct: 126 DIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184

Query: 127 TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-EDFGANT 185
              + R +     G+P ++APEV          D WSLG  + EM+ G P +  +    T
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244

Query: 186 LSRIGFSDELPRFPTQS--SELGRDFLDK-CLRREP--GERWSCDQLLKHPFLQSV 236
             ++    E   FP +   SE  +D + + C   E   G     +++  HPF + V
Sbjct: 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSN-GVEEIKSHPFFEGV 299

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 45/135 (33%), Positives = 64/135 (47%), Gaps = 16/135 (11%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G++       +     I L      I S +KYL     VH D+  +N+LV  NS+
Sbjct: 85  EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSN 142

Query: 114 FV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            V K++DFG +       EA  + TRG KI  R    W APE +        SDVWS G 
Sbjct: 143 LVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGI 197

Query: 167 TIIEMVT--GKPAWE 179
            + E+++   +P WE
Sbjct: 198 VMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 12/141 (8%)

Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA-DEITLR-----SHTYCIVSALKY 90
           VSY  PT +   R++       G+  D   T      DE+ L      S +Y +   + +
Sbjct: 175 VSYVVPTKADKRRSVR-----SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSF 229

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
           L S+N +H D+  +N+L+  +    K+ DFG A +        VK   R    WMAPE +
Sbjct: 230 LASKNCIHRDLAARNILL-THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI 288

Query: 151 RGECQGPESDVWSLGCTIIEM 171
                  ESDVWS G  + E+
Sbjct: 289 FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++ A++YLH   I+H D+K +N+ +  +   V L DFGAA    V           G+  
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCLGDFGAAC-FPVDINANKYYGWAGTIA 248

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGAN-----------TLSRIG- 190
             APE++  +  GP  D+WS G  + EM T   + +E  G +            + R G 
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308

Query: 191 FSDELPRFPTQSSELGRDFLDKCLR--REPGER 221
             +E P      + L   ++    +  R+PG R
Sbjct: 309 HPNEFPIDAQ--ANLDEIYIGLAKKSSRKPGSR 339

Length = 391

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 35/201 (17%)

Query: 47  SCRN-----LHLEYLPGGTVSD------LATTLNAYADE----ITLRSHTYC-----IVS 86
           +C N     + +EY P G + D      +  T  A+A E     TL S         + +
Sbjct: 71  ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVAT 130

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGSPLW 144
            ++YL  +  +H D+  +NVLVG N +  K+ADFG +   E  V  T G     R    W
Sbjct: 131 GMQYLSEKQFIHRDLAARNVLVGENLA-SKIADFGLSRGEEVYVKKTMG-----RLPVRW 184

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRI--GFSDELPRFPT 200
           MA E +       +SDVWS G  + E+V+  G P      A    ++  G+  E PR   
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR--- 241

Query: 201 QSSELGRDFLDKCLRREPGER 221
              +   + + +C R  P ER
Sbjct: 242 NCDDEVYELMRQCWRDRPYER 262

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 52.6 bits (126), Expect = 9e-08
 Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 15/151 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAA----GEATVSDTRGVKIQP 138
           + S +KYL     VH  +    VLV  NS  V K++ F        EA  +   G     
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLV--NSDLVCKISGFRRLQEDKSEAIYTTMSG----- 168

Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELP 196
           +   LW APE ++       SDVWS G  + E+++   +P W+  G + +  +     LP
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
                 + L +  LD C ++E GER    Q+
Sbjct: 229 APRNCPNLLHQLMLD-CWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 52.6 bits (126), Expect = 9e-08
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 9/134 (6%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++  G +SD          + TL      +   + YL S N++H D+  +N LVG 
Sbjct: 76  LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135

Query: 111 NSSFVKLADFGAAG---EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCT 167
           N   VK++DFG      +   + + G K   +    W +PEV        +SDVWS G  
Sbjct: 136 N-QVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSKSDVWSFGVL 190

Query: 168 IIEMVT-GKPAWED 180
           + E+ + GK  +E+
Sbjct: 191 MWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 3/98 (3%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   +++L S+N VH D+  +NVL+      VK+ DFG A +  + D+  V  
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARD-IMHDSNYVSK 296

Query: 137 QPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
                P+ WMAPE +        SDVWS G  + E+ +
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 17/98 (17%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD--------TRGVK 135
           I   + YLH R ++H D+  +N ++      VK+ D   + +    D         R VK
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
                   WMA E +  +     SDVWS G  + E++T
Sbjct: 185 --------WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 39/141 (27%), Positives = 64/141 (45%), Gaps = 7/141 (4%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + ++  RN +H D++  N+LV   S   K+ADFG A    + D      +    P+
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLA--RVIEDNEYTAREGAKFPI 167

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPT 200
            W APE +       +SDVWS G  ++E+VT G+  +        +  +     +PR   
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 227

Query: 201 QSSELGRDFLDKCLRREPGER 221
              EL  + + +C +  P ER
Sbjct: 228 CPEEL-YNIMMRCWKNRPEER 247

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 43/142 (30%), Positives = 62/142 (43%), Gaps = 15/142 (10%)

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGSPL 143
             + YL  +  +H D+  +N+LVG N    K+ADFG +   E  V  T G     R    
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVKKTMG-----RLPVR 176

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRI--GFSDELPRFP 199
           WMA E +        SDVWS G  + E+V+  G P      A    ++  G+  E P   
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL-- 234

Query: 200 TQSSELGRDFLDKCLRREPGER 221
               +   D + +C R +P ER
Sbjct: 235 -NCDDEVYDLMRQCWREKPYER 255

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 4/147 (2%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  + I   ++YL    +VH D+  +NVLV      +K++DFG + +    D+   + 
Sbjct: 129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDE 194
           + R    WMA E +       +SDVWS G  + E+VT  G P          + +     
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR 247

Query: 195 LPRFPTQSSELGRDFLDKCLRREPGER 221
           + R P   SE   + +  C ++EP +R
Sbjct: 248 MER-PENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 28/194 (14%)

Query: 45  SSSCRNLHLEYLP--GGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHC 99
           +     L   + P   G+ +    T + +   +T+     +++ +   +++L SR  +H 
Sbjct: 139 AGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHR 198

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPE 158
           D+  +N+L+  N+  VK+ DFG A +    D   V+      PL WMAPE +  +    +
Sbjct: 199 DLAARNILLSENN-VVKICDFGLARD-IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256

Query: 159 SDVWSLGCTIIEMVTGKPAWEDF--GANTLSRIGFSDEL---------PRFPTQSSELGR 207
           SDVWS G  +         WE F  GA+    +  ++E           R P  ++    
Sbjct: 257 SDVWSFGVLL---------WEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIY 307

Query: 208 DFLDKCLRREPGER 221
             +  C + +P ER
Sbjct: 308 RIMLACWQGDPKER 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 40/143 (27%), Positives = 66/143 (46%), Gaps = 11/143 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + + + Y+   N +H D++  N+LVG +    K+ADFG A    + D      Q    P+
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLA--RLIEDNEYTARQGAKFPI 167

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT---LSRIGFSDELPRF 198
            W APE         +SDVWS G  + E+VT G+  +   G N    L ++     +P  
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP--GMNNREVLEQVERGYRMP-C 224

Query: 199 PTQSSELGRDFLDKCLRREPGER 221
           P        + + +C +++P ER
Sbjct: 225 PQDCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 7/141 (4%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + Y+   N +H D++  N+LVG N    K+ADFG A    + D      Q    P+
Sbjct: 111 IADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLA--RLIEDNEYTARQGAKFPI 167

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPT 200
            W APE         +SDVWS G  + E+VT G+  +        L ++     +P  P 
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP-CPQ 226

Query: 201 QSSELGRDFLDKCLRREPGER 221
              E   + +  C +++P ER
Sbjct: 227 GCPESLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 19/110 (17%)

Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQ 137
           H  C  + ++Y+HS+ ++H D+K  N+L+G     V L D+GAA   +    D   + + 
Sbjct: 120 HKIC--ATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVD 176

Query: 138 PR--------------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            R              G+P +MAPE + G      +D+++LG  + +M+T
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 14/101 (13%)

Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSF-VKLADFGAAGEA------TVSDTRGVKIQPRG 140
           ++YL S+  VH D+  +N ++  + SF VK+ADFG A +       +V +  G K+  + 
Sbjct: 111 MEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK- 167

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
              WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 168 ---WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 14/113 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-P 142
           I + ++YL S   VH D+  +N+L+G     VK++D G + E   +D    ++QP+   P
Sbjct: 133 IAAGMEYLSSHFFVHKDLAARNILIG-EQLHVKISDLGLSREIYSADY--YRVQPKSLLP 189

Query: 143 L-WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
           + WM PE +       +SD+WS G  +         WE F        GFS++
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVL---------WEIFSFGLQPYYGFSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 43/142 (30%), Positives = 58/142 (40%), Gaps = 30/142 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY------------LGDDVSYE--APTTSSSCRNLHL 53
           K I RG+FG V +   + N  ++A             +   V  E  A   S S   +HL
Sbjct: 10  KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69

Query: 54  --------------EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                         EYL GG V  L   +  Y DE     +   +  AL YLH   I+H 
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSL-LHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128

Query: 100 DVKGKNVLVGPNSSFVKLADFG 121
           D+K  N+L+  N   +KL DFG
Sbjct: 129 DLKPDNMLIS-NEGHIKLTDFG 149

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 30/178 (16%)

Query: 71  YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD 130
           YA EI L          L+++H+R +V+ D+K  N+L+  +   V+++D G A + +   
Sbjct: 102 YAAEIIL---------GLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFS--- 148

Query: 131 TRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--- 183
               K +P    G+  +MAPEV+ +G      +D +SLGC + +++ G   +        
Sbjct: 149 ----KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Query: 184 NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSV 236
           + + R+  +      P   S   R  L+  L+R+   R  C      ++ +HPF +S+
Sbjct: 205 HEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 36/139 (25%), Positives = 56/139 (40%), Gaps = 9/139 (6%)

Query: 90  YLHSRNIVHCDVKGKNVLV----GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM 145
           YL   + +H D+  +N LV          VK+ DFG A +   SD    + +      WM
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRF--PTQS 202
           APE +       +SDVWS G  + E++T G+  +     N    +       R   P   
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP--ALNNQEVLQHVTAGGRLQKPENC 238

Query: 203 SELGRDFLDKCLRREPGER 221
            +     +  C  ++P ER
Sbjct: 239 PDKIYQLMTNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 41/125 (32%), Positives = 58/125 (46%), Gaps = 15/125 (12%)

Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF 114
           YL     ++L T      D  TL+     I   L +LH  N +H D+  +N L+  + + 
Sbjct: 85  YLRSCRKAELMT-----PDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT- 138

Query: 115 VKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEV---VRGEC----QGPESDVWSLGC 166
           VK+ D+G +      D   V       PL W+APE+   V G      Q  ES+VWSLG 
Sbjct: 139 VKIGDYGLSHNKYKEDYY-VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197

Query: 167 TIIEM 171
           TI E+
Sbjct: 198 TIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 5/137 (3%)

Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K +  G  P+ W 
Sbjct: 108 MKYLEETNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALGADENYYKAKTHGKWPVKWY 165

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSE 204
           APE +       +SDVWS G  + E  + G+  ++    N ++++  S E    P +   
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPP 225

Query: 205 LGRDFLDKCLRREPGER 221
              D +  C      ER
Sbjct: 226 EMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 50.2 bits (120), Expect = 9e-07
 Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 15/162 (9%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S+++ +   +++L SR  +H D+  +N+L+  N+  VK+ DFG A +    D   V+ 
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARD-IYKDPDYVRK 232

Query: 137 QPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT-------GKPAWEDFGANTLSR 188
                PL WMAPE +  +    +SDVWS G  + E+ +       G    E+F    L  
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF-CRRLKE 291

Query: 189 IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH 230
            G     P + T   E+    LD C    P +R +  +L++ 
Sbjct: 292 -GTRMRAPEYAT--PEIYSIMLD-CWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 63/232 (27%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY-------------LGD-----DVSYEAPT------ 43
           K IGRG+FG V +   +  G V+A              +G      D+  EA +      
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 44  --TSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
             +     NL+L  E+LPGG +  L    +   +E T + +    V A+  +H    +H 
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET-QFYIAETVLAIDSIHQLGFIHR 125

Query: 100 DVKGKNVLVGPNSSFVKLADFGAA---------------------------------GEA 126
           D+K  N+L+  +   VKL+DFG                                    E 
Sbjct: 126 DIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184

Query: 127 TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW 178
              + R +     G+P ++APEV          D WSLG  + EM+ G P +
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 10/105 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR----GVKIQPR 139
           I   + YL    +VH D+  +NVLV  + + VK+ DFG A    + +T     G K+  +
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLV-KSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGA 183
               WMA E +       +SDVWS G T+ E++T G   ++   A
Sbjct: 177 ----WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 11/152 (7%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG---EATVSDTRGVKIQP 138
             +   + YL S+  +H D+  +N LV      VK++DFG +    +   + + G K   
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGC-VKVSDFGLSRYVLDDEYTSSVGSKFPV 165

Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELP 196
           R    W  PEV+       +SDVW+ G  + E+ + GK  +E F  + T+ ++     L 
Sbjct: 166 R----WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY 221

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           R P  +SE     +  C   +  ER +  QLL
Sbjct: 222 R-PHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 26/138 (18%)

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE---ATVSDTRGVKIQPRGSP 142
           + ++YL S++ +H D+  +N LV   +  +K++DFG + E      + T G+K  P    
Sbjct: 105 AGMEYLESKHCIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQIPVK-- 161

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
            W APE +       ESDVWS G  +         WE F    +           +   S
Sbjct: 162 -WTAPEALNYGRYSSESDVWSFGILL---------WEAFSLGAVP----------YANLS 201

Query: 203 SELGRDFLDKCLRREPGE 220
           ++  R+ +++ +R    E
Sbjct: 202 NQQTREAIEQGVRLPCPE 219

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 36/126 (28%), Positives = 55/126 (43%), Gaps = 13/126 (10%)

Query: 54  EYLPGGTVSDLATTLNAYADEI-TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T       I  L      I   + ++  +N +H D++  N+LV   +
Sbjct: 80  EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS-ET 138

Query: 113 SFVKLADFGAA-----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCT 167
              K+ADFG A      E T  +     I+      W APE +       +SDVWS G  
Sbjct: 139 LCCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGTFTIKSDVWSFGIL 192

Query: 168 IIEMVT 173
           + E+VT
Sbjct: 193 LTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 59/251 (23%), Positives = 99/251 (39%), Gaps = 65/251 (25%)

Query: 51  LHLEYLPGGTVSDLATTLNAY---ADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L +E+LPGG   DL T L  Y   ++++T R +    V A++ +H    +H D+K  N+L
Sbjct: 78  LIMEFLPGG---DLMTMLIKYDTFSEDVT-RFYMAECVLAIEAVHKLGFIHRDIKPDNIL 133

Query: 108 VGPNSSFVKLADFG--------------------AAGEATVSDTRGV------------- 134
           +      +KL+DFG                     + +  + +   V             
Sbjct: 134 ID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192

Query: 135 KIQ------------PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW--ED 180
           +I               G+P ++APE+   +  G E D WSLG  + E + G P +  E+
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSEN 252

Query: 181 FGANTLSRIGFSDELPRFP---TQSSELGRDFLDKCLRREPGE--RWSCDQLLKHPFLQS 235
               T  +I    E   FP     S E   D + + +        R    ++  HPF + 
Sbjct: 253 -SHETYRKIINWRETLYFPDDIHLSVE-AEDLIRRLITNAENRLGRGGAHEIKSHPFFRG 310

Query: 236 VSPSDANTVAE 246
           V   D +T+ +
Sbjct: 311 V---DWDTIRQ 318

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 1/90 (1%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + YL    +VH ++  +N+L+  + S V++ADFG A      D +    + +    
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILL-KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           WMA E +       +SDVWS G T+ EM++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 51/217 (23%), Positives = 85/217 (39%), Gaps = 65/217 (29%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--------SFVKLADFGAAGEATVSD--TRG 133
           ++ AL Y+H    VH  VK  ++L+  +         S + + + G      V D     
Sbjct: 110 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR-VVHDFPKYS 168

Query: 134 VKIQPRGSPLWMAPEVVRGECQG--PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF 191
           VK+ P     W++PEV++   QG   +SD++S+G T  E+  G   ++D  A  +     
Sbjct: 169 VKVLP-----WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 223

Query: 192 S--------------DELPRFPTQS---SELG---------------------------- 206
           +              +EL   P++S   S LG                            
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283

Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVS--PSDA 241
             F+++CL+R P  R S   LL H F + +    S+A
Sbjct: 284 HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA 320

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 47/198 (23%), Positives = 97/198 (48%), Gaps = 26/198 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L+ + GG   DL   L+ +    E  +R +   I+  L+++H+R +V+ D+K  N+L+  
Sbjct: 76  LDLMNGG---DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGC 166
           +   V+++D G A + +       K +P    G+  +MAPEV+ +G      +D +SLGC
Sbjct: 133 HGH-VRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184

Query: 167 TIIEMVTGKPAWEDFGA---NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
            + +++ G   +        + + R+  +  +    + S EL +  L+  L+R+  +R  
Sbjct: 185 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL-KSLLEGLLQRDVSKRLG 243

Query: 224 C-----DQLLKHPFLQSV 236
           C      ++ +H F + +
Sbjct: 244 CLGRGAQEVKEHVFFKGI 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 41/154 (26%), Positives = 58/154 (37%), Gaps = 30/154 (19%)

Query: 27  GDVFAYLGDDVSYEAPTTSSS---CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYC 83
           GD+  +L         + S S    R   L  LP      L                   
Sbjct: 93  GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQ-------------- 138

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG------AAGEATVSDTRGVKIQ 137
           + + + YL  R  VH D+  +N LVG N   VK+ADFG      +A     S+   + I+
Sbjct: 139 VAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
                 WM PE +       ESDVW+ G  + E+
Sbjct: 198 ------WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 53/191 (27%), Positives = 82/191 (42%), Gaps = 37/191 (19%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGDVFA--YLGDDVSYEAPTTSSSCRNL----- 51
           G+ IG G FG V         VAV     DV A  +L +     A  T    +NL     
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEE----TAVMTKLHHKNLVRLLG 66

Query: 52  ---H------LEYLPGGT-VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
              H      +E +  G  V+ L T   A    I L   +  +   ++YL S+ +VH D+
Sbjct: 67  VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 102 KGKNVLVGPNSSFVKLADFG-AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
             +N+LV  +    K++DFG A   +   D   + ++      W APE ++ +    +SD
Sbjct: 127 AARNILVSED-GVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSD 179

Query: 161 VWSLGCTIIEM 171
           VWS G  + E+
Sbjct: 180 VWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 44/138 (31%), Positives = 66/138 (47%), Gaps = 20/138 (14%)

Query: 51  LHLEYLPGGTVSDLATTLNA-------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           L LE+ P G   DL   L +        A +  L+     + S L +LH  + +H D+  
Sbjct: 72  LVLEFCPLG---DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLAL 128

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVV--RGEC-----Q 155
           +N  +  + S VK+ D+G A E    D    K      PL W+APE+V  RG+      Q
Sbjct: 129 RNCQLTADLS-VKIGDYGLALEQYPEDYYITKDC-HAVPLRWLAPELVEIRGQDLLPKDQ 186

Query: 156 GPESDVWSLGCTIIEMVT 173
             +S++WSLG T+ E+ T
Sbjct: 187 TKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 1/90 (1%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S ++YL S+N +H D+  +N ++  N + V +ADFG + +    D        +    
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMT-VCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W+A E +        SDVW+ G T+ E++T
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 9/94 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD----TRGVKIQPR 139
           I   ++YL +RN +H D+  +N ++  + + V +ADFG + +    D     R  K+  +
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGLSKKIYSGDYYRQGRIAKMPVK 180

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
               W+A E +       +SDVW+ G T+ E+ T
Sbjct: 181 ----WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S ++YL S++ +H D+  +N ++  N + V +ADFG + +    D      Q R + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGDYYR---QGRIAKM 176

Query: 144 ---WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
              W+A E +       +SDVWS G T+ E+ T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 62/242 (25%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           ++Y+PGG +  L   +  + +++  R +   +  A++ +H    +H D+K  N+L+  + 
Sbjct: 80  MDYIPGGDMMSLLIRMGIFPEDLA-RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG 138

Query: 113 SFVKLADFG--------------AAGEATVSDTR--------------GVKIQPR----- 139
             +KL DFG               +G+    D+               G +++P      
Sbjct: 139 H-IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA 197

Query: 140 ------------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-- 185
                       G+P ++APEV+         D WS+G  + EM+ G+P    F A T  
Sbjct: 198 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP---FLAQTPL 254

Query: 186 ---LSRIGFSDELPRFPTQS--SELGRDFLDKCLRREPGERW---SCDQLLKHPFLQSVS 237
              +  I +   L   P Q+  S    D + K L R P +R      D++  HPF +++ 
Sbjct: 255 ETQMKVINWQTSL-HIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID 312

Query: 238 PS 239
            S
Sbjct: 313 FS 314

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 31/112 (27%), Positives = 53/112 (47%), Gaps = 12/112 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I + +++L S ++VH D+  +NVLV    + VK++D G   E   +D   +         
Sbjct: 133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 144 WMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
           WM+PE +  G+    +SD+WS G  +         WE F        G+S++
Sbjct: 192 WMSPEAIMYGKFS-IDSDIWSYGVVL---------WEVFSYGLQPYCGYSNQ 233

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 1/88 (1%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++ AL YLH R I+H DVK +N+ +    + V L DFGAA +              G+  
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLE 252

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +PE++  +    ++D+WS G  + EM
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR---GVKIQPRG 140
           I   + YL+++  VH D+  +N +V  + + VK+ DFG   +   +D     G  + P  
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
              WMAPE ++       SD+WS G  + E+ +
Sbjct: 187 ---WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 58/241 (24%), Positives = 90/241 (37%), Gaps = 60/241 (24%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           ++Y+PGG +  L   +  +  E+  R +   +  A++ +H    +H D+K  N+L+  + 
Sbjct: 80  MDYIPGGDMMSLLIRMEVFP-EVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG 138

Query: 113 SFVKLADFG--------------AAGEATVSDT------------------------RGV 134
             +KL DFG                G     D+                        R  
Sbjct: 139 H-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRAT 197

Query: 135 KIQPR-------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-- 185
           K   R       G+P ++APEV+  +      D WS+G  + EM+ G+P    F A T  
Sbjct: 198 KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP---FLAPTPT 254

Query: 186 ---LSRIGFSDELPRFPTQS--SELGRDFLDK--CLRREPGERWSCDQLLKHPFLQSVSP 238
              L  I + + L   P Q   S    D + K  C   E   R   D +  HPF   V  
Sbjct: 255 ETQLKVINWENTL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313

Query: 239 S 239
           S
Sbjct: 314 S 314

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 51/189 (26%), Positives = 77/189 (40%), Gaps = 21/189 (11%)

Query: 51  LHLEYLPGGTV-SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
           L L++  GG + S ++  LN   + +   +    +V AL  LH   IV  D+   N+L+ 
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAE--MVVALDALHREGIVCRDLNPNNILLD 119

Query: 110 PNSSFVKLADFGAAGEATVS-DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
            +   ++L  F    E   S D   V        ++ APEV     +    D WSLG  +
Sbjct: 120 -DRGHIQLTYFSRWSEVEDSCDGEAV------ENMYCAPEVGGISEETEACDWWSLGAIL 172

Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC---- 224
            E++TGK   E   +     I     L   P   SE  R  L + L+  P ER       
Sbjct: 173 FELLTGKTLVECHPSG----INTHTTL-NIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227

Query: 225 -DQLLKHPF 232
            + +  HPF
Sbjct: 228 VEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 7/93 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR---GVKIQPRG 140
           I   + YL++   VH D+  +N +V  + + VK+ DFG   +   +D     G  + P  
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLLP-- 184

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
              WM+PE ++       SDVWS G  + E+ T
Sbjct: 185 -VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 9e-05
 Identities = 32/114 (28%), Positives = 46/114 (40%), Gaps = 29/114 (25%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG--- 140
           I+ AL  LHS  IVH DVK +N++    S   K+ D GAA +  V    G+   P+    
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV----GINYIPKEFLL 319

Query: 141 SPLWMAPEVVRGECQGPES----------------------DVWSLGCTIIEMV 172
            P + APE      Q P +                      D++S G   ++M 
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373

Length = 566

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 21/105 (20%)

Query: 87  ALKYLHSR-NIVHCDVKGKNVLVG---------------PNSSFVKLADFGAAGEATVSD 130
           AL Y H+  +++H D+K +N+L+                P+   V++ D G   +   S 
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR 302

Query: 131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK 175
           T  V  +      + +PEVV G      +D+WS+GC I E+ TGK
Sbjct: 303 TAIVSTRH-----YRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 5/98 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   ++YL   + +H D+  +N LV  ++  VK++DFG      V D           P+
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMT--RYVLDDEYTSSSGAKFPV 165

Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWE 179
            W  PEV        +SDVWS G  + E+ T GK  +E
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 22/100 (22%)

Query: 87  ALKYLHSRNIVHCDVKGKNVLV-------GPNSSFVKLADFGAAGEATVSDTRGVKIQPR 139
           AL +L  + + H +V  KNVL+         N  F+KL+D G      +S T    + P+
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG------ISIT----VLPK 161

Query: 140 GSPL----WMAPEVVRGECQ-GPESDVWSLGCTIIEMVTG 174
              L    W+ PE +         +D WS G T+ E+ +G
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 23/95 (24%), Positives = 49/95 (51%), Gaps = 12/95 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---- 139
           ++ A++Y+H + ++H D+K +N+ +  +   V L DFG A        R    +      
Sbjct: 276 LLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV-LGDFGTA--MPFEKER----EAFDYGW 328

Query: 140 -GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            G+    +PE++ G+     +D+WS G  +++M++
Sbjct: 329 VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.3 bits (94), Expect = 9e-04
 Identities = 40/153 (26%), Positives = 61/153 (39%), Gaps = 35/153 (22%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV------GPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           + SAL YL  +++VH +V  KN+L+      G    F+KL+D G             +I 
Sbjct: 114 LASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP 173

Query: 138 PRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP 196
                 W+APE V         +D WS G T+         WE         I ++ E+P
Sbjct: 174 ------WIAPECVEDSKNLSIAADKWSFGTTL---------WE---------ICYNGEIP 209

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
                 +E  R +  +C+   P    SC +L  
Sbjct: 210 LKDKTLAEKERFYEGQCMLVTP----SCKELAD 238

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 9e-04
 Identities = 45/185 (24%), Positives = 79/185 (42%), Gaps = 38/185 (20%)

Query: 84  IVSALKYLHS-------RNIVHCDVKGKNVLVGPNSSFV----------------KLADF 120
           ++ AL Y H+         ++H D+K +N+ +      +                K+ DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186

Query: 121 GAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG--PESDVWSLGCTIIEMVTGKPAW 178
           G +    +       +   G+P + +PE++  E +    +SD+W+LGC I E+ +GK  +
Sbjct: 187 GLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Query: 179 EDFGANTLSRIGFSDELPRFPT-----QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               AN  S++    EL R P      +S EL    +   L     ER S  Q L +  +
Sbjct: 244 HK--ANNFSQL--ISELKRGPDLPIKGKSKELNI-LIKNLLNLSAKERPSALQCLGYQII 298

Query: 234 QSVSP 238
           ++V P
Sbjct: 299 KNVGP 303

Length = 1021

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 15/119 (12%)

Query: 124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA 183
           G A V   R +     G+P ++APE++ G+  GP  D W+LG  + E +TG P + D   
Sbjct: 531 GAAPVEGERIL-----GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFND--- 582

Query: 184 NTLSRIGFSDELPR---FPTQSSEL---GRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
            T  ++ F + L R   +P    +L    ++ ++  L  +P +R    +L +HP    V
Sbjct: 583 ETPQQV-FQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGV 640

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 28/145 (19%)

Query: 47  SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           S  +L   Y P G              E  + +  +  +  L YLH    +H ++K  ++
Sbjct: 85  SANSLLKTYFPEGM------------SEALIGNILFGALRGLNYLHQNGYIHRNIKASHI 132

Query: 107 LVGPN--------SSFVKLADFGAAGEATVSDTR-GVKIQPRGSPLWMAPEVVRGECQG- 156
           L+  +        S    L   G   +      +    + P     W++PE++R +  G 
Sbjct: 133 LISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-----WLSPELLRQDLYGY 187

Query: 157 -PESDVWSLGCTIIEMVTGKPAWED 180
             +SD++S+G T  E+ TG+  ++D
Sbjct: 188 NVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	408
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.74
smart00090	237	RIO RIO-like kinase.	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.66
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.63
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.6
PRK10345	210	hypothetical protein; Provisional	99.59
PRK14879	211	serine/threonine protein kinase; Provisional	99.57
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.54
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.35
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.27
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.21
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.21
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.2
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.06
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.05
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.72
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.67
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
KOG1243	690	consensus Protein kinase [General function predict	98.59
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.56
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.48
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.16
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.14
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.1
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.0
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.63
PRK09902	216	hypothetical protein; Provisional	97.48
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.34
PF01636	239	APH: Phosphotransferase enzyme family This family	96.9
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.84
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	96.38
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.23
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	96.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	96.02
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	95.35
PLN02876	822	acyl-CoA dehydrogenase	95.34
PRK10593	297	hypothetical protein; Provisional	94.6
PRK05231	319	homoserine kinase; Provisional	92.85
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	92.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	92.33
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.23
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	92.11
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	92.01
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	91.49
KOG2270	520	consensus Serine/threonine protein kinase involved	91.48
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	91.22
COG2334	331	Putative homoserine kinase type II (protein kinase	90.8
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	90.64
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	89.73
PRK10271	188	thiK thiamine kinase; Provisional	89.49
PLN02236	344	choline kinase	89.22
KOG1093	725	consensus Predicted protein kinase (contains TBC a	89.03
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	88.87
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	88.35
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	87.54
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	87.19
PHA03111	444	Ser/Thr kinase; Provisional	86.03
PRK06149	972	hypothetical protein; Provisional	85.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	84.78
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	84.5
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	83.96
PRK06148	1013	hypothetical protein; Provisional	83.5
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	82.89
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	81.72
PRK11768	325	serine/threonine protein kinase; Provisional	81.28
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	80.67

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=394.90  Aligned_cols=236  Identities=31%  Similarity=0.431  Sum_probs=211.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.|+||+|+||+||+++.++|++.||+|...                            +...-.|++...+|||+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            57999999999999999999999999999986543                            12333578888999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||.|+..|++ .+.++|..++-|+.+|+.||.|||++|||||||||+|||||.+|+ ++|+|||+++..-....  
T Consensus       105 d~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH-i~LtDFgL~k~~~~~~~--  180 (357)
T KOG0598|consen  105 DYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH-IKLTDFGLCKEDLKDGD--  180 (357)
T ss_pred             eccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc-EEEeccccchhcccCCC--
Confidence            99999999999985 567799999999999999999999999999999999999999996 99999999976443322  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      .+.++|||+.|||||++.+.+|+.++|+||||+++|+|++|.+||...+...+.+.+.....+..|...+++++++++++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL  260 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence            34458999999999999999999999999999999999999999999988888888777777788888999999999999


Q ss_pred             cccCCCCCC----CHHHHHcCCCCCCCCCCCc
Q 042746          214 LRREPGERW----SCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       214 L~~dP~~R~----s~~ell~hpf~~~~~~~~~  241 (408)
                      |.+||.+|.    .+.+|.+||||..+.|+..
T Consensus       261 L~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  261 LKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             hccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence            999999996    7889999999999988754

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-50  Score=401.49  Aligned_cols=240  Identities=29%  Similarity=0.475  Sum_probs=209.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|.+|+.||.|+|++|++|+++.+++.||+|..++                             .....|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            479999999999999999999999999999876442                             122346778889999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      +||+++|+|.++|++. +.++|..++.|++||+.||+|||++|||||||||+||||+.+++ +||+|||.|+.+......
T Consensus       153 Le~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh-ikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH-IKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc-EEEeeccccccCChhhcc
Confidence            9999999999999965 67799999999999999999999999999999999999999996 999999999766543221


Q ss_pred             -----------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCC
Q 042746          133 -----------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       133 -----------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~  201 (408)
                                 .....++||..|.+||++.....++.+|||+|||++|+|+.|++||.+.+...+.+.+....+ .+|..
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-~fp~~  309 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-EFPEG  309 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-cCCCC
Confidence                       112458999999999999999999999999999999999999999998887776666555555 67788


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCcccc
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV  244 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~~~~~  244 (408)
                      .++.++|||+++|..||.+|+|+.||.+||||..+.|......
T Consensus       310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~  352 (604)
T KOG0592|consen  310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQ  352 (604)
T ss_pred             CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhc
Confidence            9999999999999999999999999999999999998864433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-49  Score=373.26  Aligned_cols=233  Identities=27%  Similarity=0.444  Sum_probs=209.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++.+.||.|+||+|.+++++.++..||+|..++                            .+...+.+..++|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4689999999999999999999999999999876441                            122345677889999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||.|++++++. +.++|..++-|++||+.||+|||+++|++|||||+|||||.+|. +||+|||+|+....    
T Consensus       123 meyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~-iKitDFGFAK~v~~----  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH-IKITDFGFAKRVSG----  196 (355)
T ss_pred             EeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc-EEEEeccceEEecC----
Confidence            9999999999999954 56799999999999999999999999999999999999999996 99999999977642    


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                       .+.+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||.+.+...+...+....+ .+|...++++++||++
T Consensus       197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~  274 (355)
T KOG0616|consen  197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKK  274 (355)
T ss_pred             -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHH
Confidence             25678999999999999999999999999999999999999999999998888888887777 7889999999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCCCc
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~~~  241 (408)
                      +|+.|-.+|.     ...+|.+||||+.+.|...
T Consensus       275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             HHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            9999999995     5679999999998887643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=382.73  Aligned_cols=231  Identities=30%  Similarity=0.492  Sum_probs=203.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc--------------------------cceeccCCCCC-cceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------VSYEAPTTSSS-CRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--------------------------~~~~~~~~~~~-~~~LVmEy   55 (408)
                      +.+.++.||+|..|+||+++++.|++.+|+|...                          +.+.+.|..+. .++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4567899999999999999999999999998752                          33445555666 48999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |.||+|.++++.. +.++|..+..++.++++||.|||+ ++||||||||+|||++..|. |||||||.++.....    .
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe-VKicDFGVS~~lvnS----~  233 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE-VKICDFGVSGILVNS----I  233 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC-EEeccccccHHhhhh----h
Confidence            9999999999854 667999999999999999999995 99999999999999999885 999999999877654    4


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCC-----ChhhhhhhcccCCCCCCCCC-CcHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-----GANTLSRIGFSDELPRFPTQ-SSELGRD  208 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~-----~~~~~~~~~~~~~~p~~~~~-~s~~~~~  208 (408)
                      ..+++||..|||||.+.+..|+.++||||||++++|+++|+.||...     +..++...+.....|.+|.. +|+++++
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~  313 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS  313 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            56788999999999999999999999999999999999999999764     44555556677888899986 9999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          209 FLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ||..||++||.+|||+.|+++|||++.....
T Consensus       314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  314 FVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            9999999999999999999999999865544

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-49  Score=399.01  Aligned_cols=228  Identities=32%  Similarity=0.463  Sum_probs=205.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVmE   54 (408)
                      +|.+++.||+|||++||.+++..+|+.||+|...                            +.+...|++.+++|||+|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            4999999999999999999999999999987643                            446667899999999999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +|+.++|..+++ ..+.++|.+++.+++||+.||.|||+++|+|||||..|+||+++.. |||+|||+|........  .
T Consensus        99 LC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~-VKIgDFGLAt~le~~~E--r  174 (592)
T KOG0575|consen   99 LCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN-VKIGDFGLATQLEYDGE--R  174 (592)
T ss_pred             ecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc-EEecccceeeeecCccc--c
Confidence            999999999998 5678899999999999999999999999999999999999999875 99999999987765544  3


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ..+.||||.|+|||++....++..+||||+||++|.||.|+|||+.....+....+....+ .+|...|.++++||.+||
T Consensus       175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL  253 (592)
T KOG0575|consen  175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKLL  253 (592)
T ss_pred             cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHHh
Confidence            4567999999999999999999999999999999999999999998877766665555554 567799999999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ++||.+|||++++|.|+||..
T Consensus       254 ~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  254 RPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             cCCcccCCCHHHHhcCHhhhC
Confidence            999999999999999999943

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=386.52  Aligned_cols=233  Identities=26%  Similarity=0.408  Sum_probs=195.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------------~~~~~~~~~~~~   49 (408)
                      +.|.+.+.||+|+||.|.+|.+++|++.||+|....                                .....++.....
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            468999999999999999999999999999976432                                222334555667


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccc
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEAT  127 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~  127 (408)
                      |+||||+.||+|++.+- .++.+.|...+.+++||+.||.|||++||+||||||+|||+..+.  -.+||+|||+|+...
T Consensus       252 YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g  330 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG  330 (475)
T ss_pred             EEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence            99999999999999987 467889999999999999999999999999999999999997651  248999999997765


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCC---CCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCC---CC
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGEC---QGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRF---PT  200 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~---~~  200 (408)
                      .   .....+.||||.|.|||++.+..   +..++|+|||||+||-+|+|.+||.+..... +.+.+..+.++..   ..
T Consensus       331 ~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  331 E---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             c---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            2   33456789999999999998754   3458899999999999999999998765444 5555555555433   35


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ..++++++||++||..||+.|||++|+|+||||+..+.
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            68999999999999999999999999999999986553

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.4e-48  Score=383.93  Aligned_cols=239  Identities=29%  Similarity=0.465  Sum_probs=200.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LV   52 (408)
                      +++|++.+.||+|+||.||+|+.++||..||+|...                            |.+...|++...+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            478999999999999999999999999999997644                            2344468888999999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc----
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV----  128 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~----  128 (408)
                      |||+|||++..+|.+ .+.++|..++.|+++++.|++-||++|+|||||||+|+|||..|+ +||+|||++.-...    
T Consensus       220 MEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH-iKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH-IKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC-Eeeccccccchhhhhhhh
Confidence            999999999999984 578899999999999999999999999999999999999999996 99999999832110    


Q ss_pred             ------------------CCCC-----------------------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHH
Q 042746          129 ------------------SDTR-----------------------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCT  167 (408)
Q Consensus       129 ------------------~~~~-----------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvi  167 (408)
                                        ....                       ......+|||.|||||++.+..|+..+|+||||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                              0000                       00123469999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCChhhhhhhccc--CCCCCCC--CCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCCCCCC
Q 042746          168 IIEMVTGKPAWEDFGANTLSRIGFS--DELPRFP--TQSSELGRDFLDKCLRREPGERW---SCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       168 l~eLltG~~Pf~~~~~~~~~~~~~~--~~~p~~~--~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hpf~~~~~~~~  240 (408)
                      +||||.|.|||....+....+.+..  ..+ .+|  ...+.+++|||.+||. ||.+|.   +++||.+||||+.+.|+.
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l-~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~  455 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETL-KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH  455 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence            9999999999998887766554422  222 222  3567999999999999 999998   589999999999999885


Q ss_pred             ccc
Q 042746          241 ANT  243 (408)
Q Consensus       241 ~~~  243 (408)
                      ...
T Consensus       456 l~~  458 (550)
T KOG0605|consen  456 LRE  458 (550)
T ss_pred             hhc
Confidence            443

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-48  Score=393.23  Aligned_cols=236  Identities=25%  Similarity=0.364  Sum_probs=207.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~L   51 (408)
                      +++|++.++||+|+||+|++|..+.+++.||+|..++                             .....+++..+++.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            5789999999999999999999999999999875431                             12234678889999


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+.||++..+.  ..+.++|..++-|+++|+.||+|||++||||||||.+|||||.+|+ +||+|||++++.-... 
T Consensus       447 vmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh-~kiADFGlcKe~m~~g-  522 (694)
T KOG0694|consen  447 VMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH-VKIADFGLCKEGMGQG-  522 (694)
T ss_pred             EEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-EEecccccccccCCCC-
Confidence            99999999954443  3467899999999999999999999999999999999999999996 9999999998765333 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ..+.++||||.|||||++.+..|+.++|+|||||+|||||.|++||.+.+.+++...+...++ .+|.++|.++.++++
T Consensus       523 -~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~  600 (694)
T KOG0694|consen  523 -DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMR  600 (694)
T ss_pred             -CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHH
Confidence             256789999999999999999999999999999999999999999999898888887766654 789999999999999


Q ss_pred             HhcccCCCCCCC-----HHHHHcCCCCCCCCCCCcc
Q 042746          212 KCLRREPGERWS-----CDQLLKHPFLQSVSPSDAN  242 (408)
Q Consensus       212 ~~L~~dP~~R~s-----~~ell~hpf~~~~~~~~~~  242 (408)
                      ++|.++|++|..     +++|.+||||+.+.|+...
T Consensus       601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~  636 (694)
T KOG0694|consen  601 RLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL  636 (694)
T ss_pred             HHhccCcccccCCCCCCchhhhhCCccccCCHHHHh
Confidence            999999999994     6889999999999877543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=369.84  Aligned_cols=236  Identities=42%  Similarity=0.776  Sum_probs=197.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eecc-CCCC-CcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAP-TTSS-SCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~-~~~~-~~~~LVmE   54 (408)
                      .+|..++.||+|+||+||++.+.++|..+|+|..+..                         +.+. .... ..++|+||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            4699999999999999999999999999998865542                         1111 1112 26899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC-CCCcEEEeecCCcccccc-CCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATV-SDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~-~~~~vkL~DFGla~~~~~-~~~~  132 (408)
                      |++||+|.+++.+.++.++|..++.+++||+.||+|||++||+||||||+|||++. ++ .+||+|||+++.... ....
T Consensus        97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC-eEEeccCccccccccccccc
Confidence            99999999999987667899999999999999999999999999999999999999 56 499999999977653 1111


Q ss_pred             cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCC-C-hhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDF-G-ANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~-~-~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      .......|||.|||||++.+. ....++|||||||++.||+||++||... . ...+..+......|.+|...|+++++|
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F  255 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF  255 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence            223456799999999999953 3345999999999999999999999873 3 334555555667889999999999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      |.+||.+||++|||++|+|+|||......
T Consensus       256 l~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  256 LRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999986554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=366.10  Aligned_cols=235  Identities=29%  Similarity=0.433  Sum_probs=201.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +.+|.+.+.||+|+||+||+|++++++..||+|....                           .+....+.++++||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            3689999999999999999999999999999976442                           2333455677899999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--C---CcEEEeecCCcccccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--S---SFVKLADFGAAGEATV  128 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~---~~vkL~DFGla~~~~~  128 (408)
                      |||.||+|.++++.+ +.++|..++.++.||+.||++||+++||||||||+||||+..  .   ..+||+|||+|+....
T Consensus        89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            999999999999965 477999999999999999999999999999999999999764  2   3589999999988764


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--cCCCCCCCCCCcHHH
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SDELPRFPTQSSELG  206 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--~~~~p~~~~~~s~~~  206 (408)
                      .   ....+.||||.|||||++..+.|+.|+|+||+|+++|++++|++||+.....++.....  ....|.++...++..
T Consensus       168 ~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~  244 (429)
T KOG0595|consen  168 G---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPL  244 (429)
T ss_pred             h---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCch
Confidence            3   34567899999999999999999999999999999999999999999877766654322  233566677788888


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      .+++..+|..+|.+|.+..+.+.|+++......
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~  277 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANPQD  277 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCccc
Confidence            899999999999999999999999999866543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=373.19  Aligned_cols=229  Identities=31%  Similarity=0.483  Sum_probs=198.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----e--------------------------eccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----Y--------------------------EAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----~--------------------------~~~~~~~~~~~   50 (408)
                      .+|.+++.||+|+||+|++|.+..++..+|+|..+..     .                          .........++
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            5899999999999999999999999999998753321     0                          00122344578


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC-CCcEEEeecCCccccccC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN-SSFVKLADFGAAGEATVS  129 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~-~~~vkL~DFGla~~~~~~  129 (408)
                      +||||+.||+|++++.. .+.+.|..++.+++||++||+|||++||+||||||+|||++.+ +. +||+|||++....  
T Consensus        97 ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~-~Kl~DFG~s~~~~--  172 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN-LKLSDFGLSAISP--  172 (370)
T ss_pred             EEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC-EEEeccccccccC--
Confidence            99999999999999997 7788999999999999999999999999999999999999998 64 9999999997663  


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCC-C-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCC-cHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGEC-Q-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS-SELG  206 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~-~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~-s~~~  206 (408)
                      .......+.||||.|+|||++.+.. | +.++||||+||+||.|++|..||.+.+...+.+.+....+ .+|... |+++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~-~~p~~~~S~~~  251 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF-KIPSYLLSPEA  251 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-cCCCCcCCHHH
Confidence            2223456789999999999999876 7 5889999999999999999999999887777777555554 677788 9999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ++|+.+||..||.+|+|+.+++.||||+.
T Consensus       252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  252 RSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999996

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-46  Score=378.16  Aligned_cols=231  Identities=30%  Similarity=0.441  Sum_probs=203.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .-|.+|+.||.|+.|.|-+|++..||+..|+|.....                            .....+.+..+|||+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4699999999999999999999999999998764422                            222345677899999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||.|++++-. ++.++|..+.++++||+.|+.|||..+|+||||||+|+||+.+++ |||+|||+|.....   ..
T Consensus        92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~---gk  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVP---GK  166 (786)
T ss_pred             EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccC---Cc
Confidence            99999999999985 467789999999999999999999999999999999999999887 99999999955433   23


Q ss_pred             ccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ...+.||+|.|.|||++.|.+| +.++||||+|||||.||+|+.||++.+...+......+.+ .+|..+|.++++||.+
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRR  245 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHH
Confidence            4556799999999999999988 7899999999999999999999999998888877655555 7789999999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ||..||++|+|.+||++|||+.....
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCC
Confidence            99999999999999999999987653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=366.69  Aligned_cols=230  Identities=33%  Similarity=0.510  Sum_probs=204.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee--------------------------ccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE--------------------------APTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~--------------------------~~~~~~~~~~LVmEy~   56 (408)
                      .|+....||+|+||.||+|.|..|++.||+|..++...                          +.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            58888999999999999999999999999987653211                          1122344567899999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      .||++.++++ .+..++|..+..++++++.||.|||.++.+|||||+.|||+..++. +||+|||++.+.+.....  ..
T Consensus        94 ~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~-vkl~DfgVa~ql~~~~~r--r~  169 (467)
T KOG0201|consen   94 GGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD-VKLADFGVAGQLTNTVKR--RK  169 (467)
T ss_pred             cCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc-EEEEecceeeeeechhhc--cc
Confidence            9999999998 5566699999999999999999999999999999999999999875 999999999887765543  36


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      +++|||.|||||++.+..|+.++||||||++.+||++|.+||.+..+......+-...+|.+...+|+.+++|+..||++
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence            78999999999999998999999999999999999999999999888777777777888888899999999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~  236 (408)
                      ||+.||+|.++|+|+|++..
T Consensus       250 ~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  250 NPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             CcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999873

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-45  Score=346.08  Aligned_cols=232  Identities=28%  Similarity=0.468  Sum_probs=190.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      |++|+...++|+|+||+||+|++++||+.||+|+..-                           .....|.....++||+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            8899999999999999999999999999999987431                           1222345566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |||.. ++.+.+++.....++..++.|++|++.|+.|+|++++|||||||+||||+.++ ++||||||+|+.......  
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd--  156 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGD--  156 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcc--
Confidence            99987 77778887777889999999999999999999999999999999999999988 599999999988764222  


Q ss_pred             ccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCC-Chhhhhhhc-------------ccC-----
Q 042746          134 VKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIG-------------FSD-----  193 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~-~~~~~~~~~-------------~~~-----  193 (408)
                      .....+.|.||+|||.+.+ ..|+..+||||+||++.||++|.+.|.+. +.+++..+.             +..     
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            3445678999999999998 68999999999999999999999999864 344443221             100     


Q ss_pred             --CCCCC---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          194 --ELPRF---------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       194 --~~p~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                        .+|..         -+..+..+.||+++||..||.+|++.+|+|.||||+..
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence              11111         12456678899999999999999999999999999643

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-44  Score=351.93  Aligned_cols=237  Identities=27%  Similarity=0.399  Sum_probs=199.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .++++.+.||.|.-|+||+|....++..||+|..+.                            ...+.++.+++.+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456788999999999999999999999999988662                            2233467888999999


Q ss_pred             eccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC---
Q 042746           54 EYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS---  129 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~---  129 (408)
                      |||+||+|..+.++. ++.+++..++.|+++++.||+|||-.|||+|||||+||||.++|+ |.|+||.++......   
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH-IMLsDFDLS~~~~~~Pt~  235 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH-IMLSDFDLSLRCPVSPTL  235 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc-EEeeeccccccCCCCCee
Confidence            999999999999864 568999999999999999999999999999999999999999996 999999987432110   


Q ss_pred             ------------------------------CCC---------------------cccccCCCCCCCCChhhHhCCCCCCC
Q 042746          130 ------------------------------DTR---------------------GVKIQPRGSPLWMAPEVVRGECQGPE  158 (408)
Q Consensus       130 ------------------------------~~~---------------------~~~~~~~Gt~~y~APE~l~~~~~~~~  158 (408)
                                                    ...                     .....++||-.|+|||+++|..++.+
T Consensus       236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA  315 (459)
T KOG0610|consen  236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA  315 (459)
T ss_pred             eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence                                          000                     01124579999999999999999999


Q ss_pred             CCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC--CCCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHcCCC
Q 042746          159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE--LPRFPTQSSELGRDFLDKCLRREPGERWS----CDQLLKHPF  232 (408)
Q Consensus       159 sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~p~~~~~~s~~~~~li~~~L~~dP~~R~s----~~ell~hpf  232 (408)
                      +|||+|||++||||.|..||.+.+..+....+....  +|..+ ..+..++|||+++|.+||++|..    ++||.+|||
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF  394 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF  394 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence            999999999999999999999877655554444333  23332 56788999999999999999997    999999999


Q ss_pred             CCCCCCCC
Q 042746          233 LQSVSPSD  240 (408)
Q Consensus       233 ~~~~~~~~  240 (408)
                      |+++.|.-
T Consensus       395 F~gVnWaL  402 (459)
T KOG0610|consen  395 FEGVNWAL  402 (459)
T ss_pred             ccCCChhh
Confidence            99999873

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-46  Score=344.49  Aligned_cols=219  Identities=26%  Similarity=0.365  Sum_probs=193.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eec-cCCCCCc-ceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEA-PTTSSSC-RNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~-~~~~~~~-~~LVm   53 (408)
                      +|++.+.||+|+||+||++.+..++..+|.|+....                           +.+ .+.+++. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            589999999999999999999999999998875521                           111 2333344 89999


Q ss_pred             eccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           54 EYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHS--RN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        54 Ey~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~--~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      |||.+|+|.+++++   .++.++|..++.++.|++.||..+|+  ..  |+||||||.||+|+.+| .+||+|||+++.+
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r~l  178 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLGRFL  178 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhHhHh
Confidence            99999999999986   35688999999999999999999999  44  99999999999999988 4999999999877


Q ss_pred             ccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCC-CCCcHH
Q 042746          127 TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP-TQSSEL  205 (408)
Q Consensus       127 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~-~~~s~~  205 (408)
                      ....  ....+.+|||.||+||.+...+|++++|||||||++|||..-++||.+.+...+.+.+..+.+|++| ..+|.+
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~  256 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTD  256 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhH
Confidence            5433  3455678999999999999999999999999999999999999999998888888888888998888 789999


Q ss_pred             HHHHHHHhcccCCCCCCCH
Q 042746          206 GRDFLDKCLRREPGERWSC  224 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~  224 (408)
                      ++.+|..|+..||.+||+.
T Consensus       257 l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  257 LRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHHccCCcccCCCc
Confidence            9999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-45  Score=360.34  Aligned_cols=233  Identities=23%  Similarity=0.398  Sum_probs=192.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------ecc-CCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAP-TTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~-~~~~~~~~LV   52 (408)
                      |++|...+.||.|.||.||+|+.+.+++.||+|+....+                           ... .+.++++|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            679999999999999999999999999999997755221                           111 2334489999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||||.. +|+++++.++..++|..|+.|++||++||+|+|.+|+.|||+||+|||+..+. .+||+|||+|++.....  
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~Skp--  164 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKP--  164 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccCC--
Confidence            999987 99999999999999999999999999999999999999999999999998655 59999999999876543  


Q ss_pred             cccccCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhcc-------------------
Q 042746          133 GVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGF-------------------  191 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~~-------------------  191 (408)
                       .....+-|.||+|||++. ...|+.++|+||+||+++|+++-++.|.+.+. +++.++..                   
T Consensus       165 -PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  165 -PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             -CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence             344566899999999985 56789999999999999999999999986543 33333210                   


Q ss_pred             -cCCCCCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 -SDELPRF--------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 -~~~~p~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                       .-.+|..        -+..++++.++|.+||.+||.+|||+.|+|+||||+....
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence             1112221        2347888999999999999999999999999999985543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=360.89  Aligned_cols=230  Identities=31%  Similarity=0.479  Sum_probs=204.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      |.+|.+.+.||+|+||+||+|+.+.|.+.||+|-.+                           +.+...++...++++|.
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            789999999999999999999999999999997543                           22344577888999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |||.| +|+.++. ..+.++|+.++.+++|++.||.|||+++|+|||+||+|||++.++. +|++|||+|+.....  ..
T Consensus        81 e~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~-~KlcdFg~Ar~m~~~--t~  155 (808)
T KOG0597|consen   81 EYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT-LKLCDFGLARAMSTN--TS  155 (808)
T ss_pred             hhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc-eeechhhhhhhcccC--ce
Confidence            99998 9999998 5678899999999999999999999999999999999999988875 999999999876542  23


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ......|||.|||||++.+.+|+..+|+|||||++||+++|+|||-.....++.+.+..+.. .+|...+..++.|++.+
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl~gL  234 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFLQGL  234 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHHHHH
Confidence            44556799999999999999999999999999999999999999998887787777655544 66778999999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      |.+||.+|+|..+++.|||.++.
T Consensus       235 L~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  235 LIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             hhcChhhcccHHHHhcChHHhhh
Confidence            99999999999999999999753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-44  Score=357.96  Aligned_cols=230  Identities=33%  Similarity=0.507  Sum_probs=195.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee-------------------------ccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE-------------------------APTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~-------------------------~~~~~~~~~~LVmEy~   56 (408)
                      ..|..-..||+|+.|.||.|+...+++.||+|..+....                         ..+.....+++||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            357888999999999999999999999999988764322                         2223346689999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +||+|.|++.+  ..++|.+|..+.++++.||+|||.+||+|||||.+|||++.++. +||+|||++.+......  ...
T Consensus       353 ~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~-vKltDFGFcaqi~~~~~--KR~  427 (550)
T KOG0578|consen  353 EGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS-VKLTDFGFCAQISEEQS--KRS  427 (550)
T ss_pred             CCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc-EEEeeeeeeeccccccC--ccc
Confidence            99999999974  56899999999999999999999999999999999999999886 99999999987765554  344


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC--CCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR--FPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~--~~~~~s~~~~~li~~~L  214 (408)
                      +.+|||.|||||++....|++++||||||++++||+.|++||-..++......+.....|.  .+...|+.+++||++||
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL  507 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL  507 (550)
T ss_pred             cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence            5689999999999999999999999999999999999999997554443333333444443  35679999999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +.|+.+|+++.|||+||||+..
T Consensus       508 ~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  508 VVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             hcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.6e-43  Score=345.03  Aligned_cols=231  Identities=23%  Similarity=0.393  Sum_probs=194.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++.+.||+|+||+||+|+++.+++.+|+|....                            .+...+..+...++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            4689999999999999999999999999999875321                            112234456678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....   
T Consensus        97 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~---  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVPDR---  171 (329)
T ss_pred             EcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC-EEEeeccCceEcCCC---
Confidence            999999999999985 456789999999999999999999999999999999999998875 999999999755322   


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||................ +.+|...+..+++||.+
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKG  248 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHH
Confidence              123569999999999999989999999999999999999999998766555444433333 45677889999999999


Q ss_pred             hcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      ||+.||.+|++     ++++++||||....+.
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            99999999996     7999999999875544

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-43  Score=338.11  Aligned_cols=230  Identities=27%  Similarity=0.398  Sum_probs=193.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|.....                            +......+...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4799999999999999999999999999998764311                            111234556789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......    
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~-~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDR----  154 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEEEecCcchhccCC----
Confidence            99999999999985 456789999999999999999999999999999999999998875 999999998655321    


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                       ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||................ +.++...++.+++||.+|
T Consensus       155 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~  232 (291)
T cd05612         155 -TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKL  232 (291)
T ss_pred             -cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHH
Confidence             123469999999999999889999999999999999999999998766555444433333 356677899999999999


Q ss_pred             cccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          214 LRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      |+.||.+|++     ++|+++||||....+.
T Consensus       233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             cCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            9999999995     9999999999876544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7e-43  Score=343.77  Aligned_cols=227  Identities=26%  Similarity=0.413  Sum_probs=189.9

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||+|+++.+++.+|+|....                            .....+..+...+|||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            579999999999999999999999875431                            1112234566788999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR  139 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  139 (408)
                      +|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......+
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~-~kl~DfG~a~~~~~~~--~~~~~~~  156 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDG--ATMKTFC  156 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC-EEEeeCCCCcccccCC--Cccccee
Confidence            99999974 457799999999999999999999999999999999999998875 9999999986532211  1223456


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCC
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG  219 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~  219 (408)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+............ +.+|...++.+++||.+||++||+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccCCHH
Confidence            9999999999999999999999999999999999999998766655554443333 356778899999999999999999


Q ss_pred             CCC-----CHHHHHcCCCCCCCCCC
Q 042746          220 ERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       220 ~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +||     ++.++++||||....+.
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999     89999999999887654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.6e-43  Score=322.21  Aligned_cols=235  Identities=25%  Similarity=0.389  Sum_probs=193.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      +++|...+.||+|.||.||+|+|..||+.||+|+..+.                           ....+.+...+.||+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            57899999999999999999999999999999876532                           122345566788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++- +|...++.....++...++.|+.|+++||+|||++.|+||||||.|+|++++|. +||+|||+|+.........
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~-lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ-LKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc-EEeecccchhccCCCCccc
Confidence            99987 999999998899999999999999999999999999999999999999999984 9999999998876544322


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCC-Chhhhhhhccc-------------------
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFS-------------------  192 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~-~~~~~~~~~~~-------------------  192 (408)
                      .  ..+-|.||.|||.+.|. .|+..+|+||.||++.||+.|.|-|.+. +.+++..+...                   
T Consensus       159 ~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  159 T--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             c--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            2  22679999999999885 6899999999999999999999988754 33443322100                   


Q ss_pred             --CCCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 --DELPR-----FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 --~~~p~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                        ...|.     +-...++++.||+.+||..||.+|+|+.|+++|+||...+..
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence              00111     113456778999999999999999999999999999975543

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.9e-42  Score=339.33  Aligned_cols=232  Identities=22%  Similarity=0.345  Sum_probs=192.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVm   53 (408)
                      +|++.+.||+|+||+||+|.+..+++.+|+|.....                             +...+......++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999998753210                             111233456688999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~~--  156 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGK--  156 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC-EEEeecCcceecCCCCC--
Confidence            99999999999974 456789999999999999999999999999999999999998875 99999999864322211  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      .....+||+.|+|||++.+..++.++|+|||||++|+|++|++||.............. ..+.++...++.+.+++.+|
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~  235 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSYPKSLSKEAVSICKGL  235 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHH
Confidence            22345699999999999999899999999999999999999999987665555444333 33456778899999999999


Q ss_pred             cccCCCCCCCH-----HHHHcCCCCCCCCCC
Q 042746          214 LRREPGERWSC-----DQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~s~-----~ell~hpf~~~~~~~  239 (408)
                      |.+||.+|++.     +++++||||....+.
T Consensus       236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         236 LTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999976     899999999876553

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-42  Score=339.05  Aligned_cols=232  Identities=22%  Similarity=0.343  Sum_probs=193.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVm   53 (408)
                      +|++.+.||+|+||+||+|++..+++.+|+|.....                             +...+......+|||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999998753211                             111233456678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~kL~DfG~~~~~~~~~~--  156 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGV--  156 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc-EEEccCCCceecCCCCC--
Confidence            99999999999874 456799999999999999999999999999999999999998875 99999999865432211  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      .....+||+.|+|||++.+..++.++|+|||||++|+|++|++||.......+........ +.+|...++++++++.+|
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  235 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGL  235 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHH
Confidence            2234579999999999999999999999999999999999999998776665554433333 356678899999999999


Q ss_pred             cccCCCCCCCH-----HHHHcCCCCCCCCCC
Q 042746          214 LRREPGERWSC-----DQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~s~-----~ell~hpf~~~~~~~  239 (408)
                      |++||.+|+++     .++++||||+...+.
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             cccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999974     899999999877654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.5e-42  Score=331.61  Aligned_cols=232  Identities=22%  Similarity=0.347  Sum_probs=189.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .|++.+.||+|+||+||+|.+..+++.+|+|....                            .....+..+...++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            58999999999999999999999999999875321                            01112345567889999


Q ss_pred             ccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           55 YLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        55 y~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++.......   
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~-~kl~Dfg~~~~~~~~~---  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGE---  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC-EEEeeCCCcEEcCCCC---
Confidence            999999998886533 46789999999999999999999999999999999999998875 9999999986543221   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----hhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----TLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|++||......    ..... .......++...++++.+|
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hhcccccCCccCCHHHHHH
Confidence            122346899999999999989999999999999999999999999864332    11111 1223335566789999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          210 LDKCLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       210 i~~~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      +.+||+.||.+||+     ++++++||||....+.
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence            99999999999997     8999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=335.41  Aligned_cols=231  Identities=26%  Similarity=0.370  Sum_probs=189.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||.||+|++..+++.||+|.....                            +...+......+|||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            3799999999999999999999999999998754311                            112234556789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....     
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kL~Dfg~a~~~~~-----  153 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-----  153 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-EEEEeCcCCccccc-----
Confidence            99999999999974 456799999999999999999999999999999999999998875 99999999965433     


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--cC--CCCCCC---CCCcHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SD--ELPRFP---TQSSELG  206 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--~~--~~p~~~---~~~s~~~  206 (408)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.............  ..  ..|...   ...+.++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHH
Confidence            2234569999999999999899999999999999999999999998765544322111  11  111111   2458899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      .+||.+||..+|.+||++.|+++||||....+.
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~  266 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN  266 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence            999999999999999999999999999976543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.8e-42  Score=342.20  Aligned_cols=236  Identities=25%  Similarity=0.339  Sum_probs=187.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|....                            .....+.....++|||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            579999999999999999999999999999886431                            1122234566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC--
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT--  131 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--  131 (408)
                      ||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~-vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC-EEEeeccCccccccccccc
Confidence            99999999999985 457899999999999999999999999999999999999998875 99999999865422100  


Q ss_pred             -------------------------------CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCC
Q 042746          132 -------------------------------RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWED  180 (408)
Q Consensus       132 -------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~  180 (408)
                                                     .......+||+.|+|||++.+..++.++|||||||++|+|++|++||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                           0011235799999999999999999999999999999999999999987


Q ss_pred             CChhhhhhhccc-CCCCCCCC--CCcHHHHHHHHHhcccCCC---CCCCHHHHHcCCCCCCCCCCC
Q 042746          181 FGANTLSRIGFS-DELPRFPT--QSSELGRDFLDKCLRREPG---ERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       181 ~~~~~~~~~~~~-~~~p~~~~--~~s~~~~~li~~~L~~dP~---~R~s~~ell~hpf~~~~~~~~  240 (408)
                      .........+.. .....+|.  ..++++++||.+|+. +|.   .||+++|+++||||+...+..
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            665444333222 11112222  468899999999775 444   468999999999999877654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=335.29  Aligned_cols=236  Identities=27%  Similarity=0.413  Sum_probs=209.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      |++|...|+||+|.||+|-+++.+.+++.||+|....                            ..+-.++.+..+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            6789999999999999999999999999999865331                            122246677889999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+.||.|+-.+.+ .+.++|...+.|..+|++||.|||+++||+||||.+|+|||.+|+ +||+|||++++....  .
T Consensus       247 MeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH-IKitDFGLCKE~I~~--g  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH-IKITDFGLCKEEIKY--G  322 (516)
T ss_pred             EEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc-eEeeecccchhcccc--c
Confidence            999999999998885 456789999999999999999999999999999999999999996 999999999765432  2


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ....++||||.|+|||++....|+.++|+|.+||++|||++|+.||...+.+.+...+....+ .+|...+++++.|+..
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~-kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL-KFPRTLSPEAKTLLSG  401 (516)
T ss_pred             ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-cCCccCCHHHHHHHHH
Confidence            346689999999999999999999999999999999999999999998888888888777776 7889999999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCCCc
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~~~  241 (408)
                      +|.+||.+|.     .+.||++|+||..+.|...
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~  435 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT  435 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence            9999999998     5889999999999988743

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=372.11  Aligned_cols=235  Identities=29%  Similarity=0.408  Sum_probs=197.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|.+.++||+|+||.|.+++.+.|+++||+|....                            ...-.|++++++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            579999999999999999999999999999875432                            1222478899999999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|..++.+.. .++|..++.|+++|+.||.-||+.|+|||||||+|||||..|+ +||+|||.+-....... -
T Consensus       155 dY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH-ikLADFGsClkm~~dG~-V  231 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH-IKLADFGSCLKMDADGT-V  231 (1317)
T ss_pred             ecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc-EeeccchhHHhcCCCCc-E
Confidence            9999999999999776 8899999999999999999999999999999999999999996 99999999866543322 2


Q ss_pred             ccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCCC--CCCcHH
Q 042746          134 VKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRFP--TQSSEL  205 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~~--~~~s~~  205 (408)
                      .....+|||.|++||+++.     +.|+..+|+||+||++|||+.|..||....... +.++........+|  ...|+.
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            3345689999999999963     468999999999999999999999998665443 33333222333444  568999


Q ss_pred             HHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWS---CDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s---~~ell~hpf~~~~~~~~  240 (408)
                      +++||.+++. +|..|..   ++++.+||||.+..|..
T Consensus       312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             HHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence            9999999886 7888987   99999999999999853

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.5e-42  Score=336.68  Aligned_cols=227  Identities=27%  Similarity=0.421  Sum_probs=189.0

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|+++.+++.||+|.....                             +...+......+|||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            5799999999999999999999998754311                             11123345668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.......  .....
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~-~kL~DfG~~~~~~~~~~--~~~~~  156 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGK--TTSTF  156 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc-EEEeeCCCCeecCcCCC--ccccc
Confidence            999998874 456899999999999999999999999999999999999998875 99999999865322211  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+...+........ +.++...+.++++||.+||++||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP  235 (320)
T cd05590         157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNP  235 (320)
T ss_pred             ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCH
Confidence            69999999999999889999999999999999999999998877666555443333 35667889999999999999999


Q ss_pred             CCCCCH------HHHHcCCCCCCCCCC
Q 042746          219 GERWSC------DQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~------~ell~hpf~~~~~~~  239 (408)
                      .+|+++      +++++||||....+.
T Consensus       236 ~~R~~~~~~~~~~~~~~h~~f~~~~~~  262 (320)
T cd05590         236 TMRLGSLTLGGEEAILRHPFFKELDWE  262 (320)
T ss_pred             HHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999998      899999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=325.37  Aligned_cols=231  Identities=24%  Similarity=0.345  Sum_probs=195.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      +.|.+-..||+|.|+.||++.+..||+.|++|..+.                           .......+..+.|||+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            578889999999999999999999999987654332                           22233456678899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC--CCCcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP--NSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~--~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ++.|++|..-+-.+ ...+|..+-.+++||+.+|.|+|.+||||||+||+|+||-+  ++.-+||+|||+|.+..   ..
T Consensus        91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g  166 (355)
T KOG0033|consen   91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DG  166 (355)
T ss_pred             cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---Cc
Confidence            99999997766543 45689999999999999999999999999999999999954  34459999999998876   22


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~l  209 (408)
                      .......|||.|||||+++..+|+..+|||+.||+||-||.|.+||.+.+...+++.+..+.+   ++..+..++++++|
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            345567899999999999999999999999999999999999999998777776665544433   22446789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +++||..||.+|+|+.|+|+|||+.+.
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999999764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.3e-42  Score=339.34  Aligned_cols=230  Identities=23%  Similarity=0.316  Sum_probs=191.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-cEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-DVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      ++|++.+.||+|+||+||+|.+..++ ..+|+|....                            .+...+......+||
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            57999999999999999999987665 5788765321                            122223455678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++......   
T Consensus       110 ~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~-ikL~DFG~a~~~~~~---  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDTR---  184 (340)
T ss_pred             EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC-EEEecCCCCeecCCC---
Confidence            999999999999984 456799999999999999999999999999999999999998874 999999999654321   


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        .....||+.|+|||++.+..++.++|+|||||++|+|++|.+||............... ...+|...++.++++|++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~  261 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG-IIYFPKFLDNNCKHLMKK  261 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHH
Confidence              23456999999999999988999999999999999999999999876655444443333 335667789999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||+.||.+|+     +++|+++||||....+.
T Consensus       262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             HcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999996     89999999999976654

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-41  Score=336.13  Aligned_cols=227  Identities=26%  Similarity=0.413  Sum_probs=188.8

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||+|.+..+++.+|+|.....                            ....+..+...+|||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            5799999999999999999999998754311                            112234566788999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR  139 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  139 (408)
                      +|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......+
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~-~kL~DfG~~~~~~~~~--~~~~~~~  156 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDA--ATMKTFC  156 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc-EEEecCcCCccCCCcc--ccccccc
Confidence            99998874 456899999999999999999999999999999999999998875 9999999986532221  1223457


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCC
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG  219 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~  219 (408)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+............ +.+|...++++++||.+||.+||+
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-ccCCCCCCHHHHHHHHHHcCCCHH
Confidence            9999999999999889999999999999999999999998766555544433333 356778899999999999999999


Q ss_pred             CCC-----CHHHHHcCCCCCCCCCC
Q 042746          220 ERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       220 ~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +|+     ++.|+++||||....+.
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            997     89999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=335.15  Aligned_cols=237  Identities=26%  Similarity=0.433  Sum_probs=200.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      ..|++...||.|..++||+|+..-+++.||+|..+.                          .+...|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            479999999999999999999999999999987652                          233346667789999999


Q ss_pred             cCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc-
Q 042746           56 LPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG-  133 (408)
Q Consensus        56 ~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~-  133 (408)
                      |.+|++.++++.. ...++|..|..++++++.||.|||++|.||||||+.||||+.+|. |||+|||.+........+. 
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~-VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT-VKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc-EEEcCceeeeeecccCceee
Confidence            9999999999863 456899999999999999999999999999999999999999986 9999999875544333221 


Q ss_pred             cc-ccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC-----C----CC
Q 042746          134 VK-IQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF-----P----TQ  201 (408)
Q Consensus       134 ~~-~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~-----~----~~  201 (408)
                      .. .++.|||.|||||++..  ..|+.|+||||||++..||.+|..||....+.++.-....+.+|..     +    ..
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~  264 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKK  264 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhh
Confidence            11 45689999999999654  4789999999999999999999999999888777666666666622     1    23


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ++..++.++..||++||.+|||++++|+|+||+.....
T Consensus       265 ~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  265 FSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             hcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            56778999999999999999999999999999876543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=336.92  Aligned_cols=235  Identities=30%  Similarity=0.426  Sum_probs=191.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|.....                            +...+..+...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4799999999999999999999999999998864311                            111234567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC---
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD---  130 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---  130 (408)
                      ||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEeecCCCCccCcccCccc
Confidence            999999999999854 67899999999999999999999999999999999999998875 9999999987654322   


Q ss_pred             ------------------------CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh
Q 042746          131 ------------------------TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL  186 (408)
Q Consensus       131 ------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~  186 (408)
                                              .........||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                    00112335699999999999999999999999999999999999999987664433


Q ss_pred             hhhccc-CCCCCCCC--CCcHHHHHHHHHhcccCCCCCCC-HHHHHcCCCCCCCCCC
Q 042746          187 SRIGFS-DELPRFPT--QSSELGRDFLDKCLRREPGERWS-CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       187 ~~~~~~-~~~p~~~~--~~s~~~~~li~~~L~~dP~~R~s-~~ell~hpf~~~~~~~  239 (408)
                      ...... .....+|.  ..++++++||.+||. ||.+|++ ++|+++||||....+.
T Consensus       239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence            322221 11112222  358999999999997 9999999 9999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-42  Score=343.83  Aligned_cols=233  Identities=26%  Similarity=0.394  Sum_probs=188.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee---------------------------ccC-C-CCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---------------------------APT-T-SSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~---------------------------~~~-~-~~~~~~LV   52 (408)
                      +.|+.+++||+|.||.||+|++..||+.||+|+.....+                           ... . ....+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            568889999999999999999999999999987543221                           111 1 13568999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      +|||+. +|..++...+..+++.+|+.|+.||+.||+|||++||+|||||.+|||||.+|. +||+|||+|+........
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~-LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV-LKIADFGLARFYTPSGSA  274 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC-EEeccccceeeccCCCCc
Confidence            999998 999999877778999999999999999999999999999999999999998885 999999999876654433


Q ss_pred             cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc------------cCCCCC--
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF------------SDELPR--  197 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~------------~~~~p~--  197 (408)
                      . ....+-|.||.|||++.|. .|+.++|+||.||||.||++|++.|.+.........++            ...+|.  
T Consensus       275 ~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  275 P-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             c-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence            2 3344569999999999986 68999999999999999999999998755332222111            011220  


Q ss_pred             -------C-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          198 -------F-------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       198 -------~-------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                             +       ....++.+.+|+.+||..||.+|.|+.++|+|+||...+
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p  407 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP  407 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence                   0       124677788999999999999999999999999995433

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-41  Score=333.82  Aligned_cols=227  Identities=26%  Similarity=0.414  Sum_probs=188.4

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|+++.+++.||+|.....                             ....+..+...+|||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            5799999999999999999999998754311                             11123345678999999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~--~~~~~~  156 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGD--NRASTF  156 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEeCccCCCeecccCC--Cceecc
Confidence            999999874 456789999999999999999999999999999999999998875 9999999986432211  123345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+.... ....+.++...+.++++||.+||+.||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP  235 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-RVDTPHYPRWITKESKDILEKLFERDP  235 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            7999999999999999999999999999999999999999876655554433 233456777899999999999999999


Q ss_pred             CCCCCH-HHHHcCCCCCCCCCC
Q 042746          219 GERWSC-DQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~-~ell~hpf~~~~~~~  239 (408)
                      ++|+++ +++++||||....+.
T Consensus       236 ~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         236 TRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             HHcCCChHHHHcCCCcCCCCHH
Confidence            999997 589999999876543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.5e-41  Score=328.48  Aligned_cols=229  Identities=23%  Similarity=0.408  Sum_probs=182.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmE   54 (408)
                      |++|++.+.||+|+||+||+|++..+++.||+|.....                          ....+..+.+.++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            57899999999999999999999999999998754311                          1122344567889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++ +|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  .
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~DfG~~~~~~~~~~--~  159 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE-LKLADFGLARAKSVPTK--T  159 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEECcCcceeeccCCCc--c
Confidence            9986 999998866667899999999999999999999999999999999999998875 99999999865432221  1


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--------------------c-
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--------------------S-  192 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--------------------~-  192 (408)
                      .....|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.............                    . 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            223468999999999876 467899999999999999999999997654322111100                    0 


Q ss_pred             CCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 DELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ...|.        .....++++++||.+||++||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            00111        112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.5e-41  Score=333.35  Aligned_cols=233  Identities=27%  Similarity=0.411  Sum_probs=186.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEc---CCCcEEEEeeccc------------------------------ceeccCCCCCcc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV------------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~------------------------------~~~~~~~~~~~~   49 (408)
                      +|++++.||+|+||+||+|++.   .+++.+|+|....                              .+...+..+...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5999999999999999998874   5788888875321                              011123445667


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~-~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC-EEEeeCcCCcccccc
Confidence            899999999999999974 456799999999999999999999999999999999999998875 999999999764332


Q ss_pred             CCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCcH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      ... .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....    ...... .....+.++...++
T Consensus       159 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (332)
T cd05614         159 EKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR-ILKCDPPFPSFIGP  236 (332)
T ss_pred             CCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCH
Confidence            221 22345799999999999875 478899999999999999999999964321    122222 22333456678899


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      .++++|.+||+.||++||     +++++++||||+...+.
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  276 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE  276 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999999999999999999     88899999999876543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.5e-42  Score=336.06  Aligned_cols=236  Identities=28%  Similarity=0.409  Sum_probs=190.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|.+.+.||+|+||+||+|++..+++.+|+|.....                            +...+......+|||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4799999999999999999999999999998764311                            111233456789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++......... 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMV-  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC-EEeccCCCCeECCCCCce-
Confidence            999999999999876678899999999999999999999999999999999999998875 999999999765432221 


Q ss_pred             ccccCCCCCCCCChhhHh------CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-CCCCCCC--CCCcH
Q 042746          134 VKIQPRGSPLWMAPEVVR------GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-DELPRFP--TQSSE  204 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~------~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-~~~p~~~--~~~s~  204 (408)
                      ......||+.|+|||++.      +..++.++|||||||++|+|++|+.||.............. .....++  ...++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS  238 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCH
Confidence            222346899999999997      45678899999999999999999999986554333222211 1112222  35788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                      .+++||.+||. +|.+|||+.++++||||....+..
T Consensus       239 ~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         239 DFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             HHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence            99999999998 999999999999999999766543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.7e-42  Score=325.08  Aligned_cols=235  Identities=25%  Similarity=0.375  Sum_probs=190.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec-----------------------------cCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA-----------------------------PTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~-----------------------------~~~~~~~~~L   51 (408)
                      +++|+....|++|+||.||+|+|++|++.||+|+.....+.                             ....-+.+||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            46789999999999999999999999999999875422111                             0112234889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |||||+. +|..++......+.+.+++.++.|++.||+|||.+.|+||||||+|+|++..|. +||+|||+|+.......
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~-lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI-LKIADFGLAREYGSPLK  232 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc-EEecccchhhhhcCCcc
Confidence            9999988 999999988888999999999999999999999999999999999999988874 99999999998876533


Q ss_pred             CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhh----------cccC------
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRI----------GFSD------  193 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~----------~~~~------  193 (408)
                      .  ....+-|.||.|||++.+. .|+.++|+||+|||+.||++++|.|.+... +++.++          +|.+      
T Consensus       233 ~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  233 P--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             c--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            2  3344679999999999885 689999999999999999999999986543 333222          0100      


Q ss_pred             ----CCC---------CCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ----ELP---------RFPTQ-SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ----~~p---------~~~~~-~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                          .++         .++.. .++...+|++.+|..||.+|.|++|.|+|+||...+.+
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                011         11112 56888999999999999999999999999999986533

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=331.36  Aligned_cols=223  Identities=28%  Similarity=0.403  Sum_probs=186.3

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||+|+||+||+|++..+++.||+|....                            .+...+......++||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            7999999999999999999999885321                            111223455678999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS  141 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  141 (408)
                      .+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  .....+||
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~~gt  156 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDD--KTNTFCGT  156 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc-EEEEECcccccCccCCC--ccccccCC
Confidence            999975 456799999999999999999999999999999999999998875 99999999865322211  22345699


Q ss_pred             CCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       142 ~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      +.|+|||++.+..++.++|||||||++|+|++|++||............... .+.++...++.+++||.+||..||.+|
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence            9999999999999999999999999999999999999876665555443333 346677889999999999999999999


Q ss_pred             C---CHHHHHcCCCCCCCC
Q 042746          222 W---SCDQLLKHPFLQSVS  237 (408)
Q Consensus       222 ~---s~~ell~hpf~~~~~  237 (408)
                      |   ++.|+++||||....
T Consensus       236 ~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CCCCCHHHHHcCCCcCCCC
Confidence            7   579999999998754

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-41  Score=332.67  Aligned_cols=232  Identities=22%  Similarity=0.330  Sum_probs=192.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVm   53 (408)
                      +|.+.+.||+|+||+||+|.++.+++.||+|.....                             +...+......+|||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            588999999999999999999999999998853210                             111234456688999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~-ikL~Dfg~~~~~~~~~~--  156 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGV--  156 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEeccccccccCCCCc--
Confidence            99999999999874 456899999999999999999999999999999999999998875 99999999865332211  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ......||+.|+|||++.+..++.++|+|||||++|+|++|++||................ ..+|...+.++++++.+|
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~  235 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGL  235 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHH
Confidence            2234569999999999999889999999999999999999999998776655544433333 356677889999999999


Q ss_pred             cccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          214 LRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      |++||.+|++     ..++++||||....+.
T Consensus       236 l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         236 MTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             cccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence            9999999997     4789999999977543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.1e-41  Score=332.87  Aligned_cols=227  Identities=26%  Similarity=0.405  Sum_probs=188.4

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.||+|.....                             +...+......+|||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            5799999999999999999999998753211                             11123445668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  .....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~-~kL~Dfg~~~~~~~~~~--~~~~~  156 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGV--TTTTF  156 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEeecccceecccCCc--ccccc
Confidence            999999874 456789999999999999999999999999999999999998875 99999999865332221  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|+|||||++|+|++|++||...+............ +.+|...++++.++|.+||++||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~dp  235 (321)
T cd05591         157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTKNP  235 (321)
T ss_pred             ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCH
Confidence            69999999999999889999999999999999999999998776665555443333 35567789999999999999999


Q ss_pred             CCCC-------CHHHHHcCCCCCCCCCC
Q 042746          219 GERW-------SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~-------s~~ell~hpf~~~~~~~  239 (408)
                      ++|+       ++.++++||||....+.
T Consensus       236 ~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         236 NKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             HHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            9999       89999999999876544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.5e-41  Score=339.36  Aligned_cols=235  Identities=23%  Similarity=0.334  Sum_probs=185.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .|++++.||+|+||+||+|++..+++.||+|....                            .+...+.....++||||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999876431                            11223445667899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC---
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT---  131 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---  131 (408)
                      |++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........   
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~-~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC-EEEeeCcCCccccccccccc
Confidence            9999999999974 456799999999999999999999999999999999999998874 99999999753211000   


Q ss_pred             ------------------------------------------CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHH
Q 042746          132 ------------------------------------------RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTII  169 (408)
Q Consensus       132 ------------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~  169 (408)
                                                                .......+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                      00112357999999999999988999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhh-hcccCCCCCCC--CCCcHHHHHHHHHhc--ccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          170 EMVTGKPAWEDFGANTLSR-IGFSDELPRFP--TQSSELGRDFLDKCL--RREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       170 eLltG~~Pf~~~~~~~~~~-~~~~~~~p~~~--~~~s~~~~~li~~~L--~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +|++|.+||.......... +.........+  ...++++++||.+|+  ..+|..|+++.|+++||||....+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            9999999998765433222 21111112222  257899999999965  4555569999999999999876554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-42  Score=331.06  Aligned_cols=235  Identities=30%  Similarity=0.458  Sum_probs=190.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------c----eeccCCC-CCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------S----YEAPTTS-SSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~----~~~~~~~-~~~~~LVmEy   55 (408)
                      .+|.-.+++|+|+||.||+|+...+++.+|+|+.-.                     .    +....+. .-+.+|||||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            468889999999999999999999999999987321                     1    1111122 3467899999


Q ss_pred             cCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      +|. +|.+.+++.   +..++...++.|++||++||.|||+.||+||||||+|||+|.+.+.+||+|||.|+........
T Consensus       104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn  182 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN  182 (364)
T ss_pred             chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence            997 999999863   6778999999999999999999999999999999999999999778999999999887654432


Q ss_pred             cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhccc------------------
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFS------------------  192 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~~~------------------  192 (408)
                         .+...|..|+|||.+.|. .|+.+.||||.||++.||+.|++.|.+.+. +++..+...                  
T Consensus       183 ---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  183 ---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             ---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence               334469999999999885 689999999999999999999999986543 222222100                  


Q ss_pred             CCCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          193 DELPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       193 ~~~p~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                      ...|.         +....++++.+|+.++|..+|.+|.++.|++.||||+....+.
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence            01111         3345788999999999999999999999999999999776553

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.7e-41  Score=331.73  Aligned_cols=226  Identities=27%  Similarity=0.449  Sum_probs=187.7

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|.+..+++.||+|.....                             +...+......++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            5799999999999999999999998753211                             11122345668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++......  ......
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~--~~~~~~  156 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGE--GKASTF  156 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC-EEEccCcCCeECCCCC--Cccccc
Confidence            999999975 456799999999999999999999999999999999999998875 9999999996543222  123345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+...+.... ....+.++...+.++.+||.+||+.||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~ll~~~l~~~P  235 (316)
T cd05592         157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI-LNDRPHFPRWISKEAKDCLSKLFERDP  235 (316)
T ss_pred             cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            7999999999999988999999999999999999999999877665554443 334556778899999999999999999


Q ss_pred             CCCCCH-HHHHcCCCCCCCCC
Q 042746          219 GERWSC-DQLLKHPFLQSVSP  238 (408)
Q Consensus       219 ~~R~s~-~ell~hpf~~~~~~  238 (408)
                      .+||++ .++++||||....+
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         236 TKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             HHcCCChHHHHcCcccCCCCH
Confidence            999986 58899999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-41  Score=337.06  Aligned_cols=235  Identities=26%  Similarity=0.391  Sum_probs=189.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.+|+|....                            .....+..+..++|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            479999999999999999999999999999986432                            1122244567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-  132 (408)
                      ||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......... 
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEeecccceecccccccc
Confidence            99999999999975 456899999999999999999999999999999999999998885 999999998653221100 


Q ss_pred             -----------------------------------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCC
Q 042746          133 -----------------------------------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA  177 (408)
Q Consensus       133 -----------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~P  177 (408)
                                                         ......+||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                               011134699999999999998899999999999999999999999


Q ss_pred             CCCCChhhhhhhccc-CCCCCCC--CCCcHHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCCC
Q 042746          178 WEDFGANTLSRIGFS-DELPRFP--TQSSELGRDFLDKCLRREPGERWS---CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       178 f~~~~~~~~~~~~~~-~~~p~~~--~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hpf~~~~~~~  239 (408)
                      |.............. .....++  ...++++++||.+||. +|.+|++   +.|+++||||+...+.
T Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            987655443322211 1111222  2468899999999996 9999997   9999999999877543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-41  Score=338.60  Aligned_cols=236  Identities=25%  Similarity=0.372  Sum_probs=189.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|.++.+++.+|+|....                            .....+..+..++|||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            579999999999999999999999999999875421                            1122344566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC--
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT--  131 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--  131 (408)
                      ||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~-vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC-EEEeeccCCcccccccccc
Confidence            99999999999974 456799999999999999999999999999999999999998875 99999999864321100  


Q ss_pred             -------------------------------CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCC
Q 042746          132 -------------------------------RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWED  180 (408)
Q Consensus       132 -------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~  180 (408)
                                                     .......+||+.|+|||++.+..++.++|||||||++|+|++|++||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                           0011235799999999999999999999999999999999999999987


Q ss_pred             CChhhhhhhccc-CCCCCCC--CCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCCCCCC
Q 042746          181 FGANTLSRIGFS-DELPRFP--TQSSELGRDFLDKCLRREPGERW---SCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       181 ~~~~~~~~~~~~-~~~p~~~--~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hpf~~~~~~~~  240 (408)
                      ............ .....+|  ...++++++||.+++ .||.+|+   ++.|+++||||+...+..
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence            665444332221 1111222  236889999999987 4999998   589999999999877654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-41  Score=333.13  Aligned_cols=227  Identities=26%  Similarity=0.422  Sum_probs=188.3

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||++++..+++.||+|.....                            +...+......+|||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            5799999999999999999999998754311                            112244556788999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR  139 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  139 (408)
                      +|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  ......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~~--~~~~~~  156 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGA--TMKTFC  156 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC-EEecccHHhccccCCCC--cccccc
Confidence            99998874 456799999999999999999999999999999999999998875 99999999865322111  123456


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCC
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG  219 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~  219 (408)
                      ||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+............ ..+|...++.+++||.+||++||.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHH
Confidence            9999999999999889999999999999999999999998766555544433333 356678899999999999999999


Q ss_pred             CCC-----CHHHHHcCCCCCCCCCC
Q 042746          220 ERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       220 ~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +|+     ++.++++||||....+.
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            998     89999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.8e-41  Score=331.37  Aligned_cols=230  Identities=26%  Similarity=0.373  Sum_probs=190.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcceEE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~LV   52 (408)
                      |++.+.||+|+||+||+|.+..+++.||+|.....                               +...+......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999998764311                               11123345668899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|...+.  ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~-~kL~Dfg~~~~~~~~~--  155 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFG--  155 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc-EEeCcccCCccCCCCC--
Confidence            99999999998885  357899999999999999999999999999999999999998875 9999999986533221  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||............... .+.+|...++.+.++|.+
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~  234 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-EVRYPRFLSREAISIMRR  234 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHH
Confidence            1223457999999999999988999999999999999999999999876655544433232 335667789999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||++||.+||     ++.++++||||....+.
T Consensus       235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence            9999999999     69999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-41  Score=333.95  Aligned_cols=227  Identities=26%  Similarity=0.419  Sum_probs=187.9

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||+|.+..+++.+|+|.....                            +...+..+...+|||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5799999999999999999999998754311                            112234556789999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      +|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +||+|||+++.......  .....
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~-~kL~Dfg~~~~~~~~~~--~~~~~  156 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGA--TMKTF  156 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC-EEEecCCCCeecCCCCc--ccccc
Confidence            99998874 4578999999999999999999997 79999999999999998875 99999999865322211  12235


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ..+|...++++.+||.+||++||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            69999999999999889999999999999999999999998766655554433332 35667889999999999999999


Q ss_pred             CCCC-----CHHHHHcCCCCCCCCCC
Q 042746          219 GERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ++|+     ++.++++||||....+.
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9997     89999999999876544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.9e-41  Score=338.07  Aligned_cols=234  Identities=23%  Similarity=0.340  Sum_probs=186.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .|++.+.||+|+||+||+|++..+++.+|+|....                            .+...+..+..++||||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            69999999999999999999999999999886431                            11223445667899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC----
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD----  130 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~----  130 (408)
                      |++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......    
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~-~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEEeECCCCccccccccccc
Confidence            9999999999975 356789999999999999999999999999999999999998875 9999999975321100    


Q ss_pred             -----------------------------------------CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHH
Q 042746          131 -----------------------------------------TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTII  169 (408)
Q Consensus       131 -----------------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~  169 (408)
                                                               ........+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~  239 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  239 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence                                                     000112346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhhccc-CCCCCC--CCCCcHHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCCC
Q 042746          170 EMVTGKPAWEDFGANTLSRIGFS-DELPRF--PTQSSELGRDFLDKCLRREPGERWS---CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       170 eLltG~~Pf~~~~~~~~~~~~~~-~~~p~~--~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hpf~~~~~~~  239 (408)
                      +|++|++||.............. ......  ....++++.++|.+|+ .+|.+|++   ++|+++||||+...+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            99999999987554332222111 111122  2457889999999986 59999997   9999999999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.9e-41  Score=326.92  Aligned_cols=233  Identities=24%  Similarity=0.392  Sum_probs=182.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|.....                          ....+..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            6899999999999999999999999999998764311                          11223345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++ ++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  ..
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~--~~  160 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE-LKLADFGLARAKSVPSH--TY  160 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECCCCcceeccCCCc--cC
Confidence            96 5888888766677899999999999999999999999999999999999998875 99999999865432211  22


Q ss_pred             ccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hhhhhcccC------------CCCCC--
Q 042746          136 IQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSD------------ELPRF--  198 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~~~~~~~~------------~~p~~--  198 (408)
                      ....||+.|+|||++.+. .++.++|+|||||++|+|++|.+||......  .+..+....            ..+.+  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            335689999999998764 5788999999999999999999999764321  111110000            00000  


Q ss_pred             ----------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          199 ----------------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       199 ----------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                      ....++.+++|+.+||+.||.+|||+.|+++||||+...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                            0123567899999999999999999999999999987654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-42  Score=342.40  Aligned_cols=234  Identities=26%  Similarity=0.414  Sum_probs=210.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCc-ceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSC-RNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~-~~LV   52 (408)
                      |++|..++.||+|+||.+++++++..++.+.+|...                           +.+...+..+.+ ++|+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            689999999999999999999999999999887654                           233445566666 9999


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           53 LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |+||+||+|.+.+.+.+ ..++|+.+..|+.||+.||+|||+++|+|||||++|||++.++. |||.|||+|+...... 
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~-VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK-VKLGDFGLAKILNPED-  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc-eeecchhhhhhcCCch-
Confidence            99999999999998755 78899999999999999999999999999999999999999886 8999999998887654 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ....+..|||.||.||++.+.+|+.++|||||||++|||++-+++|...+...+...+......++|..++.+++.+|.
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence             2455678999999999999999999999999999999999999999999998888777777778889999999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .||.++|..||++.++|.+|.+....
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999999999999999999887443

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=336.58  Aligned_cols=235  Identities=24%  Similarity=0.373  Sum_probs=186.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|.++.+++.+|+|....                            .+...+..+...||||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999985421                            1122344567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC--
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT--  131 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~--  131 (408)
                      ||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC-EEEeecccccccccccccc
Confidence            99999999999974 467799999999999999999999999999999999999998875 99999999853211000  


Q ss_pred             -----------C--------------------------------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHH
Q 042746          132 -----------R--------------------------------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI  168 (408)
Q Consensus       132 -----------~--------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil  168 (408)
                                 .                                ......+||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                       0                                000124699999999999998899999999999999


Q ss_pred             HHHHhCCCCCCCCChhhhhhhccc-CCCCCCCC--CCcHHHHHHHHHhcccCCCCC---CCHHHHHcCCCCCCCCCC
Q 042746          169 IEMVTGKPAWEDFGANTLSRIGFS-DELPRFPT--QSSELGRDFLDKCLRREPGER---WSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       169 ~eLltG~~Pf~~~~~~~~~~~~~~-~~~p~~~~--~~s~~~~~li~~~L~~dP~~R---~s~~ell~hpf~~~~~~~  239 (408)
                      |+|++|.+||...........+.. .....+|.  ..+.++++||.+||. +|.+|   +++.|++.||||....+.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~  314 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWD  314 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            999999999986554443322211 11122332  478899999999997 77765   599999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.8e-41  Score=323.37  Aligned_cols=229  Identities=23%  Similarity=0.358  Sum_probs=180.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .+|++.+.||+|+||+||+|+++.+++.+++|.....                           +...+..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4799999999999999999999999999998753311                           1112344566889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++++.+..+.. ....+++..++.++.||+.||+|||+++|+||||||+||+++.++. +||+|||++......... .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~-~  157 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV-LKLCDFGFARNLSEGSNA-N  157 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEEeeccCcccccccccc-c
Confidence            999977765544 4567899999999999999999999999999999999999998874 999999999765432211 1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh-hhhc-cc-------------------C
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIG-FS-------------------D  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-~~~~-~~-------------------~  193 (408)
                      .....||+.|+|||++.+..++.++|+|||||++|+|++|++||........ ..+. ..                   .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            2234689999999999988899999999999999999999999976432211 1000 00                   0


Q ss_pred             CCC----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 ELP----------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 ~~p----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..|          ......|..+++||++||++||++|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            001          0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.5e-41  Score=331.29  Aligned_cols=227  Identities=26%  Similarity=0.401  Sum_probs=183.8

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|.+..+++.+|+|.....                             +...+.....++|||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            5799999999999999999999998754311                             11123345668999999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......
T Consensus        81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~~~~~~~~~--~~~~~~  156 (329)
T cd05588          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPG--DTTSTF  156 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEECcCccccccccCC--Cccccc
Confidence            999998874 467899999999999999999999999999999999999998875 9999999986432211  122345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---------hhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---------TLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---------~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      +||+.|+|||++.+..++.++|+|||||++|+|++|+.||......         ...... ......+|...+..+.++
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~l  235 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKASSV  235 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-HcCCCCCCCCCCHHHHHH
Confidence            7999999999999998999999999999999999999999632211         112222 223345677889999999


Q ss_pred             HHHhcccCCCCCCC------HHHHHcCCCCCCCCCC
Q 042746          210 LDKCLRREPGERWS------CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       210 i~~~L~~dP~~R~s------~~ell~hpf~~~~~~~  239 (408)
                      |.+||++||.+|+|      +.++++||||....+.
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence            99999999999997      7899999999876543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.2e-41  Score=330.93  Aligned_cols=227  Identities=27%  Similarity=0.369  Sum_probs=187.2

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.+|+|.....                             +...+......++||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            5799999999999999999999998764311                             11112345667899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~-~kl~Dfg~~~~~~~~~--~~~~~~  156 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHS--KTTSTF  156 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc-EEEeccCCCcccccCC--Cccccc
Confidence            999999974 457799999999999999999999999999999999999998875 9999999986532221  122345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+........ ..++...++.+.++|.+||++||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCH
Confidence            69999999999999989999999999999999999999998776655544433333 34556679999999999999999


Q ss_pred             CCCCCH----HHHHcCCCCCCCCCC
Q 042746          219 GERWSC----DQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~----~ell~hpf~~~~~~~  239 (408)
                      .+||++    .|++.||||....+.
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            999987    699999999876543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.5e-41  Score=329.68  Aligned_cols=227  Identities=27%  Similarity=0.402  Sum_probs=187.5

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.||+|.....                             +...+.....++|||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            5799999999999999999999998853311                             11123345567899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++........  .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~  156 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDA--KTCTF  156 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC-EEEccCCcceECCCCCC--ceeee
Confidence            999999974 456789999999999999999999999999999999999998875 99999999864322211  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|..||...+......... ...+.++...+.++++||.+||..||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~~P  235 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-MDNPCYPRWLTREAKDILVKLFVREP  235 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCCCccCCHHHHHHHHHHhccCH
Confidence            69999999999999889999999999999999999999998766555444332 22345667889999999999999999


Q ss_pred             CCCCCHH-HHHcCCCCCCCCCC
Q 042746          219 GERWSCD-QLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~~-ell~hpf~~~~~~~  239 (408)
                      .+||++. ++++||||....+.
T Consensus       236 ~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         236 ERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             hhcCCChHHHHcCcccCCCCHH
Confidence            9999996 89999999887654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.2e-41  Score=336.99  Aligned_cols=234  Identities=22%  Similarity=0.330  Sum_probs=186.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.+|+|....                            .....+..+..++|||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            379999999999999999999999999999986431                            1122244567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC---
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD---  130 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---  130 (408)
                      ||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.......   
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~-ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC-EEEEeCCCCcccccccccc
Confidence            99999999999975 456799999999999999999999999999999999999998875 9999999974221000   


Q ss_pred             --------------------------------------CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHH
Q 042746          131 --------------------------------------TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV  172 (408)
Q Consensus       131 --------------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLl  172 (408)
                                                            ........+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                  000011347999999999999999999999999999999999


Q ss_pred             hCCCCCCCCChhhhhh-hc-ccCCCC-CCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCCCC
Q 042746          173 TGKPAWEDFGANTLSR-IG-FSDELP-RFPTQSSELGRDFLDKCLRREPGERW---SCDQLLKHPFLQSVSP  238 (408)
Q Consensus       173 tG~~Pf~~~~~~~~~~-~~-~~~~~p-~~~~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hpf~~~~~~  238 (408)
                      +|++||.......... +. +....+ ......++++.++|.+|+ .+|.+|+   ++.|+++||||.....
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            9999998765443322 21 111111 112357889999999976 5999999   9999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-40  Score=334.94  Aligned_cols=234  Identities=26%  Similarity=0.361  Sum_probs=189.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|+++.+++.+|+|....                            .+...+..+...+|||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            579999999999999999999999999999886431                            1112244566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++..  ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ .
T Consensus       123 Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~-~kL~DfG~~~~~~~~~~-~  198 (370)
T cd05596         123 EYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGM-V  198 (370)
T ss_pred             cCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC-EEEEeccceeeccCCCc-c
Confidence            99999999999864  45789999999999999999999999999999999999998875 99999999865432211 1


Q ss_pred             ccccCCCCCCCCChhhHhCC----CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC-CCCCCCC--CCcHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGE----CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD-ELPRFPT--QSSELG  206 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~----~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~-~~p~~~~--~~s~~~  206 (408)
                      .....+||+.|+|||++.+.    .++.++|+|||||++|+|++|++||...........+... ....+|.  ..|.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            12345799999999999754    3788999999999999999999999876654443333221 1223333  578999


Q ss_pred             HHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       207 ~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~~  239 (408)
                      ++||.+||+.+|.+  |+|++|+++||||+...+.
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~  313 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT  313 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence            99999999999988  9999999999999875543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-41  Score=310.47  Aligned_cols=229  Identities=26%  Similarity=0.373  Sum_probs=196.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LV   52 (408)
                      +++|.++|.||+|.||.||+|+.++++-.+|+|...++                            ..+.+-++...||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            57899999999999999999999999999999764321                            11123345568899


Q ss_pred             EeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           53 LEYLPGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        53 mEy~~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +||.++|+|+..++. ....++|.....|++|++.||.|+|..+||||||||+|+|++..+. +|++|||-+-...    
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~-lkiAdfGwsV~~p----  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAP----  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC-eeccCCCceeecC----
Confidence            999999999999984 3456799999999999999999999999999999999999999885 9999999874443    


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .+...+.|||..|.+||+..+..++..+|+|++|+++||++.|.+||......+.++.+..-.+ .+|...+..++|+|.
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~-~~p~~is~~a~dlI~  254 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL-KFPSTISGGAADLIS  254 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc-cCCcccChhHHHHHH
Confidence            2335567899999999999999999999999999999999999999998776655555444443 567899999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      +||.++|.+|.+..|++.|||...
T Consensus       255 ~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  255 RLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-40  Score=328.98  Aligned_cols=226  Identities=27%  Similarity=0.419  Sum_probs=182.8

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.+|+|.....                             +...+......+|||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            5799999999999999999999988754311                             11123345668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.......  .....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~-~kL~DfG~~~~~~~~~~--~~~~~  156 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGD--TTSTF  156 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC-EEEeeCCccccccCCCC--ccccc
Confidence            999998874 457899999999999999999999999999999999999998875 99999999865322111  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh---------hhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA---------NTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~---------~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||.....         ..+..... .....+|...+..++++
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~-~~~~~~p~~~~~~~~~l  235 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKAASV  235 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-cCCCCCCCCCCHHHHHH
Confidence            799999999999999999999999999999999999999953211         11122222 23335677889999999


Q ss_pred             HHHhcccCCCCCCC------HHHHHcCCCCCCCCC
Q 042746          210 LDKCLRREPGERWS------CDQLLKHPFLQSVSP  238 (408)
Q Consensus       210 i~~~L~~dP~~R~s------~~ell~hpf~~~~~~  238 (408)
                      |.+||+.||.+|++      +.++++||||....+
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            99999999999998      589999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=334.67  Aligned_cols=230  Identities=27%  Similarity=0.391  Sum_probs=194.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LV   52 (408)
                      ..|++++.||+|.||.||+|+++.||+.+|+|....                             .+...++....++||
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            369999999999999999999999999999876442                             223345566788999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC---CcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS---SFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~---~~vkL~DFGla~~~~~~  129 (408)
                      ||+|.||.|++.+...  .++|..+..+++|++.+++|||+.||+||||||+|+|+....   ..+|++|||++..... 
T Consensus       115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            9999999999999865  389999999999999999999999999999999999996542   2599999999977655 


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELG  206 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~  206 (408)
                        .......+|||.|+|||++...+|+..+|+||+|+++|.|+.|.+||...........+....+   ......++..+
T Consensus       192 --~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a  269 (382)
T KOG0032|consen  192 --GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA  269 (382)
T ss_pred             --CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence              2345567899999999999999999999999999999999999999988765444433333322   12224568999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ++||.+||..||.+|+|+.++|+|||+...
T Consensus       270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999999998865

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-40  Score=347.22  Aligned_cols=234  Identities=23%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCC--------CC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTT--------SS   46 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~--------~~   46 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|......                           ...+.        ..
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            58999999999999999999999999999998643210                           00000        01


Q ss_pred             CcceEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           47 SCRNLHLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        47 ~~~~LVmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      ..+++||||+++|+|.+++...   ...+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||++
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~-vkL~DFGls  190 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-VKLGDFGFS  190 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC-EEEEecccC
Confidence            1367999999999999998653   356899999999999999999999999999999999999998875 999999999


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCc
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s  203 (408)
                      +..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.................+.++...+
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  270 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS  270 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Confidence            76543322223345679999999999999889999999999999999999999998776655555445555556777889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +++++++.+||+.||.+||++.++++|||++..
T Consensus       271 ~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            999999999999999999999999999998754

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-40  Score=327.33  Aligned_cols=236  Identities=25%  Similarity=0.348  Sum_probs=188.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+++++.+++.+|+|....                            .....+......+|||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            579999999999999999999999999999876431                            0111234556789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++........ .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~-~kL~DfG~a~~~~~~~~-~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGT-V  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC-EEEeecchheecccCCc-c
Confidence            999999999999876677899999999999999999999999999999999999998875 99999999865432211 1


Q ss_pred             ccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC----CCCCCCCCCcH
Q 042746          134 VKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD----ELPRFPTQSSE  204 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~----~~p~~~~~~s~  204 (408)
                      .....+||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...............    ..|......++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence            1223569999999999963     45788999999999999999999999876544433332221    22333346789


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~~  239 (408)
                      ++++||.+||..++++  |++++|+++||||....+.
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence            9999999999765554  6899999999999887654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=323.94  Aligned_cols=235  Identities=27%  Similarity=0.439  Sum_probs=186.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec------------------------------c--CCCCCcce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------------------P--TTSSSCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~------------------------------~--~~~~~~~~   50 (408)
                      .|...+.||+|+||.|..|.++.|++.||+|+..-.+..                              +  ...-+-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            456679999999999999999999999999875411110                              1  12234579


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +|+|+| +-+|.++++ .+..+++..++.+++||+.||+|+|+.+|+||||||.|+|++.+.. +||+|||+|+......
T Consensus       103 iV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~-lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD-LKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC-EEeccccceeeccccC
Confidence            999999 459999997 4455899999999999999999999999999999999999999986 9999999998775432


Q ss_pred             CCcccccCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhh---------------c---
Q 042746          131 TRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRI---------------G---  190 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~---------------~---  190 (408)
                      .....+..+.|.||.|||++. ...|+.+.||||+|||+.||++|++.|.+.+.. ++..+               .   
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            222334567899999999985 457899999999999999999999999765422 21111               0   


Q ss_pred             ---ccCCCCCCC--------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          191 ---FSDELPRFP--------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       191 ---~~~~~p~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                         +...+|..|        +..++++.+|+++||..||.+|+|++|+|+|||+...+...
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence               111122221        36788999999999999999999999999999999877553

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.3e-40  Score=327.04  Aligned_cols=227  Identities=27%  Similarity=0.438  Sum_probs=188.2

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|.+..+++.+|+|.....                             +...+......++||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            5799999999999999999999998753311                             11123445678999999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+.+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.......  .....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~  156 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGV--TTSTF  156 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc-EEecccCCCeecCcCCC--cccce
Confidence            999999874 456799999999999999999999999999999999999998875 99999999865322221  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|+|||||++|+|++|+.||............... .+.++...+..+++||.+||..||
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~dP  235 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYPRWLSKEAKSILKSFLTKNP  235 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHccCCH
Confidence            6999999999999999999999999999999999999999876655554443333 335667789999999999999999


Q ss_pred             CCCCCH-----HHHHcCCCCCCCCCC
Q 042746          219 GERWSC-----DQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~-----~ell~hpf~~~~~~~  239 (408)
                      .+|||+     .+++.||||....+.
T Consensus       236 ~~R~s~~~~~~~~ll~~~~~~~~~~~  261 (318)
T cd05570         236 EKRLGCLPTGEQDIKGHPFFREIDWD  261 (318)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            999999     999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=325.09  Aligned_cols=236  Identities=25%  Similarity=0.352  Sum_probs=187.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||++++..+++.||+|....                            .+...+..+...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            579999999999999999999999999999986431                            1111234566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.+....+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++......... 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~~-  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTV-  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC-EEEEECCceeecCCCCCc-
Confidence            999999999999866677899999999999999999999999999999999999998875 999999998654322211 


Q ss_pred             ccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc----CCCCCCCCCCcH
Q 042746          134 VKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS----DELPRFPTQSSE  204 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~----~~~p~~~~~~s~  204 (408)
                      ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||...........+..    ...|......++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence            1122469999999999973     3568899999999999999999999987654433222211    122333345789


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~~  239 (408)
                      .+++||.+||..++++  |+++.++++||||....+.
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence            9999999998764444  7899999999999876544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3e-40  Score=326.29  Aligned_cols=236  Identities=24%  Similarity=0.356  Sum_probs=188.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||++++..+++.+|+|....                            .+...+..++..+|||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999875421                            0111234567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++........ .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~-~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGT-V  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC-EEEEeccceeeccCCCc-e
Confidence            999999999999876677899999999999999999999999999999999999998875 99999999866543221 1


Q ss_pred             ccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC----CCCCCCCCCcH
Q 042746          134 VKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD----ELPRFPTQSSE  204 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~----~~p~~~~~~s~  204 (408)
                      ......||+.|+|||++.+     ..++.++|+|||||++|+|++|+.||...............    .+|......++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence            1223569999999999976     45788999999999999999999999866544333322221    12232345689


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~~  239 (408)
                      .++++|.+||..++.+  |++++++++||||+...+.
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence            9999999999876654  4689999999999876654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-40  Score=326.99  Aligned_cols=227  Identities=25%  Similarity=0.363  Sum_probs=186.1

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.+|+|.....                             +...+......++||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            5799999999999999999999988753310                             11123345668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+.+..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  .....
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~-~kl~DfG~a~~~~~~~~--~~~~~  156 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNG--TTSTF  156 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC-EEEccCCCCcccccCCC--Ccccc
Confidence            999999975 456788999999999999999999999999999999999998875 99999999865432211  23345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|||||||++|+|++|.+||................. .++...++.++++|.+||++||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-CCCCCCCHHHHHHHHHHcccCH
Confidence            799999999999999999999999999999999999999987665555444333332 4456788999999999999999


Q ss_pred             CCCCCHH----HHHcCCCCCCCCCC
Q 042746          219 GERWSCD----QLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~~----ell~hpf~~~~~~~  239 (408)
                      .+|+++.    ++++|+||....+.
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~~~~~  260 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSPINWD  260 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCCCCHH
Confidence            9999865    89999999876554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-40  Score=327.52  Aligned_cols=227  Identities=27%  Similarity=0.396  Sum_probs=184.2

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|.+..+++.+|+|.....                             +...+.....++|||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            5799999999999999999999988754311                             11123345668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~--~~~~~~  156 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPG--DTTSTF  156 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC-EEEeccccceeccCCC--Cceecc
Confidence            999998874 456899999999999999999999999999999999999998875 9999999986432211  122345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-------hhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-------NTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-------~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      +||+.|+|||++.+..++.++|+|||||++|+|++|..||.....       ....... ......+|...+..+.++|.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHHH
Confidence            799999999999999999999999999999999999999963211       1122222 23334567788999999999


Q ss_pred             HhcccCCCCCCC------HHHHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERWS------CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~s------~~ell~hpf~~~~~~~  239 (408)
                      +||++||.+|++      ++++++||||....+.
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            999999999997      5799999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=330.88  Aligned_cols=226  Identities=24%  Similarity=0.322  Sum_probs=182.6

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcceEEEeccCC
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      ||+|+||+||+|++..+++.+|+|.....                               +...+......++||||++|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999998764311                               00112345668999999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~-~kl~Dfg~a~~~~~~~~--~~~~~  156 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNK--TTNTF  156 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEecCCcCcCCCCCCC--CccCc
Confidence            999999874 456799999999999999999999999999999999999998875 99999999865332221  22345


Q ss_pred             CCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042746          139 RGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE  217 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~d  217 (408)
                      +||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+............++.+++||.+||++|
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~  236 (330)
T cd05586         157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN  236 (330)
T ss_pred             cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCC
Confidence            799999999999764 4789999999999999999999999876655544443333332222357889999999999999


Q ss_pred             CCCCC----CHHHHHcCCCCCCCCCC
Q 042746          218 PGERW----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       218 P~~R~----s~~ell~hpf~~~~~~~  239 (408)
                      |.+||    ++.|+++||||....+.
T Consensus       237 P~~R~~~~~~~~~ll~h~~~~~~~~~  262 (330)
T cd05586         237 PQHRLGAHRDAVELKEHPFFADIDWD  262 (330)
T ss_pred             HHHCCCCCCCHHHHhcCccccCCCHH
Confidence            99998    78999999999875543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-40  Score=324.37  Aligned_cols=234  Identities=23%  Similarity=0.382  Sum_probs=180.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------ecc-----CCCCCcce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAP-----TTSSSCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~-----~~~~~~~~   50 (408)
                      +|++.+.||+|+||.||+|++..+++.|++|......                           ...     .......+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6999999999999999999999999999998643110                           000     01113478


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-EEEccCcccccccccc
Confidence            9999996 589998874 456799999999999999999999999999999999999998875 9999999997543222


Q ss_pred             CC-cccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh------------------
Q 042746          131 TR-GVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI------------------  189 (408)
Q Consensus       131 ~~-~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~------------------  189 (408)
                      .. .......||+.|+|||++.+  ..++.++|||||||++|+|++|++||...........                  
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            11 11233569999999999976  5788999999999999999999999975442211000                  


Q ss_pred             --------cccCCCC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          190 --------GFSDELP----RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       190 --------~~~~~~p----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                              ......+    ......++.+.++|.+||+.||++|||++|+++||||......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~  299 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV  299 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence                    0000000    0112456788999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-42  Score=319.57  Aligned_cols=231  Identities=24%  Similarity=0.384  Sum_probs=197.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------------ceeccCCCCCc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------------SYEAPTTSSSC   48 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------------~~~~~~~~~~~   48 (408)
                      +|...+.||+|..++|-.+.++.|++.+|+|..++                                  ......+.+.+
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            57888999999999999999999999999877552                                  23345667788


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +++|+|.|+.|.|+|++. ...-++|+..+++++||+.|++|||.++|+||||||+|||++++.+ +||+|||+|.....
T Consensus        98 ~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~-i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN-IKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc-eEEeccceeeccCC
Confidence            899999999999999998 4567899999999999999999999999999999999999998875 99999999988765


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC------CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC---CCC
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP---RFP  199 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p---~~~  199 (408)
                      ...   ....||||+|+|||.+..      ..|+..+|+||+||++|.||.|.+||..-....+.+.+..+.+.   +-.
T Consensus       176 Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  176 GEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             chh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            443   345789999999999963      35788899999999999999999999887777666666555432   112


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+.|...+|||.+||+.||.+|+|++|+|+||||.+...
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            467888999999999999999999999999999965543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-40  Score=331.31  Aligned_cols=233  Identities=24%  Similarity=0.356  Sum_probs=186.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.+|+|....                            .+...+..+...++||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            579999999999999999999999999999875321                            1222344567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++..  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++........ .
T Consensus       123 Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~-~kL~DFG~a~~~~~~~~-~  198 (370)
T cd05621         123 EYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGM-V  198 (370)
T ss_pred             cCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC-EEEEecccceecccCCc-e
Confidence            99999999999974  35789999999999999999999999999999999999998875 99999999976532221 1


Q ss_pred             ccccCCCCCCCCChhhHhCCC----CCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-CCCCCCCC--CCcHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGEC----QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-DELPRFPT--QSSELG  206 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~----~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-~~~p~~~~--~~s~~~  206 (408)
                      .....+||+.|+|||++.+..    ++.++|+|||||++|+|++|++||...........+.. .....+|.  ..+..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence            123457999999999997643    67899999999999999999999987654433332222 11223333  468899


Q ss_pred             HHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       207 ~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~  238 (408)
                      ++++.+||..++.+  |+|+.|+++||||+...+
T Consensus       279 ~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             HHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence            99999999865544  889999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-40  Score=327.50  Aligned_cols=226  Identities=27%  Similarity=0.380  Sum_probs=186.4

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.+|+|.....                             +...+..+...+|||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            5799999999999999999999998754211                             11123445678899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  .....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~-~kL~DfG~~~~~~~~~~--~~~~~  156 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSD--TTTTF  156 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEEeecCCcccCCCCCC--Ccccc
Confidence            999998874 457799999999999999999999999999999999999998885 99999999865322211  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+......... ..+...+..+.++|.+||.+||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEKDR  235 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhccCH
Confidence            799999999999999899999999999999999999999987766555544433333 3445678899999999999999


Q ss_pred             CCCCCH----HHHHcCCCCCCCCC
Q 042746          219 GERWSC----DQLLKHPFLQSVSP  238 (408)
Q Consensus       219 ~~R~s~----~ell~hpf~~~~~~  238 (408)
                      .+||++    .+++.||||....+
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCCCH
Confidence            999976    59999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=330.18  Aligned_cols=232  Identities=27%  Similarity=0.389  Sum_probs=187.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------------------ec
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------------------EA   41 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------------------~~   41 (408)
                      |..|++++.||+|.||+|.+|++..+++.||+|......                                       ..
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            457999999999999999999999999999997654210                                       00


Q ss_pred             c--CCCCCcceEEEeccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           42 P--TTSSSCRNLHLEYLPGGTVSDLATTLNAY-ADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        42 ~--~~~~~~~~LVmEy~~gGsL~~~l~~~~~~-l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                      .  -.....+|||+|||..|.+...=  .... +++.+++.|++.++.||+|||.+|||||||||+|+||+.+| ++||+
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIs  252 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKIS  252 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEee
Confidence            0  11345689999999999776432  2334 88999999999999999999999999999999999999997 59999


Q ss_pred             ecCCccccccCC---CCcccccCCCCCCCCChhhHhCCC----CCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc
Q 042746          119 DFGAAGEATVSD---TRGVKIQPRGSPLWMAPEVVRGEC----QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       119 DFGla~~~~~~~---~~~~~~~~~Gt~~y~APE~l~~~~----~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~  191 (408)
                      |||.+.......   .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+.....+...+.
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv  332 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV  332 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence            999987653221   111223357999999999998732    3678899999999999999999998877777776665


Q ss_pred             cCCCCCCCC--CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          192 SDELPRFPT--QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       192 ~~~~p~~~~--~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ...+ .+|.  ...++++|||.+||.+||++|+++.+|..|||....
T Consensus       333 n~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  333 NDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            5543 3443  368899999999999999999999999999999765

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-40  Score=340.58  Aligned_cols=233  Identities=29%  Similarity=0.432  Sum_probs=181.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceecc--------CCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAP--------TTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~--------~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|....                     .....        .....++++|
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv  145 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV  145 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence            469999999999999999999999999999985421                     00000        0112346789


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||+++ +|.+++..   .+..+++..++.++.||+.||+|||+++|+||||||+|||++.++..+||+|||+|+.....
T Consensus       146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  224 (440)
T PTZ00036        146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG  224 (440)
T ss_pred             EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC
Confidence            999986 78777753   35678999999999999999999999999999999999999877656999999999765432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhccc---------------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFS---------------  192 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~---------------  192 (408)
                      ..   .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... .+..+...               
T Consensus       225 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~  301 (440)
T PTZ00036        225 QR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN  301 (440)
T ss_pred             CC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence            21   2235689999999998764 6899999999999999999999999764322 11111000               


Q ss_pred             ---CCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          193 ---DELP---------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       193 ---~~~p---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                         ..+|         .+|...++++++||.+||.+||.+|||+.|+++||||.....
T Consensus       302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence               0011         123456789999999999999999999999999999987643

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.2e-40  Score=317.06  Aligned_cols=226  Identities=26%  Similarity=0.398  Sum_probs=182.4

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||+|+||+||++.++.+++.+|+|.....                            ....+..+...+|||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999998764311                            11123445668899999999999


Q ss_pred             HHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           62 SDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        62 ~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      .+.+..   ....+++..+..++.||+.||+|||+++|+||||||+||+++.++. ++|+|||++........  .....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~~~~--~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQS--KTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCccceecCCCCc--ccccc
Confidence            988754   2346899999999999999999999999999999999999988775 99999999865443221  12234


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----hhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----TLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||......    ....... .....++...++.+++++.+||
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHh
Confidence            6899999999999998999999999999999999999999754321    1111111 2223455678999999999999


Q ss_pred             ccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          215 RREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       215 ~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +.||++||     +++++++||||+...+.
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence            99999999     88999999999886554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-40  Score=323.81  Aligned_cols=228  Identities=28%  Similarity=0.372  Sum_probs=185.8

Q ss_pred             eceeeecCCeeEEEEEEc---CCCcEEEEeeccc-----------------------------ceeccCCCCCcceEEEe
Q 042746            7 GKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .+.||+|+||+||+|++.   .+++.+|+|....                             .+...+..+...++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            378999999999999874   5778888875321                             11223445567899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++||+|.+++.. .+.+.+..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  .
T Consensus        81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~  156 (323)
T cd05584          81 YLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGT--V  156 (323)
T ss_pred             CCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEeeCcCCeecccCCC--c
Confidence            9999999999974 456788999999999999999999999999999999999998875 99999999865432221  1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|++||................ ..++...++.+++||.+||
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l  235 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLL  235 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHc
Confidence            233569999999999998889999999999999999999999998766544433333333 3566778999999999999


Q ss_pred             ccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          215 RREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       215 ~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ++||++||     ++.+++.||||....+.
T Consensus       236 ~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~  265 (323)
T cd05584         236 KRNPSSRLGAGPGDAAEVQSHPFFRHVNWD  265 (323)
T ss_pred             ccCHhHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999999     89999999999876543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-40  Score=324.00  Aligned_cols=227  Identities=26%  Similarity=0.356  Sum_probs=186.4

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||+||+|++..+++.+|+|....                             .+...+......+|||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            579999999999999999999998875321                             111123345668899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  ......
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~--~~~~~~  156 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGVEPE--ETTSTF  156 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC-EEEccCCCCccCCCCC--Cccccc
Confidence            999998874 456789999999999999999999999999999999999998875 9999999986532221  122345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +||+.|+|||++.+..++.++|+|||||++|+|++|.+||...+...+....... ...++...+..+.++|.+||++||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCH
Confidence            7999999999999988999999999999999999999999877665555444333 335666788899999999999999


Q ss_pred             CCCCCH----HHHHcCCCCCCCCCC
Q 042746          219 GERWSC----DQLLKHPFLQSVSPS  239 (408)
Q Consensus       219 ~~R~s~----~ell~hpf~~~~~~~  239 (408)
                      .+|+++    .|+++||||....+.
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            999965    599999999865543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=331.55  Aligned_cols=234  Identities=26%  Similarity=0.380  Sum_probs=202.9

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      |.+.+.||+|-|+.|.+|++..||..||+|..+..                           .......+..+|||+|+=
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            77889999999999999999999999999876632                           222233455689999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      .+|+|+|+|-++...+.|..++.|++||+.|+.|+|+..+|||||||+|+++-+.-+.+||+|||++..+.+...   ..
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~  176 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LT  176 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch---hh
Confidence            999999999888888999999999999999999999999999999999999887766799999999977665443   45


Q ss_pred             cCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      +.||+..|-|||++.|..| -+++||||||||||.|++|++||+..+..+...++...++ ..|...+.++++||..||.
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-tvPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-TVPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-cCchhhhHHHHHHHHHHHh
Confidence            6789999999999999877 5788999999999999999999997665555445455544 6788999999999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCCCCCCc
Q 042746          216 REPGERWSCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~~~~~~~~~  241 (408)
                      .||.+|.+.+||..|+|++...+...
T Consensus       256 RdPkkRAslEeI~s~~Wlq~~D~~~s  281 (864)
T KOG4717|consen  256 RDPKKRASLEEIVSTSWLQAGDRGLS  281 (864)
T ss_pred             cCchhhccHHHHhccccccCCCCCcc
Confidence            99999999999999999998775543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=319.07  Aligned_cols=235  Identities=26%  Similarity=0.450  Sum_probs=186.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec----------------------------cCCCCC-----
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA----------------------------PTTSSS-----   47 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~----------------------------~~~~~~-----   47 (408)
                      |..|...+.||+|+||+||+|+++.+|+.||+|+.....+.                            .....+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34678888999999999999999999999999875533221                            111122     


Q ss_pred             -cceEEEeccCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           48 -CRNLHLEYLPGGTVSDLATTLN---AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        48 -~~~LVmEy~~gGsL~~~l~~~~---~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                       .++||+||+.- +|.+++....   ..++...++.+++||+.||+|||+++|+||||||+||||+.+|. +||+|||+|
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~-lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV-LKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc-EeeeccchH
Confidence             67899999976 9999998765   46788999999999999999999999999999999999999875 999999999


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhc-----------
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIG-----------  190 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~-----------  190 (408)
                      +.......  .....++|.+|.|||++.+. .|+..+||||+|||++||+++++.|.+... +++..+.           
T Consensus       168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            86553322  24556789999999999987 789999999999999999999999986543 2322220           


Q ss_pred             --------ccCCCCCCC---------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 --------FSDELPRFP---------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 --------~~~~~p~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                              +...++..+         +..+++..+++.+||+.+|.+|.|+..+|.||||......
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence                    001111111         1233578999999999999999999999999999876543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9e-40  Score=314.95  Aligned_cols=227  Identities=28%  Similarity=0.402  Sum_probs=176.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-CCcEEEEeecccce----------------------ecc-------------CCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-NGDVFAYLGDDVSY----------------------EAP-------------TTS   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-t~~~va~k~~~~~~----------------------~~~-------------~~~   45 (408)
                      .+|++.+.||+|+||+||+|++.. ++..+|+|......                      ..+             ...
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999965 46778776432110                      000             112


Q ss_pred             CCcceEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ....++||||++ ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~-~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC-EEEccccceE
Confidence            345789999997 4899988753 345789999999999999999999999999999999999998875 9999999996


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-C------CC--
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-D------EL--  195 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-~------~~--  195 (408)
                      ......   ......||+.|+|||++.+..++.++|+|||||++|+|++|++||...........+.. .      ..  
T Consensus       159 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         159 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            554321   22344689999999999988899999999999999999999999986543222111100 0      00  


Q ss_pred             -----------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          196 -----------------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       196 -----------------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                                       ..+....++.+++|+.+||+.||++|||+.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             01113467888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-39  Score=327.49  Aligned_cols=233  Identities=24%  Similarity=0.335  Sum_probs=185.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|+++.+++.+|+|....                            .+...+..+...++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999876321                            1122234566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ .
T Consensus       123 Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~-ikL~DfG~a~~~~~~~~-~  198 (371)
T cd05622         123 EYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGM-V  198 (371)
T ss_pred             cCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC-EEEEeCCceeEcCcCCc-c
Confidence            99999999999974  35789999999999999999999999999999999999998875 99999999976543221 1


Q ss_pred             ccccCCCCCCCCChhhHhCCC----CCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC-CCCCCC--CCCcHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGEC----QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD-ELPRFP--TQSSELG  206 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~----~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~-~~p~~~--~~~s~~~  206 (408)
                      .....+||+.|+|||++.+..    ++.++|||||||++|+|++|.+||...+.......+... ....++  ...+..+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            123457999999999997643    788999999999999999999999876654443332221 111222  3678999


Q ss_pred             HHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       207 ~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~  238 (408)
                      +++|.+||..++.+  |++++|+++||||+...+
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence            99999999844433  779999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=314.55  Aligned_cols=234  Identities=25%  Similarity=0.376  Sum_probs=190.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmE   54 (408)
                      +|++.+.||+|+||+||++.+..++..+|+|.....                            +...+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            589999999999999999999999999998754210                            1112344567899999


Q ss_pred             ccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           55 YLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        55 y~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |++||+|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++.++. ++|+|||++........  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~--  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGET--  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC-EEEeeCCCceecCCCCc--
Confidence            99999999988654 346899999999999999999999999999999999999998874 99999999865432221  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh---hhcccCCCCCCCCCCcHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~---~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                       .....|++.|+|||++.+..++.++|+||+||++|+|++|+.||.........   ........+.++...+..+++|+
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence             22346899999999999888999999999999999999999999864432211   11122333455667889999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHcCCCCCCCCCCC
Q 042746          211 DKCLRREPGERW-----SCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       211 ~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~~  240 (408)
                      .+||+.||++||     +++++++||||....++.
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence            999999999999     899999999998766553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.6e-40  Score=337.69  Aligned_cols=230  Identities=21%  Similarity=0.290  Sum_probs=177.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccC-CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPT-TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~-~~~~~~~   50 (408)
                      .+|++.+.||+|+||+||+|.+..+++.||+|.....                              +...+ ....+++
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            4799999999999999999999999999999864210                              00001 1234678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCC---------------c
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSS---------------F  114 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~---------------~  114 (408)
                      ||||++ |++|.+++.+ .+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.               .
T Consensus       209 iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             EEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            999998 6789988874 3578999999999999999999998 59999999999999986542               3


Q ss_pred             EEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--cc
Q 042746          115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--FS  192 (408)
Q Consensus       115 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--~~  192 (408)
                      +||+|||.+.....     .....+||+.|+|||++.+..++.++|||||||++|||++|++||...+........  ..
T Consensus       287 vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        287 VRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             EEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence            99999998754321     123457999999999999999999999999999999999999999765432211100  00


Q ss_pred             CCC------------------------CCC---------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 DEL------------------------PRF---------------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ~~~------------------------p~~---------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +.+                        +..               ....++.+.|||.+||.+||.+|||++|+|+||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence            000                        000               00124567899999999999999999999999999


Q ss_pred             CCCCC
Q 042746          234 QSVSP  238 (408)
Q Consensus       234 ~~~~~  238 (408)
                      ....+
T Consensus       442 ~~~~~  446 (467)
T PTZ00284        442 LKYYP  446 (467)
T ss_pred             cccCC
Confidence            87554

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-39  Score=321.05  Aligned_cols=230  Identities=25%  Similarity=0.400  Sum_probs=185.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||.||+|++..++..+++|.....                          +...+..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            6899999999999999999999999999988754311                          11223345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++||+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++.......    
T Consensus        85 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~----  158 (331)
T cd06649          85 MDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM----  158 (331)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc-EEEccCcccccccccc----
Confidence            999999999975 45679999999999999999999986 6999999999999998875 9999999986553221    


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc------------------------
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG------------------------  190 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~------------------------  190 (408)
                      .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......+....                        
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence            22346899999999999988999999999999999999999999754432221110                        


Q ss_pred             ----------------------ccCCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 ----------------------FSDELPRF-PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 ----------------------~~~~~p~~-~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                            .....|.. ....++++++||.+||.+||++|||+.|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                  00111111 124678899999999999999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.7e-40  Score=319.35  Aligned_cols=235  Identities=22%  Similarity=0.415  Sum_probs=185.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmE   54 (408)
                      |++|++.+.||+|+||+||+|+++.+++.+++|.....                          +......+...++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            67899999999999999999999999999998754311                          1112334566889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++ +|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  .
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~--~  160 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSVPTK--T  160 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECccccceecCCCcc--c
Confidence            9986 898888766667899999999999999999999999999999999999998875 99999999865432221  1


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---------------------c
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---------------------S  192 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---------------------~  192 (408)
                      .....+|+.|+|||++.+ ..++.++|+|||||++|+|++|++||...+.........                     .
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            223457999999999876 457889999999999999999999997654322211100                     0


Q ss_pred             CCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 DELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ...+.        .....++++++||.+||+.||.+|||+.|+++||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            00111        112467889999999999999999999999999999876543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.5e-40  Score=339.67  Aligned_cols=233  Identities=25%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCC-CcEEEEeecc-------------------------cceeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFN-GDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t-~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy~   56 (408)
                      .|.+.+.||+|+||.||+|.+..+ +..+++|...                         +.+...+..+...+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            499999999999999999999888 6777766422                         12223345567889999999


Q ss_pred             CCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           57 PGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        57 ~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      +||+|.+++...   ...+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~-~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-IKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc-EEEEeCcCceecCCccccc
Confidence            999999988642   346789999999999999999999999999999999999998874 9999999997654332222


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......+.........+.++...+..+++||.+|
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  306 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPL  306 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHH
Confidence            23456799999999999998899999999999999999999999987666555544444555566677889999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      |.+||++||++.+++.|||++..
T Consensus       307 L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        307 LSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             hccChhhCcCHHHHHhCHHHHHH
Confidence            99999999999999999998643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=322.53  Aligned_cols=229  Identities=24%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|.||+|.+|.+...|+.||+|...                            +.....|+....+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            36899999999999999999999999999986533                            22334567777788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||..+|.|.|++.. .+.++|.+++.+++||++|+.|+|+++++|||||.+|||||.|++ +||+|||++..+..   ..
T Consensus       133 EYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N-iKIADFGLSNly~~---~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN-IKIADFGLSNLYAD---KK  207 (668)
T ss_pred             EecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC-eeeeccchhhhhcc---cc
Confidence            99999999999985 467899999999999999999999999999999999999999986 99999999966543   33


Q ss_pred             ccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ...++||+|.|.+||+++|.+| ++.+|-|||||+||.|+.|..||++.+...+.+.+..+.+..  +..+.++.-||+.
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRw  285 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRW  285 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHH
Confidence            4567899999999999999988 789999999999999999999999998888877766666533  2345567889999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||..||.+|.|+++|-.|=|+....
T Consensus       286 mLmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  286 MLMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             HHhcCcccchhHHHHhhhheeeccc
Confidence            9999999999999999998886443

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.7e-39  Score=303.69  Aligned_cols=228  Identities=25%  Similarity=0.420  Sum_probs=189.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCC-CCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTT-SSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~-~~~~~~LVmE   54 (408)
                      .|++.+.||+|+||.||++.++.+++.+++|.....                           +...+. .+..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            599999999999999999999999999988764211                           111122 3445789999


Q ss_pred             ccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           55 YLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        55 y~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |+++++|.+++... ...+++..++.++.|++.+|+|||++|++|+||||+||+++.++. ++|+|||++........  
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~-~~l~df~~~~~~~~~~~--  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI-IKVGDLGIARVLENQCD--  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc-EEEecccceEEecccCC--
Confidence            99999999999753 456899999999999999999999999999999999999988774 99999999865532221  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ......|++.|+|||++.+..++.++|+||||+++++|++|+.||...+.............+..+...++.+.+|+.+|
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM  237 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence            22345689999999999998889999999999999999999999987665544443445555666778899999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~  233 (408)
                      |+.||++|||+.++++||||
T Consensus       238 l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         238 LSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             hccCcccCCCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-39  Score=310.34  Aligned_cols=226  Identities=26%  Similarity=0.350  Sum_probs=177.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee----------------------cc--------C-----CCCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE----------------------AP--------T-----TSSS   47 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~----------------------~~--------~-----~~~~   47 (408)
                      +|++.+.||+|+||+||+|+++.+++.+++|.......                      .+        +     ....
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            59999999999999999999999999999875331100                      00        0     1123


Q ss_pred             cceEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      ..+++|||+++ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ-VKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECccCccccc
Confidence            46899999986 8988887543 34799999999999999999999999999999999999998875 999999998765


Q ss_pred             ccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh-hhc----------cc---
Q 042746          127 TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS-RIG----------FS---  192 (408)
Q Consensus       127 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~-~~~----------~~---  192 (408)
                      .....   .....||+.|+|||++.+..++.++|||||||++|+|++|++||......... .+.          +.   
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         159 SCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            42221   22345899999999999888999999999999999999999999754332211 110          00   


Q ss_pred             ----CCC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 ----DEL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ----~~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                          ...        .......+..++++|.+||++||.+|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                000        01113467788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-39  Score=311.41  Aligned_cols=226  Identities=25%  Similarity=0.365  Sum_probs=180.8

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||+|+||+||++.++.+++.+|+|....                            .....++.+...++||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999875431                            111223455678899999999999


Q ss_pred             HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCC
Q 042746           62 SDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG  140 (408)
Q Consensus        62 ~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G  140 (408)
                      .+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++|+|||++.......   ......|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~-~~l~Dfg~~~~~~~~~---~~~~~~~  156 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN-CRLSDLGLAVELKDGK---TITQRAG  156 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC-EEEeeceeeeecCCCc---eeeccCC
Confidence            98886433 35788999999999999999999999999999999999998875 9999999986543221   1223468


Q ss_pred             CCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       141 t~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ++.|+|||++.+..++.++|+|||||++|+|++|+.||.....    ............+......++++++|+.+||++
T Consensus       157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            9999999999988899999999999999999999999976432    122222223333223346788999999999999


Q ss_pred             CCCCCCCH----HHHHcCCCCCCCCCC
Q 042746          217 EPGERWSC----DQLLKHPFLQSVSPS  239 (408)
Q Consensus       217 dP~~R~s~----~ell~hpf~~~~~~~  239 (408)
                      ||.+||++    +++++||||+...++
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCCCHH
Confidence            99999999    678899999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=326.29  Aligned_cols=236  Identities=25%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      ..|+.-|+||+||||.||-+.-+.||+.||.|..+                            +.+.-.+++...++|||
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            46788999999999999999999999999875433                            22233467788899999


Q ss_pred             eccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ..|.||+|.-.|.+.+ ..++|..++.|+++|+.||++||+.+||+||+||+|||||+.|+ ++|+|.|+|........ 
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh-vRISDLGLAvei~~g~~-  342 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH-VRISDLGLAVEIPEGKP-  342 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC-eEeeccceEEecCCCCc-
Confidence            9999999988777654 46799999999999999999999999999999999999999996 99999999976654332 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCcHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSSELGRD  208 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s~~~~~  208 (408)
                        ....+||.+|||||++.++.|+..+|+|||||++|+|+.|+.||.....    +++.+.... ....++...|+++++
T Consensus       343 --~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~-~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  343 --IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE-DPEEYSDKFSEEAKS  419 (591)
T ss_pred             --cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc-chhhcccccCHHHHH
Confidence              2233799999999999999999999999999999999999999976432    233333333 333677899999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHcCCCCCCCCCCCcc
Q 042746          209 FLDKCLRREPGERW-----SCDQLLKHPFLQSVSPSDAN  242 (408)
Q Consensus       209 li~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~~~~  242 (408)
                      |++.+|.+||.+|.     +++++.+||||+.+++....
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle  458 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE  458 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence            99999999999998     67899999999999877543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-39  Score=320.04  Aligned_cols=227  Identities=24%  Similarity=0.365  Sum_probs=185.6

Q ss_pred             eceeeecCCeeEEEEEE---cCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEecc
Q 042746            7 GKCIGRGSFGTVNVAVD---RFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d---~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+.||+|+||+||++++   ..+++.+|+|....                           .+...+..+...+|||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36899999999999987   46788898875331                           1112234556788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  ...
T Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~~~--~~~  156 (318)
T cd05582          81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK--KAY  156 (318)
T ss_pred             CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc-EEEeeccCCcccCCCCC--cee
Confidence            99999999974 456899999999999999999999999999999999999998875 99999999875433211  223


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ...||+.|+|||++.+..++.++|+|||||++|+|++|+.||................ ..+|...++.+++||.+||++
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence            4579999999999998888999999999999999999999998766544444333332 355677899999999999999


Q ss_pred             CCCCCCC-----HHHHHcCCCCCCCCC
Q 042746          217 EPGERWS-----CDQLLKHPFLQSVSP  238 (408)
Q Consensus       217 dP~~R~s-----~~ell~hpf~~~~~~  238 (408)
                      ||.+||+     +.+++.||||....+
T Consensus       236 ~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         236 NPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             CHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            9999999     778999999987643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=320.95  Aligned_cols=236  Identities=22%  Similarity=0.371  Sum_probs=201.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--e---------------------------eccCCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--Y---------------------------EAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--~---------------------------~~~~~~~~~~~LVm   53 (408)
                      +|-+..+||+|+||+|.+|..+-|.+.||+|.....  .                           ...++.-..+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            577899999999999999999999999987643211  1                           11244556689999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+.||+|.-.++..++ +.|..+..|+++|+-||-|||++|||+||||.+||+|+.+|+ +||+|||++++-....  .
T Consensus       430 EyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH-iKi~DFGmcKEni~~~--~  505 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIFDG--V  505 (683)
T ss_pred             EEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc-eEeeecccccccccCC--c
Confidence            99999999888886654 577888899999999999999999999999999999999996 9999999997644332  3


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ++.++||||.|+|||++..++|+.++|+||+||+|||||.|++||+..+..++.+.+..... .+|...|.++.++++.+
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPKSLSKEAVAICKGL  584 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcccccHHHHHHHHHH
Confidence            46678999999999999999999999999999999999999999999998888887655554 78889999999999999


Q ss_pred             cccCCCCCCCH-----HHHHcCCCCCCCCCCCccc
Q 042746          214 LRREPGERWSC-----DQLLKHPFLQSVSPSDANT  243 (408)
Q Consensus       214 L~~dP~~R~s~-----~ell~hpf~~~~~~~~~~~  243 (408)
                      |.+.|.+|..+     .+|..||||+.+.|.....
T Consensus       585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~  619 (683)
T KOG0696|consen  585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER  619 (683)
T ss_pred             hhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence            99999999843     5799999999988765433

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-39  Score=311.74  Aligned_cols=231  Identities=23%  Similarity=0.365  Sum_probs=186.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmE   54 (408)
                      +|++.+.||+|+||+||+|.+..+++.+++|.....                            ....+......+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            588999999999999999999999999998753211                            1112234566889999


Q ss_pred             ccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           55 YLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        55 y~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |++|++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++........  
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~--  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQT--  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC-EEEeeccceeecCCCcc--
Confidence            999999999886533 35789999999999999999999999999999999999998875 99999999865432211  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----hhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----TLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                       .....|++.|+|||++.+..++.++|+||+|+++|+|++|++||......    ..... .......++...++.+++|
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh-hhhhhhhcCccCCHHHHHH
Confidence             12346899999999999988999999999999999999999999754321    11111 1111223456788899999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHcCCCCCCCCC
Q 042746          210 LDKCLRREPGERWS-----CDQLLKHPFLQSVSP  238 (408)
Q Consensus       210 i~~~L~~dP~~R~s-----~~ell~hpf~~~~~~  238 (408)
                      +.+||+.||.+|||     ++|+++||||+....
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF  269 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence            99999999999999     899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=319.32  Aligned_cols=232  Identities=31%  Similarity=0.490  Sum_probs=198.2

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------eeccCCCCCcceEEEeccCCCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------YEAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------~~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      |.+..+||+|+||.||+|+++.+|+++|+|+..+.                       +.+..-...-++||||||.-|+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence            44678899999999999999999999999875432                       2222223445889999999999


Q ss_pred             HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCC
Q 042746           61 VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG  140 (408)
Q Consensus        61 L~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G  140 (408)
                      +.++++.++..+.|.+|..+++.-+.||+|||...-||||||.-||||+.+|. .||+|||.|.+++.....  ..+..|
T Consensus       115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~-AKLADFGVAGQLTDTMAK--RNTVIG  191 (502)
T KOG0574|consen  115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI-AKLADFGVAGQLTDTMAK--RNTVIG  191 (502)
T ss_pred             HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch-hhhhhccccchhhhhHHh--hCcccc
Confidence            99999999999999999999999999999999999999999999999999985 999999999887755432  345679


Q ss_pred             CCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CCCCcHHHHHHHHHhcccCC
Q 042746          141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       141 t~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~~~s~~~~~li~~~L~~dP  218 (408)
                      ||.|||||++..-.|+.++||||||++..||..|++||.+..+......+-...+|.+  |..-|.++-||+++||.++|
T Consensus       192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~P  271 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKP  271 (502)
T ss_pred             CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCH
Confidence            9999999999999999999999999999999999999998776655544444444444  34567789999999999999


Q ss_pred             CCCCCHHHHHcCCCCCCCCC
Q 042746          219 GERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       219 ~~R~s~~ell~hpf~~~~~~  238 (408)
                      ++|-|+.++++|||++....
T Consensus       272 E~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  272 EERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             HHHHHHHHHhhhhhhcCCCc
Confidence            99999999999999987654

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-39  Score=327.64  Aligned_cols=233  Identities=20%  Similarity=0.231  Sum_probs=180.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------cceeccCCCCCcceEEEeccCCCCHH
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------VSYEAPTTSSSCRNLHLEYLPGGTVS   62 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------~~~~~~~~~~~~~~LVmEy~~gGsL~   62 (408)
                      .+|++.+.||+|+||.||+|++..+++.+|+|...                   +.+...+......+++|||+. ++|.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~  170 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY  170 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence            46999999999999999999999999999998643                   122223445667889999996 5898


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCC
Q 042746           63 DLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP  142 (408)
Q Consensus        63 ~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~  142 (408)
                      .++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|....... ........||+
T Consensus       171 ~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~-vkL~DFG~a~~~~~~~-~~~~~~~~gt~  247 (391)
T PHA03212        171 CYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD-VCLGDFGAACFPVDIN-ANKYYGWAGTI  247 (391)
T ss_pred             HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC-EEEEeCCccccccccc-ccccccccCcc
Confidence            88874 356789999999999999999999999999999999999998875 9999999986533211 11223457999


Q ss_pred             CCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--------hhhhhhc---------------------c--
Q 042746          143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--------NTLSRIG---------------------F--  191 (408)
Q Consensus       143 ~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--------~~~~~~~---------------------~--  191 (408)
                      .|+|||++.+..++.++|||||||++|+|++|..||-....        ..+..+.                     +  
T Consensus       248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~  327 (391)
T PHA03212        248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG  327 (391)
T ss_pred             CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence            99999999998899999999999999999999977632110        0000000                     0  


Q ss_pred             ----cCCCCC-CC-----CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 ----SDELPR-FP-----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 ----~~~~p~-~~-----~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                          ....|. .+     ...+.++.+||.+||++||.+|||+.|+|+||||+....
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence                000000 00     123567899999999999999999999999999987543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=322.00  Aligned_cols=229  Identities=31%  Similarity=0.458  Sum_probs=181.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      .+|++++.||+|+||+||+|++..+++.|++|....                          .+...+.....+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            468889999999999999999999999999886421                          112234456678899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +++|+|.+.     ...++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......  ..
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kL~DfG~~~~~~~~~~--~~  225 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN-VKIADFGVSRILAQTMD--PC  225 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-EEEcccccceecccccc--cc
Confidence            999998643     34468888999999999999999999999999999999998875 99999999876543221  12


Q ss_pred             ccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh---hhhcccCCCCCCCCCCcHHHH
Q 042746          136 IQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL---SRIGFSDELPRFPTQSSELGR  207 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~---~~~~~~~~~p~~~~~~s~~~~  207 (408)
                      ....||+.|+|||++..     ...+.++|||||||++|+|++|+.||........   .........+..+...+..++
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR  305 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence            23469999999999853     2345689999999999999999999974332221   111222334455667889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||.+||..||++|||+.|+++||||.....
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            9999999999999999999999999987543

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=334.13  Aligned_cols=229  Identities=32%  Similarity=0.559  Sum_probs=200.1

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCCCCCcceEEEeccCCCCHH
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEYLPGGTVS   62 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy~~gGsL~   62 (408)
                      -+||+|.||+||-|+|..|..-.|+|...                         +.+.+...++.++-|+||-.|||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999999999999987654                         33444556677888999999999999


Q ss_pred             HHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCC
Q 042746           63 DLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG  140 (408)
Q Consensus        63 ~~l~~~~~~l--~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G  140 (408)
                      ++++..-+++  +|..+-.|.+||+.||.|||++.|||||||-+|+|++...+.+||.|||-++.......  .+-++.|
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETFTG  738 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETFTG  738 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc--ccccccc
Confidence            9999887888  89999999999999999999999999999999999998877899999999977654332  3445679


Q ss_pred             CCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          141 SPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       141 t~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      |..|||||++..+  .|+.++|||||||++.||.||+|||...+  ...+.++...+.-|++|...+.+++.||.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            9999999999764  68999999999999999999999998654  4556677777777899999999999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ||.+||++.++|..||++..+.
T Consensus       819 d~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             CcccCccHHHhccCcccccCCC
Confidence            9999999999999999987643

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=335.69  Aligned_cols=233  Identities=31%  Similarity=0.482  Sum_probs=193.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEeccC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      -|.|+.-||.|+||+||+|+++.++-..|.|..+..                         ....+-.++.++|+.|||+
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            478888999999999999999987776665543321                         1111223566889999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||-+..++-..+..++|.+|..+.+|++.||.|||+++|||||||.-|||+..+|. ++|+|||++......  .....+
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd-irLADFGVSAKn~~t--~qkRDs  189 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD-IRLADFGVSAKNKST--RQKRDS  189 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-EeeecccccccchhH--Hhhhcc
Confidence            99999999889999999999999999999999999999999999999999999986 999999998543322  223446


Q ss_pred             CCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CCCCcHHHHHHH
Q 042746          138 PRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGRDFL  210 (408)
Q Consensus       138 ~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~~~s~~~~~li  210 (408)
                      +.|||.|||||+..     ..+|+.++||||||++|++|..+.||-.+.++....-.+-...+|.+  |..-+..+.||+
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfL  269 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFL  269 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHH
Confidence            78999999999974     56899999999999999999999999888776655544444555544  556778899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+||.+||..||++.++++||||...+.
T Consensus       270 k~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  270 KRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            9999999999999999999999986653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=320.91  Aligned_cols=222  Identities=29%  Similarity=0.411  Sum_probs=184.1

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCC-cceEEEecc
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSS-CRNLHLEYL   56 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~-~~~LVmEy~   56 (408)
                      .+.+.||+|+||+||++....+. .+|+|...                           +.+.+...... .+.|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            45677999999999999997433 16665433                           22334444444 688999999


Q ss_pred             CCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           57 PGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        57 ~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~g-iiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++|+|.+++.. .+..++...+..++.||+.|++|||+++ ||||||||+|||++.+..++||+|||+++.......  .
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~--~  200 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT--S  200 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc--c
Confidence            99999999987 3788999999999999999999999999 999999999999998864599999999977654321  1


Q ss_pred             cccCCCCCCCCChhhHh--CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVR--GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~--~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .....||+.|||||+++  ...|+.++||||||+++|||+||+.||.+....+ ...+......|.+|...++.+..++.
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~  280 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLME  280 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHH
Confidence            22257999999999999  5699999999999999999999999999866533 33444567778888889999999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      +||..||.+||++.|++.
T Consensus       281 ~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  281 RCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HhCCCCCCcCCCHHHHHH
Confidence            999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-39  Score=317.99  Aligned_cols=227  Identities=22%  Similarity=0.310  Sum_probs=175.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-----cCCCcEEEEeecccc---------------------------eeccC-CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-----RFNGDVFAYLGDDVS---------------------------YEAPT-TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-----~~t~~~va~k~~~~~---------------------------~~~~~-~~~~~   48 (408)
                      ++|++++.||+|+||+||+|.+     ..++..||+|.....                           +.+.+ .....
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            5899999999999999999985     334566777653210                           11111 12345


Q ss_pred             ceEEEeccCCCCHHHHHHHhC-----------------------------------------------------------
Q 042746           49 RNLHLEYLPGGTVSDLATTLN-----------------------------------------------------------   69 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~-----------------------------------------------------------   69 (408)
                      ++++|||++||+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            789999999999999997531                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCCh
Q 042746           70 --AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAP  147 (408)
Q Consensus        70 --~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~AP  147 (408)
                        ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...............+++.|+||
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~-~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc-EEEeecccccccccCcchhcccCCCCCccccCc
Confidence              23677888999999999999999999999999999999998874 999999999765322211112223467889999


Q ss_pred             hhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 042746          148 EVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCD  225 (408)
Q Consensus       148 E~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~  225 (408)
                      |++.+..++.++|||||||++|+|++ |.+||....... ..........+..+...++.+.+++.+||..||.+|||+.
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  325 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFS  325 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999889999999999999999997 999998654322 2222223334455677889999999999999999999999


Q ss_pred             HHHc
Q 042746          226 QLLK  229 (408)
Q Consensus       226 ell~  229 (408)
                      |+++
T Consensus       326 el~~  329 (338)
T cd05102         326 ALVE  329 (338)
T ss_pred             HHHH
Confidence            9976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.8e-39  Score=319.50  Aligned_cols=228  Identities=24%  Similarity=0.326  Sum_probs=177.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee---------------------------ccC------CCCC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---------------------------APT------TSSS   47 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~---------------------------~~~------~~~~   47 (408)
                      +.+|++.+.||+|+||+||+|.+..+++.+|+|.......                           ..+      ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            3689999999999999999999999999999886432110                           001      1223


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ..++||||+++ +|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc-EEEEeCCCccccC
Confidence            46899999976 7777775   34688999999999999999999999999999999999998875 9999999997553


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc---------------
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS---------------  192 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~---------------  192 (408)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..........               
T Consensus       178 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         178 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            322   12334689999999999999999999999999999999999999976442211110000               


Q ss_pred             ------CCCC--------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          193 ------DELP--------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       193 ------~~~p--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                            ...|                    ......+..+++||.+||+.||.+|||+.|+|+||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                  0000                    0111235678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=302.39  Aligned_cols=230  Identities=36%  Similarity=0.633  Sum_probs=188.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|.+++.||+|+||.||+|.+..+++.+++|....                              .+.+....+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999998875321                              11122345567889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||++|++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||+++.......
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~-~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccceecccccc
Confidence            9999999999999975 356789999999999999999999999999999999999998775 99999999865432211


Q ss_pred             Cc-ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHHHH
Q 042746          132 RG-VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       132 ~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      .. ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....... ..........+.++...+..+.++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNF  239 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHH
Confidence            11 1123458899999999999889999999999999999999999997654332 233323334456677889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      |.+||.++|.+|||+.|+++||||
T Consensus       240 i~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         240 LRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.9e-39  Score=329.31  Aligned_cols=229  Identities=31%  Similarity=0.435  Sum_probs=183.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------------cceeccCCCCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------------~~~~~~~~~~~~~~LV   52 (408)
                      +|.+.++||+|+||+|-+|.|..|++.||+|...                              +.+...+...++++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            6899999999999999999999999999987543                              2334456667889999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC-CCCcEEEeecCCccccccCC
Q 042746           53 LEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~-~~~~vkL~DFGla~~~~~~~  130 (408)
                      .|.+.- +|.++++.. ...++...++.++.||+.+|.+||+.||||+||||+||||.. +...|||+|||.|.......
T Consensus       267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v  345 (586)
T KOG0667|consen  267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV  345 (586)
T ss_pred             ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence            999976 999999863 346789999999999999999999999999999999999964 33359999999997654332


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcc------------------
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGF------------------  191 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~------------------  191 (408)
                      .     +.+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+ +..+.-                  
T Consensus       346 y-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k  420 (586)
T KOG0667|consen  346 Y-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK  420 (586)
T ss_pred             e-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence            2     4456999999999999999999999999999999999999997654322 111100                  


Q ss_pred             ---c-CCCC----------------------------CCC-----------CCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          192 ---S-DELP----------------------------RFP-----------TQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       192 ---~-~~~p----------------------------~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                         . ...|                            ..|           ......+.|||.+||++||.+|+|+.|+|
T Consensus       421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal  500 (586)
T KOG0667|consen  421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL  500 (586)
T ss_pred             ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence               0 0000                            011           12234568999999999999999999999


Q ss_pred             cCCCCCCCC
Q 042746          229 KHPFLQSVS  237 (408)
Q Consensus       229 ~hpf~~~~~  237 (408)
                      +||||....
T Consensus       501 ~Hpfl~~~~  509 (586)
T KOG0667|consen  501 NHPFLTGTS  509 (586)
T ss_pred             cCccccccc
Confidence            999998554

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-38  Score=298.20  Aligned_cols=228  Identities=26%  Similarity=0.374  Sum_probs=191.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||+||+|.+..+++.+++|....                           .+...+..+...+++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            58999999999999999999999999998875431                           112223455678999999


Q ss_pred             cCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++|++|.+++... +..+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++........  .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~-~~l~df~~~~~~~~~~~--~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN-VKIGDLGVAKLLSDNTN--F  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC-EEEcccccceeccCccc--h
Confidence            9999999999764 457889999999999999999999999999999999999998875 99999999865543221  1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .....|++.|+|||++.+..++.++|+||||+++++|++|+.||.................+.++..++..+.+++.+||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCL  237 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHc
Confidence            22346899999999999988999999999999999999999999876655544444455566666678899999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCC
Q 042746          215 RREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~  233 (408)
                      +.+|++||++.++++|||+
T Consensus       238 ~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         238 TKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             cCCcccCcCHHHHhhCCCC
Confidence            9999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-38  Score=317.50  Aligned_cols=228  Identities=25%  Similarity=0.343  Sum_probs=176.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSS   47 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~   47 (408)
                      +.+|++.+.||+|+||+||+|++..+++.+|+|.....                           +...+      ....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            36899999999999999999999999999998864311                           01111      1123


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ..++||||+++ +|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~-~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEecCCCccccc
Confidence            46899999986 5666654   34788999999999999999999999999999999999998875 9999999996543


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh------------------
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI------------------  189 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~------------------  189 (408)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......                  
T Consensus       175 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         175 TNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            221   12334689999999999998899999999999999999999999975432111000                  


Q ss_pred             ---cccCCCCC--------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          190 ---GFSDELPR--------------------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       190 ---~~~~~~p~--------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                         .+....+.                    .....++.+++||.+||..||++|||+.|+++||||...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence               00000000                    112246778999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.5e-39  Score=317.22  Aligned_cols=229  Identities=26%  Similarity=0.417  Sum_probs=183.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||.||+|.+..++..+++|....                          .+...+..+...+|||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            589999999999999999999999999998864321                          112223456678999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++||+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++.......    
T Consensus        85 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~~~~~~~~~----  158 (333)
T cd06650          85 MDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM----  158 (333)
T ss_pred             CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC-EEEeeCCcchhhhhhc----
Confidence            999999999975 45678999999999999999999985 7999999999999998875 9999999986543221    


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh-------------------------
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------------------------  189 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~-------------------------  189 (408)
                      .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......+...                         
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence            1234689999999999998899999999999999999999999975432222110                         


Q ss_pred             -------------------cccCCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          190 -------------------GFSDELPRFP-TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       190 -------------------~~~~~~p~~~-~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                                         ......|..+ ...+.++++||.+||++||++|||+.|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                               0111112222 2357789999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-38  Score=315.94  Aligned_cols=228  Identities=25%  Similarity=0.308  Sum_probs=177.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSS   47 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~   47 (408)
                      +++|++.+.||+|+||.||+|.+..+++.+|+|.....                           ....+      ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999999999999998764311                           00011      1223


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ..+++|||+++ +|.+.+.   ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~-~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC-EEEeeCcccccCC
Confidence            46899999976 6776665   35789999999999999999999999999999999999998875 9999999997543


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------------
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------------  190 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------------  190 (408)
                      ...   ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||............                 
T Consensus       171 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         171 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             Ccc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            322   123356899999999999988999999999999999999999999754421110000                 


Q ss_pred             ----ccCCC--------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          191 ----FSDEL--------------------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       191 ----~~~~~--------------------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                          +....                    ...+...+..+++||.+||+.||++|||+.|+++||||...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                00000                    01112245678999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.8e-38  Score=308.40  Aligned_cols=233  Identities=21%  Similarity=0.406  Sum_probs=184.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmE   54 (408)
                      +++|++.+.||+|+||.||+|++..+++.+++|.....                          +...+..+...++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            57899999999999999999999999999988754311                          1122344566889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++ +|.+++......+++..++.++.||+.||+|||+++|+|+||||+|||++.++. ++|+|||++........  .
T Consensus        85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~--~  160 (301)
T cd07873          85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTK--T  160 (301)
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc-EEECcCcchhccCCCCC--c
Confidence            9985 999988876677899999999999999999999999999999999999998875 99999999865432221  1


Q ss_pred             cccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------c----------c
Q 042746          135 KIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------F----------S  192 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------~----------~  192 (408)
                      .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+........           +          .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            2234578999999998764 4788999999999999999999999765432211100           0          0


Q ss_pred             CCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          193 DELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       193 ~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ...|.        .....++.+++||.+||+.||.+|||++|+++||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            01111        1234678899999999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-39  Score=306.38  Aligned_cols=226  Identities=35%  Similarity=0.520  Sum_probs=180.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      |++++.||+|+||+||++++..+++.+++|.....                           ...........+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999998764421                           112233466678999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++. ....+++..+..++.||+.||++||+++++|+||||+||+++.++. ++|+|||.+....  .......
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~-~~l~Dfg~~~~~~--~~~~~~~  156 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE-VKLIDFGSSVKLS--ENNENFN  156 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE-EEESSGTTTEEST--STTSEBS
T ss_pred             cccccccccc-cccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccc--ccccccc
Confidence            9999999998 4567799999999999999999999999999999999999997774 9999999986431  1112233


Q ss_pred             cCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh---hhhhcccCCCC---CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT---LSRIGFSDELP---RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~---~~~~~~~~~~p---~~~~~~s~~~~~l  209 (408)
                      ...+++.|+|||++. +..++.++|+||||+++++|++|..||.......   ..........+   ......++.++++
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            456899999999998 7788999999999999999999999998762211   11111111100   1111224789999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      |.+||+.||++|||+.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-38  Score=304.80  Aligned_cols=233  Identities=21%  Similarity=0.334  Sum_probs=187.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.....                            ....+..+...+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            488999999999999999999999999998754211                            1112334566889999


Q ss_pred             ccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           55 YLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        55 y~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |+++++|.+++...+ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++|+|||++.......   
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~---  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGE---  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC-EEEecCCcceecCCCC---
Confidence            999999998886533 46899999999999999999999999999999999999998874 9999999986543221   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh---cccCCCCCCCCCCcHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI---GFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~---~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........   ......+.++...+..+.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            12234689999999999988899999999999999999999999986543221111   112222344566788899999


Q ss_pred             HHhcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          211 DKCLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       211 ~~~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      .+||+.||++||+     +.++++||||......
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence            9999999999999     8899999999877544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-40  Score=328.57  Aligned_cols=227  Identities=35%  Similarity=0.516  Sum_probs=190.6

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEec
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      |...+-||.|+||.||.|+|..|.+.||+|+...                            .+.+.+..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            5667899999999999999999999999987652                            223333445567899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      |-| +..|++....+++.|..|..+..+.+.||+|||+++.||||||.-||||.+.| .|||+|||.|....      ..
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~------PA  179 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA------PA  179 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcC------ch
Confidence            986 99999998899999999999999999999999999999999999999999888 59999999985443      24


Q ss_pred             ccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCC-ChhhhhhhcccCCCCCCC-CCCcHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFP-TQSSELGRDFL  210 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~-~~~~~~~~~~~~~~p~~~-~~~s~~~~~li  210 (408)
                      .+++|||.|||||++..   +.|+-++||||||++++||...+||+-.. .+..++.+ -....|.++ ..-|..++.|+
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-AQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-HhcCCCCCCCchhHHHHHHHH
Confidence            46889999999999963   46899999999999999999999995443 34455554 345556655 34678899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +.||.+-|.+|||.+++|+|+|+....++
T Consensus       259 d~CLqKipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence            99999999999999999999999765443

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-38  Score=299.08  Aligned_cols=229  Identities=34%  Similarity=0.634  Sum_probs=186.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------------eeccCCCCCc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------------YEAPTTSSSC   48 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------------~~~~~~~~~~   48 (408)
                      +|++++.||+|+||.||+|.+..+++.+++|.....                                  ....+.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            589999999999999999999999999988743211                                  1112334566


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+++|||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~-~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG-IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC-EEecccCCCccccc
Confidence            78999999999999999754 56789999999999999999999999999999999999988875 99999999876542


Q ss_pred             CCCC----cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          129 SDTR----GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       129 ~~~~----~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      ....    .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.................+..+...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISS  238 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCH
Confidence            2110    111234588999999999988889999999999999999999999986543322222223444566677889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      .++++|.+||+.||.+||++.|+++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.6e-38  Score=295.83  Aligned_cols=228  Identities=25%  Similarity=0.414  Sum_probs=189.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||.||+|.+..+++.+++|.....                           ....+..+...++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            699999999999999999999999999988754321                           11122345668899999


Q ss_pred             cCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++|++|.+++... +..+++..+..++.|++.+|+|||++|++|+||||+||+++.++..+||+|||++........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---
Confidence            9999999999764 345799999999999999999999999999999999999987766689999999976543221   


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.............+.++...+..+++++.+||
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  237 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML  237 (256)
T ss_pred             ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence            12345899999999999888899999999999999999999999876554444433444445566678899999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCC
Q 042746          215 RREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~  233 (408)
                      ..||++|||+.|+++||||
T Consensus       238 ~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         238 NLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             cCChhhCCCHHHHhhCCCC
Confidence            9999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2e-38  Score=318.08  Aligned_cols=231  Identities=23%  Similarity=0.344  Sum_probs=179.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCC-----cce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSS-----CRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~-----~~~   50 (408)
                      +|++++.||+|+||+||+|.+..+++.||+|......                           ...+....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5889999999999999999999999999998643110                           00111222     578


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+.+ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus        81 lv~e~~~~-~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~-~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQS-DLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeecccc-CHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC-EEeccccceeecccCc
Confidence            99999974 7888876 3457899999999999999999999999999999999999998874 9999999997543322


Q ss_pred             CCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-------------------
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-------------------  190 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-------------------  190 (408)
                      .. ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...+.......+                   
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         158 SK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             cc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            11 12234689999999999875 4788999999999999999999999765432211110                   


Q ss_pred             ----c--cCCCC------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 ----F--SDELP------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 ----~--~~~~p------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                          .  ....+      ......++++.+||.+||+.||.+|||+.|+++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                0  00011      12234578899999999999999999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.9e-38  Score=303.10  Aligned_cols=230  Identities=27%  Similarity=0.379  Sum_probs=192.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||.||++.+..+++.+++|....                            .....+......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            479999999999999999999999999999875321                            1111233456788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|.|||++.++. +||+|||++......    
T Consensus        81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~-~kl~dfg~~~~~~~~----  154 (290)
T cd05580          81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKGR----  154 (290)
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC-EEEeeCCCccccCCC----
Confidence            999999999999854 67899999999999999999999999999999999999998875 999999998765432    


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                       .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||............. ...+.++...+..++++|.+|
T Consensus       155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~  232 (290)
T cd05580         155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRFPSFFSPDAKDLIRNL  232 (290)
T ss_pred             -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccCCccCCHHHHHHHHHH
Confidence             223468999999999988888899999999999999999999998766444433332 233456677899999999999


Q ss_pred             cccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          214 LRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      |..||.+|+     +++|+++||||....+.
T Consensus       233 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         233 LQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             ccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence            999999999     89999999999876644

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-38  Score=298.34  Aligned_cols=231  Identities=35%  Similarity=0.560  Sum_probs=188.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~L   51 (408)
                      +|++++.||+|+||.||++.+..+++.+++|.....                               +...+......++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            599999999999999999999999999988754321                               1112345567889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++|++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++..+||+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999975 456789999999999999999999999999999999999987765699999999876543321


Q ss_pred             C--cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh----hhhcccCCCCCCCCCCcHH
Q 042746          132 R--GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL----SRIGFSDELPRFPTQSSEL  205 (408)
Q Consensus       132 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~----~~~~~~~~~p~~~~~~s~~  205 (408)
                      .  .......|+..|+|||++.+..++.++|+||||+++++|++|..||........    .........+..+...+++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence            1  111234588999999999988889999999999999999999999975432211    1111223345666778899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +++++.+||..+|.+||++.|+++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-38  Score=312.65  Aligned_cols=228  Identities=22%  Similarity=0.357  Sum_probs=178.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccC------CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPT------TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~------~~~~~   48 (408)
                      ++|++.+.||+|+||+||+|.+..+++.||+|......                           ...+      .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            58999999999999999999999999999998643110                           0001      11234


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+++||++ |++|.++++  ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus        95 ~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~-~kl~Dfg~~~~~~~  170 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADD  170 (343)
T ss_pred             EEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC-EEEcCCccceecCC
Confidence            68999988 679998886  356899999999999999999999999999999999999998875 99999999976532


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------------  190 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------------  190 (408)
                      .     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........                 
T Consensus       171 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             C-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            2     223468999999999977 46789999999999999999999999764322111000                 


Q ss_pred             -----ccCCCCCCC--------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          191 -----FSDELPRFP--------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       191 -----~~~~~p~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                           +....+..+        ...++.+.+||.+||..||.+|||+.|+++||||.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                 000111111        235667899999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.9e-38  Score=297.11  Aligned_cols=231  Identities=29%  Similarity=0.476  Sum_probs=186.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++++.||.|+||+||+|.+..++..+++|.....                          .......+...+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4799999999999999999999999999988754311                          11123445678899999


Q ss_pred             cCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-
Q 042746           56 LPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~--~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-  132 (408)
                      ++|++|.+++...  ...+++..++.++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~-~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS-VKIADFGVSASLADGGDRT  159 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC-EEEcccchHHHhccCcccc
Confidence            9999999999753  246799999999999999999999999999999999999998875 999999998665443222 


Q ss_pred             -cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCC-----CCCcHH
Q 042746          133 -GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP-----TQSSEL  205 (408)
Q Consensus       133 -~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~-----~~~s~~  205 (408)
                       .......|++.|+|||++... .++.++|+||||+++++|++|+.||.................+.++     ...++.
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS  239 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence             122334689999999999876 7889999999999999999999999865543333222222222222     256788


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +++++.+||..||++|||+.|+++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         240 FRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-38  Score=315.87  Aligned_cols=229  Identities=23%  Similarity=0.272  Sum_probs=177.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------cceeccCCCCCcceEEEeccCCCCHH
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------VSYEAPTTSSSCRNLHLEYLPGGTVS   62 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------~~~~~~~~~~~~~~LVmEy~~gGsL~   62 (408)
                      .+|++.+.||+|+||+||+|++..+++.+++|...                   +.+...+......++||||+. ++|.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~  144 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLY  144 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHH
Confidence            36999999999999999999999999999988532                   112223445566889999996 4899


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCC
Q 042746           63 DLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP  142 (408)
Q Consensus        63 ~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~  142 (408)
                      +++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......   ......||+
T Consensus       145 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~---~~~~~~gt~  220 (357)
T PHA03209        145 TYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ-VCIGDLGAAQFPVVAP---AFLGLAGTV  220 (357)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEecCccccccccCc---ccccccccc
Confidence            988776778899999999999999999999999999999999999998875 9999999986432211   122356899


Q ss_pred             CCCChhhHhCCCCCCCCCcchHHHHHHHHHhCC-CCCCCCChh----------hhhhhcc-----cCCCC----------
Q 042746          143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGAN----------TLSRIGF-----SDELP----------  196 (408)
Q Consensus       143 ~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~-~Pf~~~~~~----------~~~~~~~-----~~~~p----------  196 (408)
                      .|+|||++.+..++.++|||||||++|+|+++. ++|......          .+.....     ...++          
T Consensus       221 ~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  300 (357)
T PHA03209        221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRG  300 (357)
T ss_pred             cccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHH
Confidence            999999999988999999999999999999854 444432111          0110000     00000          


Q ss_pred             ----------CC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          197 ----------RF-------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       197 ----------~~-------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                                ..       ....+.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        301 FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                      00       0134567788999999999999999999999999975

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.4e-38  Score=304.03  Aligned_cols=235  Identities=31%  Similarity=0.446  Sum_probs=187.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      +.|++.+.||+|+||.||+|.+..+++.+++|....                         .....+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            469999999999999999999999999998876431                         1112233456789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|++|..++......+++..+..++.||+.+|+|||+++++||||||+||+++.++. ++|+|||++........  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~dfg~~~~~~~~~~--~~~  168 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD-IKLADFGVSAKNVKTLQ--RRD  168 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC-EEEccCccceecccccc--ccc
Confidence            999999988766677899999999999999999999999999999999999988774 99999999865332211  122


Q ss_pred             cCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~l  209 (408)
                      ...+++.|+|||++.     ...++.++|+|||||++|+|++|.+||.................+  ..+...+.++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            345889999999985     344678899999999999999999999765543332222222222  2345677889999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      |.+||..||++||++.|+++||||..+.+.
T Consensus       249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         249 LKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             HHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            999999999999999999999999876544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.3e-38  Score=302.51  Aligned_cols=224  Identities=22%  Similarity=0.367  Sum_probs=179.4

Q ss_pred             eeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcceEEEeccC
Q 042746            9 CIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         9 ~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .||+|+||.||++.+..+++.+|+|.....                               ....+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999988743210                               0011223456789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|.+++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++.++. ++|+|||++.......    ...
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~-~~l~dfg~~~~~~~~~----~~~  154 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKK----PHA  154 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC-EEEccCCcceeccccC----ccC
Confidence            9999998874 456899999999999999999999999999999999999998874 9999999986543221    123


Q ss_pred             CCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---hhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          138 PRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       138 ~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ..|++.|+|||.+. +..++.++|+||+||++|+|++|..||......   ...... ....+.++...+.+++++|.+|
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHH
Confidence            46899999999986 456789999999999999999999999754322   122211 1222345667889999999999


Q ss_pred             cccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          214 LRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      |..||.+|+     |+.|+++||||+.....
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~  264 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ  264 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence            999999999     69999999999986644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=302.48  Aligned_cols=232  Identities=29%  Similarity=0.440  Sum_probs=188.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|++.+.||.|+||+||++.+..++..+++|....                         .+...+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            579999999999999999999999999998876431                         1122234566789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++......+++..++.++.|++.+|.|||+++|+|+||||+||+++.++. ++|+|||++........  ...
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~--~~~  161 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD-VKLADFGVSAKNKSTLQ--KRD  161 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC-EEEccCccchhhccccc--ccc
Confidence            999999999876678899999999999999999999999999999999999998875 99999999865432221  122


Q ss_pred             cCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~l  209 (408)
                      ...|++.|+|||++..     ..++.++|+||||+++|+|++|++||.................+  ..+...+.++.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            3458999999999853     44677899999999999999999999876544433222222222  2245678899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      |.+||+.+|.+||++.++++||||...
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.8e-38  Score=299.55  Aligned_cols=228  Identities=29%  Similarity=0.416  Sum_probs=181.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCC------CCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTT------SSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~------~~~~~~L   51 (408)
                      .|++.+.||+|+||+||+|.+..+++.+++|.....                         ....+.      .....++
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            588899999999999999999999999988764311                         000111      1245789


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           52 HLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +|||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+|+||||+||+++.++. ++|+|||++.......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~-~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRTV  165 (272)
T ss_pred             EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC-EEEccCCCceeccccc
Confidence            99999999999999863 346789999999999999999999999999999999999998875 9999999987543222


Q ss_pred             CCcccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC-CCCCCCCCCcH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD-ELPRFPTQSSE  204 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~s~  204 (408)
                      .  ......|++.|+|||++.     +..++.++|+|||||++|+|++|..||............... .....+...+.
T Consensus       166 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (272)
T cd06637         166 G--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK  243 (272)
T ss_pred             c--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCH
Confidence            1  223456899999999986     335788999999999999999999999765433222221111 12222345778


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      .+++|+.+||..||.+|||+.|+++||||
T Consensus       244 ~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         244 KFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=355.01  Aligned_cols=233  Identities=35%  Similarity=0.647  Sum_probs=194.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~~~LVmE   54 (408)
                      .+|+.+..||.|-||+||-|++.+||...|+|...                           +.+.+...+....+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            47999999999999999999999999998886533                           122223334455678899


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC--CC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD--TR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--~~  132 (408)
                      ||.||+|.++++ +++..+|...+.|..|++.||+|||++|||||||||+||+|+.+| .+|++|||.|.......  ..
T Consensus      1315 yC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhcCC
Confidence            999999999998 577889999999999999999999999999999999999999988 59999999997665432  11


Q ss_pred             cccccCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCCCCCCCCCcHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELPRFPTQSSELGRD  208 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~s~~~~~  208 (408)
                      .......|||.|||||++.+.   ...-++|||||||++.||+||+.||...+.+ ++....-.+..|++|...|++.+|
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~d 1472 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRD 1472 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHH
Confidence            223345799999999999764   4678899999999999999999999865432 333333467788999999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          209 FLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ||.+||..||++|+++.||+.|.|-+..
T Consensus      1473 Fle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1473 FLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            9999999999999999999999987643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.1e-38  Score=307.09  Aligned_cols=226  Identities=22%  Similarity=0.325  Sum_probs=166.0

Q ss_pred             eceeeecCCeeEEEEEEc--CCCcEEEEeecccc-----------------------eeccC--CCCCcceEEEeccCCC
Q 042746            7 GKCIGRGSFGTVNVAVDR--FNGDVFAYLGDDVS-----------------------YEAPT--TSSSCRNLHLEYLPGG   59 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~--~t~~~va~k~~~~~-----------------------~~~~~--~~~~~~~LVmEy~~gG   59 (408)
                      ++.||+|+||+||+|+++  .+++.+|+|.....                       +...+  ..+...+++|||+.+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            689999999999999976  46678888754311                       11111  234567899999975 


Q ss_pred             CHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCcccccc
Q 042746           60 TVSDLATTL--------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATV  128 (408)
Q Consensus        60 sL~~~l~~~--------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~  128 (408)
                      +|.+++...        ...+++..++.++.||+.||+|||++||+||||||+|||+..   ....+||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence            888887532        124789999999999999999999999999999999999942   223599999999976543


Q ss_pred             CCCC-cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChh----------hhhhhccc----
Q 042746          129 SDTR-GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----------TLSRIGFS----  192 (408)
Q Consensus       129 ~~~~-~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----------~~~~~~~~----  192 (408)
                      .... .......||+.|+|||++.+. .++.++|+||+||++|+|++|++||......          .+..+...    
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  244 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence            2211 112345689999999999874 5789999999999999999999999642210          00000000    


Q ss_pred             --------CCCC------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 --------DELP------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 --------~~~p------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                              ...+                        ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                    0000                        0011235568899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=301.55  Aligned_cols=233  Identities=27%  Similarity=0.379  Sum_probs=189.0

Q ss_pred             CCeEe-eceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------cc----eeccCCCCCcceEEEec
Q 042746            2 VSWVR-GKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------VS----YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~-~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------~~----~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++ -++||-|-.|+|-.+.++.|++.||+|..-                     +.    ++..+....++.+|||+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            56666 468999999999999999999999875421                     11    22334456778899999


Q ss_pred             cCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~  132 (408)
                      ++||.|++.++.++ ..++|.++..+++||..|+.|||+.+|.||||||+|+|...++  ..+||+|||+|+......  
T Consensus       141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~--  218 (400)
T KOG0604|consen  141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG--  218 (400)
T ss_pred             ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc--
Confidence            99999999998754 3689999999999999999999999999999999999986532  359999999998765432  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh----hhhhcccCCC--CC-CCCCCcHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRIGFSDEL--PR-FPTQSSEL  205 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~----~~~~~~~~~~--p~-~~~~~s~~  205 (408)
                       ...++|-||.|.|||++..+.|+...|+||+||++|-||+|.+||.......    +...+..+.+  |. -....|++
T Consensus       219 -~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~  297 (400)
T KOG0604|consen  219 -DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEA  297 (400)
T ss_pred             -cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHH
Confidence             3456788999999999999999999999999999999999999997543222    2222222222  21 12467999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ++|+|+++|..+|.+|.|++|++.|||+.+..
T Consensus       298 aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  298 AKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             HHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            99999999999999999999999999998654

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-38  Score=323.23  Aligned_cols=232  Identities=22%  Similarity=0.230  Sum_probs=179.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------cceeccCCCCCcceEEEeccCCCCHH
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------VSYEAPTTSSSCRNLHLEYLPGGTVS   62 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------~~~~~~~~~~~~~~LVmEy~~gGsL~   62 (408)
                      ..|++.+.||+|+||.||+|++..+++.|++|...                   +.+......+...+|+|||+. ++|.
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~  247 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY  247 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence            36999999999999999999999999999998532                   112222334566789999996 6899


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCC
Q 042746           63 DLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP  142 (408)
Q Consensus        63 ~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~  142 (408)
                      +++......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...............||+
T Consensus       248 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~-vkL~DFGla~~~~~~~~~~~~~~~~GT~  326 (461)
T PHA03211        248 TYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED-ICLGDFGAACFARGSWSTPFHYGIAGTV  326 (461)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC-EEEcccCCceecccccccccccccCCCc
Confidence            988765667899999999999999999999999999999999999998875 9999999997654322222223456999


Q ss_pred             CCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC--------hhhhhhhccc-----CCCCC------------
Q 042746          143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--------ANTLSRIGFS-----DELPR------------  197 (408)
Q Consensus       143 ~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--------~~~~~~~~~~-----~~~p~------------  197 (408)
                      .|+|||++.+..++.++|||||||++|||++|..|+-...        ...+.+++..     ..++.            
T Consensus       327 ~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~  406 (461)
T PHA03211        327 DTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH  406 (461)
T ss_pred             CCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh
Confidence            9999999999989999999999999999999875542111        1111111100     00110            


Q ss_pred             ---------C-----C--CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          198 ---------F-----P--TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       198 ---------~-----~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                               .     .  ...+.++++||.+||+.||.+|||+.|+|+||||+.
T Consensus       407 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        407 RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                     0     0  124567899999999999999999999999999974

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=300.02  Aligned_cols=231  Identities=32%  Similarity=0.524  Sum_probs=190.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||.|+||.||+|++..+++.+++|.....                          ....+..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4799999999999999999999999999988754321                          11122345667899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +++++|.+++..  ..+++..++.++.|++.+|.|||+++++|+||+|+||+++.++. ++|+|||++........  ..
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~--~~  155 (274)
T cd06609          81 CGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD-VKLADFGVSGQLTSTMS--KR  155 (274)
T ss_pred             eCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEcccccceeeccccc--cc
Confidence            999999999974  37899999999999999999999999999999999999998875 99999999876543321  12


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCC-CcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ-SSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~-~s~~~~~li~~~L  214 (408)
                      ....|++.|+|||++.+..++.++|+||||+++|+|++|++||.................+..+.. .++++.+++.+||
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l  235 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL  235 (274)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence            334689999999999988899999999999999999999999986654444333333344454545 7889999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ..||++|||++++++||||....
T Consensus       236 ~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         236 NKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             hCChhhCcCHHHHhhChhhcCCC
Confidence            99999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=319.10  Aligned_cols=230  Identities=27%  Similarity=0.336  Sum_probs=179.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVmE   54 (408)
                      .|++.+.||+||.++||++...+.+..+ +|+..                            +........+..+|+|||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iya-lkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYA-LKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchh-hhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            5899999999999999999987555443 32211                            223333445788999999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |=. -+|..+|++.....+.-.++.|..|||.++.++|++||||.||||.|+|+-.+  .+||+|||+|...........
T Consensus       441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG--~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG--RLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee--eEEeeeechhcccCcccccee
Confidence            965 49999999877776667899999999999999999999999999999998543  699999999987766554444


Q ss_pred             cccCCCCCCCCChhhHhCCC-----------CCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcccCCCCCCCCC
Q 042746          135 KIQPRGSPLWMAPEVVRGEC-----------QGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~-----------~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~p~~~~~  201 (408)
                      .-..+||+.||+||.+....           .+.++||||||||||+|+.|++||..+.  ...+..+.-.+.-.++|..
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~  597 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDI  597 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCC
Confidence            55668999999999996432           3578999999999999999999998754  2333333222121244444


Q ss_pred             CcHH-HHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          202 SSEL-GRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       202 ~s~~-~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .+.. +.++++.||..||++|||+.|+|+|||++..
T Consensus       598 ~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  598 PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            4444 8999999999999999999999999999863

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.8e-38  Score=300.19  Aligned_cols=232  Identities=31%  Similarity=0.450  Sum_probs=185.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEeccC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      -|++.+.||+|+||+||+|.+..++..++++....                         .....+..+...++||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            36888999999999999999999999988865431                         11122344567889999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +++|..++......+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++........  ....
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~~~~~~~--~~~~  162 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQ--RRDS  162 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC-EEEcccccccccccccc--cccc
Confidence            99999988765667899999999999999999999999999999999999998875 99999999865432211  1223


Q ss_pred             CCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC--CCCCCCCCcHHHHHHH
Q 042746          138 PRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE--LPRFPTQSSELGRDFL  210 (408)
Q Consensus       138 ~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~p~~~~~~s~~~~~li  210 (408)
                      ..|++.|+|||++.     +..++.++|+|||||++|+|++|++||................  ....+...+..+++||
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL  242 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence            46899999999984     3456789999999999999999999998765433222211111  1233456788999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+||+.||.+||+++++++||||....
T Consensus       243 ~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         243 KKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             HHHccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-37  Score=293.23  Aligned_cols=228  Identities=25%  Similarity=0.423  Sum_probs=190.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||+||++.+..+++.+++|....                           .+...+......++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            69999999999999999999999999998875321                           122234556778999999


Q ss_pred             cCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++++|.+.+... ...+++..+..++.|++.+|.|||+++++|+||+|+||+++.++. ++|+|||++........  .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~-~~l~d~~~~~~~~~~~~--~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-IKLGDFGIARVLNSTVE--L  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEEeeccceeecCcchh--h
Confidence            9999999998753 335789999999999999999999999999999999999988774 99999999865433221  1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .....|++.|+|||++.+..++.++|+||||+++++|++|+.||..............+..+..+...+.++.++|.+||
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF  237 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence            12345889999999999888899999999999999999999999876655544444455556667788999999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCC
Q 042746          215 RREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~  233 (408)
                      +.+|.+||++.|+++||||
T Consensus       238 ~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         238 KRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hCChhhCcCHHHHhhCcCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-38  Score=316.03  Aligned_cols=235  Identities=18%  Similarity=0.153  Sum_probs=180.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC--CCcEEEEeecc--------------------cceeccCCCCCcceEEEeccCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF--NGDVFAYLGDD--------------------VSYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~--t~~~va~k~~~--------------------~~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      .+|++++.||+|+||+||+|....  ++..+++|...                    +.....+......+++|||+. +
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  170 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C  170 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence            369999999999999999997643  45667766432                    112222344567889999997 5


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR  139 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  139 (408)
                      +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++................
T Consensus       171 ~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~-~~l~DfG~a~~~~~~~~~~~~~~~~  248 (392)
T PHA03207        171 DLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN-AVLGDFGAACKLDAHPDTPQCYGWS  248 (392)
T ss_pred             CHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC-EEEccCccccccCcccccccccccc
Confidence            8888885 4567899999999999999999999999999999999999998875 9999999997654433322233457


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----hhhhhc-------------------------
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----TLSRIG-------------------------  190 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----~~~~~~-------------------------  190 (408)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||......    .+..+.                         
T Consensus       249 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (392)
T PHA03207        249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY  328 (392)
T ss_pred             cccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh
Confidence            999999999999988999999999999999999999999653211    111000                         


Q ss_pred             -ccCCCC-CCC-----CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 -FSDELP-RFP-----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 -~~~~~p-~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                       .....+ ..+     ...+.++++||.+||..||++|||+.|+|+||||...++.
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~  384 (392)
T PHA03207        329 AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN  384 (392)
T ss_pred             cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence             000000 001     1346678999999999999999999999999999876554

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-37  Score=299.61  Aligned_cols=231  Identities=31%  Similarity=0.457  Sum_probs=186.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|++..++..+++|.....                          +...+..+...+++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            5799999999999999999999999999988753311                          11123456778999999


Q ss_pred             cCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~--~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ++|++|.+++...  ...+++..+..++.||+.+|.|||+ .+|+|+||||+||+++.++ .+||+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCCc--
Confidence            9999999998753  2368999999999999999999997 5999999999999999876 49999999986543221  


Q ss_pred             cccccCCCCCCCCChhhHhCC------CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh---hhcccCCCCCCCCCCc
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE------CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RIGFSDELPRFPTQSS  203 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~------~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~---~~~~~~~~p~~~~~~s  203 (408)
                        .....|++.|+|||++.+.      .++.++|+|||||++|+|++|+.||.........   ........+..+...+
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS  235 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence              2234588999999998654      3478999999999999999999999754332221   1122344556677789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .++.+||.+||..+|++||++.+++.||||....
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=8.2e-38  Score=299.95  Aligned_cols=228  Identities=21%  Similarity=0.288  Sum_probs=184.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||.||+|.+...+     ..+++|....                          .+..........+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47899999999999999999987665     5667664321                          1111223445678


Q ss_pred             EEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcE
Q 042746           51 LHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV  115 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~v  115 (408)
                      ++|||+++|+|.+++....               ..+++..+..++.||+.||+|||+++++|+||||+||+++.++. +
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-~  163 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-V  163 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-E
Confidence            9999999999999997531               45788899999999999999999999999999999999998874 9


Q ss_pred             EEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCC
Q 042746          116 KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE  194 (408)
Q Consensus       116 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~  194 (408)
                      +|+|||+++...............+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.......+........
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ  243 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999865433222222233456889999999988889999999999999999998 999998777666655555555


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+...++.+.+|+.+||+.||.+||++.|++++
T Consensus       244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            666677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.3e-37  Score=302.40  Aligned_cols=233  Identities=34%  Similarity=0.549  Sum_probs=187.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||.||+|++..+++.+++|....                         .....+..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            479999999999999999999999999999876431                         1122234456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|++|.+++..  ..+++..+..++.|++.+|.|||+.+++||||||+|||++.++. ++|+|||++........  ...
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~-~~l~Dfg~~~~~~~~~~--~~~  173 (297)
T cd06656          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQS--KRS  173 (297)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEECcCccceEccCCcc--CcC
Confidence            99999999863  46789999999999999999999999999999999999988774 99999999865433221  112


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC--CCCCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--PRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~--p~~~~~~s~~~~~li~~~L  214 (408)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...+.............  ...+...+..+++|+.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL  253 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence            34589999999999988889999999999999999999999976543222111111111  1234567888999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ..||++||++.++++||||....+.
T Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         254 EMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             cCChhhCcCHHHHhcCchhcccccc
Confidence            9999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-37  Score=297.84  Aligned_cols=224  Identities=24%  Similarity=0.329  Sum_probs=182.2

Q ss_pred             CCeEeecee--eecCCeeEEEEEEcCCCcEEEEeecccc---------------------eeccCCCCCcceEEEeccCC
Q 042746            2 VSWVRGKCI--GRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         2 ~~Y~~~~~I--G~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      .+|.+.+.+  |+|+||.||++.++.++..++++.....                     ....+...+..++||||++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~   93 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKD   93 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCC
Confidence            356676666  9999999999999999999987654321                     11123345568899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++..++|+|||++......      ...
T Consensus        94 ~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~  166 (267)
T PHA03390         94 GDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCY  166 (267)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccC
Confidence            9999999754 478999999999999999999999999999999999999988745999999998654322      123


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-----hhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-----LSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-----~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      .|++.|+|||++.+..++.++|+||||+++|+|++|..||.......     +....  ...+..+...++.+++||.+|
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~  244 (267)
T PHA03390        167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSM  244 (267)
T ss_pred             CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHH
Confidence            58999999999998889999999999999999999999997543222     11111  222344557899999999999


Q ss_pred             cccCCCCCCC-HHHHHcCCCCC
Q 042746          214 LRREPGERWS-CDQLLKHPFLQ  234 (408)
Q Consensus       214 L~~dP~~R~s-~~ell~hpf~~  234 (408)
                      |+.||.+|++ ++|+++||||.
T Consensus       245 l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        245 LKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hccChhhCCchHHHHhcCCccc
Confidence            9999999996 69999999996

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-37  Score=301.58  Aligned_cols=230  Identities=33%  Similarity=0.528  Sum_probs=185.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||.||+|++..+++.+++|.....                         ....+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4799999999999999999999999999988754321                         111233456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|++|.+++..  ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++........  ...
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~--~~~  174 (296)
T cd06654         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS--KRS  174 (296)
T ss_pred             CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhcccccc--ccC
Confidence            99999999863  4578999999999999999999999999999999999998877 499999999865432221  122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC--CCCCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--PRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~--p~~~~~~s~~~~~li~~~L  214 (408)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|++||.................  ...+...+..+.+++.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            34689999999999988889999999999999999999999976543222111111111  1234567888999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .+||++|||+.|+++||||...
T Consensus       255 ~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         255 DMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             cCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.7e-37  Score=296.28  Aligned_cols=226  Identities=20%  Similarity=0.272  Sum_probs=180.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc---CCCcEEEEeeccc--------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||.||+|.++   ..+..+|+|....                          .+.+.+..+...++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            36999999999999999999875   3455777765321                          122223456678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++......+++..++.++.||+.||+|||++|++||||||+|||++.++. ++++|||.+........ 
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~-~~l~dfg~~~~~~~~~~-  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV-CKISGFRRLQEDKSEAI-  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc-EEECCCcccccccccch-
Confidence            9999999999999866667899999999999999999999999999999999999998874 99999998755322211 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......+++.|+|||.+.+..++.++|||||||++|++++ |..||.................+..+...+..+.+++.
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML  242 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            11112345678999999999889999999999999999775 99999876655444433333344556778899999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      +||+.+|.+||++.||++
T Consensus       243 ~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         243 DCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHcCCCchhCCCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.8e-37  Score=297.79  Aligned_cols=229  Identities=31%  Similarity=0.408  Sum_probs=180.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccC------CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPT------TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~------~~~~~~~   50 (408)
                      ..|++.+.||+|+||.||+|.+..+++.+++|.....                         +...+      ......+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            4689999999999999999999999999988753311                         00011      1245678


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           51 LHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ++|||+++|+|.+++... ...+++..+..++.||+.+|+|||+++++|+||||+||+++.++. ++|+|||++......
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~-~~l~dfg~~~~~~~~  174 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRT  174 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCcchhhhhcc
Confidence            999999999999999763 345789999999999999999999999999999999999998875 999999998654322


Q ss_pred             CCCcccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhh-hcccCCCCCCCCCCc
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR-IGFSDELPRFPTQSS  203 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~-~~~~~~~p~~~~~~s  203 (408)
                      ..  ......|++.|+|||++.     ...++.++|+|||||++|+|++|.+||.......... ..............+
T Consensus       175 ~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (282)
T cd06636         175 VG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS  252 (282)
T ss_pred             cc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccC
Confidence            11  123356899999999986     3457889999999999999999999997654322221 111111112234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..+.+||.+||..||.+|||+.|+++||||
T Consensus       253 ~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-37  Score=298.19  Aligned_cols=235  Identities=20%  Similarity=0.295  Sum_probs=185.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      ++|++.+.||+|+||.||+|.++.     .+..+++|....                          .....+......+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            579999999999999999997653     234677764321                          1122234455678


Q ss_pred             EEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           51 LHLEYLPGGTVSDLATTLN---------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      ++|||+++|+|.+++...+         ..++...+..++.||+.||.|||+++|+||||||+||+++.++. ++|+|||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~-~~L~Dfg  164 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT-VKIGDFG  164 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc-EEECcCC
Confidence            9999999999999997532         22356678899999999999999999999999999999998875 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      +++...............++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.................+..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (288)
T cd05061         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD  244 (288)
T ss_pred             ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            9875433222111122345778999999998889999999999999999998 789998766655555444455555666


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHc------CCCCCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLK------HPFLQSVS  237 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~------hpf~~~~~  237 (408)
                      ..++.+++++.+||+.||++|||+.++++      ||||.++.
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            77889999999999999999999999986      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-37  Score=291.75  Aligned_cols=228  Identities=26%  Similarity=0.422  Sum_probs=190.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eecc--CCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAP--TTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~--~~~~~~~~LVm   53 (408)
                      +|++.+.||.|+||.||+|.+..++..++++.....                           +...  .......+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            589999999999999999999999999988653210                           1111  12344578999


Q ss_pred             eccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           54 EYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLH-----SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH-----~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ||+++++|.+++...   ...+++..++.++.||+.||+|||     +.+++|+||||+||+++.++. +||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~-~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN-VKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC-EEEeccccccc
Confidence            999999999999754   567899999999999999999999     999999999999999998774 99999999876


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHH
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSEL  205 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~  205 (408)
                      ......  ......|++.|+|||++.+..++.++|+||||+++++|++|+.||.......+.........+.++...+..
T Consensus       160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd08217         160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE  237 (265)
T ss_pred             ccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHH
Confidence            543321  122346899999999999888899999999999999999999999877665555555555566777788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +.+++.+||..+|++||++.++++|||+
T Consensus       238 ~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         238 LNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-37  Score=294.43  Aligned_cols=228  Identities=34%  Similarity=0.643  Sum_probs=183.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------------ceeccCCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------------~~~~~~~~~~~~~L   51 (408)
                      +|++++.||+|+||+||+|.+. +++.+++|....                               .+...+......++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5899999999999999999874 778888774321                               11112334567889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC-
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-  130 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-  130 (408)
                      +|||++|++|.+++.+. ..+++..+..++.|++.+|+|||+++|+|+||||+||+++.++. ++|+|||++....... 
T Consensus        80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI-IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe-EEeccchhhHhhhhccc
Confidence            99999999999999753 46789999999999999999999999999999999999998874 9999999986542211 


Q ss_pred             ---CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh-hhhc-ccCCCCCCCCCCcHH
Q 042746          131 ---TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIG-FSDELPRFPTQSSEL  205 (408)
Q Consensus       131 ---~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-~~~~-~~~~~p~~~~~~s~~  205 (408)
                         .........|++.|+|||++.+..++.++|+||||+++|+|++|..||........ ..+. .....|..+...+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA  237 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence               11112234589999999999988889999999999999999999999976443222 1111 123345667788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +.++|.+||.++|++||++.|+++||||
T Consensus       238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         238 AIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-37  Score=298.82  Aligned_cols=227  Identities=24%  Similarity=0.356  Sum_probs=176.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||+||+|++..+|+.+++|.....                           ....+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            699999999999999999999999999988754321                           01123345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +++ +|.+++......+++..++.++.||+.||.|||+++++||||||+||+++.++. +||+|||++........  ..
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~~--~~  156 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE-LKLADFGLARAFGIPVR--CY  156 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc-EEECccchhhccCCCCC--Cc
Confidence            975 888888766677899999999999999999999999999999999999998875 99999999865433221  12


Q ss_pred             ccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCC-CCCChhhhhhhc-------------------ccCC
Q 042746          136 IQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAW-EDFGANTLSRIG-------------------FSDE  194 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf-~~~~~~~~~~~~-------------------~~~~  194 (408)
                      ....+++.|+|||++.+. .++.++|+|||||++|+|++|..|| ...+........                   ....
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            234578999999998775 4688999999999999999988775 332221111000                   0001


Q ss_pred             CCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          195 LPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       195 ~p~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      .+.         .....++++++||.+||+.||.+|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            111         113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=300.99  Aligned_cols=236  Identities=26%  Similarity=0.390  Sum_probs=189.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|.+..+++.+++|.....                            ...........+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4799999999999999999999999999998754321                            111234456688999


Q ss_pred             eccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||+.|++|.+++... +..+++..++.++.||+.+|+|||++|++|+||||+||+++.++. ++|+|||++.........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC-EEEeecchhhcccccccc
Confidence            999999999998753 356899999999999999999999999999999999999998875 999999998644221100


Q ss_pred             ---------------------------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh
Q 042746          133 ---------------------------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT  185 (408)
Q Consensus       133 ---------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~  185 (408)
                                                 .......||..|+|||++.+..++.++||||||+++|+|++|+.||...+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                       01112368999999999998888999999999999999999999998665443


Q ss_pred             hhhhcccCCCCCCCC--CCcHHHHHHHHHhcccCCCCCCC----HHHHHcCCCCCCCCCC
Q 042746          186 LSRIGFSDELPRFPT--QSSELGRDFLDKCLRREPGERWS----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       186 ~~~~~~~~~~p~~~~--~~s~~~~~li~~~L~~dP~~R~s----~~ell~hpf~~~~~~~  239 (408)
                      ......... +.++.  ..+..++++|.+||..||++|||    ++|+++||||+...++
T Consensus       240 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~  298 (316)
T cd05574         240 TFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA  298 (316)
T ss_pred             HHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence            332222222 12222  26889999999999999999999    9999999999986654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-37  Score=290.45  Aligned_cols=228  Identities=23%  Similarity=0.393  Sum_probs=190.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||.|+||.||.+++..+++.+++|.....                           +...+......+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            699999999999999999999999999988753321                           12223455667899999


Q ss_pred             cCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++|+|.+++... ...+++..+..++.|++.+|.|||++|++|+||||+||+++.++. +||+|||++........  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~-~kl~d~~~~~~~~~~~~--~  157 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYS--M  157 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC-EEECcCcceEEcccccc--c
Confidence            9999999999764 456799999999999999999999999999999999999998875 99999999865533221  1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .....|++.|+|||++.+..++.++|+||||+++++|++|..||.................+..+...+.++.+++.+||
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL  237 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHc
Confidence            22346899999999998888889999999999999999999999876555544433445555555678899999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCC
Q 042746          215 RREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~  233 (408)
                      .++|.+||++.++++|||+
T Consensus       238 ~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         238 QQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ccCcccCCCHHHHhhCcCC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-37  Score=293.92  Aligned_cols=230  Identities=38%  Similarity=0.662  Sum_probs=184.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccC--CCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPT--TSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~--~~~~~~   49 (408)
                      .+|++++.||+|+||.||+|.+..++..+++|.....                              +...+  ......
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4799999999999999999999999999988753210                              11111  123567


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      +++|||+++++|.+++.. ...+++..++.++.||+.+|+|||+++|+|+||||+||+++.++. +||+|||+++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~-~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEccCCCccccccc
Confidence            899999999999999974 345789999999999999999999999999999999999998875 999999998654321


Q ss_pred             C-CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHH
Q 042746          130 D-TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGR  207 (408)
Q Consensus       130 ~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~  207 (408)
                      . .........++..|+|||++.+..++.++|+||+||++|+|++|++||....... ..........|.++...++.++
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHAR  239 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHH
Confidence            1 1111223458899999999998888999999999999999999999998654332 2222223334566777889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +++ +||..+|++||++.|+++||||+
T Consensus       240 ~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         240 DFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            999 57778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-37  Score=292.32  Aligned_cols=225  Identities=22%  Similarity=0.350  Sum_probs=186.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      +|++.+.||+|+||.||++.+..+++.+++|....                          .....+..+...+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            68999999999999999999999999998875321                          1112234556789999999


Q ss_pred             CCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++|+|.+++.. .+..+++..+..++.||+.||.|||++||+|+||||+||+++.++. ++|+|||.+........  ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~--~~  157 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLTSPGA--YA  157 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc-EEEcccCcceeeccccc--cc
Confidence            99999998865 3456789999999999999999999999999999999999998875 99999999865533221  12


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.............+..+...+..+++||.+||+
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence            23468999999999998889999999999999999999999998766555444444455555667788999999999999


Q ss_pred             cCCCCCCCHHHHHcC
Q 042746          216 REPGERWSCDQLLKH  230 (408)
Q Consensus       216 ~dP~~R~s~~ell~h  230 (408)
                      .||.+|||+.|++.-
T Consensus       238 ~~P~~Rp~~~~il~~  252 (255)
T cd08219         238 RNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCCCHHHHhhc
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-37  Score=290.07  Aligned_cols=226  Identities=40%  Similarity=0.719  Sum_probs=186.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccCCCCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~~~~~~~~LV   52 (408)
                      +|+..+.||+|+||+||+|.+..++..+++|.....                              +......+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            589999999999999999999999999988753211                              11223345667899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++|++|.+++.+. ..+++..+..++.||+.+|+|||++|++|+||+|+||+++.++. +||+|||++.......  
T Consensus        81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~-~kl~d~~~~~~~~~~~--  156 (258)
T cd06632          81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV-VKLADFGMAKQVVEFS--  156 (258)
T ss_pred             EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEccCccceeccccc--
Confidence            9999999999999754 45789999999999999999999999999999999999998875 9999999986543322  


Q ss_pred             cccccCCCCCCCCChhhHhCCC-CCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~-~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                       ......|++.|+|||.+.... ++.++|+||||+++|+|++|++||....... ..........+.++...++.+++|+
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  235 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFI  235 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence             122345899999999998766 8899999999999999999999997655322 2222222445666777889999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      .+||..+|++||++.+++.|||+
T Consensus       236 ~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         236 LKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHhhcCcccCcCHHHHhcCCCC
Confidence            99999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.6e-37  Score=294.08  Aligned_cols=227  Identities=28%  Similarity=0.418  Sum_probs=178.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++++.||+|+||.||+|++..+++.+++|.....                         +...+..+...++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            4799999999999999999999999999988754311                         111233456678999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++. ++|+|||++........  ...
T Consensus        89 ~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~-~~l~dfg~~~~~~~~~~--~~~  164 (267)
T cd06646          89 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD-VKLADFGVAAKITATIA--KRK  164 (267)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC-EEECcCccceeeccccc--ccC
Confidence            99999999874 457799999999999999999999999999999999999988875 99999999976532221  122


Q ss_pred             cCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh-hhhcccC-CCC--CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSD-ELP--RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-~~~~~~~-~~p--~~~~~~s~~~~~l  209 (408)
                      ...|++.|+|||.+.   ...++.++|+||+||++|+|++|+.||........ ....... ..+  ..+...+..+.+|
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF  244 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence            346899999999985   34467899999999999999999999865432221 1111111 111  1123467889999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPF  232 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf  232 (408)
                      |.+||..+|++|||++++++|+|
T Consensus       245 i~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         245 VKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHhhCChhhCcCHHHHhcCCC
Confidence            99999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.2e-37  Score=296.28  Aligned_cols=227  Identities=27%  Similarity=0.409  Sum_probs=179.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.....                         ...........+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4788999999999999999999999999988764321                         111223456688999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++.. .+.+++..++.++.|++.+|+|||++|++|+||||+||+++.++. ++|+|||++........  ...
T Consensus        89 ~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~~--~~~  164 (267)
T cd06645          89 GGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIA--KRK  164 (267)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEECcceeeeEccCccc--ccc
Confidence            99999999874 457899999999999999999999999999999999999998875 99999999865432211  123


Q ss_pred             cCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh-hhhcccCC-CCCC--CCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDE-LPRF--PTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-~~~~~~~~-~p~~--~~~~s~~~~~l  209 (408)
                      ...|++.|+|||++.   ...++.++|+|||||++|+|++|.+||........ ........ .+..  ....+..+.++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            346899999999985   44578899999999999999999999865433221 11111111 1111  12467789999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPF  232 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf  232 (408)
                      +.+||..+|++|||++++++|||
T Consensus       245 i~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.2e-37  Score=289.84  Aligned_cols=229  Identities=34%  Similarity=0.506  Sum_probs=187.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      ++|++.+.||+|+||.||+|++..+++.+++|....                       ...+.+..+...++++||+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            579999999999999999999999899988875331                       122234456678899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      ++|.+++...+..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++........  .....
T Consensus        83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~-~~l~dfg~~~~~~~~~~--~~~~~  159 (256)
T cd06612          83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ-AKLADFGVSGQLTDTMA--KRNTV  159 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc-EEEcccccchhcccCcc--ccccc
Confidence            9999999876778899999999999999999999999999999999999998875 99999999876543321  12234


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~li~~~L~~  216 (408)
                      .|++.|+|||++.+..++.++|+||||+++|+|++|++||.................+  ..+...+..+.++|.+||+.
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVK  239 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhc
Confidence            4789999999999888999999999999999999999999865433322221111111  22345678899999999999


Q ss_pred             CCCCCCCHHHHHcCCCC
Q 042746          217 EPGERWSCDQLLKHPFL  233 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~  233 (408)
                      ||++|||+.|++.||||
T Consensus       240 ~P~~Rps~~~il~~~~~  256 (256)
T cd06612         240 DPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ChhhCcCHHHHhcCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.7e-37  Score=296.27  Aligned_cols=224  Identities=23%  Similarity=0.379  Sum_probs=181.5

Q ss_pred             eeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcceEEEeccC
Q 042746            9 CIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         9 ~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .||+|+||+||+|.+..+++.+|+|.....                               +...+......++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999998753211                               1111334556789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|.+++.. .+.+++..++.++.|++.||+|||+++|+||||||+||+++.++. +||+|||++.......    ...
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~-~kl~dfg~~~~~~~~~----~~~  154 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKK----PHA  154 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC-EEEccCcCccccCccC----CcC
Confidence            9999998874 457899999999999999999999999999999999999998874 9999999986543221    223


Q ss_pred             CCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCC---hhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          138 PRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~---~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ..|++.|+|||++.+. .++.++|+||+|+++|+|++|+.||....   ........ ....+.++...+..+.+++.+|
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHH
Confidence            4689999999999754 68899999999999999999999997652   22222222 2223455667789999999999


Q ss_pred             cccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          214 LRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      |..+|.+||     ++.++++||||....+.
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence            999999999     99999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-37  Score=296.76  Aligned_cols=227  Identities=27%  Similarity=0.433  Sum_probs=177.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||+||+|++..++..+++|.....                           +.+.+..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            699999999999999999999999999998764321                           11123355678999999


Q ss_pred             cCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           56 LPGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        56 ~~gGsL~~~l~~~~--~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ++ ++|.+++....  ..+++..++.++.||+.||+|||+++++|+||||+||+++.++. ++|+|||++........  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~--  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV-IKLADFGLARAFGIPVR--  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc-EEECcccceeecCCCcc--
Confidence            98 58988886532  56899999999999999999999999999999999999998875 99999999865432211  


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhh-------------------ccc
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRI-------------------GFS  192 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~-------------------~~~  192 (408)
                      ......+++.|+|||++.+. .++.++|+||||+++|+|++|++||....... ....                   .+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            12234578999999998764 46889999999999999999999997543211 1000                   000


Q ss_pred             CCC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 DEL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ~~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ...        .......+++++++|.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            000        01123468889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-37  Score=295.14  Aligned_cols=230  Identities=29%  Similarity=0.463  Sum_probs=187.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce--------------------------eccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY--------------------------EAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~--------------------------~~~~~~~~~~~LVmEy   55 (408)
                      ++|+..+.||+|+||.||+|.++.+++.+++|......                          ...+..+...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47899999999999999999999999999887533210                          1112345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++++|.+++......+++..+..++.|++.+|+|||+ .+++|+||||+||+++.++. ++|+|||.+........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~-~~l~d~g~~~~~~~~~~---  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ-IKLCDFGVSGQLVNSLA---  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC-EEEeecccchhhHHHHh---
Confidence            99999999998655778999999999999999999999 99999999999999998774 99999999865532211   


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC-----hhhhhhhcccCCCCCCCCC-CcHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG-----ANTLSRIGFSDELPRFPTQ-SSELGRD  208 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~-----~~~~~~~~~~~~~p~~~~~-~s~~~~~  208 (408)
                       ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....     .............+..+.. .+.++++
T Consensus       157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence             11568999999999999889999999999999999999999996542     2222222223334444444 7889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          209 FLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +|.+||..||.+|||+.|++.||||+..
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5e-37  Score=289.51  Aligned_cols=229  Identities=26%  Similarity=0.383  Sum_probs=189.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||.||++.++.++..+++|.....                           +......+...++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            689999999999999999999999999988764321                           11123345667899999


Q ss_pred             cCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++++|.+++.... ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++..+||+|||.+........  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~  158 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--L  158 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--c
Confidence            99999999987543 35789999999999999999999999999999999999988866679999999866543221  1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .....|++.|+|||++.+..++.++|+||||+++++|++|..||.................+..+...+..++++|.+||
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF  238 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence            22345899999999998888899999999999999999999999866554444433444455556677889999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCC
Q 042746          215 RREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~  233 (408)
                      ..+|++|||+.|+++||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-37  Score=295.30  Aligned_cols=230  Identities=30%  Similarity=0.446  Sum_probs=182.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      ++|++.+.||+|+||.||+|+++.+++.||+|.....                           +......+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4799999999999999999999999999999854321                           1111234556889999


Q ss_pred             ccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           55 YLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        55 y~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |++ |+|.+++..   .+..+++..++.++.||+.||+|||++ +++||||||+||+++.++. +||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ-VKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC-EEEeeccccccccccc
Confidence            997 588888765   234689999999999999999999998 9999999999999998875 9999999987553221


Q ss_pred             CCcccccCCCCCCCCChhhHhC----CCCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcccCCCCCCC-CCCc
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRG----ECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFP-TQSS  203 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~p~~~-~~~s  203 (408)
                      .   .....|+..|+|||++.+    ..++.++|+||||+++|+|++|+.||....  ...+... .....+.++ ..++
T Consensus       159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  234 (283)
T cd06617         159 A---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-VEEPSPQLPAEKFS  234 (283)
T ss_pred             c---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH-HhcCCCCCCccccC
Confidence            1   122458899999999865    446889999999999999999999997532  2222222 222333333 3578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .++++||.+||..+|.+||++.+++.||||....
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            8999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-37  Score=305.98  Aligned_cols=231  Identities=23%  Similarity=0.357  Sum_probs=176.2

Q ss_pred             eeceeeec--CCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEecc
Q 042746            6 RGKCIGRG--SFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         6 ~~~~IG~G--~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      ++++||+|  +|++||++.++.+++.||+|.....                           +...+..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56889999  7899999999999999999865421                           112234456688999999


Q ss_pred             CCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC----
Q 042746           57 PGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT----  131 (408)
Q Consensus        57 ~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~----  131 (408)
                      ++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. +++.||+.+........    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~-~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc-EEEcccchhhccccccccccc
Confidence            999999999753 345899999999999999999999999999999999999998875 99999986543221110    


Q ss_pred             -CcccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC------------
Q 042746          132 -RGVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP------------  196 (408)
Q Consensus       132 -~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p------------  196 (408)
                       ........++..|+|||++.+  ..++.++|||||||++|+|++|+.||.................+            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence             001122346788999999976  45889999999999999999999999754322111100000000            


Q ss_pred             ---------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          197 ---------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       197 ---------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                                       ......++.+++||.+||+.||++|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                             01123467889999999999999999999999999998643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=292.68  Aligned_cols=223  Identities=29%  Similarity=0.416  Sum_probs=180.7

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||.||+|.+..+++.+++|.....                             ....+......+++|||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            6799999999999999999999998754211                             11122344567899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      ++|.++++. ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++. ++|+|||++.....      ....
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~------~~~~  153 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH-LKLTDFGLSRNGLE------NKKF  153 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-EEEeecccceeccc------cccC
Confidence            999999974 356799999999999999999999999999999999999998875 99999999865432      1234


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC---CCCCCCCCCcHHHHHHHHHhcc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD---ELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~---~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|.+||...............   ..+......++.+.+++.+||+
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            5889999999998888899999999999999999999999866544433221111   1122334578899999999999


Q ss_pred             cCCCCCC---CHHHHHcCCCCCCCCC
Q 042746          216 REPGERW---SCDQLLKHPFLQSVSP  238 (408)
Q Consensus       216 ~dP~~R~---s~~ell~hpf~~~~~~  238 (408)
                      .||++||   +++|++.||||....|
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhcCCC
Confidence            9999999   5579999999987665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.3e-37  Score=294.26  Aligned_cols=229  Identities=30%  Similarity=0.436  Sum_probs=180.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eecc-----CCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAP-----TTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~-----~~~~~~~~L   51 (408)
                      ++|++.+.||+|+||+||+|++..+++.+++|.....                         ....     ...+...++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            6899999999999999999999999999988753210                         0000     123456899


Q ss_pred             EEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           52 HLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +|||++|++|.+++..   ....+++..++.++.|++.||.|||+++++||||||+||+++.++. +||+|||++.....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~-~kl~dfg~~~~~~~  176 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTS  176 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC-EEEccCCceeeccc
Confidence            9999999999998763   2356789999999999999999999999999999999999998875 99999999866543


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCC
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQ  201 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~  201 (408)
                      ...  ......|++.|+|||++..     ..++.++|+|||||++|+|++|+.||.................+  ..+..
T Consensus       177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (286)
T cd06638         177 TRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL  254 (286)
T ss_pred             CCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence            221  1223468999999999853     34788999999999999999999999765432222111111111  23345


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      .+..+.++|.+||+.||++|||+.|+++|+||
T Consensus       255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            67889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-37  Score=291.93  Aligned_cols=229  Identities=32%  Similarity=0.635  Sum_probs=181.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------------ceeccCCCCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------------SYEAPTTSSS   47 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------------~~~~~~~~~~   47 (408)
                      +|.+.+.||.|+||+||+|.+..+++.+++|....                                   ..........
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            79999999999999999999999999998875321                                   0111233456


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ..++||||++|++|.+++... +.+++..++.++.||+.+|.|||+++++|+||||+||+++.++. ++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~-~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI-CKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe-EEEeecccccccc
Confidence            678999999999999999854 56799999999999999999999999999999999999998874 9999999986543


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCC--CCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCC----CC
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGEC--QGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRF----PT  200 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~----~~  200 (408)
                      ............|+..|+|||.+....  ++.++|+||||++++++++|..||....... ..........+.+    ..
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM  239 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence            322211223346899999999998654  7889999999999999999999997544322 2111111111122    23


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      .++..++++|.+||.++|++|||++++++|||+
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            457899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.2e-37  Score=299.71  Aligned_cols=229  Identities=28%  Similarity=0.449  Sum_probs=183.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||.||++.+..++..+++|....                          .+...+..+...+|+|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            479999999999999999999999999888765321                          112223456678899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++|++|.+++... ..+++..+..++.||+.||.|||+ ++++|+||||+|||++.++. +||+|||++.......    
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~----  154 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM----  154 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc-EEEccCCCcccccccc----
Confidence            9999999999854 667999999999999999999997 69999999999999998875 9999999986543221    


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc------------------------
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG------------------------  190 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~------------------------  190 (408)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||............                        
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP  234 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence            22356899999999998888899999999999999999999998643322211110                        


Q ss_pred             ------------ccCCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          191 ------------FSDELPRFP-TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       191 ------------~~~~~p~~~-~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                                  .....|..+ ...+.++++|+.+||..||++|||+.|+++||||...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                        011112222 1367789999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-37  Score=292.24  Aligned_cols=229  Identities=31%  Similarity=0.451  Sum_probs=180.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccC------CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPT------TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~------~~~~~~~   50 (408)
                      ++|++.+.||+|+||+||+|.++.+++.+++|.....                         +.+.+      ......+
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            6899999999999999999999999999888753311                         00111      1234578


Q ss_pred             EEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           51 LHLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ++|||+++++|.+++...   +..+++..++.++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||++....
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~-~~l~d~~~~~~~~  164 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLD  164 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe-EEECCCccceecc
Confidence            999999999999998753   467899999999999999999999999999999999999998875 9999999986543


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CC
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PT  200 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~  200 (408)
                      ....  ......|++.|+|||++..     ..++.++|+||||+++|+|++|++||.................+..  +.
T Consensus       165 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (275)
T cd06608         165 STLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE  242 (275)
T ss_pred             cchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchh
Confidence            2221  1223458999999999864     2467889999999999999999999976443222222122222222  22


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..+..+++||.+||..||++|||+.|+++|||+
T Consensus       243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            367789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.3e-37  Score=296.28  Aligned_cols=226  Identities=29%  Similarity=0.422  Sum_probs=180.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|++..+++.+++|.....                          ....+..++..+++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4789999999999999999999999999998764211                          11123345567899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +++++|..+     ..+++..+..++.|++.||+|||++||+|+||||+|||++.++. ++|+|||++.......    .
T Consensus        81 ~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~-~~l~dfg~~~~~~~~~----~  150 (279)
T cd06619          81 MDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ-VKLCDFGVSTQLVNSI----A  150 (279)
T ss_pred             CCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC-EEEeeCCcceeccccc----c
Confidence            999998654     24588899999999999999999999999999999999998875 9999999986543221    2


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-------hhhhhcccCCCCCC-CCCCcHHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-------TLSRIGFSDELPRF-PTQSSELGR  207 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-------~~~~~~~~~~~p~~-~~~~s~~~~  207 (408)
                      ....||+.|+|||++.+..++.++|+||||+++|+|++|+.||......       ...........+.. ....+++++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV  230 (279)
T ss_pred             cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence            2356899999999999888999999999999999999999999643211       11111111222222 235778899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +|+.+||..||.+||+++|+++||||....
T Consensus       231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         231 HFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=299.74  Aligned_cols=236  Identities=25%  Similarity=0.384  Sum_probs=198.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~L   51 (408)
                      +.+|.+.++||+|+|++|-+++.++|.+.||+|.....                             ....++.+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            35789999999999999999999999999998754321                             1112556677889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |.||.+||+|.-.++ .++.++|+.++.|-.+|+.||.|||++|||+||||.+|+|++..|+ +||+|+|++++.-... 
T Consensus       329 vieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh-ikltdygmcke~l~~g-  405 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGLGPG-  405 (593)
T ss_pred             EEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc-eeecccchhhcCCCCC-
Confidence            999999999988887 4677899999999999999999999999999999999999999996 9999999997654332 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC--------hhhhhhhcccCCCCCCCCCCc
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--------ANTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--------~~~~~~~~~~~~~p~~~~~~s  203 (408)
                       ..+.++||||.|+|||++++..|++++|+|+|||++|||+.|+.||+-.+        .+-+.+++..+.. .+|...|
T Consensus       406 -d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-riprsls  483 (593)
T KOG0695|consen  406 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-RIPRSLS  483 (593)
T ss_pred             -cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-cccceee
Confidence             24678999999999999999999999999999999999999999996322        1223444444433 6778888


Q ss_pred             HHHHHHHHHhcccCCCCCC------CHHHHHcCCCCCCCCCCCc
Q 042746          204 ELGRDFLDKCLRREPGERW------SCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~------s~~ell~hpf~~~~~~~~~  241 (408)
                      -.+..+++..|++||.+|.      .+.++..|+||+.+.|+..
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence            8889999999999999997      4679999999998877643

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=335.98  Aligned_cols=235  Identities=21%  Similarity=0.317  Sum_probs=184.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccC--CCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPT--TSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~--~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|.+..++..+++|....                           .+...+  .....+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            4689999999999999999999999999998875431                           111111  23356889


Q ss_pred             EEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeecCCCCCCEEEcCC----------
Q 042746           52 HLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSR-------NIVHCDVKGKNVLVGPN----------  111 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~-------giiHrDLKp~NILl~~~----------  111 (408)
                      ||||+++|+|.++|...   ...+++..++.++.||+.||+|||+.       +|+||||||+||||+.+          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            99999999999999752   35689999999999999999999985       49999999999999642          


Q ss_pred             ------CCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh
Q 042746          112 ------SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA  183 (408)
Q Consensus       112 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~  183 (408)
                            ...+||+|||++.......   ......||+.|+|||++.+  ..++.++|||||||++|+|++|.+||.....
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                  1248999999997653322   1233469999999999965  3578999999999999999999999975432


Q ss_pred             -hhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          184 -NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       184 -~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                       ..+.... ...........+.++.+||.+||..+|.+||++.|+|.|||+....++
T Consensus       249 ~~qli~~l-k~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        249 FSQLISEL-KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             HHHHHHHH-hcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence             2332222 111111124568899999999999999999999999999999876544

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.2e-37  Score=293.66  Aligned_cols=228  Identities=29%  Similarity=0.454  Sum_probs=178.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      ++|++.+.||+|+||.||+|+++.+++.+++|.....                           ....+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            5799999999999999999999999999988753211                           1112334556789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++++|..++. ....+++..++.++.||+.+|+|||+++++|+||||+||+++.++. ++|+|||++........  .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~~--~  156 (286)
T cd07847          81 YCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGD--D  156 (286)
T ss_pred             ccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc-EEECccccceecCCCcc--c
Confidence            999988887776 3456799999999999999999999999999999999999998874 99999999976543221  1


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhc-------------c-------c
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIG-------------F-------S  192 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~-------------~-------~  192 (408)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||....... ...+.             +       .
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            122357889999999876 457889999999999999999999997544221 11100             0       0


Q ss_pred             CCCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 DELPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ~~~p~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ...|.         .....+..+.+|+.+||++||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00010         012457788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.4e-37  Score=290.17  Aligned_cols=231  Identities=35%  Similarity=0.594  Sum_probs=184.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccCCC--CCc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPTTS--SSC   48 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~~~--~~~   48 (408)
                      +.+|++++.||+|+||+||+|.+..++..+++|.....                              ....+..  ...
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            36899999999999999999999999999998753210                              0111112  346


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ++++|||++|++|.+++... ..+++..+..++.|++.+|+|||+++++|+||||+||+++.++. ++|+|||++.....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~l~Dfg~~~~~~~  158 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN-VKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC-EEECcCcccccccc
Confidence            78999999999999999754 45788999999999999999999999999999999999998874 99999999875432


Q ss_pred             CCC-CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCCCCCCCCCcHHH
Q 042746          129 SDT-RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       129 ~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      ... ........|+..|+|||++.+..++.++|+||||+++|+|++|++||...... ...........+..|...+..+
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC  238 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHH
Confidence            211 11122345899999999998888899999999999999999999999765322 2222222333455666778889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      .++|.+||. +|++||+++|+++|||+.
T Consensus       239 ~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         239 RDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.3e-37  Score=298.56  Aligned_cols=233  Identities=22%  Similarity=0.343  Sum_probs=181.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCC--CCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTT--SSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~--~~~~~~L   51 (408)
                      +++|++.+.||+|+||.||+|.+..+++.|++|......                           ...+.  .....++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            478999999999999999999999999999987643110                           00111  1245789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+.+ +|.+++......+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++........
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC-LKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECccceeeecCCccC
Confidence            9999975 899998866677899999999999999999999999999999999999998874 99999999976543221


Q ss_pred             CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc------------------
Q 042746          132 RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS------------------  192 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~------------------  192 (408)
                        ......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||...+..........                  
T Consensus       164 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         164 --PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             --CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence              1122346888999999876 4578999999999999999999999976543322111000                  


Q ss_pred             -CC--CCCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          193 -DE--LPRF--------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       193 -~~--~p~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                       ..  .+..        ....++.+.+||.+||..||++|||+.|+++||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence             00  0000        123578889999999999999999999999999998544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.8e-37  Score=286.87  Aligned_cols=228  Identities=29%  Similarity=0.451  Sum_probs=193.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||.||++.+..+++.+++|......                           ...+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            6899999999999999999999999999887654221                           1112234667899999


Q ss_pred             cCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      +++++|.+++...   +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTV--  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc-EEECCccceeecccCc--
Confidence            9999999999864   377899999999999999999999999999999999999998774 9999999986554332  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||.................+.++...+..+.+++.+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS  237 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            12233468999999999998889999999999999999999999998776665555545555667777889999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ||..+|++|||+.|+++||||
T Consensus       238 ~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         238 LLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.4e-37  Score=295.47  Aligned_cols=229  Identities=24%  Similarity=0.372  Sum_probs=180.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++++.||+|+||.||+|.+..+++.+++|.....                           ....+..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            699999999999999999999999999988764321                           11122345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      + |++|.+++......+++..++.++.||+.+|+|||+++++|+||||+||+++.++. ++|+|||++........ ...
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~-~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEP-RLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc-EEEeeeeecccccCCCC-Ccc
Confidence            9 99999999876677899999999999999999999999999999999999998775 99999999876543321 122


Q ss_pred             ccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh-hhc-----------------------
Q 042746          136 IQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS-RIG-----------------------  190 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~-~~~-----------------------  190 (408)
                      ....|++.|+|||++.+. .++.++||||||+++|+|++|.+||......... ...                       
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            334689999999998654 4688999999999999999999888654321111 000                       


Q ss_pred             -ccCCC----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          191 -FSDEL----PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       191 -~~~~~----p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                       +....    .......+..+.+||.+||..||++|||++++++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             00000    011124568889999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.2e-37  Score=298.24  Aligned_cols=231  Identities=33%  Similarity=0.543  Sum_probs=187.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||.|+||+||+|++..+++.+++|.....                         ....+......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            3699999999999999999999999999988754311                         112234456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|++|..++..  ..+++..+..++.|++.+|+|||++|++|+||||+||+++.++. +||+|||++........  ...
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~-~kl~dfg~~~~~~~~~~--~~~  173 (296)
T cd06655          99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS-VKLTDFGFCAQITPEQS--KRS  173 (296)
T ss_pred             CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEccCccchhcccccc--cCC
Confidence            99999998863  46799999999999999999999999999999999999988775 99999999865443221  122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC--CCCCCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE--LPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~p~~~~~~s~~~~~li~~~L  214 (408)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||................  ....+...++.+++||.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL  253 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHh
Confidence            3468999999999998888999999999999999999999998654432211111111  12334567889999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ..||.+|||+.++++||||....
T Consensus       254 ~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         254 EMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             hcChhhCCCHHHHhhChHhhhcc
Confidence            99999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.5e-37  Score=289.84  Aligned_cols=225  Identities=27%  Similarity=0.391  Sum_probs=187.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmE   54 (408)
                      +|++.+.||.|+||.||+|.+..+++.+++|.....                            ....+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            599999999999999999999999999988754311                            1112345667899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++|++|.+++... ..+++..+..++.||+.+|.|||+++++|+||||+||+++.++. ++|+|||++.......   .
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~l~d~~~~~~~~~~~---~  155 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDT---L  155 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC-EEEeecccccccCCCc---c
Confidence            99999999999754 57899999999999999999999999999999999999998875 9999999986554322   1


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh---hhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA---NTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~---~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.....   ...... .....+..+...+..+.++|.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hccccccCcccCcHHHHHHHH
Confidence            2234588999999999988889999999999999999999999986553   222222 222445666778899999999


Q ss_pred             HhcccCCCCCCCH--HHHHcCCCC
Q 042746          212 KCLRREPGERWSC--DQLLKHPFL  233 (408)
Q Consensus       212 ~~L~~dP~~R~s~--~ell~hpf~  233 (408)
                      +||..||.+||++  .|+++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-36  Score=293.22  Aligned_cols=230  Identities=31%  Similarity=0.472  Sum_probs=180.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccC-----CCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPT-----TSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~-----~~~~~~~L   51 (408)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.....                         ....+     ......++
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            5799999999999999999999999999988754311                         00000     01235789


Q ss_pred             EEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           52 HLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ||||++||+|.++++.   .+..+++..++.++.|++.||+|||+++++|+||||+||+++.++. +||+|||++.....
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~-~kl~dfg~~~~~~~  180 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTS  180 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEeecccchhccc
Confidence            9999999999998864   3456799999999999999999999999999999999999988875 99999999865443


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCC-----CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC--CCCC
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGE-----CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR--FPTQ  201 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~--~~~~  201 (408)
                      ....  .....|++.|+|||++...     .++.++|+|||||++|+|++|++||.................+.  .+..
T Consensus       181 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (291)
T cd06639         181 TRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK  258 (291)
T ss_pred             cccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccc
Confidence            2211  1234589999999998653     25789999999999999999999997654322221111222222  2345


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      .+..+.++|.+||+.+|++||++.|+++||||+
T Consensus       259 ~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            667899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-36  Score=290.44  Aligned_cols=226  Identities=33%  Similarity=0.556  Sum_probs=180.4

Q ss_pred             eeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEeccCCCC
Q 042746            6 RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         6 ~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      .-..||+|+||.||+|++..++..+++|....                         .+.+....+...++++||+++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            34689999999999999999999998875331                         11222345567889999999999


Q ss_pred             HHHHHHHhCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           61 VSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        61 L~~~l~~~~~~l--~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |.+++......+  ++..+..++.||+.||+|||+++|+||||||+||+++.+...++|+|||++........  .....
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  169 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETF  169 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccC
Confidence            999998654555  78889999999999999999999999999999999987444699999999865432221  12223


Q ss_pred             CCCCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          139 RGSPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      .|++.|+|||++.+.  .++.++|+||||+++|+|++|++||......  ...........+.++...++++++|+.+||
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  249 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF  249 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHc
Confidence            589999999998764  3788999999999999999999999754322  122222233445667788899999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCC
Q 042746          215 RREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~  233 (408)
                      ..+|.+|||+.|++.||||
T Consensus       250 ~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         250 EPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCCchhCCCHHHHHhCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.2e-37  Score=293.84  Aligned_cols=229  Identities=19%  Similarity=0.222  Sum_probs=181.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||.||+|.+..     ++..+++|....                          ............+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            468999999999999999999987     677888775331                          1112233455678


Q ss_pred             EEEeccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCC
Q 042746           51 LHLEYLPGGTVSDLATTLN------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGA  122 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGl  122 (408)
                      ++|||++|++|.+++....      ..+++..+..++.||+.+|+|||+++++||||||+||+++.++  ..+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999997643      2478999999999999999999999999999999999998653  3589999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~  201 (408)
                      ++................++.|+|||++.+..++.++|||||||++|+|++ |..||.................+..+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKG  245 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            976532211111111223567999999998889999999999999999997 9999987655554444333334455677


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+.+++.+||+.+|++|||+.++++|
T Consensus       246 ~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         246 CPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.4e-37  Score=297.04  Aligned_cols=235  Identities=25%  Similarity=0.324  Sum_probs=187.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||.||++.+..+++.|++|.....                            ....+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4799999999999999999999999999988753311                            111233456678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-  132 (408)
                      ||++|++|.++++.. +.+++..+..++.|++.||+|||+++++||||||+||+++.++. ++|+|||+++........ 
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~-~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC-EEEeeCCCccccCcCcccc
Confidence            999999999999754 56799999999999999999999999999999999999998874 999999998632111100 


Q ss_pred             ------------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC--CCCCC
Q 042746          133 ------------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD--ELPRF  198 (408)
Q Consensus       133 ------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~--~~p~~  198 (408)
                                  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......+.......  ..|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG  238 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc
Confidence                        0011235788999999998888999999999999999999999999866555444333222  22333


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCC
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWS---CDQLLKHPFLQSVSP  238 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s---~~ell~hpf~~~~~~  238 (408)
                      +...+.+++++|.+||++||++||+   +.|+++||||....+
T Consensus       239 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            3467888999999999999999997   789999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-37  Score=309.99  Aligned_cols=227  Identities=24%  Similarity=0.261  Sum_probs=175.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      ++|++++.||+|+||.||+|++..++     ..||+|....                           .+.+.+......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            46999999999999999999975544     4688775421                           111223345568


Q ss_pred             eEEEeccCCCCHHHHHHHhC------------------------------------------------------------
Q 042746           50 NLHLEYLPGGTVSDLATTLN------------------------------------------------------------   69 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~------------------------------------------------------------   69 (408)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            89999999999999986421                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCC
Q 042746           70 ---------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG  140 (408)
Q Consensus        70 ---------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G  140 (408)
                               ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...............+
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~  276 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGNARL  276 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccCCCC
Confidence                     2367788999999999999999999999999999999998776 599999999876533221111112235


Q ss_pred             CCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       141 t~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      ++.|+|||++.+..++.++|||||||++|+|++ |+.||....... ..........+..+...++++++++.+||+.||
T Consensus       277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  356 (374)
T cd05106         277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEP  356 (374)
T ss_pred             ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCCh
Confidence            678999999998889999999999999999997 999998654332 222222222334556678999999999999999


Q ss_pred             CCCCCHHHHHc
Q 042746          219 GERWSCDQLLK  229 (408)
Q Consensus       219 ~~R~s~~ell~  229 (408)
                      .+|||+.++++
T Consensus       357 ~~RPs~~~l~~  367 (374)
T cd05106         357 TERPTFSQISQ  367 (374)
T ss_pred             hhCcCHHHHHH
Confidence            99999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=295.41  Aligned_cols=229  Identities=23%  Similarity=0.411  Sum_probs=178.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmE   54 (408)
                      +++|++.+.||+|+||+||+|.++.+++.|++|.....                          ....+..+...++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            47899999999999999999999999999998764211                          1122345667889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++ +|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++.++. +||+|||+++.......  .
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~--~  159 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE-LKLADFGLARAKSVPSK--T  159 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC-EEECccccccccCCCCc--c
Confidence            9986 999998876677899999999999999999999999999999999999998875 99999999865432211  1


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCC-hhhhhhhcc-------cC------------
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGF-------SD------------  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~-~~~~~~~~~-------~~------------  193 (408)
                      .....+++.|+|||++.+ ..++.++|+||+|+++|+|++|++||.... .........       ..            
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            122346889999999876 457889999999999999999999996543 111100000       00            


Q ss_pred             --CCC--------CCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 --ELP--------RFPTQSS--ELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 --~~p--------~~~~~~s--~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                        ..+        ......+  ..+.+++.+||+.+|.+|||+.|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence              000        0001223  778899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.8e-37  Score=295.02  Aligned_cols=227  Identities=25%  Similarity=0.333  Sum_probs=180.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeeccc-------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~L   51 (408)
                      ++|.+.+.||+|+||+||++.+.     .++..+++|....                         .+..........++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            47899999999999999999863     3445566654321                         12223345667899


Q ss_pred             EEeccCCCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEee
Q 042746           52 HLEYLPGGTVSDLATTLN------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD  119 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~D  119 (408)
                      +|||+++++|.+++...+            ..+++..+..++.||+.+|+|||++|++||||||+|||++.++. +||+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-~kl~d  163 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-VKIGD  163 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-EEecc
Confidence            999999999999997532            24799999999999999999999999999999999999998874 99999


Q ss_pred             cCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCC
Q 042746          120 FGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRF  198 (408)
Q Consensus       120 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~  198 (408)
                      ||+++...............+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.................+..
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~  243 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR  243 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999875533221111223346788999999998889999999999999999998 9999987665554444444444555


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         244 PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            6678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-37  Score=295.25  Aligned_cols=230  Identities=33%  Similarity=0.522  Sum_probs=188.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      .|+..+.||.|+||.||+|.+..+++.+++|.....                          ....+..+...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            478899999999999999999999999988753311                          111233456789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +||+|.+++..  ..+++..+..++.|++.+|+|||+++++|+||+|+||+++.++. ++|+|||++........  ...
T Consensus        85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06640          85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC-EEEcccccceeccCCcc--ccc
Confidence            99999999863  56789999999999999999999999999999999999998774 99999999866543221  122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ...++..|+|||++.+..++.++|+||||+++|+|++|++||.................+..+...+..+.+++.+||+.
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence            34578899999999988889999999999999999999999986554443333333445566667788899999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +|++||++.++++||||....
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         240 DPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             CcccCcCHHHHHhChHhhhcc
Confidence            999999999999999996543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-37  Score=299.78  Aligned_cols=227  Identities=24%  Similarity=0.282  Sum_probs=181.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE----EEEeecccc--------------------------eeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV----FAYLGDDVS--------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~----va~k~~~~~--------------------------~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|++..++..    +++|.....                          +.+.. .....++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~-~~~~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-cCCCcee
Confidence            4799999999999999999998777664    676653211                          01111 1234579


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.......
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~  164 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEK  164 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc-EEEccccccccccCCCc
Confidence            99999999999999876667889999999999999999999999999999999999988875 99999999976543322


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......+..+......+..+...+..+.+++
T Consensus       165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  244 (316)
T cd05108         165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM  244 (316)
T ss_pred             ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            211222234678999999999889999999999999999997 9999987665554444333333344567788899999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q 042746          211 DKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+||..||.+||++.+++.+
T Consensus       245 ~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         245 VKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.7e-37  Score=294.19  Aligned_cols=229  Identities=19%  Similarity=0.270  Sum_probs=182.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEc----CCCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDR----FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~----~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      +.+|++.+.||+|+||+||+|.+.    .++..+++|....                          .....+......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            467999999999999999999864    3456777765431                          1111233456678


Q ss_pred             EEEeccCCCCHHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCc
Q 042746           51 LHLEYLPGGTVSDLATTL----------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF  114 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~----------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~  114 (408)
                      ++|||+++|+|.+++...                ...+++..+..++.||+.||+|||+++++||||||+|||++.++. 
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-  162 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence            999999999999998532                124678889999999999999999999999999999999998874 


Q ss_pred             EEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccC
Q 042746          115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSD  193 (408)
Q Consensus       115 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~  193 (408)
                      +||+|||+++...............++..|+|||++.+..++.++|+||||+++|+|++ |.+||...............
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  242 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR  242 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999976543322222233346778999999988889999999999999999998 99999876655544444444


Q ss_pred             CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       194 ~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+..+...++.+++++.+||+.||.+||++.+++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         243 QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5555667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.2e-37  Score=293.11  Aligned_cols=228  Identities=19%  Similarity=0.289  Sum_probs=180.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      ++|++.+.||+|+||+||+|.++.     ++..+++|....                          .....+......+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            479999999999999999998753     345677765321                          1111233456678


Q ss_pred             EEEeccCCCCHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           51 LHLEYLPGGTVSDLATTLNA---------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~---------~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      +||||+++|+|.+++.....         .++...+..++.|++.||+|||+++++|+||||+||+++.++. ++|+|||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~-~~l~dfg  164 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG  164 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC-EEECCCC
Confidence            99999999999999975322         3467788899999999999999999999999999999998875 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      +++...............+++.|+|||++.+..++.++|+|||||++|+|++ |..||.................+..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (277)
T cd05062         165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD  244 (277)
T ss_pred             CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            9865433222111122345788999999998889999999999999999999 789998766655554444445556667


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+..+++++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         245 NCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.8e-37  Score=288.72  Aligned_cols=221  Identities=21%  Similarity=0.286  Sum_probs=175.7

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEeccCCCCH
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      +.||+|+||+||+|++..+++.+++|....                          .....+......+|||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            479999999999999999999999875321                          112223445667899999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS  141 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  141 (408)
                      .+++...+..+++..++.++.|++.||.|||+++++||||||+||+++.++. +||+|||++................++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc-EEECccccCcccccccccccCCCCCCc
Confidence            9999866667899999999999999999999999999999999999998875 999999998654322111101111234


Q ss_pred             CCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 042746          142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE  220 (408)
Q Consensus       142 ~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~  220 (408)
                      ..|+|||.+.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+.+|+.+||+.+|++
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ  239 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence            56999999998889999999999999999997 99999765544443333333334556677899999999999999999


Q ss_pred             CCCHHHHHc
Q 042746          221 RWSCDQLLK  229 (408)
Q Consensus       221 R~s~~ell~  229 (408)
                      |||+.|+++
T Consensus       240 Rps~~~~~~  248 (252)
T cd05084         240 RPSFSTVHQ  248 (252)
T ss_pred             CcCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=289.73  Aligned_cols=228  Identities=22%  Similarity=0.266  Sum_probs=181.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC---CcEEEEeecccc--------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN---GDVFAYLGDDVS--------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t---~~~va~k~~~~~--------------------------~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|.++.+   ...+++|.....                          +..........+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            4699999999999999999998755   346777653311                          11123345667899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++++|.+++....+.+++..+..++.|++.||+|||+++|+|+||||+|||++.++. ++|+|||++.........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~-~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV-CKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC-EEECccchhhcccccccc
Confidence            9999999999999876667899999999999999999999999999999999999998875 999999999766422221


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.................+..+...++.+.+++.
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  242 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLML  242 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            11222345678999999998889999999999999999998 99999766555444433333333445677899999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||+.+|++||++.|++++
T Consensus       243 ~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         243 DCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHcCCCcccCcCHHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.8e-37  Score=308.39  Aligned_cols=228  Identities=23%  Similarity=0.287  Sum_probs=175.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-----cCCCcEEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-----RFNGDVFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-----~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      .+|++++.||+|+||+||+|.+     ..++..||+|....                           ...+.+......
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3699999999999999999974     45666788875321                           111123345567


Q ss_pred             eEEEeccCCCCHHHHHHHhC------------------------------------------------------------
Q 042746           50 NLHLEYLPGGTVSDLATTLN------------------------------------------------------------   69 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~------------------------------------------------------------   69 (408)
                      ++||||++||+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            89999999999999986432                                                            


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           70 --------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        70 --------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                                    ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCccccccc
Confidence                          1467788899999999999999999999999999999998876 4999999999765432221111


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-hhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...... ...........+..+...+.++++|+.+|
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  353 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSC  353 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHH
Confidence            12335677999999999999999999999999999998 89999765432 22222222223344556788999999999


Q ss_pred             cccCCCCCCCHHHHHcC
Q 042746          214 LRREPGERWSCDQLLKH  230 (408)
Q Consensus       214 L~~dP~~R~s~~ell~h  230 (408)
                      |+.||++|||+.|+++.
T Consensus       354 l~~dP~~RPs~~eil~~  370 (375)
T cd05104         354 WDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ccCChhHCcCHHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-37  Score=288.48  Aligned_cols=228  Identities=29%  Similarity=0.433  Sum_probs=183.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|++.+.||.|+||.||+|.+..+++.+++|....                         .+..........+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            689999999999999999999999999888865331                         1112233456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++......+++..+..++.|++.+|+|||+++++|+||||+||+++.++. +||+|||++........  ...
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~g~~~~~~~~~~--~~~  159 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIA--KRK  159 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC-EEECccccchhhhhhhh--ccc
Confidence            999999999866577899999999999999999999999999999999999998875 99999999865443221  122


Q ss_pred             cCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC----CCCCCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD----ELPRFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~----~~p~~~~~~s~~~~~l  209 (408)
                      ...+++.|+|||++.+.   .++.++|+||||+++|+|++|++||...............    .....+...+..+++|
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            34688999999999876   7889999999999999999999999765433222211111    1111223456788999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPF  232 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf  232 (408)
                      +.+||..+|.+|||+.+++.|||
T Consensus       240 i~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         240 IKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-36  Score=288.95  Aligned_cols=224  Identities=27%  Similarity=0.429  Sum_probs=183.6

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||.|+||.||+|++..+++.+++|.....                            +...+..+...+++|||++|++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999988754311                            11223455678899999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS  141 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  141 (408)
                      .+++.+ ...+++..+..++.||+.||+|||+++++|+||||+||+++.++. ++|+|||++.......   ......|+
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~-~~l~df~~~~~~~~~~---~~~~~~~~  155 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQ---KTWTFCGT  155 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC-EEEeeCCcccccCccc---ccccccCC
Confidence            999975 345789999999999999999999999999999999999998875 9999999987654332   12234689


Q ss_pred             CCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcc-cCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGF-SDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       142 ~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~-~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||....  ......... ....+.+|...++.++++|.+||..||
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999999988888999999999999999999999998655  333332222 133445666678899999999999999


Q ss_pred             CCCCC-----HHHHHcCCCCCCCCC
Q 042746          219 GERWS-----CDQLLKHPFLQSVSP  238 (408)
Q Consensus       219 ~~R~s-----~~ell~hpf~~~~~~  238 (408)
                      ++||+     +.|+++||||....+
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCCCC
Confidence            99999     999999999987654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.4e-37  Score=292.58  Aligned_cols=226  Identities=23%  Similarity=0.263  Sum_probs=179.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE----EEEeecccce--------------------------eccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV----FAYLGDDVSY--------------------------EAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~----va~k~~~~~~--------------------------~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|.+..++..    ||+|......                          .+.. .....++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGIC-LTSTVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEE-cCCCcEE
Confidence            4789999999999999999998877764    6666432100                          0001 1234579


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~-~kL~dfG~~~~~~~~~~  164 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDET  164 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc-EEECCCCceeecccccc
Confidence            99999999999999865667899999999999999999999999999999999999988775 99999999976543222


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.......+.........+..+...+..+.+++
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  244 (279)
T cd05109         165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIM  244 (279)
T ss_pred             eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHH
Confidence            111112235678999999998889999999999999999998 9999987665554444334444455567888999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||+.||++||++.|++.
T Consensus       245 ~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         245 VKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-36  Score=292.59  Aligned_cols=226  Identities=23%  Similarity=0.265  Sum_probs=181.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE----EEEeecccc--------------------------eeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV----FAYLGDDVS--------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~----va~k~~~~~--------------------------~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|++..+++.    +++|.....                          ..+ .......++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~-~~~~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLG-ICPGASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEE-EECCCccEE
Confidence            5789999999999999999999888774    444432210                          000 111234678


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+++|+|.+++......+++..+..++.||+.||+|||+++++||||||+|||++.++. +||+|||+++.......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~-~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDK  164 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-EEEcCCccceeccCCCc
Confidence            99999999999999876678899999999999999999999999999999999999998774 99999999976543322


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........++..|+|||++.+..++.++|+||||+++|+|++ |..||..............+..+..+...+.+..+++
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  244 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM  244 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHH
Confidence            222223457788999999998889999999999999999998 9999987665554444434444455566778889999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||..||++|||+.|+++
T Consensus       245 ~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         245 VKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHcCCCcccCcCHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.3e-37  Score=295.49  Aligned_cols=230  Identities=32%  Similarity=0.511  Sum_probs=187.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      .|+..+.||+|+||.||+|.+..++..+++|.....                          ....+..++..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            477789999999999999999999999988753311                          112244566789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++.  ...+++..++.++.||+.||.|||+++++|+||+|+||+++.++. ++|+|||++........  ...
T Consensus        85 ~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06642          85 GGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD-VKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             CCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC-EEEccccccccccCcch--hhh
Confidence            9999999986  356789999999999999999999999999999999999998774 99999999865543221  122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ...|+..|+|||++.+..++.++|+||||+++|+|++|+.||.................+..+...+..+.+++.+||..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            34588999999999988889999999999999999999999976544333322223334455566788899999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +|++||++.++++||||....
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         240 DPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             CcccCcCHHHHHHhHHHHHHh
Confidence            999999999999999997543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=289.84  Aligned_cols=227  Identities=18%  Similarity=0.269  Sum_probs=183.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      ++|++.+.||+|+||.||+|.++...     ..+++|....                          .+.+.+......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            57999999999999999999987544     6777765321                          1222334556789


Q ss_pred             EEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           51 LHLEYLPGGTVSDLATTLN---------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      ++|||+++|+|.+++....         ..+++..+..++.||+.||.|||+++++||||||+|||++.++. +||+|||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~-~kl~dfg  164 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT-VKIGDFG  164 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC-EEECCcc
Confidence            9999999999999997432         23577889999999999999999999999999999999998875 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      +++...............++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.................+..+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (277)
T cd05032         165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE  244 (277)
T ss_pred             cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC
Confidence            9875543322111223346788999999988889999999999999999998 999998766655554444445556677


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..+..+.+++.+||+.+|++|||+.|++.
T Consensus       245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         245 NCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            78999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8.7e-37  Score=322.02  Aligned_cols=237  Identities=22%  Similarity=0.217  Sum_probs=172.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCC----CcEEEEeecccce---------------------ecc------CCCCCcc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFN----GDVFAYLGDDVSY---------------------EAP------TTSSSCR   49 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t----~~~va~k~~~~~~---------------------~~~------~~~~~~~   49 (408)
                      +++|++++.||+|+||+||+|++..+    +..+++|......                     ...      ...+...
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  210 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEY  210 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCce
Confidence            36899999999999999999999999    8999988633100                     000      1345668


Q ss_pred             eEEEeccCCCCHHHHHHHhCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAY-------------------ADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP  110 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~-------------------l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~  110 (408)
                      +|||||+++++|.+++......                   ..+..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus       211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~  290 (566)
T PLN03225        211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE  290 (566)
T ss_pred             EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeC
Confidence            9999999999999998743211                   123457789999999999999999999999999999987


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCC----------------------CCCCCCcchHHHHH
Q 042746          111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC----------------------QGPESDVWSLGCTI  168 (408)
Q Consensus       111 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----------------------~~~~sDiWSLGvil  168 (408)
                      +...+||+|||+|+....... .......||+.|+|||++....                      ++.++|||||||++
T Consensus       291 ~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL  369 (566)
T PLN03225        291 GSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF  369 (566)
T ss_pred             CCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence            544699999999975533221 1233457899999999774322                      33456999999999


Q ss_pred             HHHHhCCCCCCCCChhhhhhh---------cccCCCC-----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          169 IEMVTGKPAWEDFGANTLSRI---------GFSDELP-----------RFPTQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       169 ~eLltG~~Pf~~~~~~~~~~~---------~~~~~~p-----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                      |||+++..|+.... ..+...         .+....+           ......+....+||.+||++||.+|||+.|+|
T Consensus       370 ~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L  448 (566)
T PLN03225        370 LQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAAL  448 (566)
T ss_pred             HHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHh
Confidence            99999877754321 111100         0000000           01112234456899999999999999999999


Q ss_pred             cCCCCCCCCCC
Q 042746          229 KHPFLQSVSPS  239 (408)
Q Consensus       229 ~hpf~~~~~~~  239 (408)
                      +||||......
T Consensus       449 ~Hpff~~~~~~  459 (566)
T PLN03225        449 AHPYFDREGLL  459 (566)
T ss_pred             CCcCcCCCCcc
Confidence            99999875543

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.3e-37  Score=298.84  Aligned_cols=225  Identities=23%  Similarity=0.311  Sum_probs=164.4

Q ss_pred             eceeeecCCeeEEEEEEcC--CCcEEEEeeccc-----------------------ceeccC--CCCCcceEEEeccCCC
Q 042746            7 GKCIGRGSFGTVNVAVDRF--NGDVFAYLGDDV-----------------------SYEAPT--TSSSCRNLHLEYLPGG   59 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~--t~~~va~k~~~~-----------------------~~~~~~--~~~~~~~LVmEy~~gG   59 (408)
                      ++.||+|+||+||+|+++.  ++..+|+|....                       .+...+  ..+...+++|||+++ 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            6789999999999999764  557788765321                       011111  234567899999876 


Q ss_pred             CHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc----CCCCcEEEeecCCccccc
Q 042746           60 TVSDLATTL--------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG----PNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        60 sL~~~l~~~--------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~----~~~~~vkL~DFGla~~~~  127 (408)
                      +|.+++...        ...+++..++.++.||+.||+|||+++|+||||||+|||+.    .++ .+||+|||+++...
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~  163 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFN  163 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceeccC
Confidence            788877531        12478899999999999999999999999999999999994    333 59999999997654


Q ss_pred             cCCCC-cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhh----------hhhhc-----
Q 042746          128 VSDTR-GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----------LSRIG-----  190 (408)
Q Consensus       128 ~~~~~-~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~----------~~~~~-----  190 (408)
                      ..... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.......          +....     
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            32211 112234689999999999764 57899999999999999999999996422110          00000     


Q ss_pred             --------c--cC---------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          191 --------F--SD---------------------ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       191 --------~--~~---------------------~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                              .  ..                     ..+......+..+++||.+||+.||.+|||+.|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    0  00                     0001112235668899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.5e-36  Score=287.03  Aligned_cols=231  Identities=30%  Similarity=0.471  Sum_probs=190.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      .+|++.+.||+|++|.||+|.+..+++.+++|.....                          +...+......+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            4799999999999999999999999999998763321                          11123345678899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++++|.+++... ..+++..+..++.||+.+|+|||+ ++++|+||+|+||+++.++. ++|+|||++.........  
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~-~~l~df~~~~~~~~~~~~--  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE-VKIADFGISKVLENTLDQ--  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC-EEEccCccceecccCCCc--
Confidence            9999999999854 677999999999999999999999 99999999999999998875 999999998665432221  


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC---hhhhhhhcccCCCCCCCCC-CcHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDELPRFPTQ-SSELGRDFL  210 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~---~~~~~~~~~~~~~p~~~~~-~s~~~~~li  210 (408)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....   .............+..+.. .+..+.++|
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            123457899999999998888999999999999999999999997653   2233332234444555556 788999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .+||..+|++||++.|+++|||++..
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-36  Score=295.29  Aligned_cols=227  Identities=21%  Similarity=0.245  Sum_probs=171.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC----------------CCcEEEEeeccc--------------------------ce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF----------------NGDVFAYLGDDV--------------------------SY   39 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~----------------t~~~va~k~~~~--------------------------~~   39 (408)
                      .+|++.+.||+|+||.||+|.+..                ++..+|+|....                          .+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            479999999999999999998643                233577765321                          11


Q ss_pred             eccCCCCCcceEEEeccCCCCHHHHHHHhC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042746           40 EAPTTSSSCRNLHLEYLPGGTVSDLATTLN------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDV  101 (408)
Q Consensus        40 ~~~~~~~~~~~LVmEy~~gGsL~~~l~~~~------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDL  101 (408)
                      .+.+......+|+|||+++|+|.+++....                  ..++...+..++.||+.||.|||++||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            112234456789999999999999986421                  23567788999999999999999999999999


Q ss_pred             CCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh--CCCCCC
Q 042746          102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWE  179 (408)
Q Consensus       102 Kp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt--G~~Pf~  179 (408)
                      ||+|||++.++. +||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++  +..||.
T Consensus       165 kp~Nill~~~~~-~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         165 ATRNCLVGENLT-IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             chhheEEcCCcc-EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            999999998875 99999999975533222112223346788999999998889999999999999999986  667887


Q ss_pred             CCChhhhhhhc-------ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          180 DFGANTLSRIG-------FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       180 ~~~~~~~~~~~-------~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ...........       .....+..+...++.+.+|+.+||..||++|||+.|+.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             cCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            65433322110       011122334567888999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-36  Score=284.93  Aligned_cols=229  Identities=35%  Similarity=0.606  Sum_probs=183.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~~~~LVmEy   55 (408)
                      +|.+.+.||+|+||.||++.+..+++.+++|......                           ..........++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            6999999999999999999999999999887643211                           1122345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc-
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV-  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~-  134 (408)
                      +++++|.+++.. +..+++..+..++.|++.||+|||++|++|+||+|+||+++.++. +||+|||++........... 
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEcccccccccCCCCCcccc
Confidence            999999999984 445789999999999999999999999999999999999998775 99999999866543322111 


Q ss_pred             -cccCCCCCCCCChhhHhCCC---CCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhcccCCCCCCCCCC--cHHHH
Q 042746          135 -KIQPRGSPLWMAPEVVRGEC---QGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQS--SELGR  207 (408)
Q Consensus       135 -~~~~~Gt~~y~APE~l~~~~---~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~p~~~~~~--s~~~~  207 (408)
                       .....+++.|+|||++.+..   ++.++|+||||++++++++|+.||..... ............+.+|...  ++.+.
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK  238 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence             11345789999999998765   78999999999999999999999975422 2222112223444555544  88899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +||.+||+.+|.+|||+.|++.|||+
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=290.43  Aligned_cols=230  Identities=33%  Similarity=0.507  Sum_probs=185.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .|++.+.||+|+||.||+|++..+++.+++|.....                             +.+.+..+...+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            488899999999999999999999999998753211                             111123445678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++|++|.++++.  ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++........  
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSS--  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcc--
Confidence            99999999999864  4788999999999999999999999999999999999999877 499999999866543321  


Q ss_pred             ccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCC-CcHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ-SSELGRDFLD  211 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~-~s~~~~~li~  211 (408)
                      ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.................+.++.. .+.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            1223468999999999875 4568899999999999999999999986554433322222333444443 7889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +||+.||++||++.|++.||||+...
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999997644

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.4e-37  Score=292.19  Aligned_cols=227  Identities=24%  Similarity=0.336  Sum_probs=181.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC-----CcEEEEeecccc--------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN-----GDVFAYLGDDVS--------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t-----~~~va~k~~~~~--------------------------~~~~~~~~~~~~   50 (408)
                      .+|.+.+.||+|+||+||+|.+...     +..+++|.....                          +...+......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            4788999999999999999987543     567777653211                          111233446688


Q ss_pred             EEEeccCCCCHHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEE
Q 042746           51 LHLEYLPGGTVSDLATTLN-------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKL  117 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL  117 (408)
                      ++|||++|++|.+++...+             ..+++..+..++.||+.+|+|||++|++||||||+||+++.++. +||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-~kl  163 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-VKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe-EEE
Confidence            9999999999999997532             34678889999999999999999999999999999999998874 999


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      +|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.................+
T Consensus       164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~  243 (280)
T cd05049         164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL  243 (280)
T ss_pred             CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999865432221111122345788999999999889999999999999999998 99999876655555544455555


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..+...+..+++++.+||..||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            566778899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-36  Score=287.00  Aligned_cols=225  Identities=21%  Similarity=0.269  Sum_probs=182.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +|++.+.||+|+||+||+|.++.+++.+++|.....                        +......+...+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            588999999999999999999999999988763311                        11223345667899999999


Q ss_pred             CCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           59 GTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        59 GsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ++|.+++... ...+++..++.++.|++.+|+|||+++++||||||+||+++.++. +||+|||++......... ....
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~df~~~~~~~~~~~~-~~~~  164 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYT-AHAG  164 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc-EEeCCCccccccccceee-ccCC
Confidence            9999999753 345789999999999999999999999999999999999988874 999999998665432211 1111


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.................+..+...+..+.+++.+||..
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  244 (263)
T cd05052         165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQW  244 (263)
T ss_pred             CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccC
Confidence            234667999999998889999999999999999998 9999987666555444333334456677889999999999999


Q ss_pred             CCCCCCCHHHHHc
Q 042746          217 EPGERWSCDQLLK  229 (408)
Q Consensus       217 dP~~R~s~~ell~  229 (408)
                      ||++|||+.++++
T Consensus       245 ~p~~Rp~~~~l~~  257 (263)
T cd05052         245 NPSDRPSFAEIHQ  257 (263)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-36  Score=284.09  Aligned_cols=222  Identities=24%  Similarity=0.331  Sum_probs=182.5

Q ss_pred             ceeeecCCeeEEEEEEcCC---CcEEEEeecccc--------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFN---GDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t---~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||.||+|.+...   +..+++|.....                          +..........+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            5799999999999999876   777877653311                          11123345678899999999


Q ss_pred             CCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           59 GTVSDLATTL--------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        59 GsL~~~l~~~--------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ++|.+++...        ...+++..+..++.||+.||+|||+++++|+||||+||+++.++. +||+|||.+.......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~-~~l~dfg~~~~~~~~~  159 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDDD  159 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc-EEEccccccccccccc
Confidence            9999999865        477899999999999999999999999999999999999999875 9999999997665432


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      .........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.......+.........+..+...++.+.++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL  239 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence            1122233457889999999998889999999999999999999 699998876655555444444556667789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q 042746          210 LDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~h  230 (408)
                      +.+||..+|.+|||+.|++++
T Consensus       240 i~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         240 MLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-36  Score=293.09  Aligned_cols=230  Identities=24%  Similarity=0.391  Sum_probs=175.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee----------------------------ccCCCCC-----c
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE----------------------------APTTSSS-----C   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~----------------------------~~~~~~~-----~   48 (408)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.......                            .......     .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            579999999999999999999999999999875432110                            0011111     2


Q ss_pred             ceEEEeccCCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           49 RNLHLEYLPGGTVSDLATTL----NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~----~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .+++|||+++ +|.+++...    ...+++..++.++.||+.||+|||+++|+||||||+||+++.++..+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            6899999996 898888653    23579999999999999999999999999999999999999834469999999986


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-----------
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-----------  192 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-----------  192 (408)
                      .......  ......+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||..............           
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            5433221  1122357889999999875 4578999999999999999999999975432211110000           


Q ss_pred             --------CCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          193 --------DELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       193 --------~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                              ...+.        .....++.+.+||.+||..||.+||++.|++.||||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    00011        1124678899999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.3e-36  Score=281.03  Aligned_cols=226  Identities=31%  Similarity=0.505  Sum_probs=184.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-------------------------eccCCCCCcceEEEeccC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-------------------------EAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-------------------------~~~~~~~~~~~LVmEy~~   57 (408)
                      +|+..+.||+|++|.||++.+..+++.+++|......                         ...+..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            5899999999999999999999999999887643221                         112334566789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      |++|.+++......+++..+..++.|++.+|+|||++|++|+||+|+||+++.++. ++|+|||.+........   ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~---~~~  156 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKA---RNT  156 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe-EEEeecccccccccccc---ccc
Confidence            99999999865567899999999999999999999999999999999999998775 99999999866543321   233


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCC--cHHHHHHHHHhcc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS--SELGRDFLDKCLR  215 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~--s~~~~~li~~~L~  215 (408)
                      ..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.................+..+...  +..+.++|.+||+
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  236 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ  236 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence            45899999999999888899999999999999999999999876433322222223333333333  7889999999999


Q ss_pred             cCCCCCCCHHHHHcCCC
Q 042746          216 REPGERWSCDQLLKHPF  232 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf  232 (408)
                      .||++|||+.|+++|||
T Consensus       237 ~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         237 KNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CChhhCCCHHHHhcCCC
Confidence            99999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.1e-37  Score=296.35  Aligned_cols=231  Identities=30%  Similarity=0.486  Sum_probs=183.5

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEeccCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      |.....||+|+||.||++.+..++..+++|.....                         ....+......+++|||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            45567899999999999999999999998764321                         11123345678999999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      ++|.+++..  ..+++..+..++.||+.||+|||+++|+||||||+||+++.++. ++|+|||++........  .....
T Consensus       104 ~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~-~kL~dfg~~~~~~~~~~--~~~~~  178 (292)
T cd06658         104 GALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVP--KRKSL  178 (292)
T ss_pred             CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-EEEccCcchhhcccccc--cCcee
Confidence            999998853  45789999999999999999999999999999999999998874 99999999865432221  12234


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC--CCCCCCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD--ELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~--~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...............  .........+..+++++.+||..
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  258 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVR  258 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccC
Confidence            5899999999998888999999999999999999999999765443322221111  11122235688899999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ||.+|||+.|+++||||....++
T Consensus       259 ~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         259 EPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ChhHCcCHHHHhhChhhhccCCc
Confidence            99999999999999999866544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.5e-37  Score=292.88  Aligned_cols=228  Identities=17%  Similarity=0.204  Sum_probs=182.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC-----CcEEEEeecccc--------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN-----GDVFAYLGDDVS--------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t-----~~~va~k~~~~~--------------------------~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||+||+|.+..+     ++.+|+|.....                          +.+........+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4688999999999999999988654     467888764321                          111223345577


Q ss_pred             EEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcE
Q 042746           51 LHLEYLPGGTVSDLATTL---------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV  115 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~---------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~v  115 (408)
                      +++||+++++|.+++...               ...+++..+..++.|++.||+|||++||+||||||+||+++.++. +
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-~  163 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-V  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-e
Confidence            899999999999998532               234678889999999999999999999999999999999988775 9


Q ss_pred             EEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCC
Q 042746          116 KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE  194 (408)
Q Consensus       116 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~  194 (408)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||................
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ  243 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876543222112223346789999999988889999999999999999998 889998776665555555555


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+...+..+.+|+.+||+.+|.+||++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            556677889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-36  Score=290.30  Aligned_cols=226  Identities=26%  Similarity=0.404  Sum_probs=182.2

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||+|+||+||+|.+..+++.+++|....                            .....+......++||||++|++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            7999999999999999999998875421                            111223445678899999999999


Q ss_pred             HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCC
Q 042746           62 SDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG  140 (408)
Q Consensus        62 ~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G  140 (408)
                      .+++...+ ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||++.......   ......+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~-~~l~dfg~~~~~~~~~---~~~~~~~  156 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGK---KIKGRAG  156 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC-EEEccCcchhhhccCC---ccccccC
Confidence            99997544 36799999999999999999999999999999999999998875 9999999986543211   1223457


Q ss_pred             CCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       141 t~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      +..|+|||++.+..++.++|+||||+++|+|++|+.||.....    ..+.... .......+...++.++++|.+||+.
T Consensus       157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHHccC
Confidence            8899999999888889999999999999999999999976433    1222221 2223345567789999999999999


Q ss_pred             CCCCCC-----CHHHHHcCCCCCCCCCCC
Q 042746          217 EPGERW-----SCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       217 dP~~R~-----s~~ell~hpf~~~~~~~~  240 (408)
                      ||.+||     ++.++++||||....+..
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            999999     888999999998776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-36  Score=302.14  Aligned_cols=228  Identities=23%  Similarity=0.291  Sum_probs=176.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeecccc------------------e---------ec-cCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDDVS------------------Y---------EA-PTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~~~------------------~---------~~-~~~~~~~   48 (408)
                      ++|++.+.||+|+||.||+|++..     +++.|++|.....                  .         .. ....+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            479999999999999999997544     4467888753210                  0         00 0123355


Q ss_pred             ceEEEeccCCCCHHHHHHHhC-----------------------------------------------------------
Q 042746           49 RNLHLEYLPGGTVSDLATTLN-----------------------------------------------------------   69 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~-----------------------------------------------------------   69 (408)
                      ++++|||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            789999999999999986421                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChh
Q 042746           70 -AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE  148 (408)
Q Consensus        70 -~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE  148 (408)
                       ..+++..+..++.||+.||+|||+++|+||||||+|||++.++. ++|+|||+++...............+++.|+|||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~-vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV-VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc-EEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence             25688889999999999999999999999999999999998774 9999999997653322211122334677899999


Q ss_pred             hHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 042746          149 VVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ  226 (408)
Q Consensus       149 ~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  226 (408)
                      ++.+..++.++|||||||++|+|++ |.+||....... +.........+..+...++.+.+++.+||+.+|++||++.|
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e  325 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSE  325 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999999999999998 999997643322 22222222333445667889999999999999999999999


Q ss_pred             HHcC
Q 042746          227 LLKH  230 (408)
Q Consensus       227 ll~h  230 (408)
                      +++|
T Consensus       326 ll~~  329 (337)
T cd05054         326 LVEI  329 (337)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.3e-36  Score=281.33  Aligned_cols=229  Identities=46%  Similarity=0.799  Sum_probs=188.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCC--CcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSS--SCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~--~~~~LVm   53 (408)
                      +|++.+.||+|++|.||+|.+..+++.+++|......                           .......  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5899999999999999999999999999887543221                           1122233  6789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++++|.+++.... .+++..+..++.|++.+|+|||+++++|+||+|+||+++.++. ++|+|||.+..........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC-EEEcccccEEecccccccc
Confidence            9999999999998544 7899999999999999999999999999999999999998775 9999999986654433211


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      ......++..|+|||.+.+..++.++|+||||+++++|++|..||....  .............+.++...+..+++|+.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            1233468999999999998888999999999999999999999998655  12222222224556677778999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +||..||++||++.|+++||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-36  Score=290.91  Aligned_cols=229  Identities=32%  Similarity=0.521  Sum_probs=189.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      -|++.+.||+|+||.||+|.+..++..+++|....                          .+...+..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            37788999999999999999999999999875331                          1111233456688999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++.  ...+++..+..++.|++.+|.|||++|++|+||||.||+++.++. ++|+|||++........  ...
T Consensus        85 ~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~-~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06641          85 GGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC-EEEeecccceecccchh--hhc
Confidence            9999999986  356789999999999999999999999999999999999988875 99999999865543221  122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ...|+..|+|||.+.+..++.++|+|||||++|+|++|..||.................+.++...+..+.+++.+||..
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK  239 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            34588999999999888888999999999999999999999987654444333334445566677889999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~  236 (408)
                      +|.+||++.++++||||...
T Consensus       240 ~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         240 EPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ChhhCcCHHHHHhCHHHhhh
Confidence            99999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.6e-36  Score=291.28  Aligned_cols=228  Identities=24%  Similarity=0.319  Sum_probs=181.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      .+|++.+.||+|+||.||++.+....     ..+++|....                           .+......+...
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            47999999999999999999987544     5667664321                           111123345567


Q ss_pred             eEEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCc
Q 042746           50 NLHLEYLPGGTVSDLATTL---------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF  114 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~---------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~  114 (408)
                      +++|||+++|+|.+++...               ...+++..+..++.||+.||+|||+++|+||||||+|||++.++ .
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~-~  170 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-V  170 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC-e
Confidence            8999999999999999642               34578999999999999999999999999999999999998877 4


Q ss_pred             EEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccC
Q 042746          115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSD  193 (408)
Q Consensus       115 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~  193 (408)
                      +||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  250 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG  250 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999976543222111222335678999999998889999999999999999997 99999877666555554444


Q ss_pred             CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       194 ~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+..+...+..+.+|+.+||..||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         251 YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4455666778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=310.77  Aligned_cols=217  Identities=26%  Similarity=0.423  Sum_probs=187.6

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeec------------------ccceeccCCCCCcceEEEeccCCCCHHHHHHHh
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGD------------------DVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTL   68 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~------------------~~~~~~~~~~~~~~~LVmEy~~gGsL~~~l~~~   68 (408)
                      .+.||.|+.|.||+++..  ++.||+|+.                  .+.|++......+++||||||+.|-|..+|+ .
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-a  205 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-A  205 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-c
Confidence            578999999999999875  777877542                  2567778888999999999999999999998 5


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChh
Q 042746           69 NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE  148 (408)
Q Consensus        69 ~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE  148 (408)
                      +..+.......|..+|+.|+.|||.++|||||||.-||||..+. .|||+|||-++.....   .+.+.++||..|||||
T Consensus       206 ~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPE  281 (904)
T KOG4721|consen  206 GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDK---STKMSFAGTVAWMAPE  281 (904)
T ss_pred             cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhh---hhhhhhhhhHhhhCHH
Confidence            66778888899999999999999999999999999999998887 5999999999776543   4567889999999999


Q ss_pred             hHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc--CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 042746          149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS--DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ  226 (408)
Q Consensus       149 ~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~--~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  226 (408)
                      ++++++.+.|+|||||||+|||||||..||.+.+...+.+-.-.  ..+ ..|..++..++-||+.||+-.|..||++.+
T Consensus       282 vIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~L-pvPstcP~GfklL~Kqcw~sKpRNRPSFrq  360 (904)
T KOG4721|consen  282 VIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHL-PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQ  360 (904)
T ss_pred             HhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccc-cCcccCchHHHHHHHHHHhcCCCCCccHHH
Confidence            99999999999999999999999999999998776665543211  122 346778888999999999999999999999


Q ss_pred             HHcCC
Q 042746          227 LLKHP  231 (408)
Q Consensus       227 ll~hp  231 (408)
                      |+.|-
T Consensus       361 il~Hl  365 (904)
T KOG4721|consen  361 ILLHL  365 (904)
T ss_pred             HHHHH
Confidence            99984

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.5e-36  Score=294.24  Aligned_cols=225  Identities=25%  Similarity=0.327  Sum_probs=176.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEE--EEeecc---------------------------cceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVF--AYLGDD---------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~v--a~k~~~---------------------------~~~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|.+..++..+  +++...                           +.+...+..+...+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57999999999999999999998887643  444321                           0111223455678899


Q ss_pred             EeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEE
Q 042746           53 LEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKL  117 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL  117 (408)
                      |||+++|+|.+++...+               ..+++..++.++.||+.||+|||++|++||||||+|||++.++. +||
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-~kl  165 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKI  165 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-EEe
Confidence            99999999999997532               25688999999999999999999999999999999999998874 999


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      +|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.................+
T Consensus       166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  242 (303)
T cd05088         166 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  242 (303)
T ss_pred             CccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence            99999864321111   111234667999999988888999999999999999998 99999766554444332222223


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+...++.+.+|+.+||+.+|++||++++++.+
T Consensus       243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-36  Score=291.14  Aligned_cols=229  Identities=28%  Similarity=0.385  Sum_probs=183.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||++.+..+++.+++|....                          .....+.....++|||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            578999999999999999999999999998874321                          111223345678899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++++|.+++.. .+.+++..+..++.|++.+|.|||+ ++++||||||+||+++.++. ++|+|||++.......    
T Consensus        85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~-~~l~d~gl~~~~~~~~----  158 (284)
T cd06620          85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ-IKLCDFGVSGELINSI----  158 (284)
T ss_pred             CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc-EEEccCCcccchhhhc----
Confidence            999999999875 4567999999999999999999997 68999999999999988774 9999999986542221    


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-----------hhhhhcccCCCCCCCCC-C
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-----------TLSRIGFSDELPRFPTQ-S  202 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-----------~~~~~~~~~~~p~~~~~-~  202 (408)
                      .....|+..|+|||++.+..++.++|+|||||++|+|++|..||......           ...........+.++.. .
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF  238 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence            12346899999999998888899999999999999999999999754331           11111222233333333 6


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +..+.+|+.+||++||.+|||+.|+++||||...
T Consensus       239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            7889999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-36  Score=286.13  Aligned_cols=226  Identities=20%  Similarity=0.266  Sum_probs=178.3

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCC---cEEEEeecccc---------------------------eeccC------CCCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNG---DVFAYLGDDVS---------------------------YEAPT------TSSS   47 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~---~~va~k~~~~~---------------------------~~~~~------~~~~   47 (408)
                      |++++.||+|+||+||+|....++   ..+|+|.....                           +.+..      ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            678999999999999999976544   67777753311                           00001      1123


Q ss_pred             cceEEEeccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTL-----NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~-----~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      ..+++|||+++|+|.+++...     ...+++..+..++.|++.||+|||+++++||||||+||+++.++. +||+|||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe-EEECCccc
Confidence            468999999999999988542     235789999999999999999999999999999999999998874 99999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~  201 (408)
                      ++...............++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+...............+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED  239 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence            976543322111122235678999999988889999999999999999999 9999987665555444444455566778


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+.+++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.4e-36  Score=281.44  Aligned_cols=226  Identities=27%  Similarity=0.412  Sum_probs=190.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|+||.||++.++.+++.+++|.....                           ....+......+++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            589999999999999999999999999988764321                           11123345668899999


Q ss_pred             cCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      +++++|.+++.+.   +..+++..+..++.|++.||+|||++|++|+||+|.||+++.++. +||+|||++.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~-~kl~d~g~~~~~~~~~--  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL-VKIGDLGISKVLKKNM--  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc-EEEeeccchhhhccCC--
Confidence            9999999998752   356789999999999999999999999999999999999998764 9999999986654331  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        .....|++.|+|||.+.+..++.++|+||||+++++|++|+.||...+...+.........+..+...+.++++++.+
T Consensus       158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08530         158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS  235 (256)
T ss_pred             --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHH
Confidence              122458899999999999888999999999999999999999998877665555545556666777888999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ||..+|++|||+.|+++||++
T Consensus       236 ~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         236 MLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-36  Score=294.57  Aligned_cols=228  Identities=24%  Similarity=0.307  Sum_probs=179.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC-------CcEEEEeecccc---------------------------eeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN-------GDVFAYLGDDVS---------------------------YEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t-------~~~va~k~~~~~---------------------------~~~~~~~~~   47 (408)
                      ++|++++.||+|+||+||+|++...       ...+++|.....                           +...+....
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            5799999999999999999987532       235666543311                           111223445


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..++||||+++|+|.+++....               ..++...+..++.|++.||+|||++|++||||||+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            6789999999999999997532               2467888999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||++................+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.......+.....
T Consensus       178 ~-~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  256 (307)
T cd05098         178 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  256 (307)
T ss_pred             c-EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            4 99999999865432211111112234578999999998889999999999999999998 899998766655554443


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...+.++++|+.+||..+|.+|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         257 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            444445566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3e-36  Score=291.53  Aligned_cols=233  Identities=24%  Similarity=0.369  Sum_probs=181.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce------------------------------eccCCCCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY------------------------------EAPTTSSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~------------------------------~~~~~~~~~~~LV   52 (408)
                      +|++.+.||+|+||.||+|.+..+++.+++|......                              ...+..++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            5899999999999999999999999999887643211                              1112234567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+ +|+|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++........ 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~-~~l~dfg~~~~~~~~~~-  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNR-  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC-EEEccceeeeeccCCCc-
Confidence            9999 88999999854447899999999999999999999999999999999999998875 99999999866543221 


Q ss_pred             cccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-------------------
Q 042746          133 GVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-------------------  192 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-------------------  192 (408)
                       ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||..............                   
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (298)
T cd07841         158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY  236 (298)
T ss_pred             -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence             1222346889999999865 4578899999999999999999888865432211110000                   


Q ss_pred             ---CCCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 ---DELP-----RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ---~~~p-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                         ...+     ......+..+.+||.+||.+||++|||+.|++.||||.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence               0000     1113456788999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.7e-36  Score=289.03  Aligned_cols=231  Identities=30%  Similarity=0.492  Sum_probs=184.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEeccC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .|...+.||+|++|.||++.+..+++.+++|.....                         ....+...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355567999999999999999999999988754311                         1112334566789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      |++|.+++..  ..+++..+..++.||+.+|+|||++|++||||||+||+++.++. ++|+|||++........  ....
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~d~g~~~~~~~~~~--~~~~  174 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQVSKEVP--RRKS  174 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc-EEEcccccchhhccCCc--cccc
Confidence            9999999975  56789999999999999999999999999999999999998874 99999998865432211  1223


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CCCCcHHHHHHHHHhcc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLR  215 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~~~s~~~~~li~~~L~  215 (408)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.................+..  +...+..+.+|+.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  254 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV  254 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence            4589999999999988899999999999999999999999976544333222222222222  23367889999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCCCC
Q 042746          216 REPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+|++|||+.++++||||....+
T Consensus       255 ~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         255 RDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             cChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.9e-36  Score=287.57  Aligned_cols=224  Identities=24%  Similarity=0.364  Sum_probs=175.0

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCC--CcceEEEe
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSS--SCRNLHLE   54 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~--~~~~LVmE   54 (408)
                      |++.+.||+|+||.||+|.+..+++.+++|.....                           ....+..+  ...++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            78899999999999999999999999988753321                           01111223  56899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++ +|.+.+......+++..++.++.||+.||+|||+++++||||||+||+++. + .+||+|||++........   
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~---  154 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKPP---  154 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccCCC---
Confidence            9975 888888765567899999999999999999999999999999999999998 5 599999999976533221   


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--------------------ccC
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------------------FSD  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--------------------~~~  193 (408)
                      .....+++.|+|||++.. ..++.++|+|||||++|+|++|.+||...+........                    ...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            122457899999998754 45688999999999999999999999764432211000                    000


Q ss_pred             CCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 ELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 ~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..|        ......+..+.++|.+||++||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            000        1113467889999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.5e-36  Score=283.21  Aligned_cols=226  Identities=29%  Similarity=0.504  Sum_probs=182.1

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||.|+||+||++++..+++.+++|.....                            ...........+++|||++|++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999998864321                            11123345668899999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC------Cccc
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT------RGVK  135 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~------~~~~  135 (408)
                      .+++...+ .+++..+..++.||+.+|+|||+++++|+||+|+||+++.++. ++|+|||++........      ....
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC-EEEEecccchhcccCcccccccccccc
Confidence            99998544 6799999999999999999999999999999999999998875 99999999865433211      0112


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCC--CcHHHHHHHHHh
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ--SSELGRDFLDKC  213 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~--~s~~~~~li~~~  213 (408)
                      ....+++.|+|||.+....++.++|+||||+++|+|++|..||................. ..+..  .+..+.+|+.+|
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~  237 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKL  237 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHH
Confidence            234578899999999888889999999999999999999999987665554433322222 23333  388899999999


Q ss_pred             cccCCCCCCCH---HHHHcCCCCCCCCC
Q 042746          214 LRREPGERWSC---DQLLKHPFLQSVSP  238 (408)
Q Consensus       214 L~~dP~~R~s~---~ell~hpf~~~~~~  238 (408)
                      |+.+|.+|||+   .++++||||..+.|
T Consensus       238 l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         238 LVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             hcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            99999999999   99999999987643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-36  Score=290.05  Aligned_cols=227  Identities=24%  Similarity=0.331  Sum_probs=179.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeeccc-------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDDV-------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~~-------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|.+.+.||+|+||.||+|.+..     ++..+++|....                         .+..........++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            368999999999999999998643     344466554321                         11222344566889


Q ss_pred             EEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEE
Q 042746           52 HLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK  116 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vk  116 (408)
                      ||||+++++|.+++....               ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-~~~  163 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVK  163 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cEE
Confidence            999999999999997532               3478899999999999999999999999999999999999887 499


Q ss_pred             EeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCC
Q 042746          117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDEL  195 (408)
Q Consensus       117 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~  195 (408)
                      |+|||++................+++.|+|||++.+..++.++|+||||+++|+|++ |..||.................
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  243 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV  243 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence            999999865433222112223456888999999999889999999999999999998 9999977665554444444455


Q ss_pred             CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       196 p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +..+...+..+.+++.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         244 LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            5556677889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.1e-36  Score=286.47  Aligned_cols=229  Identities=29%  Similarity=0.431  Sum_probs=187.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-----------------------------eccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-----------------------------EAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-----------------------------~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||.||+|.+..+++.+++|......                             ...+..+...+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999887643210                             0113345668899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++++|.+++... ..+++..++.++.|++.+|.|||++|++|+||||+||+++.++. ++|+|||++.........
T Consensus        81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~-~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC-EEecCCccccccCCcccc
Confidence            9999999999999854 47899999999999999999999999999999999999998875 999999998654432210


Q ss_pred             ------------------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC
Q 042746          133 ------------------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE  194 (408)
Q Consensus       133 ------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~  194 (408)
                                        .......|++.|+|||++....++.++|+||||++++++++|..||............. ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~  237 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KL  237 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hc
Confidence                              11223457899999999988888999999999999999999999998765433333222 22


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCH----HHHHcCCCC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSC----DQLLKHPFL  233 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~----~ell~hpf~  233 (408)
                      ...++...++.+.+||.+||+.+|++||++    .++++||||
T Consensus       238 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         238 EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            224556778899999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.4e-36  Score=291.25  Aligned_cols=225  Identities=24%  Similarity=0.307  Sum_probs=176.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE--EEEeeccc---------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV--FAYLGDDV---------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~--va~k~~~~---------------------------~~~~~~~~~~~~~LV   52 (408)
                      ++|++.+.||+|+||+||+|++..++..  ++++....                           .....+......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            5899999999999999999999887753  34432210                           011112334557899


Q ss_pred             EeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEE
Q 042746           53 LEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKL  117 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL  117 (408)
                      |||+++|+|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA-SKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe-EEE
Confidence            99999999999997532               34788999999999999999999999999999999999998774 999


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      +|||++........   ......+..|+|||++.+..++.++|||||||++|+|++ |..||.................+
T Consensus       161 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         161 ADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             CCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            99999864321111   111223557999999998889999999999999999997 99999876655544443334344


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+...+..+++|+.+||+.+|.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5566788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.6e-36  Score=283.41  Aligned_cols=225  Identities=21%  Similarity=0.260  Sum_probs=179.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||.||++..+. +..+++|...                        +.+...+......+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            468999999999999999998865 4567776422                        111222345566889999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.++........ ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYT-SSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCcee-ccCC
Confidence            9999999976555688999999999999999999999999999999999998877 4999999998654322211 1112


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..++..|+|||++.+..++.++|+||||+++|+|++ |++||.................+..+...+..+.+++.+||..
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~  240 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHE  240 (256)
T ss_pred             CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccC
Confidence            234567999999998889999999999999999999 9999987665544443333444445666788899999999999


Q ss_pred             CCCCCCCHHHHHc
Q 042746          217 EPGERWSCDQLLK  229 (408)
Q Consensus       217 dP~~R~s~~ell~  229 (408)
                      +|.+||++.|+++
T Consensus       241 ~p~~Rps~~~l~~  253 (256)
T cd05114         241 KPEGRPTFAELLR  253 (256)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-36  Score=280.15  Aligned_cols=227  Identities=32%  Similarity=0.563  Sum_probs=187.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||+|++|.||++.+..+++.+++|......                           ......++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            6899999999999999999999999999887643211                           1112345667899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +++++|.+++... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++ .++|+|||++.........  .
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~--~  156 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKD--D  156 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCccc--c
Confidence            9999999999854 5779999999999999999999999999999999999999876 4999999999765433221  2


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ....+++.|+|||.+.+..++.++|+||||+++++|++|..||.................+.++...+..+++++.+||.
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  236 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ  236 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence            23458999999999988878999999999999999999999997655333222222344556677888999999999999


Q ss_pred             cCCCCCCCHHHHHcCCCC
Q 042746          216 REPGERWSCDQLLKHPFL  233 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~  233 (408)
                      .+|++|||+.+++.||||
T Consensus       237 ~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         237 KDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=284.44  Aligned_cols=226  Identities=22%  Similarity=0.266  Sum_probs=178.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||.||+|.++ ++..+++|....                        ............++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            36899999999999999999886 455676654321                        11122344556789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      |++|.+++......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||+++........ ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~-~kl~dfg~~~~~~~~~~~-~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV-VKVSDFGLARYVLDDQYT-SSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc-EEECCcccceeccccccc-ccCC
Confidence            99999999866667899999999999999999999999999999999999998875 999999998654322111 1111


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+.+++.+||..
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  240 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE  240 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            123457999999998889999999999999999999 8999986654444433333333445567889999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      +|++|||+.|+++.
T Consensus       241 ~p~~Rpt~~~~l~~  254 (256)
T cd05059         241 KPEDRPAFKKLLSQ  254 (256)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=288.25  Aligned_cols=229  Identities=29%  Similarity=0.498  Sum_probs=179.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .+|++.+.||+|+||.||+|.+..+++.+++|.....                           ....+..+...+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            4799999999999999999999999999998753311                           1112234556889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++++.+..+.. ....+++..+..++.||+.||+|||+++++|+||||+||+++.++. +||+|||++........ ..
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~-~kl~d~g~~~~~~~~~~-~~  157 (288)
T cd07833          81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV-LKLCDFGFARALRARPA-SP  157 (288)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEEeeecccccCCCcc-cc
Confidence            999977766665 4456799999999999999999999999999999999999998775 99999999876543322 12


Q ss_pred             cccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhh-------------cc------cC
Q 042746          135 KIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRI-------------GF------SD  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~-------------~~------~~  193 (408)
                      .....+++.|+|||++.+. .++.++|+||||+++|+|++|++||....... +...             .+      ..
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            2335688999999999887 78999999999999999999999997543211 1000             00      00


Q ss_pred             -CCC----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 -ELP----------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 -~~p----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                       ..+          .++...+.++++||.+||..+|++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             000          1233457889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.3e-36  Score=288.95  Aligned_cols=228  Identities=29%  Similarity=0.429  Sum_probs=178.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      ++|++.+.||+|+||+||+|.+..+++.+++|.....                           ....+..+...+++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            4799999999999999999999999999998753211                           1112345567899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++++|..+... ...+++..++.++.||+.+|+|||+++++|+||+|+||+++.++. ++|+|||++........  .
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~-~~l~dfg~~~~~~~~~~--~  156 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGE--V  156 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc-EEEEeeeeeeeccCCcc--c
Confidence            9999988887763 445799999999999999999999999999999999999998874 99999999865433221  1


Q ss_pred             cccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh-hhhc-------------c-------c
Q 042746          135 KIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIG-------------F-------S  192 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-~~~~-------------~-------~  192 (408)
                      .....++..|+|||++.+. .++.++|+||||+++++|++|++||........ ..+.             .       .
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            2234578999999998763 467889999999999999999999965432111 0000             0       0


Q ss_pred             CCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 DELP---------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ~~~p---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ...+         ......+..+++|+.+||+.+|++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0001         1123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.3e-36  Score=283.92  Aligned_cols=227  Identities=24%  Similarity=0.374  Sum_probs=182.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~LV   52 (408)
                      +|.+.+.||+|+||+||++++..++..++++....                              ............+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            69999999999999999999988766554332110                              001112334567899


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||+++++|.+++..   .+..+++..++.++.|++.||.|||++|++|+||||+||+++.+  .++|+|||++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeecCCC
Confidence            999999999998864   34568999999999999999999999999999999999999753  4999999998655332


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      ..  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.................+..+...+.++.++
T Consensus       159 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (260)
T cd08222         159 CD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI  236 (260)
T ss_pred             cc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence            21  1223458999999999988888899999999999999999999997655444433334455666677788999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      |.+||..+|++||++.|+++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         237 MQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.7e-36  Score=289.46  Aligned_cols=228  Identities=24%  Similarity=0.405  Sum_probs=174.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      .+|++.+.||+|+||.||+|.+..+++.+++|.....                          ....+..+...++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            5799999999999999999999999999988753211                          11123344567899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +. ++|.+.+......+++..++.++.||+.||.|||++||+|+||||+|||++.++. ++|+|||+++.......  ..
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~--~~  160 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQ--TY  160 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc-EEEeccccccccCCCCC--CC
Confidence            96 6787777655566788899999999999999999999999999999999998875 99999999865432221  12


Q ss_pred             ccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hhhhhc----------------------
Q 042746          136 IQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIG----------------------  190 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~~~~~----------------------  190 (408)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||......  .+....                      
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            234579999999998764 5788999999999999999999999754321  111000                      


Q ss_pred             --ccCCCCC----CC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          191 --FSDELPR----FP--TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       191 --~~~~~p~----~~--~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                        .....+.    ..  ...+..+.+++.+||..||.+|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              0000000    00  0125678999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.2e-36  Score=297.25  Aligned_cols=228  Identities=25%  Similarity=0.332  Sum_probs=177.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~~   48 (408)
                      .+|++.+.||+|+||+||+|.+..+++.+++|.....                           ....+      .....
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4799999999999999999999999999999864311                           00001      11234


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .++||||+.+ +|.+.+..   .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++....
T Consensus        96 ~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~  170 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT  170 (353)
T ss_pred             EEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC-EEEccCccceeCCC
Confidence            6899999975 88888763   2789999999999999999999999999999999999998875 99999999976543


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc------------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG------------------  190 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~------------------  190 (408)
                      ...   .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+........                  
T Consensus       171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         171 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            221   22345899999999999999999999999999999999999999754321100000                  


Q ss_pred             ---cc------------CCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 ---FS------------DELP---------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 ---~~------------~~~p---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                         +.            ...+         ..+...++.+++||.+||+.||++|||+.|+|+||||+...
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence               00            0000         00123466789999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.1e-36  Score=290.06  Aligned_cols=231  Identities=25%  Similarity=0.365  Sum_probs=176.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccC--------CC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPT--------TS   45 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~--------~~   45 (408)
                      +++|++.+.||+|+||.||+|++..+++.+++|......                           ....        ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            468999999999999999999999999999987532110                           0000        01


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ....++||||+.+ +|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++. +||+|||++..
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~  168 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI-LKLADFGLARA  168 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc-EEECcCCCccc
Confidence            1235899999975 888888766557899999999999999999999999999999999999998874 99999999975


Q ss_pred             cccCCCC--cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--ccC-------
Q 042746          126 ATVSDTR--GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--FSD-------  193 (408)
Q Consensus       126 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--~~~-------  193 (408)
                      .......  .......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||............  ..+       
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            5432211  112234578899999998765 4688999999999999999999999765432211000  000       


Q ss_pred             ------------CCCC----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 ------------ELPR----------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 ------------~~p~----------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                                  ..+.          .+...+..+.+||.+||..||.+|||++|+++||||
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        0000          011235677899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-36  Score=294.71  Aligned_cols=233  Identities=24%  Similarity=0.369  Sum_probs=178.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eec-----cCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEA-----PTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~-----~~~~~~~~~   50 (408)
                      ++|++.+.||+|+||+||+|++..+++.|++|.....                          ...     ........+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            5899999999999999999999999999998854210                          000     011123468


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ++|||+++ +|.+++.  ...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......
T Consensus        85 lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC-EEECcccceeeccccc
Confidence            99999975 8888875  356899999999999999999999999999999999999998875 9999999986643322


Q ss_pred             C-CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhh----------------hc--
Q 042746          131 T-RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR----------------IG--  190 (408)
Q Consensus       131 ~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~----------------~~--  190 (408)
                      . ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...+......                +.  
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1 111223468999999998765 467899999999999999999999997543211100                00  


Q ss_pred             ----ccCCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          191 ----FSDELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       191 ----~~~~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                          +....+        ......++.+.+||.+||+.||++|||+.|+++||||.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                000000        011245777899999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.9e-36  Score=291.21  Aligned_cols=229  Identities=25%  Similarity=0.371  Sum_probs=179.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCC--CcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSS--SCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~--~~~~L   51 (408)
                      +++|++.+.||.|+||.||+|.+..+++.+++|......                           .......  ...+|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            468999999999999999999999999999887543110                           1111122  67899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +|||+++ +|.+++......+++..++.++.||+.||+|||+++++|+||||+||+++.++. +||+|||++........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc-EEEeecCceeeccCCcc
Confidence            9999985 999999866667899999999999999999999999999999999999998874 99999999876543321


Q ss_pred             CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc-------------------
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------------------  191 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~-------------------  191 (408)
                        ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.............                   
T Consensus       162 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         162 --PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             --ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence              12234578999999999765 45889999999999999999999997543322111000                   


Q ss_pred             -----------cCCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          192 -----------SDELPRFPTQ-SSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       192 -----------~~~~p~~~~~-~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                                 ......++.. .++.++++|.+||+.||++|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                       0000112222 57889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.7e-36  Score=289.91  Aligned_cols=233  Identities=25%  Similarity=0.390  Sum_probs=179.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      |++|++.+.||+|++|+||+|.++.+++.+++|.....                           +...+..+...++||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            57899999999999999999999999999988754311                           112234456788999


Q ss_pred             eccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||+++ +|.+.+..... .+++..++.++.||+.||+|||+++++|+||||+||+++.++..+||+|||++........ 
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-  158 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-  158 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence            99975 78887764333 3578889999999999999999999999999999999986555699999999965432211 


Q ss_pred             cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--------------------
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--------------------  191 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--------------------  191 (408)
                       ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.............                    
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (294)
T PLN00009        159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY  237 (294)
T ss_pred             -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence             11234578999999998764 57889999999999999999999997543321111000                    


Q ss_pred             cCCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          192 SDELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       192 ~~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ....+.        .....++.+.+++.+||+.+|++||++.+++.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            000111        113467888999999999999999999999999999864

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.1e-36  Score=284.62  Aligned_cols=226  Identities=20%  Similarity=0.282  Sum_probs=175.5

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCc--EEEEeecccc---------------------------eecc-C-----CCCCc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGD--VFAYLGDDVS---------------------------YEAP-T-----TSSSC   48 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~--~va~k~~~~~---------------------------~~~~-~-----~~~~~   48 (408)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.....                           .... +     .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999988876  4666543211                           0000 0     11224


Q ss_pred             ceEEEeccCCCCHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           49 RNLHLEYLPGGTVSDLATTL-----NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~-----~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .+++|||+++|+|.+++...     ...+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN-VCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC-EEECCCCcc
Confidence            67999999999999987432     234789999999999999999999999999999999999988875 999999999


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCC
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  202 (408)
                      +...............+++.|+|||.+.+..++.++|+||||+++|+|++ |++||.................+..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC  239 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            76543221111122345778999999998889999999999999999999 89999876554444433344444555678


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +..+++++.+||+.||++|||+.|++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         240 LDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.5e-36  Score=290.44  Aligned_cols=231  Identities=34%  Similarity=0.561  Sum_probs=185.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|.+.+.||+|+||+||++.+..+++.+++|.....                         +...+......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5799999999999999999999999999988764321                         111233455688999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++..  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++........  ...
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~-~kL~dfg~~~~~~~~~~--~~~  173 (293)
T cd06647          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQS--KRS  173 (293)
T ss_pred             CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC-EEEccCcceeccccccc--ccc
Confidence            99999999874  45688899999999999999999999999999999999998774 99999998865443222  122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC--CCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR--FPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~--~~~~~s~~~~~li~~~L  214 (408)
                      ...|++.|+|||.+.+..++.++|+||||+++|++++|+.||.................+.  .+...+..+++++.+||
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence            3458999999999988888999999999999999999999997654332221111122222  23346778999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ..+|++||++.+++.||||+...
T Consensus       254 ~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         254 EMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             cCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999998655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.4e-36  Score=290.79  Aligned_cols=228  Identities=25%  Similarity=0.318  Sum_probs=178.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-------CCCcEEEEeeccc---------------------------ceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-------FNGDVFAYLGDDV---------------------------SYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-------~t~~~va~k~~~~---------------------------~~~~~~~~~~   47 (408)
                      ++|++++.||+|+||.||+|+..       .++..+++|....                           ..........
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            47999999999999999999753       2334566664321                           1111233445


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..+++|||+++|+|.+++....               ..++...+..++.||+.||+|||++|++||||||+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            6789999999999999997532               2457778899999999999999999999999999999998877


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                       .+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.......+.....
T Consensus       175 -~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  253 (304)
T cd05101         175 -VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  253 (304)
T ss_pred             -cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence             499999999976543222222223346788999999998889999999999999999998 889998766666555443


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...+..+++|+.+||..+|.+|||+.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         254 EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            444444556788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=282.19  Aligned_cols=229  Identities=35%  Similarity=0.611  Sum_probs=184.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccC--CCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPT--TSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~--~~~~~~   49 (408)
                      .+|++++.||+|+||.||+|.+..+++.+++|.....                              .....  .....+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4799999999999999999999999999998753210                              00011  123457


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      +++|||++|++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++. ++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN-VKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEECccccccccccc
Confidence            8999999999999999753 45789999999999999999999999999999999999998875 999999999765321


Q ss_pred             CC-CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCCCCCCCCCcHHHH
Q 042746          130 DT-RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDELPRFPTQSSELGR  207 (408)
Q Consensus       130 ~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~p~~~~~~s~~~~  207 (408)
                      .. ........|++.|+|||++.+..++.++|+|||||++|+|++|++||....... ..........+.+|...++.++
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  239 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACR  239 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHH
Confidence            11 111123458999999999998888999999999999999999999998654332 3333333344567788899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +++.+||. +|.+||++.+++.|||+
T Consensus       240 ~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         240 DFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999999 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-36  Score=284.63  Aligned_cols=224  Identities=21%  Similarity=0.245  Sum_probs=180.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++++.||+|+||.||+|.+.. +..+++|.....                         +..........+++|||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            368999999999999999999988 777777653311                         112234456678999999


Q ss_pred             CCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++|+|.+++... +..+++..+..++.||+.||+|||++|++|+||||+||+++.++. +||+|||++.........  .
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~-~kl~d~g~~~~~~~~~~~--~  161 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV-CKVADFGLARLIKEDVYL--S  161 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce-EEEccccchhhcCCcccc--c
Confidence            999999999753 346789999999999999999999999999999999999998874 999999998665332211  1


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.................+..+...++.+.+++.+||
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  241 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECW  241 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHc
Confidence            12345678999999998889999999999999999998 89999866544443333333334556678899999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 042746          215 RREPGERWSCDQLLK  229 (408)
Q Consensus       215 ~~dP~~R~s~~ell~  229 (408)
                      +.||.+|||+.++++
T Consensus       242 ~~~p~~Rpt~~~l~~  256 (261)
T cd05148         242 AAEPEDRPSFKALRE  256 (261)
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-35  Score=281.96  Aligned_cols=226  Identities=22%  Similarity=0.243  Sum_probs=179.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+.. +..+++|....                        .+.+........+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            469999999999999999998764 33466654221                        11222334456789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +|+|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||.++........ ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYT-SSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCcee-ecCC
Confidence            9999999986555789999999999999999999999999999999999999877 4999999998654332211 1112


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..++..|+|||++.+..++.++|+||||+++|+|++ |..||.................+..+...+..+++++.+||+.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  240 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHE  240 (256)
T ss_pred             CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            235667999999998889999999999999999998 9999987665544443334444445566788999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||.+||++.+++.+
T Consensus       241 ~p~~Rp~~~~ll~~  254 (256)
T cd05113         241 KAEERPTFQQLLSS  254 (256)
T ss_pred             CcccCCCHHHHHHh
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=308.95  Aligned_cols=232  Identities=31%  Similarity=0.429  Sum_probs=200.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      ..|.+.+.||+|.|++|.+|++..|+..||+|..+..                           .....+.+..+|||||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            4699999999999999999999999999999875532                           2223345677899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+.+|.+++++.+.+ ...+..++.++.|++++++|||+++|+|||||++||||+.+.+ +||+|||++..+...   ..
T Consensus       136 ya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn-ikIaDfgfS~~~~~~---~~  210 (596)
T KOG0586|consen  136 YASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN-IKIADFGFSTFFDYG---LM  210 (596)
T ss_pred             eccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc-eeeeccccceeeccc---cc
Confidence            999999999999654 4566999999999999999999999999999999999999875 999999999776533   34


Q ss_pred             cccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          135 KIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ..+.||+|.|.|||++.+..| ++.+|+||||+++|.|+.|..||++.....+......+.+ .+|-..+.++.++|+++
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~-rIp~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY-RIPFYMSCDCEDLLRKF  289 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-cccceeechhHHHHHHh
Confidence            556889999999999999866 7899999999999999999999998877776665555544 56677889999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      |.++|.+|++.++++.|.|.......
T Consensus       290 lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  290 LVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             hccCccccCCHHHhhhhcccchhhhh
Confidence            99999999999999999999765544

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-35  Score=290.33  Aligned_cols=227  Identities=25%  Similarity=0.304  Sum_probs=177.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-------CCcEEEEeeccc---------------------------ceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-------NGDVFAYLGDDV---------------------------SYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-------t~~~va~k~~~~---------------------------~~~~~~~~~~   47 (408)
                      ++|++++.||+|+||.||+|.+..       ....+++|....                           .+...+..+.
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            478999999999999999998643       233566654221                           1111223445


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..+++|||+++|+|.+++....               ..++...+..++.||+.||.|||++|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            6889999999999999997532               3478888999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||+++...............+++.|+|||++.+..++.++|+||||+++|+|++ |..||.............
T Consensus       172 ~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  250 (314)
T cd05099         172 V-MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR  250 (314)
T ss_pred             c-EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            4 99999999976543221111122234578999999998889999999999999999999 899998766555554433


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ....+..+...+.++++++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         251 EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            44334556677889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.2e-36  Score=287.13  Aligned_cols=226  Identities=23%  Similarity=0.305  Sum_probs=176.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeecc-------------------------cceeccCCCCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LV   52 (408)
                      +|+..+.||+|+||.||++...     .++..++++...                         +.+...+......+++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            6788999999999999999753     345567665432                         1122233445668899


Q ss_pred             EeccCCCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           53 LEYLPGGTVSDLATTLN--------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~--------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                      |||+++|+|.+++....              ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~~kL~  164 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIG  164 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-CEEEC
Confidence            99999999999997543              2478899999999999999999999999999999999998876 49999


Q ss_pred             ecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCC
Q 042746          119 DFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPR  197 (408)
Q Consensus       119 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~  197 (408)
                      |||++................+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.................+.
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE  244 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCC
Confidence            9999865433221111222335788999999999889999999999999999998 999997655444333333333345


Q ss_pred             CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       198 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+...++.+.+|+.+||..||.+||++.|+++
T Consensus       245 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            55678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-35  Score=279.98  Aligned_cols=226  Identities=27%  Similarity=0.401  Sum_probs=181.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++.+.||+|+||.||+|.+..+++.+++|....                            .....+...+..+++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            4689999999999999999999999999998874321                            111123345667899


Q ss_pred             EeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||+++|+|.+++...   +..+++..+..++.||+.+|.|||++|++|+||||+||+++.++. ++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~-~~l~d~~~~~~~~~~  159 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc-EEEeccceeeeccCC
Confidence            9999999999998642   345789999999999999999999999999999999999998875 999999998654322


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCCC-CCcHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFPT-QSSELG  206 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~~-~~s~~~  206 (408)
                      ..  ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ............+..+. ..+..+
T Consensus       160 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             Cc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            21  12234589999999999988899999999999999999999999965432  12222222333344444 678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 042746          207 RDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .++|.+||..+|++|||+.++++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-36  Score=306.33  Aligned_cols=234  Identities=24%  Similarity=0.374  Sum_probs=187.6

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEEec
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVmEy   55 (408)
                      |+.++.||-|+||+|.+++..+|...||+|...                            +.+.-.|+++.++|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            778999999999999999999998888775321                            2344468889999999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC------
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS------  129 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~------  129 (408)
                      ++||++..+|-+. +.++|..++.|+++|..|++++|..|+|||||||+|||||.+|+ |||+|||++.-+...      
T Consensus       711 IPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc-eeeeeccccccceeccccccc
Confidence            9999999999854 56799999999999999999999999999999999999999996 999999998321110      


Q ss_pred             ---CC-------------------------------CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCC
Q 042746          130 ---DT-------------------------------RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK  175 (408)
Q Consensus       130 ---~~-------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~  175 (408)
                         +.                               .-.....+||+.|+|||++....|+..+|+||.|||||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence               00                               00012346999999999999999999999999999999999999


Q ss_pred             CCCCCCChh-hhhhhc-ccCCCC-CCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHcCCCCCCCCCCC
Q 042746          176 PAWEDFGAN-TLSRIG-FSDELP-RFPTQSSELGRDFLDKCLRREPGERW---SCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       176 ~Pf~~~~~~-~~~~~~-~~~~~p-~~~~~~s~~~~~li~~~L~~dP~~R~---s~~ell~hpf~~~~~~~~  240 (408)
                      +||.+.... +..+++ |...+. .+...+|+++.++|.++- -+++.|.   .++|+..||||+.+....
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence            999865432 223332 333221 223578999999998864 5788888   567899999999887553

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-35  Score=282.19  Aligned_cols=227  Identities=24%  Similarity=0.334  Sum_probs=180.5

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++.+.||+|+||.||+|++..+++.+++|....                            .....+......+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            4689999999999999999999999999999874321                            011122344567899


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||+++|+|.+++..   ....+++..+..++.||+.||+|||+++++|+||||+||+++.++. ++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~-~~l~d~g~~~~~~~~  159 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC-EEECccccceeccch
Confidence            999999999998864   2345789999999999999999999999999999999999998875 999999998665432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCC-CCCCcHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRF-PTQSSELG  206 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~-~~~~s~~~  206 (408)
                      ..  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....  ............|.. +...+..+
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            21  12234589999999999888889999999999999999999999865432  222222222233333 34577889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ++++.+||..+|++||++.|+++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-35  Score=280.82  Aligned_cols=221  Identities=24%  Similarity=0.318  Sum_probs=177.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------eec-cCCCCCcceEEEecc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------YEA-PTTSSSCRNLHLEYL   56 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------~~~-~~~~~~~~~LVmEy~   56 (408)
                      +.+|++.+.||+|+||.||++...  +..+++|.....                       ... ....+...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            467999999999999999999765  666666543211                       111 123445689999999


Q ss_pred             CCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++++|.+++...+. .+++..+..++.||+.+|+|||++|++||||||+||+++.++. +||+|||+++......     
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~-~kl~dfg~~~~~~~~~-----  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ-----  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc-EEecCCccceeccccC-----
Confidence            99999999976443 4789999999999999999999999999999999999998874 9999999986543221     


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....++..|+|||++.+..++.++|+|||||++|+|++ |++||.................+..+...++.+++++.+||
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (256)
T cd05082         157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW  236 (256)
T ss_pred             CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence            12234678999999998889999999999999999997 99999876655554433334344556678899999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 042746          215 RREPGERWSCDQLLK  229 (408)
Q Consensus       215 ~~dP~~R~s~~ell~  229 (408)
                      +.+|++|||+.++++
T Consensus       237 ~~~p~~Rpt~~~l~~  251 (256)
T cd05082         237 HLDAATRPSFLQLRE  251 (256)
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=309.56  Aligned_cols=221  Identities=25%  Similarity=0.322  Sum_probs=184.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------eeccCCCCCcceEEEeccCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------YEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.|.+...||.|+|+.|..+.+..+++.+++|.....                      ...........|+|||++.|+
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~  401 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG  401 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence            5688889999999999999999999999887654422                      222344566789999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc-CCCCcEEEeecCCccccccCCCCcccccC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG-PNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~-~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      .|.+.+... .. ....+..|++||+.++.|||++||+||||||+|||++ ..+ .++|+|||.++.....     ..++
T Consensus       402 ell~ri~~~-~~-~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~-----~~tp  473 (612)
T KOG0603|consen  402 ELLRRIRSK-PE-FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS-----CDTP  473 (612)
T ss_pred             HHHHHHHhc-ch-hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh-----hccc
Confidence            998888643 22 3377788999999999999999999999999999994 555 4999999999877654     3345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE  217 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~d  217 (408)
                      +-|..|.|||++....|+.++||||||++||+||+|+.||...... ++...   -..+.+....|..+++||++||+.|
T Consensus       474 ~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---i~~~~~s~~vS~~AKdLl~~LL~~d  550 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---IQMPKFSECVSDEAKDLLQQLLQVD  550 (612)
T ss_pred             chhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh---hcCCccccccCHHHHHHHHHhccCC
Confidence            6799999999999999999999999999999999999999865433 22222   2233445789999999999999999


Q ss_pred             CCCCCCHHHHHcCCCC
Q 042746          218 PGERWSCDQLLKHPFL  233 (408)
Q Consensus       218 P~~R~s~~ell~hpf~  233 (408)
                      |.+|+++.+++.||||
T Consensus       551 P~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  551 PALRLGADEIGAHPWF  566 (612)
T ss_pred             hhhCcChhhhccCcch
Confidence            9999999999999999

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.4e-36  Score=290.31  Aligned_cols=229  Identities=31%  Similarity=0.474  Sum_probs=182.4

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEeccCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      |.....||+|+||.||+|.+..+++.+++|.....                         ....+..+...+++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            44566899999999999999999999988764311                         11123345678899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      ++|.+++..  ..+++..++.++.|++.||+|||++|++||||||+||+++.++. +||+|||++........  .....
T Consensus       103 ~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~-~kL~dfg~~~~~~~~~~--~~~~~  177 (297)
T cd06659         103 GALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP--KRKSL  177 (297)
T ss_pred             CCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc-EEEeechhHhhcccccc--cccce
Confidence            999998863  46789999999999999999999999999999999999998875 99999999865432221  12234


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC--CCCCCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE--LPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      .|++.|+|||++.+..++.++|+||||+++|+|++|+.||................  ....+...+..+.++|.+||+.
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            68999999999998889999999999999999999999997554333222211111  1122345678899999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +|.+||++.++++||||....
T Consensus       258 ~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         258 EPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             CcccCcCHHHHhhChhhccCC
Confidence            999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-35  Score=280.53  Aligned_cols=225  Identities=23%  Similarity=0.260  Sum_probs=176.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++.+.||+|+||.||+|.+. ++..+++|....                        ............+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            57999999999999999999976 455677764321                        11122345566889999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.+++... ...++...+..++.|++.||+|||+++++||||||+||+++.++. ++|+|||++......... ...
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~~~~-~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIEDNEYT-ARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc-EEECCCccceecCCCcee-ccC
Confidence            99999999753 456788899999999999999999999999999999999998874 999999999665332211 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||++.+..++.++|+||||+++|+|++ |..||.................+..+...+..+.+++.+||+
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWK  242 (261)
T ss_pred             CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            2235678999999998888999999999999999998 999998655444333322222223335678899999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .+|++||+++++++
T Consensus       243 ~~p~~Rp~~~~i~~  256 (261)
T cd05072         243 EKAEERPTFDYLQS  256 (261)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-36  Score=286.22  Aligned_cols=227  Identities=26%  Similarity=0.409  Sum_probs=176.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +|++.+.||.|+||.||+|+++.+++.+++|.....                           ....+..+...+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            589999999999999999999999999998754321                           11123455678899999


Q ss_pred             cCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++ ++|.+++... +..+++..++.++.|++.||+|||+++++|+||+|+||+++.++. +||+|||++........  .
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~-~~l~dfg~~~~~~~~~~--~  156 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR--T  156 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEeeccchhhcccCcc--c
Confidence            97 5898888653 356789999999999999999999999999999999999998875 99999999865432221  1


Q ss_pred             cccCCCCCCCCChhhHhCCC-CCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcc-------------------cC
Q 042746          135 KIQPRGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGF-------------------SD  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~-~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~-------------------~~  193 (408)
                      .....+++.|+|||++.+.. ++.++|+||||+++|+|+||+.||....... ..+...                   ..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            22335788999999987643 5788999999999999999999997543211 111000                   00


Q ss_pred             CCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 ELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 ~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..+        ......++.++++|.+||+.||.+|||+.|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            000        1123467888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=283.30  Aligned_cols=226  Identities=25%  Similarity=0.275  Sum_probs=181.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc----EEEEeecccc--------------------------eeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD----VFAYLGDDVS--------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~----~va~k~~~~~--------------------------~~~~~~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|.++.++.    .+++|.....                          ..+... ....++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCceEE
Confidence            479999999999999999999887775    3666543211                          000111 145679


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +|||+++|+|.+++......+++..+..++.||+.||+|||+++++||||||+||+++.++. +||+|||+++.......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~-~kL~dfg~~~~~~~~~~  164 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEK  164 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe-EEECCCcccccccCccc
Confidence            99999999999999876667899999999999999999999999999999999999988774 99999999976543222


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........+++.|+|||.+....++.++|+||||+++|++++ |+.||.......+............+...+..+.+++
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (279)
T cd05057         165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVL  244 (279)
T ss_pred             ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            111112224567999999988888999999999999999998 9999988776665554444444455667888999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||..||++||++.++++
T Consensus       245 ~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         245 VKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHcCCChhhCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=301.98  Aligned_cols=222  Identities=22%  Similarity=0.292  Sum_probs=179.5

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccCCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +++.+.||+|-||.||+|..+.+. .||+|...                        +.+.+....+.-+||||||++.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            345889999999999999997542 34443221                        23333444445689999999999


Q ss_pred             CHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           60 TVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        60 sL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      +|.++|+. .+..++......++.||+.|++||+++++|||||-+.||||+.+. .+||+|||+|+........ .....
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~~Y~-~~~~~  364 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDDEYT-ASEGG  364 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccccccCCCcee-ecCCC
Confidence            99999996 567888999999999999999999999999999999999999887 6999999999943322221 11111


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE  217 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~d  217 (408)
                      .-...|.|||.+....++.+||||||||+|+||+| |+.||......+..+....+...+-|..+|+.+.+++..||..+
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~  444 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHED  444 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCC
Confidence            22345999999999999999999999999999998 99999988777666665566655667889999999999999999


Q ss_pred             CCCCCCHHHHH
Q 042746          218 PGERWSCDQLL  228 (408)
Q Consensus       218 P~~R~s~~ell  228 (408)
                      |++|||++.+.
T Consensus       445 P~~RPtF~~L~  455 (468)
T KOG0197|consen  445 PEDRPTFETLR  455 (468)
T ss_pred             cccCCCHHHHH
Confidence            99999998664

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-35  Score=282.05  Aligned_cols=226  Identities=26%  Similarity=0.357  Sum_probs=179.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++.+.||+|+||.||+|.+..+++.+++|....                            .....+..+...+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            4789999999999999999999999999999875321                            011123345567899


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||++|++|.+++..   ....+++..++.++.||+.+|.|||++|++|+||||+||+++.++. ++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~dfg~~~~~~~~  159 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEECcchhhhccccC
Confidence            999999999999874   2346789999999999999999999999999999999999998875 999999998654322


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hhhhhcccCCCCC-CCCCCcHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPR-FPTQSSELG  206 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~p~-~~~~~s~~~  206 (408)
                      ..  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......  ...........+. .+...++.+
T Consensus       160 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             Cc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence            21  122346899999999999888999999999999999999999999654322  2222211222222 234578899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 042746          207 RDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++++.+||..||++|||+.++++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=7.4e-36  Score=280.63  Aligned_cols=209  Identities=25%  Similarity=0.305  Sum_probs=170.7

Q ss_pred             cCCeeEEEEEEcCCCcEEEEeecccc--------------------eeccCCCCCcceEEEeccCCCCHHHHHHHhCCCC
Q 042746           13 GSFGTVNVAVDRFNGDVFAYLGDDVS--------------------YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA   72 (408)
Q Consensus        13 G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------~~~~~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l   72 (408)
                      |.||+||+|+++.+++.+++|.....                    +...+......+++|||++||+|.+++... ..+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l   82 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNI   82 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCC
Confidence            89999999999999999998765421                    112234456788999999999999998754 457


Q ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhC
Q 042746           73 DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG  152 (408)
Q Consensus        73 ~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~  152 (408)
                      ++..+..++.|++.||+|||++||+||||||+||+++.++. ++++|||.+.......     ....++..|+|||++.+
T Consensus        83 ~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~  156 (237)
T cd05576          83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH-IQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGI  156 (237)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC-EEEecccchhcccccc-----ccCCcCccccCCcccCC
Confidence            99999999999999999999999999999999999998875 9999999875543221     12346788999999988


Q ss_pred             CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH-----HHH
Q 042746          153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC-----DQL  227 (408)
Q Consensus       153 ~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~el  227 (408)
                      ..++.++|+||+|+++|+|++|..||........     ......+|...++.++++|.+||+.||++|+++     +|+
T Consensus       157 ~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~  231 (237)
T cd05576         157 SEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI  231 (237)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence            8889999999999999999999988764321110     111123556788999999999999999999985     999


Q ss_pred             HcCCCC
Q 042746          228 LKHPFL  233 (408)
Q Consensus       228 l~hpf~  233 (408)
                      ++||||
T Consensus       232 ~~h~~~  237 (237)
T cd05576         232 KSHPFF  237 (237)
T ss_pred             HcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-35  Score=284.55  Aligned_cols=227  Identities=25%  Similarity=0.436  Sum_probs=177.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      +|++.+.||.|++|+||+|++..++..+++|.....                          ....+......+|||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            699999999999999999999999999998754321                          111233456678999999


Q ss_pred             CCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           57 PGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        57 ~gGsL~~~l~~~~--~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++ +|.+++....  ..+++..+..++.||+.||+|||++|++||||||+||+++.++. ++|+|||++........  .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~-~~l~d~g~~~~~~~~~~--~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVN--T  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc-EEEeecchhhhhcCCcc--c
Confidence            86 8988887543  45799999999999999999999999999999999999998875 99999999865432211  1


Q ss_pred             cccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--------------------ccC
Q 042746          135 KIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------------------FSD  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--------------------~~~  193 (408)
                      .....+++.|++||++.+. .++.++|+||||+++|+|++|++||............                    +..
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            2234578999999998764 5688999999999999999999999764432211100                    001


Q ss_pred             CCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 ELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 ~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..|.        +....+..+++++.+||+.||.+||++.|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1111        112457788999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-35  Score=280.30  Aligned_cols=227  Identities=21%  Similarity=0.282  Sum_probs=178.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeecccc--------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDVS--------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~~--------------------------~~~~~~~~~~~~LV   52 (408)
                      .+|+..+.||+|+||.||+|++..+++   .+++|.....                          ....+......+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            468999999999999999999987665   5677653311                          11123345567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++++|.+++....+.+++..+..++.|++.||+|||++|++|+||||+||+++.++. +||+|||++.........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~-~kl~dfg~~~~~~~~~~~  163 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE-CKVSDFGLSRVLEDDPEG  163 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc-EEECCCccceeccccccc
Confidence            9999999999999866677899999999999999999999999999999999999998774 999999998655432211


Q ss_pred             cc-cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 GV-KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 ~~-~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      .. ......++.|+|||++.+..++.++|+|||||++|+|++ |..||....................+...+..+.+++
T Consensus       164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  243 (268)
T cd05063         164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLM  243 (268)
T ss_pred             ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            11 111123457999999998888999999999999999997 9999976555444443333323333456788899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||..+|++||++.++++
T Consensus       244 ~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         244 LQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHcCCCcccCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-35  Score=286.81  Aligned_cols=231  Identities=23%  Similarity=0.371  Sum_probs=176.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccC--------CC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPT--------TS   45 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~--------~~   45 (408)
                      +++|++.+.||+|+||.||+|.++.+++.+++|......                           ...+        ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999999999999887532110                           0000        12


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ...++++|||+.+ +|.+.+......+++..++.++.||+.+|+|||++||+|+||||+||+++.++. ++|+|||++..
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~  164 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI-LKIADFGLARP  164 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEECcCccchh
Confidence            3356899999976 777777655567899999999999999999999999999999999999998875 99999999865


Q ss_pred             cccCCCC---------cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc---
Q 042746          126 ATVSDTR---------GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS---  192 (408)
Q Consensus       126 ~~~~~~~---------~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~---  192 (408)
                      .......         .......|++.|+|||++.+. .++.++|+||||+++|+|++|++||..............   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            4322211         111223578899999998764 578999999999999999999999976543322111000   


Q ss_pred             ----------CCCC---------CCC-------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 ----------DELP---------RFP-------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ----------~~~p---------~~~-------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                                ...+         ..+       ...++.+.+||.+||+.||.+|||+.|++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                      0000         000       2344678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-35  Score=282.58  Aligned_cols=231  Identities=29%  Similarity=0.444  Sum_probs=181.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eecc--CCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAP--TTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~--~~~~~~~~LVm   53 (408)
                      ++|+..+.||.|++|.||+|.+..+++.+++|.....                          +...  ......++++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            5799999999999999999999999999988753311                          1111  12234678999


Q ss_pred             eccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           54 EYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        54 Ey~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ||++|++|.+++..   ....+++..+..++.||+.+|.|||+++++|+||+|+||+++.++. ++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~-~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ-VKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe-EEEeeccccccccccc
Confidence            99999999988754   3456789999999999999999999999999999999999998875 9999999986543222


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-----hhhhhhcccCCCCCCC------
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-----NTLSRIGFSDELPRFP------  199 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-----~~~~~~~~~~~~p~~~------  199 (408)
                      .    ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....     ............+.++      
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             c----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            1    134578899999999988899999999999999999999999975421     1111111111112211      


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ...++.+++||.+||..+|++|||+.|++.||||....
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            13457889999999999999999999999999996543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.7e-35  Score=284.93  Aligned_cols=234  Identities=32%  Similarity=0.514  Sum_probs=188.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce------------------------eccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY------------------------EAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~------------------------~~~~~~~~~~~LVmEy~~   57 (408)
                      +.|++.+.||+|+||.||+|.+..++..+++|......                        ...+......++++||++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            46888999999999999999999999999887544211                        112334466889999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      |++|.+++......+++..+..++.|++.+|+|||++|++|+||||+||+++.++. ++|+|||++........  ....
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~-~~l~d~~~~~~~~~~~~--~~~~  175 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKS--KRNS  175 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC-EEECccchhhhhccchh--hhcc
Confidence            99999999875547899999999999999999999999999999999999998775 99999998854432211  1223


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCC--CCCcHHHHHHHHHhcc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP--TQSSELGRDFLDKCLR  215 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~--~~~s~~~~~li~~~L~  215 (408)
                      ..+++.|+|||++.+..++.++|+||||+++|+|++|+.||.................+..+  ...+..++++|.+||+
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV  255 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhc
Confidence            35789999999999888999999999999999999999999876544332222222222222  2367889999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCCCC
Q 042746          216 REPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+|.+|||+.+++.||||....+
T Consensus       256 ~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         256 KDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             cChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-35  Score=291.55  Aligned_cols=233  Identities=23%  Similarity=0.341  Sum_probs=177.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-------------------------ecc--------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-------------------------EAP--------------   42 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-------------------------~~~--------------   42 (408)
                      .+|++.+.||.|+||.||+|.+..++..+++|......                         ...              
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            58999999999999999999999999999987543210                         000              


Q ss_pred             CCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           43 TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        43 ~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      .......+++|||+++ +|.+++.  ...+++..++.++.||+.||+|||++||+||||||+||+++.++..+||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYMET-DLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeecccc-cHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence            0111346899999985 8988886  346789999999999999999999999999999999999986655699999999


Q ss_pred             ccccccCCC-CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---------
Q 042746          123 AGEATVSDT-RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---------  191 (408)
Q Consensus       123 a~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---------  191 (408)
                      +........ ........|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.............         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            865432211 111122357899999998754 567889999999999999999999997543221111000         


Q ss_pred             ---------------cCCCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          192 ---------------SDELP-----RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       192 ---------------~~~~p-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                     ....+     ......+.++++||.+||+.||.+|||+.|+++||||+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence                           00000     11234678889999999999999999999999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-35  Score=284.87  Aligned_cols=226  Identities=24%  Similarity=0.310  Sum_probs=176.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeecc--------------------------cceeccCCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDD--------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~--------------------------~~~~~~~~~~~~~~L   51 (408)
                      +|++.+.||+|+||+||+|.+....     ..+++|...                          +.+...+..+...++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            5899999999999999999986422     346655321                          112222345566789


Q ss_pred             EEeccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE
Q 042746           52 HLEYLPGGTVSDLATTLN-----------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV  108 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~-----------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl  108 (408)
                      +|||+++|+|.+++....                       ..+++..+..++.|++.||+|||+++++||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            999999999999986421                       246788899999999999999999999999999999999


Q ss_pred             cCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhh
Q 042746          109 GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLS  187 (408)
Q Consensus       109 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~  187 (408)
                      +.++ .+||+|||+++...............++..|+|||++.+..++.++||||||+++++|++ |..||.......+.
T Consensus       161 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         161 AEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             cCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            8877 499999999865432222111222346778999999988889999999999999999998 99999876665554


Q ss_pred             hhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          188 RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       188 ~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ........+..+...+..+.+|+.+||+.+|++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            443333333445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-35  Score=285.64  Aligned_cols=230  Identities=28%  Similarity=0.439  Sum_probs=177.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      ++|+..+.||+|+||.||++.+..+++.+++|.....                           +.+....+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4677889999999999999999999999998764311                           1111223455678999


Q ss_pred             ccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           55 YLPGGTVSDLATT----LNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        55 y~~gGsL~~~l~~----~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |+.+ +|.++...    ....+++..+..++.|++.||+|||+. +++||||||+||+++.++. +||+|||++......
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~  161 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDS  161 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc-EEEeecchhHHhccC
Confidence            9875 66554332    245689999999999999999999975 9999999999999998874 999999998654332


Q ss_pred             CCCcccccCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCC----C
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFP----T  200 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~----~  200 (408)
                      ..   .....|++.|+|||++.+.   .++.++|+||||+++|+|++|++||.....  ..+... .....|.++    .
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  237 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV-VKGDPPILSNSEER  237 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhh-cCCCCCcCCCcCCC
Confidence            21   1223589999999999876   688999999999999999999999976542  112221 122222222    2


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ..+..+.+|+.+||++||++|||++|+++||||....
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            4688899999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-35  Score=294.01  Aligned_cols=228  Identities=23%  Similarity=0.305  Sum_probs=174.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-----cCCCcEEEEeecccce---------------------------ecc-CCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-----RFNGDVFAYLGDDVSY---------------------------EAP-TTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-----~~t~~~va~k~~~~~~---------------------------~~~-~~~~~~   48 (408)
                      ++|++++.||+|+||+||+|++     ..+++.||+|......                           ... ...+..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4799999999999999999985     3567788887543110                           000 122345


Q ss_pred             ceEEEeccCCCCHHHHHHHhC-----------------------------------------------------------
Q 042746           49 RNLHLEYLPGGTVSDLATTLN-----------------------------------------------------------   69 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~-----------------------------------------------------------   69 (408)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986421                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCC
Q 042746           70 -------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP  142 (408)
Q Consensus        70 -------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~  142 (408)
                             ..++...+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||++................+++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCCCc
Confidence                   2356777889999999999999999999999999999999877 49999999987643222111112234567


Q ss_pred             CCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-hhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 042746          143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE  220 (408)
Q Consensus       143 ~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~  220 (408)
                      .|+|||++.+..++.++|+||||+++|+|++ |..||...... ...........+..+...++.+.+++.+||+.||++
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~  325 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ  325 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            8999999998889999999999999999997 99999764322 222222223333445667888999999999999999


Q ss_pred             CCCHHHHHcC
Q 042746          221 RWSCDQLLKH  230 (408)
Q Consensus       221 R~s~~ell~h  230 (408)
                      |||+.|+++|
T Consensus       326 Rps~~eil~~  335 (343)
T cd05103         326 RPTFSELVEH  335 (343)
T ss_pred             CcCHHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.5e-35  Score=279.43  Aligned_cols=220  Identities=22%  Similarity=0.304  Sum_probs=174.2

Q ss_pred             ceeeecCCeeEEEEEE--cCCCcEEEEeeccccee-------------------cc-------CCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVD--RFNGDVFAYLGDDVSYE-------------------AP-------TTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d--~~t~~~va~k~~~~~~~-------------------~~-------~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||+|.+  ..++..+++|.......                   .+       .......+++|||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~   80 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELG   80 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCC
Confidence            3689999999999965  45677888875431100                   00       11234568999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc-ccccC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG-VKIQP  138 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~-~~~~~  138 (408)
                      +|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......... .....
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCCC
Confidence            99999974 45679999999999999999999999999999999999999876 49999999997654332111 11122


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE  217 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~d  217 (408)
                      .+++.|+|||.+....++.++|+|||||++|+|++ |++||.................+..|...+++++++|.+||+.|
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            34678999999988888999999999999999998 99999876655554444444455677788999999999999999


Q ss_pred             CCCCCCHHHHHc
Q 042746          218 PGERWSCDQLLK  229 (408)
Q Consensus       218 P~~R~s~~ell~  229 (408)
                      |++||++.+|..
T Consensus       239 p~~Rp~~~~i~~  250 (257)
T cd05116         239 VDERPGFAVVEL  250 (257)
T ss_pred             chhCcCHHHHHH
Confidence            999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=286.87  Aligned_cols=229  Identities=24%  Similarity=0.384  Sum_probs=174.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcC--CCcEEEEeecccc----------------------------eeccCCCC--Ccce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRF--NGDVFAYLGDDVS----------------------------YEAPTTSS--SCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~--t~~~va~k~~~~~----------------------------~~~~~~~~--~~~~   50 (408)
                      +|++.+.||+|+||.||+|.+..  ++..+|+|.....                            +...+...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999998  8899998754431                            11112233  6789


Q ss_pred             EEEeccCCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC----CCCcEEEeecCC
Q 042746           51 LHLEYLPGGTVSDLATTL----NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP----NSSFVKLADFGA  122 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~----~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~----~~~~vkL~DFGl  122 (408)
                      +||||+++ +|.+++...    ...+++..++.++.||+.||+|||+++|+||||||+||+++.    ++ .+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL  158 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence            99999986 777776532    236789999999999999999999999999999999999988    66 499999999


Q ss_pred             ccccccCCC-CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhh----------hhhh-
Q 042746          123 AGEATVSDT-RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----------LSRI-  189 (408)
Q Consensus       123 a~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~----------~~~~-  189 (408)
                      +........ ........+++.|+|||++.+. .++.++|+||||+++++|++|++||.......          +... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            876533221 1112234678999999998764 57889999999999999999999997543221          0000 


Q ss_pred             ------------------cc-----cCCCCCCC-----------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          190 ------------------GF-----SDELPRFP-----------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       190 ------------------~~-----~~~~p~~~-----------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                                        .+     ......++           ...+..+.+++.+||..||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                              00     00000111           1456778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.7e-35  Score=284.06  Aligned_cols=233  Identities=27%  Similarity=0.416  Sum_probs=184.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEc---CCCcEEEEeeccc------------------------------ceeccCCCCCcc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV------------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~------------------------------~~~~~~~~~~~~   49 (408)
                      +|++.+.||.|+||.||+|.+.   .++..|++|....                              .+...++.+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999985   4788888874321                              011123345567


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++. +||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~-~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC-EEEeeCccceecccc
Confidence            899999999999999975 456789999999999999999999999999999999999998874 999999998765332


Q ss_pred             CCCcccccCCCCCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCc
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s  203 (408)
                      .. .......|++.|+|||.+...  .++.++|+||||+++|+|++|..||...+.    ..+.... ....+.++...+
T Consensus       159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (290)
T cd05613         159 EV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQEMS  236 (290)
T ss_pred             cc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh-hccCCCCCccCC
Confidence            21 112235689999999998753  467899999999999999999999964321    1222221 222345566788


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +.+.+++.+||..||++||     ++++++.||||....+.
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence            9999999999999999997     88999999999887654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-35  Score=279.12  Aligned_cols=225  Identities=22%  Similarity=0.229  Sum_probs=177.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||.||+|.+.. ++.+++|....                        .+...+...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            468999999999999999999764 46677765331                        11122334566789999999


Q ss_pred             CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      |++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++......... ...
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~~~-~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI-CKVADFGLARVIKEDIYE-ARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC-EEECCcceEEEccCCccc-ccC
Confidence            999999997543 46789999999999999999999999999999999999998875 999999998765422111 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ....+..|+|||++.+..++.++|+||||+++|+|++ |+.||.................+..+...+..+.+++.+||+
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  242 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWK  242 (261)
T ss_pred             CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhh
Confidence            1123457999999998889999999999999999999 999998766544433322222233455678899999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .+|.+||++.++++
T Consensus       243 ~~P~~Rp~~~~l~~  256 (261)
T cd05068         243 EDPDDRPTFETLQW  256 (261)
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.4e-35  Score=280.03  Aligned_cols=227  Identities=22%  Similarity=0.276  Sum_probs=177.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeecccc--------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDVS--------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~~--------------------------~~~~~~~~~~~~LV   52 (408)
                      ..|++.+.||+|+||.||+|.++.+++   .+++|.....                          +...+..+...+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            468999999999999999999987775   4777653311                          11223445667899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++....+.+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccCccc
Confidence            999999999999987666789999999999999999999999999999999999998877 4999999998654332211


Q ss_pred             cccccCC---CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHH
Q 042746          133 GVKIQPR---GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD  208 (408)
Q Consensus       133 ~~~~~~~---Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~  208 (408)
                      .......   .+..|+|||++.+..++.++|+|||||++|++++ |..||....................+...+..+.+
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  242 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ  242 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence            1111111   2457999999998889999999999999999886 99999766544433332222222334567888999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q 042746          209 FLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+||..+|.+||++.+++.
T Consensus       243 li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         243 LMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.6e-35  Score=279.82  Aligned_cols=227  Identities=22%  Similarity=0.292  Sum_probs=178.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeeccc--------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDV--------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~--------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||.||+|.+..++.   .+++|....                          .+...+..+...+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            479999999999999999999876554   577764321                          111123345668899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++|++|.+++......+++..+..++.|++.||+|||+++++||||||+|||++.++. ++|+|||++.........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe-EEeCCCCcccccccccce
Confidence            9999999999999876667899999999999999999999999999999999999998874 999999998765432211


Q ss_pred             c-ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 G-VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 ~-~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      . ......+++.|+|||.+.+..++.++|+||||+++|++++ |..||.................+..+...++.+++++
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM  242 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHH
Confidence            1 1111223567999999998889999999999999999886 9999987654433332222222334456788899999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||+++|.+||++.++++
T Consensus       243 ~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         243 LDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHcccCchhCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.7e-35  Score=285.31  Aligned_cols=233  Identities=27%  Similarity=0.385  Sum_probs=182.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      +++|++.+.||+|+||+||+|.+..+++.+++|.....                           ..+.+......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            36899999999999999999999999999988764311                           111223455688999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||+++ +|.+++......+++..+..++.||+.+|+|||+ ++|+||||+|+||+++.++ .+||+|||++........ 
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~~-  170 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSKA-  170 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCCc-
Confidence            99865 8888887766788999999999999999999997 6999999999999998877 499999999865432221 


Q ss_pred             cccccCCCCCCCCChhhHhCCC----CCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCCCCCC--CCCcHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGEC----QGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELPRFP--TQSSEL  205 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~----~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~p~~~--~~~s~~  205 (408)
                        .....+++.|+|||.+.+..    ++.++|+||||+++|+|++|+.||...... ...........+..+  ...+..
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (296)
T cd06618         171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD  248 (296)
T ss_pred             --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence              12234788999999997653    788999999999999999999999753221 111112222223332  246888


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +++|+.+||..||.+||++.++++||||.....
T Consensus       249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            999999999999999999999999999986443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-35  Score=291.30  Aligned_cols=236  Identities=23%  Similarity=0.358  Sum_probs=182.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee---------------------------ccC----CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---------------------------APT----TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~---------------------------~~~----~~~~~~~   50 (408)
                      ++|++.+.||+|+||.||+|.++.+++.|++|.......                           ..+    ......+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            579999999999999999999999999999875332110                           001    1234578


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+. |+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||+++.++. +||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEecccccceeecccC
Confidence            9999996 589988864 456899999999999999999999999999999999999998875 9999999986654322


Q ss_pred             CC--cccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------------
Q 042746          131 TR--GVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------------  190 (408)
Q Consensus       131 ~~--~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------------  190 (408)
                      ..  .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|++||...+........                 
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            11  11223468999999999866 45789999999999999999999999764322110000                 


Q ss_pred             ------c--cCCCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          191 ------F--SDELPR-----FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       191 ------~--~~~~p~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                            .  ....+.     .....++.++++|.+||+.+|.+|||+.+++.||||.......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                  0  000001     1134688899999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-35  Score=290.82  Aligned_cols=233  Identities=24%  Similarity=0.380  Sum_probs=180.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee-------------------c--------cC-----CCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE-------------------A--------PT-----TSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~-------------------~--------~~-----~~~~~~   49 (408)
                      .+|.+.+.||+|+||+||+|++..++..+++|.......                   .        .+     ......
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            579999999999999999999999999999886432110                   0        00     011346


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      +|+|||+. ++|.+++.. .+.+++..++.++.||+.||.|||+++++||||||+||+++.++. +||+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~-~kL~Dfg~~~~~~~~  161 (337)
T cd07858          85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-EEECcCccccccCCC
Confidence            89999996 589988874 467899999999999999999999999999999999999998875 999999998765432


Q ss_pred             CCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc------------------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG------------------  190 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~------------------  190 (408)
                      ..  ......++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+........                  
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 GD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             cc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            11  1223457899999999875 46889999999999999999999999754321100000                  


Q ss_pred             ----ccCCC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 ----FSDEL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 ----~~~~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                          +....        .......++.++++|.+||+.+|++|||+.|+++||||......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                00000        01123578889999999999999999999999999999876443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=282.59  Aligned_cols=229  Identities=26%  Similarity=0.397  Sum_probs=181.0

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEeccC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      +....||.|+-|+|++++.+.+|...|+|...-                           ...+.|..+.-++|.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            456789999999999999999999999986431                           11111222222333466664


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      - .+..++++..++++|..+-.+...++.||.||.+ ++|+|||+||+|||+|..|. +||+|||++........   ..
T Consensus       175 ~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn-iKlCDFGIsGrlvdSkA---ht  249 (391)
T KOG0983|consen  175 T-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN-IKLCDFGISGRLVDSKA---HT  249 (391)
T ss_pred             H-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC-EEeecccccceeecccc---cc
Confidence            3 4566777778899999999999999999999985 68999999999999999986 99999999977654432   22


Q ss_pred             cCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcccCCCCCCCC--CCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPT--QSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~p~~~~--~~s~~~~~l  209 (408)
                      ...|.+.|||||.+...   .|+.++||||||++++||.||+.||...+  .+.+.. +...++|.++.  .+|+++++|
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk-vln~ePP~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK-VLNEEPPLLPGHMGFSPDFQSF  328 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-HHhcCCCCCCcccCcCHHHHHH
Confidence            34599999999999643   68899999999999999999999998743  333333 34566666664  379999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +..||.+|+.+||...++|+|||+....+.
T Consensus       329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             HHHHhhcCcccCcchHHHhcCcceeecchh
Confidence            999999999999999999999999866543

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-35  Score=278.56  Aligned_cols=224  Identities=22%  Similarity=0.269  Sum_probs=176.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++.+.||+|+||.||+|.+. ++..+++|.....                        ..... .....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-CCCCcEEEEEecC
Confidence            57999999999999999999876 4455766543210                        11111 2345789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +++|.+++... ...+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||++......... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~-~~~  161 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT-ARQ  161 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc-ccc
Confidence            99999999753 34578999999999999999999999999999999999999877 4999999999654332211 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||++.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+++|+.+||.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWK  241 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcc
Confidence            2235667999999988889999999999999999999 899998765544444333333445566788999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      ++|++|||+.++..
T Consensus       242 ~~p~~Rpt~~~l~~  255 (260)
T cd05070         242 KDPEERPTFEYLQS  255 (260)
T ss_pred             cCcccCcCHHHHHH
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.3e-35  Score=279.05  Aligned_cols=224  Identities=25%  Similarity=0.284  Sum_probs=176.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+..++ .+++|.....                        ..... .....+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCcEEEEEcCC
Confidence            47999999999999999999987664 4777643311                        01111 2345689999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.+++... +..+++..+..++.|++.||+|||+++++||||||+||+++.++. ++|+|||.+......... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~-~~L~dfg~~~~~~~~~~~-~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYT-ARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc-EEeccCCceeeccccccc-ccc
Confidence            99999999753 345788999999999999999999999999999999999998875 999999998654332211 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||++.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+.+++.+||+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  241 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR  241 (262)
T ss_pred             CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence            2346778999999988889999999999999999999 899998765544433333332233455678899999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      +||++||++.++++
T Consensus       242 ~~p~~Rp~~~~~~~  255 (262)
T cd05071         242 KEPEERPTFEYLQA  255 (262)
T ss_pred             CCcccCCCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.7e-35  Score=299.09  Aligned_cols=227  Identities=25%  Similarity=0.275  Sum_probs=175.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      ++|++++.||+|+||+||+|.+...+     ..||+|....                           .+.+.+......
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            46889999999999999999875433     3577765421                           112223445678


Q ss_pred             eEEEeccCCCCHHHHHHHhC------------------------------------------------------------
Q 042746           50 NLHLEYLPGGTVSDLATTLN------------------------------------------------------------   69 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~------------------------------------------------------------   69 (408)
                      +|||||+++|+|.+++....                                                            
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            99999999999999886421                                                            


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCc
Q 042746           70 -----------------------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF  114 (408)
Q Consensus        70 -----------------------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~  114 (408)
                                                         ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~-~  275 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK-I  275 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC-E
Confidence                                               2367778889999999999999999999999999999999877 4


Q ss_pred             EEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-hhhhhccc
Q 042746          115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIGFS  192 (408)
Q Consensus       115 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~  192 (408)
                      +||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||...... ........
T Consensus       276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~  355 (400)
T cd05105         276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS  355 (400)
T ss_pred             EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhc
Confidence            99999999976543222112223346788999999998889999999999999999997 99999764332 22222222


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       193 ~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ...+..+...+..+++++.+||+.||++|||+.++.+
T Consensus       356 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            3333455678889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.9e-35  Score=282.67  Aligned_cols=233  Identities=28%  Similarity=0.422  Sum_probs=182.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEc---CCCcEEEEeecccc------------------------------eeccCCCCCcc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDVS------------------------------YEAPTTSSSCR   49 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~~------------------------------~~~~~~~~~~~   49 (408)
                      +|++.+.||+|+||.||+|.+.   .+++.+++|.....                              ....+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   45677877643210                              01123344567


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ++||||+++|+|.+.+.. ...+++..++.++.|++.+|+|||+.+++|+||||.||+++.++. ++|+|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC-EEEEECccccccccc
Confidence            899999999999999874 456789999999999999999999999999999999999998874 999999998664432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCC--CCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCc
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGEC--QGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s  203 (408)
                      .. .......|++.|+|||.+.+..  ++.++|+||||+++|+|++|..||...+.    ..+..... ...+..+...+
T Consensus       159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (288)
T cd05583         159 EE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KSKPPFPKTMS  236 (288)
T ss_pred             cc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-ccCCCCCcccC
Confidence            21 1122345899999999987654  67899999999999999999999964321    12222212 22345566788


Q ss_pred             HHHHHHHHHhcccCCCCCCC---HHHHHcCCCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWS---CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s---~~ell~hpf~~~~~~~  239 (408)
                      ..+++++.+||+.||++|||   +.++++||||+...+.
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            89999999999999999998   5678999999987764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-35  Score=289.74  Aligned_cols=228  Identities=24%  Similarity=0.308  Sum_probs=178.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-------cEEEEeeccc---------------------------ceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-------DVFAYLGDDV---------------------------SYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-------~~va~k~~~~---------------------------~~~~~~~~~~   47 (408)
                      .+|++++.||+|+||.||+|.+...+       ..+++|....                           .+...+..+.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            36999999999999999999875322       2466654221                           1111233445


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..+++|||+++|+|.+++....               ..++...+..++.||+.||+|||++|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            6789999999999999997532               2356778889999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus       172 ~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  250 (334)
T cd05100         172 V-MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK  250 (334)
T ss_pred             c-EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            4 99999999865433221111222334677999999999889999999999999999998 899998776666555444


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...+..+.+++.+||+.+|.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         251 EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            444445566778899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=305.18  Aligned_cols=236  Identities=24%  Similarity=0.372  Sum_probs=200.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      .+..++-.||-||||.|=++.-+.....||+|-..                            +.+...+.++.++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            35567889999999999998877655556553221                            12223456778899999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |-|-||.|...++.+ +.+++...+.|+..++.|++|||++|||+|||||+|++|+.+|- +||+|||+|+.......  
T Consensus       500 EaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy-~KLVDFGFAKki~~g~K--  575 (732)
T KOG0614|consen  500 EACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY-LKLVDFGFAKKIGSGRK--  575 (732)
T ss_pred             HhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc-eEEeehhhHHHhccCCc--
Confidence            999999999999964 56799999999999999999999999999999999999999985 99999999988765543  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC-CCCCCCCCCcHHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD-ELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~-~~p~~~~~~s~~~~~li~~  212 (408)
                       +-++||||.|.|||++.+..++.++|.||||+++||||+|.+||...++...+..+.++ ....+|..++..+.+||++
T Consensus       576 -TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~  654 (732)
T KOG0614|consen  576 -TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK  654 (732)
T ss_pred             -eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence             45789999999999999999999999999999999999999999998888777666543 3346778899999999999


Q ss_pred             hcccCCCCCCC-----HHHHHcCCCCCCCCCCCcc
Q 042746          213 CLRREPGERWS-----CDQLLKHPFLQSVSPSDAN  242 (408)
Q Consensus       213 ~L~~dP~~R~s-----~~ell~hpf~~~~~~~~~~  242 (408)
                      +-..+|.+|..     +.+|.+|.||.+..|....
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr  689 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLR  689 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhh
Confidence            99999999984     7899999999998877543

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.8e-35  Score=286.00  Aligned_cols=227  Identities=23%  Similarity=0.286  Sum_probs=175.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeecccc---------------------------eeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDVS---------------------------YEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~~---------------------------~~~~~~~~~~~   49 (408)
                      ++|++.+.||+|+||.||+|.+.     .++..+|+|.....                           ....+......
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            47899999999999999999863     34556777643210                           11122344567


Q ss_pred             eEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           50 NLHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +++|||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+|+||||+|||++.++ .++|+|||+++....
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~  193 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARDIMN  193 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCcccccccC
Confidence            89999999999999997533 3479999999999999999999999999999999999998776 599999999875533


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhh-hhcccCCCCCCCCCCcHHH
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLS-RIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~-~~~~~~~~p~~~~~~s~~~  206 (408)
                      ...........+++.|+|||++.+..++.++|||||||++|+|++ |.+||......... ........+..+...++.+
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEI  273 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHH
Confidence            221111112346788999999998889999999999999999998 99999765543222 2222222233455678899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 042746          207 RDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+|+.+||+++|++|||+.|+++
T Consensus       274 ~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         274 YDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-35  Score=275.74  Aligned_cols=220  Identities=22%  Similarity=0.279  Sum_probs=174.7

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEeccCCCCH
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      +.||+|+||.||+|.+.. ++.+++|.....                          ...........+++|||++|++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            579999999999999988 898988753211                          11123345667899999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS  141 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  141 (408)
                      .+++......+++..+..++.|++.+|+|||+++++||||||+|||++.++. ++|+|||++................++
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~-~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc-EEEeeccccccccCCcceeccccCcce
Confidence            9999766667789999999999999999999999999999999999998874 999999998654321111111112235


Q ss_pred             CCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 042746          142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE  220 (408)
Q Consensus       142 ~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~  220 (408)
                      ..|+|||++.+..++.++|+||||+++|+|++ |..||.................+..+...+..+.+++.+||+.+|.+
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  238 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN  238 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence            67999999988889999999999999999999 89999876654444433333233445677889999999999999999


Q ss_pred             CCCHHHHHc
Q 042746          221 RWSCDQLLK  229 (408)
Q Consensus       221 R~s~~ell~  229 (408)
                      |||+.|+++
T Consensus       239 Rp~~~ell~  247 (251)
T cd05041         239 RPSFSEIYN  247 (251)
T ss_pred             CcCHHHHHH
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.2e-35  Score=318.68  Aligned_cols=229  Identities=22%  Similarity=0.267  Sum_probs=175.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LV   52 (408)
                      |.+|++++.||+|+||+||+|++..+++.||+|.....                            .......+...+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            68999999999999999999999999999999864321                            11122345567899


Q ss_pred             EeccCCCCHHHHHHHh----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           53 LEYLPGGTVSDLATTL----------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~----------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      |||++||+|.+++...          ....+...+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~-vKLiDFGL  159 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE-VVILDWGA  159 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC-EEEEecCc
Confidence            9999999999998642          123445677889999999999999999999999999999998875 99999999


Q ss_pred             ccccccCCC----------------CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh
Q 042746          123 AGEATVSDT----------------RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL  186 (408)
Q Consensus       123 a~~~~~~~~----------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~  186 (408)
                      ++.......                .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            975521110                0011124699999999999999999999999999999999999999976443322


Q ss_pred             hhhcccCCCCCC--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          187 SRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       187 ~~~~~~~~~p~~--~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ............  ....++.+.+++.+||..||++|++..+.+.+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            211111111111  13567889999999999999999976665543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.3e-35  Score=283.35  Aligned_cols=213  Identities=14%  Similarity=0.118  Sum_probs=172.5

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccC----CCCCcceEEEec
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPT----TSSSCRNLHLEY   55 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~----~~~~~~~LVmEy   55 (408)
                      ..||+|++|.||+|..  +++.||+|.....                            +.+.+    ......++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6899999999999988  6888888754311                            11111    113467899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++||+|.+++.. ...+++.....++.|++.||.|||+ .+++||||||+|||++.++. +||+|||+++......    
T Consensus       104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~-~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc-EEEcccchHhhhcccc----
Confidence            999999999985 4567888999999999999999998 49999999999999998874 9999999987543221    


Q ss_pred             cccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc-cCCCCCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-SDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~-~~~~p~~~~~~s~~~~~li~  211 (408)
                       ....|++.|+|||++.+  ..++.++|||||||++|+|++|+.||.......+..... ....+.++...++.+++|+.
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~  256 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVE  256 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHH
Confidence             23458999999999976  678999999999999999999999999776555444332 23334555578899999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      +||+.||++|||+.|+++
T Consensus       257 ~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        257 ACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHhcCCcccCcCHHHHHH
Confidence            999999999999999986

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.9e-35  Score=281.93  Aligned_cols=227  Identities=23%  Similarity=0.255  Sum_probs=175.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC----------------cEEEEeeccc--------------------------ce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG----------------DVFAYLGDDV--------------------------SY   39 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~----------------~~va~k~~~~--------------------------~~   39 (408)
                      .+|++++.||+|+||.||+|.+..++                ..+++|....                          .+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            57999999999999999999987655                3356554321                          11


Q ss_pred             eccCCCCCcceEEEeccCCCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc
Q 042746           40 EAPTTSSSCRNLHLEYLPGGTVSDLATTLN----------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG  109 (408)
Q Consensus        40 ~~~~~~~~~~~LVmEy~~gGsL~~~l~~~~----------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~  109 (408)
                      ...+..+...+++|||+++++|.+++....          ..+++..++.++.|++.||+|||+++++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            112234466889999999999999997543          2578999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh--CCCCCCCCChhhhh
Q 042746          110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLS  187 (408)
Q Consensus       110 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt--G~~Pf~~~~~~~~~  187 (408)
                      .++. ++|+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++  +..||.........
T Consensus       165 ~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05051         165 KNYT-IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI  243 (296)
T ss_pred             CCCc-eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence            8864 99999999876543322222233456788999999998889999999999999999998  77888765433322


Q ss_pred             hhcc-------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          188 RIGF-------SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       188 ~~~~-------~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ....       .......+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            2111       11112234456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.8e-35  Score=281.42  Aligned_cols=227  Identities=21%  Similarity=0.242  Sum_probs=177.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||.||+|.+..     ++..+++|....                          ........+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            479999999999999999999753     567787765321                          1111233455678


Q ss_pred             EEEeccCCCCHHHHHHHhC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc
Q 042746           51 LHLEYLPGGTVSDLATTLN---------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG  109 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~  109 (408)
                      ++|||+++|+|.+++....                     ..+++..+..++.||+.||+|||+++++||||||+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            9999999999999997432                     2367888899999999999999999999999999999999


Q ss_pred             CCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhh
Q 042746          110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSR  188 (408)
Q Consensus       110 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~  188 (408)
                      .++. ++|+|||++.................++.|+|||.+.+..++.++|+|||||++|+|++ |..||..........
T Consensus       165 ~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~  243 (288)
T cd05050         165 ENMV-VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY  243 (288)
T ss_pred             CCCc-eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            8875 99999999865432221111112234677999999998889999999999999999997 888987655554444


Q ss_pred             hcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          189 IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       189 ~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .......+..+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         244 YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            33334444455677889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.2e-35  Score=276.97  Aligned_cols=219  Identities=19%  Similarity=0.259  Sum_probs=173.1

Q ss_pred             eeeecCCeeEEEEEEc--CCCcEEEEeecccc--------------------------eeccCCCCCcceEEEeccCCCC
Q 042746            9 CIGRGSFGTVNVAVDR--FNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         9 ~IG~G~fG~Vy~a~d~--~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      .||+|+||.||+|++.  .++..+++|.....                          ..+.. .....++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-~~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-cCCCeEEEEEeCCCCC
Confidence            4899999999999875  34455776643211                          11111 2345789999999999


Q ss_pred             HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc-ccccCC
Q 042746           61 VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG-VKIQPR  139 (408)
Q Consensus        61 L~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~-~~~~~~  139 (408)
                      |.+++......+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||++.......... ......
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccCCCC
Confidence            9999986667789999999999999999999999999999999999998877 49999999986543322111 111122


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      +++.|+|||++.+..++.++|+||||+++|+|++ |..||.................+..+...++++.+++.+||..||
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~  239 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW  239 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence            4578999999998889999999999999999996 999998766555544444445556677889999999999999999


Q ss_pred             CCCCCHHHHHc
Q 042746          219 GERWSCDQLLK  229 (408)
Q Consensus       219 ~~R~s~~ell~  229 (408)
                      ++||++.++.+
T Consensus       240 ~~Rp~~~~i~~  250 (257)
T cd05115         240 EDRPNFAKVEE  250 (257)
T ss_pred             hhCcCHHHHHH
Confidence            99999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=264.79  Aligned_cols=233  Identities=27%  Similarity=0.437  Sum_probs=188.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      |.+|.-.++||+|.||+||+|++..|++.||+|...                           +........++.+.||+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            678899999999999999999999999999987532                           11222334566788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |||.. +|..+....++.++...+++++.|+++||.|+|+++++|||+||+|+||+.+|. +||+|||+++.......  
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge-lkladfglarafgipvr--  156 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE-LKLADFGLARAFGIPVR--  156 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc-EEecccchhhhcCCceE--
Confidence            99976 898888888999999999999999999999999999999999999999999985 99999999987765432  


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhh-hhhcc------------------c
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTL-SRIGF------------------S  192 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~-~~~~~------------------~  192 (408)
                      .....+-|.+|.+|.++.+. -|+.+.|+||.||++.|+.. |++.|.+.+.... .++-.                  .
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            23344579999999999886 47888999999999999985 8888987665432 22210                  1


Q ss_pred             CCCCCCCC---------CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          193 DELPRFPT---------QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       193 ~~~p~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ..+|.+|.         ..+...+|+++++|.-+|.+|++++++++||||.+..
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            11222322         2334568999999999999999999999999997643

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.7e-35  Score=274.05  Aligned_cols=224  Identities=24%  Similarity=0.327  Sum_probs=181.2

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCC----cEEEEeecccc--------------------------eeccCCCCCcceEEE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNG----DVFAYLGDDVS--------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~----~~va~k~~~~~--------------------------~~~~~~~~~~~~LVm   53 (408)
                      +++++.||+|+||.||+|.+..++    ..+++|.....                          +...+......+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999999877    77887654321                          111233446688999


Q ss_pred             eccCCCCHHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTLNAY-ADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~-l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||+++++|.+++...... +++..+..++.||+.+|+|||+++++|+||||+||+++.++ .++|+|||++.........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceeccccccc
Confidence            999999999999764443 89999999999999999999999999999999999999887 4999999998665433211


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      ... ...+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+.+++.
T Consensus       160 ~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      160 KKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             ccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence            111 2236789999999988888999999999999999998 89999876655554444444455566678899999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      +||..||.+|||+.|+++
T Consensus       239 ~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      239 QCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHCcCChhhCcCHHHHHh
Confidence            999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=281.05  Aligned_cols=226  Identities=24%  Similarity=0.398  Sum_probs=178.3

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~~~~LVmEy~   56 (408)
                      |++.+.||+|++|.||+|.+..+++.+++|......                           ......+...+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            678899999999999999999999999887543211                           11123446678999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++ +|.+++......+++..+..++.||+.+|.|||+++|+|+||||+||+++.++. ++|+|||.+........  ...
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~-~~l~df~~~~~~~~~~~--~~~  156 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV-LKLADFGLARSFGSPVR--PYT  156 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc-EEEeeeeeeEecCCCcc--ccc
Confidence            86 898888766678899999999999999999999999999999999999998775 99999999866543321  122


Q ss_pred             cCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---cC-------------------
Q 042746          137 QPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SD-------------------  193 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---~~-------------------  193 (408)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.........   ..                   
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            23578899999999876 68899999999999999999999997644322111000   00                   


Q ss_pred             -------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 -------ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 -------~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                             ..+......+..+++||.+||++||.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                   0001122467889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.2e-35  Score=285.03  Aligned_cols=227  Identities=32%  Similarity=0.459  Sum_probs=180.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .|.+.+.||+|+||+||+|.+..+++.+++|....                            ...+.+..+...++|||
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            58899999999999999999999999998875321                            01112234456789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++| +|.+++......+++..+..++.||+.+|.|||+++|+|+||+|+||+++.++. ++|+|||++......     
T Consensus        96 ~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~-~kL~dfg~~~~~~~~-----  168 (307)
T cd06607          96 YCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT-VKLADFGSASLVSPA-----  168 (307)
T ss_pred             hhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC-EEEeecCcceecCCC-----
Confidence            9985 788877655667899999999999999999999999999999999999998875 999999998654322     


Q ss_pred             cccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC-CCCCcHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF-PTQSSELGRDFL  210 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~-~~~~s~~~~~li  210 (408)
                       ....|++.|+|||++.   ...++.++|+||||+++|+|++|++||...+.............+.. +...+..++++|
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (307)
T cd06607         169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV  247 (307)
T ss_pred             -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence             1245788999999984   34578899999999999999999999976554332222222222332 234678899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+||..||++||++.+++.||||....
T Consensus       248 ~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         248 DSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHhcCChhhCcCHHHHhcChhhcccC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4e-35  Score=284.64  Aligned_cols=230  Identities=30%  Similarity=0.490  Sum_probs=182.1

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEeccCCC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      .....||+|+||.||++.+..+++.+++|.....                         ....+......+++|||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            3456899999999999999999999998764311                         111233456788999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR  139 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  139 (408)
                      +|.+++.  ...+++..++.++.|++.+|+|||++|++|+||||+||+++.++. ++|+|||++........  ......
T Consensus       103 ~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~-~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         103 ALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-EEEcccccceecccccc--cccccc
Confidence            9999885  345789999999999999999999999999999999999998875 99999999865432211  122345


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC--CCCCCcHHHHHHHHHhcccC
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR--FPTQSSELGRDFLDKCLRRE  217 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~--~~~~~s~~~~~li~~~L~~d  217 (408)
                      |++.|+|||++.+..++.++|+||+|+++|+|++|.+||.................+.  .....+..+.+++.+||..|
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            8999999999988888999999999999999999999997654333222211111111  12356788999999999999


Q ss_pred             CCCCCCHHHHHcCCCCCCCCCC
Q 042746          218 PGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       218 P~~R~s~~ell~hpf~~~~~~~  239 (408)
                      |.+||++.+++.||||....++
T Consensus       258 P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             cccCcCHHHHhcChHHhccCCC
Confidence            9999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=311.40  Aligned_cols=223  Identities=28%  Similarity=0.427  Sum_probs=177.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc--------------------------cceecc----CCC---CCcc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------VSYEAP----TTS---SSCR   49 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--------------------------~~~~~~----~~~---~~~~   49 (408)
                      ++++.++|-+|||+.||+|.+...+..||+|+.-                          |.+...    ...   .-.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5789999999999999999999998999887643                          222221    001   1235


Q ss_pred             eEEEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           50 NLHLEYLPGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      .|.||||+||.|.|++.. ....|+|.+|++|++|+++|+++||...  |||||||-+||||+.++. .||||||.|...
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~-~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN-YKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC-EEeCcccccccc
Confidence            688999999999999975 3556999999999999999999999998  999999999999999885 999999998543


Q ss_pred             ccCCCCcc-------cccCCCCCCCCChhhH---hCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC
Q 042746          127 TVSDTRGV-------KIQPRGSPLWMAPEVV---RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       127 ~~~~~~~~-------~~~~~Gt~~y~APE~l---~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      ........       .+..--||.|+|||++   ++.+.+.|+|||||||+||-|+....||++.+...+....+  .+|
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y--~~P  274 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY--SFP  274 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc--cCC
Confidence            22221100       1112359999999998   47788999999999999999999999999876555444322  233


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .. +.++..+++||..||+.||.+||++-+++.
T Consensus       275 ~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  275 PF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             CC-ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence            33 467888999999999999999999988875

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-35  Score=275.06  Aligned_cols=225  Identities=24%  Similarity=0.278  Sum_probs=177.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++.+.||+|+||+||+|.+.. +..+++|....                        ............+++|||++
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            689999999999999999999864 46677764321                        11122334466889999999


Q ss_pred             CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +++|.+++.... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++. +||+|||++......... ...
T Consensus        85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~-~~l~d~g~~~~~~~~~~~-~~~  162 (261)
T cd05034          85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV-CKIADFGLARLIEDDEYT-ARE  162 (261)
T ss_pred             CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC-EEECccccceeccchhhh-hhh
Confidence            999999997533 46789999999999999999999999999999999999998875 999999998654321111 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.................+..+...+..+.+++.+||.
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  242 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWD  242 (261)
T ss_pred             ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            1224678999999998889999999999999999998 999997655444333333332334445668899999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .+|.+||++++++.
T Consensus       243 ~~p~~Rp~~~~l~~  256 (261)
T cd05034         243 KDPEERPTFEYLQS  256 (261)
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-35  Score=288.38  Aligned_cols=234  Identities=25%  Similarity=0.379  Sum_probs=183.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCC-----Ccce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSS-----SCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~-----~~~~   50 (408)
                      +|++.+.||+|+||.||+|++..+++.+++|......                           ...+...     ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999999999987543211                           0111122     3679


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ++|||+++ +|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||++.++. ++|+|||++.......
T Consensus        81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~-~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD-LKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEcccCceEeecccc
Confidence            99999985 89988874 447899999999999999999999999999999999999998874 9999999997654332


Q ss_pred             C-CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc--C-------------
Q 042746          131 T-RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS--D-------------  193 (408)
Q Consensus       131 ~-~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~--~-------------  193 (408)
                      . ........+++.|+|||++.+. .++.++|+||||+++|+|++|++||..............  +             
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence            1 0112234579999999999887 789999999999999999999999976543322111000  0             


Q ss_pred             ---------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ---------------ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ---------------~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                     .........+..+.+||.+||+++|.+|||+.++++||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                           0001123367889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-35  Score=278.95  Aligned_cols=225  Identities=26%  Similarity=0.357  Sum_probs=175.3

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce------------------------------eccCCCCC-----c
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY------------------------------EAPTTSSS-----C   48 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~------------------------------~~~~~~~~-----~   48 (408)
                      |++.+.||+|+||.||+|+++.+++.+++|......                              ...+....     .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            789999999999999999999999999887643110                              00011122     3


Q ss_pred             ceEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      .+++|||+++ +|.+++.... ..+++..++.++.|++.||+|||+++++|+||||+||+++.++ .+||+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence            7899999986 8999887543 3579999999999999999999999999999999999999987 49999999986654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc---------------
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS---------------  192 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~---------------  192 (408)
                      ....   .....+++.|+|||++.+..++.++|+|||||++|+|++|.+||..............               
T Consensus       159 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         159 FEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             CCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            3321   1223478899999999998899999999999999999999999976543222111100               


Q ss_pred             ---CCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 ---DELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ---~~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                         ...+        ......++.+.++|.+||+.||.+||++.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence               0000        0011345677899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.9e-35  Score=275.49  Aligned_cols=224  Identities=21%  Similarity=0.268  Sum_probs=177.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||.||+|.++ +++.+++|.....                        .... ......+++|||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV-VTQEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEE-EccCCcEEEEEcCC
Confidence            57999999999999999999876 4677888753311                        1111 12445789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +++|.+++... +..+++..+..++.|++.+|+|||++|++||||||+||+++.++. ++|+|||++......... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~-~~l~dfg~~~~~~~~~~~-~~~  161 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC-CKIADFGLARLIEDNEYT-ARE  161 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC-EEEccCcceeecCCCCcc-ccc
Confidence            99999998753 346788999999999999999999999999999999999998874 999999998655422111 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||++.+..++.++|+||||+++|+|++ |++||.................+..+...+..+++++.+||+
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWK  241 (260)
T ss_pred             CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            2345678999999998889999999999999999999 999998765544443322333334556678899999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .+|++|||+++++.
T Consensus       242 ~~p~~Rp~~~~l~~  255 (260)
T cd05067         242 EKPEERPTFEYLRS  255 (260)
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-34  Score=276.94  Aligned_cols=226  Identities=24%  Similarity=0.302  Sum_probs=177.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC---CcEEEEeecccc--------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN---GDVFAYLGDDVS--------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t---~~~va~k~~~~~--------------------------~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||.||+|.+..+   ...+++|.....                          +.... .....+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE-cCCCcEEE
Confidence            3689999999999999999998655   335666543211                          11111 23456899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++......+++..+..++.||+.||+|||+++++|+||||+||+++.++. ++|+|||+++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~  163 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYY  163 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC-eEEccCceeeecccccce
Confidence            9999999999999865666899999999999999999999999999999999999998774 999999998654432211


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ......+++.|+|||.+....++.++|+||||+++|+|++ |..||.................+..+...+..+++++.
T Consensus       164 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (270)
T cd05056         164 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT  242 (270)
T ss_pred             -ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence             1112234578999999988889999999999999999986 99999876544433333333334556678889999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||..+|.+|||+.+++..
T Consensus       243 ~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         243 KCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-35  Score=281.43  Aligned_cols=226  Identities=26%  Similarity=0.400  Sum_probs=176.1

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~~~~LVmEy~   56 (408)
                      |++.+.||.|++|+||+|.++.++..+++|......                           ...+..+...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            778999999999999999999999999987543211                           11233456788999999


Q ss_pred             CCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      + ++|.+++.... ..+++..+..++.|++.+|+|||+++++|+||+|+||+++.++ .++|+|||++........  ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~--~~  156 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVR--TY  156 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCcc--cc
Confidence            6 58999987543 3579999999999999999999999999999999999999877 499999999865432211  12


Q ss_pred             ccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--------------------cc--
Q 042746          136 IQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------------------FS--  192 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--------------------~~--  192 (408)
                      ....+++.|+|||++.+. .++.++|+||||+++|+|++|++||............                    ..  
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            233568899999988764 5688999999999999999999999754432111000                    00  


Q ss_pred             ------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          193 ------DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       193 ------~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                            ..........+..+.++|.+||+.||.+|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                  00111234567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5e-35  Score=284.08  Aligned_cols=223  Identities=21%  Similarity=0.310  Sum_probs=165.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC---CcEEEEeecccceec------------------------cCCC---------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN---GDVFAYLGDDVSYEA------------------------PTTS---------   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t---~~~va~k~~~~~~~~------------------------~~~~---------   45 (408)
                      .+|++.+.||+|+||+||+|.+..+   +..++++........                        ....         
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            3799999999999999999999887   555555532211000                        0000         


Q ss_pred             -------CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           46 -------SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        46 -------~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                             ....+++||++.. ++.+++... ...++..++.++.|++.||+|||+++|+||||||+|||++.++. ++|+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~-~~l~  168 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR-GYII  168 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc-EEEE
Confidence                   0123577888754 677777643 34578889999999999999999999999999999999998775 9999


Q ss_pred             ecCCccccccCCC-----CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhh-----
Q 042746          119 DFGAAGEATVSDT-----RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLS-----  187 (408)
Q Consensus       119 DFGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~-----  187 (408)
                      |||+|+.......     ........||+.|+|||++.+..++.++|||||||++|+|++|++||..... ....     
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            9999976532211     1112234699999999999999999999999999999999999999986532 1111     


Q ss_pred             ---hhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          188 ---RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       188 ---~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                         .......  ......++.+.++++.|+..+|.+||++.++++
T Consensus       249 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 DFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence               1111111  112345788999999999999999999999875

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-34  Score=274.25  Aligned_cols=226  Identities=24%  Similarity=0.291  Sum_probs=178.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||.||+|.+.. +..+++|....                        .....+......+++|||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            478999999999999999998864 56677764321                        11122334556789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +++|.+++......+++..++.++.|++.+|+|||+++++|+||||+||+++.++ .++|+|||++......... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~-~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYT-SSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCccc-ccCC
Confidence            9999999986666788999999999999999999999999999999999998776 4999999998654322111 1112


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..++..|+|||++.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+.+|+.+||+.
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~  240 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE  240 (256)
T ss_pred             CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccc
Confidence            234678999999998888999999999999999998 9999987654444433222222234556789999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      +|++|||+.|++++
T Consensus       241 ~p~~Rp~~~~~l~~  254 (256)
T cd05112         241 RPEDRPSFSLLLHQ  254 (256)
T ss_pred             ChhhCCCHHHHHHh
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.2e-35  Score=283.75  Aligned_cols=227  Identities=24%  Similarity=0.268  Sum_probs=178.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE----EEEeecccc--------------------------eeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV----FAYLGDDVS--------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~----va~k~~~~~--------------------------~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||.||+|.+..++..    +++|.....                          ..+.. .....++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC-LSPTIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE-cCCCcee
Confidence            4688999999999999999999888874    455432210                          00111 1233568


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+++|+|.+++......+++..+..++.|++.||+|||+++|+||||||+||+++.++. +||+|||+++.......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~-~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEK  164 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc-eEEccccccccccCccc
Confidence            99999999999999866667899999999999999999999999999999999999988775 99999999976543222


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.................+..+...+..+.+++
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  244 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVM  244 (303)
T ss_pred             ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            111222345778999999998889999999999999999997 9999987655544443333333344566788899999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q 042746          211 DKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+||..+|++||++.++++.
T Consensus       245 ~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         245 VKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-34  Score=274.74  Aligned_cols=222  Identities=21%  Similarity=0.292  Sum_probs=171.9

Q ss_pred             ceeeecCCeeEEEEEEcCC---CcEEEEeeccc--------------------------ceec-cCCCCCcceEEEeccC
Q 042746            8 KCIGRGSFGTVNVAVDRFN---GDVFAYLGDDV--------------------------SYEA-PTTSSSCRNLHLEYLP   57 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t---~~~va~k~~~~--------------------------~~~~-~~~~~~~~~LVmEy~~   57 (408)
                      +.||+|+||+||+|.+...   ...+++|....                          .+.. ....+...+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            5799999999999997643   34577765321                          0111 1123445789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC--ccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR--GVK  135 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~--~~~  135 (408)
                      +|+|.+++.......++..+..++.||+.||+|||+++++||||||+|||++.++. +||+|||+++........  ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~-~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT-VKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc-EEECCccccccccCCcceeeccc
Confidence            99999999865566678888999999999999999999999999999999998875 999999998654322110  111


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.+++.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  239 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW  239 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence            12346778999999988889999999999999999999 57778766555544444444444555667889999999999


Q ss_pred             ccCCCCCCCHHHHHcC
Q 042746          215 RREPGERWSCDQLLKH  230 (408)
Q Consensus       215 ~~dP~~R~s~~ell~h  230 (408)
                      ..+|++||++.|+++.
T Consensus       240 ~~~p~~Rp~~~~il~~  255 (262)
T cd05058         240 HPKPEMRPTFSELVSR  255 (262)
T ss_pred             CCChhhCCCHHHHHHH
Confidence            9999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-34  Score=283.67  Aligned_cols=226  Identities=33%  Similarity=0.484  Sum_probs=179.4

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEec
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      |...+.||+|+||+||+|++..++..+++|.....                            +...+......+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55678899999999999999999999988764311                            11122345567899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +.| +|.+++......+++..+..++.||+.+|.|||++|++|+||||+||+++.++. +||+|||++.....      .
T Consensus       103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~-~kL~dfg~~~~~~~------~  174 (313)
T cd06633         103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASKSSP------A  174 (313)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC-EEEeecCCCcccCC------C
Confidence            975 888888766677899999999999999999999999999999999999988875 99999999854321      1


Q ss_pred             ccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC-CCCCcHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF-PTQSSELGRDFLD  211 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~-~~~~s~~~~~li~  211 (408)
                      ....|++.|+|||++.   ...++.++|+||||+++|+|++|.+||.................+.. ....+..+++|+.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  254 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD  254 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            2346899999999984   35578899999999999999999999976543332222222223322 2356778999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +||+++|.+||++.++++||||....
T Consensus       255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         255 YCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999998644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.7e-35  Score=282.31  Aligned_cols=230  Identities=25%  Similarity=0.365  Sum_probs=176.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCC---------
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTT---------   44 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~---------   44 (408)
                      +++|++.+.||+|+||+||+|.++.+++.+++|......                           ...+.         
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            368999999999999999999999999999886543110                           00011         


Q ss_pred             -CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           45 -SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        45 -~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                       .....+|++||+++ +|.+++......+++..++.++.||+.||+|||++||+|+||||+||+++.++. +||+|||++
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~-~kl~dfg~~  163 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ-IKLADFGLA  163 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc-EEeCccccc
Confidence             12367899999987 777777655557899999999999999999999999999999999999998875 999999998


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc---ccCC----C
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG---FSDE----L  195 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~---~~~~----~  195 (408)
                      ........ .......+++.|+|||++.+. .++.++|+|||||++++|++|++||............   ....    .
T Consensus       164 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         164 RLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             ccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            65543221 111223467889999998754 5688999999999999999999999754322111100   0000    0


Q ss_pred             C----------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          196 P----------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       196 p----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      |                      ......+..+.+++.+||..||.+|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            0                      0112357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-34  Score=274.99  Aligned_cols=224  Identities=22%  Similarity=0.274  Sum_probs=175.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|.+.+.||+|+||.||+|.+..+. .+++|.....                        ..... .....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCcEEEEEcCC
Confidence            57999999999999999999987664 4666542210                        01111 2345789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.+++... ...+++..+..++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++......... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~-~~l~dfg~~~~~~~~~~~-~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV-CKIADFGLARLIEDNEYT-ARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe-EEECCCccceEccCCccc-ccC
Confidence            99999999753 335788999999999999999999999999999999999998874 999999999654322211 111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.................+..+...+..+++++.+||.
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  241 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK  241 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcc
Confidence            2235678999999998889999999999999999999 999998765444433333333334556788999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      +||++||+++++++
T Consensus       242 ~~p~~Rp~~~~i~~  255 (260)
T cd05069         242 KDPDERPTFEYIQS  255 (260)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=273.73  Aligned_cols=220  Identities=23%  Similarity=0.326  Sum_probs=178.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||.||+|.+.  ++.+++|.....                        +..........++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            47899999999999999999875  777877654311                        1122334566889999999


Q ss_pred             CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +++|.++++... ..+++..++.++.|++.+|.|||+++++|+||||+||+++.++. +||+|||.++.......     
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~-~~l~d~g~~~~~~~~~~-----  157 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV-AKVSDFGLAKEASQGQD-----  157 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC-EEEcccccccccccccc-----
Confidence            999999997543 26899999999999999999999999999999999999998874 99999999976532211     


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...++..|+|||++....++.++|+||||+++|+|++ |..||.......+.........+..+...++.+.++|.+||+
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWE  237 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhc
Confidence            2234567999999988888999999999999999997 999998776655544333333345556778999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .+|++|||+.|+++
T Consensus       238 ~~p~~Rp~~~~l~~  251 (256)
T cd05039         238 LDPAKRPTFKQLRE  251 (256)
T ss_pred             cChhhCcCHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-34  Score=288.12  Aligned_cols=230  Identities=22%  Similarity=0.344  Sum_probs=178.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------ecc------CCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAP------TTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~------~~~~~~   48 (408)
                      ++|++.+.||+|+||.||+|.+..+++.|++|......                           ...      ......
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            68999999999999999999999999999988643110                           000      011234


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+++++++ |++|.++++.  ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus        97 ~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~-~kl~dfg~~~~~~~  172 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDD  172 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC-EEEecccccccccc
Confidence            67788876 7799988863  45789999999999999999999999999999999999998875 99999999865432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------------  190 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------------  190 (408)
                      .     .....|++.|+|||.+.+ ..++.++|+|||||++|+|++|++||............                 
T Consensus       173 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             c-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            1     123458999999999876 46788999999999999999999999754322211100                 


Q ss_pred             -----ccCCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          191 -----FSDELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       191 -----~~~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                           +....+.        .....++.+++||.+||+.||.+||++.+++.||||.....+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence                 0000011        1123577889999999999999999999999999999766543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=273.76  Aligned_cols=219  Identities=21%  Similarity=0.266  Sum_probs=173.0

Q ss_pred             ceeeecCCeeEEEEEEcCCC---cEEEEeecccc--------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNG---DVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~---~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||.||+|++..++   ..+++|.....                          +.+. ......+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV-CKGEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEE-EcCCceEEEEEeCCC
Confidence            57999999999999887665   66777653311                          1111 123457899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc-ccc
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV-KIQ  137 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~-~~~  137 (408)
                      |+|.+++... ..+++..+..++.|++.+|+|||+++++|+||||+|||++.++. +||+|||+++.......... ...
T Consensus        80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~-~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc-EEeccccccceeecCCcccccccC
Confidence            9999999854 36799999999999999999999999999999999999998875 99999999876543222111 111


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++ |.+||....................+...+..+++++.+||..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            123567999999998889999999999999999998 9999987665554444333333455667889999999999999


Q ss_pred             CCCCCCCHHHHHc
Q 042746          217 EPGERWSCDQLLK  229 (408)
Q Consensus       217 dP~~R~s~~ell~  229 (408)
                      +|++||++.++++
T Consensus       238 ~p~~Rp~~~~l~~  250 (257)
T cd05060         238 RPEDRPTFSELES  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-35  Score=288.74  Aligned_cols=229  Identities=23%  Similarity=0.359  Sum_probs=179.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee---------------------------ccCCC------CCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---------------------------APTTS------SSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~---------------------------~~~~~------~~~   48 (408)
                      ++|++.+.||+|+||+||+|++..+++.+++|.......                           ..+..      ...
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            579999999999999999999999999999886432100                           00111      124


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .++|+||+ |++|.+++..  ..+++..++.++.||+.+|+|||++||+||||||+||+++.++. ++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~-~kL~dfg~~~~~~~  170 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARHTDD  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-EEEccccccccccc
Confidence            78999998 5699999873  56899999999999999999999999999999999999998875 99999999865532


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc--C------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS--D------------  193 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~--~------------  193 (408)
                      .     .....+++.|+|||.+.+. .++.++|+||||+++|+|++|++||..............  .            
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         171 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             c-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence            2     2234578999999998763 678899999999999999999999975443221111000  0            


Q ss_pred             --------CC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 --------EL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 --------~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                              ..        .......++.+.+||.+||+.||.+|||+.|+++||||......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                    00        01112357889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=277.05  Aligned_cols=218  Identities=26%  Similarity=0.344  Sum_probs=169.1

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEE--EEeeccc---------------------------ceeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVF--AYLGDDV---------------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~v--a~k~~~~---------------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|+||.||+|.+..++..+  ++|....                           .+...+......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46999999999999998888643  4443210                           111123344567899999999


Q ss_pred             CCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           59 GTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        59 GsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      |+|.+++....               ..+++..+..++.|++.||+|||++|++||||||+|||++.++. +||+|||++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~-~kl~dfgl~  159 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLS  159 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe-EEECCCCCc
Confidence            99999997532               24678999999999999999999999999999999999998874 999999998


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCC
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  202 (408)
                      ........   ......++.|+|||++.+..++.++|+||||+++|+|++ |..||.................+..+...
T Consensus       160 ~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (270)
T cd05047         160 RGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC  236 (270)
T ss_pred             cccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcC
Confidence            53321111   111234667999999988889999999999999999997 99999765544444333233333445567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +.++.+++.+||..||.+|||+.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         237 DDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-34  Score=276.81  Aligned_cols=227  Identities=17%  Similarity=0.204  Sum_probs=178.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC----CcEEEEeeccc--------------------------ceec-cCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN----GDVFAYLGDDV--------------------------SYEA-PTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t----~~~va~k~~~~--------------------------~~~~-~~~~~~~~~   50 (408)
                      ++|++.+.||+|+||.||+|.+..+    +..+++|....                          .... ....+...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            5799999999999999999999873    45666654221                          0111 122345678


Q ss_pred             EEEeccCCCCHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           51 LHLEYLPGGTVSDLATTLN-------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      +++||+++|+|.+++....       ..+++..+..++.||+.||+|||+++++||||||+||+++.++. +||+|||++
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~-~kl~d~g~~  164 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNALS  164 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc-EEECCCCCc
Confidence            9999999999999997532       45789999999999999999999999999999999999988774 999999999


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCC
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  202 (408)
                      +...............++..|+|||++.+..++.++||||||+++|++++ |++||.......+.........+..+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINC  244 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcC
Confidence            76543322111122345777999999998889999999999999999998 99999876655544433333333444567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+.+++.+||..||++|||+.|+++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         245 PDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=277.91  Aligned_cols=225  Identities=24%  Similarity=0.372  Sum_probs=175.6

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee---------------------------ccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---------------------------APTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~---------------------------~~~~~~~~~~LVmEy~   56 (408)
                      |++.+.||+|+||+||+|++..+++.+++|.......                           ..+..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7899999999999999999999999998876332110                           1123456788999999


Q ss_pred             CCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                       +|+|.+++.... ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++. ++|+|||++........   .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~-~~l~d~~~~~~~~~~~~---~  155 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV-VKIADFGLAREIRSRPP---Y  155 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC-EEEeecccceeccCCCC---c
Confidence             779999887543 46799999999999999999999999999999999999998875 99999999865533221   1


Q ss_pred             ccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc---------------------ccC
Q 042746          136 IQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG---------------------FSD  193 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~---------------------~~~  193 (408)
                      ....++..|+|||++.+ ..++.++|+||||+++++|++|++||............                     ...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            23457899999998854 45788999999999999999999999754322111000                     000


Q ss_pred             CC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          194 EL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       194 ~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ..        .......+..+++||.+||..||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00        01112336789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=299.15  Aligned_cols=227  Identities=28%  Similarity=0.363  Sum_probs=188.8

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEeccCCC
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      .++||.|.||+||-|++++||+.||+|..++                           .++.-++....++.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            4789999999999999999999999987652                           2233356677788999999986


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--CCcEEEeecCCccccccCCCCccccc
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      -|.-++....+.++|...+.++.||+.||.|||.++|+|+||||+||||...  ..++||+|||+|+.......   ...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---Rrs  725 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRS  725 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhh
Confidence            6666677678899999999999999999999999999999999999999754  45699999999987765443   345


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCC-ChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~-~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      .+|||.|+|||+++.+.|...-|+||.|||+|.-|.|..||... +..+..+..---.+|.....+++.+.|||+.+|+.
T Consensus       726 VVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqV  805 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQV  805 (888)
T ss_pred             hcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHH
Confidence            67999999999999999999999999999999999999999753 33332222111122333467899999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~  236 (408)
                      .-.+|+|++..+.|||+++.
T Consensus       806 km~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  806 KMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHhcchHhhccchhhhcc
Confidence            99999999999999999865

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=287.30  Aligned_cols=229  Identities=25%  Similarity=0.378  Sum_probs=178.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCC------Cc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSS------SC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~------~~   48 (408)
                      ++|++.+.||+|+||+||+|++..++..|++|.....                           ....+..+      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            5899999999999999999999999999999864211                           00011111      23


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +++||||+ |++|.+++.  ...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~-~kl~dfg~~~~~~~  170 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQTDS  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeeccccccccc
Confidence            58999999 679998886  356899999999999999999999999999999999999998875 99999999865432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF----------------  191 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~----------------  191 (408)
                      .     .....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||.............                
T Consensus       171 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         171 E-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             C-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            2     123457999999999976 457889999999999999999999997543221110000                


Q ss_pred             ------cCCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          192 ------SDELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       192 ------~~~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                            ....+        ......++.+.++|.+||+.||++|||+.+++.||||+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                  00011        1123567789999999999999999999999999999876443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-34  Score=270.96  Aligned_cols=220  Identities=21%  Similarity=0.285  Sum_probs=172.9

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEeccCCCCH
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ++||+|+||.||+|... ++..+++|.....                          ...........++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47999999999999865 6778887753211                          11122344567899999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS  141 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  141 (408)
                      .+++......+++..+..++.|++.+|.|||++|++|+||||+||+++.++. +||+|||++......... ......++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~-~~l~d~g~~~~~~~~~~~-~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV-LKISDFGMSRQEDDGIYS-SSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe-EEECCCccceeccccccc-cCCCCCCc
Confidence            9999766667789999999999999999999999999999999999988874 999999998654322111 11112346


Q ss_pred             CCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 042746          142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE  220 (408)
Q Consensus       142 ~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~  220 (408)
                      +.|+|||++.+..++.++|+||||+++|++++ |..||.................+..+...+..+.+++.+||+.+|++
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN  237 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence            77999999988888999999999999999998 99999866544433333333333455678899999999999999999


Q ss_pred             CCCHHHHHcC
Q 042746          221 RWSCDQLLKH  230 (408)
Q Consensus       221 R~s~~ell~h  230 (408)
                      ||++.|+++.
T Consensus       238 Rp~~~~l~~~  247 (250)
T cd05085         238 RPKFSELQKE  247 (250)
T ss_pred             CCCHHHHHHH
Confidence            9999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=300.08  Aligned_cols=221  Identities=27%  Similarity=0.365  Sum_probs=178.1

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~~~LVmEy~   56 (408)
                      ..++..||+|+||+||+|++.  |. ||+|...                           +.|.+....+.. .||..+|
T Consensus       394 v~l~~rIGsGsFGtV~Rg~wh--Gd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC  469 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWH--GD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC  469 (678)
T ss_pred             hhccceeccccccceeecccc--cc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence            456899999999999999985  33 4554332                           123333333333 7999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|.+|+.++......++....+.|++||++|+.|||.++|||||||..||||..++. |||+|||++.............
T Consensus       470 eGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k-VkIgDFGLatvk~~w~g~~q~~  548 (678)
T KOG0193|consen  470 EGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK-VKIGDFGLATVKTRWSGEQQLE  548 (678)
T ss_pred             cCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc-EEEecccceeeeeeeccccccC
Confidence            999999999877788899999999999999999999999999999999999988775 9999999996554444444445


Q ss_pred             cCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC-C---CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL-P---RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~-p---~~~~~~s~~~~~l  209 (408)
                      ...|...|||||+++.   .+|++.+||||||+++|||++|..||.....+++....-.+.+ |   ......++++++|
T Consensus       549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~L  628 (678)
T KOG0193|consen  549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRL  628 (678)
T ss_pred             CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHH
Confidence            5678999999999975   4789999999999999999999999996666666655444422 1   2234567789999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q 042746          210 LDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~  229 (408)
                      +..||.+++++||.+.+||.
T Consensus       629 l~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  629 LSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHhcCcccCccHHHHHH
Confidence            99999999999999999886

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-34  Score=278.91  Aligned_cols=227  Identities=25%  Similarity=0.326  Sum_probs=172.3

Q ss_pred             CeEeeceeeecCCeeEEEEEE----cCCCcEEEEeecccc--------------------------eeccCCC--CCcce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVD----RFNGDVFAYLGDDVS--------------------------YEAPTTS--SSCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d----~~t~~~va~k~~~~~--------------------------~~~~~~~--~~~~~   50 (408)
                      .|++.+.||+|+||.||+|..    ..++..+++|.....                          .......  ....+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            378899999999999999984    456778888764311                          0111111  35678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ++|||++|++|.+++......+++..+..++.||+.+|+|||++|++||||||+||+++.++. ++|+|||++.......
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-~~l~dfg~~~~~~~~~  163 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC-EEECCCccccccccCc
Confidence            999999999999999765556799999999999999999999999999999999999988875 9999999987654322


Q ss_pred             CC-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh---------------hhhhhhcccCC
Q 042746          131 TR-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA---------------NTLSRIGFSDE  194 (408)
Q Consensus       131 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~---------------~~~~~~~~~~~  194 (408)
                      .. .......++..|+|||++.+..++.++|+||||+++|+|+++..|+.....               ...........
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK  243 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence            11 111234567789999999888899999999999999999998766432100               00000111112


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            223345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-35  Score=279.02  Aligned_cols=215  Identities=19%  Similarity=0.265  Sum_probs=166.7

Q ss_pred             ceeeecCCeeEEEEEEcCCCcE-------EEEeecc-------------------------cceeccCCCCCcceEEEec
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDV-------FAYLGDD-------------------------VSYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~-------va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy   55 (408)
                      +.||+|+||+||+|.+..++..       +++|...                         +.....+..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            4799999999999998766543       4433321                         1112223344567899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCc-------EEEeecCCcccccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF-------VKLADFGAAGEATV  128 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~-------vkL~DFGla~~~~~  128 (408)
                      +++|+|.+++...+..+++..+..++.||+.||+|||+++|+||||||+||+++.++..       ++++|||++.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999998666678999999999999999999999999999999999999876542       79999999854432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCCCCCCCCcHHH
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      .      ....+++.|+|||++.+ ..++.++|+||||+++|+|++| .+||...........  ....+.+|...+.++
T Consensus       161 ~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  232 (258)
T cd05078         161 K------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF--YEDRHQLPAPKWTEL  232 (258)
T ss_pred             c------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH--HHccccCCCCCcHHH
Confidence            1      12457889999999986 4578899999999999999998 577765444332222  122234555677889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+|+.+||+.||++|||++++++.
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHh
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=269.44  Aligned_cols=227  Identities=22%  Similarity=0.315  Sum_probs=177.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec------------------------------cCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------------------PTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~------------------------------~~~~~~~~~L   51 (408)
                      .+|++.+.||+|||+-||++....++..||+|+.......                              ........||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            3799999999999999999999999999999875422110                              0113345899


Q ss_pred             EEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           52 HLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      ++.|...|+|.+.++.   .+..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+ .++|.|||.+.+.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a  179 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQA  179 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccCcccc
Confidence            9999999999998876   3568999999999999999999999998  99999999999998866 4999999999765


Q ss_pred             ccCCCCcc-------cccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhccc--
Q 042746          127 TVSDTRGV-------KIQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFS--  192 (408)
Q Consensus       127 ~~~~~~~~-------~~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~--  192 (408)
                      ........       ......|..|+|||.+.-   ...+.++|||||||+||.|+.|..||+..-.  ..+.-....  
T Consensus       180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q  259 (302)
T KOG2345|consen  180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ  259 (302)
T ss_pred             ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence            54322111       011236999999999964   4568999999999999999999999974211  011100111  


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       193 ~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      -..|.- ..+|+.+.++|+.||+.||.+||++.+++.+
T Consensus       260 ~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  260 ISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             cccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            112222 3488999999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=270.28  Aligned_cols=219  Identities=31%  Similarity=0.474  Sum_probs=180.8

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEeccCCCCH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ||+|+||.||++.+..+++.+++|.....                            ....++.+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            79999999999999999999988753211                            01123456678999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS  141 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt  141 (408)
                      .+++... ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++. ++|+|||++........  ......++
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~-~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (250)
T cd05123          81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGS--RTNTFCGT  156 (250)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc-EEEeecCcceecccCCC--cccCCcCC
Confidence            9999854 46799999999999999999999999999999999999998875 99999999866543211  12234588


Q ss_pred             CCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       142 ~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      ..|+|||.+.+...+.++|+||||+++|+|++|..||.............. ..+.++...+..+.+++.+||..||++|
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence            999999999988888999999999999999999999976655444443333 3345667778999999999999999999


Q ss_pred             CCH---HHHHcCCCC
Q 042746          222 WSC---DQLLKHPFL  233 (408)
Q Consensus       222 ~s~---~ell~hpf~  233 (408)
                      |++   +++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=280.21  Aligned_cols=227  Identities=21%  Similarity=0.241  Sum_probs=171.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc--------------EEEEeeccc--------------------------ceec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD--------------VFAYLGDDV--------------------------SYEA   41 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~--------------~va~k~~~~--------------------------~~~~   41 (408)
                      .+|++.+.||+|+||.||+|++..++.              .+++|....                          ....
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            379999999999999999998865432              366654321                          1112


Q ss_pred             cCCCCCcceEEEeccCCCCHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC
Q 042746           42 PTTSSSCRNLHLEYLPGGTVSDLATTLN-----------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP  110 (408)
Q Consensus        42 ~~~~~~~~~LVmEy~~gGsL~~~l~~~~-----------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~  110 (408)
                      .+......++||||+++++|.+++....           ..+++..+..++.|++.||+|||+++++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            2334566889999999999999986432           13578888999999999999999999999999999999998


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh--CCCCCCCCChhhhhh
Q 042746          111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSR  188 (408)
Q Consensus       111 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt--G~~Pf~~~~~~~~~~  188 (408)
                      ++. +||+|||++................+++.|+|||++.+..++.++|+||||+++|+|++  +..||..........
T Consensus       165 ~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         165 HYT-IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             CCc-EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            774 99999999865432221111122345778999999998889999999999999999988  678887654433221


Q ss_pred             hc-------ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          189 IG-------FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       189 ~~-------~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..       ........+...++.+.+|+.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            11       111122334457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-34  Score=282.07  Aligned_cols=226  Identities=34%  Similarity=0.463  Sum_probs=180.2

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEec
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      |...+.||+|+||+||+|++..++..+++|.....                            .......+...+|||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            67789999999999999999999999988764311                            11112344567899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++| +|.+++......+++..+..++.||+.+|.|||+++|+||||+|+||+++.++. ++|+|||++.....      .
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~-~kl~dfg~~~~~~~------~  178 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ-VKLADFGSASIASP------A  178 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC-EEEecCCCccccCC------c
Confidence            985 888888766677899999999999999999999999999999999999988774 99999999854332      1


Q ss_pred             ccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC-CCCCCCCcHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL-PRFPTQSSELGRDFLD  211 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~-p~~~~~~s~~~~~li~  211 (408)
                      ....|++.|+|||++.   ...++.++|+|||||++|+|++|.+||................. +......++.+++++.
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  258 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD  258 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence            2345899999999984   34578899999999999999999999876543332222222222 2233457788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +||+.+|.+||++.++++|+|+....
T Consensus       259 ~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         259 SCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHccCCcccCcCHHHHHhChhhhccC
Confidence            99999999999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.9e-34  Score=281.60  Aligned_cols=227  Identities=34%  Similarity=0.468  Sum_probs=179.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .|...+.||+|+||+||+|++..+++.+++|.....                            ....+......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            467788999999999999999999999988753210                            1111223456789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+. |+|.+++......+++..+..++.|++.+|.|||+++++||||||+||+++.++ .++|+|||++......     
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~-----  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-----  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-----
Confidence            997 588888765666789999999999999999999999999999999999998877 4999999998654321     


Q ss_pred             cccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC-CCCCCcHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR-FPTQSSELGRDFL  210 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~-~~~~~s~~~~~li  210 (408)
                       ....|++.|+|||++.   ...++.++|||||||++|+|++|..||.................+. .+...+..+++||
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence             2345889999999985   3457889999999999999999999987654332222212222222 2346788899999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+||..+|.+||++.++++|||+....
T Consensus       248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         248 DSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHhhCCcccCCCHHHHhhCccccccC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-34  Score=275.12  Aligned_cols=222  Identities=21%  Similarity=0.276  Sum_probs=171.9

Q ss_pred             ceeeecCCeeEEEEEEcCCC------cEEEEeecc--------------------------cceeccCCCCCcceEEEec
Q 042746            8 KCIGRGSFGTVNVAVDRFNG------DVFAYLGDD--------------------------VSYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~------~~va~k~~~--------------------------~~~~~~~~~~~~~~LVmEy   55 (408)
                      +.||+|+||.||+|.++.+.      +.+++|...                          +.+...+..+...+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            47999999999999987544      456554321                          1122223445668899999


Q ss_pred             cCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC----CcEEEeecCCccc
Q 042746           56 LPGGTVSDLATTL------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS----SFVKLADFGAAGE  125 (408)
Q Consensus        56 ~~gGsL~~~l~~~------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~----~~vkL~DFGla~~  125 (408)
                      ++||+|.+++...      ...+++..+..++.||+.+|+|||+++++|+||||+||+++.++    ..++|+|||+++.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999999752      23467889999999999999999999999999999999998765    2499999999865


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      ..............++..|+|||++.+..++.++|+||||+++|+|++ |+.||.................+..+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD  240 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchH
Confidence            533221111122345788999999998889999999999999999998 9999986554444433333344455667889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+.+++.+||.++|.+||++.++++
T Consensus       241 ~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         241 KIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1e-34  Score=312.37  Aligned_cols=122  Identities=31%  Similarity=0.422  Sum_probs=105.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      |.+|++.+.||+|+||+||+|.+..+++.||+|....                            .+...+......+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            5789999999999999999999999999999876431                            111123345678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      |||++|++|.+++.. .+.+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++
T Consensus        83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~-vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH-IKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC-EEEEeCCCCc
Confidence            999999999999974 456789999999999999999999999999999999999998874 9999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.4e-34  Score=271.32  Aligned_cols=225  Identities=22%  Similarity=0.285  Sum_probs=175.0

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEecc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      +++|++.+.||+|+||.||++.+.. +..+++|....                        ........ ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            3689999999999999999998664 44566654321                        01111222 5578999999


Q ss_pred             CCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++|+|.+++... +..++...+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||.+........ ...
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~-~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEY-TAR  160 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCc-ccc
Confidence            999999999753 34567888999999999999999999999999999999998887 499999999865432211 111


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....++..|+|||++.+..++.++|+||||+++|++++ |.+||....................+...+..+.+++.+||
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  240 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCW  240 (260)
T ss_pred             cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHc
Confidence            12235677999999998888999999999999999998 99999876554444333233333445677889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 042746          215 RREPGERWSCDQLLK  229 (408)
Q Consensus       215 ~~dP~~R~s~~ell~  229 (408)
                      +++|++||++.++++
T Consensus       241 ~~~p~~Rp~~~~l~~  255 (260)
T cd05073         241 KNRPEERPTFEYIQS  255 (260)
T ss_pred             ccCcccCcCHHHHHH
Confidence            999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=275.14  Aligned_cols=226  Identities=26%  Similarity=0.413  Sum_probs=177.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCCCcceEEEecc
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~~~~~LVmEy~   56 (408)
                      |+..+.||+|+||.||+|++..+++.+++|......                           ..........++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            778899999999999999999999999987544221                           11123446788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++ +|.+++......+++..+..++.|++.+|+|||++||+|+||+|+||+++.++. ++|+|||++........  ...
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~-~~l~d~g~~~~~~~~~~--~~~  156 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLR--TYT  156 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC-EEEecCCcccccCCCcc--ccC
Confidence            85 999999865457899999999999999999999999999999999999998775 99999999876543221  122


Q ss_pred             cCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--------------------ccCCC
Q 042746          137 QPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------------------FSDEL  195 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--------------------~~~~~  195 (408)
                      ...++..|+|||.+.+. .++.++|+||||+++++|++|.+||............                    +....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            23467889999999776 7889999999999999999999999764322111000                    01111


Q ss_pred             CCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          196 PRF--------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       196 p~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +..        .+..+..+.++|.+||..||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            111        11246789999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-34  Score=275.70  Aligned_cols=226  Identities=23%  Similarity=0.314  Sum_probs=172.6

Q ss_pred             CeEeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc-------------------------eecc--CCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS-------------------------YEAP--TTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~-------------------------~~~~--~~~~~~~~L   51 (408)
                      +|++.+.||+|+||+||+|.    +..++..+++|.....                         +...  ......+++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            68999999999999999997    4567888888764311                         1111  123346789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~-~~l~dfg~~~~~~~~~~  163 (284)
T cd05081          85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKE  163 (284)
T ss_pred             EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe-EEECCCcccccccCCCc
Confidence            99999999999999765567899999999999999999999999999999999999998875 99999999976543221


Q ss_pred             Ccc-cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh----------------hhhcccCC
Q 042746          132 RGV-KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL----------------SRIGFSDE  194 (408)
Q Consensus       132 ~~~-~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~----------------~~~~~~~~  194 (408)
                      ... .....++..|+|||++.+..++.++|+||||+++++|++|..|+........                ........
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05081         164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG  243 (284)
T ss_pred             ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence            111 1112234569999999988899999999999999999998776543221110                01111112


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+..+...+..+.+|+.+||..+|++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         244 RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22334567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-34  Score=272.81  Aligned_cols=219  Identities=22%  Similarity=0.340  Sum_probs=174.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------eeccCCCCCcceEEEeccCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      .+|++.+.||+|+||.||++..  +++.+++|.....                       +...+ ..+..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEE-cCCCcEEEEECCCC
Confidence            4799999999999999999864  6777877653311                       11112 12346899999999


Q ss_pred             CCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           59 GTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        59 GsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++........     .
T Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~-~kl~Dfg~~~~~~~~~~-----~  156 (254)
T cd05083          83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV-AKVSDFGLARVGSMGVD-----N  156 (254)
T ss_pred             CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc-EEECCCccceeccccCC-----C
Confidence            99999997543 35789999999999999999999999999999999999998874 99999999865432211     1


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ...+..|+|||.+.+..++.++|+||||+++|+|++ |++||.................+..+...+..+.+++.+||+.
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  236 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWET  236 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCC
Confidence            234677999999988889999999999999999997 9999987665554444333333444567788999999999999


Q ss_pred             CCCCCCCHHHHHc
Q 042746          217 EPGERWSCDQLLK  229 (408)
Q Consensus       217 dP~~R~s~~ell~  229 (408)
                      +|.+||++.+++.
T Consensus       237 ~p~~Rp~~~~l~~  249 (254)
T cd05083         237 EPKKRPSFHKLRE  249 (254)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-34  Score=283.59  Aligned_cols=233  Identities=23%  Similarity=0.364  Sum_probs=177.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCC--CcEEEEeeccccee--------------------cc------------CCCCCc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFN--GDVFAYLGDDVSYE--------------------AP------------TTSSSC   48 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t--~~~va~k~~~~~~~--------------------~~------------~~~~~~   48 (408)
                      +|++.+.||+|+||.||++++..+  +..+++|.......                    .+            ......
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999988  88898875331100                    00            011234


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .++++||+. ++|.+++. ....+++..++.++.||+.||+|||++|++||||||+|||++.++. +||+|||++.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~-~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC-EEeCcCCCceeccc
Confidence            678899986 58999886 3567799999999999999999999999999999999999998875 99999999975443


Q ss_pred             CCCC--cccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh----------------
Q 042746          129 SDTR--GVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----------------  189 (408)
Q Consensus       129 ~~~~--~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~----------------  189 (408)
                      ....  .......||+.|+|||++.+ ..++.++|+||||+++|+|++|++||...+.......                
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            2211  11223468999999998876 4678999999999999999999999975432111000                


Q ss_pred             ----------cc-c---CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          190 ----------GF-S---DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       190 ----------~~-~---~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                .. .   ..++......+..+++|+.+||+.||.+|||+.|++.|||++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                      00 0   0011112235788999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-34  Score=293.31  Aligned_cols=228  Identities=24%  Similarity=0.288  Sum_probs=175.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeecccc---------------------------eeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDVS---------------------------YEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~~---------------------------~~~~~~~~~~~   49 (408)
                      ++|.+++.||+|+||.||+|++.     .+++.||+|.....                           +.+........
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            36788999999999999999964     34567888754311                           11123344567


Q ss_pred             eEEEeccCCCCHHHHHHHhC------------------------------------------------------------
Q 042746           50 NLHLEYLPGGTVSDLATTLN------------------------------------------------------------   69 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~------------------------------------------------------------   69 (408)
                      ++||||+++|+|.+++....                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            89999999999999996421                                                            


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           70 -------------------------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        70 -------------------------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                                                           ..++...+..++.||+.||+|||+++++||||||+|||++.++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                 1245667888999999999999999999999999999998876


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-hhhhc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-LSRIG  190 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-~~~~~  190 (408)
                       .+||+|||+++...............+++.|+|||++.+..++.++|+||||+++|+|++ |..||....... .....
T Consensus       277 -~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~  355 (401)
T cd05107         277 -LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI  355 (401)
T ss_pred             -EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence             599999999975432221111122356888999999998889999999999999999998 899997644333 22222


Q ss_pred             ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       191 ~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .....+..|...+.++.+|+.+||..+|.+||++.|+++.
T Consensus       356 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2333345566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=304.78  Aligned_cols=231  Identities=30%  Similarity=0.439  Sum_probs=193.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~~~~~~~~L   51 (408)
                      +.|++...||.|.+|+||+++.+++++..|+|..+..                              ++.....+..++|
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            5799999999999999999999999999887654411                              0111234567999


Q ss_pred             EEeccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           52 HLEYLPGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |||||.||+..|+++. .+..+.|..|..+++.++.||.+||.+.++|||||-+|||++.++. |||+|||++.+.+...
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~-VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDSTV  177 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc-EEEeeeeeeeeeeccc
Confidence            9999999999999987 4667899999999999999999999999999999999999999986 9999999998876654


Q ss_pred             CCcccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CCCCc
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSS  203 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~~~s  203 (408)
                      .  ...+..|||.|||||++..     ..|+..+|+||||++..||..|.+|+-+..+......+-...+|.+  |..-+
T Consensus       178 g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs  255 (953)
T KOG0587|consen  178 G--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWS  255 (953)
T ss_pred             c--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHH
Confidence            4  3456789999999999953     3568889999999999999999999987655444433344444544  34567


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      +.+.+||..||.+|-.+||+..++++|||...
T Consensus       256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  256 KKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             HHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            88999999999999999999999999999974

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.5e-34  Score=277.52  Aligned_cols=226  Identities=23%  Similarity=0.266  Sum_probs=169.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcC----------------CCcEEEEeecccc--------------------------ee
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRF----------------NGDVFAYLGDDVS--------------------------YE   40 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~----------------t~~~va~k~~~~~--------------------------~~   40 (408)
                      +|++.+.||+|+||+||++.+..                ++..+++|.....                          +.
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   85 (296)
T cd05095           6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL   85 (296)
T ss_pred             hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            69999999999999999986543                2334666543211                          11


Q ss_pred             ccCCCCCcceEEEeccCCCCHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC
Q 042746           41 APTTSSSCRNLHLEYLPGGTVSDLATTLN----------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP  110 (408)
Q Consensus        41 ~~~~~~~~~~LVmEy~~gGsL~~~l~~~~----------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~  110 (408)
                      ..+..+...+++|||+++|+|.+++....          ..+++..+..++.||+.||+|||++|++|+||||+|||++.
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~  165 (296)
T cd05095          86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK  165 (296)
T ss_pred             EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC
Confidence            12233456789999999999999997532          23567789999999999999999999999999999999988


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh--CCCCCCCCChhhhhh
Q 042746          111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSR  188 (408)
Q Consensus       111 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt--G~~Pf~~~~~~~~~~  188 (408)
                      ++. ++|+|||+++...............+++.|+|||...+..++.++|+|||||++|+|++  |..||..........
T Consensus       166 ~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~  244 (296)
T cd05095         166 NYT-IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE  244 (296)
T ss_pred             CCC-EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence            774 99999999875433221111112234678999999988889999999999999999998  778987654333221


Q ss_pred             hc-------ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          189 IG-------FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       189 ~~-------~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..       ........+...++.+++|+.+||+.||.+||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            10       011112234556788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.9e-35  Score=279.55  Aligned_cols=224  Identities=26%  Similarity=0.323  Sum_probs=173.0

Q ss_pred             EeeceeeecCCeeEEEEEEc----CCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEe
Q 042746            5 VRGKCIGRGSFGTVNVAVDR----FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~----~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .+.+.||.|+||.||+|...    ..+..|++|....                          .+.+........++|||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            56889999999999999998    3445566655421                          11222223445789999


Q ss_pred             ccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           55 YLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        55 y~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |+++|+|.+++... ...+++..+..++.||+.||.|||+++++|+||+++|||++.++ .+||+|||++..........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence            99999999999876 56789999999999999999999999999999999999999887 59999999997663222211


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+...............+..+...+..+.++|.+
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  240 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ  240 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence            2222346778999999998889999999999999999999 789998876665544434444455667789999999999


Q ss_pred             hcccCCCCCCCHHHHHc
Q 042746          213 CLRREPGERWSCDQLLK  229 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~  229 (408)
                      ||..||.+|||+.++++
T Consensus       241 C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  241 CWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HT-SSGGGS--HHHHHH
T ss_pred             HcCCChhhCcCHHHHHh
Confidence            99999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-34  Score=274.54  Aligned_cols=225  Identities=22%  Similarity=0.321  Sum_probs=170.7

Q ss_pred             CCe-EeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc--------------------------eecc--CCCCCc
Q 042746            2 VSW-VRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS--------------------------YEAP--TTSSSC   48 (408)
Q Consensus         2 ~~Y-~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~--------------------------~~~~--~~~~~~   48 (408)
                      .+| ++.+.||+|+||+||++.    ...++..+++|.....                          +...  ......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            456 899999999999998765    3456777887654311                          1111  112345


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+++|||+++|+|.+++..  ..+++..++.++.|++.||+|||+++|+||||||+|||++.++ .++|+|||+++....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCC
Confidence            7899999999999999974  3579999999999999999999999999999999999998887 499999999876543


Q ss_pred             CCCCc-ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hh-------------hhhccc
Q 042746          129 SDTRG-VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TL-------------SRIGFS  192 (408)
Q Consensus       129 ~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~-------------~~~~~~  192 (408)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++|..||......  ..             ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            22111 111223567799999998888899999999999999999999998643211  00             000111


Q ss_pred             CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       193 ~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ...+..+...+..+++++.+||+.||++|||+++++.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1222345667889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.6e-35  Score=287.33  Aligned_cols=230  Identities=20%  Similarity=0.318  Sum_probs=171.3

Q ss_pred             ceeeec--CCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRG--SFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G--~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      ..||+|  +||+||+|.+..+++.||+|.....                           ....+..+...+++|||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  9999999999999999998764321                           11223445667899999999


Q ss_pred             CCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc----
Q 042746           59 GTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG----  133 (408)
Q Consensus        59 GsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~----  133 (408)
                      ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++||+.+..........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL-VSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc-EEEechHHHhhhhccCccccccc
Confidence            9999999764 235789999999999999999999999999999999999998874 9999998653221111000    


Q ss_pred             -ccccCCCCCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC----------------
Q 042746          134 -VKIQPRGSPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE----------------  194 (408)
Q Consensus       134 -~~~~~~Gt~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~----------------  194 (408)
                       ......++..|+|||++.+.  .++.++|+|||||++|+|++|++||................                
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence             00112356779999999764  46889999999999999999999997643222111000000                


Q ss_pred             ------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          195 ------------------------------LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       195 ------------------------------~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                                    ....+...++.+++|+.+||..||++|||+.|+++||||.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                          00111235677899999999999999999999999999976543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-34  Score=285.14  Aligned_cols=227  Identities=26%  Similarity=0.393  Sum_probs=175.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCC------CCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTS------SSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~------~~~   48 (408)
                      .+|.+.+.||+|+||+||+|++..+++.+++|......                           ...+..      ...
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            57999999999999999999999999999987643110                           000111      123


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ++++|||+.. +|.++.   +..+++..+..++.|++.||+|||+++++||||||+||+++.++. +||+|||+++....
T Consensus        95 ~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~-~kL~dfg~~~~~~~  169 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLARHADA  169 (342)
T ss_pred             EEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEeeCCCCcCCCC
Confidence            5899999975 776654   346789999999999999999999999999999999999998875 99999999865432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF----------------  191 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~----------------  191 (408)
                      .     .....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.........                
T Consensus       170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         170 E-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             C-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            1     123457899999999876 457889999999999999999999998654322111000                


Q ss_pred             ------cCCCCCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 ------SDELPRF--------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 ------~~~~p~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                            ....+..        ....++.+.+||.+||+.||.+||++.|++.||||.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                  0001111        1245678899999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=276.21  Aligned_cols=227  Identities=28%  Similarity=0.452  Sum_probs=177.0

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCCC--CcceEEEe
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTSS--SCRNLHLE   54 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~~--~~~~LVmE   54 (408)
                      |++.+.||.|+||.||+|++..+++.+++|......                           .......  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            788999999999999999999999999887654221                           0112223  67899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+++ +|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++......... .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~-~~l~d~g~~~~~~~~~~~-~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSA-D  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC-EEEccccceeeccCCCcc-c
Confidence            9985 899988765567899999999999999999999999999999999999998875 999999998765433211 1


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-------CCCC----------
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-------DELP----------  196 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-------~~~p----------  196 (408)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..............       ...+          
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            122346888999998765 3578899999999999999999999976553322111000       0000          


Q ss_pred             -------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          197 -------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       197 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                                   .+....++.+.+++.+||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         0011137888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.4e-34  Score=272.05  Aligned_cols=220  Identities=25%  Similarity=0.309  Sum_probs=163.1

Q ss_pred             ceeeecCCeeEEEEEEcC--CCcEEEEeeccc--------------------------ceeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRF--NGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~--t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||.||+|.+..  ++..+++|....                          ...+.+......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            469999999999998653  445666664321                          1122234455678999999999


Q ss_pred             CHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           60 TVSDLATTLN----AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        60 sL~~~l~~~~----~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +|.+++....    ...++..++.++.|++.||+|||+++++||||||+||+++.++. +||+|||++............
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~-~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT-VKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc-EEECCccccccccCcceeecC
Confidence            9999997532    23466778899999999999999999999999999999998774 999999998654322211112


Q ss_pred             ccCCCCCCCCChhhHhCC-------CCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhccc-----CCCCCCCCCC
Q 042746          136 IQPRGSPLWMAPEVVRGE-------CQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFS-----DELPRFPTQS  202 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-------~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~-----~~~p~~~~~~  202 (408)
                      ....|++.|+|||++.+.       .++.++|+||||+++|+|++ |..||..............     ...|......
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            234578889999998642       35789999999999999996 9999986554433221111     1122333456


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+.+++.+|+ .+|++|||++||++
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            788899999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.5e-35  Score=279.48  Aligned_cols=235  Identities=24%  Similarity=0.316  Sum_probs=176.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc----EEEEeecccc---------------------------eeccC-CCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD----VFAYLGDDVS---------------------------YEAPT-TSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~----~va~k~~~~~---------------------------~~~~~-~~~~~~   49 (408)
                      ..|+..+.||+|.||.||+|+.++++.    .+|+|+.+-.                           ....+ +.+..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468999999999999999998777766    4565543311                           11112 237789


Q ss_pred             eEEEeccCCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC---CcEEEeecCC
Q 042746           50 NLHLEYLPGGTVSDLATTL----NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS---SFVKLADFGA  122 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~----~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~---~~vkL~DFGl  122 (408)
                      +|++||++. +|..+|+.+    ...++...+++++.||+.|+.|||++-|+||||||.|||+..++   +.|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999987 899998763    45678899999999999999999999999999999999997662   2599999999


Q ss_pred             ccccccCCCCc-ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCC----------hhhhhhhc
Q 042746          123 AGEATVSDTRG-VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFG----------ANTLSRIG  190 (408)
Q Consensus       123 a~~~~~~~~~~-~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~----------~~~~~~~~  190 (408)
                      ++.....-... .....+-|.+|.|||.+.|. .|+.+.|+||.|||+.||+|-+|.|....          ..++.++-
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            98776543221 12223569999999999986 57899999999999999999998885321          11222220


Q ss_pred             c------c------CCCCCC-----------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          191 F------S------DELPRF-----------------------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       191 ~------~------~~~p~~-----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      .      .      ..+|.+                       -..-++.+.+|+.+||+.||.+|+|++++|+|+||..
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            0      0      111111                       0112344779999999999999999999999999986


Q ss_pred             CC
Q 042746          236 VS  237 (408)
Q Consensus       236 ~~  237 (408)
                      ..
T Consensus       343 d~  344 (438)
T KOG0666|consen  343 DP  344 (438)
T ss_pred             CC
Confidence            54

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-34  Score=284.23  Aligned_cols=233  Identities=26%  Similarity=0.400  Sum_probs=179.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccC--CCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPT--TSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~--~~~~~~~L   51 (408)
                      ++|++.+.||+|+||.||+|.+..+++.+++|.....                            +.+.+  ......++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            5799999999999999999999999999988754211                            00111  12345789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++ +|.+++..  ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++........
T Consensus        87 v~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~-~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          87 VFEYMET-DLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEE  162 (337)
T ss_pred             Eeccccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc-EEEeeccchhccccccc
Confidence            9999985 99998874  37788999999999999999999999999999999999998885 99999999875543221


Q ss_pred             C---cccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh-hhc----------------
Q 042746          132 R---GVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS-RIG----------------  190 (408)
Q Consensus       132 ~---~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~-~~~----------------  190 (408)
                      .   .......|++.|+|||++.+ ..++.++|+||||+++|+|++|++||......... +..                
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence            1   12223468999999998765 45788999999999999999999999754322110 000                


Q ss_pred             ----------c---cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          191 ----------F---SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       191 ----------~---~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                .   ...........+..+.++|.+||+.||++|||+.++++|||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                      0   00011112236788999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.7e-34  Score=268.35  Aligned_cols=220  Identities=23%  Similarity=0.302  Sum_probs=171.8

Q ss_pred             ceeeecCCeeEEEEEEcC-CCc--EEEEeecccce--------------------------eccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDRF-NGD--VFAYLGDDVSY--------------------------EAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~-t~~--~va~k~~~~~~--------------------------~~~~~~~~~~~LVmEy~~g   58 (408)
                      +.||+|++|+||+|.+.. ++.  .+++|......                          ...+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            479999999999999876 333  46766533211                          111222 667899999999


Q ss_pred             CCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-cccc
Q 042746           59 GTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-GVKI  136 (408)
Q Consensus        59 GsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-~~~~  136 (408)
                      |+|.+.+.... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++ .+||+|||++......... ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEeccccccccccccccceeccc
Confidence            99999998654 5678999999999999999999999999999999999999887 4999999999765432211 1111


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc-cCCCCCCCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF-SDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~-~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ...++..|+|||++.+..++.++|+|||||++|+|++ |+.||............. .......+...+..+.+++.+||
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW  238 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence            3457888999999998889999999999999999998 999997655444332221 22223344567889999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 042746          215 RREPGERWSCDQLLK  229 (408)
Q Consensus       215 ~~dP~~R~s~~ell~  229 (408)
                      +.+|++|||+.|+++
T Consensus       239 ~~~p~~Rps~~~~~~  253 (257)
T cd05040         239 AHNPADRPTFAALRE  253 (257)
T ss_pred             CCCcccCCCHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-34  Score=283.32  Aligned_cols=235  Identities=23%  Similarity=0.364  Sum_probs=178.2

Q ss_pred             CCeE-eeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------------------eec
Q 042746            2 VSWV-RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------------------YEA   41 (408)
Q Consensus         2 ~~Y~-~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------------------~~~   41 (408)
                      .+|. +.+.||.|+||+||+|++..+++.+++|.....                                       ...
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3565 468899999999999999999999988753211                                       011


Q ss_pred             cCCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           42 PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        42 ~~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      .+......+++|||++ |+|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~-~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI-CKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC-EEECCcc
Confidence            1223456789999997 589999874 456799999999999999999999999999999999999998874 9999999


Q ss_pred             CccccccCC------------CCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhh
Q 042746          122 AAGEATVSD------------TRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR  188 (408)
Q Consensus       122 la~~~~~~~------------~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~  188 (408)
                      ++.......            .........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            986543110            01111223578899999999764 46889999999999999999999997654322111


Q ss_pred             hccc-------C------C--------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          189 IGFS-------D------E--------------LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       189 ~~~~-------~------~--------------~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ....       .      .              ........+..+.++|.+||+++|++|||++|++.||||+.....
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            1000       0      0              001112457788999999999999999999999999999865443

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4e-34  Score=272.38  Aligned_cols=224  Identities=22%  Similarity=0.341  Sum_probs=178.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcC-CCcEEEEeeccc------------------------------------ceeccCCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRF-NGDVFAYLGDDV------------------------------------SYEAPTTS   45 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~-t~~~va~k~~~~------------------------------------~~~~~~~~   45 (408)
                      +|++.+.||+|+||.||+|.+.. +++.+++|....                                    .....+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58999999999999999999988 677787764321                                    01112334


Q ss_pred             CCcceEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           46 SSCRNLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      +...+++|||++|++|.+++..   ....+++..++.++.|++.+|.|||+ .+++|+||||+||+++.++. ++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~-~~l~dfg  159 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFG  159 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc-EEEeccc
Confidence            5678899999999999998854   34568899999999999999999996 68999999999999998875 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC-CCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR-FPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~-~~~  200 (408)
                      ++.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|++||.................+. ...
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            997654332   2234568999999999998888999999999999999999999998665444333322222222 223


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..++.+.+++.+||..||++||++.|+..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            678899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-34  Score=302.11  Aligned_cols=233  Identities=18%  Similarity=0.184  Sum_probs=166.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEE-Ee------------------e------------------------cccc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFA-YL------------------G------------------------DDVS   38 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va-~k------------------~------------------------~~~~   38 (408)
                      .+|++++.||+|+||+||+|..+....... .+                  .                        ..+.
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            579999999999999999987654322110 00                  0                        0011


Q ss_pred             eeccCCCCCcceEEEeccCCCCHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCc
Q 042746           39 YEAPTTSSSCRNLHLEYLPGGTVSDLATTL----NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF  114 (408)
Q Consensus        39 ~~~~~~~~~~~~LVmEy~~gGsL~~~l~~~----~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~  114 (408)
                      +...+......|+++|++.+ +|.+++...    ........++.++.||+.||+|||++||+||||||+|||++.++. 
T Consensus       228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-  305 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-  305 (501)
T ss_pred             EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence            22223445667899999964 777776532    122335677889999999999999999999999999999998875 


Q ss_pred             EEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCC-CCCCCCh---hhhhhhc
Q 042746          115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP-AWEDFGA---NTLSRIG  190 (408)
Q Consensus       115 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~-Pf~~~~~---~~~~~~~  190 (408)
                      +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|.. ||.....   ..+..+.
T Consensus       306 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        306 IVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             EEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999999976543221 11223569999999999999989999999999999999999875 4443221   1111110


Q ss_pred             c-----cCCCCC----------------C---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 F-----SDELPR----------------F---------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 ~-----~~~~p~----------------~---------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .     ...+|.                .         ....+.++.++|.+||++||++|||+.|+|.||||....
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            0     000100                0         012456678889999999999999999999999997644

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.9e-34  Score=271.50  Aligned_cols=220  Identities=23%  Similarity=0.299  Sum_probs=161.5

Q ss_pred             ceeeecCCeeEEEEEEcC--CCcEEEEeecc--------------------------cceeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRF--NGDVFAYLGDD--------------------------VSYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~--t~~~va~k~~~--------------------------~~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||+|....  ....+++|...                          +.+.+.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999996543  23345555321                          11122234456688999999999


Q ss_pred             CHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           60 TVSDLATTLNA----YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        60 sL~~~l~~~~~----~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +|.+++.....    ..++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||++............
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS-VKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc-EEEeccccccccccchheecc
Confidence            99999975432    2457788899999999999999999999999999999998875 999999998654322111111


Q ss_pred             ccCCCCCCCCChhhHhC-------CCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhccc-----CCCCCCCCCC
Q 042746          136 IQPRGSPLWMAPEVVRG-------ECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFS-----DELPRFPTQS  202 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~-------~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~-----~~~p~~~~~~  202 (408)
                      ....+++.|+|||++..       ..++.++|||||||++|+|++ |.+||..............     ...|..+...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKY  239 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccC
Confidence            22345778999999853       346789999999999999999 8899976544332221111     1123445567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++...+++..|+ .||++|||++|++.
T Consensus       240 ~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         240 SDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            888899999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=276.41  Aligned_cols=231  Identities=26%  Similarity=0.405  Sum_probs=185.1

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEeccCCCC
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      .+.||+|+||.|--++...|+..||+|..++.                          ....|+++..+|||||-+.||.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            46899999999999999999999999875532                          2334778888999999999999


Q ss_pred             HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC--cEEEeecCCccccccCC-----CCc
Q 042746           61 VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS--FVKLADFGAAGEATVSD-----TRG  133 (408)
Q Consensus        61 L~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~--~vkL~DFGla~~~~~~~-----~~~  133 (408)
                      |.+.|++ ...++|.++.+++.+|+.||.|||.+||.||||||+|||-...++  -+||+||.+........     ...
T Consensus       163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            9999985 467899999999999999999999999999999999999754322  38999998874332221     222


Q ss_pred             ccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh---------------hhhhhhcccC
Q 042746          134 VKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGA---------------NTLSRIGFSD  193 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~---------------~~~~~~~~~~  193 (408)
                      ...+++|+..|||||+..     ...|+.+.|+||||||+|-||.|.+||.+.-.               +.+...+-.+
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            345678999999999974     24689999999999999999999999964321               1222222222


Q ss_pred             CCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ~~p~~~----~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      .+ .+|    ..+|.+++|++..+|.+|+.+|.++.++++|||++...+.
T Consensus       322 kY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  322 KY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             CC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            22 333    4689999999999999999999999999999999876654

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-35  Score=296.10  Aligned_cols=223  Identities=29%  Similarity=0.417  Sum_probs=185.9

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeec-----------------------------ccceecc--CCCCCcceEEEec
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGD-----------------------------DVSYEAP--TTSSSCRNLHLEY   55 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~-----------------------------~~~~~~~--~~~~~~~~LVmEy   55 (408)
                      ...||+|+|=+||+|.|..+|..||.-..                             .+.+...  .....++.+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            56899999999999999999998864110                             1122221  2234568899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      +..|+|..+.++. +..+.+.++.|++|||.||.|||++.  |||||||.+||||+.+.+.|||+|.|+|.......   
T Consensus       125 ~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---  200 (632)
T ss_pred             ccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc---
Confidence            9999999999965 45689999999999999999999985  99999999999999887789999999997654333   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCC-CChhhhhhhcccCCCCC-CCCCCcHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWED-FGANTLSRIGFSDELPR-FPTQSSELGRDFLD  211 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~-~~~~~~~~~~~~~~~p~-~~~~~s~~~~~li~  211 (408)
                       .....|||.|||||++. +.|+..+||||||+.+.||+|+..||.. .++.++++...++..|. +...-.+++++||.
T Consensus       201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe  278 (632)
T KOG0584|consen  201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE  278 (632)
T ss_pred             -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence             23367999999999998 6699999999999999999999999975 56778888777776653 33445788999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +||.. .+.|+|+.|+|+||||+..
T Consensus       279 kCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  279 KCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHhcC-chhccCHHHHhhChhhccc
Confidence            99999 9999999999999999864

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-33  Score=269.62  Aligned_cols=227  Identities=19%  Similarity=0.227  Sum_probs=175.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||+||+|+.+.+.     +.+++|....                          .+...+......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            47899999999999999999976543     4566654321                          1122234456688


Q ss_pred             EEEeccCCCCHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           51 LHLEYLPGGTVSDLATTLN--------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~--------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      ++|||+++|+|.+++....        ..+++..+..++.||+.+|+|||+++|+||||||+||+++.++. ++++|||+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~-~~l~~~~~  163 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE-VKVSLLSL  163 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc-EEEccccc
Confidence            9999999999999997543        15789999999999999999999999999999999999998875 99999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCC-CCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDEL-PRFPT  200 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~-p~~~~  200 (408)
                      +........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||................. ...+.
T Consensus       164 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  242 (275)
T cd05046         164 SKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPE  242 (275)
T ss_pred             ccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCC
Confidence            864432211 11122346778999999988888899999999999999998 8899976544443333222221 12345


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+..+.+++.+||..+|.+|||+.|++++
T Consensus       243 ~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         243 GCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-33  Score=275.43  Aligned_cols=223  Identities=22%  Similarity=0.321  Sum_probs=166.7

Q ss_pred             CCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEeccCCCCHHHHHH
Q 042746           14 SFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYLPGGTVSDLAT   66 (408)
Q Consensus        14 ~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~~gGsL~~~l~   66 (408)
                      ++|.||++++..+++.+|+|.....                           ....+..+...+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4566777777889999999864321                           1112334566889999999999999997


Q ss_pred             Hh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC-----CcccccCCC
Q 042746           67 TL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT-----RGVKIQPRG  140 (408)
Q Consensus        67 ~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-----~~~~~~~~G  140 (408)
                      .. ...+++..+..++.||+.||+|||+++|+||||||+||+++.++. +||+|||.+........     ........+
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~-~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc-eEEecCccceeeccccccccccccccccccc
Confidence            53 346789999999999999999999999999999999999998775 99999998854432111     011123357


Q ss_pred             CCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC---------CC--------------
Q 042746          141 SPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD---------EL--------------  195 (408)
Q Consensus       141 t~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~---------~~--------------  195 (408)
                      +..|+|||++.+.  .++.++|+||+||++|+|++|+.||...............         ..              
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            8889999999763  5788999999999999999999999754322111000000         00              


Q ss_pred             ----------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          196 ----------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       196 ----------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                ...+...+.++.+|+.+||..||++|||+.|+++||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                      011123356788999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-33  Score=269.21  Aligned_cols=215  Identities=20%  Similarity=0.259  Sum_probs=163.0

Q ss_pred             ceeeecCCeeEEEEEEcCCC------------cEEEEeecc-------------------------cceeccCCCCCcce
Q 042746            8 KCIGRGSFGTVNVAVDRFNG------------DVFAYLGDD-------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~------------~~va~k~~~-------------------------~~~~~~~~~~~~~~   50 (408)
                      +.||+|+||+||+|+...+.            ..+++|...                         +........+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            46899999999999854322            234554322                         11222233455678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC------cEEEeecCCcc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS------FVKLADFGAAG  124 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~------~vkL~DFGla~  124 (408)
                      ++|||+++|+|..++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.      .++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            999999999999998766677899999999999999999999999999999999999976542      28999999985


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHH-hCCCCCCCCChhhhhhhcccCCCCCCCCCC
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMV-TGKPAWEDFGANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLl-tG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  202 (408)
                      .....      ....|++.|+|||++. +..++.++|||||||++|+|+ +|..||............ .... ......
T Consensus       161 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~-~~~~~~  232 (262)
T cd05077         161 TVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQC-MLVTPS  232 (262)
T ss_pred             cccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCc-cCCCCC
Confidence            44221      1234788999999987 466889999999999999998 588998765443332221 1111 222334


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +.++++||.+||+.||.+||++.+|+++
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            6788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-33  Score=266.56  Aligned_cols=213  Identities=22%  Similarity=0.336  Sum_probs=162.7

Q ss_pred             ceeeecCCeeEEEEEEcCCCc----------EEEEeeccc------------------------ceeccCCCCCcceEEE
Q 042746            8 KCIGRGSFGTVNVAVDRFNGD----------VFAYLGDDV------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~----------~va~k~~~~------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +.||+|+||.||+|.+..++.          .+++|....                        ...+.... ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            479999999999999988772          244432111                        11111222 4568999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC------cEEEeecCCccccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS------FVKLADFGAAGEAT  127 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~------~vkL~DFGla~~~~  127 (408)
                      ||+++|+|.+++......++...+..++.||+.||+|||++||+||||||+|||++.++.      .+||+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            999999999999866557899999999999999999999999999999999999987651      39999999986543


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      .      .....++..|+|||++.+.  .++.++|+||||+++++|++ |..||............ . .....+.....
T Consensus       160 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~  231 (259)
T cd05037         160 S------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-Q-DQHRLPMPDCA  231 (259)
T ss_pred             c------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-h-cCCCCCCCCch
Confidence            2      1123467889999999876  78899999999999999999 68888765432222111 1 11122222347


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+.+++.+||..+|.+|||+.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHH
Confidence            8899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-33  Score=277.51  Aligned_cols=229  Identities=26%  Similarity=0.369  Sum_probs=177.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCC-CCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTT-SSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~-~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||.||+|.+..++..+++|.....                           ....+. .....+++|
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            5799999999999999999999999999998853210                           111121 234678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+ +++|.++++  ...+++..+..++.||+.||+|||+++|+||||||+||+++.++. ++|+|||++......    
T Consensus        90 e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~-~~l~dfg~~~~~~~~----  161 (328)
T cd07856          90 ELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD-LKICDFGLARIQDPQ----  161 (328)
T ss_pred             ehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC-EEeCccccccccCCC----
Confidence            998 458988886  345788889999999999999999999999999999999998774 999999998644221    


Q ss_pred             ccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh---------------hhc-------
Q 042746          134 VKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---------------RIG-------  190 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~---------------~~~-------  190 (408)
                       .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||.........               ...       
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence             122357889999999866 56889999999999999999999999754321110               000       


Q ss_pred             ----c--cCCCC--CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 ----F--SDELP--RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 ----~--~~~~p--~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                          .  ....|  ......+..++++|.+||+.+|++|||+++++.||||.....+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                0  00000  1113467889999999999999999999999999999765543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-33  Score=271.07  Aligned_cols=178  Identities=25%  Similarity=0.380  Sum_probs=142.0

Q ss_pred             CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC------CcEEEe
Q 042746           45 SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS------SFVKLA  118 (408)
Q Consensus        45 ~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~------~~vkL~  118 (408)
                      .+...+|||||+++|+|.+++....+.+++..+..++.||+.||+|||+++|+||||||+|||++..+      ..+|++
T Consensus        87 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~  166 (274)
T cd05076          87 RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLS  166 (274)
T ss_pred             eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeec
Confidence            44567899999999999999976667789999999999999999999999999999999999997532      238999


Q ss_pred             ecCCccccccCCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHH-hCCCCCCCCChhhhhhhcccCCCC
Q 042746          119 DFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMV-TGKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       119 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLl-tG~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      |||++.......      ...+++.|+|||.+.+ ..++.++|+||||+++|+|+ +|++||............ . ...
T Consensus       167 d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~-~~~  238 (274)
T cd05076         167 DPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-E-KKH  238 (274)
T ss_pred             CCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH-H-hcc
Confidence            999875432211      1246888999999875 56789999999999999985 699999865544332221 1 112


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+...++.+.++|.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         239 RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            3344456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.8e-33  Score=266.80  Aligned_cols=226  Identities=21%  Similarity=0.300  Sum_probs=172.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcC---CCcEEEEeecccc---------------------------eeccCC---CC---C
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRF---NGDVFAYLGDDVS---------------------------YEAPTT---SS---S   47 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~---t~~~va~k~~~~~---------------------------~~~~~~---~~---~   47 (408)
                      |++.+.||+|+||+||+|.+..   +++.+++|.....                           ......   ..   .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            7789999999999999998654   5677888643211                           000000   01   1


Q ss_pred             cceEEEeccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN-----AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~-----~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      ..++++||+++|+|.+++....     ..+++..+..++.||+.||+|||+++|+||||||+||+++.++. +||+|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~-~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT-VCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC-EEECcccc
Confidence            2468899999999998875321     24688899999999999999999999999999999999988775 99999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~  201 (408)
                      ++...............+++.|++||.+.+..++.++||||||+++|+|++ |++||.................+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD  239 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            876543221111222345678999999998889999999999999999999 8999987665544433333333344456


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+.+++.+||+.+|++|||+.|++++
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-33  Score=265.84  Aligned_cols=220  Identities=20%  Similarity=0.272  Sum_probs=160.2

Q ss_pred             ceeeecCCeeEEEEEEcCCCc--EEEEeecc--------------------------cceeccCCCCCcceEEEeccCCC
Q 042746            8 KCIGRGSFGTVNVAVDRFNGD--VFAYLGDD--------------------------VSYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~--~va~k~~~--------------------------~~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +.||+|+||+||++....++.  .++++...                          +.+...+......+++|||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            369999999999997654432  23333211                          11222234456678999999999


Q ss_pred             CHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           60 TVSDLATTLN---AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        60 sL~~~l~~~~---~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|.+++....   ...++..++.++.||+.||+|||+++++||||||+|||++.++. ++|+|||++.............
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~-~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT-VKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc-EEecccccccccCcchhhhccc
Confidence            9999997532   34567788899999999999999999999999999999998875 9999999985432211111222


Q ss_pred             cCCCCCCCCChhhHhC-------CCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccC-----CCCCCCCCCc
Q 042746          137 QPRGSPLWMAPEVVRG-------ECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSD-----ELPRFPTQSS  203 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~-------~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~-----~~p~~~~~~s  203 (408)
                      ...|++.|+|||++..       ..++.++||||||+++|+|++ |.+||...............     ..|..+...+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            3468899999999853       234678999999999999997 57888765543322221111     1234445678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +.+.+++.+|| .+|++||++.|+++
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            88999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.8e-34  Score=306.30  Aligned_cols=181  Identities=23%  Similarity=0.380  Sum_probs=138.3

Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l-~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      ++||-||||+.-+|.+++.. +.+. .....+++++||+.||.|+|++|||||||||.||+|+++++ |||+|||+|...
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~-VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS-VKIGDFGLATDL  747 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC-eeecccccchhh
Confidence            46899999999888888764 3333 46778999999999999999999999999999999998886 999999999651


Q ss_pred             c----cC------------CCCcccccCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCC--Chhh
Q 042746          127 T----VS------------DTRGVKIQPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDF--GANT  185 (408)
Q Consensus       127 ~----~~------------~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~--~~~~  185 (408)
                      .    ..            ......+..+||..|+|||++.+.   .|+.|+|+|||||++|||+.   ||...  ....
T Consensus       748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i  824 (1351)
T KOG1035|consen  748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI  824 (1351)
T ss_pred             hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH
Confidence            1    00            011123456799999999999765   49999999999999999995   35432  1122


Q ss_pred             hhhhcccCCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          186 LSRIGFSDELPRF---PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       186 ~~~~~~~~~~p~~---~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +... ....+|..   ...--+..+.+|..||+.||++||||.|+|++.||-
T Consensus       825 L~~L-R~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  825 LTNL-RKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHhc-ccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            2222 13333332   333334456799999999999999999999999986

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-33  Score=265.79  Aligned_cols=226  Identities=26%  Similarity=0.329  Sum_probs=172.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcC----CCcEEEEeecccce--------------------------eccCCC--CCcce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRF----NGDVFAYLGDDVSY--------------------------EAPTTS--SSCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~----t~~~va~k~~~~~~--------------------------~~~~~~--~~~~~   50 (408)
                      .|++.+.||+|+||.||+|....    ++..+++|......                          ......  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            57888999999999999998653    47788886533111                          111112  44678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ++|||+++++|.+++......+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++.......
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~-~~l~dfg~~~~~~~~~  163 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDK  163 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC-EEEcccccccccccCC
Confidence            999999999999999866556899999999999999999999999999999999999998874 9999999997654222


Q ss_pred             CCc-ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh---------------hhhhcccCC
Q 042746          131 TRG-VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT---------------LSRIGFSDE  194 (408)
Q Consensus       131 ~~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~---------------~~~~~~~~~  194 (408)
                      ... ......++..|+|||.+.+..++.++|+||||+++++|++|..||.......               .........
T Consensus       164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05038         164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE  243 (284)
T ss_pred             cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC
Confidence            111 1111234567999999998889999999999999999999999986432111               111111111


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ....+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         244 RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22234456788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=276.88  Aligned_cols=229  Identities=23%  Similarity=0.336  Sum_probs=176.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------------cceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------------~~~~~~~~~~~~~~L   51 (408)
                      .+|.+.+.+|+|.||+|-.+.|..++..+|+|...                              +.+..-+.-.++.+|
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            47999999999999999999999999988876432                              111112445566788


Q ss_pred             EEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC-------------------
Q 042746           52 HLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN-------------------  111 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~-------------------  111 (408)
                      |.|.+ |-++++++... -.+++...++.+.+||+.+++|||+++++|-||||+|||+-..                   
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence            99988 55999999852 2457899999999999999999999999999999999998311                   


Q ss_pred             CCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh---hhh
Q 042746          112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT---LSR  188 (408)
Q Consensus       112 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~---~~~  188 (408)
                      ...|+++|||.|.......     ...+-|..|.|||++.+-+++..+||||+||||+||.+|...|+.....+   +.+
T Consensus       248 s~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe  322 (415)
T KOG0671|consen  248 STAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME  322 (415)
T ss_pred             CcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence            1248999999995543222     33457999999999999999999999999999999999999997654211   111


Q ss_pred             hcccCCCC------------------CCC-------------------------CCCcHHHHHHHHHhcccCCCCCCCHH
Q 042746          189 IGFSDELP------------------RFP-------------------------TQSSELGRDFLDKCLRREPGERWSCD  225 (408)
Q Consensus       189 ~~~~~~~p------------------~~~-------------------------~~~s~~~~~li~~~L~~dP~~R~s~~  225 (408)
                      .+. +..|                  .++                         .....++.|||++||.+||.+|+|+.
T Consensus       323 rIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  323 RIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             Hhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            110 0111                  000                         01123467999999999999999999


Q ss_pred             HHHcCCCCCCCC
Q 042746          226 QLLKHPFLQSVS  237 (408)
Q Consensus       226 ell~hpf~~~~~  237 (408)
                      |+|.||||+...
T Consensus       402 EAL~HpFF~~~~  413 (415)
T KOG0671|consen  402 EALSHPFFARLT  413 (415)
T ss_pred             HHhcCHHhhcCC
Confidence            999999998654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-32  Score=283.97  Aligned_cols=232  Identities=19%  Similarity=0.200  Sum_probs=165.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC----------------CCcEEEEeeccccee-------------------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF----------------NGDVFAYLGDDVSYE-------------------------   40 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~----------------t~~~va~k~~~~~~~-------------------------   40 (408)
                      ++|++.++||+|+||+||+|.+..                .++.||+|.......                         
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            689999999999999999997532                345678876431100                         


Q ss_pred             -------------------cc--------CCCCCcceEEEeccCCCCHHHHHHHhCC-----------------------
Q 042746           41 -------------------AP--------TTSSSCRNLHLEYLPGGTVSDLATTLNA-----------------------   70 (408)
Q Consensus        41 -------------------~~--------~~~~~~~~LVmEy~~gGsL~~~l~~~~~-----------------------   70 (408)
                                         ..        ...+...+|||||+++|+|.+++....+                       
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence                               00        0112346899999999999999864221                       


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhH
Q 042746           71 YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV  150 (408)
Q Consensus        71 ~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l  150 (408)
                      .++...++.++.|++.+|.|||+++|+||||||+|||++.++. +||+|||++......... ......+||.|+|||++
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~-~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc-EEEEeCcCccccccCCcc-CccccCCCcceeChhhh
Confidence            2245678899999999999999999999999999999998874 999999998654322111 11123458999999998


Q ss_pred             hCCC--------------------C--CCCCCcchHHHHHHHHHhCCC-CCCCCChhh--h--------hhhcccCCCC-
Q 042746          151 RGEC--------------------Q--GPESDVWSLGCTIIEMVTGKP-AWEDFGANT--L--------SRIGFSDELP-  196 (408)
Q Consensus       151 ~~~~--------------------~--~~~sDiWSLGvil~eLltG~~-Pf~~~~~~~--~--------~~~~~~~~~p-  196 (408)
                      ....                    |  ..+.|+||+||++|+|++|.. ||.......  .        .+........ 
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            6421                    1  124799999999999999875 775321100  0        0000111111 


Q ss_pred             -CCCCCCcHHHHHHHHHhcccCC---CCCCCHHHHHcCCCCCC
Q 042746          197 -RFPTQSSELGRDFLDKCLRREP---GERWSCDQLLKHPFLQS  235 (408)
Q Consensus       197 -~~~~~~s~~~~~li~~~L~~dP---~~R~s~~ell~hpf~~~  235 (408)
                       ......++.++||+.+||.++|   .+|+|++|+|+||||..
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence             1224568889999999999876   68999999999999963

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.2e-33  Score=281.01  Aligned_cols=229  Identities=28%  Similarity=0.393  Sum_probs=185.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------------cceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------------~~~~~~~~~~~~~~L   51 (408)
                      .+|.+....|+|-|++|-.|.|..-++.||+|...                              +.+...|...++++|
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            36899999999999999999999999999987532                              112234667889999


Q ss_pred             EEeccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           52 HLEYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |+|-+.- +|.+++++.+.  .+....++.|+.||+.||..|...||+|.||||+|||+++...++||||||.|..+...
T Consensus       512 VFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en  590 (752)
T KOG0670|consen  512 VFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN  590 (752)
T ss_pred             Eehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc
Confidence            9999975 99999998644  57889999999999999999999999999999999999998888999999999776544


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh--cccCCCC-----------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELP-----------  196 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~--~~~~~~p-----------  196 (408)
                      ...    ...-+..|.|||++.|-+|+...|+||.||+||||+||+..|.+...+++.+.  ...+.+|           
T Consensus       591 eit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~d  666 (752)
T KOG0670|consen  591 EIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKD  666 (752)
T ss_pred             ccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhh
Confidence            432    12247789999999999999999999999999999999999977554444322  1111111           


Q ss_pred             -------------------------------------------CCCCC---CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 -------------------------------------------RFPTQ---SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 -------------------------------------------~~~~~---~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                                                                 .+|..   .-..+++||.+||..||++|.|+.|+|+|
T Consensus       667 qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  667 QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                                                       01111   11346899999999999999999999999


Q ss_pred             CCCCC
Q 042746          231 PFLQS  235 (408)
Q Consensus       231 pf~~~  235 (408)
                      |||..
T Consensus       747 pFi~~  751 (752)
T KOG0670|consen  747 PFITE  751 (752)
T ss_pred             CcccC
Confidence            99964

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-32  Score=294.85  Aligned_cols=226  Identities=21%  Similarity=0.287  Sum_probs=179.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcE-----EEEeeccc--------------------------ceeccCCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDV-----FAYLGDDV--------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~-----va~k~~~~--------------------------~~~~~~~~~~~~~L   51 (408)
                      +-++++.||+|+||.||.|.-......     ||+|....                          ...+..-.....+|
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            456789999999999999987654443     67765331                          11111122344678


Q ss_pred             EEeccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           52 HLEYLPGGTVSDLATTL------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ++|||+||+|..+|++.      ...+.......++.||+.|.+||+++++|||||...|+||+... .+||+|||+|+.
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIaDFGlArD  851 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIADFGLARD  851 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEcccchhHh
Confidence            99999999999999986      67789999999999999999999999999999999999999886 599999999984


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      ..............-...|||||.+....++.++|||||||+|||+++ |..||.+.+..++......+..-..|..++.
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~  931 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPE  931 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCCh
Confidence            433222111111112345999999999999999999999999999998 9999998776665553333334466788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+.++|..||+.+|++||++..|++
T Consensus       932 ~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  932 KLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHHHHHHHccCChhhCccHHHHHh
Confidence            9999999999999999999999987

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=278.99  Aligned_cols=223  Identities=21%  Similarity=0.340  Sum_probs=180.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCc---E-EEEeecc----------------------------cceeccCCCCCcceE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGD---V-FAYLGDD----------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~---~-va~k~~~----------------------------~~~~~~~~~~~~~~L   51 (408)
                      -.+++.||+|+||.||+|.-+..+.   . ||+|...                            +.+.+....+.-++|
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3557999999999999998887644   3 6776533                            122333344455789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |||+|+||+|.++|++.+..++..+...++.+.+.||+|||++++|||||-..|+|++.++ .+||+|||+++.......
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~~~~~~~  317 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRAGSQYVM  317 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccCCcceee
Confidence            9999999999999998777789999999999999999999999999999999999998876 489999999976642211


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhc-ccCCCCCCCCCCcHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIG-FSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~-~~~~~p~~~~~~s~~~~~l  209 (408)
                      ...  ...-...|+|||.+....|++++||||+||++||+++ |..||......+....+ ..+.....|...+.+.+.+
T Consensus       318 ~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~  395 (474)
T KOG0194|consen  318 KKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV  395 (474)
T ss_pred             ccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence            110  1113456999999999999999999999999999998 88899988777766655 4455556667888899999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q 042746          210 LDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~  229 (408)
                      +.+|+..||++|||+.++.+
T Consensus       396 ~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  396 MKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHhccCChhhccCHHHHHH
Confidence            99999999999999998875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-34  Score=264.22  Aligned_cols=228  Identities=29%  Similarity=0.395  Sum_probs=179.6

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEeccC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      +....||+|+||+|++..++.+|+..|+|.....                           +.+..-.+.-.+|.||+|.
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            3456899999999999999999999999875421                           1111112334578899996


Q ss_pred             CCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           58 GGTVSDLATT----LNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        58 gGsL~~~l~~----~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      - +|..+.+.    .+..++|..+-.+....+.||.||.. .+||||||||+||||+..|. +||||||++.++..... 
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~-vKLCDFGIcGqLv~SiA-  223 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD-VKLCDFGICGQLVDSIA-  223 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC-EeeecccchHhHHHHHH-
Confidence            4 66554432    35678899888999899999999985 58999999999999999986 99999999977654332 


Q ss_pred             cccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCC-----CCCc
Q 042746          133 GVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFP-----TQSS  203 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~-----~~~s  203 (408)
                        .....|...|||||.+..  ..|+.++|+||||++|||+.||..||..++.  +++.++ ..+.+|.+.     -.++
T Consensus       224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V-v~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV-VIGDPPILLFDKECVHYS  300 (361)
T ss_pred             --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH-HcCCCCeecCcccccccC
Confidence              233468899999999964  3589999999999999999999999998763  333333 455555442     2477


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ..+..||..||.+|-+.||...+++++||++....
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            88999999999999999999999999999986543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1.3e-33  Score=259.89  Aligned_cols=235  Identities=24%  Similarity=0.374  Sum_probs=180.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------------eecc-CCCCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------------YEAP-TTSSS   47 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------------~~~~-~~~~~   47 (408)
                      .|....+||+|.||.||+|+.+.+++.||+++.-..                                  +..+ .....
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            466778999999999999999999999877542100                                  0001 11234


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      .+|||+.+|+. +|+.++.+....++...|+.++.+++.||.|+|.+.|+|||+||+|+||+.++ .+||+|||+++.+.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~fs  175 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARAFS  175 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeecccccccee
Confidence            58999999987 99999987777889999999999999999999999999999999999999887 59999999997654


Q ss_pred             cCCC--CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-------ccC----
Q 042746          128 VSDT--RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-------FSD----  193 (408)
Q Consensus       128 ~~~~--~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-------~~~----  193 (408)
                      ....  .......+-|.+|.+||.+.|. .|+++.|+|..||++.+|.|+.+.+......+....+       ...    
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~  255 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN  255 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence            3321  1112233459999999999875 6899999999999999999999998765432211110       000    


Q ss_pred             ----------CCCCCC-------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ----------ELPRFP-------------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ----------~~p~~~-------------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                .+++++             -.-++++.||++++|..||.+|+.++++++|.||...+.+
T Consensus       256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                      001111             1124577899999999999999999999999999765433

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=3.8e-32  Score=279.40  Aligned_cols=216  Identities=26%  Similarity=0.379  Sum_probs=167.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCC------CCcce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTS------SSCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~------~~~~~   50 (408)
                      .|..-+.||+||||.||+++++.||+.+|+|....                          ...+..+.      ...-.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            47778899999999999999999999999875431                          11111111      22346


Q ss_pred             EEEeccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--C-CcEEEeecCCccc
Q 042746           51 LHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--S-SFVKLADFGAAGE  125 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~--~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~-~~vkL~DFGla~~  125 (408)
                      |+||||+||+|..+++..  ...++|.+++.++..+..||.|||++||+||||||.||++-..  | ..-||+|||.|+.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            899999999999999752  3468999999999999999999999999999999999998432  3 3469999999988


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-----hhhh-----------
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-----TLSR-----------  188 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-----~~~~-----------  188 (408)
                      .....   ...+..||+.|.+||++. +..|+..+|.||+||++|+.+||..||..+...     .+..           
T Consensus       174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI  250 (732)
T ss_pred             CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence            76544   456678999999999998 588999999999999999999999999654322     1111           


Q ss_pred             ---------hcccCCCCCCCCCCcHHH----HHHHHHhcccCCCCCC
Q 042746          189 ---------IGFSDELPRFPTQSSELG----RDFLDKCLRREPGERW  222 (408)
Q Consensus       189 ---------~~~~~~~p~~~~~~s~~~----~~li~~~L~~dP~~R~  222 (408)
                               +.++..+|. |...++..    -.++..+|+.+|.+|.
T Consensus       251 ~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                     122333433 44444443    3577789999999998

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=267.32  Aligned_cols=224  Identities=27%  Similarity=0.344  Sum_probs=167.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-------------------------eccCCCCC-cceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-------------------------EAPTTSSS-CRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-------------------------~~~~~~~~-~~~LVmEy   55 (408)
                      ++|...+.||+|+||.||+|.-.++ ..||+|......                         .+...+.. ...||+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            4566778999999999999998765 888888543211                         11122334 58999999


Q ss_pred             cCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           56 LPGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRN---IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~g---iiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +++|+|.+.+..... .+++.....|+.+++.||+|||...   ||||||||+|||||.+.. .||+|||+|+..... .
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~-aKlsDFGLa~~~~~~-~  231 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN-AKLSDFGLAKLGPEG-D  231 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC-EEccCccCcccCCcc-c
Confidence            999999999986555 8899999999999999999999864   999999999999998885 999999999655431 1


Q ss_pred             CcccccC-CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC---hhhhhh----hcccCCC-----CCC
Q 042746          132 RGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSR----IGFSDEL-----PRF  198 (408)
Q Consensus       132 ~~~~~~~-~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~---~~~~~~----~~~~~~~-----p~~  198 (408)
                      . ..... .||.+|+|||++.....+.++|||||||++.||++|+.|.+...   ...+..    .......     |.+
T Consensus       232 ~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  232 T-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             c-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            1 11112 79999999999988888999999999999999999998876432   111110    0000011     111


Q ss_pred             C-CCCc--HH---HHHHHHHhcccCCCCCCCHHHHHc
Q 042746          199 P-TQSS--EL---GRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       199 ~-~~~s--~~---~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      . ...+  ..   +..+..+|++.+|.+||++.|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1 2222  22   345677899999999999999755

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.2e-30  Score=241.28  Aligned_cols=215  Identities=33%  Similarity=0.466  Sum_probs=172.3

Q ss_pred             CCeeEEEEEEcCCCcEEEEeeccccee--------------------------ccCCCCCcceEEEeccCCCCHHHHHHH
Q 042746           14 SFGTVNVAVDRFNGDVFAYLGDDVSYE--------------------------APTTSSSCRNLHLEYLPGGTVSDLATT   67 (408)
Q Consensus        14 ~fG~Vy~a~d~~t~~~va~k~~~~~~~--------------------------~~~~~~~~~~LVmEy~~gGsL~~~l~~   67 (408)
                      +||.||+|++..+++.+++|.......                          .........++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            689999999999999998876432111                          012233567899999999999999975


Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCCh
Q 042746           68 LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAP  147 (408)
Q Consensus        68 ~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~AP  147 (408)
                      .. .+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++. ++|+|||.+.......   ......+++.|++|
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~-~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p  155 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH-VKLADFGLARQLDPGG---LLTTFVGTPEYMAP  155 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc-EEEccccceeeecccc---ccccccCCcCCCCH
Confidence            43 3789999999999999999999999999999999999998874 9999999997654332   12234588999999


Q ss_pred             hhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCC-CChhhhhhhcccCCCCCCCCC--CcHHHHHHHHHhcccCCCCCCCH
Q 042746          148 EVVRGECQGPESDVWSLGCTIIEMVTGKPAWED-FGANTLSRIGFSDELPRFPTQ--SSELGRDFLDKCLRREPGERWSC  224 (408)
Q Consensus       148 E~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~-~~~~~~~~~~~~~~~p~~~~~--~s~~~~~li~~~L~~dP~~R~s~  224 (408)
                      |.+.+..++.++|+||||+++++|++|..||.. ...............+..+..  .+..+.+++.+||..+|++||++
T Consensus       156 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~  235 (244)
T smart00220      156 EVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTA  235 (244)
T ss_pred             HHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCH
Confidence            999988888999999999999999999999976 444444433322222222222  77889999999999999999999


Q ss_pred             HHHHcCCCC
Q 042746          225 DQLLKHPFL  233 (408)
Q Consensus       225 ~ell~hpf~  233 (408)
                      .++++||||
T Consensus       236 ~~~~~~~~~  244 (244)
T smart00220      236 EEALQHPFF  244 (244)
T ss_pred             HHHhhCCCC
Confidence            999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=1.6e-31  Score=280.15  Aligned_cols=225  Identities=23%  Similarity=0.307  Sum_probs=182.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCC-----CcEEEEeecc--------------------------cceeccCCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFN-----GDVFAYLGDD--------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t-----~~~va~k~~~--------------------------~~~~~~~~~~~~~~L   51 (408)
                      +-++.+.||+|+||+||+|+-..-     ...||+|..+                          |.+.+....++-+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            456788999999999999876432     2346665422                          334444455666889


Q ss_pred             EEeccCCCCHHHHHHHh---------CC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           52 HLEYLPGGTVSDLATTL---------NA----YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~---------~~----~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                      |+|||..|||.++|+-.         +.    .++..+...++.||+.|++||-++.+|||||-..|+||.++- .|||+
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l-~VKIs  645 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL-VVKIS  645 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce-EEEec
Confidence            99999999999999753         11    277889999999999999999999999999999999999887 59999


Q ss_pred             ecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCC
Q 042746          119 DFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPR  197 (408)
Q Consensus       119 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~  197 (408)
                      |||+++.....+.........-...|||||-|....|+.+|||||+||+|||+++ |+.||.....++....+..+.+-.
T Consensus       646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~  725 (774)
T KOG1026|consen  646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLS  725 (774)
T ss_pred             ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCccc
Confidence            9999987655443222111112456999999999999999999999999999997 999999887777666666777778


Q ss_pred             CCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          198 FPTQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       198 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                      .|..++..+.+|+..||+.+|++||++.||-
T Consensus       726 ~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  726 CPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            8899999999999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=7.4e-32  Score=280.82  Aligned_cols=229  Identities=24%  Similarity=0.310  Sum_probs=176.3

Q ss_pred             EeeceeeecCCe-eEEEEEEcCCCcEEEEeecc-----------------------cceeccCCCCCcceEEEeccCCCC
Q 042746            5 VRGKCIGRGSFG-TVNVAVDRFNGDVFAYLGDD-----------------------VSYEAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         5 ~~~~~IG~G~fG-~Vy~a~d~~t~~~va~k~~~-----------------------~~~~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      ...+++|.|+.| .||+|...  ++.||+|..-                       +.+....+++.++||.+|.|.. +
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            345789999998 67999875  7788876521                       4566667788899999999987 9


Q ss_pred             HHHHHHHh--CCCCCH-HHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CC-CcEEEeecCCccccccCCCC-
Q 042746           61 VSDLATTL--NAYADE-ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NS-SFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        61 L~~~l~~~--~~~l~e-~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~-~~vkL~DFGla~~~~~~~~~-  132 (408)
                      |.++++..  ...... ...+..+.|++.||++||+.+||||||||+||||..   ++ ..++|+|||+++........ 
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            99999863  111111 445788999999999999999999999999999976   23 35899999999887655432 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......||-+|+|||++.......++||+||||++|+.++| .+||.+.-..+..-+.-...+-.+......+++|||.
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~  748 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAKDLIS  748 (903)
T ss_pred             hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHHHHHH
Confidence            224456799999999999998888899999999999999985 9999875443322221112222222222228999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +|++++|..||++.++|.||||...
T Consensus       749 ~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  749 RMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HhcCCCcccCCCHHHHhCCCccCCh
Confidence            9999999999999999999999654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=257.08  Aligned_cols=106  Identities=23%  Similarity=0.249  Sum_probs=88.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc--------------------------------cc----eeccCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------------VS----YEAPTTS   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--------------------------------~~----~~~~~~~   45 (408)
                      .+|.+.|+||.|-|++||+|.|..+.+.||+|...                                +.    |......
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            47999999999999999999999999999987633                                11    1112234


Q ss_pred             CCcceEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEE
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLV  108 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl  108 (408)
                      ..++++|+|++. -+|..+|+.. -+.++-..++.|++|||.||.|||. .||||-||||+|||+
T Consensus       158 G~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            567899999995 5899988763 3567899999999999999999996 599999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.5e-31  Score=240.96  Aligned_cols=230  Identities=24%  Similarity=0.332  Sum_probs=174.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------cee-------------c--cCCCCCcceEEEec
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------SYE-------------A--PTTSSSCRNLHLEY   55 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------~~~-------------~--~~~~~~~~~LVmEy   55 (408)
                      +++|++.+.+|+|.++.||.|++..+++.+-+|....          ...             .  .-.......||+||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            4789999999999999999999998888775543221          000             0  01123445689999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +.+.+...+-.    .++.-.|+.+++||+.||.|||++||+|||+||.|++|+.....++|+|+|+|....+....+. 
T Consensus       117 v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV-  191 (338)
T KOG0668|consen  117 VNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-  191 (338)
T ss_pred             hccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee-
Confidence            99987766654    4578889999999999999999999999999999999998776799999999977665544322 


Q ss_pred             ccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCC-C-CChhhhhhhc----------------------
Q 042746          136 IQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-D-FGANTLSRIG----------------------  190 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~-~-~~~~~~~~~~----------------------  190 (408)
                        .+.+..|--||.+.. ..|+.+-|+|||||++..|+..+-||- + .+.+++.++.                      
T Consensus       192 --RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~  269 (338)
T KOG0668|consen  192 --RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ  269 (338)
T ss_pred             --eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence              346788999999965 567899999999999999999988873 2 2333332210                      


Q ss_pred             ------------ccCCCC-CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 ------------FSDELP-RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 ------------~~~~~p-~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                  |..-.+ .-....++++.||++++|..|..+|+|+.|+|.||||....
T Consensus       270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                        000000 11123568999999999999999999999999999997543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=249.12  Aligned_cols=229  Identities=24%  Similarity=0.353  Sum_probs=173.2

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------eeccCCCCCc-----------------ceE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------YEAPTTSSSC-----------------RNL   51 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------~~~~~~~~~~-----------------~~L   51 (408)
                      .+.-|.||-|+||.||.+.|..+|+.++.|+....               +...+.+++.                 +|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            45678999999999999999999999988765421               1112222221                 355


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +.|.+.. +|..++- ....++...++.+++||++||+|||+.+|+||||||-|+|++.|- .+||+|||+|+.......
T Consensus       135 ~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhh
Confidence            6677653 6666654 345678889999999999999999999999999999999999987 599999999987665554


Q ss_pred             CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--------------------
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------------------  190 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--------------------  190 (408)
                      .+++ ..+-|..|.|||++.|. .|+.++||||.||++.||+..+..|...++-+....+                    
T Consensus       212 ~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  212 LNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            4443 33458999999999885 6799999999999999999999888765443221110                    


Q ss_pred             ---cc--CCCCCCC--------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          191 ---FS--DELPRFP--------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       191 ---~~--~~~p~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                         ..  .+.|.++        ..-..+..+++.++|.+||.+|++.++++.|++....
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence               01  1112111        1233456789999999999999999999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-31  Score=256.50  Aligned_cols=233  Identities=23%  Similarity=0.293  Sum_probs=181.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce--------------------------------eccC-CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY--------------------------------EAPT-TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~--------------------------------~~~~-~~~~~   48 (408)
                      ++|-...+||+|||+.||+|.|...++.+|+|...+..                                ...+ .+...
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            46778899999999999999999999999987654211                                1111 12334


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCC--CCcEEEeecCCcc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPN--SSFVKLADFGAAG  124 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~--~~~vkL~DFGla~  124 (408)
                      ++-|+|||+|-+|.-+++. .+.++|+.++.|+-||+.||.||.+..  |||-||||.||||-.+  .+.+||+|||+++
T Consensus       543 FCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             ceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            5678999999999999984 567899999999999999999999764  9999999999998532  2359999999998


Q ss_pred             ccccCCC-----CcccccCCCCCCCCChhhHhCC----CCCCCCCcchHHHHHHHHHhCCCCCCCCC-hhhhhh---hcc
Q 042746          125 EATVSDT-----RGVKIQPRGSPLWMAPEVVRGE----CQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSR---IGF  191 (408)
Q Consensus       125 ~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~----~~~~~sDiWSLGvil~eLltG~~Pf~~~~-~~~~~~---~~~  191 (408)
                      .......     ...+....||-||++||.+.-.    ..+.++||||.|||+|+.+.|+-||...- ...+.+   +..
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            7654322     2234567899999999998532    35889999999999999999999997532 222221   111


Q ss_pred             c--CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          192 S--DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       192 ~--~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .  ..+|.. +..+.++++||++||.+.-++|..+.++-.||||...
T Consensus       702 AtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  702 ATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             ceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            1  123333 4578889999999999999999999999999999753

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=246.58  Aligned_cols=223  Identities=26%  Similarity=0.404  Sum_probs=174.3

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec---------------------------cC------CCCCcc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA---------------------------PT------TSSSCR   49 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~---------------------------~~------~~~~~~   49 (408)
                      +|.-.+.+|.|.- .|-.|.|.-+++.+++|+....+..                           .+      ++-...
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            6778899999998 8889999999999988765422111                           11      112236


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |+||||+.. +|.+.+.   ..++.+.++.+++|++.|++|||+.||+||||||+||++..+.. +||.|||+|+.....
T Consensus        97 y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~-lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   97 YLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT-LKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh-eeeccchhhcccCcc
Confidence            799999976 8988886   45688899999999999999999999999999999999998874 999999999776544


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhh-------------------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRI-------------------  189 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~-------------------  189 (408)
                         ...+..+.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+. ++..++                   
T Consensus       172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence               233455789999999999998899999999999999999999988864321 111100                   


Q ss_pred             -------------cccCCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          190 -------------GFSDELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       190 -------------~~~~~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                                   .+...+|        ..+..-+..+++++.+||..||++|.+++++|+|||++
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                         0011111        11123456789999999999999999999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=265.66  Aligned_cols=231  Identities=29%  Similarity=0.440  Sum_probs=184.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|.....+|.|.||.||+|+|+.+++..|+|..+..                         +.+.......++|.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            5799999999999999999999999999877654311                         111122334468999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      .||+|++.-. .-+.++|.++....++.++||+|||++|-+|||||-.|||++..+. +|++|||.+.+.+....  ...
T Consensus        95 gggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD-vklaDfgvsaqitati~--Krk  170 (829)
T KOG0576|consen   95 GGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD-VKLADFGVSAQITATIA--KRK  170 (829)
T ss_pred             CCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc-eeecccCchhhhhhhhh--hhh
Confidence            9999999775 4678899999999999999999999999999999999999999986 99999999977654432  345


Q ss_pred             cCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCC-ChhhhhhhcccCC-CCC--CCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDE-LPR--FPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~-~~~~~~~~~~~~~-~p~--~~~~~s~~~~~l  209 (408)
                      .+.|||.|||||+..   ...|...+|+|++|++..|+-.-++|--+. .+..+.-...+.. .|.  .+..-++.+-+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            678999999999983   456899999999999999999888774433 3333332222221 222  233457788999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ++.+|.++|++||+++.+|.|||+...
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccc
Confidence            999999999999999999999999643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=1.1e-29  Score=284.11  Aligned_cols=216  Identities=21%  Similarity=0.233  Sum_probs=162.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceeccCCCCCcceEEEeccCCCCH
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      .|...+.||+|+||+||+|++..++..||+|....                     .+.+....+...++||||+++|+|
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence            35567799999999999999999999999986431                     122223445668899999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLH---SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH---~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      .++++    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++. .++. ||.+......      ...
T Consensus       771 ~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~-~~~~-~~~~~~~~~~------~~~  838 (968)
T PLN00113        771 SEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE-PHLR-LSLPGLLCTD------TKC  838 (968)
T ss_pred             HHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc-eEEE-eccccccccC------CCc
Confidence            99996    3688889999999999999999   669999999999999987764 5554 6655332211      122


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-----hhhhhcccCC------CCCC------CCC
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-----TLSRIGFSDE------LPRF------PTQ  201 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-----~~~~~~~~~~------~p~~------~~~  201 (408)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...+......      -|..      +..
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (968)
T PLN00113        839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN  918 (968)
T ss_pred             cccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence            5799999999999988999999999999999999999998532110     0000000000      0111      111


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ...++.+++.+||+.||++|||+.|+++.
T Consensus       919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        919 EIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            12345688999999999999999999875

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.96  E-value=8e-30  Score=258.07  Aligned_cols=222  Identities=24%  Similarity=0.291  Sum_probs=177.8

Q ss_pred             EeeceeeecCCeeEEEEEEcCC--CcE--EEEeecccc--------------eeccCC-----------CCCcceEEEec
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFN--GDV--FAYLGDDVS--------------YEAPTT-----------SSSCRNLHLEY   55 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t--~~~--va~k~~~~~--------------~~~~~~-----------~~~~~~LVmEy   55 (408)
                      ++.+.||.|-||.||+|+...-  |+.  ||+|.-+..              ....+.           .++-.+||||.
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL  471 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL  471 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence            4578999999999999987543  333  555532210              001111           23346899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++-|.|..+++..+..++-.....|.+||..+|.|||+.++|||||...|||+.... .+||+|||+++......... .
T Consensus       472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~yYk-a  549 (974)
T KOG4257|consen  472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDDAYYK-A  549 (974)
T ss_pred             ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhccccchhh-c
Confidence            999999999998888999999999999999999999999999999999999998775 69999999998876544321 1


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....-..-|||||-++-..++.++|||-|||.+||++. |.-||......+....+..+..++.|+.+++.+..|+.+||
T Consensus       550 S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcW  629 (974)
T KOG4257|consen  550 SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCW  629 (974)
T ss_pred             cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHh
Confidence            12222445999999999899999999999999999886 99999886655555445567777888999999999999999


Q ss_pred             ccCCCCCCCHHHHH
Q 042746          215 RREPGERWSCDQLL  228 (408)
Q Consensus       215 ~~dP~~R~s~~ell  228 (408)
                      ..||.+||++.||.
T Consensus       630 ayeP~kRPrftei~  643 (974)
T KOG4257|consen  630 AYEPSKRPRFTEIK  643 (974)
T ss_pred             ccCcccCCcHHHHH
Confidence            99999999987764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.7e-30  Score=257.11  Aligned_cols=223  Identities=22%  Similarity=0.273  Sum_probs=185.2

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccCCCC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      +...+||-|.||.||.+++++..-.+|+|...                        +.+.+..+.+.-+|||.|||..|+
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            44678999999999999999988888876432                        233445566777899999999999


Q ss_pred             HHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCC
Q 042746           61 VSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR  139 (408)
Q Consensus        61 L~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  139 (408)
                      |.++|+..++ ..+......|+.||.+|++||..+++|||||...|.|+.++. .+|++|||+++..+.+...... ...
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgDTYTAHA-GAK  427 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGDTYTAHA-GAK  427 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhcCCceeccc-Ccc
Confidence            9999997554 456667789999999999999999999999999999998876 6999999999887654321111 111


Q ss_pred             CCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042746          140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP  218 (408)
Q Consensus       140 Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP  218 (408)
                      -..-|.|||-+....++.++|||+|||+|||+.| |..||...+..+.+.....+....-|..+++....|+..||++.|
T Consensus       428 FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsP  507 (1157)
T KOG4278|consen  428 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSP  507 (1157)
T ss_pred             CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCc
Confidence            2445999999999999999999999999999998 899999988888777665555556678899999999999999999


Q ss_pred             CCCCCHHHHHc
Q 042746          219 GERWSCDQLLK  229 (408)
Q Consensus       219 ~~R~s~~ell~  229 (408)
                      .+||++.|+-+
T Consensus       508 sDRPsFaeiHq  518 (1157)
T KOG4278|consen  508 SDRPSFAEIHQ  518 (1157)
T ss_pred             ccCccHHHHHH
Confidence            99999998754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=268.15  Aligned_cols=224  Identities=22%  Similarity=0.290  Sum_probs=181.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCc---EEEEeeccc--------------ceeccCCCCC------------cceEEEe
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDV--------------SYEAPTTSSS------------CRNLHLE   54 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~--------------~~~~~~~~~~------------~~~LVmE   54 (408)
                      ..|.++||.|.||.|++++.+..++   .||+|..+.              ...+.|.+.+            -+.||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            3578999999999999999998885   477775442              2333344433            3568999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ||++|+|..+|+...+.++..++..|++.|+.|++||-+.++|||||.+.|||++.+- .+|++|||+++........ .
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvledd~~~-~  788 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEA-A  788 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecccCCCc-c
Confidence            9999999999999888899999999999999999999999999999999999999987 5999999999877544421 2


Q ss_pred             cccCCC--CCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          135 KIQPRG--SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~G--t~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      +.+..|  ...|.|||.+....++.++|+||+||++||.+. |..||.+....+....+..+...+.|-.++..+..|+.
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMl  868 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLML  868 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHH
Confidence            222222  345999999999999999999999999999875 99998877655554444344333445678888999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      .||++|-+.||++.||+.
T Consensus       869 dCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  869 DCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHHhhcCCCHHHHHH
Confidence            999999999999999887

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=7.6e-30  Score=249.42  Aligned_cols=231  Identities=25%  Similarity=0.321  Sum_probs=172.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcC---CCcEEEEeecccc------------------------eeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRF---NGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~---t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      .|....+||.|.|++||+|.+..   ....||+|.....                        ....+..+....+||||
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~  116 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY  116 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence            57889999999999999999988   7888998775421                        22234456678899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC-----
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-----  130 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-----  130 (408)
                      ++.-+..++..    .++-..++.|++.++.||+++|++|||||||||.|+|.+...+.-.|+|||+|.......     
T Consensus       117 ~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  117 FEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             cCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            99988888876    446888999999999999999999999999999999999876678899999995110000     


Q ss_pred             -C------------------------C------------cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHH
Q 042746          131 -T------------------------R------------GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMV  172 (408)
Q Consensus       131 -~------------------------~------------~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLl  172 (408)
                       .                        .            .......|||+|.|||++... ..++++||||.|||+..++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence             0                        0            000112499999999999764 4588999999999999999


Q ss_pred             hCCCCCCCCC--hh------------hhhh------h--ccc-CCCC----------------------------CCCCC
Q 042746          173 TGKPAWEDFG--AN------------TLSR------I--GFS-DELP----------------------------RFPTQ  201 (408)
Q Consensus       173 tG~~Pf~~~~--~~------------~~~~------~--~~~-~~~p----------------------------~~~~~  201 (408)
                      +++.||-...  ..            .+.+      .  .+. ...|                            .....
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            9999982110  00            0000      0  000 0000                            01123


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+..+.+|+++||+.||.+|+|++|+|+||||....
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            455789999999999999999999999999998543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1e-29  Score=278.97  Aligned_cols=188  Identities=19%  Similarity=0.183  Sum_probs=140.0

Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC-------------
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-------------  112 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~-------------  112 (408)
                      ...++++|||+ +++|.+++......+++..++.+++||+.||+|||++||+||||||+||||+..+             
T Consensus        52 ~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~  130 (793)
T PLN00181         52 DDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDS  130 (793)
T ss_pred             cchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcc
Confidence            34677889988 4599999976556689999999999999999999999999999999999995422             


Q ss_pred             -----CcEEEeecCCccccccCCC--------------CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh
Q 042746          113 -----SFVKLADFGAAGEATVSDT--------------RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT  173 (408)
Q Consensus       113 -----~~vkL~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt  173 (408)
                           ..+|++|||+++.......              ........||+.|||||++.+..|+.++|||||||+||||++
T Consensus       131 ~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~  210 (793)
T PLN00181        131 GSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC  210 (793)
T ss_pred             cccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhh
Confidence                 2366777777654211000              000112458999999999999999999999999999999999


Q ss_pred             CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          174 GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       174 G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      |.+|+..... .+.... ....|.......+...+++.+||++||.+||++.|+++||||...
T Consensus       211 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        211 PVSSREEKSR-TMSSLR-HRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CCCchhhHHH-HHHHHH-HhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            9998764221 111111 111222111224456789999999999999999999999999753

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=3.4e-29  Score=224.13  Aligned_cols=160  Identities=23%  Similarity=0.299  Sum_probs=127.7

Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++...+..+++..++.++.||+.||+|||+++      ||+|||++.++. +|+  ||++.......       .
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~-~~~--fG~~~~~~~~~-------~   64 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL-LKL--DGSVAFKTPEQ-------S   64 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc-eee--ccceEeecccc-------C
Confidence            6999999876778999999999999999999999998      999999998874 888  99986543321       2


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhcccCCCCC------CCCCCcH--HHHHH
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPR------FPTQSSE--LGRDF  209 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~p~------~~~~~s~--~~~~l  209 (408)
                      .||+.|||||++.+..++.++|||||||++|+|++|++||..... ............+.      .+...+.  .++++
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            589999999999999999999999999999999999999975432 11111111111111      1122333  58999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +.+||..||.+||++.|+++|+|+.
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHH
Confidence            9999999999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-29  Score=224.13  Aligned_cols=190  Identities=26%  Similarity=0.397  Sum_probs=148.6

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEeccC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ..+..||+|++|.|=+.++..+|...|+|...+                           .+.+..-.....+|.||.+.
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            346789999999999999999999999987542                           22333334445779999996


Q ss_pred             CCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           58 GGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        58 gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      - +|..+-++   +++..+|..+-+++-.++.||.|||++ .+||||+||.|||++.+|. +|+||||++..+...... 
T Consensus       129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq-VKiCDFGIsG~L~dSiAk-  205 (282)
T KOG0984|consen  129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ-VKICDFGISGYLVDSIAK-  205 (282)
T ss_pred             h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc-EEEcccccceeehhhhHH-
Confidence            5 77665543   577889999999999999999999976 8999999999999999985 999999999766544322 


Q ss_pred             ccccCCCCCCCCChhhHhC----CCCCCCCCcchHHHHHHHHHhCCCCCCCCC-hhhhhhhcccCCCCCCC
Q 042746          134 VKIQPRGSPLWMAPEVVRG----ECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFP  199 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~-~~~~~~~~~~~~~p~~~  199 (408)
                        ....|...|||||.+..    ..|+.++||||||++++||.+++.||+.+. +.+..........|.+|
T Consensus       206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp  274 (282)
T KOG0984|consen  206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP  274 (282)
T ss_pred             --HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence              12458889999999964    368899999999999999999999998764 23333333445555555

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-29  Score=254.09  Aligned_cols=225  Identities=24%  Similarity=0.262  Sum_probs=177.5

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCC-cE--EEEeeccccee--------------ccCCCC-----------CcceEEEec
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNG-DV--FAYLGDDVSYE--------------APTTSS-----------SCRNLHLEY   55 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~-~~--va~k~~~~~~~--------------~~~~~~-----------~~~~LVmEy   55 (408)
                      .++.+.||+|+||.|+.|.+...+ +.  ||+|-......              ...++.           .-..+|||+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL  191 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL  191 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence            456789999999999999887644 33  45543221111              011111           224478999


Q ss_pred             cCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +++|+|.+.|++ ....+--.....|+.||+.|+.||.++++|||||-..||||-... .|||+|||+.+.+........
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccceeccCCCCcceE
Confidence            999999999987 556677788889999999999999999999999999999997754 699999999988765544332


Q ss_pred             ccc-CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          135 KIQ-PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       135 ~~~-~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ... ..-...|.|||.++...++.++|+|++||++|||++ |+-||.+-...++.+.+-.++...-|..+++++.+++..
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~  350 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKN  350 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHH
Confidence            211 123456999999999999999999999999999998 899999877766666555666556678899999999999


Q ss_pred             hcccCCCCCCCHHHHHc
Q 042746          213 CLRREPGERWSCDQLLK  229 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~  229 (408)
                      ||..+|.+|||+..|..
T Consensus       351 cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  351 CWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             hccCCccccccHHHHHH
Confidence            99999999999988864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=256.09  Aligned_cols=224  Identities=25%  Similarity=0.301  Sum_probs=181.6

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee------------------ccCC-----------CCCcceEEEec
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE------------------APTT-----------SSSCRNLHLEY   55 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~------------------~~~~-----------~~~~~~LVmEy   55 (408)
                      +..++||+|+||+||++.+.-.++.|++....+.+.                  ....           ....+.||++|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~  778 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL  778 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence            457899999999999999987787764432211110                  0011           11235688999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +|+|+|.++++.....+..+....|.+||++|+.|||.+.++||||-..|||+..-+ .+|+.|||+|+...........
T Consensus       779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~~ey~~  857 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDEKEYSA  857 (1177)
T ss_pred             cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCcccccccc
Confidence            999999999999888999999999999999999999999999999999999998766 4999999999887765543333


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....-.+-|||-|.++...|+.++||||+||++||++| |..|+......++......+..-..|+..+-++..++.+||
T Consensus       858 ~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCw  937 (1177)
T KOG1025|consen  858 PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCW  937 (1177)
T ss_pred             cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHh
Confidence            22223456999999999999999999999999999998 99999988777776665455545677899999999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 042746          215 RREPGERWSCDQLLK  229 (408)
Q Consensus       215 ~~dP~~R~s~~ell~  229 (408)
                      ..|+..||+++++..
T Consensus       938 mid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  938 MIDADSRPTFKELAE  952 (1177)
T ss_pred             ccCcccCccHHHHHH
Confidence            999999999988754

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=255.26  Aligned_cols=223  Identities=26%  Similarity=0.337  Sum_probs=174.5

Q ss_pred             EeeceeeecCCeeEEEEEEcCC-------CcEEEEeecc---------------------------cceeccCCCCCcce
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFN-------GDVFAYLGDD---------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t-------~~~va~k~~~---------------------------~~~~~~~~~~~~~~   50 (408)
                      .+++.||+|.||+|++|.-..-       ...||+|...                           +...+.......++
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            5677999999999999864311       2345665422                           11222233356688


Q ss_pred             EEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcE
Q 042746           51 LHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV  115 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~v  115 (408)
                      +|+||+..|+|.+++++..               ..+.......+++||+.|++||++.+++||||-+.|||+..+. .+
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~-~~  457 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK-VI  457 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC-EE
Confidence            9999999999999998765               3478889999999999999999999999999999999998875 69


Q ss_pred             EEeecCCccccccCCCCcccccCCCCC--CCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCC-hhhhhhhcc
Q 042746          116 KLADFGAAGEATVSDTRGVKIQPRGSP--LWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFG-ANTLSRIGF  191 (408)
Q Consensus       116 kL~DFGla~~~~~~~~~~~~~~~~Gt~--~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~-~~~~~~~~~  191 (408)
                      ||+|||+|+.......... ....|+.  .|||||.+....|+.++||||+||+|||+++ |..||.+.. ...+.....
T Consensus       458 kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~  536 (609)
T KOG0200|consen  458 KIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK  536 (609)
T ss_pred             EEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence            9999999986443332111 1112222  3999999999999999999999999999998 899998754 334444444


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+.....|...++++.+++..||+.+|++||++.|+..
T Consensus       537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            56666778889999999999999999999999998865

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=246.33  Aligned_cols=226  Identities=23%  Similarity=0.237  Sum_probs=176.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc--------------------------cceeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------VSYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--------------------------~~~~~~~~~~~~~~LVmEy~   56 (408)
                      ...++++||+|.||.|.+|.-.. +..||+|...                          +...+....+.-+++||||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            35678999999999999998753 6788887533                          12222334455677899999


Q ss_pred             CCCCHHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l-~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +.|+|.+++..+..+. .-....+++.||++|++||.+.+++||||.+.|+|++.+.. +||+|||+++.+...+.....
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~-iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT-IKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc-EEecCcccccccccCCceeee
Confidence            9999999998653333 44455679999999999999999999999999999999985 999999999876555443333


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh--CCCCCCCCChhhhhhhc-------ccCCCCCCCCCCcHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIG-------FSDELPRFPTQSSELG  206 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt--G~~Pf~~~~~~~~~~~~-------~~~~~p~~~~~~s~~~  206 (408)
                      -..+-...|||||.+....++.++|+|++|+++||+++  ...||.....++..+..       -...++..|..++..+
T Consensus       697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l  776 (807)
T KOG1094|consen  697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL  776 (807)
T ss_pred             cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence            23334567999999998889999999999999999865  78999876554443321       1122345567788889


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .++|.+||..|-.+||+++++..|
T Consensus       777 yelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  777 YELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             HHHHHHHhchhhhcCCCHHHHHHH
Confidence            999999999999999999998654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.4e-28  Score=237.33  Aligned_cols=219  Identities=22%  Similarity=0.284  Sum_probs=166.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCC----CCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTT----SSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~----~~~~~~LVmE   54 (408)
                      ..++..+||+|.||+||+|.-.  ++.||+|.....                        |....+    ....++||+|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            4566789999999999999874  699999875421                        211111    2346789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR---------NIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~---------giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      |-+.|+|.++|+.  .-++.....+++..|++||+|||+.         .|+|||||.+||||..+.. ..|+|||+|..
T Consensus       289 fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT-ccIaDFGLAl~  365 (534)
T KOG3653|consen  289 FHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT-CCIADFGLALR  365 (534)
T ss_pred             eccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc-EEeeccceeEE
Confidence            9999999999973  5668999999999999999999974         5999999999999998885 89999999988


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCC-C-----CCCCcchHHHHHHHHHhCC------------CCCCC-----CC
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-G-----PESDVWSLGCTIIEMVTGK------------PAWED-----FG  182 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~-----~~sDiWSLGvil~eLltG~------------~Pf~~-----~~  182 (408)
                      +............+||..|||||++.+... .     .+.||||+|.+||||++.-            .||+.     ..
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            776655555556789999999999987522 1     3579999999999998752            33431     12


Q ss_pred             hhhhhhhc-ccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHH
Q 042746          183 ANTLSRIG-FSDELPRFPT-----QSSELGRDFLDKCLRREPGERWSCDQ  226 (408)
Q Consensus       183 ~~~~~~~~-~~~~~p~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~e  226 (408)
                      .+++.... ..+..|.+|.     .....+++.+.-||..||+.|.|+.=
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            23333322 2334455553     23455788999999999999999853

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-28  Score=225.59  Aligned_cols=226  Identities=23%  Similarity=0.344  Sum_probs=172.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      +.|.+.+.||+|-||++-+|+++.++..+.+|....                          .+...++....+.++|||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            568999999999999999999999999887765331                          122235566677899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE-cCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl-~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +|-|+|.+-+..  ..+.|...+.++.|+++|+.|+|++++||||||.+|||| +.+...+||+|||+.+..........
T Consensus       104 aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~  181 (378)
T KOG1345|consen  104 APRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLE  181 (378)
T ss_pred             CccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehhhh
Confidence            999999988763  456799999999999999999999999999999999998 45666799999999876544332211


Q ss_pred             cccCCCCCCCCChhhHhC---CC--CCCCCCcchHHHHHHHHHhCCCCCCCCChhhh---hhhc----ccCCCCCCCCCC
Q 042746          135 KIQPRGSPLWMAPEVVRG---EC--QGPESDVWSLGCTIIEMVTGKPAWEDFGANTL---SRIG----FSDELPRFPTQS  202 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~---~~--~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~---~~~~----~~~~~p~~~~~~  202 (408)
                           -+..|.+||...-   +.  ..+.+|+|.||+++|.+|||.+||+......-   ....    ....+|..-...
T Consensus       182 -----~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  182 -----YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             -----hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence                 2566999998753   22  36789999999999999999999985322211   1111    122344444567


Q ss_pred             cHHHHHHHHHhcccCCCCC---CCHHHHHcCCCCC
Q 042746          203 SELGRDFLDKCLRREPGER---WSCDQLLKHPFLQ  234 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R---~s~~ell~hpf~~  234 (408)
                      ++.+..+.++-|..+|++|   .++....+..|..
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            8888889999999999999   5666666665553

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=6.7e-26  Score=203.77  Aligned_cols=187  Identities=33%  Similarity=0.498  Sum_probs=155.5

Q ss_pred             eeecCCeeEEEEEEcCCCcEEEEeeccccee--------------------------ccCCCCCcceEEEeccCCCCHHH
Q 042746           10 IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE--------------------------APTTSSSCRNLHLEYLPGGTVSD   63 (408)
Q Consensus        10 IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~--------------------------~~~~~~~~~~LVmEy~~gGsL~~   63 (408)
                      ||+|++|.||++.+..+++.+++|.......                          .........++++||++|++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999998899888775442211                          11223356789999999999999


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC-CCCcEEEeecCCccccccCCCCcccccCCCCC
Q 042746           64 LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVSDTRGVKIQPRGSP  142 (408)
Q Consensus        64 ~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~  142 (408)
                      ++......++...+..++.+++.+|++||++|++|+||+|.||+++. ++ .++|+|||.+........  ......+..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~  157 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKS--LLKTIVGTP  157 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcc--hhhcccCCC
Confidence            99865356789999999999999999999999999999999999998 55 599999999865543221  122345788


Q ss_pred             CCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          143 LWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       143 ~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      .|++||.+... .++.++|+|+||+++++|                                ..+.+++.+|+..||++|
T Consensus       158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R  205 (215)
T cd00180         158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKR  205 (215)
T ss_pred             CccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccC
Confidence            99999999886 788999999999999998                                677899999999999999


Q ss_pred             CCHHHHHcCC
Q 042746          222 WSCDQLLKHP  231 (408)
Q Consensus       222 ~s~~ell~hp  231 (408)
                      |++.++++|+
T Consensus       206 ~~~~~l~~~~  215 (215)
T cd00180         206 PSAKEILEHL  215 (215)
T ss_pred             cCHHHHhhCC
Confidence            9999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=232.87  Aligned_cols=172  Identities=27%  Similarity=0.354  Sum_probs=146.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------------------cceeccCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------------------VSYEAPTTS   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------------------~~~~~~~~~   45 (408)
                      .+|+..+.+|.|+||+|++|+++.+...|-+|...                                    +++...|+.
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46999999999999999999999998777554321                                    233445788


Q ss_pred             CCcceEEEecc-CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           46 SSCRNLHLEYL-PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        46 ~~~~~LVmEy~-~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      +.++||+||-= +|-+|+++|. .+..++|.+++.+++|++.|+++||++||||||||-+|++++.+| .+||+|||.|.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeeccchh
Confidence            88999999974 4668999998 567789999999999999999999999999999999999999998 59999999986


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCC
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWE  179 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~  179 (408)
                      .....    ..-.++||..|.|||++.|++| +..-|||+||++||.++....||.
T Consensus       719 ~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            54332    3446789999999999999988 677899999999999998888875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2e-25  Score=219.54  Aligned_cols=222  Identities=23%  Similarity=0.273  Sum_probs=163.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec------------------------c----CCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------------P----TTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~------------------------~----~~~~~~~~LVmE   54 (408)
                      ..++.+.||+|-||.||+|.+.  |+.||+|.....-+.                        .    ...--+++||.+
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            3577899999999999999996  888888765422111                        1    011124789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR--------NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~--------giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      |-+.|+|+|+|.+  ..++-....+++..++.||++||-.        .|.|||||..|||+..++. +-|+|+|+|-..
T Consensus       290 YHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~-C~IADLGLAv~h  366 (513)
T KOG2052|consen  290 YHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRH  366 (513)
T ss_pred             cccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc-EEEeeceeeEEe
Confidence            9999999999985  5667888889999999999999964        4999999999999999985 999999999443


Q ss_pred             ccC--CCCcccccCCCCCCCCChhhHhCCC----C--CCCCCcchHHHHHHHHHhC----------CCCCCCC-----Ch
Q 042746          127 TVS--DTRGVKIQPRGSPLWMAPEVVRGEC----Q--GPESDVWSLGCTIIEMVTG----------KPAWEDF-----GA  183 (408)
Q Consensus       127 ~~~--~~~~~~~~~~Gt~~y~APE~l~~~~----~--~~~sDiWSLGvil~eLltG----------~~Pf~~~-----~~  183 (408)
                      ...  .........+||..|||||++...-    +  ...+||||||.++||++..          ++||.+.     ..
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            322  1122334568999999999997531    1  3468999999999999753          5888653     34


Q ss_pred             hhhhhhccc-CCCCCCCC-CCc-HH---HHHHHHHhcccCCCCCCCHHHHHc
Q 042746          184 NTLSRIGFS-DELPRFPT-QSS-EL---GRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       184 ~~~~~~~~~-~~~p~~~~-~~s-~~---~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +++..+... +..|.+|. +.+ +.   +..+++.||..||.-|.|+-.+.+
T Consensus       447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            455554432 23344443 222 22   346889999999999999877765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=8.9e-25  Score=200.73  Aligned_cols=175  Identities=33%  Similarity=0.479  Sum_probs=143.3

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee--------------------------ccCCCCCcceEEEeccC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE--------------------------APTTSSSCRNLHLEYLP   57 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~--------------------------~~~~~~~~~~LVmEy~~   57 (408)
                      |.+++.||.|++|+||++.+..+++.+++|.......                          .........++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6789999999999999999999899998876543211                          01123356789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +++|.+++......+++..+..++.|++.+|.|||+++++|+||+|.||+++.++ .++|+|||.+......... ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~-~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAA-LLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccc-cccc
Confidence            9999999985433278999999999999999999999999999999999999886 4999999998665433200 1223


Q ss_pred             CCCCCCCCChhhH-hCCCCCCCCCcchHHHHHHHHHhCCCCCCC
Q 042746          138 PRGSPLWMAPEVV-RGECQGPESDVWSLGCTIIEMVTGKPAWED  180 (408)
Q Consensus       138 ~~Gt~~y~APE~l-~~~~~~~~sDiWSLGvil~eLltG~~Pf~~  180 (408)
                      ..++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4578899999999 666778899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.4e-25  Score=237.29  Aligned_cols=231  Identities=25%  Similarity=0.358  Sum_probs=175.5

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---e----------------eccCCCC------------CcceEEE
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---Y----------------EAPTTSS------------SCRNLHL   53 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---~----------------~~~~~~~------------~~~~LVm   53 (408)
                      ...+++|.|++|.|+.+......+.++.+...+.   .                ...+...            ....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3578999999999998888777776554432110   0                0000000            1112349


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-  132 (408)
                      |||++ +|+.++.. .++++...+..++.||+.||+|+|+.||.|||+||+|+++..++ .+||+|||.+......... 
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcchh
Confidence            99999 99999973 35788999999999999999999999999999999999999988 5999999998665544443 


Q ss_pred             -cccccCCCCCCCCChhhHhCCCCCC-CCCcchHHHHHHHHHhCCCCCCCCChhhhh--hh------cccCCCCCCCCCC
Q 042746          133 -GVKIQPRGSPLWMAPEVVRGECQGP-ESDVWSLGCTIIEMVTGKPAWEDFGANTLS--RI------GFSDELPRFPTQS  202 (408)
Q Consensus       133 -~~~~~~~Gt~~y~APE~l~~~~~~~-~sDiWSLGvil~eLltG~~Pf~~~~~~~~~--~~------~~~~~~p~~~~~~  202 (408)
                       ......+|+..|+|||++.+..|++ .+||||.|++++.|.+|+.||......+..  ..      .....+..+....
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence             4556678999999999999988855 579999999999999999999754333211  11      1111122233456


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +...+.+|.+||+.||.+|.|+++|++.+||+.+..
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            778899999999999999999999999999987653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.91  E-value=6.4e-24  Score=206.01  Aligned_cols=226  Identities=18%  Similarity=0.199  Sum_probs=174.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEE-----e--ecc-----c-------------------ceec-cCCCCCcce
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAY-----L--GDD-----V-------------------SYEA-PTTSSSCRN   50 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~-----k--~~~-----~-------------------~~~~-~~~~~~~~~   50 (408)
                      +++..-.+-+|.||.||.|++.+....-..     |  +..     +                   ...+ ..+....-.
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            455666788999999999987754433210     0  000     0                   0000 112233445


Q ss_pred             EEEeccCCCCHHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           51 LHLEYLPGGTVSDLATTL-------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~-------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++.+..-|+|..+++..       ....+-.++..++.|++.|++|||+++|||.||...|.+|++.- ++||+|-.++
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L-qVkltDsaLS  443 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL-QVKLTDSALS  443 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe-eEEeccchhc
Confidence            678888889999999832       22345677889999999999999999999999999999999886 4999999999


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCC
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~  202 (408)
                      +..-+.+..-.-...-....||+||.+.++.|+.++|+|||||++|||+| |+.|+.+.++.++......+..-..|-++
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NC  523 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNC  523 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCC
Confidence            87655432211111123566999999999999999999999999999998 99999999988888776677666778899


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +.++..++..||..+|++||+++|+..
T Consensus       524 PDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  524 PDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            999999999999999999999999864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.6e-23  Score=203.59  Aligned_cols=227  Identities=23%  Similarity=0.258  Sum_probs=169.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCC-cEEEEeecccc-----------------------------eeccC-CCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNG-DVFAYLGDDVS-----------------------------YEAPT-TSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~-~~va~k~~~~~-----------------------------~~~~~-~~~~~~~L   51 (408)
                      +|.+++.||+|+||.||++.+..++ ..+|+|.....                             +.... ..+.+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998886 45555432211                             01112 34556789


Q ss_pred             EEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC----CcEEEeecCCcc--
Q 042746           52 HLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS----SFVKLADFGAAG--  124 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~----~~vkL~DFGla~--  124 (408)
                      ||+.+ |.+|.++..... +.++...+..++.|++.+|++||+.|++||||||+|+++....    ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99998 669999886654 7889999999999999999999999999999999999998653    459999999998  


Q ss_pred             ccccCCC---Ccc---cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----hhhhhcccCC
Q 042746          125 EATVSDT---RGV---KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----TLSRIGFSDE  194 (408)
Q Consensus       125 ~~~~~~~---~~~---~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----~~~~~~~~~~  194 (408)
                      .......   ...   .....||..|+++....+...+.+.|+||++.++.+++.|..||......    ..........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~  257 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL  257 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence            3222221   111   23456999999999999999999999999999999999999999764421    1111111111


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ........+..+.++...+-..+...+|....+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  258 TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111234456677778877777899999987766543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=222.73  Aligned_cols=217  Identities=27%  Similarity=0.409  Sum_probs=173.5

Q ss_pred             eeeecCCeeEEEEEEc---CCCcEEEEeecc----------------------------cceeccCCCCCcceEEEeccC
Q 042746            9 CIGRGSFGTVNVAVDR---FNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         9 ~IG~G~fG~Vy~a~d~---~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|+|+||+|++++..   +.+..+|++...                            +.....++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            4799999999976432   233334332211                            112223556677889999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|+..+.+ ...+++...+.+...++.+++++|+.+++|||+|++||+++.+|+ +++.|||+++........     
T Consensus        81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~~~~-----  153 (612)
T KOG0603|consen   81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKEKIA-----  153 (612)
T ss_pred             cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc-cccCCchhhhHhHhhhhc-----
Confidence            9999988874 455678888999999999999999999999999999999999996 999999999776543321     


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE  217 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~d  217 (408)
                       |||..|||||+++  .+..++|+||+|++.|+|++|..||..   +.+.++ ...+ +..|...+..+++++..++.++
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~~~~I-l~~~-~~~p~~l~~~a~~~~~~l~~r~  225 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DTMKRI-LKAE-LEMPRELSAEARSLFRQLFKRN  225 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HHHHHH-hhhc-cCCchhhhHHHHHHHHHHHhhC
Confidence             8999999999999  578899999999999999999999987   333332 2323 3667889999999999999999


Q ss_pred             CCCCC-----CHHHHHcCCCCCCCCCCC
Q 042746          218 PGERW-----SCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       218 P~~R~-----s~~ell~hpf~~~~~~~~  240 (408)
                      |..|.     .+.|+++|+||+...+..
T Consensus       226 p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  226 PENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             HHHHhccCcchhHHHhccchheeeeHhh
Confidence            99998     357999999999887763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=3.6e-22  Score=188.94  Aligned_cols=230  Identities=32%  Similarity=0.464  Sum_probs=172.6

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-----------------------------cceeccCCCCCcceEEEe
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-----------------------------VSYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-----------------------------~~~~~~~~~~~~~~LVmE   54 (408)
                      |.+.+.||.|+||.||++.+.   ..++++...                             +.....+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999998   444332211                             111111223333689999


Q ss_pred             ccCCCCHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~--~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |+.++++.+++....  ..+++..+..++.|++.+++|+|+.+++|||+||+||+++..+..++++|||++.........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777543  268999999999999999999999999999999999999987634999999998754433321


Q ss_pred             c----ccccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCC----C
Q 042746          133 G----VKIQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELP----R  197 (408)
Q Consensus       133 ~----~~~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p----~  197 (408)
                      .    ......||+.|+|||.+.+   ..+....|+||+|++++++++|..||.....    ............+    .
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence            1    2345679999999999988   5778899999999999999999999876553    2333322222222    1


Q ss_pred             CCCCC----cHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          198 FPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       198 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .....    .....+++.+++..+|..|.+..+...+++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            11111    2468899999999999999999998888666543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=2.4e-23  Score=222.27  Aligned_cols=220  Identities=25%  Similarity=0.324  Sum_probs=167.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee----ccCCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHH
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE----APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL   77 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~----~~~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i   77 (408)
                      .+|..+|.|-.|+||.||+.+++.|.+.||+|.++....    ..+.+..  +.|      |+-..+++.. +.++-.. 
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~np--fvv------gDc~tllk~~-g~lPvdm-  152 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNP--FVV------GDCATLLKNI-GPLPVDM-  152 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCc--cee------chhhhhcccC-CCCcchh-
Confidence            367889999999999999999999999999954432221    1122222  222      5666666532 2333322 


Q ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC-------------CcccccCCCCCCC
Q 042746           78 RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT-------------RGVKIQPRGSPLW  144 (408)
Q Consensus        78 ~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-------------~~~~~~~~Gt~~y  144 (408)
                             +.+++|||+-||+|||+||+|++|..-|+ +|+.|||+++.......             .......||||.|
T Consensus       153 -------vla~Eylh~ygivhrdlkpdnllIT~mGh-iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPey  224 (1205)
T KOG0606|consen  153 -------VLAVEYLHSYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEY  224 (1205)
T ss_pred             -------hHHhHhhccCCeecCCCCCCcceeeeccc-ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccc
Confidence                   67899999999999999999999998885 99999999753211100             0112345899999


Q ss_pred             CChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC--CCCCCCCCCcHHHHHHHHHhcccCCCCCC
Q 042746          145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD--ELPRFPTQSSELGRDFLDKCLRREPGERW  222 (408)
Q Consensus       145 ~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~--~~p~~~~~~s~~~~~li~~~L~~dP~~R~  222 (408)
                      .|||++..+.|+..+|||++|+++|+.+-|..||.....+.+.......  ..|+-...++++++++|.++|+.+|..|.
T Consensus       225 iaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  225 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            9999999999999999999999999999999999888777766543332  23343456788999999999999999997


Q ss_pred             ---CHHHHHcCCCCCCCCCC
Q 042746          223 ---SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       223 ---s~~ell~hpf~~~~~~~  239 (408)
                         .+-++.+|+||+...+.
T Consensus       305 gt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  305 GTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccchhhhhhhccceeecccc
Confidence               56789999999987765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=3.6e-22  Score=183.46  Aligned_cols=222  Identities=21%  Similarity=0.243  Sum_probs=168.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec------------------------cCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------------PTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~------------------------~~~~~~~~~LVmEy~~   57 (408)
                      .+|.++|.||.|+||.+|+|....+|+.||+|........                        ..++..+-.+|||.+ 
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence            5799999999999999999999999999999875422111                        234455667999998 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC--CCCcEEEeecCCccccccCCCC---
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP--NSSFVKLADFGAAGEATVSDTR---  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~--~~~~vkL~DFGla~~~~~~~~~---  132 (408)
                      |.+|.++..-..+.++.+.+.-++-|++.-++|+|.+++|||||||+|.|..-  ..+.+-|+|||+|+........   
T Consensus        94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI  173 (341)
T KOG1163|consen   94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI  173 (341)
T ss_pred             CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence            67999999988889999999999999999999999999999999999999753  3345899999999775433221   


Q ss_pred             --cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh-------hhcccCCCCCCCCCCc
Q 042746          133 --GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS-------RIGFSDELPRFPTQSS  203 (408)
Q Consensus       133 --~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~-------~~~~~~~~p~~~~~~s  203 (408)
                        .......||..|.+-....+...+.+-|+=|+|.+|.+..-|..||++.....-.       ....+-.+..+-..+|
T Consensus       174 pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P  253 (341)
T KOG1163|consen  174 PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFP  253 (341)
T ss_pred             ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCc
Confidence              1112345999999988888777788899999999999999999999976543322       1111212222334567


Q ss_pred             HHHHHHHHHhcccCCCCCCCH
Q 042746          204 ELGRDFLDKCLRREPGERWSC  224 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~  224 (408)
                      .++.-.+.-|=..--++-|..
T Consensus       254 ~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  254 AEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHHHHHHHHHhhcCCCCCCcH
Confidence            777777777755544555543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5.5e-22  Score=189.40  Aligned_cols=182  Identities=24%  Similarity=0.385  Sum_probs=151.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceecc------------------------CCCCCcceEEEeccCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAP------------------------TTSSSCRNLHLEYLPG   58 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~~------------------------~~~~~~~~LVmEy~~g   58 (408)
                      .|++||+||+|+||..|++.+.-++++||+|-.....+++                        .++..+-.||||++ |
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G  107 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G  107 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence            6999999999999999999999999999998655332221                        12233345899998 6


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC----CCcEEEeecCCccccccCCCC--
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN----SSFVKLADFGAAGEATVSDTR--  132 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~----~~~vkL~DFGla~~~~~~~~~--  132 (408)
                      .+|.|+..-.++.++.+.+..++.|++.-++|+|++.+|+|||||+|+||..-    .+.|-++|||+|++.......  
T Consensus       108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH  187 (449)
T KOG1165|consen  108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH  187 (449)
T ss_pred             cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc
Confidence            79999999889999999999999999999999999999999999999999642    245899999999876554321  


Q ss_pred             ---cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh
Q 042746          133 ---GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT  185 (408)
Q Consensus       133 ---~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~  185 (408)
                         .......||..||+-....|...+.+-|+=|||-++++.|-|..||.+.....
T Consensus       188 IPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  188 IPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             CccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence               12334569999999999989888999999999999999999999998765433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.8e-21  Score=194.44  Aligned_cols=153  Identities=18%  Similarity=0.127  Sum_probs=110.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcC-CCcEEEEeecccc------------eec---------------cCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRF-NGDVFAYLGDDVS------------YEA---------------PTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~-t~~~va~k~~~~~------------~~~---------------~~~~~~~~~LV   52 (408)
                      +.+|++++.||+|+||+||+|.+.. +++.+|+|.....            +..               ........+||
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LV   96 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLV   96 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEE
Confidence            4689999999999999999999886 6777788753211            000               00012346899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV-KGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDL-Kp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |||++|++|... .    ...   ...++.|++.+|+|||++||+|||| ||+|||++.++. +||+|||+|+.......
T Consensus        97 mE~~~G~~L~~~-~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~-ikLiDFGlA~~~~~~~~  167 (365)
T PRK09188         97 RGWTEGVPLHLA-R----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE-AAVIDFQLASVFRRRGA  167 (365)
T ss_pred             EEccCCCCHHHh-C----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC-EEEEECccceecccCcc
Confidence            999999999732 1    111   1467899999999999999999999 999999987764 99999999976543321


Q ss_pred             Ccc------cccCCCCCCCCChhhHhCCC------CCCCCCcc
Q 042746          132 RGV------KIQPRGSPLWMAPEVVRGEC------QGPESDVW  162 (408)
Q Consensus       132 ~~~------~~~~~Gt~~y~APE~l~~~~------~~~~sDiW  162 (408)
                      ...      .....+++.|+|||.+....      .+..+|-|
T Consensus       168 ~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        168 LYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             hhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            111      12446889999999986431      23446666

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.7e-21  Score=189.75  Aligned_cols=178  Identities=21%  Similarity=0.297  Sum_probs=137.6

Q ss_pred             CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC---CCcEEEeecC
Q 042746           45 SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN---SSFVKLADFG  121 (408)
Q Consensus        45 ~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~---~~~vkL~DFG  121 (408)
                      +...+||||.-++. +|.+++-.  ...+....+.++.|++.|+.|||++||.|||+|.+|||+.-+   -..+.++|||
T Consensus       314 ~~~tlylvMkrY~~-tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFG  390 (598)
T KOG4158|consen  314 EPKTLYLVMKRYRQ-TLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFG  390 (598)
T ss_pred             CCceEEEehhcchh-hHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccc
Confidence            34568899999987 99999863  344677888999999999999999999999999999998432   2358999999


Q ss_pred             CccccccC----CCCcccccCCCCCCCCChhhHhCCC------CCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc
Q 042746          122 AAGEATVS----DTRGVKIQPRGSPLWMAPEVVRGEC------QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       122 la~~~~~~----~~~~~~~~~~Gt~~y~APE~l~~~~------~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~  191 (408)
                      ++--....    ..........|...-||||+....+      ...++|.|+.|.+.||++....||...+...+....+
T Consensus       391 CcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y  470 (598)
T KOG4158|consen  391 CCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY  470 (598)
T ss_pred             eeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence            87322111    1111223446889999999986432      2468999999999999999999998754443332222


Q ss_pred             -cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 042746          192 -SDELPRFPTQSSELGRDFLDKCLRREPGERWSCD  225 (408)
Q Consensus       192 -~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~  225 (408)
                       ...+|.+|...++.+++++..+|+.||++|+++.
T Consensus       471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence             3467889999999999999999999999999764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=4.3e-21  Score=184.83  Aligned_cols=207  Identities=25%  Similarity=0.285  Sum_probs=136.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-----------------------------------ecc-----
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-----------------------------------EAP-----   42 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-----------------------------------~~~-----   42 (408)
                      .+.+++.||.|+|+.||.+.|..|++.+++|..-..-                                   ..+     
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4678999999999999999999999999986532100                                   000     


Q ss_pred             -------CC---CCC-----cceEEEeccCCCCHHHHHHH---hCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042746           43 -------TT---SSS-----CRNLHLEYLPGGTVSDLATT---LNAY---ADEITLRSHTYCIVSALKYLHSRNIVHCDV  101 (408)
Q Consensus        43 -------~~---~~~-----~~~LVmEy~~gGsL~~~l~~---~~~~---l~e~~i~~i~~qIl~~L~yLH~~giiHrDL  101 (408)
                             ..   ...     ..+++|.-+. ++|.+++.-   ....   +.......+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                   00   001     1245677775 488887653   2221   112233456689999999999999999999


Q ss_pred             CCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCC--------CCCCCCCcchHHHHHHHHHh
Q 042746          102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE--------CQGPESDVWSLGCTIIEMVT  173 (408)
Q Consensus       102 Kp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--------~~~~~sDiWSLGvil~eLlt  173 (408)
                      ||+|++++.+|. +.|+||+..........     ....+..|.+||.....        .++.+.|.|+||+++|.|.+
T Consensus       172 ~~~nfll~~~G~-v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  172 KPENFLLDQDGG-VFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ceeeEEEcCCCC-EEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            999999999986 99999987754432111     12346789999988542        46788899999999999999


Q ss_pred             CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          174 GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       174 G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      +..||............+.    ... ..++..+.||..+|++||.+|
T Consensus       246 ~~lPf~~~~~~~~~~~~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEWDFS----RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGGGGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccccch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999986543333222222    333 678899999999999999987

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=2.1e-19  Score=195.09  Aligned_cols=173  Identities=25%  Similarity=0.279  Sum_probs=144.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec-------------------------cCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA-------------------------PTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~-------------------------~~~~~~~~~LVmEy~   56 (408)
                      +.|.|.+.||+|+||+||+|.+.+ ++.||+|........                         ...-.+--+||+||.
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~  776 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS  776 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence            468999999999999999999988 999999875421100                         011123356999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc------CCCCcEEEeecCCccccccCC
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG------PNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~------~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +-|+|.+++. ..+.+++..+..+..||+..|+.||..+|||+||||+|.||.      .+...++|+|||.+.......
T Consensus       777 ~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp  855 (974)
T KOG1166|consen  777 PYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP  855 (974)
T ss_pred             ccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence            9999999998 567789999999999999999999999999999999999994      223349999999997666555


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCC
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP  176 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~  176 (408)
                      ........++|-.+-.+|+..|.+++..+|.|.|+.+++.||.|+.
T Consensus       856 ~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  856 DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            4445566788999999999999999999999999999999999974

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=2e-20  Score=200.26  Aligned_cols=223  Identities=19%  Similarity=0.263  Sum_probs=158.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEecc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      +|...+.||++-|=+|.+|++...--++++.....                          .+......+...|||-+|.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            57778999999999999999986554444432211                          1111233445567889999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc--
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV--  134 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~--  134 (408)
                      .. +|+|.+. ...++...+.+.|+.||+.||.-+|..||+|+|||.+||||..=+ .+.|+||..-+..........  
T Consensus       104 kh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  104 KH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             hh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCcccc
Confidence            87 9999987 456788899999999999999999999999999999999998754 799999987654432221111  


Q ss_pred             ---cccCCCCCCCCChhhHhCC----------C-CCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC--C
Q 042746          135 ---KIQPRGSPLWMAPEVVRGE----------C-QGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP--R  197 (408)
Q Consensus       135 ---~~~~~Gt~~y~APE~l~~~----------~-~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p--~  197 (408)
                         .-+...-..|.|||.+...          + .+++-||||+||+++||++ |+|||.-...-......  ...+  .
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~--~~~~e~~  258 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN--ADDPEQL  258 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC--ccCHHHH
Confidence               1111233469999998642          1 3567799999999999987 89999632211111110  0000  1


Q ss_pred             CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       198 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +....+...+.+|..|++.||++|.++++.|+.
T Consensus       259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            112234467999999999999999999999983

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=3.5e-20  Score=186.66  Aligned_cols=179  Identities=22%  Similarity=0.330  Sum_probs=136.6

Q ss_pred             CcceEEEeccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           47 SCRNLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        47 ~~~~LVmEy~~gGsL~~~l~~~--~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .++||.|++|...+|.++|.+.  ....+....+.++.|+..+++|   ++.+|||+||.||+...+. .+||.|||+..
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~t  404 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVT  404 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhhee
Confidence            3578999999999999999642  3345667788999999999999   9999999999999998776 59999999985


Q ss_pred             ccccCC----CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC-CC
Q 042746          125 EATVSD----TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP-RF  198 (408)
Q Consensus       125 ~~~~~~----~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p-~~  198 (408)
                      ......    .......-.||.+||+||++++..|+.++||||||++|+||+. -..+|.........   -.+.+| .+
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~---r~g~ip~~~  481 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDI---RDGIIPPEF  481 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhh---hcCCCChHH
Confidence            543322    1112234569999999999999999999999999999999998 34444332222211   223333 33


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ...++. -.+|+..||...|.+||++.+.-.|+|.
T Consensus       482 ~~d~p~-e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  482 LQDYPE-EYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcCcH-HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            334444 4689999999999999988888878775

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=8e-19  Score=160.69  Aligned_cols=116  Identities=19%  Similarity=0.180  Sum_probs=90.6

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeeccccee---c---------c-------------------------------C
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE---A---------P-------------------------------T   43 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~---~---------~-------------------------------~   43 (408)
                      ...||+|+||+||+|.+. +|+.||+|.......   .         .                               .
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999997 899999886532210   0         0                               0


Q ss_pred             -CC-----CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEEcCCCCcEE
Q 042746           44 -TS-----SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL-HSRNIVHCDVKGKNVLVGPNSSFVK  116 (408)
Q Consensus        44 -~~-----~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yL-H~~giiHrDLKp~NILl~~~~~~vk  116 (408)
                       ..     ....+|||||++|+++..... ....+++..+..++.|++.+|.|+ |+.||+||||||+|||++. + .++
T Consensus        81 v~~p~~~~~~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-~v~  157 (190)
T cd05147          81 IPCPEPILLKSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-KLY  157 (190)
T ss_pred             CCCCcEEEecCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C-cEE
Confidence             00     012379999999988765533 245678999999999999999999 7999999999999999984 4 499


Q ss_pred             EeecCCcccc
Q 042746          117 LADFGAAGEA  126 (408)
Q Consensus       117 L~DFGla~~~  126 (408)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1e-18  Score=159.66  Aligned_cols=117  Identities=18%  Similarity=0.151  Sum_probs=90.5

Q ss_pred             eeceeeecCCeeEEEEEEcCCCcEEEEeecccceec-------------------------------------------c
Q 042746            6 RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA-------------------------------------------P   42 (408)
Q Consensus         6 ~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~-------------------------------------------~   42 (408)
                      +.+.||+|+||+||+|.+. +|+.||+|........                                           .
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3678999999999999988 8999998864422100                                           0


Q ss_pred             C-CCC-----CcceEEEeccCCCCHHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCc
Q 042746           43 T-TSS-----SCRNLHLEYLPGGTVSDL-ATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSF  114 (408)
Q Consensus        43 ~-~~~-----~~~~LVmEy~~gGsL~~~-l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~  114 (408)
                      . ...     ...+|||||++|+++... +.  ...+++..+..++.|++.+|.++|+ +||+||||||+|||++ ++ .
T Consensus        80 ~i~~p~~~~~~~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~-~  155 (190)
T cd05145          80 GVPVPEPILLKKNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG-K  155 (190)
T ss_pred             CCCCceEEEecCCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC-C
Confidence            0 000     112799999999865443 43  3456888899999999999999999 9999999999999998 55 4


Q ss_pred             EEEeecCCccccc
Q 042746          115 VKLADFGAAGEAT  127 (408)
Q Consensus       115 vkL~DFGla~~~~  127 (408)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=3.7e-19  Score=188.54  Aligned_cols=234  Identities=26%  Similarity=0.377  Sum_probs=179.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEE-EEeecc----------------------------cceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVF-AYLGDD----------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~v-a~k~~~----------------------------~~~~~~~~~~~~~~LV   52 (408)
                      ..|.+.+.||+|+|+.|-++....+.... +.+...                            +............+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            46889999999999999988875554433 322211                            1112223345567799


Q ss_pred             EeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc-C
Q 042746           53 LEYLPGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLH-SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-S  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH-~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~-~  129 (408)
                      ++|..||++++.+..... ..+......++.|+..+|.|+| ..++.||||||+|.+++..+..++++|||+|..... .
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            999999999998832333 5677778899999999999999 999999999999999998873499999999977665 4


Q ss_pred             CCCcccccCCC-CCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC----CCCCCCCCc
Q 042746          130 DTRGVKIQPRG-SPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE----LPRFPTQSS  203 (408)
Q Consensus       130 ~~~~~~~~~~G-t~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~----~p~~~~~~s  203 (408)
                      .........+| ++.|+|||...+. ...+..|+||+|+++..+++|..||............+...    ........+
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSIS  259 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCC
Confidence            44445556788 9999999999884 55788999999999999999999997654333222211111    122335667


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ....+++.++|..+|+.|.+.+++..+||+..
T Consensus       260 ~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  260 DQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             hhhhhcccccccCCchhccccccccccccccc
Confidence            77889999999999999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.74  E-value=7.4e-18  Score=157.95  Aligned_cols=144  Identities=15%  Similarity=0.143  Sum_probs=102.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------eec------------------cCC---
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------YEA------------------PTT---   44 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------~~~------------------~~~---   44 (408)
                      .+|+..++||.|+||.||++.+  ++..+++|.....                +..                  .+.   
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            3799999999999999999755  3556666543210                000                  000   


Q ss_pred             -----CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEee
Q 042746           45 -----SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD  119 (408)
Q Consensus        45 -----~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~D  119 (408)
                           -....+|+|||++|.+|.++..     +++.    ...+++.+|..+|++|++|||+||.||++++++  ++|+|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liD  177 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIID  177 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEE
Confidence                 1234689999999999988742     2332    456899999999999999999999999998775  99999


Q ss_pred             cCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHH
Q 042746          120 FGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV  172 (408)
Q Consensus       120 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLl  172 (408)
                      ||...........              ..+.....|+.++|+||||+++..+.
T Consensus       178 fg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9988544221110              11334445778999999999887544

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=5.4e-17  Score=153.67  Aligned_cols=120  Identities=19%  Similarity=0.138  Sum_probs=93.5

Q ss_pred             eEeeceeeecCCeeEEEEE-EcCCCcEEEEeecccceec-----------------------------------------
Q 042746            4 WVRGKCIGRGSFGTVNVAV-DRFNGDVFAYLGDDVSYEA-----------------------------------------   41 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~-d~~t~~~va~k~~~~~~~~-----------------------------------------   41 (408)
                      |.+.+.||+|+||.||+|+ +..+|+.||+|........                                         
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            7788999999999999999 7779999998754321100                                         


Q ss_pred             -cCC-----CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeecCCCCCCEEEcCCCCc
Q 042746           42 -PTT-----SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPNSSF  114 (408)
Q Consensus        42 -~~~-----~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g-iiHrDLKp~NILl~~~~~~  114 (408)
                       ...     .....+|||||++|++|...... .....+..+..++.||+.+|++||++| |+||||||+||+++ ++ .
T Consensus       110 ~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~-~  186 (237)
T smart00090      110 AGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG-K  186 (237)
T ss_pred             cCCCCCeeeEecCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC-C
Confidence             000     01235799999999888765532 334566677899999999999999999 99999999999998 55 4


Q ss_pred             EEEeecCCcccc
Q 042746          115 VKLADFGAAGEA  126 (408)
Q Consensus       115 vkL~DFGla~~~  126 (408)
                      ++|+|||.+...
T Consensus       187 i~LiDFg~a~~~  198 (237)
T smart00090      187 VVIIDVSQSVEL  198 (237)
T ss_pred             EEEEEChhhhcc
Confidence            999999998543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=5.8e-16  Score=142.85  Aligned_cols=164  Identities=17%  Similarity=0.111  Sum_probs=112.8

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecc-----------------cceeccCC---------CCCcceEEEeccCC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-----------------VSYEAPTT---------SSSCRNLHLEYLPG   58 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-----------------~~~~~~~~---------~~~~~~LVmEy~~g   58 (408)
                      .....|++|+||+||++..  .+..+......                 +.......         .-...+++|||+.|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G   82 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG   82 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence            4578999999999998766  34444321110                 00000000         01235899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC-CCCCEEEcCCCCcEEEeecCCccccccCCCC----c
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV-KGKNVLVGPNSSFVKLADFGAAGEATVSDTR----G  133 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDL-Kp~NILl~~~~~~vkL~DFGla~~~~~~~~~----~  133 (408)
                      .+|.+.+..       . ...++.|++.+|+++|++||+|||| ||+|||++.++. ++|+|||+|.........    .
T Consensus        83 ~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~-i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         83 AAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS-PAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             ccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC-EEEEECCCceecCCcchHHHHHH
Confidence            998764421       1 1357889999999999999999999 799999998775 999999999744322210    0


Q ss_pred             -------ccccCCCCCCCCChhhHhCC-CCC-CCCCcchHHHHHHHHHhCCCCCC
Q 042746          134 -------VKIQPRGSPLWMAPEVVRGE-CQG-PESDVWSLGCTIIEMVTGKPAWE  179 (408)
Q Consensus       134 -------~~~~~~Gt~~y~APE~l~~~-~~~-~~sDiWSLGvil~eLltG~~Pf~  179 (408)
                             ...-...++.|++|+.-+-- ..+ ...++++.|.-+|.++|+..|+-
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                   00112378999999887543 222 56789999999999999988754

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.64  E-value=4.4e-16  Score=145.71  Aligned_cols=213  Identities=18%  Similarity=0.267  Sum_probs=155.3

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeec---------c----------------cceeccCCCCCcceEEEeccCCCCH
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGD---------D----------------VSYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~---------~----------------~~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      .-+|...-.|..|++++..+.-..++...         +                ....+.......+.++..|+|-|+|
T Consensus       195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            44566777889999988766554433211         0                1112233455678899999999999


Q ss_pred             HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCC-cEEEeecCCccccccCCCCccccc
Q 042746           62 SDLATTL-NAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        62 ~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +.++... +...+..++.+++.++++|++|||+..  |.---|....+++|++-. .+-++|--++.+..         .
T Consensus       275 ynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~---------g  345 (448)
T KOG0195|consen  275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEV---------G  345 (448)
T ss_pred             HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeecc---------c
Confidence            9999753 234577788999999999999999875  334568888899987642 24455544432211         1


Q ss_pred             CCCCCCCCChhhHhCCCC---CCCCCcchHHHHHHHHHhCCCCCCCCChhhhh-hhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          138 PRGSPLWMAPEVVRGECQ---GPESDVWSLGCTIIEMVTGKPAWEDFGANTLS-RIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~---~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~-~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ..-+|.||+||.++..+.   -.++|+|||++++|||.|...||.+..+.+.. ++...+-.+.+|+..+.....|++-|
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ic  425 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNIC  425 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHH
Confidence            113889999999987654   35689999999999999999999988766543 33455556788888999999999999


Q ss_pred             cccCCCCCCCHHHHH
Q 042746          214 LRREPGERWSCDQLL  228 (408)
Q Consensus       214 L~~dP~~R~s~~ell  228 (408)
                      ++.||.+||.++.++
T Consensus       426 mnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  426 MNEDPGKRPKFDMIV  440 (448)
T ss_pred             hcCCCCcCCCcceeh
Confidence            999999999987654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.63  E-value=4.2e-16  Score=167.35  Aligned_cols=239  Identities=23%  Similarity=0.291  Sum_probs=186.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------c-------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------V-------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------~-------------------~~~~~~~~~~~~~LVm   53 (408)
                      +.+.+.+.+-+|+++.++.+.-..++..++.+...         +                   .....+....-.+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            56677889999999999999888888544322111         0                   0001122344578999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC----
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS----  129 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~----  129 (408)
                      +|+.|++|...+... +..++...+.++..+..+++|||+..+.|||++|.|+|+..+++ .++.|||........    
T Consensus       884 ~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh-~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH-RPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC-cccCccccccccccccCcC
Confidence            999999999999854 46688888999999999999999999999999999999998886 999999843211100    


Q ss_pred             -----------------C------C--CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh
Q 042746          130 -----------------D------T--RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN  184 (408)
Q Consensus       130 -----------------~------~--~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~  184 (408)
                                       .      .  ........||+.|.+||.+.+...+..+|+|++|+++++.++|.+||......
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence                             0      0  01122346999999999999999999999999999999999999999988777


Q ss_pred             hhhhhcccCC--CCCCCCCCcHHHHHHHHHhcccCCCCCCCHH---HHHcCCCCCCCCCCCcc
Q 042746          185 TLSRIGFSDE--LPRFPTQSSELGRDFLDKCLRREPGERWSCD---QLLKHPFLQSVSPSDAN  242 (408)
Q Consensus       185 ~~~~~~~~~~--~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~---ell~hpf~~~~~~~~~~  242 (408)
                      +..+.+....  .|.-+...+..+++++.++|..+|.+|..+.   +.-.||||+...|....
T Consensus      1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            7766554443  3344566788999999999999999999877   89999999998887543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.62  E-value=8.3e-16  Score=141.07  Aligned_cols=115  Identities=17%  Similarity=0.169  Sum_probs=89.2

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------------------ecc--
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------------------EAP--   42 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------------------~~~--   42 (408)
                      |.+.+.||+|+||.||++.+. +++.+++|......                                       ...  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            788999999999999999885 79999988421100                                       000  


Q ss_pred             ----CCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           43 ----TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        43 ----~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                          .......+++|||++|++|.++..       ......++.+++.++.++|++||+||||||+||+++.++ .++|+
T Consensus        96 ~v~~~~~~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~~li  167 (198)
T cd05144          96 PVPKPIDWNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-KIYII  167 (198)
T ss_pred             CCCceeecCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cEEEE
Confidence                001124579999999999876543       133567889999999999999999999999999998876 49999


Q ss_pred             ecCCccccc
Q 042746          119 DFGAAGEAT  127 (408)
Q Consensus       119 DFGla~~~~  127 (408)
                      |||++....
T Consensus       168 Dfg~~~~~~  176 (198)
T cd05144         168 DWPQMVSTD  176 (198)
T ss_pred             ECCccccCC
Confidence            999995443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=2.3e-15  Score=136.19  Aligned_cols=116  Identities=21%  Similarity=0.189  Sum_probs=84.3

Q ss_pred             eeceeeecCCeeEEEEEEcCCCcEEEEeeccccee------cc------------------------------------C
Q 042746            6 RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE------AP------------------------------------T   43 (408)
Q Consensus         6 ~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~------~~------------------------------------~   43 (408)
                      +++.||+|+||+||+|.+. +++.|++|.......      ..                                    .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3678999999999999987 788998875321100      00                                    0


Q ss_pred             C-----CCCcceEEEeccCCCCHHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEE
Q 042746           44 T-----SSSCRNLHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVK  116 (408)
Q Consensus        44 ~-----~~~~~~LVmEy~~gGsL~~-~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vk  116 (408)
                      .     .....+|+|||++|+++.. .+....   ....++.++.+++.++.++|+ ++|+|+||||+||+++ ++ .++
T Consensus        80 ~~~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~---~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~~~  154 (187)
T cd05119          80 PVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVR---LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-KVY  154 (187)
T ss_pred             CCCceEecCCCEEEEEEeCCCCccChhhhhhh---hcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-cEE
Confidence            0     0023479999999954431 122111   115678899999999999999 9999999999999999 55 499


Q ss_pred             EeecCCccccc
Q 042746          117 LADFGAAGEAT  127 (408)
Q Consensus       117 L~DFGla~~~~  127 (408)
                      |+|||.+....
T Consensus       155 liDfg~a~~~~  165 (187)
T cd05119         155 IIDVPQAVEID  165 (187)
T ss_pred             EEECccccccc
Confidence            99999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.60  E-value=3.1e-15  Score=153.11  Aligned_cols=184  Identities=22%  Similarity=0.285  Sum_probs=136.9

Q ss_pred             CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           45 SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI-VHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        45 ~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~gi-iHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .+....+|.+||+-|+|.|.+....-.++......++++|+.||+|||...| .|+.++..|.+++..- .+||+|||+.
T Consensus        18 ~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w-~lklt~~Gl~   96 (484)
T KOG1023|consen   18 DGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRW-VLKLTDFGLN   96 (484)
T ss_pred             cCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeE-EEEechhhhc
Confidence            3467889999999999999999767778888899999999999999998766 8999999999999887 4999999997


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCC-------CCCCCCcchHHHHHHHHHhCCCCCCCCC--h--hhhhhhccc
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGEC-------QGPESDVWSLGCTIIEMVTGKPAWEDFG--A--NTLSRIGFS  192 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-------~~~~sDiWSLGvil~eLltG~~Pf~~~~--~--~~~~~~~~~  192 (408)
                      ................-...|.|||.+++..       .+.+.|+||+|++++|+++.+.||....  .  .++......
T Consensus        97 ~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen   97 SLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             ccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence            6553211100111112355699999998742       3566899999999999999999997532  1  122221112


Q ss_pred             -CCC---CCCC-C-CCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          193 -DEL---PRFP-T-QSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       193 -~~~---p~~~-~-~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                       +..   |.+. . ...+++..++..||..+|.+||+++++-.
T Consensus       177 ~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  177 GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence             221   2111 1 23446788999999999999999998754

>PRK10345 hypothetical protein; Provisional

Probab=99.59  E-value=5.6e-15  Score=137.29  Aligned_cols=116  Identities=15%  Similarity=0.170  Sum_probs=81.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCC---C
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSS---S   47 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~---~   47 (408)
                      |..+.-.+.||+|+||.||.  +..++.. ++|....                              .+.+..+++   .
T Consensus         1 ~i~L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g   77 (210)
T PRK10345          1 MIRLSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG   77 (210)
T ss_pred             CeecCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence            45667788999999999995  7666655 3443221                              111112222   1


Q ss_pred             c-ceEEEec--cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeecCCCCCCEEEcCC---CCcEEEeec
Q 042746           48 C-RNLHLEY--LPGGTVSDLATTLNAYADEITLRSHTYCIVSAL-KYLHSRNIVHCDVKGKNVLVGPN---SSFVKLADF  120 (408)
Q Consensus        48 ~-~~LVmEy--~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L-~yLH~~giiHrDLKp~NILl~~~---~~~vkL~DF  120 (408)
                      . +.+||||  +++|+|.+++++  ..+++.  ..++.|++.++ +|||+++|+||||||+|||++.+   ...++|+||
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            2 3478999  668999999974  235555  35688888888 99999999999999999999743   225999995


Q ss_pred             CCc
Q 042746          121 GAA  123 (408)
Q Consensus       121 Gla  123 (408)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.57  E-value=1.7e-14  Score=132.93  Aligned_cols=109  Identities=21%  Similarity=0.170  Sum_probs=83.8

Q ss_pred             ceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eec---cCCCCCcceEEEe
Q 042746            8 KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEA---PTTSSSCRNLHLE   54 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~---~~~~~~~~~LVmE   54 (408)
                      +.||+|++|.||+|.+  ++..+++|.....                              ...   ........+|+||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            6899999999999987  4555655531100                              000   0112345679999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      |++|++|.+++....    . ....++.+++.+|.++|+.+++|+|++|.|||++ ++ .++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            999999999986421    2 7788999999999999999999999999999998 44 499999999854

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.54  E-value=2.1e-14  Score=151.31  Aligned_cols=112  Identities=18%  Similarity=0.185  Sum_probs=83.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------ee--------ccCCCCCcceEE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------YE--------APTTSSSCRNLH   52 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------~~--------~~~~~~~~~~LV   52 (408)
                      |...+.||+|+||+||++.+......++.+.....                       ..        .........+||
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            45678999999999999987655544433211100                       00        001123346799


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      |||++|++|.+++.         ....++.|++.+|.|||++|++||||||+|||++ ++ .++|+|||+++..
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~~  477 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKYS  477 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCcccccC
Confidence            99999999999885         2467899999999999999999999999999994 44 4999999999553

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.54  E-value=1.6e-14  Score=131.98  Aligned_cols=105  Identities=21%  Similarity=0.252  Sum_probs=79.0

Q ss_pred             eeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eec-----c---CCCCCcceEEEec
Q 042746            9 CIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEA-----P---TTSSSCRNLHLEY   55 (408)
Q Consensus         9 ~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~-----~---~~~~~~~~LVmEy   55 (408)
                      .||+|+||+||++..  ++..+.+|.....                         ...     +   .......+|+|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999985  4555555541100                         000     0   0123345799999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ++|++|.+++....    .    .++.|++.+|.+||+.|++|+|+||.||+++ ++ .++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            99999999876321    1    7889999999999999999999999999998 54 599999999855

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=8.1e-14  Score=143.00  Aligned_cols=230  Identities=23%  Similarity=0.239  Sum_probs=171.5

Q ss_pred             eEeeceeee--cCCeeEEEEEE--cCCCcEEEEeeccccee----------------------------ccCCCCCcceE
Q 042746            4 WVRGKCIGR--GSFGTVNVAVD--RFNGDVFAYLGDDVSYE----------------------------APTTSSSCRNL   51 (408)
Q Consensus         4 Y~~~~~IG~--G~fG~Vy~a~d--~~t~~~va~k~~~~~~~----------------------------~~~~~~~~~~L   51 (408)
                      +.+.+.+|.  |++|.||.+..  ..++..+|.++......                            ...+.....++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            445778999  99999999988  88888888876442211                            12334556788


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVS----ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~----~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      -+|++. .+|.++.......+++..++..+.+...    ||.++|+.+++|-|+||+||++..+....+++|||+.....
T Consensus       196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~  274 (524)
T KOG0601|consen  196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS  274 (524)
T ss_pred             eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence            899986 6888888877778899999999999999    99999999999999999999998884459999999987665


Q ss_pred             cCCCCc---ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          128 VSDTRG---VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~---~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      ......   ..+...|...|++||.+++. ++.+.|+++||.+..+..++..+...-......++.-......+-...+.
T Consensus       275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~  353 (524)
T KOG0601|consen  275 DGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSS  353 (524)
T ss_pred             CCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcch
Confidence            443211   11233588889999999887 78999999999999998888655432211111111000011122334455


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      .+...+..+++.+|-.|+++..+++|+++..
T Consensus       354 ~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  354 SLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            5566899999999999999999999999863

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.35  E-value=8e-12  Score=118.50  Aligned_cols=69  Identities=22%  Similarity=0.340  Sum_probs=58.2

Q ss_pred             eEEEeccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           50 NLHLEYLPG-GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        50 ~LVmEy~~g-GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      +|||||++| .+|.+++..  ..+++..    +.||+.+|.+||++||+||||||.|||++.++. ++|+|||.+..
T Consensus       122 ~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~-v~LIDfg~~~~  191 (239)
T PRK01723        122 DILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK-FWLIDFDRGEL  191 (239)
T ss_pred             eEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC-EEEEECCCccc
Confidence            499999998 699998863  3445543    568999999999999999999999999988764 99999999844

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.27  E-value=2.1e-11  Score=104.25  Aligned_cols=109  Identities=19%  Similarity=0.205  Sum_probs=82.3

Q ss_pred             eeceeeecCCeeEEEEEEcCCCcEEEEeecccce-------------------------eccCCCCCcceEEEeccCCCC
Q 042746            6 RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-------------------------EAPTTSSSCRNLHLEYLPGGT   60 (408)
Q Consensus         6 ~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-------------------------~~~~~~~~~~~LVmEy~~gGs   60 (408)
                      +.+.||+|.++.||++.+..  ..+++|......                         ......+...+++|||++|+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            46889999999999999865  445554332111                         011222345789999999987


Q ss_pred             HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           61 VSDLATTLNAYADEITLRSHTYCIVSALKYLHSR---NIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        61 L~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~---giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      +..+        +......++.+++.+|+++|..   +++|+|+||.||+++..+ .++++|||.+..
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            7654        4556677889999999999985   699999999999998855 599999999853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.23  E-value=3.7e-11  Score=123.61  Aligned_cols=75  Identities=24%  Similarity=0.346  Sum_probs=57.4

Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHH-HHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVS-ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~-~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      .+|+|||++|++|.++........+   ...++.+++. .+..+|..|++|+|+||.||+++.++. ++++|||++....
T Consensus       233 ~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~-i~liDfG~~~~l~  308 (437)
T TIGR01982       233 RVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK-IIALDFGIVGRLS  308 (437)
T ss_pred             ceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCc-EEEEeCCCeeECC
Confidence            4599999999999988753222222   2344555554 478899999999999999999988875 9999999986553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.21  E-value=1.6e-11  Score=126.21  Aligned_cols=223  Identities=23%  Similarity=0.202  Sum_probs=159.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-CCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-FNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      .++.....||.|.|+.||..... .++..|+++....                            .+..........||-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            35677889999999999987755 5566665533110                            011112233456688


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      .|||.++++...+. ....+++...+++..|++.++.++|+..++|+|+||+||++..++...++.|||+......... 
T Consensus       345 ~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-  422 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-  422 (524)
T ss_pred             hhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc-
Confidence            99999999877663 4457789999999999999999999999999999999999987644689999999854322211 


Q ss_pred             cccccCCCCCCCC--ChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 GVKIQPRGSPLWM--APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 ~~~~~~~Gt~~y~--APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                          .....-.++  +|.......+..++|++|||..+.+.+++.+.-...  .. ...+..+..|..+... .+++.+.
T Consensus       423 ----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--~~-~~~i~~~~~p~~~~~~-~~~q~~~  494 (524)
T KOG0601|consen  423 ----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--VQ-SLTIRSGDTPNLPGLK-LQLQVLL  494 (524)
T ss_pred             ----cccccccccccchhhccccccccccccccccccccccccCcccCccc--cc-ceeeecccccCCCchH-Hhhhhhh
Confidence                111233333  555556667889999999999999999987432211  11 1122345555655544 7888999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +.+...++..|+.+.++..|+-|.
T Consensus       495 kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  495 KVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhcCCccccchhhhhhcccchhh
Confidence            999999999999999998886654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=4.2e-11  Score=115.32  Aligned_cols=188  Identities=22%  Similarity=0.275  Sum_probs=127.8

Q ss_pred             CCCcceEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEee
Q 042746           45 SSSCRNLHLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLAD  119 (408)
Q Consensus        45 ~~~~~~LVmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~D  119 (408)
                      +.....++.||+.-|+|.++|++.   +..+..+..++|..||+.||.|||+..  |+|+++..+.|++..++ .+|+. 
T Consensus       143 e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig-  220 (458)
T KOG1266|consen  143 EKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIG-  220 (458)
T ss_pred             cccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEec-
Confidence            344567899999999999999763   456788889999999999999999874  99999999999998765 36553 


Q ss_pred             cCCccccccCCC---CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC
Q 042746          120 FGAAGEATVSDT---RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       120 FGla~~~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      -+..........   ........+-++|.|||.=.....+.++|||++|....+|..+..--..................
T Consensus       221 ~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~  300 (458)
T KOG1266|consen  221 SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII  300 (458)
T ss_pred             ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee
Confidence            221111111100   01112234788899998765555677899999999889998876331111111111110111110


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                         ......-++++.+||+..|+.||++.+++.||.+-.++
T Consensus       301 ---~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh  338 (458)
T KOG1266|consen  301 ---GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH  338 (458)
T ss_pred             ---eccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence               11122336799999999999999999999999987665

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.20  E-value=3e-11  Score=126.38  Aligned_cols=118  Identities=19%  Similarity=0.145  Sum_probs=82.5

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-------------------------------------------
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-------------------------------------------   39 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-------------------------------------------   39 (408)
                      +|.. +.||.|++|+||+|+.+++|+.||+|......                                           
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3454 78999999999999999889999988643110                                           


Q ss_pred             --------------eccCCCCCc-------------ceEEEeccCCCCHHHHHHHh-CC----CCCHHHHHHHHHHHHHH
Q 042746           40 --------------EAPTTSSSC-------------RNLHLEYLPGGTVSDLATTL-NA----YADEITLRSHTYCIVSA   87 (408)
Q Consensus        40 --------------~~~~~~~~~-------------~~LVmEy~~gGsL~~~l~~~-~~----~l~e~~i~~i~~qIl~~   87 (408)
                                    ...+...+.             .+|||||+.|+.|.++..-. .+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence                          001112222             24999999999998753211 12    233444555555554  


Q ss_pred             HHHHHHCCCeecCCCCCCEEEcCCC---CcEEEeecCCcccccc
Q 042746           88 LKYLHSRNIVHCDVKGKNVLVGPNS---SFVKLADFGAAGEATV  128 (408)
Q Consensus        88 L~yLH~~giiHrDLKp~NILl~~~~---~~vkL~DFGla~~~~~  128 (408)
                           ..|++|+|+||.||+++.++   ..++++|||++.....
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 59999999999999998876   2499999999866543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.06  E-value=1.4e-10  Score=121.17  Aligned_cols=157  Identities=24%  Similarity=0.293  Sum_probs=116.2

Q ss_pred             HHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC-------CCCcccccCCCCCCCCChhhHhC
Q 042746           81 TYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS-------DTRGVKIQPRGSPLWMAPEVVRG  152 (408)
Q Consensus        81 ~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~-------~~~~~~~~~~Gt~~y~APE~l~~  152 (408)
                      +.+.+.||.|+|. .++||+.|.|++|.++.++. .||+.|+++-.....       ..........-...|.|||++.+
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~-wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD-WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcc-eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3445689999995 58999999999999999886 999999987433321       01111112235677999999999


Q ss_pred             CCCCCCCCcchHHHHHHHHH-hCCCCCCCCChhhhhhh---cccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          153 ECQGPESDVWSLGCTIIEMV-TGKPAWEDFGANTLSRI---GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       153 ~~~~~~sDiWSLGvil~eLl-tG~~Pf~~~~~~~~~~~---~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                      ...+.++|++|||+++|.+. .|+.-+...+.......   ...-....+....++++++=+.++|..++..||++.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence            88899999999999999998 67766665432222211   111112234467788999999999999999999999999


Q ss_pred             cCCCCCCCCC
Q 042746          229 KHPFLQSVSP  238 (408)
Q Consensus       229 ~hpf~~~~~~  238 (408)
                      ..|||.+...
T Consensus       264 ~~~ff~D~~~  273 (700)
T KOG2137|consen  264 SIPFFSDPGL  273 (700)
T ss_pred             cccccCCchh
Confidence            9999987543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.05  E-value=1.1e-09  Score=100.50  Aligned_cols=74  Identities=22%  Similarity=0.296  Sum_probs=57.4

Q ss_pred             ceEEEeccCCCCHH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           49 RNLHLEYLPGGTVS-DLATTLNAYADEITLRSHTYCIVSALKYL-HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        49 ~~LVmEy~~gGsL~-~~l~~~~~~l~e~~i~~i~~qIl~~L~yL-H~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      .+|||||+.+..+. ..++  ...+++..+..+..|++.+|..| |+.|++|+||++.|||++. + .+.|+|||.+-..
T Consensus        99 ~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146          99 HVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             CEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            35899999876443 2333  23445666778889999999998 8999999999999999974 3 4999999988443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.99  E-value=1.9e-09  Score=95.53  Aligned_cols=105  Identities=19%  Similarity=0.149  Sum_probs=75.0

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeecccce------e--------------cc---CCCCCcceEEEeccCCCCHHH
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY------E--------------AP---TTSSSCRNLHLEYLPGGTVSD   63 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~------~--------------~~---~~~~~~~~LVmEy~~gGsL~~   63 (408)
                      .+.|+.|.++.||++...  +..+.+|......      .              .+   .......++||||++|.++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence            467899999999999865  6667665432110      0              00   001123579999999988764


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           64 LATTLNAYADEITLRSHTYCIVSALKYLHSRNI-----VHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        64 ~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~gi-----iHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .         .......+.+++.+|+.||+.++     +|+|+||.||+++ ++ .++++||+.+.
T Consensus        81 ~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          81 E---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             c---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            3         01123456789999999999985     9999999999998 44 49999999884

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.72  E-value=8.9e-08  Score=86.16  Aligned_cols=115  Identities=22%  Similarity=0.279  Sum_probs=81.2

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeeccc-ceec-----------------------------c---CCCCCcceEEE
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-SYEA-----------------------------P---TTSSSCRNLHL   53 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-~~~~-----------------------------~---~~~~~~~~LVm   53 (408)
                      ...|-+|+-+.|+.+.+.  |+..-+|.... .+-.                             +   +.+.+.-.|+|
T Consensus        12 l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             ceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            457889999999998874  55543332110 0000                             0   11223345899


Q ss_pred             eccCC-CCHHHHHHHhCCCCCHHH-HHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcE--EEeecCCc
Q 042746           54 EYLPG-GTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV--KLADFGAA  123 (408)
Q Consensus        54 Ey~~g-GsL~~~l~~~~~~l~e~~-i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~v--kL~DFGla  123 (408)
                      ||++| .++.+++......-.+.. ...++++|=..+.-||.++|+|+||..+||+|.+++..+  .++|||++
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            99988 578888876443333333 367888888889999999999999999999998877655  89999998

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.67  E-value=1.3e-07  Score=85.25  Aligned_cols=68  Identities=21%  Similarity=0.315  Sum_probs=54.5

Q ss_pred             CcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           47 SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        47 ~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ....|+|||++|-.|.+.+...    .    ..+++.+=.-+.-||.+||+|+||.++||++..++  +.++|||++.
T Consensus        72 ~~~~I~me~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~--i~~IDfGLg~  139 (204)
T COG3642          72 DNGLIVMEYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR--IYFIDFGLGE  139 (204)
T ss_pred             CCCEEEEEEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc--EEEEECCccc
Confidence            3456999999999999888743    2    33445555567889999999999999999997653  8999999984

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=3.8e-07  Score=91.06  Aligned_cols=173  Identities=16%  Similarity=0.214  Sum_probs=115.6

Q ss_pred             ceEEEeccCCCCH-HHHHH---H--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           49 RNLHLEYLPGGTV-SDLAT---T--LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        49 ~~LVmEy~~gGsL-~~~l~---~--~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      .-+.|..++|-.= ..+..   +  .-...+.....+.++.|+.+.+-||.+|.+-+|+.++|+|+++++. +.|+|-..
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~-V~LVdsDs  163 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK-VVLVDSDS  163 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce-EEEEcccc
Confidence            4567777777421 11111   1  1223467788899999999999999999999999999999998875 88987432


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhC-CCCCCCCCh--------h-hhh
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTG-KPAWEDFGA--------N-TLS  187 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~--------~-~~~  187 (408)
                      -   ............+|.+.|.+||..+     +..-+...|.|.||+++|+||.| ++||.+...        + .+.
T Consensus       164 f---qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia  240 (637)
T COG4248         164 F---QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA  240 (637)
T ss_pred             e---eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence            1   1112223345678999999999886     22346778999999999999986 999975311        1 110


Q ss_pred             hh--cc-----cC--CCCC-CC-CCCcHHHHHHHHHhccc--CCCCCCCHH
Q 042746          188 RI--GF-----SD--ELPR-FP-TQSSELGRDFLDKCLRR--EPGERWSCD  225 (408)
Q Consensus       188 ~~--~~-----~~--~~p~-~~-~~~s~~~~~li~~~L~~--dP~~R~s~~  225 (408)
                      .-  .+     .+  ..|. +| ...+++++.|..+|+..  ++.-|||++
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            00  00     00  1111 11 24678888898888865  356899875

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.59  E-value=6.9e-07  Score=93.63  Aligned_cols=127  Identities=23%  Similarity=0.287  Sum_probs=92.8

Q ss_pred             ceeccCCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEcCCCCcEE
Q 042746           38 SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH-SRNIVHCDVKGKNVLVGPNSSFVK  116 (408)
Q Consensus        38 ~~~~~~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH-~~giiHrDLKp~NILl~~~~~~vk  116 (408)
                      .+....+.+.+.|||+|-+.  -|..+++..+    +..+..-++||+.||.||| +.+++|++|..+.|+++..|. .|
T Consensus        73 ~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge-Wk  145 (690)
T KOG1243|consen   73 SYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE-WK  145 (690)
T ss_pred             hhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc-EE
Confidence            34445667778999999986  5677776543    6777888999999999998 668999999999999999986 99


Q ss_pred             EeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCC
Q 042746          117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK  175 (408)
Q Consensus       117 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~  175 (408)
                      |.+|-++.........  .....---.|..|+.+....  ...|.|-|||++++++.|.
T Consensus       146 Lggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  146 LGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             EeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            9999877544322210  01111122356666544332  4579999999999999993

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.56  E-value=2.7e-07  Score=89.03  Aligned_cols=77  Identities=16%  Similarity=0.104  Sum_probs=63.7

Q ss_pred             cceEEEeccCCC-CHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC------CCCcEEEee
Q 042746           48 CRNLHLEYLPGG-TVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP------NSSFVKLAD  119 (408)
Q Consensus        48 ~~~LVmEy~~gG-sL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~------~~~~vkL~D  119 (408)
                      .-+||||+++|- +|.+++... ....++.....++.+++..+.-||++||+|+|+++.|||++.      +...+.|+|
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            367999999986 899988642 234466777899999999999999999999999999999975      123589999


Q ss_pred             cCCcc
Q 042746          120 FGAAG  124 (408)
Q Consensus       120 FGla~  124 (408)
                      |+.+.
T Consensus       189 l~r~~  193 (268)
T PRK15123        189 LHRAQ  193 (268)
T ss_pred             CCccc
Confidence            99874

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=3.4e-07  Score=84.83  Aligned_cols=77  Identities=26%  Similarity=0.311  Sum_probs=64.9

Q ss_pred             cceEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCcc
Q 042746           48 CRNLHLEYLPGG-TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAG  124 (408)
Q Consensus        48 ~~~LVmEy~~gG-sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~  124 (408)
                      ..+||+|+++|- +|.+++..... .+......++.++...+.-||++||+|+|+++.|||++.++  ..+.|+||+.++
T Consensus        91 ~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen   91 RSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             eEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            357999999984 79999875333 56777789999999999999999999999999999998775  238899999875


Q ss_pred             c
Q 042746          125 E  125 (408)
Q Consensus       125 ~  125 (408)
                      .
T Consensus       170 ~  170 (206)
T PF06293_consen  170 F  170 (206)
T ss_pred             e
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.48  E-value=6.5e-07  Score=82.34  Aligned_cols=115  Identities=18%  Similarity=0.151  Sum_probs=77.6

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEeecccce----------------------------eccCCCC---CcceEEEec
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY----------------------------EAPTTSS---SCRNLHLEY   55 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~----------------------------~~~~~~~---~~~~LVmEy   55 (408)
                      .+.||.|.++.||++.... |+.+.+|......                            .......   ...+++|||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998754 4556555322110                            0001111   256899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS------------------------------------------   93 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~------------------------------------------   93 (408)
                      ++|.++.+.+..  ..+++.....++.+++..|..||+                                          
T Consensus        82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            999988765421  345666666667777777777763                                          


Q ss_pred             --------------CCCeecCCCCCCEEEcCC-CCcEEEeecCCcc
Q 042746           94 --------------RNIVHCDVKGKNVLVGPN-SSFVKLADFGAAG  124 (408)
Q Consensus        94 --------------~giiHrDLKp~NILl~~~-~~~vkL~DFGla~  124 (408)
                                    ..++|+|++|.||+++.+ ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          246999999999999883 2348899999874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.32  E-value=2.3e-06  Score=81.59  Aligned_cols=112  Identities=24%  Similarity=0.287  Sum_probs=78.8

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---e-----------------------------------------
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---Y-----------------------------------------   39 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---~-----------------------------------------   39 (408)
                      +.++..||-|.-+.||.|.+. .|.++++|-....   +                                         
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            346889999999999999998 5666666432210   0                                         


Q ss_pred             ecc-CCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           40 EAP-TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        40 ~~~-~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                      ..+ --..+...+||||+.|-.|...      .++......++..|+.-+.-+-..||||+|+++-||+++++|. +.++
T Consensus       172 ~VP~P~~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-~~vI  244 (304)
T COG0478         172 KVPKPIAWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-IVVI  244 (304)
T ss_pred             CCCCccccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-EEEE
Confidence            000 0122345699999999655432      1134445566666777777666999999999999999999986 9999


Q ss_pred             ecCCc
Q 042746          119 DFGAA  123 (408)
Q Consensus       119 DFGla  123 (408)
                      ||--+
T Consensus       245 DwPQ~  249 (304)
T COG0478         245 DWPQA  249 (304)
T ss_pred             eCccc
Confidence            99655

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.27  E-value=6.4e-07  Score=81.85  Aligned_cols=72  Identities=26%  Similarity=0.345  Sum_probs=48.2

Q ss_pred             eEEEeccC--CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           50 NLHLEYLP--GGTVSDLATTLNAYADEITLRSHTYCIVSALKY-LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        50 ~LVmEy~~--gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~y-LH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      .|||||++  |..+..+.. .  .++......++.+++..+.. +|..|++|+||.+.|||++.+  .+.++|||.+...
T Consensus        82 ~ivME~I~~~G~~~~~l~~-~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qav~~  156 (188)
T PF01163_consen   82 VIVMEYIGEDGVPLPRLKD-V--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQAVDS  156 (188)
T ss_dssp             EEEEE--EETTEEGGCHHH-C--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTEEET
T ss_pred             EEEEEecCCCccchhhHHh-c--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCcceec
Confidence            49999999  655554443 2  11234456677778875554 689999999999999999877  3999999988443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.16  E-value=3.2e-05  Score=79.30  Aligned_cols=188  Identities=20%  Similarity=0.191  Sum_probs=127.4

Q ss_pred             CeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCC----CCCcceEEEeccCC-CCHHHH
Q 042746           15 FGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTT----SSSCRNLHLEYLPG-GTVSDL   64 (408)
Q Consensus        15 fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~----~~~~~~LVmEy~~g-GsL~~~   64 (408)
                      -.+.|+|....+|..|.++...                         +.+...+.    .+..+.||++|+|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3588999999999999776652                         11111122    24456799999997 456664


Q ss_pred             HHH--------------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           65 ATT--------------LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        65 l~~--------------~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      --.              .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+. +++|...|+........
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecCCC
Confidence            421              133467899999999999999999999999999999999998765 47777666653332221


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCC-CCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~P-f~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                                    .+|  +.+   ..+-|.=.||.+++.|.||.-- +........       ....+...++.+++++
T Consensus       448 --------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-------~~~~I~~~yS~D~rn~  501 (655)
T KOG3741|consen  448 --------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS-------HLTRITTTYSTDLRNV  501 (655)
T ss_pred             --------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH-------HHHHhhhhhhHHHHHH
Confidence                          011  111   1345788899999999999522 111111111       0113345788899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q 042746          210 LDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~h  230 (408)
                      |.-+...++.+ -++.+++.|
T Consensus       502 v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  502 VEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHhcCccc-ccHHHHHHH
Confidence            99998888886 578888764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.14  E-value=5.4e-07  Score=93.97  Aligned_cols=222  Identities=20%  Similarity=0.163  Sum_probs=145.7

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEE-EEee-----------------c--ccceeccCCCCCcceEEEeccCCC-CHHHHH
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVF-AYLG-----------------D--DVSYEAPTTSSSCRNLHLEYLPGG-TVSDLA   65 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~v-a~k~-----------------~--~~~~~~~~~~~~~~~LVmEy~~gG-sL~~~l   65 (408)
                      .+-+++|+++++++.+...+.... .+..                 -  .+......+.+...++.|+|+.+| +....+
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~  326 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM  326 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC
Confidence            345688999999999887766543 1100                 0  112222233455677899999887 333222


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCC
Q 042746           66 TTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM  145 (408)
Q Consensus        66 ~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~  145 (408)
                      ....-.+.+-+.....+.-..+|+++|+.--+|+|    ||+...+  ..++.||+....++....   ..+..+++.++
T Consensus       327 ~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~---~~t~~~~~~~~  397 (829)
T KOG0576|consen  327 TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMK---PRTAIGTPEPL  397 (829)
T ss_pred             ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccc---cccCCCCCCCC
Confidence            21112233444455566667899999998889999    8888664  489999999877665442   34456999999


Q ss_pred             ChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCC---CCCcHHHHHHHHHhcccCCCCCC
Q 042746          146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP---TQSSELGRDFLDKCLRREPGERW  222 (408)
Q Consensus       146 APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~---~~~s~~~~~li~~~L~~dP~~R~  222 (408)
                      |||+.....+....|.|++++-..++.-|.+|-... +.....+......|.+.   .+....-+++...|+...|..|+
T Consensus       398 ~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P-~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pk  476 (829)
T KOG0576|consen  398 APEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP-PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPK  476 (829)
T ss_pred             CchhhcccccccCCCccCCCcchhhcCCCCCCCCCC-ccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCc
Confidence            999999999999999999999888888887775431 11111111111011111   12222223578889999999999


Q ss_pred             CHHHHHcCCCCCCCCC
Q 042746          223 SCDQLLKHPFLQSVSP  238 (408)
Q Consensus       223 s~~ell~hpf~~~~~~  238 (408)
                      ...+++.|.+|...+.
T Consensus       477 v~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  477 VHMGACFSKVFNGCPL  492 (829)
T ss_pred             chhhHHHHHHhccCcc
Confidence            9999999999986553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=9.9e-06  Score=84.74  Aligned_cols=77  Identities=29%  Similarity=0.374  Sum_probs=55.2

Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ..|+|||+.|-.+.+........++.+.+.....+.  -+..+-..|+.|.|.+|-||+++.++. +.+.|||+......
T Consensus       241 ~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~-i~~lDfGi~g~l~~  317 (517)
T COG0661         241 RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGR-IVLLDFGIVGRLDP  317 (517)
T ss_pred             cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCc-EEEEcCcceecCCH
Confidence            348999999999988864444455644433332222  233444589999999999999999985 99999999865543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.00  E-value=9.6e-06  Score=75.59  Aligned_cols=65  Identities=31%  Similarity=0.403  Sum_probs=50.9

Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ..|+|||++|..|.++..     +++.    +...|...+.-||+.|+.|+|.+|.|+++..+ + ++++||+..+
T Consensus       118 ~~ll~EYIeG~~l~d~~~-----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~-i~iID~~~k~  182 (229)
T PF06176_consen  118 YVLLMEYIEGVELNDIED-----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G-IRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEecCeecccchh-----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c-EEEEECcccc
Confidence            348999999988876543     2222    33456678899999999999999999999855 3 9999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.86  E-value=8.3e-05  Score=77.86  Aligned_cols=77  Identities=22%  Similarity=0.280  Sum_probs=54.0

Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGE  125 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~  125 (408)
                      ..|+|||++|.-+.|+-.-....++...+..-+.+..  ++-|=..|++|.|-+|-||++++   .+..+.+.|||+...
T Consensus       277 RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  277 RVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             eEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            3489999999988776544445556665444333321  23344678999999999999984   344699999999865


Q ss_pred             cc
Q 042746          126 AT  127 (408)
Q Consensus       126 ~~  127 (408)
                      ..
T Consensus       355 is  356 (538)
T KOG1235|consen  355 IS  356 (538)
T ss_pred             cc
Confidence            54

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.80  E-value=5.1e-05  Score=84.26  Aligned_cols=171  Identities=22%  Similarity=0.280  Sum_probs=117.8

Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCC---CEEEcCCCCcEEEe--ecCCccc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK---NVLVGPNSSFVKLA--DFGAAGE  125 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~---NILl~~~~~~vkL~--DFGla~~  125 (408)
                      +..||++.-++.+.+++. +..+....+.+..+++.||.|+|++...|.-+...   +-..+..+ .+.+.  ||+.++.
T Consensus       263 v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~  340 (1351)
T KOG1035|consen  263 VLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKP  340 (1351)
T ss_pred             HHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccc-eeecchhhhccccc
Confidence            457889999999988854 56688889999999999999999996665555444   22223333 24444  8888766


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCCCCC--CCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCc
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE--SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~--sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s  203 (408)
                      .........   ..-+..+.+||......+..+  .|+|.+|.....+..|..+-....          ...+-++....
T Consensus       341 l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~----------~~~~~l~~~~~  407 (1351)
T KOG1035|consen  341 LPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA----------VPVSLLDVLST  407 (1351)
T ss_pred             CCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc----------chhhhhccccc
Confidence            554433221   123666888888877666544  699999999999998865422110          00011111222


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ....+++.+|+.-++++|+++.+++.|||....
T Consensus       408 ~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  408 SELLDALPKCLDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence            256789999999999999999999999998643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.63  E-value=0.00015  Score=68.68  Aligned_cols=72  Identities=17%  Similarity=0.137  Sum_probs=53.1

Q ss_pred             eEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           50 NLHLEYLPGG-TVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        50 ~LVmEy~~gG-sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      .|||||++.. .-+-.|+  ...++...+..+..+++..+.-|-. .++||+||+.=|||+. ++ .+.++|||-|-.
T Consensus       142 VLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~QaV~  215 (268)
T COG1718         142 VLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQAVT  215 (268)
T ss_pred             eEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECccccc
Confidence            4899999764 1111222  2233344678888889999888877 8999999999999998 44 489999998843

>PRK09902 hypothetical protein; Provisional

Probab=97.48  E-value=0.00049  Score=63.93  Aligned_cols=77  Identities=16%  Similarity=0.111  Sum_probs=61.1

Q ss_pred             ceEEEeccCC-CCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC-cEEEeecCCccc
Q 042746           49 RNLHLEYLPG-GTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-FVKLADFGAAGE  125 (408)
Q Consensus        49 ~~LVmEy~~g-GsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~-~vkL~DFGla~~  125 (408)
                      -+||+|-++| -+|.+++.... ...++.....++.++...+.-||+.|+.|+|+-+.||+++.++. .++++||--++.
T Consensus       100 A~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        100 ALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            4699998774 47888876421 23467777889999999999999999999999999999985542 389999976643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.34  E-value=2.7e-05  Score=88.23  Aligned_cols=185  Identities=13%  Similarity=-0.044  Sum_probs=127.3

Q ss_pred             CcceEEEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEcCCCCcEEEe
Q 042746           47 SCRNLHLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRN-----IVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        47 ~~~~LVmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~g-----iiHrDLKp~NILl~~~~~~vkL~  118 (408)
                      ...|..++|+.+|.+++.+-+.   ...+++..+.....+.+.+..-+|+..     .+|+++|+-|.+|..+-. +|+.
T Consensus      1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~-v~~g 1382 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYN-VKLG 1382 (2724)
T ss_pred             hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCc-cccc
Confidence            3457889999999999988652   223445555555555577777777652     789999999999988764 9999


Q ss_pred             ecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC
Q 042746          119 DFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF  198 (408)
Q Consensus       119 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~  198 (408)
                      ++|+.+..+...  .......++|.|++|++.+.-.++.++|+|.+++.+|.+-.|..+|-......+..+...+....+
T Consensus      1383 k~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sI 1460 (2724)
T KOG1826|consen 1383 KGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSI 1460 (2724)
T ss_pred             ccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccc
Confidence            999997222211  122234578899999999888888889999999999999999988865544444444333333333


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +...|.++-.....+|...-..||.-...+.-+.+.
T Consensus      1461 e~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1461 EKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            333333333344455555666788877777766664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.90  E-value=0.0089  Score=54.82  Aligned_cols=31  Identities=32%  Similarity=0.596  Sum_probs=20.1

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ..++|+|+.|.|||+++++..+-|+||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3599999999999999433345799998873

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.84  E-value=0.0091  Score=56.12  Aligned_cols=28  Identities=21%  Similarity=0.335  Sum_probs=24.2

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .++|+|++|.||+++.++  +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC--cEEEechhcC
Confidence            478999999999998764  8899999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=96.38  E-value=0.02  Score=53.86  Aligned_cols=29  Identities=31%  Similarity=0.546  Sum_probs=24.8

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .++|+|+.|.|||++.++ .+.|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGK-FSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCc-EEEEEEccccc
Confidence            489999999999998754 47899999873

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.23  E-value=0.0026  Score=62.63  Aligned_cols=111  Identities=18%  Similarity=0.238  Sum_probs=73.1

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------cc-----------------------e
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------VS-----------------------Y   39 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------~~-----------------------~   39 (408)
                      |.+|+.||-|.-+-||++-+.. |.++++|-..                     .+                       +
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4578999999999999998874 4444322110                     00                       1


Q ss_pred             eccCC-CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEe
Q 042746           40 EAPTT-SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLA  118 (408)
Q Consensus        40 ~~~~~-~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~  118 (408)
                      ..+.. +.+...+|||++.|-.|.+.-+    ..+...   +...+..-+--|-.+|+||+|..--||+++.++. ++++
T Consensus       173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-i~vI  244 (465)
T KOG2268|consen  173 PVPKPIDHNRHCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-IVVI  244 (465)
T ss_pred             CCCCcccccceeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCC-EEEe
Confidence            11111 2334568899999977765432    123333   3334444566678999999999999999998775 9999


Q ss_pred             ecCCc
Q 042746          119 DFGAA  123 (408)
Q Consensus       119 DFGla  123 (408)
                      ||--.
T Consensus       245 DFPQm  249 (465)
T KOG2268|consen  245 DFPQM  249 (465)
T ss_pred             echHh
Confidence            99543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=96.06  E-value=0.05  Score=50.31  Aligned_cols=39  Identities=36%  Similarity=0.415  Sum_probs=32.5

Q ss_pred             HHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           79 SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        79 ~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .-+.+|++-|..+|..||+-+|+|+.|..   +   -||+|||.+
T Consensus       168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             hHHHHHHHHHHHHHHCCeeeccCcccccc---C---CEEEecccC
Confidence            34567888889999999999999999976   2   469999865

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=96.02  E-value=0.053  Score=49.50  Aligned_cols=73  Identities=18%  Similarity=0.199  Sum_probs=56.7

Q ss_pred             eEEEeccCCCCHHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           50 NLHLEYLPGGTVSDL---ATTLNAYADEITLRSHTYCIVSALKYLHS---RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~---l~~~~~~l~e~~i~~i~~qIl~~L~yLH~---~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++.||.+.+++...   +.+. ...+......++.+++..+++|+.   ..+.-.|++|+|+-++.++. +|++|...+
T Consensus        32 ~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~-lk~iDld~v  109 (188)
T PF12260_consen   32 FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR-LKLIDLDDV  109 (188)
T ss_pred             EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc-EEEEechhc
Confidence            578999987765421   1111 123788889999999999999998   45778999999999998875 999999876


Q ss_pred             c
Q 042746          124 G  124 (408)
Q Consensus       124 ~  124 (408)
                      .
T Consensus       110 ~  110 (188)
T PF12260_consen  110 F  110 (188)
T ss_pred             c
Confidence            3

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=95.35  E-value=0.082  Score=47.93  Aligned_cols=106  Identities=25%  Similarity=0.271  Sum_probs=66.2

Q ss_pred             eceeeecCCeeEEEEEEcCCCcEEEEee--cccc------------eeccCCCCCcc------eEEEeccCCCCHHHHHH
Q 042746            7 GKCIGRGSFGTVNVAVDRFNGDVFAYLG--DDVS------------YEAPTTSSSCR------NLHLEYLPGGTVSDLAT   66 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d~~t~~~va~k~--~~~~------------~~~~~~~~~~~------~LVmEy~~gGsL~~~l~   66 (408)
                      .+.||+|.+|.||++.+.  +..+++|.  .+..            ......-...+      .+.|||+.|-.|.++-.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~~~~~  104 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLGKLEI  104 (201)
T ss_pred             hhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchhhhhh
Confidence            578999999999999986  44555543  2211            01111111112      35699999988887654


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCC--CCEEEcCCCCcEEEeecCCcc
Q 042746           67 TLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG--KNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        67 ~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp--~NILl~~~~~~vkL~DFGla~  124 (408)
                      .  .  +...+..    ++..---|-..||-|..|+-  .||++..+  .+-|+||-.|.
T Consensus       105 ~--~--~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv~~~--~~~iIDFd~At  154 (201)
T COG2112         105 G--G--DRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLVNDR--DVYIIDFDSAT  154 (201)
T ss_pred             c--c--cHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEecCC--cEEEEEccchh
Confidence            1  1  3333333    44443446678999999984  57777554  38899999885

>PLN02876 acyl-CoA dehydrogenase

Probab=95.34  E-value=0.11  Score=58.03  Aligned_cols=31  Identities=23%  Similarity=0.399  Sum_probs=25.0

Q ss_pred             CCeecCCCCCCEEEcCC-CCcEEEeecCCccc
Q 042746           95 NIVHCDVKGKNVLVGPN-SSFVKLADFGAAGE  125 (408)
Q Consensus        95 giiHrDLKp~NILl~~~-~~~vkL~DFGla~~  125 (408)
                      .+||+|+++.|||++++ +...-|.||.++..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            49999999999999863 33457999998743

>PRK10593 hypothetical protein; Provisional

Probab=94.60  E-value=0.32  Score=47.58  Aligned_cols=28  Identities=18%  Similarity=0.370  Sum_probs=22.0

Q ss_pred             CCeecCCCCCCEEEcCC-CCcEEEeecCC
Q 042746           95 NIVHCDVKGKNVLVGPN-SSFVKLADFGA  122 (408)
Q Consensus        95 giiHrDLKp~NILl~~~-~~~vkL~DFGl  122 (408)
                      .++|+|+++.||+++.+ +..+.|.|...
T Consensus       194 sLlHGDlw~gNvl~~~~~~~i~~liDPa~  222 (297)
T PRK10593        194 VLVHGNFTLRSMLKDPRSDQLLAMLNPGL  222 (297)
T ss_pred             eeEeCCCCcccEEECCCCCceEEEECchH
Confidence            58999999999999865 33366888763

>PRK05231 homoserine kinase; Provisional

Probab=92.85  E-value=0.25  Score=48.36  Aligned_cols=29  Identities=31%  Similarity=0.464  Sum_probs=24.5

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++||+|++|.|||++.+ ...-++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~~-~~~~iIDf~~~  215 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGD-RLSGFIDFYFA  215 (319)
T ss_pred             cccCCCCCCCCcEEEECC-ceEEEEecccc
Confidence            379999999999999855 33579999987

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=92.81  E-value=0.14  Score=48.06  Aligned_cols=29  Identities=31%  Similarity=0.470  Sum_probs=24.1

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      +++|+|++|.|||++.+ ....|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDG-RLSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECC-CEEEEEeCcccC
Confidence            48999999999999765 335799999873

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=92.33  E-value=0.23  Score=48.58  Aligned_cols=29  Identities=34%  Similarity=0.463  Sum_probs=25.5

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .+++|+|+++.||+++.++ ...|+||+.+
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~  215 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDS-VKGVIDFYFA  215 (307)
T ss_pred             CccCCCCCCcCcEEEECCc-eEEEeecccc
Confidence            5799999999999998775 4689999987

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.23  E-value=0.29  Score=47.55  Aligned_cols=28  Identities=29%  Similarity=0.405  Sum_probs=24.2

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .+++|+|+++.||+++. +. +.|+||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~-i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NE-VYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-Cc-EEEEECccc
Confidence            47899999999999987 43 889999866

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=92.11  E-value=0.6  Score=43.06  Aligned_cols=68  Identities=25%  Similarity=0.311  Sum_probs=45.3

Q ss_pred             eEEEeccCC------CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--C-cEEEee-
Q 042746           50 NLHLEYLPG------GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--S-FVKLAD-  119 (408)
Q Consensus        50 ~LVmEy~~g------GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~-~vkL~D-  119 (408)
                      -+|+|.+.+      -+|.+++++  +.+++ .++..+.   .-.+||-+++|+.+|++|.||++....  . .+.|+| 
T Consensus        93 Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG  166 (199)
T PF10707_consen   93 GLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDG  166 (199)
T ss_pred             EEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeC
Confidence            366776543      357888853  34455 4444433   446788899999999999999996432  2 478888 


Q ss_pred             cCCc
Q 042746          120 FGAA  123 (408)
Q Consensus       120 FGla  123 (408)
                      ||..
T Consensus       167 ~G~~  170 (199)
T PF10707_consen  167 LGEK  170 (199)
T ss_pred             CCCc
Confidence            5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=92.01  E-value=0.41  Score=48.18  Aligned_cols=73  Identities=21%  Similarity=0.264  Sum_probs=50.7

Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ....|++|++= |+.|. .+    .....+++..++.+-+..++-+..+ .+=|||+...||||+ +|+ |.|+||-+++
T Consensus       298 ~~y~yl~~kdh-gt~is-~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn-vtLIDfklsR  369 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN-VTLIDFKLSR  369 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc-eEEEEeeeee
Confidence            34456777773 33443 22    2335666777877766666555544 578999999999999 665 9999999998


Q ss_pred             cc
Q 042746          125 EA  126 (408)
Q Consensus       125 ~~  126 (408)
                      ..
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            43

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=91.49  E-value=0.2  Score=46.61  Aligned_cols=29  Identities=24%  Similarity=0.361  Sum_probs=24.6

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++|+|+++.|||++.+++.+.++||-.|
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            58999999999999873235999999877

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=91.48  E-value=0.83  Score=46.17  Aligned_cols=71  Identities=18%  Similarity=0.158  Sum_probs=50.9

Q ss_pred             eEEEeccCCCC-HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           50 NLHLEYLPGGT-VSDLATTLNAYADEITLRSHTYCIVSALKYLH-SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        50 ~LVmEy~~gGs-L~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH-~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .|||+|+..-. .+-.|+  ...++...+..+-.|++.-+.-|. ..++||.||.--|+|+-.+  .+.++|-+-+-
T Consensus       240 VLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG--~lyiIDVSQSV  312 (520)
T KOG2270|consen  240 VLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG--KLYIIDVSQSV  312 (520)
T ss_pred             eEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC--EEEEEEccccc
Confidence            48999997421 222332  345666677777777777777665 5689999999999999643  49999988763

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=91.22  E-value=0.32  Score=46.95  Aligned_cols=29  Identities=31%  Similarity=0.477  Sum_probs=24.9

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .+++|+|++|.|||++.++ .+.|+||..+
T Consensus       175 ~~l~HgD~~~~Nil~~~~~-~~~iIDfe~a  203 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE-LSGVIDFYFA  203 (296)
T ss_pred             CcCCccCcCcccEEEeCCc-eEEEeehhhh
Confidence            4799999999999998764 3689999887

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=90.80  E-value=0.33  Score=48.35  Aligned_cols=28  Identities=32%  Similarity=0.538  Sum_probs=24.9

Q ss_pred             CeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           96 IVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        96 iiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      +||+|+.|.||+++.+...+.++||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            9999999999999987644789999987

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=90.64  E-value=0.56  Score=45.49  Aligned_cols=28  Identities=29%  Similarity=0.320  Sum_probs=24.5

Q ss_pred             CCeecCCCCCCEEEcCC----CCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLVGPN----SSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl~~~----~~~vkL~DFGla  123 (408)
                      .++|+|++|.|||++.+    + .+.++||..|
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETK-KLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCC-cEEEEeeCCC
Confidence            58999999999999874    5 4999999887

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=89.73  E-value=0.68  Score=42.29  Aligned_cols=31  Identities=23%  Similarity=0.285  Sum_probs=25.2

Q ss_pred             CCCeecCCCCCCEEEcCCCC----cEEEeecCCcc
Q 042746           94 RNIVHCDVKGKNVLVGPNSS----FVKLADFGAAG  124 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~----~vkL~DFGla~  124 (408)
                      ..++|+|+.+.||++..++.    .+.++||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            46899999999999975432    48999999874

subfamily of choline kinases

>PRK10271 thiK thiamine kinase; Provisional

Probab=89.49  E-value=0.31  Score=44.53  Aligned_cols=29  Identities=28%  Similarity=0.509  Sum_probs=24.4

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      -.+|+|+.|.||++.+++  ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            369999999999997654  88999998843

>PLN02236 choline kinase

Probab=89.22  E-value=0.44  Score=47.63  Aligned_cols=29  Identities=17%  Similarity=0.406  Sum_probs=24.9

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++|+|+++.|||++.+.+.+.++||..|
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya  229 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYA  229 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence            58999999999999864445999999877

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=89.03  E-value=0.2  Score=52.41  Aligned_cols=80  Identities=28%  Similarity=0.286  Sum_probs=55.0

Q ss_pred             CCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-CCCC----------CCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 042746          157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-DELP----------RFPTQSSELGRDFLDKCLRREPGERWSCD  225 (408)
Q Consensus       157 ~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-~~~p----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~  225 (408)
                      +++||||+|.++.++..|..-|.............. ...+          .+.-..+....++..+|+-..|..||...
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence            499999999999999999877654332222221111 0000          00112445567889999999999999999


Q ss_pred             HHHcCCCCCCC
Q 042746          226 QLLKHPFLQSV  236 (408)
Q Consensus       226 ell~hpf~~~~  236 (408)
                      ++++++-|..+
T Consensus       190 ~~~k~~i~~ev  200 (725)
T KOG1093|consen  190 ELSKRCSFTEV  200 (725)
T ss_pred             HHhcCccHHHH
Confidence            99999998766

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=88.87  E-value=0.31  Score=47.24  Aligned_cols=31  Identities=23%  Similarity=0.381  Sum_probs=25.5

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      .++|+|++|.|||++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987554467999998843

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=88.35  E-value=0.43  Score=47.59  Aligned_cols=55  Identities=20%  Similarity=0.168  Sum_probs=35.4

Q ss_pred             HHHHHHHHHHHHHHHHHHH----HCCCeecCCCCCCEEEcCCCC-----------------cEEEeecCCcccccc
Q 042746           74 EITLRSHTYCIVSALKYLH----SRNIVHCDVKGKNVLVGPNSS-----------------FVKLADFGAAGEATV  128 (408)
Q Consensus        74 e~~i~~i~~qIl~~L~yLH----~~giiHrDLKp~NILl~~~~~-----------------~vkL~DFGla~~~~~  128 (408)
                      ...++.++.||+.-.--+-    ..+++|-||||+|||+-+...                 ..+|.||.+|.....
T Consensus       274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i  349 (434)
T PF05445_consen  274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANI  349 (434)
T ss_pred             HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhccc
Confidence            4456777778754321132    346999999999999943321                 256788888755443

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=87.54  E-value=0.79  Score=44.28  Aligned_cols=40  Identities=25%  Similarity=0.312  Sum_probs=29.5

Q ss_pred             HHHHHHHHHHC--CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           84 IVSALKYLHSR--NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        84 Il~~L~yLH~~--giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      +-..+.-+|..  -++|+|+.|.|+|.++.+. ++|+||--|.
T Consensus       141 l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~-l~LIDWEyAg  182 (269)
T COG0510         141 LRRALEEVPKDDLVPCHNDLNPGNLLLTDKGG-LFLIDWEYAG  182 (269)
T ss_pred             HHHHhhhcCCCceeeecCCCCccceEEcCCCc-EEEEecccCC
Confidence            33344444433  4899999999999988665 9999997663

>TIGR02721 ycfN_thiK thiamine kinase

Probab=87.19  E-value=0.45  Score=45.07  Aligned_cols=28  Identities=36%  Similarity=0.546  Sum_probs=24.4

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .++|+|+.|.||+++.++  +.|+||..|.
T Consensus       147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~  174 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG--LKLIDWEYAS  174 (256)
T ss_pred             eeecCCCCcCcEEEeCCC--CEEEeccccC
Confidence            489999999999998764  7899998873

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PHA03111 Ser/Thr kinase; Provisional

Probab=86.03  E-value=1.5  Score=43.82  Aligned_cols=38  Identities=18%  Similarity=0.148  Sum_probs=27.5

Q ss_pred             HHHHHHHHHHHHHHHHHHHH----CCCeecCCCCCCEEEcCC
Q 042746           74 EITLRSHTYCIVSALKYLHS----RNIVHCDVKGKNVLVGPN  111 (408)
Q Consensus        74 e~~i~~i~~qIl~~L~yLH~----~giiHrDLKp~NILl~~~  111 (408)
                      ...++.++.||+.-.-.+-+    .+++|-||||+|||+-+.
T Consensus       278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            44577888888664434433    469999999999999544

>PRK06149 hypothetical protein; Provisional

Probab=85.96  E-value=0.91  Score=51.80  Aligned_cols=31  Identities=26%  Similarity=0.319  Sum_probs=25.1

Q ss_pred             CCCeecCCCCCCEEEcCCC----CcEEEeecCCcc
Q 042746           94 RNIVHCDVKGKNVLVGPNS----SFVKLADFGAAG  124 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~----~~vkL~DFGla~  124 (408)
                      .++||.|+++.|||++.+.    ...-|+|||-+.
T Consensus       208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            5799999999999998653    224799999773

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=84.78  E-value=1.5  Score=43.56  Aligned_cols=28  Identities=18%  Similarity=0.343  Sum_probs=24.2

Q ss_pred             CeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           96 IVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        96 iiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      ++|+|+.+.|||++++++.++++||..|
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEccccc
Confidence            7899999999999765445999999887

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=84.50  E-value=0.6  Score=42.87  Aligned_cols=28  Identities=36%  Similarity=0.489  Sum_probs=18.3

Q ss_pred             CCeecCCCCCCEEE-cCCCCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLV-GPNSSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl-~~~~~~vkL~DFGla  123 (408)
                      -++|+|+.|.|||+ +.++ .++++||-.|
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya  172 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYA  172 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHH
Confidence            48899999999999 4455 5999999887

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=83.96  E-value=1.6  Score=42.66  Aligned_cols=29  Identities=17%  Similarity=0.200  Sum_probs=25.5

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      +++|+|+.+.|+|++.++. +.++||-.+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~-~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG-GYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC-EEEEEhhhcc
Confidence            6999999999999988764 8899998773

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK06148 hypothetical protein; Provisional

Probab=83.50  E-value=1.5  Score=50.31  Aligned_cols=32  Identities=31%  Similarity=0.531  Sum_probs=26.0

Q ss_pred             CCCeecCCCCCCEEEcCCC--CcEEEeecCCccc
Q 042746           94 RNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGE  125 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~  125 (408)
                      .++||+|+.+.|||++.++  ...-|+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999998764  3345999998743

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=82.89  E-value=1.8  Score=41.67  Aligned_cols=29  Identities=31%  Similarity=0.336  Sum_probs=24.1

Q ss_pred             CeecCCCCCCEEEcCCCC----cEEEeecCCcc
Q 042746           96 IVHCDVKGKNVLVGPNSS----FVKLADFGAAG  124 (408)
Q Consensus        96 iiHrDLKp~NILl~~~~~----~vkL~DFGla~  124 (408)
                      ++|+|+++.|||+..++.    .++++||.+++
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeecccccc
Confidence            899999999999976532    48999998874

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=81.72  E-value=1.2  Score=42.19  Aligned_cols=38  Identities=24%  Similarity=0.311  Sum_probs=32.3

Q ss_pred             HHHHHHHHH--CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           85 VSALKYLHS--RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        85 l~~L~yLH~--~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      +..|.-.|+  .+.+|+|-.|+||+-|..|. +||.|-+..
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~-lKlVDP~~L  190 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY-LKLVDPVCL  190 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCC-EEecChhhh
Confidence            456778884  46999999999999999985 999998865

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=81.28  E-value=3  Score=41.28  Aligned_cols=28  Identities=21%  Similarity=0.234  Sum_probs=23.3

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .++||+|+.+.|||++ + . +.++||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~-~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-G-PHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-C-cEEEeCCCCC
Confidence            3689999999999995 3 3 7799999873

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=80.67  E-value=1.3  Score=43.98  Aligned_cols=39  Identities=23%  Similarity=0.436  Sum_probs=31.9

Q ss_pred             HHHHHHHC--------CCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           87 ALKYLHSR--------NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        87 ~L~yLH~~--------giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      -..+|+++        .++|+|+++.||++++++. +-+.||+++...
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lG  229 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP-TGVLDWELATLG  229 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe-eEEEeccccccC
Confidence            35566655        4899999999999998886 899999998544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	408
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-27
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-27
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-26
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-26
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-26
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-25
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-25
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-25
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-25
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-25
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-25
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-25
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-25
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-25
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-25
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-25
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-22
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-22
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-22
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-21
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-20
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-19
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-19
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-19
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-18
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-18
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-16
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-16
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-15
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-15
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-15
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-15
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-15
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-15
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-15
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-15
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-15
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-15
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-15
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-14
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-13
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-13
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-13
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-13
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-13
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-13
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-13
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-13
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-13
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-12
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-11
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-11
3soa_A	444	Full-Length Human Camkii Length = 444		5e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		8e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-10
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-10
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-10
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-10
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-10
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-10
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-10
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-10
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-10
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-10
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-09
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-09
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-09
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-09
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		9e-09
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		5e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-08
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-07
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-07
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-07
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		8e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-07
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		8e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-06
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		4e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 68/190 (35%), Positives = 108/190 (56%), Gaps = 11/190 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H D+K  N+L+G + 
Sbjct: 96  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++  + +  G+P WMAPEVV  +  GP+ D+WSLG   IEM+
Sbjct: 154 S-VKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +LL
Sbjct: 211 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
Query: 229 KHPFLQSVSP 238
           +H FL+   P
Sbjct: 269 QHQFLKIAKP 278

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 68/190 (35%), Positives = 107/190 (56%), Gaps = 11/190 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H D+K  N+L+G + 
Sbjct: 96  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++   +   G+P WMAPEVV  +  GP+ D+WSLG   IEM+
Sbjct: 154 S-VKLTDFGFCAQITPEQSKRSXM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +LL
Sbjct: 211 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 268
Query: 229 KHPFLQSVSP 238
           +H FL+   P
Sbjct: 269 QHQFLKIAKP 278

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/190 (35%), Positives = 107/190 (56%), Gaps = 11/190 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H D+K  N+L+G + 
Sbjct: 97  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 154
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++   +   G+P WMAPEVV  +  GP+ D+WSLG   IEM+
Sbjct: 155 S-VKLTDFGFCAQITPEQSKRSXM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211
Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +L+
Sbjct: 212 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269
Query: 229 KHPFLQSVSP 238
           +H FL+   P
Sbjct: 270 QHQFLKIAKP 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/190 (35%), Positives = 107/190 (56%), Gaps = 11/190 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H D+K  N+L+G + 
Sbjct: 96  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++   +   G+P WMAPEVV  +  GP+ D+WSLG   IEM+
Sbjct: 154 S-VKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +LL
Sbjct: 211 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
Query: 229 KHPFLQSVSP 238
           +H FL+   P
Sbjct: 269 QHQFLKIAKP 278

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 66/190 (34%), Positives = 107/190 (56%), Gaps = 11/190 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H ++K  N+L+G + 
Sbjct: 97  MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDG 154
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           S VKL DFG   + T   ++   +   G+P WMAPEVV  +  GP+ D+WSLG   IEM+
Sbjct: 155 S-VKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 211
Query: 173 TGKPAWEDFGANTLSRIGF--SDELPRF--PTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            G+P +     N L  +    ++  P    P + S + RDFL++CL  +  +R S  +L+
Sbjct: 212 EGEPPY--LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELI 269
Query: 229 KHPFLQSVSP 238
           +H FL+   P
Sbjct: 270 QHQFLKIAKP 279

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 116/250 (46%), Gaps = 31/250 (12%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDV---------SYEAPTTSSSCRNLH-------- 52
           IG+GSFG V   +D     V A    D+           +  T  S C + +        
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EYL GG+  DL        DE  + +    I+  L YLHS   +H D+K 
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKA 148
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NVL+      VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+WS
Sbjct: 149 ANVLLSEQGD-VKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWS 205
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LG T IE+  G+P   D     +  +   +  P      ++  ++F+D CL ++P  R +
Sbjct: 206 LGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPT 265
Query: 224 CDQLLKHPFL 233
             +LLKH F+
Sbjct: 266 AKELLKHKFI 275

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 117/250 (46%), Gaps = 31/250 (12%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------YEAPTTSSSCRNLH-------- 52
           IG+GSFG V   +D     V A    D+           +  T  S C + +        
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EYL GG+  DL        DE  + +    I+  L YLHS   +H D+K 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 132
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NVL+  +   VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+WS
Sbjct: 133 ANVLLSEHGE-VKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWS 189
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LG T IE+  G+P   +     +  +   +  P      S+  ++F++ CL +EP  R +
Sbjct: 190 LGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 224 CDQLLKHPFL 233
             +LLKH F+
Sbjct: 250 AKELLKHKFI 259

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 117/250 (46%), Gaps = 31/250 (12%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------YEAPTTSSSCRNLH-------- 52
           IG+GSFG V   +D     V A    D+           +  T  S C + +        
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EYL GG+  DL        DE  + +    I+  L YLHS   +H D+K 
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 147
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NVL+  +   VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+WS
Sbjct: 148 ANVLLSEHGE-VKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWS 204
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LG T IE+  G+P   +     +  +   +  P      S+  ++F++ CL +EP  R +
Sbjct: 205 LGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 264
Query: 224 CDQLLKHPFL 233
             +LLKH F+
Sbjct: 265 AKELLKHKFI 274

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 117/250 (46%), Gaps = 31/250 (12%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------YEAPTTSSSCRNLH-------- 52
           IG+GSFG V   +D     V A    D+           +  T  S C + +        
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EYL GG+  DL        DE  + +    I+  L YLHS   +H D+K 
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKA 132
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NVL+  +   VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+WS
Sbjct: 133 ANVLLSEHGE-VKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 189
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LG T IE+  G+P   +     +  +   +  P      S+  ++F++ CL +EP  R +
Sbjct: 190 LGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPT 249
Query: 224 CDQLLKHPFL 233
             +LLKH F+
Sbjct: 250 AKELLKHKFI 259

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 118/250 (47%), Gaps = 31/250 (12%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------EAPTTSSSCRNLH-------- 52
           IG+GSFG V   +D    +V A    D+           +  T  S C + +        
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 53  ---------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    +EYL GG+  DL        +E  + +    I+  L YLHS   +H D+K 
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKA 144
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NVL+      VKLADFG AG+ T  DT+  +    G+P WMAPEV++      ++D+WS
Sbjct: 145 ANVLLSEQGD-VKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWS 201
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LG T IE+  G+P   D     +  +   +  P    Q S+  ++F++ CL ++P  R +
Sbjct: 202 LGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPT 261
Query: 224 CDQLLKHPFL 233
             +LLKH F+
Sbjct: 262 AKELLKHKFI 271

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 120/256 (46%), Gaps = 31/256 (12%)
Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------YEAPTTSSSCRNLH-- 52
           + + + IG+GSFG V   +D     V A    D+           +  T  S C + +  
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 53  ---------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
                          +EYL GG+  DL        DE  + +    I+  L YLHS   +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKI 146
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           H D+K  NVL+  +   VKLADFG AG+ T  DT+  +    G+P WMAPEV++      
Sbjct: 147 HRDIKAANVLLSEHGE-VKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE 217
           ++D+WSLG T IE+  G+P   +     +  +   +  P      S+  ++F++ CL +E
Sbjct: 204 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 263
Query: 218 PGERWSCDQLLKHPFL 233
           P  R +  +LLKH F+
Sbjct: 264 PSFRPTAKELLKHKFI 279

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 116/251 (46%), Gaps = 28/251 (11%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAP------TTSSSCRNLH----------- 52
           +G GS+G+V  A+ +  G + A     V  +        +    C + H           
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 53  ------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
                 +EY   G+VSD+    N    E  + +     +  L+YLH    +H D+K  N+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
           L+       KLADFG AG+ T  D    +    G+P WMAPEV++       +D+WSLG 
Sbjct: 157 LLN-TEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGI 213
Query: 167 TIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGERWSC 224
           T IEM  GKP + D        +  ++  P F  P   S+   DF+ +CL + P +R + 
Sbjct: 214 TAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATA 273
Query: 225 DQLLKHPFLQS 235
            QLL+HPF++S
Sbjct: 274 TQLLQHPFVRS 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+L GG ++D+ T      ++I   +    ++ AL  LH++ ++H D+K  ++L+  + 
Sbjct: 105 MEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 161
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IEMV
Sbjct: 162 GRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 219
Query: 173 TGKPAWED---FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            G+P + +     A  + R      L      S  L + FLD+ L R+P +R +  +LLK
Sbjct: 220 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL-KGFLDRLLVRDPAQRATAAELLK 278
Query: 230 HPFLQSVSP 238
           HPFL    P
Sbjct: 279 HPFLAKAGP 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+L GG ++D+ T      ++I   +    ++ AL  LH++ ++H D+K  ++L+  + 
Sbjct: 100 MEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 156
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IEMV
Sbjct: 157 GRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 214
Query: 173 TGKPAWED---FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            G+P + +     A  + R      L      S  L + FLD+ L R+P +R +  +LLK
Sbjct: 215 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL-KGFLDRLLVRDPAQRATAAELLK 273
Query: 230 HPFLQSVSP 238
           HPFL    P
Sbjct: 274 HPFLAKAGP 282

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+L GG ++D+ T      ++I   +    ++ AL  LH++ ++H D+K  ++L+  + 
Sbjct: 107 MEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 163
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IEMV
Sbjct: 164 GRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 221
Query: 173 TGKPAWED---FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            G+P + +     A  + R      L      S  L + FLD+ L R+P +R +  +LLK
Sbjct: 222 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL-KGFLDRLLVRDPAQRATAAELLK 280
Query: 230 HPFLQSVSP 238
           HPFL    P
Sbjct: 281 HPFLAKAGP 289

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+L GG ++D+ T      ++I   +    ++ AL  LH++ ++H D+K  ++L+  + 
Sbjct: 150 MEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 206
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IEMV
Sbjct: 207 GRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 264
Query: 173 TGKPAWED---FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            G+P + +     A  + R      L      S  L + FLD+ L R+P +R +  +LLK
Sbjct: 265 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL-KGFLDRLLVRDPAQRATAAELLK 323
Query: 230 HPFLQSVSP 238
           HPFL    P
Sbjct: 324 HPFLAKAGP 332

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+L GG ++D+ T      ++I   +    ++ AL  LH++ ++H D+K  ++L+  + 
Sbjct: 96  MEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 152
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IEMV
Sbjct: 153 GRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
Query: 173 TGKPAWED---FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            G+P + +     A  + R      L      S  L + FLD+ L R+P +R +  +LLK
Sbjct: 211 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL-KGFLDRLLVRDPAQRATAAELLK 269
Query: 230 HPFLQSVSP 238
           HPFL    P
Sbjct: 270 HPFLAKAGP 278

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+L GG ++D+ T      ++I   +    ++ AL  LH++ ++H D+K  ++L+  + 
Sbjct: 227 MEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGVIHRDIKSDSILLT-HD 283
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VKL+DFG   + +    R   +   G+P WMAPE++     GPE D+WSLG  +IEMV
Sbjct: 284 GRVKLSDFGFCAQVSKEVPRRKXLV--GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 341
Query: 173 TGKPAW---EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            G+P +       A  + R      L      S  L + FLD+ L R+P +R +  +LLK
Sbjct: 342 DGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSL-KGFLDRLLVRDPAQRATAAELLK 400
Query: 230 HPFLQSVSP 238
           HPFL    P
Sbjct: 401 HPFLAKAGP 409

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 104/186 (55%), Gaps = 13/186 (6%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           +E+L GG ++D+ + +    ++I     T C  ++ AL YLH++ ++H D+K  ++L+  
Sbjct: 121 MEFLQGGALTDIVSQVRLNEEQIA----TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL 176
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           +   VKL+DFG    A +S     +    G+P WMAPEV+       E D+WSLG  +IE
Sbjct: 177 DGR-VKLSDFGFC--AQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
Query: 171 MVTGKPAW-EDFGANTLSRIGFSDELPRFPT--QSSELGRDFLDKCLRREPGERWSCDQL 227
           MV G+P +  D     + R+  S   P+     + S + RDFL++ L R+P ER +  +L
Sbjct: 234 MVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
Query: 228 LKHPFL 233
           L HPFL
Sbjct: 293 LDHPFL 298

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSR 94
           V Y    + +    + +E +PGG++S L  +       +E T+  +T  I+  LKYLH  
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-----RGSPLWMAPEV 149
            IVH D+KG NVL+   S  +K++DFG +        R   I P      G+  +MAPE+
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTS-------KRLAGINPCTETFTGTLQYMAPEI 194
Query: 150 V----RGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSS 203
           +    RG   G  +D+WSLGCTIIEM TGKP + + G     + ++G     P  P   S
Sbjct: 195 IDKGPRG--YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
              + F+ KC   +P +R   + LL   FL+  S
Sbjct: 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSR 94
           V Y    + +    + +E +PGG++S L  +       +E T+  +T  I+  LKYLH  
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP-----RGSPLWMAPEV 149
            IVH D+KG NVL+   S  +K++DFG +        R   I P      G+  +MAPE+
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTS-------KRLAGINPCTETFTGTLQYMAPEI 180
Query: 150 V----RGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSS 203
           +    RG   G  +D+WSLGCTIIEM TGKP + + G     + ++G     P  P   S
Sbjct: 181 IDKGPRG--YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 238
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
              + F+ KC   +P +R   + LL   FL+
Sbjct: 239 AEAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 15/192 (7%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           +E+L GG ++D+ T      ++I     T C  ++ AL YLH++ ++H D+K  ++L+  
Sbjct: 121 MEFLEGGALTDIVTHTRMNEEQIA----TVCLSVLRALSYLHNQGVIHRDIKSDSILLTS 176
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           +   +KL+DFG    A VS     +    G+P WMAPEV+     G E D+WSLG  +IE
Sbjct: 177 DGR-IKLSDFGFC--AQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 233
Query: 171 MVTGKPAW-EDFGANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           M+ G+P +  +     + RI   D LP   +   + S + R FLD  L REP +R +  +
Sbjct: 234 MIDGEPPYFNEPPLQAMRRI--RDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQE 291
Query: 227 LLKHPFLQSVSP 238
           LL HPFL+   P
Sbjct: 292 LLGHPFLKLAGP 303

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 91/158 (57%), Gaps = 8/158 (5%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R   + I++ + YLHS  I+H D+   N+L+  N + +K+ADFG A +  +   +   + 
Sbjct: 115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLC 173
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSD-EL 195
             G+P +++PE+      G ESDVWSLGC    ++ G+P ++ D   NTL+++  +D E+
Sbjct: 174 --GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231
Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           P F +  +   +D + + LRR P +R S   +L HPF+
Sbjct: 232 PSFLSIEA---KDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 121/281 (43%), Gaps = 52/281 (18%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFA-----YLGDDVSYEAPTTSSSCRNLHLEYLPG------ 58
           IG GSFG V  A D  N +V A     Y G   + +        R L     P       
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 59  ----------------GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
                           G+ SDL         E+ + + T+  +  L YLHS N++H DVK
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181
Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---ES 159
             N+L+      VKL DFG+A     ++         G+P WMAPEV+    +G    + 
Sbjct: 182 AGNILLS-EPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEVILAMDEGQYDGKV 234
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SDELPRFPT-QSSELGRDFLDKCLRR 216
           DVWSLG T IE+   KP    F  N +S +     +E P   +   SE  R+F+D CL++
Sbjct: 235 DVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 217 EPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVN 257
            P +R + + LLKH F+          + E  P  ++D + 
Sbjct: 293 IPQDRPTSEVLLKHRFV----------LRERPPTVIMDLIQ 323

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/212 (34%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           + +E+ PGG V  +   L+    E  ++     ++ AL +LHS+ I+H D+K  NVL+  
Sbjct: 93  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGECQGP-----ESDV 161
               ++LADFG      VS      +Q R    G+P WMAPEVV  E         ++D+
Sbjct: 153 EGD-IRLADFG------VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205
Query: 162 WSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREP 218
           WSLG T+IEM   +P   +      L +I  SD  P    P++ S   RDFL   L + P
Sbjct: 206 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNP 264
Query: 219 GERWSCDQLLKHPFLQSVSPSDA--NTVAESS 248
             R S  QLL+HPF+ S++ + A    VAE+ 
Sbjct: 265 ETRPSAAQLLEHPFVSSITSNKALRELVAEAK 296

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 121/281 (43%), Gaps = 52/281 (18%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFA-----YLGDDVSYEAPTTSSSCRNLHLEYLPG------ 58
           IG GSFG V  A D  N +V A     Y G   + +        R L     P       
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 59  ----------------GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
                           G+ SDL         E+ + + T+  +  L YLHS N++H DVK
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---ES 159
             N+L+      VKL DFG+A     ++         G+P WMAPEV+    +G    + 
Sbjct: 143 AGNILLS-EPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYDGKV 195
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--SDELPRFPT-QSSELGRDFLDKCLRR 216
           DVWSLG T IE+   KP    F  N +S +     +E P   +   SE  R+F+D CL++
Sbjct: 196 DVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 217 EPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVN 257
            P +R + + LLKH F+          + E  P  ++D + 
Sbjct: 254 IPQDRPTSEVLLKHRFV----------LRERPPTVIMDLIQ 284

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 97/193 (50%), Gaps = 20/193 (10%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+  GG V  +   L     E  ++      + AL YLH   I+H D+K  N+L   + 
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG 172
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGECQGP-----ESDVWS 163
             +KLADFG + + T +      IQ R    G+P WMAPEVV  E         ++DVWS
Sbjct: 173 D-IKLADFGVSAKNTRT------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 225
Query: 164 LGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGE 220
           LG T+IEM   +P   +      L +I  S E P    P++ S   +DFL KCL +    
Sbjct: 226 LGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKDFLKKCLEKNVDA 284
Query: 221 RWSCDQLLKHPFL 233
           RW+  QLL+HPF+
Sbjct: 285 RWTTSQLLQHPFV 297

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/212 (34%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           + +E+ PGG V  +   L+    E  ++     ++ AL +LHS+ I+H D+K  NVL+  
Sbjct: 85  IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 144
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGECQGP-----ESDV 161
               ++LADFG      VS      +Q R    G+P WMAPEVV  E         ++D+
Sbjct: 145 EGD-IRLADFG------VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 197
Query: 162 WSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREP 218
           WSLG T+IEM   +P   +      L +I  SD  P    P++ S   RDFL   L + P
Sbjct: 198 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNP 256
Query: 219 GERWSCDQLLKHPFLQSVSPSDA--NTVAESS 248
             R S  QLL+HPF+ S++ + A    VAE+ 
Sbjct: 257 ETRPSAAQLLEHPFVSSITSNKALRELVAEAK 288

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+  GG V  +   L     E  ++      + AL YLH   I+H D+K  N+L   + 
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG 172
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR--GSPLWMAPEVVRGECQGP-----ESDVWSLG 165
             +KLADFG + +    +TR ++ +    G+P WMAPEVV  E         ++DVWSLG
Sbjct: 173 D-IKLADFGVSAK----NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 227
Query: 166 CTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGERW 222
            T+IEM   +P   +      L +I  S E P    P++ S   +DFL KCL +    RW
Sbjct: 228 ITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKDFLKKCLEKNVDARW 286
Query: 223 SCDQLLKHPFL 233
           +  QLL+HPF+
Sbjct: 287 TTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E+  GG V  +   L     E  ++      + AL YLH   I+H D+K  N+L   + 
Sbjct: 113 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG 172
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR--GSPLWMAPEVVRGECQGP-----ESDVWSLG 165
             +KLADFG + +    +TR ++ +    G+P WMAPEVV  E         ++DVWSLG
Sbjct: 173 D-IKLADFGVSAK----NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 227
Query: 166 CTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRREPGERW 222
            T+IEM   +P   +      L +I  S E P    P++ S   +DFL KCL +    RW
Sbjct: 228 ITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSNFKDFLKKCLEKNVDARW 286
Query: 223 SCDQLLKHPFL 233
           +  QLL+HPF+
Sbjct: 287 TTSQLLQHPFV 297

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 133/279 (47%), Gaps = 53/279 (18%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 130
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 131 IHRDIKPENLLLG-SAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPEMIEGRMHD 185
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 237
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
           + + L+  P +R    ++L+HP++ + S   +N+  + S
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKES 276

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 118/234 (50%), Gaps = 22/234 (9%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVL 107
           L +E+   G+V+DL    N   + +      Y    I+  L +LH   ++H D+KG+NVL
Sbjct: 104 LVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE------SDV 161
           +  N+  VKL DFG +  A +  T G +    G+P WMAPEV+  + + P+      SD+
Sbjct: 162 LTENAE-VKLVDFGVS--AQLDRTVGRRNTFIGTPYWMAPEVIACD-ENPDATYDFKSDL 217
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS-SELGRDFLDKCLRREPGE 220
           WSLG T IEM  G P   D        +   +  PR  ++  S+  + F++ CL +   +
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQ 277
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEAS 274
           R + +QL+KHPF++   P++     +     + D ++   ++ G  D+ + E S
Sbjct: 278 RPATEQLMKHPFIRD-QPNERQVRIQ-----LKDHIDRTKKKRGEKDETEYEYS 325

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 129/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P G V      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 78  LYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ---RTATYITELANALSYCHSKRV 134
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 135 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRXXLX----GTLDYLPPEMIEGRMHD 189
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 241
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 53/285 (18%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
           + + L+  P +R    ++L+HP++ + S   +N   + S    L+
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALE 281

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S     + +  G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSR----RTELCGTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 74
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 75  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 131
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 132 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 186
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 238
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 132
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 133 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGRMHD 187
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 239
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      + ++E    S    I+  + YLH++ I H D+K +N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +KL DFG A E  + D  GV+ +   G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 151 KNIPIPHIKLIDFGLAHE--IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 167 TIIEMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ I      F +E   F +Q+SEL +DF+ K L +E  +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEE---FFSQTSELAKDFIRKLLVKETRK 263
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAES 247
           R +  + L+HP++  V    A    ES
Sbjct: 264 RLTIQEALRHPWITPVDTQQAMVRRES 290

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 134
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 135 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 189
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 241
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 130
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 131 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 185
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 237
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 132
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 133 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 187
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 239
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 30  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 89
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 90  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 146
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 147 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 201
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 253
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 254 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 286

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 98
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 99  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 155
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 156 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 210
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 262
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 39  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 98
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 99  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 155
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 156 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHD 210
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 262
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      + ++E    S    I+  + YLH++ I H D+K +N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +KL DFG A E  + D  GV+ +   G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 151 KNIPIPHIKLIDFGLAHE--IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 167 TIIEMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ I      F +E   F +Q+SEL +DF+ K L +E  +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEE---FFSQTSELAKDFIRKLLVKETRK 263
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAES 247
           R +  + L+HP++  V    A    ES
Sbjct: 264 RLTIQEALRHPWITPVDNQQAMVRRES 290

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 134
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 135 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 189
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 241
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 74  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 130
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 131 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMHD 185
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 237
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      + ++E    S    I+  + YLH++ I H D+K +N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +KL DFG A E  + D  GV+ +   G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 151 KNIPIPHIKLIDFGLAHE--IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 167 TIIEMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ I      F +E   F +Q+SEL +DF+ K L +E  +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITAVSYDFDEE---FFSQTSELAKDFIRKLLVKETRK 263
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAES 247
           R +  + L+HP++  V    A    ES
Sbjct: 264 RLTIQEALRHPWITPVDNQQAMVRRES 290

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKKV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQDTYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANS 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANS 264

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 132
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 133 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 187
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 239
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANS 267

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYA-------DEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           L ++ L GG+V D+   + A         DE T+ +    ++  L+YLH    +H DVK 
Sbjct: 90  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149
Query: 104 KNVLVGPNSSFVKLADFG-AAGEATVSDTRGVKIQPR--GSPLWMAPEV---VRGECQGP 157
            N+L+G + S V++ADFG +A  AT  D    K++    G+P WMAPEV   VRG     
Sbjct: 150 GNILLGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG--YDF 206
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPT--QSSEL----GRDF-- 209
           ++D+WS G T IE+ TG   +  +    +  +   ++ P   T  Q  E+    G+ F  
Sbjct: 207 KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK 266
Query: 210 -LDKCLRREPGERWSCDQLLKHPFLQS 235
            +  CL+++P +R +  +LL+H F Q 
Sbjct: 267 MISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 78  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 134
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE + G    
Sbjct: 135 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEXIEGRXHD 189
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 241
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 242 ISRLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 129/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 18  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 77
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P G V      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 78  LYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ---RTATYITELANALSYCHSKRV 134
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 135 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 189
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 241
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANS 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 132
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 133 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 187
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 239
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANS 267

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 25/207 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYA-------DEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           L ++ L GG+V D+   + A         DE T+ +    ++  L+YLH    +H DVK 
Sbjct: 85  LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 144
Query: 104 KNVLVGPNSSFVKLADFG-AAGEATVSDTRGVKIQPR--GSPLWMAPEV---VRGECQGP 157
            N+L+G + S V++ADFG +A  AT  D    K++    G+P WMAPEV   VRG     
Sbjct: 145 GNILLGEDGS-VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG--YDF 201
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPT--QSSEL----GRDF-- 209
           ++D+WS G T IE+ TG   +  +    +  +   ++ P   T  Q  E+    G+ F  
Sbjct: 202 KADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK 261
Query: 210 -LDKCLRREPGERWSCDQLLKHPFLQS 235
            +  CL+++P +R +  +LL+H F Q 
Sbjct: 262 MISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 17  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 133
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 134 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 188
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 240
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 241 ISRLLKHNPSQRPMLREVLEHPWITANS 268

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 132
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+A+FG +  A  S    +     G+  ++ PE++ G    
Sbjct: 133 IHRDIKPENLLLG-SAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 187
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 239
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 13  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 72
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 73  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 129
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 130 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPPEMIEGRMHD 184
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 236
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITANS 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 12  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 71
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 72  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 128
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 129 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 183
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 235
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 236 ISRLLKHNPSQRPMLREVLEHPWITANS 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 53/273 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 15  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 74
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 75  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 131
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+A+FG +  A  S    +     G+  ++ PE++ G    
Sbjct: 132 IHRDIKPENLLLG-SAGELKIANFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 186
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 238
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           + + L+  P +R    ++L+HP++ + S   +N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 128/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  +V  ++     +   
Sbjct: 16  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 75
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 76  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 132
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 133 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHD 187
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 239
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITANS 267

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 53/268 (19%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++    + A                 L  +V  ++     +   
Sbjct: 10  GRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 69
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 70  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHSKRV 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G ++  +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 127 IHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 181
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRIGFSDELPRFPTQSSELGRDF 209
            + D+WSLG    E + GKP +E   ANT       +SR+ F+     FP   +E  RD 
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFE---ANTYQETYKRISRVEFT-----FPDFVTEGARDL 233
Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + + L+  P +R    ++L+HP++ + S
Sbjct: 234 ISRLLKHNPSQRPMLREVLEHPWITANS 261

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      + ++E    S    I+  + YLH++ I H D+K +N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +KL DFG A E  + D  GV+ +   G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 151 KNIPIPHIKLIDFGLAHE--IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 167 TIIEMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ I      F +E   F + +SEL +DF+ K L +E  +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEE---FFSHTSELAKDFIRKLLVKETRK 263
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAES 247
           R +  + L+HP++  V    A    ES
Sbjct: 264 RLTIQEALRHPWITPVDNQQAMVRRES 290

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      + ++E    S    I+  + YLH++ I H D+K +N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +KL DFG A E  + D  GV+ +   G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 151 KNIPIPHIKLIDFGLAHE--IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 167 TIIEMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ I      F +E   F + +SEL +DF+ K L +E  +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEE---FFSHTSELAKDFIRKLLVKETRK 263
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAES 247
           R +  + L+HP++  V    A    ES
Sbjct: 264 RLTIQEALRHPWITPVDNQQAMVRRES 290

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 47/265 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A +R +  + A                 L  +V  ++     +   
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ---RTATYITELANALSYCHSKRV 133
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G N   +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 134 IHRDIKPENLLLGSNGE-LKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHD 188
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRIGFSDELPRFPTQSSELGRDFLDK 212
            + D+WSLG    E + G P +E          +SR+ F+     FP   +E  RD + +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----FPDFVTEGARDLISR 243
Query: 213 CLRREPGERWSCDQLLKHPFLQSVS 237
            L+    +R +  ++L+HP++++ S
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANS 268

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 124/265 (46%), Gaps = 47/265 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A +R +  + A                 L  +V  ++     +   
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P GTV      L+ + ++   R+ TY   + +AL Y HS+ +
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ---RTATYITELANALSYCHSKRV 133
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G N   +K+ADFG +  A  S    +     G+  ++ PE++ G    
Sbjct: 134 IHRDIKPENLLLGSNGE-LKIADFGWSVHAPSSRRDTLC----GTLDYLPPEMIEGRMHD 188
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRIGFSDELPRFPTQSSELGRDFLDK 212
            + D+WSLG    E + G P +E          +SR+ F+     FP   +E  RD + +
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFT-----FPDFVTEGARDLISR 243
Query: 213 CLRREPGERWSCDQLLKHPFLQSVS 237
            L+    +R +  ++L+HP++++ S
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKANS 268

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      + ++E    S    I+  + YLH++ I H D+K +N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEE-EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQP-RGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +KL DFG A E  + D  GV+ +   G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 151 KNIPIPHIKLIDFGLAHE--IED--GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
Query: 167 TIIEMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ I      F +E   F + +SEL +DF+ K L +E  +
Sbjct: 207 ITYILLSGASPFLGDTKQETLANITSVSYDFDEE---FFSHTSELAKDFIRKLLVKETRK 263
Query: 221 RWSCDQLLKHPFLQSVSPSDA 241
           R +  + L+HP++  V    A
Sbjct: 264 RLTIQEALRHPWITPVDNQQA 284

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 49  RNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           R LHL  EY     + +L        + + ++S T+  + A+ + H  N +H DVK +N+
Sbjct: 75  RRLHLVFEYCDHTVLHELDRYQRGVPEHL-VKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 107 LVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSL 164
           L+    S +KL DFG A   T  SD    ++  R    + +PE++ G+ Q GP  DVW++
Sbjct: 134 LIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRW---YRSPELLVGDTQYGPPVDVWAI 189
Query: 165 GCTIIEMVTGKPAW---EDFGANTLSRIGFSDELPRF-----------------PTQSSE 204
           GC   E+++G P W    D     L R    D +PR                  P     
Sbjct: 190 GCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEP 249
Query: 205 LGRDF----------LDKCLRREPGERWSCDQLLKHPFLQSV 236
           L   F          L  CL  +P ER +C+QLL HP+ +++
Sbjct: 250 LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 86  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 144
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+           +  G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 145 GE-IKLCDFGVSGQLIDEMAN----EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 199
Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKH 230
             G+          L     ++  P+ P+    L  +DF++KCL + P ER    QL+ H
Sbjct: 200 AVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVH 259
Query: 231 PFLQSVSPSDANTV 244
            F++    SDA  V
Sbjct: 260 AFIKR---SDAEEV 270

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTT----------------------- 44
           K IG+G+F  V +A     G   A    D +   PT+                       
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 45  ----SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               +     L +EY  GG V D     +    E   RS    IVSA++Y H + IVH D
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 136
Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPE 158
           +K +N+L+  + + +K+ADFG + E TV    G K+    GSP + APE+ +G +  GPE
Sbjct: 137 LKAENLLLDADMN-IKIADFGFSNEFTV----GGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            DVWSLG  +  +V+G   ++      L       +  R P   S    + L + L   P
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLNP 250
Query: 219 GERWSCDQLLK 229
            +R + +Q++K
Sbjct: 251 IKRGTLEQIMK 261

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 102 MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 160
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 161 GE-IKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 215
Query: 172 VTGKPAWEDFGANTLSRIGFSDEL-----PRFPTQSSELG-RDFLDKCLRREPGERWSCD 225
             G+      G+ +++     D +     P+ P+    L  +DF++KCL + P ER    
Sbjct: 216 AVGRYPIGS-GSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 274
Query: 226 QLLKHPFLQSVSPSDANTV 244
           QL+ H F++    SDA  V
Sbjct: 275 QLMVHAFIKR---SDAEEV 290

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 89/175 (50%), Gaps = 16/175 (9%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           DE   R +T  IVSAL+YLH + I+H D+K +N+L+  +   +++ DFG A   +    +
Sbjct: 130 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQ 188
Query: 133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSR 188
                  G+  +++PE++  +     SD+W+LGC I ++V G P +    E      + +
Sbjct: 189 ARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 248
Query: 189 IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ------LLKHPFLQSVS 237
           + +      FP +     RD ++K L  +  +R  C++      L  HPF +SV+
Sbjct: 249 LEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 116/303 (38%), Gaps = 68/303 (22%)
Query: 10  IGRGSFGTVNVAVDRFNGDVF-----------------------AYLGDDVSYEAP---- 42
           IG G++G V  A D  NG  F                       A L    ++E P    
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 43  -----TTSSSCRNLHLEYLPGGTVSDLATTLNAYAD----EITLRSHTYCIVSALKYLHS 93
                T S + R   L  +      DL T L+   +      T++   + ++  L +LHS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEVVRG 152
             +VH D+K +N+LV  +S  +KLADFG A   +      + +      LW  APEV+  
Sbjct: 139 HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQ 193
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWE-----DFGANTLSRIGFSDE--------LPR-- 197
                  D+WS+GC   EM   KP +      D     L  IG   E        LPR  
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 198 -----------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
                      F T   ELG+D L KCL   P +R S    L HP+ Q +     N  + 
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSH 313
Query: 247 SSP 249
             P
Sbjct: 314 LPP 316

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 111 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 170 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV 228
Query: 173 TGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ------ 226
            G P +   G   L           FP +     RD ++K L  +  +R  C++      
Sbjct: 229 AGLPPFRA-GNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287
Query: 227 LLKHPFLQSVS 237
           L  HPF +SV+
Sbjct: 288 LKAHPFFESVT 298

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 93/181 (51%), Gaps = 9/181 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY  GG V D     + +  E   R+    IVSA++Y H + IVH D+K +N+L+  
Sbjct: 83  LVMEYASGGEVFDYLVA-HGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 141
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTI 168
           + + +K+ADFG + E T     G K+    GSP + APE+ +G +  GPE DVWSLG  +
Sbjct: 142 DMN-IKIADFGFSNEFTF----GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 196
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             +V+G   ++      L       +  R P   S    + L K L   P +R + +Q++
Sbjct: 197 YTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 255
Query: 229 K 229
           K
Sbjct: 256 K 256

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 113/290 (38%), Gaps = 68/290 (23%)
Query: 10  IGRGSFGTVNVAVDRFNGDVF-----------------------AYLGDDVSYEAP---- 42
           IG G++G V  A D  NG  F                       A L    ++E P    
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 43  -----TTSSSCRNLHLEYLPGGTVSDLATTLNAYAD----EITLRSHTYCIVSALKYLHS 93
                T S + R   L  +      DL T L+   +      T++   + ++  L +LHS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEVVRG 152
             +VH D+K +N+LV  +S  +KLADFG A   +      + +      LW  APEV+  
Sbjct: 139 HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQ 193
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWE-----DFGANTLSRIGFSDE--------LPR-- 197
                  D+WS+GC   EM   KP +      D     L  IG   E        LPR  
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 198 -----------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                      F T   ELG+D L KCL   P +R S    L HP+ Q +
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 93  LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 151
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 152 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 210
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 211 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 265
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 266 GYGPLKAHPFFESVT 280

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 108 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 166
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 167 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 226 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 280
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 281 GYGPLKAHPFFESVT 295

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTT----------------------- 44
           K IG+G+F  V +A     G   A    D +   PT+                       
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 45  ----SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               +     L +EY  GG V D     +    E   RS    IVSA++Y H + IVH D
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPE 158
           +K +N+L+  + + +K+ADFG + E TV    G K+    G+P + APE+ +G +  GPE
Sbjct: 140 LKAENLLLDADMN-IKIADFGFSNEFTV----GGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            DVWSLG  +  +V+G   ++      L       +  R P   S    + L + L   P
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVLNP 253
Query: 219 GERWSCDQLLK 229
            +R + +Q++K
Sbjct: 254 IKRGTLEQIMK 264

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 20/197 (10%)
Query: 51  LHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV- 108
           L LE + GG + D LA   +   DE T       I+  + YLHS+ I H D+K +N+++ 
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEAT--QFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142
Query: 109 ---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
               PN   +KL DFG A +    +         G+P ++APE+V  E  G E+D+WS+G
Sbjct: 143 DKNVPNPR-IKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIG 198
Query: 166 CTIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPG 219
                +++G  P   +    TL+ I      F +E   + + +SEL +DF+ + L ++P 
Sbjct: 199 VITYILLSGASPFLGETKQETLTNISAVNYDFDEE---YFSNTSELAKDFIRRLLVKDPK 255
Query: 220 ERWSCDQLLKHPFLQSV 236
            R +  Q L+H +++++
Sbjct: 256 RRMTIAQSLEHSWIKAI 272

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 86  LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 144
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 145 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 203
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 204 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 258
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 259 GYGPLKAHPFFESVT 273

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 108 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 166
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 167 H-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 226 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 280
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 281 GYGPLKAHPFFESVT 295

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 109 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 167
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 168 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 227 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 282 GYGPLKAHPFFESVT 296

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 111 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 170 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 229 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 284 GYGPLKAHPFFESVT 298

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 87  LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 145
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 146 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 205 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 259
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 260 GYGPLKAHPFFESVT 274

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 109 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 167
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 168 H-IQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 227 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 282 GYGPLKAHPFFESVT 296

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 112/288 (38%), Gaps = 68/288 (23%)
Query: 10  IGRGSFGTVNVAVDRFNGDVF-----------------------AYLGDDVSYEAP---- 42
           IG G++G V  A D  NG  F                       A L    ++E P    
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 43  -----TTSSSCRNLHLEYLPGGTVSDLATTLNAYAD----EITLRSHTYCIVSALKYLHS 93
                T S + R   L  +      DL T L+   +      T++   + ++  L +LHS
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEVVRG 152
             +VH D+K +N+LV  +S  +KLADFG A   +      + +      LW  APEV+  
Sbjct: 139 HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQ 193
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWE-----DFGANTLSRIGFSDE--------LPR-- 197
                  D+WS+GC   EM   KP +      D     L  IG   E        LPR  
Sbjct: 194 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 198 -----------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
                      F T   ELG+D L KCL   P +R S    L HP+ Q
Sbjct: 254 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 109 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 167
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 168 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 227 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 282 GYGPLKAHPFFESVT 296

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 116 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 174
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 175 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 233
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 234 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 288
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 289 GYGPLKAHPFFESVT 303

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 111 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 170 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 229 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 284 GYGPLKAHPFFESVT 298

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 109 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 167
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 168 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 227 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 281
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 282 GYGPLKAHPFFESVT 296

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 88  LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 146
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 147 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 205
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 206 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 260
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 261 GYGPLKAHPFFESVT 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 112 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 170
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 171 H-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 230 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 284
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 285 GYGPLKAHPFFESVT 299

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 89  LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 147
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 148 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 206
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 207 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 261
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 262 GYGPLKAHPFFESVT 276

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 112 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 170
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 171 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 230 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 284
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 285 GYGPLKAHPFFESVT 299

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 111 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 170 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP +     RD ++K L  +  +R  C++  
Sbjct: 229 AGLPPFRAGNEYLIFQKIIKLEYD-----FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 284 GYGPLKAHPFFESVT 298

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 9/191 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 111 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 169
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 170 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 173 TGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ------ 226
            G P +   G   L           FP +     RD ++K L  +  +R  C++      
Sbjct: 229 AGLPPFRA-GNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287
Query: 227 LLKHPFLQSVS 237
           L  HPF +SV+
Sbjct: 288 LKAHPFFESVT 298

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 20/197 (10%)
Query: 51  LHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV- 108
           L LE + GG + D LA   +   DE T       I+  + YLHS+ I H D+K +N+++ 
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEAT--QFLKQILDGVHYLHSKRIAHFDLKPENIMLL 163
Query: 109 ---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
               PN   +KL DFG A +    +         G+P ++APE+V  E  G E+D+WS+G
Sbjct: 164 DKNVPNPR-IKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIG 219
Query: 166 CTIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPG 219
                +++G  P   +    TL+ I      F +E   + + +SEL +DF+ + L ++P 
Sbjct: 220 VITYILLSGASPFLGETKQETLTNISAVNYDFDEE---YFSNTSELAKDFIRRLLVKDPK 276
Query: 220 ERWSCDQLLKHPFLQSV 236
            R    Q L+H +++++
Sbjct: 277 RRMXIAQSLEHSWIKAI 293

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY  GG V D     +    E   R+    IVSA++Y H + IVH D+K +N+L+  
Sbjct: 90  LVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 148
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTI 168
           + + +K+ADFG + E T     G K+    GSP + APE+ +G +  GPE DVWSLG  +
Sbjct: 149 DMN-IKIADFGFSNEFTF----GNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             +V+G   ++      L       +  R P   S    + L K L   P +R + +Q++
Sbjct: 204 YTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262
Query: 229 K 229
           K
Sbjct: 263 K 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY  GG V D     +    E   R+    IVSA++Y H + IVH D+K +N+L+  
Sbjct: 90  LVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 148
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTI 168
           + + +K+ADFG + E T     G K+    GSP + APE+ +G +  GPE DVWSLG  +
Sbjct: 149 DMN-IKIADFGFSNEFTF----GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             +V+G   ++      L       +  R P   S    + L K L   P +R + +Q++
Sbjct: 204 YTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262
Query: 229 K 229
           K
Sbjct: 263 K 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY  GG V D     +    E   R+    IVSA++Y H + IVH D+K +N+L+  
Sbjct: 90  LVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 148
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTI 168
           + + +K+ADFG + E T     G K+    GSP + APE+ +G +  GPE DVWSLG  +
Sbjct: 149 DMN-IKIADFGFSNEFTF----GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             +V+G   ++      L       +  R P   S    + L K L   P +R + +Q++
Sbjct: 204 YTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262
Query: 229 K 229
           K
Sbjct: 263 K 263

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY  GG V D     +    E   R+    IVSA++Y H + IVH D+K +N+L+  
Sbjct: 90  LVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 148
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTI 168
           + + +K+ADFG + E T     G K+    GSP + APE+ +G +  GPE DVWSLG  +
Sbjct: 149 DMN-IKIADFGFSNEFTF----GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             +V+G   ++      L       +  R P   S    + L K L   P +R + +Q++
Sbjct: 204 YTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262
Query: 229 K 229
           K
Sbjct: 263 K 263

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           L Y   G +      + ++ DE   R +T  IVSAL+YLH + I+H D+K +N+L+  + 
Sbjct: 114 LSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM 172
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +++ DFG A   +    +       G+  +++PE++  +     SD+W+LGC I ++V
Sbjct: 173 H-IQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 231
Query: 173 TGKPAW----EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ-- 226
            G P +    E      + ++ +      FP       RD ++K L  +  +R  C++  
Sbjct: 232 AGLPPFRAGNEYLIFQKIIKLEYD-----FPAAFFPKARDLVEKLLVLDATKRLGCEEME 286
Query: 227 ----LLKHPFLQSVS 237
               L  HPF +SV+
Sbjct: 287 GYGPLKAHPFFESVT 301

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 39/267 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDV------------SYEA 41
            ++  K +G+GSFG V +A  +     FA          + DDV            ++E 
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 42  PT------TSSSCRNLH--LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYL 91
           P       T  +  NL   +EYL GG   DL   + +       R+  Y   I+  L++L
Sbjct: 78  PFLTHMFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           HS+ IV+ D+K  N+L+  +   +K+ADFG   E  + D +       G+P ++APE++ 
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFC--GTPDYIAPEILL 191
Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
           G+      D WS G  + EM+ G+  +       L      D  P +P    +  +D L 
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLV 250
Query: 212 KCLRREPGERWSCD-QLLKHPFLQSVS 237
           K   REP +R      + +HP  + ++
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 39/262 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDV------------SYEAPT--- 43
           K +G+GSFG V +A  +     FA          + DDV            ++E P    
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 44  ---TSSSCRNLH--LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
              T  +  NL   +EYL GG   DL   + +       R+  Y   I+  L++LHS+ I
Sbjct: 84  MFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 140
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           V+ D+K  N+L+  +   +K+ADFG   E  + D +  +    G+P ++APE++ G+   
Sbjct: 141 VYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFC--GTPDYIAPEILLGQKYN 197
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
              D WS G  + EM+ G+  +       L      D  P +P    +  +D L K   R
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVR 256
Query: 217 EPGERWSCD-QLLKHPFLQSVS 237
           EP +R      + +HP  + ++
Sbjct: 257 EPEKRLGVRGDIRQHPLFREIN 278

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSR 94
           V+      + +  +L L+Y+ GG   +L T L+            Y   IV AL++LH  
Sbjct: 122 VTLHYAFQTETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
            I++ D+K +N+L+  N   V L DFG + E  V+D         G+  +MAP++VRG  
Sbjct: 179 GIIYRDIKLENILLDSNGHVV-LTDFGLSKEF-VADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 155 QGPESDV--WSLGCTIIEMVTG-KPAWEDFGANT---LSRIGFSDELPRFPTQSSELGRD 208
            G +  V  WSLG  + E++TG  P   D   N+   +SR     E P +P + S L +D
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSALAKD 295
Query: 209 FLDKCLRREPGERWSC-----DQLLKHPFLQSVSPSD 240
            + + L ++P +R  C     D++ +H F Q ++  D
Sbjct: 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 332

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EY  GG V D     +    E   R+    IVSA++Y H + IVH D+K +N+L+  
Sbjct: 90  LVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDA 148
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTI 168
           + + +K+ADFG + E T     G K+    G+P + APE+ +G +  GPE DVWSLG  +
Sbjct: 149 DMN-IKIADFGFSNEFTF----GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
             +V+G   ++      L       +  R P   S    + L K L   P +R + +Q++
Sbjct: 204 YTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262
Query: 229 K 229
           K
Sbjct: 263 K 263

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 129
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKXFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 20/196 (10%)
Query: 51  LHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV- 108
           L LE + GG + D LA   +   DE T       I+  + YLHS+ I H D+K +N+++ 
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEAT--QFLKQILDGVHYLHSKRIAHFDLKPENIMLL 149
Query: 109 ---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
               PN   +KL DFG A +    +         G+P ++APE+V  E  G E+D+WS+G
Sbjct: 150 DKNVPNPR-IKLIDFGIAHKIEAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIG 205
Query: 166 CTIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPG 219
                +++G  P   +    TL+ I      F +E   + + +SEL +DF+ + L ++P 
Sbjct: 206 VITYILLSGASPFLGETKQETLTNISAVNYDFDEE---YFSNTSELAKDFIRRLLVKDPK 262
Query: 220 ERWSCDQLLKHPFLQS 235
            R    Q L+H ++++
Sbjct: 263 RRMXIAQSLEHSWIKA 278

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 134
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 135 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKXFC-GTPEYLAPEVLEDNDYGRAV 191
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 192 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 250
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 251 QRLGGGPSDAKEVMEHRFFLSINWQDV 277

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 129
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 129
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 129
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKXFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 227
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 171
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 172 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 230
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q
Sbjct: 231 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 132
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 133 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 189
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 190 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 248
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 249 QRLGGGPSDAKEVMEHRFFLSINWQDV 275

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 116/267 (43%), Gaps = 45/267 (16%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLE------------- 54
           + IG+G+F  V   ++R  G  FA    DV+    +   S  +L  E             
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 55  -----YLPGGTV---------SDLATTLNAYAD------EITLRSHTYCIVSALKYLHSR 94
                Y   G +         +DL   +   AD      E     +   I+ AL+Y H  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 95  NIVHCDVKGKNVLVGP--NSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV 149
           NI+H DVK +NVL+    NS+ VKL DFG A   GE+ +    G ++   G+P +MAPEV
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRV---GTPHFMAPEV 204
Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGR 207
           V+ E  G   DVW  G  +  +++G   +          I  G     PR  +  SE  +
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
           D + + L  +P ER +  + L HP+L+
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 246
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 24/188 (12%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 167
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 168 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 226
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q +    
Sbjct: 227 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ-IQTHP 282
Query: 241 ANTVAESS 248
            N +A+ +
Sbjct: 283 VNQMAKGT 290

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           R +    L+HP+   + P D      S+      W + +FE+
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQQALSSA------WSHPQFEK 295

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 274
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           R +    L+HP+   + P D      S+      W + +FE+
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQQALSSA------WSHPQFEK 295

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 274
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 83  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 141
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 142 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 172 VTGK-----PAWEDFGANTLSRIGFSDEL-----PRFPTQSSELG-RDFLDKCLRREPGE 220
             G+     P  ++     ++     D +     P+ P+    L  +DF++KCL + P E
Sbjct: 197 AVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 256
Query: 221 RWSCDQLLKHPFLQSVSPSDANTV 244
           R    QL+ H F++    SDA  V
Sbjct: 257 RADLKQLMVHAFIKR---SDAEEV 277

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 23/174 (13%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +     T  VK  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 274
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           R +    L+HP+   + P D      S+      W + +FE+
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQQALSSA------WSHPQFEK 295

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 120/267 (44%), Gaps = 38/267 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--------LGDDVSYEAPTTSSSCRNLH------- 52
           K +G+G+FG V +  ++  G  +A         +  D      T S   +N         
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                        +EY  GG +    +    + +E   R +   IVSAL+YLHSR++V+ 
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSALEYLHSRDVVYR 129
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+++  +   +K+ DFG   E  +SD   +K    G+P ++APEV+     G   
Sbjct: 130 DIKLENLMLDKDGH-IKITDFGLCKEG-ISDGATMKXFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L   L+++P 
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAGLLKKDPK 245
Query: 220 ERW-----SCDQLLKHPFLQSVSPSDA 241
           +R         ++++H F  S++  D 
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDV 272

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 91/168 (54%), Gaps = 15/168 (8%)
Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQ 137
           +T  IVS L++LH RNI++ D+K +NVL+  + + V+++D G A E  A  + T+G    
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA-- 350
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDE 194
             G+P +MAPE++ GE      D ++LG T+ EM+  +  +   G    N   +    ++
Sbjct: 351 --GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 195 LPRFPTQSSELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVS 237
              +P + S   +DF +  L+++P +R      SCD L  HP  + +S
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 91/168 (54%), Gaps = 15/168 (8%)
Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQ 137
           +T  IVS L++LH RNI++ D+K +NVL+  + + V+++D G A E  A  + T+G    
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA-- 350
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDE 194
             G+P +MAPE++ GE      D ++LG T+ EM+  +  +   G    N   +    ++
Sbjct: 351 --GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 195 LPRFPTQSSELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVS 237
              +P + S   +DF +  L+++P +R      SCD L  HP  + +S
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 91/168 (54%), Gaps = 15/168 (8%)
Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQ 137
           +T  IVS L++LH RNI++ D+K +NVL+  + + V+++D G A E  A  + T+G    
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA-- 350
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDE 194
             G+P +MAPE++ GE      D ++LG T+ EM+  +  +   G    N   +    ++
Sbjct: 351 --GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 195 LPRFPTQSSELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVS 237
              +P + S   +DF +  L+++P +R      SCD L  HP  + +S
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 261
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           R +    L+HP+   + P D      S+      W + +FE+
Sbjct: 262 RMTIQDSLQHPW---IKPKDTQQALSSA------WSHPQFEK 294

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 204
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 205 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 261
Query: 221 RWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
           R +    L+HP+++      A + A S P+
Sbjct: 262 RMTIQDSLQHPWIKPKDTQQALSSAWSHPQ 291

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 91/168 (54%), Gaps = 15/168 (8%)
Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQ 137
           +T  IVS L++LH RNI++ D+K +NVL+  + + V+++D G A E  A  + T+G    
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYA-- 350
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDE 194
             G+P +MAPE++ GE      D ++LG T+ EM+  +  +   G    N   +    ++
Sbjct: 351 --GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
Query: 195 LPRFPTQSSELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVS 237
              +P + S   +DF +  L+++P +R      SCD L  HP  + +S
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 16/192 (8%)
Query: 58  GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF-VK 116
            G++     +L+    E  + +    I SAL YLH++ I H D+K +N L   N SF +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 117 LADFGAAGE---ATVSDTRGVKIQPRGSPLWMAPEVVR--GECQGPESDVWSLGCTIIEM 171
           L DFG + E       +  G+  +  G+P ++APEV+    E  GP+ D WS G  +  +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 172 VTGK---PAWEDFGANTLSRI---GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCD 225
           + G    P   D  A+T+S++       E P +   S  L RD L   L R   ER+   
Sbjct: 270 LMGAVPFPGVND--ADTISQVLNKKLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAM 326
Query: 226 QLLKHPFLQSVS 237
           + L+HP++   S
Sbjct: 327 RALQHPWISQFS 338

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++    + DL    N   D   ++ + + I++ + + HS NI+H D+K +N+LV  
Sbjct: 101 LVFEFVDHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS- 158
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTII 169
            S  VKL DFG A   T++    V      +  + APE++ G+ + G   DVW++GC + 
Sbjct: 159 QSGVVKLCDFGFA--RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216
Query: 170 EMVTGKPAW------------------------EDFGAN------TLSRIGFSDELPRFP 199
           EM  G+P +                        E F  N       L  I   + L R  
Sbjct: 217 EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY 276
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
            + SE+  D   KCL  +P +R  C +LL H F Q
Sbjct: 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 123/264 (46%), Gaps = 41/264 (15%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAY-------------LGDD------------V 37
           +++  + +G G+F  V +   R  G +FA              L ++            V
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSR 94
           + E    S++   L ++ + GG + D       Y ++   + ++     ++SA+KYLH  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----VLSAVKYLHEN 125
Query: 95  NIVHCDVKGKNVL-VGPN-SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG 152
            IVH D+K +N+L + P  +S + + DFG +      +  G+     G+P ++APEV+  
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI--GFSDELPRFPTQSSELGRDF 209
           +      D WS+G     ++ G P  +E+  +    +I  G+ +    F    SE  +DF
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 210 LDKCLRREPGERWSCDQLLKHPFL 233
           +   L ++P ER++C++ L HP++
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWI 265

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 89/178 (50%), Gaps = 9/178 (5%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY  GG V D     +    E   R+    IVSA++Y H + IVH D+K +N+L+  + +
Sbjct: 93  EYASGGEVFDYLVA-HGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXN 151
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEM 171
            +K+ADFG + E T     G K+    G+P + APE+ +G +  GPE DVWSLG  +  +
Sbjct: 152 -IKIADFGFSNEFTF----GNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 206
Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
           V+G   ++      L       +  R P   S    + L K L   P +R + +Q+ K
Sbjct: 207 VSGSLPFDGQNLKELRERVLRGKY-RIPFYXSTDCENLLKKFLILNPSKRGTLEQIXK 263

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 21/202 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPAFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDAN 242
           R +    L+HP+++   P D  
Sbjct: 263 RMTIQDSLQHPWIK---PKDTQ 281

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 24/188 (12%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           +S+   ++ A+  +H   IVH D+K  N L+      +KL DFG A +        VK  
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDXXXVVKDS 187
Query: 138 PRGSPLWMAPEVVRGECQGPES-----------DVWSLGCTIIEMVTGKPAWEDFGANTL 186
             G+  +M PE ++      E+           DVWSLGC +  M  GK  ++    N +
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQI 246
Query: 187 SRI------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
           S++          E P  P +  +   D L  CL+R+P +R S  +LL HP++Q +    
Sbjct: 247 SKLHAIIDPNHEIEFPDIPEKDLQ---DVLKCCLKRDPKQRISIPELLAHPYVQ-IQTHP 302
Query: 241 ANTVAESS 248
            N +A+ +
Sbjct: 303 VNQMAKGT 310

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 97/189 (51%), Gaps = 26/189 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS---SFVKLADFGAAGEATV-SDTRGVKIQPR 139
           I++ + YLHS  I H D+K +N+++   +     +K+ DFG A +    ++ + +     
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----F 178
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIG-----FSD 193
           G+P ++APE+V  E  G E+D+WS+G     +++G  P   D    TL+ +      F D
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 238
Query: 194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVL 253
           E   + + +S L +DF+ + L ++P +R +    L+HP+   + P D      S+     
Sbjct: 239 E---YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW---IKPKDTQQALSSA----- 287
Query: 254 DWVNSEFEE 262
            W + +FE+
Sbjct: 288 -WSHPQFEK 295

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 114/270 (42%), Gaps = 40/270 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY--LGDDVSYEAPTTS---------SSCRN------ 50
           + +G+GSFG V +A  +  GD++A   L  DV  +              S  RN      
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 51  ------------LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                         +E++ GG +       +   DE   R +   I+SAL +LH + I++
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEIISALMFLHDKGIIY 147
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K  NVL+  +    KLADFG   E   +          G+P ++APE+++    GP 
Sbjct: 148 RDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFC--GTPDYIAPEILQEMLYGPA 204
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W++G  + EM+ G   +E    + L     +DE+  +PT   E     L   + + P
Sbjct: 205 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFMTKNP 263
Query: 219 GERWSC------DQLLKHPFLQSVSPSDAN 242
             R           +L+HPF + +  +  N
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFKEIDWAQLN 293

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDAN 242
           R +    L+HP+   + P D  
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQ 281

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDAN 242
           R +    L+HP+   + P D  
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQ 281

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDAN 242
           R +    L+HP+   + P D  
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQ 281

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 118/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 33  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 88  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 147
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A E +         Q  GS LWMAPEV+R + + P 
Sbjct: 148 RDLKSNNIFLHEDLT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 264
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 265 LMAECLKKKRDERPLFPQIL 284

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 118/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 96  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 155
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A E +         Q  GS LWMAPEV+R + + P 
Sbjct: 156 RDLKSNNIFLHEDLT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 273 LMAECLKKKRDERPLFPQIL 292

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQSVSPSDAN 242
           R +    L+HP+   + P D  
Sbjct: 263 RMTIQDSLQHPW---IKPKDTQ 281

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 91/196 (46%), Gaps = 35/196 (17%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTT----------------------- 44
           K IG+G+F  V +A     G   A    D +   PT+                       
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 45  ----SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               +     L +EY  GG V D     +    E   R+    IVSA++Y H + IVH D
Sbjct: 81  EVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQKYIVHRD 139
Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG-ECQGPE 158
           +K +N+L+  + + +K+ADFG + E TV    G K+    GSP + APE+ +G +  GPE
Sbjct: 140 LKAENLLLDGDMN-IKIADFGFSNEFTV----GNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 159 SDVWSLGCTIIEMVTG 174
            DVWSLG  +  +V+G
Sbjct: 195 VDVWSLGVILYTLVSG 210

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQ 234
           R +    L+HP+++
Sbjct: 263 RMTIQDSLQHPWIK 276

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 118/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 68  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A E +         Q  GS LWMAPEV+R + + P 
Sbjct: 128 RDLKSNNIFLHEDLT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 245 LMAECLKKKRDERPLFPQIL 264

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 99/194 (51%), Gaps = 18/194 (9%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            +     +K+ DFG A +    ++ + +     G+P ++APE+V  E  G E+D+WS+G 
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGV 205
Query: 167 TIIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGE 220
               +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +
Sbjct: 206 ITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKK 262
Query: 221 RWSCDQLLKHPFLQ 234
           R +    L+HP+++
Sbjct: 263 RMTIQDSLQHPWIK 276

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG--EATVSDTRGVKIQPRGS 141
           I  ALK++H R I+H D+K +N+ +  + + V+L DFG A    +TV   R       G+
Sbjct: 134 ICLALKHVHDRKILHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTVELARACI----GT 188
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ 201
           P +++PE+   +    +SD+W+LGC + E+ T K A+E      L     S   P     
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLH 248
Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            S   R  + +  +R P +R S + +L+  F+
Sbjct: 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 117/258 (45%), Gaps = 42/258 (16%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYC----------------IVSALKYLHSRNIVH 98
              G + +     +  + +  +L  H +                     + YLH+++I+H
Sbjct: 84  LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  +++ VK+ DFG A E +         Q  GS LWMAPEV+R +   P 
Sbjct: 144 RDLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFG-----ANTLSRIGFSDELPRFPTQSSELGRDFL 210
             +SDV++ G  + E++TG+  + +          + R   S +L +  +   +  +  +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262
Query: 211 DKCLRREPGERWSCDQLL 228
            +CL+++  ER S  ++L
Sbjct: 263 AECLKKKRDERPSFPRIL 280

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L LE + GG + D      +  +E         I++ + YLHS  I H D+K +N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEE-EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149
Query: 111 NS---SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCT 167
            +     +K+ DFG A +    +         G+P ++APE+V  E  G E+D+WS+G  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 168 IIEMVTG-KPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              +++G  P   D    TL+ +      F DE   + + +S L +DF+ + L ++P +R
Sbjct: 207 TYILLSGASPFLGDTKQETLANVSAVNYEFEDE---YFSNTSALAKDFIRRLLVKDPKKR 263
Query: 222 WSCDQLLKHPFLQSVSPSDAN 242
            +    L+HP+   + P D  
Sbjct: 264 MTIQDSLQHPW---IKPKDTQ 281

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 116/258 (44%), Gaps = 42/258 (16%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYC----------------IVSALKYLHSRNIVH 98
              G +       +  + +  +L  H +                     + YLH+++I+H
Sbjct: 84  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  +++ VK+ DFG A E +         Q  GS LWMAPEV+R +   P 
Sbjct: 144 RDLKSNNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFG-----ANTLSRIGFSDELPRFPTQSSELGRDFL 210
             +SDV++ G  + E++TG+  + +          + R   S +L +  +   +  +  +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 262
Query: 211 DKCLRREPGERWSCDQLL 228
            +CL+++  ER S  ++L
Sbjct: 263 AECLKKKRDERPSFPRIL 280

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 55/286 (19%)
Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
           APT         + +L G  +  L  T +   D I      Y I+  LKY+HS N++H D
Sbjct: 112 APTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC--YFLYQILRGLKYIHSANVLHRD 169
Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           +K  N+L+      +K+ DFG A  A    D  G   +   +  + APE++       +S
Sbjct: 170 LKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKS 228
Query: 160 -DVWSLGCTIIEM---------------------VTGKPAWEDF-------GANTLSRIG 190
            D+WS+GC + EM                     + G P+ ED          N L  + 
Sbjct: 229 IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 288
Query: 191 FSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL-QSVSPSDANTVAE 246
             +++P    FP   S+   D LDK L   P +R   +Q L HP+L Q   PSD   +AE
Sbjct: 289 HKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD-EPIAE 346
Query: 247 SSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGAIWEP 292
           +  +                 D +L+   +E++ +L     A ++P
Sbjct: 347 APFKF----------------DMELDDLPKEKLKELIFEETARFQP 376

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 46/274 (16%)
Query: 9   CIGRGSFGTVNVAVDRFNGDVFAY-LGDDVSYEAPTTSSSCRNLHL-------------- 53
            +G+GSFG V    DR     +A  + +  S +   TS+  R + L              
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 54  ------------EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                       E   GG + D       +++    R     + S + Y+H  NIVH D+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHKHNIVHRDL 147
Query: 102 KGKNVLVGPNSS--FVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPE 158
           K +N+L+        +K+ DFG +        +  K++ R G+  ++APEV+RG     +
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLS----TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDELPRFPTQSSELGRDFLDK 212
            DVWS G  +  +++G P +  +G N    L R+    ++ +LP++ T S +  +D + K
Sbjct: 203 CDVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDD-AKDLIRK 259
Query: 213 CLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
            L   P  R +  Q L+HP++Q  S S+  T+++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYS-SETPTISD 292

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 45/267 (16%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAY-LGDDVSYEAPTTSSSCRNLHL--------------- 53
           +G+GSFG V    DR     +A  + +  S +   TS+  R + L               
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 54  -----------EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
                      E   GG + D       +++    R     + S + Y+H  NIVH D+K
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHKHNIVHRDLK 148
Query: 103 GKNVLVGPNSS--FVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPES 159
            +N+L+        +K+ DFG +        +  K++ R G+  ++APEV+RG     + 
Sbjct: 149 PENILLESKEKDCDIKIIDFGLS----TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKC 203
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDELPRFPTQSSELGRDFLDKC 213
           DVWS G  +  +++G P +  +G N    L R+    ++ +LP++ T S +  +D + K 
Sbjct: 204 DVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDD-AKDLIRKM 260
Query: 214 LRREPGERWSCDQLLKHPFLQSVSPSD 240
           L   P  R +  Q L+HP++Q  S  +
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSEE 287

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 105/253 (41%), Gaps = 29/253 (11%)
Query: 2   VSWVRGKC-IGRGSFGTVNVAVDRFNGDVFA--------YLGDDVSYEAPTTSSSCR--- 49
           V W   +  +GRGSFG V+   D+  G   A        +  +++   A  TS       
Sbjct: 73  VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLY 132
Query: 50  ---------NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
                    N+ +E L GG++  L        ++  L  +    +  L+YLHSR I+H D
Sbjct: 133 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRAL-YYLGQALEGLEYLHSRRILHGD 191
Query: 101 VKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           VK  NVL+  + S   L DFG A     +    D       P G+   MAPEVV G    
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP-GTETHMAPEVVLGRSCD 250
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDFLDKCL 214
            + DVWS  C ++ M+ G   W  F    L     S+  P    P   + L    + + L
Sbjct: 251 AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGL 310
Query: 215 RREPGERWSCDQL 227
           R+EP  R S  +L
Sbjct: 311 RKEPIHRVSAAEL 323

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+   S  +K+ DFG A  A    D  G   +   
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTSD-LKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 252 EDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 310
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 311 AHPYLAQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 353
Query: 288 AIWEP 292
           A ++P
Sbjct: 354 ARFQP 358

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 106/262 (40%), Gaps = 47/262 (17%)
Query: 2   VSWVRGKC-IGRGSFGTVNVAVDRFNGDVFA--------YLGDDVSYEAPTTSSSCR--- 49
           V W   +  +GRGSFG V+   D+  G   A        +  +++   A  TS       
Sbjct: 92  VHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLY 151
Query: 50  ---------NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
                    N+ +E L GG++  L        ++  L  +    +  L+YLHSR I+H D
Sbjct: 152 GAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRAL-YYLGQALEGLEYLHSRRILHGD 210
Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-------------GSPLWMAP 147
           VK  NVL+  + S   L DFG A          V +QP              G+   MAP
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHA----------VCLQPDGLGKSLLTGDYIPGTETHMAP 260
Query: 148 EVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSEL 205
           EVV G     + DVWS  C ++ M+ G   W  F    L     S+  P    P   + L
Sbjct: 261 EVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPL 320
Query: 206 GRDFLDKCLRREPGERWSCDQL 227
               + + LR+EP  R S  +L
Sbjct: 321 TAQAIQEGLRKEPIHRVSAAEL 342

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 118/264 (44%), Gaps = 45/264 (17%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAY-LGDDVSYEAPTTSSSCRNLHL--------------- 53
           +G+GSFG V    DR     +A  + +  S +   TS+  R + L               
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 54  -----------EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
                      E   GG + D       +++    R     + S + Y+H  NIVH D+K
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHKHNIVHRDLK 148
Query: 103 GKNVLVGPNSS--FVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPES 159
            +N+L+        +K+ DFG +        +  K++ R G+  ++APEV+RG     + 
Sbjct: 149 PENILLESKEKDCDIKIIDFGLS----TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKC 203
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDELPRFPTQSSELGRDFLDKC 213
           DVWS G  +  +++G P +  +G N    L R+    ++ +LP++ T S +  +D + K 
Sbjct: 204 DVWSAGVILYILLSGTPPF--YGKNEYDILKRVETGKYAFDLPQWRTISDD-AKDLIRKM 260
Query: 214 LRREPGERWSCDQLLKHPFLQSVS 237
           L   P  R +  Q L+HP++Q  S
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYS 284

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 118/272 (43%), Gaps = 39/272 (14%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEA----PTTSS 46
           G+ +G+G FG V +A ++ N  + A                 L  ++  ++    P    
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 79
Query: 47  SCRNLH--------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
                H        LE+ P G   +L   L  +      RS T+   +  AL Y H R +
Sbjct: 80  MYNYFHDRKRIYLMLEFAPRG---ELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 136
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G     +K+ADFG +  A     R +     G+  ++ PE++ G+   
Sbjct: 137 IHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHD 191
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
            + D+W  G    E + G P ++        R   + +L +FP   S+  +D + K LR 
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISKLLRY 250
Query: 217 EPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
            P +R     +++HP++++ S      V +S+
Sbjct: 251 HPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 282

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EDFGA-------NTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 308
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 309 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 351
Query: 288 AIWEP 292
           A ++P
Sbjct: 352 ARFQP 356

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G + +     +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 68  LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 128 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 245 LMAECLKKKRDERPLFPQIL 264

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 40  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 95  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 154
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 155 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 271
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 272 LMAECLKKKRDERPLFPQIL 291

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 96  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 155
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 156 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 273 LMAECLKKKRDERPLFPQIL 292

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 127/307 (41%), Gaps = 70/307 (22%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDR--------------FNGDVFA-------YLGDDVSYE- 40
           ++V    +G G++G+V  A+D+              F  ++FA        L   + +E 
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 41  ------APTTSSSCRNLHLEYLPGGTV-SDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                   T +SS RN +  YL    + +DL   +     E  ++   Y ++  LKY+HS
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS 162
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             +VH D+K  N+ V  +   +K+ DFG A  A    T  V  +      + APEV+   
Sbjct: 163 AGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSW 216
Query: 154 CQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRI----------------------- 189
               ++ D+WS+GC + EM+TGK  ++  G + L ++                       
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGKTLFK--GKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274
Query: 190 -GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             +   LP+ P +        +S    D L+K L  +  +R +  Q L HPF +     +
Sbjct: 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334
Query: 241 ANTVAES 247
             T A+ 
Sbjct: 335 EETEAQQ 341

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 32/198 (16%)
Query: 80  HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR 139
           + Y +  A+ ++HS  I H D+K +N+LV    + +KL DFG+A +   S+     I  R
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSR 205
Query: 140 GSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP- 196
               + APE++ G  +  P  D+WS+GC   E++ GKP +  +   + L RI      P 
Sbjct: 206 ---FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 197 --------------RFPTQSSE------------LGRDFLDKCLRREPGERWSCDQLLKH 230
                         RFPT  ++            L  D L++ LR EP  R +  + + H
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322
Query: 231 PFLQSVSPSDANTVAESS 248
           PF   +  S  + V  +S
Sbjct: 323 PFFDHLRNSYESEVKNNS 340

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 18  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 73  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 132
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 133 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 250 LMAECLKKKRDERPLFPQIL 269

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 127/307 (41%), Gaps = 70/307 (22%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDR--------------FNGDVFA-------YLGDDVSYE- 40
           ++V    +G G++G+V  A+D+              F  ++FA        L   + +E 
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 41  ------APTTSSSCRNLHLEYLPGGTV-SDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                   T +SS RN +  YL    + +DL   +     E  ++   Y ++  LKY+HS
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             +VH D+K  N+ V  +   +K+ DFG A  A    T  V  +      + APEV+   
Sbjct: 145 AGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSW 198
Query: 154 CQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRI----------------------- 189
               ++ D+WS+GC + EM+TGK  ++  G + L ++                       
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFK--GKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 190 -GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             +   LP+ P +        +S    D L+K L  +  +R +  Q L HPF +     +
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316
Query: 241 ANTVAES 247
             T A+ 
Sbjct: 317 EETEAQQ 323

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EDFGA-------NTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 250 EDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 308
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 309 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 351
Query: 288 AIWEP 292
           A ++P
Sbjct: 352 ARFQP 356

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 123/297 (41%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 42  PTTSSSCRNLHLE---YLPGGTV-SDLATTLNAYA----DEITLRSHTYCIVSALKYLHS 93
           P        +H E   YL    V  DL T ++A A        ++S+ + ++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 173
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 18  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 73  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 132
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 133 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 250 LMAECLKKKRDERPLFPQIL 269

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 68  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 127
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 128 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 245 LMAECLKKKRDERPLFPQIL 264

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 117/260 (45%), Gaps = 46/260 (17%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 15  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCI----------------VSALKYLHSRNIVH 98
              G +       +  + +  +L  H + I                   + YLH+++I+H
Sbjct: 70  LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH 129
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P 
Sbjct: 130 RDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRD 208
             +SDV++ G  + E++TG+  + +   N   +I F       S +L +  +   +  + 
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNI--NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 246
Query: 209 FLDKCLRREPGERWSCDQLL 228
            + +CL+++  ER    Q+L
Sbjct: 247 LMAECLKKKRDERPLFPQIL 266

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 15/159 (9%)
Query: 84  IVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           IV AL++LHS+ +++H DVK  NVL+      VK+ DFG +G    S  + +     G  
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDSVAKTID---AGCK 217
Query: 143 LWMAPEVVRGECQGP----ESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELP 196
            +MAPE +  E        +SD+WSLG T+IE+   +  ++ +G     L ++   +  P
Sbjct: 218 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSP 276
Query: 197 RFPTQ--SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + P    S+E   DF  +CL++   ER +  +L++HPF 
Sbjct: 277 QLPADKFSAEF-VDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 308
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 309 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 351
Query: 288 AIWEP 292
           A ++P
Sbjct: 352 ARFQP 356

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 312
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 313 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 355
Query: 288 AIWEP 292
           A ++P
Sbjct: 356 ARFQP 360

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 93  LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 152 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 206 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 262 DPKARFTTEEALRHPWLQ 279

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNIVHCDVKGKNVLV 108
           L LE+ P G   +L   L  +      RS T+   +  AL Y H R ++H D+K +N+L+
Sbjct: 91  LMLEFAPRG---ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM 147
Query: 109 GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
           G     +K+ADFG +  A     R +     G+  ++ PE++ G+    + D+W  G   
Sbjct: 148 GYKGE-LKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            E + G P ++        R   + +L +FP   S+  +D + K LR  P +R     ++
Sbjct: 203 YEFLVGMPPFDSPSHTETHRRIVNVDL-KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVM 261
Query: 229 KHPFLQSVSPSDANTVAESS 248
           +HP++++ S      V +S+
Sbjct: 262 EHPWVKANSRRVLPPVYQST 281

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTXD-LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 312
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 313 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 355
Query: 288 AIWEP 292
           A ++P
Sbjct: 356 ARFQP 360

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 93  LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 152 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 206 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 262 DPKARFTTEEALRHPWLQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 93  LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 152 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 206 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 262 DPKARFTTEEALRHPWLQ 279

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/258 (23%), Positives = 115/258 (44%), Gaps = 42/258 (16%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS------------SCRNLHLE 54
           G+ IG GSFGTV     +++GDV   +   ++  APT                 R++++ 
Sbjct: 17  GQRIGSGSFGTVYKG--KWHGDVAVKM---LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYC----------------IVSALKYLHSRNIVH 98
              G +       +  + +  +L  H +                     + YLH+++I+H
Sbjct: 72  LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 131
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP- 157
            D+K  N+ +  +++ VK+ DFG A   +         Q  GS LWMAPEV+R +   P 
Sbjct: 132 RDLKSNNIFLHEDNT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 158 --ESDVWSLGCTIIEMVTGKPAWEDFG-----ANTLSRIGFSDELPRFPTQSSELGRDFL 210
             +SDV++ G  + E++TG+  + +          + R   S +L +  +   +  +  +
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLM 250
Query: 211 DKCLRREPGERWSCDQLL 228
            +CL+++  ER S  ++L
Sbjct: 251 AECLKKKRDERPSFPRIL 268

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 92  LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 150
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 151 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 204
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 205 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 260
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 261 DPKARFTTEEALRHPWLQ 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 99  LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 157
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 158 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 211
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 212 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 267
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 268 DPKARFTTEEALRHPWLQ 285

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 111/262 (42%), Gaps = 37/262 (14%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHL---------------- 53
           IG GSFGTV+ A +    DV   +  +  + A   +   R + +                
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 54  ----------EYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRN--IVHC 99
                     EYL  G++  L     A    DE    S  Y +   + YLH+RN  IVH 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K  N+LV    + VK+ DFG +     S     K    G+P WMAPEV+R E    +S
Sbjct: 164 DLKSPNLLVDKKYT-VKVCDFGLS-RLKASXFLXSKXA-AGTPEWMAPEVLRDEPSNEKS 220
Query: 160 DVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
           DV+S G  + E+ T +  W +   A  ++ +GF  +    P   +      ++ C   EP
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEP 280
Query: 219 GERWSCDQL--LKHPFLQSVSP 238
            +R S   +  L  P ++S  P
Sbjct: 281 WKRPSFATIMDLLRPLIKSAVP 302

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 232 LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 290
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 291 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 344
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 345 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 400
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 401 DPKARFTTEEALRHPWLQ 418

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 312
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 313 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 355
Query: 288 AIWEP 292
           A ++P
Sbjct: 356 ARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 255 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 313
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 314 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 356
Query: 288 AIWEP 292
           A ++P
Sbjct: 357 ARFQP 361

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 252 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 310
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 311 AHPYLAQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 353
Query: 288 AIWEP 292
           A ++P
Sbjct: 354 ARFQP 358

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 113/264 (42%), Gaps = 41/264 (15%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHL---------------- 53
           IG GSFGTV+ A +    DV   +  +  + A   +   R + +                
Sbjct: 45  IGAGSFGTVHRA-EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 54  ----------EYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRN--IVHC 99
                     EYL  G++  L     A    DE    S  Y +   + YLH+RN  IVH 
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 100 DVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           ++K  N+LV    + VK+ DFG +    +T   ++       G+P WMAPEV+R E    
Sbjct: 164 NLKSPNLLVDKKYT-VKVCDFGLSRLKASTFLSSKSAA----GTPEWMAPEVLRDEPSNE 218
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
           +SDV+S G  + E+ T +  W +   A  ++ +GF  +    P   +      ++ C   
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 278
Query: 217 EPGERWSCDQL--LKHPFLQSVSP 238
           EP +R S   +  L  P ++S  P
Sbjct: 279 EPWKRPSFATIMDLLRPLIKSAVP 302

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 308
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 309 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 351
Query: 288 AIWEP 292
           A ++P
Sbjct: 352 ARFQP 356

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 312
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 313 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 355
Query: 288 AIWEP 292
           A ++P
Sbjct: 356 ARFQP 360

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 27/198 (13%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE + GG + D     N    E T + + Y ++ A++YLH   I+H D+K +NVL+    
Sbjct: 218 LELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 276
Query: 113 S--FVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV---VRGECQGPESDVWSL 164
               +K+ DFG +   GE ++  T        G+P ++APEV   V         D WSL
Sbjct: 277 EDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDE--------LPRFPTQSSELGRDFLDKCLRR 216
           G  +   ++G P + +      +++   D+        +P    + SE   D + K L  
Sbjct: 331 GVILFICLSGYPPFSEHR----TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 386
Query: 217 EPGERWSCDQLLKHPFLQ 234
           +P  R++ ++ L+HP+LQ
Sbjct: 387 DPKARFTTEEALRHPWLQ 404

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 247
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 248 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 306
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 307 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 349
Query: 288 AIWEP 292
           A ++P
Sbjct: 350 ARFQP 354

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 20/196 (10%)
Query: 49  RNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           RN +L  E   GG + D    L     E+        ++S   YLH  NIVH D+K +N+
Sbjct: 77  RNYYLVMEVYRGGELFD-EIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENL 135
Query: 107 LVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWS 163
           L+   S  + +K+ DFG +    V    G K++ R G+  ++APEV+R +    + DVWS
Sbjct: 136 LLESKSRDALIKIVDFGLSAHFEV----GGKMKERLGTAYYIAPEVLRKKYD-EKCDVWS 190
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP------TQSSELGRDFLDKCLRRE 217
            G  +  ++ G P    FG  T   I    E  +F       TQ S+  +  +   L  E
Sbjct: 191 CGVILYILLCGYPP---FGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYE 247
Query: 218 PGERWSCDQLLKHPFL 233
           P +R S ++ L HP++
Sbjct: 248 PSKRISAEEALNHPWI 263

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 136 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 255 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 313
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 314 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 356
Query: 288 AIWEP 292
           A ++P
Sbjct: 357 ARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 137 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 255
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 256 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 314
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 315 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 357
Query: 288 AIWEP 292
           A ++P
Sbjct: 358 ARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 128 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 246
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 247 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 305
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 306 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 348
Query: 288 AIWEP 292
           A ++P
Sbjct: 349 ARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 312
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 313 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 355
Query: 288 AIWEP 292
           A ++P
Sbjct: 356 ARFQP 360

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 139 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 257
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 258 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 316
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 317 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 359
Query: 288 AIWEP 292
           A ++P
Sbjct: 360 ARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 131 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 250 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 308
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 309 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 351
Query: 288 AIWEP 292
           A ++P
Sbjct: 352 ARFQP 356

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 133 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 252 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 310
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 311 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 353
Query: 288 AIWEP 292
           A ++P
Sbjct: 354 ARFQP 358

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 312
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 313 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 355
Query: 288 AIWEP 292
           A ++P
Sbjct: 356 ARFQP 360

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 173
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 270 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 328
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 329 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 371
Query: 288 AIWEP 292
           A ++P
Sbjct: 372 ARFQP 376

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV--GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++S + YLH  NIVH D+K +N+L+      + +K+ DFG +  A   + + +K +  G+
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKMK-ERLGT 201
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ 201
             ++APEV+R +    + DVWS+G  +  ++ G P    FG  T   I    E  ++   
Sbjct: 202 AYYIAPEVLRKKYD-EKCDVWSIGVILFILLAGYPP---FGGQTDQEILRKVEKGKYTFD 257
Query: 202 S------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           S      SE  +D + + L+ +   R S  Q L+HP+++ +
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 106/245 (43%), Gaps = 53/245 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 129 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--------------------- 178
           +  + APE++       +S D+WS+GC + EM++ +P +                     
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQ 247
Query: 179 EDF-------GANTLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           ED          N L  +   +++P    FP   S+   D LDK L   P +R   +Q L
Sbjct: 248 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHKRIEVEQAL 306
Query: 229 KHPFL-QSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERMGKLAGSSG 287
            HP+L Q   PSD   +AE+  +                 D +L+   +E++ +L     
Sbjct: 307 AHPYLEQYYDPSD-EPIAEAPFKF----------------DMELDDLPKEKLKELIFEET 349
Query: 288 AIWEP 292
           A ++P
Sbjct: 350 ARFQP 354

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 15/159 (9%)
Query: 84  IVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           IV AL++LHS+ +++H DVK  NVL+      VK+ DFG +G       + +     G  
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDVAKDID---AGCK 173
Query: 143 LWMAPEVVRGECQGP----ESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELP 196
            +MAPE +  E        +SD+WSLG T+IE+   +  ++ +G     L ++   +  P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPSP 232
Query: 197 RFPTQ--SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + P    S+E   DF  +CL++   ER +  +L++HPF 
Sbjct: 233 QLPADKFSAEF-VDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 34/255 (13%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFA-------------YLGDDVSYEAPTTSSSCRNLH---- 52
           +G G+FG V+  V++  G VF               + +++S           NLH    
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 53  --------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                   LE+L GG + D     +    E  + ++       LK++H  +IVH D+K +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 105 NVLV-GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           N++     +S VK+ DFG A +    +   V      +  + APE+V  E  G  +D+W+
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWA 235
Query: 164 LGCTIIEMVTG-KPAWEDFGANTLSRIGFSD---ELPRFPTQSSELGRDFLDKCLRREPG 219
           +G     +++G  P   +    TL  +   D   +   F + S E  +DF+   L++EP 
Sbjct: 236 IGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE-AKDFIKNLLQKEPR 294
Query: 220 ERWSCDQLLKHPFLQ 234
           +R +    L+HP+L+
Sbjct: 295 KRLTVHDALEHPWLK 309

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 49  RNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           RN +L  E   GG + D    L     E+        ++S   YLH  NIVH D+K +N+
Sbjct: 94  RNYYLVMEVYRGGELFD-EIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENL 152
Query: 107 LVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWS 163
           L+   S  + +K+ DFG +    V    G K++ R G+  ++APEV+R +    + DVWS
Sbjct: 153 LLESKSRDALIKIVDFGLSAHFEV----GGKMKERLGTAYYIAPEVLRKKYD-EKCDVWS 207
Query: 164 LGCTIIEMVTGKPAWEDFGANT----LSRI---GFSDELPRFPTQSSELGRDFLDKCLRR 216
            G  +  ++ G P    FG  T    L R+    FS + P + TQ S+  +  +   L  
Sbjct: 208 CGVILYILLCGYPP---FGGQTDQEILKRVEKGKFSFDPPDW-TQVSDEAKQLVKLMLTY 263
Query: 217 EPGERWSCDQLLKHPFL 233
           EP +R S ++ L HP++
Sbjct: 264 EPSKRISAEEALNHPWI 280

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ ++ ++H  +IVH D+K +N+L+      + VKLADFG A E  V   +       G+
Sbjct: 139 ILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGEQQAWFGFAGT 196
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----GFSDELPR 197
           P +++PEV+R +  G   D+W+ G  +  ++ G P + D   + L +      +    P 
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPE 256
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + T + E  ++ +++ L   P +R + DQ LKHP++
Sbjct: 257 WDTVTPE-AKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 118/275 (42%), Gaps = 55/275 (20%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC------------------- 48
           K IGRG+FG V V   +    VFA    +         ++C                   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 49  -------RNLHL--EYLPGGTVSDLATTLNAYADEI---TLRSHTYCIVSALKYLHSRNI 96
                   NL+L  +Y  GG   DL T L+ + D +     R +   +V A+  +H  + 
Sbjct: 140 HYAFQDDNNLYLVMDYYVGG---DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGA----AGEATVSDTRGVKIQPRGSPLWMAPEVVRG 152
           VH D+K  N+L+  N   ++LADFG+      + TV  +  V     G+P +++PE+++ 
Sbjct: 197 VHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAV-----GTPDYISPEILQA 250
Query: 153 E-----CQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPTQ---SS 203
                   GPE D WSLG  + EM+ G+ P + +    T  +I    E  +FPTQ    S
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310
Query: 204 ELGRDFLDK--CLRREPGERWSCDQLLKHPFLQSV 236
           E  +D + +  C R     +   +   KHPF   +
Sbjct: 311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 63/125 (50%), Gaps = 2/125 (1%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            L +EYLP G + D      A  D   L  ++  I   ++YL SR  VH D+  +N+LV 
Sbjct: 86  RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 145
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTI 168
            + + VK+ADFG A    +     V  +P  SP+ W APE +       +SDVWS G  +
Sbjct: 146 -SEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 204
Query: 169 IEMVT 173
            E+ T
Sbjct: 205 YELFT 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++     +P  
Sbjct: 124 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLT---EPCY 179
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 180 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 239
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 240 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 123 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 175
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 173
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 112/267 (41%), Gaps = 45/267 (16%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLE------------- 54
           + IG+G F  V   ++R  G  FA    DV+    +   S  +L  E             
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 55  -----YLPGGTV---------SDLATTLNAYAD------EITLRSHTYCIVSALKYLHSR 94
                Y   G +         +DL   +   AD      E     +   I+ AL+Y H  
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 151
Query: 95  NIVHCDVKGKNVLVGP--NSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV 149
           NI+H DVK   VL+    NS+ VKL  FG A   GE+ +    G ++   G+P +MAPEV
Sbjct: 152 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRV---GTPHFMAPEV 206
Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGR 207
           V+ E  G   DVW  G  +  +++G   +          I  G     PR  +  SE  +
Sbjct: 207 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAK 266
Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
           D + + L  +P ER +  + L HP+L+
Sbjct: 267 DLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L+  L  + D   L        +S+ + ++  L + HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 123 HRVLHRDLKPENLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 129 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVT------LWYRAPEI 181
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 241
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 298

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 42  PTTSSSCRNLHLE---YLPGGTV-SDLATTLNAYA----DEITLRSHTYCIVSALKYLHS 93
           P        +H E   YL    +  DL T ++A A        ++S+ + ++  L + HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 126 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVT------LWYRAPEI 178
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 238
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 239 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L+  L  + D   L        +S+ + ++  L + HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 125 HRVLHRDLKPENLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A   G    + T  V        LW  APE+
Sbjct: 129 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVT------LWYRAPEI 181
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 241
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 242 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 298

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
           SYE    SSS   L  + +  G + D  T   A +++ T RS    ++ A+ +LH+ NIV
Sbjct: 168 SYE----SSSFMFLVFDLMRKGELFDYLTEKVALSEKET-RSIMRSLLEAVSFLHANNIV 222
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQ- 155
           H D+K +N+L+  N   ++L+DFG +         G K++   G+P ++APE+++     
Sbjct: 223 HRDLKPENILLDDNMQ-IRLSDFGFSCHLEP----GEKLRELCGTPGYLAPEILKCSMDE 277
Query: 156 -----GPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GFSDELPRFPTQSSELG 206
                G E D+W+ G  +  ++ G P  W       L  I    +    P +  +SS + 
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTV- 336
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           +D + + L+ +P  R + +Q L+HPF +
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 225
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 286 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 13/190 (6%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL-VG 109
           L +EY+ GG + D     +    E+        I   ++++H   I+H D+K +N+L V 
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTII 169
            ++  +K+ DFG A      +   V     G+P ++APEVV  +     +D+WS+G    
Sbjct: 223 RDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279
Query: 170 EMVTG-KPAWEDFGANTLSRI-----GFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
            +++G  P   D  A TL+ I        DE   F   S E  ++F+ K L +E   R S
Sbjct: 280 MLLSGLSPFLGDNDAETLNNILACRWDLEDE--EFQDISEE-AKEFISKLLIKEKSWRIS 336
Query: 224 CDQLLKHPFL 233
             + LKHP+L
Sbjct: 337 ASEALKHPWL 346

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 138
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 139 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 140
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 141 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 112/267 (41%), Gaps = 45/267 (16%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLE------------- 54
           + IG+G F  V   ++R  G  FA    DV+    +   S  +L  E             
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 55  -----YLPGGTV---------SDLATTLNAYAD------EITLRSHTYCIVSALKYLHSR 94
                Y   G +         +DL   +   AD      E     +   I+ AL+Y H  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 95  NIVHCDVKGKNVLVGP--NSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV 149
           NI+H DVK   VL+    NS+ VKL  FG A   GE+ +    G ++   G+P +MAPEV
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRV---GTPHFMAPEV 204
Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGR 207
           V+ E  G   DVW  G  +  +++G   +          I  G     PR  +  SE  +
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAK 264
Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
           D + + L  +P ER +  + L HP+L+
Sbjct: 265 DLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 176 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 231
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 232 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 291
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 292 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L+  L  + D   L        +S+ + ++  L + HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 124 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 125 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 180
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 181 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 240
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 241 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L+  L  + D   L        +S+ + ++  L + HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 139
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 140 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 137 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 124 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 179
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 180 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 239
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 240 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 134 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 181
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 182 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 241
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 242 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 181
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 182 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 241
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 242 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 165 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 134 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 152 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 137
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 138 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 131 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 186
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 187 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 246
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 247 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 134 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 131
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 132 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 123 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           ++Y+ GG +  L      + + +  + +   +  AL+YLHS++I++ D+K +N+L+  N 
Sbjct: 85  MDYIEGGELFSLLRKSQRFPNPVA-KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 143
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             +K+ DFG A    V D   V     G+P ++APEVV  +      D WS G  I EM+
Sbjct: 144 H-IKITDFGFA--KYVPD---VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 173 TG-KPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW-----SCDQ 226
            G  P ++     T  +I  + EL RFP   +E  +D L + + R+  +R        + 
Sbjct: 198 AGYTPFYDSNTMKTYEKI-LNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTED 255
Query: 227 LLKHPFLQSV 236
           +  HP+ + V
Sbjct: 256 VKNHPWFKEV 265

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 132 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 187
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 188 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 247
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 248 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 132
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 133 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 9/217 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L ++ + GG + D       Y +    R   + ++ A+KYLH   IVH D+K +N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 111 --NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
               S + ++DFG +    + D   V     G+P ++APEV+  +      D WS+G   
Sbjct: 152 LDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPR---FPTQSSELGRDFLDKCLRREPGERWSCD 225
             ++ G P + D     L       E      +    S+  +DF+   + ++P +R++C+
Sbjct: 209 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 268
Query: 226 QLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           Q L+HP++   +  D N     S +   ++  S++++
Sbjct: 269 QALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 130 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 185
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 186 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 245
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 246 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 63/124 (50%), Gaps = 2/124 (1%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EYLP G + D      A  D   L  ++  I   ++YL SR  VH D+  +N+LV  
Sbjct: 90  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE- 148
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTII 169
           + + VK+ADFG A    +     V  +P  SP+ W APE +       +SDVWS G  + 
Sbjct: 149 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 208
Query: 170 EMVT 173
           E+ T
Sbjct: 209 ELFT 212

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 152 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 124 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 63/124 (50%), Gaps = 2/124 (1%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EYLP G + D      A  D   L  ++  I   ++YL SR  VH D+  +N+LV  
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE- 161
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTII 169
           + + VK+ADFG A    +     V  +P  SP+ W APE +       +SDVWS G  + 
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 221
Query: 170 EMVT 173
           E+ T
Sbjct: 222 ELFT 225

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 126 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 238
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 239 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 173
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 140 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 195
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D+WSLG  +  ++ G P +          G  T  R+G  +
Sbjct: 196 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 255
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  + + HP++
Sbjct: 256 ----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 9/217 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L ++ + GG + D       Y +    R   + ++ A+KYLH   IVH D+K +N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 111 --NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
               S + ++DFG +    + D   V     G+P ++APEV+  +      D WS+G   
Sbjct: 152 LDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPR---FPTQSSELGRDFLDKCLRREPGERWSCD 225
             ++ G P + D     L       E      +    S+  +DF+   + ++P +R++C+
Sbjct: 209 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 268
Query: 226 QLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           Q L+HP++   +  D N     S +   ++  S++++
Sbjct: 269 QALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/124 (35%), Positives = 63/124 (50%), Gaps = 2/124 (1%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L +EYLP G + D      A  D   L  ++  I   ++YL SR  VH D+  +N+LV  
Sbjct: 91  LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE- 149
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTII 169
           + + VK+ADFG A    +     V  +P  SP+ W APE +       +SDVWS G  + 
Sbjct: 150 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 209
Query: 170 EMVT 173
           E+ T
Sbjct: 210 ELFT 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 44/256 (17%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRN----------LHLEYLPGG 59
           IG GSFGTV     +++GDV   +   V    P    + RN          +++    G 
Sbjct: 44  IGSGSFGTVYKG--KWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 60  TVSDLATTLNAYADEITLRSHTYC----------------IVSALKYLHSRNIVHCDVKG 103
              D    +  + +  +L  H +                     + YLH++NI+H D+K 
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKS 160
Query: 104 KNVLVGPNSSFVKLADFGAAG-EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---ES 159
            N+ +    + VK+ DFG A  ++  S ++ V+ QP GS LWMAPEV+R +   P   +S
Sbjct: 161 NNIFLHEGLT-VKIGDFGLATVKSRWSGSQQVE-QPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------SDELPRFPTQSSELGRDFLDK 212
           DV+S G  + E++TG+  +     N   +I F       S +L +      +  +  +  
Sbjct: 219 DVYSYGIVLYELMTGELPYSHI--NNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVAD 276
Query: 213 CLRREPGERWSCDQLL 228
           C+++   ER    Q+L
Sbjct: 277 CVKKVKEERPLFPQIL 292

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 112/288 (38%), Gaps = 67/288 (23%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA-------------------PTTSSSCRN 50
           IG G++G V  A ++  G+V A     +  E                    P        
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHSRNIVHCDVK 102
           +H E         L   L  + D   L        +S+ + ++  L + HS  ++H D+K
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 129
Query: 103 GKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEVVRG-ECQGP 157
            +N+L+    + +KLADFG A   G    + T  V        LW  APE++ G +    
Sbjct: 130 PQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEV------VTLWYRAPEILLGCKYYST 182
Query: 158 ESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL------------PRFPT 200
             D+WSLGC   EMVT +  +  D   + L RI    G  DE+            P FP 
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 201 QS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
            +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 25/165 (15%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV--GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I +A+++LHS NI H DVK +N+L       + +KL DFG A E T +  +     P  +
Sbjct: 118 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYT 173
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-------------LSR 188
           P ++APEV+  E      D+WSLG  +  ++ G P    F +NT             L +
Sbjct: 174 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSNTGQAISPGMKRRIRLGQ 230
Query: 189 IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            GF +  P + ++ SE  +  +   L+ +P ER +  Q + HP++
Sbjct: 231 YGFPN--PEW-SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 95/234 (40%), Gaps = 50/234 (21%)
Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCR--------------- 49
           + G+ +G+G FG       R  G+V   + + + ++  T  +  +               
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMV-MKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 50  -----------NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                      N   EY+ GGT+  +  ++++        S    I S + YLHS NI+H
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT-----RGVKIQPR-------GSPLWMA 146
            D+   N LV  N + V +ADFG A       T     R +K   R       G+P WMA
Sbjct: 132 RDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 147 PEVVRGECQGPESDVWSLG---CTIIEMVTGKPAW----EDFGANTLSRIGFSD 193
           PE++ G     + DV+S G   C II  V   P +     DFG N     GF D
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR---GFLD 241

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 123 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 124 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 25/165 (15%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV--GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I +A+++LHS NI H DVK +N+L       + +KL DFG A E T +  +     P  +
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYT 192
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-------------LSR 188
           P ++APEV+  E      D+WSLG  +  ++ G P    F +NT             L +
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSNTGQAISPGMKRRIRLGQ 249
Query: 189 IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            GF +  P + ++ SE  +  +   L+ +P ER +  Q + HP++
Sbjct: 250 YGFPN--PEW-SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 9/217 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L ++ + GG + D       Y +    R   + ++ A+KYLH   IVH D+K +N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 111 --NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
               S + ++DFG +    + D   V     G+P ++APEV+  +      D WS+G   
Sbjct: 152 LDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPR---FPTQSSELGRDFLDKCLRREPGERWSCD 225
             ++ G P + D     L       E      +    S+  +DF+   + ++P +R++C+
Sbjct: 209 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 268
Query: 226 QLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
           Q L+HP++   +  D N     S +   ++  S++++
Sbjct: 269 QALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 123 HRVLHRDLKPENLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 122/297 (41%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 42  PTTSSSCRNLHLE---YLPGGTV-SDLATTLNAYA----DEITLRSHTYCIVSALKYLHS 93
           P        +H E   YL    V  DL   ++A A        ++S+ + ++  L + HS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 125 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 294

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 108/227 (47%), Gaps = 19/227 (8%)
Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
           +E PT  S    L LE + GG + D       Y  E         I+ A+ YLH   IVH
Sbjct: 117 FETPTEIS----LVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVH 171
Query: 99  CDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ 155
            D+K +N+L     P++  +K+ADFG +    + + + +     G+P + APE++RG   
Sbjct: 172 RDLKPENLLYATPAPDAP-LKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 156 GPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSEL---GRDFLD 211
           GPE D+WS+G     ++ G +P +++ G   + R   + E         E+    +D + 
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287
Query: 212 KCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNS 258
           K +  +P +R +  Q L+HP+   V+   AN V   + +  L   N+
Sbjct: 288 KLIVLDPKKRLTTFQALQHPW---VTGKAANFVHMDTAQKKLQEFNA 331

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +           +E   R ++  I  AL YLH R I++ D+K  NVL+  + 
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SE 189
Query: 113 SFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +KL D+G   E     DT        G+P ++APE++RGE  G   D W+LG  + EM
Sbjct: 190 GHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246
Query: 172 VTGKPAWEDFGA---------NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
           + G+  ++  G+         + L ++    ++ R P   S      L   L ++P ER 
Sbjct: 247 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKDPKERL 305
Query: 223 SCD------QLLKHPFLQSV 236
            C        +  HPF ++V
Sbjct: 306 GCHPQTGFADIQGHPFFRNV 325

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 137 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 124 HRVLHRDLKPENLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 293

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 33/261 (12%)
Query: 4   WVRGKCIGRGSFGTVNVAVD------------RFNGDVFAYLGDDVSYEAPTTSSSCRNL 51
           ++  + +GRG FG V+  V+            +  G     +  ++S        +  +L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 52  H------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
           H             E++ G  + +   T     +E  + S+ + +  AL++LHS NI H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 100 DVKGKNVLVGP-NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           D++ +N++     SS +K+ +FG A +    D   +      +P + APEV + +     
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVSTA 183
Query: 159 SDVWSLGCTIIEMVTG-KPAWEDFGANTLSRI---GFSDELPRFPTQSSELGRDFLDKCL 214
           +D+WSLG  +  +++G  P   +     +  I    ++ +   F   S E   DF+D+ L
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE-AMDFVDRLL 242
Query: 215 RREPGERWSCDQLLKHPFLQS 235
            +E   R +  + L+HP+L+ 
Sbjct: 243 VKERKSRMTASEALQHPWLKQ 263

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 117/297 (39%), Gaps = 67/297 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 122 HRVLHRDLKPENLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               P FP  +            E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 95  NLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 210
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +           +E   R ++  I  AL YLH R I++ D+K  NVL+  + 
Sbjct: 100 IEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SE 157
Query: 113 SFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +KL D+G   E     DT        G+P ++APE++RGE  G   D W+LG  + EM
Sbjct: 158 GHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 214
Query: 172 VTGKPAWEDFGA---------NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
           + G+  ++  G+         + L ++    ++ R P   S      L   L ++P ER 
Sbjct: 215 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSMSVKAASVLKSFLNKDPKERL 273
Query: 223 SC------DQLLKHPFLQSV 236
            C        +  HPF ++V
Sbjct: 274 GCLPQTGFADIQGHPFFRNV 293

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +           +E   R ++  I  AL YLH R I++ D+K  NVL+  + 
Sbjct: 85  IEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SE 142
Query: 113 SFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +KL D+G   E     DT        G+P ++APE++RGE  G   D W+LG  + EM
Sbjct: 143 GHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 199
Query: 172 VTGKPAWEDFGA---------NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
           + G+  ++  G+         + L ++    ++ R P   S      L   L ++P ER 
Sbjct: 200 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKDPKERL 258
Query: 223 SCD------QLLKHPFLQSVS 237
            C        +  HPF ++V 
Sbjct: 259 GCHPQTGFADIQGHPFFRNVD 279

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 53/236 (22%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 110 MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 168
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 169 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 172 VTGK----------------------------------PAWEDFGANTLSRIGFSDEL-- 195
             G+                                       FG ++   +   + L  
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283
Query: 196 ------PRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
                 P+ P+    L  +DF++KCL + P ER    QL+ H F++    SDA  V
Sbjct: 284 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDAEEV 336

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +           +E   R ++  I  AL YLH R I++ D+K  NVL+  + 
Sbjct: 89  IEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SE 146
Query: 113 SFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +KL D+G   E     DT        G+P ++APE++RGE  G   D W+LG  + EM
Sbjct: 147 GHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203
Query: 172 VTGKPAWEDFGA---------NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
           + G+  ++  G+         + L ++    ++ R P   S      L   L ++P ER 
Sbjct: 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RIPRSLSVKAASVLKSFLNKDPKERL 262
Query: 223 SCD------QLLKHPFLQSVS 237
            C        +  HPF ++V 
Sbjct: 263 GCHPQTGFADIQGHPFFRNVD 283

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L ++ + GG + D       Y +    R   + ++ A+KYLH   IVH D+K +N+L   
Sbjct: 93  LIMQLVSGGELFDRIVEKGFYTERDASRL-IFQVLDAVKYLHDLGIVHRDLKPENLLYYS 151
Query: 111 --NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
               S + ++DFG +    + D   V     G+P ++APEV+  +      D WS+G   
Sbjct: 152 LDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208
Query: 169 IEMVTGKPAWEDFGANTLSRIGFSDELPR---FPTQSSELGRDFLDKCLRREPGERWSCD 225
             ++ G P + D     L       E      +    S+  +DF+   + ++P +R++C+
Sbjct: 209 YILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCE 268
Query: 226 QLLKHPFLQSVSPSDANT 243
           Q L+HP++   +  D N 
Sbjct: 269 QALQHPWIAGDTALDKNI 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 48  CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           C  L +EY+ G T+S+   +    + + T  + T  I+  +K+ H   IVH D+K +N+L
Sbjct: 85  CYYLVMEYIEGPTLSEYIESHGPLSVD-TAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143
Query: 108 VGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSL 164
           +  N +  K+ DFG A    E +++ T  V     G+  + +PE  +GE     +D++S+
Sbjct: 144 IDSNKTL-KIFDFGIAKALSETSLTQTNHV----LGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 165 GCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ-SSELGRDFLDKCLR---REPGE 220
           G  + EM+ G+P +    A +++     D +P   T    ++ +   +  LR   ++   
Sbjct: 199 GIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKAN 258
Query: 221 RWSCDQLLK 229
           R+   Q +K
Sbjct: 259 RYKTIQEMK 267

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 44/247 (17%)
Query: 50  NLHLEYLPGGT--VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           NL LEY+P      S     L      + ++ + Y ++ +L Y+HS  I H D+K +N+L
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 108 VGPNSSFVKLADFGA-----AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DV 161
           + P S  +KL DFG+     AGE  VS           S  + APE++ G      + D+
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPNVSXI--------CSRYYRAPELIFGATNYTTNIDI 225
Query: 162 WSLGCTIIEMVTGKPAWE-DFGANTLSRI------------------GFSDELPRF-PTQ 201
           WS GC + E++ G+P +  + G + L  I                      + P+  P  
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285
Query: 202 SSELGR--------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVL 253
            S++ R        D + + L   P  R +  + L HPF   +   +A          + 
Sbjct: 286 FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLF 345
Query: 254 DWVNSEF 260
           +W   E 
Sbjct: 346 NWTKEEL 352

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 244
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 115/294 (39%), Gaps = 67/294 (22%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA------------------- 41
           M ++ + + IG G++G V  A ++  G+V A     +  E                    
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITL--------RSHTYCIVSALKYLHS 93
           P        +H E         L   L  + D   L        +S+ + ++  L + HS
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-APEV 149
             ++H D+K +N+L+    + +KLADFG A         GV ++        LW  APE+
Sbjct: 122 HRVLHRDLKPQNLLINTEGA-IKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 150 VRG-ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----GFSDEL-------- 195
           + G +      D+WSLGC   EMVT +  +  D   + L RI    G  DE+        
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 234
Query: 196 ----PRFPTQS-----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
               P FP  +            E GR  L + L  +P +R S    L HPF Q
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 107 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 165
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 166 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 222
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 223 CVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 50  NLHLEYLPGGT--VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           NL L+Y+P     V+   +        I ++ + Y +  +L Y+HS  I H D+K +N+L
Sbjct: 96  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 155
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGC 166
           + P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS GC
Sbjct: 156 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAGC 212
Query: 167 TIIEMVTGKPAWE-DFGANTLSRI 189
            + E++ G+P +  D G + L  I
Sbjct: 213 VLAELLLGQPIFPGDSGVDQLVEI 236

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 50  NLHLEYLPGGT--VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           NL L+Y+P     V+   +        I ++ + Y +  +L Y+HS  I H D+K +N+L
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGC 166
           + P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS GC
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAGC 211
Query: 167 TIIEMVTGKPAWE-DFGANTLSRI 189
            + E++ G+P +  D G + L  I
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 114 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 172
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 173 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 229
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 230 CVLAELLLGQPIFPGDSGVDQLVEI 254

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 53/260 (20%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   ++   D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 111 ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 169
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A+ +      +  R    + APEV+ G       D+WS+GC + E+V G       
Sbjct: 170 LARTASTNFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 226
Query: 175 ------------------------KPAWEDFGANTLSR--IGFSDELPR--FPTQS---- 202
                                   +P   ++  N  +   I F +  P   FP++S    
Sbjct: 227 DHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDK 286
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +P +R S D+ L+HP++     P++    AE+ P  + D   ++
Sbjct: 287 IKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE----AEAPPPQIYD---AQ 339
Query: 260 FEEEGTSDDEKLEASARERM 279
            EE   + +E  E   +E M
Sbjct: 340 LEEREHAIEEWKELIYKEVM 359

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 107 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 165
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 166 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 222
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 223 CVLAELLLGQPIFPGDSGVDQLVEI 247

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 99  NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 157
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 158 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 214
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 215 CVLAELLLGQPIFPGDSGVDQLVEI 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 50  NLHLEYLPGGT--VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           NL L+Y+P     V+   +        I ++ + Y +  +L Y+HS  I H D+K +N+L
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGC 166
           + P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS GC
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAGC 211
Query: 167 TIIEMVTGKPAWE-DFGANTLSRI 189
            + E++ G+P +  D G + L  I
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  EYLP G++ D         D I L  +T  I   ++YL ++
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 134
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H ++  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 135 RYIHRNLATRNILV-ENENRVKIGDFGLT-KVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 39/263 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY---------LGDDVSYEAPTTSSSCRNLH------ 52
           K +G+G+FG V +  ++  G  +A            D+V++          + H      
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 216
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVH 98
                        +EY  GG +    +    ++++   R +   IVSAL YLHS +N+V+
Sbjct: 217 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHSEKNVVY 275
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+++  +   +K+ DFG   E  + D   +K    G+P ++APEV+     G  
Sbjct: 276 RDLKLENLMLDKDGH-IKITDFGLCKEG-IKDGATMKTFC-GTPEYLAPEVLEDNDYGRA 332
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W LG  + EM+ G+  + +     L  +   +E+ RFP       +  L   L+++P
Sbjct: 333 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 391
Query: 219 GERW-----SCDQLLKHPFLQSV 236
            +R         ++++H F   +
Sbjct: 392 KQRLGGGSEDAKEIMQHRFFAGI 414

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 50  NLHLEYLPGGT--VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           NL L+Y+P     V+   +        I ++ + Y +  +L Y+HS  I H D+K +N+L
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGC 166
           + P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS GC
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAGC 211
Query: 167 TIIEMVTGKPAWE-DFGANTLSRI 189
            + E++ G+P +  D G + L  I
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 103 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 161
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 162 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR---YYRAPELIFGATDYTSSIDVWSAG 218
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 219 CVLAELLLGQPIFPGDSGVDQLVEI 243

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 244
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 245 CVLAELLLGQPIFPGDSGVDQLVEI 269

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 131 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 189
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 190 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 246
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 247 CVLAELLLGQPIFPGDSGVDQLVEI 271

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 133 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 191
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 192 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 248
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 249 CVLAELLLGQPIFPGDSGVDQLVEI 273

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 50  NLHLEYLPGGT--VSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           NL L+Y+P     V+   +        I ++ + Y +  +L Y+HS  I H D+K +N+L
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGC 166
           + P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS GC
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAGC 211
Query: 167 TIIEMVTGKPAWE-DFGANTLSRI 189
            + E++ G+P +  D G + L  I
Sbjct: 212 VLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 145 MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 203
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 204 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 258
Query: 172 VTGK-----PAWED----FGANT-----------------LSRIGF-------------- 191
             G+     P  ++    FG                    LS  G               
Sbjct: 259 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 318
Query: 192 --SDELPRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             ++  P+ P+    L  +DF++KCL + P ER    QL+ H F++    SDA  V
Sbjct: 319 IVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDAEEV 371

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEI---TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L ++Y  GG   DL T L+ + D++     R +   +V A+  +H  + VH D+K  NVL
Sbjct: 167 LVMDYYVGG---DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL 223
Query: 108 VGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGE-----CQGPE 158
           +  N   ++LADFG+      + TV  +  V     G+P +++PE+++         GPE
Sbjct: 224 LDVNGH-IRLADFGSCLKMNDDGTVQSSVAV-----GTPDYISPEILQAMEDGMGKYGPE 277
Query: 159 SDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFP---TQSSELGRDFLDK-- 212
            D WSLG  + EM+ G+ P + +    T  +I   +E  +FP   T  SE  +D + +  
Sbjct: 278 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 337
Query: 213 CLRREPGERWSCDQLLKHPFLQSVS 237
           C R     +   +   KH F + ++
Sbjct: 338 CSRERRLGQNGIEDFKKHAFFEGLN 362

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 39/263 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY---------LGDDVSYEAPTTSSSCRNLH------ 52
           K +G+G+FG V +  ++  G  +A            D+V++          + H      
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVH 98
                        +EY  GG +    +    ++++   R +   IVSAL YLHS +N+V+
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHSEKNVVY 272
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+++  +   +K+ DFG   E  + D   +K    G+P ++APEV+     G  
Sbjct: 273 RDLKLENLMLDKDGH-IKITDFGLCKEG-IKDGATMKTFC-GTPEYLAPEVLEDNDYGRA 329
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W LG  + EM+ G+  + +     L  +   +E+ RFP       +  L   L+++P
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 388
Query: 219 GERW-----SCDQLLKHPFLQSV 236
            +R         ++++H F   +
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFAGI 411

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 123 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 181
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 182 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 238
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 239 CVLAELLLGQPIFPGDSGVDQLVEI 263

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 108 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 166
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 167 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 223
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 224 CVLAELLLGQPIFPGDSGVDQLVEI 248

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 95  NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 210
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 174 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 232
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 233 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 289
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 290 CVLAELLLGQPIFPGDSGVDQLVEI 314

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEI---TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L ++Y  GG   DL T L+ + D++     R +   +V A+  +H  + VH D+K  NVL
Sbjct: 151 LVMDYYVGG---DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVL 207
Query: 108 VGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGE-----CQGPE 158
           +  N   ++LADFG+      + TV  +  V     G+P +++PE+++         GPE
Sbjct: 208 LDVNGH-IRLADFGSCLKMNDDGTVQSSVAV-----GTPDYISPEILQAMEDGMGKYGPE 261
Query: 159 SDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFP---TQSSELGRDFLDK-- 212
            D WSLG  + EM+ G+ P + +    T  +I   +E  +FP   T  SE  +D + +  
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLI 321
Query: 213 CLRREPGERWSCDQLLKHPFLQSVS 237
           C R     +   +   KH F + ++
Sbjct: 322 CSRERRLGQNGIEDFKKHAFFEGLN 346

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   IV   +YLH   ++H D+K  N+ +  +   VK+ DFG A +      R   + 
Sbjct: 124 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLC 182
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP 196
             G+P ++APEV+  +    E DVWS+GC +  ++ GKP +E      T  RI  ++   
Sbjct: 183 --GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 238
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             P   + +    + K L+ +P  R + ++LL   F  S
Sbjct: 239 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 277

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   IV   +YLH   ++H D+K  N+ +  +   VK+ DFG A +      R   + 
Sbjct: 120 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLC 178
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP 196
             G+P ++APEV+  +    E DVWS+GC +  ++ GKP +E      T  RI  ++   
Sbjct: 179 --GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 234
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             P   + +    + K L+ +P  R + ++LL   F  S
Sbjct: 235 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I+ A++Y H   IVH D+K +N+L+  N + VK+ADFG +    ++D   +K    GSP 
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLSN--IMTDGNFLKTSC-GSPN 172
Query: 144 WMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWED-FGANTLSRIGFSDELPRFPTQ 201
           + APEV+ G+   GPE DVWS G  +  M+ G+  ++D F  N   ++     +   P  
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYV--MPDF 230
Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFE 261
            S   +  + + +  +P +R +  ++ + P+     P               D++    E
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP---------------DYLRPMEE 275
Query: 262 EEGTSDDEKLEASARERMG 280
            +G+  D ++ +   E MG
Sbjct: 276 VQGSYADSRIVSKLGEAMG 294

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 100 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 158
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 159 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 215
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 216 CVLAELLLGQPIFPGDSGVDQLVEI 240

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 43/263 (16%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----SYEAPTTSS---SCRNLHLEYLPG 58
           G  + RG F   +VAV R   + F++   +V     S E P       + ++   +Y+  
Sbjct: 38  GTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI-- 95
Query: 59  GTVSDLATTLNAYADE----------ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
             +   A TL  Y ++          ITL   T    S L +LHS NIVH D+K  N+L+
Sbjct: 96  -AIELCAATLQEYVEQKDFAHLGLEPITLLQQT---TSGLAHLHSLNIVHRDLKPHNILI 151
Query: 109 G-PNSS---FVKLADFG-----AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
             PN+       ++DFG     A G  + S   GV     G+  W+APE++  +C+   +
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP----GTEGWIAPEMLSEDCKENPT 207
Query: 160 ---DVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSE-LGRDFLDKC 213
              D++S GC    +++    P  +         +G        P +  + + R+ ++K 
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM 267
Query: 214 LRREPGERWSCDQLLKHPFLQSV 236
           +  +P +R S   +LKHPF  S+
Sbjct: 268 IAMDPQKRPSAKHVLKHPFFWSL 290

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADE---ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           NL L+Y+P  TV  +A   +        I ++ + Y +  +L Y+HS  I H D+K +N+
Sbjct: 95  NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLG 165
           L+ P+++ +KL DFG+A +    +     I  R    + APE++ G      S DVWS G
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDYTSSIDVWSAG 210
Query: 166 CTIIEMVTGKPAWE-DFGANTLSRI 189
           C + E++ G+P +  D G + L  I
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEI 235

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   IV   +YLH   ++H D+K  N+ +  +   VK+ DFG A +      R   + 
Sbjct: 120 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKTLC 178
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP 196
             G+P ++APEV+  +    E DVWS+GC +  ++ GKP +E      T  RI  ++   
Sbjct: 179 --GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 234
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             P   + +    + K L+ +P  R + ++LL   F  S
Sbjct: 235 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 83  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 141
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 142 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 172 VTGK-----PAWED----FGANT-----------------LSRIGF-------------- 191
             G+     P  ++    FG                    LS  G               
Sbjct: 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256
Query: 192 --SDELPRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             ++  P+ P+    L  +DF++KCL + P ER    QL+ H F++    SDA  V
Sbjct: 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDAEEV 309

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 83  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 141
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 142 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 172 VTGK-----PAWED----FGANT-----------------LSRIGF-------------- 191
             G+     P  ++    FG                    LS  G               
Sbjct: 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256
Query: 192 --SDELPRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             ++  P+ P+    L  +DF++KCL + P ER    QL+ H F++    SDA  V
Sbjct: 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDAEEV 309

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++K+ADFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++K+ADFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   IV   +YLH   ++H D+K  N+ +  +   VK+ DFG A +      R   + 
Sbjct: 118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLC 176
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP 196
             G+P ++APEV+  +    E DVWS+GC +  ++ GKP +E      T  RI  ++   
Sbjct: 177 --GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 232
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             P   + +    + K L+ +P  R + ++LL   F  S
Sbjct: 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 83  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 141
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 142 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 172 VTGK-----PAWED----FGANT-----------------LSRIGF-------------- 191
             G+     P  ++    FG                    LS  G               
Sbjct: 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256
Query: 192 --SDELPRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             ++  P+ P+    L  +DF++KCL + P ER    QL+ H F++    SDA  V
Sbjct: 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDAEEV 309

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L+  +    D   +    Y ++  +K+LHS  I+H D+K  N++V  +++ +K+ DFG
Sbjct: 113 ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDAT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 53/236 (22%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        ++I L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 83  MEHMDGGSLDQVLKKAGRIPEQI-LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR 141
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +M+PE ++G     +SD+WS+G +++EM
Sbjct: 142 GE-IKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196
Query: 172 VTGK-----PAWED----FGANT-----------------LSRIGF-------------- 191
             G+     P  ++    FG                    LS  G               
Sbjct: 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDY 256
Query: 192 --SDELPRFPTQSSELG-RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             ++  P+ P+    L  +DF++KCL + P ER    QL+ H F++    SDA  V
Sbjct: 257 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR---SDAEEV 309

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   IV   +YLH   ++H D+K  N+ +  +   VK+ DFG A +      R   + 
Sbjct: 142 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLC 200
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP 196
             G+P ++APEV+  +    E DVWS+GC +  ++ GKP +E      T  RI  ++   
Sbjct: 201 --GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 256
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             P   + +    + K L+ +P  R + ++LL   F  S
Sbjct: 257 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 295

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           V Y+    S+  RNL L  E+LP G++ +         D I L  +T  I   ++YL ++
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPL-WMAPEVVRG 152
             +H D+  +N+LV  N + VK+ DFG   +    D    K+ +P  SP+ W APE +  
Sbjct: 137 RYIHRDLATRNILV-ENENRVKIGDFGLT-KVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                 SDVWS G  + E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 38/200 (19%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+      +K+ DFG A  A    D  G   +   
Sbjct: 151 YQILRGLKYIHSANVLHRDLKPSNLLINTTCD-LKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEM---------------------VTGKPAW 178
           +  + APE++       +S D+WS+GC + EM                     + G P+ 
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 179 EDFG--ANTLSRIGFSDELPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           ED     N  +R  +   LP          FP   S+   D LD+ L   P +R + ++ 
Sbjct: 270 EDLNCIINMKAR-NYLQSLPSKTKVAWAKLFPKSDSK-ALDLLDRMLTFNPNKRITVEEA 327
Query: 228 LKHPFL-QSVSPSDANTVAE 246
           L HP+L Q   P+D     E
Sbjct: 328 LAHPYLEQYYDPTDEPVAEE 347

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ ++ + H   IVH D+K +N+L+   S  + VKLADFG A E  V   +       G+
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----GFSDELPR 197
           P +++PEV+R +  G   D+W+ G  +  ++ G P + D   + L +      +    P 
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 229
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + T + E  +D ++K L   P +R +  + LKHP++
Sbjct: 230 WDTVTPE-AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   IV   +YLH   ++H D+K  N+ +  +   VK+ DFG A +      R   + 
Sbjct: 144 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLC 202
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELP 196
             G+P ++APEV+  +    E DVWS+GC +  ++ GKP +E      T  RI  ++   
Sbjct: 203 --GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 258
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             P   + +    + K L+ +P  R + ++LL   F  S
Sbjct: 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 16/179 (8%)
Query: 66  TTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAG 124
           + L+    E  L   T   V AL +L     I+H D+K  N+L+   S  +KL DFG +G
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISG 174
Query: 125 EA--TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE--SDVWSLGCTIIEMVTGK---PA 177
           +   +++ TR    +P  +P  + P   R   QG +  SDVWSLG T+ E+ TG+   P 
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPERIDPSASR---QGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 178 WEDFGANTLSRIGFSDELPRFPTQSSELGR---DFLDKCLRREPGERWSCDQLLKHPFL 233
           W     + L+++   D      ++  E      +F++ CL ++  +R    +LLKHPF+
Sbjct: 232 WNSV-FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 39/263 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY---------LGDDVSYEAPTTSSSCRNLH------ 52
           K +G+G+FG V +  ++  G  +A            D+V++          + H      
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVH 98
                        +EY  GG +    +    ++++   R +   IVSAL YLHS +N+V+
Sbjct: 74  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHSEKNVVY 132
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+++  +   +K+ DFG   E  + D   +K    G+P ++APEV+     G  
Sbjct: 133 RDLKLENLMLDKDGH-IKITDFGLCKEG-IKDGATMKXFC-GTPEYLAPEVLEDNDYGRA 189
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W LG  + EM+ G+  + +     L  +   +E+ RFP       +  L   L+++P
Sbjct: 190 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 248
Query: 219 GERW-----SCDQLLKHPFLQSV 236
            +R         ++++H F   +
Sbjct: 249 KQRLGGGSEDAKEIMQHRFFAGI 271

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L+  +    D   +    Y ++  +K+LHS  I+H D+K  N++V  +++ +K+ DFG
Sbjct: 113 ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDAT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K IG GSFG V +      G+ +A    D                            V
Sbjct: 45  RIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++K+ADFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 111/260 (42%), Gaps = 53/260 (20%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   ++   D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  +      +  R    + APEV+ G       D+WS+GC + E+V G       
Sbjct: 172 LARTACTNFMMTPYVVTR---YYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIFQGT 228
Query: 175 ------------------------KPAWEDFGAN--TLSRIGFSDELPR--FPTQS---- 202
                                   +P   ++  N      I F +  P   FP++S    
Sbjct: 229 DHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +P +R S D+ L+HP++     P++    AE+ P  + D   ++
Sbjct: 289 IKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAE----AEAPPPQIYD---AQ 341
Query: 260 FEEEGTSDDEKLEASARERM 279
            EE   + +E  E   +E M
Sbjct: 342 LEEREHAIEEWKELIYKEVM 361

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 54  EYLPGGTVSDLATTLNAYAD-EITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---G 109
           E + GG + D       +++ E +   HT  I   ++YLHS+ +VH D+K  N+L     
Sbjct: 101 ELMRGGELLDKILRQKFFSEREASFVLHT--IGKTVEYLHSQGVVHRDLKPSNILYVDES 158
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTII 169
            N   +++ DFG A +    +  G+ + P  +  ++APEV++ +      D+WSLG  + 
Sbjct: 159 GNPECLRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 170 EMVTGKPAWEDFGANT----LSRIG---FSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            M+ G   + +  ++T    L+RIG   F+     + T  SE  +D + K L  +P +R 
Sbjct: 217 TMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT-VSETAKDLVSKMLHVDPHQRL 275
Query: 223 SCDQLLKHPFL 233
           +  Q+L+HP++
Sbjct: 276 TAKQVLQHPWV 286

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 9/156 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ ++ + H   IVH D+K +N+L+   S  + VKLADFG A E  V   +       G+
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----GFSDELPR 197
           P +++PEV+R +  G   D+W+ G  +  ++ G P + D   + L +      +    P 
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 229
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + T + E  +D ++K L   P +R +  + LKHP++
Sbjct: 230 WDTVTPE-AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 39/263 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY---------LGDDVSYEAPTTSSSCRNLH------ 52
           K +G+G+FG V +  ++  G  +A            D+V++          + H      
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVH 98
                        +EY  GG +    +    ++++   R +   IVSAL YLHS +N+V+
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHSEKNVVY 133
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+++  +   +K+ DFG   E  + D   +K    G+P ++APEV+     G  
Sbjct: 134 RDLKLENLMLDKDGH-IKITDFGLCKEG-IKDGATMKXFC-GTPEYLAPEVLEDNDYGRA 190
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W LG  + EM+ G+  + +     L  +   +E+ RFP       +  L   L+++P
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 249
Query: 219 GERW-----SCDQLLKHPFLQSV 236
            +R         ++++H F   +
Sbjct: 250 KQRLGGGSEDAKEIMQHRFFAGI 272

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 98/191 (51%), Gaps = 16/191 (8%)
Query: 54  EYLPGGTVSDLATTLNAYAD-EITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---G 109
           E + GG + D       +++ E +   HT  I   ++YLHS+ +VH D+K  N+L     
Sbjct: 101 ELMRGGELLDKILRQKFFSEREASFVLHT--IGKTVEYLHSQGVVHRDLKPSNILYVDES 158
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTII 169
            N   +++ DFG A +    +  G+ + P  +  ++APEV++ +      D+WSLG  + 
Sbjct: 159 GNPECLRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 170 EMVTGKPAWEDFGANT----LSRIG---FSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            M+ G   + +  ++T    L+RIG   F+     + T  SE  +D + K L  +P +R 
Sbjct: 217 TMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNT-VSETAKDLVSKMLHVDPHQRL 275
Query: 223 SCDQLLKHPFL 233
           +  Q+L+HP++
Sbjct: 276 TAKQVLQHPWV 286

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L+  +    D   +    Y ++  +K+LHS  I+H D+K  N++V  +++ +K+ DFG
Sbjct: 113 ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDAT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + LEY PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 105 VKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 163
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++K+ADFG A        +G      G+P ++APE++  +   
Sbjct: 164 IYRDLKPENLLID-QQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 275
Query: 216 REPGERW 222
            +  +R+
Sbjct: 276 VDLTKRF 282

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 41/269 (15%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNG----------------DVFAYLGDDVS-------- 38
            +V G  +G G+FG V +   +  G                DV   +  ++         
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 39  -----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                Y+  +T +    + +EY+ GG + D     +   +E+  R     I+SA+ Y H 
Sbjct: 72  HIIKLYQVISTPTDFFMV-MEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR 129
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             +VH D+K +NVL+  + +  K+ADFG +    +SD   ++    GSP + APEV+ G 
Sbjct: 130 HMVVHRDLKPENVLLDAHMN-AKIADFGLSN--MMSDGEFLRTSC-GSPNYAAPEVISGR 185
Query: 154 CQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFL 210
              GPE D+WS G  +  ++ G   ++D    TL +   G    +P +  +S       L
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA---TLL 242
Query: 211 DKCLRREPGERWSCDQLLKHPFLQSVSPS 239
              L+ +P +R +   + +H + +   PS
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 39/263 (14%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY---------LGDDVSYEAPTTSSSCRNLH------ 52
           K +G+G+FG V +  ++  G  +A            D+V++          + H      
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 53  -------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVH 98
                        +EY  GG +    +    ++++   R +   IVSAL YLHS +N+V+
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEIVSALDYLHSEKNVVY 134
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+++  +   +K+ DFG   E  + D   +K    G+P ++APEV+     G  
Sbjct: 135 RDLKLENLMLDKDGH-IKITDFGLCKEG-IKDGATMKXFC-GTPEYLAPEVLEDNDYGRA 191
Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W LG  + EM+ G+  + +     L  +   +E+ RFP       +  L   L+++P
Sbjct: 192 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDP 250
Query: 219 GERW-----SCDQLLKHPFLQSV 236
            +R         ++++H F   +
Sbjct: 251 KQRLGGGSEDAKEIMQHRFFAGI 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 41/269 (15%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNG----------------DVFAYLGDDVS-------- 38
            +V G  +G G+FG V +   +  G                DV   +  ++         
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 39  -----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                Y+  +T +    + +EY+ GG + D     +   +E+  R     I+SA+ Y H 
Sbjct: 72  HIIKLYQVISTPTDFFMV-MEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR 129
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             +VH D+K +NVL+  + +  K+ADFG +    +SD   ++    GSP + APEV+ G 
Sbjct: 130 HMVVHRDLKPENVLLDAHMN-AKIADFGLSN--MMSDGEFLR-DSCGSPNYAAPEVISGR 185
Query: 154 CQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFL 210
              GPE D+WS G  +  ++ G   ++D    TL +   G    +P +  +S       L
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA---TLL 242
Query: 211 DKCLRREPGERWSCDQLLKHPFLQSVSPS 239
              L+ +P +R +   + +H + +   PS
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 13/162 (8%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           + I   ++YLH++ +VH D+K  N+L      N   +++ DFG A +    +  G+ + P
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTP 180
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIG---F 191
             +  ++APEV+  +      D+WSLG  +  M+TG   +    +D     L+RIG   F
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           S     +    S+  +D + K L  +P +R +   +L+HP++
Sbjct: 241 SLS-GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 101/244 (41%), Gaps = 28/244 (11%)
Query: 10  IGRGSFGTVNVAVDRFNG----------------DVFAYLGDDVSYEAPTTSSSCR---- 49
           +GRGSFG V+   D+  G                ++ A  G       P   +       
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWV 141
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
           N+ +E L GG++  L   +    ++  L  +    +  L+YLH+R I+H DVK  NVL+ 
Sbjct: 142 NIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQP----RGSPLWMAPEVVRGECQGPESDVWSLG 165
            + S   L DFG A      D  G  +       G+   MAPEVV G+    + D+WS  
Sbjct: 201 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 259
Query: 166 CTIIEMVTGKPAWEDF--GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           C ++ M+ G   W  +  G   L        +   P   + L    + + LR+EP  R S
Sbjct: 260 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 319
Query: 224 CDQL 227
             +L
Sbjct: 320 AMEL 323

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 101/244 (41%), Gaps = 28/244 (11%)
Query: 10  IGRGSFGTVNVAVDRFNG----------------DVFAYLGDDVSYEAPTTSSSCR---- 49
           +GRGSFG V+   D+  G                ++ A  G       P   +       
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
           N+ +E L GG++  L   +    ++  L  +    +  L+YLH+R I+H DVK  NVL+ 
Sbjct: 126 NIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQP----RGSPLWMAPEVVRGECQGPESDVWSLG 165
            + S   L DFG A      D  G  +       G+   MAPEVV G+    + D+WS  
Sbjct: 185 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243
Query: 166 CTIIEMVTGKPAWEDF--GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           C ++ M+ G   W  +  G   L        +   P   + L    + + LR+EP  R S
Sbjct: 244 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
Query: 224 CDQL 227
             +L
Sbjct: 304 AMEL 307

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 80/156 (51%), Gaps = 9/156 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ A+ + H   +VH D+K +N+L+      + VKLADFG A E  V   +       G+
Sbjct: 112 ILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----GFSDELPR 197
           P +++PEV+R E  G   D+W+ G  +  ++ G P + D   + L +      +    P 
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPE 229
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + T + E  ++ +++ L   P +R +  + LKHP++
Sbjct: 230 WDTVTPE-AKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++S + Y+H   IVH D+K +N+L+   S  + +++ DFG +     S     KI   G+
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GT 191
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDEL 195
             ++APEV+ G     + DVWS G  +  +++G P +   GAN    L ++    ++ EL
Sbjct: 192 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN--GANEYDILKKVEKGKYTFEL 248
Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
           P++  + SE  +D + K L   P  R S    L H ++Q+ +    +    S    +L+
Sbjct: 249 PQWK-KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 306

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ FA    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 101/244 (41%), Gaps = 28/244 (11%)
Query: 10  IGRGSFGTVNVAVDRFNG----------------DVFAYLGDDVSYEAPTTSSSCR---- 49
           +GRGSFG V+   D+  G                ++ A  G       P   +       
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWV 139
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
           N+ +E L GG++  L   +    ++  L  +    +  L+YLH+R I+H DVK  NVL+ 
Sbjct: 140 NIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQP----RGSPLWMAPEVVRGECQGPESDVWSLG 165
            + S   L DFG A      D  G  +       G+   MAPEVV G+    + D+WS  
Sbjct: 199 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 257
Query: 166 CTIIEMVTGKPAWEDF--GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           C ++ M+ G   W  +  G   L        +   P   + L    + + LR+EP  R S
Sbjct: 258 CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 317
Query: 224 CDQL 227
             +L
Sbjct: 318 AMEL 321

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
           I  A++YLHS NI H DVK +N+L     PN + +KL DFG A E T  ++      P  
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSHNSLTT---PCY 225
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSD 193
           +P ++APEV+  E      D WSLG     ++ G P +          G  T  R G  +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYE 285
Query: 194 ELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               FP    ++ SE  +  +   L+ EP +R +  +   HP++
Sbjct: 286 ----FPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ FA    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ FA    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L+  +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 112/254 (44%), Gaps = 34/254 (13%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYL---------GDDVSYEAPTTS----SSCRNLH---- 52
           +G G+FG V+   +R  G+ FA            + V  E  T S     +  NLH    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 53  --------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                    E++ GG + +     +    E     +   +   L ++H  N VH D+K +
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 284
Query: 105 NVL-VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           N++     S+ +KL DFG    A +   + VK+   G+  + APEV  G+  G  +D+WS
Sbjct: 285 NIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 164 LGCTIIEMVTG-KPAWEDFGANTLSRIGFSD---ELPRFPTQSSELGRDFLDKCLRREPG 219
           +G     +++G  P   +    TL  +   D   +   F +  SE G+DF+ K L  +P 
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-SGISEDGKDFIRKLLLADPN 400
Query: 220 ERWSCDQLLKHPFL 233
            R +  Q L+HP+L
Sbjct: 401 TRMTIHQALEHPWL 414

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++S + Y+H   IVH D+K +N+L+   S  + +++ DFG +     S     KI   G+
Sbjct: 159 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GT 215
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDEL 195
             ++APEV+ G     + DVWS G  +  +++G P +   GAN    L ++    ++ EL
Sbjct: 216 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN--GANEYDILKKVEKGKYTFEL 272
Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
           P++  + SE  +D + K L   P  R S    L H ++Q+ +    +    S    +L+
Sbjct: 273 PQWK-KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 330

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S     ++  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPEVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNA 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++S + Y+H   IVH D+K +N+L+   S  + +++ DFG +     S     KI   G+
Sbjct: 158 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GT 214
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDEL 195
             ++APEV+ G     + DVWS G  +  +++G P +   GAN    L ++    ++ EL
Sbjct: 215 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN--GANEYDILKKVEKGKYTFEL 271
Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
           P++  + SE  +D + K L   P  R S    L H ++Q+ +    +    S    +L+
Sbjct: 272 PQWK-KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 329

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 112/254 (44%), Gaps = 34/254 (13%)
Query: 10  IGRGSFGTVNVAVDRFNGDVFAYL---------GDDVSYEAPTTS----SSCRNLH---- 52
           +G G+FG V+   +R  G+ FA            + V  E  T S     +  NLH    
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 53  --------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                    E++ GG + +     +    E     +   +   L ++H  N VH D+K +
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 178
Query: 105 NVL-VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           N++     S+ +KL DFG    A +   + VK+   G+  + APEV  G+  G  +D+WS
Sbjct: 179 NIMFTTKRSNELKLIDFGLT--AHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWS 235
Query: 164 LGCTIIEMVTG-KPAWEDFGANTLSRIGFSD---ELPRFPTQSSELGRDFLDKCLRREPG 219
           +G     +++G  P   +    TL  +   D   +   F +  SE G+DF+ K L  +P 
Sbjct: 236 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF-SGISEDGKDFIRKLLLADPN 294
Query: 220 ERWSCDQLLKHPFL 233
            R +  Q L+HP+L
Sbjct: 295 TRMTIHQALEHPWL 308

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 9/161 (5%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R +   ++  ++YLH + I+H D+K  N+LVG +   +K+ADFG + E   SD   +   
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSD--ALLSN 196
Query: 138 PRGSPLWMAPEVV---RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
             G+P +MAPE +   R    G   DVW++G T+   V G+  + D     L     S  
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQA 256
Query: 195 LPRFPTQS--SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           L  FP Q   +E  +D + + L + P  R    ++  HP++
Sbjct: 257 L-EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 112/267 (41%), Gaps = 37/267 (13%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNG----------------DVFAYLGDDVS-------- 38
            ++ G  +G G+FG V V      G                DV   +  ++         
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 39  -----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                Y+  +T S    + +EY+ GG + D     N   DE   R     I+S + Y H 
Sbjct: 77  HIIKLYQVISTPSDIFMV-MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR 134
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             +VH D+K +NVL+  + +  K+ADFG +    +SD   ++    GSP + APEV+ G 
Sbjct: 135 HMVVHRDLKPENVLLDAHMN-AKIADFGLSN--MMSDGEFLRXSC-GSPNYAAPEVISGR 190
Query: 154 CQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
              GPE D+WS G  +  ++ G   ++D    TL +    D +   P   +      L  
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-KICDGIFYTPQYLNPSVISLLKH 249
Query: 213 CLRREPGERWSCDQLLKHPFLQSVSPS 239
            L+ +P +R +   + +H + +   P 
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPK 276

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++S + Y+H   IVH D+K +N+L+   S  + +++ DFG +     S     KI   G+
Sbjct: 141 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GT 197
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDEL 195
             ++APEV+ G     + DVWS G  +  +++G P +   GAN    L ++    ++ EL
Sbjct: 198 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN--GANEYDILKKVEKGKYTFEL 254
Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
           P++  + SE  +D + K L   P  R S    L H ++Q+ +
Sbjct: 255 PQWK-KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 295

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 13/190 (6%)
Query: 53  LEYLPGGTVSDL---ATTLNAYADE-ITLRSHTYCIVSALKYLHSRN-----IVHCDVKG 103
           +EY  GG ++ +    T    Y DE   LR  T   + ALK  H R+     ++H D+K 
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRSDGGHTVLHRDLKP 144
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NV +    + VKL DFG A      DT   K    G+P +M+PE +       +SD+WS
Sbjct: 145 ANVFLDGKQN-VKLGDFGLA-RILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LGC + E+    P +  F    L+      +  R P + S+   + + + L  +   R S
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 261
Query: 224 CDQLLKHPFL 233
            +++L++P +
Sbjct: 262 VEEILENPLI 271

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 114 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 172
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 173 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 290 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 349
Query: 260 FEE 262
            EE
Sbjct: 350 IEE 352

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 13/190 (6%)
Query: 53  LEYLPGGTVSDL---ATTLNAYADE-ITLRSHTYCIVSALKYLHSRN-----IVHCDVKG 103
           +EY  GG ++ +    T    Y DE   LR  T   + ALK  H R+     ++H D+K 
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRSDGGHTVLHRDLKP 144
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NV +    + VKL DFG A    ++       +  G+P +M+PE +       +SD+WS
Sbjct: 145 ANVFLDGKQN-VKLGDFGLA--RILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LGC + E+    P +  F    L+      +  R P + S+   + + + L  +   R S
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 261
Query: 224 CDQLLKHPFL 233
            +++L++P +
Sbjct: 262 VEEILENPLI 271

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ A+ + H   +VH D+K +N+L+      + VKLADFG A E  V   +       G+
Sbjct: 130 ILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGT 187
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----GFSDELPR 197
           P +++PEV+R +  G   D+W+ G  +  ++ G P + D   + L +      +    P 
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 247
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + T + E  +D ++K L   P +R +  + LKHP++   S
Sbjct: 248 WDTVTPE-AKDLINKMLTINPSKRITAAEALKHPWISHRS 286

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S     ++  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMEPEVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                    P   ++  N     G+S E   P   FP  S    
Sbjct: 229 DYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 13/190 (6%)
Query: 53  LEYLPGGTVSDL---ATTLNAYADE-ITLRSHTYCIVSALKYLHSRN-----IVHCDVKG 103
           +EY  GG ++ +    T    Y DE   LR  T   + ALK  H R+     ++H D+K 
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL-ALKECHRRSDGGHTVLHRDLKP 144
Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            NV +    + VKL DFG A      DT   K    G+P +M+PE +       +SD+WS
Sbjct: 145 ANVFLDGKQN-VKLGDFGLA-RILNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
           LGC + E+    P +  F    L+      +  R P + S+   + + + L  +   R S
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPS 261
Query: 224 CDQLLKHPFL 233
            +++L++P +
Sbjct: 262 VEEILENPLI 271

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 15/189 (7%)
Query: 56  LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPNSSF 114
           L G     L   +     E  L   T  IV AL YL  ++ ++H DVK  N+L+      
Sbjct: 105 LMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ- 163
Query: 115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQGPE----SDVWSLGCTII 169
           +KL DFG +G   V D    K +  G   +MAPE +   +   P+    +DVWSLG +++
Sbjct: 164 IKLCDFGISGR-LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 170 EMVTGKPAWEDFGAN--TLSRIGFSDELPRFPTQSSELG--RDFLDKCLRREPGERWSCD 225
           E+ TG+  +++   +   L+++   +E P  P      G  + F+  CL ++  +R   +
Sbjct: 221 ELATGQFPYKNCKTDFEVLTKV-LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYN 279
Query: 226 QLLKHPFLQ 234
           +LL+H F++
Sbjct: 280 KLLEHSFIK 288

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 82/157 (52%), Gaps = 11/157 (7%)
Query: 84  IVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI--QPRG 140
           IV AL++LHS+ +++H DVK  NVL+      VK  DFG +G       + +    +P  
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRF 198
           +P  + PE+   +    +SD+WSLG T IE+   +  ++ +G     L ++   +  P+ 
Sbjct: 204 APERINPEL-NQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQV-VEEPSPQL 261
Query: 199 PTQ--SSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           P    S+E   DF  +CL++   ER +  +L +HPF 
Sbjct: 262 PADKFSAEF-VDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 164
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 276
Query: 217 EPGERW 222
           +  +R+
Sbjct: 277 DLTKRF 282

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
           AL +LHS+ +VH DVK  N+ +GP     KL DFG   E   +    V+    G P +MA
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQ---EGDPRYMA 224
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMV------TGKPAWEDFGANTLSRIGFSDELPRFPT 200
           PE+++G   G  +DV+SLG TI+E+        G   W+      L         P F  
Sbjct: 225 PELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--------PEFTA 275
Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             S   R  L   L  +P  R + + LL  P L+ 
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 164
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 276
Query: 217 EPGERW 222
           +  +R+
Sbjct: 277 DLTKRF 282

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 66  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 126 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 184
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 185 YRDLKPENLLID-QQGYIQVTDFGFA-----KRVKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 296
Query: 217 EPGERW 222
           +  +R+
Sbjct: 297 DLTKRF 302

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 97
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 98  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 156
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 157 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 268
Query: 217 EPGERW 222
           +  +R+
Sbjct: 269 DLTKRF 274

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 164
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 276
Query: 217 EPGERW 222
           +  +R+
Sbjct: 277 DLTKRF 282

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L+  +    D   +    Y ++  +K+LHS  I+H D+K  N++V  +++ +K+ DFG
Sbjct: 113 ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDAT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+G  + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 286
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 93  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELK 151
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 152 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 208 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 260
Query: 236 V 236
           V
Sbjct: 261 V 261

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 44/274 (16%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY----------------LGDDVSYEAPTTSSSCRN 50
           G+ +G+G FG V +A ++ +  + A                 L  ++  +A     +   
Sbjct: 28  GRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILR 87
Query: 51  LH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALKYLHSRNI 96
           L+            LEY P G   +L   L         R+ T    +  AL Y H + +
Sbjct: 88  LYNYFYDRRRIYLILEYAPRG---ELYKELQKSCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K +N+L+G     +K+ADFG +  A     + +     G+  ++ PE++ G    
Sbjct: 145 IHRDIKPENLLLG-LKGELKIADFGWSVHAPSLRRKTMC----GTLDYLPPEMIEGRMHN 199
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
            + D+W +G    E++ G P +E    N   R     +L +FP       +D + K LR 
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL-KFPASVPTGAQDLISKLLRH 258
Query: 217 EPGERWSCDQLLKHPFLQSVS-----PSDANTVA 245
            P ER    Q+  HP++++ S     PS   +VA
Sbjct: 259 NPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 89/221 (40%), Gaps = 64/221 (28%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFVKLADFGAAGEATVSDTRGVK 135
           +R   + I+  L  LH   I+HCD+K +N+L+     S +K+ DFG++            
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTX 259
Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW--EDFG---ANTLSRIG 190
           IQ R    + APEV+ G   G   D+WSLGC + E++TG P    ED G   A  +  +G
Sbjct: 260 IQSR---FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316
Query: 191 FSDE-----------------LPRF-------------------------PTQSSELGR- 207
              +                  PR+                         P +S E G  
Sbjct: 317 MPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376
Query: 208 ----------DFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
                     DFL +CL  +P  R +  Q L+HP+L+   P
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 64/222 (28%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFVKLADFGAAGEATVSDTRGVK 135
           +R   + I+  L  LH   I+HCD+K +N+L+     S +K+ DFG++            
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTX 259
Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW--EDFG---ANTLSRIG 190
           IQ R    + APEV+ G   G   D+WSLGC + E++TG P    ED G   A  +  +G
Sbjct: 260 IQSR---FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316
Query: 191 FSDE-----------------LPRF-------------------------PTQSSELGR- 207
              +                  PR+                         P +S E G  
Sbjct: 317 MPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376
Query: 208 ----------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                     DFL +CL  +P  R +  Q L+HP+L+   P 
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++S + Y H   IVH D+K +N+L+   S  + +++ DFG +     S     KI   G+
Sbjct: 135 VLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI---GT 191
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI---GFSDEL 195
             ++APEV+ G     + DVWS G  +  +++G P +   GAN    L ++    ++ EL
Sbjct: 192 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN--GANEYDILKKVEKGKYTFEL 248
Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
           P++  + SE  +D + K L   P  R S    L H ++Q+ +    +    S    +L+
Sbjct: 249 PQWK-KVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 306

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L+  +    D   +    Y ++  +K+LHS  I+H D+K  N++V  +++ +K+ DFG
Sbjct: 113 ANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDAT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+G  + EM+ G       
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGT 228
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 229 DHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 163
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 164 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 275
Query: 216 REPGERW 222
            +  +R+
Sbjct: 276 VDLTKRF 282

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 286
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 106 ANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXT-LKILDFG 164
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 165 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 279
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 84/191 (43%), Gaps = 9/191 (4%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHS 93
           + Y A     +  N+ LE    G +S +          I  R+   +   + SAL+++HS
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
           R ++H D+K  NV +   +  VKL D G     +   T    +   G+P +M+PE +   
Sbjct: 155 RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERIHEN 211
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RIGFSDELPRFPTQSSELGRDFL 210
               +SD+WSLGC + EM   +  +     N  S   +I   D  P      SE  R  +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271
Query: 211 DKCLRREPGER 221
           + C+  +P +R
Sbjct: 272 NMCINPDPEKR 282

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 38  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 97
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+PGG +      +  +  E   R +   IV   +YLHS +++
Sbjct: 98  KLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLI 156
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 157 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 210
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 268
Query: 217 EPGERW 222
           +  +R+
Sbjct: 269 DLTKRF 274

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   +  G+ +A    D                            V
Sbjct: 46  RIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY PGG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 164
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+++     ++K+ DFG A        +G      G+P ++APE++  +    
Sbjct: 165 YRDLKPENLMID-QQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 276
Query: 217 EPGERW 222
           +  +R+
Sbjct: 277 DLTKRF 282

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDT-RGVKIQPRG 140
           I+ ++ Y HS  IVH ++K +N+L+   +  + VKLADFG A E   S+   G      G
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----G 169
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GFSDELP 196
           +P +++PEV++ +      D+W+ G  +  ++ G P  W++      ++I    +    P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 229
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            + T + E  +  +D  L   P +R + DQ LK P++
Sbjct: 230 EWDTVTPE-AKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 12/132 (9%)
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCIVS-----ALKYLHSRNIVHCDVKGKNVLVG 109
           Y+P G++ D  + L+       L  H  C ++      + +LH  + +H D+K  N+L+ 
Sbjct: 105 YMPNGSLLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL- 160
Query: 110 PNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
            + +F  K++DFG A  +       +  +  G+  +MAPE +RGE   P+SD++S G  +
Sbjct: 161 -DEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEIT-PKSDIYSFGVVL 218
Query: 169 IEMVTGKPAWED 180
           +E++TG PA ++
Sbjct: 219 LEIITGLPAVDE 230

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDT-RGVKIQPRG 140
           I+ ++ Y HS  IVH ++K +N+L+   +  + VKLADFG A E   S+   G      G
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----G 169
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GFSDELP 196
           +P +++PEV++ +      D+W+ G  +  ++ G P  W++      ++I    +    P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 229
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            + T + E  +  +D  L   P +R + DQ LK P++
Sbjct: 230 EWDTVTPE-AKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 163
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 164 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWTLCGTPEYLAPEIILSKGYN 217
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 275
Query: 216 REPGERW 222
            +  +R+
Sbjct: 276 VDLTKRF 282

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 42/229 (18%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
           S  C  L  E++       L        D   ++ + Y ++  + + H   I+H D+K +
Sbjct: 90  SERCLTLVFEFMEKDLKKVLDENKTGLQDS-QIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 105 NVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEVVRGECQGPES- 159
           N+L+  + + +KLADFG A   G    S T  V        LW  AP+V+ G  +   S 
Sbjct: 149 NLLINSDGA-LKLADFGLARAFGIPVRSYTHEV------VTLWYRAPDVLMGSKKYSTSV 201
Query: 160 DVWSLGCTIIEMVTGKPAW-----EDFGANTLSRIGFSD--------ELPRFPTQSSEL- 205
           D+WS+GC   EM+TGKP +     +D      S +G  +        ELP +  ++ ++ 
Sbjct: 202 DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261
Query: 206 ---------------GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                          G D L   L  +P +R S    + HP+ + + P 
Sbjct: 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 115 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 173
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG------- 174
            A  A  S      +  R    + APEV+ G       D+WS+GC + EM+ G       
Sbjct: 174 LARTAGTSFMMVPFVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 230
Query: 175 ------------------------KPAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                   +P    +  N     G+S E   P   FP  S    
Sbjct: 231 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 290
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 291 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 350
Query: 260 FEE 262
            EE
Sbjct: 351 IEE 353

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDT-RGVKIQPRG 140
           I+ ++ Y HS  IVH ++K +N+L+   +  + VKLADFG A E   S+   G      G
Sbjct: 113 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----G 168
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GFSDELP 196
           +P +++PEV++ +      D+W+ G  +  ++ G P  W++      ++I    +    P
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 228
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            + T + E  +  +D  L   P +R + DQ LK P++
Sbjct: 229 EWDTVTPE-AKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 42/229 (18%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
           S  C  L  E++       L        D   ++ + Y ++  + + H   I+H D+K +
Sbjct: 90  SERCLTLVFEFMEKDLKKVLDENKTGLQDS-QIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148
Query: 105 NVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWM-APEVVRGECQGPES- 159
           N+L+  + + +KLADFG A   G    S T  V        LW  AP+V+ G  +   S 
Sbjct: 149 NLLINSDGA-LKLADFGLARAFGIPVRSYTHEV------VTLWYRAPDVLMGSKKYSTSV 201
Query: 160 DVWSLGCTIIEMVTGKPAW-----EDFGANTLSRIGFSD--------ELPRFPTQSSEL- 205
           D+WS+GC   EM+TGKP +     +D      S +G  +        ELP +  ++ ++ 
Sbjct: 202 DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261
Query: 206 ---------------GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                          G D L   L  +P +R S    + HP+ + + P 
Sbjct: 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 72/132 (54%), Gaps = 12/132 (9%)
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCIVS-----ALKYLHSRNIVHCDVKGKNVLVG 109
           Y+P G++ D  + L+       L  H  C ++      + +LH  + +H D+K  N+L+ 
Sbjct: 111 YMPNGSLLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL- 166
Query: 110 PNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
            + +F  K++DFG A  +       +  +  G+  +MAPE +RGE   P+SD++S G  +
Sbjct: 167 -DEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEIT-PKSDIYSFGVVL 224
Query: 169 IEMVTGKPAWED 180
           +E++TG PA ++
Sbjct: 225 LEIITGLPAVDE 236

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 12/188 (6%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 90  VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 148
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 149 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWTLCGTPEYLAPEIILSKGYN 202
Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCL 214
              D W+LG  I EM  G P    F A+   +I         RFP+  S   +D L   L
Sbjct: 203 KAVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 259
Query: 215 RREPGERW 222
           + +  +R+
Sbjct: 260 QVDLTKRF 267

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 22/137 (16%)
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCIVS-----ALKYLHSRNIVHCDVKGKNVLVG 109
           Y+P G++ D  + L+       L  H  C ++      + +LH  + +H D+K  N+L+ 
Sbjct: 111 YMPNGSLLDRLSCLDGTP---PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL- 166
Query: 110 PNSSFV-KLADFGAAGEA-----TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            + +F  K++DFG A  +     TV  +R V     G+  +MAPE +RGE   P+SD++S
Sbjct: 167 -DEAFTAKISDFGLARASEKFAQTVMXSRIV-----GTTAYMAPEALRGEIT-PKSDIYS 219
Query: 164 LGCTIIEMVTGKPAWED 180
            G  ++E++TG PA ++
Sbjct: 220 FGVVLLEIITGLPAVDE 236

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDT-RGVKIQPRG 140
           I+ ++ Y HS  IVH ++K +N+L+   +  + VKLADFG A E   S+   G      G
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA----G 192
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GFSDELP 196
           +P +++PEV++ +      D+W+ G  +  ++ G P  W++      ++I    +    P
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP 252
Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            + T + E  +  +D  L   P +R + DQ LK P++
Sbjct: 253 EWDTVTPE-AKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 28/201 (13%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYC-----IVSALKYLHSRNIVHCDVKGKN 105
           L LEYL GG +            E      T C     I  AL +LH + I++ D+K +N
Sbjct: 98  LILEYLSGGEL------FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
           +++  +   VKL DFG   E+    T  V     G+  +MAPE++         D WSLG
Sbjct: 152 IMLN-HQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLG 208
Query: 166 CTIIEMVTGKPAWEDFGAN---TLSRI-GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
             + +M+TG P +   G N   T+ +I      LP + TQ +   RD L K L+R    R
Sbjct: 209 ALMYDMLTGAPPFT--GENRKKTIDKILKCKLNLPPYLTQEA---RDLLKKLLKRNAASR 263
Query: 222 W-----SCDQLLKHPFLQSVS 237
                    ++  HPF + ++
Sbjct: 264 LGAGPGDAGEVQAHPFFRHIN 284

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 96  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 154
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 155 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 210
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 211 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 263
Query: 236 V 236
           V
Sbjct: 264 V 264

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 286
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 28/201 (13%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYC-----IVSALKYLHSRNIVHCDVKGKN 105
           L LEYL GG +            E      T C     I  AL +LH + I++ D+K +N
Sbjct: 98  LILEYLSGGEL------FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
           +++  +   VKL DFG   E+    T  V     G+  +MAPE++         D WSLG
Sbjct: 152 IMLN-HQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLG 208
Query: 166 CTIIEMVTGKPAWEDFGAN---TLSRI-GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
             + +M+TG P +   G N   T+ +I      LP + TQ +   RD L K L+R    R
Sbjct: 209 ALMYDMLTGAPPFT--GENRKKTIDKILKCKLNLPPYLTQEA---RDLLKKLLKRNAASR 263
Query: 222 W-----SCDQLLKHPFLQSVS 237
                    ++  HPF + ++
Sbjct: 264 LGAGPGDAGEVQAHPFFRHIN 284

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 93  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 151
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 152 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 208 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 260
Query: 236 V 236
           V
Sbjct: 261 V 261

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 64/222 (28%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFVKLADFGAAGEATVSDTRGVK 135
           +R   + I+  L  LH   I+HCD+K +N+L+     S +K+ DFG++            
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXX 259
Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW--EDFG---ANTLSRIG 190
           IQ R    + APEV+ G   G   D+WSLGC + E++TG P    ED G   A  +  +G
Sbjct: 260 IQSR---FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316
Query: 191 FSDE-----------------LPRF-------------------------PTQSSELGR- 207
              +                  PR+                         P +S E G  
Sbjct: 317 MPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376
Query: 208 ----------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                     DFL +CL  +P  R +  Q L+HP+L+   P 
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+++     ++K+ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLMID-QQGYIKVTDFGLAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 97  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 155
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 156 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 211
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 212 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 264
Query: 236 V 236
           V
Sbjct: 265 V 265

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 9/160 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ A+ + H   +VH ++K +N+L+      + VKLADFG A E  V   +       G+
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGT 176
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----GFSDELPR 197
           P +++PEV+R +  G   D+W+ G  +  ++ G P + D   + L +      +    P 
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
           + T + E  +D ++K L   P +R +  + LKHP++   S
Sbjct: 237 WDTVTPE-AKDLINKMLTINPSKRITAAEALKHPWISHRS 275

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+++     ++K+ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLMID-QQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 98  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 156
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 157 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 212
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 213 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 265
Query: 236 V 236
           V
Sbjct: 266 V 266

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  +  E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 98  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 156
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 157 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 212
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 213 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 265
Query: 236 V 236
           V
Sbjct: 266 V 266

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  +  E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 97  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 155
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 156 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 211
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 212 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 264
Query: 236 V 236
           V
Sbjct: 265 V 265

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+PGG +      +  +  E   R +   IV   +YLHS ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDL 163
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 164 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 218 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 275
Query: 216 REPGERW 222
            +  +R+
Sbjct: 276 VDLTKRF 282

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 286
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 98  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 156
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 157 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 212
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 213 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 265
Query: 236 V 236
           V
Sbjct: 266 V 266

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+PGG + +L +  N    E   R +T  +V AL  +HS   +H DVK  N+L+   S
Sbjct: 148 MEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KS 204
Query: 113 SFVKLADFGA----AGEATVSDTRGVKIQPRGSPLWMAPEVVRGE----CQGPESDVWSL 164
             +KLADFG       E  V     V     G+P +++PEV++ +      G E D WS+
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSV 259
Query: 165 GCTIIEMVTGK-PAWEDFGANTLSRI 189
           G  + EM+ G  P + D    T S+I
Sbjct: 260 GVFLYEMLVGDTPFYADSLVGTYSKI 285

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 85  VSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW 144
           +  ++YLH+  ++H D+K  N+ +  +   VK+ DFG A +      R   +   G+P +
Sbjct: 136 IQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKDLC--GTPNY 192
Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELPRFPTQSS 203
           +APEV+  +    E D+WSLGC +  ++ GKP +E      T  RI  ++     P   +
Sbjct: 193 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHIN 250
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
            +    + + L  +P  R S  +LL   F  S
Sbjct: 251 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 282

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 140 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 198
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 199 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 255 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 307
Query: 236 V 236
           V
Sbjct: 308 V 308

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+PGG + +L +  N    E   R +T  +V AL  +HS   +H DVK  N+L+   S
Sbjct: 153 MEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KS 209
Query: 113 SFVKLADFGA----AGEATVSDTRGVKIQPRGSPLWMAPEVVRGE----CQGPESDVWSL 164
             +KLADFG       E  V     V     G+P +++PEV++ +      G E D WS+
Sbjct: 210 GHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSV 264
Query: 165 GCTIIEMVTGK-PAWEDFGANTLSRI 189
           G  + EM+ G  P + D    T S+I
Sbjct: 265 GVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 74/146 (50%), Gaps = 17/146 (11%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+PGG + +L +  N    E   R +T  +V AL  +HS   +H DVK  N+L+   S
Sbjct: 153 MEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD-KS 209
Query: 113 SFVKLADFGA----AGEATVSDTRGVKIQPRGSPLWMAPEVVRGE----CQGPESDVWSL 164
             +KLADFG       E  V     V     G+P +++PEV++ +      G E D WS+
Sbjct: 210 GHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSV 264
Query: 165 GCTIIEMVTGK-PAWEDFGANTLSRI 189
           G  + EM+ G  P + D    T S+I
Sbjct: 265 GVFLYEMLVGDTPFYADSLVGTYSKI 290

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 96/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S     ++  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMEPEVVTR---YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                    P    +  N     G+S E   P   FP  S    
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 288
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 289 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 348
Query: 260 FEE 262
            EE
Sbjct: 349 IEE 351

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 140 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 198
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 199 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 255 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 307
Query: 236 V 236
           V
Sbjct: 308 V 308

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 85  VSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW 144
           +  ++YLH+  ++H D+K  N+ +  +   VK+ DFG A +      R   +   G+P +
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKXLC--GTPNY 208
Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELPRFPTQSS 203
           +APEV+  +    E D+WSLGC +  ++ GKP +E      T  RI  ++     P   +
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHIN 266
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
            +    + + L  +P  R S  +LL   F  S
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           + +T +S    +++ + Y H R ++H D+K +N+L+      +K+ADFG A    +    
Sbjct: 98  ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVR- 155
Query: 133 GVKIQPRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI 189
             K       LW  AP+V+ G  +   + D+WS+GC   EMV G P +     A+ L RI
Sbjct: 156 --KYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213
Query: 190 ----GFSD--------ELPRF----------PTQS-----SELGRDFLDKCLRREPGERW 222
               G  +        ELP++          P +S      E G D L K L+ +P +R 
Sbjct: 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
Query: 223 SCDQLLKHPFLQ 234
           +  Q L+H + +
Sbjct: 274 TAKQALEHAYFK 285

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV---SALKYLHSRNI 96
           EA T +     + +EY+ G T+ D+  T       +T +     I     AL + H   I
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           +H DVK  N+L+   ++ VK+ DFG A    ++D+     Q     G+  +++PE  RG+
Sbjct: 138 IHRDVKPANILISATNA-VKVVDFGIA--RAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAW 178
                SDV+SLGC + E++TG+P +
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 125 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 184 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 240 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 292
Query: 236 V 236
           V
Sbjct: 293 V 293

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY PGG +      +  +  E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+++     ++K+ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLMID-QQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 113 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 171
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 172 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F   +      SSE  +  +  CL   P +R + +++  HP++Q 
Sbjct: 228 IPFEHDEEIIRGQVFFRQRV------SSEC-QHLIRWCLALRPSDRPTFEEIQNHPWMQD 280
Query: 236 V 236
           V
Sbjct: 281 V 281

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 85  VSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW 144
           +  ++YLH+  ++H D+K  N+ +  +   VK+ DFG A +      R   +   G+P +
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKDLC--GTPNY 208
Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELPRFPTQSS 203
           +APEV+  +    E D+WSLGC +  ++ GKP +E      T  RI  ++     P   +
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHIN 266
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
            +    + + L  +P  R S  +LL   F  S
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 93  PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 151
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 152 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 208 IPFEHDEEIIGGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 260
Query: 236 V 236
           V
Sbjct: 261 V 261

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 45/268 (16%)
Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA----------------YLGDDVSYEAPTTSSSC 48
           +  K +GRG F  V   + +  G  +A                 L +    E   +    
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 49  RNLH------------LEYLPGGTVSDLAT-TLNAYADEITLRSHTYCIVSALKYLHSRN 95
            NLH            LEY  GG +  L    L     E  +      I+  + YLH  N
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 96  IVHCDVKGKNVLVGPNSSF--VKLADFGAAGE-ATVSDTRGVKIQPRGSPLWMAPEVVRG 152
           IVH D+K +N+L+        +K+ DFG + +     + R +     G+P ++APE++  
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MGTPEYLAPEILNY 207
Query: 153 ECQGPESDVWSLGCTIIEMVT------GKPAWEDFGANTLSRIGFSDELPRFPTQSSELG 206
           +     +D+W++G     ++T      G+   E +   +   + +S+E     +  S+L 
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET---FSSVSQLA 264
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQ 234
            DF+   L + P +R + +  L H +LQ
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQ 292

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 112 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 170
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 171 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 227 IPFEHDEEIIRGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 279
Query: 236 V 236
           V
Sbjct: 280 V 280

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           + +T +S    +++ + Y H R ++H D+K +N+L+      +K+ADFG A    +    
Sbjct: 98  ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVR- 155
Query: 133 GVKIQPRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI 189
             K       LW  AP+V+ G  +   + D+WS+GC   EMV G P +     A+ L RI
Sbjct: 156 --KYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRI 213
Query: 190 ----GFSD--------ELPRF----------PTQS-----SELGRDFLDKCLRREPGERW 222
               G  +        ELP++          P +S      E G D L K L+ +P +R 
Sbjct: 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
Query: 223 SCDQLLKHPFLQ 234
           +  Q L+H + +
Sbjct: 274 TAKQALEHAYFK 285

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 85  VSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW 144
           +  ++YLH+  ++H D+K  N+ +  +   VK+ DFG A +      R   +   G+P +
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMD-VKIGDFGLATKIEFDGERKKTLC--GTPNY 208
Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFSDELPRFPTQSS 203
           +APEV+  +    E D+WSLGC +  ++ GKP +E      T  RI  ++     P   +
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEY--SVPRHIN 266
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
            +    + + L  +P  R S  +LL   F  S
Sbjct: 267 PVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLXGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 132 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 191 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F   +      SSE  +  +  CL   P +R + +++  HP++Q 
Sbjct: 247 IPFEHDEEIIRGQVFFRQRV------SSEC-QHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
Query: 236 V 236
           V
Sbjct: 300 V 300

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           + +T +S    +++ + Y H R ++H D+K +N+L+      +K+ADFG A    +    
Sbjct: 98  ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVR- 155
Query: 133 GVKIQPRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI 189
             K       LW  AP+V+ G  +   + D+WS+GC   EMV G P +     A+ L RI
Sbjct: 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213
Query: 190 ----GFSD--------ELPRF----------PTQS-----SELGRDFLDKCLRREPGERW 222
               G  +        ELP++          P +S      E G D L K L+ +P +R 
Sbjct: 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
Query: 223 SCDQLLKHPFLQ 234
           +  Q L+H + +
Sbjct: 274 TAKQALEHAYFK 285

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY PGG +      +  ++ E   R +   IV   +YLHS ++++ D+K +N+++    
Sbjct: 121 MEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQ 178
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
            ++K+ DFG A        +G      G+P ++APE++  +      D W+LG  I EM 
Sbjct: 179 GYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 173 TGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            G P  + D       +I  S ++ RFP+  S   +D L   L+ +  +R+
Sbjct: 234 AGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 151 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 209
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 210 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 324
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 95/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 118 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 176
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 177 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 233
Query: 176 -------------------------PAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                    P    +  N     G+S E   P   FP  S    
Sbjct: 234 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 293
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 294 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 353
Query: 260 FEE 262
            EE
Sbjct: 354 IEE 356

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLAGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 45/253 (17%)
Query: 10  IGRGSFGTV--------NVAVDRFNGD-----VFAYLGDDVSYEAPTTSS---SCRN--- 50
           +GRG+FG V        +VA+ +   +         L        P       +C N   
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC 75
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV--SALKYLHS---RNIVHCDVKGKN 105
           L +EY  GG++ ++              + ++C+     + YLHS   + ++H D+K  N
Sbjct: 76  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
           +L+    + +K+ DFG A +     T       +GS  WMAPEV  G     + DV+S G
Sbjct: 136 LLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEGSNYSEKCDVFSWG 190
Query: 166 CTIIEMVTGKPAWEDFGANTL---------SRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             + E++T +  +++ G             +R      LP+ P +S       + +C  +
Sbjct: 191 IILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIES------LMTRCWSK 243
Query: 217 EPGERWSCDQLLK 229
           +P +R S ++++K
Sbjct: 244 DPSQRPSMEEIVK 256

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NVL+    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV--GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           ++ A+ YLH   IVH D+K +N+L       S + ++DFG +      D         G+
Sbjct: 129 VLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC---GT 185
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR---F 198
           P ++APEV+  +      D WS+G     ++ G P + D   + L       E      +
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPY 245
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               S+  +DF+   + ++P +R++C+Q  +HP++
Sbjct: 246 WDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWI 280

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY PGG +      +  ++ E   R +   IV   +YLHS ++++ D+K +N+++    
Sbjct: 121 MEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQ 178
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
            ++K+ DFG A        +G      G+P ++APE++  +      D W+LG  I EM 
Sbjct: 179 GYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 173 TGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            G P  + D       +I  S ++ RFP+  S   +D L   L+ +  +R+
Sbjct: 234 AGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 45/253 (17%)
Query: 10  IGRGSFGTV--------NVAVDRFNGD-----VFAYLGDDVSYEAPTTSS---SCRN--- 50
           +GRG+FG V        +VA+ +   +         L        P       +C N   
Sbjct: 17  VGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC 76
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV--SALKYLHS---RNIVHCDVKGKN 105
           L +EY  GG++ ++              + ++C+     + YLHS   + ++H D+K  N
Sbjct: 77  LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 136
Query: 106 VLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLG 165
           +L+    + +K+ DFG A +     T       +GS  WMAPEV  G     + DV+S G
Sbjct: 137 LLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEGSNYSEKCDVFSWG 191
Query: 166 CTIIEMVTGKPAWEDFGANTL---------SRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             + E++T +  +++ G             +R      LP+ P +S       + +C  +
Sbjct: 192 IILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK-PIES------LMTRCWSK 244
Query: 217 EPGERWSCDQLLK 229
           +P +R S ++++K
Sbjct: 245 DPSQRPSMEEIVK 257

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 151 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 209
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 210 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 324
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 15/193 (7%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+PGG + +L +  N    E   + +T  +V AL  +HS  ++H DVK  N+L+  + 
Sbjct: 154 MEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 211
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGE----CQGPESDVWSLGCT 167
             +KLADFG      + +T  V      G+P +++PEV++ +      G E D WS+G  
Sbjct: 212 H-LKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 268
Query: 168 IIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPTQS--SELGRDFLDKCL--RREPGERW 222
           + EM+ G  P + D    T S+I        FP  +  S+  ++ +   L  R     R 
Sbjct: 269 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRN 328
Query: 223 SCDQLLKHPFLQS 235
             +++ +HPF ++
Sbjct: 329 GVEEIKQHPFFKN 341

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 120 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 178
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 179 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 234
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 235 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 287
Query: 236 V 236
           V
Sbjct: 288 V 288

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 114 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 172
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 173 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 287
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 24/198 (12%)
Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV---SALKYLHSRNI 96
           EA T +     + +EY+ G T+ D+  T       +T +     I     AL + H   I
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQNGI 137
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           +H DVK  N+++   ++ VK+ DFG A    ++D+     Q     G+  +++PE  RG+
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIA--RAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS----DELP---RFPTQSSELG 206
                SDV+SLGC + E++TG+P    F  ++   + +     D +P   R    S++L 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP---FTGDSPDSVAYQHVREDPIPPSARHEGLSADLD 251
Query: 207 RDFLDKCLRREPGERWSC 224
              L K L + P  R+  
Sbjct: 252 AVVL-KALAKNPENRYQT 268

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 114 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 172
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 173 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 230 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 287
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 288 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 286
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  +A E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFA-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 95/243 (39%), Gaps = 46/243 (18%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 107 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 165
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 166 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 222
Query: 176 -------------------------PAWEDFGANTLSRIGFSDE--LPR--FPTQS---- 202
                                    P    +  N     G+S E   P   FP  S    
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNK 282
Query: 203 --SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWVNSE 259
             +   RD L K L  +  +R S D+ L+HP++     PS+A       P   LD     
Sbjct: 283 LKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHT 342
Query: 260 FEE 262
            EE
Sbjct: 343 IEE 345

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 112 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 170
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 171 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 227
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 228 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 285
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 286 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 106 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 164
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 165 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 279
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 113 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 171
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 172 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 229 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 286
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 287 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 107 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 165
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 166 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 280
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 112 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 170
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 171 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 227 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 279
Query: 236 V 236
           V
Sbjct: 280 V 280

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 125 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 184 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 240 IPFEHDEEIIGGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 292
Query: 236 V 236
           V
Sbjct: 293 V 293

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 86/215 (40%), Gaps = 49/215 (22%)
Query: 62  SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG 121
           ++L   +    D   +    Y ++  +K+LHS  I+H D+K  N++V  + + +K+ DFG
Sbjct: 107 ANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFG 165
Query: 122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK------ 175
            A  A  S      +  R    + APEV+ G       D+WS+GC + EMV  K      
Sbjct: 166 LARTAGTSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222
Query: 176 -------------------------PAWEDFGANTLSRIG------FSDELPRFPTQS-- 202
                                    P   ++  N     G      F D L  FP  S  
Sbjct: 223 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL--FPADSEH 280
Query: 203 ----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
               +   RD L K L  +P +R S D  L+HP++
Sbjct: 281 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+++     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLMID-QQGYIQVTDFGLAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 4/157 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I + + YL S++ VH D+  +N LVG N   VK+ DFG + +   +D   V         
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           WM PE +       ESDVWSLG  + E+ T GK  W     N +        + + P   
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC 255
Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
            +   + +  C +REP  R +   +  H  LQ+++ +
Sbjct: 256 PQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAKA 290

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 113 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 171
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 172 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 228 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 280
Query: 236 V 236
           V
Sbjct: 281 V 281

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 126 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 185 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 241 IPFEHDEEIIGGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 293
Query: 236 V 236
           V
Sbjct: 294 V 294

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY PGG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+++     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLMID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 125 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 184 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 240 IPFEHDEEIIGGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 292
Query: 236 V 236
           V
Sbjct: 293 V 293

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 140 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 198
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 199 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 255 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 307
Query: 236 V 236
           V
Sbjct: 308 V 308

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 145 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 203
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 204 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 260 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 312
Query: 236 V 236
           V
Sbjct: 313 V 313

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 126 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 184
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 185 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGATWTLCGTPEYLAPEIILSKGYNK 238
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 296
Query: 217 EPGERW 222
           +  +R+
Sbjct: 297 DLTKRF 302

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 10/171 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY PGG +      +  +  E   R +   IV   +YLHS ++++ D+K +N+++    
Sbjct: 121 MEYAPGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMID-QQ 178
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
            ++K+ DFG A        +G      G+P ++APE++  +      D W+LG  I EM 
Sbjct: 179 GYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 173 TGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            G P  + D       +I  S ++ RFP+  S   +D L   L+ +  +R+
Sbjct: 234 AGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 126 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 185 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R  ++   L R     CL   P +R + +++  HP++Q 
Sbjct: 241 IPFEHDEEIIGGQVFFRQ---RVSSECQHLIR----WCLALRPSDRPTFEEIQNHPWMQD 293
Query: 236 V 236
           V
Sbjct: 294 V 294

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV---SALKYLHSRNI 96
           EA T +     + +EY+ G T+ D+  T       +T +     I     AL + H   I
Sbjct: 99  EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGI 154
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           +H DVK  N+++   ++ VK+ DFG A    ++D+     Q     G+  +++PE  RG+
Sbjct: 155 IHRDVKPANIMISATNA-VKVMDFGIA--RAIADSGNSVTQTAAVIGTAQYLSPEQARGD 211
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAW 178
                SDV+SLGC + E++TG+P +
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV---SALKYLHSRNI 96
           EA T +     + +EY+ G T+ D+  T       +T +     I     AL + H   I
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           +H DVK  N+++   ++ VK+ DFG A    ++D+     Q     G+  +++PE  RG+
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIA--RAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAW 178
                SDV+SLGC + E++TG+P +
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 113 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 171
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 172 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227
Query: 176 PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +E        ++ F     R   +   L R     CL   P +R + +++  HP++Q 
Sbjct: 228 IPFEHDEEIIRGQVFFRQ---RVSXECQHLIR----WCLALRPXDRPTFEEIQNHPWMQD 280
Query: 236 V 236
           V
Sbjct: 281 V 281

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV---SALKYLHSRNI 96
           EA T +     + +EY+ G T+ D+  T       +T +     I     AL + H   I
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           +H DVK  N+++   ++ VK+ DFG A    ++D+     Q     G+  +++PE  RG+
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIA--RAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAW 178
                SDV+SLGC + E++TG+P +
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 13/145 (8%)
Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIV---SALKYLHSRNI 96
           EA T +     + +EY+ G T+ D+  T       +T +     I     AL + H   I
Sbjct: 82  EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGI 137
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           +H DVK  N+++   ++ VK+ DFG A    ++D+     Q     G+  +++PE  RG+
Sbjct: 138 IHRDVKPANIMISATNA-VKVMDFGIA--RAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 154 CQGPESDVWSLGCTIIEMVTGKPAW 178
                SDV+SLGC + E++TG+P +
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           + I   ++YLH++ +VH D+K  N+L      N   +++ DFG A +    +  G+   P
Sbjct: 123 FTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLXTP 180
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAW----EDFGANTLSRIG---F 191
             +  ++APEV+  +      D+WSLG  +   +TG   +    +D     L+RIG   F
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           S     +    S+  +D + K L  +P +R +   +L+HP++
Sbjct: 241 SLS-GGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 112 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 224
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 225 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 284
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 285 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 331

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 126 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 185 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 176 PAWED----FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP 231
             +E      G     R   S E            +  +  CL   P +R + +++  HP
Sbjct: 241 IPFEHDEEIIGGQVFFRQRVSXEC-----------QHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 232 FLQSV 236
           ++Q V
Sbjct: 290 WMQDV 294

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 125 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 183
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 184 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 239
Query: 176 PAWED----FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP 231
             +E      G     R   S E            +  +  CL   P +R + +++  HP
Sbjct: 240 IPFEHDEEIIGGQVFFRQRVSXEC-----------QHLIRWCLALRPSDRPTFEEIQNHP 288
Query: 232 FLQSV 236
           ++Q V
Sbjct: 289 WMQDV 293

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 21/185 (11%)
Query: 57  PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK 116
           P   + D  T   A  +E+  RS  + ++ A+++ H+  ++H D+K +N+L+  N   +K
Sbjct: 126 PVQDLFDFITERGALQEELA-RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 184
Query: 117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGK 175
           L DFG+   A + DT  V     G+ ++  PE +R     G  + VWSLG  + +MV G 
Sbjct: 185 LIDFGSG--ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 240
Query: 176 PAWED----FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP 231
             +E      G     R   S E            +  +  CL   P +R + +++  HP
Sbjct: 241 IPFEHDEEIIGGQVFFRQRVSXEC-----------QHLIRWCLALRPSDRPTFEEIQNHP 289
Query: 232 FLQSV 236
           ++Q V
Sbjct: 290 WMQDV 294

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPN 111
           +EY  GG + +       ++++   R     ++S + Y H+  + H D+K +N L+ G  
Sbjct: 94  MEYASGGELFERICNAGRFSED-EARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSP 152
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCT 167
           +  +K+ADFG +  + +        QP+   G+P ++APEV+ + E  G  +DVWS G T
Sbjct: 153 APRLKIADFGYSKASVLHS------QPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 168 IIEMVTGKPAWED------FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           +  M+ G   +ED      F       +     +P +   S E  R  + +    +P +R
Sbjct: 207 LYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC-RHLISRIFVADPAKR 265
Query: 222 WSCDQLLKHPFLQSVSPSD 240
            S  ++  H +     P+D
Sbjct: 266 ISIPEIRNHEWFLKNLPAD 284

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I+SA++Y H   IVH D+K +N+L+  + + VK+ADFG +    ++D   +K    GSP 
Sbjct: 122 IISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSN--IMTDGNFLKTSC-GSPN 177
Query: 144 WMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           + APEV+ G+   GPE DVWS G  +  M+  +  ++D     L +   S+ +   P   
Sbjct: 178 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-NISNGVYTLPKFL 236
Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK 229
           S      + + L   P  R S  ++++
Sbjct: 237 SPGAAGLIKRMLIVNPLNRISIHEIMQ 263

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 118 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 173
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 174 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 230
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 231 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 290
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 291 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 337

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 89/227 (39%), Gaps = 45/227 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLRQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                        DFLDK LR +   R +  + ++HP+  +V    A
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQA 332

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I+SA++Y H   IVH D+K +N+L+  + + VK+ADFG +    ++D   +K    GSP 
Sbjct: 121 IISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSN--IMTDGNFLKTSC-GSPN 176
Query: 144 WMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           + APEV+ G+   GPE DVWS G  +  M+  +  ++D     L +   S+ +   P   
Sbjct: 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-NISNGVYTLPKFL 235
Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK 229
           S      + + L   P  R S  ++++
Sbjct: 236 SPGAAGLIKRMLIVNPLNRISIHEIMQ 262

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I+SA++Y H   IVH D+K +N+L+  + + VK+ADFG +    ++D   +K    GSP 
Sbjct: 112 IISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSN--IMTDGNFLKTSC-GSPN 167
Query: 144 WMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           + APEV+ G+   GPE DVWS G  +  M+  +  ++D     L +   S+ +   P   
Sbjct: 168 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-NISNGVYTLPKFL 226
Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK 229
           S      + + L   P  R S  ++++
Sbjct: 227 SPGAAGLIKRMLIVNPLNRISIHEIMQ 253

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 6/147 (4%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I+SA++Y H   IVH D+K +N+L+  + + VK+ADFG +    ++D   +K    GSP 
Sbjct: 116 IISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSN--IMTDGNFLKTSC-GSPN 171
Query: 144 WMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           + APEV+ G+   GPE DVWS G  +  M+  +  ++D     L +   S+ +   P   
Sbjct: 172 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK-NISNGVYTLPKFL 230
Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK 229
           S      + + L   P  R S  ++++
Sbjct: 231 SPGAAGLIKRMLIVNPLNRISIHEIMQ 257

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 46  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 105
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 106 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 164
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 165 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 218
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 276
Query: 217 EPGERW 222
           +  +R+
Sbjct: 277 DLTKRF 282

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 45/222 (20%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                        DFLDK LR +   R +  + ++HP+  +V
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 45/222 (20%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 112 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 167
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 168 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 224
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 225 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 284
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                        DFLDK LR +   R +  + ++HP+  +V
Sbjct: 285 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEV 149
           LH  NIVH D+K +N+L+  + + +KL DFG + +       G K++   G+P ++APE+
Sbjct: 127 LHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLD----PGEKLREVCGTPSYLAPEI 181
Query: 150 VRGECQ--------GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL----PR 197
           +  EC         G E D+WS G  +  ++ G P +       + R+  S       P 
Sbjct: 182 I--ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 239
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
           +   S  + +D + + L  +P +R++ ++ L HPF Q 
Sbjct: 240 WDDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEV 149
           LH  NIVH D+K +N+L+  + + +KL DFG + +       G K++   G+P ++APE+
Sbjct: 140 LHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLD----PGEKLRSVCGTPSYLAPEI 194
Query: 150 VRGECQ--------GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL----PR 197
           +  EC         G E D+WS G  +  ++ G P +       + R+  S       P 
Sbjct: 195 I--ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
           +   S  + +D + + L  +P +R++ ++ L HPF Q 
Sbjct: 253 WDDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 45/222 (20%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                        DFLDK LR +   R +  + ++HP+  +V
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 40/247 (16%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLR 215
             D W+LG  I EM  G P    F A+   +I         RFP+  S   +D L   L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEV 149
           LH  NIVH D+K +N+L+  + + +KL DFG + +       G K++   G+P ++APE+
Sbjct: 140 LHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLD----PGEKLREVCGTPSYLAPEI 194
Query: 150 VRGECQ--------GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL----PR 197
           +  EC         G E D+WS G  +  ++ G P +       + R+  S       P 
Sbjct: 195 I--ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252
Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
           +   S  + +D + + L  +P +R++ ++ L HPF Q 
Sbjct: 253 WDDYSDTV-KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 40/247 (16%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 32  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 91
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 92  KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 150
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 151 YRDLKPENLLID-EQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 204
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLR 215
             D W+LG  I EM  G P    F A+   +I         RFP+  S   +D L   L+
Sbjct: 205 AVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 261
Query: 216 REPGERW 222
            +  +R+
Sbjct: 262 VDLTKRF 268

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 45/222 (20%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 111 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 166
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 167 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 283
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                        DFLDK LR +   R +  + ++HP+  +V
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 45/234 (19%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E++       L  TL  Y     +R + Y I+ AL Y HS  I+H DVK  NV++    
Sbjct: 113 FEHVNNTDFKQLYQTLTDY----DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH 168
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A          V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 169 RKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 225
Query: 172 VTGKPAWEDFGAN--TLSRIG-------FSDELPRF-----PTQSSELGR---------- 207
           +  K  +     N   L RI          D + ++     P  +  LGR          
Sbjct: 226 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV 285
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
                        DFLDK LR +   R +  + ++HP+   V    +   A+++
Sbjct: 286 HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPVVKEQSQPCADNA 339

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNS-SFVKLADFG-AAGEATVSDTRGVK----I 136
           + SAL +LH++ I H D+K +N+L   PN  S VK+ DFG  +G     D   +     +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL 179
Query: 137 QPRGSPLWMAPEVV-----RGECQGPESDVWSLGCTIIEMVTGKP----------AWEDF 181
            P GS  +MAPEVV              D+WSLG  +  +++G P           W+  
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239
Query: 182 GANTLSRIGFSDELP----RFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            A    +    + +      FP +     S   +D + K L R+  +R S  Q+L+HP++
Sbjct: 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 234 QSVSPSD 240
           Q  +P +
Sbjct: 300 QGCAPEN 306

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 120 HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 175
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 176 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 232
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 233 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQLEALVGRH 291
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 292 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 346

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADEPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 10/187 (5%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDL 162
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           ++ D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +   
Sbjct: 163 IYRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 157 PESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
              D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 47/236 (19%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           ++   Y  + A+K LH  N++H D+K  N+L+  N   +K+ DFG A    + ++     
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLA--RIIDESAADNS 170
Query: 137 QPRGSPLWM----------APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGA 183
           +P G    M          APEV+    +   + DVWS GC + E+   +P +   D+  
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 184 NTLSRIG---------------------FSDELPRFPTQSSE--------LGRDFLDKCL 214
             L   G                     +   LP +P    E         G D L + L
Sbjct: 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEK 270
             +P +R +  + L+HP+LQ+    +     E  P    ++    ++E  T+ D K
Sbjct: 291 VFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF--DHYKEALTTKDLK 344

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  +  E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 66  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 125
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  +  E   R +   IV   +YLHS +++
Sbjct: 126 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLI 184
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 185 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 238
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 296
Query: 217 EPGERW 222
           +  +R+
Sbjct: 297 DLTKRF 302

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 40/247 (16%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  +  E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLR 215
             D W+LG  I EM  G P    F A+   +I         RFP+  S   +D L   L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 40/247 (16%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 40  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 99
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  +  E   R +   IV   +YLHS +++
Sbjct: 100 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLI 158
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 159 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 212
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLR 215
             D W+LG  I EM  G P    F A+   +I         RFP+  S   +D L   L+
Sbjct: 213 AVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 269
Query: 216 REPGERW 222
            +  +R+
Sbjct: 270 VDLTKRF 276

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 47/236 (19%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           ++   Y  + A+K LH  N++H D+K  N+L+  N   +K+ DFG A    + ++     
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLA--RIIDESAADNS 170
Query: 137 QPRGSPLWM----------APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGA 183
           +P G    M          APEV+    +   + DVWS GC + E+   +P +   D+  
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 184 NTLSRIG---------------------FSDELPRFPTQSSE--------LGRDFLDKCL 214
             L   G                     +   LP +P    E         G D L + L
Sbjct: 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEK 270
             +P +R +  + L+HP+LQ+    +     E  P    ++    ++E  T+ D K
Sbjct: 291 VFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF--DHYKEALTTKDLK 344

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 47/236 (19%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           ++   Y  + A+K LH  N++H D+K  N+L+  N   +K+ DFG A    + ++     
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLA--RIIDESAADNS 170
Query: 137 QPRGSPLWM----------APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGA 183
           +P G    M          APEV+    +   + DVWS GC + E+   +P +   D+  
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 184 NTLSRIG---------------------FSDELPRFPTQSSE--------LGRDFLDKCL 214
             L   G                     +   LP +P    E         G D L + L
Sbjct: 231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEK 270
             +P +R +  + L+HP+LQ+    +     E  P    ++    ++E  T+ D K
Sbjct: 291 VFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF--DHYKEALTTKDLK 344

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 48/242 (19%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 101 HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 156
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 157 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 213
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 214 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 272
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSV-SPSDANTV 244
                                 DFLDK LR +  ER +  + + HP+ Q V +  ++ T 
Sbjct: 273 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTR 332
Query: 245 AE 246
           AE
Sbjct: 333 AE 334

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 99  HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 154
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 155 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 211
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 212 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 270
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 99  HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 154
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 155 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 211
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 212 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 270
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 99  HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 154
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 155 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 211
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 212 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 270
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 100 HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 155
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 156 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 212
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 213 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 271
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 272 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 326

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 99  HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 154
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 155 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 211
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 212 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 270
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 40/247 (16%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  +  E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFX-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLR 215
             D W+LG  I EM  G P    F A+   +I         RFP+  S   +D L   L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPP---FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ 274
Query: 216 REPGERW 222
            +  +R+
Sbjct: 275 VDLTKRF 281

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 10/152 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           +++AL Y HS+++VH D+K +N+L    S  S +K+ DFG A E   SD         G+
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA-ELFKSDEHSTN--AAGT 189
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ 201
            L+MAPEV + +    + D+WS G  +  ++TG   +       + +     E P +  +
Sbjct: 190 ALYMAPEVFKRDVTF-KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-PNYAVE 247
Query: 202 SSEL---GRDFLDKCLRREPGERWSCDQLLKH 230
              L     D L + L ++P  R S  Q+L H
Sbjct: 248 CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 99  HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 154
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 155 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 211
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 212 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 270
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 100 HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 155
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 156 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 212
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 213 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 271
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 272 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 326

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 47/235 (20%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
            S   +L  EY+       L  TL  Y     +R + Y ++ AL Y HS+ I+H DVK  
Sbjct: 99  HSKTPSLIFEYVNNTDFKVLYPTLTDY----DIRYYIYELLKALDYCHSQGIMHRDVKPH 154
Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWS 163
           NV++      ++L D+G A          V++  R    +  PE +V  +      D+WS
Sbjct: 155 NVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGPELLVDLQDYDYSLDMWS 211
Query: 164 LGCTIIEMVTGKPAWEDFG----------ANTLSRIGFSDELPRF-----PTQSSELGR- 207
           LGC    M+  K  +  +G          A  L   G +  L ++     P   + +GR 
Sbjct: 212 LGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVGRH 270
Query: 208 ----------------------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                                 DFLDK LR +  ER +  + + HP+ Q V  ++
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 109/272 (40%), Gaps = 40/272 (14%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 80  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 139 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 256
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
             +P +R +   L    FL    P+D   + +
Sbjct: 257 AHKPEDRPTFVAL--RDFLLEAQPTDMRALQD 286

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 2/147 (1%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I S + YL S++ VH D+  +N LVG N   VK+ DFG + +   +D   V         
Sbjct: 142 IASGMVYLASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQS 202
           WM PE +       ESDVWS G  + E+ T GK  W       +        +   P   
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVC 260
Query: 203 SELGRDFLDKCLRREPGERWSCDQLLK 229
            +   D +  C +REP +R +  ++ K
Sbjct: 261 PKEVYDVMLGCWQREPQQRLNIKEIYK 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 66/126 (52%), Gaps = 6/126 (4%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            L +EY+P G++ D     +    ++ L +   C    + YLH+++ +H D+  +NVL+ 
Sbjct: 111 QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--EGMAYLHAQHYIHRDLAARNVLLD 168
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP-LWMAPEVVRGECQGPESDVWSLGCT 167
            N   VK+ DFG A +A        +++  G SP  W APE ++       SDVWS G T
Sbjct: 169 -NDRLVKIGDFGLA-KAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 168 IIEMVT 173
           + E++T
Sbjct: 227 LYELLT 232

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 102/239 (42%), Gaps = 38/239 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQ 274

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I +M  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYQMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 107/266 (40%), Gaps = 40/266 (15%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 86  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 145 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 262
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSD 240
             +P +R +   L    FL    P+D
Sbjct: 263 AHKPEDRPTFVAL--RDFLLEAQPTD 286

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-- 95
           S+E+      C  L  E    GT+            ++ LRS    I+  L++LH+R   
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV-LRSWCRQILKGLQFLHTRTPP 151
Query: 96  IVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
           I+H D+K  N+ + GP  S VK+ D G A     S  + V     G+P + APE    E 
Sbjct: 152 IIHRDLKCDNIFITGPTGS-VKIGDLGLATLKRASFAKAVI----GTPEFXAPEXYE-EK 205
Query: 155 QGPESDVWSLGCTIIEMVTGKPAWED--FGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
                DV++ G   +E  T +  + +    A    R+    +   F   +    ++ ++ 
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265
Query: 213 CLRREPGERWSCDQLLKHPFLQ 234
           C+R+   ER+S   LL H F Q
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQ 287

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 106/246 (43%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+++     ++++ DFG A        +G      G+P ++APE++  +    
Sbjct: 164 YRDLKPENLIID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEIIISKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + Y+  +N +H D++  NVLV   S   K+ADFG A    + D      +    P+
Sbjct: 119 IAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLA--RVIEDNEYTAREGAKFPI 175
Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GK-PAWEDFGANTLSRIGFSDELPRFPT 200
            W APE +   C   +SDVWS G  + E+VT GK P      A+ ++ +     +PR   
Sbjct: 176 KWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVEN 235
Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
              EL  D +  C + +  ER + D      +LQSV
Sbjct: 236 CPDEL-YDIMKMCWKEKAEERPTFD------YLQSV 264

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 83/182 (45%), Gaps = 27/182 (14%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEI---TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L +EY  GG   DL T L+ + + I     R +   IV A+  +H    VH D+K  N+L
Sbjct: 138 LVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194
Query: 108 VGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRG-------ECQG 156
           +      ++LADFG+      + TV     V     G+P +++PE+++           G
Sbjct: 195 LD-RCGHIRLADFGSCLKLRADGTVRSLVAV-----GTPDYLSPEILQAVGGGPGTGSYG 248
Query: 157 PESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDE---LPRFPTQSSELGRDFLDK 212
           PE D W+LG    EM  G+ P + D  A T  +I    E   LP       E  RDF+ +
Sbjct: 249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQR 308
Query: 213 CL 214
            L
Sbjct: 309 LL 310

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 107/266 (40%), Gaps = 40/266 (15%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 76  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 135 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 252
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSD 240
             +P +R +   L    FL    P+D
Sbjct: 253 AHKPEDRPTFVAL--RDFLLEAQPTD 276

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 28/199 (14%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P  T  DL      Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 121 STYLRSKRNEFVPYKTPEDL------YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 175 AARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 234 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 286
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 287 -CWHGEPSQRPTFSELVEH 304

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I   + Y+  +N +H D++  NVLV   S   K+ADFG A    + D      +    P+
Sbjct: 118 IAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLA--RVIEDNEYTAREGAKFPI 174
Query: 144 -WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GK-PAWEDFGANTLSRIGFSDELPRFPT 200
            W APE +   C   +S+VWS G  + E+VT GK P      A+ +S +     +PR   
Sbjct: 175 KWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMEN 234
Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
              EL  D +  C + +  ER + D      +LQSV
Sbjct: 235 CPDEL-YDIMKMCWKEKAEERPTFD------YLQSV 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 10/98 (10%)
Query: 95  NIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPLWMAPEVVRG 152
           +I+HCD+K +N+L+  P  S +K+ DFG++ +       G +I Q   S  + +PEV+ G
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL------GQRIYQXIQSRFYRSPEVLLG 232
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG 190
                  D+WSLGC ++EM TG+P +   GAN + ++ 
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFS--GANEVDQMN 268

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 107/266 (40%), Gaps = 40/266 (15%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 86  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 145 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 262
Query: 215 RREPGERWSCDQLLKHPFLQSVSPSD 240
             +P +R +   L    FL    P+D
Sbjct: 263 AHKPEDRPTFVAL--RDFLLEAQPTD 286

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 71  YADEITLR---SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT 127
           Y + IT+    S+++ +   +++L SR  +H D+  +N+L+  N+  VK+ DFG A +  
Sbjct: 192 YKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENN-VVKICDFGLARDIY 250
Query: 128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-------GKPAWED 180
            +     K   R    WMAPE +  +    +SDVWS G  + E+ +       G    ED
Sbjct: 251 KNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED 310
Query: 181 FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           F +    R G     P + T   E+ +  LD C  R+P ER
Sbjct: 311 FCSRL--REGMRMRAPEYST--PEIYQIMLD-CWHRDPKER 346

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 10/98 (10%)
Query: 95  NIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPLWMAPEVVRG 152
           +I+HCD+K +N+L+  P  S +K+ DFG++ +       G +I Q   S  + +PEV+ G
Sbjct: 160 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL------GQRIYQXIQSRFYRSPEVLLG 213
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG 190
                  D+WSLGC ++EM TG+P +   GAN + ++ 
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFS--GANEVDQMN 249

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 124/303 (40%), Gaps = 77/303 (25%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYEAPTTSSSCRNL-HLEY 55
           M  + + + IG G++GTV  A +R   ++ A     L DD   +    SS+ R +  L+ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKE 57
Query: 56  LPGGTV--------SDLATTL----------------NAYADEITLRSHTYCIVSALKYL 91
           L    +        SD   TL                N   D   ++S  + ++  L + 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-AP 147
           HSRN++H D+K +N+L+  N   +KLADFG A         G+ ++   +    LW   P
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGE-LKLADFGLAR------AFGIPVRCYSAEVVTLWYRPP 170
Query: 148 EVVRG-ECQGPESDVWSLGCTIIEM----------------------VTGKPAWEDFGAN 184
           +V+ G +      D+WS GC   E+                      + G P  E +   
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWP-- 228
Query: 185 TLSRIGFSDELPRFPTQSSEL---------GRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
           +++++      P +P  +S +         GRD L   L+  P +R S ++ L+HP+   
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
Query: 236 VSP 238
             P
Sbjct: 289 FCP 291

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPN 111
           +EY  GG + +       ++++   R     ++S + Y H+  + H D+K +N L+ G  
Sbjct: 93  MEYASGGELFERICNAGRFSED-EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 151
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCT 167
           +  +K+ DFG +  + +        QP+   G+P ++APEV+ + E  G  +DVWS G T
Sbjct: 152 APRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 205
Query: 168 IIEMVTGKPAWED------FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           +  M+ G   +ED      F       +     +P +   S E  R  + +    +P +R
Sbjct: 206 LYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC-RHLISRIFVADPAKR 264
Query: 222 WSCDQLLKHPFLQSVSPSD 240
            S  ++  H +     P+D
Sbjct: 265 ISIPEIRNHEWFLKNLPAD 283

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 66/126 (52%), Gaps = 6/126 (4%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            L +EY+P G++ D     +    ++ L +   C    + YLHS++ +H ++  +NVL+ 
Sbjct: 94  QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--EGMAYLHSQHYIHRNLAARNVLLD 151
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP-LWMAPEVVRGECQGPESDVWSLGCT 167
            N   VK+ DFG A +A        +++  G SP  W APE ++       SDVWS G T
Sbjct: 152 -NDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 168 IIEMVT 173
           + E++T
Sbjct: 210 LYELLT 215

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 66/124 (53%), Gaps = 7/124 (5%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCDVKGKNVLVGPN 111
           +E++ GG++  +        +EI L   +  ++  L YL  ++ I+H DVK  N+LV   
Sbjct: 93  MEHMDGGSLDQVLKEAKRIPEEI-LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR 151
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL DFG +G+   S          G+  +MAPE ++G     +SD+WS+G +++E+
Sbjct: 152 GE-IKLCDFGVSGQLIDSMANSFV----GTRSYMAPERLQGTHYSVQSDIWSMGLSLVEL 206
Query: 172 VTGK 175
             G+
Sbjct: 207 AVGR 210

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P ++AP ++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPAIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 38/251 (15%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA----PTTSSSCRNLHL---------- 53
           + IG+G FG V +   R N      + +D + +A     +  +  R+ +L          
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 54  --------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                   EY+  G++ D L +   +      L   +  +  A++YL   N VH D+  +
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 137
Query: 105 NVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           NVLV  ++   K++DFG   EA+   DT  + ++      W APE +R      +SDVWS
Sbjct: 138 NVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFSTKSDVWS 190
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
            G  + E+ +       FG     RI   D +PR          D     +       W 
Sbjct: 191 FGILLWEIYS-------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 243
Query: 224 CDQLLKHPFLQ 234
            D  ++  FLQ
Sbjct: 244 LDAAMRPSFLQ 254

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 100/247 (40%), Gaps = 38/247 (15%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 76  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 135 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 252
Query: 215 RREPGER 221
             +P +R
Sbjct: 253 AHKPEDR 259

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 107/244 (43%), Gaps = 20/244 (8%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATT 67
           K I RG     NV  +  N     +  + V ++    + +   + +EY  GG + +    
Sbjct: 50  KYIERGEKIAANVKREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICN 108
Query: 68  LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEA 126
              ++++   R     ++S + Y H+  + H D+K +N L+ G  +  +K+ DFG +  +
Sbjct: 109 AGRFSED-EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 167
Query: 127 TVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCTIIEMVTGKPAWED-- 180
            +        QP+   G+P ++APEV+ + E  G  +DVWS G T+  M+ G   +ED  
Sbjct: 168 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPE 221
Query: 181 ----FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
               F       +     +P +   S E  R  + +    +P +R S  ++  H +    
Sbjct: 222 EPKNFRKTIHRILNVQYAIPDYVHISPEC-RHLISRIFVADPAKRISIPEIRNHEWFLKN 280
Query: 237 SPSD 240
            P+D
Sbjct: 281 LPAD 284

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 38/246 (15%)
Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------V 37
           R K +G GSFG V +   + +G+ +A    D                            V
Sbjct: 45  RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E     +S   + +EY+ GG +      +  ++ E   R +   IV   +YLHS +++
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSLDLI 163
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K +N+L+     ++++ DFG A        +G      G+P  +APE++  +    
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKR-----VKGRTWXLCGTPEALAPEIILSKGYNK 217
Query: 158 ESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
             D W+LG  I EM  G P  + D       +I  S ++ RFP+  S   +D L   L+ 
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKV-RFPSHFSSDLKDLLRNLLQV 275
Query: 217 EPGERW 222
           +  +R+
Sbjct: 276 DLTKRF 281

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 22/146 (15%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SAL YLHS NIV+ D+K +N+L+      V L DFG   E    ++        G+P 
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFC--GTPE 204
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS 203
           ++APEV+  +      D W LG  + EM+ G P                   P +   ++
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP-------------------PFYSRNTA 245
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLK 229
           E+  + L+K L+ +P    S   LL+
Sbjct: 246 EMYDNILNKPLQLKPNITNSARHLLE 271

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 42/269 (15%)
Query: 10  IGRGSFGTVNVAVD------RFNGDVFAYLGDDV-----------SYEAPT------TSS 46
           IGRGS+G V +AV       R    +  Y  +DV           S + P       T  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 47  SCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
              +++L  E   GG + +       + +    R     ++SA+ Y H  N+ H D+K +
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DVLSAVAYCHKLNVAHRDLKPE 135
Query: 105 NVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVW 162
           N L   +S  S +KL DFG A           K+   G+P +++P+V+ G   GPE D W
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVLEG-LYGPECDEW 191
Query: 163 SLGCTIIEMVTGKPAWEDFGANTLSRIGFS--DELPRFPTQS----SELGRDFLDKCLRR 216
           S G  +  ++ G P    F A T   +     +    FP +     S      + + L +
Sbjct: 192 SAGVMMYVLLCGYPP---FSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248
Query: 217 EPGERWSCDQLLKHP-FLQSVSPSDANTV 244
            P +R +  Q L+H  F + +S S  N +
Sbjct: 249 SPKQRITSLQALEHEWFEKQLSSSPRNLL 277

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 42/270 (15%)
Query: 9   CIGRGSFGTVNVAVD------RFNGDVFAYLGDDV-----------SYEAPT------TS 45
            IGRGS+G V +AV       R    +  Y  +DV           S + P       T 
Sbjct: 33  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 46  SSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
               +++L  E   GG + +       + +    R     ++SA+ Y H  N+ H D+K 
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DVLSAVAYCHKLNVAHRDLKP 151
Query: 104 KNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           +N L   +S  S +KL DFG A           K+   G+P +++P+V+ G   GPE D 
Sbjct: 152 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVLEG-LYGPECDE 207
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFS--DELPRFPTQS----SELGRDFLDKCLR 215
           WS G  +  ++ G P    F A T   +     +    FP +     S      + + L 
Sbjct: 208 WSAGVMMYVLLCGYPP---FSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLT 264
Query: 216 REPGERWSCDQLLKHP-FLQSVSPSDANTV 244
           + P +R +  Q L+H  F + +S S  N +
Sbjct: 265 KSPKQRITSLQALEHEWFEKQLSSSPRNLL 294

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 41/193 (21%)
Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
            Y ++  L+Y+H+  I+H D+K  N+ V  +   +K+ DFG A +A  S+  G  +    
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQAD-SEMXGXVV---- 187
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------- 190
           +  + APEV+    +  ++ D+WS+GC + EM+TGK  ++  G++ L ++          
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK--GSDHLDQLKEIMKVTGTP 245
Query: 191 --------FSDE-------LPRFP--------TQSSELGRDFLDKCLRREPGERWSCDQL 227
                    SDE       LP           T +S L  + L+K L  +  +R +  + 
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 305
Query: 228 LKHPFLQSVSPSD 240
           L HP+ +S+  ++
Sbjct: 306 LAHPYFESLHDTE 318

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +S  +K+ DFG A       T  V      +
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDSE-LKILDFGLARHTDDEMTGYV-----AT 191
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 251
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 252 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 311
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 312 AYFAQYHDPDDEPVAD 327

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNS-SFVKLADFG-AAGEATVSDTRGVK----I 136
           + SAL +LH++ I H D+K +N+L   PN  S VK+ DF   +G     D   +     +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 137 QPRGSPLWMAPEVVRGECQ-----GPESDVWSLGCTIIEMVTGKP----------AWEDF 181
            P GS  +MAPEVV    +         D+WSLG  +  +++G P           W+  
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239
Query: 182 GANTLSRIGFSDELP----RFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            A    +    + +      FP +     S   +D + K L R+  +R S  Q+L+HP++
Sbjct: 240 EACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 234 QSVSPSD 240
           Q  +P +
Sbjct: 300 QGCAPEN 306

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +S  +K+ DFG A       T  V      +
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDSE-LKILDFGLARHTDDEMTGYV-----AT 187
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 247
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 248 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 307
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 308 AYFAQYHDPDDEPVAD 323

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 60/123 (48%), Gaps = 7/123 (5%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           EY+P G + D     N   +E+T     Y    I SA++YL  +N +H D+  +N LVG 
Sbjct: 108 EYMPYGNLLDYLRECNR--EEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 165
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           N   VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E
Sbjct: 166 N-HVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWE 223
Query: 171 MVT 173
           + T
Sbjct: 224 IAT 226

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 114 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 170
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 231 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 261

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 100/247 (40%), Gaps = 38/247 (15%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 76  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 135 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 252
Query: 215 RREPGER 221
             +P +R
Sbjct: 253 AHKPEDR 259

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 137 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 193
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 194 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 254 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 284

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 39/199 (19%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 161 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 214
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDFG-------------AN 184
             + APE++        + D+WS+GC + E++TG+   P  +                A+
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPAS 274
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            +SR+       + + LP+ P +        ++ L  D L+K L  +  +R +  + L H
Sbjct: 275 VISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAH 334
Query: 231 PFLQSVSPSDANTVAESSP 249
           P+       D +   ES P
Sbjct: 335 PYFSQY--HDPDDEPESEP 351

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 102/251 (40%), Gaps = 38/251 (15%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC----RNLHL---------- 53
           + IG+G FG V +   R N      + +D + +A    +S     R+ +L          
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 54  --------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                   EY+  G++ D L +   +      L   +  +  A++YL   N VH D+  +
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 131
Query: 105 NVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           NVLV  ++   K++DFG   EA+   DT  + ++      W APE +R +    +SDVWS
Sbjct: 132 NVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWS 184
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
            G  + E+ +       FG     RI   D +PR          D     +       W 
Sbjct: 185 FGILLWEIYS-------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 237
Query: 224 CDQLLKHPFLQ 234
            D  ++  FLQ
Sbjct: 238 LDAAMRPSFLQ 248

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG---EATVSDTRGVKIQPRG 140
           +V+A+++ HSR +VH D+K +N+L+       KL DFG+     +   +D  G ++    
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVY--S 205
Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPT 200
            P W++    R +     + VWSLG  + +MV G   +E        +     EL  FP 
Sbjct: 206 PPEWIS----RHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL-HFPA 254
Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             S      + +CL  +P  R S +++L  P++Q+
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 102/251 (40%), Gaps = 38/251 (15%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA----PTTSSSCRNLHL---------- 53
           + IG+G FG V +   R N      + +D + +A     +  +  R+ +L          
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 54  --------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                   EY+  G++ D L +   +      L   +  +  A++YL   N VH D+  +
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 146
Query: 105 NVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           NVLV  ++   K++DFG   EA+   DT  + ++      W APE +R +    +SDVWS
Sbjct: 147 NVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWS 199
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
            G  + E+ +       FG     RI   D +PR          D     +       W 
Sbjct: 200 FGILLWEIYS-------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 252
Query: 224 CDQLLKHPFLQ 234
            D  ++  FLQ
Sbjct: 253 LDAAMRPSFLQ 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 100/247 (40%), Gaps = 38/247 (15%)
Query: 10  IGRGSFG-------------TVNVAVDRFNGDVFAY---LGDDVSYEAPTTSSSCRNLHL 53
           +G GSFG             TV+VAV     DV +    + D +       S   RNL  
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 54  EY-----LPGGTVSDLATTLNAYADEI----------TLRSHTYCIVSALKYLHSRNIVH 98
            Y      P   V++LA  L +  D +          TL  +   +   + YL S+  +H
Sbjct: 80  LYGVVLTPPMKMVTELAP-LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGP 157
            D+  +N+L+      VK+ DFG       +D   V  + R  P  W APE ++      
Sbjct: 139 RDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 158 ESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCL 214
            SD W  G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C 
Sbjct: 198 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCW 256
Query: 215 RREPGER 221
             +P +R
Sbjct: 257 AHKPEDR 263

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 50/238 (21%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            EY+       L   L     +  +R + Y ++ AL Y HS+ I+H DVK  NV++    
Sbjct: 114 FEYINNTDFKQLYQILT----DFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQ 169
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A     +    V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 170 KKLRLIDWGLAEFYHPAQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 226
Query: 172 VTGKPAWEDFGANT-----LSRIGFSDEL------------PRFPTQSSELGR------- 207
           +  +  +     N      ++++  ++EL            P F     +  R       
Sbjct: 227 IFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFI 286
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSV-----SPSDANTVAES 247
                        D LDK LR +  +R +  + ++HP+   V      PS  N V  S
Sbjct: 287 HSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQPSADNAVLSS 344

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 165
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 166 XXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 226 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 256

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 112 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 168
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 169 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 229 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 165
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 226 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 256

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 123/301 (40%), Gaps = 73/301 (24%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYEAPTTSSSCRNL-HLEY 55
           M  + + + IG G++GTV  A +R   ++ A     L DD   +    SS+ R +  L+ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKE 57
Query: 56  LPGGTV--------SDLATTL----------------NAYADEITLRSHTYCIVSALKYL 91
           L    +        SD   TL                N   D   ++S  + ++  L + 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS---PLWM-AP 147
           HSRN++H D+K +N+L+  N   +KLA+FG A         G+ ++   +    LW   P
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGE-LKLANFGLAR------AFGIPVRCYSAEVVTLWYRPP 170
Query: 148 EVVRG-ECQGPESDVWSLGCTIIEMVT-GKPAW-----EDFGANTLSRIGFSDE------ 194
           +V+ G +      D+WS GC   E+   G+P +     +D        +G   E      
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 195 --------LPRFPTQSSEL---------GRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                    P +P  +S +         GRD L   L+  P +R S ++ L+HP+     
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
Query: 238 P 238
           P
Sbjct: 291 P 291

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 165
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 226 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 256

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 106 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 162
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 223 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 253

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 12/132 (9%)
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCIVS-----ALKYLHSRNIVHCDVKGKNVLVG 109
           Y P G++ D  + L+       L  H  C ++      + +LH  + +H D+K  N+L+ 
Sbjct: 102 YXPNGSLLDRLSCLDGTP---PLSWHXRCKIAQGAANGINFLHENHHIHRDIKSANILL- 157
Query: 110 PNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
            + +F  K++DFG A  +          +  G+  + APE +RGE   P+SD++S G  +
Sbjct: 158 -DEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEIT-PKSDIYSFGVVL 215
Query: 169 IEMVTGKPAWED 180
           +E++TG PA ++
Sbjct: 216 LEIITGLPAVDE 227

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 111 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 167
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 168 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 228 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 258

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N+  +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDXXKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 6/126 (4%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            L +EY+P G++ D     +    ++ L +   C    + YLH+++ +H ++  +NVL+ 
Sbjct: 94  QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQIC--EGMAYLHAQHYIHRNLAARNVLLD 151
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP-LWMAPEVVRGECQGPESDVWSLGCT 167
            N   VK+ DFG A +A        +++  G SP  W APE ++       SDVWS G T
Sbjct: 152 -NDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 168 IIEMVT 173
           + E++T
Sbjct: 210 LYELLT 215

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 9/184 (4%)
Query: 78  RSHTYC--IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
           ++H Y   ++  L+YLHS+ IVH D+K  N+L+    + +K++  G A            
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTC 168
Query: 136 IQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRIGFS 192
              +GSP +  PE+  G     G + D+WS G T+  + TG   +E D        IG  
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG 228
Query: 193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP-FLQSVSPSDANTVAESSPRC 251
                 P        D L   L  EP +R+S  Q+ +H  F +   P++A      SP  
Sbjct: 229 SY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDT 286
Query: 252 VLDW 255
              W
Sbjct: 287 KDRW 290

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N+  +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDXXKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 10/98 (10%)
Query: 95  NIVHCDVKGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKI-QPRGSPLWMAPEVVRG 152
           +I+HCD+K +N+L+  P    +K+ DFG++ +       G +I Q   S  + +PEV+ G
Sbjct: 179 SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL------GQRIYQXIQSRFYRSPEVLLG 232
Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG 190
                  D+WSLGC ++EM TG+P +   GAN + ++ 
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFS--GANEVDQMN 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 51  LHLEYLPGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           L L++L GG   DL T L+      E  ++ +   +  AL +LHS  I++ D+K +N+L+
Sbjct: 104 LILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 160
Query: 109 GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
                 +KL DFG + E+   + +       G+  +MAPEVV        +D WS G  +
Sbjct: 161 DEEGH-IKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLM 217
Query: 169 IEMVT------GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            EM+T      GK   E       +++G    +P+F +  ++     L    +R P  R 
Sbjct: 218 FEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ---SLLRMLFKRNPANRL 270
Query: 223 SC-----DQLLKHPFLQSV 236
                  +++ +H F  ++
Sbjct: 271 GAGPDGVEEIKRHSFFSTI 289

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 8/179 (4%)
Query: 53  LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIE 170
               K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E
Sbjct: 151 -LVCKVADFGLA--RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 171 MVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           + T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 208 LTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 51  LHLEYLPGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           L L++L GG   DL T L+      E  ++ +   +  AL +LHS  I++ D+K +N+L+
Sbjct: 103 LILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 109 GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
                 +KL DFG + E+   + +       G+  +MAPEVV        +D WS G  +
Sbjct: 160 DEEGH-IKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLM 216
Query: 169 IEMVT------GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            EM+T      GK   E       +++G    +P+F +  ++     L    +R P  R 
Sbjct: 217 FEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ---SLLRMLFKRNPANRL 269
Query: 223 SC-----DQLLKHPFLQSV 236
                  +++ +H F  ++
Sbjct: 270 GAGPDGVEEIKRHSFFSTI 288

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 32/187 (17%)
Query: 76  TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
           T++      +  L +LH+  IVH D+K +N+LV    + VKLADFG A   +      + 
Sbjct: 113 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQ----MA 167
Query: 136 IQPRGSPLWM-APEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-----EDFGANTLSRI 189
           + P    LW  APEV+         D+WS+GC   EM   KP +      D        I
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 190 GFSDE--------LPR--FP-----------TQSSELGRDFLDKCLRREPGERWSCDQLL 228
           G   E        LPR  FP            +  E G   L + L   P +R S  + L
Sbjct: 228 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 229 KHPFLQS 235
           +H +L  
Sbjct: 288 QHSYLHK 294

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 148 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 206
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 146 LVSCTYQLARGMEYLASQKCIHRDLTARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 204
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G +       +     + L      I + +KYL + N VH D+  +N+LV  NS+
Sbjct: 126 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSN 183
Query: 114 FV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            V K++DFG +       EAT + T G KI  R    W APE +        SDVWS G 
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYT-TSGGKIPIR----WTAPEAISYRKFTSASDVWSFGI 238
Query: 167 TIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS- 223
            + E++T   +P WE      +  I     LP  P          + +C ++E   R   
Sbjct: 239 VMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKF 297
Query: 224 ------CDQLLKHPFLQSVSPSDANTVAESSPRC 251
                  D+L++       +P    T+A+  PR 
Sbjct: 298 ADIVSILDKLIR-------APDSLKTLADFDPRV 324

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 32/187 (17%)
Query: 76  TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
           T++      +  L +LH+  IVH D+K +N+LV    + VKLADFG A   +      + 
Sbjct: 113 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQ----MA 167
Query: 136 IQPRGSPLWM-APEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-----EDFGANTLSRI 189
           + P    LW  APEV+         D+WS+GC   EM   KP +      D        I
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 190 GFSDE--------LPR--FP-----------TQSSELGRDFLDKCLRREPGERWSCDQLL 228
           G   E        LPR  FP            +  E G   L + L   P +R S  + L
Sbjct: 228 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 229 KHPFLQS 235
           +H +L  
Sbjct: 288 QHSYLHK 294

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 151 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 209
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV  N   VKL DFG +    + D+ 
Sbjct: 489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLS--RYMEDST 545
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 606 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 636

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 32/187 (17%)
Query: 76  TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
           T++      +  L +LH+  IVH D+K +N+LV    + VKLADFG A   +      + 
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQ----MA 175
Query: 136 IQPRGSPLWM-APEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-----EDFGANTLSRI 189
           + P    LW  APEV+         D+WS+GC   EM   KP +      D        I
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 190 GFSDE--------LPR--FP-----------TQSSELGRDFLDKCLRREPGERWSCDQLL 228
           G   E        LPR  FP            +  E G   L + L   P +R S  + L
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295
Query: 229 KHPFLQS 235
           +H +L  
Sbjct: 296 QHSYLHK 302

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 51  LHLEYLPGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           L L++L GG   DL T L+      E  ++ +   +  AL +LHS  I++ D+K +N+L+
Sbjct: 103 LILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 109 GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
                 +KL DFG + E+   + +       G+  +MAPEVV        +D WS G  +
Sbjct: 160 D-EEGHIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLM 216
Query: 169 IEMVT------GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            EM+T      GK   E       +++G    +P+F +  ++     L    +R P  R 
Sbjct: 217 FEMLTGTLPFQGKDRKETMTMILKAKLG----MPQFLSPEAQ---SLLRMLFKRNPANRL 269
Query: 223 SC-----DQLLKHPFLQSV 236
                  +++ +H F  ++
Sbjct: 270 GAGPDGVEEIKRHSFFSTI 288

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKIXDFGLARD 193
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 246
Query: 186 LSRIGFSDELPRFPTQ----------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E  R   +          + E+ +  LD C   EP +R +  +L++H
Sbjct: 247 YPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 300

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 8/179 (4%)
Query: 53  LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N
Sbjct: 91  IEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIE 170
               K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E
Sbjct: 151 -LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 171 MVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           + T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 208 LTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG A       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLARVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKNTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/323 (20%), Positives = 122/323 (37%), Gaps = 102/323 (31%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSC------------------- 48
           K +G+G++G V  ++DR  G+V A      +++  T +                      
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 49  ---------RNLHLEYLPGGTVSDLATTLNAYADEITLRSHT-YCIVSALKYLHSRNIVH 98
                    R+++L +      +DL   + A   E   + +  Y ++  +KYLHS  ++H
Sbjct: 75  LNVLRADNDRDVYLVF--DYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLH 132
Query: 99  CDVKGKNVLVGPNSSFVKLADFGAA-------------------GEATVSDTRGVKIQPR 139
            D+K  N+L+      VK+ADFG +                         D + +     
Sbjct: 133 RDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYV 191
Query: 140 GSPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF 198
            +  + APE++ G  +  +  D+WSLGC + E++ GKP +   G++T++++     +  F
Sbjct: 192 ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP--GSSTMNQLERIIGVIDF 249
Query: 199 PTQS------------------------------------------------SELGRDFL 210
           P+                                                  +E   D L
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309
Query: 211 DKCLRREPGERWSCDQLLKHPFL 233
           DK L+  P +R S +  LKHPF+
Sbjct: 310 DKLLQFNPNKRISANDALKHPFV 332

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA----PTTSSSCRNLHL---------- 53
           + IG+G FG V +   R N      + +D + +A     +  +  R+ +L          
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 54  --------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
                   EY+  G++ D L +   +      L   +  +  A++YL   N VH D+  +
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318
Query: 105 NVLVGPNSSFVKLADFGAAGEAT-VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           NVLV  ++   K++DFG   EA+   DT  + ++      W APE +R +    +SDVWS
Sbjct: 319 NVLVSEDN-VAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWS 371
Query: 164 LGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR 197
            G  + E+ +       FG     RI   D +PR
Sbjct: 372 FGILLWEIYS-------FGRVPYPRIPLKDVVPR 398

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +K+ADFG A +    D      
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTT 263
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/188 (22%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTT--------SSSCRNLHL 53
           +  ++     +G +   N  +++F+ +++  +    S + P                L  
Sbjct: 66  IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           E+  GG + +     + + DE    +    I+S + YLH  NIVH D+K +N+L+   +S
Sbjct: 126 EFYEGGELFEQIINRHKF-DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNS 184
Query: 114 F--VKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
              +K+ DFG +       ++  K++ R G+  ++APEV++ +    + DVWS G  +  
Sbjct: 185 LLNIKIVDFGLSSFF----SKDYKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYI 239
Query: 171 MVTGKPAW 178
           ++ G P +
Sbjct: 240 LLCGYPPF 247

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 77/187 (41%), Gaps = 32/187 (17%)
Query: 76  TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
           T++      +  L +LH+  IVH D+K +N+LV    + VKLADFG A   +      + 
Sbjct: 113 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQ----MA 167
Query: 136 IQPRGSPLWM-APEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-----EDFGANTLSRI 189
           + P    LW  APEV+         D+WS+GC   EM   KP +      D        I
Sbjct: 168 LFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 227
Query: 190 GFSDE--------LPR--FP-----------TQSSELGRDFLDKCLRREPGERWSCDQLL 228
           G   E        LPR  FP            +  E G   L + L   P +R S  + L
Sbjct: 228 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 287
Query: 229 KHPFLQS 235
           +H +L  
Sbjct: 288 QHSYLHK 294

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 82  EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 140
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 141 LVCKVADFGLA--RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 198
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 199 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 255

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 143 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLARHTDDEMTGYV-----AT 196
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 256
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 257 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 316
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 317 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 355

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 84  IVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           ++++  Y+H+ +NI H DVK  N+L+  N   VKL+DFG +        +G     RG+ 
Sbjct: 160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKKIKG----SRGTY 214
Query: 143 LWMAPEVVRGEC--QGPESDVWSLGCTIIEMVTGKPAW-------EDFGANTLSRIGFSD 193
            +M PE    E    G + D+WSLG  +  M      +       E F       I +  
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 194 ELPRF--PTQS----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
           +   F  P  +          S    DFL   LR+ P ER + +  LKH +L   +  D
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 306 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLARHTDDEMTGYV-----AT 190
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 250
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 251 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 310
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 311 AYFAQYHDPDDEPVAD 326

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 43  TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
           T   S RN  + Y P     D  T  +       L  +++ +   +++L SR  +H D+ 
Sbjct: 123 TYLRSKRNEFVPYKPEDLYKDFLTLEH-------LIXYSFQVAKGMEFLASRKXIHRDLA 175
Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVW 162
            +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDVW
Sbjct: 176 ARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 163 SLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLDK 212
           S G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD 
Sbjct: 235 SFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD- 286
Query: 213 CLRREPGERWSCDQLLKH 230
           C   EP +R +  +L++H
Sbjct: 287 CWHGEPSQRPTFSELVEH 304

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXE-LKILDFGLARHTDDEMTGYV-----AT 190
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 250
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 251 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 310
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 311 AYFAQYHDPDDEPVAD 326

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 111/305 (36%), Gaps = 81/305 (26%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS-SCRNL----HLEY------- 55
           + IG G++G V+ A  R  G   A      +++  T +  + R L    H ++       
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 56  ------LPGGTVSDLATTLNAYADEIT-------------LRSHTYCIVSALKYLHSRNI 96
                 +P G    +   L+    ++              +R   Y ++  LKY+HS  +
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQV 179
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K  N+LV  N   +K+ DFG A        RG+   P     +M   V     + 
Sbjct: 180 IHRDLKPSNLLVNENCE-LKIGDFGMA--------RGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 157 PE-----------SDVWSLGCT---------------------IIEMVTGKPAWEDFGAN 184
           PE            D+WS+GC                      +I MV G P+     A 
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290
Query: 185 TLSRI-GFSDELPR---FPTQSSELGRD-----FLDKCLRREPGERWSCDQLLKHPFLQS 235
              R+  +   LP     P ++   G D      L + LR EP  R S    L+HPFL  
Sbjct: 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350
Query: 236 VSPSD 240
               D
Sbjct: 351 YHDPD 355

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 69/133 (51%), Gaps = 12/133 (9%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPN 111
           +EY  GG + +       ++++   R     ++S + Y HS  I H D+K +N L+ G  
Sbjct: 95  MEYASGGELYERICNAGRFSED-EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP 153
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCT 167
           +  +K+ DFG +  + +        QP+   G+P ++APEV+ R E  G  +DVWS G T
Sbjct: 154 APRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 168 IIEMVTGKPAWED 180
           +  M+ G   +ED
Sbjct: 208 LYVMLVGAYPFED 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 30/185 (16%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNS-SFVKLADFGAAGEATVSD-----TRGVKI 136
           + +AL +LH++ I H D+K +N+L   P   S VK+ DF       +++     T     
Sbjct: 120 VAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 137 QPRGSPLWMAPEVV-----RGECQGPESDVWSLGCTIIEMVTGKPAWEDF-GAN------ 184
            P GS  +MAPEVV     +        D+WSLG  +  M++G P +    GA+      
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRG 239
Query: 185 TLSRI-------GFSDELPRFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            + R+          +    FP +     S   +D + K L R+  +R S  Q+L+HP++
Sbjct: 240 EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299
Query: 234 QSVSP 238
           Q  +P
Sbjct: 300 QGQAP 304

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 150
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 151 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 208
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 209 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 150
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 151 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 208
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 209 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           I   L+ LH   IV+ D+K +N+L+  +   ++++D G A    V    G  I+ R G+ 
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLA----VHVPEGQTIKGRVGTV 349
Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
            +MAPEVV+ E      D W+LGC + EM+ G+  ++      + R      +   P + 
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEY 408
Query: 203 SE----LGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSVS 237
           SE      R    + L ++P ER  C      ++ +HP  + ++
Sbjct: 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L   +  I S + Y+   N VH D++  N+LVG N 
Sbjct: 89  EYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGEN- 147
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 148 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 205
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 206 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 262

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 81  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 139
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 140 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 197
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 198 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 254

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 85  EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 143
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 144 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 201
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 202 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 258

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 156
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 157 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 209
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 210 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 269
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 270 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 328
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 329 TTGDWLN 335

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 59/245 (24%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRG 133
           ++S  Y I+  + YLH+  ++H D+K  N+LV   GP    VK+AD G A          
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 134 VKIQPRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW----ED------F 181
             + P     W  APE++ G     ++ D+W++GC   E++T +P +    ED      +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249
Query: 182 GANTLSRI----GFS-----DELPRFPTQSSELGRDF----------------------- 209
             + L RI    GF      +++ + P  S+ L +DF                       
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHST-LMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 210 -----LDKCLRREPGERWSCDQLLKHP-FLQSVSPSDANTVAESSPRCVLDWVNSEFEEE 263
                L K L  +P +R + +Q ++ P FL+   P+     ++    C + +   EF  E
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT-----SDVFAGCQIPYPKREFLTE 363
Query: 264 GTSDD 268
              DD
Sbjct: 364 EEPDD 368

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 83  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 141
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 142 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 199
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 200 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 256

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 316
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 317 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 375 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 431

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           I   L+ LH   IV+ D+K +N+L+  +   ++++D G A    V    G  I+ R G+ 
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLD-DHGHIRISDLGLA----VHVPEGQTIKGRVGTV 349
Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQS 202
            +MAPEVV+ E      D W+LGC + EM+ G+  ++      + R      +   P + 
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEY 408
Query: 203 SE----LGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSVS 237
           SE      R    + L ++P ER  C      ++ +HP  + ++
Sbjct: 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 15/158 (9%)
Query: 84  IVSALKYLHSRNIV---HCDVKGKNVLV-------GPNSSFVKLADFGAAGEATVSDTRG 133
           I   + YLH   IV   H D+K  N+L+         ++  +K+ DFG A E      R 
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH----RT 169
Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFS 192
            K+   G+  WMAPEV+R       SDVWS G  + E++TG+  +    G      +  +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
Query: 193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH 230
                 P+   E     ++ C   +P  R S   +L  
Sbjct: 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 111/305 (36%), Gaps = 81/305 (26%)
Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSS-SCRNL----HLEY------- 55
           + IG G++G V+ A  R  G   A      +++  T +  + R L    H ++       
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 56  ------LPGGTVSDLATTLNAYADEIT-------------LRSHTYCIVSALKYLHSRNI 96
                 +P G    +   L+    ++              +R   Y ++  LKY+HS  +
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQV 180
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K  N+LV  N   +K+ DFG A        RG+   P     +M   V     + 
Sbjct: 181 IHRDLKPSNLLVNENCE-LKIGDFGMA--------RGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 157 PE-----------SDVWSLGCT---------------------IIEMVTGKPAWEDFGAN 184
           PE            D+WS+GC                      +I MV G P+     A 
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 291
Query: 185 TLSRI-GFSDELPR---FPTQSSELGRD-----FLDKCLRREPGERWSCDQLLKHPFLQS 235
              R+  +   LP     P ++   G D      L + LR EP  R S    L+HPFL  
Sbjct: 292 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 351
Query: 236 VSPSD 240
               D
Sbjct: 352 YHDPD 356

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L   +  I S + Y+   N VH D++  N+LVG N 
Sbjct: 89  EYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGEN- 147
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 148 LVCKVADFGLA--RLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 205
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 206 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 262

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 55  YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF 114
           +L G  ++++  +     D +      Y I+  LKY+HS +I+H D+K  N+ V  +S  
Sbjct: 107 HLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIHSADIIHRDLKPSNLAVNEDSE- 163
Query: 115 VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVT 173
           +K+ DFG         T  V      +  + APE++       ++ D+WS+GC + E++T
Sbjct: 164 LKILDFGLCRHTDDEMTGYV-----ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 174 GK---PAWEDF-------------GANTLSRI------GFSDELPRFPTQ--------SS 203
           G+   P  +               GA  L +I       +   L + P          ++
Sbjct: 219 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 278
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
            L  D L+K L  +  +R +  Q L H +       D   VA+
Sbjct: 279 PLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 321

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 150
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 151 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 208
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 209 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 316
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 317 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 375 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 431

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYAD-----EITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           L +EY  GG   DL   LN + +     E  +R+    I SAL+YLH   I+H D+K +N
Sbjct: 96  LAMEYCEGG---DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 152
Query: 106 VLV--GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           +++  GP     K+ D G A E    D   +  +  G+  ++APE++  +      D WS
Sbjct: 153 IVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWS 209
Query: 164 LGCTIIEMVTG----KPAWE 179
            G    E +TG     P W+
Sbjct: 210 FGTLAFECITGFRPFLPNWQ 229

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 79/179 (44%), Gaps = 8/179 (4%)
Query: 53  LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +EY+  G + D L   +  Y     L      I S + Y+   N VH D++  N+LVG N
Sbjct: 91  MEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIE 170
               K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E
Sbjct: 151 -LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTE 207
Query: 171 MVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           + T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 208 LTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +     I L      I + +KYL     
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY 145
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W APE 
Sbjct: 146 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTAPEA 198
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+V+   +P WE    + +  +     LP      + L +
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALYQ 258
Query: 208 DFLDKCLRREPGERWSCDQLL 228
             LD C ++E   R   D+++
Sbjct: 259 LMLD-CWQKERNSRPKFDEIV 278

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S TY +   ++YL S+  +H D+  +NVLV  N + +++ADFG A +    D      
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMRIADFGLARDINNIDYYKKTT 217
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 316
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 317 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 375 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 431

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 17/140 (12%)
Query: 51  LHLEYLPGGTVSDLATTLNAYAD-----EITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           L +EY  GG   DL   LN + +     E  +R+    I SAL+YLH   I+H D+K +N
Sbjct: 95  LAMEYCEGG---DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151
Query: 106 VLV--GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           +++  GP     K+ D G A E    D   +  +  G+  ++APE++  +      D WS
Sbjct: 152 IVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 164 LGCTIIEMVTG----KPAWE 179
            G    E +TG     P W+
Sbjct: 209 FGTLAFECITGFRPFLPNWQ 228

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTADEMTGYV-----AT 192
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 313 AYFAQYHDPDDEPVAD 328

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 45/222 (20%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            EY+       L   L     +  +R + Y ++ AL Y HS+ I+H DVK  NV++    
Sbjct: 119 FEYINNTDFKQLYQILT----DFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQ 174
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEM 171
             ++L D+G A     +    V++  R    +  PE +V  +      D+WSLGC +  M
Sbjct: 175 KKLRLIDWGLAEFYHPAQEYNVRVASR---YFKGPELLVDYQMYDYSLDMWSLGCMLASM 231
Query: 172 VTGKPAWEDFGANT-----LSRIGFSDEL------------PRFPTQSSELGR------- 207
           +  +  +     N      ++++  ++EL            P F     +  R       
Sbjct: 232 IFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFI 291
Query: 208 -------------DFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                        D LDK LR +  +R +  + ++HP+   V
Sbjct: 292 HSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYFYPV 333

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 26/199 (13%)
Query: 51  LHLEYLPGGTVSDLATTLN--AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           L L++L GG   DL T L+      E  ++ +   +   L +LHS  I++ D+K +N+L+
Sbjct: 107 LILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILL 163
Query: 109 GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
                 +KL DFG + EA   + +       G+  +MAPEVV  +     +D WS G  +
Sbjct: 164 D-EEGHIKLTDFGLSKEAIDHEKKAYSFC--GTVEYMAPEVVNRQGHSHSADWWSYGVLM 220
Query: 169 IEMVT------GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            EM+T      GK   E       +++G    +P+F +  ++     L    +R P  R 
Sbjct: 221 FEMLTGSLPFQGKDRKETMTLILKAKLG----MPQFLSTEAQ---SLLRALFKRNPANRL 273
Query: 223 -----SCDQLLKHPFLQSV 236
                  +++ +H F  ++
Sbjct: 274 GSGPDGAEEIKRHVFYSTI 292

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTADEMTGYV-----AT 192
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 313 AYFAQYHDPDDEPVAD 328

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTADEMTGYV-----AT 192
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 313 AYFAQYHDPDDEPVAD 328

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 37/198 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAESS 248
            +       D   VA+ +
Sbjct: 306 AYFAQYHDPDDEPVADPT 323

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGXV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 140 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 192
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 252
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 253 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 311
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 312 TTGDWLN 318

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 190
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 250
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 251 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 310
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 311 AYFAQYHDPDDEPVAD 326

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 187
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 247
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 248 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 307
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 308 AYFAQYHDPDDEPVAD 323

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 192
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 313 AYFAQYHDPDDEPVAD 328

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 181
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 242 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 302 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 340

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 111 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 165
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 166 AARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 225 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 278 -CWHGEPSQRPTFSELVEH 295

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 39/200 (19%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAESSPR 250
            +       D   VA+  PR
Sbjct: 306 AYFAQYHDPDDEPVAD--PR 323

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 187
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 247
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 248 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 307
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 308 AYFAQYHDPDDEPVAD 323

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 181
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 242 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 302 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 340

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 190
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 250
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 251 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 310
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 311 AYFAQYHDPDDEPVAD 326

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 131 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 184
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 185 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 244
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 245 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 304
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 305 AYFAQYHDPDDEPVAD 320

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 191
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 251
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 252 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 311
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 312 AYFAQYHDPDDEPVAD 327

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 135 DLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLS-EKNVVKICDFGLARD 193
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 194 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 246
Query: 186 LSRIGFSDEL---------PRFPTQSS-ELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E           R P  ++ E+ +  LD C   EP +R +  +L++H
Sbjct: 247 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 300

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 205
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 266 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 325
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 326 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 364

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L      Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 399
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 400 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R+EP ER + + L
Sbjct: 458 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYL 514

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 111 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 165
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 166 AARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 225 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 278 -CWHGEPSQRPTFSELVEH 295

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 143 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 196
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 256
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 257 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 316
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 317 AYFAQYHDPDDEPVAD 332

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 130 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 183
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 243
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 244 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 303
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 304 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 342

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 155 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 208
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 268
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 269 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 328
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 329 AYFAQYHDPDDEPVAD 344

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/294 (21%), Positives = 115/294 (39%), Gaps = 64/294 (21%)
Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNL----HLEYL 56
           M ++++   +G G++ TV     +   ++ A     + +E     ++ R +     L++ 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 57  PGGTVSDLATT--------------LNAYADEI-------TLRSHTYCIVSALKYLHSRN 95
              T+ D+  T              L  Y D+         ++   + ++  L Y H + 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWM-APEVVRGE 153
           ++H D+K +N+L+      +KLADFG A   ++ + T   ++      LW   P+++ G 
Sbjct: 121 VLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEV----VTLWYRPPDILLGS 175
Query: 154 CQ-GPESDVWSLGCTIIEMVTGKPAW------------------------------EDFG 182
                + D+W +GC   EM TG+P +                              E+F 
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235
Query: 183 ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                +      L   P   S+ G D L K L+ E   R S +  +KHPF  S+
Sbjct: 236 TYNYPKYRAEALLSHAPRLDSD-GADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 120 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 175 AARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 234 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 286
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 287 -CWHGEPSQRPTFSELVEH 304

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 129 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 182
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 242
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 243 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 302
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 303 AYFAQYHDPDDEPVAD 318

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 151 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 204
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 264
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 265 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 324
Query: 231 PFLQSVSPSDANTVA-------ESSPRCVLDWVNSEFEE 262
            +       D   VA       ES    + +W +  ++E
Sbjct: 325 AYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDE 363

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 197
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 258 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 317
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 318 AYFAQYHDPDDEPVAD 333

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 197
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 258 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 317
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 318 AYFAQYHDPDDEPVAD 333

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 197
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 257
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 258 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 317
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 318 AYFAQYHDPDDEPVAD 333

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 142 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 195
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 255
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 256 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 315
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 316 AYFAQYHDPDDEPVAD 331

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 191
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 251
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 252 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 311
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 312 AYFAQYHDPDDEPVAD 327

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 129 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 182
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 242
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 243 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 302
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 303 AYFAQYHDPDDEPVAD 318

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S+   +  E++  G++       +     I L      I + +KYL   N 
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 156
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA-------GEATVSDTRGVKIQPRGSPLWMAPE 148
           VH D+  +N+LV  NS+ V K++DFG +        + T +   G KI  R    W APE
Sbjct: 157 VHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR----WTAPE 210
Query: 149 VVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELG 206
            ++       SDVWS G  + E+++   +P W+    + ++ I     LP      S L 
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 270
Query: 207 RDFLDKCLRREPGER-------WSCDQLLKHP-FLQSVSP 238
           +  LD C +++   R        + D+++++P  L++++P
Sbjct: 271 QLMLD-CWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAP 309

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 181
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 302 AYFAQYHDPDDEPVAD 317

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 191
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 251
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 252 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 311
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 312 AYFAQYHDPDDEPVAD 327

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 187
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 247
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 248 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 307
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 308 AYFAQYHDPDDEPVAD 323

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 166
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 167 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 219
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 220 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 279
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 280 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 338
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 339 TTGDWLN 345

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 182 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 240
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 241 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 293
Query: 186 LSRIGFSDELPRFPTQSS----------ELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E  R   + +          E+ +  LD C   EP +R +  +L++H
Sbjct: 294 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 347

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 29/200 (14%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 120 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESD 160
             +N+L+    + VK+ DFG A +    D   V+      PL WMAPE +       +SD
Sbjct: 175 AARNILLS-EKNVVKICDFGLARD-IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 161 VWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFL 210
           VWS G  + E+ +        GA+    +   +E           R P  ++ E+ +  L
Sbjct: 233 VWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 285
Query: 211 DKCLRREPGERWSCDQLLKH 230
           D C   EP +R +  +L++H
Sbjct: 286 D-CWHGEPSQRPTFSELVEH 304

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 151 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 204
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 264
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 265 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 324
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 325 AYFAQYHDPDDEPVAD 340

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDEMTGYV-----AT 205
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 266 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 325
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 326 AYFAQYHDPDDEPVAD 341

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 111 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 165
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 166 AARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 225 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 278 -CWHGEPSQRPTFSELVEH 295

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            L +EY+P G++ D          ++ L +   C    + YLH+++ +H  +  +NVL+ 
Sbjct: 89  QLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--EGMAYLHAQHYIHRALAARNVLLD 146
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP-LWMAPEVVRGECQ-GPESDVWSLGC 166
            N   VK+ DFG A +A        +++  G SP  W APE ++ EC+    SDVWS G 
Sbjct: 147 -NDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPECLK-ECKFYYASDVWSFGV 203
Query: 167 TIIEMVT 173
           T+ E++T
Sbjct: 204 TLYELLT 210

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 191 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 249
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 250 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 302
Query: 186 LSRIGFSDEL---------PRFPTQSS-ELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E           R P  ++ E+ +  LD C   EP +R +  +L++H
Sbjct: 303 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 356

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 50  NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            L +EY+P G++ D          ++ L +   C    + YLH+++ +H  +  +NVL+ 
Sbjct: 88  QLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQIC--EGMAYLHAQHYIHRALAARNVLLD 145
Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP-LWMAPEVVRGECQ-GPESDVWSLGC 166
            N   VK+ DFG A +A        +++  G SP  W APE ++ EC+    SDVWS G 
Sbjct: 146 -NDRLVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPECLK-ECKFYYASDVWSFGV 202
Query: 167 TIIEMVT 173
           T+ E++T
Sbjct: 203 TLYELLT 209

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 189 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 247
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 248 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 300
Query: 186 LSRIGFSDEL---------PRFPTQSS-ELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E           R P  ++ E+ +  LD C   EP +R +  +L++H
Sbjct: 301 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 354

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 157 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 211
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 212 AARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 271 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 323
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 324 -CWHGEPSQRPTFSELVEH 341

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 111 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 165
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 166 AARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 224
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 225 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 277
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 278 -CWHGEPSQRPTFSELVEH 295

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV      VKL DFG +    + D+ 
Sbjct: 109 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDC-VKLGDFGLS--RYMEDST 165
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 166 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 226 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 256

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 242
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 295
Query: 186 LSRIGFSDEL---------PRFPTQSS-ELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E           R P  ++ E+ +  LD C   EP +R +  +L++H
Sbjct: 296 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 349

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 27/199 (13%)
Query: 45  SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDV 101
           S+  R+   E++P     +     + Y D +TL     +++ +   +++L SR  +H D+
Sbjct: 120 STYLRSKRNEFVPYKVAPE-----DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174
Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N+L+    + VK+ DFG A +         K   R    WMAPE +       +SDV
Sbjct: 175 AARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233
Query: 162 WSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPTQSS-ELGRDFLD 211
           WS G  + E+ +        GA+    +   +E           R P  ++ E+ +  LD
Sbjct: 234 WSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 286
Query: 212 KCLRREPGERWSCDQLLKH 230
            C   EP +R +  +L++H
Sbjct: 287 -CWHGEPSQRPTFSELVEH 304

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 57/127 (44%), Gaps = 8/127 (6%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L +E+LP G+   L   L    ++I L+    +   I   + YL SR  VH D+  +NVL
Sbjct: 90  LIMEFLPSGS---LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 146
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP-LWMAPEVVRGECQGPESDVWSLGC 166
           V      VK+ DFG                 R SP  W APE +        SDVWS G 
Sbjct: 147 VESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGV 205
Query: 167 TIIEMVT 173
           T+ E++T
Sbjct: 206 TLHELLT 212

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  EY+  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG         EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLGRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
            Y ++  LKY+HS  I+H D+K  NV V  +S  +++ DFG A +A    T  V      
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSE-LRILDFGLARQADEEMTGYV-----A 190
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGANTLSRI-------- 189
           +  + APE++       ++ D+WS+GC + E++ GK  +   D+  + L RI        
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY-IDQLKRIMEVVGTPS 249
Query: 190 -------------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLL 228
                         +   LP  P +        ++ L  D L + L  +  +R S  + L
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 309
Query: 229 KHPFL-QSVSPSDA------NTVAESSPRCVLDWVNSEFEE 262
            H +  Q   P D       +   E+  R + +W    ++E
Sbjct: 310 AHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWKELTYQE 350

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 69  NAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE 125
           + Y D +TL     +++ +   +++L SR  +H D+  +N+L+    + VK+ DFG A +
Sbjct: 141 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 199
Query: 126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
                    K   R    WMAPE +       +SDVWS G  + E+ +        GA+ 
Sbjct: 200 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASP 252
Query: 186 LSRIGFSDEL---------PRFPTQSS-ELGRDFLDKCLRREPGERWSCDQLLKH 230
              +   +E           R P  ++ E+ +  LD C   EP +R +  +L++H
Sbjct: 253 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 306

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G + D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 92  EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 150
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 151 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 208
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 209 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 46/221 (20%)
Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
            Y ++  LKY+HS  I+H D+K  NV V  +S  +++ DFG A +A    T  V      
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSE-LRILDFGLARQADEEMTGYV-----A 190
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGANTLSRI-------- 189
           +  + APE++       ++ D+WS+GC + E++ GK  +   D+  + L RI        
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY-IDQLKRIMEVVGTPS 249
Query: 190 -------------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLL 228
                         +   LP  P +        ++ L  D L + L  +  +R S  + L
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 309
Query: 229 KHPFL-QSVSPSDA------NTVAESSPRCVLDWVNSEFEE 262
            H +  Q   P D       +   E+  R + +W    ++E
Sbjct: 310 AHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWKELTYQE 350

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/127 (33%), Positives = 57/127 (44%), Gaps = 8/127 (6%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRS---HTYCIVSALKYLHSRNIVHCDVKGKNVL 107
           L +E+LP G+   L   L    ++I L+    +   I   + YL SR  VH D+  +NVL
Sbjct: 102 LIMEFLPSGS---LKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVL 158
Query: 108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP-LWMAPEVVRGECQGPESDVWSLGC 166
           V      VK+ DFG                 R SP  W APE +        SDVWS G 
Sbjct: 159 VESEHQ-VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGV 217
Query: 167 TIIEMVT 173
           T+ E++T
Sbjct: 218 TLHELLT 224

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPN 111
           +EY  GG + +       ++++   R     ++S + Y H+  + H D+K +N L+ G  
Sbjct: 94  MEYASGGELFERICNAGRFSED-EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 152
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCT 167
           +  +K+  FG +  + +        QP+   G+P ++APEV+ + E  G  +DVWS G T
Sbjct: 153 APRLKICAFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 168 IIEMVTGKPAWED------FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           +  M+ G   +ED      F       +     +P +   S E  R  + +    +P +R
Sbjct: 207 LYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC-RHLISRIFVADPAKR 265
Query: 222 WSCDQLLKHPFLQSVSPSD 240
            S  ++  H +     P+D
Sbjct: 266 ISIPEIRNHEWFLKNLPAD 284

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-GPN 111
           +EY  GG + +       ++++   R     ++S + Y H+  + H D+K +N L+ G  
Sbjct: 94  MEYASGGELFERICNAGRFSED-EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 152
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGCT 167
           +  +K+  FG +  + +        QP+   G+P ++APEV+ + E  G  +DVWS G T
Sbjct: 153 APRLKICAFGYSKSSVLHS------QPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVT 206
Query: 168 IIEMVTGKPAWED------FGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           +  M+ G   +ED      F       +     +P +   S E  R  + +    +P +R
Sbjct: 207 LYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC-RHLISRIFVADPAKR 265
Query: 222 WSCDQLLKHPFLQSVSPSD 240
            S  ++  H +     P+D
Sbjct: 266 ISIPEIRNHEWFLKNLPAD 284

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D+   N+LVG N 
Sbjct: 92  EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGEN- 150
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 151 LVCKVADFGLA--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 208
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 209 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 265

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 7/152 (4%)
Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           D  +L  + Y + +AL YL S+  VH D+  +NVLV      VKL DFG +    + D+ 
Sbjct: 489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDC-VKLGDFGLS--RYMEDST 545
Query: 133 GVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVTG--KPAWEDFGANTLSRI 189
             K      P+ WMAPE +        SDVW  G  + E++    KP       + + RI
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
              + LP  P     L    + KC   +P  R
Sbjct: 606 ENGERLPMPPNCPPTL-YSLMTKCWAYDPSRR 636

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 7/119 (5%)
Query: 75  ITLRSHTYCIVSALKYLH--SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
           I ++   + ++ ++  LH  S N+ H D+K  NVLV      +KL DFG+A + + S+  
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 133 GVKIQPRGSPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWE-DFGANTLSRI 189
              I  R    + APE++ G      + D+WS+GC   EM+ G+P +  D  A  L  I
Sbjct: 189 VAYICSR---YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A   T  +  G       +
Sbjct: 155 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH-TDDEMXGYV----AT 208
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 268
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 269 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 328
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 329 AYFAQYHDPDDEPVAD 344

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 103/224 (45%), Gaps = 14/224 (6%)
Query: 19  NVAVDRFNG--DVFAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSD-LATTLNAYADEI 75
           +V +  +NG  D F Y  +  S  +  + + C  + +E+   GT+   +        D++
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 76  TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK 135
                   I   + Y+HS+ +++ D+K  N+ +  ++  VK+ DFG     T     G +
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLV---TSLKNDGKR 178
Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV-TGKPAWEDFGANTLSRIGFSDE 194
            + +G+  +M+PE +  +  G E D+++LG  + E++     A+E     T  R G   +
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD 238
Query: 195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
           +  F  +   L    L K L ++P +R +  ++L+   +   SP
Sbjct: 239 I--FDKKEKTL----LQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ D+G A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDYGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 63  DLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD 119
           DLA  L+    + TL   +     +++ L Y+H   I+H D+K  NVL+      +KLAD
Sbjct: 109 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLAD 167
Query: 120 FGAAGEATVS-DTRGVKIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP 176
           FG A   +++ +++  +   R   LW   PE++ GE   GP  D+W  GC + EM T  P
Sbjct: 168 FGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
Query: 177 ------------------------AWEDFGANTL---------SRIGFSDELPRFPTQSS 203
                                    W +     L          +    D L  +     
Sbjct: 228 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 287
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWV 256
            L  D +DK L  +P +R   D  L H F  S   PSD   +  +    + +++
Sbjct: 288 AL--DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 8/178 (4%)
Query: 54  EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D L   +  Y     L      I S + Y+   N VH D++  N+LVG N 
Sbjct: 259 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN- 317
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG      + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 318 LVCKVADFGLG--RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 375
Query: 172 VT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
            T G+  +        L ++     +P  P +  E   D + +C R++P ER + + L
Sbjct: 376 TTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKDPEERPTFEYL 432

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A   T  +  G       +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH-TDDEMAGFV----AT 181
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 242 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 302 AYFAQYHDPDDEPVAD 317

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 63  DLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD 119
           DLA  L+    + TL   +     +++ L Y+H   I+H D+K  NVL+      +KLAD
Sbjct: 110 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLAD 168
Query: 120 FGAAGEATVS-DTRGVKIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP 176
           FG A   +++ +++  +   R   LW   PE++ GE   GP  D+W  GC + EM T  P
Sbjct: 169 FGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228
Query: 177 ------------------------AWEDFGANTL---------SRIGFSDELPRFPTQSS 203
                                    W +     L          +    D L  +     
Sbjct: 229 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 288
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSD 240
            L  D +DK L  +P +R   D  L H F  S   PSD
Sbjct: 289 AL--DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 324

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 63  DLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD 119
           DLA  L+    + TL   +     +++ L Y+H   I+H D+K  NVL+      +KLAD
Sbjct: 110 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLAD 168
Query: 120 FGAAGEATVS-DTRGVKIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP 176
           FG A   +++ +++  +   R   LW   PE++ GE   GP  D+W  GC + EM T  P
Sbjct: 169 FGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228
Query: 177 ------------------------AWEDFGANTL---------SRIGFSDELPRFPTQSS 203
                                    W +     L          +    D L  +     
Sbjct: 229 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 288
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSDANTVAESSPRCVLDWV 256
            L  D +DK L  +P +R   D  L H F  S   PSD   +  +    + +++
Sbjct: 289 AL--DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 340

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A      D     +  R  
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHT--DDEMXGXVATRW- 207
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 208 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 265
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 266 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 325
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 326 AYFAQYHDPDDEPVAD 341

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A   T  +  G       +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH-TDDEMAGFV----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 63  DLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD 119
           DLA  L+    + TL   +     +++ L Y+H   I+H D+K  NVL+      +KLAD
Sbjct: 110 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLAD 168
Query: 120 FGAAGEATVS-DTRGVKIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP 176
           FG A   +++ +++  +   R   LW   PE++ GE   GP  D+W  GC + EM T  P
Sbjct: 169 FGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 228
Query: 177 ------------------------AWEDFGANTL---------SRIGFSDELPRFPTQSS 203
                                    W +     L          +    D L  +     
Sbjct: 229 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 288
Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS-VSPSD 240
            L  D +DK L  +P +R   D  L H F  S   PSD
Sbjct: 289 AL--DLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 324

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 84/196 (42%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A   T  +  G       +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH-TDDEMAGFV----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 80/173 (46%), Gaps = 7/173 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +      +  + +   +  +   I   L +LH R I++ D+K  NV++  + 
Sbjct: 99  MEYVNGGDLMYHIQQVGKFKEPQAV-FYAAEISIGLFFLHKRGIIYRDLKLDNVMLD-SE 156
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +K+ADFG   E  +    GV  +   G+P ++APE++  +  G   D W+ G  + EM
Sbjct: 157 GHIKIADFGMCKEHMMD---GVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 213
Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC 224
           + G+P ++    + L +    +    +P   S+         + + P +R  C
Sbjct: 214 LAGQPPFDGEDEDELFQ-SIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLGC 265

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGS 141
           +   + YL  +  +H D+  +N+LVG N    K+ADFG +   E  V  T G     R  
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMG-----RLP 194
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFP 199
             WMA E +        SDVWS G  + E+V+  G P      A    ++     L + P
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-P 253
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLL 228
               +   D + +C R +P ER S  Q+L
Sbjct: 254 LNCDDEVYDLMRQCWREKPYERPSFAQIL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGS 141
           +   + YL  +  +H D+  +N+LVG N    K+ADFG +   E  V  T G     R  
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMG-----RLP 204
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFP 199
             WMA E +        SDVWS G  + E+V+  G P      A    ++     L + P
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-P 263
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLL 228
               +   D + +C R +P ER S  Q+L
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 3/122 (2%)
Query: 53  LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N
Sbjct: 93  IEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 152
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+
Sbjct: 153 -HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210
Query: 172 VT 173
            T
Sbjct: 211 AT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 58/122 (47%), Gaps = 3/122 (2%)
Query: 53  LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N
Sbjct: 89  IEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 148
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+
Sbjct: 149 -HLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206
Query: 172 VT 173
            T
Sbjct: 207 AT 208

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 141 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 50/213 (23%)
Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADE-ITLRSHTYCIVS---ALKYLHSR 94
           YE       C  + +E L GG   +L + +    D+  T R  +  + S   A++YLHS 
Sbjct: 80  YENLYAGRKCLLIVMECLDGG---ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136
Query: 95  NIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           NI H DVK +N+L     PN + +KL DFG A E T                        
Sbjct: 137 NIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETT------------------------ 171
Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDF-------GANTLSRIGFSDELPRFP----T 200
           GE      D+WSLG  +  ++ G P +          G  T  R+G  +    FP    +
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE----FPNPEWS 227
Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
           + SE  +  +   L+ EP +R +  + + HP++
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 145 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV  ++  +K+ADFG A +    D      
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV  ++  +K+ADFG A +    D      
Sbjct: 144 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTT 202
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 1/97 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  Y +   ++YL S+  +H D+  +NVLV    + +K+ADFG A +    D      
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
             R    WMAPE +       +SDVWS G  + E+ T
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 102 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 160
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 161 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 219
Query: 173 T 173
           T
Sbjct: 220 T 220

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 3/122 (2%)
Query: 53  LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +E++  G + D     N      + L      I SA++YL  +N +H D+  +N LVG N
Sbjct: 86  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 145
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+
Sbjct: 146 -HLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203
Query: 172 VT 173
            T
Sbjct: 204 AT 205

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 94  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 152
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 153 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 173 T 173
           T
Sbjct: 212 T 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 94  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 152
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 153 HLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211
Query: 173 T 173
           T
Sbjct: 212 T 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 91  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 149
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 150 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 173 T 173
           T
Sbjct: 209 T 209

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 182
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 91  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 149
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 150 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 173 T 173
           T
Sbjct: 209 T 209

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 125 ISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 182
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 3/122 (2%)
Query: 53  LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +E++  G + D     N      + L      I SA++YL  +N +H D+  +N LVG N
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 147
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+
Sbjct: 148 -HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 172 VT 173
            T
Sbjct: 206 AT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 89  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 147
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 148 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 173 T 173
           T
Sbjct: 207 T 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 93  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 151
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 152 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210
Query: 173 T 173
           T
Sbjct: 211 T 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 89  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 147
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 148 HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206
Query: 173 T 173
           T
Sbjct: 207 T 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 3/122 (2%)
Query: 53  LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           +E++  G + D     N      + L      I SA++YL  +N +H D+  +N LVG N
Sbjct: 88  IEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN 147
Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+
Sbjct: 148 -HLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205
Query: 172 VT 173
            T
Sbjct: 206 AT 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 15/200 (7%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V  E   T      + +E++  G +       +     I L      I + ++YL     
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY 166
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA-----GEATVSDTRGVKIQPRGSPLWMAPEVV 150
           VH D+  +N+LV  NS+ V K++DFG +         V  T G KI  R    W APE +
Sbjct: 167 VHRDLAARNILV--NSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR----WTAPEAI 220
Query: 151 RGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD 208
           +       SDVWS G  + E+++   +P W+    + +  I     LP      + L + 
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQL 280
Query: 209 FLDKCLRREPGERWSCDQLL 228
            LD C ++E  ER   +Q++
Sbjct: 281 MLD-CWQKERAERPKFEQIV 299

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT-GDTXTAHAGAKFPIK 175
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T+S    +  E++  G +       +     I L      I S ++YL   + 
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY 137
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGA-------AGEATVSDTRGVKIQPRGSPLWMAPE 148
           VH D+  +N+LV  NS+ V K++DFG        + + T + + G KI  R    W APE
Sbjct: 138 VHRDLAARNILV--NSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIR----WTAPE 191
Query: 149 VVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELG 206
            +        SD WS G  + E+++   +P W+    + ++ I     LP  P   + L 
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLH 251
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
           +  LD C        W  D+  +  F Q VS  D
Sbjct: 252 QLMLD-C--------WQKDRNARPRFPQVVSALD 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 90  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 148
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 149 HLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 207
Query: 173 T 173
           T
Sbjct: 208 T 208

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 2/146 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  + I   ++YL   ++VH D+  +N+LV      +K++DFG + +    D+   + 
Sbjct: 152 LISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRK-MKISDFGLSRDVYEEDSXVKRS 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDEL 195
           Q R    WMA E +       +SDVWS G  + E+VT G   +       L  +  +   
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR 270
Query: 196 PRFPTQSSELGRDFLDKCLRREPGER 221
              P   SE     + +C ++EP +R
Sbjct: 271 MERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 9/184 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++  G +SD   T        TL      +   + YL    ++H D+  +N LVG 
Sbjct: 82  LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 141
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           N   +K++DFG      + D        +    W +PEV        +SDVWS G  + E
Sbjct: 142 N-QVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199
Query: 171 MVT-GKPAWEDFGANTLSR---IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           + + GK  +E+   + +      GF    PR    +S      ++ C R  P +R +  +
Sbjct: 200 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWRERPEDRPAFSR 256
Query: 227 LLKH 230
           LL+ 
Sbjct: 257 LLRQ 260

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 57/121 (47%), Gaps = 3/121 (2%)
Query: 54  EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           E++  G + D     N    + + L      I SA++YL  +N +H D+  +N LVG N 
Sbjct: 91  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN- 149
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
             VK+ADFG +   T  DT       +    W APE +       +SDVW+ G  + E+ 
Sbjct: 150 HLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208
Query: 173 T 173
           T
Sbjct: 209 T 209

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 84/225 (37%), Gaps = 78/225 (34%)
Query: 82  YCI--VSALKYLHSRNIVHCDVKGKNVLVG------------------------PNSSFV 115
           YCI  + AL YL   ++ H D+K +N+L+                           S+ +
Sbjct: 142 YCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 116 KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG- 174
           KL DFG A     SD  G  I  R    + APEV+        SD+WS GC + E+ TG 
Sbjct: 202 KLIDFGCA--TFKSDYHGSIINTRQ---YRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 175 --------------------------------------------KPAWEDFGANTLSRIG 190
                                                       K AW +  A++++ I 
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPE-NASSINSIK 315
Query: 191 FSDE-LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
              + LP +     EL  DFL   L+ +P  R S  +LLKH FL+
Sbjct: 316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 2/146 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  + I   ++YL    +VH D+  +N+LV      +K++DFG + +    D+   + 
Sbjct: 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK-MKISDFGLSRDVYEEDSXVKRS 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDEL 195
           Q R    WMA E +       +SDVWS G  + E+VT G   +       L  +  +   
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR 270
Query: 196 PRFPTQSSELGRDFLDKCLRREPGER 221
              P   SE     + +C ++EP +R
Sbjct: 271 MERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           S  +  + + C  + +E+   GT+   +        D++        I   + Y+HS+ +
Sbjct: 98  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL 157
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K  N+ +  ++  VK+ DFG     T     G + + +G+  +M+PE +  +  G
Sbjct: 158 IHRDLKPSNIFL-VDTKQVKIGDFGLV---TSLKNDGKRTRSKGTLRYMSPEQISSQDYG 213
Query: 157 PESDVWSLGCTIIEMV-TGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
            E D+++LG  + E++     A+E     T  R G   ++  F  +   L    L K L 
Sbjct: 214 KEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDI--FDKKEKTL----LQKLLS 267
Query: 216 REPGERWSCDQLLKHPFLQSVSP 238
           ++P +R +  ++L+   +   SP
Sbjct: 268 KKPEDRPNTSEILRTLTVWKKSP 290

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 40/189 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  L  LH   +VH D+   N+L+  N+  + + DF  A E T    +   +  R  
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRW- 198
Query: 142 PLWMAPEVVRGECQGPES--DVWSLGCTIIEM---------------------VTGKPAW 178
             + APE+V  + +G     D+WS GC + EM                     V G P  
Sbjct: 199 --YRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 179 E-----------DFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           E           D+  N+LS +         PT +  +  D + K L   P  R S +Q 
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 228 LKHPFLQSV 236
           L+HP+ +S+
Sbjct: 315 LRHPYFESL 323

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 82/198 (41%), Gaps = 38/198 (19%)
Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
           R   Y ++  LKY+HS N++H D+K  N+ +      +K+ DFG A       +    + 
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 138 PRGSPLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE- 194
                 W  +P ++       ++ D+W+ GC   EM+TGK  +   GA+ L ++    E 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA--GAHELEQMQLILES 240
Query: 195 ---------------LPRF----------------PTQSSELGRDFLDKCLRREPGERWS 223
                          +P +                P  S E   DFL++ L   P +R +
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE-AVDFLEQILTFSPMDRLT 299
Query: 224 CDQLLKHPFLQSVS-PSD 240
            ++ L HP++   S P D
Sbjct: 300 AEEALSHPYMSIYSFPMD 317

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 2/146 (1%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L S  + I   ++YL    +VH D+  +N+LV      +K++DFG + +    D+   + 
Sbjct: 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK-MKISDFGLSRDVYEEDSYVKRS 210
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDEL 195
           Q R    WMA E +       +SDVWS G  + E+VT G   +       L  +  +   
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR 270
Query: 196 PRFPTQSSELGRDFLDKCLRREPGER 221
              P   SE     + +C ++EP +R
Sbjct: 271 MERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 40/189 (21%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  L  LH   +VH D+   N+L+  N+  + + DF  A E T    +   +  R  
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRW- 198
Query: 142 PLWMAPEVVRGECQGPES--DVWSLGCTIIEM---------------------VTGKPAW 178
             + APE+V  + +G     D+WS GC + EM                     V G P  
Sbjct: 199 --YRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 179 E-----------DFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
           E           D+  N+LS +         PT +  +  D + K L   P  R S +Q 
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 228 LKHPFLQSV 236
           L+HP+ +S+
Sbjct: 315 LRHPYFESL 323

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT-GDTFTAHAGAKFPIK 175
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 89  TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 148
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 149 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 203
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 204 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 243

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 10  IGRGSFGTVNVAVDRFNGDVF-------AYLGDDVSYEAPTTSSSCRNLHLEYLPGG-TV 61
           IG G FG V   V R    V        +  G +       T S CR+ HL  L G    
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 62  SDLATTLNAYADEITLRSHTY-----------------CIVSA--LKYLHSRNIVHCDVK 102
            +    +  Y +   L+ H Y                 CI +A  L YLH+R I+H DVK
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 103 GKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             N+L+  N  FV K+ DFG + + T  D   +    +G+  ++ PE         +SDV
Sbjct: 167 SINILLDEN--FVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 162 WSLGCTIIEMVTGKPA 177
           +S G  + E++  + A
Sbjct: 225 YSFGVVLFEVLCARSA 240

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S+   +  E++  G++       +     I L      I + +KYL   N 
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 130
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA-------GEATVSDTRGVKIQPRGSPLWMAPE 148
           VH  +  +N+LV  NS+ V K++DFG +        + T +   G KI  R    W APE
Sbjct: 131 VHRALAARNILV--NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR----WTAPE 184
Query: 149 VVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELG 206
            ++       SDVWS G  + E+++   +P W+    + ++ I     LP      S L 
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 244
Query: 207 RDFLDKCLRREPGER-------WSCDQLLKHP-FLQSVSP 238
           +  LD C +++   R        + D+++++P  L++++P
Sbjct: 245 QLMLD-CWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAP 283

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   + +L S+N +H DV  +NVL+  N    K+ DFG A +        VK   R    
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRF 198
           WMAPE +       +SDVWS G  + E+ + G   +     N+    L + G+    P F
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 291
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             ++       +  C   EP  R +  Q+    FLQ  +  D
Sbjct: 292 APKNI---YSIMQACWALEPTHRPTFQQICS--FLQEQAQED 328

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 9/184 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++  G +SD   T        TL      +   + YL   +++H D+  +N LVG 
Sbjct: 79  LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGE 138
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           N   +K++DFG      + D        +    W +PEV        +SDVWS G  + E
Sbjct: 139 N-QVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 196
Query: 171 MVT-GKPAWEDFGANTLSR---IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           + + GK  +E+   + +      GF    PR    +S      ++ C +  P +R +  +
Sbjct: 197 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSR 253
Query: 227 LLKH 230
           LL+ 
Sbjct: 254 LLRQ 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   + +L S+N +H DV  +NVL+  N    K+ DFG A +        VK   R    
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRF 198
           WMAPE +       +SDVWS G  + E+ + G   +     N+    L + G+    P F
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 279
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             ++       +  C   EP  R +  Q+    FLQ  +  D
Sbjct: 280 APKNI---YSIMQACWALEPTHRPTFQQICS--FLQEQAQED 316

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DF  A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFYLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   + +L S+N +H DV  +NVL+  N    K+ DFG A +        VK   R    
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRF 198
           WMAPE +       +SDVWS G  + E+ + G   +     N+    L + G+    P F
Sbjct: 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 291
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             ++       +  C   EP  R +  Q+    FLQ  +  D
Sbjct: 292 APKNI---YSIMQACWALEPTHRPTFQQICS--FLQEQAQED 328

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 46/221 (20%)
Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG 140
            Y ++  LKY+HS  I+H D+K  NV V  +   +++ DFG A +A    T  V      
Sbjct: 129 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQADEEMTGYV-----A 182
Query: 141 SPLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGKPAW--EDFGANTLSRI-------- 189
           +  + APE++       ++ D+WS+GC + E++ GK  +   D+  + L RI        
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY-IDQLKRIMEVVGTPS 241
Query: 190 -------------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLL 228
                         +   LP  P +        ++ L  D L + L  +  +R S  + L
Sbjct: 242 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 301
Query: 229 KHPFL-QSVSPSDA------NTVAESSPRCVLDWVNSEFEE 262
            H +  Q   P D       +   E+  R + +W    ++E
Sbjct: 302 AHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWKELTYQE 342

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   + +L S+N +H DV  +NVL+  N    K+ DFG A +        VK   R    
Sbjct: 167 VAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 225
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRF 198
           WMAPE +       +SDVWS G  + E+ + G   +     N+    L + G+    P F
Sbjct: 226 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 285
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             ++       +  C   EP  R +  Q+    FLQ  +  D
Sbjct: 286 APKNI---YSIMQACWALEPTHRPTFQQICS--FLQEQAQED 322

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   + +L S+N +H DV  +NVL+  N    K+ DFG A +        VK   R    
Sbjct: 175 VAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 233
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRF 198
           WMAPE +       +SDVWS G  + E+ + G   +     N+    L + G+    P F
Sbjct: 234 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 293
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             ++       +  C   EP  R +  Q+    FLQ  +  D
Sbjct: 294 APKNI---YSIMQACWALEPTHRPTFQQICS--FLQEQAQED 330

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 11/149 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGS 141
           +   + YL  +  +H ++  +N+LVG N    K+ADFG +   E  V  T G     R  
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG-----RLP 201
Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFP 199
             WMA E +        SDVWS G  + E+V+  G P      A    ++     L + P
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK-P 260
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLL 228
               +   D + +C R +P ER S  Q+L
Sbjct: 261 LNCDDEVYDLMRQCWREKPYERPSFAQIL 289

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 11/162 (6%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +   + +L S+N +H DV  +NVL+  N    K+ DFG A +        VK   R    
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRIGFSDELPRF 198
           WMAPE +       +SDVWS G  + E+ + G   +     N+    L + G+    P F
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAF 287
Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             ++       +  C   EP  R +  Q+    FLQ  +  D
Sbjct: 288 APKNI---YSIMQACWALEPTHRPTFQQICS--FLQEQAQED 324

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+  FG A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILGFGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  E +  G++       +A    I L      I S +KYL     
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 140 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 192
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 193 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 252
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 253 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 311
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 312 TTGDWLN 318

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 91  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 150
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 151 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 205
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 206 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 245

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 59/278 (21%)
Query: 10  IGRGSFGTVNVAVDRFNG-----------------------DVFAY--LGDD---VSYEA 41
           IG G FG+V   V R +G                       +V+A+  LG     V Y +
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 74
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                    +  EY  GG+++D  +    + +Y  E  L+     +   L+Y+HS ++VH
Sbjct: 75  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 134
Query: 99  CDVKGKNVLVG----PNSS--------------FVKLADFGAAGEATVSDTRGVKIQPRG 140
            D+K  N+ +     PN++                K+ D G     +            G
Sbjct: 135 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EG 188
Query: 141 SPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP 199
              ++A EV++      P++D+++L  T++     +P   +       R G    LPR P
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQWHEIRQG---RLPRIP 245
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
              S+   + L   +  +P  R S   L+KH  L S S
Sbjct: 246 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 283

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 95  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 154
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 155 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 209
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 210 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 249

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 90  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 149
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 150 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 204
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 90  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 149
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 150 VLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 204
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 89  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 148
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 149 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 203
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 204 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 243

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 88  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 148 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 202
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 92  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 151
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 152 VLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 206
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 207 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 246

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T+S    +  E++  G +       +     I L      I S ++YL   + 
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY 139
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGA-------AGEATVSDTRGVKIQPRGSPLWMAPE 148
           VH D+  +N+LV  NS+ V K++DFG        + + T + + G KI  R    W APE
Sbjct: 140 VHRDLAARNILV--NSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIR----WTAPE 193
Query: 149 VVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELG 206
            +        SD WS G  + E+++   +P W+    + ++ I     LP  P   + L 
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLH 253
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
           +  LD C        W  D+  +  F Q VS  D
Sbjct: 254 QLMLD-C--------WQKDRNARPRFPQVVSALD 278

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  E +  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 90  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 149
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 150 VLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 204
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 205 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 244

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ D G A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDAGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 74/188 (39%), Gaps = 45/188 (23%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-- 141
           ++  L + H   I+H D+K +N+L+      +KL DFG A         G+ +    S  
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLA------RAFGIPVNTFSSEV 169
Query: 142 -PLWM-APEVVRGECQGPES-DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS------ 192
             LW  AP+V+ G      S D+WS GC + EM+TGKP +         ++ F       
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229
Query: 193 -------DELPRF-----------------PTQSSELG---RDFLDKCLRREPGERWSCD 225
                   +LP++                 P     L     DFL   L+  P  R S  
Sbjct: 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK 289
Query: 226 QLLKHPFL 233
           Q L HP+ 
Sbjct: 290 QALHHPWF 297

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 9/181 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           E++  G +SD   T        TL      +   + YL    ++H D+  +N LVG N  
Sbjct: 83  EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-Q 141
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            +K++DFG      + D        +    W +PEV        +SDVWS G  + E+ +
Sbjct: 142 VIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
Query: 174 -GKPAWEDFGANTLSR---IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
            GK  +E+   + +      GF    PR    +S      ++ C R  P +R +  +LL+
Sbjct: 201 EGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWRERPEDRPAFSRLLR 257
Query: 230 H 230
Sbjct: 258 Q 258

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 104/247 (42%), Gaps = 34/247 (13%)
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +  E   T S    +  E +  G++       +A    I L      I S +KYL     
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 97  VHCDVKGKNVLVGPNSSFV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEV 149
           VH D+  +N+L+  NS+ V K++DFG +       EA  + TRG KI  R    W +PE 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLSRVLEDDPEAAYT-TRGGKIPIR----WTSPEA 221
Query: 150 VRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGR 207
           +        SDVWS G  + E+++   +P WE    + +  +     LP      + L +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQ 281
Query: 208 DFLDKCLRREPGERWS-------CDQLLKHP----FLQSVSPSDANTVAESSP------R 250
             LD C +++   R          D+L+++P     + S +   +N + + S       R
Sbjct: 282 LMLD-CWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFR 340
Query: 251 CVLDWVN 257
              DW+N
Sbjct: 341 TTGDWLN 347

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 46  SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKN 105
           +S   L ++ +P G + D             L +    I   + YL  R +VH D+  +N
Sbjct: 92  TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 151
Query: 106 VLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
           VLV      VK+ DFG A     E       G K+  +    WMA E +       +SDV
Sbjct: 152 VLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK----WMALESILHRIYTHQSDV 206
Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPRFP 199
           WS G T+ E++T G   ++   A+ +S I    E LP+ P
Sbjct: 207 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 246

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 88  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 147
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 148 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 204
Query: 172 VT 173
           VT
Sbjct: 205 VT 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 125 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ D G A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDRGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 147 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 172 VT 173
           VT
Sbjct: 204 VT 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G++       +     I L      I S +KYL   + VH D+  +N+LV  NS+
Sbjct: 89  EYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILV--NSN 146
Query: 114 FV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            V K++DFG +       EA  + TRG KI  R    W APE +        SDVWS G 
Sbjct: 147 LVCKVSDFGMSRVLEDDPEAAYT-TRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGI 201
Query: 167 TIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS- 223
            + E+++   +P W+    + +  I     LP        L +  LD C ++E  +R   
Sbjct: 202 VMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD-CWQKERSDRPKF 260
Query: 224 ------CDQLLKHP 231
                  D+L+++P
Sbjct: 261 GQIVNMLDKLIRNP 274

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 89  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 148
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 149 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 205
Query: 172 VT 173
           VT
Sbjct: 206 VT 207

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H ++  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 384
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 7/91 (7%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           +VSA+ YL  ++I+H D+K +N+++  + + +KL DFG+A        RG       G+ 
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYL----ERGKLFYTFCGTI 193
Query: 143 LWMAPEVVRGE-CQGPESDVWSLGCTIIEMV 172
            + APEV+ G   +GPE ++WSLG T+  +V
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 160 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 219 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 274
Query: 198 FP 199
            P
Sbjct: 275 PP 276

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 9/184 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++  G +SD   T        TL      +   + YL    ++H D+  +N LVG 
Sbjct: 79  LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 138
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           N   +K++DFG      + D        +    W +PEV        +SDVWS G  + E
Sbjct: 139 N-QVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 196
Query: 171 MVT-GKPAWEDFGANTLSR---IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           + + GK  +E+   + +      GF    PR    +S      ++ C +  P +R +  +
Sbjct: 197 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSR 253
Query: 227 LLKH 230
           LL+ 
Sbjct: 254 LLRQ 257

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G++G V +AV+R   +  A    D                          
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G++       +     I L      I S +KYL   + VH D+  +N+LV  NS+
Sbjct: 95  EYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILV--NSN 152
Query: 114 FV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            V K++DFG +       EA  + TRG KI  R    W APE +        SDVWS G 
Sbjct: 153 LVCKVSDFGMSRVLEDDPEAAYT-TRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGI 207
Query: 167 TIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS- 223
            + E+++   +P W+    + +  I     LP        L +  LD C ++E  +R   
Sbjct: 208 VMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD-CWQKERSDRPKF 266
Query: 224 ------CDQLLKHP 231
                  D+L+++P
Sbjct: 267 GQIVNMLDKLIRNP 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 147 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 172 VT 173
           VT
Sbjct: 204 VT 205

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 9/184 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++  G +SD   T        TL      +   + YL    ++H D+  +N LVG 
Sbjct: 77  LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           N   +K++DFG      + D        +    W +PEV        +SDVWS G  + E
Sbjct: 137 N-QVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 194
Query: 171 MVT-GKPAWEDFGANTLSR---IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           + + GK  +E+   + +      GF    PR    +S      ++ C +  P +R +  +
Sbjct: 195 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSR 251
Query: 227 LLKH 230
           LL+ 
Sbjct: 252 LLRQ 255

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 96  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 155
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 156 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 212
Query: 172 VT 173
           VT
Sbjct: 213 VT 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 93  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 152
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 153 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 172 VT 173
           VT
Sbjct: 210 VT 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 82  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 141
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 142 S-CKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 198
Query: 172 VT 173
           VT
Sbjct: 199 VT 200

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 29/203 (14%)
Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------V 37
           W   + +G G++G V +AV+R   +  A    D                          V
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
            +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQG 156
           H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E   
Sbjct: 128 HRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 157 PESDVWSLGCTIIEMVTGKPAWE 179
              DVWS G  +  M+ G+  W+
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 29/203 (14%)
Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------V 37
           W   + +G G++G V +AV+R   +  A    D                          V
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
            +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I 
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 126
Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQG 156
           H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E   
Sbjct: 127 HRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 157 PESDVWSLGCTIIEMVTGKPAWE 179
              DVWS G  +  M+ G+  W+
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 9/124 (7%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146
Query: 113 SFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTII 169
           S  K+ADFG A    +A  +   G K   +    W APE +       +SDVWS G  + 
Sbjct: 147 S-CKIADFGLARLIEDAEXTAREGAKFPIK----WTAPEAINYGTFTIKSDVWSFGILLT 201
Query: 170 EMVT 173
           E+VT
Sbjct: 202 EIVT 205

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 136 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 195 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 250
Query: 198 FP 199
            P
Sbjct: 251 PP 252

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 37/196 (18%)
Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ D G A       T  V      +
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDGGLARHTDDEMTGYV-----AT 185
Query: 142 PLWMAPEVVRGECQGPES-DVWSLGCTIIEMVTGK---PAWEDF-------------GAN 184
             + APE++       ++ D+WS+GC + E++TG+   P  +               GA 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 245
Query: 185 TLSRI------GFSDELPRFPTQ--------SSELGRDFLDKCLRREPGERWSCDQLLKH 230
            L +I       +   L + P          ++ L  D L+K L  +  +R +  Q L H
Sbjct: 246 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 305
Query: 231 PFLQSVSPSDANTVAE 246
            +       D   VA+
Sbjct: 306 AYFAQYHDPDDEPVAD 321

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 24/194 (12%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G++       +     I L      I S +KYL   + VH D+  +N+LV  NS+
Sbjct: 110 EYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILV--NSN 167
Query: 114 FV-KLADFGAA------GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
            V K++DFG +       EA  + TRG KI  R    W APE +        SDVWS G 
Sbjct: 168 LVCKVSDFGMSRVLEDDPEAAYT-TRGGKIPIR----WTAPEAIAYRKFTSASDVWSYGI 222
Query: 167 TIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWS- 223
            + E+++   +P W+    + +  I     LP        L +  LD C ++E  +R   
Sbjct: 223 VMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALHQLMLD-CWQKERSDRPKF 281
Query: 224 ------CDQLLKHP 231
                  D+L+++P
Sbjct: 282 GQIVNMLDKLIRNP 295

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 151 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 210 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 265
Query: 198 FP 199
            P
Sbjct: 266 PP 267

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 132 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 191 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 246
Query: 198 FP 199
            P
Sbjct: 247 PP 248

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 95  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 154
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 155 S-CKIADFGLA--RLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 211
Query: 172 VT 173
           VT
Sbjct: 212 VT 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 120 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 179 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234
Query: 198 FP 199
            P
Sbjct: 235 PP 236

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 192 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 198 FP 199
            P
Sbjct: 248 PP 249

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 87  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 147 S-CKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 203
Query: 172 VT 173
           VT
Sbjct: 204 VT 205

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 6/158 (3%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + + + YL   + VH D+  +N LVG     VK+ DFG + +   +D   V  +      
Sbjct: 144 VAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQ 201
           WM PE +       ESDVWS G  + E+ T GK  W        +  I    EL R P  
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER-PRA 261
Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                   +  C +REP +R S   +  H  LQ+++ +
Sbjct: 262 CPPEVYAIMRGCWQREPQQRHSIKDV--HARLQALAQA 297

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I SA++YL  +N +H ++  +N LVG N   VK+ADFG +   T  DT       +    
Sbjct: 366 ISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 423
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           W APE +       +SDVW+ G  + E+ T
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 185 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 198 FP 199
            P
Sbjct: 241 PP 242

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 188 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 198 FP 199
            P
Sbjct: 244 PP 245

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 185 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 198 FP 199
            P
Sbjct: 241 PP 242

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 185 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 198 FP 199
            P
Sbjct: 241 PP 242

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKLADFGAA----GEATVSDTRGVKIQP 138
           I   + YL  R +VH D+  +NVLV  PN   VK+ DFG A    G+    +  G K+  
Sbjct: 126 IAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPI 183
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKP 176
           +    WMA E +       +SDVWS G TI E++T  GKP
Sbjct: 184 K----WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 92  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 151
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 152 S-CKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 208
Query: 172 VT 173
           VT
Sbjct: 209 VT 210

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 188 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 198 FP 199
            P
Sbjct: 244 PP 245

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 187 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 198 FP 199
            P
Sbjct: 243 PP 244

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 129 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 188 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 243
Query: 198 FP 199
            P
Sbjct: 244 PP 245

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 192 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 198 FP 199
            P
Sbjct: 248 PP 249

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 69/158 (43%), Gaps = 6/158 (3%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + + + YL   + VH D+  +N LVG     VK+ DFG + +   +D   V  +      
Sbjct: 138 VAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQ 201
           WM PE +       ESDVWS G  + E+ T GK  W        +  I    EL R P  
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER-PRA 255
Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                   +  C +REP +R S   +  H  LQ+++ +
Sbjct: 256 CPPEVYAIMRGCWQREPQQRHSIKDV--HARLQALAQA 291

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 9/184 (4%)
Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L  E++  G +SD   T        TL      +   + YL    ++H D+  +N LVG 
Sbjct: 99  LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 158
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
           N   +K++DFG      + D        +    W +PEV        +SDVWS G  + E
Sbjct: 159 N-QVIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 216
Query: 171 MVT-GKPAWEDFGANTLSR---IGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
           + + GK  +E+   + +      GF    PR    +S      ++ C +  P +R +  +
Sbjct: 217 VFSEGKIPYENRSNSEVVEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSR 273
Query: 227 LLKH 230
           LL+ 
Sbjct: 274 LLRQ 277

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 93  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 152
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 153 S-CKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 209
Query: 172 VT 173
           VT
Sbjct: 210 VT 211

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 185 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 198 FP 199
            P
Sbjct: 241 PP 242

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 128 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 187 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 242
Query: 198 FP 199
            P
Sbjct: 243 PP 244

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 133 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 192 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 247
Query: 198 FP 199
            P
Sbjct: 248 PP 249

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 22/139 (15%)
Query: 51  LHLEYLPGGTVSDL--ATTLNAYADEI--TLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           + +EY   GT+ DL  +  LN   DE     R     I+ AL Y+HS+ I+H D+K  N+
Sbjct: 92  IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ----ILEALSYIHSQGIIHRDLKPMNI 147
Query: 107 LVGPNSSFVKLADFGAAGEATVS------DTRGVK------IQPRGSPLWMAPEVVRGEC 154
            +  + + VK+ DFG A     S      D++ +           G+ +++A EV+ G  
Sbjct: 148 FIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 155 QGPES-DVWSLGCTIIEMV 172
              E  D++SLG    EM+
Sbjct: 207 HYNEKIDMYSLGIIFFEMI 225

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 123 IAEGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 182 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 237
Query: 198 FP 199
            P
Sbjct: 238 PP 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 58/122 (47%), Gaps = 11/122 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPR 139
           I   + YL  R +VH D+  +NVLV      VK+ DFG A     E       G K+  +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE-LPR 197
               WMA E +       +SDVWS G T+ E++T G   ++   A+ +S I    E LP+
Sbjct: 185 ----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 198 FP 199
            P
Sbjct: 241 PP 242

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H D++  N+LV    
Sbjct: 97  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 156
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 157 S-CKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 213
Query: 172 VT 173
           VT
Sbjct: 214 VT 215

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 48/221 (21%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           GK IG G+FG + +  + +  +  A   + +   AP        LHLEY           
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDG 66
Query: 56  -------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                              L G ++ DL    +      T+      ++S ++Y+HS+N+
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 97  VHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMA 146
           ++ DVK +N L+G         + + DFG A E    +T+   I  R      G+  +M+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKK-HIPYREHKSLTGTARYMS 185
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS 187
                G+ Q    D+ +LG   +  + G   W+   A+TL 
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 1/95 (1%)
Query: 79  SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           S +Y +   + +L S+N +H D+  +N+L+  +    K+ DFG A +        VK   
Sbjct: 167 SFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           R    WMAPE +       ESDVWS G  + E+ +
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 1/95 (1%)
Query: 79  SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           S +Y +   + +L S+N +H D+  +N+L+  +    K+ DFG A +        VK   
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           R    WMAPE +       ESDVWS G  + E+ +
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 68/156 (43%), Gaps = 6/156 (3%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + + + YL   + VH D+  +N LVG     VK+ DFG + +   +D   V  +      
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQ 201
           WM PE +       ESDVWS G  + E+ T GK  W        +  I    EL R P  
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER-PRA 284
Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                   +  C +REP +R S   +  H  LQ+++
Sbjct: 285 CPPEVYAIMRGCWQREPQQRHSIKDV--HARLQALA 318

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 59/278 (21%)
Query: 10  IGRGSFGTVNVAVDRFNG-----------------------DVFAY--LGDD---VSYEA 41
           IG G FG+V   V R +G                       +V+A+  LG     V Y +
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                    +  EY  GG+++D  +    + +Y  E  L+     +   L+Y+HS ++VH
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 136
Query: 99  CDVKGKNVLVG----PNSS--------------FVKLADFGAAGEATVSDTRGVKIQPRG 140
            D+K  N+ +     PN++                K+ D G     +            G
Sbjct: 137 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EG 190
Query: 141 SPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP 199
              ++A EV++      P++D+++L  T++     +P   +       R G    LPR P
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG---RLPRIP 247
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
              S+   + L   +  +P  R S   L+KH  L S S
Sbjct: 248 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 1/95 (1%)
Query: 79  SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           S +Y +   + +L S+N +H D+  +N+L+  +    K+ DFG A +        VK   
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           R    WMAPE +       ESDVWS G  + E+ +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 59/278 (21%)
Query: 10  IGRGSFGTVNVAVDRFNG-----------------------DVFAY--LGDD---VSYEA 41
           IG G FG+V   V R +G                       +V+A+  LG     V Y +
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                    +  EY  GG+++D  +    + +Y  E  L+     +   L+Y+HS ++VH
Sbjct: 79  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 138
Query: 99  CDVKGKNVLVG----PNSS--------------FVKLADFGAAGEATVSDTRGVKIQPRG 140
            D+K  N+ +     PN++                K+ D G     +            G
Sbjct: 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EG 192
Query: 141 SPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP 199
              ++A EV++      P++D+++L  T++     +P   +       R G    LPR P
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG---RLPRIP 249
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
              S+   + L   +  +P  R S   L+KH  L S S
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 1/95 (1%)
Query: 79  SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           S +Y +   + +L S+N +H D+  +N+L+  +    K+ DFG A +        VK   
Sbjct: 165 SFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           R    WMAPE +       ESDVWS G  + E+ +
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 91/279 (32%)
Query: 70  AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA------ 123
            Y  E+ +++  Y ++  +KY+HS  I+H D+K  N LV  + S VK+ DFG A      
Sbjct: 151 VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYP 209
Query: 124 ----------------GEATVSDTRGVKIQPRGSPL---WMAPEVVRGECQGPES-DVWS 163
                              T   T+ +K Q  G  +   + APE++  +    E+ DVWS
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269
Query: 164 LGCTIIEM---------------------------------------------------- 171
           +GC   E+                                                    
Sbjct: 270 IGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329
Query: 172 VTGKPAWEDFGA----------NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           + G P+ ED  A              +   +D   RFP  S++     L + L   P +R
Sbjct: 330 ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD-AIHLLKRMLVFNPNKR 388
Query: 222 WSCDQLLKHPFLQSVSPSDANTVAESSPRCVL-DWVNSE 259
            + ++ L HPF + V  ++  T A    R    DW+N +
Sbjct: 389 ITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMD 427

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 69  NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG---- 124
           N +  E T++     +V AL YL ++ I+H D+K  N+L+  +   V + DF  A     
Sbjct: 109 NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPR 167
Query: 125 EATVSDTRGVKIQPRGSPLWMAPEVV---RGECQGPESDVWSLGCTIIEMVTGKPAWEDF 181
           E  ++   G K        +MAPE+    +G       D WSLG T  E++ G+  +   
Sbjct: 168 ETQITTMAGTKP-------YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220
Query: 182 GANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLRREPGERWS 223
            + +   I   F   +  +P+  S+     L K L   P +R+S
Sbjct: 221 SSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFS 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 7/173 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +      +  + +   +  +   I   L +L S+ I++ D+K  NV++  + 
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAV-FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-SE 478
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +K+ADFG   E       GV  +   G+P ++APE++  +  G   D W+ G  + EM
Sbjct: 479 GHIKIADFGMCKENIWD---GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC 224
           + G+  +E    + L +      +  +P   S+         + + PG+R  C
Sbjct: 536 LAGQAPFEGEDEDELFQSIMEHNVA-YPKSMSKEAVAICKGLMTKHPGKRLGC 587

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 7/173 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +EY+ GG +      +  + +   +  +   I   L +L S+ I++ D+K  NV++  + 
Sbjct: 100 MEYVNGGDLMYHIQQVGRFKEPHAV-FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD-SE 157
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             +K+ADFG   E       GV  +   G+P ++APE++  +  G   D W+ G  + EM
Sbjct: 158 GHIKIADFGMCKENIWD---GVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC 224
           + G+  +E    + L +    +    +P   S+         + + PG+R  C
Sbjct: 215 LAGQAPFEGEDEDELFQ-SIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 266

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLV-GPNSSFVKLADFGAA----GEATVSDTRGVKIQP 138
           I   + YL  R +VH D+  +NVLV  PN   VK+ DFG A    G+    +  G K+  
Sbjct: 149 IAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPI 206
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKP 176
           +    WMA E +       +SDVWS G TI E++T  GKP
Sbjct: 207 K----WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 59/278 (21%)
Query: 10  IGRGSFGTVNVAVDRFNG-----------------------DVFAY--LGDD---VSYEA 41
           IG G FG+V   V R +G                       +V+A+  LG     V Y +
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 76
Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                    +  EY  GG+++D  +    + +Y  E  L+     +   L+Y+HS ++VH
Sbjct: 77  AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVH 136
Query: 99  CDVKGKNVLVG----PNSS--------------FVKLADFGAAGEATVSDTRGVKIQPRG 140
            D+K  N+ +     PN++                K+ D G     +            G
Sbjct: 137 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EG 190
Query: 141 SPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP 199
              ++A EV++      P++D+++L  T++     +P   +       R G    LPR P
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQG---RLPRIP 247
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
              S+   + L   +  +P  R S   L+KH  L S S
Sbjct: 248 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 1/127 (0%)
Query: 47  SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           S   L  +YLP G++ D             L +    I   + YL    +VH ++  +NV
Sbjct: 105 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNV 164
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
           L+  + S V++ADFG A      D + +  + +    WMA E +       +SDVWS G 
Sbjct: 165 LLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 223
Query: 167 TIIEMVT 173
           T+ E++T
Sbjct: 224 TVWELMT 230

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 1/95 (1%)
Query: 79  SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
           S +Y +   + +L S+N +H D+  +N+L+  +    K+ DFG A          VK   
Sbjct: 172 SFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           R    WMAPE +       ESDVWS G  + E+ +
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 59/127 (46%), Gaps = 1/127 (0%)
Query: 47  SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           S   L  +YLP G++ D             L +    I   + YL    +VH ++  +NV
Sbjct: 87  SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNV 146
Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGC 166
           L+  + S V++ADFG A      D + +  + +    WMA E +       +SDVWS G 
Sbjct: 147 LLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 167 TIIEMVT 173
           T+ E++T
Sbjct: 206 TVWELMT 212

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 16/169 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSP 142
           I   + ++  RN +H D++  N+LV  ++S V K+ADFG A    + D      +    P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLA--RVIEDNEYTAREGAKFP 348
Query: 143 L-WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSR-IGFSDELPRFP 199
           + W APE +       +SDVWS G  ++E+VT G+  +       + R +     +PR P
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-P 407
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
               E   + + +C +  P ER + +      ++QSV   D  T  ES 
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFE------YIQSVL-DDFYTATESQ 449

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 11/180 (6%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 84  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 142
Query: 114 FVKLADFGAAG---EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
            VK++DFG +    +   + +RG K   R SP    PEV+       +SD+W+ G  + E
Sbjct: 143 VVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP----PEVLMYSKFSSKSDIWAFGVLMWE 198
Query: 171 MVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
           + + GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 199 IYSLGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 49/222 (22%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           GK IG G+FG + +  + +  +  A   + +   AP        LHLEY           
Sbjct: 5   GKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAP-------QLHLEYRFYKQLGSAGE 57
Query: 56  --------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
                               L G ++ DL    +      T+      ++S ++Y+HS+N
Sbjct: 58  GLPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLLSRMEYVHSKN 117
Query: 96  IVHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWM 145
           +++ DVK +N L+G         + + DFG A E    +T+   I  R      G+  +M
Sbjct: 118 LIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKK-HIPYREHKSLTGTARYM 176
Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS 187
           +     G+ Q    D+ +LG   +  + G   W+   A+TL 
Sbjct: 177 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 218

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 2/87 (2%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMA 146
           +KYL  +N VH D+  +NVL+  N  + K++DFG +      D+          PL W A
Sbjct: 123 MKYLEEKNFVHRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVT 173
           PE +        SDVWS G T+ E ++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 53  LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L+ + GG   DL   L+ +    E  +R +   I+  L+++H+R +V+ D+K  N+L+  
Sbjct: 271 LDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGC 166
           +   V+++D G A + +       K +P    G+  +MAPEV+ +G      +D +SLGC
Sbjct: 328 HGH-VRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 167 TIIEMVTGKPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGER 221
            + +++ G   +          I       + ELP   + S EL R  L+  L+R+   R
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPEL-RSLLEGLLQRDVNRR 436
Query: 222 WSC-----DQLLKHPFLQSV 236
             C      ++ + PF +S+
Sbjct: 437 LGCLGRGAQEVKESPFFRSL 456

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 15/157 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSP 142
           I   + ++  RN +H D++  N+LV  ++S V K+ADFG A    + D      +    P
Sbjct: 120 IAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLA--RVIEDNEYTAREGAKFP 175
Query: 143 L-WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSR-IGFSDELPRFP 199
           + W APE +       +SDVWS G  ++E+VT G+  +       + R +     +PR P
Sbjct: 176 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-P 234
Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
               E   + + +C +  P ER + +      ++QSV
Sbjct: 235 ENCPEELYNIMMRCWKNRPEERPTFE------YIQSV 265

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 53  LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L+ + GG   DL   L+ +    E  +R +   I+  L+++H+R +V+ D+K  N+L+  
Sbjct: 270 LDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 326
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGC 166
           +   V+++D G A + +       K +P    G+  +MAPEV+ +G      +D +SLGC
Sbjct: 327 HGH-VRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 378
Query: 167 TIIEMVTGKPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGER 221
            + +++ G   +          I       + ELP   + S EL R  L+  L+R+   R
Sbjct: 379 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPEL-RSLLEGLLQRDVNRR 435
Query: 222 WSC-----DQLLKHPFLQSV 236
             C      ++ + PF +S+
Sbjct: 436 LGCLGRGAQEVKESPFFRSL 455

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEI-TLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D        A ++  L      + + + Y+   N +H D++  N+LVG N 
Sbjct: 83  EYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-NG 141
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
              K+ADFG A    + D      Q    P+ W APE         +SDVWS G  + E+
Sbjct: 142 LICKIADFGLA--RLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 199
Query: 172 VT 173
           VT
Sbjct: 200 VT 201

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 81/196 (41%), Gaps = 30/196 (15%)
Query: 10  IGRGSFGTVNVAVDRFNGDVF-------AYLGDDVSYEAPTTSSSCRNLHLEYLPGG-TV 61
           IG G FG V   V R    V        +  G +       T S CR+ HL  L G    
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 62  SDLATTLNAYADEITLRSHTY-----------------CIVSA--LKYLHSRNIVHCDVK 102
            +    +  Y +   L+ H Y                 CI +A  L YLH+R I+H DVK
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166
Query: 103 GKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             N+L+  N  FV K+ DFG + + T      +    +G+  ++ PE         +SDV
Sbjct: 167 SINILLDEN--FVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 162 WSLGCTIIEMVTGKPA 177
           +S G  + E++  + A
Sbjct: 225 YSFGVVLFEVLCARSA 240

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 53  LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L+ + GG   DL   L+ +    E  +R +   I+  L+++H+R +V+ D+K  N+L+  
Sbjct: 271 LDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGC 166
           +   V+++D G A + +       K +P    G+  +MAPEV+ +G      +D +SLGC
Sbjct: 328 HGH-VRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 167 TIIEMVTGKPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGER 221
            + +++ G   +          I       + ELP   + S EL R  L+  L+R+   R
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPEL-RSLLEGLLQRDVNRR 436
Query: 222 WSC-----DQLLKHPFLQSV 236
             C      ++ + PF +S+
Sbjct: 437 LGCLGRGAQEVKESPFFRSL 456

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 53  LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           L+ + GG   DL   L+ +    E  +R +   I+  L+++H+R +V+ D+K  N+L+  
Sbjct: 271 LDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 327
Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVV-RGECQGPESDVWSLGC 166
           +   V+++D G A + +       K +P    G+  +MAPEV+ +G      +D +SLGC
Sbjct: 328 HGH-VRISDLGLACDFS-------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 167 TIIEMVTGKPAWEDFGANTLSRIG-----FSDELPRFPTQSSELGRDFLDKCLRREPGER 221
            + +++ G   +          I       + ELP   + S EL R  L+  L+R+   R
Sbjct: 380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPEL-RSLLEGLLQRDVNRR 436
Query: 222 WSC-----DQLLKHPFLQSV 236
             C      ++ + PF +S+
Sbjct: 437 LGCLGRGAQEVKESPFFRSL 456

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 10/132 (7%)
Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
           L    Y +   +++L  ++ VH D+  +NVLV  +   VK+ DFG A +        V+ 
Sbjct: 174 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV-THGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-------GKPAWEDFGANTLSRI 189
             R    WMAPE +       +SDVWS G  + E+ +       G P   +F    L + 
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--YKLIQN 290
Query: 190 GFSDELPRFPTQ 201
           GF  + P + T+
Sbjct: 291 GFKMDQPFYATE 302

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 75  ITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVG-----PNSSFVKLADFGAAGEATV 128
           I ++  +  ++  L Y+H R  I+H D+K +NVL+       N   +K+AD G A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR 188
             T  ++ +      + +PEV+ G   G  +D+WS  C I E++TG   +E    ++ ++
Sbjct: 191 HYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 189 --------IGFSDELPRFPTQSSELGRDFLD 211
                   I    ELP +  ++ +  R F +
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFN 276

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 29/204 (14%)
Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------- 36
            W   + +G G+ G V +AV+R   +  A    D                          
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           V +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGECQ 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE++ R E  
Sbjct: 126 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 156 GPESDVWSLGCTIIEMVTGKPAWE 179
               DVWS G  +  M+ G+  W+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 75  ITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVG-----PNSSFVKLADFGAAGEATV 128
           I ++  +  ++  L Y+H R  I+H D+K +NVL+       N   +K+AD G A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR 188
             T  ++ +      + +PEV+ G   G  +D+WS  C I E++TG   +E    ++ ++
Sbjct: 191 HYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 189 --------IGFSDELPRFPTQSSELGRDFLD 211
                   I    ELP +  ++ +  R F +
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFN 276

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 56/122 (45%), Gaps = 5/122 (4%)
Query: 54  EYLPGGTVSDLATTLNAYADEIT-LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+  G++ D   T +     I  L      I   + ++  RN +H +++  N+LV    
Sbjct: 83  EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTL 142
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
           S  K+ADFG A    + D      +    P+ W APE +       +SDVWS G  + E+
Sbjct: 143 S-CKIADFGLA--RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 199
Query: 172 VT 173
           VT
Sbjct: 200 VT 201

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 134 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 192
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 193 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 196 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 142 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 201 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 140 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 198
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 199 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 238

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 142 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 201 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 48/221 (21%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           GK IG G+FG + +  + +  +  A   + +   AP        LHLEY           
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDG 66
Query: 56  -------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                              L G ++ DL    +      T+      ++S ++Y+HS+N+
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 97  VHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMA 146
           ++ DVK +N L+G         + + DF  A E    +T+   I  R      G+  +M+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK-HIPYREHKSLTGTARYMS 185
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS 187
                G+ Q    D+ +LG   +  + G   W+   A+TL 
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 226

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 139 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 197
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 198 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 161 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 219
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 220 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 259

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 141 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 199
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 200 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 239

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 141 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEXXSVHNKTGAKLP 199
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 200 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 239

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +KYL S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 160 VAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEYYSVHNKTGAKLP 218
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 219 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 258

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 80/210 (38%), Gaps = 63/210 (30%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--------SFVKLADFGAAGEATVSD--TRG 133
           ++ AL Y+H    VH  VK  ++L+  +         S + +   G   +  V D     
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR-QRVVHDFPKYS 195
Query: 134 VKIQPRGSPLWMAPEVVRGECQG--PESDVWSLGCTIIEMVTGKPAWEDFGAN------- 184
           VK+ P     W++PEV++   QG   +SD++S+G T  E+  G   ++D  A        
Sbjct: 196 VKVLP-----WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 185 ------------------------TLSRIGFSDEL------------PRFPTQS--SELG 206
                                   +++  G SD L            P  P     S   
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
             F+++CL+R P  R S   LL H F + +
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQI 340

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 87/221 (39%), Gaps = 48/221 (21%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           GK IG G+FG + +  + +  +  A   + +   AP        LHLEY           
Sbjct: 35  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDG 87
Query: 56  -------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                              L G ++ DL    +      T+      ++S ++Y+HS+N+
Sbjct: 88  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 147
Query: 97  VHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMA 146
           ++ DVK +N L+G         + + DF  A E    +T+   I  R      G+  +M+
Sbjct: 148 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK-HIPYREHKSLTGTARYMS 206
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS 187
                G+ Q    D+ +LG   +  + G   W+   A+TL 
Sbjct: 207 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 247

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 80/210 (38%), Gaps = 63/210 (30%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNS--------SFVKLADFGAAGEATVSD--TRG 133
           ++ AL Y+H    VH  VK  ++L+  +         S + +   G   +  V D     
Sbjct: 121 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR-QRVVHDFPKYS 179
Query: 134 VKIQPRGSPLWMAPEVVRGECQG--PESDVWSLGCTIIEMVTGKPAWEDFGAN------- 184
           VK+ P     W++PEV++   QG   +SD++S+G T  E+  G   ++D  A        
Sbjct: 180 VKVLP-----WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 234
Query: 185 ------------------------TLSRIGFSDEL------------PRFPTQS--SELG 206
                                   +++  G SD L            P  P     S   
Sbjct: 235 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 294
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
             F+++CL+R P  R S   LL H F + +
Sbjct: 295 HHFVEQCLQRNPDARPSASTLLNHSFFKQI 324

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 22/139 (15%)
Query: 51  LHLEYLPGGTVSDL--ATTLNAYADEI--TLRSHTYCIVSALKYLHSRNIVHCDVKGKNV 106
           + +EY    T+ DL  +  LN   DE     R     I+ AL Y+HS+ I+H D+K  N+
Sbjct: 92  IQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQ----ILEALSYIHSQGIIHRDLKPMNI 147
Query: 107 LVGPNSSFVKLADFGAAGEATVS------DTRGVK------IQPRGSPLWMAPEVVRGEC 154
            +  + + VK+ DFG A     S      D++ +           G+ +++A EV+ G  
Sbjct: 148 FIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG 206
Query: 155 QGPES-DVWSLGCTIIEMV 172
              E  D++SLG    EM+
Sbjct: 207 HYNEKIDMYSLGIIFFEMI 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 124 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENXYKAQTHGKWPVKWY 181
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 182 APECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 120 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 177
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 118 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 175
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 176 APECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 130 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 187
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 140 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 197
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 198 APECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 140 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 197
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 198 APECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 124 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 181
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 182 APECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS-PL-WM 145
           +KYL   N VH D+  +NVL+     + K++DFG + +A  +D    K Q  G  P+ W 
Sbjct: 138 MKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALRADENYYKAQTHGKWPVKWY 195
Query: 146 APEVVRGECQGPESDVWSLGCTIIE 170
           APE +       +SDVWS G  + E
Sbjct: 196 APECINYYKFSSKSDVWSFGVLMWE 220

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 99  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 157
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            VK++DFG +    + D     +  +    W  PEV+       +SD+W+ G  + E+ +
Sbjct: 158 VVKVSDFGLS-RYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
Query: 174 -GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 217 LGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 272

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSP 142
           I   + ++  RN +H D++  N+LV  ++S V K+ADFG A           ++  +   
Sbjct: 287 IAEGMAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLA-----------RVGAKFPI 333
Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSR-IGFSDELPRFPT 200
            W APE +       +SDVWS G  ++E+VT G+  +       + R +     +PR P 
Sbjct: 334 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-PE 392
Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
              E   + + +C +  P ER + +      ++QSV   D  T  ES 
Sbjct: 393 NCPEELYNIMMRCWKNRPEERPTFE------YIQSVL-DDFYTATESQ 433

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 83  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 141
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            VK++DFG +    + D     +  +    W  PEV+       +SD+W+ G  + E+ +
Sbjct: 142 VVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200
Query: 174 -GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 201 LGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 256

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 140 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLP 198
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 199 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 238

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 143 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLP 201
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 202 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 241

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 2/87 (2%)
Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMA 146
           +KYL  +N VH ++  +NVL+  N  + K++DFG +      D+          PL W A
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVT 173
           PE +        SDVWS G T+ E ++
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 147 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 206 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 245

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 90  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 148
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            VK++DFG +    + D     +  +    W  PEV+       +SD+W+ G  + E+ +
Sbjct: 149 VVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207
Query: 174 -GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 208 LGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 263

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 142 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 201 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 143 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMLDKEFDSVHNKTGAKLP 201
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 202 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 142 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 201 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 99  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 157
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            VK++DFG +    + D     +  +    W  PEV+       +SD+W+ G  + E+ +
Sbjct: 158 VVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
Query: 174 -GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 217 LGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 272

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 12/104 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA------TVSDTRGVKIQ 137
           +   +K+L S+  VH D+  +N ++    + VK+ADFG A +       +V +  G K+ 
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWED 180
            +    WMA E ++ +    +SDVWS G  + E++T G P + D
Sbjct: 260 VK----WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 79  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 137
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            VK++DFG +    + D     +  +    W  PEV+       +SD+W+ G  + E+ +
Sbjct: 138 VVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196
Query: 174 -GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 197 LGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 252

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 4/107 (3%)
Query: 69  NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV 128
           N +  +  +    + +   +KYL   N VH D+  +NVL+     + K++DFG + +A  
Sbjct: 463 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALR 520
Query: 129 SDTRGVKIQPRGS-PL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           +D    K Q  G  P+ W APE +       +SDVWS G  + E  +
Sbjct: 521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 7/150 (4%)
Query: 75  ITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV 134
           +TL  ++  I  A+ YL S N VH D+  +N+LV  +   VKL DFG +    + D    
Sbjct: 109 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS--RYIEDEDYY 165
Query: 135 KIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGF 191
           K      P+ WM+PE +        SDVW     + E+++   +P +     + +  +  
Sbjct: 166 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 225
Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGER 221
            D LP+ P     +    + +C   +P +R
Sbjct: 226 GDRLPK-PDLCPPVLYTLMTRCWDYDPSDR 254

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---- 139
           I  A+++LHS+ ++H D+K  N+    +   VK+ DFG        +     + P     
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 140 ------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
                 G+ L+M+PE + G     + D++SLG  + E++
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 5/177 (2%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G + +    +        L      +  A++YL S+  +H D+  +N LV  +  
Sbjct: 84  EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN-DQG 142
Query: 114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            VK++DFG +    + D     +  +    W  PEV+       +SD+W+ G  + E+ +
Sbjct: 143 VVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201
Query: 174 -GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL 228
            GK  +E F  + T   I     L R P  +SE     +  C   +  ER +   LL
Sbjct: 202 LGKMPYERFTNSETAEHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILL 257

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 7/172 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E  P G +             +TL  ++  I  A+ YL S N VH D+  +N+LV  + 
Sbjct: 91  MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-SP 149
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
             VKL DFG +    + D    K      P+ WM+PE +        SDVW     + E+
Sbjct: 150 ECVKLGDFGLS--RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 207
Query: 172 VT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           ++   +P +     + +  +   D LP+ P     +    + +C   +P +R
Sbjct: 208 LSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDR 258

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 4/107 (3%)
Query: 69  NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV 128
           N +  +  +    + +   +KYL   N VH D+  +NVL+     + K++DFG + +A  
Sbjct: 464 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL-VTQHYAKISDFGLS-KALR 521
Query: 129 SDTRGVKIQPRGS-PL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           +D    K Q  G  P+ W APE +       +SDVWS G  + E  +
Sbjct: 522 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 73/172 (42%), Gaps = 7/172 (4%)
Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           +E  P G +             +TL  ++  I  A+ YL S N VH D+  +N+LV  + 
Sbjct: 103 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA-SP 161
Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
             VKL DFG +    + D    K      P+ WM+PE +        SDVW     + E+
Sbjct: 162 ECVKLGDFGLS--RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEI 219
Query: 172 VT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           ++   +P +     + +  +   D LP+ P     +    + +C   +P +R
Sbjct: 220 LSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPVLYTLMTRCWDYDPSDR 270

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 10/111 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I + ++YL S ++VH D+  +NVLV    + VK++D G   E   +D   +         
Sbjct: 154 IAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLGLFREVYAADYYKLLGNSLLPIR 212
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
           WMAPE +       +SD+WS G  +         WE F        G+S++
Sbjct: 213 WMAPEAIMYGKFSIDSDIWSYGVVL---------WEVFSYGLQPYCGYSNQ 254

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 17/111 (15%)
Query: 78  RSHTYC------IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT 131
           R H  C      I  A+++LHS+ ++H D+K  N+    +   VK+ DFG        + 
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEE 219
Query: 132 RGVKIQPR----------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
               + P           G+ L+M+PE + G     + D++SLG  + E++
Sbjct: 220 EQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 10/111 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I + ++YL S ++VH D+  +NVLV    + VK++D G   E   +D   +         
Sbjct: 137 IAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLGLFREVYAADYYKLLGNSLLPIR 195
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
           WMAPE +       +SD+WS G  +         WE F        G+S++
Sbjct: 196 WMAPEAIMYGKFSIDSDIWSYGVVL---------WEVFSYGLQPYCGYSNQ 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 45/111 (40%), Gaps = 10/111 (9%)
Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           + + + YL  R  VH D+  +N LVG N   VK+ADFG +     +D             
Sbjct: 183 VAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE 194
           WM PE +       ESDVW+ G  +         WE F        G + E
Sbjct: 242 WMPPESIFYNRYTTESDVWAYGVVL---------WEIFSYGLQPYYGMAHE 283

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 75/195 (38%), Gaps = 21/195 (10%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G++     T +     + L      + + ++YL     VH D+  +NVLV  N  
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL- 188
Query: 114 FVKLADFGAA-----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
             K++DFG +            T G KI  R    W APE +        SDVWS G  +
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAXTTTGGKIPIR----WTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 169 IEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
            E++    +P W     + +S +     LP  P          +  C        W  D+
Sbjct: 245 WEVLAYGERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDC--------WHKDR 295
Query: 227 LLKHPFLQSVSPSDA 241
             +  F Q VS  DA
Sbjct: 296 AQRPRFSQIVSVLDA 310

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 50  NLHLEYL-PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV 108
           NL+L+ L     VSD    L    + I+L      I S + +LHS  I+H D+K +N+LV
Sbjct: 110 NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ---IASGVAHLHSLKIIHRDLKPQNILV 166
Query: 109 GPNSSF------------VKLADFGAAGEATVSDT--RGVKIQPRGSPLWMAPEVVRGEC 154
             +S F            + ++DFG   +        R     P G+  W APE++    
Sbjct: 167 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEEST 226
Query: 155 QGPES---DVWSLGCTIIEMVT-GKPAWEDF---GANTLSRIGFSDELPRFPTQS-SELG 206
           +   +   D++S+GC    +++ GK  + D     +N +  I   DE+     +S     
Sbjct: 227 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEA 286
Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFL 233
            D + + +  +P +R +  ++L+HP  
Sbjct: 287 TDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 48/221 (21%)
Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           GK IG G+FG + +  + +  +  A   + +   AP        LHLEY           
Sbjct: 9   GKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAP-------QLHLEYRFYKQLSATEG 61
Query: 56  -------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                              L G ++ DL    +      T+      +++ ++Y+H++++
Sbjct: 62  VPQVYYFGPXGKYNAMVLELLGPSLEDLFDLCDRTFTLKTVLMIAIQLITRMEYVHTKSL 121
Query: 97  VHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMA 146
           ++ DVK +N LVG         + + DFG A E    +T+   I  R      G+  +M+
Sbjct: 122 IYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETKK-HIPYREHKSLTGTARYMS 180
Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS 187
                G+ Q    D+ +LG   +  + G   W+   A+TL 
Sbjct: 181 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK 221

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 75/195 (38%), Gaps = 21/195 (10%)
Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+  G++     T +     + L      + + ++YL     VH D+  +NVLV  N  
Sbjct: 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL- 188
Query: 114 FVKLADFGAA-----GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI 168
             K++DFG +            T G KI  R    W APE +        SDVWS G  +
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR----WTAPEAIAFRTFSSASDVWSFGVVM 244
Query: 169 IEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ 226
            E++    +P W     + +S +     LP  P          +  C        W  D+
Sbjct: 245 WEVLAYGERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDC--------WHKDR 295
Query: 227 LLKHPFLQSVSPSDA 241
             +  F Q VS  DA
Sbjct: 296 AQRPRFSQIVSVLDA 310
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	408
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-81
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-71
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-65
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-61
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-60
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-59
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-58
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-58
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-55
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-49
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-49
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-49
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-48
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-48
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-48
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-47
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-47
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-46
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-46
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-46
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-45
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-43
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-43
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-42
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-40
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-39
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-36
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-35
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-34
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-33
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-32
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-31
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-31
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-31
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-30
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-30
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-30
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-30
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-30
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-29
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-29
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-29
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-29
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-27
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-27
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-27
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-27
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-26
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-25
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-25
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-25
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-25
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-24
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-24
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-24
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-24
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-24
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-24
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-24
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-24
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-23
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-23
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-23
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-23
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-23
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-23
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-22
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-22
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-21
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-21
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-21
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-20
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-20
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-20
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-15
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-15
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-14
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-14
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-14
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-13
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-13
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-13
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-13
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-13
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-13
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-13
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-13
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-13
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-12
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-12
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-12
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-11
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-11
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-11
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-11
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-11
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-11
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-10
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-10
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-10
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-10
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-10
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-09
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-09
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-09
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-04

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  249 bits (638), Expect = 8e-81
 Identities = 75/270 (27%), Positives = 117/270 (43%), Gaps = 33/270 (12%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD---------------------V 37
                  +G+G++G V    D  N    A       D                      V
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRN 95
            Y    + +    + +E +PGG++S L  +       +E T+  +T  I+  LKYLH   
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ 155
           IVH D+KG NVL+   S  +K++DFG +    ++          G+  +MAPE++    +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 156 G--PESDVWSLGCTIIEMVTGKPAWEDFGANT--LSRIGFSDELPRFPTQSSELGRDFLD 211
           G    +D+WSLGCTIIEM TGKP + + G     + ++G     P  P   S   + F+ 
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260

Query: 212 KCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
           KC   +P +R   + LL   FL+  S    
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKVSSKKKK 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  226 bits (579), Expect = 2e-71
 Identities = 63/262 (24%), Positives = 96/262 (36%), Gaps = 26/262 (9%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD----------------VSYEAPT 43
                 +GRGSFG V+   D+  G   A     L                   V      
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAV 119

Query: 44  TSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                 N+ +E L GG++  L   +     E     +    +  L+YLH+R I+H DVK 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCL-PEDRALYYLGQALEGLEYLHTRRILHGDVKA 178

Query: 104 KNVLVGPNSSFVKLADFGAAG---EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
            NVL+  + S   L DFG A       +  +        G+   MAPEVV G+    + D
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238

Query: 161 VWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSD-ELPRFPTQSSELGRDFLDKCLRREP 218
           +WS  C ++ M+ G   W  +       +I      +   P   + L    + + LR+EP
Sbjct: 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEP 298

Query: 219 GERWSCDQLLKHPFLQSVSPSD 240
             R S  +L +           
Sbjct: 299 VHRASAMELRRKVGKALQEVGG 320

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  208 bits (532), Expect = 4e-65
 Identities = 64/272 (23%), Positives = 102/272 (37%), Gaps = 47/272 (17%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------- 31
                 IGRGSF TV   +D       A                                
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 32  --YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
             +     S+E+      C  L  E +  GT+               LRS    I+  L+
Sbjct: 88  VRFYD---SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQ 143

Query: 90  YLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAP 147
           +LH+R   I+H D+K  N+ +   +  VK+ D G A     S  + V     G+P +MAP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAP 199

Query: 148 EVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPR-FPTQSSEL 205
           E+   +      DV++ G  ++EM T +  + +   A  + R   S   P  F   +   
Sbjct: 200 EMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
            ++ ++ C+R+   ER+S   LL H F Q  +
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  197 bits (503), Expect = 9e-61
 Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 67/288 (23%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD-------------------- 36
           +   + IG G FG+V   V R +G ++A         G                      
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 37  -VSYEAPTTSSSCRNLHL----EYLPGGTVSDL---ATTLNAYADEITLRSHTYCIVSAL 88
            V Y     S+   + H+    EY  GG+++D       + +Y  E  L+     +   L
Sbjct: 73  VVRYF----SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 89  KYLHSRNIVHCDVKGKNVLVGPN------------------SSFVKLADFGAAGEATVSD 130
           +Y+HS ++VH D+K  N+ +                         K+ D G     +   
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 131 TRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI 189
                    G   ++A EV++      P++D+++L  T++     +P       +    I
Sbjct: 189 VE------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--RNGDQWHEI 240

Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                LPR P   S+   + L   +  +P  R S   L+KH  L S S
Sbjct: 241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  198 bits (504), Expect = 8e-60
 Identities = 65/291 (22%), Positives = 105/291 (36%), Gaps = 53/291 (18%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS------------------ 38
           +   K IG G    V   ++     ++A          +                     
Sbjct: 58  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 39  -----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYL 91
                Y+   T      + +E        DL + L      D    +S+   ++ A+  +
Sbjct: 117 KIIRLYDYEITDQYI-YMVMEC-GNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           H   IVH D+K  N L+      +KL DFG A +     T  VK    G+  +M PE ++
Sbjct: 172 HQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 152 GECQ-----------GPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRF 198
                           P+SDVWSLGC +  M  GK  ++        L  I   +    F
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
           P    +  +D L  CL+R+P +R S  +LL HP++Q  +         ++ 
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  193 bits (493), Expect = 5e-59
 Identities = 66/260 (25%), Positives = 100/260 (38%), Gaps = 36/260 (13%)

Query: 3   SWVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD------------------- 36
           S+ R   +G GS+G V     + +G ++A       + G                     
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 37  --VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
             V  E          L  E   G ++        A   E  +  +    + AL +LHS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
            +VH DVK  N+ +GP     KL DFG   E   +    V+    G P +MAPE+++G  
Sbjct: 177 GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQE---GDPRYMAPELLQGSY 232

Query: 155 QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL 214
            G  +DV+SLG TI+E+          G     ++      P F    S   R  L   L
Sbjct: 233 -GTAADVFSLGLTILEVACNMELP--HGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMML 289

Query: 215 RREPGERWSCDQLLKHPFLQ 234
             +P  R + + LL  P L+
Sbjct: 290 EPDPKLRATAEALLALPVLR 309

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  193 bits (493), Expect = 1e-58
 Identities = 65/293 (22%), Positives = 106/293 (36%), Gaps = 57/293 (19%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS------------------ 38
           +   K IG G    V   ++     ++A          +                     
Sbjct: 11  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 39  -----YEAPTTSSSCRNLH--LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALK 89
                Y+   T      ++  +E        DL + L      D    +S+   ++ A+ 
Sbjct: 70  KIIRLYDYEITDQ---YIYMVMEC-GNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
            +H   IVH D+K  N L+      +KL DFG A +     T  VK    G+  +M PE 
Sbjct: 123 TIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 150 VRGECQ-----------GPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELP 196
           ++                P+SDVWSLGC +  M  GK  ++        L  I   +   
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
            FP    +  +D L  CL+R+P +R S  +LL HP++Q  +         ++ 
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 293

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  191 bits (488), Expect = 4e-58
 Identities = 65/290 (22%), Positives = 105/290 (36%), Gaps = 53/290 (18%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS----------------- 38
           +   K IG G    V   ++     ++A             +                  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 39  -----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYL 91
                Y+   T      + +E        DL + L      D    +S+   ++ A+  +
Sbjct: 89  KIIRLYDYEITDQYI-YMVMEC-GNI---DLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           H   IVH D+K  N L+      +KL DFG A +     T  VK    G+  +M PE ++
Sbjct: 144 HQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 152 GECQ-----------GPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRF 198
                           P+SDVWSLGC +  M  GK  ++        L  I   +    F
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
           P    +  +D L  CL+R+P +R S  +LL HP++Q  +         ++
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  183 bits (466), Expect = 5e-55
 Identities = 63/286 (22%), Positives = 105/286 (36%), Gaps = 45/286 (15%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD-------------------- 36
           + ++   K IGRG F  V  A    +G   A     + D                     
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 37  ----VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA------DEITLRSHTYCIVS 86
               + Y A     +  N+ LE    G   DL+  +  +        E T+  +   + S
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAG---DLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
           AL+++HSR ++H D+K  NV +      VKL D G       S          G+P +M+
Sbjct: 148 ALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLG--RFFSSKTTAAHSLVGTPYYMS 204

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRFPTQ--S 202
           PE +       +SD+WSLGC + EM   +  +     N  +L +     + P  P+   S
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
            EL R  ++ C+  +P +R     +           + +       
Sbjct: 265 EEL-RQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  169 bits (430), Expect = 3e-49
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 45/270 (16%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD----------------- 36
           M  +VR + IG GSFG   +     +G  +         +                    
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 37  ---VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTL----NAYADEITLRSHTYCIVSALK 89
              V Y      +    + ++Y  GG   DL   +         E  +      I  ALK
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGG---DLFKRINAQKGVLFQEDQILDWFVQICLALK 139

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
           ++H R I+H D+K +N+ +  + + V+L DFG A    ++ T  +     G+P +++PE+
Sbjct: 140 HVHDRKILHRDIKSQNIFLTKDGT-VQLGDFGIA--RVLNSTVELARACIGTPYYLSPEI 196

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SDELPRFPTQ-SSEL 205
              +    +SD+W+LGC + E+ T K A   F A ++  +     S   P      S +L
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHA---FEAGSMKNLVLKIISGSFPPVSLHYSYDL 253

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
            R  + +  +R P +R S + +L+  F+  
Sbjct: 254 -RSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  167 bits (426), Expect = 3e-49
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 56/271 (20%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA--------------------------------YLGD 35
           + IG+G+ GTV  A+D   G   A                                YL  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD- 84

Query: 36  DVSYEAPTTSSSCRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
             SY             L    EYL GG+++D+ T      DE  + +     + AL++L
Sbjct: 85  --SY--------LVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFL 132

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           HS  ++H D+K  N+L+G + S VKL DFG    A ++  +  +    G+P WMAPEVV 
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGS-VKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRF--PTQSSELGRD 208
            +  GP+ D+WSLG   IEM+ G+P + +      L  I  ++  P    P + S + RD
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRD 248

Query: 209 FLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
           FL++CL  +  +R S  +LL+H FL+   P 
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  167 bits (425), Expect = 9e-49
 Identities = 76/273 (27%), Positives = 118/273 (43%), Gaps = 60/273 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA--------------------------------YLGD 35
             IG GS G V +A ++ +G   A                                    
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK- 109

Query: 36  DVSYEAPTTSSSCRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYC--IVSALK 89
             SY             L    E+L GG ++D+ + +    ++I     T C  ++ AL 
Sbjct: 110 --SY--------LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA----TVCEAVLQALA 155

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
           YLH++ ++H D+K  ++L+  +   VKL+DFG    A +S     +    G+P WMAPEV
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEV 212

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRF--PTQSSELG 206
           +       E D+WSLG  +IEMV G+P +        + R+  S   P+     + S + 
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVL 271

Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
           RDFL++ L R+P ER +  +LL HPFL      
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  166 bits (423), Expect = 1e-48
 Identities = 80/268 (29%), Positives = 121/268 (45%), Gaps = 38/268 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD-------------------VSYE 40
           +   + +G GS+G+V  A+ +  G + A     +  D                   V Y 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 41  APTTSSSCRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                S  +N  L    EY   G+VSD+    N    E  + +     +  L+YLH    
Sbjct: 91  G----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           +H D+K  N+L+       KLADFG AG+  ++DT   +    G+P WMAPEV++     
Sbjct: 147 IHRDIKAGNILLNTEGH-AKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRF--PTQSSELGRDFLDKC 213
             +D+WSLG T IEM  GKP + D      +  I  +   P F  P   S+   DF+ +C
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDNFTDFVKQC 262

Query: 214 LRREPGERWSCDQLLKHPFLQSVSPSDA 241
           L + P +R +  QLL+HPF++S      
Sbjct: 263 LVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  164 bits (416), Expect = 8e-48
 Identities = 79/275 (28%), Positives = 121/275 (44%), Gaps = 45/275 (16%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA------YLGDD-------------------VS 38
           W     +G G+FG V  A ++  G + A         ++                   V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 39  YEAPTTSSSCRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                  +   +  L    E+ PGG V  +   L+    E  ++     ++ AL +LHS+
Sbjct: 81  LLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
            I+H D+K  NVL+      ++LADFG + +     T   +    G+P WMAPEVV  E 
Sbjct: 137 RIIHRDLKAGNVLMTLEGD-IRLADFGVSAK--NLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 155 Q-----GPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRF--PTQSSELG 206
                   ++D+WSLG T+IEM   +P   +      L +I  SD  P    P++ S   
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEF 252

Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
           RDFL   L + P  R S  QLL+HPF+ S++ + A
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  163 bits (415), Expect = 9e-48
 Identities = 51/273 (18%), Positives = 98/273 (35%), Gaps = 51/273 (18%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA--------------------------------YL 33
             + IG G FG V  A  R +G  +                                 + 
Sbjct: 15  EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 34  GDDVSYEAPTTSSSCRNLH-----LEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSA 87
           G D   E  + +SS          +E+   GT+   +        D++        I   
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134

Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAP 147
           + Y+HS+ +++ D+K  N+ +      VK+ DFG          R       G+  +M+P
Sbjct: 135 VDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGDFGLVTSLKNDGKRTRSK---GTLRYMSP 190

Query: 148 EVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ-SSEL 205
           E +  +  G E D+++LG  + E++     A+E   +   + +               + 
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDL----RDGIISDIFDKKE 244

Query: 206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
            +  L K L ++P +R +  ++L+   +   SP
Sbjct: 245 -KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  161 bits (410), Expect = 6e-47
 Identities = 55/280 (19%), Positives = 97/280 (34%), Gaps = 54/280 (19%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA----------------------------------- 31
              +G+G+FG V  A +  +   +A                                   
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 32  YLGDDVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
           +L      +  T       L +  EY   GT+ DL  + N              I+ AL 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---------- 139
           Y+HS+ I+H D+K  N+ +  + + VK+ DFG A     S                    
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189

Query: 140 --GSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDE 194
             G+ +++A EV+ G      + D++SLG    EM+       +   N L ++     + 
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER-VNILKKLRSVSIEF 248

Query: 195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
            P F     ++ +  +   +  +P +R     LL   +L 
Sbjct: 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  162 bits (411), Expect = 9e-47
 Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 69/288 (23%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------- 31
           +   + +G G++G V        G + A                                
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 32  YLGDDVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSAL 88
           Y G   ++           L L  E+   G+V+DL          E  +      I+  L
Sbjct: 86  YYG---AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
            +LH   ++H D+KG+NVL+  N+  VKL DFG + +  +  T G +    G+P WMAPE
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPE 199

Query: 149 VVRGECQ-----GPESDVWSLGCTIIEMVTGKPAWEDF------------GANTLSRIGF 191
           V+  +         +SD+WSLG T IEM  G P   D              A  L    +
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
           S +            + F++ CL +   +R + +QL+KHPF++     
Sbjct: 260 SKKF-----------QSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  161 bits (410), Expect = 2e-46
 Identities = 64/298 (21%), Positives = 114/298 (38%), Gaps = 59/298 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----------YLGDDVSYEAPTTSSSCRNLH----- 52
             IGRG++G+VN  V + +G + A               +  +      S    +     
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 53  ------------LEYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKYLHS-RNI 96
                       +E +            +       E  L   T   V AL +L     I
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
           +H D+K  N+L+  + + +KL DFG +G+   +++ TR       G   +MAPE +    
Sbjct: 148 IHRDIKPSNILLDRSGN-IKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDPSA 201

Query: 155 QGPE----SDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFPTQS----SE 204
                   SDVWSLG T+ E+ TG+  +  + +  + L+++    + P+         S 
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPPQLSNSEEREFSP 260

Query: 205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEE 262
              +F++ CL ++  +R    +LLKHPF+                  V  +V    ++
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVE---------VACYVCKILDQ 309

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  158 bits (402), Expect = 7e-46
 Identities = 62/271 (22%), Positives = 106/271 (39%), Gaps = 44/271 (16%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA------YLGDDVS------YEAPTTSSSCRN------- 50
           +GRG++G V       +G + A       +            +    +  C         
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 51  --------LHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHS-RNIVHC 99
                   + +E +           ++      E  L      IV AL++LHS  +++H 
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134

Query: 100 DVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           DVK  NVL+  N+   VK+ DFG +G       + +     G   +MAPE +  E     
Sbjct: 135 DVKPSNVLI--NALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQKG 189

Query: 159 ----SDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFPTQS-SELGRDFLD 211
               SD+WSLG T+IE+   +  ++ +G     L ++      P+ P    S    DF  
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPADKFSAEFVDFTS 248

Query: 212 KCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           +CL++   ER +  +L++HPF         +
Sbjct: 249 QCLKKNSKERPTYPELMQHPFFTLHESKGTD 279

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  160 bits (406), Expect = 8e-46
 Identities = 76/283 (26%), Positives = 110/283 (38%), Gaps = 70/283 (24%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTS-----------SSCRNLH 52
           +   + IG GSFG V  A D  N +V A      S +                   R+ +
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 53  L-----------------EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
                             EY  G   SDL         E+ + + T+  +  L YLHS N
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVR 151
           ++H DVK  N+L+      VKL DFG+A            + P     G+P WMAPEV+ 
Sbjct: 175 MIHRDVKAGNILLSEPGL-VKLGDFGSAS----------IMAPANSFVGTPYWMAPEVIL 223

Query: 152 GECQ---GPESDVWSLGCTIIEMVTGKPAWEDF------------GANTLSRIGFSDELP 196
              +     + DVWSLG T IE+   KP   +              +  L    +S+   
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF- 282

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                     R+F+D CL++ P +R + + LLKH F+    P 
Sbjct: 283 ----------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  161 bits (409), Expect = 2e-45
 Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 58/281 (20%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFA------------------------------ 31
           +S+     +G G+ GT+ V    F+    A                              
Sbjct: 24  ISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 32  YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
           Y     + +        + + +E     T+ +     +     +   +      S L +L
Sbjct: 83  YFC---TEK----DRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134

Query: 92  HSRNIVHCDVKGKNVLV---GPNSSF-VKLADFGAA-----GEATVSDTRGVKIQPRGSP 142
           HS NIVH D+K  N+L+     +      ++DFG       G  + S   GV     G+ 
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP----GTE 190

Query: 143 LWMAPEVVRGECQ---GPESDVWSLGCTIIEMVTGK--PAWEDFGANTLSRIG-FSDELP 196
            W+APE++  +C+       D++S GC    +++    P  +         +G  S +  
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                   + R+ ++K +  +P +R S   +LKHPF  S+ 
Sbjct: 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  157 bits (398), Expect = 5e-45
 Identities = 81/266 (30%), Positives = 125/266 (46%), Gaps = 39/266 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS---YEAPTTSSSCRNLH- 52
           + + + IG+GSFG V   +D     V A          D++     E  T  S C + + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 82

Query: 53  ----------------LEYLPGGTVSDL--ATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                           +EYL GG+  DL     L    DE  + +    I+  L YLHS 
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL----DETQIATILREILKGLDYLHSE 138

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
             +H D+K  NVL+  +   VKLADFG AG+  ++DT+  +    G+P WMAPEV++   
Sbjct: 139 KKIHRDIKAANVLLSEHGE-VKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSA 195

Query: 155 QGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSDELPRFPTQSSELGRDFLDKC 213
              ++D+WSLG T IE+  G+P   +      L  I  ++  P      S+  ++F++ C
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEAC 254

Query: 214 LRREPGERWSCDQLLKHPFLQSVSPS 239
           L +EP  R +  +LLKH F+   +  
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKK 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  152 bits (387), Expect = 1e-43
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 59/289 (20%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFAY----LG------DDVSYEAPTTSSSCRNLHL 53
           +   + IG G+   V  A      +  A     L       D++  E     S C + ++
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEI-QAMSQCHHPNI 75

Query: 54  -----------------EYLPGGTVSDLATTLNAYA-------DEITLRSHTYCIVSALK 89
                            + L GG+V D+   + A         DE T+ +    ++  L+
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLW 144
           YLH    +H DVK  N+L+G + S V++ADFG +  A ++    +          G+P W
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVS--AFLATGGDITRNKVRKTFVGTPCW 192

Query: 145 MAPEVV-RGECQGPESDVWSLGCTIIEMVTGKPAWEDF------------GANTLSRIGF 191
           MAPEV+ +      ++D+WS G T IE+ TG   +  +               +L     
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             E+ +   +  +  R  +  CL+++P +R +  +LL+H F Q     +
Sbjct: 253 DKEMLK---KYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  153 bits (388), Expect = 2e-43
 Identities = 61/274 (22%), Positives = 104/274 (37%), Gaps = 47/274 (17%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY----------LGDDVSYEAPTTSSSCRNLH----- 52
             +G G+ G V     R  G V A               +  +      S    +     
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 53  ------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHC 99
                       +E + G     L   +     E  L   T  IV AL YL     ++H 
Sbjct: 91  GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           DVK  N+L+      +KL DFG +G      +  R       G   +MAPE +       
Sbjct: 150 DVKPSNILLDERGQ-IKLCDFGISGRLVDDKAKDRSA-----GCAAYMAPERIDPPDPTK 203

Query: 158 E-----SDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRFPTQS--SELGRD 208
                 +DVWSLG +++E+ TG+  +++   +   L+++   +E P  P     S   + 
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEEPPLLPGHMGFSGDFQS 262

Query: 209 FLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           F+  CL ++  +R   ++LL+H F++     + +
Sbjct: 263 FVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  148 bits (375), Expect = 6e-42
 Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 48/270 (17%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD--------------------VS 38
               IG GS+G       + +G +          + +                     V 
Sbjct: 10  VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 69

Query: 39  YEAPTTSSSCRNLHL--EYLPGGTVSDL---ATTLNAYADEITLRSHTYCIVSALKYLHS 93
           Y       +   L++  EY  GG ++ +    T    Y DE  +      +  ALK  H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 94  RN-----IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPE 148
           R+     ++H D+K  NV +    + VKL DFG A    ++          G+P +M+PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA--RILNHDTSFAKTFVGTPYYMSPE 186

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SDELPRFPTQ-SSE 204
            +       +SD+WSLGC + E+    P    F A +   +       +  R P + S E
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQKELAGKIREGKFRRIPYRYSDE 243

Query: 205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           L  + + + L  +   R S +++L++P + 
Sbjct: 244 L-NEIITRMLNLKDYHRPSVEEILENPLIL 272

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (370), Expect = 5e-41
 Identities = 49/281 (17%), Positives = 91/281 (32%), Gaps = 53/281 (18%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA---------------------------------Y 32
             +C+GRG FG V  A ++ +   +A                                 Y
Sbjct: 9   PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 68

Query: 33  LG---DDVSYEAPTTSSSCRNLH--LEYLPGGTVSDL--ATTLNAYADEITLRSHTYCIV 85
                +  + E    SS    L+  ++      + D           +          I 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG----------AAGEATVSDTRGVK 135
            A+++LHS+ ++H D+K  N+    +   VK+ DFG               T        
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL 195
               G+ L+M+PE + G     + D++SLG  + E++   P               + + 
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVRNLKF 245

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           P   TQ        +   L   P ER     ++++   + +
Sbjct: 246 PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  143 bits (363), Expect = 7e-40
 Identities = 51/283 (18%), Positives = 92/283 (32%), Gaps = 48/283 (16%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD---------------------VSYEA 41
            + +G G F  V++     +G  +A       +                      +   A
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93

Query: 42  PTTSSSCRNLHL----EYLPGGTVSDL---ATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                            +   GT+ +          +  E  +      I   L+ +H++
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK-------IQPRGSPLWMAP 147
              H D+K  N+L+G       L D G+  +A +      +          R +  + AP
Sbjct: 154 GYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 148 EVV---RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR---IGFSDELPRFPTQ 201
           E+            +DVWSLGC +  M+ G+  ++       S    +     +P+ P  
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHP-FLQSVSPSDANT 243
           SS L    L+  +  +P +R     LL     LQ  +P    T
Sbjct: 273 SSAL-WQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTT 314

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  144 bits (365), Expect = 1e-39
 Identities = 59/353 (16%), Positives = 107/353 (30%), Gaps = 85/353 (24%)

Query: 8   KCIGRG--SFGTVNVAVDRFNGDVFA-----------YLGDDVSYEAPTTSSSCRNLH-- 52
             IG+G     TVN+A  +  G+               +   +  E    S    + +  
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL-HVSKLFNHPNIV 89

Query: 53  ---------------LEYLPGGTVSDL-ATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                            ++  G+  DL  T      +E+ +      ++ AL Y+H    
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY 149

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQPR---GSPLWMAPEVVR 151
           VH  VK  ++L+  +   V L+   +     +     R V   P+       W++PEV++
Sbjct: 150 VHRSVKASHILISVDGK-VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 152 GECQG--PESDVWSLGCTIIEMVTGKP--------------------------------- 176
              QG   +SD++S+G T  E+  G                                   
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268

Query: 177 ------------AWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSC 224
                         +    +T            +    S     F+++CL+R P  R S 
Sbjct: 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328

Query: 225 DQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARE 277
             LL H F + +    +  + E              + +  S    L  +  E
Sbjct: 329 STLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEE 381

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  142 bits (359), Expect = 2e-39
 Identities = 55/301 (18%), Positives = 92/301 (30%), Gaps = 80/301 (26%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS------------------ 38
           W+    +G+G+   V     +  GD+FA            V                   
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 39  --YEAPTTSSSCRNLHL--EYLPGGTVSD-LATTLNAYA-DEITLRSHTYCIVSALKYLH 92
             +     +++ R+  L  E+ P G++   L    NAY   E         +V  + +L 
Sbjct: 71  KLFAIEEETTT-RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 93  SRNIVHCDVKGKNVLVGPNS---SFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMA 146
              IVH ++K  N++        S  KL DFGAA    +     +        G+  ++ 
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL------YGTEEYLH 183

Query: 147 PEVVRGECQ--------GPESDVWSLGCTIIEMVTGKPAWEDFGANTL------------ 186
           P++              G   D+WS+G T     TG   +  F                 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 187 -------------SRIGFSDELPRFPTQS---SELGRDFLDKCLRREPGERWSCDQLLKH 230
                          I +S ++P   + S     L    L   L  +  + W  DQ    
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 231 P 231
            
Sbjct: 304 T 304

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  140 bits (355), Expect = 2e-38
 Identities = 62/314 (19%), Positives = 113/314 (35%), Gaps = 94/314 (29%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------------------------------YLG 34
             +G G+ G V     + +G V A                                 + G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 35  DDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS- 93
              ++ +    S C    +E++ GG++  +         E  L   +  ++  L YL   
Sbjct: 99  ---AFYSDGEISIC----MEHMDGGSLDQVLKKAGRI-PEQILGKVSIAVIKGLTYLREK 150

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE--ATVSDTRGVKIQPRGSPLWMAPEVVR 151
             I+H DVK  N+LV      +KL DFG +G+   +++++        G+  +M+PE ++
Sbjct: 151 HKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMANSF------VGTRSYMSPERLQ 203

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------------- 195
           G     +SD+WS+G +++EM  G+       A  L  +                      
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 196 --------------------------PRFPTQS-SELGRDFLDKCLRREPGERWSCDQLL 228
                                     P+ P+   S   +DF++KCL + P ER    QL+
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323

Query: 229 KHPFLQSVSPSDAN 242
            H F++     + +
Sbjct: 324 VHAFIKRSDAEEVD 337

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  137 bits (348), Expect = 8e-37
 Identities = 63/332 (18%), Positives = 114/332 (34%), Gaps = 69/332 (20%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------YLGDD----VSYE 40
            V  K +G GS GTV V    F G   A                      DD    + Y 
Sbjct: 17  VVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYC------IVSALKYLHSR 94
              T+     + LE      + DL  + N   + + L+           I S + +LHS 
Sbjct: 76  CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL 134

Query: 95  NIVHCDVKGKNVLV------------GPNSSFVKLADFGAA-----GEATVSDTRGVKIQ 137
            I+H D+K +N+LV            G  +  + ++DFG       G+++          
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN---N 191

Query: 138 PRGSPLWMAPEVVRGECQ-------GPESDVWSLGCTIIEMVTGK--PAWEDFG--ANTL 186
           P G+  W APE++                D++S+GC    +++    P  + +   +N +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251

Query: 187 S-RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVA 245
                  +              D + + +  +P +R +  ++L+HP     S        
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK------K 305

Query: 246 ESSPRCVLDWVNSEFEEEGTSDDEKLEASARE 277
                 V D +  E  +  ++   K +A +  
Sbjct: 306 LEFLLKVSDRLEIENRDPPSALLMKFDAGSDF 337

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  134 bits (338), Expect = 3e-36
 Identities = 34/197 (17%), Positives = 72/197 (36%), Gaps = 15/197 (7%)

Query: 52  HLEYLPGGTVSDL--ATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
            ++      + D           +          I  A+++LHS+ ++H D+K  N+   
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198

Query: 110 PNSSFVKLADFG----------AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
            +   VK+ DFG               T            G+ L+M+PE + G     + 
Sbjct: 199 MDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D++SLG  + E++       +     ++ +  + + P   TQ        +   L   P 
Sbjct: 258 DIFSLGLILFELLYSFSTQMER-VRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPT 315

Query: 220 ERWSCDQLLKHPFLQSV 236
           ER     ++++   +++
Sbjct: 316 ERPEATDIIENAIFENL 332

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  135 bits (341), Expect = 5e-36
 Identities = 53/303 (17%), Positives = 88/303 (29%), Gaps = 86/303 (28%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS------------------ 38
           W+    +G+G+   V     +  GD+FA            V                   
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 39  --YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA-----DEITLRSHTYCIVSALK 89
             +     +++ R+  L  E+ P G    L T L   +      E         +V  + 
Sbjct: 71  KLFAIEEETTT-RHKVLIMEFCPCG---SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 90  YLHSRNIVHCDVKGKNVLVGPNS---SFVKLADFGAA---GEATVSDTRGVKIQPRGSPL 143
           +L    IVH ++K  N++        S  KL DFGAA    +     +        G+  
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL------YGTEE 180

Query: 144 WMAPEVVRGECQ--------GPESDVWSLGCTIIEMVTGKPAWEDFGANTL--------- 186
           ++ P++              G   D+WS+G T     TG   +  F              
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 187 ----------------SRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
                             I +S ++P           L    L   L  +  + W  DQ 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 228 LKH 230
              
Sbjct: 301 FAE 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  131 bits (331), Expect = 7e-35
 Identities = 31/203 (15%), Positives = 57/203 (28%), Gaps = 29/203 (14%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC------IVSALKYLHSRNIVHCDVKGKNV 106
           L       +      L +++       H         ++  L  LH   +VH  ++  ++
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237

Query: 107 LVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ----------- 155
           ++      V L  F            G ++    S  +  PE+                 
Sbjct: 238 VLDQRGG-VFLTGFEHLVRD------GARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290

Query: 156 GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
               D W+LG  I  +           A   S   F     R      +  R  L+  LR
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----RSCKNIPQPVRALLEGFLR 345

Query: 216 REPGERWSCDQLLKHPFLQSVSP 238
               +R    Q ++ P  + +  
Sbjct: 346 YPKEDRLLPLQAMETPEYEQLRT 368

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  128 bits (325), Expect = 8e-35
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 47/277 (16%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------------YLGDDVSYEAPTTSSSCR----- 49
           G+ +G+G FG V +A ++ +  + A             +   +  E     S  R     
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNIL 72

Query: 50  NLH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
            L+            LEY P GTV      L+ + DE    ++   + +AL Y HS+ ++
Sbjct: 73  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHSKRVI 131

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGE 153
           H D+K +N+L+G     +K+ADFG +       +R      R    G+  ++ PE++ G 
Sbjct: 132 HRDIKPENLLLGSAGE-LKIADFGWS--VHAPSSR------RTDLCGTLDYLPPEMIEGR 182

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
               + D+WSLG    E + GKP +E      T  RI   +    FP   +E  RD + +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISR 240

Query: 213 CLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
            L+  P +R    ++L+HP++ + S   +N   + S 
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  127 bits (322), Expect = 2e-34
 Identities = 56/192 (29%), Positives = 94/192 (48%), Gaps = 14/192 (7%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE    G ++           E   R   + I++ + YLHS  I+H D+   N+L+  N 
Sbjct: 90  LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM 149

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGECQGPESDVWSLGCTI 168
           + +K+ADFG A +  +   +           G+P +++PE+      G ESDVWSLGC  
Sbjct: 150 N-IKIADFGLATQLKMPHEK------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMF 202

Query: 169 IEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
             ++ G+P ++     NTL+++  +D     P+  S   +D + + LRR P +R S   +
Sbjct: 203 YTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260

Query: 228 LKHPFLQSVSPS 239
           L HPF+   S +
Sbjct: 261 LDHPFMSRNSST 272

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  131 bits (332), Expect = 4e-34
 Identities = 61/290 (21%), Positives = 113/290 (38%), Gaps = 57/290 (19%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS-------------------- 38
            K +G G++G V +  D+      A              S                    
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 39  ---YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
              +E        RN +L  E   GG + D       + +E+        ++S + YLH 
Sbjct: 102 YDFFE------DKRNYYLVMECYKGGELFDEIIHRMKF-NEVDAAVIIKQVLSGVTYLHK 154

Query: 94  RNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
            NIVH D+K +N+L+      + +K+ DFG +           ++   G+  ++APEV+R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVLR 211

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GFSDELPRFPTQSSE 204
            +    + DVWS+G  +  ++ G P    FG  T   I        ++ + P +   S  
Sbjct: 212 KKY-DEKCDVWSIGVILFILLAGYPP---FGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267

Query: 205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
             +D + + L+ +   R S  Q L+HP+++ +     + +   S    ++
Sbjct: 268 -AKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIE 316

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (335), Expect = 4e-34
 Identities = 61/335 (18%), Positives = 106/335 (31%), Gaps = 79/335 (23%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS------------------ 38
           W   + +G G FG V   + +  G+  A           +                    
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 39  -----YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA-----DEITLRSHTYCIVS 86
                 +     +      L  EY  GG   DL   LN +       E  +R+    I S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGG---DLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 87  ALKYLHSRNIVHCDVKGKNVLV--GPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGS 141
           AL+YLH   I+H D+K +N+++  GP     K+ D G A    +  +           G+
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF------VGT 186

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL--------------- 186
             ++APE++  +      D WS G    E +TG   +                       
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 187 -----SRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
                  + FS  LP         +     +L   L     +R +  Q       Q++  
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

Query: 239 SDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEA 273
             +  +       V++ V+        +++E L+ 
Sbjct: 307 ILSLKLLS-----VMNMVSGRVHTYPVTENENLQN 336

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  129 bits (325), Expect = 3e-33
 Identities = 66/292 (22%), Positives = 110/292 (37%), Gaps = 61/292 (20%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS-------------------- 38
              +G+GSFG V    DR     +A            D S                    
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 39  ---YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
               E         + ++  E   GG + D       +  E         + S + Y+H 
Sbjct: 87  FEILE------DSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARIIKQVFSGITYMHK 139

Query: 94  RNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEV 149
            NIVH D+K +N+L+     +   +K+ DFG +        +  K++ R G+  ++APEV
Sbjct: 140 HNIVHRDLKPENILLESKEKDCD-IKIIDFGLS----TCFQQNTKMKDRIGTAYYIAPEV 194

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GFSDELPRFPTQS 202
           +RG     + DVWS G  +  +++G P    F       I        ++ +LP++ T S
Sbjct: 195 LRGTY-DEKCDVWSAGVILYILLSGTPP---FYGKNEYDILKRVETGKYAFDLPQWRTIS 250

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
            +  +D + K L   P  R +  Q L+HP++Q  S          S    + 
Sbjct: 251 DD-AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMT 301

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  127 bits (319), Expect = 4e-33
 Identities = 23/164 (14%), Positives = 49/164 (29%), Gaps = 18/164 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++     L S+ +VH      N+ + P+   + L D  A  +       G +      P+
Sbjct: 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSALWKV------GTRGPASSVPV 255

Query: 144 WMAPEVV---RGECQGPESDVWSLGCTIIEMVTGKPAWED--------FGANTLSRIGFS 192
             AP               + W LG +I  +      +          +   +L   G  
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315

Query: 193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                  T   +  +  + + L  +   R    + ++ P    +
Sbjct: 316 SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  127 bits (321), Expect = 9e-33
 Identities = 61/279 (21%), Positives = 107/279 (38%), Gaps = 58/279 (20%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------------YLGDDV----------------- 37
            + +G+GSFG V +  D+  G   A               + +                 
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 38  ---SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH 92
               +E           +L  E   GG + D   +   +  E+        ++S + Y+H
Sbjct: 91  LYEFFE------DKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYMH 143

Query: 93  SRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
              IVH D+K +N+L+   S  + +++ DFG +     S     KI   G+  ++APEV+
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL 200

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GFSDELPRFPTQSS 203
            G     + DVWS G  +  +++G P    F       I        ++ ELP++   S 
Sbjct: 201 HGTY-DEKCDVWSTGVILYILLSGCPP---FNGANEYDILKKVEKGKYTFELPQWKKVSE 256

Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
              +D + K L   P  R S    L H ++Q+ +    +
Sbjct: 257 S-AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (313), Expect = 1e-32
 Identities = 49/294 (16%), Positives = 98/294 (33%), Gaps = 55/294 (18%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA---------------------------------YL 33
            + +  G F  V  A D  +G  +A                                 + 
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 34  GDDVSYEAPTTSSSCRNLHLEYLPGGTVSDL--ATTLNAYADEITLRSHTYCIVSALKYL 91
                 +  + +     L L  L  G + +              T+    Y    A++++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 92  HSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR---------- 139
           H +   I+H D+K +N+L+    +  KL DFG+A   +         Q R          
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTI-KLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 140 GSPLWMAPEVV---RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP 196
            +P++  PE++        G + D+W+LGC +  +   +  +ED     +    +S  +P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS--IP 269

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF-LQSVSPSDANTVAESSP 249
              TQ +      +   L+  P ER S  +++     + +    +  +      
Sbjct: 270 PHDTQYTVF-HSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 7e-32
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 15/188 (7%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE     ++ +L     A   E   R +   IV   +YLH   ++H D+K  N+ +  + 
Sbjct: 94  LELCRRRSLLELHKRRKAL-TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 152

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGECQGPESDVWSLGCTI 168
             VK+ DFG A +      R      +    G+P ++APEV+  +    E DVWS+GC +
Sbjct: 153 E-VKIGDFGLATKVEYDGER------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205

Query: 169 IEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
             ++ GKP +E      T  RI  ++     P   + +    + K L+ +P  R + ++L
Sbjct: 206 YTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINEL 263

Query: 228 LKHPFLQS 235
           L   F  S
Sbjct: 264 LNDEFFTS 271

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  121 bits (305), Expect = 8e-32
 Identities = 59/255 (23%), Positives = 104/255 (40%), Gaps = 32/255 (12%)

Query: 7   GKCIGRGSFGTV-------NVAVDRFN-GDVFAYLGDDVSYEAPTTSS-----------S 47
           G+ IG GSFGTV       +VAV   N              E                  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 48  CRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                L    ++  G ++           +   L          + YLH+++I+H D+K 
Sbjct: 89  STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKS 148

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---ESD 160
            N+ +  +++ VK+ DFG A E +         Q  GS LWMAPEV+R +   P   +SD
Sbjct: 149 NNIFLHEDNT-VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207

Query: 161 VWSLGCTIIEMVTGKPAWEDFGANT--LSRIGFSD---ELPRFPTQSSELGRDFLDKCLR 215
           V++ G  + E++TG+  + +       +  +G      +L +  +   +  +  + +CL+
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLK 267

Query: 216 REPGERWSCDQLLKH 230
           ++  ER S  ++L  
Sbjct: 268 KKRDERPSFPRILAE 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  121 bits (305), Expect = 9e-32
 Identities = 58/291 (19%), Positives = 110/291 (37%), Gaps = 82/291 (28%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDV--------------------- 37
            + +G+G+F  V   V +  G  FA            D                      
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 38  --SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCI 84
             S +  +        +L  + + GG   +L        ++I  R              I
Sbjct: 71  HDSIQEES------FHYLVFDLVTGG---ELF-------EDIVAREFYSEADASHCIQQI 114

Query: 85  VSALKYLHSRNIVHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPR--- 139
           + ++ Y HS  IVH ++K +N+L+      + VKLADFG A          +++      
Sbjct: 115 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA----------IEVNDSEAW 164

Query: 140 ----GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GF 191
               G+P +++PEV++ +      D+W+ G  +  ++ G P  W++      ++I    +
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
               P + T + E  +  +D  L   P +R + DQ LK P++ +     + 
Sbjct: 225 DYPSPEWDTVTPE-AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (307), Expect = 1e-31
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 9/185 (4%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           LE     ++ +L     A   E   R +   IV   +YLH   ++H D+K  N+ +  + 
Sbjct: 120 LELCRRRSLLELHKRRKAL-TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
             VK+ DFG A   T  +  G + +   G+P ++APEV+  +    E DVWS+GC +  +
Sbjct: 179 E-VKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234

Query: 172 VTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH 230
           + GKP +E      T  RI  ++     P   + +    + K L+ +P  R + ++LL  
Sbjct: 235 LVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292

Query: 231 PFLQS 235
            F  S
Sbjct: 293 EFFTS 297

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (308), Expect = 1e-31
 Identities = 38/281 (13%), Positives = 75/281 (26%), Gaps = 71/281 (25%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV------------------------------------- 29
              +G G+F  V  A      D                                      
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 30  ----FAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLA----TTLNAYADEITLRSHT 81
                A+L  + S            L  E    GT+ +       T      +  + S  
Sbjct: 130 MKFYSAHLFQNGSV-----------LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGP----------NSSFVKLADFGAAGEATVSDT 131
             ++  ++ +H   I+H D+K  N ++G            S+ + L D G + +  +   
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF 191
             +      +  +   E++  +    + D + +  T+  M+ G         N       
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---KVKNEGGECKP 295

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF 232
                R P    ++  +F    L            LL+   
Sbjct: 296 EGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  121 bits (305), Expect = 1e-31
 Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 73/285 (25%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS--------------------- 38
            + +G G+F  V +   R  G +FA           D S                     
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 39  -YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIVS 86
            YE+        + +L  + + GG   +L        D I  R              ++S
Sbjct: 74  IYEST------THYYLVMQLVSGG---ELF-------DRILERGVYTEKDASLVIQQVLS 117

Query: 87  ALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           A+KYLH   IVH D+K +N+L      NS  + + DFG +      +  G+     G+P 
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSK-IMITDFGLS----KMEQNGIMSTACGTPG 172

Query: 144 WMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI-----GFSDELPR 197
           ++APEV+  +      D WS+G     ++ G P  +E+  +    +I      F    P 
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES--PF 230

Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           +   S    +DF+   L ++P ER++C++ L HP++   +    +
Sbjct: 231 WDDISES-AKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRD 274

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  124 bits (313), Expect = 2e-31
 Identities = 50/284 (17%), Positives = 106/284 (37%), Gaps = 60/284 (21%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVSYEAPTTSSSC----------- 48
            + +G G++G V +  ++      A               +                   
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 49  ------------------RNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSAL 88
                             +  +L  E+  GG + +     + + DE    +    I+S +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGI 159

Query: 89  KYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLW 144
            YLH  NIVH D+K +N+L+       + +K+ DFG +       ++  K++ R G+  +
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLN-IKIVDFGLS----SFFSKDYKLRDRLGTAYY 214

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GFSDELPR 197
           +APEV++ +    + DVWS G  +  ++ G P    FG      I        +  +   
Sbjct: 215 IAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPP---FGGQNDQDIIKKVEKGKYYFDFND 270

Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
           +   S E  ++ +   L  +  +R + ++ L   +++  + +  
Sbjct: 271 WKNISDE-AKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  121 bits (305), Expect = 2e-31
 Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 73/298 (24%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------------YLGDDV----------------- 37
           G+ +G G F  V    ++  G  +A              G                    
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 38  ------SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                  YE  T      ++ L  E + GG + D      +   E    S    I+  + 
Sbjct: 77  VITLHDVYENRT------DVVLILELVSGGELFDFLAQKESL-SEEEATSFIKQILDGVN 129

Query: 90  YLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR------- 139
           YLH++ I H D+K +N+++         +KL DFG A           +I+         
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----------HEIEDGVEFKNIF 179

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI-----GFSD 193
           G+P ++APE+V  E  G E+D+WS+G     +++G  P   D    TL+ I      F +
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239

Query: 194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRC 251
               F   +SEL +DF+ K L +E  +R +  + L+HP++  V    A    ES    
Sbjct: 240 --EFFS-HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNL 294

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  121 bits (306), Expect = 2e-31
 Identities = 59/300 (19%), Positives = 113/300 (37%), Gaps = 82/300 (27%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDV--------------------- 37
            + +G+G+F  V   V +  G  FA            D                      
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 38  --SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCI 84
             S +  +        +L  + + GG   +L        ++I  R              I
Sbjct: 94  HDSIQEES------FHYLVFDLVTGG---ELF-------EDIVAREFYSEADASHCIQQI 137

Query: 85  VSALKYLHSRNIVHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPR--- 139
           + ++ Y HS  IVH ++K +N+L+      + VKLADFG A          +++      
Sbjct: 138 LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA----------IEVNDSEAW 187

Query: 140 ----GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRI---GF 191
               G+P +++PEV++ +      D+W+ G  +  ++ G P  W++      ++I    +
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRC 251
               P + T + E  +  +D  L   P +R + DQ LK P++ +     +    + +  C
Sbjct: 248 DYPSPEWDTVTPE-AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 306

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  122 bits (307), Expect = 2e-31
 Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 84/297 (28%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGD--DV-------------------- 37
            + +G G+FG V+  V++  G VF        Y  D   V                    
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115

Query: 38  SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYC----------IV 85
           ++E          + L  E+L GG   +L        D I    +               
Sbjct: 116 AFEDKY------EMVLILEFLSGG---ELF-------DRIAAEDYKMSEAEVINYMRQAC 159

Query: 86  SALKYLHSRNIVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----- 139
             LK++H  +IVH D+K +N++     +S VK+ DFG A           K+ P      
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA----------TKLNPDEIVKV 209

Query: 140 --GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI-----GF 191
              +  + APE+V  E  G  +D+W++G     +++G  P   +    TL  +      F
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
            ++   F + S E  +DF+   L++EP +R +    L+HP+L+    +  + +  S 
Sbjct: 270 DED--AFSSVSPE-AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 323

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (302), Expect = 2e-31
 Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 47/262 (17%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------------YLGDDVSYEAPTTSSSCR----- 49
           G+ +G+G FG V +A ++ N  + A             +   +  E     S  R     
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI-EIQSHLRHPNIL 77

Query: 50  NLH------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
            ++            LE+ P G +         + DE    +    +  AL Y H R ++
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSATFMEELADALHYCHERKVI 136

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR----GSPLWMAPEVVRGE 153
           H D+K +N+L+G     +K+ADFG +        R      R    G+  ++ PE++ G+
Sbjct: 137 HRDIKPENLLMGYKGE-LKIADFGWS--VHAPSLR------RRTMCGTLDYLPPEMIEGK 187

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPTQSSELGRDFLDK 212
               + D+W  G    E + G P ++         RI  + +L +FP   S+  +D + K
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI-VNVDL-KFPPFLSDGSKDLISK 245

Query: 213 CLRREPGERWSCDQLLKHPFLQ 234
            LR  P +R     +++HP+++
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVK 267

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  120 bits (302), Expect = 7e-31
 Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 65/278 (23%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------------YLGDDVSYEA--------PT- 43
            + IG+G F  V   ++R  G  FA                 +D+  EA        P  
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 44  -----TSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHT-------------YC 83
                T SS   L++  E++ G    DL         EI  R+                 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGA---DLC-------FEIVKRADAGFVYSEAVASHYMRQ 138

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           I+ AL+Y H  NI+H DVK   VL+    NS+ VKL  FG A    + ++  V     G+
Sbjct: 139 ILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVGT 196

Query: 142 PLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP---AWED--FGANTLSRIGFSDELP 196
           P +MAPEVV+ E  G   DVW  G  +  +++G       ++  F      +   +    
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNP--R 254

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           ++   S    +D + + L  +P ER +  + L HP+L+
Sbjct: 255 QWSHISES-AKDLVRRMLMLDPAERITVYEALNHPWLK 291

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  119 bits (300), Expect = 1e-30
 Identities = 68/273 (24%), Positives = 104/273 (38%), Gaps = 55/273 (20%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA------------------YLGD--------DVS 38
           +  + +G G  G V     R  G   A                              DV 
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDV- 90

Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSD--LATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           YE       C  + +E + GG +          A+  E         I +A+++LHS NI
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF-TEREAAEIMRDIGTAIQFLHSHNI 149

Query: 97  VHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
            H DVK +N+L      ++  +KL DFG A       T+     P  +P ++APEV+  E
Sbjct: 150 AHRDVKPENLLYTSKEKDAV-LKLTDFGFA----KETTQNALQTPCYTPYYVAPEVLGPE 204

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR--------FPTQS--- 202
                 D+WSLG  +  ++ G P    F +NT   I  S  + R        FP      
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP---FYSNTGQAI--SPGMKRRIRLGQYGFPNPEWSE 259

Query: 203 -SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
            SE  +  +   L+ +P ER +  Q + HP++ 
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  118 bits (298), Expect = 2e-30
 Identities = 68/301 (22%), Positives = 115/301 (38%), Gaps = 83/301 (27%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS------------------ 38
           +  K +GRG F  V   + +  G  +A           D  +                  
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 39  ------YEAPTTSSSCRNLHL--EYLPGG-----TVSDLATTLNAYADEITLRSHTYCIV 85
                 YE  +       + L  EY  GG      + +LA  ++    E  +      I+
Sbjct: 92  INLHEVYENTS------EIILILEYAAGGEIFSLCLPELAEMVS----ENDVIRLIKQIL 141

Query: 86  SALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR--- 139
             + YLH  NIVH D+K +N+L+    P    +K+ DFG +           KI      
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGD-IKIVDFGMS----------RKIGHACEL 190

Query: 140 ----GSPLWMAPEVVRGECQGPESDVWSLGCTIIE--MVTGK-PAWEDFGANTLSRI--- 189
               G+P ++APE++  +     +D+W++G  II   ++T   P   +    T   I   
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIG--IIAYMLLTHTSPFVGEDNQETYLNISQV 248

Query: 190 --GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAES 247
              +S+E   F +  S+L  DF+   L + P +R + +  L H +LQ     +     E+
Sbjct: 249 NVDYSEET--FSS-VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305

Query: 248 S 248
           S
Sbjct: 306 S 306

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  119 bits (300), Expect = 2e-30
 Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 73/297 (24%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA---------------YLGDDV-------------- 37
           G+ +G G F  V    ++  G  +A                  +++              
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 38  ------SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK 89
                  YE  T      ++ L  E + GG + D      + + E    S    I+  + 
Sbjct: 77  IITLHDVYENRT------DVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVN 129

Query: 90  YLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR------- 139
           YLH++ I H D+K +N+++         +KL DFG A           +I+         
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----------HEIEDGVEFKNIF 179

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI-----GFSD 193
           G+P ++APE+V  E  G E+D+WS+G     +++G  P   D    TL+ I      F +
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239

Query: 194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
           E   F   +SEL +DF+ K L +E  +R +  + L+HP++  V    A    ES   
Sbjct: 240 EF--FSQ-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVN 293

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (298), Expect = 2e-30
 Identities = 62/302 (20%), Positives = 114/302 (37%), Gaps = 67/302 (22%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------------------YLGD--------DVSY 39
            + IG GS+      + +     FA                     G         DV Y
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDV-Y 85

Query: 40  EAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIVSAL 88
           +          +++  E + GG   +L        D+I  +            + I   +
Sbjct: 86  DDGK------YVYVVTELMKGG---ELL-------DKILRQKFFSEREASAVLFTITKTV 129

Query: 89  KYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM 145
           +YLH++ +VH D+K  N+L      N   +++ DFG A +  +    G+ + P  +  ++
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPCYTANFV 187

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKP----AWEDFGANTLSRIGFSD-ELPRFP- 199
           APEV+  +      D+WSLG  +  M+TG        +D     L+RIG     L     
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247

Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP-SDANTVAESSPRCVLDWVNS 258
              S+  +D + K L  +P +R +   +L+HP++             + +P  V   + +
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAA 307

Query: 259 EF 260
            +
Sbjct: 308 TY 309

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  118 bits (297), Expect = 2e-30
 Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 16/163 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRGVKI--QPRG 140
           I SAL YLH++ I H D+K +N L     S  +KL DFG + E    +           G
Sbjct: 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236

Query: 141 SPLWMAPEVVRGECQ--GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GF 191
           +P ++APEV+    +  GP+ D WS G  +  ++ G      F     +           
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP---FPGVNDADTISQVLNKKL 293

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
             E P +   S    RD L   L R   ER+   + L+HP++ 
Sbjct: 294 CFENPNYNVLSPLA-RDLLSNLLNRNVDERFDAMRALQHPWIS 335

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  117 bits (296), Expect = 3e-30
 Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 83/292 (28%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDV--------------------S 38
            + +GRG FG V+  V+  +   +              V                    S
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 39  YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYC----------IVS 86
           +E+         L +  E++ G    D+        + I   +              +  
Sbjct: 70  FESME------ELVMIFEFISGL---DIF-------ERINTSAFELNEREIVSYVHQVCE 113

Query: 87  ALKYLHSRNIVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRGVKIQPR------ 139
           AL++LHS NI H D++ +N++     SS +K+ +FG A           +++P       
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA----------RQLKPGDNFRLL 163

Query: 140 -GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI-----GFS 192
             +P + APEV + +     +D+WSLG  +  +++G  P   +     +  I      F 
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223

Query: 193 DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
           +E   F   S E   DF+D+ L +E   R +  + L+HP+L+      +  V
Sbjct: 224 EE--AFKEISIE-AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (299), Expect = 3e-30
 Identities = 31/174 (17%), Positives = 55/174 (31%), Gaps = 18/174 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRG 140
           ++  L  LH   +VH  ++  ++++      V L  F      G + VS       +   
Sbjct: 220 VIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDGASAVSPIG----RGFA 274

Query: 141 SPLWMAPEVVRGECQGP-----ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL 195
            P   A  ++      P       D W+LG  I  +        D  A   S   F    
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC- 333

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
              P    +  R  L+  LR    +R    Q ++ P  + +    +  +     
Sbjct: 334 KNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQT 383

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  120 bits (303), Expect = 5e-30
 Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 64/287 (22%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGD--DV-------------------- 37
            + +G G+FG V+   +R  G+ FA       +  D   V                    
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221

Query: 38  SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
           ++E          + +  E++ GG + +     +    E     +   +   L ++H  N
Sbjct: 222 AFEDD------NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 96  IVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-------GSPLWMAP 147
            VH D+K +N++     S+ +KL DFG              + P+       G+  + AP
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLT----------AHLDPKQSVKVTTGTAEFAAP 325

Query: 148 EVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI-----GFSDELPRFPTQ 201
           EV  G+  G  +D+WS+G     +++G  P   +    TL  +        D    F   
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA--FS-G 382

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESS 248
            SE G+DF+ K L  +P  R +  Q L+HP+L   +    ++   SS
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  116 bits (293), Expect = 6e-30
 Identities = 55/265 (20%), Positives = 101/265 (38%), Gaps = 39/265 (14%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGDVFAYLGDDVSYEAPTTSS------------ 46
            + +GRG+FG V        +VA+ +   +           E    S             
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESER---KAFIVELRQLSRVNHPNIVKLYGA 69

Query: 47  SCRNLHL--EYLPGGTVSDL--ATTLNAYADEITLRSHTYCIVSALKYLHSRN---IVHC 99
               + L  EY  GG++ ++        Y       S        + YLHS     ++H 
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K  N+L+    + +K+ DFG A +     T        GS  WMAPEV  G     + 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEVFEGSNYSEKC 184

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--FSDELPRFPTQSSELGRDFLDKCLRRE 217
           DV+S G  + E++T +  +++ G      +    +   P       +     + +C  ++
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKD 244

Query: 218 PGERWSCDQLLKH--PFLQSVSPSD 240
           P +R S ++++K     ++    +D
Sbjct: 245 PSQRPSMEEIVKIMTHLMRYFPGAD 269

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  116 bits (294), Expect = 7e-30
 Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 91/297 (30%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------------YLGDDV----------------- 37
           G+ +G G F  V    ++  G  +A              G                    
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 38  ------SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH--------- 80
                  YE  T      ++ L  E + GG   +L        D +  +           
Sbjct: 76  VITLHEVYENKT------DVILILELVAGG---ELF-------DFLAEKESLTEEEATEF 119

Query: 81  TYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
              I++ + YLHS  I H D+K +N+++         +K+ DFG A           KI 
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----------HKID 169

Query: 138 PR-------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI 189
                    G+P ++APE+V  E  G E+D+WS+G     +++G  P   D    TL+ +
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229

Query: 190 G-----FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                 F DE   F   +S L +DF+ + L ++P +R +    L+HP+++      A
Sbjct: 230 SAVNYEFEDEY--FSN-TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  118 bits (299), Expect = 7e-30
 Identities = 60/296 (20%), Positives = 109/296 (36%), Gaps = 73/296 (24%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDV--------------------- 37
            + +G+G+F  V   V    G  +A            D                      
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 38  --SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCI 84
             S           + +L  + + GG   +L        ++I  R +            I
Sbjct: 76  HDSISEEG------HHYLIFDLVTGG---ELF-------EDIVAREYYSEADASHCIQQI 119

Query: 85  VSALKYLHSRNIVHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
           + A+ + H   +VH ++K +N+L+      + VKLADFG A E              G+P
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTP 177

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GFSDEL 195
            +++PEV+R +  G   D+W+ G  +  ++ G P    F      R+        +    
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP---FWDEDQHRLYQQIKAGAYDFPS 234

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRC 251
           P + T + E  +D ++K L   P +R +  + LKHP++   S   +    + +  C
Sbjct: 235 PEWDTVTPE-AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDC 289

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  118 bits (297), Expect = 1e-29
 Identities = 64/281 (22%), Positives = 108/281 (38%), Gaps = 57/281 (20%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVSYEAPTTSSS------CRNLH- 52
            K +G G+ G V +A +R      A             + EA    +        + L+ 
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 53  ------------------LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                             LE + GG + D          E T + + Y ++ A++YLH  
Sbjct: 200 PCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRL-KEATCKLYFYQMLLAVQYLHEN 258

Query: 95  NIVHCDVKGKNVLVGPNS--SFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEV 149
            I+H D+K +NVL+        +K+ DFG +   GE ++  T        G+P ++APEV
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC------GTPTYLAPEV 312

Query: 150 VRGECQ---GPESDVWSLGCTIIEMVTGK-PAWEDFGANTLS------RIGFSDELPRFP 199
           +            D WSLG  +   ++G  P  E     +L       +  F      + 
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP--EVWA 370

Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
             S +   D + K L  +P  R++ ++ L+HP+LQ      
Sbjct: 371 EVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  116 bits (292), Expect = 1e-29
 Identities = 72/303 (23%), Positives = 112/303 (36%), Gaps = 80/303 (26%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDDVSYEAPTT------------ 44
           M  + +   IG GS+G V    +R  G + A       +D                    
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 45  ---------SSSCRNLHL--EYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKY 90
                        R LHL  EY        +   L+ Y     E  ++S T+  + A+ +
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-----SPLWM 145
            H  N +H DVK +N+L+  +S  +KL DFG A        R +           +  W 
Sbjct: 118 CHKHNCIHRDVKPENILITKHSV-IKLCDFGFA--------RLLTGPSDYYDDEVATRWY 168

Query: 146 -APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP------------------------AWE 179
            +PE++ G+ Q GP  DVW++GC   E+++G P                          +
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228

Query: 180 DFGANTL-SRIGFSDELPRFP-----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
            F  N   S +   D     P        S      L  CL  +P ER +C+QLL HP+ 
Sbjct: 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

Query: 234 QSV 236
           +++
Sbjct: 289 ENI 291

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (293), Expect = 1e-29
 Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 34/227 (14%)

Query: 53  LEYLPGGTVSD-------LATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGK 104
            EY+   ++         L      +     ++     ++++  Y+H+ +NI H DVK  
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181

Query: 105 NVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE--CQGPESDVW 162
           N+L+  N   VKL+DFG +        +G     RG+  +M PE    E    G + D+W
Sbjct: 182 NILMDKNGR-VKLSDFGESEYMVDKKIKGS----RGTYEFMPPEFFSNESSYNGAKVDIW 236

Query: 163 SLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSD-ELPRFPTQS----------------S 203
           SLG  +  M      +          + I   + E P                      S
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS 296

Query: 204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
               DFL   LR+ P ER + +  LKH +L   +  D    ++   +
Sbjct: 297 NEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  116 bits (292), Expect = 1e-29
 Identities = 67/302 (22%), Positives = 113/302 (37%), Gaps = 88/302 (29%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA----YLGDDVSYEAPTTS-------------------- 45
           +G GS+G V    ++  G + A       DD        +                    
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLE 91

Query: 46  --SSCRNLHL--EYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKYLHSRNIVH 98
                +  +L  E++       +   L  +    D   ++ + + I++ + + HS NI+H
Sbjct: 92  VCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIH 147

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-----SPLWM-APEVVRG 152
            D+K +N+LV  +   VKL DFG A        R +           +  W  APE++ G
Sbjct: 148 RDIKPENILVSQSGV-VKLCDFGFA--------RTLAAPGEVYDDEVATRWYRAPELLVG 198

Query: 153 ECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRI-------------GFSDEL 195
           + + G   DVW++GC + EM  G+P +   G +    L  I              F+ + 
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFP--GDSDIDQLYHIMMCLGNLIPRHQELFN-KN 255

Query: 196 PRF---------PTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
           P F           +         SE+  D   KCL  +P +R  C +LL H F Q    
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315

Query: 239 SD 240
           ++
Sbjct: 316 AE 317

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  117 bits (294), Expect = 1e-29
 Identities = 70/288 (24%), Positives = 115/288 (39%), Gaps = 92/288 (31%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFA-------------------------------YLG 34
           + + +G G FG V+   +   G   A                                L 
Sbjct: 93  KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLY 152

Query: 35  DDVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYC--------- 83
           D  ++E+        ++ L  EY+ GG   +L        D I   S+            
Sbjct: 153 D--AFESKN------DIVLVMEYVDGG---ELF-------DRIIDESYNLTELDTILFMK 194

Query: 84  -IVSALKYLHSRNIVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-- 139
            I   ++++H   I+H D+K +N+L V  ++  +K+ DFG A           + +PR  
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA----------RRYKPREK 244

Query: 140 -----GSPLWMAPEVVRGECQGPESDVWSLGCTIIE--MVTGK-PAWEDFGANTLSRIG- 190
                G+P ++APEVV  +     +D+WS+G  +I   +++G  P   D  A TL+ I  
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLNNILA 302

Query: 191 ----FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
                 DE   F    SE  ++F+ K L +E   R S  + LKHP+L 
Sbjct: 303 CRWDLEDEE--FQ-DISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  115 bits (289), Expect = 2e-29
 Identities = 67/293 (22%), Positives = 107/293 (36%), Gaps = 91/293 (31%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS-------------------- 38
              +G+GSFG V    DR     +A            D S                    
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 39  ---YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCI 84
               E         + ++  E   GG   +L        DEI  R              +
Sbjct: 87  FEILEDS------SSFYIVGELYTGG---ELF-------DEIIKRKRFSEHDAARIIKQV 130

Query: 85  VSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR-- 139
            S + Y+H  NIVH D+K +N+L+     +   +K+ DFG +             Q    
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCD-IKIIDFGLS----------TCFQQNTK 179

Query: 140 -----GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----- 189
                G+  ++APEV+RG     + DVWS G  +  +++G P    F       I     
Sbjct: 180 MKDRIGTAYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPP---FYGKNEYDILKRVE 235

Query: 190 --GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
              ++ +LP++ T S +  +D + K L   P  R +  Q L+HP++Q  S  +
Sbjct: 236 TGKYAFDLPQWRTISDD-AKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  115 bits (290), Expect = 2e-29
 Identities = 73/266 (27%), Positives = 111/266 (41%), Gaps = 39/266 (14%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGDVF-AYLGDDVSYEAPTTSS----------- 46
            + IG GSFGTV        +VAV       F A   ++   E                 
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 47  SCR---NLHL--EYLPGGTVSDL--ATTLNAYADEITLRSHTYCIVSALKYLHSRN--IV 97
           +     NL +  EYL  G++  L   +      DE    S  Y +   + YLH+RN  IV
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           H ++K  N+LV    + VK+ DFG +     + T        G+P WMAPEV+R E    
Sbjct: 162 HRNLKSPNLLVDKKYT-VKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 158 ESDVWSLGCTII--EMVTGKPAWEDFGANTLS-RIGFSDELPRFPTQSSELGRDFLDKCL 214
           +SDV+S G  +I  E+ T +  W +     +   +GF  +    P   +      ++ C 
Sbjct: 219 KSDVYSFG--VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276

Query: 215 RREPGERWSCDQLLKH--PFLQSVSP 238
             EP +R S   ++    P ++S  P
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIKSAVP 302

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  114 bits (288), Expect = 2e-29
 Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 91/296 (30%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------------YLGDDV----------------- 37
           G+ +G G F  V     +  G  +A              G                    
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 38  ------SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH-------TY 82
                  +E  T      ++ L  E + GG   +L        D +  +          +
Sbjct: 70  IITLHDIFENKT------DVVLILELVSGG---ELF-------DFLAEKESLTEDEATQF 113

Query: 83  C--IVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
              I+  + YLHS+ I H D+K +N+++      +  +KL DFG A           KI+
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----------HKIE 163

Query: 138 PR-------GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI 189
                    G+P ++APE+V  E  G E+D+WS+G     +++G  P   +    TL+ I
Sbjct: 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223

Query: 190 -----GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                 F +E   F   +SEL +DF+ + L ++P  R +  Q L+H +++++   +
Sbjct: 224 SAVNYDFDEEY--FSN-TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  115 bits (291), Expect = 4e-29
 Identities = 69/279 (24%), Positives = 105/279 (37%), Gaps = 66/279 (23%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA------------------YLGD--------DVS 38
           V  + +G G  G V    ++   + FA                              DV 
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDV- 123

Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTY-----------CIVSA 87
           YE       C  + +E L GG   +L          I  R                I  A
Sbjct: 124 YENLYAGRKCLLIVMECLDGG---ELF-------SRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 88  LKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW 144
           ++YLHS NI H DVK +N+L     PN+  +KL DFG A E   +    +   P  +P +
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFGFAKE--TTSHNSLT-TPCYTPYY 229

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANT----LSRIGFSDELPRFP 199
           +APEV+  E      D+WSLG  +  ++ G P  + + G        +RI        FP
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YEFP 287

Query: 200 TQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
                  SE  +  +   L+ EP +R +  + + HP++ 
Sbjct: 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  113 bits (286), Expect = 7e-29
 Identities = 64/309 (20%), Positives = 107/309 (34%), Gaps = 69/309 (22%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA------YLGDDVSYEAP--TTSSSCRN------ 50
           ++ K +G GSF      V + +   FA       +  +   E           N      
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHE 73

Query: 51  -------LHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIVSALKYLH 92
                    L  E L GG   +L        + I  + H            +VSA+ ++H
Sbjct: 74  VFHDQLHTFLVMELLNGG---ELF-------ERIKKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 93  SRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
              +VH D+K +N+L      N   +K+ DFG A              P  +  + APE+
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLE-IKIIDFGFA--RLKPPDNQPLKTPCFTLHYAAPEL 180

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------PRFPT 200
           +         D+WSLG  +  M++G+     F ++  S    S              F  
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVP---FQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237

Query: 201 QS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ-----SVSPSDANTVAESSPRC 251
           ++    S+  +D +   L  +P +R     L  + +LQ     S +P     +  SS   
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297

Query: 252 VLDWVNSEF 260
           V   V + F
Sbjct: 298 VHTCVKATF 306

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  112 bits (283), Expect = 9e-29
 Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 87/289 (30%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY-------LGD--DV-------------------- 37
              IGRGS+G V +AV +      A        + D                        
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 38  SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIVS 86
           ++E  T      +++L  E   GG   +L        + +  +              ++S
Sbjct: 74  TFEDNT------DIYLVMELCTGG---ELF-------ERVVHKRVFRESDAARIMKDVLS 117

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPR----- 139
           A+ Y H  N+ H D+K +N L   +S  S +KL DFG A           + +P      
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA----------ARFKPGKMMRT 167

Query: 140 --GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------G 190
             G+P +++P+V+ G   GPE D WS G  +  ++ G P    F A T S +        
Sbjct: 168 KVGTPYYVSPQVLEGLY-GPECDEWSAGVMMYVLLCGYPP---FSAPTDSEVMLKIREGT 223

Query: 191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
           F+     +   S +     + + L + P +R +  Q L+H + +    S
Sbjct: 224 FTFPEKDWLNVSPQ-AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  112 bits (283), Expect = 1e-28
 Identities = 57/302 (18%), Positives = 107/302 (35%), Gaps = 97/302 (32%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-----------YLGDDV------------------ 37
            + +GRG    V   + +     +A           +  ++V                  
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 38  ----------SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH----- 80
                     +YE  T         L  + +  G   +L        D +T +       
Sbjct: 82  GHPNIIQLKDTYETNT------FFFLVFDLMKKG---ELF-------DYLTEKVTLSEKE 125

Query: 81  ----TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI 136
                  ++  +  LH  NIVH D+K +N+L+  + + +KL DFG +           ++
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFS----------CQL 174

Query: 137 QPR-------GSPLWMAPEVVRGECQ------GPESDVWSLGCTIIEMVTGKPA-WEDFG 182
            P        G+P ++APE++           G E D+WS G  +  ++ G P  W    
Sbjct: 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234

Query: 183 ANTLSRIGFSDELPRFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
              L  I   +   +F +      S+  +D + + L  +P +R++ ++ L HPF Q    
Sbjct: 235 MLMLRMIMSGN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292

Query: 239 SD 240
            +
Sbjct: 293 EE 294

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  113 bits (285), Expect = 1e-28
 Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 87/292 (29%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLG-------DDV--------------------SY 39
              +GRG+   V     +     +A            V                     +
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 40  EAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIVSAL 88
           E PT       + L  E + GG   +L        D I  + +            I+ A+
Sbjct: 118 ETPT------EISLVLELVTGG---ELF-------DRIVEKGYYSERDAADAVKQILEAV 161

Query: 89  KYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPR------ 139
            YLH   IVH D+K +N+L     P++  +K+ADFG +            ++ +      
Sbjct: 162 AYLHENGIVHRDLKPENLLYATPAPDAP-LKIADFGLS----------KIVEHQVLMKTV 210

Query: 140 -GSPLWMAPEVVRGECQGPESDVWSLG-CTIIEMVTGKPA-WEDFGANTLSR------IG 190
            G+P + APE++RG   GPE D+WS+G  T I ++ G    +++ G   + R        
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYI-LLCGFEPFYDERGDQFMFRRILNCEYY 269

Query: 191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDAN 242
           F    P +   S    +D + K +  +P +R +  Q L+HP++   + +  +
Sbjct: 270 FIS--PWWDEVSLN-AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (281), Expect = 2e-28
 Identities = 54/274 (19%), Positives = 100/274 (36%), Gaps = 63/274 (22%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDV---------------------- 37
            + +G G+FG V++  +R +G                +                      
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 38  -SYEAPTTSSSCRNLHL--EYLPGGTVSD---LATTLNAYADEITLRSHTYCIVSALKYL 91
             +E         N+++  E   GG + +    A        E  +      +++AL Y 
Sbjct: 87  EVFE------DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 92  HSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRGVKIQPR-------GSP 142
           HS+++VH D+K +N+L    S  S +K+ DFG A             +         G+ 
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA----------ELFKSDEHSTNAAGTA 190

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSRIGFSD-ELPRFPT 200
           L+MAPEV + +    + D+WS G  +  ++TG              +  + +        
Sbjct: 191 LYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR 249

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
             +    D L + L ++P  R S  Q+L H + +
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  112 bits (282), Expect = 2e-28
 Identities = 64/304 (21%), Positives = 104/304 (34%), Gaps = 83/304 (27%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSYEAPT--TSSSCRN--- 50
           ++   +G G+   V   ++      +A         ++   V  E          RN   
Sbjct: 16  LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 51  ----------LHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIVSALK 89
                      +L  E + GG    +          I  R H            + SAL 
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGG---SIL-------SHIHKRRHFNELEASVVVQDVASALD 125

Query: 90  YLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAA-----GEATVSDTRGVKIQPRGS 141
           +LH++ I H D+K +N+L       S  VK+ DF               +    + P GS
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 142 PLWMAPEVVRGECQ-----GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP 196
             +MAPEVV    +         D+WSLG  +  +++G P    F     S  G+     
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCGSDCGWDRGEA 241

Query: 197 RFPTQS---------------------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
               Q+                     S   +D + K L R+  +R S  Q+L+HP++Q 
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

Query: 236 VSPS 239
            +P 
Sbjct: 302 CAPE 305

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (279), Expect = 6e-28
 Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 49/270 (18%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSYEAPTTS-----SSCR--- 49
           GK +G GSF TV +A +      +A            + V Y    T      S      
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY---VTRERDVMSRLDHPF 91

Query: 50  --NLH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHS 93
              L+            L Y   G   +L   +      DE   R +T  IVSAL+YLH 
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNG---ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
           + I+H D+K +N+L+  +   +++ DFG A   +    +       G+  +++PE++  +
Sbjct: 149 KGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPTQSSELGRDFLDK 212
                SD+W+LGC I ++V G P +       +  +I    E   FP +     RD ++K
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-IKLEY-DFPEKFFPKARDLVEK 265

Query: 213 CLRREPGERWSC------DQLLKHPFLQSV 236
            L  +  +R  C        L  HPF +SV
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  112 bits (282), Expect = 8e-28
 Identities = 61/268 (22%), Positives = 104/268 (38%), Gaps = 49/268 (18%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA--YLG-------DDVSYEAPTTS-----SSCR---- 49
           + IG+GSFG V +        ++A  Y+        ++V                     
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN---VFKELQIMQGLEHPFL 77

Query: 50  -NLH------------LEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSR 94
            NL             ++ L GG   DL   L  N +  E T++     +V AL YL ++
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV---R 151
            I+H D+K  N+L+  +   V + DF  A                G+  +MAPE+    +
Sbjct: 135 RIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRK 190

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDF 209
           G       D WSLG T  E++ G+  +    + +   I   F   +  +P+  S+     
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250

Query: 210 LDKCLRREPGERWSCDQLLK-HPFLQSV 236
           L K L   P +R+S    ++  P++  +
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  110 bits (277), Expect = 1e-27
 Identities = 55/262 (20%), Positives = 85/262 (32%), Gaps = 41/262 (15%)

Query: 7   GKCIGRGSFGTV-------NVAVDRFN-GDVFAYLGDDVSYEAPTTSSSCR--NL----- 51
           G+ IG+G FG V        VA+   +              E        R  N+     
Sbjct: 38  GELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREV-MAYRQTRHENVVLFMG 96

Query: 52  ------HL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                 HL        G T+  +        D    R     IV  + YLH++ I+H D+
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156

Query: 102 KGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           K KNV        V + DFG     G               G    +APE++R      E
Sbjct: 157 KSKNVFYDNGK--VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 159 ---------SDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRD 208
                    SDV++LG    E+   +  ++       + ++G   +         +   D
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISD 274

Query: 209 FLDKCLRREPGERWSCDQLLKH 230
            L  C   E  ER +  +L+  
Sbjct: 275 ILLFCWAFEQEERPTFTKLMDM 296

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  109 bits (274), Expect = 1e-27
 Identities = 37/260 (14%), Positives = 85/260 (32%), Gaps = 46/260 (17%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFN-GDVFAYLGDDVSYEAP--------------- 42
              +     G +        ++ V      D       D + E P               
Sbjct: 15  LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 43  -TTSSSCRNLHL--EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRN--I 96
              S    +  L   ++P G++ + L    N   D+         +   + +LH+    I
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
               +  ++V++  + +  +++            + G       +P W+APE ++ + + 
Sbjct: 135 PRHALNSRSVMIDEDMT-ARISMADVK---FSFQSPGR----MYAPAWVAPEALQKKPED 186

Query: 157 PE---SDVWSLGCTII--EMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFL 210
                +D+WS    ++  E+VT +  + D        ++      P  P   S      +
Sbjct: 187 TNRRSADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244

Query: 211 DKCLRREPGERWSCDQLLKH 230
             C+  +P +R   D ++  
Sbjct: 245 KICMNEDPAKRPKFDMIVPI 264

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  109 bits (276), Expect = 1e-27
 Identities = 71/306 (23%), Positives = 102/306 (33%), Gaps = 92/306 (30%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA------YLGDDVSYEAPTTS------------------ 45
           IG G++GTV  A D  +G   A        G       P ++                  
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 46  ------------SSCRNLHL--EYLPGGTVSDLATTLNAYA----DEITLRSHTYCIVSA 87
                            + L  E++      DL T L+          T++      +  
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP----L 143
           L +LH+  IVH D+K +N+LV  +   VKLADFG A        R    Q   +P    L
Sbjct: 133 LDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLA--------RIYSYQMALTPVVVTL 183

Query: 144 WM-APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI--------- 189
           W  APEV+         D+WS+GC   EM   KP    F  N+    L +I         
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL---FCGNSEADQLGKIFDLIGLPPE 240

Query: 190 ----GFSD----ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
                         P    +          E G   L + L   P +R S  + L+H +L
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

Query: 234 QSVSPS 239
                +
Sbjct: 301 HKDEGN 306

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 5e-27
 Identities = 61/291 (20%), Positives = 105/291 (36%), Gaps = 75/291 (25%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVSYEAPTTSS------------- 46
            K +G G+ G V +A +R      A             + EA    +             
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 47  ----------SCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH---------TYCIV 85
                        + ++  E + GG   +L        D++               Y ++
Sbjct: 75  PCIIKIKNFFDAEDYYIVLELMEGG---ELF-------DKVVGNKRLKEATCKLYFYQML 124

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAA---GEATVSDTRGVKIQPRG 140
            A++YLH   I+H D+K +NVL+        +K+ DFG +   GE ++  T        G
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC------G 178

Query: 141 SPLWMAPEVVRGECQ---GPESDVWSLGCTIIEMVTGKPA-WEDFGANTLSR------IG 190
           +P ++APEV+            D WSLG  +   ++G P   E     +L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

Query: 191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
           F      +   S +   D + K L  +P  R++ ++ L+HP+LQ       
Sbjct: 239 FIP--EVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK 286

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (275), Expect = 5e-27
 Identities = 61/295 (20%), Positives = 108/295 (36%), Gaps = 96/295 (32%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-----------------YLGDDV------------ 37
              IGRG    V   V R  G  FA                  + +              
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 38  ---------SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSH------ 80
                    SYE+ +       + L  + +  G   +L        D +T +        
Sbjct: 159 HPHIITLIDSYESSS------FMFLVFDLMRKG---ELF-------DYLTEKVALSEKET 202

Query: 81  ---TYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
                 ++ A+ +LH+ NIVH D+K +N+L+  N   ++L+DFG +            ++
Sbjct: 203 RSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFS----------CHLE 251

Query: 138 PR-------GSPLWMAPEVVRGECQ------GPESDVWSLGCTIIEMVTGKPA-WEDFGA 183
           P        G+P ++APE+++          G E D+W+ G  +  ++ G P  W     
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311

Query: 184 NTLSRIGFSDELPRFPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
             L  I       +F +      S   +D + + L+ +P  R + +Q L+HPF +
Sbjct: 312 LMLRMIMEGQ--YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  110 bits (277), Expect = 5e-27
 Identities = 63/300 (21%), Positives = 99/300 (33%), Gaps = 89/300 (29%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------------------------YLGDDVSYE 40
           K IG GSFG V  A    +G++ A                            L       
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSS 119

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYA------DEITLRSHTYCIVSALKYLHSR 94
                    NL L+Y+P      +      Y+        I ++ + Y +  +L Y+HS 
Sbjct: 120 GEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVS--DTRGVKIQPRGSPLWM-A 146
            I H D+K +N+L+ P+++ +KL DFG+A     GE  VS   +R           +  A
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-----------YYRA 224

Query: 147 PEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW---------------------EDFGAN 184
           PE++ G        DVWS GC + E++ G+P +                     E     
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284

Query: 185 TLSRIGFSDELPRFPTQS---------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
             +   F    P+                       + L   P  R +  +   H F   
Sbjct: 285 NPNYTEFK--FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  107 bits (270), Expect = 7e-27
 Identities = 52/270 (19%), Positives = 99/270 (36%), Gaps = 56/270 (20%)

Query: 7   GKCIGRGSFGTV----------NVAVDRFNGDVFAYLGDDVSY------EAPTTSS---- 46
            K IG+G FG V           VA+            + +        E    S+    
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 47  -------SCRN-LHL--EYLPGGTVSDLATTLNAYADEITLRSHT---YCIVSALKYLHS 93
                     N   +  E++P G +      L   A  I           I   ++Y+ +
Sbjct: 84  NIVKLYGLMHNPPRMVMEFVPCGDLYHR---LLDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 94  RN--IVHCDVKGKNVLVGPNSSF----VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAP 147
           +N  IVH D++  N+ +           K+ADFG + ++  S +  +     G+  WMAP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL-----GNFQWMAP 195

Query: 148 EVVRGECQ--GPESDVWSLGCTII--EMVTGKPAWEDFG---ANTLSRIGFSDELPRFPT 200
           E +  E +    ++D +S    +I   ++TG+  ++++       ++ I      P  P 
Sbjct: 196 ETIGAEEESYTEKADTYSFA--MILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKH 230
                 R+ ++ C   +P +R     ++K 
Sbjct: 254 DCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  107 bits (270), Expect = 9e-27
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 11/187 (5%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
            E +  G V ++ T       E   R +   ++  ++YLH + I+H D+K  N+LVG + 
Sbjct: 117 FELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG 174

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ---GPESDVWSLGCTII 169
             +K+ADFG + E   SD   +     G+P +MAPE +    +   G   DVW++G T+ 
Sbjct: 175 H-IKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 170 EMVTGKPAWEDFGANTL-SRIGFSD-ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQL 227
             V G+  + D     L S+I     E P  P  + +L +D + + L + P  R    ++
Sbjct: 232 CFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDL-KDLITRMLDKNPESRIVVPEI 290

Query: 228 LKHPFLQ 234
             HP++ 
Sbjct: 291 KLHPWVT 297

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  107 bits (270), Expect = 1e-26
 Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 22/172 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRGVKIQP 138
           ++ A+++ H+  ++H D+K +N+L+  N   +KL DFG+         T  D        
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-------- 209

Query: 139 RGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR 197
            G+ ++  PE +R     G  + VWSLG  + +MV G   +E         I        
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-----DEEI--IRGQVF 261

Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
           F  + S   +  +  CL   P +R + +++  HP++Q V             
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS 313

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  107 bits (270), Expect = 3e-26
 Identities = 69/352 (19%), Positives = 115/352 (32%), Gaps = 101/352 (28%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFA-------------------YLGD------ 35
           M  +   +  G+G+FGTV +  ++  G   A                    L        
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81

Query: 36  ----DVSYEAPTTSSSCR----NLHLEYLPGGTVSDLATTLNAYA------DEITLRSHT 81
                  Y         R    N+ +EY+P      L      Y         I ++   
Sbjct: 82  VQLQSYFY--TLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 82  YCIVSALKYLH--SRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVS--DTR 132
           + ++ ++  LH  S N+ H D+K  NVLV      +KL DFG+A      E  V+   +R
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 133 GVKIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP-------------- 176
                      +  APE++ G        D+WS+GC   EM+ G+P              
Sbjct: 196 -----------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244

Query: 177 ----------AWEDFGAN-------TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
                            +           I +S+       + ++   D L   L+  P 
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304

Query: 220 ERWSCDQLLKHPFLQSV-SPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEK 270
           ER    + L HP+   +  P+      +  P  +  +     E E  S+ +K
Sbjct: 305 ERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRF--LPNEIEVMSEAQK 354

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  106 bits (267), Expect = 4e-26
 Identities = 65/243 (26%), Positives = 93/243 (38%), Gaps = 54/243 (22%)

Query: 36  DVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA----DEITLRSHTYCIVSALKYL 91
           DV   + T   +   L  E++      DL T L+          T++   + ++  L +L
Sbjct: 81  DVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP----LWM-A 146
           HS  +VH D+K +N+LV  +S  +KLADFG A        R    Q   +     LW  A
Sbjct: 137 HSHRVVHRDLKPQNILVT-SSGQIKLADFGLA--------RIYSFQMALTSVVVTLWYRA 187

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI------------- 189
           PEV+         D+WS+GC   EM   KP    F  ++    L +I             
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPL---FRGSSDVDQLGKILDVIGLPGEEDWP 244

Query: 190 GFSD----ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                          Q          ELG+D L KCL   P +R S    L HP+ Q + 
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

Query: 238 PSD 240
              
Sbjct: 305 RCK 307

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  105 bits (264), Expect = 4e-26
 Identities = 62/264 (23%), Positives = 97/264 (36%), Gaps = 48/264 (18%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGDVFAYLGD---DVSYEAPTTSS--------- 46
            + IG G FG V         VAV     D    +     +V  EA   +          
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 47  --SCR---NLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN---I 96
              C    NL L  E+  GG ++ + +          L +    I   + YLH      I
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 97  VHCDVKGKNVLVG-------PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
           +H D+K  N+L+         ++  +K+ DFG A E   +          G+  WMAPEV
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEV 185

Query: 150 VRGECQGPESDVWSLGCTII--EMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELG 206
           +R       SDVWS G  ++  E++TG+  +    G      +  +      P+   E  
Sbjct: 186 IRASMFSKGSDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF 243

Query: 207 RDFLDKCLRREPGERWSCDQLLKH 230
              ++ C   +P  R S   +L  
Sbjct: 244 AKLMEDCWNPDPHSRPSFTNILDQ 267

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  106 bits (266), Expect = 4e-26
 Identities = 58/263 (22%), Positives = 94/263 (35%), Gaps = 42/263 (15%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-----YLGDD--------------------VSYEA 41
           G+ +G+G FG       R  G+V          ++                    + +  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                   N   EY+ GGT+  +  ++++        S    I S + YLHS NI+H D+
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134

Query: 102 KGKNVLVGPNSSFVKLADFGAA------------GEATVSDTRGVKIQPRGSPLWMAPEV 149
              N LV  N + V +ADFG A              +     R  +    G+P WMAPE+
Sbjct: 135 NSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF 209
           + G     + DV+S G  + E++    A  D+   T+                      F
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-RYCPPNCPPSF 252

Query: 210 LD---KCLRREPGERWSCDQLLK 229
                +C   +P +R S  +L  
Sbjct: 253 FPITVRCCDLDPEKRPSFVKLEH 275

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (266), Expect = 4e-26
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 22/172 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRGVKIQP 138
           +V+A+++ HSR +VH D+K +N+L+       KL DFG+         T  D        
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-------- 199

Query: 139 RGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR 197
            G+ ++  PE +         + VWSLG  + +MV G   +E         I   +    
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER-----DQEI--LEAELH 251

Query: 198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSP 249
           FP   S      + +CL  +P  R S +++L  P++Q+ +       ++  P
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (263), Expect = 8e-26
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 19/173 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG---AAGEATVSDTRGVKIQPRG 140
           I SAL   H+    H DVK +N+LV  +  F  L DFG   A  +  ++   G  +   G
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEKLTQL-GNTV---G 197

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--FSDELPRF 198
           +  +MAPE          +D+++L C + E +TG P    +  + LS +G   +  +PR 
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP---YQGDQLSVMGAHINQAIPRP 254

Query: 199 PTQSSELGRDF---LDKCLRREPGERW-SCDQLLK--HPFLQSVSPSDANTVA 245
            T    +   F   + + + + P +R+ +C  L    H  L +     A  + 
Sbjct: 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDIL 307

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  106 bits (266), Expect = 1e-25
 Identities = 66/299 (22%), Positives = 101/299 (33%), Gaps = 88/299 (29%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDV----------FAY----------------LGDDVSYEA 41
           K IG GSFG V  A    + +V          F                  L        
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNG 105

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYA------DEITLRSHTYCIVSALKYLHSRN 95
                   NL LEY+P      +      YA        + ++ + Y ++ +L Y+HS  
Sbjct: 106 DKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSD--TRGVKIQPRGSPLWM-AP 147
           I H D+K +N+L+ P S  +KL DFG+A     GE  VS   +R           +  AP
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-----------YYRAP 210

Query: 148 EVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW---------------------EDFGANT 185
           E++ G        D+WS GC + E++ G+P +                     E      
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 186 LSRIGFSDELPRFPTQS---------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
            + +      P+                   D + + L   P  R +  + L HPF   
Sbjct: 271 PNYMEHK--FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (262), Expect = 2e-25
 Identities = 75/301 (24%), Positives = 117/301 (38%), Gaps = 45/301 (14%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS-------------------- 38
            K IG+G+F  V +A     G   A             +                     
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 39  YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
           +E   T      L+L  EY  GG V D     +    E   RS    IVSA++Y H + I
Sbjct: 80  FEVIETEK---TLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRI 135

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGEC- 154
           VH D+K +N+L+  + + +K+ADFG +     +   G K+    G+P + APE+ +G+  
Sbjct: 136 VHRDLKAENLLLDADMN-IKIADFGFS--NEFTV--GGKLDAFCGAPPYAAPELFQGKKY 190

Query: 155 QGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPTQSSELGRDFLDKC 213
            GPE DVWSLG  +  +V+G   ++      L  R+       R P   S    + L + 
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRF 248

Query: 214 LRREPGERWSCDQLLKHP-FLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDEKLE 272
           L   P +R + +Q++K           +     E                 G S +E  E
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQE 308

Query: 273 A 273
           +
Sbjct: 309 S 309

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  107 bits (269), Expect = 2e-25
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 60/277 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---E----APTTSSSCRNL 51
           + +GRG FG V     +  G ++A                    E    A   S    +L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 52  H------------LEYLPGGTVSDLATTLNAYA------DEITLRSHTYCIVSALKYLHS 93
                        +  + GG   D+   +           E     +T  IVS L++LH 
Sbjct: 251 AYAFETKTDLCLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG 152
           RNI++ D+K +NVL+  +   V+++D G A E         K +   G+P +MAPE++ G
Sbjct: 308 RNIIYRDLKPENVLL-DDDGNVRISDLGLAVELK---AGQTKTKGYAGTPGFMAPELLLG 363

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--------PRFPTQSSE 204
           E      D ++LG T+ EM+  +  +   G         + EL          +P + S 
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQRVLEQAVTYPDKFSP 418

Query: 205 LGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSV 236
             +DF +  L+++P +R        D L  HP  + +
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (261), Expect = 2e-25
 Identities = 57/235 (24%), Positives = 92/235 (39%), Gaps = 60/235 (25%)

Query: 49  RNLHL--EYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           R L L  E++      DL   L+       +  ++ + Y ++  + + H   I+H D+K 
Sbjct: 92  RCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKP 147

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP----LWM-APEVVRG-ECQG 156
           +N+L+  +   +KLADFG A        R   I  R  +     LW  AP+V+ G +   
Sbjct: 148 QNLLIN-SDGALKLADFGLA--------RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI-------------GFSD------ 193
              D+WS+GC   EM+TGKP    F   T    L +I                +      
Sbjct: 199 TSVDIWSIGCIFAEMITGKPL---FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255

Query: 194 -ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                F  +          + G D L   L  +P +R S    + HP+ + + P 
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  103 bits (259), Expect = 3e-25
 Identities = 64/281 (22%), Positives = 95/281 (33%), Gaps = 91/281 (32%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA------------------YLGD--------DVS 38
           V  + +G G  G V    ++   + FA                              DV 
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDV- 79

Query: 39  YEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTY-----------CIV 85
           YE     +  + L +  E L GG   +L          I  R                I 
Sbjct: 80  YE--NLYAGRKCLLIVMECLDGG---ELF-------SRIQDRGDQAFTEREASEIMKSIG 127

Query: 86  SALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
            A++YLHS NI H DVK +N+L     PN+  +KL DFG                     
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAI-LKLTDFG--------------------- 165

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA-WEDFGANT----LSRIGFSDELPR 197
              A E   GE      D+WSLG  +  ++ G P  + + G        +RI        
Sbjct: 166 --FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--YE 220

Query: 198 FPTQS----SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           FP       SE  +  +   L+ EP +R +  + + HP++ 
Sbjct: 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  104 bits (261), Expect = 4e-25
 Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 49/266 (18%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---EAPTTSSSCR-----N 50
           K +G+GSFG V +A  +     FA          + DDV     E    S +       +
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           +             +EYL GG   DL   + +    D      +   I+  L++LHS+ I
Sbjct: 83  MFCTFQTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           V+ D+K  N+L+  +   +K+ADFG   E        +    +     G+P ++APE++ 
Sbjct: 140 VYRDLKLDNILLDKDG-HIKIADFGMCKE-------NMLGDAKTNTFCGTPDYIAPEILL 191

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
           G+      D WS G  + EM+ G+  +       L      D    +P    +  +D L 
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP-FYPRWLEKEAKDLLV 250

Query: 212 KCLRREPGERWSC-DQLLKHPFLQSV 236
           K   REP +R      + +HP  + +
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPLFREI 276

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  106 bits (266), Expect = 4e-25
 Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 63/277 (22%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVS-------------------- 38
           + +G+G FG V     R  G ++A               +                    
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 39  -YEAPTTSSSCRNLHLEYLPGGTVSDLATTL----NAYADEITLRSHTYCIVSALKYLHS 93
            Y   T  + C  L L  + GG   DL   +     A   E     +   I   L+ LH 
Sbjct: 250 AYAYETKDALC--LVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRG 152
             IV+ D+K +N+L+  +   ++++D G A         G  I+ R G+  +MAPEVV+ 
Sbjct: 305 ERIVYRDLKPENILL-DDHGHIRISDLGLAVHVP----EGQTIKGRVGTVGYMAPEVVKN 359

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--------PRFPTQSSE 204
           E      D W+LGC + EM+ G+  ++             +E+          +  + S 
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVKEVPEEYSERFSP 414

Query: 205 LGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSV 236
             R    + L ++P ER  C      ++ +HP  + +
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  103 bits (260), Expect = 4e-25
 Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 52/269 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---E----APTTSSSCRNL 51
           K +G+G+FG V +  ++  G  +A            D+V++   E      T       L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 52  H------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIV 97
                        +EY  GG   +L   L+      E   R +   IVSAL+YLHSR++V
Sbjct: 71  KYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRG 152
           + D+K +N+++  +   +K+ DFG   E       G+          G+P ++APEV+  
Sbjct: 128 YRDIKLENLMLDKDG-HIKITDFGLCKE-------GISDGATMKTFCGTPEYLAPEVLED 179

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
              G   D W LG  + EM+ G+  + +     L  +   +E+ RFP   S   +  L  
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI-RFPRTLSPEAKSLLAG 238

Query: 213 CLRREPGERWSC-----DQLLKHPFLQSV 236
            L+++P +R         ++++H F  S+
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  103 bits (259), Expect = 5e-25
 Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 91/303 (30%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYE-APTTS------------------- 45
           +G G++G V  A+D    +  A     L  +   E  P T+                   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 46  ---SSCRNLHL--EYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIVH 98
                   LHL  EY      +DL   ++         ++S  Y +++ + + HSR  +H
Sbjct: 100 SVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLH 155

Query: 99  CDVKGKNVLV----GPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP----LWM-APE 148
            D+K +N+L+       +  +K+ DFG A        R   I  R  +     LW   PE
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLA--------RAFGIPIRQFTHEIITLWYRPPE 207

Query: 149 VVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI-------------- 189
           ++ G        D+WS+ C   EM+   P    F  ++    L +I              
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPL---FPGDSEIDQLFKIFEVLGLPDDTTWPG 264

Query: 190 -----GFSDELPRFPTQS---------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
                 +    P+F  ++          + G D L   L  +P +R S    L+HP+   
Sbjct: 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

Query: 236 VSP 238
              
Sbjct: 325 NDF 327

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (257), Expect = 5e-25
 Identities = 45/179 (25%), Positives = 84/179 (46%), Gaps = 21/179 (11%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+ G T+S+   +    + +  +   T  I+  +K+ H   IVH D+K +N+L+  N +
Sbjct: 91  EYIEGPTLSEYIESHGPLSVDTAINF-TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149

Query: 114 FVKLADFG---AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
            +K+ DFG   A  E +++ T  V     G+  + +PE  +GE     +D++S+G  + E
Sbjct: 150 -LKIFDFGIAKALSETSLTQTNHV----LGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204

Query: 171 MVTGKPAWEDFGANTLSRIGF---SDELPRFPTQ-----SSELGRDFLDKCLRREPGER 221
           M+ G+P +   G   +S I      D +P   T         L  + + +   ++   R
Sbjct: 205 MLVGEPPFN--GETAVS-IAIKHIQDSVPNVTTDVRKDIPQSL-SNVILRATEKDKANR 259

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  103 bits (259), Expect = 7e-25
 Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 54/233 (23%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKIQPRG 140
           Y  + A+K LH  N++H D+K  N+L+  NS+  +K+ DFG A    + ++     +P G
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLI--NSNCDLKVCDFGLA--RIIDESAADNSEPTG 174

Query: 141 SPLWM----------APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT---- 185
               M          APEV+    +     DVWS GC + E+   +P +   G +     
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP--GRDYRHQL 232

Query: 186 ---------------LSRIG------FSDELPRFPTQS--------SELGRDFLDKCLRR 216
                          L  I       +   LP +P           +  G D L + L  
Sbjct: 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVF 292

Query: 217 EPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
           +P +R +  + L+HP+LQ+    +     E  P    ++   +  +E  +  +
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEF---DHYKEALTTKD 342

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (257), Expect = 9e-25
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 17/206 (8%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSP 142
           +VSA+ YL  ++I+H D+K +N+++  + + +KL DFG+A        RG       G+ 
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYL----ERGKLFYTFCGTI 193

Query: 143 LWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQ 201
            + APEV+ G   +GPE ++WSLG T+  +V  +  + +                  P  
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL--EETVEAAI-----HPPYL 246

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFE 261
            S+     +   L+  P  R + ++L+  P++         T  E       +   S   
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE---SGVL 303

Query: 262 EEGTSDDEKLEASARERMGKLAGSSG 287
              + +      S   +  +L G  G
Sbjct: 304 SAASLEMGNRSLSDVAQAQELCGGEG 329

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  103 bits (258), Expect = 1e-24
 Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 61/279 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---EAPTTSSSCR-----N 50
           + IGRGS+  V +   +    ++A            +D+ +   E      +        
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           LH            +EY+ GG   DL   +       E   R ++  I  AL YLH R I
Sbjct: 75  LHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           ++ D+K  NVL+      +KL D+G   E       G++         G+P ++APE++R
Sbjct: 132 IYRDLKLDNVLLDSEG-HIKLTDYGMCKE-------GLRPGDTTSTFCGTPNYIAPEILR 183

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--------PRFPTQSS 203
           GE  G   D W+LG  + EM+ G+  ++  G++        D L         R P   S
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243

Query: 204 ELGRDFLDKCLRREPGERWSC------DQLLKHPFLQSV 236
                 L   L ++P ER  C        +  HPF ++V
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  102 bits (256), Expect = 1e-24
 Identities = 69/310 (22%), Positives = 116/310 (37%), Gaps = 90/310 (29%)

Query: 1   MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYE-APTTS---------- 45
           M ++++   +G G++ TV     +   ++ A     L  +   E AP T+          
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDL 57

Query: 46  ------------SSCRNLHL--EYLPGGTVSDLATTLNAYADEITL---RSHTYCIVSAL 88
                        + ++L L  EYL      DL   L+   + I +   +   + ++  L
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113

Query: 89  KYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP----L 143
            Y H + ++H D+K +N+L+      +KLADFG A        R   I  +        L
Sbjct: 114 AYCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLA--------RAKSIPTKTYDNEVVTL 164

Query: 144 WM-APEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI-------- 189
           W   P+++ G      + D+W +GC   EM TG+P    F  +T    L  I        
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL---FPGSTVEEQLHFIFRILGTPT 221

Query: 190 -----GFSD-------ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLK 229
                G            P++  ++           G D L K L+ E   R S +  +K
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281

Query: 230 HPFLQSVSPS 239
           HPF  S+   
Sbjct: 282 HPFFLSLGER 291

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  105 bits (263), Expect = 1e-24
 Identities = 57/271 (21%), Positives = 111/271 (40%), Gaps = 51/271 (18%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---E----APTTSSSCR-- 49
           + IGRG FG V        G ++A          +    +    E    +  ++  C   
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 50  -NLH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSR 94
             +             L+ + GG   DL   L+ +    E  +R +   I+  L+++H+R
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RGE 153
            +V+ D+K  N+L+      V+++D G A + +            G+  +MAPEV+ +G 
Sbjct: 312 FVVYRDLKPANILL-DEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGV 366

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWEDFGA---NTLSRIGFSDELPRFPTQSSELGRDFL 210
                +D +SLGC + +++ G   +        + + R+  +  +   P   S   R  L
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLL 425

Query: 211 DKCLRREPGERWSC-----DQLLKHPFLQSV 236
           +  L+R+   R  C      ++ + PF +S+
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  102 bits (257), Expect = 1e-24
 Identities = 71/331 (21%), Positives = 122/331 (36%), Gaps = 91/331 (27%)

Query: 8   KCIGRGSFGTVNVAVDRFNG---------DVFAYLGD----------------------- 35
             +G G++G+V  A+D+ +G           F                            
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 36  DVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
           DV +   ++  +  + +L   ++     +DL   +     E  ++   Y ++  LKY+HS
Sbjct: 90  DV-FTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW-MAPEVVRG 152
             +VH D+K  N+ V  +   +K+ DFG A  A    T  V         W  APEV+  
Sbjct: 145 AGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADAEMTGYV------VTRWYRAPEVILS 197

Query: 153 ECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT------------------LSRIG--- 190
                   D+WS+GC + EM+TGK  ++  G +                   + ++    
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFK--GKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 191 ---FSDELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV-SP 238
              +   LP+ P +         S    D L+K L  +  +R +  Q L HPF +    P
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315

Query: 239 SDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
            +     E+  +   D      E E  + DE
Sbjct: 316 EE-----ETEAQQPFDD---SLEHEKLTVDE 338

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  102 bits (257), Expect = 2e-24
 Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 58/223 (26%)

Query: 77  LRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGP-----NSSFVKLADFGAAGEATVSD 130
           ++  +  ++  L Y+H R  I+H D+K +NVL+       N   +K+AD G A      +
Sbjct: 133 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190

Query: 131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP-----AWEDFGANT 185
                IQ R    + +PEV+ G   G  +D+WS  C I E++TG           +  + 
Sbjct: 191 HYTNSIQTR---EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

Query: 186 --LSRI-------------------------------------GFSDELPRFPTQSSELG 206
             +++I                                        D L      S +  
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307

Query: 207 RDFLD---KCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
           ++  D     L+ +P +R     L+ HP+L+     +   V +
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  103 bits (258), Expect = 2e-24
 Identities = 69/277 (24%), Positives = 102/277 (36%), Gaps = 57/277 (20%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSYEAPT-------TSSSCR-- 49
           K IGRG+F  V V   +  G V+A             +VS             +   R  
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVNGDRRWI 123

Query: 50  -NLH------------LEYLPGGTVSDLATTLNAYADEITL-RSHTYC--IVSALKYLHS 93
             LH            +EY  GG   DL T L+ + + I    +  Y   IV A+  +H 
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGG---DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
              VH D+K  N+L+      ++LADFG+  +     T        G+P +++PE+++  
Sbjct: 181 LGYVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSL-VAVGTPDYLSPEILQAV 238

Query: 154 CQ-------GPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPTQS--- 202
                    GPE D W+LG    EM  G+  +          +I    E    P      
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298

Query: 203 SELGRDFLDKCLRREPGERWSC---DQLLKHPFLQSV 236
            E  RDF+ + L   P  R           HPF   +
Sbjct: 299 PEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFFFGL 334

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  101 bits (253), Expect = 2e-24
 Identities = 56/232 (24%), Positives = 91/232 (39%), Gaps = 59/232 (25%)

Query: 49  RNLHL--EYLPGGTVSDLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIVHCDVKG 103
           + L L  E+L      DL   L+     +     +S    +++ + Y H R ++H D+K 
Sbjct: 73  KRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKP 128

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP----LWM-APEVVRG-ECQG 156
           +N+L+      +K+ADFG A        R   I  R  +     LW  AP+V+ G +   
Sbjct: 129 QNLLIN-REGELKIADFGLA--------RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI-------------GFSD------ 193
              D+WS+GC   EMV G P    F   +    L RI               ++      
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPL---FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 194 ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
               +             E G D L K L+ +P +R +  Q L+H + +  +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN 288

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  104 bits (261), Expect = 2e-24
 Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 23/171 (13%)

Query: 54  EYLPGGTVSD-LATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           EY+ G ++       L  A A    L      I+ AL YLHS  +V+ D+K +N+++   
Sbjct: 164 EYVGGQSLKRSKGQKLPVAEAIAYLLE-----ILPALSYLHSIGLVYNDLKPENIMLTEE 218

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              +KL D GA   + ++    +     G+P + APE+VR       +D++++G T+  +
Sbjct: 219 Q--LKLIDLGAV--SRINSFGYLY----GTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269

Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
               P         +  +   D + +        GR  L + +  +P +R+
Sbjct: 270 TLDLPT---RNGRYVDGLPEDDPVLKTY---DSYGR-LLRRAIDPDPRQRF 313

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (255), Expect = 2e-24
 Identities = 69/310 (22%), Positives = 99/310 (31%), Gaps = 101/310 (32%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFA---------------------------------YLGDD 36
           IG+G+FG V  A  R  G   A                                  L + 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 37  VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITL---RSHTYCIVSALKYL 91
              +A   +    +++L  ++       DLA  L+    + TL   +     +++ L Y+
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP--------- 142
           H   I+H D+K  NVL+      +KLADFG A        R   +     P         
Sbjct: 141 HRNKILHRDMKAANVLIT-RDGVLKLADFGLA--------RAFSLAKNSQPNRYTNRVVT 191

Query: 143 LWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI------- 189
           LW   PE++ GE   GP  D+W  GC + EM T  P       NT    L+ I       
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI---MQGNTEQHQLALISQLCGSI 248

Query: 190 ------GFSDELP-----RFPTQ-------------SSELGRDFLDKCLRREPGERWSCD 225
                                                     D +DK L  +P +R   D
Sbjct: 249 TPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 307

Query: 226 QLLKHPFLQS 235
             L H F  S
Sbjct: 308 DALNHDFFWS 317

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  102 bits (255), Expect = 3e-24
 Identities = 61/280 (21%), Positives = 103/280 (36%), Gaps = 68/280 (24%)

Query: 50  NLHLEYLPGGTVSDLATTLNAYAD------EITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           N+ +EY+P      L   L ++           +  + Y +  A+ ++HS  I H D+K 
Sbjct: 114 NVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKP 169

Query: 104 KNVLVGPNSSFVKLADFGAA-----GEATVSD--TRGVKIQPRGSPLWM-APEVVRGECQ 155
           +N+LV    + +KL DFG+A      E +V+   +R           +  APE++ G  +
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR-----------FYRAPELMLGATE 218

Query: 156 -GPESDVWSLGCTIIEMVTGK---------------------PAWEDFGANTLSRIGFSD 193
             P  D+WS+GC   E++ GK                     P  E              
Sbjct: 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR- 277

Query: 194 ELPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             P           P  +  L  D L++ LR EP  R +  + + HPF   +  S  + V
Sbjct: 278 -FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEV 336

Query: 245 AESS--PRCVLDWVNSEFEEEGTSDDEKLEASARERMGKL 282
             +S  P  V   +   F         +L       + ++
Sbjct: 337 KNNSNFPHGVNQNIPQLFN----FSPYELSIIPGNVLNRI 372

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  101 bits (253), Expect = 3e-24
 Identities = 43/201 (21%), Positives = 73/201 (36%), Gaps = 52/201 (25%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  LKY+HS N++H D+K  N+ +      +K+ DFG A        R +       
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA--------RIMDPHYSHK 178

Query: 142 PLWM---------APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT------ 185
                        +P ++          D+W+ GC   EM+TGK  +   GA+       
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA--GAHELEQMQL 236

Query: 186 ------------LSRIG-----FSDELPRFPTQS--------SELGRDFLDKCLRREPGE 220
                          +      +       P +         S    DFL++ L   P +
Sbjct: 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 221 RWSCDQLLKHPFLQSVS-PSD 240
           R + ++ L HP++   S P D
Sbjct: 297 RLTAEEALSHPYMSIYSFPMD 317

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  102 bits (257), Expect = 3e-24
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 51/269 (18%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSYEAPTTSSSCR--------- 49
           K +G+G+FG V +  ++  G  +A            D+V++    T +  R         
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH----TLTENRVLQNSRHPF 209

Query: 50  --NLH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHS 93
              L             +EY  GG   +L   L+      E   R +   IVSAL YLHS
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266

Query: 94  -RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG 152
            +N+V+ D+K +N+++  +   +K+ DFG   E              G+P ++APEV+  
Sbjct: 267 EKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLED 323

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
              G   D W LG  + EM+ G+  + +     L  +   +E+ RFP       +  L  
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-RFPRTLGPEAKSLLSG 382

Query: 213 CLRREPGERWSC-----DQLLKHPFLQSV 236
            L+++P +R         ++++H F   +
Sbjct: 383 LLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  102 bits (255), Expect = 4e-24
 Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 61/279 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY--------EAPTTSSSCRN 50
           + IGRGS+  V +   +    ++A            +D+ +        E  +       
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           LH            +EY+ GG   DL   +       E   R ++  I  AL YLH R I
Sbjct: 118 LHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           ++ D+K  NVL+      +KL D+G   E       G++         G+P ++APE++R
Sbjct: 175 IYRDLKLDNVLLDSEG-HIKLTDYGMCKE-------GLRPGDTTSTFCGTPNYIAPEILR 226

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--------PRFPTQSS 203
           GE  G   D W+LG  + EM+ G+  ++  G++        D L         R P   S
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286

Query: 204 ELGRDFLDKCLRREPGERWSC------DQLLKHPFLQSV 236
                 L   L ++P ER  C        +  HPF ++V
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (251), Expect = 5e-24
 Identities = 64/309 (20%), Positives = 105/309 (33%), Gaps = 99/309 (32%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYE-APTTS------------------- 45
           +G G++ TV   +++  G   A     L  +   E  P+T+                   
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLY 69

Query: 46  ---SSCRNLHL--EYLPGGTVSDLATTLNAYA--------DEITLRSHTYCIVSALKYLH 92
               +   L L  E++     +DL   +++          +   ++   + ++  L + H
Sbjct: 70  DVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 93  SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP----LWM-A 146
              I+H D+K +N+L+      +KL DFG A        R   I     S     LW  A
Sbjct: 126 ENKILHRDLKPQNLLIN-KRGQLKLGDFGLA--------RAFGIPVNTFSSEVVTLWYRA 176

Query: 147 PEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI------------ 189
           P+V+ G        D+WS GC + EM+TGKP    F        L  I            
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPL---FPGTNDEEQLKLIFDIMGTPNESLW 233

Query: 190 -------GFSDELPRFPTQS-------------SELGRDFLDKCLRREPGERWSCDQLLK 229
                   ++  + + P +                   DFL   L+  P  R S  Q L 
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293

Query: 230 HPFLQSVSP 238
           HP+      
Sbjct: 294 HPWFAEYYH 302

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  100 bits (251), Expect = 6e-24
 Identities = 62/276 (22%), Positives = 100/276 (36%), Gaps = 62/276 (22%)

Query: 8   KCIGRGSFGTVNVA---VDRFNGDVFA----------YLGDDVSYEAPTTS-----SSCR 49
           + +G+G +G V           G +FA              D ++   T +        +
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH---TKAERNILEEVK 79

Query: 50  -----NLH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKY 90
                +L             LEYL GG   +L   L       E T   +   I  AL +
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEISMALGH 136

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWM 145
           LH + I++ D+K +N+++      VKL DFG   E        +          G+  +M
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKE-------SIHDGTVTHTFCGTIEYM 188

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           APE++         D WSLG  + +M+TG P +               +L   P   ++ 
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-NLPPYLTQE 247

Query: 206 GRDFLDKCLRREPGERWSC-----DQLLKHPFLQSV 236
            RD L K L+R    R         ++  HPF + +
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  100 bits (252), Expect = 6e-24
 Identities = 43/235 (18%), Positives = 78/235 (33%), Gaps = 66/235 (28%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV------------------GPNSSFVKLA 118
           +R   Y +  AL++LH   + H D+K +N+L                      ++ +++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 119 DFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA- 177
           DFG+A      +     +  R    +  PEV+         DVWS+GC + E   G    
Sbjct: 185 DFGSA--TFDHEHHTTIVATR---HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239

Query: 178 ------------WEDFG-------ANTLSRIGFSDELPRFPTQSSE-------------- 204
                        +  G         T  +  F      +   SS+              
Sbjct: 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299

Query: 205 ---------LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
                       D + + L  +P +R +  + L HPF   ++P + +     +P 
Sbjct: 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  101 bits (254), Expect = 7e-24
 Identities = 54/233 (23%), Positives = 78/233 (33%), Gaps = 64/233 (27%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRGVK 135
           +R   + I+  L  LH   I+HCD+K +N+L      S +K+ DFG++            
Sbjct: 202 VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTY 259

Query: 136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTI---------------------IEMVTG 174
           IQ R    + APEV+ G   G   D+WSLGC +                     +  + G
Sbjct: 260 IQSR---FYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316

Query: 175 KP------------------------------AWEDFGANTLSRIGFSDELPRFPTQSSE 204
            P                                        SR G     P      + 
Sbjct: 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA 376

Query: 205 LGR-------DFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
           L         DFL +CL  +P  R +  Q L+HP+L+   P        S  R
Sbjct: 377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  100 bits (251), Expect = 8e-24
 Identities = 69/271 (25%), Positives = 110/271 (40%), Gaps = 54/271 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY--------EAPTTSSSCRN 50
           + +G+GSFG V +A  +  GD++A            DDV                     
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           L             +E++ GG   DL   +      DE   R +   I+SAL +LH + I
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           ++ D+K  NVL+       KLADFG   E       G+          G+P ++APE+++
Sbjct: 146 IYRDLKLDNVLLDHEG-HCKLADFGMCKE-------GICNGVTTATFCGTPDYIAPEILQ 197

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
               GP  D W++G  + EM+ G   +E    + L     +DE+  +PT   E     L 
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILK 256

Query: 212 KCLRREPGERWSC------DQLLKHPFLQSV 236
             + + P  R           +L+HPF + +
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  100 bits (251), Expect = 8e-24
 Identities = 57/270 (21%), Positives = 104/270 (38%), Gaps = 53/270 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---EAPTTSSSCR-----N 50
             +G+GSFG V ++  +   +++A            DDV     E    +   +      
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           LH            +EY+ GG   DL   +       E     +   I   L +L S+ I
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           ++ D+K  NV++      +K+ADFG   E        +          G+P ++APE++ 
Sbjct: 143 IYRDLKLDNVMLDSEG-HIKIADFGMCKE-------NIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
            +  G   D W+ G  + EM+ G+  +E    + L +      +  +P   S+       
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICK 253

Query: 212 KCLRREPGERWSC-----DQLLKHPFLQSV 236
             + + PG+R  C       + +H F + +
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  101 bits (253), Expect = 9e-24
 Identities = 67/275 (24%), Positives = 110/275 (40%), Gaps = 55/275 (20%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSYEAPT-------TSSSCR-- 49
           K IGRG+FG V V   +    VFA             + +             +   +  
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNGDSKWI 136

Query: 50  -NLH------------LEYLPGGTVSDLATTLNAYADEITL-RSHTYC--IVSALKYLHS 93
             LH            ++Y  GG   DL T L+ + D +    +  Y   +V A+  +H 
Sbjct: 137 TTLHYAFQDDNNLYLVMDYYVGG---DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
            + VH D+K  N+L+  N   ++LADFG+  +  + D         G+P +++PE+++  
Sbjct: 194 LHYVHRDIKPDNILMDMN-GHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAM 251

Query: 154 CQ-----GPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDE---LPRFPTQSSE 204
                  GPE D WSLG  + EM+ G+  +       T  +I    E    P   T  SE
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311

Query: 205 LGRDFLDKCLRREP---GERWSCDQLLKHPFLQSV 236
             +D + + +       G+    +   KHPF   +
Sbjct: 312 NAKDLIRRLICSREHRLGQN-GIEDFKKHPFFSGI 345

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  100 bits (250), Expect = 1e-23
 Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 62/231 (26%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKIQPRG 140
           Y I+  LKY+HS N++H D+K  N+L+  N++  +K+ DFG A        R        
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLL--NTTCDLKICDFGLA--------RVADPDHDH 184

Query: 141 SPLWM---------APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT----- 185
           +             APE++          D+WS+GC + EM++ +P +   G +      
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP--GKHYLDQLN 242

Query: 186 -------------LSRIG------FSDELPRFPTQS--------SELGRDFLDKCLRREP 218
                        L+ I       +   LP                   D LDK L   P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302

Query: 219 GERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
            +R   +Q L HP+L+         +AE+       +   + E +    ++
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEAP----FKF---DMELDDLPKEK 346

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  101 bits (252), Expect = 1e-23
 Identities = 68/346 (19%), Positives = 119/346 (34%), Gaps = 108/346 (31%)

Query: 8   KCIGRGSFGTVNVAVDRFNG---------DVFAYLGD----------------------- 35
           K IG G+ G V  A D               F                            
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 36  DVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
           +V +    T    ++++L  E +     ++L   +    D   +    Y ++  +K+LHS
Sbjct: 128 NV-FTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-------TRGVKIQPRGSPLWM- 145
             I+H D+K  N++V  + + +K+ DFG A  A  S        TR           +  
Sbjct: 183 AGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTR-----------YYR 230

Query: 146 APEVVRGECQGPESDVWSLGCTIIEMVTGKPAW-------------EDFG---ANTLSRI 189
           APEV+ G       D+WS+GC + EMV  K  +             E  G      + ++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 190 G-----FSDELPRFPTQS--------------------SELGRDFLDKCLRREPGERWSC 224
                 + +  P++   +                    +   RD L K L  +P +R S 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 225 DQLLKHPFLQSV-SPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
           D  L+HP++     P++           + D    + +E   + +E
Sbjct: 351 DDALQHPYINVWYDPAEVEAPPPQ----IYDK---QLDEREHTIEE 389

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 59/300 (19%), Positives = 98/300 (32%), Gaps = 100/300 (33%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYE--APTTS------------------ 45
           +G G F TV  A D+    + A     LG     +     T+                  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 46  ----SSCRNLHL--EYLPGGTVSDLATTLNAYA---DEITLRSHTYCIVSALKYLHSRNI 96
                   N+ L  +++     +DL   +   +       ++++    +  L+YLH   I
Sbjct: 78  LDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 133

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR--GSP----------LW 144
           +H D+K  N+L+  N   +KLADFG A               +  GSP           W
Sbjct: 134 LHRDLKPNNLLLDENGV-LKLADFGLA---------------KSFGSPNRAYTHQVVTRW 177

Query: 145 M-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRI--------- 189
             APE++ G    G   D+W++GC + E++   P       ++    L+RI         
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF---LPGDSDLDQLTRIFETLGTPTE 234

Query: 190 ----GFSD-----ELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPF 232
                            FP            +   D +       P  R +  Q LK  +
Sbjct: 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 61/269 (22%), Positives = 102/269 (37%), Gaps = 50/269 (18%)

Query: 8   KCIGRGSFGTVNVA---VDRFNGDVFA--------YLGDDVSYEAPTTS-----SSCR-- 49
           K +G+GSFG V +           ++A            D      T             
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHP 86

Query: 50  ---NLH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLH 92
               LH            L++L GG   DL T L+      E  ++ +   +  AL +LH
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHLH 143

Query: 93  SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG 152
           S  I++ D+K +N+L+      +KL DFG + E+   + +       G+  +MAPEVV  
Sbjct: 144 SLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFC--GTVEYMAPEVVNR 200

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
                 +D WS G  + EM+TG   ++         +    +L   P   S   +  L  
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRM 259

Query: 213 CLRREPGERWSC-----DQLLKHPFLQSV 236
             +R P  R        +++ +H F  ++
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTI 288

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 62/269 (23%), Positives = 102/269 (37%), Gaps = 52/269 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---EAPTTSSSCR-----N 50
           K IG+GSFG V +A  +     +A             +  +   E      + +      
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           LH            L+Y+ GG   +L   L       E   R +   I SAL YLHS NI
Sbjct: 104 LHFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           V+ D+K +N+L+      + L DFG   E        ++         G+P ++APEV+ 
Sbjct: 161 VYRDLKPENILLDSQG-HIVLTDFGLCKE-------NIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
            +      D W LG  + EM+ G P +       +     +  L +     +   R  L+
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL-QLKPNITNSARHLLE 271

Query: 212 KCLRREPGERWSC----DQLLKHPFLQSV 236
             L+++  +R        ++  H F   +
Sbjct: 272 GLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 45/268 (16%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---EAPTTSSSCR----NL 51
           K IGRG+FG V +   +    V+A             D ++   E    + +       L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 52  H------------LEYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSRNIVH 98
                        +EY+PGG   DL   ++ Y   E   R +T  +V AL  +HS   +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH 191

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ--- 155
            DVK  N+L+   S  +KLADFG   +              G+P +++PEV++ +     
Sbjct: 192 RDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 249

Query: 156 -GPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELPRFPTQS--SELGRDFLD 211
            G E D WS+G  + EM+ G   +       T S+I        FP  +  S+  ++ + 
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309

Query: 212 KCLRREPGER---WSCDQLLKHPFLQSV 236
             L      R      +++ +H F ++ 
Sbjct: 310 AFLTD-REVRLGRNGVEEIKRHLFFKND 336

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 16/177 (9%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS 113
           EY+ G T+ D+  T      +  +         AL + H   I+H DVK  N+++   ++
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNA 154

Query: 114 FVKLADFG---AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIE 170
            VK+ DFG   A  ++  S T+   +   G+  +++PE  RG+     SDV+SLGC + E
Sbjct: 155 -VKVMDFGIARAIADSGNSVTQTAAVI--GTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

Query: 171 MVTGKPAWEDFGANTLSRIGF---SDELPRFPTQSSELG---RDFLDKCLRREPGER 221
           ++TG+P +   G + +S + +    ++      +   L       + K L + P  R
Sbjct: 212 VLTGEPPFT--GDSPVS-VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 40/205 (19%), Positives = 78/205 (38%), Gaps = 12/205 (5%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           +++ + YLH   I H D+K +N+L+    + +K++DFG A     ++   +  +  G+  
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 144 WMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSD-ELPRFP 199
           ++APE+++         DVWS G  +  M+ G+  W+    +    S        L  + 
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232

Query: 200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ------SVSPSDANTVAESSPRCVL 253
              S      L K L   P  R +   + K  +        +  P   +     SP    
Sbjct: 233 KIDSAP-LALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFS 291

Query: 254 DWVNSEFEEEGTSDDEKLEASARER 278
             + S  +    +   +   S   +
Sbjct: 292 KHIQSNLDFSPVNSASRTPGSGWSK 316

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 98.6 bits (246), Expect = 4e-23
 Identities = 65/343 (18%), Positives = 119/343 (34%), Gaps = 102/343 (29%)

Query: 8   KCIGRGSFGTVNVAVDRFNG---------DVFAYLGD----------------------- 35
           K IG G+ G V  A D               F                            
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90

Query: 36  DVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
           +V +    +    +++++  E +     ++L   +    D   +    Y ++  +K+LHS
Sbjct: 91  NV-FTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-----APE 148
             I+H D+K  N++V  + + +K+ DFG A        R        +P  +     APE
Sbjct: 146 AGIIHRDLKPSNIVVKSDCT-LKILDFGLA--------RTAGTSFMMTPYVVTRYYRAPE 196

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAW-------------EDFG---ANTLSRIG-- 190
           V+ G       D+WS+GC + EM+ G   +             E  G      + ++   
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 191 ---FSDELPRFPTQS--------------------SELGRDFLDKCLRREPGERWSCDQL 227
              + +  P++   S                    +   RD L K L  +  +R S D+ 
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 228 LKHPFLQSV-SPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
           L+HP++     PS+A          + D    + +E   + +E
Sbjct: 317 LQHPYINVWYDPSEAEAPPPK----IPDK---QLDEREHTIEE 352

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 57/273 (20%), Positives = 96/273 (35%), Gaps = 65/273 (23%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNG----------DVFA-----------YLGDDV 37
            +   RG FG V         VAV  F            +V++           ++G + 
Sbjct: 29  LEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDL--ATTLNAYADEITLRSHTYCIVSALKYLHSR- 94
                T+      L   +   G++SD   A  +        L      +   L YLH   
Sbjct: 89  R---GTSVDVDLWLITAFHEKGSLSDFLKANVV----SWNELCHIAETMARGLAYLHEDI 141

Query: 95  ---------NIVHCDVKGKNVLVGPNSSFVKLADFGAA----GEATVSDTRGVKIQPRGS 141
                     I H D+K KNVL+  N +   +ADFG A       +  DT G      G+
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKSAGDTHGQV----GT 196

Query: 142 PLWMAPEVVRGECQGPE-----SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP 196
             +MAPEV+ G            D++++G  + E+ +   A +  G      + F +E+ 
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD--GPVDEYMLPFEEEIG 254

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
           + P+   ++    + K  R    + W     + 
Sbjct: 255 QHPSL-EDMQEVVVHKKKRPVLRDYWQKHAGMA 286

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 96.8 bits (242), Expect = 5e-23
 Identities = 73/300 (24%), Positives = 117/300 (39%), Gaps = 89/300 (29%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY----LGDDVSYE-APTTS------------------- 45
           IG G++GTV  A +R   ++ A     L DD   E  P+++                   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLH 67

Query: 46  ---SSCRNLHL--EYLPGGTVSDLATTLNAYADEITL---RSHTYCIVSALKYLHSRNIV 97
               S + L L  E+       DL    ++   ++     +S  + ++  L + HSRN++
Sbjct: 68  DVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRG-SP----LWM-APEVVR 151
           H D+K +N+L+   +  +KLA+FG A        R   I  R  S     LW   P+V+ 
Sbjct: 124 HRDLKPQNLLIN-RNGELKLANFGLA--------RAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 152 G-ECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT----LSRI-------------GFS 192
           G +      D+WS GC   E+   G+P    F  N     L RI               +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL---FPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 193 D-----ELPRFPTQS---------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
                   P +P  +         +  GRD L   L+  P +R S ++ L+HP+     P
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.1 bits (245), Expect = 6e-23
 Identities = 49/231 (21%), Positives = 77/231 (33%), Gaps = 66/231 (28%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-------TRGV 134
           Y I+  L  LH   +VH D+   N+L+  N+  + + DF  A E T           R  
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHR-- 197

Query: 135 KIQPRGSPLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT------- 185
                    W  APE+V          D+WS GC + EM   K  +   G+         
Sbjct: 198 ---------WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR--GSTFYNQLNKI 246

Query: 186 -----------LSRIG-------FSDELPRFPTQS--------SELGRDFLDKCLRREPG 219
                      +             + L   P ++          +  D + K L   P 
Sbjct: 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306

Query: 220 ERWSCDQLLKHPFLQSV-SPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
            R S +Q L+HP+ +S+  P D      +       +    F+E  T   +
Sbjct: 307 RRISTEQALRHPYFESLFDPLD-----LTEG-LSERF---HFDESVTDVYD 348

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  100 bits (249), Expect = 6e-23
 Identities = 57/270 (21%), Positives = 104/270 (38%), Gaps = 53/270 (19%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY---EAPTTSSSCR-----N 50
             +G+GSFG V ++  +   +++A            DDV     E    +   +      
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 51  LH------------LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNI 96
           LH            +EY+ GG   DL   +       E     +   I   L +L S+ I
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           ++ D+K  NV++      +K+ADFG   E        +          G+P ++APE++ 
Sbjct: 464 IYRDLKLDNVMLDSEG-HIKIADFGMCKE-------NIWDGVTTKTFCGTPDYIAPEIIA 515

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD 211
            +  G   D W+ G  + EM+ G+  +E    + L +      +  +P   S+       
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-AYPKSMSKEAVAICK 574

Query: 212 KCLRREPGERWSC-----DQLLKHPFLQSV 236
             + + PG+R  C       + +H F + +
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 47/220 (21%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y ++  L+Y+H+  I+H D+K  N+ V  +   +K+ DFG A +A    T  V       
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADSEMTGYV------V 187

Query: 142 PLWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAW--EDF--------------GA 183
             W  APEV+    +     D+WS+GC + EM+TGK  +   D                A
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247

Query: 184 NTLSRIG------FSDELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLK 229
             + R+       +   LP    +         S L  + L+K L  +  +R +  + L 
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

Query: 230 HPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
           HP+ +S+  ++     +       D     F++   + DE
Sbjct: 308 HPYFESLHDTEDEPQVQK-----YDD---SFDDVDRTLDE 339

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 63/299 (21%), Positives = 100/299 (33%), Gaps = 84/299 (28%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA--------------------YLGD--------DVSY 39
           + +GRG +  V  A++  N +                        L          D+  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADI-- 99

Query: 40  EAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
                    R   L  E++     +D         D   +R + Y I+ AL Y HS  I+
Sbjct: 100 ---VKDPVSRTPALVFEHVNN---TDFKQLYQTLTDY-DIRFYMYEILKALDYCHSMGIM 152

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWM-APEV-VRGECQ 155
           H DVK  NV++      ++L D+G A          V++  R    +   PE+ V  +  
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR----YFKGPELLVDYQMY 208

Query: 156 GPESDVWSLGCTIIEMVTGKP-------------------------AWEDFGANTLSRIG 190
               D+WSLGC +  M+  K                           + D     L    
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP-R 267

Query: 191 FSDELPRFPTQS-------------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           F+D L R   +              S    DFLDK LR +   R +  + ++HP+  +V
Sbjct: 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.7 bits (239), Expect = 1e-22
 Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 35/262 (13%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS------------------ 38
           W   + +G G++G V +AV+R   +  A          D                     
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 39  --YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
             Y      +    L LEY  GG + D     +    E   +   + +++ + YLH   I
Sbjct: 69  KFYGHRREGNIQ-YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC-Q 155
            H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE+++     
Sbjct: 127 THRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 156 GPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSD-ELPRFPTQSSELGRDFLDK 212
               DVWS G  +  M+ G+  W+    +    S        L  +    S      L K
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP-LALLHK 244

Query: 213 CLRREPGERWSCDQLLKHPFLQ 234
            L   P  R +   + K  +  
Sbjct: 245 ILVENPSARITIPDIKKDRWYN 266

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 53/222 (23%), Positives = 84/222 (37%), Gaps = 51/222 (22%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGS 141
           Y I+  LKY+HS +I+H D+K  N+ V  +   +K+ DFG A       T  V      +
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTADEMTGYV------A 191

Query: 142 PLW-MAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT-------------- 185
             W  APE++          D+WS+GC + E++TG+  +   G +               
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP--GTDHIDQLKLILRLVGTP 249

Query: 186 ----LSRIG------FSDELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQL 227
               L +I       +   L + P  +        + L  D L+K L  +  +R +  Q 
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 309

Query: 228 LKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
           L H +       D   VA+       D      E      DE
Sbjct: 310 LAHAYFAQYHDPDDEPVADP-----YDQ---SLESRDLLIDE 343

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 44/160 (27%), Positives = 69/160 (43%), Gaps = 6/160 (3%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           ++  L+YLHS+ IVH D+K  N+L+    + +K++  G A               +GSP 
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 144 WMAPEVVRGECQ--GPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPT 200
           +  PE+  G     G + D+WS G T+  + TG   +E      L   IG        P 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--YAIPG 234

Query: 201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD 240
                  D L   L  EP +R+S  Q+ +H + +   P  
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 9/193 (4%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL 143
           I+ A++Y H   IVH D+K +N+L+  N + VK+ADFG +    ++D   +K    GSP 
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLS--NIMTDGNFLK-TSCGSPN 172

Query: 144 WMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPTQ 201
           + APEV+ G+   GPE DVWS G  +  M+ G+  ++D     L  ++  +  +   P  
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDF 230

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCV-LDWVNSEF 260
            S   +  + + +  +P +R +  ++ + P+     P     + E          V+   
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLG 290

Query: 261 EEEGTSDDEKLEA 273
           E  G S+D  +EA
Sbjct: 291 EAMGFSEDYIVEA 303

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 66/263 (25%), Positives = 112/263 (42%), Gaps = 41/263 (15%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVS---------------- 38
           +V G  +G G+FG V +   +  G   A            D V                 
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 39  ----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
               Y+  +T +    + +EY+ GG + D     +   +E+  R     I+SA+ Y H  
Sbjct: 73  IIKLYQVISTPTDF-FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGE 153
            +VH D+K +NVL+  + +  K+ADFG +    +SD  G  ++   GSP + APEV+ G 
Sbjct: 131 MVVHRDLKPENVLLDAHMN-AKIADFGLS--NMMSD--GEFLRTSCGSPNYAAPEVISGR 185

Query: 154 C-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-SRIGFSDELPRFPTQSSELGRDFLD 211
              GPE D+WS G  +  ++ G   ++D    TL  +I         P   +      L 
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--FYIPEYLNRSVATLLM 243

Query: 212 KCLRREPGERWSCDQLLKHPFLQ 234
             L+ +P +R +   + +H + +
Sbjct: 244 HMLQVDPLKRATIKDIREHEWFK 266

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 47/211 (22%)

Query: 53  LEYLPGGTVSDLATTLNA-----------YADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
           L+Y+ GG   +L T L+            Y  EI L         AL++LH   I++ D+
Sbjct: 138 LDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVL---------ALEHLHKLGIIYRDI 185

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRGECQG 156
           K +N+L+  N   V L DFG + E    +T       R     G+  +MAP++VRG   G
Sbjct: 186 KLENILLDSN-GHVVLTDFGLSKEFVADETE------RAYDFCGTIEYMAPDIVRGGDSG 238

Query: 157 PESDV--WSLGCTIIEMVTGKPAWEDFGANTLSRIGF----SDELPRFPTQSSELGRDFL 210
            +  V  WSLG  + E++TG   +   G               E   +P + S L +D +
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-PYPQEMSALAKDLI 297

Query: 211 DKCLRREPGERWSC-----DQLLKHPFLQSV 236
            + L ++P +R  C     D++ +H F Q +
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 58/269 (21%), Positives = 109/269 (40%), Gaps = 55/269 (20%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSY-----------EAP----- 42
           K +G GSFG V +   + +G+ +A              + +             P     
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 43  -TTSSSCRNLH--LEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIV 97
             +     NL+  +EY+ GG   ++ + L       E   R +   IV   +YLHS +++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGG---EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLI 163

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRG 152
           + D+K +N+L+     ++++ DFG A            ++ R     G+P  +APE++  
Sbjct: 164 YRDLKPENLLIDQQG-YIQVTDFGFAKR----------VKGRTWTLCGTPEALAPEIILS 212

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
           +      D W+LG  I EM  G P +       +     S ++ RFP+  S   +D L  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRN 271

Query: 213 CLRREPGERWSC-----DQLLKHPFLQSV 236
            L+ +  +R+       + +  H +  + 
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 53/275 (19%), Positives = 95/275 (34%), Gaps = 71/275 (25%)

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVS 129
               ++S  Y I+  + YLH+  ++H D+K  N+LV   GP    VK+AD G A      
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179

Query: 130 DTR--GVKIQPRGSP------LWM-APEVVRGECQ-GPESDVWSLGCTIIEMVTGKP--- 176
             R     ++P           W  APE++ G        D+W++GC   E++T +P   
Sbjct: 180 --RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237

Query: 177 -------AWEDFGANTLSRI-------------------GFSDELPRFPTQS-------- 202
                      +  + L RI                     S  +  F   +        
Sbjct: 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK 297

Query: 203 ---------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVL 253
                           L K L  +P +R + +Q ++ P+        ++        C +
Sbjct: 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSD----VFAGCQI 353

Query: 254 DWVNSEFEEEGTSDDEKLEASARERMGKLAGSSGA 288
            +   EF  E   DD+  + + +++ G    +   
Sbjct: 354 PYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTG 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 70/282 (24%), Positives = 113/282 (40%), Gaps = 39/282 (13%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVS---------------- 38
           ++ G  +G G+FG V V      G   A            D V                 
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 39  ----YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
               Y+  +T S    + +EY+ GG + D     N   DE   R     I+S + Y H  
Sbjct: 78  IIKLYQVISTPSDI-FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR-GSPLWMAPEVVRGE 153
            +VH D+K +NVL+  + +  K+ADFG +    +SD  G  ++   GSP + APEV+ G 
Sbjct: 136 MVVHRDLKPENVLLDAHMN-AKIADFGLS--NMMSD--GEFLRTSCGSPNYAAPEVISGR 190

Query: 154 C-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
              GPE D+WS G  +  ++ G   ++D    TL +          P   +      L  
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-YTPQYLNPSVISLLKH 249

Query: 213 CLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLD 254
            L+ +P +R +   + +H + +   P        S    ++D
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMID 291

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 53/242 (21%), Positives = 84/242 (34%), Gaps = 60/242 (24%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGD---------------------VFAYLGDDV 37
            +C+G+G +G V        NVAV  F+                       +  ++  D+
Sbjct: 13  LECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 38  SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSR 94
                T+  S   L L   Y   G++ D    L     D ++       I S L +LH  
Sbjct: 73  -----TSRHSSTQLWLITHYHEMGSLYDY---LQLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 95  --------NIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGSPLW 144
                    I H D+K KN+LV  N     +AD G A     + +          G+  +
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 145 MAPEVVRGECQGPE------SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF 198
           MAPEV+    Q          D+W+ G  + E+     +          +  F D +P  
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED---YKPPFYDVVPND 240

Query: 199 PT 200
           P+
Sbjct: 241 PS 242

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 55/227 (24%), Positives = 80/227 (35%), Gaps = 74/227 (32%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV------------------------GPNS 112
           ++ +   I+ AL YL   ++ H D+K +N+L+                           S
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMV 172
           + +KL DFG A     SD  G  I  R    + APEV+        SD+WS GC + E+ 
Sbjct: 199 TGIKLIDFGCA--TFKSDYHGSIINTR---QYRAPEVILNLGWDVSSDMWSFGCVLAELY 253

Query: 173 TGKP---------------------------------------------AWEDFGANTLS 187
           TG                                               AW +  ++  S
Sbjct: 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS 313

Query: 188 RIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
                  LP +     EL  DFL   L+ +P  R S  +LLKH FL+
Sbjct: 314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 45/224 (20%), Positives = 72/224 (32%), Gaps = 66/224 (29%)

Query: 77  LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV------------------GPNSSFVKLA 118
           +R   Y I  ++ +LHS  + H D+K +N+L                      +  +K+ 
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 119 DFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP-- 176
           DFG+A      +     +  R    + APEV+         DVWS+GC +IE   G    
Sbjct: 180 DFGSA--TYDDEHHSTLVSTR---HYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

Query: 177 --------------------------------------AWEDFGANTLSRIGFSDELPRF 198
                                                  W++  +           L  F
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294

Query: 199 ---PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
                   E   D + K L  +P +R +  + LKHPF   +  S
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 68/313 (21%), Positives = 113/313 (36%), Gaps = 54/313 (17%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDDVS-----------------YEA 41
            K IG G+FG   +  D+   ++ A         + ++V                   E 
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEV 84

Query: 42  PTTSSSCRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             T +     HL    EY  GG + +          E   R     ++S + Y HS  I 
Sbjct: 85  ILTPT-----HLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 98  HCDVKGKNVLVGPNSSF-VKLADFGAAGEATVSDTRGVKIQPR---GSPLWMAPEVVRGE 153
           H D+K +N L+  + +  +K+ DFG       S +  +  QP+   G+P ++APEV+  +
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFG------YSKSSVLHSQPKSTVGTPAYIAPEVLLRQ 192

Query: 154 C-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD------ELPRFPTQSSELG 206
              G  +DVWS G T+  M+ G   +ED       R            +P     S E  
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC- 251

Query: 207 RDFLDKCLRREPGERWSCDQLLKHP-FLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGT 265
              + +    +P  R S  ++  H  FL+++     N     S     +      +    
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQ 311

Query: 266 SDDEKLEASARER 278
              E    + R R
Sbjct: 312 IISEATIPAVRNR 324

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 91.8 bits (229), Expect = 6e-21
 Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 81/282 (28%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDDVSYEAPTTS-----SSCR---- 49
           + +G GSFG V++   R NG  +A              V +   T       S       
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH---TNDERLMLSIVTHPFI 68

Query: 50  -NLH------------LEYLPGGTVSDLATTLNA-----------YADEITLRSHTYCIV 85
             +             ++Y+ GG   +L + L             YA E+ L        
Sbjct: 69  IRMWGTFQDAQQIFMIMDYIEGG---ELFSLLRKSQRFPNPVAKFYAAEVCL-------- 117

Query: 86  SALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR------ 139
            AL+YLHS++I++ D+K +N+L+  N   +K+ DFG A           K  P       
Sbjct: 118 -ALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFA-----------KYVPDVTYTLC 164

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP 199
           G+P ++APEVV  +      D WS G  I EM+ G   + D           + EL RFP
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFP 223

Query: 200 TQSSELGRDFLDKCLRREPGERWSC-----DQLLKHPFLQSV 236
              +E  +D L + + R+  +R        + +  HP+ + V
Sbjct: 224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 51/267 (19%), Positives = 85/267 (31%), Gaps = 84/267 (31%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-FVKLADFGAA---------GEATVSDT 131
           Y ++  +KYLHS  ++H D+K  N+L+  N+   VK+ADFG +                 
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILL--NAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 132 RGVKIQPRGSPLWM----------APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWED 180
                        +          APE++ G  +     D+WSLGC + E++ GKP +  
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP- 232

Query: 181 FGANT------------------LSRIG------FSDELPRFPTQS-------------- 202
            G++T                  +  I         + L                     
Sbjct: 233 -GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291

Query: 203 ----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCV 252
                     +E   D LDK L+  P +R S +  LKHPF+      +     +      
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHII--- 348

Query: 253 LDWVNSEFEEEGTSDDEKLEASARERM 279
                    +      +      R  +
Sbjct: 349 -TI---PINDNVKHSIDDY----RNLV 367

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 53/279 (18%), Positives = 98/279 (35%), Gaps = 57/279 (20%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNG----------DVFA-----------YLGDDV 37
            + IGRG +G V         VAV  F+           +++            ++  D 
Sbjct: 18  LELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS---- 93
              A         L +EY P G++    +     +D ++     + +   L YLH+    
Sbjct: 78  RVTADGRMEYL--LVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRGLAYLHTELPR 133

Query: 94  -----RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSP 142
                  I H D+  +NVLV  + +   ++DFG +   T +       +        G+ 
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192

Query: 143 LWMAPEVVRG-------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL 195
            +MAPEV+ G       E    + D+++LG    E+           +    ++ F  E+
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
              PT   ++      +  R +  E W  + L      +
Sbjct: 253 GNHPT-FEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 89.0 bits (221), Expect = 7e-20
 Identities = 59/271 (21%), Positives = 99/271 (36%), Gaps = 61/271 (22%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGD---------------------VFAYLGDDV 37
            K IG+G +G V         VAV  F                        +  ++  D+
Sbjct: 42  VKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 38  SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSR 94
                  + S   L+L  +Y   G++ D    L +   D  ++    Y  VS L +LH+ 
Sbjct: 102 -----KGTGSWTQLYLITDYHENGSLYDY---LKSTTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 95  N--------IVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGSPLW 144
                    I H D+K KN+LV  N +   +AD G A    +  ++         G+  +
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 145 MAPEVVRGECQGPE------SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF 198
           M PEV+              +D++S G  + E+          G     ++ + D +P  
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC---VSGGIVEEYQLPYHDLVPSD 269

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
           P+   ++      K LR     RWS D+ L+
Sbjct: 270 PS-YEDMREIVCIKKLRPSFPNRWSSDECLR 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 56/271 (20%), Positives = 94/271 (34%), Gaps = 61/271 (22%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGD---------------------VFAYLGDDV 37
            + IG+G FG V         VAV  F+                       +  ++  D 
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 38  SYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSR 94
                 T      L L  +Y   G++ D    LN Y      +        S L +LH  
Sbjct: 107 KDNGTWT-----QLWLVSDYHEHGSLFDY---LNRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 95  --------NIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRGVKIQPRGSPLW 144
                    I H D+K KN+LV  N +   +AD G A   ++             G+  +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 145 MAPEVVRGECQGPE------SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF 198
           MAPEV+              +D++++G    E+          G +   ++ + D +P  
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC---SIGGIHEDYQLPYYDLVPSD 274

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
           P+   E+ +   ++ LR     RW   + L+
Sbjct: 275 PS-VEEMRKVVCEQKLRPNIPNRWQSCEALR 304

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 65/388 (16%), Positives = 113/388 (29%), Gaps = 135/388 (34%)

Query: 8   KCIGRGSFGTVNVAVDRFNG---------DVFAYLGD----------------------- 35
             IGRGS+G V +A D+             +F  L D                       
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 36  DVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYL 91
           D+    P        L++  E       SDL        +  E  +++  Y ++    ++
Sbjct: 92  DLII--PDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA----------GEATVSDTRGVKIQPRGS 141
           H   I+H D+K  N L+  + S VK+ DFG A              + +        +  
Sbjct: 146 HESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204

Query: 142 PLWM----------APEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGAN------ 184
              +          APE++  +       D+WS GC   E++    +  +   N      
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264

Query: 185 --------------------------------------TLSRIG------FSDELPRFPT 200
                                                  L  I       +    P    
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324

Query: 201 QS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV-SPSDANTVAESSPRC 251
            +        S+ G + L+  L+  P +R + DQ L HP+L+ V          E+    
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL-----ENFSTK 379

Query: 252 VLDWVNSEFEEEGTSDDEKLEASARERM 279
            +      F++     + +L    R   
Sbjct: 380 KIIL---PFDDWMVLSETQL----RYIF 400

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 8/103 (7%)

Query: 77  LRSHTYCIVSALKYLHSR--NIVHCDVKGKNVL-VGPNSSFVKLADFGAAGEATVSDTRG 133
            R     + +AL +L +   +I+HCD+K +N+L   P  S +K+ DFG++    +     
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIY 216

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKP 176
             IQ R    + +PEV+ G       D+WSLGC ++EM TG+P
Sbjct: 217 QYIQSR---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 7/31 (22%), Positives = 13/31 (41%)

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
           D + + L  +P  R      L+H F +  + 
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 70/400 (17%), Positives = 111/400 (27%), Gaps = 151/400 (37%)

Query: 8   KCIGRGSFGTVNVAVDRFNG---------DVFAYLGD----------------------- 35
             IG GS+G V  A D+             VF  L D                       
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118

Query: 36  DVSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYAD--EITLRSHTYCIVSALKYL 91
           D+    P        L++  E       SD            E+ +++  Y ++  +KY+
Sbjct: 119 DIVI--PKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYV 172

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---------------GEATVSDTRGVKI 136
           HS  I+H D+K  N LV  + S VK+ DFG A                            
Sbjct: 173 HSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231

Query: 137 QPRGSPLWM----------APEVVRGECQ-GPESDVWSLGC------------------- 166
             +     +          APE++  +       DVWS+GC                   
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

Query: 167 ---------------------------------TIIEMVTGKPAWEDFGANTLSRIG--- 190
                                             +I  + G P+ ED     +  +    
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED-----IEALEKED 346

Query: 191 ---FSDELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS 239
              +    P+             S      L + L   P +R + ++ L HPF + V  +
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406

Query: 240 DANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEASARERM 279
           +  T A          V   F +    D+ +L    R   
Sbjct: 407 EVETNATEK-------VRLPFNDWMNMDEPQL----RYAF 435

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 46/255 (18%), Positives = 75/255 (29%), Gaps = 101/255 (39%)

Query: 77  LRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFV-------------------- 115
           ++     ++  L YLH++  I+H D+K +N+L+  N  ++                    
Sbjct: 148 VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 116 ----------------------------KLADFGAAGEATVSDTRGVKIQPRGSPLWMAP 147
                                       K+AD G A    V       IQ R      + 
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQY---RSL 262

Query: 148 EVVRGECQGPESDVWSLGCTIIEMVTGKP------------------------------- 176
           EV+ G      +D+WS  C   E+ TG                                 
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322

Query: 177 ------AWEDFGAN-------TLSRIGFSDELP---RFPTQSSELGRDFLDKCLRREPGE 220
                 + E F           L   G  + L     +  + +    DFL   L   P +
Sbjct: 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382

Query: 221 RWSCDQLLKHPFLQS 235
           R +  + L+HP+L S
Sbjct: 383 RATAAECLRHPWLNS 397

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 41/141 (29%), Positives = 61/141 (43%), Gaps = 8/141 (5%)

Query: 54  EYLPGGTVSDLATTLNAYADEIT---LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP 110
           EYLP G    L   L  + + I    L  +T  I   ++YL ++  +H D+  +N+LV  
Sbjct: 93  EYLPYG---SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 149

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTII 169
            +  VK+ DFG               +P  SP+ W APE +        SDVWS G  + 
Sbjct: 150 ENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208

Query: 170 EMVTGKPAWEDFGANTLSRIG 190
           E+ T     +   A  +  IG
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIG 229

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 8/141 (5%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           EYLP G    L   L  + + I           I   ++YL ++  +H D+  +N+LV  
Sbjct: 124 EYLPYG---SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTII 169
            +  VK+ DFG               +P  SP+ W APE +        SDVWS G  + 
Sbjct: 181 ENR-VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239

Query: 170 EMVTGKPAWEDFGANTLSRIG 190
           E+ T     +   A  +  IG
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIG 260

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 41/124 (33%), Positives = 58/124 (46%), Gaps = 8/124 (6%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           EYLP G    L   L  +   +           I   ++YL SR  VH D+  +N+LV  
Sbjct: 106 EYLPSG---CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE- 161

Query: 111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTII 169
           + + VK+ADFG A    +     V  +P  SP+ W APE +       +SDVWS G  + 
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLY 221

Query: 170 EMVT 173
           E+ T
Sbjct: 222 ELFT 225

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 24/180 (13%), Positives = 55/180 (30%), Gaps = 45/180 (25%)

Query: 54  EYLPGGTVSDLATT--LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN 111
           E++ GG++ ++A T      A           + +A    H   +         V V  +
Sbjct: 111 EWIRGGSLQEVADTSPSPVGAIRAMQS-----LAAAADAAHRAGVALSIDHPSRVRVSID 165

Query: 112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEM 171
              V LA      +A                              P+ D+  +G ++  +
Sbjct: 166 GD-VVLAYPATMPDAN-----------------------------PQDDIRGIGASLYAL 195

Query: 172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD-------FLDKCLRREPGERWSC 224
           +  +    + G  +       D   + P + +++ RD          + ++ + G R + 
Sbjct: 196 LVNRWPLPEAGVRSGLAPAERDTAGQ-PIEPADIDRDIPFQISAVAARSVQGDGGIRSAS 254

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 64/264 (24%), Positives = 94/264 (35%), Gaps = 36/264 (13%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV-------FAYLGDDVSYEAPT-TSSSCRNL-HL---- 53
              +G+G FG V +        V            +    EA          L  L    
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 54  ---------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    EY+  G++ D L      Y     L      I S + Y+   N VH D++ 
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSD---TRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
            N+LVG N    K+ADFG A     ++    +G K   +    W APE         +SD
Sbjct: 309 ANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGRFTIKSD 363

Query: 161 VWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
           VWS G  + E+ T    P         L ++     +P  P +  E   D + +C R+EP
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEP 422

Query: 219 GERWSCDQLLKH--PFLQSVSPSD 240
            ER + + L      +  S  P  
Sbjct: 423 EERPTFEYLQAFLEDYFTSTEPQY 446

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 72.6 bits (178), Expect = 5e-14
 Identities = 64/264 (24%), Positives = 94/264 (35%), Gaps = 36/264 (13%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV-------FAYLGDDVSYEAPT-TSSSCRNL-HL---- 53
              +G+G FG V +        V            +    EA          L  L    
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 54  ---------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                    EY+  G++ D L      Y     L      I S + Y+   N VH D++ 
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSD---TRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
            N+LVG N    K+ADFG A     ++    +G K   +    W APE         +SD
Sbjct: 392 ANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGRFTIKSD 446

Query: 161 VWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
           VWS G  + E+ T    P         L ++     +P  P +  E   D + +C R+EP
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEP 505

Query: 219 GERWSCDQLLKH--PFLQSVSPSD 240
            ER + + L      +  S  P  
Sbjct: 506 EERPTFEYLQAFLEDYFTSTEPQY 529

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 52/202 (25%), Positives = 77/202 (38%), Gaps = 44/202 (21%)

Query: 7   GKCIGRGSFGTV-------------NVAVDRFNGDVFAYLGDDVSYEAPTTSS-SCRNL- 51
           G+CIG G FG V              VA+          + +    EA T       ++ 
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 52  HL-------------EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRN 95
            L             E    G   +L + L      + L S       + +AL YL S+ 
Sbjct: 455 KLIGVITENPVWIIMELCTLG---ELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVR 151
            VH D+  +NVLV  ++  VKL DFG +    ++T       K+     P+ WMAPE + 
Sbjct: 512 FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKL-----PIKWMAPESIN 565

Query: 152 GECQGPESDVWSLGCTIIEMVT 173
                  SDVW  G  + E++ 
Sbjct: 566 FRRFTSASDVWMFGVCMWEILM 587

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 37/130 (28%), Positives = 55/130 (42%), Gaps = 18/130 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            EY+  G    L T L  +  + T+         + + ++YL     VH D+  +NVLV 
Sbjct: 129 TEYMENG---SLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD 185

Query: 110 PNSSFVKLADFGAA-----GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWS 163
            N    K++DFG +            T G KI     P+ W APE +        SDVWS
Sbjct: 186 SNLV-CKVSDFGLSRVLEDDPDAAYTTTGGKI-----PIRWTAPEAIAFRTFSSASDVWS 239

Query: 164 LGCTIIEMVT 173
            G  + E++ 
Sbjct: 240 FGVVMWEVLA 249

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 50/241 (20%), Positives = 84/241 (34%), Gaps = 30/241 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            +YLP G    L   +  +   +  +        I   + YL    +VH ++  +NVL+ 
Sbjct: 93  TQYLPLG---SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK 149

Query: 110 PNSSFVKLADFGAAGEATVSD----TRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSL 164
             S  V++ADFG A      D        K      P+ WMA E +       +SDVWS 
Sbjct: 150 SPSQ-VQVADFGVADLLPPDDKQLLYSEAKT-----PIKWMALESIHFGKYTHQSDVWSY 203

Query: 165 GCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER- 221
           G T+ E++T   +P      A     +   + L +    + ++    + KC   +   R 
Sbjct: 204 GVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV-YMVMVKCWMIDENIRP 262

Query: 222 ------WSCDQLLKHPFLQSVSPSDANTVAESSP---RCVLDWVNSEFEEEGTSDDEKLE 272
                     ++ + P    V   ++       P         +     E     D  LE
Sbjct: 263 TFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLE 322

Query: 273 A 273
           A
Sbjct: 323 A 323

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 54/215 (25%), Positives = 80/215 (37%), Gaps = 50/215 (23%)

Query: 5   VRGKCIGRGSFGTV--------------NVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRN 50
            + K +G G+FGTV               VA+             ++  EA    +S  N
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDN 76

Query: 51  LHL----------------EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYL 91
            H+                + +P G    L   +  + D I  +        I   + YL
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD----TRGVKIQPRGSPL-WMA 146
             R +VH D+  +NVLV      VK+ DFG A      +      G K+     P+ WMA
Sbjct: 134 EDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMA 187

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWE 179
            E +       +SDVWS G T+ E++T   KP   
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 51/199 (25%), Positives = 78/199 (39%), Gaps = 24/199 (12%)

Query: 54  EYLPGGTVSDLATTLNAYADEITLRS-HTYC--IVSALKYLHSRNIVHCDVKGKNVLVGP 110
           E  P G    L   L  +     L +   Y   +   + YL S+  +H D+  +N+L+  
Sbjct: 100 ELAPLG---SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 156

Query: 111 NSSFVKLADFGAA-----GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSL 164
               VK+ DFG        +         K+     P  W APE ++       SD W  
Sbjct: 157 R-DLVKIGDFGLMRALPQNDDHYVMQEHRKV-----PFAWCAPESLKTRTFSHASDTWMF 210

Query: 165 GCTIIEMVT-GKPAWEDF-GANTLSRIGFSDE-LPRFPTQSSELGRDFLDKCLRREPGER 221
           G T+ EM T G+  W    G+  L +I    E LPR P    +   + + +C   +P +R
Sbjct: 211 GVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 269

Query: 222 WSCDQLLKHPFLQSVSPSD 240
            +   L    FL    P+D
Sbjct: 270 PTFVAL--RDFLLEAQPTD 286

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 54/194 (27%), Positives = 81/194 (41%), Gaps = 37/194 (19%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGDVFAYLGDDVSYEAPT-TSSSCRNL-HL--- 53
            + IG+G FG V         VAV     D  A        EA   T     NL  L   
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 54  ------------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
                       EY+  G++ D L +   +      L   +  +  A++YL   N VH D
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314

Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPES 159
           +  +NVLV  ++   K++DFG   EA+ +     K+     P+ W APE +R +    +S
Sbjct: 315 LAARNVLVSEDNV-AKVSDFGLTKEASSTQD-TGKL-----PVKWTAPEALREKKFSTKS 367

Query: 160 DVWSLGCTIIEMVT 173
           DVWS G  + E+ +
Sbjct: 368 DVWSFGILLWEIYS 381

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 55/205 (26%), Positives = 74/205 (36%), Gaps = 40/205 (19%)

Query: 5   VRGKCIGRGSFGTV--------------NVAVDRFNGDVFAYLGDD-------------- 36
            R + +G G FG V               VAV     +       D              
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 37  --VSYEAPTTSSSCRNLHL--EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALK 89
             V Y+   T      + L  E+LP G    L   L    ++I L+        I   + 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSG---SLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 90  YLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPE 148
           YL SR  VH D+  +NVLV  +   VK+ DFG                 R SP+ W APE
Sbjct: 141 YLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 149 VVRGECQGPESDVWSLGCTIIEMVT 173
            +        SDVWS G T+ E++T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 52/226 (23%), Positives = 82/226 (36%), Gaps = 50/226 (22%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           G+ IG GSFG + +  D   G+  A     +  E     +    LH+E            
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVA-----IKLEC--VKTKHPQLHIESKIYKMMQGGVG 66

Query: 56  -------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                              L G ++ DL    +      T+      ++S ++Y+HS+N 
Sbjct: 67  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126

Query: 97  VHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMAPE 148
           +H DVK  N L+G     + V + DFG A +   + T    I  R      G+  + +  
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-HQHIPYRENKNLTGTARYASIN 185

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS----RIG 190
              G  Q    D+ SLG  ++    G   W+   A T      RI 
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 18/130 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            EY+  G    L + L  +  + T+         I S +KYL     VH D+  +N+L+ 
Sbjct: 125 TEYMENG---SLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN 181

Query: 110 PNSSFVKLADFGAA-----GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWS 163
            N    K++DFG              TRG KI     P+ W +PE +        SDVWS
Sbjct: 182 SNLV-CKVSDFGLGRVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWS 235

Query: 164 LGCTIIEMVT 173
            G  + E+++
Sbjct: 236 YGIVLWEVMS 245

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 39/130 (30%), Positives = 56/130 (43%), Gaps = 18/130 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            EY+  G    L   L     E ++         I + +KYL + N VH D+  +N+LV 
Sbjct: 125 TEYMENG---ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181

Query: 110 PNSSFVKLADFGAA-----GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWS 163
            N    K++DFG +            T G KI     P+ W APE +        SDVWS
Sbjct: 182 SN-LVCKVSDFGLSRVLEDDPEATYTTSGGKI-----PIRWTAPEAISYRKFTSASDVWS 235

Query: 164 LGCTIIEMVT 173
            G  + E++T
Sbjct: 236 FGIVMWEVMT 245

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 68.4 bits (168), Expect = 3e-13
 Identities = 39/128 (30%), Positives = 57/128 (44%), Gaps = 16/128 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
           +E    G   +L + L      + L S       + +AL YL S+  VH D+  +NVLV 
Sbjct: 94  MELCTLG---ELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 150

Query: 110 PNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLG 165
            N   VKL DFG +    ++T       K+     P+ WMAPE +        SDVW  G
Sbjct: 151 SNDC-VKLGDFGLSRYMEDSTYYKASKGKL-----PIKWMAPESINFRRFTSASDVWMFG 204

Query: 166 CTIIEMVT 173
             + E++ 
Sbjct: 205 VCMWEILM 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 43/217 (19%), Positives = 79/217 (36%), Gaps = 46/217 (21%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY----------- 55
           G+ IG GSFG + +  +    +  A     +  E     +    L  E            
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVA-----IKLEN--VKTKHPQLLYESKIYRILQGGTG 64

Query: 56  -------------------LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                              L G ++ DL    +      T+      +++ ++++HS++ 
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124

Query: 97  VHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLWMAPE 148
           +H D+K  N L+G    ++ V + DFG A +   + T    I  R      G+  + +  
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST-HQHIPYRENKNLTGTARYASVN 183

Query: 149 VVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
              G  Q    D+ SLG  ++  + G   W+   A T
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 68.0 bits (167), Expect = 4e-13
 Identities = 46/202 (22%), Positives = 72/202 (35%), Gaps = 44/202 (21%)

Query: 7   GKCIGRGSFGTV-------------NVAVDRFNGDVFAYLGDDVSYEAPTTSS-SCRNL- 51
            + +G G FG V             NVAV     D      +    EA    +    ++ 
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 52  HL-------------EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRN 95
            L             E  P G   +L   L    + + + +       I  A+ YL S N
Sbjct: 77  KLIGIIEEEPTWIIMELYPYG---ELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVR 151
            VH D+  +N+LV      VKL DFG +    +         ++     P+ WM+PE + 
Sbjct: 134 CVHRDIAVRNILVASPEC-VKLGDFGLSRYIEDEDYYKASVTRL-----PIKWMSPESIN 187

Query: 152 GECQGPESDVWSLGCTIIEMVT 173
                  SDVW     + E+++
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 51/204 (25%), Positives = 75/204 (36%), Gaps = 49/204 (24%)

Query: 7   GKCIGRGSFGTV----------NVAVDRFNGDVFAYLGDDVSYEAPT-TSSSCRNL-HL- 53
           G+ IGRG+FG V           VAV      +   L      EA      S  N+  L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 54  -------------EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIV 97
                        E + GG   D  T L      + +++         + ++YL S+  +
Sbjct: 179 GVCTQKQPIYIVMELVQGG---DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VKIQPRGSPLWMAPEV 149
           H D+  +N LV   +  +K++DFG +     G    S       VK        W APE 
Sbjct: 236 HRDLAARNCLVTEKNV-LKISDFGMSREEADGVYAASGGLRQVPVK--------WTAPEA 286

Query: 150 VRGECQGPESDVWSLGCTIIEMVT 173
           +       ESDVWS G  + E  +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFS 310

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 67.6 bits (166), Expect = 6e-13
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 12/93 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG---VKIQPRG 140
           +  A++YL   N VH D+  +NVLV  ++   K++DFG   EA+ +   G   VK     
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQDTGKLPVK----- 179

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
              W APE +R +    +SDVWS G  + E+ +
Sbjct: 180 ---WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 37/130 (28%), Positives = 57/130 (43%), Gaps = 18/130 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
           +E   GG    L   L    +EI + +       +   +KYL  +N VH D+  +NVL+ 
Sbjct: 88  MEMAGGG---PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV 144

Query: 110 PNSSFVKLADFG-----AAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWS 163
               + K++DFG      A ++  +     K      PL W APE +        SDVWS
Sbjct: 145 NR-HYAKISDFGLSKALGADDSYYTARSAGKW-----PLKWYAPECINFRKFSSRSDVWS 198

Query: 164 LGCTIIEMVT 173
            G T+ E ++
Sbjct: 199 YGVTMWEALS 208

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 54/215 (25%), Positives = 80/215 (37%), Gaps = 50/215 (23%)

Query: 5   VRGKCIGRGSFGTV--------------NVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRN 50
            + K +G G+FGTV               VA+             ++  EA    +S  N
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDN 76

Query: 51  LHL----------------EYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYL 91
            H+                + +P G    L   +  + D I  +        I   + YL
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD----TRGVKIQPRGSPL-WMA 146
             R +VH D+  +NVLV      VK+ DFG A      +      G K+     P+ WMA
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKV-----PIKWMA 187

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWE 179
            E +       +SDVWS G T+ E++T   KP   
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 35/195 (17%)

Query: 7   GKCIGRGSFGTV---------NVAVDRFNGDVFAYLGDDVSYEAPT-TSSSCRNL-HL-- 53
            K +G G FG V          VAV        +   +    EA    +     L  L  
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHA 250

Query: 54  -----------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                      E++  G++ D L +   +      L   +  I   + ++  RN +H D+
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310

Query: 102 KGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           +  N+LV  +    K+ADFG A    +   +   G K   +    W APE +       +
Sbjct: 311 RAANILVSASLV-CKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEAINFGSFTIK 365

Query: 159 SDVWSLGCTIIEMVT 173
           SDVWS G  ++E+VT
Sbjct: 366 SDVWSFGILLMEIVT 380

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 13/164 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRG 140
           I SA++YL  +N +H ++  +N LVG N   VK+ADFG +      T +   G K   + 
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIK- 384

Query: 141 SPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT--GKPAWEDFGANTLSRIGFSDELPRF 198
              W APE +       +SDVW+ G  + E+ T    P      +     +     + R 
Sbjct: 385 ---WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER- 440

Query: 199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKH--PFLQSVSPSD 240
           P    E   + +  C +  P +R S  ++ +      Q  S SD
Sbjct: 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 38/122 (31%), Positives = 56/122 (45%), Gaps = 6/122 (4%)

Query: 54  EYLPGGTVSDLATTLNAY-ADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS 112
           EY+P G    L   L  +      L      I   + YLH+++ +H D+  +NVL+  N 
Sbjct: 115 EYVPLG---SLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD-ND 170

Query: 113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEM 171
             VK+ DFG A             +   SP+ W APE ++       SDVWS G T+ E+
Sbjct: 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

Query: 172 VT 173
           +T
Sbjct: 231 LT 232

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 37/130 (28%), Positives = 58/130 (44%), Gaps = 18/130 (13%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
           +E   GG    L   L    +EI + +       +   +KYL  +N VH ++  +NVL+ 
Sbjct: 414 MEMAGGG---PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV 470

Query: 110 PNSSFVKLADFG-----AAGEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWS 163
            N  + K++DFG      A ++  +     K      PL W APE +        SDVWS
Sbjct: 471 -NRHYAKISDFGLSKALGADDSYYTARSAGKW-----PLKWYAPECINFRKFSSRSDVWS 524

Query: 164 LGCTIIEMVT 173
            G T+ E ++
Sbjct: 525 YGVTMWEALS 534

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 16/128 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            EY+  G    L   L ++   +           +   + +L S   +H D+  +N LV 
Sbjct: 82  TEYISNG---CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD 138

Query: 110 PNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLG 165
            +   VK++DFG      +     + G K      P+ W APEV        +SDVW+ G
Sbjct: 139 RD-LCVKVSDFGMTRYVLDDQYVSSVGTKF-----PVKWSAPEVFHYFKYSSKSDVWAFG 192

Query: 166 CTIIEMVT 173
             + E+ +
Sbjct: 193 ILMWEVFS 200

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 47/221 (21%), Positives = 81/221 (36%), Gaps = 52/221 (23%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY-----LPGGT- 60
           G+ IG GSFG +    +  N    A     + +E     S    L  EY     L G T 
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVA-----IKFEP--RRSDAPQLRDEYRTYKLLAGCTG 67

Query: 61  ----------------VSD-----LATTLNAYADEITLRSHTYC-----IVSALKYLHSR 94
                           V D     L   L+    + +++  T       +++ ++ +H +
Sbjct: 68  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEK 125

Query: 95  NIVHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR------GSPLW 144
           ++V+ D+K  N L+G     N++ + + DFG         T    I  R      G+  +
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-KQHIPYREKKNLSGTARY 184

Query: 145 MAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
           M+     G  Q    D+ +LG   +  + G   W+   A T
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 225

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 16/128 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            E++  G    L+  L          +       +   + YL    ++H D+  +N LVG
Sbjct: 82  TEFMEHG---CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 138

Query: 110 PNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLG 165
            N   +K++DFG      +   + + G K      P+ W +PEV        +SDVWS G
Sbjct: 139 EN-QVIKVSDFGMTRFVLDDQYTSSTGTKF-----PVKWASPEVFSFSRYSSKSDVWSFG 192

Query: 166 CTIIEMVT 173
             + E+ +
Sbjct: 193 VLMWEVFS 200

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 17/153 (11%)

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEIT---LRSHTYCIVSALKYLHSRNIVH 98
            ++ SS  +  +E      V +     + Y D +T   L  +++ +   +++L SR  +H
Sbjct: 157 TSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 216

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL---WMAPEVVRGECQ 155
            D+  +N+L+   +  VK+ DFG A +          ++   + L   WMAPE +     
Sbjct: 217 RDLAARNILLSEKNV-VKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVY 272

Query: 156 GPESDVWSLGCTIIEMVT-------GKPAWEDF 181
             +SDVWS G  + E+ +       G    E+F
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 29/96 (30%), Positives = 42/96 (43%), Gaps = 12/96 (12%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG-----AAGEATVSDTRGVKIQP 138
           +   +KYL   N VH D+  +NVL+     + K++DFG      A E         K   
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKW-- 182

Query: 139 RGSPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
              P+ W APE +       +SDVWS G  + E  +
Sbjct: 183 ---PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 19/131 (14%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLR---SHTYCIVSALKYLHSRNIVHCDVKGKNVLVG 109
           L Y+  G   DL   +       T++        +   +K+L S+  VH D+  +N ++ 
Sbjct: 170 LPYMKHG---DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 226

Query: 110 PNSSFVKLADFGAA------GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVW 162
              + VK+ADFG A         +V +  G K+     P+ WMA E ++ +    +SDVW
Sbjct: 227 EKFT-VKVADFGLARDMYDKEFDSVHNKTGAKL-----PVKWMALESLQTQKFTTKSDVW 280

Query: 163 SLGCTIIEMVT 173
           S G  + E++T
Sbjct: 281 SFGVLLWELMT 291

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 30/133 (22%), Positives = 56/133 (42%), Gaps = 22/133 (16%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLV- 108
            E++  G    L T L    + I +         + +A+ +L    ++H +V  KN+L+ 
Sbjct: 91  QEFVKFG---SLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI 147

Query: 109 ------GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL-WMAPEVVR-GECQGPESD 160
                   N  F+KL+D G +   TV     ++       + W+ PE +   +     +D
Sbjct: 148 REEDRKTGNPPFIKLSDPGIS--ITVLPKDILQE-----RIPWVPPECIENPKNLNLATD 200

Query: 161 VWSLGCTIIEMVT 173
            WS G T+ E+ +
Sbjct: 201 KWSFGTTLWEICS 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 53/198 (26%), Positives = 74/198 (37%), Gaps = 41/198 (20%)

Query: 7   GKCIGRGSFGTV---------NVAVDRFNGDVFAYLGDDVSYEAPT-TSSSCRNL-HL-- 53
            + +G G FG V          VAV        +   D    EA        + L  L  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 54  -----------EYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                      EY+  G++ D L T          L      I   + ++  RN +H D+
Sbjct: 76  VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135

Query: 102 KGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQ 155
           +  N+LV    S  K+ADFG A      E T  +  G K      P+ W APE +     
Sbjct: 136 RAANILVSDTLS-CKIADFGLARLIEDNEYTARE--GAKF-----PIKWTAPEAINYGTF 187

Query: 156 GPESDVWSLGCTIIEMVT 173
             +SDVWS G  + E+VT
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 19/131 (14%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
           L Y+  G   DL   + +     T++        +   ++YL  +  VH D+  +N ++ 
Sbjct: 102 LPYMCHG---DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD 158

Query: 110 PNSSFVKLADFGAA-----GEAT-VSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVW 162
            + + VK+ADFG A      E   V   R  ++     P+ W A E ++      +SDVW
Sbjct: 159 ESFT-VKVADFGLARDILDREYYSVQQHRHARL-----PVKWTALESLQTYRFTTKSDVW 212

Query: 163 SLGCTIIEMVT 173
           S G  + E++T
Sbjct: 213 SFGVLLWELLT 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 36/131 (27%), Positives = 60/131 (45%), Gaps = 19/131 (14%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
           L Y+  G   DL   +       T++        +   +KYL S+  VH D+  +N ++ 
Sbjct: 106 LPYMKHG---DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD 162

Query: 110 PNSSFVKLADFGAAGEATVSD------TRGVKIQPRGSPL-WMAPEVVRGECQGPESDVW 162
              + VK+ADFG A +    +        G K+     P+ WMA E ++ +    +SDVW
Sbjct: 163 EKFT-VKVADFGLARDMYDKEYYSVHNKTGAKL-----PVKWMALESLQTQKFTTKSDVW 216

Query: 163 SLGCTIIEMVT 173
           S G  + E++T
Sbjct: 217 SFGVLLWELMT 227

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 5/98 (5%)

Query: 83  CIVSA--LKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPR 139
           CI +A  L YLH+R I+H DVK  N+L+  + +FV K+ DFG + + T  D   +    +
Sbjct: 145 CIGAARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISKKGTELDQTHLSTVVK 202

Query: 140 GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPA 177
           G+  ++ PE         +SDV+S G  + E++  + A
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 62.6 bits (153), Expect = 3e-11
 Identities = 31/128 (24%), Positives = 54/128 (42%), Gaps = 16/128 (12%)

Query: 53  LEYLPGGTVSDLATTLNAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGKNVLVG 109
            EY+  G    L   L         +        +  A++YL S+  +H D+  +N LV 
Sbjct: 98  TEYMANG---CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154

Query: 110 PNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPL-WMAPEVVRGECQGPESDVWSLG 165
                VK++DFG +    +   + + G K      P+ W  PEV+       +SD+W+ G
Sbjct: 155 DQGV-VKVSDFGLSRYVLDDEYTSSVGSKF-----PVRWSPPEVLMYSKFSSKSDIWAFG 208

Query: 166 CTIIEMVT 173
             + E+ +
Sbjct: 209 VLMWEIYS 216

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 10/94 (10%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRG 140
           I SA++YL  +N +H D+  +N LVG N   VK+ADFG +      T +   G K     
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKF---- 174

Query: 141 SPL-WMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
            P+ W APE +       +SDVW+ G  + E+ T
Sbjct: 175 -PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 36/138 (26%), Positives = 62/138 (44%), Gaps = 20/138 (14%)

Query: 47  SCRNLHLEYLPGGTVSDLATTLNAYADEITLR---SHTYCIVSALKYLHSRNIVHCDVKG 103
             R +   YL  G   + ++  +     +T+    S  + I   ++YL    +VH D+  
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178

Query: 104 KNVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VKIQPRGSPLWMAPEVVRGECQ 155
           +N+LV      +K++DFG +      ++ V  ++G   VK        WMA E +     
Sbjct: 179 RNILVAEGRK-MKISDFGLSRDVYEEDSYVKRSQGRIPVK--------WMAIESLFDHIY 229

Query: 156 GPESDVWSLGCTIIEMVT 173
             +SDVWS G  + E+VT
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 28/126 (22%), Positives = 48/126 (38%), Gaps = 12/126 (9%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVSDTRGVKIQPR--- 139
           I+  L+Y+H    VH D+K  N+L+   N   V L D+G A                   
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH-KAYAADPKR 219

Query: 140 ---GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS----RIGFS 192
              G+  + + +   G       D+  LG  +I+ +TG   WED   +       +I + 
Sbjct: 220 CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR 279

Query: 193 DELPRF 198
           + +   
Sbjct: 280 ENIASL 285

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 60.7 bits (148), Expect = 2e-10
 Identities = 31/101 (30%), Positives = 44/101 (43%), Gaps = 23/101 (22%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VK 135
           I S + YL S++ VH D+  +N LVG N   VK+ DFG +      +           ++
Sbjct: 142 IASGMVYLASQHFVHRDLATRNCLVGANLL-VKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200

Query: 136 IQPRGSPLWMAPEVVRGECQG---PESDVWSLGCTIIEMVT 173
                   WM PE +          ESDVWS G  + E+ T
Sbjct: 201 --------WMPPESI---MYRKFTTESDVWSFGVILWEIFT 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 17/100 (17%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG--- 133
           Y +   ++YL S+  +H D+  +NVLV  ++  +K+ADFG A      +     T G   
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYYKKTTNGRLP 256

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           VK        WMAPE +       +SDVWS G  + E+ T
Sbjct: 257 VK--------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 23/101 (22%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VK 135
           I   + YL++   VH D+  +N +V  + + VK+ DFG        +      +G   V+
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 136 IQPRGSPLWMAPEVVRGECQG---PESDVWSLGCTIIEMVT 173
                   WM+PE +     G     SDVWS G  + E+ T
Sbjct: 206 --------WMSPESL---KDGVFTTYSDVWSFGVVLWEIAT 235

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 4/91 (4%)

Query: 88  LKYLHSRNIVHCDVKGKNVLVGPNSSFV-KLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
           + +LH  + +H D+K  N+L+     F  K++DFG A  +       +  +  G+  +MA
Sbjct: 146 INFLHENHHIHRDIKSANILLDEA--FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPA 177
           PE +RGE   P+SD++S G  ++E++TG PA
Sbjct: 204 PEALRGEIT-PKSDIYSFGVVLLEIITGLPA 233

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 34/134 (25%), Positives = 59/134 (44%), Gaps = 22/134 (16%)

Query: 53  LEYLPGGTVSDLATTL-----NAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKGK 104
           L ++  G   DL   L           + L++       I   ++YL SRN +H D+  +
Sbjct: 110 LPFMKHG---DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAAR 166

Query: 105 NVLVGPNSSFVKLADFGAAGEATVSD----TRGVKIQPRGSPL-WMAPEVVRGECQGPES 159
           N ++  + + V +ADFG + +    D        K+     P+ W+A E +        S
Sbjct: 167 NCMLAEDMT-VCVADFGLSRKIYSGDYYRQGCASKL-----PVKWLALESLADNLYTVHS 220

Query: 160 DVWSLGCTIIEMVT 173
           DVW+ G T+ E++T
Sbjct: 221 DVWAFGVTMWEIMT 234

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 51/229 (22%), Positives = 84/229 (36%), Gaps = 68/229 (29%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEAPTTSSSCRNLHLEY-----LPGGT- 60
           GK IG G+FG + +  + +  +  A     +  E     S    LHLEY     L  G  
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVA-----IKLEP--MKSRAPQLHLEYRFYKQLGSGDG 66

Query: 61  ----------------VSDL------------------ATTLNAYADEITLRSHTYCIVS 86
                           V +L                   T L   A ++         +S
Sbjct: 67  IPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLM-IAIQL---------IS 116

Query: 87  ALKYLHSRNIVHCDVKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR--- 139
            ++Y+HS+N+++ DVK +N L+G         + + DF  A E    +T    I  R   
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET-KKHIPYREHK 175

Query: 140 ---GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
              G+  +M+     G+ Q    D+ +LG   +  + G   W+   A+T
Sbjct: 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 36/137 (26%), Positives = 57/137 (41%), Gaps = 28/137 (20%)

Query: 53  LEYLPGGTVSDLATTLNAYADE--------ITLRSHTYCIVSALKYLHSRNIVHCDVKGK 104
           L ++  G   DL T L     E         TL      I   ++YL +RN +H D+  +
Sbjct: 120 LPFMKYG---DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAAR 176

Query: 105 NVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VKIQPRGSPLWMAPEVVRGECQG 156
           N ++  + + V +ADFG +     G+           VK        W+A E +      
Sbjct: 177 NCMLRDDMT-VCVADFGLSKKIYSGDYYRQGRIAKMPVK--------WIAIESLADRVYT 227

Query: 157 PESDVWSLGCTIIEMVT 173
            +SDVW+ G T+ E+ T
Sbjct: 228 SKSDVWAFGVTMWEIAT 244

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 59.6 bits (145), Expect = 4e-10
 Identities = 32/115 (27%), Positives = 46/115 (40%), Gaps = 24/115 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG--- 133
           Y +   + +L S+N +H D+  +N+L+       K+ DFG A         V        
Sbjct: 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRI-TKICDFGLARDIKNDSNYVVKGNARLP 210

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-------GKPAWEDF 181
           VK        WMAPE +       ESDVWS G  + E+ +       G P    F
Sbjct: 211 VK--------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 28/101 (27%), Positives = 42/101 (41%), Gaps = 23/101 (22%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VK 135
           + + + YL   + VH D+  +N LVG     VK+ DFG +      +      R    ++
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLV-VKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 136 IQPRGSPLWMAPEVVRGECQG---PESDVWSLGCTIIEMVT 173
                   WM PE +          ESDVWS G  + E+ T
Sbjct: 226 --------WMPPESI---LYRKFTTESDVWSFGVVLWEIFT 255

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 34/141 (24%), Positives = 60/141 (42%), Gaps = 26/141 (18%)

Query: 53  LEYLPGG------------TVSDLATTLNAYADEITLR---SHTYCIVSALKYLHSRNIV 97
           +E+   G             V       + Y D +TL     +++ +   +++L SR  +
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD----TRGVKIQPRGSPL-WMAPEVVRG 152
           H D+  +N+L+   +  VK+ DFG A +             ++     PL WMAPE +  
Sbjct: 171 HRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPETIFD 224

Query: 153 ECQGPESDVWSLGCTIIEMVT 173
                +SDVWS G  + E+ +
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFS 245

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 23/103 (22%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-----TRG--- 133
             + + + YL  R  VH D+  +N LVG N   VK+ADFG +     +D           
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYYKADGNDAIP 239

Query: 134 VKIQPRGSPLWMAPEVVRGECQG---PESDVWSLGCTIIEMVT 173
           ++        WM PE +          ESDVW+ G  + E+ +
Sbjct: 240 IR--------WMPPESI---FYNRYTTESDVWAYGVVLWEIFS 271

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 17/100 (17%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG--- 133
           Y +   ++YL S+  +H D+  +NVLV  N+  +K+ADFG A      +     T G   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLP 268

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           VK        WMAPE +       +SDVWS G  + E+ T
Sbjct: 269 VK--------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 30/115 (26%), Positives = 44/115 (38%), Gaps = 24/115 (20%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG--- 133
             +   + +L S+N +H DV  +NVL+       K+ DFG A         +        
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-AKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-------GKPAWEDF 181
           VK        WMAPE +       +SDVWS G  + E+ +       G      F
Sbjct: 230 VK--------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 17/100 (17%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG--- 133
           Y +   ++YL S+  +H D+  +NVLV  N+  +K+ADFG A      +     T G   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNV-MKIADFGLARDINNIDYYKKTTNGRLP 222

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           VK        WMAPE +       +SDVWS G  + E+ T
Sbjct: 223 VK--------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 8/109 (7%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVSDTRGVKIQPR--- 139
           ++  L+Y+H    VH D+K  N+L+G  N   V LAD+G +     +     + Q     
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN-HKQYQENPRK 218

Query: 140 ---GSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT 185
              G+  + + +  +G      SDV  LG  ++  + GK  WE    + 
Sbjct: 219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 31/97 (31%), Positives = 45/97 (46%), Gaps = 14/97 (14%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA--GEATVSDTRG---VKI 136
             +   + YL  +  +H D+  +N+LVG N    K+ADFG +   E  V  T G   V+ 
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVKKTMGRLPVR- 206

Query: 137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
                  WMA E +        SDVWS G  + E+V+
Sbjct: 207 -------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 30/100 (30%), Positives = 44/100 (44%), Gaps = 17/100 (17%)

Query: 82  YCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG--- 133
           Y +   +++L  ++ VH D+  +NVLV      VK+ DFG A         V        
Sbjct: 179 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARDIMSDSNYVVRGNARLP 237

Query: 134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT 173
           VK        WMAPE +       +SDVWS G  + E+ +
Sbjct: 238 VK--------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 32/125 (25%), Positives = 56/125 (44%), Gaps = 10/125 (8%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVSDT-----RGVKIQ 137
           ++ AL++LH    VH +V  +N+ V P + S V LA +G A     S        G +  
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSP 227

Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL----SRIGFSD 193
             G   +++ ++ +G      SD+ SLG  +++ + G   W +   NT      +  F D
Sbjct: 228 HEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVD 287

Query: 194 ELPRF 198
           +   F
Sbjct: 288 KPGPF 292

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.9 bits (139), Expect = 3e-09
 Identities = 55/360 (15%), Positives = 96/360 (26%), Gaps = 114/360 (31%)

Query: 21  AVDRFNGDV----FAYLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEIT 76
            V +F  +V    + +L   +  E     S    +++E         L      +A    
Sbjct: 78  MVQKFVEEVLRINYKFLMSPIKTE-QRQPSMMTRMYIEQ-----RDRLYNDNQVFAKYNV 131

Query: 77  LRSHTYC-IVSALKYL-HSRNI-VH----CDVKGKNVLVGP---NSSFVKLADFGA---- 122
            R   Y  +  AL  L  ++N+ +         GK  +      +       DF      
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKIFWLN 188

Query: 123 AGEATVSD-------TRGVKIQPRGSPLWMAPEVVRGEC--------------QGPES-- 159
                  +           +I P  +        ++                        
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248

Query: 160 ---DVWS--------LGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRF-PTQSSELG 206
              +V +        L C I+ + T      DF  A T + I          P +   L 
Sbjct: 249 VLLNVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 207 RDFLD---KCLRRE-----P------GE-------RW------SCDQL------------ 227
             +LD   + L RE     P       E        W      +CD+L            
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 228 ---LKHPFLQ-SVSPSDANTVAESSPRCVLD--WVNSEFEEEGTSDDEKLEASARERMGK 281
               +  F + SV P  A+      P  +L   W +    +     ++  + S  E+  K
Sbjct: 368 PAEYRKMFDRLSVFPPSAHI-----PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 23/101 (22%)

Query: 84  IVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA-----GEATVSDTRG---VK 135
           I + ++YL S ++VH D+  +NVLV    + VK++D G        +           ++
Sbjct: 137 IAAGMEYLSSHHVVHKDLATRNVLVYDKLN-VKISDLGLFREVYAADYYKLLGNSLLPIR 195

Query: 136 IQPRGSPLWMAPEVVRGECQG---PESDVWSLGCTIIEMVT 173
                   WMAPE +     G    +SD+WS G  + E+ +
Sbjct: 196 --------WMAPEAIM---YGKFSIDSDIWSYGVVLWEVFS 225

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 30/140 (21%), Positives = 48/140 (34%), Gaps = 30/140 (21%)

Query: 53  LEYLPGGTVSDLATTL------NAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKG 103
           LE + GG   DL + L       +    + +    +    I    +YL   + +H D+  
Sbjct: 153 LELMAGG---DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 209

Query: 104 KNVLVGPNSS--FVKLADFGAA-----GEATVSDTRG---VKIQPRGSPLWMAPEVVRGE 153
           +N L+         K+ DFG A                  VK        WM PE     
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK--------WMPPEAFMEG 261

Query: 154 CQGPESDVWSLGCTIIEMVT 173
               ++D WS G  + E+ +
Sbjct: 262 IFTSKTDTWSFGVLLWEIFS 281

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 30/143 (20%), Positives = 50/143 (34%), Gaps = 36/143 (25%)

Query: 53  LEYLPGGTVSDLATTL------NAYADEITLRSHTYC---IVSALKYLHSRNIVHCDVKG 103
           +E + GG   DL + L       +    + +    +    I    +YL   + +H D+  
Sbjct: 112 MELMAGG---DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAA 168

Query: 104 KNVLVGPNSS--FVKLADFGAA-----GEATVSDTRG---VKIQPRGSPLWMAPEVVRGE 153
           +N L+         K+ DFG A                  VK        WM PE     
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK--------WMPPEAF--- 217

Query: 154 CQG---PESDVWSLGCTIIEMVT 173
            +G    ++D WS G  + E+ +
Sbjct: 218 MEGIFTSKTDTWSFGVLLWEIFS 240

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 11/102 (10%)

Query: 83  CIVSA--LKYLH---SRNIVHCDVKGKNVLVGPNSSF-VKLADFGAAGEATVSDTRGVKI 136
            + SA  L YLH      I+H DVK  N+L+     F   + DFG A      DT  V  
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE--FEAVVGDFGLAKLMDYKDT-HVTT 193

Query: 137 QPRGSPLWMAPE-VVRGECQGPESDVWSLGCTIIEMVTGKPA 177
             RG+   +APE +  G+    ++DV+  G  ++E++TG+ A
Sbjct: 194 AVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRA 234

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.4 bits (96), Expect = 3e-04
 Identities = 30/206 (14%), Positives = 65/206 (31%), Gaps = 33/206 (16%)

Query: 51  LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVG 109
           + LE+  GG   DL       +   T +S  + + ++L    +     H D+   NVL+ 
Sbjct: 139 IVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 110 PNSSFVKLADFGAAGEATVSDTRGVKIQPR----------GSPLWM----APEVVRGECQ 155
             S   KL        +T+  + G+++             G  ++       ++  G+  
Sbjct: 197 KTSL-KKLHYTLNGKSSTI-PSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254

Query: 156 GPESDVWSLGCTIIEMVTGKPA------WEDFGANTLSRIGFSDELPRFPTQSSELGRDF 209
             + D++ L         G+        W  +  + +       ++      ++   +  
Sbjct: 255 -YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM-----LKQMTFKTKCNTPAMKQI 308

Query: 210 LD--KCLRREPGERWSCDQLLKHPFL 233
               +   R      S   LL    L
Sbjct: 309 KRKIQEFHRTMLNFSSATDLLCQHSL 334

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	408
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.6
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.84
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.57
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.47
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.29
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.59
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.47
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.0
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.86
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.11
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.44
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.38
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	93.28
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	92.88
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	89.2
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	88.96
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	88.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	88.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	84.49
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	83.72

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-57  Score=445.36  Aligned_cols=237  Identities=27%  Similarity=0.420  Sum_probs=207.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|...                            +.+...++++..+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999998643                            12333456678899999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |||+||+|.+++++. +.++|..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+.........
T Consensus       112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~-vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC-EEEEEcCCceecCCCCCcc
Confidence            999999999999854 56899999999999999999999999999999999999998885 9999999998765444444


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ...+.+|||.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+....+ .+|...|+++++||.+|
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~l  268 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKL  268 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHHHHH
Confidence            45567899999999999999999999999999999999999999998777666655544443 66788999999999999


Q ss_pred             cccCCCCCCCHHH------HHcCCCCCCCCCCCc
Q 042746          214 LRREPGERWSCDQ------LLKHPFLQSVSPSDA  241 (408)
Q Consensus       214 L~~dP~~R~s~~e------ll~hpf~~~~~~~~~  241 (408)
                      |++||++|||++|      |++||||+++.|...
T Consensus       269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            9999999999987      689999999988754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-56  Score=444.90  Aligned_cols=232  Identities=25%  Similarity=0.409  Sum_probs=198.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      |++|++++.||+|+||+||+|+++.+++.||+|...                           +.+...++++..+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            689999999999999999999999999999998643                           22333455677899999


Q ss_pred             eccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+||+|.+++... +..++|..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||+|+......  
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~--  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT-VQLGDFGIARVLNSTV--  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC-EEECSTTEESCCCHHH--
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC-EEEcccccceeecCCc--
Confidence            999999999999754 345799999999999999999999999999999999999998885 9999999997654321  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ......+|||.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.....|..+..+|+++++||.+
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~  259 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ  259 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            12234579999999999999999999999999999999999999999887777666666777777888899999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ||++||++|||++|+|+||||+.
T Consensus       260 ~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          260 LFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HccCChhHCcCHHHHhcCHHhhc
Confidence            99999999999999999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-55  Score=434.14  Aligned_cols=231  Identities=31%  Similarity=0.495  Sum_probs=198.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEeccC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .|++.+.||+|+||+||+|+++.||+.||+|....                         .+...++.+..+|||||||+
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            59999999999999999999999999999987542                         23334556678899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|.+++.+  +.+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+|+.......  ...+
T Consensus       155 gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~--~~~~  229 (346)
T 4fih_A          155 GGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP--RRKS  229 (346)
T ss_dssp             TEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSSSC--CBCC
T ss_pred             CCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC-EEEecCcCceecCCCCC--cccc
Confidence            9999999974  46899999999999999999999999999999999999998885 99999999976643322  2345


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CCCCcHHHHHHHHHhcc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLR  215 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~~~s~~~~~li~~~L~  215 (408)
                      .+|||.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+.....+.+  +...|+++++||.+||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            7899999999999999999999999999999999999999988766655544433333332  34689999999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCCCC
Q 042746          216 REPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||++|||++|+|+||||+...+
T Consensus       310 ~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          310 RDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CChhHCcCHHHHhcCHhhcCCCC
Confidence            99999999999999999986544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-55  Score=428.62  Aligned_cols=233  Identities=23%  Similarity=0.326  Sum_probs=196.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc---CCCcEEEEeeccc---------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~L   51 (408)
                      ++|++++.||+|+||+||+|++.   .+++.||+|....                           .+...++.+..+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999984   4678899876431                           12223445677899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |||||+||+|.+++.+. +.+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+.......
T Consensus       104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC-EEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC-EEecccccceeccCCCc
Confidence            99999999999999854 57899999999999999999999999999999999999999885 99999999976543222


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                        ...+.+|||.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.... +.+|...|+++++||.
T Consensus       182 --~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  258 (304)
T 3ubd_A          182 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLR  258 (304)
T ss_dssp             --CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             --cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCcCCHHHHHHHH
Confidence              2345689999999999999999999999999999999999999999877766665554444 3567889999999999


Q ss_pred             HhcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      +||++||++|||     ++|+++||||+.+.+.
T Consensus       259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             HHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            999999999998     5799999999987654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.2e-55  Score=420.62  Aligned_cols=228  Identities=27%  Similarity=0.373  Sum_probs=184.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LV   52 (408)
                      +++|++++.||+|+||+||+|+++.+++.||+|...                            +.+...++.+..+|||
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            468999999999999999999999999999998643                            1222335567788999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+ +|+|.+++.+ .+.+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+......  
T Consensus        92 mEy~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~-vkl~DFGla~~~~~~~--  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGN--  166 (275)
T ss_dssp             EECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC-EEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC-EEEeecCCCeecCCCC--
Confidence            9999 6799999985 467899999999999999999999999999999999999998875 9999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ...+.+|||.|||||++.+..| +.++|||||||++|+|++|++||.+.+...+.+.+.... +.+|...|+++++||.
T Consensus       167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  244 (275)
T 3hyh_A          167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIK  244 (275)
T ss_dssp             ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHH
T ss_pred             -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHH
Confidence             2335689999999999998876 579999999999999999999999877766655544433 4677889999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      +||++||++|||++|+++||||+.
T Consensus       245 ~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          245 RMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHccCChhHCcCHHHHHcCccccc
Confidence            999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-54  Score=428.70  Aligned_cols=235  Identities=28%  Similarity=0.366  Sum_probs=195.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc--------------------cceeccCCCCCcceEEEeccCCCCH
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------VSYEAPTTSSSCRNLHLEYLPGGTV   61 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--------------------~~~~~~~~~~~~~~LVmEy~~gGsL   61 (408)
                      ..|+++++||+|+||+||+|+++.+|+.||+|...                    +.+...++++..+|||||||+||+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            46899999999999999999999999999998754                    2233345566788999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC---cccccC
Q 042746           62 SDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR---GVKIQP  138 (408)
Q Consensus        62 ~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~~  138 (408)
                      .+++++. +.+++..++.|+.||+.||+|||++|||||||||+||||+.++..+||+|||+|+........   ......
T Consensus       138 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~  216 (336)
T 4g3f_A          138 GQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI  216 (336)
T ss_dssp             HHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCC
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCcc
Confidence            9999854 568999999999999999999999999999999999999988756999999999866533211   122345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC--CCCCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL--PRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~--p~~~~~~s~~~~~li~~~L~~  216 (408)
                      +|||.|||||++.+..|+.++|||||||++|+|++|++||.......+...+.....  +.++..+++.+++||.+||++
T Consensus       217 ~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~  296 (336)
T 4g3f_A          217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK  296 (336)
T ss_dssp             CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred             ccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccC
Confidence            799999999999999999999999999999999999999987655544443333332  246778999999999999999


Q ss_pred             CCCCCCCHHHH-------------HcCCCCCCCC
Q 042746          217 EPGERWSCDQL-------------LKHPFLQSVS  237 (408)
Q Consensus       217 dP~~R~s~~el-------------l~hpf~~~~~  237 (408)
                      ||.+|||+.|+             ++|||+....
T Consensus       297 dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          297 EPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             SGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             CHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            99999999998             4699987654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.3e-54  Score=434.89  Aligned_cols=231  Identities=31%  Similarity=0.487  Sum_probs=198.1

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCCCCCcceEEEeccC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .|++.+.||+|+||+||+|+++.+|+.||+|...                         +.+...+..+..+|||||||+
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~  231 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  231 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence            5999999999999999999999999999998754                         223334556678999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|.++++.  +.+++..++.+++||+.||+|||++|||||||||+||||+.++. +||+|||+|+.......  ....
T Consensus       232 gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~-vKl~DFGla~~~~~~~~--~~~~  306 (423)
T 4fie_A          232 GGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVP--RRKS  306 (423)
T ss_dssp             TEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC-EEECCCTTCEECCSSCC--CBCC
T ss_pred             CCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC-EEEecCccceECCCCCc--cccc
Confidence            9999999974  46899999999999999999999999999999999999998885 99999999977644322  2345


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHHHHHhcc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~li~~~L~  215 (408)
                      .+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.......+.....+  ..+..+|+++++||.+||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            68999999999999999999999999999999999999999887665555444333333  2345789999999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCCCC
Q 042746          216 REPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||++|||+.|+|+||||+...+
T Consensus       387 ~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          387 RDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             CChhHCcCHHHHhcCHHhcCCCC
Confidence            99999999999999999986543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-53  Score=409.43  Aligned_cols=225  Identities=27%  Similarity=0.374  Sum_probs=185.0

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccC----CCCCcceEE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPT----TSSSCRNLH   52 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~----~~~~~~~LV   52 (408)
                      |++.+.||+|+||+||+|+++.++..||+|....                           .+...+    ..+..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            3778899999999999999999999999976431                           111111    124567999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcC-CCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~-~~~~vkL~DFGla~~~~~~  129 (408)
                      ||||+||+|.+++++ .+.+++..++.++.||+.||+|||+++  |+||||||+||||+. ++ .+||+|||+|+.....
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRAS  185 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGGGCCTT
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC-CEEEEeCcCCEeCCCC
Confidence            999999999999985 457899999999999999999999999  999999999999975 55 5999999999754322


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC-hhhhhhhcccCCC-CCCCCCCcHHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDEL-PRFPTQSSELGR  207 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~-~~~~~~~~~~~~~-p~~~~~~s~~~~  207 (408)
                          ...+.+|||.|||||++.+ .|+.++|||||||++|+|+||++||.+.. ...+......... +.++...+++++
T Consensus       186 ----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (290)
T 3fpq_A          186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHH
Confidence                2345689999999999976 49999999999999999999999997643 3444443333332 345567889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      +||.+||++||++|||++|+|+||||++
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.5e-52  Score=438.44  Aligned_cols=232  Identities=23%  Similarity=0.380  Sum_probs=197.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------------cceeccCCCCCcc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------------VSYEAPTTSSSCR   49 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------------~~~~~~~~~~~~~   49 (408)
                      |++|+++++||+|+||+||+|+++.||+.||+|...                               +.+...++++..+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            578999999999999999999999999999998643                               1122235567789


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||||||+||+|.+++.+. +.++|..++.|++||+.||+|||++|||||||||+||||+.++. +||+|||+|+.....
T Consensus       268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~-vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKK  345 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSC
T ss_pred             EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC-EEecccceeeecCCC
Confidence            9999999999999999854 56899999999999999999999999999999999999999885 999999999765432


Q ss_pred             CCCcccccCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---hhhhhcccCCCCCCCCCCcHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRIGFSDELPRFPTQSSEL  205 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---~~~~~~~~~~~p~~~~~~s~~  205 (408)
                          ...+.+|||.|||||++. +..|+.++|||||||++|+|++|.+||...+..   .+...+... .+.+|..+|++
T Consensus       346 ----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~-~~~~p~~~S~~  420 (689)
T 3v5w_A          346 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPE  420 (689)
T ss_dssp             ----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC-CCCCCTTSCHH
T ss_pred             ----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC-CCCCCccCCHH
Confidence                234568999999999996 567999999999999999999999999764332   233333333 34677889999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      +++||.+||++||.+|++     ++||++||||+.+.|.
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            999999999999999998     7999999999988754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-51  Score=400.54  Aligned_cols=234  Identities=18%  Similarity=0.270  Sum_probs=173.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCC-----------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTT-----------   44 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~-----------   44 (408)
                      .+|++++.||+|+||+||+|+++.+++.||+|.....                          +...+.           
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4799999999999999999999999999999864311                          111111           


Q ss_pred             -CCCcceEEEeccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           45 -SSSCRNLHLEYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        45 -~~~~~~LVmEy~~gGsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                       ....+|||||||+||+|.+++.....  ..++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~-vKl~DFG  163 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFG  163 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc-EEEccCc
Confidence             12236899999999999999985432  2355678999999999999999999999999999999998875 9999999


Q ss_pred             CccccccCCCC----------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhc
Q 042746          122 AAGEATVSDTR----------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIG  190 (408)
Q Consensus       122 la~~~~~~~~~----------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~  190 (408)
                      +|+........          ......+|||.|||||++.+..|+.++|||||||++|||++   ||..... .......
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~  240 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV  240 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence            99766543211          11234579999999999999999999999999999999996   7764321 1111112


Q ss_pred             ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 ~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      .....|..+...++.+++||.+||++||++|||+.|+++||||++..++
T Consensus       241 ~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            2334444434556778899999999999999999999999999877543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-50  Score=405.29  Aligned_cols=232  Identities=24%  Similarity=0.310  Sum_probs=179.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc---CCCcEEEEeeccc------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++++.||+|+||+||+|+++   .+++.||+|....                        .+...++.+..+|||||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            46999999999999999999986   4678899985321                        11223445677899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC---
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT---  131 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---  131 (408)
                      |++||+|.++++    .+++..++.+++||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.......   
T Consensus       101 ~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~  176 (361)
T 4f9c_A          101 YLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL  176 (361)
T ss_dssp             CCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGG
T ss_pred             CCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccc
Confidence            999999999984    4799999999999999999999999999999999999988755699999999975432211   


Q ss_pred             -----------------------CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hh
Q 042746          132 -----------------------RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NT  185 (408)
Q Consensus       132 -----------------------~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~  185 (408)
                                             .....+.+|||.|||||++.+. .|+.++||||+||++|+|++|++||.....  ..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~  256 (361)
T 4f9c_A          177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTA  256 (361)
T ss_dssp             GGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHH
Confidence                                   0112345799999999999876 589999999999999999999999953221  11


Q ss_pred             hhhhc---------------------------------------ccCCCC-------------CCCCCCcHHHHHHHHHh
Q 042746          186 LSRIG---------------------------------------FSDELP-------------RFPTQSSELGRDFLDKC  213 (408)
Q Consensus       186 ~~~~~---------------------------------------~~~~~p-------------~~~~~~s~~~~~li~~~  213 (408)
                      +..+.                                       .....|             ......|++++|||.+|
T Consensus       257 l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~l  336 (361)
T 4f9c_A          257 LAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKL  336 (361)
T ss_dssp             HHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHH
T ss_pred             HHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHH
Confidence            11000                                       000000             11235788999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      |++||++|+|++|+|+||||++++
T Consensus       337 L~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          337 LDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             TCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             CcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999998753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=407.84  Aligned_cols=235  Identities=23%  Similarity=0.342  Sum_probs=188.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceec------cCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEA------PTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~------~~~~~~~   48 (408)
                      ++|++++.||+|+||+||+|+++.||+.||+|....                           .+..      .+.....
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            479999999999999999999999999999987431                           1111      1233467


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +|||||||+ |+|.+++. ..+.+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus       134 ~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~-~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE-LKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-EEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC-EEEeecceeeeccc
Confidence            899999996 57999997 4567899999999999999999999999999999999999998885 99999999976543


Q ss_pred             CC--CCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc--C----------
Q 042746          129 SD--TRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS--D----------  193 (408)
Q Consensus       129 ~~--~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~--~----------  193 (408)
                      ..  ......+.+||+.|||||++.+. .|+.++||||+||++|+|++|++||...+.......+..  .          
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence            22  22234467899999999999875 568999999999999999999999987654333222110  0          


Q ss_pred             ----------CCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ----------ELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ----------~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                ..|.        .....++++++||.+||.+||++|||++|+|+||||+....+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence                      0111        113468899999999999999999999999999999976543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-50  Score=393.33  Aligned_cols=226  Identities=24%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeecc-------------------------cceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~L   51 (408)
                      ++|++++.||+|+||+||+|++.     .++..||+|...                         +.+.+...++..++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            47999999999999999999875     467889998643                         223334556677899


Q ss_pred             EEeccCCCCHHHHHHHhC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEee
Q 042746           52 HLEYLPGGTVSDLATTLN------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLAD  119 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~D  119 (408)
                      |||||+||+|.++++..+            ..+++..+..++.||+.||+|||+++|+||||||+||||+.++. +||+|
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-~Ki~D  171 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-VKIGD  171 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc-EEECC
Confidence            999999999999997532            46899999999999999999999999999999999999998874 99999


Q ss_pred             cCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCC
Q 042746          120 FGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRF  198 (408)
Q Consensus       120 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~  198 (408)
                      ||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |++||...+..++......+..+..
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~  251 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR  251 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCC
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999976544333222333468999999999999999999999999999999998 8999998877776666666667778


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                      |..+++++++|+.+||+.||++|||+.|++
T Consensus       252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          252 PRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            889999999999999999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.1e-50  Score=420.81  Aligned_cols=236  Identities=24%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCCCCCcceEEEec
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy   55 (408)
                      |++|++++.||+|+||+||+|+++.+|+.||+|...                         +.+...++.+..+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999999999999998532                         2233345677889999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC-CCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN-SSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~-~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+||+|.+++....+.+++..++.+++||+.||+|||++||+||||||+|||++.+ ...+||+|||+|+......   .
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---E
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC---c
Confidence            99999999997666788999999999999999999999999999999999999854 2359999999998764332   2


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~li~  211 (408)
                      ....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.......+.....   +..+...|+++++||.
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            3456899999999999999999999999999999999999999998776655544433322   1223568999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +||.+||.+|||+.|+|+||||+...+.
T Consensus       393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          393 KLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            9999999999999999999999876654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-49  Score=391.23  Aligned_cols=228  Identities=23%  Similarity=0.294  Sum_probs=184.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeecc-------------------------cceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|+..     .++..||+|...                         +.+.+...++..++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            36889999999999999999865     468889998643                         223334556677899


Q ss_pred             EEeccCCCCHHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEE
Q 042746           52 HLEYLPGGTVSDLATTLN--------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKL  117 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~--------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL  117 (408)
                      |||||+||+|.++++...              ..+++..+..++.||+.||+|||+++||||||||+||||+.++ .+||
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~-~~Ki  199 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKI  199 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-cEEE
Confidence            999999999999997532              3588999999999999999999999999999999999999887 5999


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      +|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |++||......++...+..+..+
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~  279 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL  279 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC
T ss_pred             cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999987654433333445679999999999999999999999999999999999 89999987766665555555666


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..|..+++++++|+.+||++||++|||+.|++++
T Consensus       280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            7788899999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-49  Score=388.19  Aligned_cols=228  Identities=18%  Similarity=0.232  Sum_probs=192.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-----cCCCcEEEEeecc--------------------------cceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-----RFNGDVFAYLGDD--------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-----~~t~~~va~k~~~--------------------------~~~~~~~~~~~~~~   50 (408)
                      .++++.+.||+|+||+||+|+.     ..+++.||+|...                          +.+.+....+..++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            4678899999999999999985     3567889998643                          22333345566789


Q ss_pred             EEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcE
Q 042746           51 LHLEYLPGGTVSDLATTL---------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFV  115 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~---------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~v  115 (408)
                      ||||||++|+|.++|...               ...+++..+..++.||+.||+|||+++||||||||+||||+.++. +
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-~  184 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-V  184 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-E
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC-E
Confidence            999999999999999643               235889999999999999999999999999999999999998875 9


Q ss_pred             EEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCC
Q 042746          116 KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDE  194 (408)
Q Consensus       116 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~  194 (408)
                      ||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.....+......+.
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~  264 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ  264 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999987654433333445679999999999999999999999999999999998 899999887777666666666


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .++.|..+++.+.+|+.+||+.||++|||+.||+++
T Consensus       265 ~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          265 VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            677788999999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=385.56  Aligned_cols=223  Identities=23%  Similarity=0.310  Sum_probs=174.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------------cceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------------VSYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------------~~~~~~~~~~~~~~LVmE   54 (408)
                      +++++++.||+|+||+||+|+...   .+|+|...                           +.+.+.. .+..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-~~~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-TKDNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ECCeEEEEEE
Confidence            467889999999999999998653   46776532                           1122222 2345789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ||+||+|.+++......+++..+..++.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+..........
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC---------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCCccee
Confidence            9999999999987677899999999999999999999999999999999999999887 499999999987654333333


Q ss_pred             cccCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccC----CCCCCCCCCcHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSD----ELPRFPTQSSELG  206 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~----~~p~~~~~~s~~~  206 (408)
                      ....+||+.|||||++.+.   +|+.++|||||||++|||+||++||...+.. .+.......    .++..+..+++.+
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l  270 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM  270 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence            4556899999999999753   5888999999999999999999999875433 222222121    2334566789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 042746          207 RDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++|+.+||+.||++|||+.|+++
T Consensus       271 ~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          271 KRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999998753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.4e-49  Score=390.17  Aligned_cols=228  Identities=23%  Similarity=0.300  Sum_probs=189.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-----cEEEEeecc---------------------------cceeccC-CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-----DVFAYLGDD---------------------------VSYEAPT-TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-----~~va~k~~~---------------------------~~~~~~~-~~~~~   48 (408)
                      ++|++++.||+|+||+||+|.+..++     +.||+|...                           +.+.+.. +.+..
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            57999999999999999999987654     568876532                           1222222 23456


Q ss_pred             ceEEEeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC
Q 042746           49 RNLHLEYLPGGTVSDLATTL---------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS  113 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~---------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~  113 (408)
                      ++||||||+||+|.++|+..               ...+++..+..++.||+.||+|||+++||||||||+|||++.++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999999999999753               235789999999999999999999999999999999999998874


Q ss_pred             cEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCCh-hhhhhhcc
Q 042746          114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGA-NTLSRIGF  191 (408)
Q Consensus       114 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~-~~~~~~~~  191 (408)
                       +||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |++||..... ..+.....
T Consensus       224 -vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~  302 (353)
T 4ase_A          224 -VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  302 (353)
T ss_dssp             -EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred             -EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence             99999999987654443333445679999999999999999999999999999999998 9999987653 33444444


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+..|...++++.+||.+||+.||++|||+.||++|
T Consensus       303 ~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          303 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            555667788899999999999999999999999999987

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=378.84  Aligned_cols=234  Identities=26%  Similarity=0.404  Sum_probs=196.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~L   51 (408)
                      +++|++.+.||+|+||+||+|+++.+++.||+|....                             .+...+.....++|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            4789999999999999999999999999999986431                             11222345667899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... 
T Consensus       102 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~-ikL~DFG~a~~~~~~~-  178 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNG-  178 (353)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCC---
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC-EEEccccceeecccCC-
Confidence            99999999999999854 56799999999999999999999999999999999999998885 9999999997543222 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+...+...+..... .+|...++.+++||.
T Consensus       179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~  256 (353)
T 3txo_A          179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILK  256 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHH
T ss_pred             -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHH
Confidence             223456799999999999998899999999999999999999999998777666655544443 567789999999999


Q ss_pred             HhcccCCCCCCCH------HHHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERWSC------DQLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~s~------~ell~hpf~~~~~~~  239 (408)
                      +||.+||.+||++      .|+++||||+...|.
T Consensus       257 ~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             HHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             HHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            9999999999998      899999999987655

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-46  Score=371.08  Aligned_cols=234  Identities=26%  Similarity=0.406  Sum_probs=199.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|....                            .+...+......+||
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            4789999999999999999999999999999986431                            112234456678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... 
T Consensus        84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~-  160 (337)
T 1o6l_A           84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCCTTC-
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC-EEEeeccchhhcccCCC-
Confidence            999999999999985 456799999999999999999999999999999999999998885 99999999975432221 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|++||...+...+...+.... +.+|...++++++||.+
T Consensus       161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence             2345679999999999999999999999999999999999999998877666555444433 35677899999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||.+||.+||     ++.|+++||||....+.
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999999     89999999999987654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.4e-46  Score=364.11  Aligned_cols=232  Identities=29%  Similarity=0.410  Sum_probs=197.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +.+|++.+.||+|+||+||+|++..+++.||+|....                           .+...+......++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            3689999999999999999999999999999986431                           1122234566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......   
T Consensus        94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSTTCCGGGSSSC---
T ss_pred             ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC-EEEeeccCceecCCCC---
Confidence            999999999999754 56799999999999999999999999999999999999998885 9999999997654332   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCC-CCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQG-PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~-~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      .....+||+.|+|||++.+..+. .++|||||||++|+|++|++||...+...+......... .+|...++++.+||.+
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKR  247 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHH
Confidence            23456799999999999988764 789999999999999999999998777666655444433 5667889999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ||..||.+|||++|+++||||.....
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            99999999999999999999986553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.2e-46  Score=371.43  Aligned_cols=234  Identities=26%  Similarity=0.381  Sum_probs=199.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|....                             .+...++.....+|
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            4789999999999999999999999999999986431                             11122345667899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus        96 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC-EEEeEChhhhhcccCCC
Confidence            99999999999999854 56799999999999999999999999999999999999998885 99999999975432221


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+...+... .+.+|...++++++||.
T Consensus       174 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~  250 (345)
T 1xjd_A          174 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLEKEAKDLLV  250 (345)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTSCHHHHHHHH
T ss_pred             --cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccCHHHHHHHH
Confidence              234568999999999999999999999999999999999999999887766655544333 34667789999999999


Q ss_pred             HhcccCCCCCCCHH-HHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERWSCD-QLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~s~~-ell~hpf~~~~~~~  239 (408)
                      +||..||.+||++. |+++||||+...+.
T Consensus       251 ~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          251 KLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            99999999999998 99999999987754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.2e-46  Score=376.26  Aligned_cols=234  Identities=27%  Similarity=0.410  Sum_probs=195.0

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|.....                             +...++....++|
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            36899999999999999999999999999998764311                             1122345667899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... 
T Consensus       131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-ikL~DFGla~~~~~~~-  207 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPG-  207 (396)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTT-
T ss_pred             EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC-EEEeecceeeecccCC-
Confidence            99999999999999854 56899999999999999999999999999999999999999885 9999999997533222 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC---------hhhhhhhcccCCCCCCCCCC
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---------ANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~---------~~~~~~~~~~~~~p~~~~~~  202 (408)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|++||....         ...+...+.. ..+.+|...
T Consensus       208 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~  285 (396)
T 4dc2_A          208 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSL  285 (396)
T ss_dssp             -CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-CCCCCCTTS
T ss_pred             -CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-cccCCCCcC
Confidence             23445689999999999999999999999999999999999999996321         1122222222 334677789


Q ss_pred             cHHHHHHHHHhcccCCCCCCCH------HHHHcCCCCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERWSC------DQLLKHPFLQSVSPS  239 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~------~ell~hpf~~~~~~~  239 (408)
                      ++++++||.+||++||.+||++      +|+++||||+.+.|.
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            9999999999999999999985      799999999988765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.3e-46  Score=370.45  Aligned_cols=235  Identities=20%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|.....                             +...++.....+|
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            46899999999999999999999999999999864311                             1112345567899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... 
T Consensus        99 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~-  175 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDG-  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTT-
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc-EEEEeCCcccccccCC-
Confidence            99999999999999854 46799999999999999999999999999999999999998885 9999999997543222 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|++||...+...+...+.... +.+|...++++++||.
T Consensus       176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  253 (353)
T 2i0e_A          176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICK  253 (353)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHH
Confidence             12345689999999999999999999999999999999999999998877666655544443 3567789999999999


Q ss_pred             HhcccCCCCCCC-----HHHHHcCCCCCCCCCCC
Q 042746          212 KCLRREPGERWS-----CDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       212 ~~L~~dP~~R~s-----~~ell~hpf~~~~~~~~  240 (408)
                      +||.+||.+||+     +.|+++||||+...|..
T Consensus       254 ~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             HHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence            999999999994     69999999999877653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-46  Score=362.83  Aligned_cols=231  Identities=26%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++.+.||+|+||+||+|+++.+++.||+|....                            .+...+......++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            4689999999999999999999999999999986431                            122234456678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....    
T Consensus        85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~Dfg~a~~~~~----  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPD----  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC-EEECCCSSCEECSS----
T ss_pred             EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC-EEEeecCcceecCC----
Confidence            999999999999985 456799999999999999999999999999999999999998885 99999999975432    


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.... ..+|...++++++||.+
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~  236 (318)
T 1fot_A          159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSR  236 (318)
T ss_dssp             -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHH
Confidence             1234679999999999999999999999999999999999999998776655554444433 35677889999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||..||.+||     +++|+++||||+...+.
T Consensus       237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence            9999999999     89999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.1e-45  Score=373.52  Aligned_cols=239  Identities=25%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                            .+...+..+..++|||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            589999999999999999999999999999986431                            1222345567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... .
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~-vkL~DFGla~~~~~~~~-~  231 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGT-V  231 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSC-E
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC-EEEcchhhhhhcccCCC-c
Confidence            999999999999866678899999999999999999999999999999999999998885 99999999976543222 1


Q ss_pred             ccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc----cCCCCCCCCCCcH
Q 042746          134 VKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF----SDELPRFPTQSSE  204 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~----~~~~p~~~~~~s~  204 (408)
                      .....+||+.|+|||++.     ...++.++|||||||++|+|++|++||...+.......+.    ....|......++
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  311 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE  311 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCH
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCH
Confidence            223467999999999997     4568999999999999999999999998776555443332    2234444456899


Q ss_pred             HHHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCCCcc
Q 042746          205 LGRDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSPSDAN  242 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~~~~~  242 (408)
                      ++++||.+||..+|++  |++++|+++||||+...|....
T Consensus       312 ~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          312 NAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             HHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred             HHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence            9999999999998888  9999999999999999887653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-45  Score=364.58  Aligned_cols=234  Identities=27%  Similarity=0.409  Sum_probs=194.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|.....                             +...+......+|
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999864321                             1112345567899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... 
T Consensus        88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCGGGCBCSCCTT-
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-EEEEeccccccccCCC-
Confidence            99999999999999854 56799999999999999999999999999999999999998885 9999999997543222 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC---------hhhhhhhcccCCCCCCCCCC
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---------ANTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~---------~~~~~~~~~~~~~p~~~~~~  202 (408)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|++||....         ...+...+... .+.+|...
T Consensus       165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~~~  242 (345)
T 3a8x_A          165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPRSL  242 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CCCCCTTS
T ss_pred             -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CCCCCCCC
Confidence             12345679999999999999999999999999999999999999996421         12222222222 34567789


Q ss_pred             cHHHHHHHHHhcccCCCCCCCH------HHHHcCCCCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERWSC------DQLLKHPFLQSVSPS  239 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~------~ell~hpf~~~~~~~  239 (408)
                      ++.+++||.+||++||.+||++      +|+++||||....|.
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            9999999999999999999985      899999999987654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-45  Score=367.68  Aligned_cols=235  Identities=24%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|.....                             +...+.....+||
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            36899999999999999999999999999998764311                             1112334566789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... 
T Consensus       117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-ikL~DFG~a~~~~~~~-  193 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHN-  193 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCBCGGGBCCC-
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC-EEEeeCccccccccCC-
Confidence            99999999999999854 56789999999999999999999999999999999999998885 9999999997543222 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+...+.... ..++...++.+++||.
T Consensus       194 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~  271 (373)
T 2r5t_A          194 -STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLE  271 (373)
T ss_dssp             -CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCCCSSSCHHHHHHHH
T ss_pred             -CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHH
Confidence             12345689999999999999999999999999999999999999998877666655544443 3566788999999999


Q ss_pred             HhcccCCCCCCCH----HHHHcCCCCCCCCCCC
Q 042746          212 KCLRREPGERWSC----DQLLKHPFLQSVSPSD  240 (408)
Q Consensus       212 ~~L~~dP~~R~s~----~ell~hpf~~~~~~~~  240 (408)
                      +||++||.+||++    .|+++||||+...|..
T Consensus       272 ~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          272 GLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             HHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence            9999999999986    6999999999887653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=371.30  Aligned_cols=237  Identities=25%  Similarity=0.351  Sum_probs=196.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|+++.+++.||+|....                            .+...++....+||||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            579999999999999999999999999999986431                            1122344567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++.+.+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... .
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~-vkL~DFGla~~~~~~~~-~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGT-V  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSC-E
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC-EEEeechhheeccCCCc-c
Confidence            999999999999877778899999999999999999999999999999999999998885 99999999976543221 1


Q ss_pred             ccccCCCCCCCCChhhHh-------CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc----CCCCCCCCCC
Q 042746          134 VKIQPRGSPLWMAPEVVR-------GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS----DELPRFPTQS  202 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~-------~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~----~~~p~~~~~~  202 (408)
                      .....+||+.|+|||++.       ...++.++|||||||++|+|++|++||...+.......+..    ...|..+...
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  298 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV  298 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CC
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCC
Confidence            223467999999999997       35689999999999999999999999987665544333221    2344455678


Q ss_pred             cHHHHHHHHHhcccCCCCC---CCHHHHHcCCCCCCCCCCCc
Q 042746          203 SELGRDFLDKCLRREPGER---WSCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R---~s~~ell~hpf~~~~~~~~~  241 (408)
                      ++++++||.+||. +|.+|   ++++|+++||||+...|...
T Consensus       299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            9999999999999 99998   49999999999999888754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-45  Score=364.20  Aligned_cols=231  Identities=25%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++++.||+|+||+||+|+++.+++.||+|....                            .+...+......+||
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            4689999999999999999999999999999986431                            112223456678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....   
T Consensus       120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~-~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSC---
T ss_pred             EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC-EEEcccccceeccCC---
Confidence            9999999999999864 46799999999999999999999999999999999999998885 999999999765322   


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+...+.... +.+|...++.+++||.+
T Consensus       195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~  271 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHH
T ss_pred             --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence              234579999999999999999999999999999999999999998877666555444443 35677899999999999


Q ss_pred             hcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      ||+.||.+||+     ++|+++||||....+.
T Consensus       272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            99999999998     9999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.1e-45  Score=353.49  Aligned_cols=231  Identities=33%  Similarity=0.533  Sum_probs=192.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|....                         .+...+......++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            479999999999999999999999999999986431                         1222233456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +||+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  ...
T Consensus       100 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~~~  174 (297)
T 3fxz_A          100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQS--KRS  174 (297)
T ss_dssp             TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSTTC--CBC
T ss_pred             CCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC-EEEeeCCCceecCCccc--ccC
Confidence            99999999975  36799999999999999999999999999999999999998875 99999999876543322  233


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC--CCCCCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE--LPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~p~~~~~~s~~~~~li~~~L  214 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||................  ....+...++.+++||.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  254 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence            4579999999999999999999999999999999999999998765443332222111  22345678899999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +.||.+|||+.|+++||||+...
T Consensus       255 ~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          255 EMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             CSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cCChhHCcCHHHHhhChhhcccC
Confidence            99999999999999999998644

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.5e-45  Score=390.69  Aligned_cols=235  Identities=21%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~L   51 (408)
                      +.+|++++.||+|+||+||+|+++.+++.||+|....                             .+...++....+||
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999986431                             11223455677899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.++++.. +.+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||+|+.......
T Consensus       420 V~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~-ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC-EEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc-EEEeecceeeccccCCc
Confidence            99999999999999865 56799999999999999999999999999999999999999885 99999999975432222


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                        .....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+...+...+.... +.+|...++++++||.
T Consensus       498 --~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~  574 (674)
T 3pfq_A          498 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICK  574 (674)
T ss_dssp             --CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHH
T ss_pred             --ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHH
Confidence              2445689999999999999999999999999999999999999999877776666655444 4677889999999999


Q ss_pred             HhcccCCCCCCCH-----HHHHcCCCCCCCCCCC
Q 042746          212 KCLRREPGERWSC-----DQLLKHPFLQSVSPSD  240 (408)
Q Consensus       212 ~~L~~dP~~R~s~-----~ell~hpf~~~~~~~~  240 (408)
                      +||++||.+||++     +||++||||+.+.|..
T Consensus       575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             HHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             HHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence            9999999999987     9999999999887653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.8e-44  Score=359.88  Aligned_cols=232  Identities=26%  Similarity=0.360  Sum_probs=193.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~   50 (408)
                      +.|++++.||+|+||+||+|+++.+++.||+|.....                               +...++.....+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            4799999999999999999999999999998754321                               111234556789


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC---cEEEeecCCccccc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS---FVKLADFGAAGEAT  127 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~---~vkL~DFGla~~~~  127 (408)
                      |||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.   .+||+|||++....
T Consensus        92 lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999974 567899999999999999999999999999999999999987652   59999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC---CCCCCCcH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP---RFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p---~~~~~~s~  204 (408)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+......   ..+...++
T Consensus       171 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  247 (361)
T 2yab_A          171 DGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE  247 (361)
T ss_dssp             TTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCH
Confidence            322   223457999999999999999999999999999999999999999876655554433333221   12256789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+++||.+||.+||.+|||+.|+++||||....
T Consensus       248 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            999999999999999999999999999998654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.2e-45  Score=371.47  Aligned_cols=234  Identities=25%  Similarity=0.395  Sum_probs=196.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LV   52 (408)
                      +.+|++.+.||+|+||+||+|++..+++.||+|.....                            +...+.....++||
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            35799999999999999999999999999999854311                            11122344567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      |||++||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +||+|||+++.......
T Consensus       227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC-EEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC-EEEccCCCceeccCCCc
Confidence            9999999999999754 578999999999999999999998 99999999999999998875 99999999975432221


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|++||...+...+........ +.+|...++.+++||.
T Consensus       305 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~  381 (446)
T 4ejn_A          305 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLS  381 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHH
T ss_pred             --ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHH
Confidence              2345679999999999999999999999999999999999999998877666655544443 3567788999999999


Q ss_pred             HhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +||++||.+||     +++|+++||||....+.
T Consensus       382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             HHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence            99999999999     99999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.5e-45  Score=368.69  Aligned_cols=235  Identities=24%  Similarity=0.323  Sum_probs=195.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                            .+...+..+..++|||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            589999999999999999999999999999986431                            1222345667789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... .
T Consensus       149 E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~-ikL~DFG~a~~~~~~~~-~  224 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGM-V  224 (410)
T ss_dssp             CCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTSE-E
T ss_pred             eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC-EEEeccceeEeeccCCc-c
Confidence            99999999999974  45799999999999999999999999999999999999998885 99999999976543221 1


Q ss_pred             ccccCCCCCCCCChhhHhCCC----CCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC----CCCCCCCCCcHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGEC----QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD----ELPRFPTQSSEL  205 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~----~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~----~~p~~~~~~s~~  205 (408)
                      .....+||+.|+|||++.+..    ++.++|||||||++|+|++|++||...+.......+...    ..|. ....+++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~  303 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKE  303 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT-TCCCCHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC-cccccHH
Confidence            233567999999999998765    788999999999999999999999877665554433221    2222 2468999


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHHcCCCCCCCCCCCc
Q 042746          206 GRDFLDKCLRREPGE--RWSCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       206 ~~~li~~~L~~dP~~--R~s~~ell~hpf~~~~~~~~~  241 (408)
                      +++||.+||..+|.+  |++++|+++||||+...|...
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence            999999999999988  999999999999999877643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-45  Score=357.90  Aligned_cols=224  Identities=20%  Similarity=0.230  Sum_probs=168.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCC----CCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTS----SSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~----~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++  +|+.||+|.....                        +.+....    ...++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3689999999999999999987  5899999864321                        1111111    12468999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR--------NIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~--------giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      |||+||+|.++++.  ..+++..+..++.|++.||+|||++        +|+||||||+||||+.++. +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~-~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC-EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC-EEEEeCCCCcc
Confidence            99999999999974  4578999999999999999999987        9999999999999999885 99999999976


Q ss_pred             cccCCCC--cccccCCCCCCCCChhhHhCC------CCCCCCCcchHHHHHHHHHhCCCCCCCCCh--------------
Q 042746          126 ATVSDTR--GVKIQPRGSPLWMAPEVVRGE------CQGPESDVWSLGCTIIEMVTGKPAWEDFGA--------------  183 (408)
Q Consensus       126 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~------~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--------------  183 (408)
                      .......  ......+||+.|||||++.+.      .++.++|||||||++|||+||.+||.....              
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            5433221  122345799999999999865      256789999999999999999877643211              


Q ss_pred             -hhhhhhcc-cCCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          184 -NTLSRIGF-SDELPRFPTQ-----SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       184 -~~~~~~~~-~~~~p~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                       ..+..... ....|.+|..     .++.+.+|+.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             11222111 1222344432     23467899999999999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-44  Score=357.38  Aligned_cols=231  Identities=26%  Similarity=0.382  Sum_probs=193.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++++.||+|+||+||+|.+..+++.||+|....                            .+...+......+||
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3689999999999999999999999999999985421                            112223455678899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+ +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......  
T Consensus        88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kl~DFG~s~~~~~~~--  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGN--  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC-EEECCSSCTBTTTTSB--
T ss_pred             EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC-EEEEEeccceeccCCc--
Confidence            9999 67999988754 56799999999999999999999999999999999999998875 9999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......+.... .......|...++.+++||.
T Consensus       163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-NSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-CSSCCCCCTTSCHHHHHHHH
T ss_pred             -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-HcCCCCCcccCCHHHHHHHH
Confidence             2334579999999999998766 68999999999999999999999876655554433 23334567788999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||..||.+|||++|+++||||+...+
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             HHcCCChhHCcCHHHHHhChhhccCCc
Confidence            999999999999999999999986443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-44  Score=353.92  Aligned_cols=236  Identities=22%  Similarity=0.333  Sum_probs=191.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      +++|++++.||+|+||+||+|++..+++.||+|....                          .+......+...+||||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4789999999999999999999999999999986431                          12222345567889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...........
T Consensus        86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC-EEEEEeeccceeccCCcccc
Confidence            9999999999873 456899999999999999999999999999999999999998875 99999999976543333233


Q ss_pred             cccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhh--hhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTL--SRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~--~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........  ................++.+.+||.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            345679999999999988765 7789999999999999999999986543221  1111112222223567889999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||..||.+|||+.|+++||||.....
T Consensus       244 ~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          244 KILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHccCChhhCcCHHHHhhChhhccccc
Confidence            999999999999999999999986543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5e-44  Score=343.55  Aligned_cols=234  Identities=24%  Similarity=0.383  Sum_probs=184.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      |++|++.+.||+|+||+||+|++..+++.||+|.....                           +...+..+...+|||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            68999999999999999999999999999999864311                           112233456688999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++ +|.+.+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCSCCS--
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEeecccceecCCccc--
Confidence            99986 677777666778999999999999999999999999999999999999998875 99999999976543222  


Q ss_pred             ccccCCCCCCCCChhhHhCCC-CCCCCCcchHHHHHHHHHhCCCCC-CCCChhhhhhhcc--------------------
Q 042746          134 VKIQPRGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAW-EDFGANTLSRIGF--------------------  191 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~-~~~~sDiWSLGvil~eLltG~~Pf-~~~~~~~~~~~~~--------------------  191 (408)
                      ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .............                    
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            223456899999999998765 799999999999999999887774 4333222111100                    


Q ss_pred             --------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 --------SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 --------~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                              ...........++.+++||.+||+.||++|||++|+++||||++..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                    00011222357889999999999999999999999999999987543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.8e-44  Score=347.13  Aligned_cols=234  Identities=24%  Similarity=0.417  Sum_probs=186.5

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +++|++.+.||+|+||+||+|++. +++.||+|....                           .+...+..+...+|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            478999999999999999999996 588999886431                           1222344567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++| +|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~--  174 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVR--  174 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEETTSCCC--
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC-EEEccCcCceecCCCcc--
Confidence            99986 888888876677899999999999999999999999999999999999998875 99999999976543222  


Q ss_pred             ccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---cCC---------------
Q 042746          134 VKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SDE---------------  194 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---~~~---------------  194 (408)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.............   ...               
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            2234568999999999987 568999999999999999999999997654332211110   000               


Q ss_pred             ---CC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          195 ---LP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       195 ---~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                         ..        ......++++++||.+||++||++|||+.|+++||||+...++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence               00        1123467889999999999999999999999999999987653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5e-44  Score=350.67  Aligned_cols=233  Identities=25%  Similarity=0.333  Sum_probs=191.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc---CCCcEEEEeecccc-----------------------------eeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDVS-----------------------------YEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~   49 (408)
                      .+|++.+.||+|+||+||+|++.   .+++.||+|.....                             +...+......
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            57999999999999999999985   68999998754311                             11223345678


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      +|||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           97 YLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC-EEECCCSCC------
T ss_pred             EEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc-EEEEeCCcccccccC
Confidence            9999999999999999854 56789999999999999999999999999999999999998875 999999998654322


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      ..  .....+||+.|+|||++.+..++.++||||||+++|+|++|++||................ +.+|...++.+++|
T Consensus       175 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l  251 (327)
T 3a62_A          175 GT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDL  251 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHH
T ss_pred             Cc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHH
Confidence            21  2334579999999999999889999999999999999999999998776555444433333 35667889999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          210 LDKCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       210 i~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      |.+||..||.+||     ++.|+++||||+...+.
T Consensus       252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             HHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            9999999999999     88999999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=354.60  Aligned_cols=231  Identities=23%  Similarity=0.315  Sum_probs=192.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|.+..+++.+++|...                        +.+...+......+|||||++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            68999999999999999999999999999987543                        122223445667899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC--CCCcEEEeecCCccccccCCCCccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP--NSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~--~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.  ++ .+||+|||++.......   ..
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~~~~~---~~  160 (321)
T 1tki_A           85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGD---NF  160 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEECCTTC---EE
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeECCCCC---cc
Confidence            99999999765567899999999999999999999999999999999999986  44 59999999997654322   22


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC---CCCCcHHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF---PTQSSELGRDFLDK  212 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~---~~~~s~~~~~li~~  212 (408)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.................+..   ....++++++||.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence            345689999999999998889999999999999999999999987665554443333332211   14678999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ||..||.+|||+.|+++||||+..
T Consensus       241 ~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          241 LLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HcCCChhHCcCHHHHhcChhhccC
Confidence            999999999999999999999753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=360.25  Aligned_cols=233  Identities=22%  Similarity=0.341  Sum_probs=194.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++++.||+|+||+||+|.+..+++.||+|....                            .+...+......++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3689999999999999999999999999999985321                            122234456678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......  
T Consensus        94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~-vkL~DFG~a~~~~~~~--  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRET--  169 (384)
T ss_dssp             ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECCTTC--
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC-EEEeccceeeeccCCC--
Confidence            999999999999984 567899999999999999999999999999999999999998885 9999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---hhhhhcccCCCCCCCCCCcHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                       .....+||+.|+|||++.+   ..++.++|||||||++|+|++|++||......   .+... .....+.+|...++.+
T Consensus       170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~p~~~s~~~  247 (384)
T 4fr4_A          170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FETTVVTYPSAWSQEM  247 (384)
T ss_dssp             -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-HHHCCCCCCTTSCHHH
T ss_pred             -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-HhhcccCCCCcCCHHH
Confidence             2345679999999999974   45889999999999999999999999753322   22222 2233346677889999


Q ss_pred             HHHHHHhcccCCCCCCC-HHHHHcCCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWS-CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s-~~ell~hpf~~~~~~~  239 (408)
                      ++||.+||++||.+||+ ++++++||||....+.
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence            99999999999999998 8999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=362.54  Aligned_cols=231  Identities=23%  Similarity=0.350  Sum_probs=190.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++++.||+|+||+||+|++..+++.+|+|....                           .+...+..+...+||||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            479999999999999999999999999999875431                           22233456677899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--CCcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |++||+|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+  +..+||+|||++........ 
T Consensus        91 ~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~-  168 (444)
T 3soa_A           91 LVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-  168 (444)
T ss_dssp             CCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred             eCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence            9999999999985 4678999999999999999999999999999999999999842  23599999999976543322 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC---CCCCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP---RFPTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p---~~~~~~s~~~~~l  209 (408)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+..........   ......++.+++|
T Consensus       169 -~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  247 (444)
T 3soa_A          169 -AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL  247 (444)
T ss_dssp             -BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred             -eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence             223467999999999999999999999999999999999999999877665554443333221   1224678999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      |.+||+.||.+|||+.|+|+||||..
T Consensus       248 i~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          248 INKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHcCCChhHCCCHHHHhcCccccC
Confidence            99999999999999999999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-43  Score=340.18  Aligned_cols=231  Identities=25%  Similarity=0.392  Sum_probs=181.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      |++|++++.||+|+||+||+|.+ .+++.+|+|.....                           +...+......++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999999 67899998864311                           111233456788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++ +|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--  155 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVR--  155 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC-----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEEeECccccccCcccc--
Confidence            99986 999999876678899999999999999999999999999999999999998875 99999999865432221  


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--------------------c
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--------------------S  192 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--------------------~  192 (408)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.............                    .
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            12334689999999999764 58999999999999999999999998654332211100                    0


Q ss_pred             CCC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          193 DEL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       193 ~~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ...        .......++.+++||.+||+.||++|||+.|+++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            000        01124578899999999999999999999999999999753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=347.43  Aligned_cols=235  Identities=22%  Similarity=0.402  Sum_probs=185.3

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmE   54 (408)
                      |++|++++.||+|+||+||+|++..+++.||+|.....                          +...+......+||||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999854311                          1112334566789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++| +|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~--~  156 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTK--T  156 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC-EEECSSSEEECC--------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC-EEEccCcccccccCCcc--c
Confidence            9985 999999877778999999999999999999999999999999999999998875 99999999865443221  2


Q ss_pred             cccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc---C-----------------
Q 042746          135 KIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS---D-----------------  193 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~---~-----------------  193 (408)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||..............   .                 
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            233468999999999987 5679999999999999999999999987654332211100   0                 


Q ss_pred             -CCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 -ELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 -~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                       ..+        ......++++++||.+||+.||.+|||+.|+++||||......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence             000        0113467889999999999999999999999999999877654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.1e-44  Score=353.69  Aligned_cols=231  Identities=22%  Similarity=0.357  Sum_probs=189.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------ceeccCCCCCcceEEEeccCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                      .+...+......+|||||++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg  101 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG  101 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999999986432                      1222345567789999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC---CcEEEeecCCccccccCCCCcccc
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS---SFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~---~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||+..+.   ..+||+|||+++.......  ...
T Consensus       102 ~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~  178 (342)
T 2qr7_A          102 ELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLM  178 (342)
T ss_dssp             BHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBC
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--cee
Confidence            99999974 46789999999999999999999999999999999999985432   2499999999976543322  234


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC---hhhhhhhcccCCCC---CCCCCCcHHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---ANTLSRIGFSDELP---RFPTQSSELGRDFL  210 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~---~~~~~~~~~~~~~p---~~~~~~s~~~~~li  210 (408)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|.+||....   ...+.........+   ..+...++.+++||
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  258 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLV  258 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHH
T ss_pred             ccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHH
Confidence            5679999999999998888899999999999999999999997532   22222222222221   23356899999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      .+||..||.+|||+.|+++||||..
T Consensus       259 ~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          259 SKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=345.78  Aligned_cols=232  Identities=23%  Similarity=0.344  Sum_probs=189.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~   50 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|.....                               +...+......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4699999999999999999999999999998754311                               111234456688


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC---cEEEeecCCccccc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS---FVKLADFGAAGEAT  127 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~---~vkL~DFGla~~~~  127 (408)
                      |||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.   .+||+|||++....
T Consensus        91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999974 567899999999999999999999999999999999999987652   49999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~  204 (408)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.................   +..+...++
T Consensus       170 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (326)
T 2y0a_A          170 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  246 (326)
T ss_dssp             TTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             CCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence            322   12345699999999999999999999999999999999999999987654443332222211   112246788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+++||.+||..||.+|||+.|+++||||+...
T Consensus       247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            999999999999999999999999999997543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-43  Score=354.01  Aligned_cols=237  Identities=22%  Similarity=0.347  Sum_probs=186.5

Q ss_pred             CCeEeeceeeec--CCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRG--SFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G--~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|  +||+||+|+++.+++.||+|....                           .+...+..+...+||
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            579999999999  999999999999999999986432                           122234456678999


Q ss_pred             EeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC-
Q 042746           53 LEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-  130 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-  130 (408)
                      |||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....... 
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~-~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK-VYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCGGGCEECEETTE
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEcccccceeeccccc
Confidence            9999999999999864 356899999999999999999999999999999999999998875 9999999885432211 


Q ss_pred             ----CCcccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--------
Q 042746          131 ----TRGVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--------  196 (408)
Q Consensus       131 ----~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--------  196 (408)
                          .........||+.|+|||++.+  ..++.++|||||||++|+|++|++||.................+        
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI  263 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence                1111223468999999999987  57899999999999999999999999865433322211111111        


Q ss_pred             -------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          197 -------------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       197 -------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                                           ..+...++.+++||.+||+.||.+|||+.|+++||||+.....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~  343 (389)
T 3gni_B          264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR  343 (389)
T ss_dssp             ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred             ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence                                                 1344578899999999999999999999999999999876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-43  Score=352.11  Aligned_cols=230  Identities=23%  Similarity=0.343  Sum_probs=190.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                           .+...+..+...+||||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            369999999999999999999999999999986431                           12223445667899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~  132 (408)
                      |++||+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||++.......  
T Consensus       109 ~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~--  185 (362)
T 2bdw_A          109 LVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--  185 (362)
T ss_dssp             CCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred             cCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence            9999999999874 46789999999999999999999999999999999999998643  359999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC---CCCCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP---RFPTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p---~~~~~~s~~~~~l  209 (408)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+...+..........   ......++.+++|
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  264 (362)
T 2bdw_A          186 -AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL  264 (362)
T ss_dssp             -SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHH
T ss_pred             -ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence             223457999999999999989999999999999999999999999877655544433332221   1113578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      |.+||.+||.+|||+.|+++||||..
T Consensus       265 i~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          265 IDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHcCCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999964

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-43  Score=337.92  Aligned_cols=231  Identities=27%  Similarity=0.408  Sum_probs=191.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++++.||+|+||+||+|.+..++..+++|....                            .+...+......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4789999999999999999999999999999885421                            112223455678899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......  
T Consensus        88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~-~~l~Dfg~~~~~~~~~--  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSR--  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC-EEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC-EEEEeccccccCCccc--
Confidence            9999999999999854 56799999999999999999999999999999999999998875 9999999985543222  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............. ....++...++.+++||.+
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  240 (279)
T 3fdn_A          164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTFPDFVTEGARDLISR  240 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-TCCCCCTTSCHHHHHHHHH
T ss_pred             --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-CCCCCCCcCCHHHHHHHHH
Confidence              2345689999999999999899999999999999999999999987765554443322 2235567789999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ||+.||.+|||+.|+++||||.....
T Consensus       241 ~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HhccChhhCCCHHHHhhCccccCCcc
Confidence            99999999999999999999976543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=335.43  Aligned_cols=233  Identities=27%  Similarity=0.412  Sum_probs=170.5

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++++.||+|+||+||+|++..+++.|++|....                            .+...+......++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            4689999999999999999999999999999986431                            111223455678899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++........ 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~-  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHE-  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC-EEECCCTTCEECC-----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC-EEEEeecceeeccCCCC-
Confidence            9999999999999876678899999999999999999999999999999999999998875 99999999976543222 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                       ......||+.|+|||++.+..++.++|+||||+++|+|++|++||................ ...+...+.++++||.+
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHHHHH
T ss_pred             -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHHHHH
Confidence             1233568999999999999889999999999999999999999998655443333222222 24566789999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||+.||++|||+.|+++||||....
T Consensus       246 ~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999997543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=343.73  Aligned_cols=226  Identities=27%  Similarity=0.352  Sum_probs=182.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|....                            .+...+......+|||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            369999999999999999999999999999986321                            1122234456788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+ +++|.+++...+..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||++.......   
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kl~DFG~a~~~~~~~---  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAG---  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC-EEECCCTTCEECC------
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC-EEEccceeeeecccCC---
Confidence            999 66999999877778999999999999999999999999999999999999998875 9999999986654322   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.....  ..........+.++...++.+++||.+|
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--WQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--HHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            2234569999999999987 589999999999999999999666543221  1111111122234567889999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      |+.||++|||+.|+++||||++
T Consensus       289 L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          289 LEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-43  Score=355.66  Aligned_cols=234  Identities=25%  Similarity=0.387  Sum_probs=176.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccC--CCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPT--TSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~--~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|....                            .+...+  .....++|
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            689999999999999999999999999999986421                            011111  22346899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC-
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD-  130 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-  130 (408)
                      ||||+++ +|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...... 
T Consensus        89 v~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           89 VFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEESSSCCC
T ss_pred             EecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC-EEecCCccccccccccc
Confidence            9999985 89999974  57899999999999999999999999999999999999998885 9999999997543210 


Q ss_pred             ------------------CCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc
Q 042746          131 ------------------TRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       131 ------------------~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~  191 (408)
                                        ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                              1112234579999999999987 578999999999999999999999998655332221110


Q ss_pred             c-CCCC---------------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 042746          192 S-DELP---------------------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCD  225 (408)
Q Consensus       192 ~-~~~p---------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~  225 (408)
                      . ...|                                             ..+...++++.+||.+||..||.+|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            0 0000                                             01125688999999999999999999999


Q ss_pred             HHHcCCCCCCCCCC
Q 042746          226 QLLKHPFLQSVSPS  239 (408)
Q Consensus       226 ell~hpf~~~~~~~  239 (408)
                      |+++||||+.....
T Consensus       325 e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          325 DALKHPFVSIFHNP  338 (388)
T ss_dssp             HHTTSTTTTTTCCG
T ss_pred             HHhCCHHHHHhcCC
Confidence            99999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-43  Score=369.37  Aligned_cols=234  Identities=27%  Similarity=0.403  Sum_probs=195.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|+++.+++.||+|....                            .+...++....++|||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            679999999999999999999999999999986431                            1122244566789999


Q ss_pred             eccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           54 EYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ||++||+|.+++...   ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~-vkL~DFGla~~~~~~~  343 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQ  343 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECCTTC
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC-EEEeecceeeeccCCC
Confidence            999999999999754   346899999999999999999999999999999999999998885 9999999997654332


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC----hhhhhhhcccCCCCCCCCCCcHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG----ANTLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~----~~~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|++||....    ...+...+.. ..+.+|...++.+
T Consensus       344 ~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~~  420 (543)
T 3c4z_A          344 T--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSPAS  420 (543)
T ss_dssp             C--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSCHHH
T ss_pred             c--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccCHHH
Confidence            2  2334579999999999999999999999999999999999999997643    2233333222 2345677899999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      ++||.+||++||.+||+     ++|+++||||+...+.
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            99999999999999995     5899999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.6e-43  Score=349.79  Aligned_cols=233  Identities=22%  Similarity=0.304  Sum_probs=178.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|....                        .+...+......+|||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            689999999999999999999999999999986431                        12223445667899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC-cEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++......   ...
T Consensus       100 ~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~  175 (361)
T 3uc3_A          100 GGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPK  175 (361)
T ss_dssp             SCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCC
Confidence            99999999754 46799999999999999999999999999999999999986542 49999999996433222   223


Q ss_pred             cCCCCCCCCChhhHhCCCCCCC-CCcchHHHHHHHHHhCCCCCCCCChh----hhhhhcccCCC-CCCCCCCcHHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRGECQGPE-SDVWSLGCTIIEMVTGKPAWEDFGAN----TLSRIGFSDEL-PRFPTQSSELGRDFL  210 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~-sDiWSLGvil~eLltG~~Pf~~~~~~----~~~~~~~~~~~-p~~~~~~s~~~~~li  210 (408)
                      ...||+.|+|||++.+..+..+ +|||||||++|+|++|++||......    ........... .......++.+++||
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  255 (361)
T 3uc3_A          176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI  255 (361)
T ss_dssp             -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred             CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence            4569999999999988877655 89999999999999999999864321    11111111111 112235789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+||.+||.+|||+.|+++||||....+
T Consensus       256 ~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          256 SRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            9999999999999999999999965443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-43  Score=350.76  Aligned_cols=231  Identities=27%  Similarity=0.373  Sum_probs=187.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~L   51 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                              .+...+..+...+|
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            369999999999999999999999999999986421                              11122344567899


Q ss_pred             EEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCcccc
Q 042746           52 HLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEA  126 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~  126 (408)
                      ||||++||+|.+.+...   +..+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999999888643   33589999999999999999999999999999999999997643  24999999999765


Q ss_pred             ccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC---CCCCc
Q 042746          127 TVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF---PTQSS  203 (408)
Q Consensus       127 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~---~~~~s  203 (408)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..........+ ........   ....+
T Consensus       184 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i-~~~~~~~~~~~~~~~s  260 (351)
T 3c0i_A          184 GESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI-IKGKYKMNPRQWSHIS  260 (351)
T ss_dssp             CTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH-HHTCCCCCHHHHTTSC
T ss_pred             cCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH-HcCCCCCCccccccCC
Confidence            43221  22345799999999999999899999999999999999999999987543322222 22222111   24678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      +.+++||.+||..||++|||+.|+++||||+.
T Consensus       261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            99999999999999999999999999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8e-43  Score=337.68  Aligned_cols=230  Identities=26%  Similarity=0.318  Sum_probs=182.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------------eccCCC---
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------------EAPTTS---   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------------~~~~~~---   45 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|......                                 ...+..   
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            58999999999999999999999999999998643110                                 000111   


Q ss_pred             --CCcceEEEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           46 --SSCRNLHLEYLPGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        46 --~~~~~LVmEy~~gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                        ....+++|||+.+ +|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus        89 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~  166 (308)
T 3g33_A           89 DREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGL  166 (308)
T ss_dssp             SSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC-EEECSCSC
T ss_pred             CCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-EEEeeCcc
Confidence              1147899999985 99999985432 3899999999999999999999999999999999999998875 99999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-------CCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-------DEL  195 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-------~~~  195 (408)
                      +........   .....||+.|+|||++.+..++.++|||||||++|+|++|++||..............       ...
T Consensus       167 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          167 ARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             TTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            976543222   2345699999999999999999999999999999999999999987654332221110       000


Q ss_pred             C-------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          196 P-------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       196 p-------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +                   ......++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            0                   0123578899999999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-43  Score=353.18  Aligned_cols=233  Identities=23%  Similarity=0.318  Sum_probs=192.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|++.+.||+|+||+||+|+++.+++.+++|....                         .+...+......+|||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            579999999999999999999999999999876431                         1222344566789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC-CCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN-SSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~-~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||++.......   ..
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~  207 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IV  207 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc---ce
Confidence            9999999997655678999999999999999999999999999999999999753 2359999999997654322   12


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC---CCCCCCCCcHHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE---LPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~---~p~~~~~~s~~~~~li~~  212 (408)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|.+||................   .+......++.+++||.+
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  287 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN  287 (387)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred             eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHH
Confidence            33469999999999999989999999999999999999999998765444333222221   122335678999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||..||.+|||+.|+++||||....
T Consensus       288 ~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          288 LLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             TSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.2e-43  Score=363.21  Aligned_cols=232  Identities=26%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +.+|++++.||+|+||+||+|++..+++.||+|....                            .+...+......+||
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3689999999999999999999999999999986431                            112223445678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......  
T Consensus        95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~-vkL~DFG~a~~~~~~~--  170 (476)
T 2y94_A           95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGE--  170 (476)
T ss_dssp             EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC-EEECCCSSCEECCTTC--
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC-eEEEeccchhhccccc--
Confidence            999999999999973 567899999999999999999999999999999999999998875 9999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....+........ ...|...++.+++||.
T Consensus       171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLK  248 (476)
T ss_dssp             -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHH
T ss_pred             -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHH
Confidence             2334679999999999998765 678999999999999999999998876655555443333 3566788999999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||..||.+|||+.|+++||||+...+
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            999999999999999999999986543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-43  Score=342.58  Aligned_cols=234  Identities=21%  Similarity=0.354  Sum_probs=174.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      .+|++.+.||+|+||+||+|.++.+++.||+|....                          .+...+..+...+|||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            589999999999999999999999999999986431                          122234456678999999


Q ss_pred             cCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           56 LPGGTVSDLATTLN-----AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        56 ~~gGsL~~~l~~~~-----~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ++| +|.+++....     ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus        85 ~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           85 MDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCSSCEETTSCC
T ss_pred             cCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC-EEECcCccceecCCCc
Confidence            985 9999987542     35899999999999999999999999999999999999998875 9999999997654322


Q ss_pred             CCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc-----------------
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS-----------------  192 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~-----------------  192 (408)
                      .  ......||+.|+|||++.+. .++.++|||||||++|+|++|++||..............                 
T Consensus       163 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          163 N--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             C--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             c--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            1  22345689999999999874 689999999999999999999999986554322211100                 


Q ss_pred             ---CCC-------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 ---DEL-------------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ---~~~-------------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                         ...             +..+...++.+++||.+||+.||++|||+.|+++||||+.....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence               000             01123578899999999999999999999999999999876554

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=339.69  Aligned_cols=235  Identities=26%  Similarity=0.411  Sum_probs=182.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      |++|++++.||+|+||+||+|++..+++.||+|....                           .+...+......++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            5799999999999999999999999999999985321                           1222234456678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        82 e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           82 EYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             ECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC-EEEeeCCCchhccCccc--
Confidence            9999999999887 4567899999999999999999999999999999999999998875 99999999976543221  


Q ss_pred             ccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc---------------------c
Q 042746          134 VKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG---------------------F  191 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~---------------------~  191 (408)
                      ......||+.|+|||++.+ ..++.++||||||+++|+|++|.+||............                     .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS  237 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence            1234568999999999986 56799999999999999999999999865533221110                     0


Q ss_pred             cCCCCCC---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          192 SDELPRF---------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       192 ~~~~p~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ....+..         ....++.+.+||.+||+.||.+|||++|+++||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            0011110         13578889999999999999999999999999999876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-43  Score=372.03  Aligned_cols=233  Identities=23%  Similarity=0.358  Sum_probs=195.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|+++.+++.||+|....                            .+...+.....++|||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            579999999999999999999999999999986431                            1222344567789999


Q ss_pred             eccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||++||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......  
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~-vKL~DFGla~~~~~~~--  340 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQ--  340 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEECCTTC--
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC-eEEEecccceecccCc--
Confidence            9999999999997543 34899999999999999999999999999999999999998885 9999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCCcHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQSSELGRD  208 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~s~~~~~  208 (408)
                       .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.....    ..+..... ...+.++...++++++
T Consensus       341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~-~~~~~~p~~~s~~~~d  418 (576)
T 2acx_A          341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFSPQARS  418 (576)
T ss_dssp             -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH-HCCCCCCTTSCHHHHH
T ss_pred             -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh-cccccCCccCCHHHHH
Confidence             22345799999999999998899999999999999999999999986432    22332222 2234566788999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          209 FLDKCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       209 li~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||.+||.+||.+||     +++|+++||||+...+.
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            99999999999999     78999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.6e-43  Score=346.02  Aligned_cols=226  Identities=27%  Similarity=0.313  Sum_probs=180.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|....                             .+...+......+||
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            579999999999999999999999999999986431                             111122344567899


Q ss_pred             EeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---------------------
Q 042746           53 LEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---------------------  110 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---------------------  110 (408)
                      |||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.                     
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            9999 889999998643 35899999999999999999999999999999999999975                     


Q ss_pred             ----CCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh
Q 042746          111 ----NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL  186 (408)
Q Consensus       111 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~  186 (408)
                          ++ .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|++||........
T Consensus       194 ~~~~~~-~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  267 (360)
T 3llt_A          194 YRTKST-GIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH  267 (360)
T ss_dssp             EEESCC-CEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccCCC-CEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence                44 5999999999654322     2245689999999999999999999999999999999999999976543322


Q ss_pred             hhhcc--cCC-------------------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          187 SRIGF--SDE-------------------------------------------LPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       187 ~~~~~--~~~-------------------------------------------~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      .....  ...                                           .+.++...++.+.+||.+||+.||.+|
T Consensus       268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  347 (360)
T 3llt_A          268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR  347 (360)
T ss_dssp             HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence            11100  000                                           001111234678899999999999999


Q ss_pred             CCHHHHHcCCCCC
Q 042746          222 WSCDQLLKHPFLQ  234 (408)
Q Consensus       222 ~s~~ell~hpf~~  234 (408)
                      ||+.|+|+||||+
T Consensus       348 pta~elL~hp~f~  360 (360)
T 3llt_A          348 PSPAELLKHKFLE  360 (360)
T ss_dssp             CCHHHHTTSGGGC
T ss_pred             CCHHHHhcCcccC
Confidence            9999999999995

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-42  Score=354.75  Aligned_cols=236  Identities=25%  Similarity=0.345  Sum_probs=170.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccC-----CCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPT-----TSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~-----~~~~~~   49 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                           .+...+     +....+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            579999999999999999999999999999986421                           111111     233568


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ||||||+. |+|.+++. ....+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus       133 ~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~-~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEECCCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC-EEECCCTTCBCTTSC
T ss_pred             EEEEeccc-cchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC-EeecccccchhccCc
Confidence            99999985 69999997 4567899999999999999999999999999999999999999885 999999999765422


Q ss_pred             CCC-------------------------cccccCCCCCCCCChhhH-hCCCCCCCCCcchHHHHHHHHHh----------
Q 042746          130 DTR-------------------------GVKIQPRGSPLWMAPEVV-RGECQGPESDVWSLGCTIIEMVT----------  173 (408)
Q Consensus       130 ~~~-------------------------~~~~~~~Gt~~y~APE~l-~~~~~~~~sDiWSLGvil~eLlt----------  173 (408)
                      ...                         ......+||+.|+|||++ .+..|+.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            110                         122345789999999987 45678999999999999999999          


Q ss_pred             -CCCCCCCCCh---------------------hhhhhhc---------------------ccCCC--------CCCCCCC
Q 042746          174 -GKPAWEDFGA---------------------NTLSRIG---------------------FSDEL--------PRFPTQS  202 (408)
Q Consensus       174 -G~~Pf~~~~~---------------------~~~~~~~---------------------~~~~~--------p~~~~~~  202 (408)
                       |+++|.....                     ..+..+.                     +....        .......
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6677754321                     0000000                     00000        1112346


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                      ++++.+||.+||.+||.+|||++|+|+||||+......
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            88999999999999999999999999999999887653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.3e-43  Score=355.01  Aligned_cols=231  Identities=25%  Similarity=0.339  Sum_probs=179.5

Q ss_pred             CCeEee-ceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceeccC----CCCCcceEEEec
Q 042746            2 VSWVRG-KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAPT----TSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~-~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~~----~~~~~~~LVmEy   55 (408)
                      ++|.+. +.||+|+||+||+|+++.+++.||+|....                     .+...+    ....+++|||||
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~  140 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC  140 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence            567776 799999999999999999999999986431                     111111    225568999999


Q ss_pred             cCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccccccCCC
Q 042746           56 LPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        56 ~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++ .+||+|||+++...... 
T Consensus       141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~~~~~~-  218 (400)
T 1nxk_A          141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHN-  218 (400)
T ss_dssp             CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEECC----
T ss_pred             CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc-cEEEEecccccccCCCC-
Confidence            99999999998543 35899999999999999999999999999999999999987   44 59999999997654322 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh----hhhhcccCC--CC-CCCCCCcH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSRIGFSDE--LP-RFPTQSSE  204 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~----~~~~~~~~~--~p-~~~~~~s~  204 (408)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.......    .........  .+ ......++
T Consensus       219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  296 (400)
T 1nxk_A          219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE  296 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCH
Confidence              2335679999999999999999999999999999999999999997643221    111111111  11 11246889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ++++||.+||..||.+|||+.|+++||||...
T Consensus       297 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          297 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999999754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=343.96  Aligned_cols=232  Identities=25%  Similarity=0.338  Sum_probs=181.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|....                       .+...+......+|||||++|
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            469999999999999999999999999999876432                       112223455678899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccccccCCCCccc
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.   ++ .+||+|||+++......   ..
T Consensus       133 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~~~~~---~~  207 (349)
T 2w4o_A          133 GELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEHQV---LM  207 (349)
T ss_dssp             CBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC-CEEECCCC--------------
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC-CEEEccCccccccCccc---cc
Confidence            999999974 456899999999999999999999999999999999999974   44 59999999997654322   12


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcccCCC---CCCCCCCcHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGFSDEL---PRFPTQSSELGRDFLD  211 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~---p~~~~~~s~~~~~li~  211 (408)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........   +......+..+++||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  287 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR  287 (349)
T ss_dssp             -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence            34569999999999999989999999999999999999999997654332 2222222221   1233567899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||..||++|||+.|+++||||.....
T Consensus       288 ~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          288 KLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCcc
Confidence            999999999999999999999986543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.7e-43  Score=343.52  Aligned_cols=235  Identities=21%  Similarity=0.357  Sum_probs=180.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      +++|++++.||+|+||+||+|++..+++.||+|.....                           +...+..+...+|||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            46899999999999999999999999999999864311                           111233456678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC----CcEEEeecCCccccccC
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS----SFVKLADFGAAGEATVS  129 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~----~~vkL~DFGla~~~~~~  129 (408)
                      ||++| +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++    ..+||+|||++......
T Consensus       113 e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          113 EYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             ECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             ecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            99985 99999985 45689999999999999999999999999999999999995322    24999999999665432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc-----------------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-----------------  191 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~-----------------  191 (408)
                      ..  ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.............                 
T Consensus       191 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          191 IR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            21  22344689999999999874 47999999999999999999999998655432221110                 


Q ss_pred             ---cCCCCCC---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          192 ---SDELPRF---------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       192 ---~~~~p~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                         ....+.+         +...++++++||.+||+.||.+|||+.|+++||||+...++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence               0011111         11267889999999999999999999999999999987653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=338.79  Aligned_cols=229  Identities=25%  Similarity=0.371  Sum_probs=183.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------------------
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------------------   38 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------------------   38 (408)
                      +.+|++.+.||+|+||+||+|++..+++.||+|.....                                          
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            36899999999999999999999999999998864211                                          


Q ss_pred             ---------eeccCC--CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042746           39 ---------YEAPTT--SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL  107 (408)
Q Consensus        39 ---------~~~~~~--~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NIL  107 (408)
                               +...+.  .....++||||+++|+|.+++.  ...+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence                     001111  2456889999999999988753  457899999999999999999999999999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCC---CCCCCCcchHHHHHHHHHhCCCCCCCCChh
Q 042746          108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC---QGPESDVWSLGCTIIEMVTGKPAWEDFGAN  184 (408)
Q Consensus       108 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~sDiWSLGvil~eLltG~~Pf~~~~~~  184 (408)
                      ++.++. +||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||......
T Consensus       170 ~~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          170 VGEDGH-IKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             ECTTSC-EEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             ECCCCC-EEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            998875 99999999976543221  233457999999999998764   367889999999999999999999876655


Q ss_pred             hhhhhcccCCC-CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          185 TLSRIGFSDEL-PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       185 ~~~~~~~~~~~-p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      ........... .......++.+++||.+||+.||++|||+.|+++||||.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            44333222221 122346789999999999999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-42  Score=337.82  Aligned_cols=232  Identities=26%  Similarity=0.360  Sum_probs=190.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~   50 (408)
                      ++|++++.||+|+||+||+|++..+++.+|+|.....                               +...+......+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            4699999999999999999999999999998754321                               111233456688


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC---cEEEeecCCccccc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS---FVKLADFGAAGEAT  127 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~---~vkL~DFGla~~~~  127 (408)
                      +||||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.   .+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999974 567899999999999999999999999999999999999987762   49999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~  204 (408)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.................   +..+...++
T Consensus       171 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (321)
T 2a2a_A          171 DGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSE  247 (321)
T ss_dssp             TTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             ccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCH
Confidence            322   12345699999999999999999999999999999999999999987655444333222221   112256788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+++||.+||..||.+|||+.|+++||||....
T Consensus       248 ~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            999999999999999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-42  Score=329.78  Aligned_cols=233  Identities=23%  Similarity=0.333  Sum_probs=191.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++.+.||+|+||+||+|.+..+++.|++|....                           .+...+..+...++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            589999999999999999999999999999886432                           11222345566789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~  132 (408)
                      |++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+||+++.++  ..+||+|||++........ 
T Consensus        86 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~-  163 (284)
T 3kk8_A           86 LVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-  163 (284)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB-
T ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc-
Confidence            99999999988754 5679999999999999999999999999999999999997543  2499999999965543222 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~l  209 (408)
                        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.................   .......++.+++|
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (284)
T 3kk8_A          164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL  241 (284)
T ss_dssp             --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred             --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence              2345699999999999999999999999999999999999999987665544433222221   12224678999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      |.+||+.||.+|||+.|+++||||.....
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          242 IDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHcccChhhCCCHHHHhcCccccCChh
Confidence            99999999999999999999999976543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.3e-42  Score=338.03  Aligned_cols=229  Identities=30%  Similarity=0.479  Sum_probs=188.7

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCCCCCcceEEEeccCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      |...+.||+|+||+||+|++..+++.||+|.....                         +...+......+|||||++|
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            78889999999999999999999999999864311                         11122344567899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++.  ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  .....
T Consensus       127 ~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~~~~~~~~~~--~~~~~  201 (321)
T 2c30_A          127 GALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP--KRKSL  201 (321)
T ss_dssp             CBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSSSC--CBCCC
T ss_pred             CCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc-EEEeeeeeeeecccCcc--ccccc
Confidence            99999986  356899999999999999999999999999999999999998875 99999999876543222  22345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC--CCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR--FPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~--~~~~~s~~~~~li~~~L~~  216 (408)
                      .||+.|+|||++.+..++.++||||||+++|+|++|+.||.................+.  .+...++.+++||.+||..
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            79999999999999889999999999999999999999998765544433322222222  2345788999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||++|||+.|+++||||....
T Consensus       282 dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          282 DPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             STTTSCCHHHHHTSGGGGGCC
T ss_pred             ChhhCcCHHHHhcChhhccCC
Confidence            999999999999999997543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-42  Score=332.86  Aligned_cols=231  Identities=24%  Similarity=0.385  Sum_probs=193.8

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      +++|++++.||+|+||+||+|++..+++.+++|....                            .+...+......++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            4689999999999999999999999999999886421                            112223345678899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......  
T Consensus        93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC-EEECCCTTCEECSSSC--
T ss_pred             EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC-EEEecccccccCcccc--
Confidence            9999999999999854 46799999999999999999999999999999999999998875 9999999986543221  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        .....||+.|+|||++.+..++.++|+||||+++|+|++|..||................ ..++...+..+++||.+
T Consensus       169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHH
T ss_pred             --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHH
Confidence              224568999999999999889999999999999999999999998766554444333322 35667889999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ||..||.+|||+.|+++||||+....
T Consensus       246 ~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999999985443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.3e-43  Score=343.31  Aligned_cols=231  Identities=22%  Similarity=0.290  Sum_probs=168.8

Q ss_pred             CeEee---ceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEecc
Q 042746            3 SWVRG---KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         3 ~Y~~~---~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      +|.+.   +.||+|+||+||+|+++.+++.||+|....                       .+...+..+...+|||||+
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~   88 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL   88 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence            56664   889999999999999999999999986432                       1222344566789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC--cEEEeecCCccccccCCCCcc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS--FVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~--~vkL~DFGla~~~~~~~~~~~  134 (408)
                      +||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||+++.......  .
T Consensus        89 ~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~  165 (325)
T 3kn6_A           89 NGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P  165 (325)
T ss_dssp             CSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence            99999999985 467899999999999999999999999999999999999976542  599999999975443222  2


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-------hhhhhhcccCCCCCCC----CCCc
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-------NTLSRIGFSDELPRFP----TQSS  203 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-------~~~~~~~~~~~~p~~~----~~~s  203 (408)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.....       ............ .++    ...+
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-SFEGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-CCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-CCCcccccCCC
Confidence            3345789999999999999999999999999999999999999975432       122222222222 222    2578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +++++||.+||..||.+|||+.|+++||||+...
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            9999999999999999999999999999998654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.2e-42  Score=348.72  Aligned_cols=236  Identities=23%  Similarity=0.346  Sum_probs=179.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCC-----Ccc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSS-----SCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~-----~~~   49 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|....                           .+...+...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            589999999999999999999999999999986431                           111111122     568


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ||||||+.+ +|.++++ ....+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus       106 ~lv~e~~~~-~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~-~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          106 YIVLEIADS-DLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEECCSE-EHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEEC---
T ss_pred             EEEEecCCc-CHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC-EEEccCCCccccccc
Confidence            999999975 9999997 4567899999999999999999999999999999999999998875 999999999765432


Q ss_pred             CCC--------------------cccccCCCCCCCCChhhH-hCCCCCCCCCcchHHHHHHHHHhCCCCC----------
Q 042746          130 DTR--------------------GVKIQPRGSPLWMAPEVV-RGECQGPESDVWSLGCTIIEMVTGKPAW----------  178 (408)
Q Consensus       130 ~~~--------------------~~~~~~~Gt~~y~APE~l-~~~~~~~~sDiWSLGvil~eLltG~~Pf----------  178 (408)
                      ...                    ......+||++|+|||++ .+..++.++|||||||++|+|++|..||          
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            211                    123456799999999997 4567899999999999999999854444          


Q ss_pred             -CCCCh------------------hhhhhhc---------------------ccCCCCC--------CCCCCcHHHHHHH
Q 042746          179 -EDFGA------------------NTLSRIG---------------------FSDELPR--------FPTQSSELGRDFL  210 (408)
Q Consensus       179 -~~~~~------------------~~~~~~~---------------------~~~~~p~--------~~~~~s~~~~~li  210 (408)
                       ...+.                  .++..+.                     +....+.        .....++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence             32210                  0000000                     0000000        1135789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVSPSD  240 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~~~~  240 (408)
                      .+||.+||.+|||++|+|+||||+......
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            999999999999999999999999887654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.1e-43  Score=338.14  Aligned_cols=236  Identities=24%  Similarity=0.366  Sum_probs=179.1

Q ss_pred             CCeEee-ceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRG-KCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~-~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmE   54 (408)
                      +.|++. +.||+|+||+||+|++..+++.||+|.....                          +...+..+...+||||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            468884 8899999999999999999999999864311                          1112334566889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC--cEEEeecCCccccccCCC-
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS--FVKLADFGAAGEATVSDT-  131 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~--~vkL~DFGla~~~~~~~~-  131 (408)
                      |++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||++........ 
T Consensus        92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            99999999999854 56799999999999999999999999999999999999987653  399999999865432211 


Q ss_pred             ----CcccccCCCCCCCCChhhHhC-----CCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---------------hhh
Q 042746          132 ----RGVKIQPRGSPLWMAPEVVRG-----ECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---------------TLS  187 (408)
Q Consensus       132 ----~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---------------~~~  187 (408)
                          .......+||+.|+|||++.+     ..++.++|||||||++|+|++|++||......               .+.
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                111224569999999999975     45789999999999999999999999764321               111


Q ss_pred             hhcccCCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          188 RIGFSDELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       188 ~~~~~~~~p~~~----~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ........ .++    ...++.+++||.+||..||.+|||+.|+++||||+...+.
T Consensus       251 ~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          251 ESIQEGKY-EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHCCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred             HHHhccCc-ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence            11112221 222    3578899999999999999999999999999999876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.6e-43  Score=359.61  Aligned_cols=228  Identities=25%  Similarity=0.319  Sum_probs=175.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~~   48 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                           +...+      .....
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            5799999999999999999999999999999875311                           11111      12245


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+|||||+++ +|.+.+.   ..+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus       142 ~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCCC-----
T ss_pred             EEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC-EEEEEEEeeeecCC
Confidence            6999999987 4666664   45899999999999999999999999999999999999998885 99999999976543


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc-----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-----------------  191 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~-----------------  191 (408)
                      ..   .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.......+.                 
T Consensus       217 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          217 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             Cc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            22   2334579999999999999999999999999999999999999998755322211110                 


Q ss_pred             ----cCCCCCCCC---------C-----------CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          192 ----SDELPRFPT---------Q-----------SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       192 ----~~~~p~~~~---------~-----------~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                          ....|....         .           .++++++||.+||.+||++|||++|+|+||||....
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                001111110         0           156789999999999999999999999999998644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=345.17  Aligned_cols=234  Identities=26%  Similarity=0.397  Sum_probs=188.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc---CCCcEEEEeecccc------------------------------eeccCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDVS------------------------------YEAPTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~~------------------------------~~~~~~~~~~   48 (408)
                      .+|++.+.||+|+||+||+|++.   .+++.||+|.....                              +...+.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            68999999999999999999995   58899998764311                              1111233456


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+|||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEESCSSEEEECCG
T ss_pred             EEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc-EEEeeCCCCeeccc
Confidence            78999999999999999854 46799999999999999999999999999999999999998875 99999999975432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCCh----hhhhhhcccCCCCCCCCCC
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFGA----NTLSRIGFSDELPRFPTQS  202 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~~----~~~~~~~~~~~~p~~~~~~  202 (408)
                      ... ......+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.....    ..+.... ....+.++...
T Consensus       212 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~  289 (355)
T 1vzo_A          212 DET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-LKSEPPYPQEM  289 (355)
T ss_dssp             GGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-HHCCCCCCTTS
T ss_pred             CCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH-hccCCCCCccc
Confidence            221 122345799999999999863  468899999999999999999999974322    2222222 22334667788


Q ss_pred             cHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      +..+++||.+||..||.+||     |++|+++||||....+.
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~  331 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  331 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence            99999999999999999999     99999999999987654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-42  Score=330.59  Aligned_cols=229  Identities=22%  Similarity=0.304  Sum_probs=182.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|.+..++..+++|.....                          +...+......++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            4699999999999999999999999999998764321                          12223445668899999


Q ss_pred             cCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccccccC
Q 042746           56 LPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        56 ~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~~  129 (408)
                      ++||+|.+++..   .+..+++..++.++.||+.||+|||++||+||||||+|||++.   ++ .+||+|||++......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTC-CEEECCCCCCCC----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCC-CEEEEeeecceecCCc
Confidence            999999998864   3467899999999999999999999999999999999999953   34 5999999999765432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC--CCCCCCCCCcHHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD--ELPRFPTQSSELGR  207 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~--~~p~~~~~~s~~~~  207 (408)
                      ..   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...............  ..+......++.+.
T Consensus       181 ~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          181 EH---STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             cc---CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence            21   234568999999999875 4789999999999999999999999877655544332222  12222234788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      +||.+||+.||.+|||+.|+++||||++
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            9999999999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.9e-42  Score=327.79  Aligned_cols=226  Identities=24%  Similarity=0.380  Sum_probs=183.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.|++|.....                            +...+..+...+|||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4799999999999999999999999999999864311                            111233456788999


Q ss_pred             eccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC------------------
Q 042746           54 EYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS------------------  112 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~------------------  112 (408)
                      ||++||+|.+++...   ...+++..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999753   26689999999999999999999999999999999999998432                  


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~  191 (408)
                      ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|+|++|.+|+......   ....
T Consensus       171 ~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~  241 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIR  241 (289)
T ss_dssp             CCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHH
T ss_pred             eEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHH
Confidence            249999999986654322      23589999999999876 5567999999999999999999877543221   1223


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ....+.++...++.+++||.+||+.||.+|||+.|+++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            455567778899999999999999999999999999999999754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=341.55  Aligned_cols=230  Identities=26%  Similarity=0.367  Sum_probs=178.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|.+. +++.||+|....                             .+...+..+...+||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46999999999999999999985 688899875421                             111123345678899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      || +.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+++........
T Consensus        88 ~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~-~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-EEEECCCSSSCCC------
T ss_pred             Ee-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C-cEEEeecccccccCccccc
Confidence            99 567899999985 567899999999999999999999999999999999999974 4 5999999999776543332


Q ss_pred             cccccCCCCCCCCChhhHhC-----------CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCC
Q 042746          133 GVKIQPRGSPLWMAPEVVRG-----------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFP  199 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~-----------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~  199 (408)
                      ......+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.....  ..+...........++
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  243 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence            23335579999999999975           5678899999999999999999999976432  2222222223334566


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ...++.+++||.+||+.||.+|||+.|+++||||+..
T Consensus       244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            7788899999999999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.3e-42  Score=340.16  Aligned_cols=235  Identities=23%  Similarity=0.320  Sum_probs=188.1

Q ss_pred             CeEee-ceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            3 SWVRG-KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~-~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +|.+. +.||+|+||+||+|++..+++.||+|....                            .+...+......++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            47776 999999999999999999999999875431                            1111233456688999


Q ss_pred             eccCCCCHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccccccC
Q 042746           54 EYLPGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        54 Ey~~gGsL~~~l~~-~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~~  129 (408)
                      ||++||+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.   ++ .+||+|||++......
T Consensus       109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEECCGGGCEEC---
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEeeCccccccCCc
Confidence            99999999998853 2467899999999999999999999999999999999999987   45 5999999999765432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---cCCCCCCCCCCcHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SDELPRFPTQSSELG  206 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---~~~~p~~~~~~s~~~  206 (408)
                      ..   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.............   ....+......++.+
T Consensus       188 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  264 (327)
T 3lm5_A          188 CE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA  264 (327)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             cc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHH
Confidence            21   233569999999999999999999999999999999999999998766544332211   122223345688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCc
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~~  241 (408)
                      ++||.+||+.||.+|||++|+++||||+...+...
T Consensus       265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence            99999999999999999999999999998766543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.1e-42  Score=327.94  Aligned_cols=228  Identities=25%  Similarity=0.352  Sum_probs=188.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||+||+|++..++..+++|....                         .+...+......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            469999999999999999999999999998876431                         1222234556788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---cCCCCcEEEeecCCccccccCCCCc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl---~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      +|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+   +.++ .+||+|||++.......   
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~---  163 (277)
T 3f3z_A           89 TGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPGK---  163 (277)
T ss_dssp             CSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTTS---
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCcc---
Confidence            999999999754 567999999999999999999999999999999999999   5555 49999999996654322   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCC----CCCcHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFP----TQSSELGRDF  209 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~----~~~s~~~~~l  209 (408)
                      ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||................. ..+    ...++.+++|
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  241 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-TFPEKDWLNVSPQAESL  241 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHH
T ss_pred             chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCchhhhcCCHHHHHH
Confidence            22345699999999999776 89999999999999999999999987665554443333322 222    2578899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      |.+||+.||.+|||+.|+++||||+..
T Consensus       242 i~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          242 IRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.4e-42  Score=331.77  Aligned_cols=229  Identities=25%  Similarity=0.357  Sum_probs=176.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|....                           .+...+..+...+||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            689999999999999999999999999999986431                           11222334567889999


Q ss_pred             ccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           55 YLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        55 y~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |++| +|.+++..   .+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++. +||+|||++.......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ-VKMCDFGISGYLVDDV  164 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC-EEBCCC----------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC-EEEeecCCcccccccc
Confidence            9985 88887764   456789999999999999999999998 9999999999999998875 9999999997654332


Q ss_pred             CCcccccCCCCCCCCChhhH----hCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCCCCCcH
Q 042746          131 TRGVKIQPRGSPLWMAPEVV----RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l----~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      .   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||.....  ..+............+...++
T Consensus       165 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (290)
T 3fme_A          165 A---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA  241 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             c---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence            2   2234699999999997    455678899999999999999999999986432  222222222222233356889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      .+++||.+||+.||++|||+.|+++||||+.
T Consensus       242 ~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          242 EFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            9999999999999999999999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.6e-43  Score=330.56  Aligned_cols=235  Identities=22%  Similarity=0.335  Sum_probs=188.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++++.||+|+||+||+|.+..+++.|++|.....                          +..........++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            5799999999999999999999999999999864311                          11123345667899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++............
T Consensus        87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC-EEEeeCCCccccCCCcchhcc
Confidence            999999998863 456799999999999999999999999999999999999998875 999999999765433222223


Q ss_pred             ccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhh--hhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANT--LSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.......  .................++.+++||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK  244 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence            34579999999999987665 678999999999999999999998654322  111111111112234678899999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ||+.||.+|||+.|+++||||+....
T Consensus       245 ~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          245 ILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HCCCCchhCCCHHHHhcCccccChhh
Confidence            99999999999999999999986543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.4e-43  Score=340.78  Aligned_cols=231  Identities=19%  Similarity=0.286  Sum_probs=178.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccC------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPT------------   43 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~------------   43 (408)
                      .+|++++.||+|+||+||+|+++.+++.||+|.....                          +...+            
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            5799999999999999999999999999999864310                          00000            


Q ss_pred             ---------------------------------------------CCCCcceEEEeccCCCCHHHHHHHhCC--CCCHHH
Q 042746           44 ---------------------------------------------TSSSCRNLHLEYLPGGTVSDLATTLNA--YADEIT   76 (408)
Q Consensus        44 ---------------------------------------------~~~~~~~LVmEy~~gGsL~~~l~~~~~--~l~e~~   76 (408)
                                                                   ..+...++||||++||+|.+++.....  ..++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                         111237899999999999999985322  345667


Q ss_pred             HHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC----------cccccCCCCCCCCC
Q 042746           77 LRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR----------GVKIQPRGSPLWMA  146 (408)
Q Consensus        77 i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~A  146 (408)
                      ++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++........          .......||+.|+|
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC-EEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            8999999999999999999999999999999998874 999999999765443211          11233569999999


Q ss_pred             hhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 042746          147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQ  226 (408)
Q Consensus       147 PE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  226 (408)
                      ||++.+..++.++||||||+++|+|++|..|+....  ...........|......++.+++||.+||+.||.+|||+.|
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  322 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD  322 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence            999999999999999999999999999987754321  111111223333333455677899999999999999999999


Q ss_pred             HHcCCCCCC
Q 042746          227 LLKHPFLQS  235 (408)
Q Consensus       227 ll~hpf~~~  235 (408)
                      +++||||++
T Consensus       323 ~l~~~~f~~  331 (332)
T 3qd2_B          323 IIENAIFEN  331 (332)
T ss_dssp             HHHSTTCCC
T ss_pred             Hhhchhhhc
Confidence            999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=342.02  Aligned_cols=229  Identities=24%  Similarity=0.363  Sum_probs=178.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCC------CCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTS------SSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~------~~~   48 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|.....                           +...+..      ...
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4799999999999999999999999999999875211                           0111111      134


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ++|||||+ |++|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus       105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADS  180 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCS
T ss_pred             EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC-EEEEeeeccccccc
Confidence            69999999 7899999975  56899999999999999999999999999999999999998875 99999999976532


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF----------------  191 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~----------------  191 (408)
                      .     .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.                
T Consensus       181 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          181 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             c-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            2     224568999999999987 678999999999999999999999998654322211100                


Q ss_pred             --------------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          192 --------------SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       192 --------------~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                    ...+.......++.+++||.+||..||.+|||+.|+++||||+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                          011112334678999999999999999999999999999999876644

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8e-42  Score=346.82  Aligned_cols=233  Identities=27%  Similarity=0.394  Sum_probs=183.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------eeccC------CCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------YEAPT------TSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------~~~~~------~~~~~~~LVmEy   55 (408)
                      +|++++.||+|+||+||+|++..+++.||+|.....                     +...+      ....+++|||||
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  134 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  134 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence            699999999999999999999999999999864211                     10000      122346789999


Q ss_pred             cCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      +++ +|.+++..   ....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++....... 
T Consensus       135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~-  212 (420)
T 1j1b_A          135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-  212 (420)
T ss_dssp             CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred             ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC-
Confidence            987 67776653   3567899999999999999999999999999999999999997765689999999976543222 


Q ss_pred             cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhhhcc------------------c
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSRIGF------------------S  192 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~~~~------------------~  192 (408)
                        .....||+.|+|||++.+. .++.++|||||||++|+|++|++||....... +..+..                  .
T Consensus       213 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~  290 (420)
T 1j1b_A          213 --NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  290 (420)
T ss_dssp             --CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred             --ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence              2345689999999999775 68999999999999999999999998754322 111100                  0


Q ss_pred             CCCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 DELPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ~~~p~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ..+|.         ++...++++++||.+||.+||.+|||+.|+++||||+.....
T Consensus       291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence            01111         234568899999999999999999999999999999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3e-42  Score=339.98  Aligned_cols=237  Identities=23%  Similarity=0.338  Sum_probs=184.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------eccCCC--------
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAPTTS--------   45 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~~~~--------   45 (408)
                      +.+|++++.||+|+||+||+|++..+++.||+|......                           ...+..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            368999999999999999999999999999998542110                           000111        


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ....+|||||++| +|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~~  173 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARA  173 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC-EEEccchhccc
Confidence            3457899999986 888888766677899999999999999999999999999999999999998875 99999999976


Q ss_pred             cccCC--CCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---cCCCCCC-
Q 042746          126 ATVSD--TRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---SDELPRF-  198 (408)
Q Consensus       126 ~~~~~--~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---~~~~p~~-  198 (408)
                      .....  .........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.............   ....+.. 
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            54221  1122334578999999999986 457999999999999999999999998765433222110   0001110 


Q ss_pred             CC---------------------------CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          199 PT---------------------------QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       199 ~~---------------------------~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +.                           ..++.+++||.+||..||.+|||++|+++||||.....+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            00                           026778999999999999999999999999999865443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-42  Score=351.01  Aligned_cols=232  Identities=28%  Similarity=0.367  Sum_probs=182.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|.+..+++.||+|....                              .+...+......+|
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            479999999999999999999999999999986431                              11112233566789


Q ss_pred             EEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC-cEEEeecCCccccccC
Q 042746           52 HLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-FVKLADFGAAGEATVS  129 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~  129 (408)
                      ||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++......
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~  255 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR  255 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence            999997 59999988643 35899999999999999999999999999999999999998763 2999999999654322


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc------------------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF------------------  191 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~------------------  191 (408)
                           ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.........                  
T Consensus       256 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~  330 (429)
T 3kvw_A          256 -----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAK  330 (429)
T ss_dssp             -----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHH
T ss_pred             -----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhh
Confidence                 224578999999999999999999999999999999999999998655322211000                  


Q ss_pred             ----cCCCC------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 042746          192 ----SDELP------------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP  231 (408)
Q Consensus       192 ----~~~~p------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp  231 (408)
                          ....|                                    .++...++.+++||.+||++||.+|||+.|+|+||
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hp  410 (429)
T 3kvw_A          331 NFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHP  410 (429)
T ss_dssp             HHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             hccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCCh
Confidence                00000                                    01123478899999999999999999999999999


Q ss_pred             CCCCCCCC
Q 042746          232 FLQSVSPS  239 (408)
Q Consensus       232 f~~~~~~~  239 (408)
                      ||+...+.
T Consensus       411 w~~~~~~~  418 (429)
T 3kvw_A          411 WLRRRLPK  418 (429)
T ss_dssp             TTC-----
T ss_pred             hhccCCCC
Confidence            99875543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.2e-42  Score=335.93  Aligned_cols=232  Identities=25%  Similarity=0.354  Sum_probs=193.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|.+..+++.+++|....                            .+...+......++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            479999999999999999999999999999876321                            1222234556789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus       121 e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~--  196 (335)
T 2owb_A          121 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGE--  196 (335)
T ss_dssp             CCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECCSTTC--
T ss_pred             ecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC-EEEeeccCceecccCcc--
Confidence            999999999998754 56799999999999999999999999999999999999998875 99999999976543222  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................ ..++...++.+++||.+|
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHH
Confidence            2234569999999999999989999999999999999999999998766544433322222 345677899999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      |+.||++|||+.|+++||||.....
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ccCChhHCcCHHHHhcCccccCCCc
Confidence            9999999999999999999986543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.5e-42  Score=328.36  Aligned_cols=232  Identities=25%  Similarity=0.345  Sum_probs=193.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|.+..+++.+++|....                            .+...+......++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            479999999999999999999999999999875321                            1222234556788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus        95 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~--  170 (294)
T 2rku_A           95 ELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGE--  170 (294)
T ss_dssp             ECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCSTTC--
T ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC-EEEEeccCceecccCcc--
Confidence            999999999998754 56799999999999999999999999999999999999998875 99999999976543222  


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||............... ...++...++.+.++|.+|
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  249 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKHINPVAASLIQKM  249 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCCCccccCHHHHHHHHHH
Confidence            223456999999999999988999999999999999999999999876654443332222 3356678899999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      |+.||++|||+.|+++||||.....
T Consensus       250 l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          250 LQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             cccChhhCcCHHHHhhChheecCCc
Confidence            9999999999999999999986543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7e-42  Score=341.54  Aligned_cols=228  Identities=25%  Similarity=0.318  Sum_probs=189.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-------CCCcEEEEeeccc---------------------------ceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-------FNGDVFAYLGDDV---------------------------SYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-------~t~~~va~k~~~~---------------------------~~~~~~~~~~   47 (408)
                      ++|++++.||+|+||+||+|++.       .++..||+|....                           .+...+..+.
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57999999999999999999975       3455788876431                           1122234566


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      .++|||||++||+|.+++....               ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            7899999999999999998643               2478999999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......+.....
T Consensus       241 ~-~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~  319 (370)
T 2psq_A          241 V-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  319 (370)
T ss_dssp             C-EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH
T ss_pred             C-EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence            5 99999999976544332222334567889999999999999999999999999999999 999999877766665555


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...++.+.+||.+||..||.+|||+.|++++
T Consensus       320 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          320 EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555567778899999999999999999999999999874

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=346.59  Aligned_cols=228  Identities=23%  Similarity=0.286  Sum_probs=182.0

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEeccCCC
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      ...+.||+|+||+||+|.+..+++.||+|....                         .+...+......+|||||++||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            347789999999999999999999999876431                         1222344566789999999999


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc--CCCCcEEEeecCCccccccCCCCccccc
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +|.+++......+++..++.++.||+.||+|||++||+||||||+|||+.  .++ .+||+|||+++.......   ...
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~~~~---~~~  247 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREK---LKV  247 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECCTTCB---CCC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC-cEEEEeCCCceecCCccc---ccc
Confidence            99999986666789999999999999999999999999999999999994  344 599999999976543322   233


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHHHHHhc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~li~~~L  214 (408)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....   +......++++++||.+||
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L  327 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLL  327 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTS
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHc
Confidence            4699999999999988899999999999999999999999987665443333222221   1122467899999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ..||.+|||+.|+++||||...
T Consensus       328 ~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          328 IKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-42  Score=343.27  Aligned_cols=231  Identities=28%  Similarity=0.435  Sum_probs=182.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceeccC-----------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAPT-----------------   43 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~~-----------------   43 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|....                     .+...+                 
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            589999999999999999999999999999986321                     111111                 


Q ss_pred             ---------------------CCCCcceEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Q 042746           44 ---------------------TSSSCRNLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHC   99 (408)
Q Consensus        44 ---------------------~~~~~~~LVmEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHr   99 (408)
                                           ....+.+|||||++| +|.+.+..   .+..+++..++.++.||+.||+|||++||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~  165 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHR  165 (383)
T ss_dssp             -----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence                                 233457899999995 88887764   45678999999999999999999999999999


Q ss_pred             CCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCC
Q 042746          100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAW  178 (408)
Q Consensus       100 DLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf  178 (408)
                      ||||+|||++.+...+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus       166 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            99999999985444699999999976543322   2345689999999999875 4899999999999999999999999


Q ss_pred             CCCChhhhh-hhcc------------------cCCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          179 EDFGANTLS-RIGF------------------SDELP---------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       179 ~~~~~~~~~-~~~~------------------~~~~p---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ......... .+..                  ....|         .++...++++++||.+||..||.+|||+.|+++|
T Consensus       243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            875533221 1100                  00111         1345678899999999999999999999999999


Q ss_pred             CCCCCC
Q 042746          231 PFLQSV  236 (408)
Q Consensus       231 pf~~~~  236 (408)
                      |||+..
T Consensus       323 p~f~~~  328 (383)
T 3eb0_A          323 PFFDHL  328 (383)
T ss_dssp             GGGHHH
T ss_pred             HHHHHH
Confidence            999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.8e-42  Score=329.68  Aligned_cols=236  Identities=26%  Similarity=0.432  Sum_probs=175.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      .+|++++.||+|+||+||+|.+..+++.|++|.....                          +...+......++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            5899999999999999999999999999999854311                          11122344567899999


Q ss_pred             cCCCCHHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           56 LPGGTVSDLATT-------LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        56 ~~gGsL~~~l~~-------~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ++|++|.+++..       ....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS-VQIADFGVSAFLAT  173 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-EEECCCHHHHHCC-
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC-EEEEeccchheecc
Confidence            999999999975       2456899999999999999999999999999999999999998875 99999999865432


Q ss_pred             CCC---CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---------
Q 042746          129 SDT---RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---------  195 (408)
Q Consensus       129 ~~~---~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---------  195 (408)
                      ...   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................         
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD  253 (303)
T ss_dssp             --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC----
T ss_pred             CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccccc
Confidence            211   111234569999999999976 5688999999999999999999999987654433222111111         


Q ss_pred             CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       196 p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +......++.+++||.+||+.||.+|||+.|+++||||+....
T Consensus       254 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             -CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            1233567889999999999999999999999999999986543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.5e-42  Score=335.65  Aligned_cols=230  Identities=24%  Similarity=0.295  Sum_probs=181.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------eeccCCC--CCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------YEAPTTS--SSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------~~~~~~~--~~~~~LVmEy~   56 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|.....                       +......  ....++||||+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~  115 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  115 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence            5799999999999999999999999999999864311                       1111112  45678999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.++++    .+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.......   ..
T Consensus       116 ~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~  188 (330)
T 3nsz_A          116 NNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YN  188 (330)
T ss_dssp             CCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CC
T ss_pred             CchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cc
Confidence            9999999885    3789999999999999999999999999999999999997775699999999975543322   23


Q ss_pred             cCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hhhhh------------cccCC-------
Q 042746          137 QPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRI------------GFSDE-------  194 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~~~~------------~~~~~-------  194 (408)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||......  .+..+            .....       
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  268 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence            4568999999999987 67899999999999999999999999432111  10000            00000       


Q ss_pred             ----------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          195 ----------------LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       195 ----------------~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                      ....+...++.+++||.+||+.||.+|||++|+++||||+.+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                            00112237899999999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-42  Score=340.58  Aligned_cols=238  Identities=27%  Similarity=0.367  Sum_probs=186.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|++..+++.+|+|....                              .+...+......+|
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            369999999999999999999999999999885321                              12223445667899


Q ss_pred             EEeccCCCCHHHHHHHh---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 042746           52 HLEYLPGGTVSDLATTL---------------------------------------NAYADEITLRSHTYCIVSALKYLH   92 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~---------------------------------------~~~l~e~~i~~i~~qIl~~L~yLH   92 (408)
                      ||||++||+|.+++...                                       ...+++..++.++.||+.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999988421                                       112357788999999999999999


Q ss_pred             HCCCeecCCCCCCEEEcCCCC-cEEEeecCCccccccCCCC--cccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHH
Q 042746           93 SRNIVHCDVKGKNVLVGPNSS-FVKLADFGAAGEATVSDTR--GVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCT  167 (408)
Q Consensus        93 ~~giiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvi  167 (408)
                      ++||+||||||+|||++.++. .+||+|||++.........  .......||+.|+|||++.+  ..++.++||||||++
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            999999999999999987652 4999999999765432211  12234569999999999975  578899999999999


Q ss_pred             HHHHHhCCCCCCCCChhhhhhhcccCCCCC-C--CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          168 IIEMVTGKPAWEDFGANTLSRIGFSDELPR-F--PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       168 l~eLltG~~Pf~~~~~~~~~~~~~~~~~p~-~--~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +|+|++|+.||................... .  ....++.+++||.+||+.||.+|||+.|+++||||+.....
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999998766554443333222211 1  12478999999999999999999999999999999876543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.4e-42  Score=346.28  Aligned_cols=230  Identities=26%  Similarity=0.362  Sum_probs=179.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LVm   53 (408)
                      +|++++.||+|+||+||+|.+.. ++.||+|.....                             +......+...+|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            59999999999999999999875 889998754211                             111123455678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      | +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||+++.........
T Consensus       136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~-~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S-CEEECCCSSSCCC-------
T ss_pred             e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C-eEEEEecCccccccCCCccc
Confidence            9 5678999999854 57789999999999999999999999999999999999964 4 59999999997665433222


Q ss_pred             ccccCCCCCCCCChhhHhC-----------CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCCC
Q 042746          134 VKIQPRGSPLWMAPEVVRG-----------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFPT  200 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~-----------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~~  200 (408)
                      .....+||+.|+|||++.+           ..++.++|||||||++|+|++|++||.....  ..+..+........++.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence            2345679999999999976           3578899999999999999999999976432  22222222223335566


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ..+..+++||.+||+.||.+|||+.|+++||||+...
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            7789999999999999999999999999999997543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=336.75  Aligned_cols=223  Identities=23%  Similarity=0.301  Sum_probs=185.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------------eeccCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------------YEAPTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------------~~~~~~~~~~   48 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|.....                                 +...+.....
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            4799999999999999999999999999998853321                                 1112345567


Q ss_pred             ceEEEeccCCC-CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           49 RNLHLEYLPGG-TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        49 ~~LVmEy~~gG-sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      .++||||+.+| +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc-EEEeecccceECC
Confidence            88999999777 99999974 456899999999999999999999999999999999999998875 9999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      ....   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......       .......+...++.+
T Consensus       182 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~l  251 (335)
T 3dls_A          182 RGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VEAAIHPPYLVSKEL  251 (335)
T ss_dssp             TTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TTTCCCCSSCCCHHH
T ss_pred             CCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------HhhccCCCcccCHHH
Confidence            3322   234569999999999998776 78899999999999999999999753211       111223455689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ++||.+||++||.+|||+.|+++||||...
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999753

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-42  Score=337.56  Aligned_cols=234  Identities=20%  Similarity=0.290  Sum_probs=185.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|....                              .+...+......++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            579999999999999999999999999999986431                              11122345567889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++ +|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCGGGSTTTSCCC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC-EEEEecccceeccCCcc
Confidence            9999987 899988766667899999999999999999999999999999999999998875 99999999976543222


Q ss_pred             CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc------------------
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS------------------  192 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~------------------  192 (408)
                        ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||..............                  
T Consensus       168 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          168 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             --cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence              22345799999999999764 578899999999999999999999987554322211100                  


Q ss_pred             ----CCCCCC-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 ----DELPRF-----PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ----~~~p~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                          ...+..     ....++.+++||.+||..||.+|||+.|+++||||......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                001111     14567899999999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.8e-42  Score=330.99  Aligned_cols=234  Identities=30%  Similarity=0.444  Sum_probs=188.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|++++.||+|+||+||+|++..+++.+++|....                         .+...+..+...++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            579999999999999999999999999999876431                         1122233456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.+++......+++..++.++.||+.||.|||++|++||||||+|||++.++. +||+|||++........  ...
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~~~  175 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD-IRLADFGVSAKNLKTLQ--KRD  175 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC-EEECCCHHHHHHHHHHH--C--
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC-EEEEECCCCcccccccc--ccc
Confidence            999999999877778999999999999999999999999999999999999998875 99999998753221111  112


Q ss_pred             cCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~l  209 (408)
                      ...||+.|+|||++.     +..++.++||||||+++|+|++|.+||.................+  ..+...+..+.+|
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  255 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF  255 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence            346899999999984     567889999999999999999999999876654433322222222  2345678899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      |.+||..||.+|||+.|+++||||.....
T Consensus       256 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          256 LKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            99999999999999999999999987553

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-42  Score=344.75  Aligned_cols=229  Identities=27%  Similarity=0.355  Sum_probs=179.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------eeccCCCCCcce
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------~~~~~~~~~~~~   50 (408)
                      +.+|++.+.||+|+||+||+|++..+++.||+|.....                              ....+......+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            36899999999999999999999999999999864311                              111123356678


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEcC--CCCcEEEeecCCccc
Q 042746           51 LHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLH--SRNIVHCDVKGKNVLVGP--NSSFVKLADFGAAGE  125 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH--~~giiHrDLKp~NILl~~--~~~~vkL~DFGla~~  125 (408)
                      |||||+++ +|.+++.... ..+++..++.++.||+.||.|||  +.||+||||||+|||++.  ++ .+||+|||++..
T Consensus       133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~DFG~a~~  210 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDFGSSCQ  210 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECCCTTCEE
T ss_pred             EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEeccCcee
Confidence            99999975 9999998653 56899999999999999999999  579999999999999953  44 599999999976


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc--C----------
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS--D----------  193 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~--~----------  193 (408)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+..  .          
T Consensus       211 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          211 LGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             TTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            5322     2245689999999999999999999999999999999999999986543322111000  0          


Q ss_pred             --------CCC--------------CC-CC----------------------------CCcHHHHHHHHHhcccCCCCCC
Q 042746          194 --------ELP--------------RF-PT----------------------------QSSELGRDFLDKCLRREPGERW  222 (408)
Q Consensus       194 --------~~p--------------~~-~~----------------------------~~s~~~~~li~~~L~~dP~~R~  222 (408)
                              ..|              .+ +.                            ..++.+++||.+||+.||++||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp  365 (382)
T 2vx3_A          286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI  365 (382)
T ss_dssp             TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence                    000              00 00                            0014789999999999999999


Q ss_pred             CHHHHHcCCCCCCC
Q 042746          223 SCDQLLKHPFLQSV  236 (408)
Q Consensus       223 s~~ell~hpf~~~~  236 (408)
                      |++|+|+||||+..
T Consensus       366 ta~e~L~hp~f~~~  379 (382)
T 2vx3_A          366 QPYYALQHSFFKKT  379 (382)
T ss_dssp             CHHHHTTSGGGCC-
T ss_pred             CHHHHhcCcccccC
Confidence            99999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.3e-42  Score=325.82  Aligned_cols=230  Identities=25%  Similarity=0.385  Sum_probs=184.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|.+..+++.|++|....                            .+..........++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            689999999999999999999999999999986421                            1112233456788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++. +||+|||++.......   
T Consensus        91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~~l~dfg~~~~~~~~~---  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGE---  165 (276)
T ss_dssp             ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC-EEECCCCGGGCCCC-----
T ss_pred             eccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC-EEEeecccccccCCCc---
Confidence            999999999999854 46799999999999999999999999999999999999998875 9999999986654322   


Q ss_pred             ccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ......||+.|+|||++.+..+ +.++|+||||+++|+|++|+.||.............. ..+.++...+..+.++|.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  244 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG-GVFYIPEYLNRSVATLLMH  244 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCCCTTSCHHHHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-CcccCchhcCHHHHHHHHH
Confidence            1233468999999999988765 5789999999999999999999987665554443322 2335567789999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||+.||.+|||+.|+++||||+...
T Consensus       245 ~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          245 MLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HccCChhhCCCHHHHHhChhhccCc
Confidence            9999999999999999999997644

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.5e-42  Score=327.52  Aligned_cols=234  Identities=24%  Similarity=0.388  Sum_probs=193.5

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC--CCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT--TSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~--~~~~~~~L   51 (408)
                      +++|++.+.||+|+||+||+|.+..+++.+++|.....                           +...+  ......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            36899999999999999999999999999998764311                           11111  23456889


Q ss_pred             EEeccCCCCHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           52 HLEYLPGGTVSDLATTL---NAYADEITLRSHTYCIVSALKYLHSRN-----IVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~---~~~l~e~~i~~i~~qIl~~L~yLH~~g-----iiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      ||||++||+|.+++...   ...+++..++.++.||+.||+|||+++     |+||||||+|||++.++. +||+|||++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~-~kl~dfg~~  163 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA  163 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC-EEECCCCHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC-EEEecCchh
Confidence            99999999999999753   345899999999999999999999999     999999999999998875 999999998


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCc
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s  203 (408)
                      ........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......+.........+.++...+
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (279)
T 2w5a_A          164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS  241 (279)
T ss_dssp             HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence            65433211  1223468999999999999889999999999999999999999999877665555545556667777899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +.++++|.+||+.||.+|||+.|+++|+|+....
T Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            9999999999999999999999999999997643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.6e-42  Score=329.02  Aligned_cols=230  Identities=32%  Similarity=0.513  Sum_probs=194.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      +.|++++.||+|+||+||+|++..+++.|++|.....                          +...+..+...++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            4699999999999999999999999999999864311                          11123345667899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++|++|.+++.  .+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++........  ..
T Consensus       102 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--~~  176 (303)
T 3a7i_A          102 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-VKLADFGVAGQLTDTQI--KR  176 (303)
T ss_dssp             CTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECBTTBC--CB
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC-EEEeecccceecCcccc--cc
Confidence            99999999986  357899999999999999999999999999999999999998875 99999999966543221  22


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|++||.................+.++...+..+++||.+||.
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcC
Confidence            34568999999999999889999999999999999999999998766555444434455566777889999999999999


Q ss_pred             cCCCCCCCHHHHHcCCCCCCC
Q 042746          216 REPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       216 ~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .||.+|||+.|+++||||...
T Consensus       257 ~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          257 KEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             SSGGGSCCHHHHTTCHHHHHH
T ss_pred             CChhhCcCHHHHhhChhhhcC
Confidence            999999999999999999653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=327.99  Aligned_cols=236  Identities=22%  Similarity=0.311  Sum_probs=190.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccC--CCCCcc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPT--TSSSCR   49 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~--~~~~~~   49 (408)
                      +.+|++++.||+|+||.||+|.+..+++.+++|.....                             +...+  ......
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            36899999999999999999999999999998764311                             11111  344568


Q ss_pred             eEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           50 NLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +|||||++++ |.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~-~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHP  161 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECCT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc-EEeeccccccccCc
Confidence            9999999987 77777653 456899999999999999999999999999999999999998875 99999999976543


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCC--CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHH
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQ--GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~--~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      ...........||+.|+|||++.+...  +.++||||||+++|+|++|+.||............... ...++...++.+
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~l  240 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-SYAIPGDCGPPL  240 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCCCSSSCHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-CCCCCCccCHHH
Confidence            333333345569999999999987543  67899999999999999999999877655554433233 235567889999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      .+||.+||..||.+|||+.|+++||||+...+.
T Consensus       241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            999999999999999999999999999876554

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-42  Score=345.79  Aligned_cols=228  Identities=13%  Similarity=0.039  Sum_probs=178.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-------------------e---ccC--------C--------
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-------------------E---APT--------T--------   44 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-------------------~---~~~--------~--------   44 (408)
                      +|++++.||+|+||+||+|++..+++.||+|......                   .   .+.        .        
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            5999999999999999999999999999998643210                   0   110        0        


Q ss_pred             ----------------CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHH------HHHHHHHHHHHHHHHHCCCeecCCC
Q 042746           45 ----------------SSSCRNLHLEYLPGGTVSDLATTLNAYADEITL------RSHTYCIVSALKYLHSRNIVHCDVK  102 (408)
Q Consensus        45 ----------------~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i------~~i~~qIl~~L~yLH~~giiHrDLK  102 (408)
                                      .....+|||||++ |+|.+++...+..+++...      ..++.||+.||+|||++||+|||||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence                            0023699999999 7999999876555565555      6777999999999999999999999


Q ss_pred             CCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCCC
Q 042746          103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWED  180 (408)
Q Consensus       103 p~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~~  180 (408)
                      |+|||++.++. +||+|||+++.....     .....||+.|+|||++.+  ..++.++|||||||++|+|++|++||..
T Consensus       222 p~NIll~~~~~-~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          222 PDNLFIMPDGR-LMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             GGGEEECTTSC-EEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             HHHEEECCCCC-EEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999998875 999999999755321     113446799999999987  6789999999999999999999999986


Q ss_pred             CChhhhhhh------cccCCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          181 FGANTLSRI------GFSDEL--PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       181 ~~~~~~~~~------~~~~~~--p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .........      ......  ...+...++.+++||.+||+.||++|||+.|+++||||+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            533211100      000111  122247789999999999999999999999999999997543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=330.11  Aligned_cols=233  Identities=32%  Similarity=0.483  Sum_probs=188.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      ++|++.+.||+|+||+||+|++..+++.|++|....                       .+..........++||||+++
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  108 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA  108 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence            479999999999999999999999999999986431                       112223345667899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      |+|.+++......+++..++.++.||+.||.|||++|++|+||||+||+++.++. +||+|||++........  .....
T Consensus       109 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~~~~~~~--~~~~~  185 (314)
T 3com_A          109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH-AKLADFGVAGQLTDTMA--KRNTV  185 (314)
T ss_dssp             EEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECBTTBS--CBCCC
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC-EEEeecccchhhhhhcc--ccCcc
Confidence            9999999876778899999999999999999999999999999999999998875 99999999966543221  12345


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~li~~~L~~  216 (408)
                      .||+.|+|||++.+..++.++||||||+++|+|++|+.||.................+  ..+...+..+.+||.+||..
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  265 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK  265 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred             CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccC
Confidence            6899999999999988999999999999999999999999876544332222122211  23456788999999999999


Q ss_pred             CCCCCCCHHHHHcCCCCCCCC
Q 042746          217 EPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       217 dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||.+|||+.|+++||||....
T Consensus       266 dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          266 SPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             CTTTSCCHHHHTTSHHHHTCC
T ss_pred             ChhhCcCHHHHHhCHHHhcCC
Confidence            999999999999999998654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-41  Score=341.10  Aligned_cols=234  Identities=26%  Similarity=0.411  Sum_probs=179.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceeccC------CCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAPT------TSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~~------~~~~~~~LVmE   54 (408)
                      .+|++++.||+|+||+||+|++..+++ +++|+...                     .+...+      ....+++||||
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e  118 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE  118 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence            369999999999999999999988777 66654321                     111111      22334789999


Q ss_pred             ccCCCCHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLAT--TLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~--~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |++++.+..+..  .....+++..++.+++||+.||+|||++||+||||||+|||++.....+||+|||+++....... 
T Consensus       119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~-  197 (394)
T 4e7w_A          119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-  197 (394)
T ss_dssp             CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred             ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC-
Confidence            999854433332  23567899999999999999999999999999999999999984334699999999976543322 


Q ss_pred             cccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhh-hc------------------cc
Q 042746          133 GVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR-IG------------------FS  192 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~-~~------------------~~  192 (408)
                        .....||+.|+|||++.+. .++.++|||||||++|+|++|++||...+...... +.                  ..
T Consensus       198 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  275 (394)
T 4e7w_A          198 --NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME  275 (394)
T ss_dssp             --CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred             --CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence              2345689999999999775 58999999999999999999999998755322111 10                  00


Q ss_pred             CCCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 DELPR---------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ~~~p~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ...|.         ++...++++++||.+||++||.+|||+.|+++||||+.....
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            11111         234578899999999999999999999999999999987654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-42  Score=354.98  Aligned_cols=231  Identities=23%  Similarity=0.353  Sum_probs=190.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|....                            .+...+......++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            369999999999999999999999999999986421                            1122234556789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc---CCCCcEEEeecCCccccccCC
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~---~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ||+.||+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++   .++ .+||+|||++.......
T Consensus       106 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          106 EVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             CCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCTTHHHHBCCCC
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC-cEEEEeeeeeEEccccc
Confidence            99999999999974 46789999999999999999999999999999999999995   344 59999999996654332


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC-CC--CCCCcHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP-RF--PTQSSELGR  207 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p-~~--~~~~s~~~~  207 (408)
                         .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.................+ ..  ....++.++
T Consensus       184 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          184 ---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             ---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             ---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence               2234569999999999987 5899999999999999999999999887665544433333221 11  245789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      +||.+||++||.+|||+.|+++||||+....
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            9999999999999999999999999986544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-41  Score=331.72  Aligned_cols=237  Identities=22%  Similarity=0.312  Sum_probs=172.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeecccc---------------------------eeccCCCCC----
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDVS---------------------------YEAPTTSSS----   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~~---------------------------~~~~~~~~~----   47 (408)
                      .+|++++.||+|+||+||+|.+..++.   .+|+|.....                           +...+....    
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            479999999999999999999988876   7788754321                           001111111    


Q ss_pred             --cceEEEeccCCCCHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeec
Q 042746           48 --CRNLHLEYLPGGTVSDLATTLN-----AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADF  120 (408)
Q Consensus        48 --~~~LVmEy~~gGsL~~~l~~~~-----~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DF  120 (408)
                        ..++||||+++|+|.+++....     ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-~kl~Df  181 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-VCVADF  181 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC-EEEeec
Confidence              2389999999999999996532     15899999999999999999999999999999999999998875 999999


Q ss_pred             CCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCC
Q 042746          121 GAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFP  199 (408)
Q Consensus       121 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~  199 (408)
                      |+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||.................+..+
T Consensus       182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  261 (323)
T 3qup_A          182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP  261 (323)
T ss_dssp             CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred             cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCC
Confidence            99976544332222333457888999999999999999999999999999999 99999987766666555555556677


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCC-------HHHHHcCCCCCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWS-------CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s-------~~ell~hpf~~~~~~~  239 (408)
                      ...++.+++||.+||..||.+|||       +++++.|||+......
T Consensus       262 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          262 PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            788999999999999999999999       6677889999765443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-41  Score=330.97  Aligned_cols=229  Identities=24%  Similarity=0.324  Sum_probs=181.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-cCCCcEEEEeeccc------------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-RFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||+||+|.+ ..+++.||+|....                              .....+......+
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            5899999999999999999999 56888999886431                              1111233456789


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC------------------
Q 042746           51 LHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN------------------  111 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~------------------  111 (408)
                      |||||+ +++|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+                  
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999999 889999998644 367899999999999999999999999999999999999863                  


Q ss_pred             CCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-
Q 042746          112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-  190 (408)
Q Consensus       112 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-  190 (408)
                      ...+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+........ 
T Consensus       173 ~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  247 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME  247 (339)
T ss_dssp             CCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred             CCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            224999999999654322     22456899999999999989999999999999999999999999865543221110 


Q ss_pred             -ccCCCC-----------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          191 -FSDELP-----------------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       191 -~~~~~p-----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                       .....|                                         ..+...++.+.+||.+||+.||.+|||+.|++
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  327 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL  327 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence             000000                                         11123356788999999999999999999999


Q ss_pred             cCCCCCCC
Q 042746          229 KHPFLQSV  236 (408)
Q Consensus       229 ~hpf~~~~  236 (408)
                      +||||+..
T Consensus       328 ~hp~f~~~  335 (339)
T 1z57_A          328 KHPFFDLL  335 (339)
T ss_dssp             TSGGGGGG
T ss_pred             cCHHHHHH
Confidence            99999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-41  Score=337.54  Aligned_cols=228  Identities=26%  Similarity=0.403  Sum_probs=186.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------------eeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------------YEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------------~~~~~~~~~   47 (408)
                      .+|++.+.||+|+||+||+|++..+|+.||+|.....                                  ....+....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            3699999999999999999999999999999853211                                  111123456


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ..+|||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~-ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ-IRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-EEEEecCcccccC
Confidence            678999999999999999854 56799999999999999999999999999999999999998875 9999999987654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhC------CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC---C
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRG------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR---F  198 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~---~  198 (408)
                      ...   .....+||+.|+|||++.+      ..++.++|||||||++|+|++|..||...................   .
T Consensus       252 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  328 (365)
T 2y7j_A          252 PGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE  328 (365)
T ss_dssp             TTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred             CCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            332   2234579999999999974      357889999999999999999999998765544433332222211   1


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      ....++.+.+||.+||..||.+|||+.|+++||||+
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            145788899999999999999999999999999996

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.7e-42  Score=353.65  Aligned_cols=232  Identities=25%  Similarity=0.333  Sum_probs=189.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|....                           .+...+......++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            479999999999999999999999999999986421                           12223445667899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~  132 (408)
                      |++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++..+  ..+||+|||++.......  
T Consensus       102 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--  178 (486)
T 3mwu_A          102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--  178 (486)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence            99999999998754 5679999999999999999999999999999999999996432  259999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC-CC--CCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP-RF--PTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p-~~--~~~~s~~~~~l  209 (408)
                       .....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.......+.........+ ..  ....++.+++|
T Consensus       179 -~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          179 -KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred             -ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence             22345699999999999875 889999999999999999999999877665544433333221 11  24578999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      |.+||.+||.+|||+.|+++||||+....
T Consensus       257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             HHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            99999999999999999999999986543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-41  Score=326.07  Aligned_cols=230  Identities=22%  Similarity=0.320  Sum_probs=182.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++..+++.+|+|....                            .+......+...++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            479999999999999999999999999999986421                            1122234566789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ .
T Consensus        91 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~-~  167 (294)
T 4eqm_A           91 EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIAKALSETSL-T  167 (294)
T ss_dssp             ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCSSSTTC-------
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC-EEEEeCCCccccccccc-c
Confidence            999999999999854 56799999999999999999999999999999999999998875 99999999976543221 1


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC----CCCCCcHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR----FPTQSSELGRDF  209 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~----~~~~~s~~~~~l  209 (408)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................+.    .+...++.+.++
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV  247 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence            2234569999999999999999999999999999999999999998766544333223333332    345688999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      |.+||.+||.+||+..+.+.+.|..
T Consensus       248 i~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          248 ILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHhcCCHhHccccHHHHHHHHHH
Confidence            9999999999999666666655543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.6e-42  Score=337.78  Aligned_cols=230  Identities=26%  Similarity=0.404  Sum_probs=186.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|....                          .+...+..+...+|||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            579999999999999999999999999999876431                          111223345668899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++||+|.+++... +.+++..+..++.||+.||+|||++ ||+||||||+|||++.++. +||+|||++.......    
T Consensus       113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~----  186 (360)
T 3eqc_A          113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM----  186 (360)
T ss_dssp             CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC-EEECCCCCCHHHHHHC----
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC-EEEEECCCCccccccc----
Confidence            9999999999854 4679999999999999999999996 9999999999999998875 9999999986543222    


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh-------------------------
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------------------------  189 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~-------------------------  189 (408)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......+...                         
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            2234699999999999999999999999999999999999999976544332111                         


Q ss_pred             -----------------cccCCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          190 -----------------GFSDELPRF-PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       190 -----------------~~~~~~p~~-~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                       ......+.. +...+..+++||.+||+.||.+|||+.|+++||||+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                             011112222 234788999999999999999999999999999997644

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-41  Score=323.99  Aligned_cols=234  Identities=23%  Similarity=0.354  Sum_probs=190.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------------eeccCCC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------------YEAPTTS   45 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------------~~~~~~~   45 (408)
                      .++|++.+.||+|+||+||+|.++.+++.|++|.....                                   +...+..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            36899999999999999999999999999999864211                                   1112334


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      +...+|||||+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc-EEEecccchhh
Confidence            56688999999999999999854 56799999999999999999999999999999999999998875 99999999976


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHh------CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC---
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVR------GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP---  196 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~------~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p---  196 (408)
                      .....   ......||+.|+|||++.      ...++.++||||||+++|+|++|..||..................   
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          174 LDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             cCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            54322   223456899999999986      446788999999999999999999999876655444332222221   


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ......++.+++||.+||+.||.+|||+.|+++||||+....+
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE  293 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence            1123578899999999999999999999999999999876543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=343.35  Aligned_cols=233  Identities=18%  Similarity=0.216  Sum_probs=191.7

Q ss_pred             CCeEeeceeeecCCeeEEEEE-----EcCCCcEEEEeecc--------------------------cceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV-----DRFNGDVFAYLGDD--------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~-----d~~t~~~va~k~~~--------------------------~~~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|.     +..++..||+|...                          +.+...+......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            479999999999999999999     55677889998743                          11222344566779


Q ss_pred             EEEeccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCC
Q 042746           51 LHLEYLPGGTVSDLATTLN------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGA  122 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGl  122 (408)
                      |||||++||+|.+++....      ..+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999999998654      3578999999999999999999999999999999999998543  2599999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~  201 (408)
                      ++...............||+.|+|||++.+..++.++|||||||++|+|++ |.+||.......+.........+..+..
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  310 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN  310 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            975433322222334568999999999999889999999999999999998 9999998777666665555555666778


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      .++.+.+||.+||+.||.+|||+.|+++|.++.
T Consensus       311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            899999999999999999999999999987664

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-41  Score=351.50  Aligned_cols=229  Identities=24%  Similarity=0.333  Sum_probs=185.9

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      +|++++.||+|+||+||+|+++.++..+|+|....                           .+...+......+|||||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  117 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC  117 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            69999999999999999999999999999876431                           122234456678999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCCc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++..+  ..+||+|||++.......   
T Consensus       118 ~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---  193 (494)
T 3lij_A          118 YKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---  193 (494)
T ss_dssp             CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---
Confidence            9999999998754 5679999999999999999999999999999999999997642  349999999997654322   


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC---CCCCCcHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR---FPTQSSELGRDFL  210 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~---~~~~~s~~~~~li  210 (408)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.......+.........+.   .....++.+++||
T Consensus       194 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  272 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLI  272 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHH
T ss_pred             cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHH
Confidence            2334579999999999875 58999999999999999999999998877665554433332221   1246789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .+||+.||.+|||+.|+++||||+..
T Consensus       273 ~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          273 KQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHCCCChhhCccHHHHhcCcccccC
Confidence            99999999999999999999999753

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-41  Score=336.71  Aligned_cols=228  Identities=34%  Similarity=0.461  Sum_probs=187.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .|++.+.||+|+||+||+|++..+++.||+|....                            .+.+.+..+...+||||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            48999999999999999999999999999986431                            11122334567889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+. |+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......     
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~-----  207 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA-----  207 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSSB-----
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCCC-----
Confidence            998 589888877778899999999999999999999999999999999999999887 5999999999665322     


Q ss_pred             cccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC-CCCCCCCCcHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE-LPRFPTQSSELGRDFL  210 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~-~p~~~~~~s~~~~~li  210 (408)
                       ....||+.|+|||++.   ...++.++|||||||++|+|++|++||................ .+..+...++.+++||
T Consensus       208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  286 (348)
T 1u5q_A          208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  286 (348)
T ss_dssp             -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred             -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence             2356999999999995   4568899999999999999999999998765433322222222 2233457889999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+||+.||++|||+.|+++||||....+
T Consensus       287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          287 DSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHcccChhhCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999975443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.2e-42  Score=333.56  Aligned_cols=227  Identities=23%  Similarity=0.272  Sum_probs=186.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE----EEEeeccc--------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV----FAYLGDDV--------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~----va~k~~~~--------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|++..+++.    +++|....                          .+.... .+...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE-CBSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-cCCccEE
Confidence            5799999999999999999999988876    45543210                          011111 2345789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ-VQVADFGVADLLPPDDK  170 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC-EEECSCSGGGGSCCCTT
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe-EEECCCCcccccCcccc
Confidence            99999999999999866667899999999999999999999999999999999999998875 99999999987654443


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.................+..+...+..+.++|
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVM  250 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHH
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHH
Confidence            333344568889999999998889999999999999999999 9999998776666555445555566677888899999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q 042746          211 DKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+||..||.+|||+.|+++|
T Consensus       251 ~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          251 VKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999886

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-41  Score=328.81  Aligned_cols=230  Identities=26%  Similarity=0.404  Sum_probs=189.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||+||+|++..+++.|++|....                         .+...+......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            369999999999999999999999999999876431                         1122234556788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---cCCCCcEEEeecCCccccccCCCCc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl---~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      +|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||++   +.++ .+||+|||++......    
T Consensus        89 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~----  162 (304)
T 2jam_A           89 SGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQNG----  162 (304)
T ss_dssp             CSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCCB----
T ss_pred             CCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCCC----
Confidence            999999999754 567999999999999999999999999999999999999   5555 4999999998654322    


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC---CCCCCCCCcHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE---LPRFPTQSSELGRDFL  210 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~---~p~~~~~~s~~~~~li  210 (408)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......+........   ....+...++.+++||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  242 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI  242 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence            1223458999999999999889999999999999999999999998766554433322222   1233456789999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+||..||.+|||+.|+++||||....
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          243 CHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999997643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.5e-42  Score=333.46  Aligned_cols=233  Identities=22%  Similarity=0.312  Sum_probs=181.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce----------------------------eccCCCC----Ccc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY----------------------------EAPTTSS----SCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~----------------------------~~~~~~~----~~~   49 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|......                            .......    ...
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            57999999999999999999999999999998643210                            0001111    123


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      +|||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus        92 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC-EEECCCSCC------
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC-EEEeeccCccccccc
Confidence            8999999999999999854 56799999999999999999999999999999999999998875 999999999765432


Q ss_pred             CCC-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC-C--CCCCCCcHH
Q 042746          130 DTR-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL-P--RFPTQSSEL  205 (408)
Q Consensus       130 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~-p--~~~~~~s~~  205 (408)
                      ... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||................. +  ......+++
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence            211 122335699999999999999999999999999999999999999987665544332222221 1  112457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +.+||.+||+.||.+||++.++++|+|++..
T Consensus       250 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999743

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.8e-42  Score=346.40  Aligned_cols=230  Identities=26%  Similarity=0.393  Sum_probs=178.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------------eccCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------------EAPTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------------~~~~~~~~~   48 (408)
                      ++|++.+.||+|+||+||+|.+..+++.||+|......                                 ...+ ....
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-ESSE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCc
Confidence            57999999999999999999999999999998643210                                 0011 2334


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCcccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEA  126 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~  126 (408)
                      .+|||||++||+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||+++..
T Consensus       214 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             eEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            689999999999999886 346789999999999999999999999999999999999997543  24999999999765


Q ss_pred             ccCCCCcccccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCCC---CCC
Q 042746          127 TVSDTRGVKIQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELP---RFP  199 (408)
Q Consensus       127 ~~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~p---~~~  199 (408)
                      ....   .....+||+.|+|||++.+   ..++.++|||||||++|+|++|.+||...... .+.........+   ...
T Consensus       293 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          293 GETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             CCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            4322   2234579999999999864   56788999999999999999999999764322 222222222222   222


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ...++.+++||.+||+.||.+|||++|+++||||+..
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            4678999999999999999999999999999999753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.7e-41  Score=322.92  Aligned_cols=226  Identities=27%  Similarity=0.400  Sum_probs=182.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eec----cCCCCCcceE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEA----PTTSSSCRNL   51 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~----~~~~~~~~~L   51 (408)
                      .|++.+.||+|+||+||+|.+..++..+++|.....                           +..    ........++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            489999999999999999999999999998753311                           111    1122456789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEc-CCCCcEEEeecCCcccccc
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVG-PNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~-~~~~~vkL~DFGla~~~~~  128 (408)
                      ||||+++|+|.+++... ..+++..++.++.||+.||+|||+++  |+||||||+|||++ .++ .+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGGGCCT
T ss_pred             EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC-CEEEeeCCCcccccc
Confidence            99999999999999854 56799999999999999999999999  99999999999998 455 599999999864432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-hhhhhhcccC-CCCCCCCCCcHHH
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSRIGFSD-ELPRFPTQSSELG  206 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~~~~~~-~~p~~~~~~s~~~  206 (408)
                      .    ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||..... .......... ..+.++...++.+
T Consensus       185 ~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  259 (290)
T 1t4h_A          185 S----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             c----ccccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence            2    22345699999999998754 89999999999999999999999986433 3332222222 2233455677899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      .+||.+||..||.+|||+.|+++||||++
T Consensus       260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            99999999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=329.91  Aligned_cols=233  Identities=29%  Similarity=0.416  Sum_probs=182.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------eeccCC------CCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------YEAPTT------SSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------~~~~~~------~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|++..+++.|++|.....                         +...+.      .....+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            5799999999999999999999999999998864311                         111111      145689


Q ss_pred             EEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           51 LHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~  182 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE-VKLVDFGVSAQLDRT  182 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-EEECCCTTTC-----
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC-EEEeeCcCceecCcC
Confidence            999999999999999864 357899999999999999999999999999999999999998875 999999998765432


Q ss_pred             CCCcccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC-CCCCCCc
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP-RFPTQSS  203 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p-~~~~~~s  203 (408)
                      ..  ......||+.|+|||++.     +..++.++||||||+++|+|++|..||.................+ ..+...+
T Consensus       183 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 2x7f_A          183 VG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  260 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSC
T ss_pred             cc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccC
Confidence            21  123456899999999997     456889999999999999999999999876544433322222222 2345678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      +.+++||.+||..||.+|||+.|+++||||....
T Consensus       261 ~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          261 KKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            9999999999999999999999999999997644

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-41  Score=350.89  Aligned_cols=232  Identities=20%  Similarity=0.273  Sum_probs=189.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------------------eeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------------------YEAPT   43 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------------------~~~~~   43 (408)
                      .+|++++.||+|+||+||+|+++.+++.+|+|.....                                      +...+
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            5799999999999999999999999999998764321                                      11123


Q ss_pred             CCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC--cEEEeecC
Q 042746           44 TSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS--FVKLADFG  121 (408)
Q Consensus        44 ~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~--~vkL~DFG  121 (408)
                      ......+|||||++||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            4556788999999999999999754 56799999999999999999999999999999999999987653  49999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC---C
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR---F  198 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~---~  198 (408)
                      ++.......   .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.......+...........   .
T Consensus       195 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  270 (504)
T 3q5i_A          195 LSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND  270 (504)
T ss_dssp             TCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred             CCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence            997654322   2234569999999999885 48999999999999999999999999877665554443333211   1


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ....++.+++||.+||.+||.+|||+.|+++||||+....
T Consensus       271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            1467899999999999999999999999999999986543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.6e-42  Score=334.72  Aligned_cols=231  Identities=22%  Similarity=0.311  Sum_probs=179.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-cEEEEeeccc------------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-DVFAYLGDDV------------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-~~va~k~~~~------------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|++..++ ..||+|....                              .....+......+
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            58999999999999999999998887 6888876431                              0111123356678


Q ss_pred             EEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE-------------------cC
Q 042746           51 LHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV-------------------GP  110 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl-------------------~~  110 (408)
                      |||||+ +++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||+                   +.
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999999 557777776543 468999999999999999999999999999999999999                   34


Q ss_pred             CCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc
Q 042746          111 NSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG  190 (408)
Q Consensus       111 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~  190 (408)
                      ++ .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|.+||............
T Consensus       178 ~~-~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          178 NT-SIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             CC-CEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CC-cEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            44 5999999999654322     22356999999999999999999999999999999999999999865533221110


Q ss_pred             --ccCCCC-----------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 042746          191 --FSDELP-----------------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQL  227 (408)
Q Consensus       191 --~~~~~p-----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~el  227 (408)
                        .....|                                         ......+..+.+||.+||+.||.+|||+.|+
T Consensus       252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence              000000                                         0011224578899999999999999999999


Q ss_pred             HcCCCCCCCCCC
Q 042746          228 LKHPFLQSVSPS  239 (408)
Q Consensus       228 l~hpf~~~~~~~  239 (408)
                      ++||||....+.
T Consensus       332 l~hp~f~~~~~~  343 (355)
T 2eu9_A          332 LLHPFFAGLTPE  343 (355)
T ss_dssp             TTSGGGGGCCHH
T ss_pred             hcChhhcCCChh
Confidence            999999876543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.3e-42  Score=343.07  Aligned_cols=222  Identities=16%  Similarity=0.135  Sum_probs=174.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------eeccCCC-----------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------YEAPTTS-----------------   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------~~~~~~~-----------------   45 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                   ......+                 
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            4699999999999999999999999999999874310                   0000000                 


Q ss_pred             --C------------C-----cceEEEeccCCCCHHHHHHHhCCCCC------HHHHHHHHHHHHHHHHHHHHCCCeecC
Q 042746           46 --S------------S-----CRNLHLEYLPGGTVSDLATTLNAYAD------EITLRSHTYCIVSALKYLHSRNIVHCD  100 (408)
Q Consensus        46 --~------------~-----~~~LVmEy~~gGsL~~~l~~~~~~l~------e~~i~~i~~qIl~~L~yLH~~giiHrD  100 (408)
                        .            .     ..+|+|||+ +|+|.+++...+....      +..+..++.||+.||+|||++||+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence              0            0     268999999 5799999986533222      478888999999999999999999999


Q ss_pred             CCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCC-----------CCCCCCCcchHHHHHH
Q 042746          101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE-----------CQGPESDVWSLGCTII  169 (408)
Q Consensus       101 LKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----------~~~~~sDiWSLGvil~  169 (408)
                      |||+|||++.++. +||+|||+++....     .....+| +.|+|||++.+.           .++.++|||||||++|
T Consensus       232 ikp~NIll~~~~~-~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          232 LRPVDIVLDQRGG-VFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CCGGGEEECTTCC-EEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCCC-EEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            9999999998875 99999999975322     2334568 999999999887           7999999999999999


Q ss_pred             HHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          170 EMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       170 eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +|++|+.||..............     .+...++.+++||.+||+.||.+|||+.|+++||||+..
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHCCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            99999999986554333332221     124678899999999999999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-42  Score=336.25  Aligned_cols=231  Identities=27%  Similarity=0.404  Sum_probs=181.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +++|++.+.||+|+||+||+|++..+++.|++|....                           .+...+......++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4789999999999999999999999999999985321                           1122234456688999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+++++|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........  
T Consensus       104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~--  179 (331)
T 4aaa_A          104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGE--  179 (331)
T ss_dssp             ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCTTC----------
T ss_pred             ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc-EEEEeCCCceeecCCcc--
Confidence            9999999888876 4566899999999999999999999999999999999999998875 99999999966543221  


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc---------------------
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF---------------------  191 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~---------------------  191 (408)
                      ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.............                     
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            22345689999999999875 67899999999999999999999998654322111000                     


Q ss_pred             cCCCCCC---------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          192 SDELPRF---------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       192 ~~~~p~~---------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ....+..         ....++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            0011111         1256889999999999999999999999999999974

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.4e-41  Score=335.41  Aligned_cols=235  Identities=24%  Similarity=0.384  Sum_probs=172.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccC-------CCCCcc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPT-------TSSSCR   49 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~-------~~~~~~   49 (408)
                      +++|++++.||+|+||+||+|++..+++.||+|....                        .+...+       ......
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            4689999999999999999999999999999985321                        011111       112237


Q ss_pred             eEEEeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           50 NLHLEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLH--SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH--~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||  ++||+||||||+|||++.....+||+|||++.
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            899999997 55554432   4567899999999999999999999  99999999999999998733369999999997


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc------------
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF------------  191 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~------------  191 (408)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.............            
T Consensus       181 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3e3p_A          181 KLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR  257 (360)
T ss_dssp             CCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence            6543322   2345689999999999765 47999999999999999999999998755432221110            


Q ss_pred             -------------------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          192 -------------------SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       192 -------------------~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                         ...++..+...++.+++||.+||+.||.+|||+.|+++||||+.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence                               001122233467889999999999999999999999999999987544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.6e-42  Score=340.07  Aligned_cols=228  Identities=24%  Similarity=0.320  Sum_probs=172.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCC------CCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTT------SSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~------~~~~   48 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                           +...+.      ....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            5899999999999999999999999999999864311                           111111      1236


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+|||||+++ +|.+++.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus       105 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCCCC------
T ss_pred             eEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC-EEEEEeeccccccc
Confidence            7999999986 7888885   45799999999999999999999999999999999999998875 99999999976543


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC---------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD---------------  193 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~---------------  193 (408)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+...........               
T Consensus       180 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          180 SF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            21   223456999999999999999999999999999999999999999875543222111110               


Q ss_pred             ------CCCCCC--------------C------CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          194 ------ELPRFP--------------T------QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       194 ------~~p~~~--------------~------~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                            ..|.+.              .      ..++.+++||.+||..||.+|||++|+++||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                  001110              0      0156789999999999999999999999999997543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.8e-42  Score=341.34  Aligned_cols=227  Identities=22%  Similarity=0.282  Sum_probs=177.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------------eeccCC----C
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------------YEAPTT----S   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------------~~~~~~----~   45 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                                +...+.    .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            5799999999999999999999999999999864310                                011111    3


Q ss_pred             CCcceEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCC-----------
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNS-----------  112 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~-----------  112 (408)
                      ....+|||||+. ++|.+.+... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++           
T Consensus       117 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          117 GTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            456889999994 5666666543 35689999999999999999999999 999999999999998764           


Q ss_pred             -------------------------------------CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCC
Q 042746          113 -------------------------------------SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ  155 (408)
Q Consensus       113 -------------------------------------~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~  155 (408)
                                                           ..+||+|||++......     .....||+.|+|||++.+..+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~  270 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGY  270 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCC
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCC
Confidence                                                 15999999999765432     223468999999999999999


Q ss_pred             CCCCCcchHHHHHHHHHhCCCCCCCCChhhh-------hhh-cccCCCC-------------------------------
Q 042746          156 GPESDVWSLGCTIIEMVTGKPAWEDFGANTL-------SRI-GFSDELP-------------------------------  196 (408)
Q Consensus       156 ~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-------~~~-~~~~~~p-------------------------------  196 (408)
                      +.++|||||||++|+|++|++||........       ..+ ...+..|                               
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            9999999999999999999999975432110       000 0000000                               


Q ss_pred             --------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          197 --------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       197 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                              ..+...++.+++||.+||+.||.+|||+.|+++||||+
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                    11223356788999999999999999999999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.3e-40  Score=323.67  Aligned_cols=233  Identities=26%  Similarity=0.379  Sum_probs=185.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-CCCcEEEEeecccc------------------------------eeccC-----CC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-FNGDVFAYLGDDVS------------------------------YEAPT-----TS   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-~t~~~va~k~~~~~------------------------------~~~~~-----~~   45 (408)
                      .+|++.+.||+|+||+||+|++. .+++.||+|.....                              +...+     ..
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            57999999999999999999995 67888888753211                              00001     13


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ....++||||++ |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~-~kl~Dfg~~~  168 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLAR  168 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECSCCSCC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC-EEEecCcccc
Confidence            455789999998 59999998643 34899999999999999999999999999999999999998875 9999999997


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc-------------
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-------------  191 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~-------------  191 (408)
                      ......   ......||+.|+|||++.+..++.++||||||+++|+|++|++||.............             
T Consensus       169 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          169 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             cccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            654322   2234568999999999999889999999999999999999999998654332211100             


Q ss_pred             -------------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          192 -------------SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       192 -------------~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                   ......+....++.+++||.+||..||.+|||+.|+++||||+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                         001112335678999999999999999999999999999999876544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-41  Score=322.82  Aligned_cols=232  Identities=24%  Similarity=0.357  Sum_probs=186.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-------------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-------------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-------------------------------~~~~~~~~~~~~   50 (408)
                      ++|++++.||+|+||+||+|++..+++.+++|.....                               +...+......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            4799999999999999999999999999998753211                               111233456688


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC---cEEEeecCCccccc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS---FVKLADFGAAGEAT  127 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~---~vkL~DFGla~~~~  127 (408)
                      +||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.   .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999975 456799999999999999999999999999999999999987652   49999999996654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~  204 (408)
                      ....   .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.................   +..+...++
T Consensus       164 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          164 AGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             CCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            3221   2334689999999999998899999999999999999999999987665444332222211   112246788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+++||.+||..||++|||+.|+++||||+...
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            999999999999999999999999999997643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.1e-41  Score=334.82  Aligned_cols=228  Identities=25%  Similarity=0.389  Sum_probs=178.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCc------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSC------   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~------   48 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                           +...+.....      
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4799999999999999999999999999999864311                           1111122222      


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .++||||+.+ +|.+++.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus       122 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          122 FYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADA  196 (371)
T ss_dssp             CEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECSTTCC-----
T ss_pred             EEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC-EEEEecCccccccc
Confidence            3899999984 8877763   55899999999999999999999999999999999999998875 99999999975432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc---------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS---------------  192 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~---------------  192 (408)
                      .     .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..........               
T Consensus       197 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          197 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             C-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            2     223568999999999987 6789999999999999999999999987553322111100               


Q ss_pred             ---------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 ---------------DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ---------------~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                     ...+..+...++.+++||.+||+.||.+|||+.|+++||||+....+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence                           00011224568899999999999999999999999999999876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.3e-41  Score=333.44  Aligned_cols=233  Identities=24%  Similarity=0.339  Sum_probs=184.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccC-----CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPT-----TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~-----~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                          +...+     ......+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            4799999999999999999999999999999864310                          00011     1224578


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+.| +|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus       107 iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCGGG
T ss_pred             EEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC-EEEEeCcceEecCCCC
Confidence            99999985 99999974  46899999999999999999999999999999999999998875 9999999997654332


Q ss_pred             C-CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc----------------
Q 042746          131 T-RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS----------------  192 (408)
Q Consensus       131 ~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~----------------  192 (408)
                      . .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||..............                
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            1 112234579999999998765 4589999999999999999999999986543332211100                


Q ss_pred             ------CCC--------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          193 ------DEL--------PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       193 ------~~~--------p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                            ...        .......++.+++||.+||++||.+|||+.|+++||||+....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                  000        0112456889999999999999999999999999999987643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=342.55  Aligned_cols=235  Identities=21%  Similarity=0.295  Sum_probs=165.1

Q ss_pred             CeEe-eceeeecCCeeEEEEEEc--CCCcEEEEeecccc-----------------------eeccC--CCCCcceEEEe
Q 042746            3 SWVR-GKCIGRGSFGTVNVAVDR--FNGDVFAYLGDDVS-----------------------YEAPT--TSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~-~~~IG~G~fG~Vy~a~d~--~t~~~va~k~~~~~-----------------------~~~~~--~~~~~~~LVmE   54 (408)
                      .|++ +++||+|+||+||+|+++  .+++.||+|.....                       +...+  ......+||||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            4666 779999999999999966  57888999864311                       11112  34567899999


Q ss_pred             ccCCCCHHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----cCCCCcEEEeecCC
Q 042746           55 YLPGGTVSDLATTL--------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV----GPNSSFVKLADFGA  122 (408)
Q Consensus        55 y~~gGsL~~~l~~~--------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl----~~~~~~vkL~DFGl  122 (408)
                      |+.| +|.+++...        ...+++..++.++.||+.||+|||++||+||||||+|||+    +.++ .+||+|||+
T Consensus       101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~Dfg~  178 (405)
T 3rgf_A          101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGF  178 (405)
T ss_dssp             CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CEEECCTTC
T ss_pred             CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cEEEEECCC
Confidence            9985 888887632        1248999999999999999999999999999999999999    4445 599999999


Q ss_pred             ccccccCCC-CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChh----------hhhhhc
Q 042746          123 AGEATVSDT-RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----------TLSRIG  190 (408)
Q Consensus       123 a~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----------~~~~~~  190 (408)
                      ++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||......          .+..+.
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            976543221 1122345799999999999874 5899999999999999999999999643321          111110


Q ss_pred             ccCCCC------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          191 FSDELP------------------------------------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       191 ~~~~~p------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      .....|                                    ......++.+.+||.+||..||.+|||++|+|+||||.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence            000000                                    00112266789999999999999999999999999998


Q ss_pred             CCCCC
Q 042746          235 SVSPS  239 (408)
Q Consensus       235 ~~~~~  239 (408)
                      .....
T Consensus       339 ~~~~~  343 (405)
T 3rgf_A          339 EDPLP  343 (405)
T ss_dssp             SSSCC
T ss_pred             cCCCC
Confidence            76544

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.6e-41  Score=339.32  Aligned_cols=227  Identities=23%  Similarity=0.299  Sum_probs=188.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      .+|++++.||+|+||+||+|.+..+++.||+|....                          .+.+....+...+|||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            479999999999999999999999999999986431                          112223445668999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++||+|.++++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~-~kl~DfG~s~~~~~~~~~~~~  272 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADGVYAASG  272 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCGGGCEECTTSEEECCS
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc-EEECcCCCceecCCCceeecC
Confidence            9999999999877777899999999999999999999999999999999999998875 999999999754322111111


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....+++.|+|||++.+..++.++|||||||++|||++ |..||.................+..|...++.+.+||.+||
T Consensus       273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  352 (377)
T 3cbl_A          273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCW  352 (377)
T ss_dssp             SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            11224677999999998889999999999999999998 99999887766555544444455667788999999999999


Q ss_pred             ccCCCCCCCHHHHHc
Q 042746          215 RREPGERWSCDQLLK  229 (408)
Q Consensus       215 ~~dP~~R~s~~ell~  229 (408)
                      +.||++|||+.++++
T Consensus       353 ~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          353 AYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-41  Score=338.35  Aligned_cols=229  Identities=21%  Similarity=0.331  Sum_probs=167.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~~   48 (408)
                      .+|++.+.||+|+||+||+|.+..+++.||+|.....                           +...+      .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            5799999999999999999999999999999875311                           00111      12255


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .+++|||+ +++|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus       109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-~kL~DFG~a~~~~~  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTAD  184 (367)
T ss_dssp             CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC-EEEeeccccccccc
Confidence            79999999 6799999874  56899999999999999999999999999999999999998875 99999999976432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhccc---------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFS---------------  192 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~---------------  192 (408)
                      .     .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+..               
T Consensus       185 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          185 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             c-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            2     223569999999999987 6789999999999999999999999987553322111000               


Q ss_pred             -------CCCCCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 -------DELPRF--------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 -------~~~p~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                             ..++..        ....++.+++||.+||..||.+|||+.|+|+||||.....+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                   011111        13467889999999999999999999999999999976544

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=329.88  Aligned_cols=227  Identities=20%  Similarity=0.257  Sum_probs=186.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeeccc--------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDV--------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~--------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|.+..+++   .||+|....                          .+...+......+||
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            479999999999999999999987665   488876431                          122234455678899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.++++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++........
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV-CKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCSSCEECC----C
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC-EEECCCCcccccccCccc
Confidence            9999999999999876678899999999999999999999999999999999999998875 999999999765433221


Q ss_pred             -cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 -GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 -~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                       .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.................+..+...++.+.+||
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  287 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLM  287 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHH
Confidence             12223346788999999998889999999999999999999 9999988776666555444545566778899999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||..||.+|||+.|+++
T Consensus       288 ~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          288 LDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999999999886

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-41  Score=319.52  Aligned_cols=226  Identities=23%  Similarity=0.295  Sum_probs=188.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+. +++.||+|....                        .+...+..+...++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57999999999999999999987 466788876431                        12223445667899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +|+|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++........ .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~-~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQY-TSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC-EEECCTTGGGGBCCHHH-HSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC-EEecccccccccccccc-ccccC
Confidence            99999999876777899999999999999999999999999999999999988875 99999999965432211 11223


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..||+.|+|||++.+..++.++|+||||+++|+|++ |++||.................+..+...++.+.+++.+||+.
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  246 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRE  246 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccC
Confidence            356888999999998889999999999999999999 9999998776665555445545566777899999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||.+|||+.|+++|
T Consensus       247 ~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          247 RPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=329.94  Aligned_cols=228  Identities=21%  Similarity=0.245  Sum_probs=189.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|++.     .+++.||+|....                          .+...+......+
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            57999999999999999999998     4558888876431                          1222344566789


Q ss_pred             EEEeccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042746           51 LHLEYLPGGTVSDLATTLN-----------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL  107 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-----------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NIL  107 (408)
                      |||||++||+|.+++....                       ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            9999999999999998642                       56899999999999999999999999999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhh
Q 042746          108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTL  186 (408)
Q Consensus       108 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~  186 (408)
                      ++.++. +||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus       207 ~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  285 (343)
T 1luf_A          207 VGENMV-VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  285 (343)
T ss_dssp             ECGGGC-EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCe-EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH
Confidence            998875 99999999965543322222334567899999999998889999999999999999999 9999988776666


Q ss_pred             hhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          187 SRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       187 ~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .........+..+...++.+.++|.+||..||.+|||+.|++++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          286 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            55555566667778899999999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=333.67  Aligned_cols=228  Identities=24%  Similarity=0.321  Sum_probs=191.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC-------cEEEEeeccc---------------------------ceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG-------DVFAYLGDDV---------------------------SYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~-------~~va~k~~~~---------------------------~~~~~~~~~~   47 (408)
                      ++|++++.||+|+||+||+|++..++       ..||+|....                           .+...+..+.
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            47999999999999999999986433       4688775321                           1222344566


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..+|||||++||+|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            7899999999999999998653               3589999999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......+.....
T Consensus       229 ~-~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~  307 (382)
T 3tt0_A          229 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  307 (382)
T ss_dssp             C-EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             c-EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            5 99999999976654332223334567889999999999999999999999999999999 999999877776666555


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...++.+.+||.+||+.||.+|||+.|++++
T Consensus       308 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          308 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555666778899999999999999999999999999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.2e-41  Score=325.06  Aligned_cols=228  Identities=24%  Similarity=0.298  Sum_probs=189.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|.+.     .++..||+|....                          .+...+......+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            47999999999999999999984     4557888876431                          1222344566789


Q ss_pred             EEEeccCCCCHHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042746           51 LHLEYLPGGTVSDLATTLNA-----------------------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL  107 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~-----------------------~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NIL  107 (408)
                      +||||++||+|.+++.....                       .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999999999999986432                       3789999999999999999999999999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhh
Q 042746          108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTL  186 (408)
Q Consensus       108 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~  186 (408)
                      ++.++ .+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......+
T Consensus       183 i~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  261 (314)
T 2ivs_A          183 VAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL  261 (314)
T ss_dssp             EETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99887 499999999976543332222334457889999999999889999999999999999999 9999988776666


Q ss_pred             hhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          187 SRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       187 ~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .........+..+...++.+.++|.+||+.||.+|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55555555566777899999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-41  Score=334.31  Aligned_cols=228  Identities=23%  Similarity=0.308  Sum_probs=184.5

Q ss_pred             CCeEeeceeeecCCeeEEEEE-----EcCCCcEEEEeeccc---------------------------ceeccCC-CCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV-----DRFNGDVFAYLGDDV---------------------------SYEAPTT-SSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~-----d~~t~~~va~k~~~~---------------------------~~~~~~~-~~~~   48 (408)
                      ++|++++.||+|+||+||+|+     +..+++.||+|....                           .+.+... .+..
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            589999999999999999999     566778899886431                           1111112 2345


Q ss_pred             ceEEEeccCCCCHHHHHHHhCC----------------------------------------------------------
Q 042746           49 RNLHLEYLPGGTVSDLATTLNA----------------------------------------------------------   70 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~----------------------------------------------------------   70 (408)
                      .++||||++||+|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8899999999999999975432                                                          


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCC
Q 042746           71 -------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPL  143 (408)
Q Consensus        71 -------~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~  143 (408)
                             .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++................||+.
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc-EEEEeccceeeecccccchhccccCCCce
Confidence                   2789999999999999999999999999999999999998875 99999999976543333223334568999


Q ss_pred             CCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-hhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          144 WMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       144 y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      |+|||++.+..++.++||||||+++|+|++ |.+||...... ...........+..+...++.+.+++.+||..||.+|
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R  340 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR  340 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999989999999999999999998 99999875533 2223333344456677889999999999999999999


Q ss_pred             CCHHHHHcC
Q 042746          222 WSCDQLLKH  230 (408)
Q Consensus       222 ~s~~ell~h  230 (408)
                      ||+.|+++|
T Consensus       341 ps~~ell~~  349 (359)
T 3vhe_A          341 PTFSELVEH  349 (359)
T ss_dssp             CCHHHHHHH
T ss_pred             CCHHHHHHH
Confidence            999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-41  Score=327.67  Aligned_cols=228  Identities=20%  Similarity=0.295  Sum_probs=189.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|++.     .+++.|++|....                          .+..........+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            47999999999999999999987     4677888876431                          1222234556789


Q ss_pred             EEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           51 LHLEYLPGGTVSDLATTLN---------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      +||||++||+|.+++....         ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~-~kl~Dfg  183 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG  183 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-EEECCTT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe-EEECcCc
Confidence            9999999999999997532         45689999999999999999999999999999999999998875 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      ++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.................+..+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD  263 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCC
Confidence            9976543332222233457899999999999889999999999999999999 899998877666665555556666778


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..++.+++||.+||..||.+|||+.|+++|
T Consensus       264 ~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          264 NCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            899999999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-40  Score=327.65  Aligned_cols=236  Identities=22%  Similarity=0.356  Sum_probs=184.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceec-----cCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEA-----PTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~-----~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|.+..+++.||+|....                          .+..     .+......+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            579999999999999999999999999999986431                          0111     112235689


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+.+ +|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus        91 lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECC---
T ss_pred             EEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc-EEEEeccccccccccc
Confidence            99999984 99999874  56899999999999999999999999999999999999998875 9999999997654321


Q ss_pred             CC--------cccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc----------
Q 042746          131 TR--------GVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF----------  191 (408)
Q Consensus       131 ~~--------~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~----------  191 (408)
                      ..        .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.........          
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence            11        01223578999999999875 678899999999999999999999998755322111000          


Q ss_pred             -------------cCCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCCCc
Q 042746          192 -------------SDELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA  241 (408)
Q Consensus       192 -------------~~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~~~  241 (408)
                                   ....+.        .....++.+++||.+||..||++|||+.|+++||||+.......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  317 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND  317 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence                         000111        12367889999999999999999999999999999998765543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.8e-41  Score=330.67  Aligned_cols=227  Identities=24%  Similarity=0.281  Sum_probs=182.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEE----EEeeccc--------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVF----AYLGDDV--------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~v----a~k~~~~--------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|++..+++.+    ++|....                          .+...+. ....++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE-SSSEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-cCCeEE
Confidence            57999999999999999999998888765    5554211                          0111111 233679


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCTTHHHHHTTTCC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC-EEEccCcceeEccCCcc
Confidence            99999999999999877778999999999999999999999999999999999999998874 99999999976554433


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.......+.........+..+...+..+.+++
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  252 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM  252 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHH
T ss_pred             cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence            333334457889999999999999999999999999999999 9999998776666655545555566778899999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q 042746          211 DKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+||+.||.+|||+.|++++
T Consensus       253 ~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          253 VKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.3e-41  Score=316.96  Aligned_cols=226  Identities=20%  Similarity=0.253  Sum_probs=188.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++.+.||+|+||+||+|.+. ++..+|+|....                        .+......+...++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            58999999999999999999876 566788775331                        12223445667899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      |++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ .....
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~-~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC-VKVSDFGMTRYVLDDQY-VSSVG  164 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC-EEECCTTCEEECCTTCE-EECCS
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC-EEEccCccceecchhhh-hcccC
Confidence            99999999877777899999999999999999999999999999999999998875 99999999965543321 11223


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..+|+.|+|||++.+..++.++||||||+++|+|++ |..||.................+..+...++.+.+++.+||+.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  244 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHE  244 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCS
T ss_pred             CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCC
Confidence            446778999999999889999999999999999999 9999987766655544444555556677899999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||.+|||+.|++++
T Consensus       245 ~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          245 LPEKRPTFQQLLSS  258 (268)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-41  Score=335.51  Aligned_cols=231  Identities=25%  Similarity=0.317  Sum_probs=163.8

Q ss_pred             CCeEee-ceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceeccC----CCCCcceEEEec
Q 042746            2 VSWVRG-KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAPT----TSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~-~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~~----~~~~~~~LVmEy   55 (408)
                      ++|++. +.||+|+||+||+|+++.+++.||+|....                     .+...+    ......+|||||
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~  107 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC  107 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence            579995 579999999999999999999999986421                     111111    124457899999


Q ss_pred             cCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~  132 (408)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++  ..+||+|||++.......  
T Consensus       108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~--  185 (336)
T 3fhr_A          108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--  185 (336)
T ss_dssp             CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence            99999999998643 3689999999999999999999999999999999999997532  349999999997554322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh----hhcccC---CCCCCCCCCcHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS----RIGFSD---ELPRFPTQSSEL  205 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~----~~~~~~---~~p~~~~~~s~~  205 (408)
                        .....||+.|+|||++.+..++.++||||||+++|+|++|..||.........    ......   .........++.
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (336)
T 3fhr_A          186 --LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED  263 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHH
T ss_pred             --cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHH
Confidence              23456899999999998888899999999999999999999999765433221    111111   111222467899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +++||.+||..||.+|||+.|+++||||+..
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          264 AKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            9999999999999999999999999999764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=325.85  Aligned_cols=227  Identities=26%  Similarity=0.342  Sum_probs=182.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++++.||+|+||+||+|.+..+++.+++|...                         +.+...+..+...++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            58999999999999999999999999999998532                         11222234456788999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC----
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR----  132 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~----  132 (408)
                      +||+|.++++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.........    
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~  168 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGL  168 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC-EEECCCTTCEECC---------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC-EEEeecccceeccccccccccc
Confidence            999999999976778899999999999999999999999999999999999998875 999999999765332211    


Q ss_pred             --------cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-c-cCCCCCCCCCC
Q 042746          133 --------GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-F-SDELPRFPTQS  202 (408)
Q Consensus       133 --------~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-~-~~~~p~~~~~~  202 (408)
                              .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ . ....+..+...
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T 3s95_A          169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC  248 (310)
T ss_dssp             -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTC
T ss_pred             ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCC
Confidence                    0112457999999999999999999999999999999999999998754322211100 0 00001234567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          249 PPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             CTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            788999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.6e-41  Score=320.92  Aligned_cols=227  Identities=20%  Similarity=0.230  Sum_probs=182.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                        +..........++||||+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            4799999999999999999999999999999853211                        111123455678999999 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC----cEEEeecCCccccccCCCC-
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS----FVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~----~vkL~DFGla~~~~~~~~~-  132 (408)
                      |++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.    .+||+|||++......... 
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (298)
T 1csn_A           89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  168 (298)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccc
Confidence            99999999877777899999999999999999999999999999999999976542    3999999999765433221 


Q ss_pred             ----cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---hh-hhh---cccCCCCCCCCC
Q 042746          133 ----GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---TL-SRI---GFSDELPRFPTQ  201 (408)
Q Consensus       133 ----~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---~~-~~~---~~~~~~p~~~~~  201 (408)
                          .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......   .. ..+   ......+.....
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1csn_A          169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG  248 (298)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred             cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhh
Confidence                1223457999999999999998999999999999999999999999874321   11 111   111222233356


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .++.+++|+.+||+.||++|||+.++++
T Consensus       249 ~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          249 FPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             SCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            7899999999999999999999999876

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=329.19  Aligned_cols=227  Identities=22%  Similarity=0.347  Sum_probs=177.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccC--CCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPT--TSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~--~~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                          +...+  ......+|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            4799999999999999999999999999999864311                          11111  1233678999


Q ss_pred             eccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----cCCCCcEEEeecCCccccc
Q 042746           54 EYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV----GPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl----~~~~~~vkL~DFGla~~~~  127 (408)
                      ||++||+|.+++.....  .+++..++.++.||+.||+|||++||+||||||+|||+    +.++ .+||+|||+++...
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARELE  167 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCEECC
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCceecC
Confidence            99999999999986433  38999999999999999999999999999999999998    5554 49999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHh--------CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-----hhhhhc----
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVR--------GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-----TLSRIG----  190 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~--------~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-----~~~~~~----  190 (408)
                      ....   .....||+.|+|||++.        +..++.++|||||||++|+|++|+.||......     .+..+.    
T Consensus       168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          168 DDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             TTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            3322   23456999999999997        567899999999999999999999999743221     111111    


Q ss_pred             ----------------ccCCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 042746          191 ----------------FSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF  232 (408)
Q Consensus       191 ----------------~~~~~p---~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf  232 (408)
                                      +....|   .++...++.+.+||.+||+.||++|||++|+++||-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                            001111   122334567889999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-40  Score=323.38  Aligned_cols=229  Identities=29%  Similarity=0.413  Sum_probs=179.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .+|++.+.||+|+||+||+|++  +++.+|+|....                           .+...+......++|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            5799999999999999999987  577888876321                           12223445667899999


Q ss_pred             ccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           55 YLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |++||+|.+++...+.  .+++..++.++.||+.||+|||++|  |+||||||+|||++.++. +||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~-~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC-EEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc-EEECCCCCCccccccc
Confidence            9999999999975322  3799999999999999999999999  999999999999998875 9999999996543322


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-ccCCCCCCCCCCcHHHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-FSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-~~~~~p~~~~~~s~~~~~l  209 (408)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............ .....+..+...++.+.+|
T Consensus       194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  271 (309)
T 3p86_A          194 L--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI  271 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred             c--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            1  123456999999999999999999999999999999999999999877655443322 3444456778899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHc--CCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLK--HPFLQS  235 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~--hpf~~~  235 (408)
                      |.+||..||.+|||+.|+++  +++++.
T Consensus       272 i~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          272 IEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999987  455543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=324.39  Aligned_cols=235  Identities=23%  Similarity=0.316  Sum_probs=178.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceec--------------c
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEA--------------P   42 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~--------------~   42 (408)
                      .+|++++.||+|+||+||+|.+..+++.||+|....                         .+..              .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            579999999999999999999999999999985321                         1110              1


Q ss_pred             CCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           43 TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        43 ~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      .......++||||++ |+|.+++.  .+.+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence            133466789999998 59999986  457899999999999999999999999999999999999986555699999999


Q ss_pred             ccccccCCC-CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC-------
Q 042746          123 AGEATVSDT-RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD-------  193 (408)
Q Consensus       123 a~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~-------  193 (408)
                      +........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...............       
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            976543211 112233457999999999876 67889999999999999999999999875543222111000       


Q ss_pred             ----------------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ----------------------ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ----------------------~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                            .....+...++.+++||.+||+.||.+|||+.|+++||||+....+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence                                  0001224578999999999999999999999999999999876554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.5e-41  Score=325.73  Aligned_cols=229  Identities=26%  Similarity=0.409  Sum_probs=182.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------------eeccCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------------YEAPTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------------~~~~~~~~~~   48 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|.....                                 +...+ ....
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAED   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE-cCCc
Confidence            4799999999999999999999999999999864211                                 01111 1233


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC--cEEEeecCCcccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS--FVKLADFGAAGEA  126 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~--~vkL~DFGla~~~  126 (408)
                      .++||||++||+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            789999999999999987 3567899999999999999999999999999999999999986542  4999999999655


Q ss_pred             ccCCCCcccccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCC---CCCC
Q 042746          127 TVSDTRGVKIQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDEL---PRFP  199 (408)
Q Consensus       127 ~~~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~---p~~~  199 (408)
                      ...   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||...... .+.........   |..+
T Consensus       168 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          168 GET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             CCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             ccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            322   1122346899999999985   456789999999999999999999999764332 22222222222   2223


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ...++.+.+||.+||..||.+|||+.|+++||||..
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            567899999999999999999999999999999974

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.8e-41  Score=320.03  Aligned_cols=232  Identities=31%  Similarity=0.516  Sum_probs=183.4

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEeccCC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      |.....||+|+||+||+|.+..+++.|++|....                         .+.+.+......++||||+++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  103 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG  103 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence            4445599999999999999999999999886321                         112223345667899999999


Q ss_pred             CCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           59 GTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        59 GsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++|.+++.....  .+++..++.++.||+.||+|||++||+||||||+||+++.....+||+|||++........  ...
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~  181 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTE  181 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--ccc
Confidence            999999986533  4568899999999999999999999999999999999987333599999999976543221  123


Q ss_pred             cCCCCCCCCChhhHhCCC--CCCCCCcchHHHHHHHHHhCCCCCCCCChhh--hhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          137 QPRGSPLWMAPEVVRGEC--QGPESDVWSLGCTIIEMVTGKPAWEDFGANT--LSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~--~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                      ...||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......  ..........+.++...++.+++||.+
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  261 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK  261 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence            456899999999997653  7889999999999999999999997643222  222222344456677889999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||+.||++|||+.|+++||||+...
T Consensus       262 ~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          262 CFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             TTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999998544

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=325.66  Aligned_cols=228  Identities=25%  Similarity=0.375  Sum_probs=179.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCC------c
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSS------C   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~------~   48 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|.....                           +...+....      .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4799999999999999999999999999999864311                           011111121      3


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      .++||||+.+ +|.+++.   ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus       104 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          104 FYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHADA  178 (353)
T ss_dssp             CEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC-EEECSTTCTTC---
T ss_pred             EEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc-EEEeecccccCCCC
Confidence            4899999984 8887764   45899999999999999999999999999999999999998875 99999999975432


Q ss_pred             CCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------------  190 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------------  190 (408)
                      .     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+........                 
T Consensus       179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            2     223468999999999987 67899999999999999999999999865532211110                 


Q ss_pred             -------------ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 -------------FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 -------------~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                                   .....+......++.+++||.+||..||.+|||+.|+++||||......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                         0111223345678999999999999999999999999999999876543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.8e-41  Score=319.47  Aligned_cols=226  Identities=22%  Similarity=0.273  Sum_probs=179.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|.....                        +..........++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence            5799999999999999999999999999999853211                        001123455678999999 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE---cCCCCcEEEeecCCccccccCCCC--
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTR--  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl---~~~~~~vkL~DFGla~~~~~~~~~--  132 (408)
                      +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+   +.++ .+||+|||++.........  
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~  166 (296)
T 4hgt_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCB
T ss_pred             CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCcccCcc
Confidence            899999998777789999999999999999999999999999999999999   5555 5999999999765433221  


Q ss_pred             ---cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh----hhh---hcccCCCCCCCCCC
Q 042746          133 ---GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSR---IGFSDELPRFPTQS  202 (408)
Q Consensus       133 ---~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~----~~~---~~~~~~~p~~~~~~  202 (408)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    ...   .......+......
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T 4hgt_A          167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY  246 (296)
T ss_dssp             CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTS
T ss_pred             CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccC
Confidence               11234579999999999999999999999999999999999999998643221    111   11111112223567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          247 PSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            889999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.7e-41  Score=318.89  Aligned_cols=226  Identities=24%  Similarity=0.300  Sum_probs=175.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC---cEEEEeeccc--------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG---DVFAYLGDDV--------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~---~~va~k~~~~--------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|++..++   ..+++|....                          .+...+ .++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEE
Confidence            57999999999999999999997643   4678776321                          111112 34567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCccccc
Confidence            999999999999987666789999999999999999999999999999999999999877 4999999999765432211


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.++|.
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  251 (281)
T 1mp8_A          173 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT  251 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             -ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence             1223457889999999998889999999999999999997 99999876655554444444555677789999999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||..||.+|||+.|++++
T Consensus       252 ~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          252 KCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1e-40  Score=318.42  Aligned_cols=226  Identities=21%  Similarity=0.255  Sum_probs=185.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+. ++..|++|....                        .+...+......++||||++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            57999999999999999999887 567788875431                        12223445667899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      ||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ .....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~-~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEY-TSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC-EEECSTTGGGGBCCHHH-HSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC-EEEcccccccccccccc-ccccC
Confidence            99999999875677899999999999999999999999999999999999998875 99999999965432211 11223


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...++.+.++|.+||+.
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  260 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE  260 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccC
Confidence            346788999999998889999999999999999998 9999998776665555444445556677899999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||.+|||+.|+++|
T Consensus       261 ~p~~Rps~~~ll~~  274 (283)
T 3gen_A          261 KADERPTFKILLSN  274 (283)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.8e-40  Score=316.62  Aligned_cols=231  Identities=23%  Similarity=0.337  Sum_probs=176.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eecc-------------CC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAP-------------TT   44 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~-------------~~   44 (408)
                      .+|++++.||+|+||+||+|++..+++.|++|.....                        +...             ..
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            4799999999999999999999999999998764310                        0000             11


Q ss_pred             CCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           45 SSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        45 ~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .....++||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~  164 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAK  164 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCCCCCS
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC-EEEeeCcchh
Confidence            245678999999999999999876667789999999999999999999999999999999999998875 9999999997


Q ss_pred             ccccCCC------------CcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCC-Chhhhhhhc
Q 042746          125 EATVSDT------------RGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIG  190 (408)
Q Consensus       125 ~~~~~~~------------~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~-~~~~~~~~~  190 (408)
                      .......            ........||+.|+|||++.+. .++.++||||||+++|+|++   ||... .........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~  241 (303)
T 1zy4_A          165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL  241 (303)
T ss_dssp             CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred             hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence            6532110            1122345699999999999865 68999999999999999998   55432 111111111


Q ss_pred             ---ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          191 ---FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       191 ---~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                         .....+.++...++.+++||.+||+.||.+|||+.|+++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence               1122234556677889999999999999999999999999999753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=326.78  Aligned_cols=226  Identities=24%  Similarity=0.286  Sum_probs=180.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEE----EEeeccc--------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVF----AYLGDDV--------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~v----a~k~~~~--------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|++..+++.+    ++|....                          .+...+. ....++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE-SSSEEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe-cCCceE
Confidence            57999999999999999999999888765    4443210                          0000111 233679


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE-EEECCTTC---------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC-EEEccCcceeEccCccc
Confidence            99999999999999887788999999999999999999999999999999999999988874 99999999976644333


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.......+.........+..+...+..+.+||
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  252 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM  252 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHH
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence            323334457889999999999999999999999999999999 9999998777666665555555566778899999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||..||.+|||+.|+++
T Consensus       253 ~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          253 RKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-40  Score=317.29  Aligned_cols=226  Identities=23%  Similarity=0.283  Sum_probs=181.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce------------------------eccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY------------------------EAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~------------------------~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|......                        ..........++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            58999999999999999999999999999998633110                        00112345678999999 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc---CCCCcEEEeecCCccccccCCCC--
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTR--  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~---~~~~~vkL~DFGla~~~~~~~~~--  132 (408)
                      +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++   .++ .+||+|||++.........  
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~  166 (296)
T 3uzp_A           88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQH  166 (296)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCB
T ss_pred             CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccccccccccc
Confidence            8999999987777899999999999999999999999999999999999994   555 5999999999765433221  


Q ss_pred             ---cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh----hhh---hcccCCCCCCCCCC
Q 042746          133 ---GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT----LSR---IGFSDELPRFPTQS  202 (408)
Q Consensus       133 ---~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~----~~~---~~~~~~~p~~~~~~  202 (408)
                         .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......    ...   .......+..+...
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T 3uzp_A          167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY  246 (296)
T ss_dssp             CCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTS
T ss_pred             cccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhC
Confidence               11234579999999999999989999999999999999999999998643211    111   11111112233567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+.+|+.+||+.||.+|||+.|+++
T Consensus       247 ~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          247 PSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            899999999999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.8e-41  Score=319.84  Aligned_cols=231  Identities=25%  Similarity=0.338  Sum_probs=186.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .+|++.+.||+|+||+||+|++..+++.|++|.....                           +...+......++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            4799999999999999999999999999998864211                           1122334566889999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC--CcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS--SFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~--~~vkL~DFGla~~~~~~~~~  132 (408)
                      |+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++  ..+||+|||++........ 
T Consensus       102 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-  179 (287)
T 2wei_A          102 LYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-  179 (287)
T ss_dssp             CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence            99999999998754 4679999999999999999999999999999999999997643  2599999999865543221 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC-CC--CCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP-RF--PTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p-~~--~~~~s~~~~~l  209 (408)
                        .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.................+ ..  ....++.+++|
T Consensus       180 --~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          180 --MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             --CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             --cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence              1223479999999999875 889999999999999999999999876655444332222221 11  14578899999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      |.+||..||.+|||+.|+++||||+...
T Consensus       257 i~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            9999999999999999999999997543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.3e-41  Score=325.98  Aligned_cols=225  Identities=24%  Similarity=0.325  Sum_probs=184.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------------eeccCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------------YEAPTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------------~~~~~~~~~~   48 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                                 +...+.....
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            5799999999999999999999999999999864321                                 1111234456


Q ss_pred             ceEEEeccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           49 RNLHLEYLPG-GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        49 ~~LVmEy~~g-GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      .++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||++....
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~  201 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  201 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence            7899999986 8999999854 5679999999999999999999999999999999999998444469999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      ...    .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....  ....    . ...++...++.+
T Consensus       202 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~----~-~~~~~~~~~~~~  270 (320)
T 3a99_A          202 DTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIR----G-QVFFRQRVSSEC  270 (320)
T ss_dssp             SSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHH----C-CCCCSSCCCHHH
T ss_pred             ccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hhhc----c-cccccccCCHHH
Confidence            322    234569999999999987655 678899999999999999999997532  1111    1 123456788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ++||.+||..||.+|||+.|+++||||+....
T Consensus       271 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            99999999999999999999999999987543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-40  Score=330.14  Aligned_cols=231  Identities=25%  Similarity=0.338  Sum_probs=178.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------------eeccCC--
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------------YEAPTT--   44 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------------~~~~~~--   44 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                                   +...+.  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5899999999999999999999999999999864310                                   000011  


Q ss_pred             --CCCcceEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCC-----CcE
Q 042746           45 --SSSCRNLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNS-----SFV  115 (408)
Q Consensus        45 --~~~~~~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~-----~~v  115 (408)
                        .....+++|||+ |++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++     ..+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence              122678999999 88999999864 34589999999999999999999998 999999999999995322     259


Q ss_pred             EEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-------hhh
Q 042746          116 KLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSR  188 (408)
Q Consensus       116 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-------~~~  188 (408)
                      ||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|++||.......       +..
T Consensus       178 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          178 KIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             EEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            99999999665432     223468999999999999999999999999999999999999997543110       000


Q ss_pred             hc-ccCC---------------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042746          189 IG-FSDE---------------------------------------LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLL  228 (408)
Q Consensus       189 ~~-~~~~---------------------------------------~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell  228 (408)
                      +. ..+.                                       ...++...++.+++||.+||+.||.+|||+.|++
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            00 0000                                       0122334567889999999999999999999999


Q ss_pred             cCCCCCCCCC
Q 042746          229 KHPFLQSVSP  238 (408)
Q Consensus       229 ~hpf~~~~~~  238 (408)
                      +||||+....
T Consensus       333 ~hp~f~~~~~  342 (373)
T 1q8y_A          333 NHPWLKDTLG  342 (373)
T ss_dssp             TCGGGTTCTT
T ss_pred             hChhhhcccC
Confidence            9999987543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=324.94  Aligned_cols=228  Identities=23%  Similarity=0.244  Sum_probs=184.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      .+|++++.||+|+||+||+|.+.     .++..||+|....                           .+...+......
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            47999999999999999999983     3566788875321                           112223455678


Q ss_pred             eEEEeccCCCCHHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042746           50 NLHLEYLPGGTVSDLATTLNA----------------------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL  107 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~----------------------~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NIL  107 (408)
                      +|||||++||+|.+++.....                      .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            999999999999999986432                      3689999999999999999999999999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-
Q 042746          108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-  185 (408)
Q Consensus       108 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-  185 (408)
                      ++.++ .+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....... 
T Consensus       205 l~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  283 (344)
T 1rjb_A          205 VTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  283 (344)
T ss_dssp             EETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             EcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence            99887 599999999976654433222334457889999999999889999999999999999998 999998755332 


Q ss_pred             hhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          186 LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       186 ~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..........+..+...++.+.+||.+||..||.+|||+.|+++|
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          284 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            222223333445667789999999999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-40  Score=328.27  Aligned_cols=231  Identities=23%  Similarity=0.304  Sum_probs=176.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------------eeccC--
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------------YEAPT--   43 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------------~~~~~--   43 (408)
                      .+|++++.||+|+||+||+|.+.. ++.||+|.....                                    +...+  
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            589999999999999999999875 889998853210                                    00001  


Q ss_pred             ---CCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeec
Q 042746           44 ---TSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADF  120 (408)
Q Consensus        44 ---~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DF  120 (408)
                         ......+|||||++ |+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-~kl~Df  178 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDF  178 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCT
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC-EEEEec
Confidence               22345789999998 5899988866667899999999999999999999999999999999999998875 999999


Q ss_pred             CCccccccCCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--------
Q 042746          121 GAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--------  191 (408)
Q Consensus       121 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--------  191 (408)
                      |++........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.............        
T Consensus       179 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          179 NLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             TC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             Ccccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99965433222   234568999999999987 678999999999999999999999998654322211100        


Q ss_pred             ---------------cCCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 ---------------SDELP--------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 ---------------~~~~p--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                     .....        ..+...++.+.+||.+||+.||.+|||+.|+++||||+....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence                           00111        112356788999999999999999999999999999987654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=329.78  Aligned_cols=223  Identities=15%  Similarity=0.135  Sum_probs=174.9

Q ss_pred             CCeEeeceeeecCCeeEEEE-----EEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVA-----VDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a-----~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|     .+..+++.||+|....                         .+......+...+|
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l  144 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL  144 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence            46999999999999999999     4778899999986431                         11222334567789


Q ss_pred             EEeccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC-----------CCCcEE
Q 042746           52 HLEYLPGGTVSDLATT----LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP-----------NSSFVK  116 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~----~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~-----------~~~~vk  116 (408)
                      ||||++||+|.+++..    ....+++..++.++.||+.||+|||++||+||||||+|||++.           ++ .+|
T Consensus       145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~-~~k  223 (365)
T 3e7e_A          145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA-GLA  223 (365)
T ss_dssp             EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT-TEE
T ss_pred             EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC-CEE
Confidence            9999999999999975    2456899999999999999999999999999999999999987           55 599


Q ss_pred             EeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC
Q 042746          117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       117 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      |+|||+|+..............+||+.|+|||++.+..++.++|||||||++|+|++|++||.........   .....+
T Consensus       224 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~  300 (365)
T 3e7e_A          224 LIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEGLFR  300 (365)
T ss_dssp             ECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECSCCT
T ss_pred             EeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---echhcc
Confidence            99999997654333333445567999999999999999999999999999999999999999643322111   112222


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..  ..++...+++.+||+.+|.+|++..+.+.+
T Consensus       301 ~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          301 RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            22  347788999999999999999765554443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=319.59  Aligned_cols=231  Identities=26%  Similarity=0.376  Sum_probs=171.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      +.+|++.+.||+|+||+||+|.+..+++.|++|....                           .+...+..+...+|||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            3689999999999999999999999999999986431                           1112233456788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||+ ++.+..+.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++. +||+|||++........ 
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~-~kl~dfg~~~~~~~~~~-  180 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ-IKLCDFGISGRLVDDKA-  180 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC-EEECCCTTC---------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC-EEEEECCCchhccCCcc-
Confidence            999 5677777766677889999999999999999999995 9999999999999998875 99999999965543221 


Q ss_pred             cccccCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCC-hhhhhhhcccCCCCCCC--CCCcH
Q 042746          133 GVKIQPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFP--TQSSE  204 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~-~~~~~~~~~~~~~p~~~--~~~s~  204 (408)
                        .....||+.|+|||++.     ...++.++||||||+++|+|++|+.||.... .............+.++  ...++
T Consensus       181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence              22346899999999995     4567889999999999999999999998633 22222222233333333  35789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .+.+||.+||+.||.+|||+.|+++||||+..
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            99999999999999999999999999999743

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-40  Score=320.72  Aligned_cols=231  Identities=26%  Similarity=0.368  Sum_probs=177.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|.+. +++.||+|.....                             +......+...+|+
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            36999999999999999999986 4888888754211                             11122345667899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      || +.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+|||++.........
T Consensus       107 ~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          107 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G-MLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T-EEEECCCSSSCC-------
T ss_pred             Ee-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C-eEEEeeccccccccCcccc
Confidence            99 567899999985 457799999999999999999999999999999999999965 4 5999999999765443322


Q ss_pred             cccccCCCCCCCCChhhHhC-----------CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCCC
Q 042746          133 GVKIQPRGSPLWMAPEVVRG-----------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRFP  199 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~-----------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~~  199 (408)
                      .......||+.|+|||++.+           ..++.++||||||+++|+|++|..||.....  ..............++
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  262 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  262 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence            22334569999999999976           4678899999999999999999999976432  1222222222333556


Q ss_pred             CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          200 TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       200 ~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ...++.+++||.+||..||.+|||+.|+++||||+...
T Consensus       263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            67789999999999999999999999999999997543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.8e-40  Score=323.00  Aligned_cols=228  Identities=25%  Similarity=0.320  Sum_probs=186.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-------CCCcEEEEeeccc---------------------------ceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-------FNGDVFAYLGDDV---------------------------SYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-------~t~~~va~k~~~~---------------------------~~~~~~~~~~   47 (408)
                      ++|++++.||+|+||+||+|.+.       .++..||+|....                           .+...+..+.
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            57999999999999999999986       4567888876431                           1122234566


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..++||||++||+|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            7899999999999999998543               2378999999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......+.....
T Consensus       195 ~-~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  273 (334)
T 2pvf_A          195 V-MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK  273 (334)
T ss_dssp             C-EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             C-EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh
Confidence            5 99999999976543322222233457889999999998889999999999999999999 999998877666555444


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...++.+.++|.+||..||.+|||+.|++++
T Consensus       274 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          274 EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            445556677889999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.1e-40  Score=323.07  Aligned_cols=226  Identities=22%  Similarity=0.277  Sum_probs=178.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                        +..........+|||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            4799999999999999999999999999999864311                        111223345678999999 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC----cEEEeecCCccccccCCCCc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS----FVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~----~vkL~DFGla~~~~~~~~~~  133 (408)
                      |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.    .+||+|||+++.........
T Consensus        88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~  167 (330)
T 2izr_A           88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK  167 (330)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC
T ss_pred             CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc
Confidence            99999999876778999999999999999999999999999999999999987652    29999999997654332211


Q ss_pred             -----ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhh---hhccc----CCCCCCCCC
Q 042746          134 -----VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLS---RIGFS----DELPRFPTQ  201 (408)
Q Consensus       134 -----~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~---~~~~~----~~~p~~~~~  201 (408)
                           ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........   .....    .........
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (330)
T 2izr_A          168 HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCEN  247 (330)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred             cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhcc
Confidence                 123567999999999999999999999999999999999999999875433221   11100    111111123


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+ .+++++.+||..||.+||+++++++
T Consensus       248 ~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          248 FP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             Ch-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            44 8999999999999999999998875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.6e-40  Score=317.84  Aligned_cols=227  Identities=24%  Similarity=0.313  Sum_probs=178.1

Q ss_pred             CCeEeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc-------------------------eeccC--CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS-------------------------YEAPT--TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~-------------------------~~~~~--~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|+    +..+++.||+|.....                         +...+  ......+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            579999999999999999999    6778999999864311                         11111  1224578


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC------
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccCCc
Confidence            99999999999999987666789999999999999999999999999999999999999887 49999999997654332


Q ss_pred             CC-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----------------hhhhhcccC
Q 042746          131 TR-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----------------TLSRIGFSD  193 (408)
Q Consensus       131 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----------------~~~~~~~~~  193 (408)
                      .. .......|++.|+|||++.+..++.++||||||+++|+|++|..||......                .........
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  248 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence            11 1122345777899999999999999999999999999999999998643211                111111223


Q ss_pred             CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       194 ~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..+..+...++.+.+||.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            344556788999999999999999999999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.4e-40  Score=326.72  Aligned_cols=228  Identities=23%  Similarity=0.346  Sum_probs=184.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------------------------e
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------------------------Y   39 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------------------------~   39 (408)
                      .+|++++.||+|+||+||+|.+  +++.||+|.....                                          +
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            5899999999999999999999  8999998763311                                          1


Q ss_pred             eccCCCCCcceEEEeccCCCCHHHH------HHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCC
Q 042746           40 EAPTTSSSCRNLHLEYLPGGTVSDL------ATTL-NAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPN  111 (408)
Q Consensus        40 ~~~~~~~~~~~LVmEy~~gGsL~~~------l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~  111 (408)
                      .+.+......++||||++||+|.++      +... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            1112345678899999999999998      5432 5678999999999999999999999 999999999999999988


Q ss_pred             CCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCC-CCCC-CCCcchHHHHHHHHHhCCCCCCCCCh-hhhhh
Q 042746          112 SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGP-ESDVWSLGCTIIEMVTGKPAWEDFGA-NTLSR  188 (408)
Q Consensus       112 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~-~sDiWSLGvil~eLltG~~Pf~~~~~-~~~~~  188 (408)
                      +. +||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||..... .....
T Consensus       189 ~~-~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          189 GR-VKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             SC-EEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             Cc-EEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            75 999999999665332    23345689999999999887 5655 89999999999999999999986554 33332


Q ss_pred             hcccCCCCCCC-------------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          189 IGFSDELPRFP-------------------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       189 ~~~~~~~p~~~-------------------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ...... +.++                   ...++.+++||.+||+.||.+|||+.|+++||||....
T Consensus       264 ~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          264 NIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            222222 2222                   56889999999999999999999999999999998654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-40  Score=310.17  Aligned_cols=226  Identities=23%  Similarity=0.290  Sum_probs=186.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+. +++.+++|....                        .+...+..+...++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57999999999999999999997 567788875431                        12223445667899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      |++|.+++......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||++........ .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~-~kl~dfg~~~~~~~~~~-~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQY-TSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC-EEECCTTGGGGBCCHHH-HSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC-EEEcccccccccccccc-ccccc
Confidence            99999999877677899999999999999999999999999999999999988875 99999999865432111 11123


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..|++.|+|||++.+..++.++|+||||+++|+|++ |++||.................+..+...++.+++++.+||+.
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~  244 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRE  244 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccC
Confidence            357888999999998889999999999999999999 8999987766555544444444455677899999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||.+|||+.|++++
T Consensus       245 ~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          245 RPEDRPAFSRLLRQ  258 (267)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=317.60  Aligned_cols=225  Identities=25%  Similarity=0.318  Sum_probs=179.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------------------eeccCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------------------YEAPTTSS   46 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------------------~~~~~~~~   46 (408)
                      .+|++++.||+|+||+||+|++..+++.|++|.....                                   +...+...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            4799999999999999999999999999999864311                                   11113344


Q ss_pred             CcceEEEec-cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           47 SCRNLHLEY-LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        47 ~~~~LVmEy-~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ...++|||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+...+||+|||++..
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL  189 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence            567899999 8999999999854 46799999999999999999999999999999999999984333699999999876


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      .....    .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....  ....     ....++...+.
T Consensus       190 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~-----~~~~~~~~~~~  258 (312)
T 2iwi_A          190 LHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EILE-----AELHFPAHVSP  258 (312)
T ss_dssp             CCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHH-----TCCCCCTTSCH
T ss_pred             cccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHhh-----hccCCcccCCH
Confidence            54322    234568999999999987655 458999999999999999999997532  1111     12245567899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .+++||.+||..||++|||+.|+++||||+....
T Consensus       259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            9999999999999999999999999999986543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4e-40  Score=314.74  Aligned_cols=226  Identities=22%  Similarity=0.277  Sum_probs=190.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+..++..+++|....                        .+...+..+...++||||++
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            479999999999999999999999999999876431                        12223445667899999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++........ ....
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~~l~Dfg~~~~~~~~~~-~~~~  170 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTY-TAHA  170 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC-EEECCCCGGGTSCSSSS-EEET
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC-EEEccCccceeccCCcc-cccc
Confidence            99999999863 345899999999999999999999999999999999999988875 99999999976543322 1222


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.+|+.+||.
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  250 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ  250 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhC
Confidence            3357889999999999889999999999999999999 999998877666655544444556677889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||.+|||+.|+++
T Consensus       251 ~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          251 WNPSDRPSFAEIHQ  264 (288)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5e-40  Score=317.42  Aligned_cols=228  Identities=23%  Similarity=0.287  Sum_probs=183.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-----cCCCcEEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-----RFNGDVFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-----~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      .+|++++.||+|+||+||+|.+     ..+++.|++|....                           .+...+..+...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            4799999999999999999985     55778888876431                           112223455678


Q ss_pred             eEEEeccCCCCHHHHHHHhCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           50 NLHLEYLPGGTVSDLATTLNA-----------------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~-----------------~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ++||||+++|+|.+++.....                 .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            999999999999999986543                 489999999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-hhhhc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-LSRIG  190 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-~~~~~  190 (408)
                       .+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....... .....
T Consensus       183 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  261 (313)
T 1t46_A          183 -ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI  261 (313)
T ss_dssp             -EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred             -CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHh
Confidence             499999999976654333222333457889999999999889999999999999999999 999998654332 22222


Q ss_pred             ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       191 ~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .....+..+...++.++++|.+||..||.+|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            2223334456789999999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-40  Score=323.77  Aligned_cols=233  Identities=17%  Similarity=0.208  Sum_probs=185.4

Q ss_pred             CCeEeeceeeecCCeeEEEEE-----EcCCCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV-----DRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~-----d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|+     +..++..||+|....                          .+.+.+......+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            579999999999999999999     667888999986431                          1222344556789


Q ss_pred             EEEeccCCCCHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--CCcEEEeecCC
Q 042746           51 LHLEYLPGGTVSDLATTLN------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGA  122 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~~~vkL~DFGl  122 (408)
                      |||||++||+|.+++....      ..+++..++.++.||+.||.|||++||+||||||+|||++.+  +..+||+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999999999999998653      347899999999999999999999999999999999999843  23599999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ  201 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~  201 (408)
                      +................||+.|+|||++.+..++.++||||||+++|+|++ |..||.................+..+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  269 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN  269 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCC
Confidence            865433222222233457999999999998889999999999999999998 9999987766655554445555566778


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      .++.+.++|.+||+.||.+|||+.|+++|.++.
T Consensus       270 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          270 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            899999999999999999999999999998764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-39  Score=313.30  Aligned_cols=227  Identities=23%  Similarity=0.287  Sum_probs=180.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeeccc--------------------------ceecc-CCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDV--------------------------SYEAP-TTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~--------------------------~~~~~-~~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|.+..++.   .+++|....                          .+... ...+...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            369999999999999999999765443   466665321                          11111 334567889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECSCGGGCCCSCGGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC-EEECcccccccccccch
Confidence            99999999999999876777899999999999999999999999999999999999998875 99999999976543221


Q ss_pred             --CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHH
Q 042746          132 --RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD  208 (408)
Q Consensus       132 --~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~  208 (408)
                        ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.+
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  263 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE  263 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence              112233457889999999999989999999999999999999 67888776655554444455555667778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHc
Q 042746          209 FLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++.+||..||.+|||+.|+++
T Consensus       264 li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          264 VMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.1e-40  Score=321.57  Aligned_cols=225  Identities=25%  Similarity=0.320  Sum_probs=184.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEE--EEeeccc---------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVF--AYLGDDV---------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~v--a~k~~~~---------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|++..++..+  ++|....                           .+...+......+||
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            58999999999999999999999999865  5554321                           111122345567899


Q ss_pred             EeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEE
Q 042746           53 LEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKL  117 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL  117 (408)
                      |||+++|+|.+++....               ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-~kL  183 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKI  183 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe-EEE
Confidence            99999999999997543               36899999999999999999999999999999999999988874 999


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      +|||+++.......   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.................+
T Consensus       184 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~  260 (327)
T 1fvr_A          184 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  260 (327)
T ss_dssp             CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred             cccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC
Confidence            99999864432221   123357889999999998888999999999999999998 99999887766655544444445


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+...++.+++||.+||..||.+|||+.|++++
T Consensus       261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5667889999999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.1e-40  Score=320.60  Aligned_cols=230  Identities=27%  Similarity=0.392  Sum_probs=165.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      .+|++++.||+|+||+||+|.++.+++.||+|....                           .+.+.+..+...+||||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            689999999999999999999999999999986431                           11122334566789999


Q ss_pred             ccCCCCHHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           55 YLPGGTVSDLATT----LNAYADEITLRSHTYCIVSALKYLHSR-NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        55 y~~gGsL~~~l~~----~~~~l~e~~i~~i~~qIl~~L~yLH~~-giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |++| +|.+++..    ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC----
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceecccc
Confidence            9986 88888764    256789999999999999999999999 999999999999999887 4999999999765432


Q ss_pred             CCCcccccCCCCCCCCChhhH----hCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccCCCCCCC----C
Q 042746          130 DTRGVKIQPRGSPLWMAPEVV----RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSDELPRFP----T  200 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l----~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~p~~~----~  200 (408)
                      ..   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||...... ...........+.++    .
T Consensus       180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3aln_A          180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER  256 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred             cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence            21   2234699999999999    4566889999999999999999999999864321 111112223333332    3


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ..++.+++||.+||..||.+|||+.|+++||||...
T Consensus       257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            578999999999999999999999999999999643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.2e-40  Score=319.21  Aligned_cols=228  Identities=23%  Similarity=0.307  Sum_probs=183.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEE-----cCCCcEEEEeecccc---------------------------eecc-CCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVD-----RFNGDVFAYLGDDVS---------------------------YEAP-TTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d-----~~t~~~va~k~~~~~---------------------------~~~~-~~~~~~   48 (408)
                      ++|++++.||+|+||+||+|.+     ..+++.||+|.....                           +... ...+..
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5799999999999999999985     456788888763311                           1111 122345


Q ss_pred             ceEEEeccCCCCHHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC
Q 042746           49 RNLHLEYLPGGTVSDLATTLNA---------------YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS  113 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~---------------~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~  113 (408)
                      .++||||++||+|.+++.....               .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~  186 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  186 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC
Confidence            8999999999999999985432               2789999999999999999999999999999999999988775


Q ss_pred             cEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-hhhhhcc
Q 042746          114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIGF  191 (408)
Q Consensus       114 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~~~~~~~  191 (408)
                       +||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...... .......
T Consensus       187 -~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~  265 (316)
T 2xir_A          187 -VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  265 (316)
T ss_dssp             -EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             -EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhc
Confidence             99999999976544332222334457899999999999889999999999999999998 99999865432 2222223


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ....+..+...++.+.++|.+||..||.+|||+.|+++|
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          266 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            334445667789999999999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.2e-39  Score=309.74  Aligned_cols=223  Identities=20%  Similarity=0.296  Sum_probs=181.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee--------------------ccCCC----------CCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE--------------------APTTS----------SSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~--------------------~~~~~----------~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|.......                    ....+          ....++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~l   98 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM   98 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEE
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeE
Confidence            589999999999999999999999999999986421100                    00011          112369


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCC----cEEEeecCCccc
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSS----FVKLADFGAAGE  125 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~----~vkL~DFGla~~  125 (408)
                      ||||+++|+|.+.+......+++..++.++.||+.||+|||++|  |+||||||+|||++.++.    .+||+|||+++.
T Consensus        99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~  178 (287)
T 4f0f_A           99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ  178 (287)
T ss_dssp             EEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBC
T ss_pred             EEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccc
Confidence            99999999999999877778999999999999999999999999  999999999999986652    399999999964


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHh--CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh---hhhcccCCCCCCCC
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVR--GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL---SRIGFSDELPRFPT  200 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~--~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~---~~~~~~~~~p~~~~  200 (408)
                      ...     ......||+.|+|||++.  ...++.++||||||+++|+|++|+.||........   .........+..+.
T Consensus       179 ~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 4f0f_A          179 SVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE  253 (287)
T ss_dssp             CSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred             ccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence            432     223456999999999994  44568899999999999999999999986554332   22222344556777


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..++.+++||.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          254 DCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            88999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=310.35  Aligned_cols=226  Identities=20%  Similarity=0.274  Sum_probs=182.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCc---EEEEeeccc--------------------------ceeccCC-CCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDV--------------------------SYEAPTT-SSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~--------------------------~~~~~~~-~~~~~~LV   52 (408)
                      .|.+++.||+|+||+||+|.+..+++   .+|+|....                          .+...+. .+...+++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            57788999999999999999876655   677765331                          0111122 23344899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC--
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD--  130 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~--  130 (408)
                      |||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT-VKVADFGLARDILDREYY  180 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECCTTSSCTTTTGGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-EEeCcCCCcccccCCccc
Confidence            9999999999999876778899999999999999999999999999999999999998875 9999999997543321  


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      .........+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||.................+..+...++.+.++
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  260 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV  260 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHH
Confidence            1112233468899999999999999999999999999999999 566676666655555544455556677889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q 042746          210 LDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~  229 (408)
                      +.+||+.||.+|||+.|+++
T Consensus       261 i~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          261 MQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999876

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6e-40  Score=328.03  Aligned_cols=227  Identities=21%  Similarity=0.265  Sum_probs=174.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc---CCCcEEEEeeccc--------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR---FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~---~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|++.   .++..||+|....                          .+.+.+......+||
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47999999999999999999987   5667788886432                          122234455678999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++........
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV-CKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC------------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC-EEECcCccccccccCCcc
Confidence            9999999999999876667899999999999999999999999999999999999998875 999999999765433211


Q ss_pred             -cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 -GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 -~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                       .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...+..+.+++
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  283 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLM  283 (373)
T ss_dssp             ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHH
T ss_pred             ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHH
Confidence             11122346788999999999889999999999999999998 9999987766555544333333344567889999999


Q ss_pred             HHhcccCCCCCCCHHHHHc
Q 042746          211 DKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~  229 (408)
                      .+||+.||.+||++.|+++
T Consensus       284 ~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          284 LDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhCcChhhCcCHHHHHH
Confidence            9999999999999999876

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-39  Score=310.53  Aligned_cols=226  Identities=22%  Similarity=0.246  Sum_probs=181.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC---CcEEEEeecccc--------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN---GDVFAYLGDDVS--------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t---~~~va~k~~~~~--------------------------~~~~~~~~~~~~LV   52 (408)
                      .+|++.+.||+|+||+||+|++..+   +..+++|.....                          +...+ .+...++|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCCEEE
Confidence            5799999999999999999997643   345787754311                          11112 23456899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC------
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCccccccccc
Confidence            999999999999987777789999999999999999999999999999999999999887 5999999999765432211


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...++.+.++|.
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  248 (281)
T 3cc6_A          170 -KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMT  248 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             -ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence             1223457889999999998889999999999999999998 99999866555544443344445566778999999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||..||.+|||+.|++++
T Consensus       249 ~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          249 RCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCchhCcCHHHHHHH
Confidence            9999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-39  Score=306.71  Aligned_cols=222  Identities=25%  Similarity=0.402  Sum_probs=174.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~L   51 (408)
                      +.+|++.+.||+|+||+||+|.+.  ++.+|+|....                             .+...+..+...++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            368999999999999999999985  77888775321                             11222345567899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCCCCEEEcCC-------CCcEEEeecC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN---IVHCDVKGKNVLVGPN-------SSFVKLADFG  121 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g---iiHrDLKp~NILl~~~-------~~~vkL~DFG  121 (408)
                      ||||++|++|.+++.  +..+++..++.++.||+.||+|||++|   |+||||||+|||++.+       ...+||+|||
T Consensus        84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999999985  467899999999999999999999999   8999999999999852       2359999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh-cccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-GFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~-~~~~~~p~~~~  200 (408)
                      ++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... ......+..+.
T Consensus       162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3dtc_A          162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS  237 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred             ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence            997554322    2234689999999999999899999999999999999999999987665443332 22333445667


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..++.+.+++.+||+.||.+|||+.|+++|
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            889999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.6e-40  Score=320.38  Aligned_cols=227  Identities=22%  Similarity=0.241  Sum_probs=178.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||+||+|++. +++.|++|....                         .+.+.+......++||||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            68999999999999999999975 688999886331                         1222344566789999999


Q ss_pred             CCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           57 PGGTVSDLATTLN---AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        57 ~gGsL~~~l~~~~---~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      +||+|.+++....   ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++..........
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC-EEECCCTTCEECSSSSCCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC-EEEeecccccccccccccc
Confidence            9999999986432   24789999999999999999999999999999999999998875 9999999997644332222


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh-------cccC---------CCCC
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------GFSD---------ELPR  197 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~-------~~~~---------~~p~  197 (408)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........       ....         ....
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK  276 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred             cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence            23344689999999999988899999999999999999999999975432221100       0000         0112


Q ss_pred             CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       198 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+...+..+.+++.+||+.||++|||+.|+++|
T Consensus       277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            223345678899999999999999999999976

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-39  Score=317.65  Aligned_cols=228  Identities=21%  Similarity=0.271  Sum_probs=179.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc----EEEEeeccc--------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD----VFAYLGDDV--------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~----~va~k~~~~--------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++.+.||+|+||+||+|.+..++.    .||+|....                          .+..........+|
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            479999999999999999999876643    477765331                          12223445567899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc-EEECCCCcchhhccccc
Confidence            99999999999999877778899999999999999999999999999999999999998875 99999999976543221


Q ss_pred             C-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          132 R-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       132 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      . .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......+.........+..+...++.+.++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  282 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL  282 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHH
Confidence            1 11222346788999999999889999999999999999999 999998776655554444444445567789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q 042746          210 LDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~h  230 (408)
                      |.+||+.||.+||++.|++++
T Consensus       283 i~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          283 MMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-40  Score=327.24  Aligned_cols=226  Identities=19%  Similarity=0.265  Sum_probs=174.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC-----CcEEEEeecccce------------------------------------e
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN-----GDVFAYLGDDVSY------------------------------------E   40 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t-----~~~va~k~~~~~~------------------------------------~   40 (408)
                      .+|++++.||+|+||+||+|.+..+     ++.||+|......                                    .
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            3799999999999999999999876     4678887632110                                    0


Q ss_pred             ccC----CCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc--CCCCc
Q 042746           41 APT----TSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG--PNSSF  114 (408)
Q Consensus        41 ~~~----~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~--~~~~~  114 (408)
                      ...    ....+.+|||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++  .++ .
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~-~  192 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-Q  192 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT-C
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC-e
Confidence            000    1124578999999 9999999987767899999999999999999999999999999999999998  665 5


Q ss_pred             EEEeecCCccccccCCCC-----cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-hhh
Q 042746          115 VKLADFGAAGEATVSDTR-----GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-LSR  188 (408)
Q Consensus       115 vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-~~~  188 (408)
                      +||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999999765432211     11233469999999999999999999999999999999999999998532211 110


Q ss_pred             ---hcccCCCCC------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          189 ---IGFSDELPR------FPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       189 ---~~~~~~~p~------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                         .......+.      .+...++.+.+|+..||..||.+||++.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence               000001000      12467889999999999999999999999876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.5e-40  Score=313.41  Aligned_cols=221  Identities=17%  Similarity=0.269  Sum_probs=178.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc-------EEEEeeccc-------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD-------VFAYLGDDV-------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~-------~va~k~~~~-------------------------~~~~~~~~~~~~   49 (408)
                      ++|++++.||+|+||+||+|++..+++       .+++|....                         .+...+..+...
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            589999999999999999999998884       577765321                         122234455677


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCc-------EEEeecCC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSF-------VKLADFGA  122 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~-------vkL~DFGl  122 (408)
                      ++||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++..       +||+|||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            89999999999999998766668999999999999999999999999999999999999877632       99999999


Q ss_pred             ccccccCCCCcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          123 AGEATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       123 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      +......      ....||+.|+|||++.+ ..++.++||||||+++|+|++ +.+||............  ...+..+.
T Consensus       168 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--~~~~~~~~  239 (289)
T 4fvq_A          168 SITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--EDRHQLPA  239 (289)
T ss_dssp             CTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--HTTCCCCC
T ss_pred             cccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--hccCCCCC
Confidence            8554321      12347899999999987 678999999999999999999 55666655444333321  12234455


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..++.+++||.+||+.||.+|||+.|+++|
T Consensus       240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          240 PKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            667788999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-39  Score=318.54  Aligned_cols=228  Identities=24%  Similarity=0.272  Sum_probs=183.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc-----EEEEeeccc---------------------------ceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD-----VFAYLGDDV---------------------------SYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~-----~va~k~~~~---------------------------~~~~~~~~~~~~   49 (408)
                      .+|++++.||+|+||+||+|.+..+++     .+++|....                           .+...+......
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999987765     677765321                           112223455678


Q ss_pred             eEEEeccCCCCHHHHHHHh-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEE
Q 042746           50 NLHLEYLPGGTVSDLATTL-------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVK  116 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~-------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vk  116 (408)
                      +|||||+++|+|.+++...             ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~k  204 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAK  204 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-EEE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC-eEE
Confidence            9999999999999999753             34578999999999999999999999999999999999998877 599


Q ss_pred             EeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhh-hhhhcccCC
Q 042746          117 LADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANT-LSRIGFSDE  194 (408)
Q Consensus       117 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~  194 (408)
                      |+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |.+||....... .........
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  284 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY  284 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC
Confidence            999999976544332222233457889999999999889999999999999999998 999998654332 222222233


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+...++.+.++|.+||+.||.+|||+.|++++
T Consensus       285 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          285 QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            344566788999999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.2e-39  Score=313.86  Aligned_cols=228  Identities=19%  Similarity=0.240  Sum_probs=177.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC---CCcEEEEeecccce---------------------------eccCCCC-----
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF---NGDVFAYLGDDVSY---------------------------EAPTTSS-----   46 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~---t~~~va~k~~~~~~---------------------------~~~~~~~-----   46 (408)
                      .+|++++.||+|+||+||+|.+..   ++..||+|......                           .......     
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            479999999999999999998876   45578887643210                           0001111     


Q ss_pred             CcceEEEeccCCCCHHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           47 SCRNLHLEYLPGGTVSDLATT-----LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        47 ~~~~LVmEy~~gGsL~~~l~~-----~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      ...++||||+++|+|.+++..     ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~-~kl~Dfg  192 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT-VCVADFG  192 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC-EEECSCS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-EEEeecC
Confidence            235899999999999999953     2356899999999999999999999999999999999999998875 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      ++................+++.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  272 (313)
T 3brb_A          193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPE  272 (313)
T ss_dssp             CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBT
T ss_pred             cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCc
Confidence            9976543322222233457889999999999999999999999999999999 999998876666555555555566777


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..++.+.++|.+||..||.+|||+.+++++
T Consensus       273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            889999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-39  Score=313.38  Aligned_cols=227  Identities=24%  Similarity=0.316  Sum_probs=181.6

Q ss_pred             CCeEeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc--------------------------eeccCCC--CCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS--------------------------YEAPTTS--SSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~--------------------------~~~~~~~--~~~~   49 (408)
                      ..|++++.||+|+||+||+|+    +..+++.||+|.....                          +...+..  ....
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            359999999999999999999    6788999999864311                          1111112  2567


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ++||||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETD  179 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcccccccccCC
Confidence            899999999999999977777889999999999999999999999999999999999998887 4999999999765433


Q ss_pred             CCC-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC---------------hhhhhhhcccC
Q 042746          130 DTR-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG---------------ANTLSRIGFSD  193 (408)
Q Consensus       130 ~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~---------------~~~~~~~~~~~  193 (408)
                      ... .......||+.|+|||++.+..++.++||||||+++|+|++|..|+....               ...........
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG  259 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred             CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence            221 12233468888999999999888999999999999999999998864321               11111222233


Q ss_pred             CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       194 ~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..+..+...++.+.+||.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            344566788999999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-39  Score=303.20  Aligned_cols=219  Identities=14%  Similarity=0.245  Sum_probs=178.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCC--CcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSS--SCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~--~~~~L   51 (408)
                      +.+|++.+.||+|+||+||+|++.  ++.+++|.....                           +.+.+...  ...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            368999999999999999999985  777887654311                           11112222  67899


Q ss_pred             EEeccCCCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           52 HLEYLPGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ||||++||+|.+++..... .+++..++.++.||+.||+|||+++  |+||||||+|||++.++. ++|.|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQS  165 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC-EEEEGGGSCCTTSC
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc-eeEEeccceeeecc
Confidence            9999999999999986433 5899999999999999999999999  999999999999998875 99999888743221


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCC---CCCcchHHHHHHHHHhCCCCCCCCChhhhh-hhcccCCCCCCCCCCcH
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGP---ESDVWSLGCTIIEMVTGKPAWEDFGANTLS-RIGFSDELPRFPTQSSE  204 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~---~sDiWSLGvil~eLltG~~Pf~~~~~~~~~-~~~~~~~~p~~~~~~s~  204 (408)
                             ....||+.|+|||++.+..++.   ++||||||+++|+|++|+.||......... ........+..+...++
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence                   1235899999999999875544   799999999999999999999876655443 22234445667788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+.++|.+||+.||.+|||+.|+++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-39  Score=310.64  Aligned_cols=223  Identities=24%  Similarity=0.369  Sum_probs=166.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .+|++++.||+|+||+||+|++..   .+|+|.....                           +.. .......++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-EECSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEe-eccCCccEEEEE
Confidence            479999999999999999998754   3666643211                           111 223455789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++|++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...........
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC-------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceecccccccccccc
Confidence            9999999999976667789999999999999999999999999999999999999887 499999999976543332223


Q ss_pred             cccCCCCCCCCChhhHh---CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhc----ccCCCCCCCCCCcHHH
Q 042746          135 KIQPRGSPLWMAPEVVR---GECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIG----FSDELPRFPTQSSELG  206 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~---~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~----~~~~~p~~~~~~s~~~  206 (408)
                      .....||+.|+|||++.   +..++.++||||||+++|+|++|+.||...... ......    .....+......++.+
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM  258 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHH
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHH
Confidence            33456999999999997   556788999999999999999999999865432 222221    1222334445788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHc
Q 042746          207 RDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++||.+||+.||.+|||+.|+++
T Consensus       259 ~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          259 KRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-39  Score=323.35  Aligned_cols=227  Identities=22%  Similarity=0.278  Sum_probs=174.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCC---cEEEEeeccc--------------------------ceecc-CCCCCcceEE
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNG---DVFAYLGDDV--------------------------SYEAP-TTSSSCRNLH   52 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~---~~va~k~~~~--------------------------~~~~~-~~~~~~~~LV   52 (408)
                      .|++++.||+|+||+||+|.+..++   ..+|+|....                          .+... ...+...++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            5888999999999999999986543   3467765321                          11111 2334567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.++++.....+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++........
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC------------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC-EEEeeccccccccccccc
Confidence            9999999999999876677899999999999999999999999999999999999998875 999999999765332211


Q ss_pred             --cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          133 --GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       133 --~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                        .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.++
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~l  328 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  328 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence              11223457889999999999999999999999999999999 788998765554444434444556667889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcC
Q 042746          210 LDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~h  230 (408)
                      |.+||+.||.+|||+.|++++
T Consensus       329 i~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          329 MLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=311.13  Aligned_cols=228  Identities=19%  Similarity=0.238  Sum_probs=185.7

Q ss_pred             CCeEeec-eeeecCCeeEEEEEEc--CCCcEEEEeecccc--------------------------eeccCCCCCcceEE
Q 042746            2 VSWVRGK-CIGRGSFGTVNVAVDR--FNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~-~IG~G~fG~Vy~a~d~--~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LV   52 (408)
                      ++|.+.+ .||+|+||+||+|.+.  .++..+|+|.....                          +.... .....++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4577766 9999999999999864  46777888764321                          11112 23457899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.........
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCE
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeeccCcce
Confidence            999999999999976667789999999999999999999999999999999999999877 5999999999765432211


Q ss_pred             -cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          133 -GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 -~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                       .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...++.+.++|
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  246 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM  246 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHH
Confidence             11223457899999999998889999999999999999998 9999988766655555445555677788999999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCC
Q 042746          211 DKCLRREPGERWSCDQLLKHP  231 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hp  231 (408)
                      .+||..||.+|||+.|+++|.
T Consensus       247 ~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          247 SDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHHH
Confidence            999999999999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.3e-39  Score=305.53  Aligned_cols=220  Identities=23%  Similarity=0.302  Sum_probs=176.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc-----------------------eecc-CCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS-----------------------YEAP-TTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~-----------------------~~~~-~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+.  ++.+++|.....                       +... .......++||||++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            58999999999999999999874  788888754311                       1111 223446899999999


Q ss_pred             CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.+++...+. .+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......     .
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~l~Dfg~~~~~~~~~-----~  172 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ-----D  172 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCCC--------------
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc-EEEeeccccccccccc-----c
Confidence            9999999976432 3789999999999999999999999999999999999998875 9999999986543321     1


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.++|.+||.
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  252 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH  252 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhc
Confidence            2357899999999999889999999999999999998 999998776655554444444556677889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||.+|||+.|+++
T Consensus       253 ~~p~~Rps~~~l~~  266 (278)
T 1byg_A          253 LDAAMRPSFLQLRE  266 (278)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.6e-39  Score=327.31  Aligned_cols=220  Identities=23%  Similarity=0.306  Sum_probs=181.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceecc-CCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAP-TTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~-~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+.  ++.||+|....                       .+.+. ...+...+|||||++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~  270 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA  270 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence            57999999999999999999885  77888875431                       11111 123346899999999


Q ss_pred             CCCHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~~-~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.++++..+. .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++......     .
T Consensus       271 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~-----~  344 (450)
T 1k9a_A          271 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ-----D  344 (450)
T ss_dssp             TCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC-EEECCCTTCEECC---------
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC-EEEeeCCCcccccccc-----c
Confidence            9999999987654 3689999999999999999999999999999999999998875 9999999997543221     1


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||..............+..+..|..+++.+.+||.+||.
T Consensus       345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  424 (450)
T 1k9a_A          345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWH  424 (450)
T ss_dssp             --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcC
Confidence            2357889999999999999999999999999999998 999998776555554444444556677899999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||.+|||+.|+++
T Consensus       425 ~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          425 LDAATRPTFLQLRE  438 (450)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.1e-39  Score=333.93  Aligned_cols=226  Identities=19%  Similarity=0.258  Sum_probs=181.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce------------------------eccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY------------------------EAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~------------------------~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|......                        ..........+|||||+ 
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            58999999999999999999999999999998533111                        01112345568999999 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEc---CCCCcEEEeecCCccccccCCCC--
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVG---PNSSFVKLADFGAAGEATVSDTR--  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~---~~~~~vkL~DFGla~~~~~~~~~--  132 (408)
                      |++|.+++......+++..++.++.||+.||+|||++||+||||||+||||+   .++ .+||+|||+++........  
T Consensus        86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~  164 (483)
T 3sv0_A           86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQH  164 (483)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCB
T ss_pred             CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccCCccccc
Confidence            8999999987778899999999999999999999999999999999999994   555 5999999999765433221  


Q ss_pred             ---cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh-------hhhcccCCCCCCCCCC
Q 042746          133 ---GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-------SRIGFSDELPRFPTQS  202 (408)
Q Consensus       133 ---~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~-------~~~~~~~~~p~~~~~~  202 (408)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........       ...........++..+
T Consensus       165 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~  244 (483)
T 3sv0_A          165 IPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGY  244 (483)
T ss_dssp             CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTS
T ss_pred             cccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCC
Confidence               112245799999999999999999999999999999999999999986543211       1111112222233567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          203 SELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ++++.+||.+||..||.+||++.+|++
T Consensus       245 p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          245 PTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            889999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-39  Score=334.94  Aligned_cols=226  Identities=22%  Similarity=0.273  Sum_probs=188.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|+++.++..||+|....                        .+.+.+......+|||||++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            468999999999999999999999999999986431                        12223445667899999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.++++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... ....
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~-~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL-VKVADFGLSRLMTGDTY-TAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEECCTTCEECCTTCCE-ECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc-EEEeecccceeccCCce-eecC
Confidence            99999999864 345889999999999999999999999999999999999988874 99999999976543221 1122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++|||||||++|+|++ |..||.......+.........+..+..+++.+.+||.+||+
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  457 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ  457 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            2346788999999998889999999999999999999 999998877666555444444456677889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||.+|||+.|+++
T Consensus       458 ~dP~~RPs~~el~~  471 (495)
T 1opk_A          458 WNPSDRPSFAEIHQ  471 (495)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             cChhHCcCHHHHHH
Confidence            99999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-39  Score=329.78  Aligned_cols=221  Identities=18%  Similarity=0.167  Sum_probs=174.7

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee----------------ccCC----------------------
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE----------------APTT----------------------   44 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~----------------~~~~----------------------   44 (408)
                      +|++++.||+|+||+||+|++..+++.||+|.......                ....                      
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            48899999999999999999999999999986441100                0000                      


Q ss_pred             ------------C-----CCcceEEEeccCCCCHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCC
Q 042746           45 ------------S-----SSCRNLHLEYLPGGTVSDLATTL------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDV  101 (408)
Q Consensus        45 ------------~-----~~~~~LVmEy~~gGsL~~~l~~~------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDL  101 (408)
                                  .     ...++++|+++ +++|.++++..      +..+++..+..++.||+.||+|||++||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                        0     11234566655 57999999532      445677888999999999999999999999999


Q ss_pred             CCCCEEEcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhH----------hCCCCCCCCCcchHHHHHHHH
Q 042746          102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV----------RGECQGPESDVWSLGCTIIEM  171 (408)
Q Consensus       102 Kp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l----------~~~~~~~~sDiWSLGvil~eL  171 (408)
                      ||+|||++.++. +||+|||+++.....     ....+| +.|+|||++          .+..++.++|||||||++|+|
T Consensus       238 Kp~NILl~~~~~-~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          238 RPVDIVLDQRGG-VFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CGGGEEECTTCC-EEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCe-EEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999886 999999998654332     334568 999999999          444578899999999999999


Q ss_pred             HhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          172 VTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       172 ltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ++|+.||............+..     ....++.+++||.+||+.||.+|||+.|+++||||+..
T Consensus       311 ltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHHHhh-----cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999999876544433333221     13567899999999999999999999999999999753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.6e-40  Score=319.06  Aligned_cols=223  Identities=21%  Similarity=0.238  Sum_probs=171.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCC----CCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTS----SSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~----~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++.  ++.||+|.....                        +...+..    ...++|||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            57999999999999999999875  788998864311                        1111111    22368999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR----------NIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~----------giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      ||+++|+|.++++.  ..+++..++.++.||+.||+|||++          ||+||||||+|||++.++. +||+|||++
T Consensus       102 e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~-~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC-EEECCCTTC
T ss_pred             ecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe-EEEccCCcc
Confidence            99999999999975  4579999999999999999999999          9999999999999998875 999999999


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCC-----CCCCCCCcchHHHHHHHHHhCCCCCCCCChh--------------
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGE-----CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--------------  184 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--------------  184 (408)
                      +...............||+.|+|||++.+.     .++.++|||||||++|+|++|+.||......              
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            765543333233345799999999999874     3456789999999999999999999753211              


Q ss_pred             --hhhhhc-ccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          185 --TLSRIG-FSDELPRFPT-----QSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       185 --~~~~~~-~~~~~p~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                        .+.... .....|.++.     ..++.+.+||.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              111111 1122222222     12355899999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=323.02  Aligned_cols=227  Identities=23%  Similarity=0.285  Sum_probs=171.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC---CCcEEEEeecccc------------------------------------eecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF---NGDVFAYLGDDVS------------------------------------YEAP   42 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~---t~~~va~k~~~~~------------------------------------~~~~   42 (408)
                      .+|++++.||+|+||+||+|.+..   ++..+++|.....                                    +...
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            479999999999999999999987   7778888754311                                    0011


Q ss_pred             ----CCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC-CcEEE
Q 042746           43 ----TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFVKL  117 (408)
Q Consensus        43 ----~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~-~~vkL  117 (408)
                          .......+|||||+ |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence                11256789999999 999999997543 789999999999999999999999999999999999998765 24999


Q ss_pred             eecCCccccccCCC-----CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhh-
Q 042746          118 ADFGAAGEATVSDT-----RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRI-  189 (408)
Q Consensus       118 ~DFGla~~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~-  189 (408)
                      +|||+++.......     ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....  ....... 
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            99999976543211     112244579999999999999989999999999999999999999996422  1111111 


Q ss_pred             -cccCCCCC------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          190 -GFSDELPR------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       190 -~~~~~~p~------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                       ......|.      .....++.++++|.+||..||++|||+.++++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          275 TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence             11111111      112678899999999999999999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=316.21  Aligned_cols=234  Identities=21%  Similarity=0.294  Sum_probs=171.0

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eec-----cCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEA-----PTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~-----~~~~~~~~~L   51 (408)
                      +++|++++.||+|+||+||+|++  +++.||+|.....                        +..     .......++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57899999999999999999976  6889998864311                        110     1222335689


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeecCCCCCCEEEcCCCCcEEEeecCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR---------NIVHCDVKGKNVLVGPNSSFVKLADFGA  122 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~---------giiHrDLKp~NILl~~~~~~vkL~DFGl  122 (408)
                      ||||++||+|.++++..  ..++..+..++.||+.||+|||++         ||+||||||+|||++.++. +||+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~-~kL~DFG~  166 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGL  166 (336)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC-EEECCCTT
T ss_pred             EEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc-EEEeeccc
Confidence            99999999999999753  348899999999999999999999         9999999999999998875 99999999


Q ss_pred             ccccccCC------CCcccccCCCCCCCCChhhHhC-------CCCCCCCCcchHHHHHHHHHhCCCCCCC-CChhhh--
Q 042746          123 AGEATVSD------TRGVKIQPRGSPLWMAPEVVRG-------ECQGPESDVWSLGCTIIEMVTGKPAWED-FGANTL--  186 (408)
Q Consensus       123 a~~~~~~~------~~~~~~~~~Gt~~y~APE~l~~-------~~~~~~sDiWSLGvil~eLltG~~Pf~~-~~~~~~--  186 (408)
                      ++......      .........||+.|+|||++.+       ..++.++|||||||++|+|++|..||.. ......  
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            97654321      1112234569999999999987       3456789999999999999999766532 111110  


Q ss_pred             ---------------hh-hcccCCCCCCCCC------CcHHHHHHHHHhcccCCCCCCCHHHHHc------CCCCCCCCC
Q 042746          187 ---------------SR-IGFSDELPRFPTQ------SSELGRDFLDKCLRREPGERWSCDQLLK------HPFLQSVSP  238 (408)
Q Consensus       187 ---------------~~-~~~~~~~p~~~~~------~s~~~~~li~~~L~~dP~~R~s~~ell~------hpf~~~~~~  238 (408)
                                     .. .......+.++..      .++.+.+||.+||+.||++|||+.|+++      ++|-++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~  326 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV  326 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC----
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccC
Confidence                           00 0111222333322      3457899999999999999999999954      777765544


Q ss_pred             C
Q 042746          239 S  239 (408)
Q Consensus       239 ~  239 (408)
                      .
T Consensus       327 ~  327 (336)
T 3g2f_A          327 S  327 (336)
T ss_dssp             -
T ss_pred             C
Confidence            3

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.6e-39  Score=308.80  Aligned_cols=225  Identities=19%  Similarity=0.246  Sum_probs=183.3

Q ss_pred             CCeEeec-eeeecCCeeEEEEEE--cCCCcEEEEeecccc---------------------------eeccCCCCCcceE
Q 042746            2 VSWVRGK-CIGRGSFGTVNVAVD--RFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~-~IG~G~fG~Vy~a~d--~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~L   51 (408)
                      .+|++.+ .||+|+||+||+|.+  ..+++.+++|.....                           +.... .....++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            4688888 999999999999954  566788888754311                           11111 3455789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeeccCCC
Confidence            9999999999999985 45689999999999999999999999999999999999999887 499999999976543322


Q ss_pred             C-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          132 R-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       132 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                      . .......|++.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...++.+.++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL  252 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1 11222346788999999998888999999999999999999 999999877666655555555667778899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q 042746          210 LDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~  229 (408)
                      |.+||+.||.+|||+.|+++
T Consensus       253 i~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          253 MNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-39  Score=317.09  Aligned_cols=228  Identities=25%  Similarity=0.340  Sum_probs=184.2

Q ss_pred             CCeEeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc-------------------------eecc--CCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS-------------------------YEAP--TTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~-------------------------~~~~--~~~~~~~~   50 (408)
                      .+|++.+.||+|+||+||+|+    +..+++.|++|.....                         +...  .......+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            579999999999999999999    6788999999864311                         1111  12456688


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |||||++||+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~~~~~~~  181 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDK  181 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE-EEECCGGGCEECCTTC
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC-EEEcccccceecccCC
Confidence            999999999999999876677899999999999999999999999999999999999998874 9999999997654332


Q ss_pred             CC-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---------------hhhhhcccCC
Q 042746          131 TR-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---------------TLSRIGFSDE  194 (408)
Q Consensus       131 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---------------~~~~~~~~~~  194 (408)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++|..||......               ..........
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (327)
T 3lxl_A          182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ  261 (327)
T ss_dssp             SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred             ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence            21 1122345888899999999988899999999999999999999998643221               1111222333


Q ss_pred             CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          195 LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       195 ~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+...++.+++||.+||+.||.+|||+.|++++
T Consensus       262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            445667889999999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-38  Score=308.50  Aligned_cols=226  Identities=26%  Similarity=0.352  Sum_probs=171.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|.+..+++.+++|....                            .+...+..+...++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            589999999999999999999999999999985431                            1112233456688999


Q ss_pred             eccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           54 EYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        54 Ey~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      ||+++|+|.+++..   ....+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~-~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCC----------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC-EEEEeccceeeecCCC
Confidence            99999999999975   3566899999999999999999999999999999999999998875 9999999986554322


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCCh--hhhhhhcccCCCCCC-CCCCcHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGA--NTLSRIGFSDELPRF-PTQSSELGR  207 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~p~~-~~~~s~~~~  207 (408)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....  ............+.. +...++.++
T Consensus       191 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  268 (310)
T 2wqm_A          191 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  268 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHH
T ss_pred             c--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHH
Confidence            1  12234689999999999998899999999999999999999999975432  222222223333333 356889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +||.+||..||.+|||+.|++++
T Consensus       269 ~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          269 QLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8e-39  Score=310.54  Aligned_cols=226  Identities=19%  Similarity=0.239  Sum_probs=173.5

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LV   52 (408)
                      +.+|++++.||+|+||+||+|.+..+++.|++|.....                            +...+..+...++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            46899999999999999999999999999999864321                            11123345667899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ 
T Consensus       113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~-~kl~Dfg~~~~~~~~~~-  189 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKL-  189 (309)
T ss_dssp             EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC-EEEecCccCcccccccc-
Confidence            9999999999999854 56799999999999999999999999999999999999998875 99999999866543221 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccC--CCCCCCCCCcHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSD--ELPRFPTQSSELGRDFL  210 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~--~~p~~~~~~s~~~~~li  210 (408)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......+.......  .....+...++.++++|
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  269 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI  269 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHH
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHH
Confidence            1122446899999999999988999999999999999999999999876544333322111  11234567888999999


Q ss_pred             HHhcccCCCCCC-CHHHHHc
Q 042746          211 DKCLRREPGERW-SCDQLLK  229 (408)
Q Consensus       211 ~~~L~~dP~~R~-s~~ell~  229 (408)
                      .+||+.||.+|| +++++++
T Consensus       270 ~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          270 ARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHTCSSGGGSCSSHHHHHH
T ss_pred             HHhccCCHHHHHHhHHHHHH
Confidence            999999999999 7888775

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=327.65  Aligned_cols=233  Identities=21%  Similarity=0.299  Sum_probs=174.0

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      +|.+.+.||+|+||+|+. ....+++.||+|....                       .+...+......+|||||++| 
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-  102 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-  102 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-
Confidence            589999999999999763 5566899999986431                       111223345667899999975 


Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC----CcEEEeecCCccccccCCCC-cc
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS----SFVKLADFGAAGEATVSDTR-GV  134 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~----~~vkL~DFGla~~~~~~~~~-~~  134 (408)
                      +|.+++........+..+..++.||+.||+|||++||+||||||+|||++.++    ..+||+|||+++........ ..
T Consensus       103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~  182 (432)
T 3p23_A          103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR  182 (432)
T ss_dssp             EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred             CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceee
Confidence            99999986655566667789999999999999999999999999999995322    13889999999765433211 12


Q ss_pred             cccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRD  208 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~  208 (408)
                      ....+||+.|+|||++.+   ..++.++|||||||++|+|++ |.+||.................+  ..+...+..+++
T Consensus       183 ~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (432)
T 3p23_A          183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE  262 (432)
T ss_dssp             ---CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHH
T ss_pred             ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHH
Confidence            334579999999999974   456789999999999999999 99999765444433322121111  112334566899


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          209 FLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||.+||+.||.+|||+.|+++||||....
T Consensus       263 li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          263 LIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             HHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            99999999999999999999999997543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=305.46  Aligned_cols=219  Identities=24%  Similarity=0.400  Sum_probs=173.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      .+|++.+.||+|+||+||+|.+.  ++.+++|....                       .+.+...  +..+|||||++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence            47999999999999999999885  67888876431                       1111111  347899999999


Q ss_pred             CCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           59 GTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHS---RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        59 GsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~---~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |+|.+++.....  .+++..+..++.||+.||+|||+   +||+||||||+|||++.++..+||+|||++......    
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            999999985432  46889999999999999999999   899999999999999888765899999999654322    


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh--hhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN--TLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                       .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......  ...........+..+...++.+.+++.
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  238 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT  238 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHH
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHH
Confidence             12345899999999999999999999999999999999999999864322  222222344455666788999999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      +||+.||.+|||+.|+++
T Consensus       239 ~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          239 RCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4.4e-39  Score=306.17  Aligned_cols=224  Identities=19%  Similarity=0.316  Sum_probs=182.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------eeccC----------------C
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------YEAPT----------------T   44 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------~~~~~----------------~   44 (408)
                      .+|++.+.||+|+||+||+|++..+++.|++|.....                     +...+                .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   90 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS   90 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence            3699999999999999999999999999998864311                     11101                1


Q ss_pred             CCCcceEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           45 SSSCRNLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        45 ~~~~~~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .....++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~  169 (284)
T 2a19_B           91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLV  169 (284)
T ss_dssp             EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcchhh
Confidence            234578999999999999999754 45789999999999999999999999999999999999999887 4999999998


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCc
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSS  203 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s  203 (408)
                      ........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||....  .........   .++...+
T Consensus       170 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~---~~~~~~~  241 (284)
T 2a19_B          170 TSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG---IISDIFD  241 (284)
T ss_dssp             EESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHTT---CCCTTSC
T ss_pred             eecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhcc---cccccCC
Confidence            76543321   234469999999999999989999999999999999999998875321  111111111   2345678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +.++++|.+||..||.+|||+.|+++|++.-
T Consensus       242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            8999999999999999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.3e-39  Score=309.18  Aligned_cols=223  Identities=24%  Similarity=0.327  Sum_probs=171.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eec----cCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEA----PTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~----~~~~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++  +++.||+|.....                        +..    ........+|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~   85 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT   85 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence            5799999999999999999988  6888998864311                        000    012234578999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH--------SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH--------~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ||+++|+|.++++  ...+++..+..++.||+.||+|||        +++|+||||||+|||++.++. +||+|||+++.
T Consensus        86 e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~  162 (301)
T 3q4u_A           86 HYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVM  162 (301)
T ss_dssp             CCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC-EEECCCTTCEE
T ss_pred             hhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC-EEEeeCCCeee
Confidence            9999999999995  457899999999999999999999        999999999999999998875 99999999965


Q ss_pred             cccCCCCc--ccccCCCCCCCCChhhHhCC------CCCCCCCcchHHHHHHHHHhC----------CCCCCCCCh----
Q 042746          126 ATVSDTRG--VKIQPRGSPLWMAPEVVRGE------CQGPESDVWSLGCTIIEMVTG----------KPAWEDFGA----  183 (408)
Q Consensus       126 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~------~~~~~sDiWSLGvil~eLltG----------~~Pf~~~~~----  183 (408)
                      ........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|          .+||.....    
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~  242 (301)
T 3q4u_A          163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS  242 (301)
T ss_dssp             EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence            44332211  12234799999999999876      344689999999999999999          888865321    


Q ss_pred             -hhhhhh-cccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          184 -NTLSRI-GFSDELPRFPT-----QSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       184 -~~~~~~-~~~~~~p~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                       ...... ......+..+.     ..++.+.+|+.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence             112211 11222333332     24577899999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-39  Score=316.45  Aligned_cols=227  Identities=21%  Similarity=0.258  Sum_probs=176.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC--------CcEEEEeecccc------------e----------------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN--------GDVFAYLGDDVS------------Y----------------------   39 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t--------~~~va~k~~~~~------------~----------------------   39 (408)
                      .+|++++.||+|+||+||+|++..+        ++.||+|.....            .                      
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            4899999999999999999999985        778888764311            0                      


Q ss_pred             -eccC-CCCCcceEEEeccCCCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC-CcE
Q 042746           40 -EAPT-TSSSCRNLHLEYLPGGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFV  115 (408)
Q Consensus        40 -~~~~-~~~~~~~LVmEy~~gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~-~~v  115 (408)
                       .... ..+...+|||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~  200 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV  200 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEE
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceE
Confidence             0000 1256789999999 99999999864 36789999999999999999999999999999999999999876 149


Q ss_pred             EEeecCCccccccCCCC-----cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhh
Q 042746          116 KLADFGAAGEATVSDTR-----GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSR  188 (408)
Q Consensus       116 kL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~  188 (408)
                      ||+|||+++........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....  ...+..
T Consensus       201 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  280 (352)
T 2jii_A          201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMK  280 (352)
T ss_dssp             EECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred             EEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHH
Confidence            99999999765432211     11233479999999999999889999999999999999999999998653  222221


Q ss_pred             hc--ccCCCCCCC------CCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          189 IG--FSDELPRFP------TQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       189 ~~--~~~~~p~~~------~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..  +....+.++      ...++.+.+||.+||..||.+|||+.|+++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          281 QKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            11  111112221      246899999999999999999999999876

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.9e-39  Score=314.84  Aligned_cols=228  Identities=22%  Similarity=0.276  Sum_probs=176.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|.+. +++.||+|.....                          +...+......++||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            57999999999999999999854 6888988764311                          11223345667899999


Q ss_pred             cCCCCHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           56 LPGGTVSDLATTLN---AYADEITLRSHTYCIVSALKYLHSR---NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        56 ~~gGsL~~~l~~~~---~~l~e~~i~~i~~qIl~~L~yLH~~---giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ++||+|.+++....   ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++. +||+|||++......
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~  187 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE-AVVGDFGLAKLMDYK  187 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC-EEECCCSSCEECCSS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC-EEeccCccccccCcc
Confidence            99999999998532   2489999999999999999999999   9999999999999998875 999999999765433


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh-----hh---h-hhccc--------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-----TL---S-RIGFS--------  192 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-----~~---~-~~~~~--------  192 (408)
                      .. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......     ..   . .....        
T Consensus       188 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (326)
T 3uim_A          188 DT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD  266 (326)
T ss_dssp             SS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC
T ss_pred             cc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC
Confidence            22 2233456999999999999888999999999999999999999999621100     00   0 00000        


Q ss_pred             -CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCC
Q 042746          193 -DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPF  232 (408)
Q Consensus       193 -~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf  232 (408)
                       ...+..+...++.+.+++.+||+.||.+|||+.|+++|-.
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          267 VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence             0011222233467899999999999999999999999744

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-38  Score=303.36  Aligned_cols=224  Identities=22%  Similarity=0.267  Sum_probs=181.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|.+. ++..+++|.....                        +.... .+...++||||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEE-cCCCcEEEEecCC
Confidence            57999999999999999999976 5667888754311                        11111 2345789999999


Q ss_pred             CCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      |++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ ....
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~-~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEY-TARE  168 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECSSSCE-ECCT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC-EEECCCcccccccCccc-cccc
Confidence            999999996432 26899999999999999999999999999999999999998875 99999999976543221 1122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...++.+.+++.+||.
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  248 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK  248 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhc
Confidence            3457889999999998888999999999999999999 999998776655544444444455667889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||++|||+.++++
T Consensus       249 ~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          249 ERPEDRPTFDYLRS  262 (279)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             cChhhCCCHHHHHH
Confidence            99999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.3e-39  Score=328.05  Aligned_cols=224  Identities=22%  Similarity=0.292  Sum_probs=181.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+. ++..||+|.....                        +.... .....+|||||++
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEE-eCCccEEEEeecC
Confidence            47999999999999999999986 4677888764321                        11112 2455789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.++++.. +..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++....... ....
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DFG~a~~~~~~~~-~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV-CKIADFGLARVIEDNEY-TARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC-EEECSTTGGGGBCCHHH-HTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc-EEEeeCCCceEcCCCce-eccC
Confidence            99999999743 236789999999999999999999999999999999999998875 99999999976532211 1112


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++|||||||++|+|++ |+.||.................+..+...++.+.+||.+||.
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~  423 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWK  423 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            2346788999999998889999999999999999999 999998876655544443444445567889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||.+|||+.+++.
T Consensus       424 ~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          424 NRPEERPTFEYIQS  437 (454)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.8e-38  Score=323.53  Aligned_cols=231  Identities=25%  Similarity=0.324  Sum_probs=167.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPGG   59 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~gG   59 (408)
                      .|...+.||+|+||+||.+ ...+++.||+|....                       .+......+...+|||||++ |
T Consensus        16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            4677899999999999875 456799999986431                       12222345567899999996 5


Q ss_pred             CHHHHHHHhCCCC------CHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC------------CcEEEeecC
Q 042746           60 TVSDLATTLNAYA------DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS------------SFVKLADFG  121 (408)
Q Consensus        60 sL~~~l~~~~~~l------~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~------------~~vkL~DFG  121 (408)
                      +|.+++.......      ++..+..++.||+.||+|||++||+||||||+|||++.++            ..+||+|||
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG  173 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG  173 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence            9999997532211      2234567999999999999999999999999999997532            259999999


Q ss_pred             CccccccCCCC--cccccCCCCCCCCChhhHhC-------CCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          122 AAGEATVSDTR--GVKIQPRGSPLWMAPEVVRG-------ECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       122 la~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~-------~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      +++........  ......+||+.|+|||++.+       ..++.++|||||||++|+|++ |.+||.............
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~  253 (434)
T 2rio_A          174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG  253 (434)
T ss_dssp             TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHT
T ss_pred             cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcC
Confidence            99765433211  11234579999999999976       567899999999999999999 999997643332211111


Q ss_pred             cCCCCCCC----CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          192 SDELPRFP----TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       192 ~~~~p~~~----~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ....+..+    ...++++++||.+||+.||.+|||+.|+++||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            11111111    234578999999999999999999999999999964

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-38  Score=324.36  Aligned_cols=230  Identities=24%  Similarity=0.286  Sum_probs=181.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+.. +..||+|.....                        +.+... +...+|||||++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCceEEEehhhc
Confidence            468999999999999999999975 456888764321                        111122 255789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.++++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... ....
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~~~-~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEY-TARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCTTC------------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC-EEECCCccceecCCCce-eccc
Confidence            99999999753 356899999999999999999999999999999999999988774 99999999976543221 1122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++||||||+++|+|++ |+.||.................+..+...++.+.+||.+||+
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~  419 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR  419 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            3346788999999998889999999999999999999 999998776655554444444455667889999999999999


Q ss_pred             cCCCCCCCHHHHHc--CCCCCC
Q 042746          216 REPGERWSCDQLLK--HPFLQS  235 (408)
Q Consensus       216 ~dP~~R~s~~ell~--hpf~~~  235 (408)
                      .||++|||++++++  +.++..
T Consensus       420 ~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          420 KEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             SSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CChhhCcCHHHHHHHHHHHhcc
Confidence            99999999999987  355543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=310.35  Aligned_cols=228  Identities=19%  Similarity=0.253  Sum_probs=175.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccC----CCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPT----TSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~----~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|....                         .+....    ......++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            469999999999999999999999999999985321                         011111    123467899


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           53 LEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        53 mEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      |||+++|+|.+++..   .+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~-~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ-PVLMDLGSMNQACIH  187 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCSSCEESCEE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC-EEEEecCcchhcccc
Confidence            999999999999986   3567899999999999999999999999999999999999998875 999999998654321


Q ss_pred             CCCc-------ccccCCCCCCCCChhhHhCCC---CCCCCCcchHHHHHHHHHhCCCCCCCCC--hhhhhhhcccCCCCC
Q 042746          130 DTRG-------VKIQPRGSPLWMAPEVVRGEC---QGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPR  197 (408)
Q Consensus       130 ~~~~-------~~~~~~Gt~~y~APE~l~~~~---~~~~sDiWSLGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~p~  197 (408)
                      ....       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||....  ...............
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  267 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP  267 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CC
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCC
Confidence            1110       012235799999999997654   6889999999999999999999996421  111111111122223


Q ss_pred             CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       198 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+...++.+.++|.+||+.||.+|||+.|++++
T Consensus       268 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          268 QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            345678999999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=308.89  Aligned_cols=224  Identities=23%  Similarity=0.322  Sum_probs=170.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCC----CcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSS----SCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~----~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++.  ++.||+|.....                        +.......    ...+|||
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~  114 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT  114 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence            47999999999999999999885  888988763211                        11111111    5678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR--------NIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~--------giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ||++||+|.++++.  ..+++..++.++.|++.||+|||++        ||+||||||+|||++.++. +||+|||++..
T Consensus       115 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~-~kl~Dfg~a~~  191 (337)
T 3mdy_A          115 DYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVK  191 (337)
T ss_dssp             CCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC-EEECCCTTCEE
T ss_pred             eccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC-EEEEeCCCcee
Confidence            99999999999974  4679999999999999999999999        9999999999999998875 99999999965


Q ss_pred             cccCCCC--cccccCCCCCCCCChhhHhCCCCCCC------CCcchHHHHHHHHHhC----------CCCCCCCCh----
Q 042746          126 ATVSDTR--GVKIQPRGSPLWMAPEVVRGECQGPE------SDVWSLGCTIIEMVTG----------KPAWEDFGA----  183 (408)
Q Consensus       126 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~------sDiWSLGvil~eLltG----------~~Pf~~~~~----  183 (408)
                      .......  .......||+.|+|||++.+..+...      +|||||||++|+|++|          +.||.....    
T Consensus       192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~  271 (337)
T 3mdy_A          192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS  271 (337)
T ss_dssp             CC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             eccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence            5432221  11124579999999999998776665      8999999999999999          677754321    


Q ss_pred             -hhhhhh-cccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          184 -NTLSRI-GFSDELPRFPT-----QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       184 -~~~~~~-~~~~~~p~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                       ...... ......+.++.     ..++.+.+||.+||+.||.+|||+.|+++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence             111111 11222233332     345678999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-38  Score=305.24  Aligned_cols=211  Identities=26%  Similarity=0.356  Sum_probs=166.2

Q ss_pred             CCeEee-ceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceeccCC----CCCcceEEEec
Q 042746            2 VSWVRG-KCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAPTT----SSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~-~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~~~----~~~~~~LVmEy   55 (408)
                      .+|.+. +.||+|+||+||+|.+..+++.||+|....                     .+...+.    .....+|||||
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~   96 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC   96 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence            578887 889999999999999999999999986431                     1111121    25668899999


Q ss_pred             cCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccccccCCC
Q 042746           56 LPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        56 ~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++ .+||+|||++....    
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~----  171 (299)
T 3m2w_A           97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETT----  171 (299)
T ss_dssp             CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECT----
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC-cEEEeccccccccc----
Confidence            99999999998643 36899999999999999999999999999999999999987   44 59999999985432    


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh---cccCCCCCCC----CCCcH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI---GFSDELPRFP----TQSSE  204 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~---~~~~~~p~~~----~~~s~  204 (408)
                                          +..++.++|||||||++|+|++|++||...........   ........++    ...++
T Consensus       172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (299)
T 3m2w_A          172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE  231 (299)
T ss_dssp             --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred             --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence                                12367789999999999999999999976543322111   1111111222    46789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      .+++||.+||+.||.+|||+.|+++||||....
T Consensus       232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            999999999999999999999999999997643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=308.47  Aligned_cols=224  Identities=20%  Similarity=0.271  Sum_probs=159.6

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceecc--------CCCCCc
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAP--------TTSSSC   48 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~--------~~~~~~   48 (408)
                      +|++++.||+|+||+||+|++..+++.||+|....                          .+...        ......
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            79999999999999999999999999999985321                          01000        133445


Q ss_pred             ceEEEeccCCCCHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           49 RNLHLEYLPGGTVSDLATT--LNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~--~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .+++|||+. |+|.+++..  ..+.+++..++.++.||+.||+|||++|  |+||||||+|||++.++. +||+|||++.
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~-~kl~Dfg~~~  186 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT-IKLCDFGSAT  186 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC-EEBCCCTTCB
T ss_pred             EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC-EEEecCccce
Confidence            789999997 699998875  3456899999999999999999999999  999999999999998875 9999999997


Q ss_pred             ccccCCCC----------cccccCCCCCCCCChhhH---hCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc
Q 042746          125 EATVSDTR----------GVKIQPRGSPLWMAPEVV---RGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       125 ~~~~~~~~----------~~~~~~~Gt~~y~APE~l---~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~  191 (408)
                      ........          .......||+.|+|||++   .+..++.++||||||+++|+|++|+.||.............
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  266 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY  266 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------C
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCcc
Confidence            65432211          011234689999999999   45667889999999999999999999998654333222111


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHP  231 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hp  231 (408)
                         ....+...+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       267 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          267 ---SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ---CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ---cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence               1122345667789999999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.6e-38  Score=305.22  Aligned_cols=223  Identities=23%  Similarity=0.330  Sum_probs=173.7

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------ceeccCCCCCcceEEEe
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      |..++.||+|+||+||+|.+  +++.+++|....                             .+..........++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44569999999999999987  577888875321                             11222344567899999


Q ss_pred             ccCCCCHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           55 YLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~--~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |++||+|.+++...  ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~-~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT-AKISDFGLARASEKFAQT  189 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECCSCSSC
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc-EEEeeccccccccccccc
Confidence            99999999999753  345899999999999999999999999999999999999998875 999999999765433322


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh--------------cccCCCCCC
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--------------GFSDELPRF  198 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~--------------~~~~~~p~~  198 (408)
                      .......||+.|+|||++.+. ++.++||||||+++|+|++|.+||...........              ......+..
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             ccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            223345699999999998865 78899999999999999999999976433221100              011222233


Q ss_pred             CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          199 PTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       199 ~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +...++.+.+++.+||..||.+|||+.|++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            34456778999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-39  Score=322.24  Aligned_cols=225  Identities=22%  Similarity=0.350  Sum_probs=173.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCC--CCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTT--SSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~--~~~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                          +...+.  .....+|||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            4799999999999999999999999999999864311                          111111  233678999


Q ss_pred             eccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEE----cCCCCcEEEeecCCccccc
Q 042746           54 EYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLV----GPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl----~~~~~~vkL~DFGla~~~~  127 (408)
                      ||++||+|.+++.....  .+++..++.++.||+.||+|||++||+||||||+|||+    +.++ .+||+|||+++...
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~~~  167 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAARELE  167 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCEECC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCceEcc
Confidence            99999999999975332  38999999999999999999999999999999999998    5554 49999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhC--------CCCCCCCCcchHHHHHHHHHhCCCCCCCCCh-----hhhhhhc----
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRG--------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGA-----NTLSRIG----  190 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~--------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~-----~~~~~~~----  190 (408)
                      ...   ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.....     ..+..+.    
T Consensus       168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          168 DDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             CCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            322   2234569999999999975        4567889999999999999999999974321     1111111    


Q ss_pred             ----------------ccCCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          191 ----------------FSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       191 ----------------~~~~~p---~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                                      +....|   .++...++.+.++|.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                            011111   1112345678899999999999999999998663

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.1e-38  Score=301.72  Aligned_cols=227  Identities=21%  Similarity=0.268  Sum_probs=174.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-CCc--EEEEeecccc----------------------------eeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-NGD--VFAYLGDDVS----------------------------YEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-t~~--~va~k~~~~~----------------------------~~~~~~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|++.. +++  .|++|.....                            +..... ....+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-cCCce
Confidence            479999999999999999998654 333  4677643211                            111112 23378


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~  175 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQND  175 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-C
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccccccc
Confidence            99999999999999987767789999999999999999999999999999999999998887 49999999997654332


Q ss_pred             CCc-ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhc-ccCCCCCCCCCCcHHHH
Q 042746          131 TRG-VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIG-FSDELPRFPTQSSELGR  207 (408)
Q Consensus       131 ~~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~-~~~~~p~~~~~~s~~~~  207 (408)
                      ... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............ .....+..+...++.++
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  255 (291)
T 1u46_A          176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY  255 (291)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred             cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHH
Confidence            211 1223457888999999998888999999999999999999 99999877655544332 22333445567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ++|.+||..||.+|||+.+++++
T Consensus       256 ~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          256 NVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCcccCcCHHHHHHH
Confidence            99999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=331.48  Aligned_cols=225  Identities=19%  Similarity=0.251  Sum_probs=178.3

Q ss_pred             CeEeec-eeeecCCeeEEEEEEcC--CCcEEEEeecccc--------------------------eeccCCCCCcceEEE
Q 042746            3 SWVRGK-CIGRGSFGTVNVAVDRF--NGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         3 ~Y~~~~-~IG~G~fG~Vy~a~d~~--t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVm   53 (408)
                      +|.+.+ .||+|+||+||+|.+..  ++..||+|.....                          +.+... ....+|||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-SSSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec-cCCeEEEE
Confidence            344555 89999999999998864  4556888764321                          111111 24578999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-  132 (408)
                      ||++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........ 
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC------
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccCCCcee
Confidence            99999999999976667789999999999999999999999999999999999999887 5999999999765432211 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......+......+..+..+..+++.+.+||.
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  573 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS  573 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            11222346789999999998889999999999999999998 99999987666655554555556677889999999999


Q ss_pred             HhcccCCCCCCCHHHHHc
Q 042746          212 KCLRREPGERWSCDQLLK  229 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~  229 (408)
                      +||..||.+||++.++++
T Consensus       574 ~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          574 DCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HTTCSSTTTSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999854

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.4e-38  Score=304.25  Aligned_cols=224  Identities=23%  Similarity=0.232  Sum_probs=173.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmE   54 (408)
                      .+|++++.||+|+||+||+|.+..+   +++|.....                           +..........++|||
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            6899999999999999999998653   555543211                           1111223456789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC---C
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD---T  131 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~  131 (408)
                      |++|++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++ ++ .+||+|||++.......   .
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----------
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCcccccccccccc
Confidence            9999999999986566789999999999999999999999999999999999998 44 59999999986543211   1


Q ss_pred             CcccccCCCCCCCCChhhHhC---------CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC-CCC
Q 042746          132 RGVKIQPRGSPLWMAPEVVRG---------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF-PTQ  201 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~---------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~-~~~  201 (408)
                      ........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||.................+.. +..
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  267 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG  267 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSS
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCC
Confidence            112233468999999999975         3468899999999999999999999987766554443333333333 235


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+.+++.+||..||.+|||+.|+++.
T Consensus       268 ~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          268 MGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            77889999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=306.26  Aligned_cols=227  Identities=24%  Similarity=0.315  Sum_probs=179.1

Q ss_pred             CCeEeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc-------------------------eeccC--CCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS-------------------------YEAPT--TSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~-------------------------~~~~~--~~~~~~~   50 (408)
                      .+|++++.||+|+||+||+|+    +..+++.|++|.....                         +....  ......+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            469999999999999999999    5678999999864311                         11111  1234678


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCSSC
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccccc
Confidence            99999999999999987667789999999999999999999999999999999999999887 49999999997654332


Q ss_pred             CC-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh----------------hhhhhcccC
Q 042746          131 TR-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN----------------TLSRIGFSD  193 (408)
Q Consensus       131 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~----------------~~~~~~~~~  193 (408)
                      .. .......+++.|+|||++.+..++.++||||||+++|+|++|..||......                .+.......
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            21 1122335778899999999888899999999999999999999998642110                111111222


Q ss_pred             CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          194 ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       194 ~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..+..+...++.+.+||.+||..||++|||+.|+++
T Consensus       280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            334456778999999999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-37  Score=331.32  Aligned_cols=226  Identities=24%  Similarity=0.298  Sum_probs=183.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC---cEEEEeeccc--------------------------ceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG---DVFAYLGDDV--------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~---~~va~k~~~~--------------------------~~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|++..++   ..+|+|....                          .+.+.. .+...+||
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCceEEE
Confidence            46999999999999999999987544   4678775321                          111122 24557899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.++++..+..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....... 
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~~~~-  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY-  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC----
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecCCCcc-
Confidence            999999999999987666789999999999999999999999999999999999999887 599999999976543221 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.................+..+...++.+.+||.
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  626 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT  626 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHH
Confidence            11223457889999999998889999999999999999997 99999887666555444445555677889999999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||..||.+|||+.|+++.
T Consensus       627 ~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          627 KCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHH
Confidence            9999999999999999863

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.5e-38  Score=305.34  Aligned_cols=223  Identities=23%  Similarity=0.347  Sum_probs=175.3

Q ss_pred             eEeeceeeecCCeeEEEEE----EcCCCcEEEEeecccc--------------------------eeccCC--CCCcceE
Q 042746            4 WVRGKCIGRGSFGTVNVAV----DRFNGDVFAYLGDDVS--------------------------YEAPTT--SSSCRNL   51 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~----d~~t~~~va~k~~~~~--------------------------~~~~~~--~~~~~~L   51 (408)
                      |++++.||+|+||+||++.    +..+++.||+|.....                          +...+.  .....+|
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            4999999999999997764    4568888998864321                          111111  2456789


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+++|+|.+++..  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........
T Consensus       113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~  189 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-VKIGDFGLAKAVPEGHE  189 (318)
T ss_dssp             EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCGGGCEECCTTCS
T ss_pred             EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC-EEECCcccccccccccc
Confidence            9999999999999964  35899999999999999999999999999999999999998875 99999999976543322


Q ss_pred             C-cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChh---------------hhhhhcccCCC
Q 042746          132 R-GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGAN---------------TLSRIGFSDEL  195 (408)
Q Consensus       132 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~---------------~~~~~~~~~~~  195 (408)
                      . .......||+.|+|||++.+..++.++||||||+++|+|++|..||......               ...........
T Consensus       190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (318)
T 3lxp_A          190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER  269 (318)
T ss_dssp             EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCC
T ss_pred             ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccC
Confidence            1 1223345888899999999988899999999999999999999999753211               11112223334


Q ss_pred             CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       196 p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +..+...++.+.+||.+||+.||.+|||+.|+++
T Consensus       270 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4566788999999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=325.60  Aligned_cols=224  Identities=25%  Similarity=0.280  Sum_probs=181.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++.+.||+|+||+||+|.+.. +..||+|.....                        +.+... +...+|||||++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe-eccceEeeehhc
Confidence            468999999999999999999975 456888754311                        111122 256789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.++++.. +..+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++....... ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~-~kl~DFG~a~~~~~~~~-~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEY-TARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCTTSTTTCCCHHH-HTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc-EEEcccccceecCCCce-eccc
Confidence            99999999753 356899999999999999999999999999999999999988774 99999999976542211 0112


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...+++.|+|||++.+..++.++|||||||++|+|++ |+.||.......+.........+..+..+++.+.+||.+||+
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~  502 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR  502 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            2346788999999998889999999999999999999 999998776655544443444445567889999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||++|||+.+|++
T Consensus       503 ~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          503 KEPEERPTFEYLQA  516 (535)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.3e-37  Score=330.04  Aligned_cols=220  Identities=20%  Similarity=0.267  Sum_probs=177.4

Q ss_pred             eceeeecCCeeEEEEEE--cCCCcEEEEeecccc---------------------------eeccCCCCCcceEEEeccC
Q 042746            7 GKCIGRGSFGTVNVAVD--RFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         7 ~~~IG~G~fG~Vy~a~d--~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+.||+|+||+||+|.+  +.+++.||+|.....                           +.+.. .....+|||||++
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~lv~E~~~  452 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAE  452 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCT
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCEEEEEEccC
Confidence            45899999999999955  456788988764321                           11111 2344789999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC-Ccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT-RGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-~~~~~  136 (408)
                      +|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....... .....
T Consensus       453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC---------
T ss_pred             CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCcccccccc
Confidence            9999999974 56789999999999999999999999999999999999999887 599999999976543221 11122


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++ |+.||.......+.........+..+...++.+.+||.+||.
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  610 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT  610 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence            3357888999999999899999999999999999998 999999877766666555666667778899999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||++|||+.++++
T Consensus       611 ~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          611 YDVENRPGFAAVEL  624 (635)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CCHhHCcCHHHHHH
Confidence            99999999999875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.4e-38  Score=332.98  Aligned_cols=233  Identities=23%  Similarity=0.292  Sum_probs=179.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccC------CCCCc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPT------TSSSC   48 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~------~~~~~   48 (408)
                      +.+|++++.||+|+||+||+|.+..+++.||+|....                          .+....      .....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            3689999999999999999999999999999985321                          111111      22566


Q ss_pred             ceEEEeccCCCCHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC--cEEEeecCCcc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNA--YADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS--FVKLADFGAAG  124 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~--~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~--~vkL~DFGla~  124 (408)
                      .+|||||++||+|.+++.....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  .+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            7899999999999999985332  5889999999999999999999999999999999999987653  38999999997


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh--------------h---
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL--------------S---  187 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~--------------~---  187 (408)
                      .......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||........              .   
T Consensus       173 ~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          173 ELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             BTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             ccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            6543322   2345799999999999999999999999999999999999999964321100              0   


Q ss_pred             ---hhcccCCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          188 ---RIGFSDELP---RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       188 ---~~~~~~~~p---~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                         ...+....|   .+....++.+.+||.+||..||.+|||+.|+++||||...
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence               000111111   1223467889999999999999999999999999999754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.3e-37  Score=302.69  Aligned_cols=224  Identities=21%  Similarity=0.266  Sum_probs=171.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCC----CcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSS----SCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~----~~~~LVm   53 (408)
                      .+|++++.||+|+||+||+|++  +++.||+|.....                        +.......    ...++||
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~  119 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS  119 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence            4699999999999999999998  4888988764311                        11111122    2678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH--------SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH--------~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ||+++|+|.+++..  ..+++..++.++.||+.||+|||        +++|+||||||+|||++.++. +||+|||++..
T Consensus       120 e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~-~kL~Dfg~~~~  196 (342)
T 1b6c_B          120 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVR  196 (342)
T ss_dssp             CCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC-EEECCCTTCEE
T ss_pred             eecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC-EEEEECCCcee
Confidence            99999999999974  45789999999999999999999        899999999999999998875 99999999966


Q ss_pred             cccCCCCc--ccccCCCCCCCCChhhHhCCCC------CCCCCcchHHHHHHHHHhC----------CCCCCCCCh----
Q 042746          126 ATVSDTRG--VKIQPRGSPLWMAPEVVRGECQ------GPESDVWSLGCTIIEMVTG----------KPAWEDFGA----  183 (408)
Q Consensus       126 ~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~------~~~sDiWSLGvil~eLltG----------~~Pf~~~~~----  183 (408)
                      ........  ......||+.|+|||++.+...      +.++||||||+++|+|++|          ..||.....    
T Consensus       197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~  276 (342)
T 1b6c_B          197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  276 (342)
T ss_dssp             EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence            54332211  1234469999999999987632      3679999999999999999          788865421    


Q ss_pred             -hhhhhhccc-CCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          184 -NTLSRIGFS-DELPRFPT-----QSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       184 -~~~~~~~~~-~~~p~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                       ..+...... ...+.++.     ..+..+.+||.+||+.||++|||+.|+++|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             222222211 22233332     234578899999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4e-38  Score=308.87  Aligned_cols=216  Identities=17%  Similarity=0.116  Sum_probs=167.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec---------------------c------------------
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA---------------------P------------------   42 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~---------------------~------------------   42 (408)
                      .+|++++.||+|+||+||+|++  +++.||+|........                     .                  
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            4689999999999999999998  6899999865422100                     0                  


Q ss_pred             ---------------------------------CCCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 042746           43 ---------------------------------TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALK   89 (408)
Q Consensus        43 ---------------------------------~~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~   89 (408)
                                                       .......+|||||+++|++.+.+.  ...+++..++.++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHH
Confidence                                             002577899999999997766663  367799999999999999999


Q ss_pred             HHH-HCCCeecCCCCCCEEEcCCC-------------------CcEEEeecCCccccccCCCCcccccCCCCCCCCChhh
Q 042746           90 YLH-SRNIVHCDVKGKNVLVGPNS-------------------SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV  149 (408)
Q Consensus        90 yLH-~~giiHrDLKp~NILl~~~~-------------------~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~  149 (408)
                      ||| ++||+||||||+|||++.++                   ..+||+|||+|+.....       ..+||+.|+|||+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~  248 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGG
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhh
Confidence            999 99999999999999998775                   15999999999765421       2369999999999


Q ss_pred             HhCCCCCCCCCcchHHHH-HHHHHhCCCCCCCCCh-----hhhh-hhcccCC-CCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042746          150 VRGECQGPESDVWSLGCT-IIEMVTGKPAWEDFGA-----NTLS-RIGFSDE-LPRFPTQSSELGRDFLDKCLRREPGER  221 (408)
Q Consensus       150 l~~~~~~~~sDiWSLGvi-l~eLltG~~Pf~~~~~-----~~~~-~~~~~~~-~p~~~~~~s~~~~~li~~~L~~dP~~R  221 (408)
                      +.+.. +.++|||||+++ .++++.|..||.....     ..+. ....... .+..+...++++++||.+||++|    
T Consensus       249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            99876 889999998777 7778889999864211     1111 1111111 11112346788999999999977    


Q ss_pred             CCHHHHH-cCCCCC
Q 042746          222 WSCDQLL-KHPFLQ  234 (408)
Q Consensus       222 ~s~~ell-~hpf~~  234 (408)
                       |+.|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.6e-36  Score=322.12  Aligned_cols=212  Identities=21%  Similarity=0.292  Sum_probs=167.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-CCcEEEEeeccc--------------------------ceeccCCCCCc-----c
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-NGDVFAYLGDDV--------------------------SYEAPTTSSSC-----R   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-t~~~va~k~~~~--------------------------~~~~~~~~~~~-----~   49 (408)
                      .+|++++.||+|+||+||+|.+.. +++.|++|....                          .+...+.....     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            579999999999999999999986 789999985421                          01111111222     6


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ||||||++|++|.+++.   ..+++..++.++.||+.||+|||++||+||||||+|||++.+  .+||+|||+++.....
T Consensus       160 ~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC
T ss_pred             EEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC
Confidence            99999999999999875   378999999999999999999999999999999999999875  5999999999765432


Q ss_pred             CCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCC--CCCCcHHHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGR  207 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~--~~~~s~~~~  207 (408)
                            ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||......         ..+..  ....++.+.
T Consensus       235 ------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~l~  298 (681)
T 2pzi_A          235 ------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDSYG  298 (681)
T ss_dssp             ------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHHHH
T ss_pred             ------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHHHH
Confidence                  2346999999999998764 88999999999999999999988642111         11111  012356789


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      +||.+||++||.+||+..+.+.|+|+.
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999888874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-34  Score=276.75  Aligned_cols=195  Identities=14%  Similarity=0.079  Sum_probs=155.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~~~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|++..+++.||+|.....                            +...+..+...+|||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            4799999999999999999999999999999875422                            111233456688999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||++|++|.++++.  + ..+..+..++.||+.||+|||++||+||||||+|||++.++. +||++++            
T Consensus       111 e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~-~kl~~~~------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD-VVLAYPA------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC-EEECSCC------------
T ss_pred             EecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC-EEEEecc------------
Confidence            99999999999952  3 356678899999999999999999999999999999998875 8887443            


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhh---hcccCCCC---CCCCCCcHHHH
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR---IGFSDELP---RFPTQSSELGR  207 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~---~~~~~~~p---~~~~~~s~~~~  207 (408)
                                |++|       ++.++|||||||++|+|++|+.||..........   .......+   ......++.++
T Consensus       175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                      3333       6889999999999999999999998755432111   11112111   22356889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHcC
Q 042746          208 DFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +||.+||++||.+| |+.|+++.
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHcccCCccC-CHHHHHHH
Confidence            99999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=3.2e-29  Score=263.91  Aligned_cols=202  Identities=14%  Similarity=0.047  Sum_probs=122.7

Q ss_pred             eeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------------ceeccCCCCCcceEE
Q 042746            9 CIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         9 ~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------------~~~~~~~~~~~~~LV   52 (408)
                      .++.|++|.+..++...+|+.|++|....                                    .+...++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45677778888878877888887765421                                    122335567889999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++|++|.++++. ++.+++.   .++.||+.||+|||++|||||||||+||||+.++. +||+|||+|+....... 
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~-vKL~DFGlAr~~~~~~~-  394 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH-ARLIDFGSIVTTPQDCS-  394 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC-EEECCCTTEESCC---C-
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC-EEEeecccCeeCCCCCc-
Confidence            999999999999984 5566665   47899999999999999999999999999998885 99999999976654322 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                       ...+.+||+.|||||++.+. +..++|+||+|++++++.++..++..    .+    +.. . .  ...  .+.++...
T Consensus       395 -~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~~----~l----~~~-~-~--~~~--~~~~l~~~  458 (569)
T 4azs_A          395 -WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWLY----AV----WQE-P-V--ERW--NFVLLLAL  458 (569)
T ss_dssp             -CSHHHHHHHHHHHHHHC------------------CCCCTTHHHHHH----HH----HTS-C-G--GGC--SHHHHHHH
T ss_pred             -cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhHH----Hh----hcC-C-C--CCC--cHHHHHHH
Confidence             23346799999999999876 56789999999998887766544310    00    110 0 0  001  13455666


Q ss_pred             hcccCCCCCCCHHHHHcCCC
Q 042746          213 CLRREPGERWSCDQLLKHPF  232 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf  232 (408)
                      ++..+|..|+.......|+|
T Consensus       459 l~~~~~~~~~~~~~~~~~~~  478 (569)
T 4azs_A          459 FEKKAKLPSAEQQRGATEQW  478 (569)
T ss_dssp             HHTGGGSCCGGGSSCCHHHH
T ss_pred             HhCCCCCCCCChhhhccchh
Confidence            66677776665544444444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=2.3e-24  Score=225.60  Aligned_cols=161  Identities=14%  Similarity=0.169  Sum_probs=116.4

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------------eccCCCCCcceE
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------------EAPTTSSSCRNL   51 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------------~~~~~~~~~~~L   51 (408)
                      ...+.||+|+||+||+|.  ..+..+++|......                                 ..........+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            346799999999999994  446666665421100                                 000112345689


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++..         +..++.||+.+|+|||++||+||||||+|||++.   .+||+|||+++.......
T Consensus       417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred             EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence            9999999999999863         5789999999999999999999999999999987   499999999977643221


Q ss_pred             Cc-----ccccCCCCCCCCChhhHhC--CCCCCCCCcchHHHHHHHHHhCCCCCC
Q 042746          132 RG-----VKIQPRGSPLWMAPEVVRG--ECQGPESDVWSLGCTIIEMVTGKPAWE  179 (408)
Q Consensus       132 ~~-----~~~~~~Gt~~y~APE~l~~--~~~~~~sDiWSLGvil~eLltG~~Pf~  179 (408)
                      ..     .....+||+.|||||++..  ..|+..+|+|+..+-..+...++.+|.
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            11     1134579999999999987  567788899999988888887776653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=3.3e-22  Score=192.42  Aligned_cols=134  Identities=17%  Similarity=0.058  Sum_probs=104.1

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------------------eeccC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------------------YEAPT   43 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------------------~~~~~   43 (408)
                      |.+++.||+|+||.||+|.+ .+++.+|+|.....                                        .....
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~  170 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY  170 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEE
Confidence            55669999999999999999 88999999875311                                        00101


Q ss_pred             CCCCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           44 TSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        44 ~~~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                       ..+..++||||++||+|.+ +.       ......++.||+.||+|||++||+||||||+|||++ ++ .+||+|||+|
T Consensus       171 -~~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~DFG~a  239 (282)
T 1zar_A          171 -AWEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWIIDFPQS  239 (282)
T ss_dssp             -EEETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEECCCTTC
T ss_pred             -eccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEEECCCC
Confidence             2245689999999999998 42       123457999999999999999999999999999999 66 5999999998


Q ss_pred             cccccCCCCcccccCCCCCCCCChhhHhC----------CCCCCCCCcchH
Q 042746          124 GEATVSDTRGVKIQPRGSPLWMAPEVVRG----------ECQGPESDVWSL  164 (408)
Q Consensus       124 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~----------~~~~~~sDiWSL  164 (408)
                      +               .+..|+|||++..          ..|+..+|+|.+
T Consensus       240 ~---------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~  275 (282)
T 1zar_A          240 V---------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINSA  275 (282)
T ss_dssp             E---------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred             e---------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence            4               2456899999864          345566677653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=2.1e-18  Score=163.38  Aligned_cols=116  Identities=21%  Similarity=0.241  Sum_probs=88.3

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcE--EEEeecccc---ee--------------------------------------
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDV--FAYLGDDVS---YE--------------------------------------   40 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~--va~k~~~~~---~~--------------------------------------   40 (408)
                      |.+++.||+|+||.||+|.+..+|+.  ||+|.....   +.                                      
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78899999999999999999888988  999852110   00                                      


Q ss_pred             cc-CC-----CCCcceEEEeccCC-C----CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEE
Q 042746           41 AP-TT-----SSSCRNLHLEYLPG-G----TVSDLATTLNAYADEITLRSHTYCIVSALKYLH-SRNIVHCDVKGKNVLV  108 (408)
Q Consensus        41 ~~-~~-----~~~~~~LVmEy~~g-G----sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH-~~giiHrDLKp~NILl  108 (408)
                      .. ..     .....+|||||+.+ |    +|.++...    .++..+..++.||+.+|.||| ++||+||||||+|||+
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl  204 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY  204 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence            00 00     01235699999942 4    66665431    235567889999999999999 9999999999999999


Q ss_pred             cCCCCcEEEeecCCcccc
Q 042746          109 GPNSSFVKLADFGAAGEA  126 (408)
Q Consensus       109 ~~~~~~vkL~DFGla~~~  126 (408)
                      +.   .++|+|||+|...
T Consensus       205 ~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          205 ID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             SS---SEEECCCTTCEET
T ss_pred             cC---cEEEEECcccccC
Confidence            87   4999999999543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.60  E-value=1.6e-15  Score=151.85  Aligned_cols=112  Identities=13%  Similarity=0.143  Sum_probs=84.9

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeecccceec----------------------------------------cC
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYEA----------------------------------------PT   43 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~~----------------------------------------~~   43 (408)
                      |++++.||+|+||.||+|.+. +|+.+|+|........                                        ..
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999986 6899999853211000                                        00


Q ss_pred             CC-----CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC-----
Q 042746           44 TS-----SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS-----  113 (408)
Q Consensus        44 ~~-----~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~-----  113 (408)
                      ..     ....+|||||++|++|.++..       ......++.||+.+|.|||++|||||||||.|||++.++.     
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~  248 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS  248 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence            00     011359999999998865431       2234678899999999999999999999999999987652     


Q ss_pred             ----cEEEeecCCc
Q 042746          114 ----FVKLADFGAA  123 (408)
Q Consensus       114 ----~vkL~DFGla  123 (408)
                          .+.|+||+-+
T Consensus       249 ~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          249 SITLTPIIIXFPQM  262 (397)
T ss_dssp             SEEEEEEECCCTTC
T ss_pred             ccccceEEEEeCCc
Confidence                2789999976

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.84  E-value=4.4e-09  Score=98.34  Aligned_cols=113  Identities=17%  Similarity=0.092  Sum_probs=82.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~~~~~~LVmEy   55 (408)
                      ..|++.+.+|.|+++.||++...  +..+.+|.....                          ...........++||||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            56889999999999999999754  566666553210                          00011233456899999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS------------------------------------------   93 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~------------------------------------------   93 (408)
                      ++|.+|.+.+.      +......++.++..+|..||+                                          
T Consensus        92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            99999886531      122234678889999999998                                          


Q ss_pred             -----------------CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 -----------------RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 -----------------~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                                       ..++|+|++|.|||++.+ ..+.|+||+.+
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a  211 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRS  211 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTC
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhc
Confidence                             448999999999999764 34679999987

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.57  E-value=1.2e-07  Score=87.60  Aligned_cols=111  Identities=18%  Similarity=0.134  Sum_probs=70.8

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~g   58 (408)
                      .|.+....+.|..+.||++.. .+|..+.+|.....                        .......+...++||||++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            455554445666799999865 45555555532110                        00111223446899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-------------------------------------------   95 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g-------------------------------------------   95 (408)
                      .+|.  ..    ..+.   ..++.++...|..||+..                                           
T Consensus       100 ~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A          100 QDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             EETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            8884  21    1121   245666777777777643                                           


Q ss_pred             ---------------CeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           96 ---------------IVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        96 ---------------iiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                                     ++|+|++|.|||++.++ .+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                           99999999999997653 46799999873

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.47  E-value=3e-07  Score=90.17  Aligned_cols=115  Identities=13%  Similarity=0.097  Sum_probs=79.9

Q ss_pred             eeceeeecCCeeEEEEEEcCCCcEEEEeecc--cc----------------------------eeccCCCC---CcceEE
Q 042746            6 RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--VS----------------------------YEAPTTSS---SCRNLH   52 (408)
Q Consensus         6 ~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--~~----------------------------~~~~~~~~---~~~~LV   52 (408)
                      ..+.|+.|.++.||++....  ..+.++...  ..                            ........   ...++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            46789999999999987653  334333221  00                            00001111   236899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS---------------------------------------   93 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~---------------------------------------   93 (408)
                      |||++|..+.+..   -..+++.....++.++...|..||+                                       
T Consensus       120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999998775421   1345778888899999999999997                                       


Q ss_pred             -------------------CCCeecCCCCCCEEEcCCC-CcEEEeecCCccc
Q 042746           94 -------------------RNIVHCDVKGKNVLVGPNS-SFVKLADFGAAGE  125 (408)
Q Consensus        94 -------------------~giiHrDLKp~NILl~~~~-~~vkL~DFGla~~  125 (408)
                                         ..++|+|++|.|||++.++ ..+.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               3589999999999998765 3468999998843

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.29  E-value=2.5e-07  Score=88.70  Aligned_cols=125  Identities=16%  Similarity=0.159  Sum_probs=84.2

Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS----------------------------------   93 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~----------------------------------   93 (408)
                      ..|+||||++|.+|.+...   ..++......++.|+...|..||+                                  
T Consensus        90 ~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK  166 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred             cceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence            3578999999998876433   245677777888888888888886                                  


Q ss_pred             ------------------------CCCeecCCCCCCEEEcCC-CCcEEEeecCCccccccCCCCcccccCCCCCCC---C
Q 042746           94 ------------------------RNIVHCDVKGKNVLVGPN-SSFVKLADFGAAGEATVSDTRGVKIQPRGSPLW---M  145 (408)
Q Consensus        94 ------------------------~giiHrDLKp~NILl~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y---~  145 (408)
                                              ..++|+|++|.||+++.+ +..+.|+||+.+........      ......+   .
T Consensus       167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~  240 (304)
T 3sg8_A          167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEY  240 (304)
T ss_dssp             HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSC
T ss_pred             cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhcccc
Confidence                                    137999999999999874 44578999998854321110      0011111   3


Q ss_pred             ChhhHhC--CCCC------------CCCCcchHHHHHHHHHhCCCCCCCC
Q 042746          146 APEVVRG--ECQG------------PESDVWSLGCTIIEMVTGKPAWEDF  181 (408)
Q Consensus       146 APE~l~~--~~~~------------~~sDiWSLGvil~eLltG~~Pf~~~  181 (408)
                      .|+....  ..|.            ...+.|+++.+++.+.+|.++|-..
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~  290 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE  290 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence            4443321  0111            1258999999999999999887543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.59  E-value=0.00035  Score=66.91  Aligned_cols=31  Identities=23%  Similarity=0.461  Sum_probs=25.1

Q ss_pred             CCeecCCCCCCEEEcC---CCCcEEEeecCCccc
Q 042746           95 NIVHCDVKGKNVLVGP---NSSFVKLADFGAAGE  125 (408)
Q Consensus        95 giiHrDLKp~NILl~~---~~~~vkL~DFGla~~  125 (408)
                      .++|+|++|.|||++.   ++..+.|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            3599999999999987   354458999998744

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.47  E-value=0.00055  Score=62.63  Aligned_cols=122  Identities=16%  Similarity=0.087  Sum_probs=80.0

Q ss_pred             CHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccccC
Q 042746           60 TVSDLATTLNAYADEITLRSHTYCIVSALKYLH-SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP  138 (408)
Q Consensus        60 sL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH-~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~~  138 (408)
                      +|.++|+..+.+++|.++|.+++|-+..|.-+- ...-..+=+.|..|++..+|. |-..+ +.+.              
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s~--------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AADD--------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C-----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-cccc--------------
Confidence            799999999999999999999999988877652 122223445578999998886 54442 1110              


Q ss_pred             CCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       139 ~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      .....+.|||... ...+.+.-|||||+++|.-+--..|                  +..+..+|+++..||..|.+-
T Consensus        98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------------cccchhhCHHHHHHHHHHHhc
Confidence            0123456777653 2345667899999999988853322                  123356788999999999765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.45  E-value=0.00046  Score=64.09  Aligned_cols=110  Identities=16%  Similarity=0.129  Sum_probs=67.8

Q ss_pred             eeeecCCe-eEEEEEEcCCCcEEEEeeccc-----------------------ceeccCCCCCcceEEEeccCCCCHHHH
Q 042746            9 CIGRGSFG-TVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPTTSSSCRNLHLEYLPGGTVSDL   64 (408)
Q Consensus         9 ~IG~G~fG-~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~~~~~~~~LVmEy~~gGsL~~~   64 (408)
                      .+..|..| .||+......+..+-+|....                       ......+.....++|||+++|.++.+.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~  110 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV  110 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence            34556555 699888776666555543220                       011112234567899999999888776


Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------------------
Q 042746           65 ATTLNAYADEITLRSHTYCIVSALKYLHSR--------------------------------------------------   94 (408)
Q Consensus        65 l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~--------------------------------------------------   94 (408)
                      ....     ......+..++...|.-||+.                                                  
T Consensus       111 ~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  185 (272)
T 4gkh_A          111 LEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK  185 (272)
T ss_dssp             HHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred             ccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence            5421     111223444455555555531                                                  


Q ss_pred             --------CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 --------NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 --------giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                              .++|+|+++.|||++.++ .+-|+||+.+.
T Consensus       186 ~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          186 LLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             TCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCcEEEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence                    278999999999998654 46799999873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.86  E-value=0.0029  Score=62.43  Aligned_cols=28  Identities=18%  Similarity=0.329  Sum_probs=24.4

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      ..++|+|++|.||+++.+ . ++++||..+
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~-~~lID~e~a  254 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-E-TKVIDPEFA  254 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-C-EEECCCTTC
T ss_pred             CceeeCCCCcCcEEEeCC-C-eEEEeCccc
Confidence            579999999999999765 3 899999877

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.11  E-value=0.0024  Score=61.85  Aligned_cols=30  Identities=20%  Similarity=0.167  Sum_probs=25.0

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ..++|+|++|.|||++. +..+.|+||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~-~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRD-FQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEET-TEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeC-CcEEEEEcccccc
Confidence            46899999999999985 4347899999874

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.44  E-value=0.058  Score=50.81  Aligned_cols=28  Identities=25%  Similarity=0.429  Sum_probs=23.1

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      .++|+|+.|.||+. .++. +.++||..+.
T Consensus       174 ~l~HgDl~~~Nil~-~~~~-~~lID~e~a~  201 (301)
T 3dxq_A          174 AACHCDPLCENFLD-TGER-MWIVDWEYSG  201 (301)
T ss_dssp             EEECSCCCGGGEEE-CSSC-EEECCCTTCE
T ss_pred             eeeccCCCcCCEEE-CCCC-EEEEeccccc
Confidence            38999999999994 4454 8999998874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.38  E-value=0.018  Score=54.70  Aligned_cols=29  Identities=28%  Similarity=0.401  Sum_probs=25.4

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      ..++|+|+++.|||++.++ .+.|+||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhc
Confidence            5799999999999997665 4999999977

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=93.28  E-value=0.05  Score=54.02  Aligned_cols=32  Identities=19%  Similarity=0.260  Sum_probs=27.1

Q ss_pred             HHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           92 HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        92 H~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      +...++|+|++|.|||++.++  ++++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC--EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC--CEEEeCccccc
Confidence            356799999999999998764  99999998844

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=92.88  E-value=0.32  Score=46.56  Aligned_cols=26  Identities=12%  Similarity=0.148  Sum_probs=22.3

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      ..++|+|+.+.|++++.++  +.|+||.
T Consensus       207 ~~l~HgD~~~~N~l~~~~~--~~~iD~~  232 (312)
T 3jr1_A          207 PSILHGNLWIENCIQVDDK--IFVCNPA  232 (312)
T ss_dssp             CEEECSSCSGGGEEEETTE--EEECSCC
T ss_pred             ceeEeCCCCcCcEeecCCC--eEEEcCc
Confidence            3599999999999998774  7899984

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=89.20  E-value=0.14  Score=48.74  Aligned_cols=33  Identities=30%  Similarity=0.318  Sum_probs=26.6

Q ss_pred             CCCeecCCCCCCEEEcCC---CCcEEEeecCCcccc
Q 042746           94 RNIVHCDVKGKNVLVGPN---SSFVKLADFGAAGEA  126 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~---~~~vkL~DFGla~~~  126 (408)
                      ..++|+|+++.|||++.+   ...+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999864   135899999988543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=88.96  E-value=0.14  Score=48.44  Aligned_cols=39  Identities=26%  Similarity=0.374  Sum_probs=29.1

Q ss_pred             HHHHHHHHH-------CCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           85 VSALKYLHS-------RNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        85 l~~L~yLH~-------~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ...++++++       .+++|+|+++.|||++.++ .+.++||+.+.
T Consensus       171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence            344555553       3699999999999998653 35799999873

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=88.86  E-value=0.28  Score=46.36  Aligned_cols=29  Identities=21%  Similarity=0.176  Sum_probs=24.4

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ..++|+|+++.|||++ +  .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D--GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence            3588999999999998 4  499999988743

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=88.56  E-value=2.2  Score=39.49  Aligned_cols=30  Identities=7%  Similarity=-0.178  Sum_probs=23.1

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEee
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLG   34 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~   34 (408)
                      ..-.+.+|.|..+.||+.... +|+.|-+|.
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~   46 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKA   46 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEE
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEE
Confidence            345678999999999998765 577776664

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=84.49  E-value=0.77  Score=44.30  Aligned_cols=27  Identities=22%  Similarity=0.432  Sum_probs=23.0

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++|+|+++.|||++.+ . +.|+||..+
T Consensus       213 ~l~HgDl~~~Nil~~~~-~-~~lID~e~a  239 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNK-C-LRLIDFEYS  239 (369)
T ss_dssp             EEECSCCCGGGEEECC--C-EEECCCTTC
T ss_pred             EEEeCCCCcccEEecCC-c-EEEEEecCC
Confidence            58999999999999754 3 899999877

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=83.72  E-value=0.54  Score=45.13  Aligned_cols=31  Identities=29%  Similarity=0.449  Sum_probs=25.9

Q ss_pred             CCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           94 RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        94 ~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ..++|+|+.+.||+++.++. +.|+||..+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~-~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEES-IYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGC-EEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCe-EEEEECCCCee
Confidence            35999999999999986654 89999987743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	408
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-48
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-45
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-35
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-31
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-31
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-11

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 6e-52
 Identities = 64/257 (24%), Positives = 113/257 (43%), Gaps = 35/257 (13%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD---------------------VS 38
           G+ +G+G FG V +A ++ +  + A        L                        + 
Sbjct: 11  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                  ++   L LEY P GTV      L+ + DE    ++   + +AL Y HS+ ++H
Sbjct: 71  LYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTATYITELANALSYCHSKRVIH 129

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+L+G     +K+ADFG +  A  S    +     G+  ++ PE++ G     +
Sbjct: 130 RDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMHDEK 184

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D+WSLG    E + GKP +E        +     E   FP   +E  RD + + L+  P
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKHNP 243

Query: 219 GERWSCDQLLKHPFLQS 235
            +R    ++L+HP++ +
Sbjct: 244 SQRPMLREVLEHPWITA 260

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  172 bits (438), Expect = 6e-51
 Identities = 60/286 (20%), Positives = 114/286 (39%), Gaps = 33/286 (11%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD------------------VSYEA 41
            + +G G+FG V+   +R  G+ FA       +  D                   V+   
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                +   +  E++ GG + +     +    E     +   +   L ++H  N VH D+
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 150

Query: 102 KGKNVLVGPNSS-FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
           K +N++     S  +KL DFG         +        G+  + APEV  G+  G  +D
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTD 207

Query: 161 VWSLGCTIIEMVTGKPAWE-DFGANTLSRI--GFSDELPRFPTQSSELGRDFLDKCLRRE 217
           +WS+G     +++G   +  +    TL  +     +      +  SE G+DF+ K L  +
Sbjct: 208 MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 267

Query: 218 PGERWSCDQLLKHPFLQSVS-PSDANTVAESSPRCVLDWVNSEFEE 262
           P  R +  Q L+HP+L   + P   + +  S    + D + ++++ 
Sbjct: 268 PNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDA 313

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 9e-50
 Identities = 76/274 (27%), Positives = 115/274 (41%), Gaps = 36/274 (13%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD---------------------VSYEA 41
              +G G+FG V  A ++    + A        +                     V    
Sbjct: 17  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 76

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                +   + +E+  GG V  +   L     E  ++      + AL YLH   I+H D+
Sbjct: 77  AFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 136

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-----G 156
           K  N+L   +   +KLADFG +  A  + T   +    G+P WMAPEVV  E        
Sbjct: 137 KAGNILFTLDGD-IKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELP-RFPTQSSELGRDFLDKCL 214
            ++DVWSLG T+IEM   +P   +      L +I  S+      P++ S   +DFL KCL
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCL 253

Query: 215 RREPGERWSCDQLLKHPFLQSVSPSD-ANTVAES 247
            +    RW+  QLL+HPF+   S       +AE+
Sbjct: 254 EKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEA 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 78/263 (29%), Positives = 113/263 (42%), Gaps = 40/263 (15%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD---------------------VSY 39
           + IG GSFG V  A D  N +V A           +                     + Y
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                      L +EY  G   SDL         E+ + + T+  +  L YLHS N++H 
Sbjct: 81  RGCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP-- 157
           DVK  N+L+      VKL DFG+A     +++        G+P WMAPEV+    +G   
Sbjct: 140 DVKAGNILLSEPGL-VKLGDFGSASIMAPANSF------VGTPYWMAPEVILAMDEGQYD 192

Query: 158 -ESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
            + DVWSLG T IE+   KP   +    + L  I  ++         SE  R+F+D CL+
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 216 REPGERWSCDQLLKHPFLQSVSP 238
           + P +R + + LLKH F+    P
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERP 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (425), Expect = 5e-49
 Identities = 61/258 (23%), Positives = 107/258 (41%), Gaps = 32/258 (12%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD------------------VSYEA 41
            + +G G+FG V+  V++  G VF        Y  D                   ++   
Sbjct: 34  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 93

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                    L LE+L GG + D     +    E  + ++       LK++H  +IVH D+
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 153

Query: 102 KGKNVLV-GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
           K +N++     +S VK+ DFG A   T  +   +      +  + APE+V  E  G  +D
Sbjct: 154 KPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTD 210

Query: 161 VWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQS--SELGRDFLDKCLRRE 217
           +W++G     +++G   +       TL  +   D        S  S   +DF+   L++E
Sbjct: 211 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 270

Query: 218 PGERWSCDQLLKHPFLQS 235
           P +R +    L+HP+L+ 
Sbjct: 271 PRKRLTVHDALEHPWLKG 288

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-48
 Identities = 62/266 (23%), Positives = 100/266 (37%), Gaps = 47/266 (17%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA----------------------------------Y 32
              IGRGSF TV   +D       A                                  +
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 33  LGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH 92
                S+E+      C  L  E +  GT+               LRS    I+  L++LH
Sbjct: 74  YD---SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM-KIKVLRSWCRQILKGLQFLH 129

Query: 93  SRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
           +R   I+H D+K  N+ +   +  VK+ D G A     S  + V     G+P +MAPE+ 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFMAPEMY 185

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFG--ANTLSRIGFSDELPRFPTQSSELGRD 208
             +      DV++ G  ++EM T +  + +    A    R+    +   F   +    ++
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244

Query: 209 FLDKCLRREPGERWSCDQLLKHPFLQ 234
            ++ C+R+   ER+S   LL H F Q
Sbjct: 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 5e-48
 Identities = 81/267 (30%), Positives = 129/267 (48%), Gaps = 32/267 (11%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA----YLGDD---------------------VS 38
           + R + IG+G+ GTV  A+D   G   A     L                        V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
           Y           + +EYL GG+++D+ T      DE  + +     + AL++LHS  ++H
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K  N+L+G + S VKL DFG   + T   ++  +    G+P WMAPEVV  +  GP+
Sbjct: 140 RDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF--PTQSSELGRDFLDKCLRR 216
            D+WSLG   IEM+ G+P + +        +  ++  P    P + S + RDFL++CL  
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256

Query: 217 EPGERWSCDQLLKHPFLQSVSPSDANT 243
           +  +R S  +LL+H FL+   P  + T
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLT 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 8e-48
 Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 39/269 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD-------------------- 36
           +  GK +G GSF TV +A +      +A       ++  +                    
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 37  -VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
            V               L Y   G +      + ++ DE   R +T  IVSAL+YLH + 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAEIVSALEYLHGKG 128

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ 155
           I+H D+K +N+L+  +   +++ DFG A   +    +       G+  +++PE++  +  
Sbjct: 129 IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 156 GPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQSSELGRDFLDKCL 214
              SD+W+LGC I ++V G P +          +I        FP +     RD ++K L
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDLVEKLL 245

Query: 215 RREPGERWSCDQ------LLKHPFLQSVS 237
             +  +R  C++      L  HPF +SV+
Sbjct: 246 VLDATKRLGCEEMEGYGPLKAHPFFESVT 274

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-48
 Identities = 53/260 (20%), Positives = 96/260 (36%), Gaps = 31/260 (11%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD-------------------V 37
           W   + +G G++G V +AV+R   +  A          D                    V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
            +       + + L LEY  GG + D     +    E   +   + +++ + YLH   I 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQG 156
           H D+K +N+L+    + +K++DFG A     ++   +  +  G+  ++APE+++  E   
Sbjct: 126 HRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 157 PESDVWSLGCTIIEMVTGKPAW--EDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL 214
              DVWS G  +  M+ G+  W          S             +        L K L
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244

Query: 215 RREPGERWSCDQLLKHPFLQ 234
              P  R +   + K  +  
Sbjct: 245 VENPSARITIPDIKKDRWYN 264

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 6e-47
 Identities = 70/313 (22%), Positives = 118/313 (37%), Gaps = 50/313 (15%)

Query: 5   VRGKCIGRGSFGTVNVAVDRFNGDVFA----------------------------YLGDD 36
           V  + +G G  G V    ++   + FA                             +   
Sbjct: 15  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD-- 72

Query: 37  VSYEAPTTSSSCRNLHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
             YE       C  + +E L GG +   +    +    E         I  A++YLHS N
Sbjct: 73  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 96  IVHCDVKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
           I H DVK +N+L      ++ +KL DFG A E T  ++      P  +P ++APEV+  E
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPE 188

Query: 154 CQGPESDVWSLGCTIIEMVTGKPAWED-------FGANTLSRIGFSDELPRFPTQSSELG 206
                 D+WSLG  +  ++ G P +          G  T  R+G  +      ++ SE  
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248

Query: 207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTS 266
           +  +   L+ EP +R +  + + HP++        +T    +P      +  + E     
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWIMQ------STKVPQTPLHTSRVLKEDKERWEDV 302

Query: 267 DDEKLEASARERM 279
            +E   A A  R+
Sbjct: 303 KEEMTSALATMRV 315

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 7e-47
 Identities = 56/257 (21%), Positives = 109/257 (42%), Gaps = 33/257 (12%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-----YLGDD-------------------VSYEAP 42
            + +GRG FG V+  V+  +   +        G D                   +     
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 43  TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
             S     +  E++ G  + +   T     +E  + S+ + +  AL++LHS NI H D++
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129

Query: 103 GKNVLVGPNSSF-VKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
            +N++     S  +K+ +FG A +    D   +      +P + APEV + +     +D+
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDM 186

Query: 162 WSLGCTIIEMVTGKPAWE-DFGANTLSRIG---FSDELPRFPTQSSELGRDFLDKCLRRE 217
           WSLG  +  +++G   +  +     +  I    ++ +   F   S E   DF+D+ L +E
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA-MDFVDRLLVKE 245

Query: 218 PGERWSCDQLLKHPFLQ 234
              R +  + L+HP+L+
Sbjct: 246 RKSRMTASEALQHPWLK 262

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-46
 Identities = 58/264 (21%), Positives = 103/264 (39%), Gaps = 40/264 (15%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD--------------------VSY 39
              IG GS+G       + +G +          + +                     V Y
Sbjct: 9   LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68

Query: 40  EAPTTSSSCRNLHL--EYLPGGTVSDL---ATTLNAYADEITLRSHTYCIVSALKYLHSR 94
                  +   L++  EY  GG ++ +    T    Y DE  +      +  ALK  H R
Sbjct: 69  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 128

Query: 95  N-----IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEV 149
           +     ++H D+K  NV +    + VKL DFG A    ++          G+P +M+PE 
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLA--RILNHDTSFAKAFVGTPYYMSPEQ 185

Query: 150 VRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF 209
           +       +SD+WSLGC + E+    P +  F    L+      +  R P + S+   + 
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEI 245

Query: 210 LDKCLRREPGERWSCDQLLKHPFL 233
           + + L  +   R S +++L++P +
Sbjct: 246 ITRMLNLKDYHRPSVEEILENPLI 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 1e-45
 Identities = 69/306 (22%), Positives = 121/306 (39%), Gaps = 38/306 (12%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDD---------------------V 37
            K +G+GSFG V +A  +     FA         L DD                      
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
                  +       +EYL GG +     + + + D      +   I+  L++LHS+ IV
Sbjct: 67  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-DLSRATFYAAEIILGLQFLHSKGIV 125

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP 157
           + D+K  N+L+  +    K+ADFG   E  + D +       G+P ++APE++ G+    
Sbjct: 126 YRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNH 182

Query: 158 ESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE 217
             D WS G  + EM+ G+  +       L      D  P +P    +  +D L K   RE
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVRE 241

Query: 218 PGERWSC-DQLLKHPFLQSVSPSD---ANTVAESSPRCVLDWVNSEFEEEGTSDDEKLEA 273
           P +R      + +HP  + ++  +           P+    +  S F++E  ++  +L  
Sbjct: 242 PEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSF 301

Query: 274 SARERM 279
           + R  +
Sbjct: 302 ADRALI 307

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 9e-45
 Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 34/256 (13%)

Query: 7   GKCIGRGSFGTV-------NVAVDRFNGDVFAYLGDD-----------------VSYEAP 42
           G+ IG GSFGTV       +VAV   N                           + +   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 71

Query: 43  TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
            +++    +  ++  G ++      +    + I L          + YLH+++I+H D+K
Sbjct: 72  YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGP---ES 159
             N+ +  + + VK+ DFG A   +         Q  GS LWMAPEV+R + + P   +S
Sbjct: 132 SNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190

Query: 160 DVWSLGCTIIEMVTGKPAWEDFG-----ANTLSRIGFSDELPRFPTQSSELGRDFLDKCL 214
           DV++ G  + E++TG+  + +          + R   S +L +  +   +  +  + +CL
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250

Query: 215 RREPGERWSCDQLLKH 230
           +++  ER    Q+L  
Sbjct: 251 KKKRDERPLFPQILAS 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 9e-45
 Identities = 62/305 (20%), Positives = 107/305 (35%), Gaps = 76/305 (24%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----YLGDD----------------------VSYEA 41
             +G G+ G V     + +G V A    +L                         V +  
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN-IVHCD 100
              S    ++ +E++ GG++  +         E  L   +  ++  L YL  ++ I+H D
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGRI-PEQILGKVSIAVIKGLTYLREKHKIMHRD 130

Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESD 160
           VK  N+LV      +KL DFG +G+   S          G+  +M+PE ++G     +SD
Sbjct: 131 VKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSD 185

Query: 161 VWSLGCTIIEMVTGKPAWEDFGANT----------------------------------- 185
           +WS+G +++EM  G+       A                                     
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245

Query: 186 --------LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                   L  I             S   +DF++KCL + P ER    QL+ H F++   
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305

Query: 238 PSDAN 242
             + +
Sbjct: 306 AEEVD 310

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (384), Expect = 6e-44
 Identities = 52/272 (19%), Positives = 101/272 (37%), Gaps = 49/272 (18%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA----------------------------------- 31
            + +GRG    V   + +     +A                                   
Sbjct: 8   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67

Query: 32  YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
              + +  +    +++   L  + +  G + D  T       E   R     ++  +  L
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICAL 126

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           H  NIVH D+K +N+L+  + + +KL DFG + +    +      +  G+P ++APE++ 
Sbjct: 127 HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIE 182

Query: 152 GECQ------GPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELPRFPTQS-- 202
                     G E D+WS G  +  ++ G P +        L  I   +     P     
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 203 SELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
           S+  +D + + L  +P +R++ ++ L HPF Q
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (386), Expect = 7e-44
 Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 35/275 (12%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD-------------------VSYE 40
              +G G+F  V +A D+    + A        L                      V+ +
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               S     L ++ + GG + D       Y  E       + ++ A+KYLH   IVH D
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRIVEKGFY-TERDASRLIFQVLDAVKYLHDLGIVHRD 132

Query: 101 VKGKNVLVG--PNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           +K +N+L       S + ++DFG +    + D   V     G+P ++APEV+  +     
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDELPRFPTQS--SELGRDFLDKCLR 215
            D WS+G     ++ G P + D   A    +I  ++     P     S+  +DF+   + 
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLME 249

Query: 216 REPGERWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
           ++P +R++C+Q L+HP++   +  D N     S +
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 284

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-43
 Identities = 53/264 (20%), Positives = 94/264 (35%), Gaps = 45/264 (17%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD----------------------- 36
           G  +G G FG+V   +   +    A        + D                        
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 37  ---VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
              +             L LE            T      E   RS  + ++ A+++ H+
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             ++H D+K +N+L+  N   +KL DFG+      +          G+ ++  PE +R  
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIRYH 184

Query: 154 -CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
              G  + VWSLG  + +MV G   +E      + R         F  + S   +  +  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIR-----GQVFFRQRVSSECQHLIRW 237

Query: 213 CLRREPGERWSCDQLLKHPFLQSV 236
           CL   P +R + +++  HP++Q V
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDV 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 61/281 (21%), Positives = 114/281 (40%), Gaps = 41/281 (14%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD----------------------- 36
           G+ +G G F  V    ++  G  +A                                   
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74

Query: 37  -VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
            ++      + +   L LE + GG + D      +   E         I++ + YLHS  
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHSLQ 133

Query: 96  IVHCDVKGKNVLV---GPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG 152
           I H D+K +N+++         +K+ DFG A +    +         G+P ++APE+V  
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPEIVNY 190

Query: 153 ECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDF 209
           E  G E+D+WS+G     +++G  P   D    TL+ +     +    + + +S L +DF
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250

Query: 210 LDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAESSPR 250
           + + L ++P +R +    L+HP+++      A + A S P+
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQ 291

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 4e-40
 Identities = 63/333 (18%), Positives = 108/333 (32%), Gaps = 61/333 (18%)

Query: 2   VSWVRGKCIGRGSFGTVNVAVDRFNGDVFA---------------------------YLG 34
           VS+   K IG GSFG V  A    +G++ A                            L 
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLR 79

Query: 35  DDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLH 92
                          NL L+Y+P            A      I ++ + Y +  +L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 93  SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG 152
           S  I H D+K +N+L+ P+++ +KL DFG+A +    +     I       + APE++ G
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRAPELIFG 196

Query: 153 ECQ-GPESDVWSLGCTIIEMVTGKPAWE----------------------------DFGA 183
                   DVWS GC + E++ G+P +                             ++  
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 184 NTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANT 243
               +I        F  ++         + L   P  R +  +   H F   +   +   
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

Query: 244 VAESSPRCVLDWVNSEFEEEGTSDDEKLEASAR 276
                   + ++   E           +   AR
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (364), Expect = 4e-40
 Identities = 56/271 (20%), Positives = 102/271 (37%), Gaps = 49/271 (18%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD----------------------- 36
            + IGRG FG V        G ++A        +                          
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 37  -VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTL--NAYADEITLRSHTYCIVSALKYLHS 93
            V       +    +  L+ + GG   DL   L  +    E  +R +   I+  L+++H+
Sbjct: 69  IVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV-RG 152
           R +V+ D+K  N+L+  +   V+++D G A + +            G+  +MAPEV+ +G
Sbjct: 126 RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 180

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI--GFSDELPRFPTQSSELGRDFL 210
                 +D +SLGC + +++ G   +          I           P   S   R  L
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 240

Query: 211 DKCLRREPGERWSC-----DQLLKHPFLQSV 236
           +  L+R+   R  C      ++ + PF +S+
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (355), Expect = 3e-39
 Identities = 59/263 (22%), Positives = 104/263 (39%), Gaps = 41/263 (15%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD---------------------VS 38
            + +G GSFG V++   R NG  +A        +                        + 
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                  +    + ++Y+ GG +  L    +        + +   +  AL+YLHS++I++
Sbjct: 69  MWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIY 127

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+L+  N   +K+ DFG A                G+P ++APEVV  +     
Sbjct: 128 RDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTKPYNKS 181

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D WS G  I EM+ G   + D           + E  RFP   +E  +D L + + R+ 
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITRDL 240

Query: 219 GERW-----SCDQLLKHPFLQSV 236
            +R        + +  HP+ + V
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEV 263

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 4e-39
 Identities = 61/263 (23%), Positives = 110/263 (41%), Gaps = 38/263 (14%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--------YLGDD--------------------VS 38
            K +G+G+FG V +  ++  G  +A         +  D                     +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 39  YEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
            +    +       +EY  GG +    +    +  E   R +   IVSAL+YLHSR++V+
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVF-TEERARFYGAEIVSALEYLHSRDVVY 128

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+K +N+++  +   +K+ DFG   E              G+P ++APEV+     G  
Sbjct: 129 RDIKLENLMLDKDGH-IKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRA 185

Query: 159 SDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREP 218
            D W LG  + EM+ G+  + +     L  +   +E  RFP   S   +  L   L+++P
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDP 244

Query: 219 GERWSC-----DQLLKHPFLQSV 236
            +R         ++++H F  S+
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSI 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-39
 Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 34/250 (13%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--YLGDDVS----------------------YEAP 42
            + IG+G FG V +   R  G+  A   + +D +                          
Sbjct: 12  LQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 43  TTSSSCRNLHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
                   +  EY+  G++ D L +   +      L   +  +  A++YL   N VH D+
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 129

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +NVLV  ++   K++DFG   EA+ +   G     +    W APE +R +    +SDV
Sbjct: 130 AARNVLVSEDNV-AKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKSDV 183

Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
           WS G  + E+ + G+  +       +            P        + +  C   +   
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAM 243

Query: 221 RWSCDQLLKH 230
           R S  QL + 
Sbjct: 244 RPSFLQLREQ 253

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 6e-38
 Identities = 60/294 (20%), Positives = 100/294 (34%), Gaps = 31/294 (10%)

Query: 6   RGKCIGRGSFGTVNVAVDRFNGDVFAY------LGDDVSYEA------------------ 41
           + K +G G+FGTV   +    G+          L +  S +A                  
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72

Query: 42  -----PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                    +S   L  + +P G + D             L +    I   + YL  R +
Sbjct: 73  VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQG 156
           VH D+  +NVLV      VK+ DFG A      +        +    WMA E +      
Sbjct: 133 VHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191

Query: 157 PESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR 215
            +SDVWS G T+ E++T G   ++   A+ +S I    E    P   +      + KC  
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWM 251

Query: 216 REPGERWSCDQLLKHPFLQSVSPSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
            +   R    +L+      +  P     +       +    +S F      +++
Sbjct: 252 IDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEED 305

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 7e-37
 Identities = 55/293 (18%), Positives = 92/293 (31%), Gaps = 52/293 (17%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA---------------------YLGDD---VSY 39
           +  G+ IG GSFG + +  D   G+  A                      +       + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                      + +E L      DL    +      T+      ++S ++Y+HS+N +H 
Sbjct: 69  RWCGAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 127

Query: 100 DVKGKNVLVGPNSSF--VKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVRG 152
           DVK  N L+G       V + DFG A +   + T             G+  + +     G
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 153 ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL-------SRIGFSDELPRFPTQSSEL 205
             Q    D+ SLG  ++    G   W+   A T        S    S  +          
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247

Query: 206 GRDFLDKCLRREPGERWSCD---QLLKHPFLQSVSPSDANTVAESSPRCVLDW 255
              +L+ C      ++       QL ++ F +     D           V DW
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY----------VFDW 290

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 8e-37
 Identities = 47/263 (17%), Positives = 87/263 (33%), Gaps = 33/263 (12%)

Query: 10  IGRGSFGTVNVAVDRFNGDVFAY------------LGDDVSYEAPTTSS----------- 46
           +G G+FG+V   V R                      +++  EA                
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 47  SCRNLHL----EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
            C+   L    E   GG +               +    + +   +KYL  +N VH D+ 
Sbjct: 77  VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSD-TRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
            +NVL+  N  + K++DFG +      D     +   +    W APE +        SDV
Sbjct: 137 ARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195

Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
           WS G T+ E ++ G+  ++      +       +    P +        +  C   +  +
Sbjct: 196 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 255

Query: 221 RWSCDQL---LKHPFLQSVSPSD 240
           R     +   ++  +    S  +
Sbjct: 256 RPDFLTVEQRMRACYYSLASKVE 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-36
 Identities = 55/258 (21%), Positives = 95/258 (36%), Gaps = 30/258 (11%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD-----------------VSYEAP 42
            + IG G FG V++     N D  A        + ++                 V     
Sbjct: 10  VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 43  TTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVK 102
               +   L  E++  G +SD   T        TL      +   + YL    ++H D+ 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128

Query: 103 GKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVW 162
            +N LVG N   +K++DFG        D        +    W +PEV        +SDVW
Sbjct: 129 ARNCLVGENQV-IKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186

Query: 163 SLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGER 221
           S G  + E+ + GK  +E+   + +     +      P  +S      ++ C +  P +R
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246

Query: 222 WSCDQLLKHPFLQSVSPS 239
            +  +LL+   L  ++ S
Sbjct: 247 PAFSRLLRQ--LAEIAES 262

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-36
 Identities = 68/292 (23%), Positives = 104/292 (35%), Gaps = 66/292 (22%)

Query: 7   GKCIGRGSFGTVNVAVDRFNG--------------------------DVFAYLGD----- 35
              IG G++G V  A D  NG                           V  +L       
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 36  -----DVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKY 90
                DV   + T   +   L  E++     + L           T++   + ++  L +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 91  LHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVV 150
           LHS  +VH D+K +N+LV  +    KLADFG A    +   +        +  + APEV+
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQI-KLADFGLA---RIYSFQMALTSVVVTLWYRAPEVL 187

Query: 151 RGECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI-------------------- 189
                    D+WS+GC   EM   KP +      + L +I                    
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 190 -----GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
                  +  + +F T   ELG+D L KCL   P +R S    L HP+ Q +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-36
 Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 26/248 (10%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV------FAYLGDD-----------------VSYEAPT 43
            K +G G FG V     R   DV         + +D                 V      
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 44  TSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           T      +  EY+  G + +    +        L      +  A++YL S+  +H D+  
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 128

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
           +N LV      VK++DFG +    + D     +  +    W  PEV+       +SD+W+
Sbjct: 129 RNCLVNDQGV-VKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186

Query: 164 LGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            G  + E+ + GK  +E F  +  +           P  +SE     +  C   +  ER 
Sbjct: 187 FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERP 246

Query: 223 SCDQLLKH 230
           +   LL +
Sbjct: 247 TFKILLSN 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-36
 Identities = 58/259 (22%), Positives = 90/259 (34%), Gaps = 28/259 (10%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV-------FAYLGDDVSYEAPTTSS------------- 46
              +G+G FG V +        V            +    EA                  
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 47  SCRNLHL--EYLPGGTVSDLATTLNA-YADEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
           S   +++  EY+  G++ D        Y     L      I S + Y+   N VH D++ 
Sbjct: 82  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 141

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            N+LVG N    K+ADFG A      +    +   +    W APE         +SDVWS
Sbjct: 142 ANILVGENLV-CKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 199

Query: 164 LGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            G  + E+ T G+  +       +            P +  E   D + +C R+EP ER 
Sbjct: 200 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 259

Query: 223 SCDQLLK--HPFLQSVSPS 239
           + + L      +  S  P 
Sbjct: 260 TFEYLQAFLEDYFTSTEPQ 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-35
 Identities = 51/286 (17%), Positives = 91/286 (31%), Gaps = 62/286 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------YLGDD---------------------V 37
             +G G F TV  A D+    + A             D                     +
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
                    S  +L  +++       +    +       ++++    +  L+YLH   I+
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-G 156
           H D+K  N+L+  N   +KLADFG A                 +  + APE++ G    G
Sbjct: 123 HRDLKPNNLLLDENGV-LKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 157 PESDVWSLGCTIIEMVTGKPAWE-DFGANTLSRI-------------------------- 189
              D+W++GC + E++   P    D   + L+RI                          
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 190 GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS 235
                L    + + +   D +       P  R +  Q LK  +  +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-35
 Identities = 49/263 (18%), Positives = 90/263 (34%), Gaps = 35/263 (13%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFAY-------------LGDDVSYEAPTTSS-------- 46
           K +G G+FGTV     +    V                L D++  EA             
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 47  -------SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
                      L +E    G ++      N +  +  +    + +   +KYL   N VH 
Sbjct: 73  MIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVS-DTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
           D+  +NVL+       K++DFG +       +    +   +    W APE +       +
Sbjct: 132 DLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 159 SDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRRE 217
           SDVWS G  + E  + G+  +     + ++ +    E    P        D ++ C   +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250

Query: 218 PGERWSCDQL---LKHPFLQSVS 237
              R     +   L++ +   V+
Sbjct: 251 VENRPGFAAVELRLRNYYYDVVN 273

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-35
 Identities = 65/309 (21%), Positives = 104/309 (33%), Gaps = 71/309 (22%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA---------------------------------YL 33
              IG G++G V  A D  N    A                                   
Sbjct: 13  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 34  GDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
                  APT         + +L G  +  L      +     +    Y I+  LKY+HS
Sbjct: 73  D---IIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHS 127

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV-SDTRGVKIQPRGSPLWMAPEVVRG 152
            N++H D+K  N+L+      +K+ DFG A  A    D  G   +   +  + APE++  
Sbjct: 128 ANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186

Query: 153 ECQ-GPESDVWSLGCTIIEMVTGKPAW-----EDFGANTLSRIGFSDE------------ 194
                   D+WS+GC + EM++ +P +      D   + L  +G   +            
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 195 -------------LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDA 241
                          R    +     D LDK L   P +R   +Q L HP+L+       
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306

Query: 242 NTVAESSPR 250
             +AE+  +
Sbjct: 307 EPIAEAPFK 315

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 60/262 (22%), Positives = 94/262 (35%), Gaps = 30/262 (11%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA--YLGDD----------------------VSYEAP 42
              +G G +G V   V +      A   L +D                      V     
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 43  TTSSSCRNLHLEYLPGGTVSD-LATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
            T      +  E++  G + D L          + L      I SA++YL  +N +H D+
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDV 161
             +N LVG N   VK+ADFG +   T  DT       +    W APE +       +SDV
Sbjct: 142 AARNCLVGENHL-VKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199

Query: 162 WSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGE 220
           W+ G  + E+ T G   +     + +  +   D     P    E   + +  C +  P +
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 259

Query: 221 RWSCDQLLK--HPFLQSVSPSD 240
           R S  ++ +      Q  S SD
Sbjct: 260 RPSFAEIHQAFETMFQESSISD 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 46/277 (16%)

Query: 7   GKCIGRGSFGTVNVAVD---RFNGDVFA-------YLGDD-------------------- 36
            K +G G++G V +         G ++A        +                       
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 37  ---VSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS 93
              V+      + +  +L L+Y+ GG +    +    +  E  ++ +   IV AL++LH 
Sbjct: 89  PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF-TEHEVQIYVGEIVLALEHLHK 147

Query: 94  RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE 153
             I++ D+K +N+L+  N   V L DFG + E    +T        G+  +MAP++VRG 
Sbjct: 148 LGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGG 205

Query: 154 CQG--PESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI--GFSDELPRFPTQSSELGRD 208
             G     D WSLG  + E++TG   +   G  N+ + I        P +P + S L +D
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265

Query: 209 FLDKCLRREPGERWSC-----DQLLKHPFLQSVSPSD 240
            + + L ++P +R  C     D++ +H F Q ++  D
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (326), Expect = 3e-35
 Identities = 51/257 (19%), Positives = 88/257 (34%), Gaps = 34/257 (13%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY-----LGDD------------------------V 37
            + IG G FG V     +  G    +     L                           +
Sbjct: 31  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 90

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIV 97
             E   T S+   +  E++  G++       +     I L      I + +KYL   N V
Sbjct: 91  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 150

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAA---GEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
           H D+  +N+LV  N    K++DFG +    + T   T    +  +    W APE ++   
Sbjct: 151 HRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209

Query: 155 QGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC 213
               SDVWS G  + E+++ G+  + D     +      D     P          +  C
Sbjct: 210 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDC 269

Query: 214 LRREPGERWSCDQLLKH 230
            +++   R    Q++  
Sbjct: 270 WQKDRNHRPKFGQIVNT 286

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  127 bits (321), Expect = 8e-35
 Identities = 53/267 (19%), Positives = 98/267 (36%), Gaps = 38/267 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDV------------------- 37
           +  G+ +G G    V++A D       A          D                     
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 38  ------SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYL 91
                 + EA T +     + +EY+ G T+ D+  T                   AL + 
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQALNFS 127

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVR 151
           H   I+H DVK  N+++   ++   +    A   A   ++        G+  +++PE  R
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDF-GANTLSRIGFSDELP---RFPTQSSELGR 207
           G+     SDV+SLGC + E++TG+P +      +   +    D +P   R    S++L  
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL-D 246

Query: 208 DFLDKCLRREPGERWSCDQLLKHPFLQ 234
             + K L + P  R+     ++   ++
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (324), Expect = 9e-35
 Identities = 63/293 (21%), Positives = 101/293 (34%), Gaps = 70/293 (23%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA------YLGDDVSYEA------------------- 41
            + +GRG +  V  A++  N +              +  E                    
Sbjct: 40  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIV 99

Query: 42  PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDV 101
               S    L  E++       L  TL     +  +R + Y I+ AL Y HS  I+H DV
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRFYMYEILKALDYCHSMGIMHRDV 155

Query: 102 KGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESD 160
           K  NV++      ++L D+G A          V++    S  +  PE++          D
Sbjct: 156 KPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLD 212

Query: 161 VWSLGCTIIEMVTGKPAW--EDFGANTLSRI----------------------GFSDELP 196
           +WSLGC +  M+  K  +       + L RI                       F+D L 
Sbjct: 213 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272

Query: 197 RFPTQS-------------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV 236
           R   +              S    DFLDK LR +   R +  + ++HP+  +V
Sbjct: 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 1e-34
 Identities = 65/286 (22%), Positives = 106/286 (37%), Gaps = 59/286 (20%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD--------------------VSYE 40
           + IG G++G V  A ++  G+V A          +                     V   
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               + +   L  E+L       +  +         ++S+ + ++  L + HS  ++H D
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127

Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRG-ECQGPES 159
           +K +N+L+    + +KLADFG A                 +  + APE++ G +      
Sbjct: 128 LKPQNLLINTEGA-IKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 160 DVWSLGCTIIEMVTGKPAWE-DFGANTLSRI----------------GFSDELPRFPTQS 202
           D+WSLGC   EMVT +  +  D   + L RI                   D  P FP  +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 203 -----------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS 237
                       E GR  L + L  +P +R S    L HPF Q V+
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 54/280 (19%), Positives = 86/280 (30%), Gaps = 57/280 (20%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGD-----------------------------VFAYLGDD- 36
           GK +G G+FG V  A                                    +   LG   
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 37  --VSYEAPTTSSSCRNLHLEYLPGGTVSDL----------------------ATTLNAYA 72
             V+     T S    L  EY   G + +                               
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
               L    Y +   +++L  ++ VH D+  +NVLV      VK+ DFG A +       
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARDIMSDSNY 220

Query: 133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIG 190
            V+   R    WMAPE +       +SDVWS G  + E+ + G   +     +    ++ 
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH 230
            +      P  ++E     +  C   +  +R S   L   
Sbjct: 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 2e-34
 Identities = 52/255 (20%), Positives = 87/255 (34%), Gaps = 28/255 (10%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV-------FAYLGDDVSYEAPTTSS-SCRN-------- 50
            + +G G FG V +     +  V        +   D    EA        +         
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 51  ------LHLEYLPGGTVSDLATTLNAYA-DEITLRSHTYCIVSALKYLHSRNIVHCDVKG 103
                 +  EY+  G++ D   T +        L      I   + ++  RN +H D++ 
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137

Query: 104 KNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWS 163
            N+LV    S  K+ADFG A      +    +   +    W APE +       +SDVWS
Sbjct: 138 ANILVSDTLSC-KIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195

Query: 164 LGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERW 222
            G  + E+VT G+  +       + +          P    E     +  C +  P +R 
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255

Query: 223 SCDQLLK--HPFLQS 235
           + D L      F  +
Sbjct: 256 TFDYLRSVLEDFFTA 270

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (318), Expect = 3e-34
 Identities = 45/265 (16%), Positives = 84/265 (31%), Gaps = 39/265 (14%)

Query: 4   WVRGKCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVSYEAPTTS--SSCRNLHL- 53
           +  G+ IG GSFG +    +  N    A            +  E  T    + C  +   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 54  -------------EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
                          L G ++ DL           T+      +++ ++ +H +++V+ D
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126

Query: 101 VKGKNVLVG----PNSSFVKLADFGAAGEATVSDTRGVKIQPR-----GSPLWMAPEVVR 151
           +K  N L+G     N++ + + DFG         T+            G+  +M+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 152 GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELG----- 206
           G  Q    D+ +LG   +  + G   W+   A T  +        +  T   EL      
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246

Query: 207 --RDFLDKCLRREPGERWSCDQLLK 229
               ++              D L  
Sbjct: 247 EFYKYMHYARNLAFDATPDYDYLQG 271

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-33
 Identities = 60/257 (23%), Positives = 94/257 (36%), Gaps = 34/257 (13%)

Query: 7   GKCIGRGSFGTV-------------NVAVDRFNGDVFAYLG--DDVSYEAPTTSS-SCRN 50
            + +G GSFG V             +VAV     DV +     DD   E     S   RN
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 51  --------------LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                         +  E  P G++ D       +    TL  +   +   + YL S+  
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV-KIQPRGSPLWMAPEVVRGECQ 155
           +H D+  +N+L+      VK+ DFG       +D   V +   +    W APE ++    
Sbjct: 133 IHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 156 GPESDVWSLGCTIIEMVT-GKPAWEDF-GANTLSRIGFSDELPRFPTQSSELGRDFLDKC 213
              SD W  G T+ EM T G+  W    G+  L +I    E    P    +   + + +C
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251

Query: 214 LRREPGERWSCDQLLKH 230
              +P +R +   L   
Sbjct: 252 WAHKPEDRPTFVALRDF 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 58/269 (21%), Positives = 88/269 (32%), Gaps = 49/269 (18%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAY--------------------------LGDD---V 37
              IG G+FG V  A  + +G                               LG     +
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDL---------------ATTLNAYADEITLRSHTY 82
           +            L +EY P G + D                A +  +      L     
Sbjct: 75  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134

Query: 83  CIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSP 142
            +   + YL  +  +H D+  +N+LVG N    K+ADFG +    V   + +    R   
Sbjct: 135 DVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG---RLPV 190

Query: 143 LWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQ 201
            WMA E +        SDVWS G  + E+V+ G   +       L            P  
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 250

Query: 202 SSELGRDFLDKCLRREPGERWSCDQLLKH 230
             +   D + +C R +P ER S  Q+L  
Sbjct: 251 CDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 61/254 (24%), Positives = 89/254 (35%), Gaps = 33/254 (12%)

Query: 7   GKCIGRGSFGTV-------------NVAVDRFNGDVFAYLGDDVSYEAPTTSS------- 46
           G+CIG G FG V              VA+          + +    EA T          
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 47  --------SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVH 98
                   +   + +E    G +           D  +L  + Y + +AL YL S+  VH
Sbjct: 72  KLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 131

Query: 99  CDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPE 158
            D+  +NVLV  N   VKL DFG +     S       + +    WMAPE +        
Sbjct: 132 RDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSA 189

Query: 159 SDVWSLGCTIIEMVTGK--PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR 216
           SDVW  G  + E++     P       + + RI   + LP  P     L    + KC   
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL-YSLMTKCWAY 248

Query: 217 EPGERWSCDQLLKH 230
           +P  R    +L   
Sbjct: 249 DPSRRPRFTELKAQ 262

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 61/283 (21%), Positives = 100/283 (35%), Gaps = 61/283 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------------------------YLGDD--VSYE 40
           + IG G++G V  A +   G+ FA                          L     V   
Sbjct: 8   EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               +     L  E+L       L        + +T +S    +++ + Y H R ++H D
Sbjct: 67  DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL-ESVTAKSFLLQLLNGIAYCHDRRVLHRD 125

Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPES 159
           +K +N+L+      +K+ADFG A    +   +           + AP+V+ G  +     
Sbjct: 126 LKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVT--LWYRAPDVLMGSKKYSTTI 182

Query: 160 DVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI---------------------------GF 191
           D+WS+GC   EMV G P +     A+ L RI                             
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQ 234
                 F     E G D L K L+ +P +R +  Q L+H + +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 66/312 (21%), Positives = 123/312 (39%), Gaps = 51/312 (16%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------YLGDD---------------------VSY 39
           K +G GSFG V +   + +G+ +A        +                        V  
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHC 99
           E     +S   + +EY+ GG +      +  +  E   R +   IV   +YLHS ++++ 
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHSLDLIYR 165

Query: 100 DVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPES 159
           D+K +N+L+     ++++ DFG A        +G      G+P  +APE++  +      
Sbjct: 166 DLKPENLLIDQQG-YIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 160 DVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRREPG 219
           D W+LG  I EM  G P +       +     S +  RFP+  S   +D L   L+ +  
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 220 ERW-----SCDQLLKHPFLQSVSPSDANTVAESSP-----RCVLDWVNSEFEEEGTSDDE 269
           +R+       + +  H +  +            +P     +   D   S F++    ++E
Sbjct: 279 KRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD--TSNFDDY---EEE 333

Query: 270 KLEASARERMGK 281
           ++  S  E+ GK
Sbjct: 334 EIRVSINEKCGK 345

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 5e-33
 Identities = 52/257 (20%), Positives = 88/257 (34%), Gaps = 34/257 (13%)

Query: 7   GKCIGRGSFGTV-------------NVAVDRFNGDVFAYLGDDVSYEA------------ 41
            + IGRG FG V             + AV   N             E             
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 42  -----PTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNI 96
                   S     + L Y+  G + +             L      +   +K+L S+  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD--TRGVKIQPRGSPLWMAPEVVRGEC 154
           VH D+  +N ++    + VK+ADFG A +    +  +   K   +    WMA E ++ + 
Sbjct: 152 VHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 155 QGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC 213
              +SDVWS G  + E++T G P + D     ++           P    +   + + KC
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270

Query: 214 LRREPGERWSCDQLLKH 230
              +   R S  +L+  
Sbjct: 271 WHPKAEMRPSFSELVSR 287

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 9e-33
 Identities = 54/274 (19%), Positives = 88/274 (32%), Gaps = 51/274 (18%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------- 37
           GK +G G+FG V +A               V                             
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77

Query: 38  -----SYEAPTTSSSCRNLHLEYLPGGTVSDL---------------ATTLNAYADEITL 77
                +     T      + +EY   G + +                +           L
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
            S  Y +   ++YL S+  +H D+  +NVLV  ++   K+ADFG A +    D       
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHIDYYKKTTN 196

Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELP 196
            R    WMAPE +       +SDVWS G  + E+ T G   +       L ++       
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM 256

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH 230
             P+  +      +  C    P +R +  QL++ 
Sbjct: 257 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-31
 Identities = 62/303 (20%), Positives = 97/303 (32%), Gaps = 72/303 (23%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----------------------------------YL 33
             IG+G+FG V  A  R  G   A                                   +
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 34  GDDVSYEAPTTSSSCR-NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLH 92
               +  +P         L  ++        L+  L  +     ++     +++ L Y+H
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQMLLNGLYYIH 134

Query: 93  SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPR--GSPLWMAPEVV 150
              I+H D+K  NVL+  +   +KLADFG A   +++             +  +  PE++
Sbjct: 135 RNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193

Query: 151 RGECQ-GPESDVWSLGCTIIEMVTGKPAWED-------------FGANTLSRIGFSDELP 196
            GE   GP  D+W  GC + EM T  P  +               G+ T       D   
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253

Query: 197 RF------------------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV-S 237
            +                           D +DK L  +P +R   D  L H F  S   
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313

Query: 238 PSD 240
           PSD
Sbjct: 314 PSD 316

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-31
 Identities = 58/274 (21%), Positives = 94/274 (34%), Gaps = 52/274 (18%)

Query: 7   GKCIGRGSFGTV---------------NVAVDRFNGD--------------VFAYLGDD- 36
           GK +G G+FG V                VAV                    V +YLG+  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 37  --VSYEAPTTSSSCRNLHLEYLPGGTVSDL-----------------ATTLNAYADEITL 77
             V+     T      +  EY   G + +                          D   L
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 78  RSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ 137
            S +Y +   + +L S+N +H D+  +N+L+       K+ DFG A +        VK  
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSNYVVKGN 206

Query: 138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIGFSDEL 195
            R    WMAPE +       ESDVWS G  + E+ + G   +     +    ++      
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266

Query: 196 PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
              P  +     D +  C   +P +R +  Q+++
Sbjct: 267 MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  119 bits (298), Expect = 2e-31
 Identities = 52/279 (18%), Positives = 87/279 (31%), Gaps = 58/279 (20%)

Query: 7   GKCIGRGSFGTV---------------NVAVDRFNGDVFAYLGDDVSYEAPT-------- 43
            + IG G+FG V                VAV     +  A +  D   EA          
Sbjct: 18  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77

Query: 44  --------TSSSCRNLHLEYLPGGTVSDLATTLNAYA----------------------- 72
                          L  EY+  G +++   +++ +                        
Sbjct: 78  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137

Query: 73  DEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR 132
                      + + + YL  R  VH D+  +N LVG N   VK+ADFG +     +D  
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYY 196

Query: 133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK--PAWEDFGANTLSRIG 190
                      WM PE +       ESDVW+ G  + E+ +    P +       +  + 
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 256

Query: 191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
               +   P        + +  C  + P +R S   + +
Sbjct: 257 -DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-30
 Identities = 61/331 (18%), Positives = 115/331 (34%), Gaps = 75/331 (22%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------YLGDDVS---------------------Y 39
           + +G G++G V  AVD   G   A       +  +  +                      
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 40  EAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYA--DEITLRSHTYCIVSALKYLHSRNIV 97
           +  T   +  +    YL    +      L  +    E  ++   Y ++  L+Y+H+  I+
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 143

Query: 98  HCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC-QG 156
           H D+K  N+ V  +    K+ DFG A +A    T  V      +  + APEV+       
Sbjct: 144 HRDLKPGNLAVNEDCEL-KILDFGLARQADSEMTGYV-----VTRWYRAPEVILNWMRYT 197

Query: 157 PESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF------------------------- 191
              D+WS+GC + EM+TGK  ++        +                            
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257

Query: 192 -----SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTVAE 246
                  +     T +S L  + L+K L  +  +R +  + L HP+ +S+  ++     +
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ 317

Query: 247 SSPRCVLDWVNSEFEEEGTSDDEKLEASARE 277
                        F++   + DE    + +E
Sbjct: 318 KYD--------DSFDDVDRTLDEWKRVTYKE 340

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 2e-30
 Identities = 58/276 (21%), Positives = 92/276 (33%), Gaps = 39/276 (14%)

Query: 6   RGKCIGRGSFGTV--------------NVAVDRFNGDVFAYLGDDVSYEAPTTSS----- 46
           R K IG G FG V               VA+             D   EA          
Sbjct: 11  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70

Query: 47  -----------SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
                          +  EY+  G +       +     + L      I + +KYL + N
Sbjct: 71  IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEA-TVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
            VH D+  +N+LV  N    K++DFG +       +        +    W APE +    
Sbjct: 131 YVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189

Query: 155 QGPESDVWSLGCTIIEMVTGK--PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK 212
               SDVWS G  + E++T    P WE      +  I     LP      S +    + +
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI-YQLMMQ 248

Query: 213 CLRREPGERWSCDQLLK--HPFLQSVSPSDANTVAE 246
           C ++E   R     ++      ++  +P    T+A+
Sbjct: 249 CWQQERARRPKFADIVSILDKLIR--APDSLKTLAD 282

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  118 bits (295), Expect = 2e-30
 Identities = 52/321 (16%), Positives = 95/321 (29%), Gaps = 87/321 (27%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDVFA----------------------------------- 31
            + +G G F TV +A D  N    A                                   
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 32  ----YLGDDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSA 87
                L     +     +     +  E L    ++ +    +     I ++  +  ++  
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 88  LKYLH-SRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
           L Y+H    I+H D+K +NVL+    S   L     A                 +  + +
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI----------------- 189
           PEV+ G   G  +D+WS  C I E++TG   +E    ++ ++                  
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 190 ------------------------------GFSDELPRFPTQSSELGRDFLDKCLRREPG 219
                                             E  +F    ++   DFL   L+ +P 
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317

Query: 220 ERWSCDQLLKHPFLQSVSPSD 240
           +R     L+ HP+L+     +
Sbjct: 318 KRADAGGLVNHPWLKDTLGME 338

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-30
 Identities = 57/281 (20%), Positives = 94/281 (33%), Gaps = 53/281 (18%)

Query: 7   GKCIGRGSFGTV---------------NVAVDRFNGDVFAYLGDDVSYE----------- 40
           GK +GRG+FG V                VAV              +  E           
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77

Query: 41  -------APTTSSSCRNLHLEYLPGGTVSDL---------------ATTLNAYADEITLR 78
                  A T       + +E+   G +S                       +     L 
Sbjct: 78  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137

Query: 79  SHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQP 138
            +++ +   +++L SR  +H D+  +N+L+   +  VK+ DFG A +         K   
Sbjct: 138 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPDYVRKGDA 196

Query: 139 RGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK--PAWEDFGANTLSRIGFSDELP 196
           R    WMAPE +       +SDVWS G  + E+ +    P           R        
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256

Query: 197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH--PFLQS 235
           R P  ++      +  C   EP +R +  +L++H    LQ+
Sbjct: 257 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 50/278 (17%), Positives = 91/278 (32%), Gaps = 48/278 (17%)

Query: 7   GKCIGRGSFGTV---------------NVAVDRFNGDVFAYLGDDVSYEAPTTSS----- 46
            + +G+GSFG V                VA+   N         +   EA          
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 47  -----------SCRNLHLEYLPGGTVSDL---------ATTLNAYADEITLRSHTYCIVS 86
                          + +E +  G +               + A      +      I  
Sbjct: 85  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 87  ALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMA 146
            + YL++   VH D+  +N +V  + + VK+ DFG   +   +D      +      WM+
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203

Query: 147 PEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSEL 205
           PE ++       SDVWS G  + E+ T  +  ++      + R      L   P    ++
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDM 263

Query: 206 GRDFLDKCLRREPGERWSCDQLLK------HPFLQSVS 237
             + +  C +  P  R S  +++        P  + VS
Sbjct: 264 LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 9e-30
 Identities = 64/337 (18%), Positives = 114/337 (33%), Gaps = 90/337 (26%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA---------------------------------YLG 34
           K IG G+ G V  A D       A                                  L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 35  DDVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSR 94
           +  + +          L +E +       +        D   +    Y ++  +K+LHS 
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHERMSYLLYQMLCGIKHLHSA 138

Query: 95  NIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGEC 154
            I+H D+K  N++V  + +  K+ DFG A  A  S      +    +  + APEV+ G  
Sbjct: 139 GIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV---VTRYYRAPEVILGMG 194

Query: 155 QGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRI--------------------GFSD 193
                D+WS+GC + EMV  K  +      +  +++                     + +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 194 ELPRFPTQS--------------------SELGRDFLDKCLRREPGERWSCDQLLKHPFL 233
             P++   +                    +   RD L K L  +P +R S D  L+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

Query: 234 QSVS-PSDANTVAESSPRCVLDWVNSEFEEEGTSDDE 269
                P++     E+ P  + D    + +E   + +E
Sbjct: 315 NVWYDPAE----VEAPPPQIYDK---QLDEREHTIEE 344

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-29
 Identities = 61/288 (21%), Positives = 99/288 (34%), Gaps = 61/288 (21%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA----YLGDD-----------------------VSYE 40
           + IG G++GTV  A +R   ++ A     L DD                       V   
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 41  APTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCD 100
               S     L  E+          +  N   D   ++S  + ++  L + HSRN++H D
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126

Query: 101 VKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGE-CQGPES 159
           +K +N+L+  N    KLA+FG A    +            +  +  P+V+ G        
Sbjct: 127 LKPQNLLINRNGEL-KLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 160 DVWSLGCTIIEMVTGKPAWEDFG--ANTLSRI---------------------------G 190
           D+WS GC   E+              + L RI                            
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP 238
            +  L     + +  GRD L   L+  P +R S ++ L+HP+     P
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 62/325 (19%), Positives = 110/325 (33%), Gaps = 79/325 (24%)

Query: 8   KCIGRGSFGTVNVAVDRFNGDVFA-------YLGD------------------------- 35
             +G G++G+V  A D   G   A       +                            
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 36  DVSYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN 95
           DV   A +         + +L G  ++++         +  ++   Y I+  LKY+HS +
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD 141

Query: 96  IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ 155
           I+H D+K  N+ V  +   +K+ DFG A       T         +  + APE++     
Sbjct: 142 IIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMH 195

Query: 156 -GPESDVWSLGCTIIEMVTGKPAWED----------------------FGANTLSRIGFS 192
                D+WS+GC + E++TG+  +                           ++ S   + 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 193 DELPRFPTQS--------SELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPSDANTV 244
             L + P  +        + L  D L+K L  +  +R +  Q L H +       D   V
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPV 315

Query: 245 AESSPRCVLDWVNSEFEEEGTSDDE 269
           A+          +  FE      DE
Sbjct: 316 ADP--------YDQSFESRDLLIDE 332

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-25
 Identities = 41/287 (14%), Positives = 81/287 (28%), Gaps = 68/287 (23%)

Query: 7   GKCIGRGSFGTV--------NVAVDRFNGD---------------------VFAYLGDDV 37
            + IG+G FG V         VAV  F+                       +  ++    
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA--- 64

Query: 38  SYEAPTTSSSCRNLHLEYLPGGTVSDLATTLNAYADEI------TLRSHTYCIVSALKYL 91
           +      + +   L  +Y   G++ D         + +      T     +  +  +   
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 92  HSRNIVHCDVKGKNVLVGPNSSFVKLADFG--AAGEATVSDTRGVKIQPRGSPLWMAPEV 149
               I H D+K KN+LV  N +   +AD G     ++             G+  +MAPEV
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 150 VRGECQ------GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRF----- 198
           +              +D++++G    E+              L         P       
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 199 ----------------PTQSSELGRDFLDKCLRREPGERWSCDQLLK 229
                             ++  +    + +C       R +  ++ K
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.3 bits (148), Expect = 1e-11
 Identities = 29/204 (14%), Positives = 51/204 (25%), Gaps = 57/204 (27%)

Query: 7   GKCIGRGSFGTVNVAVDRFNGDV------------------FAYLGDDVSYEAPTTSSSC 48
           GK +G G    V        G+                     Y     S  A  ++ + 
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 49  -RNL----------HLEYLPGGTVSDLATT-LNAYADEITLRSHTYCIVSALKYLHSRNI 96
            R L             +     + +L                    I+  +   + R I
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGI 124

Query: 97  VHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQ- 155
           VH D+   NVLV      + + DF  +                        E++  + + 
Sbjct: 125 VHGDLSQYNVLVSEEG--IWIIDFPQS---------------VEVGEEGWREILERDVRN 167

Query: 156 ---------GPESDVWSLGCTIIE 170
                      E D+ S    I++
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	408
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.34
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.18
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	94.74
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	85.35

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=411.72  Aligned_cols=228  Identities=28%  Similarity=0.425  Sum_probs=198.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LV   52 (408)
                      |++|++++.||+|+||+||+|+++.+++.||+|...                            +.+...+.++...+||
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            589999999999999999999999999999998632                            1223334566788999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......  
T Consensus        85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEECCCCSCSCCCCCC--
T ss_pred             EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC-EeecccceeeecCCCc--
Confidence            9999999999999854 56899999999999999999999999999999999999998875 9999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        ....+||+.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.... +.+|...|+++++||.+
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  237 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISR  237 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHH
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHH
Confidence              234579999999999999999999999999999999999999998877666655443333 46778899999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      ||++||++|||++|+|+||||..
T Consensus       238 ~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         238 LLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HccCCHhHCcCHHHHHcCcCcCC
Confidence            99999999999999999999963

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=413.21  Aligned_cols=234  Identities=22%  Similarity=0.337  Sum_probs=193.2

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEe
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      +++|++++.||+|+||+||+|+++.+++.||+|....                          .+...+.+++..|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            5799999999999999999999999999999986431                          12223445677899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ||+||+|.++++ ....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..........
T Consensus        84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~-~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC-EEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC-EEEccchhheeeccCCcccc
Confidence            999999999996 3567899999999999999999999999999999999999998875 99999999987654443333


Q ss_pred             cccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhh--hhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTL--SRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~--~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      ....+||+.|||||++.+..+ +.++|||||||++|+|++|++||........  .........+......|+++++||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            455689999999999998776 5789999999999999999999976443222  1111122222333567899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +||++||++|||++|+++||||+..
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=414.82  Aligned_cols=237  Identities=27%  Similarity=0.416  Sum_probs=199.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVm   53 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|...                            +.+...+..++.+||||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999998643                            12223355677889999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      |||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.........
T Consensus        88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~-vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce-EEecccccceecccCCccc
Confidence            999999999998854 56799999999999999999999999999999999999998885 9999999998765443333


Q ss_pred             ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHh
Q 042746          134 VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKC  213 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~  213 (408)
                      .....+||+.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.... +.+|...++++++||.+|
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~  244 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL  244 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHHTT
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHH
Confidence            3445679999999999999999999999999999999999999999877666655544443 466788999999999999


Q ss_pred             cccCCCCCCCHHH------HHcCCCCCCCCCCCc
Q 042746          214 LRREPGERWSCDQ------LLKHPFLQSVSPSDA  241 (408)
Q Consensus       214 L~~dP~~R~s~~e------ll~hpf~~~~~~~~~  241 (408)
                      |++||++|||++|      +++||||+.+.++..
T Consensus       245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         245 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            9999999999987      588999999887644

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=416.55  Aligned_cols=234  Identities=26%  Similarity=0.409  Sum_probs=203.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LV   52 (408)
                      |++|++++.||+|+||+||+|+++.+++.||+|...                            +.+...++++..+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            678999999999999999999999999999998643                            1222335567789999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. .+.++|..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... 
T Consensus        84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~-vkl~DFG~a~~~~~~~~-  160 (337)
T d1o6la_          84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGA-  160 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCSCCTTC-
T ss_pred             eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC-EEEeecccccccccCCc-
Confidence            999999999999985 456799999999999999999999999999999999999999885 99999999976543222 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                       .....+|||.|+|||++.+..|+.++|||||||++|+|++|++||...+...+...+.... +.+|...|+++++||.+
T Consensus       161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHh
Confidence             2345679999999999999999999999999999999999999999888777766655544 46788899999999999


Q ss_pred             hcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      ||++||.+|++     ++|+++||||....+.
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             hccCCchhhcccccccHHHHHcCcccccCCHH
Confidence            99999999994     8999999999887543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=404.07  Aligned_cols=229  Identities=25%  Similarity=0.404  Sum_probs=186.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC--CCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT--TSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~--~~~~~~~LV   52 (408)
                      ++|++.+.||+|+||+||+|+++.||+.||+|.....                           +...+  +.+..+|||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            7899999999999999999999999999999864311                           11111  234567899


Q ss_pred             EeccCCCCHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           53 LEYLPGGTVSDLATT---LNAYADEITLRSHTYCIVSALKYLHSRN-----IVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        53 mEy~~gGsL~~~l~~---~~~~l~e~~i~~i~~qIl~~L~yLH~~g-----iiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ||||+||+|.+++.+   .+..+++..++.++.||+.||+|||+++     |+||||||+|||++.++. +||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~-vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC-EEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc-EEEeecccee
Confidence            999999999999864   3567899999999999999999999976     999999999999998875 9999999997


Q ss_pred             ccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcH
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSE  204 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~  204 (408)
                      .......  .....+|||.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.....+.+|..+|+
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  240 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD  240 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            6543222  23356799999999999999999999999999999999999999998877776666566667778888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      ++++||.+||+.||.+|||++|+++|||+
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999995

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=408.99  Aligned_cols=230  Identities=33%  Similarity=0.534  Sum_probs=194.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      .+|++.+.||+|+||+||+|+++.+|+.||+|....                         .+...+..++..|||||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            379999999999999999999999999999986432                         2222345567789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +||+|.+++.+  +.+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+.......  ...
T Consensus       100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~-vkl~DFG~a~~~~~~~~--~~~  174 (293)
T d1yhwa1         100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQS--KRS  174 (293)
T ss_dssp             TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSTTC--CBC
T ss_pred             CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc-Eeeccchhheeeccccc--ccc
Confidence            99999998864  46899999999999999999999999999999999999998875 99999999976643322  234


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC--CCCCCCCCcHHHHHHHHHhc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE--LPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~p~~~~~~s~~~~~li~~~L  214 (408)
                      ..+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+............  ....+...|+++++||.+||
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  254 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence            5679999999999999999999999999999999999999998766544333222222  22445678999999999999


Q ss_pred             ccCCCCCCCHHHHHcCCCCCCC
Q 042746          215 RREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       215 ~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      ++||.+|||++|+|+||||+..
T Consensus       255 ~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         255 DMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             CSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999743

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-53  Score=405.50  Aligned_cols=231  Identities=31%  Similarity=0.448  Sum_probs=194.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-------------------------ceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-------------------------SYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-------------------------~~~~~~~~~~~~~LVmEy~   56 (408)
                      +.|++++.||+|+||+||+|+++.+++.||+|....                         .+.+.+..++..+||||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            359999999999999999999999999999986431                         2223344567789999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +||+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......  ....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~-~Kl~DFG~a~~~~~~~--~~~~  168 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTI--QRRD  168 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECHHHH--HHHT
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC-EEEEechhhhccCCCc--cccc
Confidence            999999998877788999999999999999999999999999999999999998885 9999999996543321  1223


Q ss_pred             cCCCCCCCCChhhHh-----CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC--CCCCCCcHHHHHH
Q 042746          137 QPRGSPLWMAPEVVR-----GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP--RFPTQSSELGRDF  209 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~-----~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p--~~~~~~s~~~~~l  209 (408)
                      ..+||+.|||||++.     +..|+.++|||||||++|+|++|++||...+.......+.....|  ..+...|+++++|
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            467999999999994     456789999999999999999999999877665544433333333  3345789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      |.+||++||++|||++|+++||||+.
T Consensus       249 i~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         249 LKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999964

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.8e-52  Score=405.39  Aligned_cols=231  Identities=26%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LV   52 (408)
                      |++|++++.||+|+||+||+|+++.+|+.||+|...                            +.+...+..+..+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            578999999999999999999999999999998643                            1222334566788999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||++||+|.+++.. +..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....   
T Consensus        83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~-vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDV---  157 (316)
T ss_dssp             ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC-EEECCCSSCEECSSC---
T ss_pred             eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC-EEEecCccceEeccc---
Confidence            999999999999984 566789999999999999999999999999999999999998885 999999999765432   


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        ....+||+.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.... +.+|...+++++++|.+
T Consensus       158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHH
T ss_pred             --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence              234679999999999999999999999999999999999999999877666655544444 35677899999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||.+||.+|+     |++|+++||||++..++
T Consensus       235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             HhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            9999999996     89999999999987654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-52  Score=402.23  Aligned_cols=230  Identities=24%  Similarity=0.401  Sum_probs=183.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc--------------------------cceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD--------------------------VSYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~--------------------------~~~~~~~~~~~~~~LVmEy   55 (408)
                      +.|++++.||+|+||+||+|+++.+++.||+|...                          +.+...+..+..+||||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            46999999999999999999999999999998643                          1222234566778999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC---CCCcEEEeecCCccccccCCCC
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP---NSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~---~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+..   ++ .+||+|||+|+......  
T Consensus        89 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a~~~~~~~--  164 (307)
T d1a06a_          89 VSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLSKMEDPGS--  164 (307)
T ss_dssp             CCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCC------------
T ss_pred             cCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCc-eEEEeccceeEEccCCC--
Confidence            999999999974 567899999999999999999999999999999999999953   44 59999999997654322  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDF  209 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~l  209 (408)
                       .....+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.....+...+.....   +..+...|+++++|
T Consensus       165 -~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  243 (307)
T d1a06a_         165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF  243 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             -eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence             23346799999999999999999999999999999999999999988766555444333322   23345789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          210 LDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      |.+||++||++|||++|+++||||+..
T Consensus       244 i~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         244 IRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.1e-52  Score=409.67  Aligned_cols=236  Identities=24%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCCCCCcceEEEec
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy   55 (408)
                      |++|++++.||+|+||+||+|+++.+|+.||+|...                         +.+...+..++.++|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999999999999998643                         2233345567789999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC-CCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN-SSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~-~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |+||+|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+......   .
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---C
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---c
Confidence            99999999997666779999999999999999999999999999999999999642 2359999999997654332   2


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDFLD  211 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~li~  211 (408)
                      .....||+.|||||++.+..|+.++|||||||++|+|++|++||...+.......+.....   +......|+++++||.
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            3446799999999999999999999999999999999999999987766555443333222   1222468899999999


Q ss_pred             HhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          212 KCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      +||++||++|||++|+|+||||+.....
T Consensus       262 ~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         262 KLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            9999999999999999999999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-51  Score=409.69  Aligned_cols=232  Identities=23%  Similarity=0.370  Sum_probs=196.1

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------------cceeccCCCCCcc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------------VSYEAPTTSSSCR   49 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------------~~~~~~~~~~~~~   49 (408)
                      |++|++++.||+|+||+||+|+++.||+.||+|...                               +.+...+..+..+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            789999999999999999999999999999998642                               1122234556778


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ||||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~-iKl~DFGla~~~~~~  160 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC-EEECCCTTCEECSSS
T ss_pred             EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc-EEEeeeceeeecCCC
Confidence            9999999999999999854 56799999999999999999999999999999999999998875 999999999765433


Q ss_pred             CCCcccccCCCCCCCCChhhHh-CCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh---hhhcccCCCCCCCCCCcHH
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVR-GECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL---SRIGFSDELPRFPTQSSEL  205 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~---~~~~~~~~~p~~~~~~s~~  205 (408)
                      .    ....+||+.|+|||++. +..|+.++|||||||++|+|++|++||........   .+.. ....+.++..+|++
T Consensus       161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~  235 (364)
T d1omwa3         161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPE  235 (364)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-SSCCCCCCSSSCHH
T ss_pred             c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCCCCHH
Confidence            2    23457999999999996 45789999999999999999999999986544332   2222 23344667789999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHcCCCCCCCCCC
Q 042746          206 GRDFLDKCLRREPGERWS-----CDQLLKHPFLQSVSPS  239 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s-----~~ell~hpf~~~~~~~  239 (408)
                      +++||.+||++||++|||     ++|+++||||++..+.
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence            999999999999999998     7999999999987654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=405.92  Aligned_cols=233  Identities=26%  Similarity=0.384  Sum_probs=201.7

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-----------------------------cceeccCCCCCcceE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-----------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-----------------------------~~~~~~~~~~~~~~L   51 (408)
                      |++|++++.||+|+||+||+|+++.+++.||+|...                             +.+...+..+..+||
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            799999999999999999999999999999998643                             112223456677899


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus        81 vmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~-~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC-EEECCCTTCBCCCCTTC
T ss_pred             EEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc-eeccccchhhhcccccc
Confidence            99999999999999854 56799999999999999999999999999999999999998875 99999999976543322


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                        .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+...+...+... .|.+|...|+++++||.
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-~~~~p~~~s~~~~dli~  235 (320)
T d1xjda_         159 --KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-NPFYPRWLEKEAKDLLV  235 (320)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCTTSCHHHHHHHH
T ss_pred             --cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCccCCHHHHHHHH
Confidence              233457999999999999999999999999999999999999999987777666554443 35777889999999999


Q ss_pred             HhcccCCCCCCCHH-HHHcCCCCCCCCC
Q 042746          212 KCLRREPGERWSCD-QLLKHPFLQSVSP  238 (408)
Q Consensus       212 ~~L~~dP~~R~s~~-ell~hpf~~~~~~  238 (408)
                      +||++||.+|||+. |+++||||++..+
T Consensus       236 ~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HhcccCCCCCcCHHHHHHhCchhccCCH
Confidence            99999999999995 8999999988654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=395.85  Aligned_cols=234  Identities=23%  Similarity=0.347  Sum_probs=194.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------------cceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------------~~~~~~~~~~~~~~   50 (408)
                      ++|++++.||+|+||+||+|+++.+|+.||+|...                               +.+.+.++++..+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46999999999999999999999999999998532                               11222345667789


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC---cEEEeecCCccccc
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS---FVKLADFGAAGEAT  127 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~---~vkL~DFGla~~~~  127 (408)
                      ||||||+||+|.+++... +.+++..++.+++||+.||+|||+++|+||||||+|||++.++.   .+||+|||+|....
T Consensus        90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999854 56899999999999999999999999999999999999987652   49999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC---CCCCCCcH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP---RFPTQSSE  204 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p---~~~~~~s~  204 (408)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+......   ..+...|+
T Consensus       169 ~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         169 FGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             TSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            332   233457999999999999999999999999999999999999999877665554433333221   22357889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          205 LGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       205 ~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      .+++||.+||++||++|||++|+++||||+...+.
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  280 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  280 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence            99999999999999999999999999999876554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=403.16  Aligned_cols=230  Identities=27%  Similarity=0.412  Sum_probs=188.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc--------------------------ceeccCCCCCcceEEEec
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV--------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      ++|++.+.||+|+||+||+|+++.+++.||+|....                          .+...+..+..++|||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            589999999999999999999999999999986431                          222334566778999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ++||+|.+++.+. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +||+|||+|+......    
T Consensus        86 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~-vkl~DFGla~~~~~~~----  159 (322)
T d1s9ja_          86 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM----  159 (322)
T ss_dssp             CTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC-EEECCCCCCHHHHHHT----
T ss_pred             CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC-EEEeeCCCccccCCCc----
Confidence            9999999999854 568999999999999999999997 59999999999999998885 9999999997654322    


Q ss_pred             cccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh-------------------------
Q 042746          135 KIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI-------------------------  189 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~-------------------------  189 (408)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.......                         
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            2345799999999999999999999999999999999999999975432211000                         


Q ss_pred             -----------------cccCCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          190 -----------------GFSDELPRFP-TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       190 -----------------~~~~~~p~~~-~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                       ......|..+ ...|.++++||.+||++||.+|||++|+|+||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                             0111122222 24688999999999999999999999999999997543

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-51  Score=406.76  Aligned_cols=231  Identities=25%  Similarity=0.352  Sum_probs=198.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc----------------------------ceeccCCCCCcceEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV----------------------------SYEAPTTSSSCRNLH   52 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~----------------------------~~~~~~~~~~~~~LV   52 (408)
                      |++|++++.||+|+||+||+|+++.+|+.||+|....                            .+...+......++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            5789999999999999999999999999999986431                            122234455668899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+.||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.....   
T Consensus       120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~-ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-EEECCCTTCEECSSC---
T ss_pred             cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC-EEeeeceeeeecccc---
Confidence            9999999999999854 56899999999999999999999999999999999999998875 999999999765432   


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDK  212 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~  212 (408)
                        ....+||+.|||||++.+..|+.++|||||||++|+|++|++||...+...+...+.... +.+|...++++++||.+
T Consensus       195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHH
T ss_pred             --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHH
Confidence              234579999999999999999999999999999999999999998877666555444443 45677899999999999


Q ss_pred             hcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          213 CLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       213 ~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ||++||.+|+     |++|+++||||+...+.
T Consensus       272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~  303 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence            9999999995     89999999999987654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-51  Score=404.92  Aligned_cols=233  Identities=23%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc-------------------------cceeccCCCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD-------------------------VSYEAPTTSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~-------------------------~~~~~~~~~~~~~~LVmEy~   56 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|...                         +.+...++.+..+|||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999999999999998643                         22333455677889999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcC-CCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGP-NSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~-~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +||+|.+.+...+..+++..++.++.||+.||+|||++||+||||||+||||+. +.+.+||+|||+|+......   ..
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~  185 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IV  185 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC---ce
Confidence            999999988766667899999999999999999999999999999999999973 22359999999997765432   23


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CCCCCCCcHHHHHHHHH
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PRFPTQSSELGRDFLDK  212 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~~~~~~s~~~~~li~~  212 (408)
                      ....||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.........+.....   +..+...|+++++||.+
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  265 (352)
T d1koba_         186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN  265 (352)
T ss_dssp             EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHT
T ss_pred             eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence            345799999999999999999999999999999999999999988766555443333222   23345789999999999


Q ss_pred             hcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          213 CLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       213 ~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ||++||.+|||+.|+|+||||+...
T Consensus       266 ~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         266 LLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCCc
Confidence            9999999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=386.83  Aligned_cols=225  Identities=27%  Similarity=0.392  Sum_probs=183.5

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceecc----CCCCCcceEE
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAP----TTSSSCRNLH   52 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~----~~~~~~~~LV   52 (408)
                      |++.+.||+|+||+||+|++..+++.||+|....                           .+.+.    ...+..++||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            3678899999999999999999999999876431                           11111    1234567899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRN--IVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~g--iiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      |||++||+|.+++.+. ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+...+||+|||+|+..... 
T Consensus        91 mE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-  168 (270)
T ss_dssp             EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred             EeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence            9999999999999854 56799999999999999999999999  9999999999999753335999999999654322 


Q ss_pred             CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCC-hhhhhhhcccCC-CCCCCCCCcHHHHH
Q 042746          131 TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFG-ANTLSRIGFSDE-LPRFPTQSSELGRD  208 (408)
Q Consensus       131 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~-~~~~~~~~~~~~-~p~~~~~~s~~~~~  208 (408)
                         .....+|||.|||||++.+. ++.++|||||||++|+|++|++||.... ...+........ .+.++...++++++
T Consensus       169 ---~~~~~~GT~~Y~aPE~~~~~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (270)
T d1t4ha_         169 ---FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  244 (270)
T ss_dssp             ---SBEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             ---ccCCcccCccccCHHHhCCC-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence               23356799999999999865 8999999999999999999999997643 334433333332 23445668899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcCCCCC
Q 042746          209 FLDKCLRREPGERWSCDQLLKHPFLQ  234 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~hpf~~  234 (408)
                      ||.+||++||++|||++|+++||||+
T Consensus       245 li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         245 IIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-50  Score=394.33  Aligned_cols=226  Identities=33%  Similarity=0.456  Sum_probs=189.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc----------------------------cceeccCCCCCcceEEEe
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD----------------------------VSYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~----------------------------~~~~~~~~~~~~~~LVmE   54 (408)
                      .|++.+.||+|+||+||+|++..+++.||+|...                            +.+.+.+..+...|||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4999999999999999999999999999998643                            122233445677899999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      ||+||+|..++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....      
T Consensus        96 ~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~------  167 (309)
T d1u5ra_          96 YCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP------  167 (309)
T ss_dssp             CCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS------
T ss_pred             ecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC------
Confidence            999999977665 456789999999999999999999999999999999999999887 599999999975432      


Q ss_pred             cccCCCCCCCCChhhHhC---CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCC-CCCCCCcHHHHHHH
Q 042746          135 KIQPRGSPLWMAPEVVRG---ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELP-RFPTQSSELGRDFL  210 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~---~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p-~~~~~~s~~~~~li  210 (408)
                      ....+||+.|||||++.+   ..|+.++|||||||++|+|++|++||.+...............| ..+...|+++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li  247 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            224579999999999964   35789999999999999999999999876655443333333333 33456899999999


Q ss_pred             HHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          211 DKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      .+||++||.+|||++|+|+||||...
T Consensus       248 ~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         248 DSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            99999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-49  Score=380.13  Aligned_cols=229  Identities=23%  Similarity=0.368  Sum_probs=192.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------------------ceeccCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------------------SYEAPTTSS   46 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------------------~~~~~~~~~   46 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                                   .+...+.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            689999999999999999999999999999986321                                   122234566


Q ss_pred             CcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccc
Q 042746           47 SCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEA  126 (408)
Q Consensus        47 ~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~  126 (408)
                      ...||||||++||+|.++++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~-~kl~DFG~a~~~  160 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQL  160 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-EEECCCTTCEEC
T ss_pred             cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC-eEEccchheeEc
Confidence            7789999999999999999854 57899999999999999999999999999999999999998875 999999999765


Q ss_pred             ccCCCCcccccCCCCCCCCChhhHhC------CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCC---CC
Q 042746          127 TVSDTRGVKIQPRGSPLWMAPEVVRG------ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDEL---PR  197 (408)
Q Consensus       127 ~~~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~---p~  197 (408)
                      .....   ....+||+.|+|||++.+      ..++.++||||+||++|+|++|++||...........+.....   ..
T Consensus       161 ~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         161 DPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             CTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             cCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            43322   234579999999999964      3468899999999999999999999998776555443333322   12


Q ss_pred             CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          198 FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       198 ~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      .....|+++++||.+||++||.+|||++|+++||||+.
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            23468999999999999999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=392.89  Aligned_cols=231  Identities=23%  Similarity=0.320  Sum_probs=195.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|...                        +.+...++.+..+|||||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence            68999999999999999999999999999998643                        223334566778999999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC-CcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS-SFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ||+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++......   ...
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~  161 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFR  161 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEE
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC---ccc
Confidence            9999999986666789999999999999999999999999999999999997543 359999999997654332   233


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCC---CCCCCcHHHHHHHHHh
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPR---FPTQSSELGRDFLDKC  213 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~---~~~~~s~~~~~li~~~  213 (408)
                      ...||+.|+|||.+.+..|+.++|||||||++|+|++|.+||...+.......+.......   .+...|+++++||.+|
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~  241 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL  241 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence            4568999999999999999999999999999999999999999877665555443333211   1236789999999999


Q ss_pred             cccCCCCCCCHHHHHcCCCCCC
Q 042746          214 LRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       214 L~~dP~~R~s~~ell~hpf~~~  235 (408)
                      |.+||.+|||++|+++||||+.
T Consensus       242 L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         242 LVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ccCChhHCcCHHHHhcCHhhcc
Confidence            9999999999999999999964

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=380.13  Aligned_cols=224  Identities=24%  Similarity=0.342  Sum_probs=185.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------------ceeccCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------------SYEAPTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------------~~~~~~~~~~~   48 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|....                                 .+...+..++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            479999999999999999999999999999985321                                 11112345567


Q ss_pred             ceEEEeccCC-CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           49 RNLHLEYLPG-GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        49 ~~LVmEy~~g-GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      .++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            8899999986 688888875 45789999999999999999999999999999999999998765569999999997543


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCCCC-CCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCCCCCCCCCCcHHH
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGECQ-GPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDELPRFPTQSSELG  206 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~  206 (408)
                      ..    ......||+.|+|||++.+..+ +.++|||||||++|+|++|++||....  ...+    . ...++...|+++
T Consensus       163 ~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~i~~----~-~~~~~~~~s~~~  231 (273)
T d1xwsa_         163 DT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIR----G-QVFFRQRVSSEC  231 (273)
T ss_dssp             SS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHH----C-CCCCSSCCCHHH
T ss_pred             cc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--HHhh----c-ccCCCCCCCHHH
Confidence            32    2334679999999999987655 567899999999999999999997532  1111    1 124567789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                      ++||.+||++||++|||++|+++||||++..
T Consensus       232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999998654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=393.75  Aligned_cols=232  Identities=25%  Similarity=0.372  Sum_probs=187.0

Q ss_pred             CCCeEee-ceeeecCCeeEEEEEEcCCCcEEEEeecc---------------------cceeccC----CCCCcceEEEe
Q 042746            1 MVSWVRG-KCIGRGSFGTVNVAVDRFNGDVFAYLGDD---------------------VSYEAPT----TSSSCRNLHLE   54 (408)
Q Consensus         1 ~~~Y~~~-~~IG~G~fG~Vy~a~d~~t~~~va~k~~~---------------------~~~~~~~----~~~~~~~LVmE   54 (408)
                      +++|.+. +.||+|+||+||+|++..+++.||+|...                     +.+...+    ..+..+|||||
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE   89 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   89 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence            4789876 57999999999999999999999998643                     1111112    23466899999


Q ss_pred             ccCCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--CCcEEEeecCCccccccCCC
Q 042746           55 YLPGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        55 y~~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||+||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+  ...+||+|||+|+.......
T Consensus        90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~  169 (335)
T d2ozaa1          90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  169 (335)
T ss_dssp             CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred             CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence            999999999998643 468999999999999999999999999999999999999853  23599999999976544322


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh----hhhcccCCCCCCC----CCCc
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL----SRIGFSDELPRFP----TQSS  203 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~----~~~~~~~~~p~~~----~~~s  203 (408)
                         ....+||+.|||||++.+..|+.++|||||||++|+|+||++||.+.+....    ......... .+|    ...|
T Consensus       170 ---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~s  245 (335)
T d2ozaa1         170 ---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNPEWSEVS  245 (335)
T ss_dssp             ---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS-SCCTTHHHHSC
T ss_pred             ---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC-CCCCcccccCC
Confidence               3456799999999999999999999999999999999999999976543222    111111111 222    2578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                      +++++||.+||++||++|||+.|+++||||...
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            999999999999999999999999999999653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=377.38  Aligned_cols=232  Identities=28%  Similarity=0.379  Sum_probs=186.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC-CcEEEEeecccc------------------------------eecc-----CCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN-GDVFAYLGDDVS------------------------------YEAP-----TTS   45 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t-~~~va~k~~~~~------------------------------~~~~-----~~~   45 (408)
                      ++|++++.||+|+||+||+|++..+ ++.||+|.....                              +...     ...
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            5899999999999999999999766 567898763211                              0000     122


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ....+++|||+.++++..........+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++.
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~-~kl~dfg~~~~  165 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARI  165 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECSCCSCCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC-eeecchhhhhh
Confidence            34578999999998777666656677899999999999999999999999999999999999998875 99999999865


Q ss_pred             cccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc---------------
Q 042746          126 ATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG---------------  190 (408)
Q Consensus       126 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~---------------  190 (408)
                      .....   .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+.......+               
T Consensus       166 ~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         166 YSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            44322   334567999999999999999999999999999999999999999865533221110               


Q ss_pred             -----------ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 -----------FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 -----------~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                                 .....+.++...++.+++||.+||++||++|||++|+|+||||+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                       00111234456789999999999999999999999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=382.16  Aligned_cols=229  Identities=21%  Similarity=0.282  Sum_probs=183.2

Q ss_pred             eeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------------ceeccCCCCCcceEEEec
Q 042746            6 RGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------------SYEAPTTSSSCRNLHLEY   55 (408)
Q Consensus         6 ~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------------~~~~~~~~~~~~~LVmEy   55 (408)
                      .+++||+|+||+||+|+++.+++.||+|....                              .+...+..+...+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999986431                              122334566778999999


Q ss_pred             cCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           56 LPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        56 ~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      +.|+++..+.. .+..+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+|+.......  ..
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~-~KL~DFG~a~~~~~~~~--~~  157 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNR--AY  157 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCCGGGSTTTSCCC--CC
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc-cccccCccccccCCCcc--cc
Confidence            99987766654 5667899999999999999999999999999999999999998875 99999999976544332  23


Q ss_pred             ccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc----------------------c
Q 042746          136 IQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF----------------------S  192 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~----------------------~  192 (408)
                      ...+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||...........+.                      .
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            345799999999999754 67999999999999999999999998654332211100                      0


Q ss_pred             CCCCCC-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          193 DELPRF-----PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       193 ~~~p~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      ...+..     ....++++++||.+||++||++|||++|+|+||||++.+.
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            011111     1356889999999999999999999999999999987653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=379.32  Aligned_cols=236  Identities=25%  Similarity=0.378  Sum_probs=187.4

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      ||+|++++.||+|+||+||+|++..+++.||+|....                           .+...+..+..+||||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            7999999999999999999999999999999986431                           1222344567789999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+.++.+..+.......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.......  
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~-~kl~DFG~a~~~~~~~~--  157 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVR--  157 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECSTTHHHHHCCCSB--
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc-ceeccCCcceeccCCcc--
Confidence            999875444444445667899999999999999999999999999999999999998875 99999999976543322  


Q ss_pred             ccccCCCCCCCCChhhHhCCC-CCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc--------------------cc
Q 042746          134 VKIQPRGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG--------------------FS  192 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~-~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~--------------------~~  192 (408)
                      ......||+.|+|||++.... ++.++|+|||||++|+|++|++||...+........                    ..
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            233457999999999987765 478999999999999999999999765432211100                    00


Q ss_pred             CCCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          193 DELPR--------FPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       193 ~~~p~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ...+.        .....++++++||.+||++||++|||++|+++||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            01111        112567899999999999999999999999999999877544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=381.36  Aligned_cols=228  Identities=23%  Similarity=0.256  Sum_probs=188.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc-----EEEEeecc---------------------------cceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD-----VFAYLGDD---------------------------VSYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~-----~va~k~~~---------------------------~~~~~~~~~~~~~   49 (408)
                      ++|++++.||+|+||+||+|++..+++     .||+|...                           +.+.+.+......
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            478999999999999999999977654     57776432                           2233345566778


Q ss_pred             eEEEeccCCCCHHHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042746           50 NLHLEYLPGGTVSDLATTLN----------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL  107 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~----------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NIL  107 (408)
                      +||||||+||+|.++++...                      ..+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999999999999997542                      24788999999999999999999999999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-h
Q 042746          108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-T  185 (408)
Q Consensus       108 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~  185 (408)
                      ++.++ .+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |++||.+.... .
T Consensus       197 l~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~  275 (325)
T d1rjba_         197 VTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  275 (325)
T ss_dssp             EETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             cccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence            99887 599999999987665444333344568999999999999999999999999999999998 89999875543 3


Q ss_pred             hhhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          186 LSRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       186 ~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      +..+......+..|...++++++||.+||+.||++|||++||++|
T Consensus       276 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            344434444556778899999999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=364.68  Aligned_cols=226  Identities=23%  Similarity=0.301  Sum_probs=182.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|+++ +++.||+|...                        +.+.+....+...+|||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            48999999999999999999987 56789998643                        223334455677899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|+........ ....
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~-~Kl~DFGla~~~~~~~~~-~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYT-SSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC-EEECSCC----------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC-eEecccchheeccCCCce-eecc
Confidence            99999999877778899999999999999999999999999999999999998875 999999999765433221 2233


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..||+.|+|||++.+..|+.++|||||||++|||+| |.+||.......+.........+..|...++.+.+|+.+||+.
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  241 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE  241 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccC
Confidence            568999999999999999999999999999999999 5777777666655555445555666778899999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||++|||++|+++|
T Consensus       242 ~p~~Rps~~~il~~  255 (263)
T d1sm2a_         242 RPEDRPAFSRLLRQ  255 (263)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CHhHCcCHHHHHHH
Confidence            99999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=370.14  Aligned_cols=228  Identities=22%  Similarity=0.273  Sum_probs=181.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCC-----CcEEEEeecccc---------------------------eec-cCCCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFN-----GDVFAYLGDDVS---------------------------YEA-PTTSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t-----~~~va~k~~~~~---------------------------~~~-~~~~~~~   48 (408)
                      ++|++++.||+|+||+||+|++..+     ++.||+|.....                           +.. ....+..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            5799999999999999999997654     467888764311                           111 1234456


Q ss_pred             ceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCC
Q 042746           49 RNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSS  113 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~  113 (408)
                      +++|||||+||+|.+++....               ..+++..++.++.||+.||+|||+++|+||||||+||||+.++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            899999999999999997532               35789999999999999999999999999999999999998875


Q ss_pred             cEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChh-hhhhhcc
Q 042746          114 FVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGAN-TLSRIGF  191 (408)
Q Consensus       114 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~-~~~~~~~  191 (408)
                       +||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++| .+||...... .+.....
T Consensus       173 -~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~  251 (299)
T d1ywna1         173 -VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  251 (299)
T ss_dssp             -EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             -EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence             999999999766544443344456799999999999999999999999999999999986 5788765433 3333334


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+..+..|...++++++||.+||+.||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            455667788899999999999999999999999999987

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-47  Score=369.03  Aligned_cols=228  Identities=21%  Similarity=0.294  Sum_probs=179.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc---EEEEeecc--------------------------cceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDD--------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~--------------------------~~~~~~~~~~~~~~LV   52 (408)
                      .+|++++.||+|+||+||+|+++.+++   .+|+|...                          +.+.+....+...+||
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            478999999999999999999987775   46776532                          2233334566778999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      ||||+||+|.+++....+.+++..+..++.||+.||+|||+++|+||||||+||||+.++. +||+|||+|+........
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~-~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCC------------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc-EEECCcccceEccCCCCc
Confidence            9999999999999876778899999999999999999999999999999999999998875 999999999765433221


Q ss_pred             c---ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHH
Q 042746          133 G---VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRD  208 (408)
Q Consensus       133 ~---~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~  208 (408)
                      .   ......||+.|||||++.+..++.++|||||||++|||+| |++||.+.....+......+..+..+...++.+++
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  264 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ  264 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHH
Confidence            1   1222457999999999999999999999999999999998 89999987766665555555556677789999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHcC
Q 042746          209 FLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       209 li~~~L~~dP~~R~s~~ell~h  230 (408)
                      |+.+||+.||++|||+.|++++
T Consensus       265 li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         265 LMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-47  Score=365.75  Aligned_cols=230  Identities=25%  Similarity=0.379  Sum_probs=181.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVm   53 (408)
                      |++|++.+.||+|+||+||+|+++ +++.||+|....                           .+...+..++..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            789999999999999999999996 789999987532                           1222344566788999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+.++.+..+.+ ..+.+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|........  
T Consensus        80 e~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~-~kl~DfG~a~~~~~~~~--  155 (286)
T d1ob3a_          80 EHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVR--  155 (286)
T ss_dssp             ECCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-EEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC-EEecccccceecccCcc--
Confidence            9999876666654 5678899999999999999999999999999999999999999875 99999999976543322  


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc--------------------c
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF--------------------S  192 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~--------------------~  192 (408)
                      ......|++.|+|||.+.+. +++.++|||||||++|+|++|++||.+.+.........                    .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            22334689999999999764 56899999999999999999999997654322211000                    0


Q ss_pred             --------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCC
Q 042746          193 --------DELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQS  235 (408)
Q Consensus       193 --------~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~  235 (408)
                              ...+......+++++|||++||++||++|||+.|+++||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                    0001223567889999999999999999999999999999974

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=375.55  Aligned_cols=234  Identities=24%  Similarity=0.344  Sum_probs=183.2

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------ceecc------CCCCCcceEEEec
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------SYEAP------TTSSSCRNLHLEY   55 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------~~~~~------~~~~~~~~LVmEy   55 (408)
                      +|+.+++||+|+||+||+|+++.+++.||+|....                     .+...      .....+++|||||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            69999999999999999999999999999986431                     11111      1233457899999


Q ss_pred             cCCCCHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           56 LPGGTVSDLAT--TLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        56 ~~gGsL~~~l~--~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ++++.+..+..  .....+++..++.+++||+.||+|||++||+||||||+|||++.++..+||+|||+++......   
T Consensus       101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---  177 (350)
T d1q5ka_         101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---  177 (350)
T ss_dssp             CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---
T ss_pred             cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc---
Confidence            98764444432  2456789999999999999999999999999999999999999877569999999997654332   


Q ss_pred             ccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-------------------ccC
Q 042746          134 VKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-------------------FSD  193 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-------------------~~~  193 (408)
                      ......||+.|+|||.+.+. .|+.++|||||||++|||++|++||...........+                   ...
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            23345799999999998764 6899999999999999999999999765432221110                   001


Q ss_pred             CCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          194 ELP---------RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       194 ~~p---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                      ..+         ......++++++||.+||.+||++|||+.|+|+||||+.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            111         1123578899999999999999999999999999999876543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-47  Score=368.49  Aligned_cols=226  Identities=22%  Similarity=0.271  Sum_probs=190.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|...                        +.+.+.+..+...+|||||++
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            47899999999999999999999999999998643                        223334556778899999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+|+........ ...
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~-~Kl~DFG~a~~~~~~~~~-~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYT-AHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCCTTTCCSSSSE-EET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc-EEEccccceeecCCCCce-eec
Confidence            99999999753 457899999999999999999999999999999999999998875 999999999765443221 222


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCC-CCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~-~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...||+.|+|||++.+..|+.++|||||||++|||++|. +||...+...+......+..+..+...++.+++||.+||+
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~  254 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ  254 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcC
Confidence            345899999999999999999999999999999999965 4555566666655555555667788899999999999999


Q ss_pred             cCCCCCCCHHHHHc
Q 042746          216 REPGERWSCDQLLK  229 (408)
Q Consensus       216 ~dP~~R~s~~ell~  229 (408)
                      .||++|||++|+++
T Consensus       255 ~dP~~Rps~~ei~~  268 (287)
T d1opja_         255 WNPSDRPSFAEIHQ  268 (287)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCHhHCcCHHHHHH
Confidence            99999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=368.42  Aligned_cols=224  Identities=24%  Similarity=0.351  Sum_probs=175.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEe
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLE   54 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmE   54 (408)
                      ++|++++.||+|+||+||+|+.+   ..||+|....                           .+.+ ...+..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~-~~~~~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEE-EECSSSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeE-EEeccEEEEEEe
Confidence            47899999999999999999754   3588876431                           1111 123455789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcc
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGV  134 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~  134 (408)
                      |++||+|.+++...+..+++..+..++.||+.||+|||+++|+||||||+||||+.++. +||+|||+|+..........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~-~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS-EEECCCCCSCC---------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC-EEEccccceeeccccCCccc
Confidence            99999999999876778999999999999999999999999999999999999998875 99999999977654433333


Q ss_pred             cccCCCCCCCCChhhHhCC---CCCCCCCcchHHHHHHHHHhCCCCCCCCChh-hhhhhcccC----CCCCCCCCCcHHH
Q 042746          135 KIQPRGSPLWMAPEVVRGE---CQGPESDVWSLGCTIIEMVTGKPAWEDFGAN-TLSRIGFSD----ELPRFPTQSSELG  206 (408)
Q Consensus       135 ~~~~~Gt~~y~APE~l~~~---~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-~~~~~~~~~----~~p~~~~~~s~~~  206 (408)
                      .....||+.|||||++.+.   .|+.++|||||||++|||+||+.||.+.... .+.......    ..+..+...++.+
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l  242 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM  242 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHH
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHH
Confidence            4456799999999999753   4788999999999999999999999875433 222222122    2234556788999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHcC
Q 042746          207 RDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       207 ~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ++||.+||+.||++|||+.|++++
T Consensus       243 ~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         243 KRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=358.97  Aligned_cols=226  Identities=22%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|+++ +++.||+|...                        +.+.+.+..++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57999999999999999999985 77889987633                        223344556677899999999


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccccc
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKIQ  137 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~  137 (408)
                      +|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....... .....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~-~kl~DfG~a~~~~~~~~-~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEY-TSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC-EEECCCSSCCBCSSSSC-CCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc-EEECcchhheeccCCCc-eeecc
Confidence            99999998877778899999999999999999999999999999999999998875 99999999976543322 22334


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..||+.|+|||++.+..++.++|||||||++|||+| |+.||......++.........+..|...++.+++||.+||+.
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~  240 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE  240 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccC
Confidence            578999999999999999999999999999999998 8999998877776666556666677888999999999999999


Q ss_pred             CCCCCCCHHHHHcC
Q 042746          217 EPGERWSCDQLLKH  230 (408)
Q Consensus       217 dP~~R~s~~ell~h  230 (408)
                      ||++|||++|+++|
T Consensus       241 dP~~RPt~~eil~~  254 (258)
T d1k2pa_         241 KADERPTFKILLSN  254 (258)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CHhHCcCHHHHHHH
Confidence            99999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=363.17  Aligned_cols=229  Identities=21%  Similarity=0.261  Sum_probs=188.2

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc------------------------ceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV------------------------SYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~------------------------~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|+++ ++..||+|....                        .+.+.. .++..+|||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~-~~~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCeEEEEEeCC
Confidence            47899999999999999999986 577899886431                        122222 2345789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|.+++... +..+++..+..++.||+.||+|||+++|+||||||+||||+.++. +||+|||+|+....... ....
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~-~Kl~DFGla~~~~~~~~-~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS-CKIADFGLARLIEDNEY-TARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-EEECCCTTCEECSSSCE-ECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc-eeeccccceEEccCCcc-cccc
Confidence            99999977543 335899999999999999999999999999999999999998875 99999999987653322 1223


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...||+.|||||++.+..++.++|||||||++|||+|| .+||.......+.........+..|...++++++|+.+||+
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~  248 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK  248 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcC
Confidence            45689999999999988899999999999999999995 56666666555555545555667778899999999999999


Q ss_pred             cCCCCCCCHHHHHc--CCCCC
Q 042746          216 REPGERWSCDQLLK--HPFLQ  234 (408)
Q Consensus       216 ~dP~~R~s~~ell~--hpf~~  234 (408)
                      .||++|||++|+++  |+||.
T Consensus       249 ~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         249 ERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999988  77774

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=370.41  Aligned_cols=236  Identities=25%  Similarity=0.394  Sum_probs=189.9

Q ss_pred             CCCeEeeceeeecCCeeEEEEEE---cCCCcEEEEeecccc------------------------------eeccCCCCC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVD---RFNGDVFAYLGDDVS------------------------------YEAPTTSSS   47 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d---~~t~~~va~k~~~~~------------------------------~~~~~~~~~   47 (408)
                      |++|++++.||+|+||+||+|++   +.+|+.||+|.....                              +...++...
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            57899999999999999999997   457899999864311                              111233456


Q ss_pred             cceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccc
Q 042746           48 CRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEAT  127 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  127 (408)
                      ..+++|||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-EEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC-EEEeeccchhhhc
Confidence            678999999999999999855 45689999999999999999999999999999999999998875 9999999997654


Q ss_pred             cCCCCcccccCCCCCCCCChhhHhCC--CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhh---cccCCCCCCCCCC
Q 042746          128 VSDTRGVKIQPRGSPLWMAPEVVRGE--CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRI---GFSDELPRFPTQS  202 (408)
Q Consensus       128 ~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~---~~~~~~p~~~~~~  202 (408)
                      ..... ......|++.|+|||.+.+.  .++.++|||||||+||+|++|++||...........   ......+.+|...
T Consensus       181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            33221 23345799999999999765  467899999999999999999999976543332211   1123345667789


Q ss_pred             cHHHHHHHHHhcccCCCCCC-----CHHHHHcCCCCCCCCCC
Q 042746          203 SELGRDFLDKCLRREPGERW-----SCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       203 s~~~~~li~~~L~~dP~~R~-----s~~ell~hpf~~~~~~~  239 (408)
                      ++++++||.+||++||.+||     |++|+++||||+...+.
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~  301 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD  301 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence            99999999999999999999     58999999999886643

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=367.46  Aligned_cols=231  Identities=19%  Similarity=0.264  Sum_probs=189.5

Q ss_pred             CCeEeece-eeecCCeeEEEEEEcCC--CcEEEEeecc--------------------------cceeccCCCCCcceEE
Q 042746            2 VSWVRGKC-IGRGSFGTVNVAVDRFN--GDVFAYLGDD--------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~-IG~G~fG~Vy~a~d~~t--~~~va~k~~~--------------------------~~~~~~~~~~~~~~LV   52 (408)
                      ++|.+... ||+|+||+||+|.++.+  +..||+|...                          +.+.+..+ .+..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCeEEEE
Confidence            46788885 99999999999987654  4478887633                          11222222 3457899


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC-
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT-  131 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~-  131 (408)
                      |||++||+|.+++...+..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+....... 
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCE
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhcccccccc
Confidence            999999999999876667889999999999999999999999999999999999999887 599999999976654322 


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........||+.|||||++.+..++.++|||||||++|||+| |++||......++...+..+..+..|...++++.+||
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  245 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM  245 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            122234568999999999999899999999999999999998 9999998776666555556666778889999999999


Q ss_pred             HHhcccCCCCCCCHHHH---HcCCCCC
Q 042746          211 DKCLRREPGERWSCDQL---LKHPFLQ  234 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~el---l~hpf~~  234 (408)
                      .+||+.||++|||+.++   |+|+|+.
T Consensus       246 ~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         246 SDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999887   5677764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.8e-47  Score=369.32  Aligned_cols=230  Identities=25%  Similarity=0.310  Sum_probs=183.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccC--CCCCcceEEEecc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPT--TSSSCRNLHLEYL   56 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~--~~~~~~~LVmEy~   56 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|....                       .+...+  .....+++||||+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            579999999999999999999999999999986431                       111112  2345688999999


Q ss_pred             CCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           57 PGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        57 ~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      ++++|.++.    +.+++..++.+++||+.||+|||++||+||||||+|||++.++..+||+|||+|+.......   ..
T Consensus       115 ~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~  187 (328)
T d3bqca1         115 NNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YN  187 (328)
T ss_dssp             CSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CC
T ss_pred             CCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCc---cc
Confidence            999997654    46899999999999999999999999999999999999987766699999999976543322   33


Q ss_pred             cCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhh--hhhh----------------------cc
Q 042746          137 QPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANT--LSRI----------------------GF  191 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~--~~~~----------------------~~  191 (408)
                      ..+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......  ...+                      .+
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  267 (328)
T d3bqca1         188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  267 (328)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred             ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence            45689999999999875 57999999999999999999999996533111  0000                      00


Q ss_pred             c---C----------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 S---D----------ELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 ~---~----------~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                      .   .          .........+++++|||++||.+||.+|||++|+|+||||+.+.+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            0   0          000112347889999999999999999999999999999998765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.1e-47  Score=363.67  Aligned_cols=230  Identities=22%  Similarity=0.316  Sum_probs=176.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc----------------------------eeccC----CCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS----------------------------YEAPT----TSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~----------------------------~~~~~----~~~~~~   49 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|.....                            +...+    ......
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5799999999999999999999999999999864311                            00111    112347


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      ||||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||.+......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~-~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC-EEECCCTTCEECC--
T ss_pred             EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc-ceeehhhhhhhhccc
Confidence            8999999999999998754 56899999999999999999999999999999999999998875 999999998654332


Q ss_pred             C-CCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcccCC-CC--CCCCCCcHH
Q 042746          130 D-TRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGFSDE-LP--RFPTQSSEL  205 (408)
Q Consensus       130 ~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~~~~-~p--~~~~~~s~~  205 (408)
                      . ........+||+.|||||++.+..++.++|||||||++|+|+||++||...+............ .+  ......|+.
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  244 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  244 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence            2 2223345679999999999999999999999999999999999999998776555433322222 21  234568899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHcCCCC
Q 042746          206 GRDFLDKCLRREPGERWSCDQLLKHPFL  233 (408)
Q Consensus       206 ~~~li~~~L~~dP~~R~s~~ell~hpf~  233 (408)
                      +++||.+||++||++||+..+.+.|+|.
T Consensus       245 l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         245 LDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            9999999999999999944444445543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-47  Score=360.34  Aligned_cols=226  Identities=24%  Similarity=0.305  Sum_probs=180.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC---cEEEEeecc--------------------------cceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG---DVFAYLGDD--------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~---~~va~k~~~--------------------------~~~~~~~~~~~~~~LV   52 (408)
                      ++|++++.||+|+||+||+|++..++   ..+|+|...                          +.+.+.+ .++..+||
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCeEEEE
Confidence            58999999999999999999987654   457776543                          1122223 24568999


Q ss_pred             EeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC
Q 042746           53 LEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR  132 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~  132 (408)
                      |||+++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+||+++.++ .+||+|||+|+....... 
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~-  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY-  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccCCcc-
Confidence            999999999999887777889999999999999999999999999999999999999887 499999999976543322 


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.......+......+..+..+...|+.+++||.
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  243 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT  243 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            12234568999999999999999999999999999999998 89999987777666555566666788899999999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||+.||++|||+.|+++|
T Consensus       244 ~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         244 KCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=364.18  Aligned_cols=223  Identities=20%  Similarity=0.283  Sum_probs=183.0

Q ss_pred             ceeeecCCeeEEEEEEc--CCCcEEEEeeccc---------------------------ceeccCCCCCcceEEEeccCC
Q 042746            8 KCIGRGSFGTVNVAVDR--FNGDVFAYLGDDV---------------------------SYEAPTTSSSCRNLHLEYLPG   58 (408)
Q Consensus         8 ~~IG~G~fG~Vy~a~d~--~t~~~va~k~~~~---------------------------~~~~~~~~~~~~~LVmEy~~g   58 (408)
                      |.||+|+||+||+|.+.  .+++.||+|....                           .+.+..+ .+..+|||||++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence            67999999999999865  4557788875421                           1122222 3346899999999


Q ss_pred             CCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC-ccccc
Q 042746           59 GTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR-GVKIQ  137 (408)
Q Consensus        59 GsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~-~~~~~  137 (408)
                      |+|.++++. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+........ .....
T Consensus        92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccccc
Confidence            999999984 56789999999999999999999999999999999999999887 4999999999765433221 12234


Q ss_pred             CCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhccc
Q 042746          138 PRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLRR  216 (408)
Q Consensus       138 ~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~~  216 (408)
                      ..||+.|||||++.+..++.++|||||||++|||++ |++||.+....++......+..+..|...|+++++||.+||+.
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            568999999999999989999999999999999998 8999998777766666556667778889999999999999999


Q ss_pred             CCCCCCCHHHH---HcCCCC
Q 042746          217 EPGERWSCDQL---LKHPFL  233 (408)
Q Consensus       217 dP~~R~s~~el---l~hpf~  233 (408)
                      ||++|||++|+   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   456665

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-46  Score=356.76  Aligned_cols=234  Identities=24%  Similarity=0.362  Sum_probs=187.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCCCCCcceEEE
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTTSSSCRNLHL   53 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~~~~~~~LVm   53 (408)
                      |++|++.+.||+|+||+||+|++..+++.||+|.....                           +...+......++++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            78999999999999999999999999999999864311                           122234556678999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRG  133 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~  133 (408)
                      ||+.|++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||.|+.......  
T Consensus        81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~-~kl~DFG~a~~~~~~~~--  156 (292)
T d1unla_          81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC-EEECCCTTCEECCSCCS--
T ss_pred             eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc-eeeeecchhhcccCCCc--
Confidence            9999999988876 5667799999999999999999999999999999999999998875 99999999976554332  


Q ss_pred             ccccCCCCCCCCChhhHhCCC-CCCCCCcchHHHHHHHHHhCCCCCCC-CChhhhhhh----------------------
Q 042746          134 VKIQPRGSPLWMAPEVVRGEC-QGPESDVWSLGCTIIEMVTGKPAWED-FGANTLSRI----------------------  189 (408)
Q Consensus       134 ~~~~~~Gt~~y~APE~l~~~~-~~~~sDiWSLGvil~eLltG~~Pf~~-~~~~~~~~~----------------------  189 (408)
                      ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.. .+.......                      
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            223345789999999998764 68999999999999999999988633 222211110                      


Q ss_pred             ------cccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          190 ------GFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       190 ------~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                            .............++.+++||.+||++||.+|||++|+|+||||++..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                  0011122334567889999999999999999999999999999987554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=364.23  Aligned_cols=234  Identities=24%  Similarity=0.322  Sum_probs=179.0

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce---------------------------ecc--------CCC
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY---------------------------EAP--------TTS   45 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~---------------------------~~~--------~~~   45 (408)
                      +++|++++.||+|+||+||+|++..+++.||+|......                           ...        ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999999999999998643110                           000        112


Q ss_pred             CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           46 SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      +...+++|||+.++.+.... .....+++..++.+++||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~-~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC-EEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc-EEeeecceeee
Confidence            34578999999887655443 35667899999999999999999999999999999999999999885 99999999965


Q ss_pred             cccCC--CCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc---ccCCCCC--
Q 042746          126 ATVSD--TRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG---FSDELPR--  197 (408)
Q Consensus       126 ~~~~~--~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~---~~~~~p~--  197 (408)
                      .....  ........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||............   .....+.  
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            44322  11223345799999999999865 6899999999999999999999999865433322110   0000000  


Q ss_pred             -----------------CC---------CCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCC
Q 042746          198 -----------------FP---------TQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSV  236 (408)
Q Consensus       198 -----------------~~---------~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~  236 (408)
                                       .+         ...+++++|||.+||++||++|||++|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence                             00         0136778899999999999999999999999999854

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=363.35  Aligned_cols=228  Identities=24%  Similarity=0.348  Sum_probs=177.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~~   48 (408)
                      ++|++++.||+|+||+||+|+++.+++.||+|.....                           +...+      .....
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5799999999999999999999999999999875311                           11111      12235


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      ++|||||+ |.+|..++++  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus        98 ~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~-~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQADS  173 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCS
T ss_pred             EEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc-cccccccceeccCC
Confidence            68999999 5688887763  56899999999999999999999999999999999999999885 99999999976543


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-----------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-----------------  190 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-----------------  190 (408)
                      .     .....||+.|+|||++.+. .++.++|||||||++|+|++|++||...+........                 
T Consensus       174 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         174 E-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             S-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             c-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence            2     2345699999999999764 5689999999999999999999999765432221100                 


Q ss_pred             -------------ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          191 -------------FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       191 -------------~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                                   ....++......++++++||.+||..||.+|||++|+|+||||+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                         011112233567899999999999999999999999999999997654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=364.87  Aligned_cols=227  Identities=24%  Similarity=0.281  Sum_probs=186.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE----EEEeeccc--------------------------ceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV----FAYLGDDV--------------------------SYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~----va~k~~~~--------------------------~~~~~~~~~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|++..+++.    ||+|....                          .+.+... +...++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCeeE
Confidence            4799999999999999999999988874    66654321                          1111111 234678


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +|||+.+|+|.+.+......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTTTTCC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecccccc
Confidence            9999999999999988888899999999999999999999999999999999999999887 499999999987654443


Q ss_pred             CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHH
Q 042746          132 RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFL  210 (408)
Q Consensus       132 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li  210 (408)
                      ........||+.|||||++.+..|+.++|||||||++|||+| |++||.......+......+..+..|...++.+.+|+
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li  246 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM  246 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHH
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            333444568999999999999999999999999999999998 8999998777776666556666677888999999999


Q ss_pred             HHhcccCCCCCCCHHHHHcC
Q 042746          211 DKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       211 ~~~L~~dP~~R~s~~ell~h  230 (408)
                      .+||+.||.+|||+.|+++|
T Consensus       247 ~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         247 VKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCChhhCcCHHHHHHH
Confidence            99999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=359.46  Aligned_cols=227  Identities=24%  Similarity=0.328  Sum_probs=189.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCc-------EEEEeecc---------------------------cceeccCCCCC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGD-------VFAYLGDD---------------------------VSYEAPTTSSS   47 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~-------~va~k~~~---------------------------~~~~~~~~~~~   47 (408)
                      ++|++++.||+|+||+||+|++..+++       .||+|...                           +.+.+.+.++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            689999999999999999999876653       67887643                           22333455677


Q ss_pred             cceEEEeccCCCCHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           48 CRNLHLEYLPGGTVSDLATTLN---------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        48 ~~~LVmEy~~gGsL~~~l~~~~---------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      ..++||||+++|+|.+++....               ..+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            7899999999999999997542               3479999999999999999999999999999999999999987


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGF  191 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~  191 (408)
                      . +||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++ |.+||.......+.....
T Consensus       173 ~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~  251 (299)
T d1fgka_         173 V-MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  251 (299)
T ss_dssp             C-EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             C-eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence            5 99999999987765544444455679999999999999999999999999999999998 799999888777776666


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          192 SDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       192 ~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .+..+..|...++.+++||.+||++||++|||+.|+++
T Consensus       252 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            66777888899999999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=353.87  Aligned_cols=227  Identities=20%  Similarity=0.260  Sum_probs=180.7

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCC----cEEEEeecc--------------------------cceeccCCCCCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNG----DVFAYLGDD--------------------------VSYEAPTTSSSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~----~~va~k~~~--------------------------~~~~~~~~~~~~~~L   51 (408)
                      ..|++.|+||+|+||+||+|.++.++    ..||+|...                          +.+.+........++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46999999999999999999988765    368887642                          223333445667889


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      ||||+.+|+|.+++......+++..+..++.||+.||+|||+++|+||||||+||||+.++. +||+|||+|+.......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~-~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC---------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe-EEEcccchhhcccCCCc
Confidence            99999999999999877788999999999999999999999999999999999999998875 99999999977543322


Q ss_pred             -CcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHH
Q 042746          132 -RGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDF  209 (408)
Q Consensus       132 -~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~l  209 (408)
                       ........||+.|||||++.+..++.++|||||||++|||+++ .+||.......+......+..+..+...++.+++|
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  245 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL  245 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHH
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHH
Confidence             1223345689999999999999999999999999999999995 55566555555555555555667778899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHc
Q 042746          210 LDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       210 i~~~L~~dP~~R~s~~ell~  229 (408)
                      |.+||+.||++|||+.|+++
T Consensus       246 i~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         246 MMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=354.48  Aligned_cols=233  Identities=25%  Similarity=0.293  Sum_probs=185.3

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecc------------------------cceeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDD------------------------VSYEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~------------------------~~~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|+++.+ +.||+|...                        +.+.+.+ .++..+|||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE-ecCCeEEEEEecC
Confidence            6899999999999999999999765 568988643                        1222223 2345789999999


Q ss_pred             CCCHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCcccc
Q 042746           58 GGTVSDLATTL-NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVKI  136 (408)
Q Consensus        58 gGsL~~~l~~~-~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~  136 (408)
                      +|+|..++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||+|+....... ....
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~-~kl~DfGla~~~~~~~~-~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEY-TARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-EEECCCCTTC------------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc-EEEcccchhhhccCCCc-eeec
Confidence            99999888643 456899999999999999999999999999999999999998874 99999999976543322 1223


Q ss_pred             cCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhcc
Q 042746          137 QPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCLR  215 (408)
Q Consensus       137 ~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L~  215 (408)
                      ...||+.|+|||++....++.++|||||||++|||++| .+||......++......+..+..+...++.+++||.+||+
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~  252 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR  252 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcc
Confidence            35689999999999999999999999999999999995 55566555555555444455556778899999999999999


Q ss_pred             cCCCCCCCHHHHHc--CCCCCCCCC
Q 042746          216 REPGERWSCDQLLK--HPFLQSVSP  238 (408)
Q Consensus       216 ~dP~~R~s~~ell~--hpf~~~~~~  238 (408)
                      .||++|||++++++  |+||....+
T Consensus       253 ~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         253 KEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             SSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             cCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            99999999999988  889976543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=362.04  Aligned_cols=235  Identities=24%  Similarity=0.349  Sum_probs=179.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc--------------------------eeccCCC----CCcceE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS--------------------------YEAPTTS----SSCRNL   51 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~--------------------------~~~~~~~----~~~~~L   51 (408)
                      .+|++++.||+|+||+||+|+++.+++.||+|.....                          +......    ....++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            4799999999999999999999999999999874311                          0001111    112345


Q ss_pred             EEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCC
Q 042746           52 HLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDT  131 (408)
Q Consensus        52 VmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~  131 (408)
                      +++|+.||+|.++++.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|........
T Consensus        88 l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~-~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-EEECCCTTCEECCGGGC
T ss_pred             EEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC-EEEcccCceeeccCCCc
Confidence            6677789999999974  46899999999999999999999999999999999999998875 99999999976543322


Q ss_pred             -CcccccCCCCCCCCChhhHhC-CCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc-------------------
Q 042746          132 -RGVKIQPRGSPLWMAPEVVRG-ECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG-------------------  190 (408)
Q Consensus       132 -~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~-------------------  190 (408)
                       .......+||+.|+|||++.. ..++.++||||+||++|+|++|++||............                   
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence             122345679999999999854 56788999999999999999999999765432111100                   


Q ss_pred             -------cc--CCC--CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCCC
Q 042746          191 -------FS--DEL--PRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSPS  239 (408)
Q Consensus       191 -------~~--~~~--p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~~  239 (408)
                             ..  ...  .......++++++||.+||++||.+|||++|+|+||||+.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                   00  000  01123567889999999999999999999999999999865443

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-45  Score=355.25  Aligned_cols=227  Identities=20%  Similarity=0.235  Sum_probs=189.8

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeeccc--------------------------ceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDDV--------------------------SYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~~--------------------------~~~~~~~~~~~~~   50 (408)
                      ++|++++.||+|+||+||+|+++     .+++.||+|....                          .+.+........+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999975     4567899986531                          1222344566788


Q ss_pred             EEEeccCCCCHHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEE
Q 042746           51 LHLEYLPGGTVSDLATTLN-----------------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVL  107 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~-----------------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NIL  107 (408)
                      ++|||+++|+|.+++....                       ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999997432                       24788899999999999999999999999999999999


Q ss_pred             EcCCCCcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCC-CCCCCCChhhh
Q 042746          108 VGPNSSFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGK-PAWEDFGANTL  186 (408)
Q Consensus       108 l~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~-~Pf~~~~~~~~  186 (408)
                      ++.++. +||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||......++
T Consensus       173 ld~~~~-~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~  251 (301)
T d1lufa_         173 VGENMV-VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV  251 (301)
T ss_dssp             ECGGGC-EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             ECCCCc-EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence            998875 9999999997654443333344567899999999999999999999999999999999984 78888777776


Q ss_pred             hhhcccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          187 SRIGFSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       187 ~~~~~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ......+..+..|...++++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666667777888889999999999999999999999999965

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=357.91  Aligned_cols=229  Identities=22%  Similarity=0.321  Sum_probs=179.0

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccCC-----CCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPTT-----SSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~~-----~~~~~   49 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|.....                           +...+.     ++...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            5899999999999999999999999999999874311                           000111     22334


Q ss_pred             eEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccC
Q 042746           50 NLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVS  129 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~  129 (408)
                      +++|+|+.||+|.+++.  .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++|||++......
T Consensus        98 ~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~-~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHTDDE  174 (348)
T ss_dssp             CEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-EEECCC----CCTGG
T ss_pred             EEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc-ccccccchhcccCcc
Confidence            67788889999999995  357899999999999999999999999999999999999998885 999999998654322


Q ss_pred             CCCcccccCCCCCCCCChhhHhCC-CCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhcc-----------------
Q 042746          130 DTRGVKIQPRGSPLWMAPEVVRGE-CQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIGF-----------------  191 (408)
Q Consensus       130 ~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~~-----------------  191 (408)
                           .....||+.|+|||++.+. .++.++|||||||++|+|++|++||...+.......+.                 
T Consensus       175 -----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         175 -----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             -----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             -----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence                 3345689999999998775 46889999999999999999999997654322211100                 


Q ss_pred             -----cCCCCCC--------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCCC
Q 042746          192 -----SDELPRF--------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVSP  238 (408)
Q Consensus       192 -----~~~~p~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~~  238 (408)
                           ....+..        ....++++++||.+||.+||.+|||++|+|+||||++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                 0011111        1357889999999999999999999999999999987653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=344.34  Aligned_cols=222  Identities=23%  Similarity=0.308  Sum_probs=182.6

Q ss_pred             CCCeEeeceeeecCCeeEEEEEEcCCCcEEEEeeccc-----------------------ceeccC-CCCCcceEEEecc
Q 042746            1 MVSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDV-----------------------SYEAPT-TSSSCRNLHLEYL   56 (408)
Q Consensus         1 ~~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~-----------------------~~~~~~-~~~~~~~LVmEy~   56 (408)
                      +++|++++.||+|+||.||+|+++  +..||+|....                       .+.+.. ..+..++|||||+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            468999999999999999999984  77899886541                       222222 3345689999999


Q ss_pred             CCCCHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCCccc
Q 042746           57 PGGTVSDLATTLN-AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTRGVK  135 (408)
Q Consensus        57 ~gGsL~~~l~~~~-~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~  135 (408)
                      ++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++......     
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~-~kl~dfg~s~~~~~~~-----  157 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ-----  157 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-EEECCCCC-------------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC-EeecccccceecCCCC-----
Confidence            9999999997543 35799999999999999999999999999999999999999885 9999999997654322     


Q ss_pred             ccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhcccCCCCCCCCCCcHHHHHHHHHhc
Q 042746          136 IQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIGFSDELPRFPTQSSELGRDFLDKCL  214 (408)
Q Consensus       136 ~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~~~L  214 (408)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |++||......++...+..+..|.++...++.+++||.+||
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl  237 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW  237 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence            23458999999999998899999999999999999998 79999887777766666666777888899999999999999


Q ss_pred             ccCCCCCCCHHHHHcC
Q 042746          215 RREPGERWSCDQLLKH  230 (408)
Q Consensus       215 ~~dP~~R~s~~ell~h  230 (408)
                      ..||.+|||+.|++++
T Consensus       238 ~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         238 HLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             ccCHhHCcCHHHHHHH
Confidence            9999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-45  Score=359.24  Aligned_cols=228  Identities=25%  Similarity=0.292  Sum_probs=170.5

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc---------------------------eeccC------CCCCc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS---------------------------YEAPT------TSSSC   48 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~---------------------------~~~~~------~~~~~   48 (408)
                      .+|++++.||+|+||+||+|+++.||+.||+|.....                           +...+      +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999999999999874311                           11111      23467


Q ss_pred             ceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcccccc
Q 042746           49 RNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATV  128 (408)
Q Consensus        49 ~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  128 (408)
                      +|+|||||.|+.+ +.+   ...+++..++.+++||+.||+|||++||+||||||+|||++.++. +|++|||+++....
T Consensus        97 ~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~-~kl~df~~~~~~~~  171 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC-EEECCCCC------
T ss_pred             eEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc-eeeechhhhhcccc
Confidence            8999999987544 443   356899999999999999999999999999999999999998875 99999999876544


Q ss_pred             CCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhhhc------------------
Q 042746          129 SDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSRIG------------------  190 (408)
Q Consensus       129 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~~~------------------  190 (408)
                      ...   ....+||+.|+|||++.+..++.++||||+||++|+|++|++||...+........                  
T Consensus       172 ~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         172 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             ccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            322   23456899999999999999999999999999999999999999755432211100                  


Q ss_pred             ----ccCCCCC-------------C------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHcCCCCCCCC
Q 042746          191 ----FSDELPR-------------F------PTQSSELGRDFLDKCLRREPGERWSCDQLLKHPFLQSVS  237 (408)
Q Consensus       191 ----~~~~~p~-------------~------~~~~s~~~~~li~~~L~~dP~~R~s~~ell~hpf~~~~~  237 (408)
                          .....+.             .      +...++++++||.+||.+||++|||++|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                0000000             0      012467789999999999999999999999999998643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-45  Score=352.86  Aligned_cols=225  Identities=25%  Similarity=0.304  Sum_probs=187.4

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcE--EEEeecc---------------------------cceeccCCCCCcceEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDV--FAYLGDD---------------------------VSYEAPTTSSSCRNLH   52 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~--va~k~~~---------------------------~~~~~~~~~~~~~~LV   52 (408)
                      ++|++++.||+|+||+||+|+++.++..  ||+|...                           +.+.+....+..++||
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            5899999999999999999999999875  4555422                           1111223345567899


Q ss_pred             EeccCCCCHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEE
Q 042746           53 LEYLPGGTVSDLATTL---------------NAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKL  117 (408)
Q Consensus        53 mEy~~gGsL~~~l~~~---------------~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL  117 (408)
                      |||++||+|.++++..               ...+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-~kl  168 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKI  168 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-EEE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-eEE
Confidence            9999999999999743               357899999999999999999999999999999999999998875 999


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCC
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELP  196 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p  196 (408)
                      +|||+|+.......   .....||+.|+|||.+.+..++.++|||||||++|||++| .+||...+...+......+..+
T Consensus       169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~  245 (309)
T d1fvra_         169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  245 (309)
T ss_dssp             CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred             cccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            99999976543332   2344689999999999999999999999999999999996 5688887777776665566667


Q ss_pred             CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          197 RFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       197 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                      ..+...++++++||.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7788899999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=348.12  Aligned_cols=227  Identities=20%  Similarity=0.296  Sum_probs=191.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-----CCcEEEEeecc--------------------------cceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-----NGDVFAYLGDD--------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-----t~~~va~k~~~--------------------------~~~~~~~~~~~~~~   50 (408)
                      ++|++++.||+|+||+||+|.++.     ++..||+|...                          +.+.+....+...+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            578999999999999999999863     35678988643                          12222344566789


Q ss_pred             EEEeccCCCCHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecC
Q 042746           51 LHLEYLPGGTVSDLATTLN---------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFG  121 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~---------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFG  121 (408)
                      +||||+++|+|.+++....         ..+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~-~Kl~DFG  178 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFG  178 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-EEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce-EEEeecc
Confidence            9999999999999986431         24588899999999999999999999999999999999998874 9999999


Q ss_pred             CccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhC-CCCCCCCChhhhhhhcccCCCCCCCC
Q 042746          122 AAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTG-KPAWEDFGANTLSRIGFSDELPRFPT  200 (408)
Q Consensus       122 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~p~~~~  200 (408)
                      +|+...............||+.|+|||.+.+..++.++||||||+++|||+|| .+||...+..........+..+..|.
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~  258 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD  258 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            99876544433334445689999999999999999999999999999999998 58898877777666656667777888


Q ss_pred             CCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          201 QSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       201 ~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..++.+.++|.+||+.||++|||+.|+++
T Consensus       259 ~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         259 NCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-44  Score=345.23  Aligned_cols=232  Identities=22%  Similarity=0.271  Sum_probs=181.1

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|.....                        +......+...++||||+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            4799999999999999999999999999999853321                        1111234456789999995


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC--CCcEEEeecCCccccccCCCC---
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN--SSFVKLADFGAAGEATVSDTR---  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~--~~~vkL~DFGla~~~~~~~~~---  132 (408)
                       |+|.+.+......+++..+..++.|++.||+|||++||+||||||+|||++..  +..+||+|||+|+........   
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~  165 (299)
T d1ckia_          87 -PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  165 (299)
T ss_dssp             -CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred             -CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence             57777777677889999999999999999999999999999999999998642  335999999999765433221   


Q ss_pred             --cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhhhh-------hcccCCCCCCCCCCc
Q 042746          133 --GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTLSR-------IGFSDELPRFPTQSS  203 (408)
Q Consensus       133 --~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~~~-------~~~~~~~p~~~~~~s  203 (408)
                        .......||+.|||||++.+..++.++|||||||++|||++|++||..........       .......+.....+|
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p  245 (299)
T d1ckia_         166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP  245 (299)
T ss_dssp             CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSC
T ss_pred             eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCC
Confidence              12234579999999999999999999999999999999999999997654332211       111122223345788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHH---HHcCCCCC
Q 042746          204 ELGRDFLDKCLRREPGERWSCDQ---LLKHPFLQ  234 (408)
Q Consensus       204 ~~~~~li~~~L~~dP~~R~s~~e---ll~hpf~~  234 (408)
                      +++.+||.+||+.||++||++++   +|+|+|.+
T Consensus       246 ~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999875   46677654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-44  Score=347.36  Aligned_cols=227  Identities=23%  Similarity=0.293  Sum_probs=186.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEc-----CCCcEEEEeecc---------------------------cceeccCCCCCcc
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDR-----FNGDVFAYLGDD---------------------------VSYEAPTTSSSCR   49 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~-----~t~~~va~k~~~---------------------------~~~~~~~~~~~~~   49 (408)
                      ++|++++.||+|+||+||+|++.     .+++.||+|...                           +.+.+....+...
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            57899999999999999999863     566789987643                           1223334556678


Q ss_pred             eEEEeccCCCCHHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCC
Q 042746           50 NLHLEYLPGGTVSDLATTLN-----------------AYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNS  112 (408)
Q Consensus        50 ~LVmEy~~gGsL~~~l~~~~-----------------~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~  112 (408)
                      +||||||+||+|.+++....                 ..+++..+..++.||+.||+|||+++++||||||+|||++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999999997532                 2578999999999999999999999999999999999999887


Q ss_pred             CcEEEeecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChh-hhhhhc
Q 042746          113 SFVKLADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGAN-TLSRIG  190 (408)
Q Consensus       113 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~-~~~~~~  190 (408)
                       .+|++|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||...... .+..+.
T Consensus       183 -~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i  261 (311)
T d1t46a_         183 -ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI  261 (311)
T ss_dssp             -EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred             -cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence             499999999987654433333444679999999999999999999999999999999998 67777665443 333443


Q ss_pred             ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          191 FSDELPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       191 ~~~~~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      ..+..+..+...++.+.+||.+||+.||.+|||++||++
T Consensus       262 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            445556667788999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-44  Score=340.22  Aligned_cols=226  Identities=21%  Similarity=0.275  Sum_probs=177.6

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcC-CCc--EEEEeecc----------------------------cceeccCCCCCcce
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRF-NGD--VFAYLGDD----------------------------VSYEAPTTSSSCRN   50 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~-t~~--~va~k~~~----------------------------~~~~~~~~~~~~~~   50 (408)
                      .+|++.+.||+|+||+||+|+... +++  .||+|...                            +.+.+.+. +...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-~~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-ecchh
Confidence            479999999999999999998653 333  56776532                            11222232 34578


Q ss_pred             EEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCC
Q 042746           51 LHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSD  130 (408)
Q Consensus        51 LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  130 (408)
                      +||||+++|+|.+.+....+.+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+++......
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-C
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhcccCC
Confidence            99999999999999887777899999999999999999999999999999999999999887 59999999998765443


Q ss_pred             CCc-ccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHh-CCCCCCCCChhhhhhhc-ccCCCCCCCCCCcHHHH
Q 042746          131 TRG-VKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVT-GKPAWEDFGANTLSRIG-FSDELPRFPTQSSELGR  207 (408)
Q Consensus       131 ~~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLlt-G~~Pf~~~~~~~~~~~~-~~~~~p~~~~~~s~~~~  207 (408)
                      ... ......|++.|+|||++.+..++.++|||||||++|||+| |++||...+........ .....+..+...++.++
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~  245 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY  245 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence            222 2223457889999999999999999999999999999998 89999887766554433 33444566778899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHc
Q 042746          208 DFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       208 ~li~~~L~~dP~~R~s~~ell~  229 (408)
                      +||.+||+.||++|||+.||+.
T Consensus       246 ~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         246 NVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.1e-43  Score=337.97  Aligned_cols=227  Identities=20%  Similarity=0.231  Sum_probs=179.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCCCCCcceEEEeccC
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTTSSSCRNLHLEYLP   57 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~~~~~~~LVmEy~~   57 (408)
                      .+|++++.||+|+||+||+|++..+++.||+|.....                        +......+...++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            3799999999999999999999999999999863211                        111123455678999999 


Q ss_pred             CCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCC----CCcEEEeecCCccccccCCCC-
Q 042746           58 GGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPN----SSFVKLADFGAAGEATVSDTR-  132 (408)
Q Consensus        58 gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~----~~~vkL~DFGla~~~~~~~~~-  132 (408)
                      ||+|.+++...+..+++..+..++.|++.||+|||++||+||||||+|||++.+    ...+||+|||+|+........ 
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (293)
T d1csna_          84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ  163 (293)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred             CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence            679999998877889999999999999999999999999999999999999742    235999999999765432211 


Q ss_pred             ----cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhhh----hhh---cccCCCCCCCCC
Q 042746          133 ----GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANTL----SRI---GFSDELPRFPTQ  201 (408)
Q Consensus       133 ----~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~~----~~~---~~~~~~p~~~~~  201 (408)
                          ......+||+.|||||++.+..++.++|||||||++|+|++|+.||........    .++   ......+.++..
T Consensus       164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~  243 (293)
T d1csna_         164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG  243 (293)
T ss_dssp             BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred             ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCC
Confidence                123345799999999999999999999999999999999999999975433211    111   111122233456


Q ss_pred             CcHHHHHHHHHhcccCCCCCCCHHHHHc
Q 042746          202 SSELGRDFLDKCLRREPGERWSCDQLLK  229 (408)
Q Consensus       202 ~s~~~~~li~~~L~~dP~~R~s~~ell~  229 (408)
                      .++++.+++..|+..+|++||+++.+.+
T Consensus       244 ~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         244 FPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            7889999999999999999998876644

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=337.03  Aligned_cols=225  Identities=21%  Similarity=0.245  Sum_probs=178.6

Q ss_pred             EeeceeeecCCeeEEEEEEcCCCc---EEEEeeccc--------------------------ceecc-CCCCCcceEEEe
Q 042746            5 VRGKCIGRGSFGTVNVAVDRFNGD---VFAYLGDDV--------------------------SYEAP-TTSSSCRNLHLE   54 (408)
Q Consensus         5 ~~~~~IG~G~fG~Vy~a~d~~t~~---~va~k~~~~--------------------------~~~~~-~~~~~~~~LVmE   54 (408)
                      .+.++||+|+||+||+|++..++.   .||+|....                          .+.+. ...+...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            346799999999999999876543   578876431                          11111 123456789999


Q ss_pred             ccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCccccccCCCC--
Q 042746           55 YLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAGEATVSDTR--  132 (408)
Q Consensus        55 y~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~--  132 (408)
                      ||++|+|.+++.......++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++........  
T Consensus       110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~-~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC-EEECSSGGGCCTTTTTCCCT
T ss_pred             EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC-EEEecccchhhccccccccc
Confidence            99999999999877777889999999999999999999999999999999999998874 999999999876543321  


Q ss_pred             cccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCC-CChhhhhhhcccCCCCCCCCCCcHHHHHHHH
Q 042746          133 GVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWED-FGANTLSRIGFSDELPRFPTQSSELGRDFLD  211 (408)
Q Consensus       133 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~-~~~~~~~~~~~~~~~p~~~~~~s~~~~~li~  211 (408)
                      .......||+.|+|||.+....++.++||||||+++|||++|..||.. .....+......+..+..|...++.+.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence            122335689999999999998999999999999999999997766653 3333444444455666778889999999999


Q ss_pred             HhcccCCCCCCCHHHHHcC
Q 042746          212 KCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       212 ~~L~~dP~~R~s~~ell~h  230 (408)
                      +||+.||++|||+.|+++|
T Consensus       269 ~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.9e-41  Score=328.94  Aligned_cols=231  Identities=23%  Similarity=0.307  Sum_probs=171.4

Q ss_pred             CeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccce-----------------------------------ecc--CCC
Q 042746            3 SWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSY-----------------------------------EAP--TTS   45 (408)
Q Consensus         3 ~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~-----------------------------------~~~--~~~   45 (408)
                      +|++++.||+|+||+||+|+++.+++.||+|......                                   ...  ...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            5999999999999999999999999999998643110                                   000  011


Q ss_pred             CCcceEEEeccCCCCHHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCCCCEEEcCCCC-----cEEE
Q 042746           46 SSCRNLHLEYLPGGTVSDLA--TTLNAYADEITLRSHTYCIVSALKYLHS-RNIVHCDVKGKNVLVGPNSS-----FVKL  117 (408)
Q Consensus        46 ~~~~~LVmEy~~gGsL~~~l--~~~~~~l~e~~i~~i~~qIl~~L~yLH~-~giiHrDLKp~NILl~~~~~-----~vkL  117 (408)
                      ....+++|+++..+......  ......+++..++.++.||+.||+|||+ +||+||||||+|||++.++.     .+++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence            22345667776655443333  2245678999999999999999999998 89999999999999976542     3899


Q ss_pred             eecCCccccccCCCCcccccCCCCCCCCChhhHhCCCCCCCCCcchHHHHHHHHHhCCCCCCCCChhh-------hhhh-
Q 042746          118 ADFGAAGEATVSDTRGVKIQPRGSPLWMAPEVVRGECQGPESDVWSLGCTIIEMVTGKPAWEDFGANT-------LSRI-  189 (408)
Q Consensus       118 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDiWSLGvil~eLltG~~Pf~~~~~~~-------~~~~-  189 (408)
                      +|||.|......     ....+||+.|+|||++.+..++.++|+||+||++++|++|+.||.......       +... 
T Consensus       174 ~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~  248 (362)
T d1q8ya_         174 ADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  248 (362)
T ss_dssp             CCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             eecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence            999999655432     234569999999999999999999999999999999999999996432110       0000 


Q ss_pred             ------------------------cccCC---------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          190 ------------------------GFSDE---------------LPRFPTQSSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       190 ------------------------~~~~~---------------~p~~~~~~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                                              .....               ....+...++++++||.+||.+||.+|||++|+|+|
T Consensus       249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                                    00000               001122346788999999999999999999999999


Q ss_pred             CCCCCCCC
Q 042746          231 PFLQSVSP  238 (408)
Q Consensus       231 pf~~~~~~  238 (408)
                      |||++...
T Consensus       329 p~f~~~~~  336 (362)
T d1q8ya_         329 PWLKDTLG  336 (362)
T ss_dssp             GGGTTCTT
T ss_pred             cccCCCCC
Confidence            99986543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-41  Score=325.75  Aligned_cols=224  Identities=20%  Similarity=0.230  Sum_probs=167.9

Q ss_pred             CCeEeeceeeecCCeeEEEEEEcCCCcEEEEeecccc------------------------eeccCC----CCCcceEEE
Q 042746            2 VSWVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVS------------------------YEAPTT----SSSCRNLHL   53 (408)
Q Consensus         2 ~~Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~------------------------~~~~~~----~~~~~~LVm   53 (408)
                      .+|++.+.||+|+||+||+|+.  +|+.||+|.....                        +.+...    ....++|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4799999999999999999986  6889999864311                        111111    112468999


Q ss_pred             eccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeecCCCCCCEEEcCCCCcEEEeecCCccc
Q 042746           54 EYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHS--------RNIVHCDVKGKNVLVGPNSSFVKLADFGAAGE  125 (408)
Q Consensus        54 Ey~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~--------~giiHrDLKp~NILl~~~~~~vkL~DFGla~~  125 (408)
                      ||+++|+|.++++.  ..+++.....++.|++.||+|||+        +||+||||||+||||+.++. +||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~-~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC-EEECCCTTCEE
T ss_pred             ecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC-eEEEecCcccc
Confidence            99999999999975  357899999999999999999996        59999999999999998875 99999999976


Q ss_pred             cccCCCC--cccccCCCCCCCCChhhHhCCC------CCCCCCcchHHHHHHHHHhCCCCCCCCChh-------------
Q 042746          126 ATVSDTR--GVKIQPRGSPLWMAPEVVRGEC------QGPESDVWSLGCTIIEMVTGKPAWEDFGAN-------------  184 (408)
Q Consensus       126 ~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~------~~~~sDiWSLGvil~eLltG~~Pf~~~~~~-------------  184 (408)
                      .......  .......||+.|||||++.+..      ++.++|||||||++|||+||.+||......             
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            6443321  1223457999999999998653      466899999999999999999887432211             


Q ss_pred             --hhhhhccc-CCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHHHHcC
Q 042746          185 --TLSRIGFS-DELPRFPTQ-----SSELGRDFLDKCLRREPGERWSCDQLLKH  230 (408)
Q Consensus       185 --~~~~~~~~-~~~p~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~ell~h  230 (408)
                        .+...... ...|.++..     ....+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              11111111 112333322     22457899999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=5.1e-22  Score=177.63  Aligned_cols=141  Identities=17%  Similarity=0.069  Sum_probs=98.5

Q ss_pred             eEeeceeeecCCeeEEEEEEcCCCcEEEEeeccccee-------------------------------ccCCC-------
Q 042746            4 WVRGKCIGRGSFGTVNVAVDRFNGDVFAYLGDDVSYE-------------------------------APTTS-------   45 (408)
Q Consensus         4 Y~~~~~IG~G~fG~Vy~a~d~~t~~~va~k~~~~~~~-------------------------------~~~~~-------   45 (408)
                      |.+++.||+|+||+||+|++. +|+.||+|.......                               .....       
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            578999999999999999986 688999985321000                               00000       


Q ss_pred             -CCcceEEEeccCCCCHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           46 -SSCRNLHLEYLPGGTVSDLATTLNAYADEITLRSHTYCIVSALKYLHSRNIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        46 -~~~~~LVmEy~~gGsL~~~l~~~~~~l~e~~i~~i~~qIl~~L~yLH~~giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                       ....+|+|||+++..+.+        +++..+..++.||+.+|+|||++||+||||||+|||++.+  .++|+|||+|.
T Consensus        81 ~~~~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG~a~  150 (191)
T d1zara2          81 AWEGNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSV  150 (191)
T ss_dssp             EEETTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTCE
T ss_pred             EecCCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECCCcc
Confidence             011358999999865432        3445567899999999999999999999999999999865  38999999985


Q ss_pred             ccccCCCCcccccCCCCCCCCCh------hhHhCCCCCCCCCcchHHH
Q 042746          125 EATVSDTRGVKIQPRGSPLWMAP------EVVRGECQGPESDVWSLGC  166 (408)
Q Consensus       125 ~~~~~~~~~~~~~~~Gt~~y~AP------E~l~~~~~~~~sDiWSLGv  166 (408)
                      ........          .|...      +.+ ...|+.++|+||+.-
T Consensus       151 ~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~  187 (191)
T d1zara2         151 EVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAID  187 (191)
T ss_dssp             ETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred             cCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence            54322110          01111      111 245788999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.34  E-value=0.00013  Score=65.29  Aligned_cols=28  Identities=25%  Similarity=0.480  Sum_probs=23.6

Q ss_pred             CeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           96 IVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        96 iiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ++|+|+.|.|||+++++ .+.|+||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCc-eEEEeechhcc
Confidence            78999999999998654 35699999873

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.18  E-value=0.0047  Score=58.88  Aligned_cols=27  Identities=19%  Similarity=0.336  Sum_probs=23.9

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      .++|+|++|.|||+++++  ++|+||-.|
T Consensus       224 ~LiHGDl~~gNIlv~~~~--~~vID~E~a  250 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE--TKVIDPEFA  250 (392)
T ss_dssp             EEECSCCCGGGEEECSSC--EEECCCTTC
T ss_pred             ceeccCCcCCceeEcCCc--eEEechhhc
Confidence            589999999999998763  899999887

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=94.74  E-value=0.035  Score=48.34  Aligned_cols=28  Identities=29%  Similarity=0.443  Sum_probs=23.8

Q ss_pred             CeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           96 IVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        96 iiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ++|+|+.|.|||++.+. .+-|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~-~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGR-FSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCc-eEEEEEchhcc
Confidence            79999999999998764 46799999873

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.70  E-value=0.033  Score=50.52  Aligned_cols=28  Identities=29%  Similarity=0.387  Sum_probs=24.7

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAA  123 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla  123 (408)
                      |+||+|+.++||+++.+. ..-+.||+.+
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~  211 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFA  211 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTC
T ss_pred             ccccCCcchhhhhccccc-ceeEeccccc
Confidence            699999999999998764 4689999987

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=85.35  E-value=0.25  Score=44.89  Aligned_cols=27  Identities=22%  Similarity=0.235  Sum_probs=22.4

Q ss_pred             CCeecCCCCCCEEEcCCCCcEEEeecCCcc
Q 042746           95 NIVHCDVKGKNVLVGPNSSFVKLADFGAAG  124 (408)
Q Consensus        95 giiHrDLKp~NILl~~~~~~vkL~DFGla~  124 (408)
                      ++||+|+++.|||++.+   ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~---~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG---PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS---EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC---ceEEechhcc
Confidence            58999999999999643   4589999874